Citrus Sinensis ID: 010489
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 509 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LV37 | 510 | Mitogen-activated protein | yes | no | 0.809 | 0.807 | 0.919 | 0.0 | |
| Q9C9U4 | 576 | Mitogen-activated protein | no | no | 0.937 | 0.828 | 0.758 | 0.0 | |
| Q9LM33 | 589 | Mitogen-activated protein | no | no | 0.966 | 0.835 | 0.811 | 0.0 | |
| Q5Z9J0 | 580 | Mitogen-activated protein | yes | no | 0.935 | 0.820 | 0.769 | 0.0 | |
| Q6L5F7 | 582 | Mitogen-activated protein | no | no | 0.821 | 0.718 | 0.847 | 0.0 | |
| Q5VP69 | 501 | Mitogen-activated protein | no | no | 0.801 | 0.814 | 0.852 | 0.0 | |
| Q75KK8 | 542 | Mitogen-activated protein | no | no | 0.787 | 0.739 | 0.847 | 0.0 | |
| Q8W4J2 | 567 | Mitogen-activated protein | no | no | 0.807 | 0.724 | 0.837 | 0.0 | |
| Q53N72 | 498 | Mitogen-activated protein | no | no | 0.787 | 0.805 | 0.847 | 0.0 | |
| Q0E459 | 506 | Mitogen-activated protein | no | no | 0.797 | 0.802 | 0.855 | 0.0 |
| >sp|Q9LV37|MPK9_ARATH Mitogen-activated protein kinase 9 OS=Arabidopsis thaliana GN=MPK9 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 791 bits (2043), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 379/412 (91%), Positives = 401/412 (97%)
Query: 93 MDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH 152
MDPHKK ALETEFFTEYGEASRYQIQEVIGKGSYGVV SA+DTH+GE+VAIKKINDVFEH
Sbjct: 1 MDPHKKVALETEFFTEYGEASRYQIQEVIGKGSYGVVASAIDTHSGEKVAIKKINDVFEH 60
Query: 153 VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD 212
VSDATRILREIKLLRLLRHPDIVEIKH+MLPPSRREF+DIYVVFELMESDLHQVIKANDD
Sbjct: 61 VSDATRILREIKLLRLLRHPDIVEIKHVMLPPSRREFRDIYVVFELMESDLHQVIKANDD 120
Query: 213 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272
LTPEHYQFFLYQLLRGLK+IHTANVFHRDLKPKNILAN+DCKLKICDFGLARVSFNDAPS
Sbjct: 121 LTPEHYQFFLYQLLRGLKFIHTANVFHRDLKPKNILANSDCKLKICDFGLARVSFNDAPS 180
Query: 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL 332
AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD+
Sbjct: 181 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDI 240
Query: 333 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPK 392
MTDLLGTP E+I+RIRNEKARRYLG+MR+K PVPF+HKFP+ DPLAL LL RLLAFDPK
Sbjct: 241 MTDLLGTPPPEAIARIRNEKARRYLGNMRRKPPVPFTHKFPHVDPLALRLLHRLLAFDPK 300
Query: 393 DRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQ 452
DRP+AEEALADPYF+GLANVDREPSTQPI KLEFEFERRK+ K+DVRE+IYREILEYHPQ
Sbjct: 301 DRPSAEEALADPYFYGLANVDREPSTQPIPKLEFEFERRKITKEDVRELIYREILEYHPQ 360
Query: 453 MLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPR 504
MLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEE+YGKGE+ +PLQRQHASLPR
Sbjct: 361 MLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEENYGKGEKGSPLQRQHASLPR 412
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4 |
| >sp|Q9C9U4|MPK15_ARATH Mitogen-activated protein kinase 15 OS=Arabidopsis thaliana GN=MPK15 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 789 bits (2037), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/506 (75%), Positives = 429/506 (84%), Gaps = 29/506 (5%)
Query: 1 MGGSSTLVDGVRRW--FQRHSFTNNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQH 58
MGG LVDGVRRW FQR +++S+NN++ N + S+ ++ +
Sbjct: 1 MGGGGNLVDGVRRWLFFQRRPSSSSSSNNHDQIQN-------------PPTVSNPNDDED 47
Query: 59 LQQLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQ 118
L++LT D S L+ I+V +R P+ KK EFFTEYGEA+RYQIQ
Sbjct: 48 LKKLT-----DPSKLRQIKVQQRNHLPM---------EKKGIPNAEFFTEYGEANRYQIQ 93
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
EV+GKGSYGVVGSA+DTHTGERVAIKKINDVF+H+SDATRILREIKLLRLL HPD+VEIK
Sbjct: 94 EVVGKGSYGVVGSAIDTHTGERVAIKKINDVFDHISDATRILREIKLLRLLLHPDVVEIK 153
Query: 179 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF 238
HIMLPPSRREF+D+YVVFELMESDLHQVIKANDDLTPEH+QFFLYQLLRGLKY+H ANVF
Sbjct: 154 HIMLPPSRREFRDVYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRGLKYVHAANVF 213
Query: 239 HRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKY 298
HRDLKPKNILANADCKLKICDFGLARVSFNDAP+AIFWTDYVATRWYRAPELCGSFFSKY
Sbjct: 214 HRDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFWTDYVATRWYRAPELCGSFFSKY 273
Query: 299 TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLG 358
TPAIDIWS+GCIFAEML GKPLFPGKNVVHQLD+MTD LGTP E+IS+IRN+KARRYLG
Sbjct: 274 TPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDIMTDFLGTPPPEAISKIRNDKARRYLG 333
Query: 359 SMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPST 418
+MRKKQPVPFS KFP ADP AL LLERL+AFDPKDRP+AEEALADPYF+GL++ REPST
Sbjct: 334 NMRKKQPVPFSKKFPKADPSALRLLERLIAFDPKDRPSAEEALADPYFNGLSSKVREPST 393
Query: 419 QPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQ 478
QPISKLEFEFER+KL KDD+RE+IYREILEYHPQML+EYLRGG Q SFMYPSGVDRF+RQ
Sbjct: 394 QPISKLEFEFERKKLTKDDIRELIYREILEYHPQMLEEYLRGGNQLSFMYPSGVDRFRRQ 453
Query: 479 FAHLEEHYGKGERSTPLQRQHASLPR 504
FAHLEE+ G G RS LQRQHASLPR
Sbjct: 454 FAHLEENQGPGGRSNALQRQHASLPR 479
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9LM33|MPK8_ARATH Mitogen-activated protein kinase 8 OS=Arabidopsis thaliana GN=MPK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 788 bits (2034), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/510 (81%), Positives = 446/510 (87%), Gaps = 18/510 (3%)
Query: 1 MGGSSTLVDGVRRW-FQRHSFTNNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQHL 59
MGG LVDGVRRW FQR S +++S+++NNNNNN+ N+ + SSSS+ + +
Sbjct: 1 MGGGGNLVDGVRRWLFQRPSSSSSSSSSNNNNNNH---EQPIFNSSSFSSSSNPNHSANS 57
Query: 60 QQLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQE 119
+L I ED DFSGL LI VPKR P MDPHKK ETEFFTEYGEA+RYQIQE
Sbjct: 58 GELIIEEDLDFSGLTLINVPKRNHLP-------MDPHKKG--ETEFFTEYGEANRYQIQE 108
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 179
V+GKGSYGVV SAVD+HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD+VEIKH
Sbjct: 109 VVGKGSYGVVASAVDSHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDVVEIKH 168
Query: 180 IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFH 239
IMLPPSRREF+DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY+H ANVFH
Sbjct: 169 IMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYVHAANVFH 228
Query: 240 RDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYT 299
RDLKPKNILANADCKLKICDFGLARVSFNDAP+AIFWTDYVATRWYRAPELCGSFFSKYT
Sbjct: 229 RDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFWTDYVATRWYRAPELCGSFFSKYT 288
Query: 300 PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGS 359
PAIDIWS+GCIFAEML GKPLFPGKNVVHQLDLMTD LGTP ESISRIRNEKARRYL S
Sbjct: 289 PAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDLMTDFLGTPPPESISRIRNEKARRYLSS 348
Query: 360 MRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQ 419
MRKKQPVPFSHKFP ADPLAL LLERLLAFDPKDR +AE+ALADPYF GL+N +REP+TQ
Sbjct: 349 MRKKQPVPFSHKFPKADPLALRLLERLLAFDPKDRASAEDALADPYFSGLSNSEREPTTQ 408
Query: 420 PISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQF 479
PISKLEF+FER+KL KDDVRE+IYREILEYHPQML+EYLRGG+Q SFMYPSGVDRFKRQF
Sbjct: 409 PISKLEFDFERKKLVKDDVRELIYREILEYHPQMLEEYLRGGDQLSFMYPSGVDRFKRQF 468
Query: 480 AHLEEHYGK-----GERSTPLQRQHASLPR 504
AHLEE+ GK G RST L R HASLPR
Sbjct: 469 AHLEENQGKPGAAGGGRSTALHRHHASLPR 498
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q5Z9J0|MPK12_ORYSJ Mitogen-activated protein kinase 12 OS=Oryza sativa subsp. japonica GN=MPK12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 780 bits (2015), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/504 (76%), Positives = 424/504 (84%), Gaps = 28/504 (5%)
Query: 1 MGGSSTLVDGVRRWFQRHSFTNNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQHLQ 60
MGG TLVDG RR F R + S + +S+N ++SS
Sbjct: 1 MGGGGTLVDGFRRLFHRRTA----------------SGSNQSSNAGEEAASS-------- 36
Query: 61 QLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEV 120
L + +D D L+ IR I+ P P ++ HKK+ +E EFFTEYGEAS+YQIQEV
Sbjct: 37 DLEVADDPDLVALRSIR----IRVPKRKMPLPVESHKKNTVEMEFFTEYGEASQYQIQEV 92
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
IGKGSYGVV +AVDT TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI
Sbjct: 93 IGKGSYGVVAAAVDTRTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 152
Query: 181 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 240
MLPPSRREF+DIYVVFELMESDLHQVI+ANDDLTPEHYQFFLYQLLR LKYIH ANVFHR
Sbjct: 153 MLPPSRREFQDIYVVFELMESDLHQVIRANDDLTPEHYQFFLYQLLRALKYIHAANVFHR 212
Query: 241 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP 300
DLKPKNILAN+DCKLKICDFGLAR SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP
Sbjct: 213 DLKPKNILANSDCKLKICDFGLARASFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP 272
Query: 301 AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSM 360
AIDIWSIGCIFAE+LTG+PLFPGKNVVHQLD++TDLLGTPS+E++SRIRNEKARRYL +M
Sbjct: 273 AIDIWSIGCIFAELLTGRPLFPGKNVVHQLDIITDLLGTPSSETLSRIRNEKARRYLSTM 332
Query: 361 RKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQP 420
RKK VPFS KF N DPLAL LLERLLAFDPKDR +AEEALADPYF LANV+REPS P
Sbjct: 333 RKKHAVPFSQKFRNTDPLALRLLERLLAFDPKDRSSAEEALADPYFASLANVEREPSRHP 392
Query: 421 ISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQFA 480
ISKLEFEFERRKL KDDVRE+IYREILEYHPQMLQEY++GGEQ SF+YPSGVDRFKRQFA
Sbjct: 393 ISKLEFEFERRKLTKDDVRELIYREILEYHPQMLQEYMKGGEQISFLYPSGVDRFKRQFA 452
Query: 481 HLEEHYGKGERSTPLQRQHASLPR 504
HLEE+Y KGER +PLQR+HASLPR
Sbjct: 453 HLEENYSKGERGSPLQRKHASLPR 476
|
May be involved in defense signaling pathway. Phosphorylates EREBP1 transcriptional activator in vitro. Enhances DNA-binding activity of EREBP1 to the GCC box element of pathogenesis-related (PR) gene promoters. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q6L5F7|MPK17_ORYSJ Mitogen-activated protein kinase 17 OS=Oryza sativa subsp. japonica GN=MPK17 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 759 bits (1959), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/421 (84%), Positives = 387/421 (91%), Gaps = 3/421 (0%)
Query: 84 FPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAI 143
P+ P MDP KK E +FFTEYGEA+RY++ EVIGKGSYGVV +AVDT TGERVAI
Sbjct: 77 LPVRTEPRRMDPSKK---EPDFFTEYGEANRYKVSEVIGKGSYGVVAAAVDTQTGERVAI 133
Query: 144 KKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDL 203
KKINDVF+HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF+DIYV+FELMESDL
Sbjct: 134 KKINDVFDHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFRDIYVIFELMESDL 193
Query: 204 HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 263
HQVIKANDDLTPEH+QFFLYQLLRG+KYIH A+VFHRDLKPKNILANADCKLK+CDFGLA
Sbjct: 194 HQVIKANDDLTPEHHQFFLYQLLRGMKYIHAASVFHRDLKPKNILANADCKLKVCDFGLA 253
Query: 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 323
RVSFND PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+LTGKPLFPG
Sbjct: 254 RVSFNDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAELLTGKPLFPG 313
Query: 324 KNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLL 383
KNVVHQLDLMTDLLGTPS ES+++IRNEKARRYL +MRKK VPF+ KFP DP+ALHLL
Sbjct: 314 KNVVHQLDLMTDLLGTPSAESLAKIRNEKARRYLSNMRKKPRVPFTKKFPGVDPMALHLL 373
Query: 384 ERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIY 443
ERLLAFDPKDRP+AEEAL DPYF+GLAN +REP QPISKLEFEFE+RKLAKDDVRE+IY
Sbjct: 374 ERLLAFDPKDRPSAEEALTDPYFNGLANSEREPIAQPISKLEFEFEKRKLAKDDVRELIY 433
Query: 444 REILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLP 503
REILEYHP MLQEYLRGG+Q SFMYPSGVDRFKRQFAHLEE KGE+S+P RQ+ASLP
Sbjct: 434 REILEYHPHMLQEYLRGGDQMSFMYPSGVDRFKRQFAHLEEGVSKGEKSSPQLRQNASLP 493
Query: 504 R 504
R
Sbjct: 494 R 494
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q5VP69|MPK16_ORYSJ Mitogen-activated protein kinase 16 OS=Oryza sativa subsp. japonica GN=MPK16 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 750 bits (1937), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/408 (85%), Positives = 382/408 (93%)
Query: 97 KKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDA 156
KK + E EFF+EYG+ASRY++ EV+GKGSYGVV +AVDTHTG RVAIKKINDVFEH+SDA
Sbjct: 4 KKGSGEPEFFSEYGDASRYEVTEVVGKGSYGVVAAAVDTHTGGRVAIKKINDVFEHISDA 63
Query: 157 TRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE 216
TRILREIKLLRLLRHPDIVEIKHIMLPPSRREF+DIY++FELMESDLHQVIKANDDLTPE
Sbjct: 64 TRILREIKLLRLLRHPDIVEIKHIMLPPSRREFRDIYIIFELMESDLHQVIKANDDLTPE 123
Query: 217 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276
H+QFFLYQLLRG+KYIH A+VFHRDLKPKNILANADCK+KICDFGLARVSF+D PSAIFW
Sbjct: 124 HHQFFLYQLLRGMKYIHAASVFHRDLKPKNILANADCKVKICDFGLARVSFDDTPSAIFW 183
Query: 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL 336
TDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAEML GKPLFPGKNVVHQLDLMTDL
Sbjct: 184 TDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLMGKPLFPGKNVVHQLDLMTDL 243
Query: 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT 396
LG+PS E+ISRIRNEKARRYLG+MRKK VPFS KFP ADP+ALHLLERLLAFDPKDRPT
Sbjct: 244 LGSPSGETISRIRNEKARRYLGNMRKKPRVPFSQKFPGADPMALHLLERLLAFDPKDRPT 303
Query: 397 AEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQE 456
A EAL DPYF GLAN +REP QPISKLEFEFERRKLAKDDVRE+IYREILEYHPQM+Q+
Sbjct: 304 AAEALTDPYFTGLANSEREPIAQPISKLEFEFERRKLAKDDVRELIYREILEYHPQMMQK 363
Query: 457 YLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPR 504
YLRGG+Q++F+YPSGVDRFKRQFAHLEE +G++++P RQH SLPR
Sbjct: 364 YLRGGDQSNFLYPSGVDRFKRQFAHLEEGVAQGDKTSPQLRQHVSLPR 411
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q75KK8|MPK14_ORYSJ Mitogen-activated protein kinase 14 OS=Oryza sativa subsp. japonica GN=MPK14 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 742 bits (1915), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 340/401 (84%), Positives = 378/401 (94%)
Query: 104 EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREI 163
+FFTEYGE +RY+I+EVIGKGSYGVV SA+DTHTG++VAIKKIND+FEHVSDATRILREI
Sbjct: 2 DFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGDKVAIKKINDIFEHVSDATRILREI 61
Query: 164 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 223
KLLRLLRHPDIVEIKHI+LPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY
Sbjct: 62 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 121
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV+F+D P+AIFWTDY+ATR
Sbjct: 122 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYIATR 181
Query: 284 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
WYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLD++TDLLGTPS E
Sbjct: 182 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPSPE 241
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
+ISRIRNEKARRYL SMR+K+P+PF+ KFPNADPLA+ LLER+LAFDPKDRP+AEEALAD
Sbjct: 242 TISRIRNEKARRYLNSMRRKKPIPFTQKFPNADPLAMRLLERMLAFDPKDRPSAEEALAD 301
Query: 404 PYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQ 463
PYF +ANVDREPS QPI+KLEFEFERR++ K+D+RE+IYREILEYHP+ML+E+L G E
Sbjct: 302 PYFKNIANVDREPSAQPITKLEFEFERRRITKEDIRELIYREILEYHPKMLREFLEGTES 361
Query: 464 TSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPR 504
T FMYPS VD FK+QFA+LEEHY KG + P +RQH SLPR
Sbjct: 362 TGFMYPSAVDHFKKQFAYLEEHYAKGSTAAPPERQHNSLPR 402
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q8W4J2|MPK16_ARATH Mitogen-activated protein kinase 16 OS=Arabidopsis thaliana GN=MPK16 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 740 bits (1910), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 345/412 (83%), Positives = 381/412 (92%), Gaps = 1/412 (0%)
Query: 94 DPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV 153
D KKS++E +FFTEYGE SRY+I+EVIGKGSYGVV SA DTHTGE+VAIKKIND+FEHV
Sbjct: 4 DHRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIFEHV 63
Query: 154 SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDL 213
SDATRILREIKLLRLLRHPDIVEIKHI+LPPSRREF+DIYVVFELMESDLHQVIKANDDL
Sbjct: 64 SDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKANDDL 123
Query: 214 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273
TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV+FND P+A
Sbjct: 124 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183
Query: 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLM 333
IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLDLM
Sbjct: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDLM 243
Query: 334 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD 393
TD+LGTPS E+I R+RNEKARRYL SMRKK+P+PFSHKFP+ DPLAL LLE++L+F+PKD
Sbjct: 244 TDMLGTPSAEAIGRVRNEKARRYLSSMRKKKPIPFSHKFPHTDPLALRLLEKMLSFEPKD 303
Query: 394 RPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQM 453
RPTAEEALAD YF GLA V+REPS QP++KLEFEFERR++ K+DVRE+IYRE LEYHP+M
Sbjct: 304 RPTAEEALADVYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDVRELIYRESLEYHPKM 363
Query: 454 LQEYLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQR-QHASLPR 504
L+EYL G E T+FMYPS V+ FK+QFA+LEEHY G P +R QHASLPR
Sbjct: 364 LKEYLDGSEPTNFMYPSAVEHFKKQFAYLEEHYKNGTSHNPPERQQHASLPR 415
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q53N72|MPK15_ORYSJ Mitogen-activated protein kinase 15 OS=Oryza sativa subsp. japonica GN=MPK15 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 740 bits (1910), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 340/401 (84%), Positives = 376/401 (93%)
Query: 104 EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREI 163
+FFTEYGE +RY+I+EVIGKGSYGVV SA+DTHTGE+VAIKKIND+FEHVSDATRILREI
Sbjct: 2 DFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGEKVAIKKINDIFEHVSDATRILREI 61
Query: 164 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 223
KLLRLLRHPDIVEIKHI+LPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY
Sbjct: 62 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 121
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV+F+D P+AIFWTDYVATR
Sbjct: 122 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYVATR 181
Query: 284 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
WYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLD++TDLLGTPSTE
Sbjct: 182 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPSTE 241
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
+ISRIRNEKARRYL SMR+K+P+PF+ KFPNADPLAL LLER+L+F+PKDRP AEEALAD
Sbjct: 242 AISRIRNEKARRYLSSMRRKKPIPFTQKFPNADPLALRLLERMLSFEPKDRPNAEEALAD 301
Query: 404 PYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQ 463
PYF +ANVDREPS QP++KLEFEFERR++ K+D+RE+IYR+ILEYHP ML+EYL G E
Sbjct: 302 PYFRNIANVDREPSAQPVTKLEFEFERRRITKEDIRELIYRDILEYHPNMLREYLEGTES 361
Query: 464 TSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPR 504
FMYPS VD FK+QFA+LEEHY KG + P +RQH SLPR
Sbjct: 362 AGFMYPSAVDHFKKQFAYLEEHYAKGSTAAPPERQHNSLPR 402
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q0E459|MPK13_ORYSJ Mitogen-activated protein kinase 13 OS=Oryza sativa subsp. japonica GN=MPK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 724 bits (1868), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/407 (85%), Positives = 381/407 (93%), Gaps = 1/407 (0%)
Query: 104 EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREI 163
EFFTEYGEAS+YQIQEV+GKGSYGVV +AVDTHTGERVAIKKINDVFEHVSDA RILREI
Sbjct: 2 EFFTEYGEASQYQIQEVVGKGSYGVVAAAVDTHTGERVAIKKINDVFEHVSDAIRILREI 61
Query: 164 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 223
K+LRLLRHPDIV IKHIMLPP+RREF+DIYVVFELMESDLHQVI+AN DL+PEH++FFLY
Sbjct: 62 KVLRLLRHPDIVVIKHIMLPPTRREFRDIYVVFELMESDLHQVIEANHDLSPEHHRFFLY 121
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
QLL LKYIH+ANVFHRDLKPKNILAN+DCKLKICDFGLARV+FND+PS IFWTDYVATR
Sbjct: 122 QLLCALKYIHSANVFHRDLKPKNILANSDCKLKICDFGLARVAFNDSPSTIFWTDYVATR 181
Query: 284 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
WYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTG+PLFPG+NVVHQLDL+TDLLGTPS+E
Sbjct: 182 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEILTGRPLFPGRNVVHQLDLITDLLGTPSSE 241
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
++SRIRNE AR YL M++K P+PFSHKF NADPLAL LLERLLAFDPKDRPTAEEALAD
Sbjct: 242 TLSRIRNENARGYLTGMQRKHPIPFSHKFHNADPLALRLLERLLAFDPKDRPTAEEALAD 301
Query: 404 PYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQ 463
PYF G++ + REPS P+SK EFEFERRKL KDDVREMIYREILEYHPQMLQEY+RGGEQ
Sbjct: 302 PYFRGISKLSREPSRLPVSKFEFEFERRKLTKDDVREMIYREILEYHPQMLQEYIRGGEQ 361
Query: 464 TSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPR-YVCFS 509
SF+YPSGVDRFKRQFAHLEE+Y +GERSTPL+RQHASLPR VC S
Sbjct: 362 ISFLYPSGVDRFKRQFAHLEENYSRGERSTPLRRQHASLPRERVCSS 408
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 509 | ||||||
| 399106776 | 594 | MAP kinase [Nicotiana tabacum] | 0.960 | 0.823 | 0.833 | 0.0 | |
| 399106778 | 590 | MAP kinase [Nicotiana tabacum] | 0.960 | 0.828 | 0.813 | 0.0 | |
| 359491016 | 601 | PREDICTED: mitogen-activated protein kin | 0.974 | 0.825 | 0.827 | 0.0 | |
| 449439123 | 647 | PREDICTED: mitogen-activated protein kin | 0.986 | 0.775 | 0.803 | 0.0 | |
| 449497497 | 647 | PREDICTED: mitogen-activated protein kin | 0.986 | 0.775 | 0.801 | 0.0 | |
| 255587177 | 613 | big map kinase/bmk, putative [Ricinus co | 0.958 | 0.796 | 0.817 | 0.0 | |
| 224135517 | 548 | predicted protein [Populus trichocarpa] | 0.868 | 0.806 | 0.896 | 0.0 | |
| 356512988 | 594 | PREDICTED: mitogen-activated protein kin | 0.984 | 0.843 | 0.829 | 0.0 | |
| 350539521 | 575 | mitogen-activated protein kinase 16 [Sol | 0.956 | 0.846 | 0.809 | 0.0 | |
| 356527886 | 581 | PREDICTED: mitogen-activated protein kin | 0.958 | 0.839 | 0.815 | 0.0 |
| >gi|399106776|gb|AFP20221.1| MAP kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 861 bits (2225), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 422/506 (83%), Positives = 448/506 (88%), Gaps = 17/506 (3%)
Query: 1 MGGSSTLVDGVRRWFQRHSFTNNSNNNNNNNNNN-FDSNNKKSNNINTSSSSSSHEGQHL 59
MGG +T VDG RRWFQR S T + ++N ++ +SNN + I+ S
Sbjct: 1 MGGGNTFVDGFRRWFQRRSTTTTTTTIVHSNADSILNSNNFEKKPIHFSE---------- 50
Query: 60 QQLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQE 119
++LTI+EDFD SGLKLI VPKR+ FP TMDPHKK+ E EFFTEYGEASRYQIQE
Sbjct: 51 EELTIIEDFDISGLKLISVPKRVDFPF-----TMDPHKKNTQEAEFFTEYGEASRYQIQE 105
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 179
VIGKGSYGVV SAVDT TGERVAIKKI+DVFEHVSDATRILREIKLLRLLRHPDIVEIKH
Sbjct: 106 VIGKGSYGVVASAVDTKTGERVAIKKIHDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 165
Query: 180 IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFH 239
IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFH
Sbjct: 166 IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFH 225
Query: 240 RDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYT 299
RDLKPKNILANADCKLKICDFGLARVSFND PSAIFWTDYVATRWYRAPELCGSFFSKYT
Sbjct: 226 RDLKPKNILANADCKLKICDFGLARVSFNDTPSAIFWTDYVATRWYRAPELCGSFFSKYT 285
Query: 300 PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGS 359
PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP E++++IRNEKARRYL +
Sbjct: 286 PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPPPETVAKIRNEKARRYLSN 345
Query: 360 MRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQ 419
MRKK PVPFS KFP+ DP AL LLE LLAFDPKDRP+AEEAL DPYF GL+NVDREPST
Sbjct: 346 MRKKPPVPFSQKFPHVDPFALRLLECLLAFDPKDRPSAEEALGDPYFRGLSNVDREPSTH 405
Query: 420 PISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTS-FMYPSGVDRFKRQ 478
PISKLEFEFERRKLAK+DVRE+IYREILEYHPQMLQEYLRGG+QTS FMYPSGVDRFKRQ
Sbjct: 406 PISKLEFEFERRKLAKEDVRELIYREILEYHPQMLQEYLRGGDQTSGFMYPSGVDRFKRQ 465
Query: 479 FAHLEEHYGKGERSTPLQRQHASLPR 504
FAHLEEHYGKGERSTPLQRQHASLPR
Sbjct: 466 FAHLEEHYGKGERSTPLQRQHASLPR 491
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|399106778|gb|AFP20222.1| MAP kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 856 bits (2211), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/505 (81%), Positives = 449/505 (88%), Gaps = 16/505 (3%)
Query: 1 MGGSSTLVDGVRRWFQRHSFTNNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQHLQ 60
MGG T VDGV RWFQR ++N + ++ +K +N + + + Q
Sbjct: 1 MGGGGTFVDGVLRWFQRR----------HSNEDAILTDLQKPHNTHLQERAEDNN----Q 46
Query: 61 QLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEV 120
+ TI EDFD +GLKLI+VPKR+ FPI+ ++MDP KK+ALETEFFTEYGEASRYQ+QEV
Sbjct: 47 EFTITEDFDITGLKLIKVPKRLSFPIS-AHSSMDPLKKNALETEFFTEYGEASRYQVQEV 105
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
IGKGSYGVVGSAVDTHTGERVAIKKINDVF+HVSDATRILREIKLLRLLRHPDIVEIKHI
Sbjct: 106 IGKGSYGVVGSAVDTHTGERVAIKKINDVFDHVSDATRILREIKLLRLLRHPDIVEIKHI 165
Query: 181 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 240
MLPPSRREFKDIYVVFELMESDLHQVIKAN+DLT EHYQFFLYQL+RGLKYIHTAN+FHR
Sbjct: 166 MLPPSRREFKDIYVVFELMESDLHQVIKANNDLTAEHYQFFLYQLMRGLKYIHTANIFHR 225
Query: 241 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP 300
DLKPKNILANADCKLKICDFGLARVSFND PSAIFWTDYVATRWYRAPELCGSFFSKYTP
Sbjct: 226 DLKPKNILANADCKLKICDFGLARVSFNDVPSAIFWTDYVATRWYRAPELCGSFFSKYTP 285
Query: 301 AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSM 360
AIDIWSIGCIFAE+L+GKPLFPGKNVVHQLDL+TDLLGTP E++++IRNEKARRYL SM
Sbjct: 286 AIDIWSIGCIFAELLSGKPLFPGKNVVHQLDLITDLLGTPPPETVAKIRNEKARRYLSSM 345
Query: 361 RKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQP 420
RKKQPVPF KFPNADPLAL LLERL+AFDPKDRP+AEEAL+DPYF GL+N D EPS P
Sbjct: 346 RKKQPVPFEKKFPNADPLALRLLERLIAFDPKDRPSAEEALSDPYFRGLSNADHEPSRPP 405
Query: 421 ISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTS-FMYPSGVDRFKRQF 479
ISKLEFEFE+RKLAK+DVRE+IYREILEYHPQMLQEYL GG+QTS FMYPSGVDRFKRQF
Sbjct: 406 ISKLEFEFEKRKLAKEDVRELIYREILEYHPQMLQEYLSGGDQTSGFMYPSGVDRFKRQF 465
Query: 480 AHLEEHYGKGERSTPLQRQHASLPR 504
AHLEEHYGKGERSTPLQRQHASLPR
Sbjct: 466 AHLEEHYGKGERSTPLQRQHASLPR 490
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491016|ref|XP_003634202.1| PREDICTED: mitogen-activated protein kinase 9-like [Vitis vinifera] gi|297734305|emb|CBI15552.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 853 bits (2205), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/511 (82%), Positives = 449/511 (87%), Gaps = 15/511 (2%)
Query: 3 GSSTLVDGVRRWFQRHSFTNNSNNNNNNNNNNFDSNNKKSNNINT-----SSSSSSHEGQ 57
GS TLVDGVRRWFQR S T+++ NN++ ++ S T SS+S++
Sbjct: 2 GSGTLVDGVRRWFQRRSSTSSTTTTTTTNNDSNNAAIHASCVFVTEVHAQSSASATQPRP 61
Query: 58 HLQQLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQI 117
H ++ + L LI+VPKR MDPHKK ETEFFTEYGEASRYQ+
Sbjct: 62 HHKKRQPQDPEAAPALTLIKVPKR---------RPMDPHKKGMPETEFFTEYGEASRYQV 112
Query: 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 177
QEV+GKGSYGVVGSA+DTHTGE+VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI
Sbjct: 113 QEVVGKGSYGVVGSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 172
Query: 178 KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 237
KHIMLPPSRREF+DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV
Sbjct: 173 KHIMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 232
Query: 238 FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK 297
FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK
Sbjct: 233 FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK 292
Query: 298 YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYL 357
YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS ESI+RIRNEKARRYL
Sbjct: 293 YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSAESIARIRNEKARRYL 352
Query: 358 GSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPS 417
+MRKK +PFS KFP+ADPLALHL+ERLLAFDPKDRPTAEEALADPYF GLANVDREPS
Sbjct: 353 STMRKKPSIPFSQKFPDADPLALHLVERLLAFDPKDRPTAEEALADPYFDGLANVDREPS 412
Query: 418 TQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKR 477
TQPISKLEFEFERRKL KDDVRE+IYREILEYHPQMLQEYLRGG+QTSFMYPSGVDRFKR
Sbjct: 413 TQPISKLEFEFERRKLTKDDVRELIYREILEYHPQMLQEYLRGGDQTSFMYPSGVDRFKR 472
Query: 478 QFAHLEEHYGKGERSTPLQRQHASLPR-YVC 507
QFAHLEEHYGKGERSTPLQRQHASLPR VC
Sbjct: 473 QFAHLEEHYGKGERSTPLQRQHASLPRERVC 503
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439123|ref|XP_004137337.1| PREDICTED: mitogen-activated protein kinase 9-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 840 bits (2171), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 437/544 (80%), Positives = 461/544 (84%), Gaps = 42/544 (7%)
Query: 3 GSSTLVDGVRRWFQRHSFTNNSN-----------------NNNNNNNNNFD--SNNKKSN 43
GS TLVDGVRRWFQR + +++S+ N N N + FD N S
Sbjct: 2 GSGTLVDGVRRWFQRRTSSSSSSTSNSNSNFSSNSDSSDPNLNYPNLHKFDYVDNGGVSG 61
Query: 44 NINTSS-----SSSSH------------EGQHLQQLTIVED--FDFSGLKLIRVPKRIQF 84
+ SS SS +H EG L+QL ED D+S LKLI+VPKRI
Sbjct: 62 DQLLSSDLRAQSSIAHKRKPLRKQTQLGEGGILEQLPEEEDDDLDYSALKLIKVPKRINH 121
Query: 85 ---PIAPTP-ATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGER 140
P P P A MD HKK LETEFFTEYGEASRYQ+QE+IGKGSYGVVGSAVDTHT E+
Sbjct: 122 FRNPPPPLPSALMDSHKKGGLETEFFTEYGEASRYQVQEIIGKGSYGVVGSAVDTHTDEK 181
Query: 141 VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME 200
VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF+DIYVVFELME
Sbjct: 182 VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFRDIYVVFELME 241
Query: 201 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 260
SDLHQVIKANDDLTPEH+QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF
Sbjct: 242 SDLHQVIKANDDLTPEHHQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 301
Query: 261 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL 320
GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL
Sbjct: 302 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL 361
Query: 321 FPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLAL 380
FPGKNVVHQLDLMTD+LGTPS+ESI+RIRNEKARRYL +MR+KQPVP + KFPNADPLAL
Sbjct: 362 FPGKNVVHQLDLMTDVLGTPSSESIARIRNEKARRYLSNMRRKQPVPLTQKFPNADPLAL 421
Query: 381 HLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVRE 440
LL+RLLAFDPKDRPTAEEALADPYF GLANVDREPSTQPISKLEFEFERRKL KDDVRE
Sbjct: 422 RLLQRLLAFDPKDRPTAEEALADPYFQGLANVDREPSTQPISKLEFEFERRKLTKDDVRE 481
Query: 441 MIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHA 500
+IYREILEYHPQMLQEYLR GEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHA
Sbjct: 482 LIYREILEYHPQMLQEYLRSGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHA 541
Query: 501 SLPR 504
SLPR
Sbjct: 542 SLPR 545
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449497497|ref|XP_004160419.1| PREDICTED: mitogen-activated protein kinase 9-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 839 bits (2167), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 436/544 (80%), Positives = 461/544 (84%), Gaps = 42/544 (7%)
Query: 3 GSSTLVDGVRRWFQRHSFTNNSN-----------------NNNNNNNNNFD--SNNKKSN 43
GS TLVDGVRRWFQR + +++S+ N + N + FD N S
Sbjct: 2 GSGTLVDGVRRWFQRRTSSSSSSTSNSNSNFSSNSDSSDPNLSYPNLHKFDYVDNGGVSG 61
Query: 44 NINTSS-----SSSSH------------EGQHLQQLTIVED--FDFSGLKLIRVPKRIQF 84
+ SS SS +H EG L+QL ED D+S LKLI+VPKRI
Sbjct: 62 DQLLSSDLRAQSSIAHKRKPLRKQTQLGEGGILEQLPEEEDDDLDYSALKLIKVPKRINH 121
Query: 85 ---PIAPTP-ATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGER 140
P P P A MD HKK LETEFFTEYGEASRYQ+QE+IGKGSYGVVGSAVDTHT E+
Sbjct: 122 FRNPPPPLPSALMDSHKKGGLETEFFTEYGEASRYQVQEIIGKGSYGVVGSAVDTHTDEK 181
Query: 141 VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME 200
VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF+DIYVVFELME
Sbjct: 182 VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFRDIYVVFELME 241
Query: 201 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 260
SDLHQVIKANDDLTPEH+QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF
Sbjct: 242 SDLHQVIKANDDLTPEHHQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 301
Query: 261 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL 320
GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL
Sbjct: 302 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL 361
Query: 321 FPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLAL 380
FPGKNVVHQLDLMTD+LGTPS+ESI+RIRNEKARRYL +MR+KQPVP + KFPNADPLAL
Sbjct: 362 FPGKNVVHQLDLMTDVLGTPSSESIARIRNEKARRYLSNMRRKQPVPLTQKFPNADPLAL 421
Query: 381 HLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVRE 440
LL+RLLAFDPKDRPTAEEALADPYF GLANVDREPSTQPISKLEFEFERRKL KDDVRE
Sbjct: 422 RLLQRLLAFDPKDRPTAEEALADPYFQGLANVDREPSTQPISKLEFEFERRKLTKDDVRE 481
Query: 441 MIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHA 500
+IYREILEYHPQMLQEYLR GEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHA
Sbjct: 482 LIYREILEYHPQMLQEYLRSGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHA 541
Query: 501 SLPR 504
SLPR
Sbjct: 542 SLPR 545
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255587177|ref|XP_002534166.1| big map kinase/bmk, putative [Ricinus communis] gi|223525753|gb|EEF28215.1| big map kinase/bmk, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 828 bits (2138), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/520 (81%), Positives = 449/520 (86%), Gaps = 32/520 (6%)
Query: 3 GSSTLVDGVRRWFQRHSFTNNSNNNNNNNNNNFDSNNKKSNN---------------INT 47
GS TLVDGVRRWFQR + NN+ ++ + + + S + SN+
Sbjct: 2 GSGTLVDGVRRWFQRRNNNNNNTSSASASASASASTSTSSNHYINNCIKSNKNKNNNNYR 61
Query: 48 SSSSSSHEGQHLQQ---LTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETE 104
SS G +++ LT++E+FD +GLK IRVPKRI T +MDPHKK + E E
Sbjct: 62 SSGQPDLSGGVVEEENKLTVIEEFDLTGLKCIRVPKRI------THFSMDPHKKGSAEAE 115
Query: 105 FFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK 164
FFTEYGEASRYQ+QEV+GKGSYGVVGSA+DTHTGE+VAIKKINDVFEHVSDATRILREIK
Sbjct: 116 FFTEYGEASRYQVQEVVGKGSYGVVGSAIDTHTGEKVAIKKINDVFEHVSDATRILREIK 175
Query: 165 LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQ 224
LLRLLRHPDIVEIKHIMLPPSRREF+DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQ
Sbjct: 176 LLRLLRHPDIVEIKHIMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQ 235
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW
Sbjct: 236 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 295
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344
YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP ES
Sbjct: 296 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPPPES 355
Query: 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
ISRIRNEKARRYLGSMRKKQPVP S KFPNADPLAL LLERLLAFDPKDRPTAEEALAD
Sbjct: 356 ISRIRNEKARRYLGSMRKKQPVPLSQKFPNADPLALSLLERLLAFDPKDRPTAEEALADT 415
Query: 405 YFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQT 464
YFHGLANV+REPST PISKLEFEFERRKLAKDD ILEYHPQMLQEYLRGGEQT
Sbjct: 416 YFHGLANVEREPSTNPISKLEFEFERRKLAKDD--------ILEYHPQMLQEYLRGGEQT 467
Query: 465 SFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPR 504
SFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPR
Sbjct: 468 SFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPR 507
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224135517|ref|XP_002322093.1| predicted protein [Populus trichocarpa] gi|222869089|gb|EEF06220.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 822 bits (2124), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/445 (89%), Positives = 418/445 (93%), Gaps = 3/445 (0%)
Query: 60 QQLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQE 119
+QLT++EDFD S LKLIRVPKR FP +TM KK + E +FFTEYGEAS+YQ+QE
Sbjct: 3 EQLTVIEDFDISDLKLIRVPKRFHFPPG---STMGLQKKGSAEADFFTEYGEASQYQVQE 59
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 179
VIGKGSYGVVGSA+D+HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH
Sbjct: 60 VIGKGSYGVVGSAIDSHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 119
Query: 180 IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFH 239
IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFH
Sbjct: 120 IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFH 179
Query: 240 RDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYT 299
RDLKPKNILANADCKLKICDFGLARVSFNDAPSAI WTDYVATRWYRAPELCGSFFSKYT
Sbjct: 180 RDLKPKNILANADCKLKICDFGLARVSFNDAPSAILWTDYVATRWYRAPELCGSFFSKYT 239
Query: 300 PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGS 359
PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP ESIS+IRNEKARRYL +
Sbjct: 240 PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPPPESISKIRNEKARRYLSN 299
Query: 360 MRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQ 419
MRKK PVPF KFPN DPLAL LLE LLAFDPKDRPTAEEALA+PYF+GL+NV+ EPSTQ
Sbjct: 300 MRKKPPVPFPQKFPNVDPLALRLLEGLLAFDPKDRPTAEEALANPYFNGLSNVECEPSTQ 359
Query: 420 PISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQF 479
PISKLEFEFERRK+ KDDVRE+IYREILEYHPQML+EYLRGGEQTSFMYPSGVDRFKRQF
Sbjct: 360 PISKLEFEFERRKITKDDVRELIYREILEYHPQMLKEYLRGGEQTSFMYPSGVDRFKRQF 419
Query: 480 AHLEEHYGKGERSTPLQRQHASLPR 504
AHLEEHYGKGERSTPLQRQHASLPR
Sbjct: 420 AHLEEHYGKGERSTPLQRQHASLPR 444
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356512988|ref|XP_003525196.1| PREDICTED: mitogen-activated protein kinase 15-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 822 bits (2123), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 422/509 (82%), Positives = 456/509 (89%), Gaps = 8/509 (1%)
Query: 1 MGGSSTLVDGVRRWFQRHSFTNNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQHLQ 60
MGG TLV+G+RR FQR + +++S++++++NN N +NN + + +S
Sbjct: 1 MGGGGTLVEGIRRLFQRRASSSSSSDHHDHNNVN--ANNSLVLVRDLRAQLASIPNTLHP 58
Query: 61 QLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEV 120
DFDFS LK I+VP +I F P++MD HKK A ETEFFTEYGEAS+YQIQEV
Sbjct: 59 DSDSDFDFDFSTLKPIKVPSQIPF----RPSSMDHHKKGAPETEFFTEYGEASQYQIQEV 114
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
+GKGSYGVVGSA+DTHTGE+VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI
Sbjct: 115 VGKGSYGVVGSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 174
Query: 181 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 240
MLPPSRREF+DIYVVFELMESDLHQVIKANDDLTPEH+QFFLYQLLRGLKYIHTANVFHR
Sbjct: 175 MLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRGLKYIHTANVFHR 234
Query: 241 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP 300
DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP
Sbjct: 235 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP 294
Query: 301 AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSM 360
AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP ESI+RIRNEKA+RYL SM
Sbjct: 295 AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPPPESIARIRNEKAKRYLNSM 354
Query: 361 RKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQP 420
RKKQP+PFS KFPNADPLAL LLERLLAFDPKDRP+AEEAL+DPYF GLAN+DREPSTQP
Sbjct: 355 RKKQPIPFSQKFPNADPLALRLLERLLAFDPKDRPSAEEALSDPYFTGLANMDREPSTQP 414
Query: 421 ISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQFA 480
ISKLEFEFERRKL KDDVRE+IYREILEYHPQMLQEYLRGG+QTSFMYPSGVDRFKRQFA
Sbjct: 415 ISKLEFEFERRKLTKDDVRELIYREILEYHPQMLQEYLRGGDQTSFMYPSGVDRFKRQFA 474
Query: 481 HLEEHYGKGERST-PLQRQHASLPRY-VC 507
HLEEHYGKGERST PLQRQHASLPR VC
Sbjct: 475 HLEEHYGKGERSTPPLQRQHASLPRQRVC 503
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|350539521|ref|NP_001233915.1| mitogen-activated protein kinase 16 [Solanum lycopersicum] gi|335353086|gb|AEH42672.1| mitogen-activated protein kinase 16 [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 821 bits (2120), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/505 (80%), Positives = 438/505 (86%), Gaps = 18/505 (3%)
Query: 1 MGGSSTLVDGVRRWFQRHSFTNNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQHLQ 60
MGGSST VDGV RWF TN +N S+ + E QH
Sbjct: 1 MGGSSTFVDGVLRWFHHRRHTNEDAILTQTHN---------------STDTHLQEKQH-- 43
Query: 61 QLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEV 120
+ TI EDFDF+GLKLI+VPKR PI+ + ++MDP KK+ALETEFFTEYGEASRYQ+QEV
Sbjct: 44 EFTITEDFDFTGLKLIKVPKRFHLPISSSSSSMDPTKKNALETEFFTEYGEASRYQVQEV 103
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
IGKGSYGVVGSAVDTHTGERVAIKKINDVF+HVSDATRILREIKLLRLLRHPDIVEIKHI
Sbjct: 104 IGKGSYGVVGSAVDTHTGERVAIKKINDVFDHVSDATRILREIKLLRLLRHPDIVEIKHI 163
Query: 181 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 240
MLPPSRREFKDIYVVFELMESDLHQVIKAN+DLT EHYQFFLYQLLRGLKYIHTAN+FHR
Sbjct: 164 MLPPSRREFKDIYVVFELMESDLHQVIKANNDLTHEHYQFFLYQLLRGLKYIHTANIFHR 223
Query: 241 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP 300
DLKPKNILANADCKLKICDFGLARVSFND PSAIFWTDYVATRWYRAPELCGSFFSKYTP
Sbjct: 224 DLKPKNILANADCKLKICDFGLARVSFNDVPSAIFWTDYVATRWYRAPELCGSFFSKYTP 283
Query: 301 AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSM 360
AIDIWSIGCIFAE+L+GKPLFPGKNVVHQLDL+TDLLGTP E++++IRNEKARRYL SM
Sbjct: 284 AIDIWSIGCIFAELLSGKPLFPGKNVVHQLDLITDLLGTPPPETVAKIRNEKARRYLSSM 343
Query: 361 RKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQP 420
RKKQPV F+ KFPNADPLAL LLERLLAFDPKDRP+AEE L DPYFHGL+N DREP P
Sbjct: 344 RKKQPVGFAKKFPNADPLALRLLERLLAFDPKDRPSAEEGLEDPYFHGLSNADREPCRPP 403
Query: 421 ISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTS-FMYPSGVDRFKRQF 479
ISKLEFEFE+RKLAKDDVRE+IYREILEYHPQMLQEYL G +QTS FMYPSGVDRFKRQF
Sbjct: 404 ISKLEFEFEKRKLAKDDVRELIYREILEYHPQMLQEYLSGADQTSGFMYPSGVDRFKRQF 463
Query: 480 AHLEEHYGKGERSTPLQRQHASLPR 504
AHLEEH GKGE P+ RQHASLPR
Sbjct: 464 AHLEEHAGKGEHGAPILRQHASLPR 488
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356527886|ref|XP_003532537.1| PREDICTED: mitogen-activated protein kinase 9-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 809 bits (2089), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/509 (81%), Positives = 443/509 (87%), Gaps = 21/509 (4%)
Query: 1 MGGSSTLVDGVRRWFQRHSFTNNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQHLQ 60
MGG TLV G+RR F+R + + S+++N+NN N +S ++ +S +
Sbjct: 1 MGGGGTLVQGIRRLFKRRASSPASDDHNHNNVNANNSR-VLVRDLRAQLASIPN------ 53
Query: 61 QLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEV 120
L V DFDFS LK I+VP I F P++MD HKK A ETEFFTEYGEAS+YQIQEV
Sbjct: 54 TLDPVSDFDFSTLKPIKVPTPIPF----RPSSMDHHKKGAQETEFFTEYGEASQYQIQEV 109
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
+GKGSYGVVGSA+DTHTGE+VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI
Sbjct: 110 VGKGSYGVVGSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 169
Query: 181 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 240
MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH+QFFLYQLLRGLKYIHTANVFHR
Sbjct: 170 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRGLKYIHTANVFHR 229
Query: 241 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP 300
DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP
Sbjct: 230 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP 289
Query: 301 AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSM 360
AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP ES +RIRNEKA+RYL SM
Sbjct: 290 AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPPPESTARIRNEKAKRYLNSM 349
Query: 361 RKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQP 420
RKKQP+PFS KFPNADPLAL LLE LLAFDPKDRP+AEEAL+DPYF GLAN+DREPSTQP
Sbjct: 350 RKKQPIPFSQKFPNADPLALRLLESLLAFDPKDRPSAEEALSDPYFTGLANMDREPSTQP 409
Query: 421 ISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQFA 480
ISKLEFEFERRKL KDD ILEYHPQMLQEYLRGG+QTSFMYPSGVDRFKRQFA
Sbjct: 410 ISKLEFEFERRKLTKDD--------ILEYHPQMLQEYLRGGDQTSFMYPSGVDRFKRQFA 461
Query: 481 HLEEHYGKGERST-PLQRQHASLPRY-VC 507
HLEEHYGKGERST PLQRQHASLPR VC
Sbjct: 462 HLEEHYGKGERSTPPLQRQHASLPRQRVC 490
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 509 | ||||||
| TAIR|locus:2194040 | 589 | ATMPK8 [Arabidopsis thaliana ( | 0.966 | 0.835 | 0.745 | 3.6e-199 | |
| TAIR|locus:2092717 | 510 | MPK9 "MAP kinase 9" [Arabidops | 0.809 | 0.807 | 0.868 | 5.9e-199 | |
| TAIR|locus:2027814 | 576 | MPK15 "MAP kinase 15" [Arabido | 0.858 | 0.758 | 0.767 | 3.9e-192 | |
| TAIR|locus:2179609 | 567 | MPK16 "mitogen-activated prote | 0.807 | 0.724 | 0.788 | 1.3e-180 | |
| TAIR|locus:2052357 | 606 | MPK20 "MAP kinase 20" [Arabido | 0.807 | 0.678 | 0.761 | 1.4e-174 | |
| TAIR|locus:2049552 | 486 | MPK17 "MAP kinase 17" [Arabido | 0.803 | 0.841 | 0.751 | 2.8e-169 | |
| TAIR|locus:2089576 | 598 | MPK19 "MAP kinase 19" [Arabido | 0.799 | 0.680 | 0.740 | 1.8e-165 | |
| TAIR|locus:2024887 | 615 | MPK18 "mitogen-activated prote | 0.801 | 0.663 | 0.715 | 3.4e-164 | |
| DICTYBASE|DDB_G0286353 | 529 | erkA "mitogen-activated protei | 0.707 | 0.680 | 0.466 | 6.2e-85 | |
| TAIR|locus:2124943 | 376 | MPK4 "MAP kinase 4" [Arabidops | 0.687 | 0.930 | 0.437 | 4.1e-81 |
| TAIR|locus:2194040 ATMPK8 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1928 (683.7 bits), Expect = 3.6e-199, P = 3.6e-199
Identities = 380/510 (74%), Positives = 400/510 (78%)
Query: 1 MGGSSTLVDGVRRW-FQRHXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXHEGQHL 59
MGG LVDGVRRW FQR H
Sbjct: 1 MGGGGNLVDGVRRWLFQRPSSSSSSSSSNNNNNNHEQPIFNSSSFSSSSNPN--HSANS- 57
Query: 60 QQLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQE 119
+L I ED DFSGL LI VPKR P MDPHKK ETEFFTEYGEA+RYQIQE
Sbjct: 58 GELIIEEDLDFSGLTLINVPKRNHLP-------MDPHKKG--ETEFFTEYGEANRYQIQE 108
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATXXXXXXXXXXXXXHPDIVEIKH 179
V+GKGSYGVV SAVD+HTGERVAIKKINDVFEHVSDAT HPD+VEIKH
Sbjct: 109 VVGKGSYGVVASAVDSHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDVVEIKH 168
Query: 180 IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFH 239
IMLPPSRREF+DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY+H ANVFH
Sbjct: 169 IMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYVHAANVFH 228
Query: 240 RDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYT 299
RDLKPKNILANADCKLKICDFGLARVSFNDAP+AIFWTDYVATRWYRAPELCGSFFSKYT
Sbjct: 229 RDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFWTDYVATRWYRAPELCGSFFSKYT 288
Query: 300 PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGS 359
PAIDIWS+GCIFAEML GKPLFPGKNVVHQLDLMTD LGTP ESISRIRNEKARRYL S
Sbjct: 289 PAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDLMTDFLGTPPPESISRIRNEKARRYLSS 348
Query: 360 MRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPKDRPTAEEALADPYFHGLANVDREPSTQ 419
MRKKQPVPFSHKFP ADP AFDPKDR +AE+ALADPYF GL+N +REP+TQ
Sbjct: 349 MRKKQPVPFSHKFPKADPLALRLLERLLAFDPKDRASAEDALADPYFSGLSNSEREPTTQ 408
Query: 420 PISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQF 479
PISKLEF+FER+KL KDDVRE+IYREILEYHPQML+EYLRGG+Q SFMYPSGVDRFKRQF
Sbjct: 409 PISKLEFDFERKKLVKDDVRELIYREILEYHPQMLEEYLRGGDQLSFMYPSGVDRFKRQF 468
Query: 480 AHLEEHYGK-----GERSTPLQRQHASLPR 504
AHLEE+ GK G RST L R HASLPR
Sbjct: 469 AHLEENQGKPGAAGGGRSTALHRHHASLPR 498
|
|
| TAIR|locus:2092717 MPK9 "MAP kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1926 (683.0 bits), Expect = 5.9e-199, P = 5.9e-199
Identities = 358/412 (86%), Positives = 380/412 (92%)
Query: 93 MDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH 152
MDPHKK ALETEFFTEYGEASRYQIQEVIGKGSYGVV SA+DTH+GE+VAIKKINDVFEH
Sbjct: 1 MDPHKKVALETEFFTEYGEASRYQIQEVIGKGSYGVVASAIDTHSGEKVAIKKINDVFEH 60
Query: 153 VSDATXXXXXXXXXXXXXHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD 212
VSDAT HPDIVEIKH+MLPPSRREF+DIYVVFELMESDLHQVIKANDD
Sbjct: 61 VSDATRILREIKLLRLLRHPDIVEIKHVMLPPSRREFRDIYVVFELMESDLHQVIKANDD 120
Query: 213 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272
LTPEHYQFFLYQLLRGLK+IHTANVFHRDLKPKNILAN+DCKLKICDFGLARVSFNDAPS
Sbjct: 121 LTPEHYQFFLYQLLRGLKFIHTANVFHRDLKPKNILANSDCKLKICDFGLARVSFNDAPS 180
Query: 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL 332
AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD+
Sbjct: 181 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDI 240
Query: 333 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPK 392
MTDLLGTP E+I+RIRNEKARRYLG+MR+K PVPF+HKFP+ DP AFDPK
Sbjct: 241 MTDLLGTPPPEAIARIRNEKARRYLGNMRRKPPVPFTHKFPHVDPLALRLLHRLLAFDPK 300
Query: 393 DRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQ 452
DRP+AEEALADPYF+GLANVDREPSTQPI KLEFEFERRK+ K+DVRE+IYREILEYHPQ
Sbjct: 301 DRPSAEEALADPYFYGLANVDREPSTQPIPKLEFEFERRKITKEDVRELIYREILEYHPQ 360
Query: 453 MLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPR 504
MLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEE+YGKGE+ +PLQRQHASLPR
Sbjct: 361 MLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEENYGKGEKGSPLQRQHASLPR 412
|
|
| TAIR|locus:2027814 MPK15 "MAP kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1817 (644.7 bits), Expect = 3.9e-192, Sum P(2) = 3.9e-192
Identities = 346/451 (76%), Positives = 382/451 (84%)
Query: 54 HEGQHLQQLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEAS 113
++ + L++LT D S L+ I+V +R P+ KK EFFTEYGEA+
Sbjct: 43 NDDEDLKKLT-----DPSKLRQIKVQQRNHLPM---------EKKGIPNAEFFTEYGEAN 88
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATXXXXXXXXXXXXXHPD 173
RYQIQEV+GKGSYGVVGSA+DTHTGERVAIKKINDVF+H+SDAT HPD
Sbjct: 89 RYQIQEVVGKGSYGVVGSAIDTHTGERVAIKKINDVFDHISDATRILREIKLLRLLLHPD 148
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
+VEIKHIMLPPSRREF+D+YVVFELMESDLHQVIKANDDLTPEH+QFFLYQLLRGLKY+H
Sbjct: 149 VVEIKHIMLPPSRREFRDVYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRGLKYVH 208
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP+AIFWTDYVATRWYRAPELCGS
Sbjct: 209 AANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFWTDYVATRWYRAPELCGS 268
Query: 294 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353
FFSKYTPAIDIWS+GCIFAEML GKPLFPGKNVVHQLD+MTD LGTP E+IS+IRN+KA
Sbjct: 269 FFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDIMTDFLGTPPPEAISKIRNDKA 328
Query: 354 RRYLGSMRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPKDRPTAEEALADPYFHGLANVD 413
RRYLG+MRKKQPVPFS KFP ADP AFDPKDRP+AEEALADPYF+GL++
Sbjct: 329 RRYLGNMRKKQPVPFSKKFPKADPSALRLLERLIAFDPKDRPSAEEALADPYFNGLSSKV 388
Query: 414 REPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVD 473
REPSTQPISKLEFEFER+KL KDD+RE+IYREILEYHPQML+EYLRGG Q SFMYPSGVD
Sbjct: 389 REPSTQPISKLEFEFERKKLTKDDIRELIYREILEYHPQMLEEYLRGGNQLSFMYPSGVD 448
Query: 474 RFKRQFAHLEEHYGKGERSTPLQRQHASLPR 504
RF+RQFAHLEE+ G G RS LQRQHASLPR
Sbjct: 449 RFRRQFAHLEENQGPGGRSNALQRQHASLPR 479
|
|
| TAIR|locus:2179609 MPK16 "mitogen-activated protein kinase 16" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1753 (622.1 bits), Expect = 1.3e-180, P = 1.3e-180
Identities = 325/412 (78%), Positives = 359/412 (87%)
Query: 94 DPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV 153
D KKS++E +FFTEYGE SRY+I+EVIGKGSYGVV SA DTHTGE+VAIKKIND+FEHV
Sbjct: 4 DHRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIFEHV 63
Query: 154 SDATXXXXXXXXXXXXXHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDL 213
SDAT HPDIVEIKHI+LPPSRREF+DIYVVFELMESDLHQVIKANDDL
Sbjct: 64 SDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKANDDL 123
Query: 214 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273
TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV+FND P+A
Sbjct: 124 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183
Query: 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLM 333
IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLDLM
Sbjct: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDLM 243
Query: 334 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPKD 393
TD+LGTPS E+I R+RNEKARRYL SMRKK+P+PFSHKFP+ DP +F+PKD
Sbjct: 244 TDMLGTPSAEAIGRVRNEKARRYLSSMRKKKPIPFSHKFPHTDPLALRLLEKMLSFEPKD 303
Query: 394 RPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQM 453
RPTAEEALAD YF GLA V+REPS QP++KLEFEFERR++ K+DVRE+IYRE LEYHP+M
Sbjct: 304 RPTAEEALADVYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDVRELIYRESLEYHPKM 363
Query: 454 LQEYLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQ-HASLPR 504
L+EYL G E T+FMYPS V+ FK+QFA+LEEHY G P +RQ HASLPR
Sbjct: 364 LKEYLDGSEPTNFMYPSAVEHFKKQFAYLEEHYKNGTSHNPPERQQHASLPR 415
|
|
| TAIR|locus:2052357 MPK20 "MAP kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1696 (602.1 bits), Expect = 1.4e-174, P = 1.4e-174
Identities = 313/411 (76%), Positives = 357/411 (86%)
Query: 94 DPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV 153
D KK+ LE EFF++YG+A+R+++QEVIGKGSYGVV SA+DT TGE+VAIKKI+D+FEH+
Sbjct: 4 DNRKKNNLEMEFFSDYGDANRFKVQEVIGKGSYGVVCSAIDTLTGEKVAIKKIHDIFEHI 63
Query: 154 SDATXXXXXXXXXXXXXHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDL 213
SDA HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDL
Sbjct: 64 SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDL 123
Query: 214 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273
T EHYQFFLYQLLR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARV+FND P+
Sbjct: 124 TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183
Query: 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLM 333
IFWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAE+L GKPLFPGKNVVHQLDLM
Sbjct: 184 IFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLMGKPLFPGKNVVHQLDLM 243
Query: 334 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPKD 393
TDLLGTPS ++ISR+RNEKARRYL SMRKK P+PF+ KFPNADP AFDPKD
Sbjct: 244 TDLLGTPSLDTISRVRNEKARRYLTSMRKKPPIPFAQKFPNADPLSLKLLERLLAFDPKD 303
Query: 394 RPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQM 453
RPTAEEALADPYF GLA V+REPS QPI+K+EFEFERRK+ K+D+RE+I REILEYHPQ+
Sbjct: 304 RPTAEEALADPYFKGLAKVEREPSCQPITKMEFEFERRKVTKEDIRELISREILEYHPQL 363
Query: 454 LQEYLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPR 504
L++++ G ++ SF+YPS VD+F+RQFAHLEE+ GK PL+R+HASLPR
Sbjct: 364 LKDHMNGADKASFLYPSAVDQFRRQFAHLEENSGKTGPVAPLERKHASLPR 414
|
|
| TAIR|locus:2049552 MPK17 "MAP kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1646 (584.5 bits), Expect = 2.8e-169, P = 2.8e-169
Identities = 311/414 (75%), Positives = 350/414 (84%)
Query: 101 LETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATXXX 160
LE EFFTEYGEAS+YQIQEV+GKGSYGVV SA HTG +VAIKK+ +VFEHVSDA
Sbjct: 2 LEKEFFTEYGEASQYQIQEVVGKGSYGVVASAECPHTGGKVAIKKMTNVFEHVSDAIRIL 61
Query: 161 XXXXXXXXXXHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQF 220
HPDIVEIKHIMLPP R+EFKDIYVVFELMESDLH V+K NDDLTP+H+QF
Sbjct: 62 REIKLLRLLRHPDIVEIKHIMLPPCRKEFKDIYVVFELMESDLHHVLKVNDDLTPQHHQF 121
Query: 221 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 280
FLYQLLRGLK++H+A+VFHRDLKPKNILANADCK+KICD GLARVSF D+PSA+FWTDYV
Sbjct: 122 FLYQLLRGLKFMHSAHVFHRDLKPKNILANADCKIKICDLGLARVSFTDSPSAVFWTDYV 181
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340
ATRWYRAPELCGSF+S YTPAID+WS+GCIFAEMLTGKPLFPGKNVVHQL+L+TDLLGTP
Sbjct: 182 ATRWYRAPELCGSFYSNYTPAIDMWSVGCIFAEMLTGKPLFPGKNVVHQLELVTDLLGTP 241
Query: 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPKDRPTAEEA 400
S ++SRIRNEKAR+YLG+MR+K PVPF+HKFPN DP AFDPKDRP+AEEA
Sbjct: 242 SPITLSRIRNEKARKYLGNMRRKDPVPFTHKFPNIDPVALKLLQRLIAFDPKDRPSAEEA 301
Query: 401 LADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRG 460
LADPYF GLANVD EPS QPISKLEFEFERRKL +DDVRE++YREILEYHPQMLQEYL+G
Sbjct: 302 LADPYFQGLANVDYEPSRQPISKLEFEFERRKLTRDDVRELMYREILEYHPQMLQEYLQG 361
Query: 461 GEQTS--FMYPSGVDRFKRQFAHLEEHYGKGER--STPLQRQHASLPRY-VCFS 509
E + F+YPSGVD+FK++FA LEEH E S P QR++ SLPR VC S
Sbjct: 362 EENINSHFLYPSGVDQFKQEFARLEEHNDDEEEHNSPPHQRKYTSLPRERVCSS 415
|
|
| TAIR|locus:2089576 MPK19 "MAP kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1610 (571.8 bits), Expect = 1.8e-165, P = 1.8e-165
Identities = 302/408 (74%), Positives = 343/408 (84%)
Query: 97 KKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDA 156
KK+ E EFFTEYG+A+RY+I EVIGKGSYGVV +A+DT TGE+VAIKKINDVFEHVSDA
Sbjct: 7 KKNMKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTQTGEKVAIKKINDVFEHVSDA 66
Query: 157 TXXXXXXXXXXXXXHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE 216
HPDIVEIK IMLPPS+REFKDIYVVFELMESDLHQVIKANDDLT E
Sbjct: 67 LRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTRE 126
Query: 217 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276
H+QFFLYQ+LR LKY+HTANV+HRDLKPKNILANA+CKLK+CDFGLARVSFND P+ +FW
Sbjct: 127 HHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVSFNDTPTTVFW 186
Query: 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL 336
TDYVATRWYRAPELCGSF SKYTPAIDIWSIGCIFAE+LTGKPLFPGK+VVHQLDL+TDL
Sbjct: 187 TDYVATRWYRAPELCGSFCSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
Query: 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPKDRPT 396
LGTP +E+I+ +RNEKAR+YL MRKK VPFS KFPNADP AFDPKDRPT
Sbjct: 247 LGTPKSETIAGVRNEKARKYLNEMRKKNLVPFSQKFPNADPLALRLLQRLLAFDPKDRPT 306
Query: 397 AEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQE 456
A EALADPYF LA V+REPS QPISK+EFEFERR+L KDD+RE+IYREILEYHPQ+L++
Sbjct: 307 AAEALADPYFKCLAKVEREPSCQPISKMEFEFERRRLTKDDIRELIYREILEYHPQLLKD 366
Query: 457 YLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPR 504
Y+ E +SF+YPS + ++QFA+LEE+ GK P R+HASLPR
Sbjct: 367 YMNS-EGSSFLYPSAIGHLRKQFAYLEENSGKSGPVIPPDRKHASLPR 413
|
|
| TAIR|locus:2024887 MPK18 "mitogen-activated protein kinase 18" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1598 (567.6 bits), Expect = 3.4e-164, P = 3.4e-164
Identities = 292/408 (71%), Positives = 343/408 (84%)
Query: 97 KKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDA 156
KK E EFFTEYG+A+RY+I EVIGKGSYGVV +A+DTHTGE+VAIKKINDVFEH+SDA
Sbjct: 7 KKGTKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTHTGEKVAIKKINDVFEHISDA 66
Query: 157 TXXXXXXXXXXXXXHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE 216
HPDIVEIK IMLPPS+REFKDIYVVFELMESDLHQVIKANDDLT E
Sbjct: 67 LRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTRE 126
Query: 217 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276
H+QFFLYQ+LR LK++HTANV+HRDLKPKNILANA+CKLK+CDFGLARV+FND P+ +FW
Sbjct: 127 HHQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDTPTTVFW 186
Query: 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL 336
TDYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAE+LTGKPLFPGK+VVHQL+L+TDL
Sbjct: 187 TDYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGKPLFPGKSVVHQLELITDL 246
Query: 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPKDRPT 396
LGTP +E+IS +RN+KAR+YL MRKK PV FS KF ADP AFDPKDRPT
Sbjct: 247 LGTPKSETISGVRNDKARKYLTEMRKKNPVTFSQKFSKADPLALRLLQRLLAFDPKDRPT 306
Query: 397 AEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQE 456
EALADPYF GL+ ++REPS+Q ISK+EFEFERR+L KDD+RE+IYREILEYHPQ+L++
Sbjct: 307 PAEALADPYFKGLSKIEREPSSQQISKMEFEFERRRLTKDDIRELIYREILEYHPQLLKD 366
Query: 457 YLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPR 504
Y+ G E ++F+YPS + ++QF +LEE+ + PL+R+HASLPR
Sbjct: 367 YMSGSEGSNFVYPSAIGHLRQQFTYLEENSSRNGPVIPLERKHASLPR 414
|
|
| DICTYBASE|DDB_G0286353 erkA "mitogen-activated protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 850 (304.3 bits), Expect = 6.2e-85, P = 6.2e-85
Identities = 173/371 (46%), Positives = 237/371 (63%)
Query: 86 IAPTPATMDPHKKSALETEFF--TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAI 143
+ P P T D + + F +++ RY I + IG G+YGVV SA D TGE+VAI
Sbjct: 118 LMPPPPTSDTSNFNDNISYFVYGSQFTVPRRYSIVKCIGHGAYGVVCSAKDNLTGEKVAI 177
Query: 144 KKINDVFEHVSDATXXXXXXXXXXXXXHPDIVEIKHIMLPPSRREFKDIYVVFELMESDL 203
KKI+ F+++ D H +++ IK I+ P S+ +F+D+Y+V ELM++DL
Sbjct: 178 KKISKAFDNLKDTKRTLREIHLLRHFKHENLISIKDILKPNSKEQFEDVYIVSELMDTDL 237
Query: 204 HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 263
HQ+I + L+ +H Q+F+YQ+LRGLK+IH+ANV HRDLKP N+L N DC LKICD GLA
Sbjct: 238 HQIITSPQPLSDDHCQYFVYQMLRGLKHIHSANVLHRDLKPSNLLINEDCLLKICDLGLA 297
Query: 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 323
RV DA F T+YVATRWYRAPE+ S+ +KYT AIDIWS+GCIFAE+L KPLF G
Sbjct: 298 RVE--DATHQGFMTEYVATRWYRAPEVILSW-NKYTKAIDIWSVGCIFAELLGRKPLFQG 354
Query: 324 KNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPXXXXXX 383
K+ +HQ+ L+ + +G+PS E I I NE+AR+++ +M + V F++ FP A+P
Sbjct: 355 KDYIHQITLIIETIGSPSEEDICNIANEQARQFIRNMGNQPKVNFANMFPKANPDAIDLL 414
Query: 384 XXXXAFDPKDRPTAEEALADPYFHGLANVDREPSTQPIS--KLEFEFERRKLAKDDVREM 441
FDP R T EEALA PYF L +PS +PI K FE L +D ++E+
Sbjct: 415 ERMLYFDPSKRLTVEEALAHPYFQSL----HDPSDEPICLHKFSLNFEAWDLNRDLLKEL 470
Query: 442 IYREILEYHPQ 452
IY E+L YHP+
Sbjct: 471 IYNEMLAYHPE 481
|
|
| TAIR|locus:2124943 MPK4 "MAP kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 814 (291.6 bits), Expect = 4.1e-81, P = 4.1e-81
Identities = 157/359 (43%), Positives = 229/359 (63%)
Query: 96 HKKSALETEFFTEYGEASRYQIQEV--IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV 153
H S ++ + E SR + + IG+G+YG+V +A ++ TGE VAIKKI + F+++
Sbjct: 22 HGGSYVQYNVYGNLFEVSRKYVPPLRPIGRGAYGIVCAATNSETGEEVAIKKIGNAFDNI 81
Query: 154 SDATXXXXXXXXXXXXXHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDL 213
DA H +++ +K I+ PP R F D+Y+V+ELM++DLHQ+I++N L
Sbjct: 82 IDAKRTLREIKLLKHMDHENVIAVKDIIKPPQRENFNDVYIVYELMDTDLHQIIRSNQPL 141
Query: 214 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273
T +H +FFLYQLLRGLKY+H+ANV HRDLKP N+L NA+C LK+ DFGLAR
Sbjct: 142 TDDHCRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKLGDFGLARTK----SET 197
Query: 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLM 333
F T+YV TRWYRAPEL + S+YT AIDIWS+GCI E +T +PLFPGK+ VHQL L+
Sbjct: 198 DFMTEYVVTRWYRAPELLLNC-SEYTAAIDIWSVGCILGETMTREPLFPGKDYVHQLRLI 256
Query: 334 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPKD 393
T+L+G+P S+ +R++ ARRY+ + + F+ +FPN FDP
Sbjct: 257 TELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSAGAVDLLEKMLVFDPSR 316
Query: 394 RPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQ 452
R T +EAL PY L +++ EP + F+FE+ L +++++E+IYRE ++++PQ
Sbjct: 317 RITVDEALCHPYLAPLHDINEEPVC--VRPFNFDFEQPTLTEENIKELIYRETVKFNPQ 373
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LV37 | MPK9_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.9199 | 0.8094 | 0.8078 | yes | no |
| Q5Z9J0 | MPK12_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7698 | 0.9351 | 0.8206 | yes | no |
| Q5VP69 | MPK16_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.8529 | 0.8015 | 0.8143 | no | no |
| P42525 | ERK1_DICDI | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5229 | 0.6660 | 0.6408 | yes | no |
| Q9C9U4 | MPK15_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7588 | 0.9371 | 0.8281 | no | no |
| Q84M93 | MPK17_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7874 | 0.8035 | 0.8415 | no | no |
| A2X0M1 | MPK13_ORYSI | 2, ., 7, ., 1, 1, ., 2, 4 | 0.8550 | 0.7976 | 0.8023 | N/A | no |
| Q9LM33 | MPK8_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.8117 | 0.9666 | 0.8353 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.24 | 0.991 |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00017805001 | SubName- Full=Chromosome chr17 scaffold_16, whole genome shotgun sequence; (586 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 509 | |||
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.0 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.0 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-161 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-149 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-142 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-125 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-124 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-122 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-110 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-107 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-103 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-102 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-95 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-93 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-91 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-91 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-90 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-89 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-89 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-86 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-85 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-83 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-83 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-81 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-80 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-75 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-73 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-72 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-71 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-70 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-70 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-70 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-69 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-68 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-65 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-65 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-64 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-64 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-63 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-63 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-63 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-63 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-62 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-60 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-60 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-60 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-59 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-55 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-55 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-55 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-55 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-51 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-49 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-48 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-46 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-46 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-45 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-45 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-45 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-43 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-40 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-40 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-39 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-38 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-38 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-37 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-37 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-36 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-34 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-33 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-33 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-30 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-30 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-30 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-29 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-28 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-27 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-27 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-27 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-26 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-25 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-25 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-24 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-23 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-23 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-22 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-22 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-22 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-21 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-20 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-20 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-20 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-19 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 4e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-18 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-16 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-16 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-15 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-15 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-15 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-15 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-15 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-12 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-12 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-12 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-10 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-04 | |
| pfam07655 | 95 | pfam07655, Secretin_N_2, Secretin N-terminal domai | 0.001 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 742 bits (1917), Expect = 0.0
Identities = 312/338 (92%), Positives = 327/338 (96%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
RY+IQEVIGKGSYGVV SA+DTHTGE+VAIKKINDVFEHVSDATRILREIKLLRLLRHPD
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH+QFFLYQLLR LKYIH
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
TANVFHRDLKPKNILANADCKLKICDFGLARV+FND P+AIFWTDYVATRWYRAPELCGS
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180
Query: 294 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353
FFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLDL+TDLLGTPS E+ISR+RNEKA
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240
Query: 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 413
RRYL SMRKKQPVPFS KFPNADPLAL LLERLLAFDPKDRPTAEEALADPYF GLA V+
Sbjct: 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE 300
Query: 414 REPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 451
REPS QPI+KLEFEFERR+L K+DVRE+IYREILEYHP
Sbjct: 301 REPSAQPITKLEFEFERRRLTKEDVRELIYREILEYHP 338
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 531 bits (1370), Expect = 0.0
Identities = 188/332 (56%), Positives = 244/332 (73%), Gaps = 2/332 (0%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
RY++ + IG G+YGVV SAVD TG +VAIKKI++VF+ + DA RILREIKLLR LRH +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
I+ + I+ PPS +F D+Y+V ELME+DLH+VIK+ LT +H Q+FLYQ+LRGLKY+H
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
+ANV HRDLKP NIL N++C LKICDFGLAR D F T+YV TRWYRAPEL S
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180
Query: 294 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353
S+YT AIDIWS+GCIFAE+LT KPLFPG++ + QL+L+ ++LGTPS E + I +EKA
Sbjct: 181 -SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239
Query: 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 413
R YL S+ KK P S FP A P A+ LLE++L FDPK R TA+EALA PY L + +
Sbjct: 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE 299
Query: 414 REPSTQPISKLEFEFERRKLAKDDVREMIYRE 445
EP +P +F F+ +L +++++E+IY E
Sbjct: 300 DEPVAKPPFDFDF-FDDDELTEEELKELIYEE 330
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 461 bits (1188), Expect = e-161
Identities = 187/339 (55%), Positives = 246/339 (72%), Gaps = 6/339 (1%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
++Y + IG+G+YG+V SA ++ T E+VAIKKI + F++ DA R LREIKLLR L H
Sbjct: 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHE 64
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
+++ IK IM PP R F D+Y+V+ELM++DLHQ+I+++ L+ +H Q+FLYQLLRGLKYI
Sbjct: 65 NVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H+ANV HRDLKP N+L NA+C LKICDFGLAR + F T+YV TRWYRAPEL
Sbjct: 125 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD---FMTEYVVTRWYRAPELLL 181
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
+ S+YT AID+WS+GCIFAE+L KPLFPGK+ VHQL L+T+LLG+PS E + IRNEK
Sbjct: 182 N-CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412
ARRY+ S+ F+ FP+A+PLA+ LLE++L FDP R T EEALA PY L +
Sbjct: 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300
Query: 413 DREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 451
EP Q + F+FE L ++D++E+IY E+L YHP
Sbjct: 301 SDEPVCQ--TPFSFDFEEDALTEEDIKELIYNEMLAYHP 337
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 429 bits (1104), Expect = e-149
Identities = 173/342 (50%), Positives = 236/342 (69%), Gaps = 16/342 (4%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
RYQ IG+G+YG+V SA TG +VAIKKI+ FEH + R LREIK+LR +H
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP-FEHQTFCQRTLREIKILRRFKH 62
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+I+ I I+ PPS F D+Y+V ELME+DL+++IK L+ +H Q+FLYQ+LRGLKY
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH-LSNDHIQYFLYQILRGLKY 121
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
IH+ANV HRDLKP N+L N +C LKICDFGLAR++ + F T+YVATRWYRAPE+
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
+ YT AIDIWS+GCI AEML+ +PLFPGK+ +HQL+L+ +LGTPS E ++ I +
Sbjct: 182 LNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY---FHG 408
+AR Y+ S+ K VP++ FPNADP AL LL+++L F+P R T EEALA PY +H
Sbjct: 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH- 299
Query: 409 LANVDREPSTQPISKLEFEFE---RRKLAKDDVREMIYREIL 447
+PS +P+++ F F+ L K+ ++E+I+ EI+
Sbjct: 300 ------DPSDEPVAEEPFPFDFELFDDLPKEKLKELIFEEIM 335
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 411 bits (1059), Expect = e-142
Identities = 175/334 (52%), Positives = 241/334 (72%), Gaps = 5/334 (1%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
SRY+ E IG G+YGVV SA+DT +G++VAIKKI F+ + A R LRE+K+LR +H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
+I+ I+ I+ PP +FKD+YVV +LMESDLH +I ++ LT EH ++FLYQLLRGLKYI
Sbjct: 65 NIIAIRDILRPPGA-DFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLAR-VSFNDAPSAIFWTDYVATRWYRAPELC 291
H+ANV HRDLKP N+L N DC+L+I DFG+AR +S + F T+YVATRWYRAPEL
Sbjct: 124 HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
S +YT AID+WS+GCIFAEML + LFPGKN VHQL L+ +LG+PS E ++RI ++
Sbjct: 184 LSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411
+ R+Y+ ++ +KQPVP+S FP A P AL LL ++L FDP++R T E+AL P+ +
Sbjct: 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302
Query: 412 VDREPSTQPISKLEFEFERRKLAKDDVREMIYRE 445
D EP+ P +F+FE +L+++ ++E I +E
Sbjct: 303 PDDEPTCPP--PFDFDFEAIELSREQLKEAIVKE 334
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 369 bits (950), Expect = e-125
Identities = 155/339 (45%), Positives = 212/339 (62%), Gaps = 13/339 (3%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-H 171
+Y+I + +GKG+YG+V A+D T E VA+KKI D F + +DA R REI L+ L H
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDH 66
Query: 172 PDIVEIKHIMLPPSRREF-KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 230
P+IV++ +++ + E KDIY+VFE ME+DLH VI+AN L H ++ +YQLL+ LK
Sbjct: 67 PNIVKLLNVI----KAENDKDIYLVFEYMETDLHAVIRANI-LEDVHKRYIMYQLLKALK 121
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARV--SFNDAPSAIFWTDYVATRWYRAP 288
YIH+ NV HRDLKP NIL N+DC++K+ DFGLAR + P TDYVATRWYRAP
Sbjct: 122 YIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181
Query: 289 E-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
E L GS ++YT +D+WS+GCI EML GKPLFPG + ++QL+ + +++G PS E I
Sbjct: 182 EILLGS--TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407
I++ A L S+ + P P A AL LL++LL F+P R TAEEAL PY
Sbjct: 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA 299
Query: 408 GLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREI 446
N EP + + + KL+ + R +Y EI
Sbjct: 300 QFHNPSDEPVLPYPITIPLD-DNVKLSVAEYRNKLYEEI 337
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 365 bits (939), Expect = e-124
Identities = 152/346 (43%), Positives = 216/346 (62%), Gaps = 12/346 (3%)
Query: 107 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL 166
T + RYQ +G G+YG V SA DT TG +VAIKK++ F+ A R RE++LL
Sbjct: 9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLL 68
Query: 167 RLLRHPDIVEIKHIMLPPSRRE-FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQL 225
+ + H +++ + + P S E F+D+Y+V LM +DL+ ++K L+ +H QF +YQ+
Sbjct: 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK-LSDDHIQFLVYQI 127
Query: 226 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
LRGLKYIH+A + HRDLKP NI N DC+LKI DFGLAR + ++ T YVATRWY
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM------TGYVATRWY 181
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
RAPE+ ++ Y +DIWS+GCI AE+LTGK LFPG + + QL + +L+GTP E +
Sbjct: 182 RAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
+I +E AR Y+ S+ + F F A+PLA+ LLE++L DP R TA EALA PY
Sbjct: 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300
Query: 406 FHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 451
+ + EP P + FE R L D+ +E++Y+EI+ + P
Sbjct: 301 LAEYHDPEDEPVAPPYDQS---FESRDLTVDEWKELVYKEIMNFKP 343
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 360 bits (926), Expect = e-122
Identities = 170/337 (50%), Positives = 223/337 (66%), Gaps = 9/337 (2%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHT--GERVAIKKINDVFEHVSDATRILREIKLLRLLR- 170
RY++ + +G+G+YG+V SA + T E VAIKKI +VF A R LRE+KLLR R
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 230
H +I + + M F ++Y+ ELME+DLHQ+I++ LT H+Q F+YQ+L GLK
Sbjct: 61 HKNITCL-YDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLK 119
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VSFNDAPSAIFWTDYVATRWYRAPE 289
YIH+ANV HRDLKP N+L NADC+LKICDFGLAR S N +A F T+YVATRWYRAPE
Sbjct: 120 YIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
+ SF YT AID+WS+GCI AE+L KP+F GK+ V QL+ + +LGTP E++SRI
Sbjct: 180 IMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409
+ KA+ Y+ S+ PF FPNA+PLAL LLE+LLAFDP R + EEAL PY
Sbjct: 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298
Query: 410 ANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREI 446
+ D EP Q FE E + +++R+MI E+
Sbjct: 299 HDPDDEPVCQKPFDFSFESED---SMEELRDMIIEEV 332
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 329 bits (845), Expect = e-110
Identities = 162/346 (46%), Positives = 224/346 (64%), Gaps = 24/346 (6%)
Query: 105 FFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK 164
F T + +RY + +G G++G+V SA D TG+ VAIKKI F A R RE+K
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 165 LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQ 224
LL+ LRH +I+ + I + P +DIY V EL+ +DLH+++ + L + Q+FLYQ
Sbjct: 62 LLKHLRHENIISLSDIFISP----LEDIYFVTELLGTDLHRLLTSRP-LEKQFIQYFLYQ 116
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
+LRGLKY+H+A V HRDLKP NIL N +C LKICDFGLAR+ T YV+TR+
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM------TGYVSTRY 170
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344
YRAPE+ ++ KY +DIWS GCIFAEML GKPLFPGK+ V+Q ++TDLLGTP +
Sbjct: 171 YRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229
Query: 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
I+ I +E R++ S+ K++PVPFS KF NADP A+ LLE++L FDP+ R +A EALA P
Sbjct: 230 INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289
Query: 405 Y---FHGLANVDREPSTQPISKLEFE--FERRKLAKDDVREMIYRE 445
Y +H +P+ +P+++ +F+ F L D + M+Y E
Sbjct: 290 YLAPYH-------DPTDEPVAEEKFDWSFNDADLPVDTWKVMMYSE 328
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 321 bits (824), Expect = e-107
Identities = 136/294 (46%), Positives = 178/294 (60%), Gaps = 13/294 (4%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
YQ IG+G+YGVV A D TGE VAIKKI FE LREIKLL+ L HP+I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIH 233
+++ + D+Y+VFE M++DL+++IK L + +LYQLL+GL + H
Sbjct: 61 IKLLDVFRHK-----GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCG 292
+ + HRDLKP+N+L N + LK+ DFGLAR +T YV TRWYRAPE L G
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSF---GSPVRPYTHYVVTRWYRAPELLLG 172
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
Y+ +DIWS+GCIFAE+L+ +PLFPGK+ + QL + LGTP E + +
Sbjct: 173 DKG--YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS-L 229
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
AR Y S KK +P FPNA P AL LL ++L +DP R TAE+ALA PYF
Sbjct: 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 309 bits (794), Expect = e-103
Identities = 126/296 (42%), Positives = 174/296 (58%), Gaps = 18/296 (6%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLRHP 172
Y+ E +G+G+YGVV A D TGE VA+KKI ++ + LREI LL+ L+HP
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHP 58
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKY 231
+IV++ ++ + +Y+VFE + DL + + L+P + +YQLLRGL Y
Sbjct: 59 NIVKLLDVIHTERK-----LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-L 290
H+ + HRDLKP+NIL N D LK+ DFGLAR +F +T V T WYRAPE L
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGLAR-AFGIPLRT--YTHEVVTLWYRAPEIL 170
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350
GS Y+ A+DIWS+GCIFAEM+TGKPLFPG + + QL + +LGTP+ ES +
Sbjct: 171 LGS--KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV-- 226
Query: 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
K Y + K P P DP + LL ++L ++P R +A+EAL PYF
Sbjct: 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 310 bits (796), Expect = e-102
Identities = 148/354 (41%), Positives = 211/354 (59%), Gaps = 32/354 (9%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
IG G++GVV S D G+RVA+KK+ +VF+++ R+ RE+K+L +H +++ I
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 181 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 240
+ PP F++IYVV ELM+SDLH++I + L+ +H + FLYQ+LRGLKY+H+A + HR
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHR 127
Query: 241 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFFSKYT 299
D+KP N+L N++C LKICDFGLARV D + T V T++YRAPE L GS YT
Sbjct: 128 DIKPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEVVTQYYRAPEILMGS--RHYT 183
Query: 300 PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGS 359
A+DIWS+GCIFAE+L + LF ++ + QLDL+TDLLGTPS E++ E AR ++
Sbjct: 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC-EGARAHILR 242
Query: 360 MRKKQP---VPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY-------FHG- 408
K P V ++ A+HLL R+L FDP R +A +ALA PY +H
Sbjct: 243 GPHKPPSLPVLYTLSSQATHE-AVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTC 301
Query: 409 ------------LANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYH 450
+ D EPS P E+E + V+E +++ ILE
Sbjct: 302 MCKCCYTTSGGRVYTSDFEPSANPPFDDEYEKNLTSV--RQVKEELHQFILEQQ 353
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 291 bits (746), Expect = 5e-95
Identities = 147/339 (43%), Positives = 215/339 (63%), Gaps = 12/339 (3%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
RYQ +G G+YG V +A DT TG RVA+KK++ F+ + A R RE++LL+ ++H +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 77
Query: 174 IVEIKHIMLPP-SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
++ + + P S EF D+Y+V LM +DL+ ++K LT +H QF +YQ+LRGLKYI
Sbjct: 78 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYI 136
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H+A++ HRDLKP N+ N DC+LKI DFGLAR + ++ T YVATRWYRAPE+
Sbjct: 137 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM------TGYVATRWYRAPEIML 190
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
++ Y +DIWS+GCI AE+LTG+ LFPG + + QL L+ L+GTP E + +I +E
Sbjct: 191 NWM-HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412
AR Y+ S+ + + F++ F A+PLA+ LLE++L D R TA +ALA YF +
Sbjct: 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309
Query: 413 DREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 451
D EP P + FE R L D+ + + Y E++ + P
Sbjct: 310 DDEPVADPYDQ---SFESRDLLIDEWKSLTYDEVISFVP 345
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 283 bits (727), Expect = 8e-93
Identities = 116/302 (38%), Positives = 172/302 (56%), Gaps = 29/302 (9%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK-LLRLLRHPD 173
Y++ + +G G++G V A + TGE VAIKK+ F + LRE+K L +L HP+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNEHPN 59
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKY 231
IV++K + RE ++Y VFE ME +L+Q++K + + +YQ+L+GL +
Sbjct: 60 IVKLKEV-----FRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL- 290
IH FHRDLKP+N+L + +KI DFGLAR + P +TDYV+TRWYRAPE+
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP----YTDYVSTRWYRAPEIL 170
Query: 291 --CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348
S Y+ +DIW++GCI AE+ T +PLFPG + + QL + +LGTP+ +
Sbjct: 171 LRSTS----YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE- 225
Query: 349 RNEKARRYLGSMR----KKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
+ + + P PNA P A+ L++ +L +DPK RPTA +AL P
Sbjct: 226 ----GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281
Query: 405 YF 406
YF
Sbjct: 282 YF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 281 bits (719), Expect = 7e-91
Identities = 140/339 (41%), Positives = 202/339 (59%), Gaps = 13/339 (3%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
RY + +G G+YG V SA+D TGE+VAIKK++ F+ A R RE+ LL+ ++H +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 174 IVEIKHIMLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
++ + + S EF+D Y+V M++DL +++ L+ + Q+ +YQ+L GLKYI
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYI 133
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H+A + HRDLKP N+ N DC+LKI DFGLAR + DA T YV TRWYRAPE+
Sbjct: 134 HSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA--DAE----MTGYVVTRWYRAPEVIL 187
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
++ Y +DIWS+GCI AEMLTGK LF GK+ + QL + + G P E + ++ ++
Sbjct: 188 NWM-HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412
A+ Y+ S+ K FS FP A P A+ LLE++L D R TA EAL PYF +
Sbjct: 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306
Query: 413 DREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 451
D E QP E KL+ D+ ++ IY+E+ + P
Sbjct: 307 DEETEQQPYDD---SLENEKLSVDEWKKHIYKEVKSFSP 342
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 278 bits (714), Expect = 9e-91
Identities = 119/302 (39%), Positives = 174/302 (57%), Gaps = 25/302 (8%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLRHP 172
Y+ IG+G+YG V A + TGE VA+KKI E+ + I +REIKLL+ LRHP
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHP 58
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVI-KANDDLTPEHYQFFLYQLLRGLKY 231
+IV +K I+ + IY+VFE M+ DL ++ T + ++ QLL GL+Y
Sbjct: 59 NIVRLKEIVTSKGK---GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-L 290
+H+ + HRD+K NIL N D LK+ DFGLAR + SA + T+ V T WYR PE L
Sbjct: 116 LHSNGILHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADY-TNRVITLWYRPPELL 173
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350
G+ ++Y P +D+WS+GCI AE+ GKP+F G + QL+ + +L G+P+ E+ +
Sbjct: 174 LGA--TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231
Query: 351 EKARRYLGSMRKKQPVP------FSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
+ +++ K+P F H DP AL LL++LL DPK R +A++AL
Sbjct: 232 LP---WFENLKPKKPYKRRLREFFKHLI---DPSALDLLDKLLTLDPKKRISADQALQHE 285
Query: 405 YF 406
YF
Sbjct: 286 YF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 276 bits (709), Expect = 2e-90
Identities = 109/293 (37%), Positives = 150/293 (51%), Gaps = 40/293 (13%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
Y+I E +G+GS+G V A D TG+ VAIK I D RILREIK+L+ L+HP+I
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI-KKDRERILREIKILKKLKHPNI 59
Query: 175 VEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
V + + +Y+V E E DL ++K L+ + +F+L Q+L L+Y+H
Sbjct: 60 VRLYDVFEDE-----DKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLH 114
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
+ + HRDLKP+NIL + D +K+ DFGLAR T +V T Y APE+
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL----TTFVGTPEYMAPEVLLG 170
Query: 294 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353
Y A+DIWS+G I E+LTGKP FPG + QL + +G P
Sbjct: 171 --KGYGKAVDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKP------------- 212
Query: 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
PF + P A L+ +LL DP+ R TAEEAL P+F
Sbjct: 213 -----------KPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 277 bits (709), Expect = 2e-89
Identities = 136/340 (40%), Positives = 209/340 (61%), Gaps = 12/340 (3%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
RY+ + +G G+YG V SA+D TG +VAIKK+ F+ A R RE++LL+ ++H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 173 DIVEIKHIMLPP-SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+++ + + P S F D Y+V M +DL +++K ++ L+ + QF +YQ+L+GLKY
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKY 133
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
IH A + HRDLKP N+ N DC+LKI DFGLAR + ++ T YV TRWYRAPE+
Sbjct: 134 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM------TGYVVTRWYRAPEVI 187
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
++ YT +DIWS+GCI AEMLTGKPLF G + + QL + + GTPS E + ++++E
Sbjct: 188 LNWM-HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411
A+ Y+ + + + F PNA+PLA+++LE++L D + R TA EALA PYF +
Sbjct: 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306
Query: 412 VDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 451
+ E P + F+ + ++ + + + EIL + P
Sbjct: 307 PEDETEAPP---YDDSFDEVDQSLEEWKRLTFTEILSFQP 343
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 276 bits (707), Expect = 4e-89
Identities = 138/339 (40%), Positives = 209/339 (61%), Gaps = 12/339 (3%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
RYQ +G G+YG V SA DT ++VA+KK++ F+ + A R RE++LL+ ++H +
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHEN 75
Query: 174 IVEIKHIMLPP-SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
++ + + P S F ++Y+V LM +DL+ ++K L+ EH QF +YQLLRGLKYI
Sbjct: 76 VIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK-LSDEHVQFLIYQLLRGLKYI 134
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H+A + HRDLKP N+ N DC+L+I DFGLAR + ++ T YVATRWYRAPE+
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM------TGYVATRWYRAPEIML 188
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
++ Y +DIWS+GCI AE+L GK LFPG + + QL + +++GTPS E + +I +E
Sbjct: 189 NWM-HYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412
AR+Y+ S+ F A+PLA+ LLE++L D R +A EALA PYF +
Sbjct: 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP 307
Query: 413 DREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 451
+ EP +P + E ++ ++ +E+ Y E+ + P
Sbjct: 308 EDEPEAEPYDE---SPENKERTIEEWKELTYEEVSSFKP 343
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 266 bits (682), Expect = 5e-86
Identities = 121/299 (40%), Positives = 174/299 (58%), Gaps = 20/299 (6%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
RY+I IG+G++G+V A D TGE VA+KK+ + LREIK L+ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYI 232
+V++ + S +V E M SDL +V++ + L + ++ LL+G+ Y+
Sbjct: 61 VVKLLDVFPHGSG-----FVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC- 291
H + HRDLKP N+L +AD LKI DFGLAR+ + P ++ VATRWYRAPEL
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL--YSHQVATRWYRAPELLY 173
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN- 350
G+ KY P +D+W++GCIFAE+L G PLFPG+N + QL ++ LGTP+ E+ + +
Sbjct: 174 GA--RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231
Query: 351 ---EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
K + +P+P FP+A P AL LL+ LL +DP R +A EAL PYF
Sbjct: 232 PDYNKIT-----FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 265 bits (680), Expect = 2e-85
Identities = 125/300 (41%), Positives = 168/300 (56%), Gaps = 20/300 (6%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI-NDVFEHVSDATRI--LREIKLLRLLR 170
RY+ + +G+G+Y VV A D TG VAIKKI + D LREIKLL+ L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGL 229
HP+I+ + + S I +VFE ME+DL +VIK LTP + ++ LRGL
Sbjct: 61 HPNIIGLLDVFGHKSN-----INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGL 115
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
+Y+H+ + HRDLKP N+L +D LK+ DFGLAR SF P+ T V TRWYRAPE
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR-SFGS-PNRKM-THQVVTRWYRAPE 172
Query: 290 LCGSFF--SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
L F Y +D+WS+GCIFAE+L P PG + + QL + + LGTP+ E+
Sbjct: 173 L---LFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407
+ + Y+ + P P FP A AL LL+RLL +P R TA +AL PYF
Sbjct: 230 VTSLP--DYV-EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 259 bits (665), Expect = 2e-83
Identities = 116/296 (39%), Positives = 168/296 (56%), Gaps = 12/296 (4%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Y++ V+G+G+YGVV + TGE VAIKK + + LRE+K+LR LRH +
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYI 232
IV +K RR+ + +Y+VFE +E L ++++A+ L P+ + +++QLL+ + Y
Sbjct: 62 IVNLKEAF----RRKGR-LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LC 291
H+ N+ HRD+KP+NIL + LK+CDFG AR A A TDYVATRWYRAPE L
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFAR--ALRARPASPLTDYVATRWYRAPELLV 174
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
G + Y +D+W+IGCI AE+L G+PLFPG + + QL L+ LG +
Sbjct: 175 GD--TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232
Query: 352 KARRYLGSMRKKQPVPFSHKFPNA-DPLALHLLERLLAFDPKDRPTAEEALADPYF 406
+ QP ++P AL L+ L DPK+R T +E L PYF
Sbjct: 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 261 bits (670), Expect = 2e-83
Identities = 132/348 (37%), Positives = 202/348 (58%), Gaps = 24/348 (6%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
RYQ + IG G+ G+V +A DT TG+ VAIKK++ F++V+ A R RE+ L++L+ H
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 173 DIVEIKHIMLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+I+ + ++ P S EF+D+Y+V ELM+++L QVI DL E + LYQ+L G+K+
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI--QMDLDHERMSYLLYQMLCGIKH 133
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
+H+A + HRDLKP NI+ +DC LKI DFGLAR A ++ T YV TR+YRAPE+
Sbjct: 134 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYVVTRYYRAPEVI 189
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
Y +DIWS+GCI EM+ G LFPG + + Q + + + LGTPS E +SR+
Sbjct: 190 LGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL-QP 246
Query: 352 KARRYLGSMRKKQPVPFSHKFP---------NADPL----ALHLLERLLAFDPKDRPTAE 398
R Y+ + K F FP + + L A LL ++L DP+ R + +
Sbjct: 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306
Query: 399 EALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREI 446
+AL PY + + E P + + + R+ ++ +E+IY+E+
Sbjct: 307 DALQHPYIN-VWYDPSEVEAPPPAPYDHSIDEREHTVEEWKELIYKEV 353
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 256 bits (655), Expect = 2e-81
Identities = 140/346 (40%), Positives = 189/346 (54%), Gaps = 45/346 (13%)
Query: 109 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI---LREIKL 165
+ SRY +G GS G+V SAVD+ +RVA+KKI ++D + LREIK+
Sbjct: 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIV-----LTDPQSVKHALREIKI 55
Query: 166 LRLLRHPDIVEIKHIMLPPSRR---------EFKDIYVVFELMESDLHQVIKANDDLTPE 216
+R L H +IV++ ++ P E +Y+V E ME+DL V++ L+ E
Sbjct: 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP-LSEE 114
Query: 217 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVSFNDAPSAIF 275
H + F+YQLLRGLKYIH+ANV HRDLKP N+ N D LKI DFGLAR+ +
Sbjct: 115 HARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTD 335
++ + T+WYR+P L S + YT AID+W+ GCIFAEMLTGKPLF G H+L+ M
Sbjct: 175 LSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGA---HELEQMQL 230
Query: 336 LLGTPSTESISRIRNE-----------KARRYLGSMRKKQPVPFSHKFPNADPLALHLLE 384
+L ES+ +R E R G R+ P P +P AL LE
Sbjct: 231 IL-----ESVPVVREEDRNELLNVIPSFVRNDGGEPRR----PLRDLLPGVNPEALDFLE 281
Query: 385 RLLAFDPKDRPTAEEALADPYFHGLANVDREP-STQPISKLEFEFE 429
++L F+P DR TAEEAL PY + EP S P +E E +
Sbjct: 282 QILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPFH-IEDELD 326
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 251 bits (643), Expect = 2e-80
Identities = 97/293 (33%), Positives = 144/293 (49%), Gaps = 34/293 (11%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
Y++ +G GS+G V A TG+ VA+K + E REI++LR L HP+I
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 175 VEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
V + + +Y+V E E DL + L+ + + Q+LRGL+Y+H
Sbjct: 61 VRLIDAF-----EDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
+ + HRDLKP+NIL + + +KI DFGLA+ + S T +V T WY APE+
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL---TTFVGTPWYMAPEVL-L 171
Query: 294 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353
+ Y P +D+WS+G I E+LTGKP F G+N++ QL + I RI
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQL------------QLIRRI----- 214
Query: 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
+ ++ A L+++ L DP RPTAEE L P+F
Sbjct: 215 ------LGPPLEFDEPKWSSGSEE-AKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 239 bits (612), Expect = 1e-75
Identities = 120/302 (39%), Positives = 164/302 (54%), Gaps = 25/302 (8%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLRHP 172
Y+ I +G+YGVV A D TGE VA+KK+ E + I LREI +L L+HP
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK--MEKEKEGFPITSLREINILLKLQHP 64
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKY 231
+IV +K +++ IY+V E +E DL +++ + + QLL G+ +
Sbjct: 65 NIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAH 121
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-L 290
+H + HRDLK N+L N LKICDFGLAR + +T V T WYRAPE L
Sbjct: 122 LHDNWILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKP--YTQLVVTLWYRAPELL 178
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES---ISR 347
G+ +Y+ AID+WS+GCIFAE+LT KPLFPGK+ + QL+ + LLGTP+ + S
Sbjct: 179 LGA--KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236
Query: 348 IRNEKARRYLGSMRKKQPV-PFSHKFPNA--DPLALHLLERLLAFDPKDRPTAEEALADP 404
+ K + K P KFP LL RLL +DP R +AE+AL P
Sbjct: 237 LPGAKKKT-----FTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHP 291
Query: 405 YF 406
YF
Sbjct: 292 YF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 232 bits (595), Expect = 8e-73
Identities = 113/316 (35%), Positives = 165/316 (52%), Gaps = 34/316 (10%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLR 170
Y+I +G+G++G V A TG VA+KKI + + D I LREIK+L+ L+
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI--LMHNEKDGFPITALREIKILKKLK 65
Query: 171 HPDIVEIKHIML---PPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLL 226
HP++V + + + S+R+ +Y+V M+ DL +++ LT + ++ QLL
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP--------SAIFWTD 278
G+ Y+H ++ HRD+K NIL + LKI DFGLAR P +T+
Sbjct: 126 EGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185
Query: 279 YVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 337
V TRWYR PEL G +YT A+DIW IGC+FAEM T +P+ GK+ + QL L+ L
Sbjct: 186 LVVTRWYRPPELLLGE--RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243
Query: 338 GTPSTESISRIR-------NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFD 390
GTP+ E+ R Y ++ + +F P L LL +LL+ D
Sbjct: 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE--------RFGKLGPEGLDLLSKLLSLD 295
Query: 391 PKDRPTAEEALADPYF 406
P R TA +AL PYF
Sbjct: 296 PYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 231 bits (591), Expect = 2e-72
Identities = 116/308 (37%), Positives = 161/308 (52%), Gaps = 37/308 (12%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDA---TRILREIKLLRLLR- 170
Y+ IG+G+YG V A D +TG VA+KK+ +S+ LREI LL+ L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR---VPLSEEGIPLSTLREIALLKQLES 57
Query: 171 --HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK--ANDDLTPEHYQFFLYQLL 226
HP+IV + + P + +VFE ++ DL + L PE + + QLL
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV-SFNDAPSAIFWTDYVATRWY 285
RG+ ++H+ + HRDLKP+NIL +D ++KI DFGLAR+ SF A+ T V T WY
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE---MAL--TSVVVTLWY 172
Query: 286 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE- 343
RAPE L S Y +D+WS+GCIFAE+ +PLF G + QLD + D++G PS E
Sbjct: 173 RAPEVLLQ---SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229
Query: 344 -----SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 398
S+ R S P F P L LL+++L F+P R +A
Sbjct: 230 WPRNVSLPRS----------SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAF 279
Query: 399 EALADPYF 406
EAL PYF
Sbjct: 280 EALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 229 bits (586), Expect = 2e-71
Identities = 127/295 (43%), Positives = 167/295 (56%), Gaps = 25/295 (8%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLRHPDIVEIK 178
IG+G+YG+V A DT +GE VA+KK+ ++ D I LREI LL LRHP+IVE+K
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVR--MDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 179 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANV 237
+++ + I++V E E DL ++ + + + QLLRGL+Y+H +
Sbjct: 73 EVVVG---KHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFI 129
Query: 238 FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFFS 296
HRDLK N+L LKI DFGLAR + + T V T WYRAPE L G +
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLART-YGLPAKPM--TPKVVTLWYRAPELLLGC--T 184
Query: 297 KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI----SRIRNEK 352
YT AID+W++GCI AE+L KPL PGK+ + QLDL+ LLGTP+ ESI S +
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN-ESIWPGFSDLPL-- 241
Query: 353 ARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
++ KQP HKFP L LL LL +DPK R TAEEAL YF
Sbjct: 242 VGKF---TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 226 bits (577), Expect = 2e-70
Identities = 122/298 (40%), Positives = 167/298 (56%), Gaps = 21/298 (7%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSD---ATRILREIKLLRLLRH 171
YQ E IG+G+YGVV A D TGE VA+KKI E + +T I REI LL+ L H
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIR--LETEDEGVPSTAI-REISLLKELNH 57
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVI--KANDDLTPEHYQFFLYQLLRGL 229
P+IV + ++ ++ +Y+VFE ++ DL + + L P + +LYQLL+G+
Sbjct: 58 PNIVRLLDVVHSENK-----LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
Y H+ V HRDLKP+N+L + + LK+ DFGLAR +F +T V T WYRAPE
Sbjct: 113 AYCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR-AFGVPVRT--YTHEVVTLWYRAPE 169
Query: 290 -LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348
L GS Y+ +DIWSIGCIFAEM+ +PLFPG + + QL + LGTP + +
Sbjct: 170 ILLGSRQ--YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV 227
Query: 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
Y + K S PN D L LL ++L +DP R +A+ AL PYF
Sbjct: 228 --TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 225 bits (576), Expect = 3e-70
Identities = 113/297 (38%), Positives = 173/297 (58%), Gaps = 20/297 (6%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPD 173
Y+I IG+G++ V A TG+ AIK + F+ + LREI+ LR L HP+
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPHPN 59
Query: 174 IVEIKHIML-PPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLRGLKY 231
I+ + ++ + R + +VFELM+ +L+++IK PE + ++YQLL+ L +
Sbjct: 60 ILRLIEVLFDRKTGR----LALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-- 289
+H +FHRD+KP+NIL D LK+ DFG R ++ P +T+Y++TRWYRAPE
Sbjct: 116 MHRNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPP----YTEYISTRWYRAPECL 170
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
L + Y P +DIW++GC+F E+L+ PLFPG N + Q+ + D+LGTP E + + R
Sbjct: 171 LTDGY---YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR 227
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
+ Y + K+ PNA L LL++LLA+DP +R TA++AL PYF
Sbjct: 228 KSRHMNY--NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 227 bits (579), Expect = 7e-70
Identities = 129/369 (34%), Positives = 210/369 (56%), Gaps = 29/369 (7%)
Query: 99 SALETEFFT-EYGEAS-----RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH 152
S +++F++ + +++ RYQ + IG G+ G+V +A DT G VA+KK++ F++
Sbjct: 1 SEEDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN 60
Query: 153 VSDATRILREIKLLRLLRHPDIVEIKHIMLP-PSRREFKDIYVVFELMESDLHQVIKAND 211
+ A R RE+ LL+ + H +I+ + ++ P S EF+D+Y+V ELM+++L QVI
Sbjct: 61 QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM-- 118
Query: 212 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271
+L E + LYQ+L G+K++H+A + HRDLKP NI+ +DC LKI DFGLAR A
Sbjct: 119 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AC 174
Query: 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD 331
+ T YV TR+YRAPE+ Y +DIWS+GCI E++ G +F G + + Q +
Sbjct: 175 TNFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN 232
Query: 332 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPN--------ADPL----A 379
+ + LGTPS E ++R++ R Y+ + + + F FP+ D L A
Sbjct: 233 KVIEQLGTPSAEFMNRLQ-PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQA 291
Query: 380 LHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVR 439
LL ++L DP R + +EAL PY + E P + + E R+ A ++ +
Sbjct: 292 RDLLSKMLVIDPDKRISVDEALRHPYITVWYD-PAEAEAPPPQIYDAQLEEREHAIEEWK 350
Query: 440 EMIYREILE 448
E+IY+E+++
Sbjct: 351 ELIYKEVMD 359
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 223 bits (570), Expect = 2e-69
Identities = 115/296 (38%), Positives = 171/296 (57%), Gaps = 17/296 (5%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
++ E +G+G+Y V + TGE VA+K+I+ E + +T I REI L++ L+H +I
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-REISLMKELKHENI 60
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD---LTPEHYQFFLYQLLRGLKY 231
V + ++ ++ + +VFE M+ DL + + + L P + F YQLL+G+ +
Sbjct: 61 VRLHDVIHTENK-----LMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-L 290
H V HRDLKP+N+L N +LK+ DFGLAR +F P F + V T WYRAP+ L
Sbjct: 116 CHENRVLHRDLKPQNLLINKRGELKLADFGLAR-AFG-IPVNTFSNE-VVTLWYRAPDVL 172
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350
GS Y+ +IDIWS+GCI AEM+TG+PLFPG N QL + ++GTP+ + I
Sbjct: 173 LGS--RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230
Query: 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
Y + + P FP+ADPL + LL RLL +P+ R +A +AL P+F
Sbjct: 231 --LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 7e-68
Identities = 117/324 (36%), Positives = 168/324 (51%), Gaps = 39/324 (12%)
Query: 114 RYQIQEVIGKGSYGVVGSAV--DTHTGERVAIKKI---NDVFEHVSDATRILREIKLLRL 168
+Y+I+ IG+G+YG V A + G+ AIKK + + +S + REI LLR
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSA--CREIALLRE 58
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK-----ANDDLTPEHYQFFLY 223
L+H ++V + + L + + +Y++F+ E DL Q+IK + P + L+
Sbjct: 59 LKHENVVSLVEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCK----LKICDFGLARVSFNDAPSAIFWTD- 278
Q+L G+ Y+H+ V HRDLKP NIL + +KI D GLAR+ FN + D
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL-FNAPLKPLADLDP 174
Query: 279 YVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV---------VH 328
V T WYRAPEL G+ YT AIDIW+IGCIFAE+LT +P+F G+
Sbjct: 175 VVVTIWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD 232
Query: 329 QLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFS------HKFPNADPLALHL 382
QL+ + ++LGTP+ + I+ L K + P + K D L
Sbjct: 233 QLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL 292
Query: 383 LERLLAFDPKDRPTAEEALADPYF 406
L +LL +DP R TAEEAL PYF
Sbjct: 293 LRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 211 bits (540), Expect = 5e-65
Identities = 117/304 (38%), Positives = 170/304 (55%), Gaps = 30/304 (9%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI----LREIKLLRLL 169
+Y+ IG+GSYGVV + TG+ VAIKK F D I LREI++L+ L
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKK----FVESEDDPVIKKIALREIRMLKQL 57
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRG 228
+HP++V + + RR+ K +++VFE + + ++ N PEH + ++Q L+
Sbjct: 58 KHPNLVNLIEVF----RRKRK-LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQA 112
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
+ + H N HRD+KP+NIL ++K+CDFG AR+ +TDYVATRWYRAP
Sbjct: 113 VNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL---TGPGDDYTDYVATRWYRAP 169
Query: 289 EL-CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG--TPSTESI 345
EL G ++Y P +D+W+IGC+FAE+LTG+PL+PGK+ V QL L+ LG P + I
Sbjct: 170 ELLVGD--TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227
Query: 346 SRIRNEKARRYLGSMRKKQP---VPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402
++ + +P P KFPN AL L+ L DP +R + EE L
Sbjct: 228 FS-----TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282
Query: 403 DPYF 406
PYF
Sbjct: 283 HPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 211 bits (540), Expect = 8e-65
Identities = 114/304 (37%), Positives = 170/304 (55%), Gaps = 19/304 (6%)
Query: 109 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 168
+G+ Y+ + +G+GSY V TG+ VA+K+I E + T I RE LL+
Sbjct: 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-REASLLKD 59
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVI-KANDDLTPEHYQFFLYQLLR 227
L+H +IV + I+ K + +VFE +++DL Q + L+ + + FL+QLLR
Sbjct: 60 LKHANIVTLHDII-----HTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR 114
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
GL Y H V HRDLKP+N+L + +LK+ DFGLAR PS + ++ V T WYR
Sbjct: 115 GLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARA--KSVPSKTY-SNEVVTLWYRP 171
Query: 288 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG-KNVVHQLDLMTDLLGTPSTESI 345
P+ L GS ++Y+ ++D+W +GCIF EM TG+PLFPG +V QL + +LGTP+ E+
Sbjct: 172 PDVLLGS--TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETW 229
Query: 346 SRI-RNEKARRYLGSMRKKQPVPFSHKFPNAD--PLALHLLERLLAFDPKDRPTAEEALA 402
+ N + + Y S P P + P D P L + L ++PK R +A EA+
Sbjct: 230 PGVSSNPEFKPY--SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287
Query: 403 DPYF 406
PYF
Sbjct: 288 HPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 212 bits (540), Expect = 4e-64
Identities = 128/352 (36%), Positives = 200/352 (56%), Gaps = 29/352 (8%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
RYQ + IG G+ G+V +A D VAIKK++ F++ + A R RE+ L++ + H +
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 174 IVEIKHIMLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
I+ + ++ P S EF+D+Y+V ELM+++L QVI+ +L E + LYQ+L G+K++
Sbjct: 85 IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHL 142
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H+A + HRDLKP NI+ +DC LKI DFGLAR A ++ T YV TR+YRAPE+
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYVVTRYYRAPEVIL 198
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
Y +DIWS+GCI EM+ G LFPG + + Q + + + LGTP E + +++
Sbjct: 199 GM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ-PT 255
Query: 353 ARRYLGSMRKKQPVPFSHKFPN----AD--------PLALHLLERLLAFDPKDRPTAEEA 400
R Y+ + K F FP+ AD A LL ++L D R + +EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 401 LADPYFHGLANVDREPS--TQPISKL-EFEFERRKLAKDDVREMIYREILEY 449
L PY NV +PS P K+ + + + R+ ++ +E+IY+E+++
Sbjct: 316 LQHPYI----NVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDL 363
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 211 bits (538), Expect = 4e-64
Identities = 120/324 (37%), Positives = 169/324 (52%), Gaps = 43/324 (13%)
Query: 112 ASRY-QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR------------ 158
+ RY Q +G+G+YG V A DT TG+ VAIKK+ + E +D T+
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKII-EISNDVTKDRQLVGMCGIHF 65
Query: 159 -ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH 217
LRE+K++ ++H +I+ + + + +F I +V ++M SDL +V+ LT
Sbjct: 66 TTLRELKIMNEIKHENIMGLVDVYV---EGDF--INLVMDIMASDLKKVVDRKIRLTESQ 120
Query: 218 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF-- 275
+ L Q+L GL +H HRDL P NI N+ KI DFGLAR S
Sbjct: 121 VKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 276 ---------WTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
T V T WYRAPEL G+ KY A+D+WS+GCIFAE+LTGKPLFPG+N
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGA--EKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238
Query: 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGS---MRKKQPVPFSHKFPNADPLALHL 382
+ QL + +LLGTP+ + N + L ++P FPNA A+ L
Sbjct: 239 EIDQLGRIFELLGTPNED------NWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDL 292
Query: 383 LERLLAFDPKDRPTAEEALADPYF 406
L+ LL +P +R +A+EAL YF
Sbjct: 293 LQSLLKLNPLERISAKEALKHEYF 316
|
Length = 335 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 208 bits (531), Expect = 1e-63
Identities = 116/295 (39%), Positives = 166/295 (56%), Gaps = 15/295 (5%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
+Q E IG+G+YGVV A + TGE VA+KKI E + +REI LL+ L HP+I
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYI 232
V++ ++ +Y+VFE + DL + + A+ + + +L+QLL+GL +
Sbjct: 62 VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LC 291
H+ V HRDLKP+N+L N + +K+ DFGLAR +F P + T V T WYRAPE L
Sbjct: 117 HSHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFG-VPVRTY-THEVVTLWYRAPEILL 173
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
G + Y+ A+DIWS+GCIFAEM+T + LFPG + + QL + LGTP + +
Sbjct: 174 GCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
Y S K FS P D LL ++L +DP R +A+ ALA P+F
Sbjct: 232 P--DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 210 bits (535), Expect = 2e-63
Identities = 125/350 (35%), Positives = 199/350 (56%), Gaps = 29/350 (8%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
RYQ + IG G+ G+V +A D VAIKK++ F++ + A R RE+ L++ + H +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 174 IVEIKHIMLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
I+ + ++ P S EF+D+Y+V ELM+++L QVI+ +L E + LYQ+L G+K++
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHL 135
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H+A + HRDLKP NI+ +DC LKI DFGLAR A ++ T YV TR+YRAPE+
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYVVTRYYRAPEVIL 191
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
Y +DIWS+GCI EM+ K LFPG++ + Q + + + LGTP E + +++
Sbjct: 192 GM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 248
Query: 353 ARRYLGSMRKKQPVPFSHKFPNA------------DPLALHLLERLLAFDPKDRPTAEEA 400
R Y+ + K + F FP++ A LL ++L DP R + +EA
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308
Query: 401 LADPYFHGLANVDREPS---TQPISKLEFEFERRKLAKDDVREMIYREIL 447
L PY NV +P+ P + + + R+ ++ +E+IY+E++
Sbjct: 309 LQHPYI----NVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM 354
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 207 bits (529), Expect = 2e-63
Identities = 118/302 (39%), Positives = 174/302 (57%), Gaps = 27/302 (8%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI--NDVFEHV-SDATRILREIKLLRLLR 170
+Y+ E IG+G+YG V A + T E VA+K++ +D E V S A LREI LL+ L+
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA---LREICLLKELK 57
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGL 229
H +IV + ++ + + +VFE + DL + + N D+ PE + F++QLL+GL
Sbjct: 58 HKNIVRLYDVLHSDKK-----LTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGL 112
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
+ H+ NV HRDLKP+N+L N + +LK+ DFGLAR +F P + + V T WYR P+
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR-AFG-IPVRCYSAE-VVTLWYRPPD 169
Query: 290 -LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES--- 344
L G+ Y+ +ID+WS GCIFAE+ G+PLFPG +V QL + LLGTP+ ES
Sbjct: 170 VLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPG 227
Query: 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
+S++ + K + + P + LL+ LL +P R +AEEAL P
Sbjct: 228 VSKLPDYKPYPMYPAT-----TSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP 282
Query: 405 YF 406
YF
Sbjct: 283 YF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 207 bits (528), Expect = 4e-63
Identities = 119/308 (38%), Positives = 178/308 (57%), Gaps = 38/308 (12%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI-LREIKLLRLLRHP 172
+Y+ ++G+GSYG+V TG+ VAIKK + E +I +REI++L+ LRH
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLES-EDDKMVKKIAMREIRMLKQLRHE 60
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY---------QFFLY 223
++V ++ RR+ K +Y+VFE ++ H V+ DDL E Y + +L+
Sbjct: 61 NLVN----LIEVFRRK-KRLYLVFEFVD---HTVL---DDL--EKYPNGLDESRVRKYLF 107
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
Q+LRG+++ H+ N+ HRD+KP+NIL + +K+CDFG AR AP ++ TDYVATR
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVY-TDYVATR 164
Query: 284 WYRAPEL-CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
WYRAPEL G +KY A+DIW++GC+ EMLTG+PLFPG + + QL + LG
Sbjct: 165 WYRAPELLVGD--TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGN--- 219
Query: 343 ESISRIRNEKARRYLGS-MR---KKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 398
I R + + L + MR K+ P +FP L L L ++ L DP DRP++
Sbjct: 220 -LIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSS 278
Query: 399 EALADPYF 406
+ L +F
Sbjct: 279 QLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 4e-62
Identities = 112/292 (38%), Positives = 167/292 (57%), Gaps = 16/292 (5%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
E IG+G+YGVV + TG+ VA+KKI E + +REI LL+ L+HP+IV ++
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 179 HIMLPPSRREFKDIYVVFELMESDLHQ---VIKANDDLTPEHYQFFLYQLLRGLKYIHTA 235
+++ SR +Y++FE + DL + + + E + +LYQ+L+G+ + H+
Sbjct: 66 DVLMQESR-----LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 236 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSF 294
V HRDLKP+N+L + +K+ DFGLAR +F P ++ T V T WYRAPE L GS
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFG-IPVRVY-THEVVTLWYRAPEVLLGS- 176
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354
+Y+ +DIWSIG IFAEM T KPLF G + + QL + +LGTP+ + +
Sbjct: 177 -PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV--TSLP 233
Query: 355 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
Y + K + N D L LLE++L +DP R +A++AL PYF
Sbjct: 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 200 bits (511), Expect = 2e-60
Identities = 114/308 (37%), Positives = 154/308 (50%), Gaps = 19/308 (6%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRL 168
E S+Y+ IG+G++G V A T + VA+KK+ + E+ + I LREIK+L+L
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALREIKILQL 67
Query: 169 LRHPDIV---EIKHIMLPPSRREFKDIYVVFELMESDLHQVIK-ANDDLTPEHYQFFLYQ 224
L+H ++V EI P R Y+VFE E DL ++ N T + +
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV-SFNDAPSAIFWTDYVATR 283
LL GL YIH + HRD+K NIL D LK+ DFGLAR S + +T+ V T
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 284 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
WYR PE L G Y P ID+W GCI AEM T P+ G HQL L++ L G+ +
Sbjct: 188 WYRPPELLLGE--RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245
Query: 343 ESISRIRN----EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 398
E + +K G RK V K DP AL L+++LL DP R A+
Sbjct: 246 EVWPGVDKLELFKKMELPQGQKRK---VKERLKPYVKDPHALDLIDKLLVLDPAKRIDAD 302
Query: 399 EALADPYF 406
AL +F
Sbjct: 303 TALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 198 bits (506), Expect = 8e-60
Identities = 111/300 (37%), Positives = 164/300 (54%), Gaps = 16/300 (5%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH-PD 173
Y+ E IG+G+YG V A D +TG+ VA+KK + LREI LL++L
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN-----DDLTPEHYQFFLYQLLRG 228
IV + + + +Y+VFE ++SDL + + +N L + + F+YQLL+G
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 229 LKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
+ + H V HRDLKP+N+L + LKI D GL R +F+ + +T + T WYRA
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFSIPVKS--YTHEIVTLWYRA 179
Query: 288 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
PE L GS + Y+ +DIWS+GCIFAEM +PLFPG + + QL + LLGTP+ +
Sbjct: 180 PEVLLGS--THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237
Query: 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
+ R + +P S P+ P L LL+++L +DP R +A+ AL PYF
Sbjct: 238 GVSK---LRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 9e-60
Identities = 116/303 (38%), Positives = 170/303 (56%), Gaps = 16/303 (5%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Y+ E IG+G+YGVV A D T E +A+KKI E + +REI LL+ ++H +
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY--QFFLYQLLRGLKY 231
IV ++ ++ R +Y+VFE ++ DL + + ++ D + +LYQ+LRG+ Y
Sbjct: 63 IVRLQDVVHSEKR-----LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117
Query: 232 IHTANVFHRDLKPKNILANADCK-LKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE- 289
H+ V HRDLKP+N+L + LK+ DFGLAR +F P F T V T WYRAPE
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFG-IPVRTF-THEVVTLWYRAPEI 174
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
L GS Y+ +DIWS+GCIFAEM+ KPLFPG + + +L + +LGTP+ E+ +
Sbjct: 175 LLGS--RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409
+ Y + K P + P +P + LL ++L DP R TA AL YF L
Sbjct: 233 S--LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290
Query: 410 ANV 412
+
Sbjct: 291 GDA 293
|
Length = 294 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 1e-59
Identities = 111/301 (36%), Positives = 161/301 (53%), Gaps = 18/301 (5%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
+ I IG+G+YG V A D TGE VA+KK+ E +REIK+LR L H +I
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 175 VEIKHIMLPPS-----RREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRG 228
V +K I+ +++ Y+VFE M+ DL ++++ + +H + F+ QLL G
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEG 128
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
L Y H N HRD+K NIL N ++K+ DFGLAR ++ + +T+ V T WYR P
Sbjct: 129 LNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR--LYNSEESRPYTNKVITLWYRPP 186
Query: 289 E-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE---S 344
E L G +Y PAID+WS GCI E+ T KP+F + QL+L++ L G+P
Sbjct: 187 ELLLGE--ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD 244
Query: 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
+ ++ + R++ FS P AL LL+ +L DP R TAEEAL P
Sbjct: 245 VIKLPYFNTMKPKKQYRRRLREEFSF-IP---TPALDLLDHMLTLDPSKRCTAEEALNSP 300
Query: 405 Y 405
+
Sbjct: 301 W 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 1e-55
Identities = 84/294 (28%), Positives = 129/294 (43%), Gaps = 35/294 (11%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+ E++G+GS+G V A+D TGE +A+K + + + + REI++L L+HP+
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
IV E + + E + L ++K L + + Q+L GL Y+
Sbjct: 61 IVRYYGSER---DEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL 117
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H+ + HRD+K NIL ++D +K+ DFG A+ D + T ++ APE+
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFGCAK-RLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
+Y A DIWS+GC EM TGKP + + M L S+ I
Sbjct: 177 G--EEYGRAADIWSLGCTVIEMATGKPPWS-----ELGNPMAALYKIGSSGEPPEI---- 225
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
P S A L + L DPK RPTA+E L P+
Sbjct: 226 ------------PEHLS-------EEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 4e-55
Identities = 116/305 (38%), Positives = 167/305 (54%), Gaps = 16/305 (5%)
Query: 109 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 168
+G+ Y + +G+G+Y V T VA+K+I E + T I RE+ LL+
Sbjct: 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKD 60
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLR 227
L+H +IV + I+ K + +VFE ++ DL Q + + H + FL+QLLR
Sbjct: 61 LKHANIVTLHDII-----HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLR 115
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
GL Y H V HRDLKP+N+L N +LK+ DFGLAR P+ + ++ V T WYR
Sbjct: 116 GLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA--KSIPTKTY-SNEVVTLWYRP 172
Query: 288 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
P+ L GS + Y+ ID+W +GCIF EM TG+PLFPG V QL + +LGTP+ E+
Sbjct: 173 PDILLGS--TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWP 230
Query: 347 RI-RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
I NE+ + Y + K + + P D LL +LL F+ + R +AEEA+ PY
Sbjct: 231 GILSNEEFKSY--NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288
Query: 406 FHGLA 410
FH L
Sbjct: 289 FHCLG 293
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 7e-55
Identities = 116/305 (38%), Positives = 170/305 (55%), Gaps = 16/305 (5%)
Query: 109 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 168
+G+ Y E +G+G+Y V T VA+K+I E + T I RE+ LL+
Sbjct: 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKD 60
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLR 227
L+H +IV + I+ K + +VFE ++ DL Q + ++ H + FLYQ+LR
Sbjct: 61 LKHANIVTLHDIV-----HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILR 115
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
GL Y H V HRDLKP+N+L N +LK+ DFGLAR P+ + ++ V T WYR
Sbjct: 116 GLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA--KSVPTKTY-SNEVVTLWYRP 172
Query: 288 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
P+ L GS S+Y+ ID+W +GCIF EM +G+PLFPG V +L L+ LLGTP+ E+
Sbjct: 173 PDVLLGS--SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP 230
Query: 347 RI-RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
I N++ + Y + K +P P + P D + LL + L ++ K R +AEEA+ Y
Sbjct: 231 GISSNDEFKNY--NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288
Query: 406 FHGLA 410
F L
Sbjct: 289 FRSLG 293
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 7e-55
Identities = 115/301 (38%), Positives = 169/301 (56%), Gaps = 16/301 (5%)
Query: 109 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 168
+G+ Y + +G+G+Y V T VA+K+I E + T I RE+ LL+
Sbjct: 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKN 59
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLR 227
L+H +IV + I+ + + +VFE ++SDL Q + +L H + F++QLLR
Sbjct: 60 LKHANIVTLHDII-----HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLR 114
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
GL Y H + HRDLKP+N+L N +LK+ DFGLAR P+ + ++ V T WYR
Sbjct: 115 GLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARA--KSVPTKTY-SNEVVTLWYRP 171
Query: 288 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
P+ L GS ++Y+ ID+W +GCI EM TG+P+FPG V +L L+ LLGTP+ E+
Sbjct: 172 PDVLLGS--TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWP 229
Query: 347 RI-RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
I NE+ R YL + QP+ +H P D + LL LL ++ K R +AE AL Y
Sbjct: 230 GITSNEEFRSYLFPQYRAQPL-INHA-PRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287
Query: 406 F 406
F
Sbjct: 288 F 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 4e-51
Identities = 102/296 (34%), Positives = 169/296 (57%), Gaps = 11/296 (3%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+++++ V+G+G+YGVV T E VAIKK D E+ LRE+K+LR L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKY 231
+IVE+K RR K +Y+VFE +E ++ ++++ + + PE + ++YQL++ + +
Sbjct: 61 NIVELKEAF----RRRGK-LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
H ++ HRD+KP+N+L + + LK+CDFG AR + ++ +A + T+YVATRWYR+PEL
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFAR-NLSEGSNANY-TEYVATRWYRSPELL 173
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
+ Y A+D+WS+GCI E+ G+PLFPG++ + QL + +LG E + +
Sbjct: 174 --LGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231
Query: 352 KARRYLGSMRKKQPVPFSHKFPNA-DPLALHLLERLLAFDPKDRPTAEEALADPYF 406
L P ++ + L L++ LL +P DR E+ L P F
Sbjct: 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 2e-49
Identities = 116/306 (37%), Positives = 173/306 (56%), Gaps = 23/306 (7%)
Query: 109 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 168
+G A+ Y E +G+GSY V + G+ VA+K I+ E T I RE LL+
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI-REASLLKG 59
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQ-VIKANDDLTPEHYQFFLYQLLR 227
L+H +IV + I+ F VFE M +DL Q +I+ L P + + F++QLLR
Sbjct: 60 LKHANIVLLHDIIHTKETLTF-----VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR 114
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
GL YIH ++ HRDLKP+N+L + +LK+ DFGLAR PS + ++ V T WYR
Sbjct: 115 GLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARA--KSIPSQTYSSE-VVTLWYRP 171
Query: 288 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG-KNVVHQLDLMTDLLGTPSTES- 344
P+ L G+ + Y+ A+DIW GCIF EML G+P FPG +V QL+ + +LG P+ ++
Sbjct: 172 PDVLLGA--TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTW 229
Query: 345 --ISRIRNEKARRYLGSMRKKQPVPFSH--KFPNADPLALHLLERLLAFDPKDRPTAEEA 400
+S++ N K +L ++ V + + P A+ LA ++L PKDR +A++A
Sbjct: 230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLA----SQMLMMFPKDRISAQDA 285
Query: 401 LADPYF 406
L PYF
Sbjct: 286 LLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 9e-49
Identities = 69/197 (35%), Positives = 108/197 (54%), Gaps = 13/197 (6%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
+G+G +G V A D TG++VAIK I S +LREI++L+ L HP+IV++ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS-SLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 181 MLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVF 238
+ +Y+V E E L ++K N+ L+ + L Q+L GL+Y+H+ +
Sbjct: 60 FEDENH-----LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114
Query: 239 HRDLKPKNIL-ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK 297
HRDLKP+NIL + + K+K+ DFGL+++ +D V T Y APE+
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLKTIVGTPAYMAPEVL-LGKGY 170
Query: 298 YTPAIDIWSIGCIFAEM 314
Y+ DIWS+G I E+
Sbjct: 171 YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 3e-48
Identities = 108/302 (35%), Positives = 162/302 (53%), Gaps = 22/302 (7%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGER-VAIKKINDVFEHVSDATRILREIKLLRLLR-- 170
+Y+ IG+G+YG V A D G R VA+K++ +RE+ +LR L
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 171 -HPDIVEIKHI-MLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLL 226
HP++V + + + + RE K + +VFE ++ DL + + + E + ++QLL
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETK-LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV-SFNDAPSAIFWTDYVATRWY 285
RGL ++H+ V HRDLKP+NIL + ++K+ DFGLAR+ SF A +++ V T WY
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-----VVTLWY 175
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
RAPE+ S Y +D+WS+GCIFAEM KPLF G + V QL + D++G P E
Sbjct: 176 RAPEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233
Query: 346 SRIRNEKA-RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
+ A R + QP+ + D L LL + L F+P R +A AL+ P
Sbjct: 234 P---RDVALPRQAFHSKSAQPI--EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 288
Query: 405 YF 406
YF
Sbjct: 289 YF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 1e-46
Identities = 91/303 (30%), Positives = 143/303 (47%), Gaps = 55/303 (18%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRH 171
+Y+I + IGKGS+G V G+ +K+I+ ++S+ R L E+K+L+ L H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEID--LSNMSEKEREDALNEVKILKKLNH 58
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKA---NDDLTPEHYQ--FFLYQL 225
P+I IK+ S E + +V E + DL Q IK PE Q + QL
Sbjct: 59 PNI--IKYYE---SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE-QILDWFVQL 112
Query: 226 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
LKY+H+ + HRD+KP+NI ++ +K+ DFG+++V + A V T +Y
Sbjct: 113 CLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA---KTVVGTPYY 169
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
+PELC + Y DIWS+GC+ E+ T K F G+N L+L
Sbjct: 170 LSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELAL----------- 213
Query: 346 SRIRNEKARRYLGSMRKKQPVP--FSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
+I + P+P +S + N L+ LL DP++RP+ + L
Sbjct: 214 -KILKG----------QYPPIPSQYSSELRN-------LVSSLLQKDPEERPSIAQILQS 255
Query: 404 PYF 406
P+
Sbjct: 256 PFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 166 bits (421), Expect = 5e-46
Identities = 120/432 (27%), Positives = 203/432 (46%), Gaps = 69/432 (15%)
Query: 20 FTNNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQHLQQLTIVEDFDFSGLKLIRVP 79
+ ++ N + F+ N+KK + S ++++ E + ++ I D + R P
Sbjct: 13 YEEKNHKANKGGSGKFEMNDKKLDEEERSHNNNAGEDED-EEKMIDNDIN-------RSP 64
Query: 80 KRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGE 139
+ Y++ +IG GS+GVV A+ T E
Sbjct: 65 NK--------------------------------SYKLGNIIGNGSFGVVYEAICIDTSE 92
Query: 140 RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RREFKDIY--VVF 196
+VAIKK+ + D RE+ +++ L H +I+ +K ++ K+I+ VV
Sbjct: 93 KVAIKKV------LQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVM 146
Query: 197 ELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 252
E + +H+ +K N L + + YQL R L YIH+ + HRDLKP+N+L + +
Sbjct: 147 EFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPN 206
Query: 253 C-KLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCI 310
LK+CDFG A+ S Y+ +R+YRAPEL G+ + YT ID+WS+GCI
Sbjct: 207 THTLKLCDFGSAKNLLAGQRS----VSYICSRFYRAPELMLGA--TNYTTHIDLWSLGCI 260
Query: 311 FAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSH 370
AEM+ G P+F G++ V QL + +LGTP+ + + + A ++ K
Sbjct: 261 IAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKD---LKK 317
Query: 371 KFPNADP-LALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFE 429
FP P A++ + + L ++P R EALADP+F L R+P + ++ +
Sbjct: 318 VFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL----RDPCIKLPKYIDKLPD 373
Query: 430 RRKLAKDDVREM 441
+++EM
Sbjct: 374 LFNFCDAEIKEM 385
|
Length = 440 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 1e-45
Identities = 93/296 (31%), Positives = 142/296 (47%), Gaps = 45/296 (15%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
YQ+ ++IG+G++GVV ++ TG+ VAIK+I+ I++EI LL+ L+HP+
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHY-QFFLYQLLRGLKY 231
IV K+I S +Y++ E E+ L Q+IK PE ++YQ+L+GL Y
Sbjct: 61 IV--KYI---GSIETSDSLYIILEYAENGSLRQIIKKFGPF-PESLVAVYVYQVLQGLAY 114
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLA-RVSFNDAPSAIFWTDYVATRWYRAPEL 290
+H V HRD+K NIL D +K+ DFG+A +++ V T ++ APE+
Sbjct: 115 LHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD----ASVVGTPYWMAPEV 170
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350
S + A DIWS+GC E+LTG P + + L+ M L RI
Sbjct: 171 IE--MSGASTASDIWSLGCTVIELLTGNPPY------YDLNPMAALF---------RIVQ 213
Query: 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
+ P+P P L + DP RPTA++ L P+
Sbjct: 214 D----------DHPPLP-----EGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 163 bits (412), Expect = 2e-45
Identities = 83/303 (27%), Positives = 131/303 (43%), Gaps = 35/303 (11%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDA-TRILREIKLLRLLRHPD 173
Y+I +G+GS+G V A D + VA+K + E S R LREI++L L HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 174 -IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD---LTPEHYQFFLYQLLRGL 229
IV++ V+ + L ++K L+ F L Q+L L
Sbjct: 59 NIVKLYDFFQDEGS----LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 230 KYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARV---SFNDAPSAIFWTDYVATRWY 285
+Y+H+ + HRD+KP+NIL + D +K+ DFGLA++ + + + V T Y
Sbjct: 115 EYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 286 RAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344
APE+ G + + + DIWS+G E+LTG P F G+ ++
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS-----------QT 223
Query: 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
+ I + P A LL++LLA DPK+R ++ L+
Sbjct: 224 LKIILELPTPSLASPLSPSNP-------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
Query: 405 YFH 407
Sbjct: 277 LLA 279
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 2e-45
Identities = 79/299 (26%), Positives = 129/299 (43%), Gaps = 55/299 (18%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
++I E IGKG +G V A TG+ VAIK I + +I+ EI++L+ +HP+I
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNI 59
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPE-HYQFFLYQLLRGLKYI 232
V+ L +++V E L ++K+ + E + +LL+GL+Y+
Sbjct: 60 VKYYGSYLKKDE-----LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYL 114
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H+ + HRD+K NIL +D ++K+ DFGL+ +D + V T ++ APE+
Sbjct: 115 HSNGIIHRDIKAANILLTSDGEVKLIDFGLS-AQLSDTKARNTM---VGTPYWMAPEVI- 169
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
Y DIWS+G E+ GKP +
Sbjct: 170 -NGKPYDYKADIWSLGITAIELAEGKPPY------------------------------- 197
Query: 353 ARRYLGSMR------KKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
L M+ P + +D L++ L +P+ RPTAE+ L P+
Sbjct: 198 --SELPPMKALFKIATNGPPGLRNPEKWSDEFK-DFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 4e-45
Identities = 105/306 (34%), Positives = 151/306 (49%), Gaps = 31/306 (10%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR--- 170
+Y+ IG G+YG V A D H+G VA+K + +RE+ LL+ L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 171 HPDIVEIKHIMLPP-SRREFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLR 227
HP+IV + + + RE K + +VFE ++ DL + L E + + Q LR
Sbjct: 61 HPNIVRLMDVCATSRTDRETK-VTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV-SFNDAPSAIFWTDYVATRWYR 286
GL ++H + HRDLKP+NIL + ++K+ DFGLAR+ S A T V T WYR
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-----LTPVVVTLWYR 174
Query: 287 APELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE--- 343
APE+ S Y +D+WS+GCIFAEM KPLF G + QL + DL+G P +
Sbjct: 175 APEVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232
Query: 344 ---SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400
++ R G+ + P P P + LL +L F+P R +A A
Sbjct: 233 RDVTLPR----------GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRA 282
Query: 401 LADPYF 406
L P+F
Sbjct: 283 LQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 155 bits (392), Expect = 2e-43
Identities = 112/310 (36%), Positives = 171/310 (55%), Gaps = 25/310 (8%)
Query: 109 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 168
+G+A Y+ E +G+GSY V G+ VA+K I E + T I RE LL+
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKG 59
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVI-KANDDLTPEHYQFFLYQLLR 227
L+H +IV + I+ + + +VFE + +DL Q + K L PE+ + FL+QLLR
Sbjct: 60 LKHANIVLLHDII-----HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR 114
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
GL YIH + HRDLKP+N+L + +LK+ DFGLAR PS + ++ V T WYR
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTY-SNEVVTLWYRP 171
Query: 288 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG-KNVVHQLDLMTDLLGTPSTE-- 343
P+ L GS ++Y+ +D+W +GCIF EM+ G FPG K++ QL+ + +LGTP+ +
Sbjct: 172 PDVLLGS--TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW 229
Query: 344 ----SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
S+ + E+ Y ++ S+ +A+ LA +LL PK+R +A+
Sbjct: 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSY-VNHAEDLA----SKLLQCFPKNRLSAQA 284
Query: 400 ALADPYFHGL 409
AL+ YF L
Sbjct: 285 ALSHEYFSDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 1e-40
Identities = 91/305 (29%), Positives = 141/305 (46%), Gaps = 56/305 (18%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRHP 172
Y++ E IGKGS+G V G+ + K+I+ + ++++ + ++ E+ +LR L+HP
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEID--YGNMTEKEKQQLVSEVNILRELKHP 59
Query: 173 DIVE-IKHIMLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTPEHY--QFFLYQL 225
+IV I+ ++ +Y+V E E DL Q+I K E + + QL
Sbjct: 60 NIVRYYDRIIDRSNQT----LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT-QL 114
Query: 226 LRGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 280
L L H + V HRDLKP NI +A+ +K+ DFGLA++ +D+ A YV
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA---KTYV 171
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340
T +Y +PE Y DIWS+GC+ E+ P F +N QL L
Sbjct: 172 GTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQL-------- 218
Query: 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400
S+I+ K RR P +S L +++ +L DP RP+ EE
Sbjct: 219 ----ASKIKEGKFRRI--------PYRYS------SELNE-VIKSMLNVDPDKRPSTEEL 259
Query: 401 LADPY 405
L P
Sbjct: 260 LQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 4e-40
Identities = 115/320 (35%), Positives = 164/320 (51%), Gaps = 45/320 (14%)
Query: 121 IGKGSYGVVGSAV--DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
+G+G+YG V A D A+K+I E + REI LLR L+HP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 64
Query: 179 HIMLPPSRREFKDIYVVFELMESDL------HQVIKAND---DLTPEHYQFFLYQLLRGL 229
+ L + R+ ++++F+ E DL H+ KAN L + LYQ+L G+
Sbjct: 65 KVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 230 KYIHTANVFHRDLKPKNILANADC----KLKICDFGLARVSFNDAPSAIFWTD-YVATRW 284
Y+H V HRDLKP NIL + ++KI D G AR+ FN + D V T W
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL-FNSPLKPLADLDPVVVTFW 180
Query: 285 YRAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK-------NVVH--QLDLMT 334
YRAPEL G+ YT AIDIW+IGCIFAE+LT +P+F + N H QLD +
Sbjct: 181 YRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238
Query: 335 DLLGTPSTESISRIRNEKARRYL-GSMRKKQPVPFS-------HKFPNADPLALHLLERL 386
+++G P+ + I+ L R+ S HK D A HLL++L
Sbjct: 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV-KPDSKAFHLLQKL 297
Query: 387 LAFDPKDRPTAEEALADPYF 406
L DP R T+E+A+ DPYF
Sbjct: 298 LTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 3e-39
Identities = 115/320 (35%), Positives = 162/320 (50%), Gaps = 45/320 (14%)
Query: 121 IGKGSYGVVGSA--VDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
+G+G+YG V A D + A+K+I E + REI LLR L+HP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIALQ 64
Query: 179 HIMLPPSRREFKDIYVVFELMESDL------HQVIKAND---DLTPEHYQFFLYQLLRGL 229
+ L S R+ ++++F+ E DL H+ KAN L + LYQ+L G+
Sbjct: 65 KVFLSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 230 KYIHTANVFHRDLKPKNILANADC----KLKICDFGLARVSFNDAPSAIFWTD-YVATRW 284
Y+H V HRDLKP NIL + ++KI D G AR+ FN + D V T W
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL-FNSPLKPLADLDPVVVTFW 180
Query: 285 YRAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK-------NVVH--QLDLMT 334
YRAPEL G+ YT AIDIW+IGCIFAE+LT +P+F + N H QLD +
Sbjct: 181 YRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238
Query: 335 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFS--------HKFPNADPLALHLLERL 386
++G P+ + IR L ++ S HK D LL++L
Sbjct: 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKV-KPDSKVFLLLQKL 297
Query: 387 LAFDPKDRPTAEEALADPYF 406
L DP R T+E+AL DPYF
Sbjct: 298 LTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 1e-38
Identities = 89/307 (28%), Positives = 139/307 (45%), Gaps = 69/307 (22%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI---NDVFEHVSDATRILREIKLLRLLRH 171
Y+ E IG+G+ G V A D TG+ VAIKK+ E I+ EI +++ +H
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKE------LIINEILIMKDCKH 74
Query: 172 PDIVE-IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRG 228
P+IV+ S +++VV E M+ L +I N + + ++L+G
Sbjct: 75 PNIVDYYD------SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQG 128
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFNDAPSAIFWTDY 279
L+Y+H+ NV HRD+K NIL + D +K+ DFG A R S
Sbjct: 129 LEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV------------ 176
Query: 280 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339
V T ++ APE+ Y P +DIWS+G + EM G+P + + + L L+T G
Sbjct: 177 VGTPYWMAPEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGI 233
Query: 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
P ++N + +S +F + L + L DP+ RP+AEE
Sbjct: 234 P------PLKNPEK--------------WSPEFKD-------FLNKCLVKDPEKRPSAEE 266
Query: 400 ALADPYF 406
L P+
Sbjct: 267 LLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 3e-38
Identities = 90/295 (30%), Positives = 135/295 (45%), Gaps = 35/295 (11%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
R+Q IG G++G V +AV+ TGE +A+K+I I E+K+L LL+HP+
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 174 IVEIKHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
+V+ + + RE +Y+ E L ++++ L + + QLL GL Y+
Sbjct: 61 LVKYYGVEV---HRE--KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYL 115
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLA-RVSFNDAPSAIFWTDYVATRWYRAPEL- 290
H+ + HRD+KP NI + + +K+ DFG A ++ N T Y APE+
Sbjct: 116 HSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350
G + A DIWS+GC+ EM TGK + +LD N
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPW------SELD------------------N 211
Query: 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
E + K P+P S + P L+R L DPK RPTA E L P+
Sbjct: 212 EFQIMFHVGAGHKPPIPDSLQ---LSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-37
Identities = 82/296 (27%), Positives = 129/296 (43%), Gaps = 56/296 (18%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKIN--DVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
+GKGS+G V TG+ A+K + + + + L E +L + HP IV++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR-KEVEHTLTERNILSRINHPFIVKLH 59
Query: 179 HIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
F+ +Y+V E +L + + E +F+ +++ L+Y+H+
Sbjct: 60 --------YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHS 111
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
+ +RDLKP+NIL +AD +K+ DFGLA+ ++ + T Y APE+
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT---NTFCGTPEYLAPEVLLG- 167
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354
Y A+D WS+G + EMLTGKP F ++ E +I
Sbjct: 168 -KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---------------EIYEKI------ 205
Query: 355 RYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDRPT---AEEALADPYF 406
K P+ +FP P A L+ LL DP R AEE A P+F
Sbjct: 206 -------LKDPL----RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 3e-37
Identities = 84/299 (28%), Positives = 128/299 (42%), Gaps = 69/299 (23%)
Query: 119 EVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRHP 172
+ +G+G++G V VA+K + E S+ LRE +++R L HP
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK---EDASEQQIEEFLREARIMRKLDHP 61
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLK 230
++V++ + +Y+V E ME DL ++ N L+ F Q+ RG++
Sbjct: 62 NVVKLLGVCTEEEP-----LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGME 116
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-------R 283
Y+ + N HRDL +N L + +KI DFGL+R ++D DY R
Sbjct: 117 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--------DYYRKRGGKLPIR 168
Query: 284 WYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPS 341
W APE S K+T D+WS G + E+ T G+ +PG +
Sbjct: 169 WM-APE---SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS---------------- 208
Query: 342 TESISRIRNEKARRYLGS-MRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
NE+ YL + R QP PN P L+ + A DP+DRPT E
Sbjct: 209 --------NEEVLEYLKNGYRLPQP-------PNCPPELYDLMLQCWAEDPEDRPTFSE 252
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 8e-36
Identities = 80/300 (26%), Positives = 124/300 (41%), Gaps = 70/300 (23%)
Query: 119 EVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRHP 172
+ +G+G++G V VA+K + + S+ LRE +++R L HP
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKE---DASEQQIEEFLREARIMRKLDHP 61
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGL 229
+IV++ + + +V E M DL ++ N L+ F Q+ RG+
Sbjct: 62 NIVKLLGVCTEEEP-----LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGM 116
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------- 282
+Y+ + N HRDL +N L + +KI DFGL+R ++D DY
Sbjct: 117 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--------DYYKVKGGKLPI 168
Query: 283 RWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTP 340
RW APE S K+T D+WS G + E+ T G+ +PG +
Sbjct: 169 RWM-APE---SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS--------------- 209
Query: 341 STESISRIRNEKARRYLGS-MRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
N + YL R +P PN P L+ + A DP+DRPT E
Sbjct: 210 ---------NAEVLEYLKKGYRLPKP-------PNCPPELYKLMLQCWAEDPEDRPTFSE 253
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 3e-34
Identities = 89/327 (27%), Positives = 140/327 (42%), Gaps = 84/327 (25%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK---------- 164
++ ++IG+GS+ V A + T + AIK + D ++++E K
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIK--------ILDKRQLIKEKKVKYVKIEKEV 54
Query: 165 LLRLLRHPDIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQF 220
L RL HP I+++ + F+D +Y V E + +L Q I+ L + +F
Sbjct: 55 LTRLNGHPGIIKLYY--------TFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF 106
Query: 221 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV--------------- 265
+ ++L L+Y+H+ + HRDLKP+NIL + D +KI DFG A+V
Sbjct: 107 YAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 266 --SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 323
+ + +V T Y +PEL + D+W++GCI +MLTGKP F G
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRG 224
Query: 324 KNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLL 383
N L +I + F FP P A L+
Sbjct: 225 SN--------EYLT-------FQKILKLE-------------YSFPPNFP---PDAKDLI 253
Query: 384 ERLLAFDPKDRPTA----EEALADPYF 406
E+LL DP+DR +E A P+F
Sbjct: 254 EKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 8e-34
Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 39/291 (13%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
+ +V+G+GS GVV TG+ A+KKI+ V ++LRE+K LR P +V
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 176 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ I +V E M+ L ++K + + Q+L+GL Y+HT
Sbjct: 63 KCYGAFYKEGE-----ISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 235 -ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
++ HRD+KP N+L N+ ++KI DFG+++V + T +V T Y +PE
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNT-FVGTVTYMSPERIQG 174
Query: 294 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353
Y+ A DIWS+G E GK F +LM + P + + +
Sbjct: 175 --ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232
Query: 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
R + L DPK RP+A E L P
Sbjct: 233 R--------------------------DFISACLQKDPKKRPSAAELLQHP 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 86/300 (28%), Positives = 140/300 (46%), Gaps = 51/300 (17%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN------DVFEHVSDATRILREIKLLR 167
R++ E++G GS+G V ++ G+ A+K+++ E V ++ +EI LL
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVK---QLEQEIALLS 57
Query: 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLL 226
L+HP+IV+ + RE ++Y+ EL+ L +++K + + Q+L
Sbjct: 58 KLQHPNIVQYLG-----TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL 112
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VSFNDAPSAIFWTDYVATRWY 285
GL+Y+H N HRD+K NIL + + +K+ DFG+A+ V F + + ++
Sbjct: 113 LGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-----FAKSFKGSPYW 167
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
APE+ Y A DIWS+GC EM TGKP + QL E +
Sbjct: 168 MAPEVIAQ-QGGYGLAADIWSLGCTVLEMATGKPPW------SQL------------EGV 208
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
+ + +G ++ P+P H A L L+R DP RPTA E L P+
Sbjct: 209 AAVFK------IGRSKELPPIP-DHLSDEAKDFILKCLQR----DPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 8e-33
Identities = 84/307 (27%), Positives = 128/307 (41%), Gaps = 62/307 (20%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKI--------NDVFEHVSDATRILREIKLLRLLR 170
E+IGKG+YG V A++ TGE +A+K++ + EI+ L+ L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLH------------QVIKANDDLTPEHY 218
H +IV+ Y+ FE E L ++ +
Sbjct: 67 HLNIVQ----------------YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLV 110
Query: 219 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD 278
+FF Q+L GL Y+H+ + HRDLK N+L +AD KI DFG+++ S +D
Sbjct: 111 RFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS-DDIYDNDQNMS 169
Query: 279 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338
+ ++ APE+ S+ Y+ +DIWS+GC+ EM G+
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR-------------------- 209
Query: 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 398
S A LG+ R P+P N P+AL L +P +RPTA
Sbjct: 210 ----RPWSDEEAIAAMFKLGNKRSAPPIP-PDVSMNLSPVALDFLNACFTINPDNRPTAR 264
Query: 399 EALADPY 405
E L P+
Sbjct: 265 ELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 2e-30
Identities = 73/288 (25%), Positives = 125/288 (43%), Gaps = 53/288 (18%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS-DATR-ILREIKLLRLLRHP 172
+++ VIGKG++G V T + A+K +N + V + R +L E ++L+ L HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ-KCVEKGSVRNVLNERRILQELNHP 60
Query: 173 DIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 228
+V + F+D +Y+V +L+ DL + + E +F++ +++
Sbjct: 61 FLVNL--------WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLA 112
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
L+Y+H+ + HRD+KP NIL + + I DF +A D + T T Y AP
Sbjct: 113 LEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT----TSTSGTPGYMAP 168
Query: 289 ELCGSFFSK-YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
E+ + Y+ A+D WS+G E L GK + G S +
Sbjct: 169 EV---LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGH----------------SRTIRDQ 209
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPL-ALHLLERLLAFDPKDR 394
IR ++ V +P A+ + +LL DP+ R
Sbjct: 210 IRA---------KQETADVL----YPATWSTEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSD-ATRILREIKLLRLLRH 171
+ + E IGKGS+G V A+D T + VAIK I+ E D I +EI+ L R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID--LEEAEDEIEDIQQEIQFLSQCRS 58
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLR 227
P I + L S+ ++++ E DL + K L + F L ++L
Sbjct: 59 PYITKYYGSFLKGSK-----LWIIMEYCGGGSCLDLLKPGK----LDETYIAFILREVLL 109
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-RVSFNDAPSAIFWTDYVATRWYR 286
GL+Y+H HRD+K NIL + + +K+ DFG++ +++ + F V T ++
Sbjct: 110 GLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF----VGTPFWM 165
Query: 287 APELCGSFFSKYTPAIDIWSIGCIFAEMLTGKP 319
APE+ S Y DIWS+G E+ G+P
Sbjct: 166 APEVIKQ--SGYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 6e-30
Identities = 60/233 (25%), Positives = 109/233 (46%), Gaps = 33/233 (14%)
Query: 116 QIQEVIGKGSYGVV--GSAVDTH--TGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
++ + +G+G++G V G+ T +VA+K + + + L E +++ L H
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASE-EEREEFLEEASIMKKLSH 60
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 229
P+IV + + + + +Y+V E M DL ++ + + LT + Q+ +G+
Sbjct: 61 PNIVRLLGVCT-----QGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------- 282
+Y+ + N HRDL +N L + +KI DFGL+R + D Y
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD-------YYRKRGGGKLPI 168
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
+W APE K+T D+WS G + E+ T G+ +PG + V+ L+
Sbjct: 169 KWM-APESL--KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLE 218
|
Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 81/301 (26%), Positives = 136/301 (45%), Gaps = 50/301 (16%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKIND---VFEHVSDATRILREIKLLRLLRHPDIVEI 177
I KG+YG V A TG+ AIK I + ++ D ++L E +L + P +V++
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVD--QVLTERDILSQAQSPYVVKL 58
Query: 178 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 236
+ S + K++Y+V E + DL +++ L + + ++ +++ L+Y+H+
Sbjct: 59 YY-----SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG 113
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY-----VATRWYRAPELC 291
+ HRDLKP NIL +++ LK+ DFGL++V + + V T Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
++ +D WS+GCI E L G P F G+ E I N
Sbjct: 174 LG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETP---------------EEIFQNILNG 216
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA---EEALADPYFHG 408
K + + + A+ L+ +LL DP+ R A EE P+F G
Sbjct: 217 K-------------IEWP-EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262
Query: 409 L 409
+
Sbjct: 263 I 263
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 71/208 (34%), Positives = 113/208 (54%), Gaps = 20/208 (9%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRHP 172
++I++ IGKG + VV A+ G VA+KK+ +FE + R L+EI LL+ L HP
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKV-QIFEMMDAKARQDCLKEIDLLKQLDHP 62
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIK---ANDDLTPEH--YQFFLYQLL 226
++ IK++ S E ++ +V EL ++ DL ++IK L PE +++F QL
Sbjct: 63 NV--IKYL---ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF-VQLC 116
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 286
L+++H+ + HRD+KP N+ A +K+ D GL R F+ +A V T +Y
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAH--SLVGTPYYM 173
Query: 287 APELCGSFFSKYTPAIDIWSIGCIFAEM 314
+PE + Y DIWS+GC+ EM
Sbjct: 174 SPERIHE--NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 3e-27
Identities = 76/306 (24%), Positives = 123/306 (40%), Gaps = 75/306 (24%)
Query: 119 EVIGKGSYGVV--GSAVDTHTGER-VAIKKINDVFEHVSDATR--ILREIKLLRLLRHPD 173
+ +G+G++G V G VA+K + E S+ R L+E ++++ L HP+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK---EDASEEERKDFLKEARVMKKLGHPN 57
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAN---------DDLTPEHYQFFLY 223
+V + + E + +Y+V E ME DL ++ + L+ + F
Sbjct: 58 VVRLLGVCT-----EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT- 282
Q+ +G++Y+ + HRDL +N L D +KI DFGL+R ++D Y
Sbjct: 113 QIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD-------DYYRKKT 165
Query: 283 ------RWYRAPELCGSFFS-KYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMT 334
RW APE S +T D+WS G + E+ T G +PG
Sbjct: 166 GGKLPIRWM-APE---SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG----------- 210
Query: 335 DLLGTPSTESISRIRNEKARRYLGS-MRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD 393
+ NE+ YL R +P + L+ DP+D
Sbjct: 211 -------------LSNEEVLEYLRKGYRLPKPEYCPDELYE-------LMLSCWQLDPED 250
Query: 394 RPTAEE 399
RPT E
Sbjct: 251 RPTFSE 256
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 85/299 (28%), Positives = 136/299 (45%), Gaps = 54/299 (18%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
+ I E +G+GSYG V A+ TG+ VAIK + V E + + I++EI +L+ P I
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQE---IIKEISILKQCDSPYI 60
Query: 175 VEIKHIMLPPSRREFKDIYVVFELME-------SDLHQVIKANDDLTPEHYQFFLYQLLR 227
V+ S + D+++V ME SD+ ++ N LT E LYQ L+
Sbjct: 61 VKYY-----GSYFKNTDLWIV---MEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLK 110
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
GL+Y+H+ HRD+K NIL N + + K+ DFG++ + + T ++ A
Sbjct: 111 GLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR---NTVIGTPFWMA 167
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
PE+ Y DIWS+G EM GKP P ++ +I
Sbjct: 168 PEVIQE--IGYNNKADIWSLGITAIEMAEGKP--PYSDI-------------HPMRAIFM 210
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
I N+ P +S +F + +++ L DP++RP+A + L P+
Sbjct: 211 IPNKPPPTL------SDPEKWSPEFND-------FVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 80/290 (27%), Positives = 128/290 (44%), Gaps = 48/290 (16%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR---ILREIKLLRLLRHPDIVEI 177
IG+GS G+V A D TG +VA+KK++ + R + E+ ++R +HP+IVE+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD-----LRKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 178 KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 237
L +++VV E +E I + + E +L+ L ++H V
Sbjct: 82 YSSYLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGV 136
Query: 238 FHRDLKPKNILANADCKLKICDFGL-ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 296
HRD+K +IL +D ++K+ DFG A+VS + P V T ++ APE+
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVS-KEVPRR---KSLVGTPYWMAPEVISR--L 190
Query: 297 KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 356
Y +DIWS+G + EM+ G+P + P +++ RIR+
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPY---------------FNEPPLQAMKRIRDNLP--- 232
Query: 357 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
P P L+R+L DP R TA E L P+
Sbjct: 233 ----------PKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 77/303 (25%), Positives = 124/303 (40%), Gaps = 45/303 (14%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
Y++ EVIG G+ VV +A+ E+VAIK+I D+ + + + +E++ + HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKA--NDDLTPEHY-QFFLYQLLRG 228
++V+ S ++++V + L ++K+ E L ++L+G
Sbjct: 60 NVVKYY-----TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKG 114
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP-SAIFWTDYVATRWYRA 287
L+Y+H+ HRD+K NIL D +KI DFG++ + + +V T + A
Sbjct: 115 LEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKP----LFPGKNVVHQLDLMTDLLGTPSTE 343
PE+ Y DIWS G E+ TG P K LM L P +
Sbjct: 175 PEVMEQ-VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV------LMLTLQNDPPSL 227
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
+S F ++ L DP RPTAEE L
Sbjct: 228 ETGA----------------DYKKYSKSFRK-------MISLCLQKDPSKRPTAEELLKH 264
Query: 404 PYF 406
+F
Sbjct: 265 KFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 6e-27
Identities = 83/299 (27%), Positives = 128/299 (42%), Gaps = 53/299 (17%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRH 171
Y V+GKG++G T V K++N +S+ R L EI +L LL+H
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVN--LTRLSEKERRDALNEIVILSLLQH 58
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDD-LTPEHY-QFFLYQL 225
P+I+ + F D + ME L+ I L E ++L+Q+
Sbjct: 59 PNIIAYYN--------HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQI 110
Query: 226 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
+ + YIH A + HRD+K NI +K+ DFG++++ ++ A V T +Y
Sbjct: 111 VSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA---ETVVGTPYY 167
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
+PELC KY DIW++GC+ E+LT K F N L+L+ ++ T +
Sbjct: 168 MSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVVKIVQGNYTPVV 222
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
S Y + L+ LL DP+ RPTA+E L P
Sbjct: 223 S--------VYSSELIS-------------------LVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 9e-27
Identities = 88/308 (28%), Positives = 126/308 (40%), Gaps = 63/308 (20%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
Y++ + IG G+YG V A D TGE VAIK I E D I +EI +L+ RHP
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK--LEPGDDFEIIQQEISMLKECRHP 60
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRG 228
+IV L RR+ +++V E D++QV L+ + + L+G
Sbjct: 61 NIVAYFGSYL---RRD--KLWIVMEYCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKG 113
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFNDAPSAIFWTDY 279
L Y+H HRD+K NIL D +K+ DFG++ R SF
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF------------ 161
Query: 280 VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338
+ T ++ APE Y DIW++G E+ +P P M DL
Sbjct: 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP--P----------MFDL-- 207
Query: 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNA-DPLALHLLERLLAFDPKDRPTA 397
R L + K P K P+ +++ L DPK RPTA
Sbjct: 208 -------------HPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTA 254
Query: 398 EEALADPY 405
+ L P+
Sbjct: 255 TKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 77/293 (26%), Positives = 127/293 (43%), Gaps = 43/293 (14%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
++I IGKGS+GVV V A+K+I+ + + + E ++L L I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGLKY 231
I++ S + + +V E E+ DLH+++K L + F Q+L GL +
Sbjct: 62 --IRYY---ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
+H+ + HRD+K N+ +A +KI D G+A++ + + F V T +Y +PELC
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELC 173
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
Y D+W++G + E TGK F N Q L I +I
Sbjct: 174 ED--KPYNEKSDVWALGVVLYECCTGKHPFDANN---QGAL------------ILKI--- 213
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
+R P P S + L+++ L D + RP + L +P
Sbjct: 214 --------IRGVFP-PVSQMY---SQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 80/294 (27%), Positives = 119/294 (40%), Gaps = 48/294 (16%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS----DATRILREIKLLRLLRHPDIV 175
+G G+ GVV + TG+ +A+K I + +ILRE+ +L P IV
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTI-----RLEINEAIQKQILRELDILHKCNSPYIV 62
Query: 176 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHY-QFFLYQLLRGLKYIH 233
DI + E M+ L +++K PE +L+GL Y+H
Sbjct: 63 GFYGAFY----NN-GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 234 TA-NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
+ HRD+KP NIL N+ ++K+CDFG++ N +V T Y APE
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-----TFVGTSSYMAPERIQ 172
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
+ Y+ DIWS+G E+ TG+ FP E + I NE
Sbjct: 173 G--NDYSVKSDIWSLGLSLIELATGR--FPYPP--ENDPPDGIF------ELLQYIVNEP 220
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
P S KF P + L DP++RP+ +E L P+
Sbjct: 221 P-----------PRLPSGKFS---PDFQDFVNLCLIKDPRERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 75/299 (25%), Positives = 133/299 (44%), Gaps = 46/299 (15%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR-----ILREIKLLRLL 169
++ +++G+G++G V D TG +A+K++ F+ S T+ + EI+LL+ L
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVP--FDPDSPETKKEVNALECEIQLLKNL 61
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 228
+H IV+ + R+ + + + E M + +KA LT + + Q+L G
Sbjct: 62 QHERIVQYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEG 116
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
++Y+H+ + HRD+K NIL ++ +K+ DFG ++ S T ++ +P
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 289 ELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348
E+ Y D+WS+GC EMLT KP P E+++ I
Sbjct: 177 EVISG--EGYGRKADVWSVGCTVVEMLTEKP--PWAEF----------------EAMAAI 216
Query: 349 RNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
+ + P + P + P A + L R + K RP+AEE L +
Sbjct: 217 FK---------IATQPTNP---QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 7e-26
Identities = 83/299 (27%), Positives = 131/299 (43%), Gaps = 53/299 (17%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLRH 171
+++ + +GKGSYG V + A+K+++ +S R + EI++L + H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVD--LGSMSQKEREDAVNEIRILASVNH 58
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVI---KANDDLTPEH--YQFFLYQL 225
P+I+ K L ++ + +V E DL + I K L PE ++ F+ QL
Sbjct: 59 PNIISYKEAFLDGNK-----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QL 112
Query: 226 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
LRGL+ +H + HRDLK NIL A+ +KI D G+++V + + T Y
Sbjct: 113 LRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-----IGTPHY 167
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
APE+ Y+ DIWS+GC+ EM T P F ++ M DL
Sbjct: 168 MAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARS-------MQDL--------- 209
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
R K P P + + D + + +L PK RP ++ LA P
Sbjct: 210 ----------RYKVQRGKYP-PIPPIY-SQD--LQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 73/286 (25%), Positives = 129/286 (45%), Gaps = 40/286 (13%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
IG+GS G+V A + H+G +VA+K ++ + E+ ++R +H ++VE+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 181 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 240
L ++++V+ E ++ I + L E +L+ L Y+H+ V HR
Sbjct: 87 YLVG-----EELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHR 141
Query: 241 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP 300
D+K +IL D ++K+ DFG D P V T ++ APE+ + Y
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KSLVGTPYWMAPEVISR--TPYGT 196
Query: 301 AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSM 360
+DIWS+G + EM+ G+P + + V +++ R+R+
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPV---------------QAMKRLRDS--------- 232
Query: 361 RKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
P P P+ LER+L +P++R TA+E L P+
Sbjct: 233 ----PPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 71/215 (33%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN---DVFEHVSDATRILREIKLLRLL 169
S YQ E+IG+G+YG V TG VA+K IN + VSD I RE+ LL L
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSD---IQREVALLSQL 56
Query: 170 RHPDIVEIKH----IMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQ 224
R I + P ++++ E E + ++KA + ++ + +
Sbjct: 57 RQSQPPNITKYYGSYLKGPR------LWIIMEYAEGGSVRTLMKAGP-IAEKYISVIIRE 109
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
+L LKYIH V HRD+K NIL +K+CDFG+A N S + +V T +
Sbjct: 110 VLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVA-ALLNQNSSK--RSTFVGTPY 166
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKP 319
+ APE+ Y DIWS+G EM TG P
Sbjct: 167 WMAPEVITE-GKYYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 89/305 (29%), Positives = 132/305 (43%), Gaps = 64/305 (20%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKK--INDVFEHVSDATRIL-----REIKLLRLLRHP 172
+IG GS+G V ++ +GE +A+K+ + V D R + REI LL+ L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
+IV+ L YV + + L+ + L + F+ Q+L+GL Y+
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLV----RNFVRQILKGLNYL 122
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLA-RVSFN--------DAPS---AIFWTDYV 280
H + HRD+K NIL + +KI DFG++ ++ N PS ++FW
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM--- 179
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340
APE+ + YT DIWS+GC+ EMLTGK FP T L
Sbjct: 180 ------APEVVKQ--TSYTRKADIWSLGCLVVEMLTGKHPFPD---------CTQL---- 218
Query: 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400
++I +I E A P S+ A LE+ D RPTA E
Sbjct: 219 --QAIFKI-GENAS----------PEIPSNISSEAI----DFLEKTFEIDHNKRPTAAEL 261
Query: 401 LADPY 405
L P+
Sbjct: 262 LKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 82/305 (26%), Positives = 131/305 (42%), Gaps = 46/305 (15%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-R 170
+++ EVIG+G+YG V A TG+ VAIK ++ + + I E +LR
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE---EEEIKEEYNILRKYSN 61
Query: 171 HPDIVEIKHIMLPPSRREFKD-IYVVFELME----SDLHQ-VIKANDDLTPEHYQFFLYQ 224
HP+I + + D +++V EL +DL + + K L E + L +
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
LRGL Y+H V HRD+K +NIL + ++K+ DFG++ D+ T ++ T +
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNT-FIGTPY 178
Query: 285 YRAPE--LCG-SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341
+ APE C + Y D+WS+G E+ GKP D+
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL--------CDM-------HP 223
Query: 342 TESISRI-RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400
++ +I RN K P +S KF + L + + RP EE
Sbjct: 224 MRALFKIPRNP-------PPTLKSPENWSKKFN-------DFISECLIKNYEQRPFMEEL 269
Query: 401 LADPY 405
L P+
Sbjct: 270 LEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-24
Identities = 82/299 (27%), Positives = 129/299 (43%), Gaps = 53/299 (17%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRH 171
+Y+ V+G+G++G+V + V IK+I E ++ R E ++L+LL H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIP--VEQMTKDERLAAQNECQVLKLLSH 58
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVI-KANDDLTPEH--YQFFLYQLLR 227
P+I+E L E K + +V E L + I K + L E FF+ Q+L
Sbjct: 59 PNIIEYYENFL-----EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV-QILL 112
Query: 228 GLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARV-SFNDAPSAIFWTDYVATRWY 285
L ++HT + HRDLK +NIL + +KI DFG++++ S + V T Y
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV-----VGTPCY 167
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
+PELC Y DIW++GC+ E+ + K F N+ P+
Sbjct: 168 ISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANL-------------PAL--- 209
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
L M P S ++ P L+ +L DP RP + +A P
Sbjct: 210 ----------VLKIMSGTF-APISDRY---SPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 7e-24
Identities = 93/318 (29%), Positives = 131/318 (41%), Gaps = 68/318 (21%)
Query: 104 EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREI 163
E+ EY E + V+GKG+YG+V +A D T R+AIK+I + + EI
Sbjct: 2 EYEYEYDENGE---RVVLGKGTYGIVYAARDLSTQVRIAIKEIPE--RDSRYVQPLHEEI 56
Query: 164 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-------SDLHQV----IKANDD 212
L L+H +IV+ + S F I+ ME S L + +K N+
Sbjct: 57 ALHSYLKHRNIVQY---LGSDSENGFFKIF-----MEQVPGGSLSALLRSKWGPLKDNEQ 108
Query: 213 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFG----LARVSF 267
F+ Q+L GLKY+H + HRD+K N+L N +KI DFG LA ++
Sbjct: 109 TI----IFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN- 163
Query: 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 327
P + T Y APE+ Y DIWS+GC EM TGKP F
Sbjct: 164 ---PCT---ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF------ 211
Query: 328 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLL 387
+ LG P +A + M K P A + + R
Sbjct: 212 IE-------LGEP-----------QAAMFKVGMFKIHP-EIPESLSAE---AKNFILRCF 249
Query: 388 AFDPKDRPTAEEALADPY 405
DP R +A + L DP+
Sbjct: 250 EPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 76/286 (26%), Positives = 128/286 (44%), Gaps = 40/286 (13%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
IG+GS G+V A + HTG++VA+KK++ + E+ ++R H ++V++ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD--LRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 181 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 240
L +++VV E +E I + + E +LR L Y+H V HR
Sbjct: 88 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHR 142
Query: 241 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP 300
D+K +IL +D ++K+ DFG + P V T ++ APE+ Y
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR---KSLVGTPYWMAPEVISRL--PYGT 197
Query: 301 AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSM 360
+DIWS+G + EM+ G+P + P +++ RIR+ R
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPY---------------FNEPPLQAMRRIRDNLPPR----- 237
Query: 361 RKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
V SHK + + L+ +L +P R TA+E L P+
Sbjct: 238 -----VKDSHKVSS---VLRGFLDLMLVREPSQRATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 7e-23
Identities = 73/223 (32%), Positives = 112/223 (50%), Gaps = 15/223 (6%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
RY+I + IG+GS+G + A E IK+I+ V + +E+ LL ++HP+
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLY--QLLRGLK 230
IV S +E +++V E + DL + I + Q + Q+ GLK
Sbjct: 61 IVTFFA-----SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 231 YIHTANVFHRDLKPKNILANADCKL-KICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
+IH + HRD+K +NI + + + K+ DFG+AR ND S V T +Y +PE
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LND--SMELAYTCVGTPYYLSPE 172
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL 332
+C + Y DIWS+GC+ E+ T K F G N +HQL L
Sbjct: 173 ICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVL 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDA---TRILREIKLLRLLRHPDIVEI 177
+G G +G V A+K + H+ + I E ++L HP IV++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKR--HIVETGQQEHIFSEKEILEECNHPFIVKL 58
Query: 178 KHIMLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
R FKD ++ LME +L +++ +F++ ++ +Y+H
Sbjct: 59 --------YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLH 110
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
+ +RDLKP+N+L +++ +K+ DFG A+ + + WT + T Y APE+
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT---WT-FCGTPEYVAPEII-- 164
Query: 294 FFSK-YTPAIDIWSIGCIFAEMLTGKPLF 321
+K Y ++D WS+G + E+LTG+P F
Sbjct: 165 -LNKGYDFSVDYWSLGILLYELLTGRPPF 192
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 4e-22
Identities = 81/295 (27%), Positives = 132/295 (44%), Gaps = 43/295 (14%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Y + IG+GS+G G++ IK+IN + +E+ +L ++HP+
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQF--FLYQLLRGLK 230
IV+ + S E ++Y+V + E DL++ I A + Q + Q+ LK
Sbjct: 61 IVQYQE-----SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 290
++H + HRD+K +NI D +K+ DFG+ARV + A + T +Y +PE+
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA---RTCIGTPYYLSPEI 172
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350
C + Y DIW++GC+ EM T K F N M +L+ + IR
Sbjct: 173 CEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGN-------MKNLV-------LKIIR- 215
Query: 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
GS PV SH + L L +R +P+DRP+ L +
Sbjct: 216 -------GSY---PPVS-SHYSYDLRNLVSQLFKR----NPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 6e-22
Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 40/286 (13%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
IG+GS G+V A +G+ VA+KK++ + E+ ++R +H ++VE+ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 181 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 240
L +++VV E +E I + + E +L+ L +H V HR
Sbjct: 86 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 241 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP 300
D+K +IL D ++K+ DFG + P V T ++ APEL Y P
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPELISRL--PYGP 195
Query: 301 AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSM 360
+DIWS+G + EM+ G+P + P +++ IR+ + L ++
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPY---------------FNEPPLKAMKMIRDNLPPK-LKNL 239
Query: 361 RKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
K P L+RLL DP R TA E L P+
Sbjct: 240 HK------------VSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 6e-22
Identities = 77/303 (25%), Positives = 126/303 (41%), Gaps = 56/303 (18%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR----ILREIKLLRLLRHPDI 174
+ +G G++ A D TG +A+K++ V S+ + +EI+L+ L HP I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 175 VEIKHIMLPPSRREFKDIYVVF-ELM-----ESDLHQVIKANDDLTPEHYQFFLYQLLRG 228
+ ML + + +F E M L + + + + QLLRG
Sbjct: 66 IR----MLGATCE--DSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIIN----YTEQLLRG 115
Query: 229 LKYIHTANVFHRDLKPKNILANADCK-LKICDFGLA-RVSFNDAPSAIFWTDYVATRWYR 286
L Y+H + HRD+K N+L ++ + L+I DFG A R++ + F + T +
Sbjct: 116 LSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 287 APELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL---LGTPSTE 343
APE+ +Y + D+WS+GC+ EM T KP + + + L L+ + P
Sbjct: 176 APEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP--- 230
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
+P H P + L LE P+DRP + E L
Sbjct: 231 ---------------------SIP-EHLSPGLRDVTLRCLEL----QPEDRPPSRELLKH 264
Query: 404 PYF 406
P F
Sbjct: 265 PVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 21/217 (9%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR-ILREIKLLRLLRHPD 173
+QI +G+G YG V A TGE VA+K++ + R +L E +L +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRGL 229
+V++ + F+D ++ ME D ++ L+ +H +F++ ++ +
Sbjct: 63 LVKLLY--------AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAV 114
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
+H HRDLKP+N L +A +K+ DFGL++ A S + DY+ APE
Sbjct: 115 DALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYM------APE 168
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV 326
+ Y +D WS+GC+ E L G P F G
Sbjct: 169 VLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 3e-21
Identities = 71/213 (33%), Positives = 109/213 (51%), Gaps = 18/213 (8%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 172
+Y + V+G+GS+G ++ ++ A+K+I + +R +E LL ++HP
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSR--KEAVLLAKMKHP 58
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIK-ANDDLTPEH--YQFFLYQLLRG 228
+IV K S +Y+V E + DL Q IK L PE Q+F+ Q+ G
Sbjct: 59 NIVAFKE-----SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV-QMCLG 112
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
+++IH V HRD+K KNI + K+K+ DFG AR+ + P A + YV T +Y P
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGA-YACTYVGTPYYVPP 169
Query: 289 ELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 321
E+ + Y DIWS+GCI E+ T K F
Sbjct: 170 EIWENM--PYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 3e-21
Identities = 77/294 (26%), Positives = 132/294 (44%), Gaps = 42/294 (14%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Y E IG+G+ G V +A+D TG+ VAIK+IN + I+ EI +++ L++P+
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN--LQKQPKKELIINEILVMKELKNPN 77
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
IV L +++VV E + + + + L+ L+++H
Sbjct: 78 IVNFLDSFLVGD-----ELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH 132
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGL-ARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
V HRD+K N+L D +K+ DFG A+++ P + V T ++ APE+
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT----PEQSKRSTMVGTPYWMAPEVVT 188
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
Y P +DIWS+G + EM+ G+P + +N + L L+ GTP ++ ++
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPEKL---- 241
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
P+ L R L D + R +A+E L P+
Sbjct: 242 -----------------------SPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 5e-21
Identities = 68/228 (29%), Positives = 113/228 (49%), Gaps = 15/228 (6%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Y E IG+G+ G V +A+D TG+ VAIK++N + I+ EI ++R +HP+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN--LQQQPKKELIINEILVMRENKHPN 77
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
IV L +++VV E + + + + L+ L+++H
Sbjct: 78 IVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 132
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGL-ARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
+ V HRD+K NIL D +K+ DFG A+++ P + V T ++ APE+
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT----PEQSKRSTMVGTPYWMAPEVVT 188
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340
Y P +DIWS+G + EM+ G+P + +N + L L+ GTP
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP 233
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 7e-21
Identities = 78/300 (26%), Positives = 132/300 (44%), Gaps = 46/300 (15%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI----NDVFEHVSDATRILREIKLLRLLR 170
+ EV+GKG+YG V + T+ G+ +A+K++ ++V + ++ E+ LL+ L+
Sbjct: 2 WTKGEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGL 229
H +IV+ L + I + E + + ++ L + + Q+L G+
Sbjct: 61 HVNIVQYLGTCL-----DDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGV 115
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLAR----VSFNDAPSAIFWTDYVATRWY 285
Y+H V HRD+K N++ + +K+ DFG AR V + S + + + T ++
Sbjct: 116 AYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH-GTPYW 174
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
APE+ S Y DIWSIGC EM TGKP S+
Sbjct: 175 MAPEVINE--SGYGRKSDIWSIGCTVFEMATGKPPL---------------------ASM 211
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
R+ A Y+G+ R P F A A+ + L D +RP+A + L +
Sbjct: 212 DRL---AAMFYIGAHRGLMP-RLPDSFSAA---AIDFVTSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 92.5 bits (229), Expect = 7e-21
Identities = 68/236 (28%), Positives = 116/236 (49%), Gaps = 15/236 (6%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Y E IG+G+ G V +A+D TG+ VAIK++N + I+ EI ++R ++P+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN--LQQQPKKELIINEILVMRENKNPN 77
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
IV L +++VV E + + + + L+ L ++H
Sbjct: 78 IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH 132
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGL-ARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
+ V HRD+K NIL D +K+ DFG A+++ P + V T ++ APE+
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT----PEQSKRSTMVGTPYWMAPEVVT 188
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348
Y P +DIWS+G + EM+ G+P + +N + L L+ GTP ++ R+
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPERL 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 92.5 bits (229), Expect = 8e-21
Identities = 66/236 (27%), Positives = 117/236 (49%), Gaps = 15/236 (6%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Y E IG+G+ G V +A+D TG+ VAI+++N + I+ EI ++R ++P+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
IV L +++VV E + + + + L+ L+++H
Sbjct: 79 IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGL-ARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
+ V HRD+K NIL D +K+ DFG A+++ P + V T ++ APE+
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT----PEQSKRSTMVGTPYWMAPEVVT 189
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348
Y P +DIWS+G + EM+ G+P + +N + L L+ GTP ++ ++
Sbjct: 190 R--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKL 242
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 9e-21
Identities = 88/300 (29%), Positives = 134/300 (44%), Gaps = 54/300 (18%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRHP 172
Y V+GKGSYG V G++ IKK+N + S R +E +LL L+HP
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLN--LRNASRRERKAAEQEAQLLSQLKHP 59
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DL-HQVIKANDDLTPEH--YQFFLYQLLRG 228
+IV + E +Y+V E DL H++ + L PE+ ++F+ Q+
Sbjct: 60 NIVAYRE----SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFV-QIAMA 114
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV--SFNDAPSAIFWTDYVATRWYR 286
L+Y+H ++ HRDLK +N+ +K+ D G+ARV + D S + T Y Y
Sbjct: 115 LQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPY-----YM 169
Query: 287 APELCGSFFSK-YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
+PEL F +K Y D+W++GC EM T K F K+ M L +
Sbjct: 170 SPEL---FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-------MNSL--------V 211
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
RI K P+P + P L+ +L+ P+ RP+ + L PY
Sbjct: 212 YRIIEGKL----------PPMPKDY-----SPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 86/303 (28%), Positives = 129/303 (42%), Gaps = 55/303 (18%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHT--GERVAIKKINDVFE-HVSDATRILREIKLLRLLR 170
RY +Q+ +GKGS+G V D ER+ + K V E + ++ + +E +LL L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLH---QVIKANDDLTPEHYQF-FLYQL 225
HP IV+ L E ++ E E DL + +K E+ + QL
Sbjct: 61 HPAIVKFHASFL-----ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 226 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
L G+ Y+H + HRDLK KNI + LKI DFG++R+ A T + T +Y
Sbjct: 116 LLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLA---TTFTGTPYY 171
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL--GTPSTE 343
+PE Y DIWS+GCI EM F G+N L ++ ++ TPS
Sbjct: 172 MSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPTPS-- 224
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH-LLERLLAFDPKDRPTAEEALA 402
P L+ +++ +L DP RP+A E L
Sbjct: 225 ----------------------------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256
Query: 403 DPY 405
+P+
Sbjct: 257 NPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 1e-20
Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 31/217 (14%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIK--KINDVF-----EHVSDATRILREIKLLR 167
++ + +G GS+G V +G+ A+K + EHV L E ++L+
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHV------LNEKRILQ 56
Query: 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLL 226
+RHP +V L S ++ ++Y+V E + +L ++ + +F+ Q++
Sbjct: 57 SIRHPFLVN-----LYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVV 111
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-RVSFNDAPSAIFWTDYVATRWY 285
L+Y+H+ ++ +RDLKP+N+L ++D +KI DFG A RV +T T Y
Sbjct: 112 LALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT------YT-LCGTPEY 164
Query: 286 RAPELCGSFFSK-YTPAIDIWSIGCIFAEMLTGKPLF 321
APE+ SK Y A+D W++G + EML G P F
Sbjct: 165 LAPEI---ILSKGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 97/350 (27%), Positives = 148/350 (42%), Gaps = 74/350 (21%)
Query: 104 EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRI 159
E F++ + IG GS+G V A D T E VAIKK++ E D I
Sbjct: 6 ELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD---I 62
Query: 160 LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME------SDLHQVIKANDDL 213
++E++ L+ LRHP+ +E K L RE + + +ME SD+ +V K L
Sbjct: 63 IKEVRFLQQLRHPNTIEYKGCYL----RE----HTAWLVMEYCLGSASDILEVHK--KPL 112
Query: 214 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273
+ L+GL Y+H+ HRD+K NIL +K+ DFG A + +P+
Sbjct: 113 QEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV---SPAN 169
Query: 274 IFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLD 331
F V T ++ APE+ + +Y +D+WS+G E+ K PLF ++
Sbjct: 170 SF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-------NMN 218
Query: 332 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDP 391
M+ L +S + +S F N ++ L P
Sbjct: 219 AMSALYHIAQNDSPTL----------------SSNDWSDYFRN-------FVDSCLQKIP 255
Query: 392 KDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREM 441
+DRP++EE L + V RE I L +R KD VRE+
Sbjct: 256 QDRPSSEELLKHRF------VLRERPPTVIIDL---IQR---TKDAVREL 293
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 83/329 (25%), Positives = 129/329 (39%), Gaps = 70/329 (21%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+++ +VIG+G++G V D TG+ A+K + + +R + +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDI------ 54
Query: 173 DIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 228
+ + + F+D +Y+V E M DL ++ D E +F++ +L+
Sbjct: 55 -LADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA 113
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLA----------------RVSFNDAPS 272
L +H HRD+KP NIL +AD +K+ DFGL
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 273 AIFWTDY----------VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 321
+ D+ V T Y APE L G+ Y D WS+G I EML G P F
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT---PYGLECDWWSLGVILYEMLYGFPPF 230
Query: 322 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH 381
E+ ++I N K L P P A+
Sbjct: 231 YSDT---------------LQETYNKIINWK--ESLR-------FPPDPPVS---PEAID 263
Query: 382 LLERLLAFDPKDR-PTAEEALADPYFHGL 409
L+ RLL DP+DR + EE + P+F G+
Sbjct: 264 LICRLLC-DPEDRLGSFEEIKSHPFFKGI 291
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 3e-20
Identities = 66/230 (28%), Positives = 107/230 (46%), Gaps = 29/230 (12%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGER-VAIKKIN--------DVFEHVSDATRILREIKL 165
Y + E +G G++G V + G+ +A+K+IN D E I+ E+ +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 166 LR-LLRHPDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEH--Y 218
++ LRHP+IV L R +Y+V +L+E + +K E +
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDR-----LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW 116
Query: 219 QFFLYQLLRGLKYIHTAN-VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT 277
F+ Q++ L+Y+H + HRDL P NI+ D K+ I DFGLA+ ++ T
Sbjct: 117 NIFV-QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES----KLT 171
Query: 278 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 327
V T Y PE+ + Y D+W+ GCI +M T +P F N++
Sbjct: 172 SVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNML 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 67/217 (30%), Positives = 103/217 (47%), Gaps = 42/217 (19%)
Query: 121 IGKGSYGVVGSA----VDTHTGERVAIKKIN--DVFEHVSDATRILREIKLLRLLRHPDI 174
+G+G +G V + +TGE+VA+K +N +H SD REI++LR L H +I
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD---FEREIEILRTLDHENI 68
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLY--QLLRG 228
V+ K + P R + ++ E + S D Q + + + L+ Q+ +G
Sbjct: 69 VKYKGVCEKPGGRSLR---LIMEYLPSGSLRDYLQRHRDQIN----LKRLLLFSSQICKG 121
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV---------SFNDAPSAIFWTDY 279
+ Y+ + HRDL +NIL ++ +KI DFGLA+V S IFW Y
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW--Y 179
Query: 280 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
APE C SK++ A D+WS G E+ T
Sbjct: 180 -------APE-CLR-TSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-20
Identities = 68/210 (32%), Positives = 112/210 (53%), Gaps = 20/210 (9%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLR 170
+ +QI++ IG+G + V A + VA+KK+ +FE + R ++EI LL+ L
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQ-IFEMMDAKARQDCVKEIDLLKQLN 60
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTPEH--YQFFLYQ 224
HP++ IK++ S E ++ +V EL ++ DL Q+I K L PE +++F+ Q
Sbjct: 61 HPNV--IKYL---DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV-Q 114
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
L ++++H+ V HRD+KP N+ A +K+ D GL R + +A V T +
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTPY 171
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEM 314
Y +PE + Y DIWS+GC+ EM
Sbjct: 172 YMSPERIHE--NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 56/221 (25%), Positives = 105/221 (47%), Gaps = 27/221 (12%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN--DVF-----EHVSDATRILREIKL 165
+ + +G G++G V D + A+K + +V +HV + R+L+E+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-- 58
Query: 166 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQ 224
HP I+ L + + + +Y++ E + +L ++ + + F+ +
Sbjct: 59 ----SHPFIIR-----LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE 109
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
++ L+Y+H+ + +RDLKP+NIL + + +K+ DFG A+ + WT T
Sbjct: 110 IVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-----WT-LCGTPE 163
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
Y APE+ S + A+D W++G + EML G P F N
Sbjct: 164 YLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 5e-20
Identities = 84/285 (29%), Positives = 136/285 (47%), Gaps = 42/285 (14%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR-ILREIKLLRLLRHPDIVEIKH 179
IG GS+G V A ++HT E VA+KK++ + ++ + I++E+K L+ L+HP+ +E K
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 180 IMLPPSRREFKDIYVVFELME------SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
L K+ + + +ME SDL +V K L + L+GL Y+H
Sbjct: 89 CYL-------KE-HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH 138
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
+ N+ HRD+K NIL ++K+ DFG A S +P+ +V T ++ APE+ +
Sbjct: 139 SHNMIHRDIKAGNILLTEPGQVKLADFGSASKS---SPA----NSFVGTPYWMAPEVILA 191
Query: 294 F-FSKYTPAIDIWSIGCIFAEMLTGKP-LFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
+Y +D+WS+G E+ KP LF ++ M+ L +S + NE
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPLF-------NMNAMSALYHIAQNDSPTLQSNE 244
Query: 352 KARRYLGSMRKKQPVPFS-HKFPNADPLALHLLERLLAFDPKDRP 395
+ G V + K P P + LL F +DRP
Sbjct: 245 WTDSFRGF------VDYCLQKIPQERPASAELLRH--DFVRRDRP 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 6e-20
Identities = 70/221 (31%), Positives = 112/221 (50%), Gaps = 33/221 (14%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGER---VAIKKINDVFEHVSDATR--ILREIKL 165
+AS +I++VIG G +G V S G+R VAIK + + ++ R L E +
Sbjct: 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASI 58
Query: 166 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQ 224
+ HP+I+ ++ ++ + K + +V E ME+ L ++ +D QF + Q
Sbjct: 59 MGQFDHPNIIHLEGVV-----TKSKPVMIVTEYMENGSLDAFLRKHDG------QFTVIQ 107
Query: 225 L---LRG----LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT 277
L LRG +KY+ HRDL +NIL N++ K+ DFGL+RV D P A + T
Sbjct: 108 LVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-LEDDPEAAYTT 166
Query: 278 D--YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
+ RW APE + K+T A D+WS G + E+++
Sbjct: 167 RGGKIPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 58/208 (27%), Positives = 105/208 (50%), Gaps = 7/208 (3%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN---DVFEHVSDATRILREIKLLRLLRH 171
+++ +++G+G++G V D TG +A+K++ D E + + EI+LL+ LRH
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
IV+ + P ++ I+V + + + +KA LT + + Q+L+G+ Y
Sbjct: 64 DRIVQYYGCLRDPEEKKLS-IFVEY-MPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
+H+ + HRD+K NIL ++ +K+ DFG ++ S T ++ +PE+
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKP 319
Y D+WS+ C EMLT KP
Sbjct: 182 SG--EGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 4e-19
Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 9/211 (4%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN---DVFEHVSDATRILREIKLLRLL 169
+ +++ +++G+G++G V D TG +A+K++ + E + + EI+LL+ L
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQFFLYQLLRG 228
H IV+ + P R + E M + +K+ LT + + Q+L G
Sbjct: 62 LHERIVQYYGCLRDPMERTLS---IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEG 118
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
+ Y+H+ + HRD+K NIL ++ +K+ DFG ++ S T ++ +P
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 289 ELCGSFFSKYTPAIDIWSIGCIFAEMLTGKP 319
E+ Y DIWS+GC EMLT KP
Sbjct: 179 EVISG--EGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 4e-19
Identities = 101/439 (23%), Positives = 171/439 (38%), Gaps = 65/439 (14%)
Query: 16 QRHSFTNNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQHLQQLTIVEDFDFSGLKL 75
+ + ++ NN+ + + ++ +N+ S S E + + +
Sbjct: 22 APVNALSGNSPKANNSASTGQTTSRSTNSARRSGSKRDRETATSTDSGRTKSHEGAA--- 78
Query: 76 IRVPKRIQFPIAPTPATMDPHKKSAL----------ETEFFTEYGE-----ASRYQIQEV 120
K+ P KK + E F+ GE R++I +
Sbjct: 79 --TTKQATTTPTTNVEVAPPPKKKKVTYALPNQSREEGHFYVVLGEDIDVSTQRFKILSL 136
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
+G+G++G V A D E A+K + +V ++ DA +I EI+ + +R D + +
Sbjct: 137 LGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDA-KI--EIQFMEKVRQADPADRFPL 193
Query: 181 MLPPSRREFKD----IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA- 235
M +R F++ + +V L I + + H ++Q L Y HT
Sbjct: 194 M--KIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTEL 251
Query: 236 NVFHRDLKPKNILANAD----------------CKLKICDFGLARVSFNDAPSAIFWTDY 279
++ H DLKP+NIL C+++ICD G + +AI
Sbjct: 252 HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-GCCDERHSRTAI----- 305
Query: 280 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339
V+TR YR+PE+ Y+ D+WS+GCI E+ TGK L+ + + L LM LG
Sbjct: 306 VSTRHYRSPEVVLGLGWMYS--TDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGR 363
Query: 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPN-----------ADPLALHLLERLLA 388
+E R E+AR S + +P D L L+ LL
Sbjct: 364 LPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLH 423
Query: 389 FDPKDRPTAEEALADPYFH 407
+D + R A + PY
Sbjct: 424 YDRQKRLNARQMTTHPYVL 442
|
Length = 467 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 91/303 (30%), Positives = 142/303 (46%), Gaps = 51/303 (16%)
Query: 105 FFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR-ILREI 163
FF E E ++E IG GS+G V A D T E VAIKK++ + ++ + I++E+
Sbjct: 18 FFKEDPEKLFTDLRE-IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEV 76
Query: 164 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM---ESDLHQVIKANDDLTPEHYQF 220
K L+ ++HP+ +E K L RE ++V E SDL +V K L
Sbjct: 77 KFLQRIKHPNSIEYKGCYL----RE-HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAA 129
Query: 221 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 280
+ L+GL Y+H+ N+ HRD+K NIL ++K+ DFG A ++ +P+ +V
Sbjct: 130 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA---SPA----NSFV 182
Query: 281 ATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLDLMTDLLG 338
T ++ APE+ + +Y +D+WS+G E+ K PLF ++ M+ L
Sbjct: 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-------NMNAMSALYH 235
Query: 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 398
ES + NE +S F N L + P+DRPT+E
Sbjct: 236 IAQNESPTLQSNE----------------WSDYFRNFVDSCLQKI-------PQDRPTSE 272
Query: 399 EAL 401
E L
Sbjct: 273 ELL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 5e-19
Identities = 78/283 (27%), Positives = 113/283 (39%), Gaps = 58/283 (20%)
Query: 137 TGERVAIKKINDVFEHVSDA---TRILREIKLLRLLRHPDIVE-IKHIMLPPSRREFKDI 192
TG VAIK + + + R RE L L HP+IV + PP +
Sbjct: 2 TGHEVAIKLLRT--DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-----L 54
Query: 193 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI-LAN 250
+ VFE + L +V+ A+ L + Q+L L H + HRDLKP+NI ++
Sbjct: 55 FAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQ 114
Query: 251 ADCK--LKICDFGLAR----VSFNDAPSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAID 303
+ K+ DFG+ V D + T+ + T Y APE L G TP D
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRG---EPVTPNSD 171
Query: 304 IWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKK 363
+++ G IF E LTG+ + G +V L + L
Sbjct: 172 LYAWGLIFLECLTGQRVVQGASVAEIL-----------------------YQQLS----- 203
Query: 364 QPVPFSHKFPNA---DPLALHLLERLLAFDPKDRPTAEEALAD 403
PV S P PL +L + L DP+ R + ALA+
Sbjct: 204 -PVDVS--LPPWIAGHPLG-QVLRKALNKDPRQRAASAPALAE 242
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 8e-19
Identities = 66/219 (30%), Positives = 113/219 (51%), Gaps = 20/219 (9%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLR 170
+ ++I++ IG+G + V A G VA+KK+ +F+ + R ++EI LL+ L
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQ-IFDLMDAKARADCIKEIDLLKQLN 60
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTPEH--YQFFLYQ 224
HP++++ + E ++ +V EL ++ DL ++I K L PE +++F+ Q
Sbjct: 61 HPNVIKYYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV-Q 114
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
L L+++H+ V HRD+KP N+ A +K+ D GL R + +A V T +
Sbjct: 115 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTPY 171
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 323
Y +PE + Y DIWS+GC+ EM + F G
Sbjct: 172 YMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 87/294 (29%), Positives = 128/294 (43%), Gaps = 52/294 (17%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV---SDATRILREIKLLRLLRHPDIVEI 177
IGKGS+G V T A+K I H+ S+ T L E +L + P IV +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRK--AHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58
Query: 178 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 236
K P + +Y+V + +L ++ +F+ +LL L+ +H N
Sbjct: 59 KFSFQSPEK-----LYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN 113
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 296
V +RDLKP+NIL + + +CDFGL +++ D + T Y APEL
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT---NTFCGTPEYLAPELLLGH-- 168
Query: 297 KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 356
YT A+D W++G + EMLTG P F +NV NE R+
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----------------------NEMYRKI 205
Query: 357 LGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR---PTAEEALADPYF 406
L ++P+ +FP D A LL LL+ DP R A+E P+F
Sbjct: 206 L-----QEPL----RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFF 250
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 79/299 (26%), Positives = 135/299 (45%), Gaps = 61/299 (20%)
Query: 121 IGKGSYGVVG----SAVDTHTGERVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPDIV 175
+GKG++G V + +TGE VA+KK+ + EH+ D REI++L+ L+H +IV
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRD---FEREIEILKSLQHDNIV 68
Query: 176 EIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHYQFFLY--QLLRGLKYI 232
+ K + RR + +V E L L ++ + + +H + LY Q+ +G++Y+
Sbjct: 69 KYKGVCYSAGRRNLR---LVMEYLPYGSLRDYLQKHRERL-DHRKLLLYASQICKGMEYL 124
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFND---------APSAIFWTDYVATR 283
+ HRDL +NIL ++ ++KI DFGL +V D S IFW
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY------ 178
Query: 284 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
APE SK++ A D+WS G + E+ T +D +P E
Sbjct: 179 ---APESLTE--SKFSVASDVWSFGVVLYELFT----------------YSDKSCSPPAE 217
Query: 344 SISRIRNEKAR-----RYLGSMRKKQPVPFSHKFPNADPLALH-LLERLLAFDPKDRPT 396
+ + N+K + ++ +P P P ++ +++ DP RP+
Sbjct: 218 FMRMMGNDKQGQMIVYHLIELLKNNGRLP----APPGCPAEIYAIMKECWNNDPSQRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 70/243 (28%), Positives = 116/243 (47%), Gaps = 24/243 (9%)
Query: 119 EVIGKGSYG---VVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
+V+G+GS+G +V G+ A+K + V D R E +L + HP IV
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 176 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
++ + + +Y++ + + DL + T E +F+L +L L ++H+
Sbjct: 62 KLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 116
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
+ +RDLKP+NIL + + +K+ DFGL++ S + A + T Y APE+
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVNR- 172
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL----LGTP---STESISR 347
+T + D WS G + EMLTG F GK + + MT + LG P S E+ S
Sbjct: 173 -RGHTQSADWWSFGVLMFEMLTGSLPFQGK---DRKETMTMILKAKLGMPQFLSPEAQSL 228
Query: 348 IRN 350
+R
Sbjct: 229 LRA 231
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 2e-18
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 118 QEVIGKGSYGVVGSAVDTHTGER---VAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
Q+VIG G +G V + G + VAIK + + L E ++ H +I
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-KQRQDFLSEASIMGQFSHHNI 68
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKAND-DLTPEHYQFFLYQLLRGLKYI 232
+ ++ ++ +FK ++ E ME+ L + ++ +D + + L + G+KY+
Sbjct: 69 IRLEGVV-----TKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD--YVATRWYRAPEL 290
N HRDL +NIL N++ + K+ DFGL+RV D P + T + RW APE
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRV-LEDDPEGTYTTSGGKIPIRW-TAPEA 181
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLT 316
+ K+T A D+WS G + E+++
Sbjct: 182 IA--YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 67/241 (27%), Positives = 106/241 (43%), Gaps = 42/241 (17%)
Query: 111 EASRYQIQ--EVIGKGSYGVVGSAV-DTHTGERVAIKKINDVFEHVSDATRILREIKLLR 167
E R ++ +G G +G V + T +VA+K + L+E ++++
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTT--KVAVKTLK---PGTMSPEAFLQEAQIMK 56
Query: 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQ 224
LRH +V++ + S E IY+V E M L +K+ + L Q
Sbjct: 57 KLRHDKLVQLYAVC---SEEE--PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQ 111
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWT 277
+ G+ Y+ + N HRDL +NIL + KI DFGLAR+ +D +A I WT
Sbjct: 112 IAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT 171
Query: 278 DYVATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
APE G F K D+WS G + E++T G+ +PG V+ Q++
Sbjct: 172 ---------APEAANYGRFTIKS----DVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE 218
Query: 332 L 332
Sbjct: 219 R 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 22/209 (10%)
Query: 117 IQEVIGKGSYGVVGSAVDTHTGER---VAIKKINDVFEHVSDATRI--LREIKLLRLLRH 171
I++VIG G +G V G++ VAIK + SD R+ L E ++ H
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFDH 64
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 229
P+I+ ++ ++ ++ + + ++ E ME+ L + ++ ND T L + G+
Sbjct: 65 PNIIRLEGVV---TKS--RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGM 119
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD--YVATRWYRA 287
KY+ N HRDL +NIL N++ K+ DFGL+R + A + T + RW A
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL--EDSEATYTTKGGKIPIRW-TA 176
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
PE + K+T A D+WS G + E+++
Sbjct: 177 PEAIA--YRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 5e-18
Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 23/229 (10%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI-NDVFEHVSDATRILREIKLLRLLRH 171
+ ++ +G G +G V + RVAIK + +D D + E++ L+ LRH
Sbjct: 6 EEFTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQK---EVQALKRLRH 61
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRG 228
++ + + +Y++ ELME L +++ + L Q+ G
Sbjct: 62 KHLISL-FAVCSVGE----PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEG 116
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD--YVATRWYR 286
+ Y+ N HRDL +NIL D K+ DFGLAR+ D ++ + + +W
Sbjct: 117 MAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED----VYLSSDKKIPYKW-T 171
Query: 287 APELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMT 334
APE ++ D+WS G + EM T G+ +PG N D +T
Sbjct: 172 APEAAS--HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 8e-18
Identities = 77/299 (25%), Positives = 119/299 (39%), Gaps = 49/299 (16%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIKH 179
+GKG +G V + TG+ A KK++ + L E K+L + IV + +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 180 IMLPPSRREFKDIYVVFELMES-DLH-QVIKANDDLTPE-HYQFFLYQLLRGLKYIHTAN 236
D+ +V LM DL + + PE F+ Q++ GL+++H
Sbjct: 61 AFETKD-----DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 296
+ +RDLKP+N+L + ++I D GLA V T Y APE+
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKI---KGRAGTPGYMAPEVLQG--E 169
Query: 297 KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 356
Y ++D +++GC EM+ G+ F R R EK +
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPF-------------------------RQRKEKVEKE 204
Query: 357 -LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYFHGL 409
L + V + KF P A L E LL DP+ R +A+E P F L
Sbjct: 205 ELKRRTLEMAVEYPDKF---SPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 71/291 (24%), Positives = 126/291 (43%), Gaps = 39/291 (13%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKIN---DVFEHVSDATRILREIKLLRLLRHPDIV 175
+++G+G++G V D TG +A K++ + E + + + EI+LL+ L+H IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 176 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ + R K + + E M + +KA LT + + Q+L G+ Y+H+
Sbjct: 68 QYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
+ HRD+K NIL ++ +K+ DFG ++ S T ++ +PE+
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG- 183
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354
Y D+WS+GC EMLT KP + + + + P+ + +E AR
Sbjct: 184 -EGYGRKADVWSLGCTVVEMLTEKPPWAE---YEAMAAIFKIATQPTNPQLPSHISEHAR 239
Query: 355 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
+LG + + + RP+AEE L P+
Sbjct: 240 DFLGC---------------------------IFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 76/302 (25%), Positives = 122/302 (40%), Gaps = 67/302 (22%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
I KG++G V A TG+ AIK +L++ ++ + ++ + I
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIK--------------VLKKSDMIAKNQVTNVKAERAI 49
Query: 181 MLPPSRREF----------KD-IYVVFE-LMESDLHQVIKANDDLTPEHYQFFLYQLLRG 228
M+ + KD +Y+V E L D +IK L + + ++ +++ G
Sbjct: 50 MMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLG 109
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
++ +H + HRD+KP+N+L + LK+ DFGL+R + +V T Y AP
Sbjct: 110 VEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-------KKFVGTPDYLAP 162
Query: 289 E-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
E + G D WS+GC+ E L G P F TP
Sbjct: 163 ETILG---VGDDKMSDWWSLGCVIFEFLFGYPPFHA--------------ETPD-AVFDN 204
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA---EEALADP 404
I +RR K+ P A+ L+ RLL DP R A +E + P
Sbjct: 205 I---LSRRINWPEEVKE---------FCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP 252
Query: 405 YF 406
+F
Sbjct: 253 FF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 71/267 (26%), Positives = 112/267 (41%), Gaps = 37/267 (13%)
Query: 160 LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ 219
L E LL+ + HP ++ +K ++ + V SDL+ + P
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLV---SGAITCM--VLPHYSSDLYTYLTKRSRPLPIDQA 159
Query: 220 FFLY-QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD 278
+ Q+L GL+Y+H + HRD+K +NI N ++ I D G A+ AP+ +
Sbjct: 160 LIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV-APAFLGLAG 218
Query: 279 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLF---------PGKNV-V 327
V T APE+ KY DIWS G + EML +F K+
Sbjct: 219 TVET---NAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHS 273
Query: 328 HQLDLMTDLLGTPS---TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH--- 381
H L +++ L P + SR+ Y R+ P++ ++P + L
Sbjct: 274 HLLKIISTLKVHPEEFPRDPGSRLVRGFI-EYASLERQ----PYT-RYPCFQRVNLPIDG 327
Query: 382 --LLERLLAFDPKDRPTAEEALADPYF 406
L+ ++L FD RP+AEE L P F
Sbjct: 328 EFLVHKMLTFDAAMRPSAEEILNYPMF 354
|
Length = 357 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 80/308 (25%), Positives = 124/308 (40%), Gaps = 77/308 (25%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDT-HTGER--VAIK--KINDVFEHVSDATRILREIKLLR 167
+ IG+G +G V V E+ VA+K K S + L+E ++R
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMR 62
Query: 168 LLRHPDIVE-IKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQ 224
HP IV+ I I P +++V EL +L ++ N L + YQ
Sbjct: 63 QFDHPHIVKLIGVITENP-------VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQ 115
Query: 225 LLRGLKYIHTANVFHRDLKPKNIL-ANADCKLKICDFGLARVSFNDAPSAIFWTD----Y 279
L L Y+ + HRD+ +N+L ++ DC +K+ DFGL+R + + Y
Sbjct: 116 LSTALAYLESKRFVHRDIAARNVLVSSPDC-VKLGDFGLSR-----------YLEDESYY 163
Query: 280 VATR------WYRAPELCGSFFSKYTPAIDIWSIG-CIFAEMLTG-KPLFPGKNVVHQLD 331
A++ W APE F ++T A D+W G C++ ++ G KP
Sbjct: 164 KASKGKLPIKWM-APESIN--FRRFTSASDVWMFGVCMWEILMLGVKPFQ---------- 210
Query: 332 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDP 391
G + + I RI E R P+P PN P L+ + A+DP
Sbjct: 211 ------GVKNNDVIGRI--ENGERL--------PMP-----PNCPPTLYSLMTKCWAYDP 249
Query: 392 KDRPTAEE 399
RP E
Sbjct: 250 SKRPRFTE 257
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 67/218 (30%), Positives = 109/218 (50%), Gaps = 25/218 (11%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR-ILREIKLLRLLRHPDIVEIKH 179
IG GS+G V A D E VAIKK++ + ++ + I++E++ L+ LRHP+ ++ +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 180 IMLPPSRREFKDIYVVFELME------SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
L RE + + +ME SDL +V K L + L+GL Y+H
Sbjct: 83 CYL----RE----HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH 132
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
+ N+ HRD+K NIL + +K+ DFG A + AP+ +V T ++ APE+ +
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APA----NXFVGTPYWMAPEVILA 185
Query: 294 F-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQL 330
+Y +D+WS+G E+ KP N + L
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 72/293 (24%), Positives = 128/293 (43%), Gaps = 41/293 (13%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
+G+G+ G V +TG A+K I + +ILRE+++ + + P IV+
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTIT-TDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 181 MLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLYQ-LLRGLKYIHTA 235
L S I + E E +++ +K E + + +L+GL Y+H+
Sbjct: 68 FLDESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124
Query: 236 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSF 294
+ HRD+KP NIL ++K+CDFG++ N + T +Y APE + G
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-----FTGTSFYMAPERIQG-- 177
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFP--GKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
Y+ D+WS+G E+ + FP G+ + ++L++ I + N +
Sbjct: 178 -KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS---------YIVNMPNPE 227
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
+ G+ K +S +F +++ L DP RPT + L P+
Sbjct: 228 LKDEPGNGIK-----WSEEFK-------DFIKQCLEKDPTRRPTPWDMLEHPW 268
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 83/304 (27%), Positives = 126/304 (41%), Gaps = 57/304 (18%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
++I +G G++G V A TG A K I E + + EI +L +HP+I
Sbjct: 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQ--IESEEELEDFMVEIDILSECKHPNI 64
Query: 175 VEIKH---------IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQL 225
V + I++ EF D + +M + LT ++ Q+
Sbjct: 65 VGLYEAYFYENKLWILI-----EFCDGGALDSIML-------ELERGLTEPQIRYVCRQM 112
Query: 226 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
L L ++H+ V HRDLK NIL D +K+ DFG VS + + ++ T ++
Sbjct: 113 LEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFG---VSAKNKSTLQKRDTFIGTPYW 169
Query: 286 RAPEL--CGSFFSK-YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
APE+ C +F Y DIWS+G E+ +P P H+L+ M LL +
Sbjct: 170 MAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP--PH----HELNPMRVLLKILKS 223
Query: 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402
E + QP +S F + L+ L DP DRPTA E L
Sbjct: 224 EPPTL---------------DQPSKWSSSFND-------FLKSCLVKDPDDRPTAAELLK 261
Query: 403 DPYF 406
P+
Sbjct: 262 HPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 30/214 (14%)
Query: 121 IGKGSYGVVGSAVDTHTGE-----RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
+G G +GVV H G+ VAIK I E + E K++ L HP++V
Sbjct: 12 LGSGQFGVV------HLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLV 62
Query: 176 EIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFL---YQLLRGLKY 231
++ + + + I++V E M + L ++ ++ L + ++Y
Sbjct: 63 QLYGVCT-----KQRPIFIVTEYMANGCLLNYLRERKGK--LGTEWLLDMCSDVCEAMEY 115
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
+ + HRDL +N L D +K+ DFGLAR +D ++ T + +W PE+
Sbjct: 116 LESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF-PVKW-APPEVF 173
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGK 324
+S+++ D+WS G + E+ + GK +
Sbjct: 174 D--YSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 121 IGKGSYGVVGSAVDTHTGE-----RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
+G G +GVV H G+ +VAIK IN+ D + E K++ L HP +V
Sbjct: 12 LGSGQFGVV------HLGKWRAQIKVAIKAINEGAMSEED---FIEEAKVMMKLSHPKLV 62
Query: 176 EIKHIMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
++ + + K +Y+V E ME+ L+ + + L+ + + G++Y+
Sbjct: 63 QLYGVCT-----QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE 117
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
+ HRDL +N L ++ +K+ DFG+ R +D ++ + +W PE+
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKW-SPPEVFN- 174
Query: 294 FFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 325
FSKY+ D+WS G + E+ T GK F K+
Sbjct: 175 -FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 77/318 (24%), Positives = 125/318 (39%), Gaps = 85/318 (26%)
Query: 116 QIQEVIGKGSYGVV--GSA---VDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 170
I+E +G+GS+G+V G A V RVAIK +N+ + + L E +++
Sbjct: 10 LIRE-LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-ASMRERIEFLNEASVMKEFN 67
Query: 171 HPDIVEIKHIML---PPSRREFKDIYVVFELM-ESDLHQVIKA-------NDDLTPEHYQ 219
+V + ++ P VV ELM + DL +++ N L P Q
Sbjct: 68 CHHVVRLLGVVSTGQPT--------LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 220 FFLY---QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276
F+ ++ G+ Y+ HRDL +N + D +KI DFG+ R I+
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--------DIYE 171
Query: 277 TDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVV 327
TDY + RW APE +T D+WS G + EM T + + G +
Sbjct: 172 TDYYRKGGKGLLPVRWM-APESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-- 226
Query: 328 HQLDLMTDLLGTPSTESISRIRNEKARRYLGS---MRKKQPVPFSHKFPNADPLALHLLE 384
NE+ +++ + + P D L L L+
Sbjct: 227 ----------------------NEEVLKFVIDGGHLDLPENCP--------DKL-LELMR 255
Query: 385 RLLAFDPKDRPTAEEALA 402
++PK RPT E ++
Sbjct: 256 MCWQYNPKMRPTFLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIK--------KINDVFEHVSDATRILREIK 164
S +++ E +G GS+G V A TGE AIK K+ V +HV+ IL E
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQV-QHVAQEKSILME-- 74
Query: 165 LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQ 224
L HP IV + +R F +VV + + L + + +D+ +F+ +
Sbjct: 75 ----LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVA----KFYHAE 126
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
L+ +Y+H+ ++ +RDLKP+N+L + +K+ DFG A+ P F T
Sbjct: 127 LVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK----KVPDRTF--TLCGTPE 180
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 321
Y APE+ S + A+D W++G + E + G P F
Sbjct: 181 YLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 79/288 (27%), Positives = 124/288 (43%), Gaps = 33/288 (11%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
+G G+ G V TG +A KK+ + S +ILRE++++ R P IV
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 181 MLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN-VF 238
L + +I + E M+ L ++ K + E ++ GL Y++ + +
Sbjct: 72 FLNEN-----NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIM 126
Query: 239 HRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKY 298
HRD+KP NIL N+ ++K+CDFG++ N +V T Y +PE KY
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT-----FVGTSTYMSPERIQG--GKY 179
Query: 299 TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLG 358
T D+WS+G E+ GK FP D D +G + + +I E R
Sbjct: 180 TVKSDVWSLGISIIELALGK--FPFAFSNIDDDGQDDPMGI--LDLLQQIVQEPPPR--- 232
Query: 359 SMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
+P S FP ++ L DP +RPT ++ A P F
Sbjct: 233 -------LP-SSDFP---EDLRDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 33/217 (15%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGER---VAIKKINDVFEHVSDATR--ILREIKLLRLLR 170
+I+EVIG G +G V G+R VAIK + + ++ R L E ++
Sbjct: 7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFD 63
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQL---L 226
HP+I+ ++ + + SR + ++ E ME+ L ++ ND QF + QL L
Sbjct: 64 HPNIIHLEGV-VTKSR----PVMIITEFMENGALDSFLRQNDG------QFTVIQLVGML 112
Query: 227 RG----LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY--- 279
RG +KY+ N HRDL +NIL N++ K+ DFGL+R +D + +
Sbjct: 113 RGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGK 172
Query: 280 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
+ RW APE + K+T A D+WS G + E+++
Sbjct: 173 IPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 76/294 (25%), Positives = 128/294 (43%), Gaps = 40/294 (13%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
+++ + IG G+YG V A + +TGE AIK I E D + +EI +++ +H +I
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
V L RR+ +++ E L + L+ + + L+GL Y+H
Sbjct: 69 VAYFGSYL---RRD--KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGL-ARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
+ HRD+K NIL + +K+ DFG+ A+++ A F + T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF----IGTPYWMAPEVAA 179
Query: 293 -SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
Y DIW++G E+ +P + + L LMT P
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP---------- 229
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
+ K + +S+ F H ++ L +PK RPTAE+ L P+
Sbjct: 230 ---------KLKDKMKWSNSFH-------HFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 81/307 (26%), Positives = 129/307 (42%), Gaps = 53/307 (17%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
+GKG+YG V + TG +A+K+I + S +I+ E+ +L P IV+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE-SKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 181 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLT---PEH-YQFFLYQLLRGLKYIHTA- 235
+Y+ E M++ + A T PE + Y +++GLK++
Sbjct: 68 FFIEGA-----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122
Query: 236 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE----LC 291
N+ HRD+KP N+L N + ++K+CDFG VS N S + T+ + + Y APE
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFG---VSGNLVAS-LAKTN-IGCQSYMAPERIKSGG 177
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK---NVVHQLDLMTDLLGTPSTESISRI 348
+ YT D+WS+G EM G+ +P + N+ QL + D G P T
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT------ 229
Query: 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408
P +S A + + L P RPT + L P+
Sbjct: 230 ---------------LPSGYS-------DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267
Query: 409 LANVDRE 415
N D +
Sbjct: 268 YKNADVD 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 25/209 (11%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRHPDIVEI 177
+G G+ GVV + +G +A K I+ E + A R I+RE+K+L P IV
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIH--LE-IKPAIRNQIIRELKVLHECNSPYIVGF 64
Query: 178 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFL-YQLLRGLKYIHTA 235
+I + E M+ L QV+K + PE+ + +LRGL Y+
Sbjct: 65 YGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRI-PENILGKISIAVLRGLTYLREK 118
Query: 236 -NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGS 293
+ HRD+KP NIL N+ ++K+CDFG++ + ++ +V TR Y +PE L G
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQG- 172
Query: 294 FFSKYTPAIDIWSIGCIFAEMLTGKPLFP 322
+ YT DIWS+G EM G+ +P
Sbjct: 173 --THYTVQSDIWSLGLSLVEMAIGR--YP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 21/213 (9%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKI-NDVFEHVSDATRILREIKLLRLL-RHPDIVEI 177
V+GKGS+G V A T E A+K + DV D + E ++L L +HP + ++
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 178 KHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
R +F +ME DL I+ + +F+ +++ GL+++H
Sbjct: 62 HSCFQTKDR--------LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSF-NDAPSAIFWTDYVATRWYRAPELCG 292
+ +RDLK N+L +++ +KI DFG+ + ++ F T Y APE+
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF----CGTPDYIAPEILS 169
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
+ Y PA+D W++G + EML G+ F G +
Sbjct: 170 --YQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 19/216 (8%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIK---KINDVFEHVSDATRILREIKLLRLLRH 171
++I E IGKG+YG V + G A+K I+DV E + IL+ L H
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQS-----LPNH 78
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMESD-----LHQVIKANDDLTPEHYQFFLYQLL 226
P++V+ + + +++V EL + ++ L + LY L
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 286
GL+++H + HRD+K NIL + +K+ DFG VS + + V T ++
Sbjct: 139 LGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRRNTSVGTPFWM 195
Query: 287 APELCG---SFFSKYTPAIDIWSIGCIFAEMLTGKP 319
APE+ + Y D+WS+G E+ G P
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIK---KINDVFEHVSDATRILREIKLLRLLRH 171
++I E IGKG+YG V ++ G + A+K I+D+ E + IL+ L H
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKA-----LSDH 74
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQ-VIKANDDLTPEHYQFFLYQLL 226
P++V+ + + +++V EL +DL + +K + + + L++ L
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 286
GL+++H HRD+K NIL + +K+ DFG VS + + V T ++
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRRNTSVGTPFWM 191
Query: 287 APELCG---SFFSKYTPAIDIWSIGCIFAEMLTGKP 319
APE+ S Y D+WS+G E+ G P
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 7e-16
Identities = 76/296 (25%), Positives = 123/296 (41%), Gaps = 50/296 (16%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDI 174
Q QE++G G+ G V A T +A+K I D+ + +I+ E+++L P I
Sbjct: 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ--KQIMSELEILYKCDSPYI 61
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTPEH-YQFFLYQLLRGLK 230
+ +R I + E M+ D+++ I PEH +++GL
Sbjct: 62 IGFYGAFFVENR-----ISICTEFMDGGSLDVYRKI-------PEHVLGRIAVAVVKGLT 109
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 290
Y+ + + HRD+KP N+L N ++K+CDFG++ N YV T Y APE
Sbjct: 110 YLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA-----KTYVGTNAYMAPER 164
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350
+Y D+WS+G F E+ G+ +P + LL E +
Sbjct: 165 ISG--EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL-- 220
Query: 351 EKARRYLGSMRKKQPV-PFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
PV FS KF +H + + + PK+RP E + P+
Sbjct: 221 --------------PVGQFSEKF-------VHFITQCMRKQPKERPAPENLMDHPF 255
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 9e-16
Identities = 64/249 (25%), Positives = 101/249 (40%), Gaps = 62/249 (24%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKI--NDVFE-----HVSDATRILREIKLLRLLRH 171
+VIG+G++G V TG A+KK+ +++ E HV IL E +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD------N 60
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLR 227
P +V++ + F+D ++ +ME D+ ++ D T E +F++ + +
Sbjct: 61 PWVVKLYY--------SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETIL 112
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGL------------ARVSFNDAPSAIF 275
+ IH HRD+KP N+L +A +K+ DFGL R+ + PS
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 276 WTDY-----------------------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA 312
V T Y APE+ + Y D WS+G I
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIMY 230
Query: 313 EMLTGKPLF 321
EML G P F
Sbjct: 231 EMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 77/283 (27%), Positives = 117/283 (41%), Gaps = 41/283 (14%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
E IGKGS+G V +D T E VAIK I D+ E + I +EI +L P I
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68
Query: 179 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF 238
L ++ ++++ E + + L + L ++L+GL Y+H+
Sbjct: 69 GSYLKGTK-----LWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKI 123
Query: 239 HRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKY 298
HRD+K N+L + +K+ DFG+A D + I +V T ++ APE+ S Y
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAG-QLTD--TQIKRNTFVGTPFWMAPEVIKQ--SAY 178
Query: 299 TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLG 358
DIWS+G E+ G+P L M L P
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNS------DLHPMRVLFLIPKNSP-------------P 219
Query: 359 SMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
++ + PF +E L DP+ RPTA+E L
Sbjct: 220 TLEGQYSKPFK-----------EFVEACLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 43/228 (18%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
++ IGKG +G V + + G++VA+K + D + A L E ++ LRHP++V
Sbjct: 9 KLGATIGKGEFGDV--MLGDYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTLRHPNLV 63
Query: 176 EIKHIMLPPSRREFKDIYVVFELME---------SDLHQVIKANDDLTPEHYQFFLYQLL 226
++ ++L + +Y+V E M S VI L F +
Sbjct: 64 QLLGVVL-----QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLG------FALDVC 112
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF---WTDYVATR 283
G++Y+ N HRDL +N+L + D K+ DFGLA+ + S WT
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT------ 166
Query: 284 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GK---PLFPGKNVV 327
APE K++ D+WS G + E+ + G+ P P K+VV
Sbjct: 167 ---APEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 17/212 (8%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPDIVEI 177
+V+GKGS+G V A T E AIK + DV D + E ++L L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA------- 53
Query: 178 KHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
KH L F+ +F +ME DL I+ + +F+ ++ L ++H
Sbjct: 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
V +RDLK NIL +A+ K+ DFG+ + + + T + T Y APE+
Sbjct: 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQE 170
Query: 294 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
+Y P++D W++G + EM+ G+P F N
Sbjct: 171 L--EYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 13/209 (6%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
V+GKGS+G V A T E AIK + DV D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 179 HIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 237
H R +Y V E + DL I+ H F+ ++ GL ++H+ +
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 238 FHRDLKPKNILANADCKLKICDFGLARVS-FNDAPSAIFWTDYVATRWYRAPELCGSFFS 296
+RDLK N++ +A+ +KI DFG+ + + F + F T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTF----CGTPDYIAPEIIA--YQ 176
Query: 297 KYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
Y ++D W+ G + EML G+P F G++
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 36/237 (15%)
Query: 111 EASRYQIQEV--IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 168
E R IQ + +G G +G V + +T VA+K + D L E ++++
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLK---PGTMDPKDFLAEAQIMKK 57
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQL 225
LRHP ++++ + + E IY+V ELM+ L + ++ L Q+
Sbjct: 58 LRHPKLIQLYAVC---TLEE--PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV 112
Query: 226 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWTD 278
G+ Y+ N HRDL +N+L + K+ DFGLARV D A I WT
Sbjct: 113 ASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT- 171
Query: 279 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 331
APE + +++++ D+WS G + E++T G+ +PG V+ Q+D
Sbjct: 172 --------APE--AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 55/216 (25%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 119 EVIGKGSYGVV--GSAVDTHTGER-VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
VIGKG +G V G+ +D+ + A+K +N + + + + L+E +++ HP+++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 176 EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHT 234
+ I LP E + V+ + DL I++ + T + F Q+ +G++Y+ +
Sbjct: 60 SLLGICLPS---EGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS 116
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
HRDL +N + + +K+ DFGLAR I+ +Y + + +L +
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLAR--------DIYDKEYYSVHNHTGAKLPVKW 168
Query: 295 FS-------KYTPAIDIWSIGCIFAEMLT-GKPLFP 322
+ K+T D+WS G + E++T G P +P
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 80/269 (29%), Positives = 117/269 (43%), Gaps = 39/269 (14%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKI-------NDVFEHVSDATRILREIKLLRLLRHP 172
V+G+G +G V A TGE AIK + D E + RI + RHP
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIF---ETANSERHP 62
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+V + + V E DL I + P F+ ++ GL+Y
Sbjct: 63 FLVNLFACFQTEDH-----VCFVMEYAAGGDLMMHIHTDVFSEPRA-VFYAACVVLGLQY 116
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLAR--VSFNDAPSAIFWTDYVATRWYRAPE 289
+H + +RDLK N+L + + +KI DFGL + + F D S + T + APE
Sbjct: 117 LHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-----FCGTPEFLAPE 171
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD-LMTDLLGTP---STESI 345
+ + YT A+D W +G + EML G+ FPG + D ++ D + P S E+I
Sbjct: 172 VLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAI 229
Query: 346 SRIRNEKAR---RYLGSMR------KKQP 365
S +R R R LGS KKQP
Sbjct: 230 SIMRRLLRRNPERRLGSGEKDAEDVKKQP 258
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 71/310 (22%), Positives = 121/310 (39%), Gaps = 74/310 (23%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEI 177
+++GKG G V TG+ A+K ++ + R+L E ++L L HP + +
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 178 KHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHT 234
S + + +V + +L ++++ L+ E +F+ ++L L+Y+H
Sbjct: 67 YA-----SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL 121
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT----------------- 277
+ +RDLKP+NIL + + + DF L++ S + P +
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQS-DVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 278 ----------DYVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK 324
+V T Y APE+ G + A+D W++G + EML G F G
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDG-----HGSAVDWWTLGILLYEMLYGTTPFKGS 235
Query: 325 NVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLE 384
N R+E L K+ V F P A L+
Sbjct: 236 N-----------------------RDETFSNIL-----KKEVTF-PGSPPVSSSARDLIR 266
Query: 385 RLLAFDPKDR 394
+LL DP R
Sbjct: 267 KLLVKDPSKR 276
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 84/328 (25%), Positives = 131/328 (39%), Gaps = 64/328 (19%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 170
E + + I E G+ G + +D T E V IK + AT E +LR +
Sbjct: 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIK----AGQRGGTAT----EAHILRAIN 141
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 230
HP I+++K ++ ++DL+ + A ++ +LR ++
Sbjct: 142 HPSIIQLKGTFTYNKF-----TCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQ 196
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY----- 285
Y+H + HRD+K +NI N + + DFG +A F D A ++Y
Sbjct: 197 YLHENRIIHRDIKAENIFINHPGDVCLGDFG----------AACFPVDINANKYYGWAGT 246
Query: 286 ---RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNV------VHQLDLMTD 335
APEL Y PA+DIWS G + EM T LF + Q+ L+
Sbjct: 247 IATNAPELLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR 304
Query: 336 LLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLE----------R 385
GT E + Y+G +K S + P + PL +L E +
Sbjct: 305 RSGTHPNEFPIDAQANLDEIYIGLAKK------SSRKPGSRPLWTNLYELPIDLEYLICK 358
Query: 386 LLAFDPKDRPTAE--------EALADPY 405
+LAFD RP+AE + + DPY
Sbjct: 359 MLAFDAHHRPSAEALLDFAAFQDIPDPY 386
|
Length = 391 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 69/248 (27%), Positives = 111/248 (44%), Gaps = 31/248 (12%)
Query: 85 PIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIK 144
P+ P ++ S+ + S + IG G+ G V + TG A+K
Sbjct: 46 PLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALK 105
Query: 145 KINDVFEHVSDATR--ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESD 202
I + + D R I REI++LR + HP++V+ H M + +I V+ E M+
Sbjct: 106 VI---YGNHEDTVRRQICREIEILRDVNHPNVVKC-HDMFDHN----GEIQVLLEFMDGG 157
Query: 203 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 262
+ D+ Q+L G+ Y+H ++ HRD+KP N+L N+ +KI DFG+
Sbjct: 158 SLEGTHIADEQFLADVAR---QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGV 214
Query: 263 ARV---SFNDAPSAIFWTDYVATRWYRAPE-----LCGSFFSKYTPAIDIWSIGCIFAEM 314
+R+ + + S+ V T Y +PE L + Y A DIWS+G E
Sbjct: 215 SRILAQTMDPCNSS------VGTIAYMSPERINTDLNHGAYDGY--AGDIWSLGVSILEF 266
Query: 315 LTGKPLFP 322
G+ FP
Sbjct: 267 YLGR--FP 272
|
Length = 353 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKIND-VFEHVSDATRILREIKLLR---LLRHPDIVE 176
IGKG++G V T A+K ++ + + E +L L P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 177 IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 235
+K S D+Y+V + M +L ++ + + +F++ +L+ L+++H
Sbjct: 61 LKFSFQTDS-----DLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 236 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFF 295
++ +RDLKP+NIL +A + +CDFGL++ + D + + T Y APE+
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT---NTFCGTTEYLAPEVLLD-E 171
Query: 296 SKYTPAIDIWSIGCIFAEMLTG 317
YT +D WS+G + EM G
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 6e-15
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
E IGKGS+G V +D T + VAIK I D+ E + I +EI +L P + +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 179 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF 238
L ++ ++++ E + + L L ++L+GL Y+H+
Sbjct: 69 GSYLKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI 123
Query: 239 HRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKY 298
HRD+K N+L + ++K+ DFG+A D + I +V T ++ APE+ S Y
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAG-QLTD--TQIKRNTFVGTPFWMAPEVIKQ--SAY 178
Query: 299 TPAIDIWSIGCIFAEMLTGKP 319
DIWS+G E+ G+P
Sbjct: 179 DSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 11/208 (5%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
V+GKGS+G V A T E AIK + DV D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 179 HIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 237
H R +Y V E + DL I+ H F+ ++ GL ++H+ +
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 238 FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK 297
+RDLK N++ +++ +KI DFG+ + + D + + T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT---KTFCGTPDYIAPEIIA--YQP 177
Query: 298 YTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
Y ++D W+ G + EML G+ F G++
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 7e-15
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLR-HPDIVE 176
V+GKGS+G V A +G A+K + DV D + E ++L L R HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 177 IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 235
+ P R ++ V E + DL I+ + +F+ ++ L ++H
Sbjct: 61 LYCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115
Query: 236 NVFHRDLKPKNILANADCKLKICDFGLARVS-FNDAPSAIFWTDYVATRWYRAPELCGSF 294
+ +RDLK N+L + + K+ DFG+ + FN ++ F T Y APE+
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF----CGTPDYIAPEILQEM 171
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
Y P++D W++G + EML G F +N
Sbjct: 172 L--YGPSVDWWAMGVLLYEMLCGHAPFEAEN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 9e-15
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 16/212 (7%)
Query: 120 VIGKGSYGVVGSAVDTH---TGERVAIK--KINDVFEHVSDATRILREIKLLRLLRHPDI 174
V+GKG YG V TG+ A+K K + + D E +L ++HP I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 175 VEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
V++ + + +Y++ E L +L ++ + F+L ++ L+++H
Sbjct: 63 VDLIYAFQTGGK-----LYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH 117
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
+ +RDLKP+NIL +A +K+ DFGL + S ++ + T Y APE+
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE---GTVTHTFCGTIEYMAPEILMR 174
Query: 294 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
S + A+D WS+G + +MLTG P F +N
Sbjct: 175 --SGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 9e-15
Identities = 83/298 (27%), Positives = 122/298 (40%), Gaps = 51/298 (17%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIK 178
V+GKG +G V + TG+ A KK+ + L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66
Query: 179 HIMLPPSRREFKD-IYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ E KD + +V LM DL H N E F+ ++ GL+ +H
Sbjct: 67 YAY------ETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR 120
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
+ +RDLKP+NIL + ++I D GLA + P V T Y APE+ +
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLA----VEIPEGETIRGRVGTVGYMAPEVVKN- 175
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354
+YT + D W +GC+ EM+ GK F R R EK +
Sbjct: 176 -ERYTFSPDWWGLGCLIYEMIEGKSPF-------------------------RQRKEKVK 209
Query: 355 RYLGSMR-KKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYF 406
R R K+ +S KF A + +LL DP R AEE A P+F
Sbjct: 210 REEVERRVKEDQEEYSEKF---SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 71/300 (23%), Positives = 127/300 (42%), Gaps = 52/300 (17%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPDIVEI 177
+++GKG++G V + TG+ A+K + +V + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 178 KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 237
K+ R F Y +L + + + +F+ +++ L Y+H+ +V
Sbjct: 61 KYSFQTHDRLCFVMEYA----NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDV 116
Query: 238 FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK 297
+RDLK +N++ + D +KI DFGL + +D + + T Y APE+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED--ND 171
Query: 298 YTPAIDIWSIGCIFAEMLTGKPLFPGK--NVVHQLDLMTDLLGTPSTESISRIRNEKARR 355
Y A+D W +G + EM+ G+ F + + +L LM ++
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI------------------- 212
Query: 356 YLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR-----PTAEEALADPYFHGL 409
+FP P A LL LL DPK R A+E + +F +
Sbjct: 213 ---------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 117 IQEVIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
+QE IG G +G+V G ++ +VAIK I + D + E +++ L HP +
Sbjct: 9 VQE-IGSGQFGLVWLGYWLEK---RKVAIKTIREGAMSEED---FIEEAQVMMKLSHPKL 61
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKAND-DLTPEHYQFFLYQLLRGLKYI 232
V++ + E I +VFE ME L ++A + E + G+ Y+
Sbjct: 62 VQLYGVCT-----ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL 116
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
++NV HRDL +N L + +K+ DFG+ R +D ++ T + +W +PE+
Sbjct: 117 ESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF-PVKW-SSPEVFS 174
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLT 316
FSKY+ D+WS G + E+ +
Sbjct: 175 --FSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 64/250 (25%), Positives = 118/250 (47%), Gaps = 19/250 (7%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEI 177
+++GKG++G V + +G+ A+K + +V + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 178 KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 237
K+ R F YV + L + ++D T +F+ +++ L Y+H+ +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRT----RFYGAEIVSALDYLHSGKI 116
Query: 238 FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK 297
+RDLK +N++ + D +KI DFGL + DA + + T Y APE+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM---KTFCGTPEYLAPEVLED--ND 171
Query: 298 YTPAIDIWSIGCIFAEMLTGKPLFPGKN--VVHQLDLMTDLLGTPSTESISRIRNEKARR 355
Y A+D W +G + EM+ G+ F ++ + +L LM D+ R + A+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI-------KFPRTLSADAKS 224
Query: 356 YLGSMRKKQP 365
L + K P
Sbjct: 225 LLSGLLIKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 29/225 (12%)
Query: 121 IGKGSYGVVGSAVDTHTGER---VAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVE 176
+G G++G V V + VA+K + EH + LRE ++ L HP IV
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ--EHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 177 IKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 235
+ + + +V EL L + +K ++ + +Q+ G+ Y+ +
Sbjct: 61 LIGVCKGEP------LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114
Query: 236 NVFHRDLKPKNILANADCKLKICDFGLAR-VSFND----APSAIFWTDYVATRWYRAPEL 290
+ HRDL +N+L + KI DFG++R + A +A W +WY APE
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRW----PLKWY-APE- 168
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLT--GKPL--FPGKNVVHQLD 331
C ++ K++ D+WS G E + KP G V+ L+
Sbjct: 169 CINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE 212
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 13/209 (6%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRL-LRHPDIVEI 177
V+GKGS+G V A T E AIK + DV D + E ++L L HP +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLT-- 59
Query: 178 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 236
H+ +E ++ V E + DL I+++ +F+ +++ GL+++H
Sbjct: 60 -HLFCTFQTKEH--LFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 296
+ +RDLK N+L + D +KI DFG+ + + N A + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA---STFCGTPDYIAPEILKG--Q 171
Query: 297 KYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
KY ++D WS G + EML G+ F G++
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 17/228 (7%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGER----VAIKKINDVFEHVSDATRILREIKLLRL 168
+ + +V+G G++G V V GE+ VAIK + + ++ IL E ++
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKAN-KEILDEAYVMAS 65
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLL 226
+ HP +V + I L + ++ +LM L V D++ ++ + Q+
Sbjct: 66 VDHPHVVRLLGICLSSQ------VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIA 119
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 286
+G+ Y+ + HRDL +N+L +KI DFGLA++ D V +W
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM- 178
Query: 287 APELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLM 333
A E YT D+WS G E++T G + G V DL+
Sbjct: 179 ALESI--LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 77/302 (25%), Positives = 123/302 (40%), Gaps = 51/302 (16%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIK 178
V+GKG +G V + TG+ A K++ + + L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 179 HIMLPPSRREFKD-IYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ E KD + +V +M DL H N E F+ ++L GL+ +H
Sbjct: 67 YAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
N +RDLKP+NIL + ++I D GLA P V T Y APE+ +
Sbjct: 121 ENTVYRDLKPENILLDDYGHIRISDLGLAV----KIPEGESIRGRVGTVGYMAPEVLNN- 175
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354
+YT + D W +GC+ EM+ G+ F G+ +++ E+
Sbjct: 176 -QRYTLSPDYWGLGCLIYEMIEGQSPFRGRK--------------------EKVKREEVD 214
Query: 355 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDR 414
R + + FS + A + + LL DPK R +E G V R
Sbjct: 215 RRVLETEEVYSAKFSEE-------AKSICKMLLTKDPKQRLGCQE-------EGAGEVKR 260
Query: 415 EP 416
P
Sbjct: 261 HP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 34/219 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRH 171
+ + E+IG+G +G V +TG++VA+K I DV A L E ++ L H
Sbjct: 6 QKLTLGEIIGEGEFGAVLQG--EYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHH 58
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDL---TPEHYQFFLYQLLR 227
++V + ++L +Y+V ELM + +L ++ + QF L +
Sbjct: 59 KNLVRLLGVIL------HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL-DVAE 111
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF---WTDYVATRW 284
G++Y+ + + HRDL +NIL + D K+ DFGLARV ++ WT
Sbjct: 112 GMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT------- 164
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFP 322
APE K++ D+WS G + E+ + G+ +P
Sbjct: 165 --APEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 26/218 (11%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKL-LRLLRHPDI 174
++ E +G+G+YGVV TG +A+K+I R+L ++ + +R + P
Sbjct: 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYT 62
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK---ANDDLTPEHYQFFL----YQLLR 227
V + RE D+++ E+M++ L + K PE L +++
Sbjct: 63 VTFYGALF----RE-GDVWICMEVMDTSLDKFYKKVYDKGLTIPED---ILGKIAVSIVK 114
Query: 228 GLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 286
L+Y+H+ +V HRD+KP N+L N + ++K+CDFG++ + + T + Y
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS----VAKTIDAGCKPYM 170
Query: 287 APELCGSFFSK--YTPAIDIWSIGCIFAEMLTGKPLFP 322
APE ++ Y D+WS+G E+ TG+ FP
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGR--FP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
E IGKGS+G V +D T + VAIK I D+ E + I +EI +L P + +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 179 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFF-----LYQLLRGLKYIH 233
L ++ ++++ E + A D L + F L ++L+GL Y+H
Sbjct: 69 GSYLKGTK-----LWIIMEYLGGG-----SALDLLRAGPFDEFQIATMLKEILKGLDYLH 118
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
+ HRD+K N+L + +K+ DFG+A D + I +V T ++ APE+
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAG-QLTD--TQIKRNTFVGTPFWMAPEVIQQ 175
Query: 294 FFSKYTPAIDIWSIGCIFAEMLTGKP 319
S Y DIWS+G E+ G+P
Sbjct: 176 --SAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 75/310 (24%), Positives = 128/310 (41%), Gaps = 58/310 (18%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK-LLRLLRHPD 173
+ ++ ++G+G +G V + TG+ A+K + + E + +L + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 174 IVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHY-QFFLYQLLRG 228
I ++++ F+D +Y+V E DL ++ +D E QF+L +L+
Sbjct: 63 IPQLQY--------AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA 114
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFG-LARVSFNDAPSAIFWTDYVATRWYRA 287
+ +H HRD+KP+N+L + +K+ DFG AR++ N + V T Y A
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN---KMVNSKLPVGTPDYIA 171
Query: 288 PELC----GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
PE+ G Y D WS+G I EM+ G+ F +
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA---------------K 216
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLA----LHLLERLLAFDPKDRPTAEE 399
+ + I N + R+L KFP DP L L++ LL K+R E
Sbjct: 217 TYNNIMNFQ--RFL-------------KFP-EDPKVSSDFLDLIQSLLC-GQKERLGYEG 259
Query: 400 ALADPYFHGL 409
P+F +
Sbjct: 260 LCCHPFFSKI 269
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 13/216 (6%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKIND-VFEHVSDATRILREIK-LLRLLRHPDIVE 176
+VIGKGS+G V A G+ A+K + + + + I+ E LL+ ++HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 177 IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 235
+ + S + + +Y V + + +L ++ +F+ ++ L Y+H+
Sbjct: 61 LHY-----SFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115
Query: 236 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFF 295
N+ +RDLKP+NIL ++ + + DFGL + + + T + T Y APE+
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVIRK-- 170
Query: 296 SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD 331
Y +D W +G + EML G P F ++V D
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-14
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 17/212 (8%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIK--KINDVFEHVSDATRILREIKLLRLLRHPDIVE 176
E IGKG++G V V VA+K + + + L+E ++L+ HP+IV+
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPD---LKRKFLQEAEILKQYDHPNIVK 56
Query: 177 IKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ + + + + IY+V EL+ S L + K + LT + G++Y+ +
Sbjct: 57 LIGVCV-----QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES 111
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
N HRDL +N L + LKI DFG++R + + +W APE
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW-TAPEALN-- 168
Query: 295 FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 325
+ +YT D+WS G + E + G +PG +
Sbjct: 169 YGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 11/208 (5%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
V+GKGS+G V A T E AIK + DV D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 179 HIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 237
H R +Y V E + DL I+ F+ ++ GL ++H +
Sbjct: 67 HSCFQTVDR----LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGI 122
Query: 238 FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK 297
+RDLK N++ +++ +KI DFG+ + D + + T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT---RTFCGTPDYIAPEIIA--YQP 177
Query: 298 YTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
Y ++D W+ G + EML G+P F G++
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 15/211 (7%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLL-RHPDIVE 176
+++GKGS+G V A T + AIK + DV D + E ++L L HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT- 59
Query: 177 IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 235
H+ +E +++ V E + DL I++ F+ +++ GL+++H+
Sbjct: 60 --HLYCTFQTKE--NLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115
Query: 236 NVFHRDLKPKNILANADCKLKICDFGLARVS-FNDAPSAIFWTDYVATRWYRAPELCGSF 294
+ +RDLK NIL + D +KI DFG+ + + DA + F T Y APE+
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF----CGTPDYIAPEIL--L 169
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
KY ++D WS G + EML G+ F G +
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 4e-14
Identities = 63/225 (28%), Positives = 104/225 (46%), Gaps = 44/225 (19%)
Query: 116 QIQEVIGKGSYGVVGSAV-DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
++ + +G G +G V + HT +VAIK + + L E L++ L+HP +
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGHT--KVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRL 63
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL------- 226
V + ++ + IY++ E ME+ L +K TPE + + +L+
Sbjct: 64 VRLYAVVTQ------EPIYIITEYMENGSLVDFLK-----TPEGIKLTINKLIDMAAQIA 112
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWTDY 279
G+ +I N HRDL+ NIL + KI DFGLAR+ ++ +A I WT
Sbjct: 113 EGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT-- 170
Query: 280 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG 323
APE + +T D+WS G + E++T G+ +PG
Sbjct: 171 -------APEAIN--YGTFTIKSDVWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 77/320 (24%), Positives = 122/320 (38%), Gaps = 59/320 (18%)
Query: 120 VIGKGSYG--VVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVE 176
+IGK +V A T VA+KKIN D D + +EI R L+HP+I+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSK-EDLKLLQQEIITSRQLQHPNILP 63
Query: 177 IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY---------QFFLYQLLR 227
+ S ++YVV LM + +DL H+ F L +L
Sbjct: 64 YVTSFIVDS-----ELYVVSPLMA------YGSCEDLLKTHFPEGLPELAIAFILKDVLN 112
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDF---------GLARVSFNDAP-SAIF-- 275
L YIH+ HR +K +IL + D K+ + G + +D P S++
Sbjct: 113 ALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172
Query: 276 -WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMT 334
W +PE+ Y DI+S+G E+ G P K++ L+
Sbjct: 173 PWL---------SPEVLQQNLQGYNEKSDIYSVGITACELANG--HVPFKDMPATQMLLE 221
Query: 335 DLLGTP------ST--ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERL 386
+ GT ST + ++ + R P++ F +E
Sbjct: 222 KVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTF---SEHFHQFVELC 278
Query: 387 LAFDPKDRPTAEEALADPYF 406
L DP+ RP+A + L +F
Sbjct: 279 LQRDPESRPSASQLLNHSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-14
Identities = 75/291 (25%), Positives = 124/291 (42%), Gaps = 40/291 (13%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
Y++ + +G G+YG V A + HTGE A+K I E D + I +EI +++ +H +I
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
V L SR + +++ E L + L+ + + L+GL Y+H
Sbjct: 69 VAYFGSYL--SREK---LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH 123
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGL-ARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
+ HRD+K NIL + +K+ DFG+ A+++ A F + T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF----IGTPYWMAPEVAA 179
Query: 293 -SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
Y DIW++G E+ +P + + L LM+ P
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP---------- 229
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402
+ K +S F N ++ L +PK RPTAE L
Sbjct: 230 ---------KLKDKTKWSSTFHNFVKIS-------LTKNPKKRPTAERLLT 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 9e-14
Identities = 70/240 (29%), Positives = 111/240 (46%), Gaps = 38/240 (15%)
Query: 111 EASRYQIQEV--IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 168
E R I+ V +G G +G V + +VA+K + V L E L++
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQ---AFLEEANLMKT 57
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDD---LTPEHYQFFLYQ 224
L+H +V + ++ ++ E IY++ E M + L +K+++ L P+ F Q
Sbjct: 58 LQHDKLVRLYAVV---TKEE--PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA-Q 111
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWT 277
+ G+ YI N HRDL+ N+L + KI DFGLARV ++ +A I WT
Sbjct: 112 IAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT 171
Query: 278 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDL 336
APE F +T D+WS G + E++T GK +PG + D+M+ L
Sbjct: 172 ---------APEAIN--FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS---NSDVMSAL 217
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 9e-14
Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 32/221 (14%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
Q+ + +G G +G V +VA+K + L E ++++ LRH +V
Sbjct: 9 QLIKKLGNGQFGEVWMGTWNGN-TKVAVKTLK---PGTMSPESFLEEAQIMKKLRHDKLV 64
Query: 176 EIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQF--FLYQLLRGLKYI 232
++ ++ S IY+V E M + L +K + + Q+ G+ YI
Sbjct: 65 QLYAVV---SEEP---IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWTDYVATRWY 285
N HRDL+ NIL KI DFGLAR+ ++ +A I WT
Sbjct: 119 ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT-------- 170
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 325
APE + + ++T D+WS G + E++T G+ +PG N
Sbjct: 171 -APE--AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 36/221 (16%)
Query: 116 QIQEVIGKGSYGVVGSAV-DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
++++ +G G +G V A + HT +VA+K + V L E +++ L+H +
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVE---AFLAEANVMKTLQHDKL 63
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLYQLLRGLK 230
V++ ++ +E IY++ E M D + + + P+ F Q+ G+
Sbjct: 64 VKLHAVV----TKE--PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA-QIAEGMA 116
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWTDYVATR 283
+I N HRDL+ NIL +A KI DFGLARV ++ +A I WT
Sbjct: 117 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT------ 170
Query: 284 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG 323
APE F +T D+WS G + E++T G+ +PG
Sbjct: 171 ---APEAIN--FGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 65/253 (25%), Positives = 118/253 (46%), Gaps = 25/253 (9%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPDIVEI 177
+++GKG++G V + TG A+K + +V + + E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 178 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 236
K+ R F V E +L + T E +F+ +++ L+Y+H+ +
Sbjct: 61 KYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 115
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 296
V +RD+K +N++ + D +KI DFGL + +D + + T Y APE+ +
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED--N 170
Query: 297 KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH----QLDLMTDLLGTPSTESISRIRNEK 352
Y A+D W +G + EM+ G+ P N H +L LM ++ R + +
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELILMEEI-------RFPRTLSPE 221
Query: 353 ARRYLGSMRKKQP 365
A+ L + KK P
Sbjct: 222 AKSLLAGLLKKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 78/300 (26%), Positives = 124/300 (41%), Gaps = 49/300 (16%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIK 178
V+GKG +G V + TG+ A KK+ + + L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 179 HIMLPPSRREFKD-IYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ E KD + +V LM DL H F+ ++ GL+ +H
Sbjct: 67 YAY------ETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
+ +RDLKP+NIL + ++I D GLA P V T Y APE+ +
Sbjct: 121 ERIVYRDLKPENILLDDHGHIRISDLGLAV----HVPEGQTIKGRVGTVGYMAPEVVKN- 175
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354
+YT + D W++GC+ EM+ G+ +P + +I+ E+
Sbjct: 176 -ERYTFSPDWWALGCLLYEMIAGQ--------------------SPFQQRKKKIKREEVE 214
Query: 355 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYFHGL 409
R + K+ +S KF P A L + LL DPK+R A E P F +
Sbjct: 215 RLV----KEVQEEYSEKF---SPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 85/320 (26%), Positives = 135/320 (42%), Gaps = 52/320 (16%)
Query: 116 QIQEVIGK---GSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
++ E+IG+ G++G V A + TG A K I E + + EI++L HP
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYMVEIEILATCNHP 69
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRGLK 230
IV+ +L + K ++++ E I D LT Q Q+L L+
Sbjct: 70 YIVK----LLGAFYWDGK-LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQ 124
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 290
Y+H+ + HRDLK N+L D +K+ DFG VS + + ++ T ++ APE+
Sbjct: 125 YLHSMKIIHRDLKAGNVLLTLDGDIKLADFG---VSAKNVKTLQRRDSFIGTPYWMAPEV 181
Query: 291 CGSFFSKYTP---AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
K TP DIWS+G EM +P H+L+ M LL +E +
Sbjct: 182 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH------HELNPMRVLLKIAKSEPPTL 235
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407
QP +S +F + L+ L P+ RP+A + L P+
Sbjct: 236 ---------------SQPSKWSMEFRD-------FLKTALDKHPETRPSAAQLLEHPF-- 271
Query: 408 GLANVDREPSTQPISKLEFE 427
V S +P+ +L E
Sbjct: 272 ----VSSVTSNRPLRELVAE 287
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 67/257 (26%), Positives = 110/257 (42%), Gaps = 52/257 (20%)
Query: 119 EVIGKGSYGVV-----GSAVDTHTGERVAIKKINDVFEHVSDATR-ILREIKLLRLLRHP 172
+G+G++G V + E VA+K + + +DA + RE +LL +H
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET--ASNDARKDFEREAELLTNFQHE 68
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND--------------DLTPEH 217
+IV+ + E +VFE ME DL++ ++++ +LT
Sbjct: 69 NIVKFYGVCT-----EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQ 123
Query: 218 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT 277
Q+ G+ Y+ + + HRDL +N L D +KI DFG++R ++ T
Sbjct: 124 LLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR--------DVYTT 175
Query: 278 DY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GK-PLFPGKN-- 325
DY + RW PE + K+T D+WS G + E+ T GK P + N
Sbjct: 176 DYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE 232
Query: 326 VVHQLDLMTDLLGTPST 342
V+ + LL P T
Sbjct: 233 VIECITQGR-LLQRPRT 248
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 66/254 (25%), Positives = 116/254 (45%), Gaps = 26/254 (10%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEI 177
+++GKG++G V + TG A+K + +V + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 178 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA- 235
K+ R F V E +L + + + +F+ +++ L Y+H+
Sbjct: 61 KYSFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 115
Query: 236 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFF 295
NV +RDLK +N++ + D +KI DFGL + D + + T Y APE+
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVLED-- 170
Query: 296 SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH----QLDLMTDLLGTPSTESISRIRNE 351
+ Y A+D W +G + EM+ G+ P N H +L LM ++ R +
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELILMEEI-------RFPRTLSP 221
Query: 352 KARRYLGSMRKKQP 365
+A+ L + KK P
Sbjct: 222 EAKSLLSGLLKKDP 235
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 33/213 (15%)
Query: 119 EVIGKGSYGVVGSAV-DTHTGER--VAIKKINDVFEHVSDATR-ILREIKLLRLLRHPDI 174
+ +G GS+GVV T G+ VA+K + + +SD L+E ++ L H ++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKS--DKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 175 VEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQF-FLYQLLRGLKY 231
+ + ++L + +V EL S L ++ K + Q+ G++Y
Sbjct: 59 IRLYGVVLTHP------LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRY 112
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLAR-VSFNDAPSAIFWTDYVATRWYR---- 286
+ + HRDL +NIL +D K+KI DFGL R + N+ D+ +
Sbjct: 113 LESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE--------DHYVMEEHLKVPF 164
Query: 287 ---APELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
APE ++ A D+W G EM T
Sbjct: 165 AWCAPESLR--TRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-13
Identities = 55/227 (24%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
+G G YG V V VA+K + E + L+E +++ ++HP++V++ +
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 181 ML--PPSRREFKDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTA 235
PP Y++ E M +L ++ + ++ + Q+ ++Y+
Sbjct: 71 CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 123
Query: 236 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWTDYVATRWYRAP 288
N HRDL +N L + +K+ DFGL+R+ D +A I WT AP
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT---------AP 174
Query: 289 ELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 331
E ++K++ D+W+ G + E+ T G +PG V L+
Sbjct: 175 E--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 219
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 77/308 (25%), Positives = 135/308 (43%), Gaps = 49/308 (15%)
Query: 115 YQIQEVIGKGSYG---VVGSAVDTHTGERVAIKKINDVF----EHVSDATRILREIKLLR 167
+++ +V+G G+YG +V TG+ A+K + + TR R + L
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNV--LE 59
Query: 168 LLRH-PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLL 226
+R P +V + + ++ YV M + L+Q D+ + + +F+ +++
Sbjct: 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEII 115
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 286
L+++H + +RD+K +NIL +++ + + DFGL++ ++ + + T Y
Sbjct: 116 LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY--SFCGTIEYM 173
Query: 287 APELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
APE+ + A+D WS+G + E+LTG F L G +T+S
Sbjct: 174 APEIIRG-KGGHGKAVDWWSLGILIFELLTGASPF-------------TLEGERNTQS-- 217
Query: 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEAL 401
E +RR L + P P P A LL +LL DPK R A E
Sbjct: 218 ----EVSRRIL---KCDPPFP-----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIK 265
Query: 402 ADPYFHGL 409
P+F GL
Sbjct: 266 EHPFFKGL 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 20/219 (9%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
A +++ EV+G G+YG V TG+ AIK + DV E + I EI +L+ H
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTE--DEEEEIKLEINMLKKYSH 71
Query: 172 PDIVEIKHIML----PPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLY 223
+ + PP + +++V E +DL + K N L + +
Sbjct: 72 HRNIATYYGAFIKKSPPGHDD--QLWLVMEFCGAGSVTDLVKNTKGNA-LKEDWIAYICR 128
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
++LRGL ++H V HRD+K +N+L + ++K+ DFG VS + ++ T
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVGRRNTFIGTP 185
Query: 284 WYRAPELCG---SFFSKYTPAIDIWSIGCIFAEMLTGKP 319
++ APE+ + + Y DIWS+G EM G P
Sbjct: 186 YWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 5e-13
Identities = 73/309 (23%), Positives = 132/309 (42%), Gaps = 52/309 (16%)
Query: 115 YQIQEVIGKGSYG---VVGSAVDTHTGERVAIKKINDV--------FEHVSDATRILREI 163
+++ V+G G+YG +V G+ A+K + EH TR R++
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEH----TRTERQV 57
Query: 164 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 223
L + R P +V + + ++ YV + + L+Q + T + ++
Sbjct: 58 -LEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIA 112
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
+++ L ++H + +RD+K +NIL +++ + + DFGL++ + + + T
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY--SFCGTI 170
Query: 284 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
Y APE+ + A+D WS+G + E+LTG F T E
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF-----------------TVDGE 213
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR---PTAEEA 400
S ++E +RR L K +P PF A +++LL DPK R A+E
Sbjct: 214 QNS--QSEISRRIL----KSKP-PFPKTM---SAEARDFIQKLLEKDPKKRLGANGADEI 263
Query: 401 LADPYFHGL 409
P+F G+
Sbjct: 264 KNHPFFQGI 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 81/314 (25%), Positives = 128/314 (40%), Gaps = 62/314 (19%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKI--NDVFEHVSDATRILREIKLLRLLRH-- 171
+ IG G+ G V TG +A+K++ E RIL ++ ++ L H
Sbjct: 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENK---RILMDLDVV-LKSHDC 73
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL-YQLLRGLK 230
P IV+ + S D+++ ELM + L +++K PE + +++ L
Sbjct: 74 PYIVKCYGYFITDS-----DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALH 128
Query: 231 YIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVA-TR----- 283
Y+ V HRD+KP NIL +A +K+CDFG++ D A TR
Sbjct: 129 YLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG----------RLVDSKAKTRSAGCA 178
Query: 284 WYRAPELCG--SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341
Y APE KY D+WS+G E+ TG+ FP KN + +++T
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ--FPYKNCKTEFEVLT------- 229
Query: 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
+I E+ + FS F + ++ L D + RP E L
Sbjct: 230 -----KILQEEPPSLPPNEG------FSPDFCS-------FVDLCLTKDHRKRPKYRELL 271
Query: 402 ADPYF--HGLANVD 413
P+ + A VD
Sbjct: 272 QHPFIRRYETAEVD 285
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 21/201 (10%)
Query: 121 IGKGSYGVVGSAV-DTHTGER-VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
+G G++G V + E+ VA+K + + + +LRE +++ L +P IV +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 179 HIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 237
I E + +V EL E L++ ++ N +T ++ ++Q+ G+KY+ N
Sbjct: 63 GIC------EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 238 FHRDLKPKNILANADCKLKICDFGLARVSFND-----APSAIFWTDYVATRWYRAPELCG 292
HRDL +N+L KI DFGL++ D A + W +WY APE C
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW----PVKWY-APE-CM 170
Query: 293 SFFSKYTPAIDIWSIGCIFAE 313
+++ K++ D+WS G + E
Sbjct: 171 NYY-KFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 7e-13
Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 34/224 (15%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 170
E+ R +++ +G+G +G V T RVAIK + L+E ++++ LR
Sbjct: 6 ESLRLEVK--LGQGCFGEVWMGTWNGT-TRVAIKTLK---PGTMSPEAFLQEAQVMKKLR 59
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQF--FLYQLLR 227
H +V++ ++ + IY+V E M + L +K Q Q+
Sbjct: 60 HEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 113
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWTDYV 280
G+ Y+ N HRDL+ NIL + K+ DFGLAR+ ++ +A I WT
Sbjct: 114 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT--- 170
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG 323
APE + + ++T D+WS G + E+ T G+ +PG
Sbjct: 171 ------APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 9e-13
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 13/210 (6%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEI 177
+V+GKGS+G V A GE A+K + DV D + E ++L L +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPF--L 58
Query: 178 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 236
H+ +E ++ V E + DL I+ F+ +++ GL+++H+
Sbjct: 59 THLYCTFQTKE--HLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG 116
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVS-FNDAPSAIFWTDYVATRWYRAPELCGSFF 295
+ +RDLK N++ + D +KI DFG+ + + F D ++ F T Y APE+
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF----CGTPDYIAPEILQGL- 171
Query: 296 SKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
KYT ++D WS G + EML G+ F G +
Sbjct: 172 -KYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 54/185 (29%), Positives = 92/185 (49%), Gaps = 12/185 (6%)
Query: 136 HTGERVAIK--KINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193
+TGE+VA+K K H++D + +EI++LR L H +IV+ K I K
Sbjct: 31 NTGEQVAVKSLKPESGGNHIAD---LKKEIEILRNLYHENIVKYKGICTEDGGNGIK--- 84
Query: 194 VVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 251
++ E + S L + + N + + + + Q+ +G+ Y+ + HRDL +N+L +
Sbjct: 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES 144
Query: 252 DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 311
+ ++KI DFGL + D D + ++ APE SK+ A D+WS G
Sbjct: 145 EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL--IQSKFYIASDVWSFGVTL 202
Query: 312 AEMLT 316
E+LT
Sbjct: 203 YELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 76/310 (24%), Positives = 124/310 (40%), Gaps = 66/310 (21%)
Query: 114 RY-QIQEVIGKGSYGVVG----SAVDTHTGERVAIKKINDVFEHVSDATRILR-----EI 163
RY + V+G+G +G V + TGE VA+K + + + EI
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK------RECGQQNTSGWKKEI 57
Query: 164 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFF 221
+L+ L H +IV+ K S + K + ++ E + S + K +L F
Sbjct: 58 NILKTLYHENIVKYKGCC---SEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLA--QLLLF 112
Query: 222 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA----------RVSFNDAP 271
Q+ G+ Y+H+ + HRDL +N+L + D +KI DFGLA RV D
Sbjct: 113 AQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR-EDGD 171
Query: 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT--GKPLFPGKNVVHQ 329
S +FW A E K++ A D+WS G E+LT P K
Sbjct: 172 SPVFWY---------AVECLKEN--KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-- 218
Query: 330 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLAL-HLLERLLA 388
+++G P ++ + R + + + +P P P + L++
Sbjct: 219 -----EMIG-PKQGQMTVV------RLIELLERGMRLP----CPKNCPQEVYILMKNCWE 262
Query: 389 FDPKDRPTAE 398
+ K RPT
Sbjct: 263 TEAKFRPTFR 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 19/220 (8%)
Query: 114 RYQIQEVIGKGSYGVVGSAV-----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 168
+ +G G++G V A + +VA+K + H S+ ++ E+K++
Sbjct: 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT-AHSSEREALMSELKIMSH 94
Query: 169 L-RHPDIVEIKHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDD--LTPEHYQFFLYQ 224
L H +IV L + I V+ E DL ++ + LT E F YQ
Sbjct: 95 LGNHENIVN-----LLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQ 149
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
+ +G+ ++ + N HRDL +N+L +KICDFGLAR ND+ + + +W
Sbjct: 150 VAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKW 209
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG 323
APE F YT D+WS G + E+ + G +PG
Sbjct: 210 M-APE--SIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 18/222 (8%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRH---PDIV 175
+IG+G +G V TG+ A+K ++ + T L E +L L+ P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 176 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ + P + F + +LM DLH + + + + +F+ +++ GL+++H
Sbjct: 61 CMTYAFHTPDKLCF-----ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN 115
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
V +RDLKP NIL + ++I D GLA P A V T Y APE+
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYMAPEVLQK- 169
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV--VHQLDLMT 334
+ Y + D +S+GC+ ++L G F H++D MT
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 20/219 (9%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
A +++ E++G G+YG V TG+ AIK ++ + + I +EI +L+ H
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSH 61
Query: 172 PDIVEIKHIML----PPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLY 223
+ + PP + +++V E +DL + K N L E +
Sbjct: 62 HRNIATYYGAFIKKNPPGMDD--QLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICR 118
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
++LRGL ++H V HRD+K +N+L + ++K+ DFG VS + ++ T
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVGRRNTFIGTP 175
Query: 284 WYRAPELCG---SFFSKYTPAIDIWSIGCIFAEMLTGKP 319
++ APE+ + + Y D+WS+G EM G P
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 65/235 (27%), Positives = 109/235 (46%), Gaps = 37/235 (15%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 170
E+ R ++ +G+G +G V T +VAIK + L+E ++++ LR
Sbjct: 6 ESLRLDVK--LGQGCFGEVWMGTWNGT-TKVAIKTLK---PGTMMPEAFLQEAQIMKKLR 59
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQF--FLYQLLR 227
H +V + ++ + IY+V E M + L +K D + Q Q+
Sbjct: 60 HDKLVPLYAVV------SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIAD 113
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWTDYV 280
G+ YI N HRDL+ NIL + KI DFGLAR+ ++ +A I WT
Sbjct: 114 GMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWT--- 170
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 331
APE + + ++T D+WS G + E++T G+ +PG + V+ Q++
Sbjct: 171 ------APE--AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE 217
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 11/142 (7%)
Query: 183 PPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDL 242
P S + D V L+ D + + D L+ F YQ+ RG++++ + N HRDL
Sbjct: 211 PASYKGSNDSEVK-NLLSDDGSEGLTTLDLLS------FTYQVARGMEFLASKNCVHRDL 263
Query: 243 KPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAI 302
+N+L +KICDFGLAR +D+ + ++ +W APE F + YT
Sbjct: 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWM-APE--SIFDNLYTTLS 320
Query: 303 DIWSIGCIFAEMLT-GKPLFPG 323
D+WS G + E+ + G +PG
Sbjct: 321 DVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 12/221 (5%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV--SDATRILREIKLLRL 168
+A Y + +VIG+G++G V V + ++V K+ FE + SD+ E ++
Sbjct: 41 KAEDYDVVKVIGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRG 228
P +V+ L + ++ K +Y+V E M + +N D+ + +F+ +++
Sbjct: 100 ANSPWVVQ-----LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLA 154
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
L IH+ + HRD+KP N+L + LK+ DFG D + V T Y +P
Sbjct: 155 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVRCDTAVGTPDYISP 212
Query: 289 ELCGSFFSK--YTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 327
E+ S Y D WS+G EML G F ++V
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 58/223 (26%), Positives = 109/223 (48%), Gaps = 25/223 (11%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
++ + IGKG +G V + + G +VA+K I ++ + A L E ++ LRH ++V
Sbjct: 9 KLLQTIGKGEFGDV--MLGDYRGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLV 62
Query: 176 EIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYI 232
++ +++ E +Y+V E M + L +++ L + F + ++Y+
Sbjct: 63 QLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
N HRDL +N+L + D K+ DFGL + + S+ T + +W APE
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKW-TAPEALR 172
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLT-GK---PLFPGKNVVHQLD 331
K++ D+WS G + E+ + G+ P P K+VV +++
Sbjct: 173 E--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 213
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 78/330 (23%), Positives = 129/330 (39%), Gaps = 56/330 (16%)
Query: 113 SRYQIQEVIGKGSYG-VVGSAVDTHTGERVAIKKINDVFEHVSDATRIL----------- 160
+ +++ + + G++G + A+ T E A + +N + R++
Sbjct: 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAA 207
Query: 161 ----REIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND---DL 213
EI L L H +I++I+ I+ + + Y++ + + DL+ +
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSEA-----NTYMITQKYDFDLYSFMYDEAFDWKD 262
Query: 214 TPEHYQF--FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND-A 270
P Q + QLL ++YIH + HRD+K +NI N D K+ + DFG A +
Sbjct: 263 RPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE 322
Query: 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFP----GKNV 326
W VAT +PE+ Y DIWS G I +ML+ P G
Sbjct: 323 AFDYGWVGTVAT---NSPEILAG--DGYCEITDIWSCGLILLDMLS-HDFCPIGDGGGKP 376
Query: 327 VHQLDLMTDLLGTPSTE----------SISRIRNEKARRYLGSMRKKQPVPFSHKFPNAD 376
QL + D L E I + A + + + +P ++P
Sbjct: 377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYP--- 433
Query: 377 PLALHLLERLLAFDPKDRPTAEEALADPYF 406
L ++L FD RP A E LA P F
Sbjct: 434 ------LVKMLTFDWHLRPGAAELLALPLF 457
|
Length = 501 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 13/216 (6%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKIND-VFEHVSDATRILREIK-LLRLLRHPDIVE 176
+VIGKGS+G V A G A+K + + I+ E LL+ L+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 177 IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 235
+ + + +Y V + + +L ++ +F+ ++ + Y+H+
Sbjct: 61 LHYSFQTAEK-----LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL 115
Query: 236 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFF 295
N+ +RDLKP+NIL ++ + + DFGL + + + + T Y APE+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGTPEYLAPEVLRK-- 170
Query: 296 SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD 331
Y +D W +G + EML G P F ++V D
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 69/307 (22%), Positives = 136/307 (44%), Gaps = 46/307 (14%)
Query: 115 YQIQEVIGKGSYGVVG--SAVDTH-TGERVAIKKINDVF----EHVSDATRILREIKLLR 167
+++ +V+G G+YG V V H +G+ A+K + ++ TR R++ L
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQV-LEH 60
Query: 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLR 227
+ + P +V + + ++ Y+ + + L Q + + Q + +++
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER----FKEQEVQIYSGEIVL 116
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
L+++H + +RD+K +NIL +++ + + DFGL++ D + + T Y A
Sbjct: 117 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY--SFCGTIEYMA 174
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
P++ + A+D WS+G + E+LTG F + +
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF-------------------TVDGEKN 215
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR----PT-AEEALA 402
+ E +RR L K +P P+ + LA +++RLL DPK R P+ A+E
Sbjct: 216 SQAEISRRIL----KSEP-PYPQEM---SALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267
Query: 403 DPYFHGL 409
P+F +
Sbjct: 268 HPFFQKI 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 66/285 (23%), Positives = 119/285 (41%), Gaps = 50/285 (17%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
E IG+G++G V S VA+K + A + L+E ++L+ HP+IV +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA-KFLQEARILKQYSHPNIVRLI 59
Query: 179 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLR-------GLKY 231
+ + + IY+V EL++ L E + + +L++ G++Y
Sbjct: 60 GVC-----TQKQPIYIVMELVQGGDFLTF-----LRTEGPRLKVKELIQMVENAAAGMEY 109
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
+ + + HRDL +N L LKI DFG++R + ++ + +W APE
Sbjct: 110 LESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPEAL 168
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
+ +Y+ D+WS G + E + LG ++S N+
Sbjct: 169 N--YGRYSSESDVWSFGILLWEAFS--------------------LGAVPYANLS---NQ 203
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT 396
+ R + + +P P+A L+ER +DP RP+
Sbjct: 204 QTREAI---EQGVRLPCPELCPDA---VYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 18/210 (8%)
Query: 119 EVIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVE 176
E++GKG++G V G+ D VA+K + + L E ++L+ HP+IV+
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTP---VAVKTCKEDLPQ-ELKIKFLSEARILKQYDHPNIVK 56
Query: 177 IKHIMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ + ++R+ IY+V EL+ L + K D+L + F G+ Y+ +
Sbjct: 57 LIGVC---TQRQ--PIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES 111
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
N HRDL +N L + LKI DFG++R +D + + +W APE
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSRQE-DDGIYSSSGLKQIPIKW-TAPEALN-- 167
Query: 295 FSKYTPAIDIWSIGCIFAEMLT-GKPLFPG 323
+ +Y+ D+WS G + E + G +PG
Sbjct: 168 YGRYSSESDVWSYGILLWETFSLGVCPYPG 197
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 70/232 (30%), Positives = 98/232 (42%), Gaps = 37/232 (15%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI-NDVFEHVSDATRILREIKLLRLLRHP 172
RY I +IGKG G V A D RVA+KKI D+ E+ R LRE K+ L HP
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP 62
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLR----- 227
IV + I + Y+ ++S L V + + + L
Sbjct: 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 228 --GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-----------VSFNDA---- 270
++Y+H+ V HRDLKP NIL ++ I D+G A + ++
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 271 -----PSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLT 316
P I V T Y APE L G S+ T DI+++G I +MLT
Sbjct: 183 SSMTIPGKI-----VGTPDYMAPERLLGVPASEST---DIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 78/307 (25%), Positives = 121/307 (39%), Gaps = 62/307 (20%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDV-------FEHVSDATRILREIKLLRLLRHPD 173
+GKG +G V + TG+ A KK+N +E RIL ++ H
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-------HSR 53
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTP---EHYQ-FFLYQLLRG 228
+ + L + + D+ +V +M DL I D+ P E F+ Q++ G
Sbjct: 54 FI----VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG 109
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
L+++H + +RDLKP+N+L + D ++I D GLA V D S Y T + AP
Sbjct: 110 LEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKT--KGYAGTPGFMAP 166
Query: 289 ELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348
EL +Y ++D +++G EM+ + F R
Sbjct: 167 ELLQG--EEYDFSVDYFALGVTLYEMIAARGPF-------------------------RA 199
Query: 349 RNEKA-RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALA 402
R EK + L V + KF A + E LLA DP+ R +
Sbjct: 200 RGEKVENKELKQRILNDSVTYPDKFSPA---SKSFCEALLAKDPEKRLGFRDGNCDGLRT 256
Query: 403 DPYFHGL 409
P F L
Sbjct: 257 HPLFRDL 263
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 66/246 (26%), Positives = 113/246 (45%), Gaps = 55/246 (22%)
Query: 113 SRYQIQEVIGKGSYG--VVGSAVDTHTGER---VAIKKI-NDVFEHVSDATRILREIKLL 166
R + + +G+G++G V AV VA+K + +D E D + ++ E++++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK--DLSDLVSEMEMM 69
Query: 167 RLL-RHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKAN-------------- 210
+++ +H +I+ +L +E +YVV E +L ++A
Sbjct: 70 KMIGKHKNIIN----LLGVCTQEGP-LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124
Query: 211 --DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268
+ LT + F YQ+ RG++++ + HRDL +N+L D +KI DFGLAR
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR---- 180
Query: 269 DAPSAIFWTDY--------VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLT--G 317
I DY + +W APE + F + YT D+WS G + E+ T G
Sbjct: 181 ----DIHHIDYYRKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLLWEIFTLGG 232
Query: 318 KPLFPG 323
P +PG
Sbjct: 233 SP-YPG 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 61/223 (27%), Positives = 108/223 (48%), Gaps = 21/223 (9%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDA-TRILREIKLLRLLRHPD 173
++I +VIG+G++G V HT ER+ KI + +E + A T RE + +L + D
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHT-ERIYAMKILNKWEMLKRAETACFREER--NVLVNGD 59
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHY-QFFLYQLLRG 228
I + F+D ++ +M+ DL ++ +D PE +F++ +++
Sbjct: 60 CQWITTL-----HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLA 114
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND----APSAIFWTDYVATRW 284
+ IH + HRD+KP N+L + + +++ DFG D + A+ DY++
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 327
+A E KY P D WS+G EML G+ F +++V
Sbjct: 175 LQAME---DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 21/219 (9%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV---SDATRILREIK-LLRLLRHPDIV 175
VIGKGS+G V A G+ A+K + + + + I+ E LL+ ++HP +V
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQK--KAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 176 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ + S + +Y V + + +L ++ +F+ ++ L Y+H+
Sbjct: 60 GLHY-----SFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS 114
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLAR--VSFNDAPSAIFWTDYVATRWYRAPELCG 292
N+ +RDLKP+NIL ++ + + DFGL + + + S + T Y APE+
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-----FCGTPEYLAPEVLR 169
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD 331
Y +D W +G + EML G P F ++ D
Sbjct: 170 K--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 18/222 (8%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRH---PDIV 175
+IG+G +G V TG+ A+K ++ + T L E +L L+ P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 176 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ + P + F + +LM DLH + + + +F+ +++ GL+++H
Sbjct: 61 CMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN 115
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
V +RDLKP NIL + ++I D GLA P A V T Y APE+
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYMAPEVLQKG 170
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV--HQLDLMT 334
+ Y + D +S+GC+ ++L G F H++D MT
Sbjct: 171 VA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERV----AIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
+V+G G++G V + GE V AIK +N+ ++ + E ++ + HP +
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN-VEFMDEALIMASMDHPHL 71
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
V + + L P+ I +V +LM L V + D++ + + Q+ +G+ Y+
Sbjct: 72 VRLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL 125
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
+ HRDL +N+L + +KI DFGLAR+ D + +W L
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM---ALEC 182
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLT--GKP 319
+ K+T D+WS G E++T GKP
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRHPDIVEIK 178
+G G+ GVV +G +A K I+ + A R I+RE+++L P IV
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIH---LEIKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 179 HIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN- 236
+I + E M+ L QV+K + E +LRGL Y+ +
Sbjct: 70 GAFYSDG-----EISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 124
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFF 295
+ HRD+KP NIL N+ ++K+CDFG++ + ++ +V TR Y +PE L G+ +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQGTHY 179
Query: 296 SKYTPAIDIWSIGCIFAEMLTGKPLFP 322
S + DIWS+G E+ G+ P
Sbjct: 180 SVQS---DIWSMGLSLVELAIGRYPIP 203
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 34/236 (14%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGER-----VAIKKINDVFEHVSDATRILREIKLLRLLR 170
+ + +G+G +G V A R VA+K + + S+ +L E LL+ +
Sbjct: 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN-ASSSELRDLLSEFNLLKQVN 61
Query: 171 HPDIVEI-----------------KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD- 212
HP ++++ K+ L RE + + + + + + N D
Sbjct: 62 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 213 --LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270
LT F +Q+ RG++Y+ + HRDL +N+L K+KI DFGL+R + +
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
Query: 271 PSAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLT--GKPLFPG 323
+ +W A E S F YT D+WS G + E++T G P +PG
Sbjct: 182 SYVKRSKGRIPVKWM-AIE---SLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 20/128 (15%)
Query: 208 KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267
+ LT E + +Q+ RG++++ + HRDL +NIL + + +KICDFGLAR +
Sbjct: 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 268 NDAPSAIFWTDYVAT-------RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLT-GK 318
D DYV +W APE S F K YT D+WS G + E+ + G
Sbjct: 225 KDP-------DYVRKGDARLPLKWM-APE---SIFDKVYTTQSDVWSFGVLLWEIFSLGA 273
Query: 319 PLFPGKNV 326
+PG +
Sbjct: 274 SPYPGVQI 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 21/234 (8%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
++I +G G++G V A + TG A K I+ E + + EI +L HP+I
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNI 64
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVI--KANDDLTPEHYQFFLYQLLRGLKYI 232
V+ +L E +++++ E + + LT + Q L L Y+
Sbjct: 65 VK----LLDAFYYE-NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL 119
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H + HRDLK NIL D +K+ DFG VS + + ++ T ++ APE+
Sbjct: 120 HENKIIHRDLKAGNILFTLDGDIKLADFG---VSAKNTRTIQRRDSFIGTPYWMAPEVVM 176
Query: 293 SFFSKYTP---AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
SK P D+WS+G EM +P H+L+ M LL +E
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEPPH------HELNPMRVLLKIAKSE 224
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 40/212 (18%)
Query: 192 IYVVFELMESDLHQVIKANDDL-----TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 246
++ F+ S + DDL T E + +Q+ RG++++ + HRDL +N
Sbjct: 145 LFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARN 204
Query: 247 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIW 305
IL + + +KICDFGLAR + D + + +W APE S F K YT D+W
Sbjct: 205 ILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM-APE---SIFDKVYTTQSDVW 260
Query: 306 SIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQ 364
S G + E+ + G +PG +I E +R R +
Sbjct: 261 SFGVLLWEIFSLGASPYPG----------------------VQINEEFCQRLKDGTRMRA 298
Query: 365 PVPFSHKFPNADPLALHLLERLLAFDPKDRPT 396
P NA P ++ DPK+RPT
Sbjct: 299 P-------ENATPEIYRIMLACWQGDPKERPT 323
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 13/216 (6%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKIND-VFEHVSDATRILREIK-LLRLLRHPDIVE 176
+VIGKGS+G V A + A+K + + I+ E LL+ ++HP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 177 IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 235
+ + +Y V + + +L ++ +F+ ++ L Y+H+
Sbjct: 61 LHFSFQTADK-----LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL 115
Query: 236 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFF 295
N+ +RDLKP+NIL ++ + + DFGL + N + T + T Y APE+
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTST-FCGTPEYLAPEVLHK-- 170
Query: 296 SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD 331
Y +D W +G + EML G P F +N D
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRHPDIVEIK 178
+G G+ GVV +G +A K I+ + A R I+RE+++L P IV
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIH---LEIKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 179 HIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN- 236
+I + E M+ L QV+K + + +++GL Y+ +
Sbjct: 70 GAFYSDG-----EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 124
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFF 295
+ HRD+KP NIL N+ ++K+CDFG++ + ++ +V TR Y +PE L G+ +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQGTHY 179
Query: 296 SKYTPAIDIWSIGCIFAEMLTGK-PLFP 322
S + DIWS+G EM G+ P+ P
Sbjct: 180 SVQS---DIWSMGLSLVEMAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 44/130 (33%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 200 ESDLHQVIKANDDLT--PEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 257
+ D+ I D+L E F YQ+ +G+ ++ + N HRDL +NIL KI
Sbjct: 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKI 255
Query: 258 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT- 316
CDFGLAR ND+ + + +W APE F YT D+WS G + E+ +
Sbjct: 256 CDFGLARDIRNDSNYVVKGNARLPVKWM-APE--SIFNCVYTFESDVWSYGILLWEIFSL 312
Query: 317 GKPLFPGKNV 326
G +PG V
Sbjct: 313 GSSPYPGMPV 322
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 52/224 (23%), Positives = 98/224 (43%), Gaps = 31/224 (13%)
Query: 120 VIGKGSYGVVGSA---VDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVE 176
++GKG +G V A + + ++VA+K + SD LRE ++ HP++++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 177 IKHIMLPPSRREFKDI-YVVFELME-SDLHQVIKAND------DLTPEHYQFFLYQLLRG 228
+ + L + I V+ M+ DLH + + L + F+ + G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY--------V 280
++Y+ + N HRDL +N + N + + + DFGL++ I+ DY +
Sbjct: 126 MEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK--------KIYSGDYYRQGCASKL 177
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG 323
+W L + YT D+W+ G E++T G+ + G
Sbjct: 178 PVKWLALESLADNV---YTTHSDVWAFGVTMWEIMTRGQTPYAG 218
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 38/115 (33%), Positives = 61/115 (53%), Gaps = 6/115 (5%)
Query: 211 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270
LT E + +Q+ +G++++ + HRDL +NIL + + +KICDFGLAR + D
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD- 232
Query: 271 PSAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLT-GKPLFPG 323
P + D + APE + F + YT D+WS G + E+ + G +PG
Sbjct: 233 PDYVRKGDARLPLKWMAPE---TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 69/318 (21%), Positives = 125/318 (39%), Gaps = 77/318 (24%)
Query: 113 SRYQIQE--VIGKGSYGVV----GSAVDTHTGERVAIKKINDVFEHVSDATRIL---REI 163
R +QE +G+G +G V ++ GE + + K + D RE+
Sbjct: 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVK---ALQKTKDENLQSEFRREL 59
Query: 164 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD---------L 213
+ R L H ++V + + RE + Y++ E + DL Q ++A L
Sbjct: 60 DMFRKLSHKNVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL 114
Query: 214 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273
+ + Q+ G+ ++ A HRDL +N L ++ ++K+ L++ +N
Sbjct: 115 STKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS---- 170
Query: 274 IFWTDY-------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 325
+Y + RW APE ++ D+WS G + E+ T G+ F G
Sbjct: 171 ----EYYKLRNALIPLRWL-APE--AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG-- 221
Query: 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH-LLE 384
++D E ++R++ K P P L+ L+
Sbjct: 222 -------LSD------EEVLNRLQAGKLEL---------------PVPEGCPSRLYKLMT 253
Query: 385 RLLAFDPKDRPTAEEALA 402
R A +PKDRP+ E ++
Sbjct: 254 RCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 12/221 (5%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV--SDATRILREIKLLRL 168
+A Y++ +VIG+G++G V T + A+K ++ FE + SD+ E ++
Sbjct: 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK-FEMIKRSDSAFFWEERDIMAF 99
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRG 228
P +V++ + ++ + +Y+V E M + +N D+ + +F+ +++
Sbjct: 100 ANSPWVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLA 154
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
L IH+ HRD+KP N+L + LK+ DFG + + V T Y +P
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG--MVRCDTAVGTPDYISP 212
Query: 289 ELCGSFFSK--YTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 327
E+ S Y D WS+G EML G F ++V
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 57/236 (24%), Positives = 102/236 (43%), Gaps = 48/236 (20%)
Query: 114 RYQIQEVIGKGSYGVV--------------GSAVDTHTGERVAIKKINDVFEHVSDATR- 158
+ +++E +G+G +G V G+ VA+K + +D T+
Sbjct: 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLR------ADVTKT 59
Query: 159 ----ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVI------ 207
L+EIK++ L++P+I+ + + + + ++ E ME+ DL+Q +
Sbjct: 60 ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDD-----PLCMITEYMENGDLNQFLSQREIE 114
Query: 208 ----KANDDLTPEHYQFFLY---QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 260
AN+ + LY Q+ G+KY+ + N HRDL +N L +KI DF
Sbjct: 115 STFTHANN-IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADF 173
Query: 261 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
G++R ++ I + RW + K+T A D+W+ G EM T
Sbjct: 174 GMSRNLYSGDYYRIQGRAVLPIRWMAWESI---LLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 57/219 (26%), Positives = 107/219 (48%), Gaps = 13/219 (5%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDA-TRILREIKLLRLLRHPD 173
++I +VIG+G++G V + V ++V KI + +E + A T RE + + +
Sbjct: 3 FEILKVIGRGAFGEV-AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 174 IVEIKHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKY 231
+ H ++ ++Y+V + + DL ++ +D PE +F+L +++ +
Sbjct: 62 WITTLHYAF----QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS 117
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
+H + HRD+KP NIL + + +++ DFG D + + V T Y +PE+
Sbjct: 118 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQSSVAVGTPDYISPEIL 175
Query: 292 GSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 327
+ KY P D WS+G EML G+ F +++V
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 37/218 (16%)
Query: 202 DLHQVIKA--NDDLTPEHYQ--FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 257
DL++ IK + L + Y+ YQ++ L +H+ + HRDLK NI +K+
Sbjct: 151 DLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKL 210
Query: 258 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG 317
DFG ++ ++D+ S + + T +Y APEL +Y+ D+WS+G I E+LT
Sbjct: 211 GDFGFSK-QYSDSVSLDVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTL 267
Query: 318 KPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADP 377
F G + Q ++M +L K P P P +
Sbjct: 268 HRPFKGPS---QREIMQQVL----------------------YGKYDPFP----CPVSSG 298
Query: 378 LALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDRE 415
+ LL+ LL+ +P RPT ++ L + +AN+ ++
Sbjct: 299 MKA-LLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQD 335
|
Length = 478 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 66/267 (24%), Positives = 104/267 (38%), Gaps = 44/267 (16%)
Query: 161 REIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQF 220
REI +L+ + H I+ + H + R + +V + DL + + L E
Sbjct: 135 REIDILKTISHRAIINLIH-----AYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAIT 189
Query: 221 FLYQLLRGLKYIHTANVFHRDLKPKNILAN-----------ADCKLKICDFGLARVSFND 269
+LL L Y+H + HRD+K +NI + A CKL D
Sbjct: 190 IQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP---------D 240
Query: 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV--- 326
P W+ + T +PEL Y DIWS G + EM GK V
Sbjct: 241 TPQCYGWSGTLET---NSPEL--LALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS 295
Query: 327 VHQLD-----LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVP--FSHKFPNADPLA 379
QL + L P S + ++ K +Y +R +P + D
Sbjct: 296 SSQLRSIIRCMQVHPLEFPQNGSTNLCKHFK--QYAIVLRPPYTIPPVIRKYGMHMD--V 351
Query: 380 LHLLERLLAFDPKDRPTAEEALADPYF 406
+L+ ++L FD + RP+A++ L+ P F
Sbjct: 352 EYLIAKMLTFDQEFRPSAQDILSLPLF 378
|
Length = 392 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 26/209 (12%)
Query: 119 EVIGKGSYGVVGSAVDTHTGER----VAIKKIND-----VFEHVSDATRILREIKLLRLL 169
+++G G +G V + G+ VAIK I D F+ ++D + + L
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITD------HMLAMGSL 66
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLR 227
H IV + I S + +V +L S L V + D L P+ + Q+ +
Sbjct: 67 DHAYIVRLLGICPGAS------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAK 120
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
G+ Y+ + HR+L +NIL +D ++I DFG+A + + D + +W
Sbjct: 121 GMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM-- 178
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
L F +YT D+WS G EM++
Sbjct: 179 -ALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-11
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 121 IGKGSYGVVGSAVDTHTGER--VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
+G G++G V V ++ VAIK + + E S ++RE +++ L +P IV +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK-SVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 179 HIMLPPSRREFKDIYVVFELMESD-LHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTAN 236
+ E + + +V E+ L++ + D++T + ++Q+ G+KY+ N
Sbjct: 62 GVC------EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARV-----SFNDAPSAIFWTDYVATRWYRAPELC 291
HRDL +N+L KI DFGL++ S+ A SA W +WY APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW----PLKWY-APECI 170
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLT--GKP 319
F K++ D+WS G E + KP
Sbjct: 171 N--FRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 78/306 (25%), Positives = 135/306 (44%), Gaps = 41/306 (13%)
Query: 107 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL 166
T +A +Y I V+G G+ G V A GE A+K ++ +D R E+ L
Sbjct: 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCL 85
Query: 167 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLT---PEHYQ 219
IV+ R +++ ++ +++ DL Q IK+ EH
Sbjct: 86 LNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEA 145
Query: 220 FFLY-QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD 278
L+ Q+L + ++H+ ++ HRD+K NIL ++ +K+ DFG +++ + T
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT- 204
Query: 279 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338
+ T +Y APE+ Y+ D++S+G + E+LT K F G+N+ ++M L
Sbjct: 205 FCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENME---EVMHKTL- 258
Query: 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 398
A RY P+P P+ P ++ LL+ DPK RP++
Sbjct: 259 --------------AGRY-------DPLP-----PSISPEMQEIVTALLSSDPKRRPSSS 292
Query: 399 EALADP 404
+ L P
Sbjct: 293 KLLNMP 298
|
Length = 496 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 47/226 (20%)
Query: 119 EVIGKGSYGVVGSAVDTHTGER-----VAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
E +G+G++G V T ER VAIK + + E +E +L+ L+HP+
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE-PKVQQEFRQEAELMSDLQHPN 69
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQ----------VIKANDDLTPEH---YQ 219
IV + + + + ++FE + DLH+ V + D T +
Sbjct: 70 IVCLLGVCT-----KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCS 124
Query: 220 FFL---YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276
FL Q+ G++Y+ + + HRDL +N L +KI DFGL+R I+
Sbjct: 125 DFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSR--------DIYS 176
Query: 277 TDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEM 314
DY + RW PE + K+T DIWS G + E+
Sbjct: 177 ADYYRVQSKSLLPVRWM-PPE--AILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 65/236 (27%), Positives = 104/236 (44%), Gaps = 53/236 (22%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH--------- 171
IG+G++G V + +G +A+K+I +T +E K RLL
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIR--------STVDEKEQK--RLLMDLDVVMRSSD 61
Query: 172 -PDIVEIKHIMLPPSRREFK--DIYVVFELMESDL-------HQVIKANDDLTPEHYQFF 221
P IV+ + F+ D ++ ELM+ L ++V+K+ PE
Sbjct: 62 CPYIVKFYGAL-------FREGDCWICMELMDISLDKFYKYVYEVLKSV---IPEE---I 108
Query: 222 L----YQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276
L ++ L Y+ + HRD+KP NIL + + +K+CDFG++ + +I
Sbjct: 109 LGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD----SIAK 164
Query: 277 TDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG-KNVVHQL 330
T R Y APE + S Y D+WS+G E+ TGK +P +V QL
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 36/104 (34%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 221 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 280
F Q+ +G+ ++ + N HRD+ +N+L KICDFGLAR ND+ + +
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG 323
+W APE F YT D+WS G + E+ + GK +PG
Sbjct: 277 PVKWM-APE--SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 72/298 (24%), Positives = 126/298 (42%), Gaps = 55/298 (18%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEI-- 177
+GKG +G V + +TG+ A KK++ + S L E ++L + P IV +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 178 -----KHIMLPPSRREFKDI-YVVFELMES--DLHQVIKANDDLTPEHYQFFLYQLLRGL 229
H+ L S D+ Y ++ + E ++ +VI + Q+ G+
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVI------------HYSAQITCGI 108
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
++H+ ++ +RD+KP+N+L + ++ D GLA V D + T T Y APE
Sbjct: 109 LHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTI---TQRAGTNGYMAPE 164
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
+ Y+ +D +++GC EM+ G+ P K+ ++ +
Sbjct: 165 ILKE--EPYSYPVDWFAMGCSIYEMVAGRT--PFKDHKEKVA-----------------K 203
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407
E RR L + V F H+ N + + LA P+DR + E DP H
Sbjct: 204 EELKRRTL-----EDEVKFEHQ--NFTEESKDICRLFLAKKPEDRLGSREKNDDPRKH 254
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 70/235 (29%), Positives = 104/235 (44%), Gaps = 49/235 (20%)
Query: 121 IGKGSYGVV--GSAVD---THTGE-RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
+G G++G V G+A D +G RVA+K + + L+E L+ HP+I
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK-GATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL------- 226
V++ + L + Y++ ELME DL ++ L +LL
Sbjct: 62 VKLLGVCL-----LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 227 RGLKYIHTANVFHRDLKPKNILA-----NADCKLKICDFGLARVSFNDAPSAIFWTDY-- 279
+G Y+ + HRDL +N L +AD +KI DFGLAR I+ +DY
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--------DIYKSDYYR 168
Query: 280 ------VATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 325
+ RW APE L G F T D+WS G + E+LT G+ +P N
Sbjct: 169 KEGEGLLPVRWM-APESLLDGKF----TTQSDVWSFGVLMWEILTLGQQPYPALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 64/247 (25%), Positives = 102/247 (41%), Gaps = 53/247 (21%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN--DVFE-----HVSDATRILREIKLLR 167
++ +VIG+G++G V TG A+K + D+ E H+ IL E L
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL 226
+++ + S ++ ++Y++ E + D+ ++ D LT E QF++ + +
Sbjct: 63 VVK-----------MFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETV 111
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-------RVSF------------ 267
+ IH HRD+KP N+L ++ +K+ DFGL R F
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 268 -----NDAPSAIFWT--------DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEM 314
N A W V T Y APE+ + Y D WS+G I EM
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEM 229
Query: 315 LTGKPLF 321
L G P F
Sbjct: 230 LIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 36/101 (35%), Positives = 54/101 (53%), Gaps = 5/101 (4%)
Query: 221 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 280
F YQ+ G++++ + N HRDL +N+L +KICDFGLAR D+ + ++
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT--GKP 319
+W APE F + YT D+WS G + E+ T G P
Sbjct: 304 PLKWM-APE--SIFNNLYTTLSDVWSFGILLWEIFTLGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 62/246 (25%), Positives = 103/246 (41%), Gaps = 59/246 (23%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
+VIG+G++G V TG A+K ILR+ +L + I +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMK--------------ILRKADMLEKEQVAHIRAER 52
Query: 179 HIMLPP----------SRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLR 227
I++ S ++ +++Y++ E + D+ ++ D L+ E QF++ + +
Sbjct: 53 DILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL 112
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-------RVSF-----NDAPSAIF 275
+ IH HRD+KP N+L +A +K+ DFGL R F ++ PS
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 276 WTDYVATR----W----------------YRAPELCGSFFSKYTPAIDIWSIGCIFAEML 315
+ + + R W Y APE+ + Y D WS+G I EML
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEML 230
Query: 316 TGKPLF 321
G P F
Sbjct: 231 IGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 56/199 (28%), Positives = 88/199 (44%), Gaps = 43/199 (21%)
Query: 141 VAIKKINDVFEHVSDATRI--LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 198
VA+K + SD R L+E+K+L L P+I + L + + ++ E
Sbjct: 49 VAVKVLRP---DASDNAREDFLKEVKILSRLSDPNIARL----LGVCTVD-PPLCMIMEY 100
Query: 199 ME-SDLHQVIKANDDLTPEH--------YQFFLY---QLLRGLKYIHTANVFHRDLKPKN 246
ME DL+Q ++ + T + LY Q+ G++Y+ + N HRDL +N
Sbjct: 101 MENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160
Query: 247 ILANADCKLKICDFGLARVSF-ND-------APSAIFWTDYVATRWYRAPELCGSFF-SK 297
L + +KI DFG++R + +D AP I RW A E S K
Sbjct: 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPI--------RWM-AWE---SVLLGK 208
Query: 298 YTPAIDIWSIGCIFAEMLT 316
+T D+W+ G E+LT
Sbjct: 209 FTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIK 178
V+GKG +G V + TG+ A KK+ + L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 179 HIMLPPSRREFKD-IYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ E KD + +V +M DL H N + F+ +L GL+ +
Sbjct: 67 YAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
+ +RDLKP+NIL + ++I D GLA P V T Y APE+ +
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINN- 175
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLF 321
KYT + D W +GC+ EM+ G+ F
Sbjct: 176 -EKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 72/305 (23%), Positives = 123/305 (40%), Gaps = 48/305 (15%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
+I G+YG V T +R A+KKIN + ++ E +L +P +V
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVS-- 65
Query: 179 HIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 237
+ S + + +V E +E D ++K L + + + + + L+Y+H +
Sbjct: 66 ---MFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122
Query: 238 FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF-WTDYVATRWYRAPELCGS--- 293
HRDLKP N+L + +K+ DFGL+++ + ++ TR + ++CG+
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182
Query: 294 ------FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
Y +D W++G I E L G F G D +L G ++ I
Sbjct: 183 IAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-------DTPEELFGQVISDDIEW 235
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR---PTAEEALADP 404
++A AD A L+ RLL +P +R A E
Sbjct: 236 PEGDEA-------------------LPAD--AQDLISRLLRQNPLERLGTGGAFEVKQHR 274
Query: 405 YFHGL 409
+F GL
Sbjct: 275 FFLGL 279
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 66/300 (22%), Positives = 115/300 (38%), Gaps = 65/300 (21%)
Query: 119 EVIGKGSYGVVGSA---VDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDI 174
+++G+G +G V D + +VA+K + D+ + S+ L E ++ HP++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY-SEIEEFLSEAACMKDFDHPNV 63
Query: 175 VEIKHIMLPPSRRE-FKDIYVVFELME-SDLHQ-VIKANDDLTPEHYQF-----FLYQLL 226
+++ + S + V+ M+ DLH ++ + PE F+ +
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY------- 279
G++Y+ N HRDL +N + D + + DFGL++ I+ DY
Sbjct: 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK--------KIYSGDYYRQGRIA 175
Query: 280 -VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLL 337
+ +W L YT D+W+ G E+ T G+ +PG
Sbjct: 176 KMPVKWIAIESLADRV---YTSKSDVWAFGVTMWEIATRGQTPYPG-------------- 218
Query: 338 GTPSTESISRIRNEKARRYL-GSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT 396
+ N + YL R KQP + L+ DPKDRPT
Sbjct: 219 ----------VENHEIYDYLRHGNRLKQP-------EDCLDELYDLMYSCWRADPKDRPT 261
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 64/293 (21%), Positives = 113/293 (38%), Gaps = 46/293 (15%)
Query: 119 EVIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVE 176
+ +G+G +G V G + +VA+K + S+ L E ++ HP+++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 177 IKHIMLPPSRRE-FKDIYVVFELME-SDLHQVI---KANDD---LTPEHYQFFLYQLLRG 228
+ + L E + V+ M+ DLH + + D L + F+ + G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
++Y+ + + HRDL +N + N + + + DFGL++ +N + +W
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184
Query: 289 ELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
L YT D+WS G E+ T G+ +PG
Sbjct: 185 SLADRV---YTTKSDVWSFGVTMWEIATRGQTPYPG------------------------ 217
Query: 348 IRNEKARRYL-GSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
+ N + YL R KQP P+ L+ +PKDRP+ E
Sbjct: 218 VENSEIYDYLRQGNRLKQP-------PDCLDGLYSLMSSCWLLNPKDRPSFET 263
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 47/225 (20%)
Query: 121 IGKGSYGVVGSAVDTH---TGER--VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
+G+G++G V A + ++ VA+K + + E S RE +LL +L+H IV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREAELLTVLQHQHIV 70
Query: 176 EIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND---------------DLTPEHYQ 219
+ E + + +VFE M DL++ ++++ LT
Sbjct: 71 RFYGVC-----TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 220 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY 279
Q+ G+ Y+ + + HRDL +N L +KI DFG++R I+ TDY
Sbjct: 126 AIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--------DIYSTDY 177
Query: 280 --------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
+ RW PE + K+T DIWS G + E+ T
Sbjct: 178 YRVGGRTMLPIRWM-PPE--SILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 20/169 (11%)
Query: 160 LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTP 215
L+EIK++ L+ P+I+ + + + + ++ E ME+ DL+Q + + +
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEK 121
Query: 216 EHYQFFLY--------QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267
Y Q+ G+KY+ + N HRDL +N L + +KI DFG++R +
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
+ I + RW + K+T A D+W+ G E+LT
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESI---LLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 30/204 (14%)
Query: 192 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 250
+++V E + DL ++ L EH +F+ ++ L ++H + +RDLK N+L +
Sbjct: 71 LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130
Query: 251 ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 310
AD +K+ D+G+ + + + + T Y APE+ +Y ++D W++G +
Sbjct: 131 ADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILRG--EEYGFSVDWWALGVL 185
Query: 311 FAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSH 370
EM+ G+ F D++TD + + + ++ EK R + K
Sbjct: 186 MFEMMAGRSPF---------DIITDNPDMNTEDYLFQVILEKPIRIPRFLSVK------- 229
Query: 371 KFPNADPLALHLLERLLAFDPKDR 394
A H+L+ L DPK+R
Sbjct: 230 --------ASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 6e-10
Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 20/203 (9%)
Query: 121 IGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
+G G +GVV G + VAIK I E + E K++ L H +V++
Sbjct: 12 LGTGQFGVVKYGKWRGQYD---VAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQLY 65
Query: 179 HIMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 236
+ + + IY+V E M + L+ + + P + G+ Y+ +
Sbjct: 66 GVC-----TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 296
HRDL +N L + +K+ DFGL+R +D ++ + + RW PE+ +S
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF-PVRW-SPPEVL--LYS 176
Query: 297 KYTPAIDIWSIGCIFAEMLT-GK 318
K++ D+W+ G + E+ + GK
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 39/115 (33%), Positives = 57/115 (49%), Gaps = 6/115 (5%)
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 282
YQ+ RG++Y+ + HRDL +N+L D +KI DFGLAR N +
Sbjct: 141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPV 200
Query: 283 RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTD 335
+W APE + F + YT D+WS G + E+ T G +PG V L+ +
Sbjct: 201 KWM-APE---ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 6e-10
Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 28/192 (14%)
Query: 141 VAIKKINDVFEHVSDATR--ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 198
VA+K + D SD R RE +LL L+H IV+ + + E + +VFE
Sbjct: 38 VAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EGDPLIMVFEY 88
Query: 199 ME-SDLHQVIKAN-------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKP 244
M+ DL++ ++A+ +LT Q+ G+ Y+ + + HRDL
Sbjct: 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLAT 148
Query: 245 KNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDI 304
+N L + +KI DFG++R ++ + + RW PE + K+T D+
Sbjct: 149 RNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDV 205
Query: 305 WSIGCIFAEMLT 316
WS+G + E+ T
Sbjct: 206 WSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 62/240 (25%), Positives = 108/240 (45%), Gaps = 57/240 (23%)
Query: 121 IGKGSYGVV----GSAVDTHTGER---VAIKKINDVFEHVSDATRILREIKLLRLL-RHP 172
+G+G +G V +D ++ VA+K + D D ++ E++L++L+ +H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD-KDLADLISEMELMKLIGKHK 78
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQFFL--------- 222
+I+ + + +YV+ E + +L + ++A P+ Y F +
Sbjct: 79 NIINLLGVCTQEG-----PLYVIVEYAAKGNLREFLRARRPPGPD-YTFDITKVPEEQLS 132
Query: 223 --------YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 274
YQ+ RG++Y+ + HRDL +N+L D +KI DFGLAR +
Sbjct: 133 FKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR--------GV 184
Query: 275 FWTDY--------VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLT--GKPLFPG 323
DY + +W APE + F + YT D+WS G + E+ T G P +PG
Sbjct: 185 HDIDYYKKTSNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGILMWEIFTLGGSP-YPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 57/201 (28%), Positives = 82/201 (40%), Gaps = 26/201 (12%)
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG---LARVSFNDAPSAIFWTDYV 280
QLL + YIH + HRD+K +N+L N + + DFG AR S+ S F
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW----STPFHYGIA 323
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIG-CIFAEMLTGKPLFPGKN-------------V 326
T APE+ YTP++DIWS G IF + LF +
Sbjct: 324 GTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRI 381
Query: 327 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERL 386
+ Q + D + SR+ ++ R + R P ++ D +L+ R
Sbjct: 382 IRQAQVHVDEF---PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRA 438
Query: 387 LAFDPKDRPTAEEALADPYFH 407
L FD RP+A E L P F
Sbjct: 439 LTFDGARRPSAAELLRLPLFQ 459
|
Length = 461 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 55/212 (25%), Positives = 84/212 (39%), Gaps = 26/212 (12%)
Query: 121 IGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
IG G +G V G A + RV +K++ + L+E++ R L HP++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNV---- 57
Query: 179 HIMLPPSRREFKDIYVVFELME-SDLHQVIKAND-----DLTPEHYQFFLYQLLRGLKYI 232
+ E +V E DL +++N + Q ++ GL ++
Sbjct: 58 -LQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD---YVATRWYRAPE 289
H A+ H DL +N AD +KI D+GLA P + T V RW APE
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLA---LEQYPEDYYITKDCHAVPLRWL-APE 172
Query: 290 LCGSFFS-----KYTPAIDIWSIGCIFAEMLT 316
L T +IWS+G E+ T
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 40/112 (35%), Positives = 56/112 (50%), Gaps = 24/112 (21%)
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY--- 279
YQ+ RG++Y+ + HRDL +N+L D +KI DFGLAR I DY
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--------DIHHIDYYKK 198
Query: 280 -----VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLT--GKPLFPG 323
+ +W APE + F + YT D+WS G + E+ T G P +PG
Sbjct: 199 TTNGRLPVKWM-APE---ALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-YPG 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 59/239 (24%), Positives = 104/239 (43%), Gaps = 31/239 (12%)
Query: 89 TPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYG-VVGSAVDTHTGERVAIKKIN 147
+ +T +P +K+ ++ E F +G GS+G V+ + VAIK+
Sbjct: 15 SDSTKEPKRKNKMKYEDF---------NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFE 65
Query: 148 DV-FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD---IYVVFE-LMESD 202
+ E K+L + HP V + FKD +Y+V E ++ +
Sbjct: 66 KSKIIKQKQVDHVFSERKILNYINHPFCVNL--------YGSFKDESYLYLVLEFVIGGE 117
Query: 203 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 262
++ N + F+ Q++ +Y+ + N+ +RDLKP+N+L + D +K+ DFG
Sbjct: 118 FFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGF 177
Query: 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 321
A+V + T Y APE+ + + A D W++G E+L G P F
Sbjct: 178 AKVVDTRTYT------LCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 13/205 (6%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLL-RHPDIVEI 177
VIG+GSY V T A+K I ++ D + E + HP +V +
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 178 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 236
SR ++ V E + DL ++ L EH +F+ ++ L ++H
Sbjct: 62 HSCFQTESR-----LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG 116
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 296
+ +RDLK N+L +A+ +K+ D+G+ + + + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 297 KYTPAIDIWSIGCIFAEMLTGKPLF 321
Y ++D W++G + EM+ G+ F
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 39/116 (33%), Positives = 58/116 (50%), Gaps = 8/116 (6%)
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 282
YQ+ RG++Y+ + HRDL +N+L + +KI DFGLAR N +
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPV 203
Query: 283 RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLT--GKPLFPGKNVVHQLDLMTD 335
+W APE + F + YT D+WS G + E+ T G P +PG V L+ +
Sbjct: 204 KWM-APE---ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLLKE 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 33/186 (17%)
Query: 155 DATR-----ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIK 208
DA + L+E+K+L L+ P+I+ + + + + + ++ E ME+ DL+Q +
Sbjct: 57 DANKNARNDFLKEVKILSRLKDPNIIRLLGVCV-----DEDPLCMITEYMENGDLNQFLS 111
Query: 209 A----------NDDLTPEH------YQFFLY---QLLRGLKYIHTANVFHRDLKPKNILA 249
+ ND + P H Y L+ Q+ G+KY+ + N HRDL +N L
Sbjct: 112 SHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLV 171
Query: 250 NADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGC 309
+ +KI DFG++R + I + RW A E K+T A D+W+ G
Sbjct: 172 GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWM-AWECI--LMGKFTTASDVWAFGV 228
Query: 310 IFAEML 315
E+L
Sbjct: 229 TLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 14/215 (6%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV--SDATRILREIKLLRLL 169
A + + +VIG+G++G V + + A+K ++ FE + SD+ E ++
Sbjct: 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSK-FEMIKRSDSAFFWEERDIMAHA 100
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGL 229
IV++ + K +Y+V E M + +N D+ + +F+ +++ L
Sbjct: 101 NSEWIVQLHYAFQDD-----KYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLAL 155
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLA-RVSFNDAPSAIFWTDYVATRWYRAP 288
IH+ HRD+KP N+L + LK+ DFG ++ DA + V T Y +P
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM---DANGMVRCDTAVGTPDYISP 212
Query: 289 ELCGS--FFSKYTPAIDIWSIGCIFAEMLTGKPLF 321
E+ S Y D WS+G EML G F
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 4e-09
Identities = 64/248 (25%), Positives = 105/248 (42%), Gaps = 38/248 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+ Y++ + IG G +G V T E K I+ + ++++ E+ ++R L+H
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDL---TPEHYQF-FLYQLLR 227
+IV L + ++ +Y++ E ++ DL + I+ + EH QLL
Sbjct: 73 NIVRYIDRFLNKANQK---LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129
Query: 228 GLKYIHT-------ANVFHRDLKPKNILANADCK-----------------LKICDFGLA 263
L Y H V HRDLKP+NI + + KI DFGL+
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 264 R-VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFP 322
+ + + V T +Y +PEL Y D+W++GCI E+ +GK F
Sbjct: 190 KNIGIESMAHSC-----VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244
Query: 323 GKNVVHQL 330
N QL
Sbjct: 245 KANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 34/226 (15%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERV--AIKKINDVFEHVSDATRILREIKLL-RLLRHP 172
+ Q+VIG+G++G V A G R+ AIK++ + + D E+++L +L HP
Sbjct: 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHP 68
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFE---------------LMESDLHQVI--KANDDLTP 215
+I+ +++ R + +Y+ E ++E+D I L+
Sbjct: 69 NII---NLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123
Query: 216 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275
+ F + RG+ Y+ HRDL +NIL + KI DFGL+R +
Sbjct: 124 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM- 182
Query: 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEM--LTGKP 319
+ RW L +S YT D+WS G + E+ L G P
Sbjct: 183 --GRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 6e-09
Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLL-RLLRHPDIVEI 177
VIG+GSY V T A+K + ++ D + E + + HP +V +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 178 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 236
SR ++ V E + DL ++ L EH +F+ ++ L Y+H
Sbjct: 62 HSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 116
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 296
+ +RDLK N+L +++ +K+ D+G+ + + + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 297 KYTPAIDIWSIGCIFAEMLTGKPLF 321
Y ++D W++G + EM+ G+ F
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 59/246 (23%), Positives = 97/246 (39%), Gaps = 59/246 (23%)
Query: 111 EASRYQIQEV--IGKGSYGVVGSA-----VDTHTGERVAIKKINDVFEHVSDATR--ILR 161
E R I+ V IG+G++G V A + VA+K + E S + R
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQR 57
Query: 162 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND--------- 211
E L+ HP+IV++ + K + ++FE M DL++ ++
Sbjct: 58 EAALMAEFDHPNIVKLLGVCA-----VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSH 112
Query: 212 -------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 258
L+ Q+ G+ Y+ HRDL +N L + +KI
Sbjct: 113 STSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 172
Query: 259 DFGLARVSFNDAPSAIFWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCI 310
DFGL+R I+ DY + RW PE F+++YT D+W+ G +
Sbjct: 173 DFGLSR--------NIYSADYYKASENDAIPIRWM-PPE--SIFYNRYTTESDVWAYGVV 221
Query: 311 FAEMLT 316
E+ +
Sbjct: 222 LWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 59/229 (25%), Positives = 109/229 (47%), Gaps = 33/229 (14%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
++I +VIG+G++G V AV V +K V+ A +IL + ++L+
Sbjct: 3 FEILKVIGRGAFGEV--AV-------VKMKNTGQVY-----AMKILNKWEMLKRAETACF 48
Query: 175 VEIKHIMLPPSRR-------EFKD---IYVVFEL-MESDLHQVI-KANDDLTPEHYQFFL 222
E + +++ RR F+D +Y+V + + DL ++ K D L + +F+L
Sbjct: 49 REERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL 108
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG----LARVSFNDAPSAIFWTD 278
+++ + +H HRD+KP N+L + + +++ DFG L + A+ D
Sbjct: 109 AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD 168
Query: 279 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 327
Y++ +A E +Y P D WS+G EML G+ F +++V
Sbjct: 169 YISPEILQAME---DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 48/230 (20%)
Query: 117 IQEVIGKGSYGVVGSA-----VDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
++ +G+G++G V A T VA+K + D ++ RE +LL L+H
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQH 66
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKA----------------NDDLT 214
IV+ + + + +VFE M+ DL++ ++A +L
Sbjct: 67 EHIVKFYGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121
Query: 215 PEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 274
Q+ G+ Y+ + + HRDL +N L A+ +KI DFG++R +
Sbjct: 122 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR--------DV 173
Query: 275 FWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
+ TDY + RW PE + K+T D+WS G I E+ T
Sbjct: 174 YSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 51/221 (23%), Positives = 94/221 (42%), Gaps = 29/221 (13%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTG--ERVAIKKINDVFEHVSDA--TRILREIKLL 166
R + +++ +G++G + G +D G E V +K + D H S+ T +L+E LL
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD---HASEIQVTLLLQESCLL 62
Query: 167 RLLRHPDIVEIKH----------IMLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTP 215
L H +I+ I H ++ P + K L E++ Q + +
Sbjct: 63 YGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH- 121
Query: 216 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275
Q+ G+ Y+H V H+D+ +N + + + ++KI D L+R F +
Sbjct: 122 -----MAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176
Query: 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
+ +W L +S A D+WS G + E++T
Sbjct: 177 DNENRPVKWMALESLVNKEYSS---ASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 23/222 (10%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGER---VAIKKINDVFEHVSDATRILREIKLLR 167
S + E +G+ +G V G T GE+ VAIK + D E E +
Sbjct: 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRS 63
Query: 168 LLRHPDIVEI-------KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD------LT 214
L+HP+IV + + + + S D++ F +M S V +DD L
Sbjct: 64 RLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHE-FLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 215 PEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 274
P + + Q+ G++++ + +V H+DL +N+L +KI D GL R + +
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL 182
Query: 275 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
+ RW +PE + K++ DIWS G + E+ +
Sbjct: 183 MGNSLLPIRWM-SPE--AIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 14/203 (6%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIK-KINDVFEHVSDAT--RILREIKLLRLLRHPDIV 175
+V+G G++G V + GE+V I I ++ E S IL E ++ + +P +
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 176 EIKHIMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
+ I L + + ++ +LM L V + D++ ++ + Q+ +G+ Y+
Sbjct: 73 RLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 126
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
+ HRDL +N+L +KI DFGLA++ D V +W +
Sbjct: 127 ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI--- 183
Query: 294 FFSKYTPAIDIWSIGCIFAEMLT 316
YT D+WS G E++T
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 63/234 (26%), Positives = 102/234 (43%), Gaps = 47/234 (20%)
Query: 111 EASRYQIQEV--IGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LR 161
E SR +I + +G+GS+G+V G+A D GE RVA+K +N E S RI L
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN---ESASLRERIEFLN 58
Query: 162 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKA-------NDDL 213
E +++ +V + ++ + + VV ELM DL +++ N
Sbjct: 59 EASVMKGFTCHHVVRLLGVV-----SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 113
Query: 214 TPEHYQFFLY---QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270
P Q + ++ G+ Y++ HRDL +N + D +KI DFG+ R
Sbjct: 114 PPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR------ 167
Query: 271 PSAIFWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
I+ TDY + RW L F+ + D+WS G + E+ +
Sbjct: 168 --DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSS---DMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 18/216 (8%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIK-KINDVFEHVSDAT--RILREIKLLRLLRHPDIVE 176
V+G G++G V + GE V I I + E+ S IL E ++ + P +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 177 IKHIMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ I L + + +V +LM L V + D + + + Q+ +G+ Y+
Sbjct: 74 LLGICLTST------VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE 127
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
+ HRDL +N+L + +KI DFGLAR+ D V +W +
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI---L 184
Query: 295 FSKYTPAIDIWSIGCIFAEMLT--GKPL--FPGKNV 326
++T D+WS G E++T KP P + +
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 40/152 (26%), Positives = 58/152 (38%), Gaps = 47/152 (30%)
Query: 215 PEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL----------- 262
PE +F++ +L ++ +H HRD+KP NIL + D +K+ DFGL
Sbjct: 99 PEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158
Query: 263 -----ARVSFNDAPSAIFWTD----------------------------YVATRWYRAPE 289
+ + + + W D V T Y APE
Sbjct: 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPE 218
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 321
+ YT D WS+G I EML G+P F
Sbjct: 219 VL--LRKGYTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 41/220 (18%)
Query: 121 IGKGSYGVV-----GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
+G+GS+G+V V RVAIK +N+ + + L E +++ +V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVV 72
Query: 176 EIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKA-------NDDLTPEHYQFFLY---Q 224
+ ++ + + V+ ELM DL +++ N P + + +
Sbjct: 73 RLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY----- 279
+ G+ Y++ HRDL +N + D +KI DFG+ R I+ TDY
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--------DIYETDYYRKGG 179
Query: 280 ---VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
+ RW L F+ Y+ D+WS G + E+ T
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 40/160 (25%), Positives = 72/160 (45%), Gaps = 25/160 (15%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI-------NDVFEHVSDATRILREIKLLR 167
+ +VIGKG++G V TG+ A+K + D HV +L E
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD--- 59
Query: 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLY 223
P +V + + F+D ++ +ME DL ++ D + + +F++
Sbjct: 60 ---SPWVVSLYY--------SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA 108
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 263
+ + ++ +H HRD+KP NIL + +K+ DFGL+
Sbjct: 109 ECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 41/150 (27%), Positives = 57/150 (38%), Gaps = 47/150 (31%)
Query: 215 PEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL----------- 262
E +F++ +L ++ +H HRD+KP NIL + D +K+ DFGL
Sbjct: 99 EEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158
Query: 263 -------ARV-SFNDAPSAIFWT-----------------------DYVATRWYRAPELC 291
R S PS + V T Y APE+
Sbjct: 159 YYQKGDHHRQDSME--PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL 216
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 321
+ YT D WS+G I EML G+P F
Sbjct: 217 LR--TGYTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 74/319 (23%), Positives = 118/319 (36%), Gaps = 45/319 (14%)
Query: 120 VIGKG--SYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 177
VIG+G V A TGE V +++IN T + E+ + +L HP+IV
Sbjct: 5 VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPY 64
Query: 178 KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ---------FFLYQLLRG 228
+ + + +++VV M + DL H+ + L +L+
Sbjct: 65 RATFIADN-----ELWVVTSFM------AYGSAKDLICTHFMDGMSELAIAYILQGVLKA 113
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY----VATRW 284
L YIH HR +K +IL + D K+ + N D+ V
Sbjct: 114 LDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP 173
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT----- 339
+ +PE+ Y DI+S+G E+ G P K++ L+ L GT
Sbjct: 174 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGH--VPFKDMPATQMLLEKLNGTVPCLL 231
Query: 340 -----PSTESISRIRNEKARRYLG------SMRKKQPVPFSHKFPNA-DPLALHLLERLL 387
P+ E + A LG + R SH + P H +E+ L
Sbjct: 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCL 291
Query: 388 AFDPKDRPTAEEALADPYF 406
+P RP+A L +F
Sbjct: 292 QRNPDARPSASTLLNHSFF 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 50/194 (25%), Positives = 87/194 (44%), Gaps = 27/194 (13%)
Query: 141 VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE-LM 199
VAIK + D + +E L+ L HP+IV +L +E + + ++FE L
Sbjct: 37 VAIKTLKD-INNPQQWGEFQQEASLMAELHHPNIV----CLLGVVTQE-QPVCMLFEYLN 90
Query: 200 ESDLHQVI-----------KANDDLTP----EHYQFF--LYQLLRGLKYIHTANVFHRDL 242
+ DLH+ + +++D T +H F Q+ G++Y+ + H+DL
Sbjct: 91 QGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDL 150
Query: 243 KPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAI 302
+NIL +KI D GL+R ++ + + RW PE + K++
Sbjct: 151 AARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWM-PPE--AIMYGKFSSDS 207
Query: 303 DIWSIGCIFAEMLT 316
DIWS G + E+ +
Sbjct: 208 DIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 8e-07
Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 20/208 (9%)
Query: 121 IGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
IG G +G V G +T +V +K++ V V + + L E + R L+H ++++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELR-VSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 179 HIMLPPSRREFKDIYVVFELME-SDLH---QVIKANDDLTPE--HYQFFLYQLLRGLKYI 232
E +V E DL + + + +TP+ Q ++ GL ++
Sbjct: 62 GQC-----TEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL 116
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H N H DL +N L AD +KI D+GL+ + + +V RW APEL
Sbjct: 117 HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI-APELVD 175
Query: 293 SFFSKY-----TPAIDIWSIGCIFAEML 315
T ++WS+G E+
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 39/147 (26%), Positives = 56/147 (38%), Gaps = 46/147 (31%)
Query: 219 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA--------------- 263
+F++ +L ++ +H HRD+KP NIL + D +K+ DFGL
Sbjct: 104 RFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSG 163
Query: 264 -RVSFNDAPSAIFWTD----------------------------YVATRWYRAPELCGSF 294
V + + W D V T Y APE+
Sbjct: 164 DHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL--L 221
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLF 321
+ YT D WS+G I EML G+P F
Sbjct: 222 RTGYTQLCDWWSVGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERV--AIKKINDVFEHVSDATRILREIKLL-RLLRHP 172
+ ++VIG+G++G V A+ G ++ AIK + + F +D E+++L +L HP
Sbjct: 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHP 63
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFE----------LMESDLHQVIKANDDLTPEH---YQ 219
+I+ +++ R + +Y+ E L +S +V++ + EH
Sbjct: 64 NII---NLLGACENRGY--LYIAIEYAPYGNLLDFLRKS---RVLETDPAFAKEHGTAST 115
Query: 220 FFLYQLLR-------GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272
QLL+ G++Y+ HRDL +N+L + KI DFGL+R
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175
Query: 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEM--LTGKP 319
+ + RW L +S YT D+WS G + E+ L G P
Sbjct: 176 TM---GRLPVRWMAIESLN---YSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 4e-06
Identities = 36/119 (30%), Positives = 61/119 (51%), Gaps = 12/119 (10%)
Query: 202 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDF 260
DL ++K L+ + + QL+ L +H N+ H D+K +N+L + A ++ +CD+
Sbjct: 95 DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDY 154
Query: 261 GLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGK 318
GL ++ PS Y T Y +PE + G Y + D W++G + E+LTGK
Sbjct: 155 GLCKII--GTPSC-----YDGTLDYFSPEKIKGHN---YDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 61/255 (23%), Positives = 98/255 (38%), Gaps = 52/255 (20%)
Query: 111 EASRYQIQ--EVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREI 163
E R I +G G++G V + +VA+K + + D + L E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-QDESDFLMEA 60
Query: 164 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFL 222
++ H +IV + + R +++ ELM DL ++ N +
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPR-----FILLELMAGGDLKSFLRENRPRPERPSSLTM 115
Query: 223 YQLLR-------GLKYIHTANVFHRDLKPKNILANADCK-----LKICDFGLARVSFNDA 270
LL G KY+ + HRD+ +N L CK KI DFG+AR
Sbjct: 116 KDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLT--CKGPGRVAKIADFGMAR------ 167
Query: 271 PSAIFWTDY--------VATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKP 319
I+ Y + +W PE L G F SK D+WS G + E+ + G
Sbjct: 168 --DIYRASYYRKGGRAMLPIKWM-PPEAFLDGIFTSK----TDVWSFGVLLWEIFSLGYM 220
Query: 320 LFPGKNVVHQLDLMT 334
+PG+ ++ +T
Sbjct: 221 PYPGRTNQEVMEFVT 235
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 9e-06
Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 20/210 (9%)
Query: 118 QEVIGKGSYG-VVGSAVDTHTG-ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
QE IG G +G V+ S + T TG RV +K++ + L++ R+L+HP+I+
Sbjct: 1 QE-IGNGWFGKVLLSEIYTDTGVARVVVKELK-ANASSKEQNEFLQQGDPYRILQHPNIL 58
Query: 176 EIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLY----QLLRGLK 230
+ + E +VFE E DL + L ++ G+
Sbjct: 59 QCLGQCV-----EAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVT 113
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 290
++H N H DL +N +D +K+ D+G+ + + V RW APEL
Sbjct: 114 HMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL-APEL 172
Query: 291 CGSFF-----SKYTPAIDIWSIGCIFAEML 315
G F ++ T ++W++G E+
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 30/221 (13%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERV--AIKKINDVFEHVSDATRILREIKLL-RLLRHPDIV 175
+VIG+G++G V A G R+ AIK++ + + D E+++L +L HP+I+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 176 EIKHIMLPPSRREFKDIYVVFELMESDL-----HQVIKANDDLTPEH---YQFFLYQLLR 227
+++ R + + + + + L +V++ + + QLL
Sbjct: 60 ---NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 228 -------GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 280
G+ Y+ HRDL +NIL + KI DFGL+R + +
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM---GRL 173
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEM--LTGKP 319
RW L +S YT D+WS G + E+ L G P
Sbjct: 174 PVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 19/42 (45%), Positives = 29/42 (69%)
Query: 222 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 263
+ Q+L GL+ +H + HRD+KP+N+L D ++KI DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 58/224 (25%), Positives = 82/224 (36%), Gaps = 60/224 (26%)
Query: 219 QFFLYQLLRGLKYIHTANVFHRDLKPKNIL-ANADCKLKICDFGLA---RVSFNDAPSAI 274
Q + Q+L L +H+ + HRD+KP+NI+ + KI D G A RV N P
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPK-- 315
Query: 275 FWTDYVATRWYRAPELCGSFFSKYTPA----------------------IDIWSIGCIFA 312
+++ Y APE S TP+ DI+S G IF
Sbjct: 316 ---EFLLDPRYAAPE--QYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 370
Query: 313 EMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY-LGSMRKKQPVPFSHK 371
+M FP L +D + I R K Y L + RK S
Sbjct: 371 QM-----AFPN--------LRSD------SNLIQFNRQLKRNDYDLVAWRKLVEPRASPD 411
Query: 372 FPNA-------DPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408
LL+ ++ F + R +A+ ALA PYF
Sbjct: 412 LRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDR 455
|
Length = 566 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 30/101 (29%), Positives = 45/101 (44%), Gaps = 16/101 (15%)
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG----LARVSFNDAPSAIFWTDY 279
+++ L +H + RDL P NIL + +++ F + +A
Sbjct: 93 EMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVE------- 145
Query: 280 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL 320
Y APE+ G S+ T A D WS+G I E+LTGK L
Sbjct: 146 ---NMYCAPEVGG--ISEETEACDWWSLGAILFELLTGKTL 181
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 17/155 (10%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIK------KINDVFEHVSDATRILREIKLLRLLRHPDI 174
I +G++G V + + A+K IN H A R L L + P I
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAER-----DALALSKSPFI 66
Query: 175 VEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
V + + S + ++Y+V E L+ D+ ++ E ++ ++ L Y+H
Sbjct: 67 VHLYY-----SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268
+ HRDLKP N+L + + +K+ DFGL++V+ N
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 74/326 (22%), Positives = 132/326 (40%), Gaps = 50/326 (15%)
Query: 116 QIQEVIGKG--SYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILR-EIKLLRLLRHP 172
++Q IG+G + V A T TG V ++ I D+ + + L+ E+ L RHP
Sbjct: 1 ELQVEIGRGFCNLTSVYLARHTPTGTLVTVR-ITDLENCTEEHLKALQNEVVLSHFFRHP 59
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGL 229
+I+ + S ++V+ M + ++K + ++ L+ LRGL
Sbjct: 60 NIMTSWTVFTTGSW-----LWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGL 114
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY----VATRWY 285
Y+H HR++K +IL + D + + + A D+ + +
Sbjct: 115 NYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPW 174
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST--- 342
+PEL Y DI+S+G E+ TG+ P ++++ L+ L G P +
Sbjct: 175 LSPELLRQDLYGYNVKSDIYSVGITACELATGR--VPFQDMLRTQMLLQKLKGPPYSPLD 232
Query: 343 -----ESISRIRNEKA---------------RRYLGSMRKKQPVP--FSHKFPNADPLAL 380
SR++N ++ + + S R + P FS F N
Sbjct: 233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQN------ 286
Query: 381 HLLERLLAFDPKDRPTAEEALADPYF 406
L+E L DP+ RP+A L+ +F
Sbjct: 287 -LVELCLQQDPEKRPSASSLLSHAFF 311
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 48/214 (22%), Positives = 87/214 (40%), Gaps = 21/214 (9%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGER---VAIKKINDVFEHVSDATR--ILREIKL 165
+ +I+ ++G G +G + +R VAI + SD R L E
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRA---GCSDKQRRGFLAEALT 59
Query: 166 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKAND-DLTPEHYQFFLY 223
L H +IV ++ ++ + + +V E M + L ++ ++ L L
Sbjct: 60 LGQFDHSNIVRLEGVITRGN-----TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLP 114
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT-DYVAT 282
L G+KY+ H+ L +L N+D KI F + D AI+ T +
Sbjct: 115 GLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ---EDKSEAIYTTMSGKSP 171
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
+ APE + ++ A D+WS G + E+++
Sbjct: 172 VLWAAPEAIQ--YHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|219500 pfam07655, Secretin_N_2, Secretin N-terminal domain | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.001
Identities = 11/39 (28%), Positives = 23/39 (58%)
Query: 19 SFTNNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQ 57
S T+ S +++ +N+++ SN+ + ++SSS S G
Sbjct: 20 SVTSGSVSSSGSNSSSSSSNSSNGGSSSSSSSGDSSSGT 58
|
This is a short domain found in bacterial type II/III secretory system proteins. The architecture of these proteins suggest that this family may be functionally analogous to pfam03958. Length = 95 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 509 | |||
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.74 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.5 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.49 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.49 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.47 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.46 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.43 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.31 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.27 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.22 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.09 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.06 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.05 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.01 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.01 | |
| KOG4171 | 671 | consensus Adenylate/guanylate kinase [Nucleotide t | 98.93 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.84 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.78 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.67 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.59 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.51 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.42 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.39 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.34 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.26 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.22 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.19 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.04 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.99 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.97 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.9 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.89 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.84 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.75 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.73 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.71 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.64 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.56 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.45 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.37 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.31 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.31 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.17 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.17 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.13 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.07 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.85 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.69 | |
| PLN02236 | 344 | choline kinase | 96.45 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.25 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.21 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.18 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.07 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.04 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.49 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.94 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.87 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.7 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.47 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.42 | |
| PTZ00296 | 442 | choline kinase; Provisional | 93.91 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 93.51 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.46 |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-73 Score=538.14 Aligned_cols=337 Identities=60% Similarity=0.996 Sum_probs=315.7
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
...+|..++.||+|+||.|+.|.++.+|+.||||++...+.+...+++.+||+++|+.++|+||+.+.+++..+.....+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 34567778999999999999999999999999999998889889999999999999999999999999999987778889
Q ss_pred cEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.+|+|+|+|+.||.++++.++.|++++++.+++||++||+|+|+.+|+||||||+|+|++.++.+||||||+|+.....
T Consensus 100 DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~- 178 (359)
T KOG0660|consen 100 DVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF- 178 (359)
T ss_pred eeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc-
Confidence 9999999999999999999988999999999999999999999999999999999999999999999999999987654
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
.....+++++.|+||+|||++... ..|+.++||||+||||+||++|++.|+|.+..+|+..|..++|+|+.+.+..+.+
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred CcccchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 445567999999999999998764 7999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCCCCccchhHHh
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFER 430 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 430 (509)
+.++.|+.+++..++.++...|+.+++.++||+++||.+||.+|+|++|+|+||||..+++++.+|..++.... ++.
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~~---~~~ 334 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFDS---FEH 334 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCcc---ccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999987765443 344
Q ss_pred hhcCHHHHHHHHHHHHHHhChhh
Q 010489 431 RKLAKDDVREMIYREILEYHPQM 453 (509)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~p~~ 453 (509)
. +..+++++++++|+..++|..
T Consensus 335 ~-~~~~~~r~~i~~e~~~~~~~~ 356 (359)
T KOG0660|consen 335 E-LTEEELRELIYKEILDFHPDV 356 (359)
T ss_pred c-ccHHHHHHHHHHHHHhhCccc
Confidence 4 889999999999999999863
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-64 Score=461.82 Aligned_cols=290 Identities=36% Similarity=0.665 Sum_probs=250.7
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|+.+.++|+|+||+||+|+++.||+.||||++.....+....+-.+|||++|++|+|+|+|.++++| .....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence 468999999999999999999999999999999976544455566789999999999999999999999 555679
Q ss_pred EEEEecccccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 193 YVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 193 ~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
++|+|||+.++.+.+... ..++++.++.+++|+++|+.|+|++++|||||||+||||+.+|.+||||||+|+....
T Consensus 77 hLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--- 153 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--- 153 (396)
T ss_pred EEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC---
Confidence 999999999888777765 4799999999999999999999999999999999999999999999999999998753
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
....+++++.|+||+|||++.+. ..|++.+||||+||++.||++|.+.|+|.++.+|+..|.+.+|...+....-....
T Consensus 154 pgd~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred CcchhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 22347899999999999999885 78999999999999999999999999999999999999999999877766544332
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
....=+..-....+.++...+++++..+.||+++||..||.+|++.+++|.||||.++..
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e 292 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE 292 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence 211111111123355677888999999999999999999999999999999999976644
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-62 Score=476.91 Aligned_cols=287 Identities=40% Similarity=0.701 Sum_probs=255.3
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~~ 190 (509)
..+|.++++||.|+||.||+|+.+.+|..||||++++.+....+.- -+||++.|++|. |||||++.+++.+.. .
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~-nLREvksL~kln~hpniikL~Evi~d~~----~ 83 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECM-NLREVKSLRKLNPHPNIIKLKEVIRDND----R 83 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHH-HHHHHHHHHhcCCCCcchhhHHHhhccC----c
Confidence 4689999999999999999999999999999999998777655544 468999999999 999999999996543 2
Q ss_pred cEEEEEecccccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|+|||||+.+|+++++.+ ..|++..++.|++||++||+|+|.+|+.||||||||||+.....|||+|||+||.....
T Consensus 84 ~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 84 ILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC
Confidence 69999999999999999765 47999999999999999999999999999999999999998889999999999987555
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
.+ +++|+.|+||+|||+++.. ..|+.++||||+|||++|+.+-++.|+|.++.+|+.+|+.++|+|....+...
T Consensus 164 pP----YTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg- 237 (538)
T KOG0661|consen 164 PP----YTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG- 237 (538)
T ss_pred CC----cchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH-
Confidence 44 6889999999999998774 78999999999999999999999999999999999999999999998877653
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
..-+...--.++...+.++....+.+++++.+||.+||++||++||||+++|+||||+.-
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 122233333556667778888899999999999999999999999999999999999743
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-61 Score=433.97 Aligned_cols=286 Identities=42% Similarity=0.702 Sum_probs=248.5
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
.+|..+++||+|.||+||+|++..||+.||||+++.......-....+|||+.|+.++|+||+.++++|.. ...+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~-----~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH-----KSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC-----CCce
Confidence 47899999999999999999999999999999997543333445667899999999999999999999944 4559
Q ss_pred EEEEecccccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 193 YVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 193 ~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
.||+|||+.+|...++... .++..+++.++.++++||+|||++.|+||||||.|+||+++|.+||+|||+|+.......
T Consensus 77 ~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred EEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9999999999999997654 799999999999999999999999999999999999999999999999999998755443
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
. .+..+-|+||+|||++.|. ..|+..+||||.|||++||+.|.+.|+|+++.+|+..|...+|+|.++.|..+..-
T Consensus 157 ~---~~~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 157 I---QTHQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred c---cccceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 2 2344899999999998874 78999999999999999999999999999999999999999999999988776432
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
.. |.. +...+..+....|+.++.++.||+.+||.+||.+|+++.|+|+|+||+...
T Consensus 233 pd--Y~~-~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 233 PD--YVK-IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred cc--HHH-HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 21 111 112333445568899999999999999999999999999999999998743
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-60 Score=465.06 Aligned_cols=290 Identities=37% Similarity=0.606 Sum_probs=250.9
Q ss_pred ccCCCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 108 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 108 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
.....+.|+.+++||+|+||.||+|++..+|+.||+|++..............|||.||++|.||||+++.++....
T Consensus 112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~--- 188 (560)
T KOG0600|consen 112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK--- 188 (560)
T ss_pred cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---
Confidence 34446789999999999999999999999999999999976555555667788999999999999999999998754
Q ss_pred CCCcEEEEEecccccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 188 EFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 188 ~~~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
....+|||+|||+.||.-++...+ .|++.+++.+++||+.||+|||++||+|||||.+|||||.+|.+||+|||||+++
T Consensus 189 ~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 189 LSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred CCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeec
Confidence 235699999999999999997754 7999999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
...... .++..+-|.||+|||+++|. ..|+.++|+||+||||.||++|++.|+|.+..+|++.|.+++|.|.+..|.
T Consensus 269 ~~~~~~--~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 269 TPSGSA--PYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred cCCCCc--ccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence 554433 26788999999999999985 789999999999999999999999999999999999999999999998876
Q ss_pred HhhhHHHHHhhhccCCCC--CCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010489 347 RIRNEKARRYLGSMRKKQ--PVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 407 (509)
..+-. ....++... ...+.+.+...++.+.+|+..||..||.+|.||.++|+|+||.
T Consensus 346 ~~kLP----~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 346 VSKLP----HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred cccCC----cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 32211 111111111 2234455778899999999999999999999999999999994
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-59 Score=467.08 Aligned_cols=338 Identities=92% Similarity=1.454 Sum_probs=301.8
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
+|++.+.||+|+||.||+|++..+|..||||+++...........+.+|+.+++.++||||+++++++..........+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 69999999999999999999999999999999875444444556788999999999999999999998766555556799
Q ss_pred EEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCc
Q 010489 194 VVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273 (509)
Q Consensus 194 lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 273 (509)
+|||||+++|.+++...+.+++..+..++.||++||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 160 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999998654333333
Q ss_pred ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHH
Q 010489 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353 (509)
Q Consensus 274 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (509)
......+||+.|+|||++.+....++.++|||||||++|||++|++||.+.+...++..+...+|.++...+..+.....
T Consensus 161 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 240 (338)
T cd07859 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240 (338)
T ss_pred ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence 33456789999999999865335789999999999999999999999999999999999999999999999988888887
Q ss_pred HHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCCCCccchhHHhhhc
Q 010489 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKL 433 (509)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (509)
..++..+....+.++...++..++.+.+||.+||+.||++|||++|+|+||||+++......+..++....++.+++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (338)
T cd07859 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFERRRL 320 (338)
T ss_pred HHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccccCccccccccHHHHhc
Confidence 78888777777777777788899999999999999999999999999999999998888777888889999999999999
Q ss_pred CHHHHHHHHHHHHHHhCh
Q 010489 434 AKDDVREMIYREILEYHP 451 (509)
Q Consensus 434 ~~~~~~~~~~~~~~~~~p 451 (509)
..++++..++++++.++|
T Consensus 321 ~~~~~~~~~~~~~~~~~~ 338 (338)
T cd07859 321 TKEDVRELIYREILEYHP 338 (338)
T ss_pred CHHHHHHHHHHHHHhcCC
Confidence 999999999999999887
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-60 Score=452.41 Aligned_cols=262 Identities=35% Similarity=0.590 Sum_probs=218.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccCh-----hhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV-----SDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~-----~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 186 (509)
.+.|.+.+.||+|+||.|.+|.++.||+.||||++++..... .....+.+|+++|++|+|||||+++++|..+
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~-- 248 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP-- 248 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC--
Confidence 357999999999999999999999999999999997543221 1233467999999999999999999999554
Q ss_pred CCCCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC---CCeEEeeecc
Q 010489 187 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGL 262 (509)
Q Consensus 187 ~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~---~~vkl~DFG~ 262 (509)
.+.||||||++ |+|++.+..++.+.+...+.+++||+.||.|||++||+||||||+|||+..+ ..+||+|||+
T Consensus 249 ---ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 249 ---DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred ---CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccch
Confidence 44799999999 6999999999999999999999999999999999999999999999999877 7899999999
Q ss_pred cccccCCCCCcccccccccccccccccccccccCCCC-CceeeehhhhHHHHHHhCCCCCCCCChHh-HHHHHHHhcCCC
Q 010489 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVH-QLDLMTDLLGTP 340 (509)
Q Consensus 263 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~g~~ 340 (509)
|+... ...++.+.||||.|.|||++.+....+. .++||||||||||-+++|.+||.+....- ..++|.
T Consensus 326 AK~~g----~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~------ 395 (475)
T KOG0615|consen 326 AKVSG----EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQIL------ 395 (475)
T ss_pred hhccc----cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHh------
Confidence 99764 2234678899999999999976433444 48999999999999999999998765321 111121
Q ss_pred ChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.....-.+..|..++.++++||.+||..||+.|||+.|+|+||||+..
T Consensus 396 ---------------------~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 396 ---------------------KGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred ---------------------cCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 111112234566789999999999999999999999999999999854
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-59 Score=437.79 Aligned_cols=294 Identities=38% Similarity=0.605 Sum_probs=251.6
Q ss_pred ccCCCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 108 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 108 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
.....+.|+.+..|++|+||.||+|+++.|++.||+|+++.......---..+|||.+|.+++|||||.+.++.....
T Consensus 71 gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~-- 148 (419)
T KOG0663|consen 71 GCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN-- 148 (419)
T ss_pred CcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc--
Confidence 334566899999999999999999999999999999999864433333345689999999999999999999986543
Q ss_pred CCCcEEEEEecccccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 188 EFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 188 ~~~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
...+|||||||+.||..++...+ +|...+++.++.|+++||+|||.++|+||||||+|+|++..|.+||+|||+|+.+
T Consensus 149 -~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 149 -MDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred -cceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhh
Confidence 34599999999999999998765 8999999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
..... .++..+-|.||+|||++.+. ..|+.++|+||+|||+.||+++++.|+|....+|++.|..++|+|.+..+.
T Consensus 228 gsp~k---~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 228 GSPLK---PYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP 303 (419)
T ss_pred cCCcc---cCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence 65433 25778999999999999884 789999999999999999999999999999999999999999999998877
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCC--CHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNA--DPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.+..-..... -.+...+...+...|+.. +....+|+..+|.+||.+|.||+|+|+|.||...
T Consensus 304 g~~~lp~~k~-~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 304 GYSELPAVKK-MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred Cccccchhhc-cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 6544322211 122333444555566554 4899999999999999999999999999999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-57 Score=456.26 Aligned_cols=261 Identities=33% Similarity=0.580 Sum_probs=228.4
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCc-ccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.+|...+.||+|||+.||++++..+|+.||+|++.+. ........++.+||+|.+.|+|||||+++++| ++..+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence 6899999999999999999999999999999999653 33445677899999999999999999999999 66678
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|||+|+|. ++|..++++.+.++|.+++.+++||+.||.|||+++|+|||||..|+|++++.+|||+|||||.....+.
T Consensus 93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 999999999 7899999999999999999999999999999999999999999999999999999999999999876553
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
... .+.||||.|.|||++.+ ..++..+||||+|||||.||+|+|||...+..+.+..|...
T Consensus 173 Erk---~TlCGTPNYIAPEVl~k--~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~-------------- 233 (592)
T KOG0575|consen 173 ERK---KTLCGTPNYIAPEVLNK--SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN-------------- 233 (592)
T ss_pred ccc---ceecCCCcccChhHhcc--CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc--------------
Confidence 332 46799999999999987 78999999999999999999999999988876666555321
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCC
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDR 414 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 414 (509)
....| ..+++++++||.+||+.||.+|||++++|.|+||+.-.-+..
T Consensus 234 ------------~Y~~P-----~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~ 280 (592)
T KOG0575|consen 234 ------------EYSMP-----SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPAR 280 (592)
T ss_pred ------------Ccccc-----cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCC
Confidence 00001 257899999999999999999999999999999954443333
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-57 Score=432.69 Aligned_cols=261 Identities=30% Similarity=0.511 Sum_probs=227.3
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|+++++||+|+||+||+++++.+++.||+|++++.. ....+.+...+|..||..++||.||+++..| ++..
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt~~ 98 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QTEE 98 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----ccCC
Confidence 468999999999999999999999999999999997543 2334677889999999999999999999888 4456
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|+|+||+. |+|+..+++.+.|++..++.++.+|+.||.|||++|||||||||+|||+|.+|+++|+|||+|+.....
T Consensus 99 kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 7999999998 599999999999999999999999999999999999999999999999999999999999999865443
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
... ..++|||+.|||||++.+ ..|+.++|+|||||++|||++|.+||.+.+.....+.|...
T Consensus 179 ~~~---t~tfcGT~eYmAPEil~~--~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~------------- 240 (357)
T KOG0598|consen 179 GDA---TRTFCGTPEYMAPEILLG--KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKG------------- 240 (357)
T ss_pred CCc---cccccCCccccChHHHhc--CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcC-------------
Confidence 332 245899999999999998 79999999999999999999999999998876666555331
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCC-CCHHHHHHHHHhccCCCCCCC----CHHHHhcCCcccCCcCCC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPN-ADPLALHLLERLLAFDPKDRP----TAEEALADPYFHGLANVD 413 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~Rp----t~~e~l~hp~f~~~~~~~ 413 (509)
+. ...+. ++.++++||.++|..||++|. .++++-+||||+++.+..
T Consensus 241 -------------k~-----~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~ 291 (357)
T KOG0598|consen 241 -------------KL-----PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEK 291 (357)
T ss_pred -------------cC-----CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHH
Confidence 00 01123 688999999999999999996 689999999999887743
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-57 Score=431.65 Aligned_cols=287 Identities=39% Similarity=0.672 Sum_probs=247.5
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
.|.-.+++|+|+||.||+|....+++.||||++-... +---+|+++|+.+.|||||++..+|......+.-++.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 5888999999999999999999999999999984321 1224799999999999999999998766544455778
Q ss_pred EEEecccccHHHHHHh----CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC-CCeEEeeecccccccC
Q 010489 194 VVFELMESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVSFN 268 (509)
Q Consensus 194 lv~e~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~-~~vkl~DFG~a~~~~~ 268 (509)
+|||||+.+|.+.++. +..++.-.++-+.+||++||.|||+.|||||||||.|||||.+ |.+||||||.|+....
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 9999999999988874 5689999999999999999999999999999999999999987 9999999999998866
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
..+. .++..|+.|+|||++.+. ..|+.+.||||.|||++||+-|++.|+|++..+|+..|.+++|+|+.+.+..+
T Consensus 179 ~epn----iSYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 179 GEPN----ISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred CCCc----eeEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 6654 567899999999998884 78999999999999999999999999999999999999999999999999887
Q ss_pred hhHHHHHhhhccCCCCCCCCCC-CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSH-KFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDR 414 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 414 (509)
...... ...+.-.+.++.. .....++++.+|+.++|+++|.+|.++.|+|.||||..+.+++.
T Consensus 254 n~~y~~---~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~ 317 (364)
T KOG0658|consen 254 NPNYTE---FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNT 317 (364)
T ss_pred Cccccc---ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCc
Confidence 654321 1222333344444 45678999999999999999999999999999999998887643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-57 Score=428.69 Aligned_cols=261 Identities=27% Similarity=0.477 Sum_probs=221.2
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++.+.++.||+|..|+||+|+|+.|++.+|+|++... .+....+++.+|+++++.++||+||.+|++|..... .+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~i 153 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EI 153 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eE
Confidence 4667789999999999999999999999999999432 344567889999999999999999999999965431 48
Q ss_pred EEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhh-CCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|+||||+ |+|.+++...++++|.....|+.++++||.|||. .+||||||||+||||++.|+|||||||.++...+.
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999 6899999888999999999999999999999995 99999999999999999999999999999876554
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCC--ChHhHHHHHHHhcCCCChhHHHHh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK--NVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~--~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
...+++||..|||||.+.+ ..|+.++||||||++++||.+|+.||... .....++++..++
T Consensus 233 ----~a~tfvGT~~YMsPERi~g--~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv----------- 295 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISG--ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV----------- 295 (364)
T ss_pred ----hcccccccccccChhhhcC--CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-----------
Confidence 2467899999999999998 79999999999999999999999999874 1222232222222
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
...|..+... .+++++++||..||++||.+||++.|+++|||+++...
T Consensus 296 -------------~~ppP~lP~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 296 -------------DEPPPRLPEG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred -------------cCCCCCCCcc--cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 1122211111 47899999999999999999999999999999987544
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-55 Score=418.58 Aligned_cols=293 Identities=39% Similarity=0.686 Sum_probs=248.4
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCC-cceeeeeecCCCc-CCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD-IVEIKHIMLPPSR-REFK 190 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~~~~~~~~~~~-~~~~ 190 (509)
..|..+++||+|+||+||+|+++.+|+.||+|++.-.......-....+|+.+|+.|+|+| |+.+++++..... ....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4577888999999999999999999999999999754443333455689999999999999 9999999976542 3344
Q ss_pred cEEEEEecccccHHHHHHhCC----CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 191 DIYVVFELMESDLHQVIKAND----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~----~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
.+|+|+||++.+|..++.... .++...++.+++||+.||+|||+++|+||||||.||||+++|.+||+|||+|+..
T Consensus 91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~ 170 (323)
T KOG0594|consen 91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAF 170 (323)
T ss_pred eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHh
Confidence 699999999999999998755 5888899999999999999999999999999999999999999999999999965
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
.-... .++..++|.||+|||++.+. ..|+..+||||+|||++||+++++.|+|.+..+++..|..++|+|..+.|.
T Consensus 171 ~ip~~---~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 171 SIPMR---TYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred cCCcc---cccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 32221 25677999999999999884 579999999999999999999999999999999999999999999998877
Q ss_pred HhhhHHHHHhhhccCCCC-CCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 347 RIRNEKARRYLGSMRKKQ-PVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
....-. .+-..++... +.++....+..++.+.+++.+||+.+|.+|.|++.+|.||||..+..
T Consensus 247 ~v~~~~--~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 247 GVSSLP--DYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred Cccccc--cccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 654211 1111333333 55566666777889999999999999999999999999999987643
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-55 Score=429.61 Aligned_cols=265 Identities=31% Similarity=0.527 Sum_probs=227.4
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~ 188 (509)
...+|.+++.||+|+|++|++|+++.+++.||||++.+... ...-.+-+.+|-.+|.+| .||.|++|+..|. +
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ-----D 145 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQ-----D 145 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEee-----c
Confidence 35689999999999999999999999999999999865322 122345567899999999 7999999999994 4
Q ss_pred CCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 189 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
...+|+|+||++ |+|.++|.+-+.|++..+++++.||+.||+|||++|||||||||+|||+|.+|++||+|||.|+.+.
T Consensus 146 ~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 146 EESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred ccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 456999999998 7999999999999999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCC----------cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhc
Q 010489 268 NDAPS----------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 337 (509)
Q Consensus 268 ~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 337 (509)
..... .-...+++||..|.+||++.. ...++.+|||+||||||.|+.|.+||.+.+....+..|..+-
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~--~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~ 303 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND--SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD 303 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcC--CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc
Confidence 33221 111256899999999999988 788999999999999999999999999999877777765531
Q ss_pred CCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCC
Q 010489 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 413 (509)
Q Consensus 338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 413 (509)
- .+ -++.++.+.|||+++|..||.+|+|+++|.+||||.++.+.+
T Consensus 304 y----------------------------~f---p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 304 Y----------------------------EF---PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred c----------------------------cC---CCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 0 11 134568899999999999999999999999999999887654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-54 Score=423.92 Aligned_cols=267 Identities=28% Similarity=0.460 Sum_probs=224.8
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|+++++||+|+||.||+|+.+.||..||+|++++.. ....+...++.|-.+|....+|.||+++..| ++..
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~~ 214 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDKE 214 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCCC
Confidence 578999999999999999999999999999999997632 2345677888999999999999999999999 4556
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
++||||||++ ||+..+|...+.|+++.+++++.+++.|++.||..|+|||||||+|+|||..|++||+|||||......
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred eeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 7999999998 699999999999999999999999999999999999999999999999999999999999999542110
Q ss_pred -----------------------CCC-----cc----------------cccccccccccccccccccccCCCCCceeee
Q 010489 270 -----------------------APS-----AI----------------FWTDYVATRWYRAPELCGSFFSKYTPAIDIW 305 (509)
Q Consensus 270 -----------------------~~~-----~~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw 305 (509)
... .. ...+.+|||.|||||++.+ ..|+..+|+|
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~--kgY~~~cDwW 372 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG--KGYGKECDWW 372 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc--CCCCccccHH
Confidence 000 00 0123699999999999998 7899999999
Q ss_pred hhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHH
Q 010489 306 SIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLER 385 (509)
Q Consensus 306 SlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 385 (509)
|||||+||||.|.+||.+++..+....|...-.. + ..| ....+++++.|||.+
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~--------------------l----~fP---~~~~~s~eA~DLI~r 425 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET--------------------L----KFP---EEVDLSDEAKDLITR 425 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh--------------------c----cCC---CcCcccHHHHHHHHH
Confidence 9999999999999999999887766665432100 0 000 012356899999999
Q ss_pred hccCCCCCCCC---HHHHhcCCcccCCcCCC
Q 010489 386 LLAFDPKDRPT---AEEALADPYFHGLANVD 413 (509)
Q Consensus 386 ~L~~dP~~Rpt---~~e~l~hp~f~~~~~~~ 413 (509)
||. ||++|.. ++||.+||||+++.+..
T Consensus 426 ll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~ 455 (550)
T KOG0605|consen 426 LLC-DPENRLGSKGAEEIKKHPFFKGVDWDH 455 (550)
T ss_pred Hhc-CHHHhcCcccHHHHhcCCccccCCcch
Confidence 999 9999975 99999999999988754
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-54 Score=412.04 Aligned_cols=259 Identities=33% Similarity=0.490 Sum_probs=219.7
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
..++|.+.+.||+|+||+||+|+++.++..||||.+.+..-.....+-+..|+++|+.++|||||.+++++..+ +
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~-----~ 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD-----D 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC-----C
Confidence 35789999999999999999999999999999999976544556667788999999999999999999999554 4
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC------CCeEEeeeccc
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD------CKLKICDFGLA 263 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~------~~vkl~DFG~a 263 (509)
++|+|||||. |||.+++++.+.+++..++.++.||+.||++||+++||||||||+|||++.. -.+||+|||+|
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 6999999999 7999999999999999999999999999999999999999999999999875 45899999999
Q ss_pred ccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChh
Q 010489 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (509)
+...... ...+.||+|.|||||++.. ..|+.|+|+||+|+|+|+|++|++||...+..+.+..+.+..
T Consensus 163 R~L~~~~----~a~tlcGSplYMAPEV~~~--~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~------ 230 (429)
T KOG0595|consen 163 RFLQPGS----MAETLCGSPLYMAPEVIMS--QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN------ 230 (429)
T ss_pred hhCCchh----HHHHhhCCccccCHHHHHh--ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc------
Confidence 9875332 3466899999999999976 799999999999999999999999999877655444322210
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
...+. .-...+....+|+...|+.+|.+|.+..+.+.|+++..
T Consensus 231 ------------------~~~~~----~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 231 ------------------EIVPV----LPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred ------------------cccCc----hhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 00010 01123455679999999999999999999999999864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-54 Score=395.35 Aligned_cols=257 Identities=26% Similarity=0.482 Sum_probs=223.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCc-ccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++++.||.|+||+|.+++++.+|..||+|++++. .....+.+....|..+|+.+.||.++++++.+ .+..
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCC
Confidence 35799999999999999999999999999999999642 23345667788999999999999999999988 4456
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
++||||||.+ |.|+.++++.++|++..+++++.||+.||+|||+++|++|||||||||+|.+|.+||+|||+|+.....
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 7999999999 589999999999999999999999999999999999999999999999999999999999999875332
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
.-+.||||.|+|||++.. .+|+.++|+|||||++|||+.|.+||...+.....+.|...-
T Consensus 198 ------T~TlCGTPeYLAPEii~s--k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~------------ 257 (355)
T KOG0616|consen 198 ------TWTLCGTPEYLAPEIIQS--KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK------------ 257 (355)
T ss_pred ------EEEecCCccccChHHhhc--CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc------------
Confidence 245799999999999988 799999999999999999999999999988766666654310
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCC-----CCHHHHhcCCcccCCcCC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYFHGLANV 412 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R-----pt~~e~l~hp~f~~~~~~ 412 (509)
..+ .+-.+++++|||.++|+.|-.+| ....++..||||+++.+.
T Consensus 258 ----------------v~f---P~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~ 306 (355)
T KOG0616|consen 258 ----------------VKF---PSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWE 306 (355)
T ss_pred ----------------ccC---CcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHH
Confidence 001 12467899999999999999999 357899999999987653
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-53 Score=421.32 Aligned_cols=257 Identities=32% Similarity=0.568 Sum_probs=227.8
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
.+|.+.+.||+|+||+||+|+.+.+.+.||||.+.+......+.+.+.+|++|++.++|||||.+++.| +...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 478999999999999999999999999999999988777778889999999999999999999999988 555679
Q ss_pred EEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCC
Q 010489 193 YVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (509)
Q Consensus 193 ~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 272 (509)
|+|.|||.|+|+.++...+.++|+.+..|++|++.||.|||+.+|+|||+||.|||++..|.+|+||||+|+.+.. .
T Consensus 77 ~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~---~ 153 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST---N 153 (808)
T ss_pred EEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc---C
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999997643 3
Q ss_pred cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHH
Q 010489 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (509)
Q Consensus 273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (509)
....+..-|||.|||||++.+ +.|+..+|+||||||+|||++|++||...+..+....|.
T Consensus 154 t~vltsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~------------------ 213 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL------------------ 213 (808)
T ss_pred ceeeeeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh------------------
Confidence 334677899999999999987 899999999999999999999999998765433333332
Q ss_pred HHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
.....++ +.++..++.||+.+|.+||.+|+|+.+++.|||+++-.
T Consensus 214 ---------~d~v~~p----~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 214 ---------KDPVKPP----STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred ---------cCCCCCc----ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence 1111111 26788999999999999999999999999999997543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-53 Score=423.74 Aligned_cols=261 Identities=30% Similarity=0.491 Sum_probs=224.1
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.+-|++++.||.|+.|.|.+|+|..||+.+|||++.+.. ........+.+||-||+.+.||||+.+++++ +...
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCc
Confidence 466999999999999999999999999999999997652 2233456789999999999999999999999 4556
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
++|+|.||++ |.|++++...+++++.++.+++.||+.|+.|||..+||||||||+|+|+|..+.+||+|||+|.....+
T Consensus 86 ~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 7999999998 689999999999999999999999999999999999999999999999999999999999999865333
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
. .+.+.||+|.|.|||++.|. ...+.++||||+|||||.||+|+.||.+.+....+.++....
T Consensus 166 k----lLeTSCGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~------------ 228 (786)
T KOG0588|consen 166 K----LLETSCGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV------------ 228 (786)
T ss_pred c----cccccCCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc------------
Confidence 2 24678999999999999983 334678999999999999999999999776544443332210
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 413 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 413 (509)
. +....+++++++||.+||..||++|+|.+||++|||+.+.....
T Consensus 229 ---------------f----~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 229 ---------------F----EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLP 273 (786)
T ss_pred ---------------c----cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence 0 01146899999999999999999999999999999998876644
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-52 Score=418.33 Aligned_cols=257 Identities=33% Similarity=0.552 Sum_probs=217.2
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc--C-hhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCc
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE--H-VSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSR 186 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~-~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~ 186 (509)
..++|.+++.||+|+||+|++|.+..++..||||++.+... . ....+.+.+|+.+++.++ ||||+++++++....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~- 93 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT- 93 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC-
Confidence 35689999999999999999999999999999998765311 1 133456678999999999 999999999996553
Q ss_pred CCCCcEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC-CCeEEeeecccc
Q 010489 187 REFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLAR 264 (509)
Q Consensus 187 ~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~-~~vkl~DFG~a~ 264 (509)
.+|+|||||.| +|++.+...+++.|.+++.++.||+.|++|||++||+||||||+|||++.+ +++||+|||++.
T Consensus 94 ----~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 ----KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred ----eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 49999999994 999999999999999999999999999999999999999999999999999 999999999998
Q ss_pred cccCCCCCcccccccccccccccccccccccCC-CC-CceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCCh
Q 010489 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK-YT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342 (509)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~ 342 (509)
... .......+.|||+.|+|||++.+ .. |+ .++||||+|||||.|++|+.||...+.......|..
T Consensus 170 ~~~---~~~~~l~t~cGsp~Y~aPEvl~~--~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~------- 237 (370)
T KOG0583|consen 170 ISP---GEDGLLKTFCGSPAYAAPEVLSG--KGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK------- 237 (370)
T ss_pred ccC---CCCCcccCCCCCcccCCHHHhCC--CCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc-------
Confidence 763 12223577899999999999988 34 64 789999999999999999999988665444333211
Q ss_pred hHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCC-CHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNA-DPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
....+. ..+ ++++.+|+.+||..||.+|+|+.+++.||||+.
T Consensus 238 ---------------------~~~~~p---~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 238 ---------------------GEFKIP---SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ---------------------CCccCC---CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 111111 123 899999999999999999999999999999986
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-54 Score=388.28 Aligned_cols=259 Identities=31% Similarity=0.514 Sum_probs=223.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.+.|++.+.||+|.|++|++|.+..+|+.+|+|.++-......+.+.+.+|++|-+.|+||||+++.+.+ .+...
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccce
Confidence 3579999999999999999999999999999999875444445788899999999999999999998877 44566
Q ss_pred EEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC---CCeEEeeeccccccc
Q 010489 192 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVSF 267 (509)
Q Consensus 192 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~---~~vkl~DFG~a~~~~ 267 (509)
.|||+|+|+| +|...|.+..-++|..+..++.||++||.|+|.+||||||+||+|+|+-+. .-+||+|||+|....
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 8999999995 787777666778999999999999999999999999999999999998654 349999999998765
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
....+.+.+|||.|||||++.. .+|+..+|||+.|||||-||.|.+||.+++..+.++.|..
T Consensus 165 ----~g~~~~G~~GtP~fmaPEvvrk--dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~------------ 226 (355)
T KOG0033|consen 165 ----DGEAWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA------------ 226 (355)
T ss_pred ----CccccccccCCCcccCHHHhhc--CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc------------
Confidence 2234678899999999999988 7999999999999999999999999999876555554422
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
....-....|+.+++++++|+++||..||.+|+|+.|+|+|||+.+
T Consensus 227 ---------------g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 227 ---------------GAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred ---------------cccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 1111223467889999999999999999999999999999999975
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-52 Score=420.62 Aligned_cols=284 Identities=36% Similarity=0.634 Sum_probs=236.5
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-C-----CCcceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-H-----PDIVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h-----~niv~~~~~~~~~~ 185 (509)
..+|.|++.||+|+||.|-+|.+..|++.||||+++.. .....+...|+.+|..|+ | -|+|+++++|...
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr- 260 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR- 260 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc-
Confidence 34899999999999999999999999999999999753 345566778999999997 4 5799999999554
Q ss_pred cCCCCcEEEEEecccccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC--CCeEEeeec
Q 010489 186 RREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD--CKLKICDFG 261 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~--~~vkl~DFG 261 (509)
+++|||+|+++.+|+++++.+. .|+...++.|+.||+.||.+||..||||+|||||||||..- ..|||+|||
T Consensus 261 ----~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 261 ----NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ----cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence 5699999999999999999875 69999999999999999999999999999999999999764 469999999
Q ss_pred ccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCC
Q 010489 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341 (509)
Q Consensus 262 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~ 341 (509)
.|...... ...++-++.|+|||++.| .+|+.+.||||||||++||++|.+.|+|.+..+|+..|..++|.|+
T Consensus 337 SSc~~~q~------vytYiQSRfYRAPEVILG--lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp 408 (586)
T KOG0667|consen 337 SSCFESQR------VYTYIQSRFYRAPEVILG--LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP 408 (586)
T ss_pred cccccCCc------ceeeeeccccccchhhcc--CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence 99864221 136899999999999999 7999999999999999999999999999999999999999999999
Q ss_pred hhHHHHhhhHHHHHhhhc----------------------------cCC--CCC---CCCCCCCC-CCCHHHHHHHHHhc
Q 010489 342 TESISRIRNEKARRYLGS----------------------------MRK--KQP---VPFSHKFP-NADPLALHLLERLL 387 (509)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~----------------------------~~~--~~~---~~~~~~~~-~~~~~~~~li~~~L 387 (509)
...++..... ..++.. ... ..| ..+....+ .....+.|||.+||
T Consensus 409 ~~mL~~~~~~--~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L 486 (586)
T KOG0667|consen 409 PKMLDTAKKA--HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCL 486 (586)
T ss_pred HHHHHhcccc--ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHh
Confidence 9988765432 111111 000 011 11222222 23456799999999
Q ss_pred cCCCCCCCCHHHHhcCCcccCCcCCC
Q 010489 388 AFDPKDRPTAEEALADPYFHGLANVD 413 (509)
Q Consensus 388 ~~dP~~Rpt~~e~l~hp~f~~~~~~~ 413 (509)
.+||.+|+|+.++|+||||.+.....
T Consensus 487 ~~dP~~R~tp~qal~Hpfl~~~~~~~ 512 (586)
T KOG0667|consen 487 EWDPAERITPAQALNHPFLTGTSLER 512 (586)
T ss_pred ccCchhcCCHHHHhcCcccccccccc
Confidence 99999999999999999998665543
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-51 Score=411.96 Aligned_cols=328 Identities=41% Similarity=0.798 Sum_probs=265.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc-CCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~-~~~~ 190 (509)
.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++..... ....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 468999999999999999999999999999999987544333445667899999999999999999998864322 2335
Q ss_pred cEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.+|++||+++++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~~~~~~~~~~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~- 171 (343)
T cd07878 94 EVYLVTNLMGADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE- 171 (343)
T ss_pred cEEEEeecCCCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC-
Confidence 689999999989988775 457999999999999999999999999999999999999999999999999999864321
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..+.+..+..
T Consensus 172 -----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 172 -----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred -----cCCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 2446899999999998652 4688999999999999999999999999998888888888889988888777776
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCCCCccchhHHh
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFER 430 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 430 (509)
.....++..++......+...+...++.+.+||.+||..||.+|||+.|+|+||||.....+...+...+ .....+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~---~~~~~~~ 322 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEP---YDESPEN 322 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCccccccCc---cccchhh
Confidence 6666666655554444445555677889999999999999999999999999999998766554333222 2222334
Q ss_pred hhcCHHHHHHHHHHHHHHhC
Q 010489 431 RKLAKDDVREMIYREILEYH 450 (509)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~ 450 (509)
+....+++++..+.+...+.
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~ 342 (343)
T cd07878 323 KERTIEEWKELTYEEVSSFK 342 (343)
T ss_pred hhccHHHHHHHHHHHHHhcC
Confidence 44555677666666654443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-51 Score=409.07 Aligned_cols=334 Identities=56% Similarity=0.997 Sum_probs=283.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
..+|.+.+.||+|+||+||+|.+..+++.||||.+............+.+|+.+++.++|+||+++++++..........
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45899999999999999999999999999999998754444445567789999999999999999999886554444566
Q ss_pred EEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 192 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
+|+||||++++|.+++...+.+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 162 (337)
T cd07858 84 VYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG- 162 (337)
T ss_pred EEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-
Confidence 8999999999999999888899999999999999999999999999999999999999999999999999997653321
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
.......++..|+|||.+... ..++.++|||||||++|+|++|++||.+.+....+..+...+|.+..+.+..+...
T Consensus 163 --~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 163 --DFMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred --ccccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 122445789999999987642 35889999999999999999999999999888888889999999888877766666
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCCCCccchhHHhh
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERR 431 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (509)
....++..........+....+.+++.+.+||.+||+.||++|||++++++||||..+.+....+..+ ..+.+.+|+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~--~~~~~~~~~~ 317 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQ--TPFSFDFEED 317 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccCC--Cccchhhhhh
Confidence 66666665554444444445667899999999999999999999999999999999988777665544 3567778888
Q ss_pred hcCHHHHHHHHHHHHHHhCh
Q 010489 432 KLAKDDVREMIYREILEYHP 451 (509)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~p 451 (509)
....+++++.++.|.+.+||
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~ 337 (337)
T cd07858 318 ALTEEDIKELIYNEMLAYHP 337 (337)
T ss_pred hcCHHHHHHHHHHHHhhcCC
Confidence 89999999999999988876
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-51 Score=400.13 Aligned_cols=285 Identities=36% Similarity=0.654 Sum_probs=233.4
Q ss_pred CCCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 110 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 110 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
+..++|++.++||+|+||.||+|.+..++..||+|+++.... ......+.+|+.+++.++||||+++++++.. .
T Consensus 2 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~ 75 (288)
T cd07871 2 GKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHT-----E 75 (288)
T ss_pred CccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-----C
Confidence 345789999999999999999999999999999999864321 1223456789999999999999999999844 3
Q ss_pred CcEEEEEecccccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 190 KDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 190 ~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
...|+||||++++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 76 RCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred CeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 4589999999999999887654 578999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... ......||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.+..+.+..+
T Consensus 156 ~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 156 PTK---TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred CCc---cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcc
Confidence 221 12345789999999988652 56899999999999999999999999999999999999999999988876654
Q ss_pred hhHH-HHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 349 RNEK-ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 349 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
.... ...+. .+.....+.....+.+++++++||.+||.+||.+|||++|+|+||||
T Consensus 232 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 232 TSNEEFRSYL--FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccchhhhccc--cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 3221 11111 11111222223345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-50 Score=410.83 Aligned_cols=292 Identities=45% Similarity=0.772 Sum_probs=241.0
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
+|++++.||+|+||.||+|.+..+|+.||||++..........+++.+|+.+++.++||||+++++++..........+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 47889999999999999999999999999999875544445567788999999999999999999998765433445789
Q ss_pred EEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCc
Q 010489 194 VVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273 (509)
Q Consensus 194 lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 273 (509)
+||||+.++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~- 159 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK- 159 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc-
Confidence 9999999999999988888999999999999999999999999999999999999999999999999999864332211
Q ss_pred ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHH
Q 010489 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353 (509)
Q Consensus 274 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (509)
......+|+.|+|||++.+. ..++.++|||||||++|||++|+.||.+.+..+++..+...+|.++.+.+...... .
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~-~ 236 (372)
T cd07853 160 -HMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG-A 236 (372)
T ss_pred -cCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH-H
Confidence 22445789999999998763 45889999999999999999999999999999999999999999988766554322 2
Q ss_pred HHhhhccCCCCCC--CCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 354 RRYLGSMRKKQPV--PFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 354 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
...+.......+. .........++++.+||.+||..||++|||+.|+|+||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 2222221111111 0112234568899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-51 Score=395.50 Aligned_cols=275 Identities=29% Similarity=0.440 Sum_probs=227.6
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
..++|++..+||.|..++||+|+...+++.||||+++-... ..+...+.+|+..|+.++||||++++..|....
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc-~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~----- 97 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC-NNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS----- 97 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh-hhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc-----
Confidence 35689999999999999999999999999999999974322 234788999999999999999999999996654
Q ss_pred cEEEEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 191 DIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
.+|+||.||. |++++++... ..++|..+..|++++++||.|||.+|-||||||+.||||+.+|.|||+|||.+..+.
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 4999999999 7899999764 369999999999999999999999999999999999999999999999999987766
Q ss_pred CCCCCcccc-cccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 268 NDAPSAIFW-TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 268 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
......... ..++||++|||||++......|+.|+|||||||+..||.+|..||..-.... .++.++-+.|+.....
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--vLl~tLqn~pp~~~t~ 255 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--VLLLTLQNDPPTLLTS 255 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--HHHHHhcCCCCCcccc
Confidence 555444333 6789999999999976666889999999999999999999999997654433 2344455555432222
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCC
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 412 (509)
....+.. ...+..++.+|..||.+||.+||||+++|+|+||++....
T Consensus 256 ~~~~d~~-------------------k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 256 GLDKDED-------------------KKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred cCChHHh-------------------hhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 2211111 1235578999999999999999999999999999876554
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-52 Score=386.17 Aligned_cols=292 Identities=39% Similarity=0.642 Sum_probs=239.3
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCc----EEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGE----RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~----~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
..|++++.||+|+||.||+|..+.++. .||||+++.......-.....||+.+++.++||||+.+..+++..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~---- 99 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH---- 99 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence 469999999999999999997655433 799999976544444456778999999999999999999999753
Q ss_pred CCcEEEEEecccccHHHHHHhC-----CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC----CCeEEee
Q 010489 189 FKDIYVVFELMESDLHQVIKAN-----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD----CKLKICD 259 (509)
Q Consensus 189 ~~~~~lv~e~~~~~L~~~l~~~-----~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~----~~vkl~D 259 (509)
...+++++||.+.||.++|.-+ ..++...++.|+.||+.|+.|||++.|+||||||.||||..+ |.|||+|
T Consensus 100 d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 100 DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 3569999999999999999643 368999999999999999999999999999999999999888 8999999
Q ss_pred ecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCC---------hHhHH
Q 010489 260 FGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN---------VVHQL 330 (509)
Q Consensus 260 FG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---------~~~~~ 330 (509)
||+++.+.+.-..-......+-|.||+|||++.|. ..|++++||||+|||+.||++-++.|.+.. ..+|+
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 99999876544333334567899999999999884 789999999999999999999999998753 36789
Q ss_pred HHHHHhcCCCChhHHHHhhhHH-HHHhhhccCCCCCCC-----CCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 010489 331 DLMTDLLGTPSTESISRIRNEK-ARRYLGSMRKKQPVP-----FSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404 (509)
Q Consensus 331 ~~i~~~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 404 (509)
+.|..++|+|..+.+..++.-. ....+..++...... +-..+..-++.+.+|+.+||++||.+|+|++++|+|+
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 9999999999999887765422 223344333322222 1122233466699999999999999999999999999
Q ss_pred cccCC
Q 010489 405 YFHGL 409 (509)
Q Consensus 405 ~f~~~ 409 (509)
||..-
T Consensus 339 yF~~d 343 (438)
T KOG0666|consen 339 YFTED 343 (438)
T ss_pred ccccC
Confidence 99753
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-53 Score=384.01 Aligned_cols=256 Identities=32% Similarity=0.482 Sum_probs=212.1
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
.+|+|+++||+|+||.||++.+..+|..||.|.++-...+....+.+..|+.+|++|+|||||++++.-.. ++..-+
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~evl 95 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEVL 95 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchhh
Confidence 47999999999999999999999999999999998555555667789999999999999999999873322 222348
Q ss_pred EEEEeccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHhHhhhhhh--CC--eeecCCCCCcEEECCCCCeEEeeeccc
Q 010489 193 YVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHT--AN--VFHRDLKPKNILANADCKLKICDFGLA 263 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~--~~--ivHrDlKp~NILl~~~~~vkl~DFG~a 263 (509)
+||||||+ |||.+.++. ...++|..++.++.|++.||..+|+ .. |+||||||.||+++.+|.|||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 99999999 799988853 3579999999999999999999999 44 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChh
Q 010489 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (509)
+...... .+..+++|||.||+||.+.+ .+|+.++||||+||++|||+.-++||.|++.......|...--
T Consensus 176 r~l~s~~---tfA~S~VGTPyYMSPE~i~~--~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~----- 245 (375)
T KOG0591|consen 176 RFLSSKT---TFAHSLVGTPYYMSPERIHE--SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY----- 245 (375)
T ss_pred hHhcchh---HHHHhhcCCCcccCHHHHhc--CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC-----
Confidence 9874433 34577899999999999988 8999999999999999999999999999976555555543210
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
+|.+ . .-.|..+..||..|+..||+.||+. +|++..+.
T Consensus 246 --------------------~~~p-~---~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~ 283 (375)
T KOG0591|consen 246 --------------------PPLP-D---EHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQ 283 (375)
T ss_pred --------------------CCCc-H---HHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHH
Confidence 0111 0 1245678999999999999999986 55554443
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-50 Score=405.77 Aligned_cols=293 Identities=38% Similarity=0.691 Sum_probs=237.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc-CCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~-~~~~ 190 (509)
.++|++.+.||+|+||.||+|.+..+|..||||++............+.+|+.+++.++||||+++++++..... ....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 468999999999999999999999999999999997654444556778899999999999999999999865432 2345
Q ss_pred cEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.+|+||||++++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 100 ~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 177 (359)
T cd07876 100 DVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF 177 (359)
T ss_pred eeEEEEeCCCcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCc
Confidence 6899999999998887743 58899999999999999999999999999999999999999999999999997542221
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.|..+.......
T Consensus 178 ----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 178 ----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred ----cCCCCcccCCCCCchhccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 1244689999999999987 6899999999999999999999999999998888888888899888776655432
Q ss_pred HHHHHhhhccCCCCCCCCCCC------------CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCC
Q 010489 351 EKARRYLGSMRKKQPVPFSHK------------FPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 413 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 413 (509)
. ...+....+......+... ....++.+.+||.+||..||++|||+.|+|+||||..+.++.
T Consensus 252 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~ 325 (359)
T cd07876 252 T-VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPA 325 (359)
T ss_pred H-HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcc
Confidence 1 2222222221111111111 112467899999999999999999999999999998665543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-50 Score=406.17 Aligned_cols=326 Identities=36% Similarity=0.656 Sum_probs=254.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc-CCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~-~~~~ 190 (509)
.++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++..... ....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 468999999999999999999999999999999997654445556778899999999999999999998865432 3345
Q ss_pred cEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.+|+||||++++|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 103 ~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~ 180 (364)
T cd07875 103 DVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180 (364)
T ss_pred eEEEEEeCCCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC
Confidence 6899999999999888754 48899999999999999999999999999999999999999999999999997643221
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.|..+....+..
T Consensus 181 ----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 181 ----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred ----cccCCcccCCcCCHHHHhC--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 1245689999999999987 6899999999999999999999999999999999999989899888766555432
Q ss_pred HHHHHhhhccCCCCCCCCC------------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCC
Q 010489 351 EKARRYLGSMRKKQPVPFS------------HKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPST 418 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~ 418 (509)
. ...+....+......+. ......+..+++||.+||+.||.+|||+.++|+||||..+.+....+..
T Consensus 255 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~ 333 (364)
T cd07875 255 T-VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAP 333 (364)
T ss_pred H-HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCCCC
Confidence 2 22222221111111111 1112235679999999999999999999999999999876655443322
Q ss_pred CCCCccchhHHhhhcCHHHHHHHHHHHHH
Q 010489 419 QPISKLEFEFERRKLAKDDVREMIYREIL 447 (509)
Q Consensus 419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (509)
.+.. -+...+.+....+++++.+++++.
T Consensus 334 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 361 (364)
T cd07875 334 PPKI-PDKQLDEREHTIEEWKELIYKEVM 361 (364)
T ss_pred CCCC-CCccchhhhccHHHHHHHHHHHHH
Confidence 2211 122234455667778877777764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-50 Score=404.16 Aligned_cols=332 Identities=51% Similarity=0.887 Sum_probs=270.3
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||+|+||.||+|.+..+|+.||||+++.. ........+.+|+.+++.++||||+++++++..........
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 46899999999999999999999999999999998642 22234566788999999999999999999887665555567
Q ss_pred EEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 192 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
+|+|+||++++|.+++.. ..+++..++.++.|+++||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 161 (336)
T cd07849 83 VYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161 (336)
T ss_pred EEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence 899999999999887754 5799999999999999999999999999999999999999999999999999976543322
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
.........||+.|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+...+...+...++.+..+.+..+...
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 162 HTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred ccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence 22223446889999999987542 56889999999999999999999999999988889999999999988888777666
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCCCCccchhHHhh
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERR 431 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (509)
....++.........++....+..++++.+||.+||+.||++|||+.++++||||+.+.++..++..+....++++.. +
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~-~ 319 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELF-D 319 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCCChhhccc-c
Confidence 666665555444444444445667889999999999999999999999999999999888766665544444444333 4
Q ss_pred hcCHHHHHHHHHHHHH
Q 010489 432 KLAKDDVREMIYREIL 447 (509)
Q Consensus 432 ~~~~~~~~~~~~~~~~ 447 (509)
.+.++..++.|..++.
T Consensus 320 ~~~~~~~~~~~~~~~~ 335 (336)
T cd07849 320 DLPKEKLKELIFEEIM 335 (336)
T ss_pred ccCHHHHHHHHHHHhc
Confidence 4557777777776653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=408.77 Aligned_cols=257 Identities=31% Similarity=0.525 Sum_probs=220.9
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
....|...++||+|+.|.||.|....+++.||||.+..... ...+-++.|+.+|+..+|+|||.+++.|+.. .
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q--~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----d 343 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ--PKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----D 343 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC--CchhhhHHHHHHHHhccchHHHHHHHHhccc-----c
Confidence 35679999999999999999999999999999999965322 2345678999999999999999999988655 4
Q ss_pred cEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|+|||||+| +|.+++. ...++|.++..|++++++||+|||.+||+|||||.+|||++.+|.+||+|||+|......
T Consensus 344 eLWVVMEym~ggsLTDvVt-~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 344 ELWVVMEYMEGGSLTDVVT-KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred eeEEEEeecCCCchhhhhh-cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 59999999995 6666664 446999999999999999999999999999999999999999999999999999887655
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
..+ ..+.+|||+|||||++.. ..|++++||||||++++||+-|++||-.++....+.+|..- |+|.
T Consensus 423 ~~K---R~TmVGTPYWMAPEVvtr--k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~-------- 488 (550)
T KOG0578|consen 423 QSK---RSTMVGTPYWMAPEVVTR--KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPK-------- 488 (550)
T ss_pred cCc---cccccCCCCccchhhhhh--cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCC--------
Confidence 543 467899999999999987 79999999999999999999999999888877666665431 2221
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
-.....++++++|||.+||+.|+.+|++|.|+|+||||+.
T Consensus 489 -------------------lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 489 -------------------LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred -------------------cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 1223468999999999999999999999999999999953
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=417.48 Aligned_cols=285 Identities=27% Similarity=0.437 Sum_probs=224.6
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCC------CcceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP------DIVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~------niv~~~~~~~~~~ 185 (509)
.++|+++++||+|+||+||+|.+..+++.||||+++... ........|+.+++.++|. +++.+++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~- 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE- 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-
Confidence 468999999999999999999999999999999996421 2233456688888777654 478888877432
Q ss_pred cCCCCcEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhh-CCeeecCCCCCcEEECCCC-----------
Q 010489 186 RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADC----------- 253 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDlKp~NILl~~~~----------- 253 (509)
..++|+|||+++++|.+++...+.+++..++.|+.||+.||+|||+ .|||||||||+|||++.++
T Consensus 204 ---~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 204 ---TGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred ---CceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 3468999999999999999888899999999999999999999998 5999999999999998765
Q ss_pred -----CeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHh
Q 010489 254 -----KLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH 328 (509)
Q Consensus 254 -----~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 328 (509)
.+||+|||++..... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~------~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERH------SRTAIVSTRHYRSPEVVLG--LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred CCCCceEEECCCCccccCcc------ccccccCCccccCcHHhhc--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 499999998864211 1245689999999999987 689999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCC----CC-----CCC--CCCCHHHHHHHHHhccCCCCCCCCH
Q 010489 329 QLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVP----FS-----HKF--PNADPLALHLLERLLAFDPKDRPTA 397 (509)
Q Consensus 329 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~-----~~~--~~~~~~~~~li~~~L~~dP~~Rpt~ 397 (509)
++..+...+|.++.+............+........+.. +. ... ...++.+.|||.+||.+||++|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 999999999988776554332222222222111111000 00 000 0125678899999999999999999
Q ss_pred HHHhcCCcccCCcC
Q 010489 398 EEALADPYFHGLAN 411 (509)
Q Consensus 398 ~e~l~hp~f~~~~~ 411 (509)
+|+|+||||..+..
T Consensus 433 ~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 433 RQMTTHPYVLKYYP 446 (467)
T ss_pred HHHhcCccccccCC
Confidence 99999999987654
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-51 Score=413.25 Aligned_cols=262 Identities=25% Similarity=0.424 Sum_probs=224.3
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCc-ccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~ 188 (509)
...+|+++++||+|+||+|++|..+.+++.||||++++. .-...+......|.+|+.... ||.++.++.+|.+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT----- 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT----- 440 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc-----
Confidence 356899999999999999999999999999999999764 334456788889999998875 9999999999954
Q ss_pred CCcEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 189 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 189 ~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
..++|+||||+.|+..-.++..+.|++..+..|+..|+.||.|||++||||||||.+|||+|.+|++||+|||+++....
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred CCeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 45699999999964344555667899999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... ..+++||||.|||||++.+ ..|+.++|+|||||+|||||.|..||+|++..+..+.|..-
T Consensus 521 ~g~---~TsTfCGTpey~aPEil~e--~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d------------ 583 (694)
T KOG0694|consen 521 QGD---RTSTFCGTPEFLAPEVLTE--QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND------------ 583 (694)
T ss_pred CCC---ccccccCChhhcChhhhcc--CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------
Confidence 332 2467899999999999998 79999999999999999999999999999987777666431
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCcCCC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLANVD 413 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~f~~~~~~~ 413 (509)
... ....++.++.++|+++|++||++|.. +++|.+||||+.+.+.+
T Consensus 584 --------------~~~-----yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~ 634 (694)
T KOG0694|consen 584 --------------EVR-----YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDD 634 (694)
T ss_pred --------------CCC-----CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHH
Confidence 000 11247889999999999999999986 58999999999887753
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-51 Score=350.21 Aligned_cols=284 Identities=38% Similarity=0.652 Sum_probs=238.2
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
.|.-.++||+|.||+|++|+++.+++.||+|.++-...+...-...++||.+|+.++|.|||+++++.. ..+.+.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh-----sdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc-----cCceeE
Confidence 466788999999999999999999999999999754444445567899999999999999999999984 445699
Q ss_pred EEEecccccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCC
Q 010489 194 VVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (509)
Q Consensus 194 lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 272 (509)
+|+|||..+|..++.. ++.++.+.++.++.|+++||.|+|++++.||||||.|+||+.+|++||+|||+++...-..
T Consensus 78 lvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv-- 155 (292)
T KOG0662|consen 78 LVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-- 155 (292)
T ss_pred EeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--
Confidence 9999999999998865 5789999999999999999999999999999999999999999999999999998653221
Q ss_pred cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
..++..+.|.||++|.++.+. .-|+...|+||.|||+.|+.. |++.|+|.+..+|+..|.+++|+|.++.+..+..-
T Consensus 156 -rcysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 156 -RCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred -EeeeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 123455789999999998873 679999999999999999986 88999999999999999999999999877654321
Q ss_pred HHHHhhhccCC-CCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 352 KARRYLGSMRK-KQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 352 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
. .|. ..+- .....|+...|.++..-+||++++|.-+|.+|++++++|+||||...
T Consensus 234 p--dyk-~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 234 P--DYK-PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred C--CCc-ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 1 000 0000 11123445556777788999999999999999999999999999764
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=391.96 Aligned_cols=269 Identities=28% Similarity=0.433 Sum_probs=218.2
Q ss_pred cCCCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc------------ChhhHHhHHHHHHHHHHcCCCCcce
Q 010489 109 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE------------HVSDATRILREIKLLRLLRHPDIVE 176 (509)
Q Consensus 109 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~------------~~~~~~~~~~Ei~~l~~l~h~niv~ 176 (509)
....+.|++++.||+|.||.|.+|++..+++.||||++.+... .....+++.+||.||++|.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 3446789999999999999999999999999999999964211 1112357889999999999999999
Q ss_pred eeeeecCCCcCCCCcEEEEEecccccHHHHHHhCCC-CCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCe
Q 010489 177 IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 255 (509)
Q Consensus 177 ~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~-l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~v 255 (509)
++++.-++. ..++|||+|||...-..+....+. +++.+++.|+++++.||+|||.+|||||||||+|+||+++|+|
T Consensus 173 LiEvLDDP~---s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 173 LIEVLDDPE---SDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEEeecCcc---cCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcE
Confidence 999986654 367999999999544445545555 9999999999999999999999999999999999999999999
Q ss_pred EEeeecccccccCC--CCCccccccccccccccccccccccc--CCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHH
Q 010489 256 KICDFGLARVSFND--APSAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD 331 (509)
Q Consensus 256 kl~DFG~a~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 331 (509)
||+|||.+...... ......+...+|||.|+|||.+.+.. ...+.+.||||+||+||.|+.|+.||-+....+..+
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~ 329 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD 329 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence 99999998754221 12222344579999999999987631 234678999999999999999999999888776666
Q ss_pred HHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 332 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 332 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
+|... |..+ ...+.+..+++|||.+||.+||++|++..++..|||...-
T Consensus 330 KIvn~----------------------------pL~f-P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 330 KIVND----------------------------PLEF-PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHhcC----------------------------cccC-CCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 65321 1111 1223567889999999999999999999999999999654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=390.32 Aligned_cols=264 Identities=30% Similarity=0.453 Sum_probs=211.3
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
..+|..++.||+|+||.||++.+..+|..+|||.+... +....+.+.+|+.+|++++|||||++++....... ..
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~ 90 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DE 90 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---ee
Confidence 34678889999999999999999999999999998653 11226678999999999999999999986432221 36
Q ss_pred EEEEEeccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC-CCCeEEeeecccccccC
Q 010489 192 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVSFN 268 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~-~~~vkl~DFG~a~~~~~ 268 (509)
++|.|||+. |+|.+++...+ .|++..++.+..||++||+|||++||+||||||+|||++. +|.+||+|||++.....
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 899999999 69999999877 7999999999999999999999999999999999999999 79999999999987653
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCC-ChHhHHHHHHHhcCCCChhHHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK-NVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
............||+.|||||++.. .....+++|||||||++.||+||++||... .....+-.+.
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~-g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig------------- 236 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRN-GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIG------------- 236 (313)
T ss_pred ccccccccccccCCccccCchhhcC-CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHh-------------
Confidence 1222122345799999999999984 123345999999999999999999999763 2111111110
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
.....| .....+++++++||.+||.+||++||||+++|+|||.++..
T Consensus 237 ------------~~~~~P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 237 ------------REDSLP----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred ------------ccCCCC----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 001111 22245889999999999999999999999999999997643
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-49 Score=399.57 Aligned_cols=292 Identities=38% Similarity=0.688 Sum_probs=236.5
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc-CCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~-~~~~ 190 (509)
.++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++..... ....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 468999999999999999999999999999999997654445556778899999999999999999998865432 2345
Q ss_pred cEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.+|+||||+++++.+.+.. .+++..+..++.|+++||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 96 ~~~lv~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 173 (355)
T cd07874 96 DVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173 (355)
T ss_pred eeEEEhhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCcc
Confidence 6899999999998887754 48899999999999999999999999999999999999999999999999997543221
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+..+.......
T Consensus 174 ----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 174 ----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred ----ccCCccccCCccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 1244689999999999877 6789999999999999999999999999998888888888888888776655432
Q ss_pred HHHHHhhhccCCCCCCCC-----------C-CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCC
Q 010489 351 EKARRYLGSMRKKQPVPF-----------S-HKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~-----------~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 412 (509)
. ...+....+......+ . ......+..+++||.+||..||++|||+.|+|+||||..+.+.
T Consensus 248 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~ 320 (355)
T cd07874 248 T-VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP 320 (355)
T ss_pred H-HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence 2 2222221111110000 0 1112245678999999999999999999999999999866543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=411.27 Aligned_cols=287 Identities=34% Similarity=0.617 Sum_probs=229.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc---CC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR---RE 188 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~---~~ 188 (509)
..+|++++.||+|+||.||+|.+..+++.||||++... .....+|+.+|+.++||||+++++++..... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC------cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 35799999999999999999999999999999988532 1223579999999999999999988754432 22
Q ss_pred CCcEEEEEecccccHHHHHH----hCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCC-CeEEeeeccc
Q 010489 189 FKDIYVVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLA 263 (509)
Q Consensus 189 ~~~~~lv~e~~~~~L~~~l~----~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~-~vkl~DFG~a 263 (509)
...+++||||++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|
T Consensus 139 ~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 139 NIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred ceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 23578999999998877764 345799999999999999999999999999999999999999665 6999999999
Q ss_pred ccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChh
Q 010489 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (509)
+....... ....+||+.|+|||++.+. ..|+.++|||||||++|||++|.+||.+.+..+++..+...+|.|..+
T Consensus 219 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 219 KNLLAGQR----SVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred hhccCCCC----cccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 86533221 2346889999999987652 468999999999999999999999999999999999999999998877
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCC-CCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCC
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 412 (509)
.+.......... .++...+..+...++ ..++++++||.+||++||.+|||+.|+|+||||+.+.+.
T Consensus 294 ~~~~~~~~~~~~---~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~ 360 (440)
T PTZ00036 294 QLKEMNPNYADI---KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP 360 (440)
T ss_pred HHHHhchhhhcc---cCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence 665432211000 011111111222222 467899999999999999999999999999999887653
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=395.10 Aligned_cols=289 Identities=34% Similarity=0.603 Sum_probs=224.9
Q ss_pred CCCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 110 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 110 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
+..++|++.+.||+|+||.||+|.+..+++.||||+++.... ......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 75 (303)
T cd07869 2 GKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTK----- 75 (303)
T ss_pred CccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecC-----
Confidence 456789999999999999999999999999999999864322 12234567899999999999999999998543
Q ss_pred CcEEEEEecccccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 190 KDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 190 ~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
..+|+||||++++|.+++... +.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 76 ETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred CeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 468999999999998888664 5789999999999999999999999999999999999999999999999999875322
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCC-hHhHHHHHHHhcCCCChhHHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN-VVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
... ......||+.|+|||++.+. ..++.++|||||||++|||++|..||.+.. ..+.+..+...++.+....+..
T Consensus 156 ~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 156 PSH---TYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred CCc---cCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccc
Confidence 111 12445789999999988652 468889999999999999999999998754 3456677777777776554433
Q ss_pred hhhHHHHHhh-hccCCCCCCCCCCCCC--CCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 348 IRNEKARRYL-GSMRKKQPVPFSHKFP--NADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 348 ~~~~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
..... .+. ..+....+..+...+. ..++.+.+||.+||+.||++|||+.|+|+||||+++.
T Consensus 232 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 232 VHSLP--HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred hhhcc--ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 21100 000 0000001111111111 2457899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=390.63 Aligned_cols=284 Identities=36% Similarity=0.601 Sum_probs=227.8
Q ss_pred CCeeEeeeeeccCceEEEEEEEcC-CCcEEEEEEecCcccChhhHHhHHHHHHHHHHc---CCCCcceeeeeecCCCcCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTH-TGERVAIKKINDVFEHVSDATRILREIKLLRLL---RHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~niv~~~~~~~~~~~~~ 188 (509)
.+|++.+.||+|+||.||+|++.. ++..||+|+++.............+|+.+++.+ .||||+++++++.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 379999999999999999999854 578899999865433333344566788877766 6999999999986544344
Q ss_pred CCcEEEEEecccccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 189 FKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 189 ~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
...+++||||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 5679999999999999988754 35899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+..+....+.+..+.+.
T Consensus 161 ~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 161 SFQM----ALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred cCCc----ccccccccccccChHHHhC--CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 3321 1244579999999999876 678999999999999999999999999999888888888888877655432
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
...... ...+....+.++....+.+++.+.+||.+||+.||++|||+.++|+||||
T Consensus 235 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALP----RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhccc----chhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 211000 00111222333334446788899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=380.38 Aligned_cols=265 Identities=27% Similarity=0.404 Sum_probs=221.5
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++++.||.|.-|+||+|..+.++..+|+|++.+... ......++..|-.||+.+.||.++.+|..| +...
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~~ 150 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETDK 150 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----eccc
Confidence 4678999999999999999999999999999999975432 234456788899999999999999999999 4456
Q ss_pred cEEEEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 191 DIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
+.|+|||||. |+|+.+.+++ +.|++..+++++.+++-||+|||-.|||+||||||||||.++|+|.|+||.|+....
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 6999999999 5899888765 479999999999999999999999999999999999999999999999999874320
Q ss_pred C---------------------------------C-C-------------------CCcccccccccccccccccccccc
Q 010489 268 N---------------------------------D-A-------------------PSAIFWTDYVATRWYRAPELCGSF 294 (509)
Q Consensus 268 ~---------------------------------~-~-------------------~~~~~~~~~~gt~~y~aPE~~~~~ 294 (509)
. . . +......+++||-.|.|||++.|
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G- 309 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG- 309 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-
Confidence 0 0 0 00011235799999999999999
Q ss_pred cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCC
Q 010489 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPN 374 (509)
Q Consensus 295 ~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (509)
...+.++|||+|||++||||.|..||.|.+..+.+..|+. . +..+.. .+.
T Consensus 310 -~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~---~-------------------------~l~Fp~-~~~ 359 (459)
T KOG0610|consen 310 -EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG---Q-------------------------PLKFPE-EPE 359 (459)
T ss_pred -CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc---C-------------------------CCcCCC-CCc
Confidence 7899999999999999999999999999987666655432 1 111111 125
Q ss_pred CCHHHHHHHHHhccCCCCCCCC----HHHHhcCCcccCCcCC
Q 010489 375 ADPLALHLLERLLAFDPKDRPT----AEEALADPYFHGLANV 412 (509)
Q Consensus 375 ~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~ 412 (509)
++..++|||+++|.+||.+|.. |+||.+||||+++.+.
T Consensus 360 vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 360 VSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred chhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 6788999999999999999998 9999999999999875
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=389.78 Aligned_cols=285 Identities=34% Similarity=0.644 Sum_probs=225.2
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++.+.||+|+||.||+|+++.+++.||+|+++...........+.+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-----RGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-----CCEE
Confidence 37999999999999999999999999999999987543333445677899999999999999999998843 3568
Q ss_pred EEEEecccccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 193 YVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 193 ~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
|+||||+++++.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99999999876665544 45799999999999999999999999999999999999999999999999999986532221
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|++||++.+..+.+..+....+..+...+......
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 156 A--NYTEYVATRWYRSPELLLG--APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred c--cccccccccccCCcHHHcC--CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence 1 1234679999999999877 67899999999999999999999999998888887778877777665544322111
Q ss_pred HHHHhhhccCCCCCCCC-CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 352 KARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
.............+... ......+++++.+||.+||++||++|||++++|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00000000000000000 11123468889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=375.46 Aligned_cols=329 Identities=37% Similarity=0.690 Sum_probs=274.3
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc-CCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~-~~~~ 190 (509)
..||.-++.+|.|+- .|..|.+.-.++.||+|++...+......++..+|..++..+.|+||++++.+|..... .++.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 468999999999998 88889999999999999987777777778899999999999999999999999976532 4467
Q ss_pred cEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.+|+|||||..+|.+.+. -.++...+.+|++|++.|++|||+.||+||||||+||+++.++.+||.|||+|+....+
T Consensus 95 e~y~v~e~m~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~- 171 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD- 171 (369)
T ss_pred hHHHHHHhhhhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc-
Confidence 799999999999999887 35788899999999999999999999999999999999999999999999999854222
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
...+.++.|+.|+|||++.+ ..|.+.+||||+|||+.||++|...|+|++..+|..++...+|+|....+..+..
T Consensus 172 ---~~mtpyVvtRyyrapevil~--~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 172 ---FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred ---cccCchhheeeccCchheec--cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 35688999999999999988 4599999999999999999999999999999999999999999999998877653
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCC------------CCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCC
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPN------------ADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPST 418 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~ 418 (509)
..+.++...++.....++..+|+ -+..+++|+.+||..||++|.+++++|+||||+-+... .++..
T Consensus 247 -~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~-~ev~a 324 (369)
T KOG0665|consen 247 -TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDP-DEVEA 324 (369)
T ss_pred -HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeeccc-ccccC
Confidence 34445444444333444333332 24568999999999999999999999999999944332 23333
Q ss_pred CCCCccchhHHhhhcCHHHHHHHHHHHHHHhCh
Q 010489 419 QPISKLEFEFERRKLAKDDVREMIYREILEYHP 451 (509)
Q Consensus 419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p 451 (509)
++.......++.+....++++++|++|+.++.+
T Consensus 325 p~pe~~d~~~d~~~~t~~e~ke~If~ev~~f~~ 357 (369)
T KOG0665|consen 325 PPPEIYDKQLDEREHTIEEWKELIFKEVQRFEE 357 (369)
T ss_pred CCCchhhhhcccccCCHHHHHHHHHHHHHhhcc
Confidence 332334445566666799999999999999887
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-49 Score=395.91 Aligned_cols=326 Identities=53% Similarity=0.942 Sum_probs=272.6
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
.+|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+|+.++||||+++++++.... .....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence 6899999999999999999999999999999998754433345667788999999999999999999875543 344678
Q ss_pred EEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCC
Q 010489 193 YVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (509)
Q Consensus 193 ~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 272 (509)
|+||||++++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 84 YVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred EEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 99999999999999988888999999999999999999999999999999999999999999999999999765332211
Q ss_pred -cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 273 -AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 273 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
........|+.+|+|||.+.+. ..++.++|||||||++|||++|++||.+.+...++..+...+|.|+.+.+......
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 1112345889999999987652 46889999999999999999999999999998999999999999999888777766
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCCCCccchhHHhh
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERR 431 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (509)
....+........+.++...++..++.+.++|.+||+.||.+||++++++.||||++......++. ....+++.++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 320 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPT--CPPPFDFDFEAI 320 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCccccc--CCCCCCCChhhh
Confidence 666666666666666666666778999999999999999999999999999999998877666544 345567777777
Q ss_pred hcCHHHHHHHH
Q 010489 432 KLAKDDVREMI 442 (509)
Q Consensus 432 ~~~~~~~~~~~ 442 (509)
....+.+.+.|
T Consensus 321 ~~~~~~~~~~~ 331 (334)
T cd07855 321 ELSREQLKEAI 331 (334)
T ss_pred hcChhhHHHHh
Confidence 66666554433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=402.74 Aligned_cols=284 Identities=26% Similarity=0.377 Sum_probs=221.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
..+|++++.||+|+||.||+|.+..+++.||||+.. ...+.+|+.+|+.++||||+++++++... ..
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~ 157 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYN-----KF 157 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEEC-----Ce
Confidence 357999999999999999999999999999999753 23467899999999999999999998443 45
Q ss_pred EEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 192 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
.++|||++.++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 158 ~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 158 TCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred eEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 89999999999999998888899999999999999999999999999999999999999999999999999975322111
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCC-------hHhHHHHHHHhcCCCChhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN-------VVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~g~~~~~~ 344 (509)
......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.. ...++..+...+|.++.+.
T Consensus 238 --~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 238 --NKYYGWAGTIATNAPELLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred --cccccccCccCCCChhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 11245689999999999877 689999999999999999999998775432 3456777777777655432
Q ss_pred HHHhhhHHHHHhhhccCC--CCC--CCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCC
Q 010489 345 ISRIRNEKARRYLGSMRK--KQP--VPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~--~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 412 (509)
...........+...... ..+ .+.......++.++.+||.+||++||.+|||++|+|+||||+.+..+
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 111000000001010000 001 01011112356789999999999999999999999999999876543
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=388.64 Aligned_cols=290 Identities=37% Similarity=0.656 Sum_probs=236.8
Q ss_pred CCCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 110 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 110 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
+...+|.+.+.||+|+||.||+|++..+++.||+|+++.... ......+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 76 (309)
T cd07872 3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHT-----D 76 (309)
T ss_pred CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEee-----C
Confidence 445789999999999999999999999999999999864322 2223456789999999999999999999854 3
Q ss_pred CcEEEEEecccccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 190 KDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 190 ~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
...|+||||++++|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 77 KSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred CeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 4589999999999988886554 589999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... ......+|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.+..+.+..+
T Consensus 157 ~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 157 PTK---TYSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI 232 (309)
T ss_pred Ccc---ccccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhh
Confidence 221 12345789999999988652 46889999999999999999999999999988899999999999888776654
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
......... ..+...+.++....+.+++++.+||.+||..||.+|||++|+|+||||+.+.
T Consensus 233 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 233 SSNDEFKNY-NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred cchhhhhhh-hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 332211111 1122223333334467889999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-49 Score=393.50 Aligned_cols=329 Identities=57% Similarity=0.968 Sum_probs=276.4
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
+|++.+.||.|+||.||+|.+..+++.||||++..........+.+.+|+.+++.++|+||+++++++..........+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 58999999999999999999998999999999976544345567788999999999999999999998766434455789
Q ss_pred EEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCc
Q 010489 194 VVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273 (509)
Q Consensus 194 lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 273 (509)
+||||++++|.+++.....+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++..........
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~ 160 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccc
Confidence 99999999999999887899999999999999999999999999999999999999999999999999998764433211
Q ss_pred ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHH
Q 010489 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353 (509)
Q Consensus 274 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (509)
.......+|+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+..+.+........
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 161 GFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred ccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 223456789999999998772 3789999999999999999999999999999999999999999998887776666666
Q ss_pred HHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCCCCccchhHHhhhc
Q 010489 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKL 433 (509)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (509)
..++.......+.++....+..++.+.+||.+||++||.+||+++++++||||+++..+..+...+...++. .++..++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 318 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFD-FFDDDEL 318 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCccccc-ccchhhc
Confidence 666666666666666666778899999999999999999999999999999999988877666555444331 2466677
Q ss_pred CHHHHHHHHHH
Q 010489 434 AKDDVREMIYR 444 (509)
Q Consensus 434 ~~~~~~~~~~~ 444 (509)
..++.++.|+.
T Consensus 319 ~~~~~~~~~~~ 329 (330)
T cd07834 319 TEEELKELIYE 329 (330)
T ss_pred CHHHHhHHhhc
Confidence 77777766653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-51 Score=368.98 Aligned_cols=263 Identities=30% Similarity=0.510 Sum_probs=219.6
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-----cCh-hhHHhHHHHHHHHHHc-CCCCcceeeeeecCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-----EHV-SDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~-~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~ 185 (509)
..|.-.+.||+|..++|.+|.++.+|..+|+|++.... ... .-.....+|+.||+++ .||+|+++.+++..++
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 45777899999999999999999999999999985321 111 1234456899999997 4999999999996665
Q ss_pred cCCCCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 186 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
+ +++|+|+|+ |.|++++...-.+++.....|++|+++|++|||..+||||||||+|||++++.++||+|||+|+
T Consensus 97 F-----~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 97 F-----VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred h-----hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceee
Confidence 4 899999999 8999999988899999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccccccccccccccc----cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCC
Q 010489 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340 (509)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~ 340 (509)
....+. .....||||+|.|||.+... ...|+..+|+||+|||||.||.|.+||......-++..|..
T Consensus 172 ~l~~Ge----kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime----- 242 (411)
T KOG0599|consen 172 QLEPGE----KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME----- 242 (411)
T ss_pred ccCCch----hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh-----
Confidence 765443 35778999999999987432 35789999999999999999999999986554444443322
Q ss_pred ChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
.....-+..|.+++..++|||.+||+.||.+|+|++|+|+||||.++..
T Consensus 243 ----------------------GkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~ 291 (411)
T KOG0599|consen 243 ----------------------GKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ 291 (411)
T ss_pred ----------------------cccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence 1111223456778899999999999999999999999999999976544
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=384.10 Aligned_cols=283 Identities=35% Similarity=0.611 Sum_probs=226.5
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc---CCCCcceeeeeecCCCcCCCC
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL---RHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~niv~~~~~~~~~~~~~~~ 190 (509)
+|++.+.||+|+||.||+|.++.+++.||+|.++...........+.+|+.+++.+ .||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 58999999999999999999999999999999875333222234456777777665 699999999998655444456
Q ss_pred cEEEEEecccccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 191 DIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
.+++||||+.++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 68999999999999888764 3589999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+....+.+..+....+.+....+...
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 161 QMA----LTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred ccc----CCCccccccccCchHhhC--CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 221 234578999999999876 67899999999999999999999999998888888888877776655433211
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
.... ...+....+.++....+.++..+.+||.+||++||++|||+.+++.||||
T Consensus 235 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLP----RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccc----ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0000 00111122223334456778899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=390.26 Aligned_cols=329 Identities=45% Similarity=0.845 Sum_probs=276.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc-CCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~-~~~~ 190 (509)
.++|++.+.||+|+||.||+|++..+++.||||++............+.+|+.+++.+.||||+++.+++..... ....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 468999999999999999999999999999999986543334455677899999999999999999987755432 3345
Q ss_pred cEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.+|+|+||++++|.+++.. ..+++..+..++.||++||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 94 ~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~- 171 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE- 171 (343)
T ss_pred cEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc-
Confidence 6899999999999988865 57999999999999999999999999999999999999999999999999999764322
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
.....++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+....+.+....+.++..
T Consensus 172 -----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 172 -----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred -----ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence 2345789999999987652 3678899999999999999999999999988888888888888888888887777
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCCCCccchhHHh
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFER 430 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 430 (509)
.....++..........+...+...++.+.+||.+||..||++|||+.++++||||+.+.....++. .......++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~---~~~~~~~~~~ 322 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPV---APPYDQSFES 322 (343)
T ss_pred hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccccc---ccccCcchhh
Confidence 7666676665555555555555667899999999999999999999999999999998877655443 2234466788
Q ss_pred hhcCHHHHHHHHHHHHHHhCh
Q 010489 431 RKLAKDDVREMIYREILEYHP 451 (509)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~p 451 (509)
..+..+++++.++.++..+.|
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07851 323 RDLTVDEWKELVYKEIMNFKP 343 (343)
T ss_pred hhcCHHHHHHHhHHHHHhccC
Confidence 889999999999999988765
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=389.52 Aligned_cols=259 Identities=32% Similarity=0.528 Sum_probs=222.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~ 189 (509)
...|++.+.||+|.||+||+|+++.+|+.||+|++.+... .......+.+|+.+|+++. |||||.++++|.+.
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~----- 108 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP----- 108 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC-----
Confidence 4579999999999999999999999999999999975433 2234567889999999998 99999999999544
Q ss_pred CcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC----CCeEEeeecccc
Q 010489 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD----CKLKICDFGLAR 264 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~----~~vkl~DFG~a~ 264 (509)
..+|+|||+|. |+|++.+... .+++..+..++.|++.|++|||+.||+||||||+|+|+... +.+|++|||+|.
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 46999999999 6899998776 49999999999999999999999999999999999998654 479999999998
Q ss_pred cccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
.... .......+||+.|+|||++.. ..|+..+||||+||++|.|++|.+||.+.+.......|..
T Consensus 188 ~~~~----~~~~~~~~Gtp~y~APEvl~~--~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~--------- 252 (382)
T KOG0032|consen 188 FIKP----GERLHTIVGTPEYVAPEVLGG--RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR--------- 252 (382)
T ss_pred EccC----CceEeeecCCccccCchhhcC--CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc---------
Confidence 7654 223567899999999999987 6899999999999999999999999999886444433221
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.........|+.++..+.+||.+||..||.+|+|+.++|+|||++..
T Consensus 253 ------------------~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 253 ------------------GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred ------------------CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 11222345678899999999999999999999999999999999875
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-48 Score=388.15 Aligned_cols=254 Identities=26% Similarity=0.436 Sum_probs=213.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
..+|++.+.||+|+||.||+|++..+++.||||+++... ........+.+|+.+++.++||||+++++++.. ..
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-----EN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-----CC
Confidence 467999999999999999999999999999999986421 122345668899999999999999999999854 34
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|+||||+. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 6899999998 589999988889999999999999999999999999999999999999999999999999999765322
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
. ...+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+.......+..
T Consensus 172 ~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~-------------- 229 (329)
T PTZ00263 172 T------FTLCGTPEYLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA-------------- 229 (329)
T ss_pred c------ceecCChhhcCHHHHcC--CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc--------------
Confidence 1 23579999999999887 6789999999999999999999999987664333222211
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGL 409 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~f~~~ 409 (509)
...+ + ...+++.+.+||.+||+.||.+||+ +++++.||||++.
T Consensus 230 ------------~~~~--~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 230 ------------GRLK--F---PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred ------------CCcC--C---CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 0000 0 1236788999999999999999997 7999999999864
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=387.24 Aligned_cols=324 Identities=39% Similarity=0.691 Sum_probs=252.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc-CCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~-~~~~ 190 (509)
..+|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++..... .+..
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 468999999999999999999999999999999987544444455677899999999999999999998865432 3345
Q ss_pred cEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
..|+||||+.++|.+.+... +++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 172 (353)
T cd07850 95 DVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 172 (353)
T ss_pred cEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC
Confidence 68999999999999888654 8999999999999999999999999999999999999999999999999997643222
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
. .....|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+...+|.|..+....+..
T Consensus 173 ~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T cd07850 173 M----MTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246 (353)
T ss_pred C----CCCCcccccccCHHHHhC--CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 1 234578999999999877 6889999999999999999999999999998888888989999988876555432
Q ss_pred HHHHHhhhccCCCCCCCCCCC-------------CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCC
Q 010489 351 EKARRYLGSMRKKQPVPFSHK-------------FPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPS 417 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~ 417 (509)
.. ..+..........++... ....++.+.+||.+||..||++|||+.|+|+||||+.+.+......
T Consensus 247 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~~~~ 325 (353)
T cd07850 247 TV-RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEVEA 325 (353)
T ss_pred hh-hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCccCCC
Confidence 21 122221111111111111 1234667899999999999999999999999999987666433222
Q ss_pred CCCCCccchhHHhhhcCHHHHHHHHHHH
Q 010489 418 TQPISKLEFEFERRKLAKDDVREMIYRE 445 (509)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (509)
..+ ...+...+.+....++++..++.+
T Consensus 326 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T cd07850 326 PPP-APYDHSIDEREHTVEEWKELIYKE 352 (353)
T ss_pred CCC-CccccccccccccHHHHHHHHHhh
Confidence 222 223333456666677777766654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=387.71 Aligned_cols=251 Identities=26% Similarity=0.448 Sum_probs=208.8
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEe
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 197 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 197 (509)
+.||+|+||.||+|.+..+|+.||||+++... ........+.+|+.+++.++||||+++++++.. ...+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-----HDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-----CCEEEEEEe
Confidence 46999999999999999999999999987432 122345667899999999999999999998843 456999999
Q ss_pred ccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCcccc
Q 010489 198 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276 (509)
Q Consensus 198 ~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 276 (509)
|++ ++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---~~ 152 (323)
T cd05571 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA---TM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC---cc
Confidence 998 58999998888999999999999999999999999999999999999999999999999999875322211 12
Q ss_pred cccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHh
Q 010489 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 356 (509)
Q Consensus 277 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (509)
...+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--------------------- 209 (323)
T cd05571 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------------- 209 (323)
T ss_pred cceecCccccChhhhcC--CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc---------------------
Confidence 45689999999999977 6899999999999999999999999987664333222210
Q ss_pred hhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCc
Q 010489 357 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (509)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~ 410 (509)
... . ....+++++.+||.+||..||++|| ++.++++||||+++.
T Consensus 210 -----~~~--~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~ 258 (323)
T cd05571 210 -----EEI--R---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN 258 (323)
T ss_pred -----CCC--C---CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 000 0 1134688999999999999999999 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=383.06 Aligned_cols=254 Identities=24% Similarity=0.399 Sum_probs=212.4
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|++.+.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++. +...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH-----DQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc-----cCCe
Confidence 36999999999999999999999999999999986421 12234556789999999999999999998874 3456
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|+||||+. ++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 899999998 5899999888899999999999999999999999999999999999999999999999999997653221
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 156 ------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-------------- 213 (291)
T cd05612 156 ------WTLCGTPEYLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-------------- 213 (291)
T ss_pred ------ccccCChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 23579999999999877 67899999999999999999999999876643333222110
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCc
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLA 410 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~f~~~~ 410 (509)
. ..+ ....++.+++||++||+.||.+||+ ++++++||||..+.
T Consensus 214 ------------~--~~~---~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 214 ------------K--LEF---PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD 261 (291)
T ss_pred ------------C--cCC---CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence 0 001 1235788999999999999999995 99999999997654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=354.80 Aligned_cols=256 Identities=26% Similarity=0.401 Sum_probs=220.3
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCc-ccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
..++|++++.||+|-||.||+|+.+.++..||+|++.+. ........++.+|++|-..|+||||++++++|.+.
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~----- 94 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS----- 94 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc-----
Confidence 457899999999999999999999999999999998542 22333456788999999999999999999999554
Q ss_pred CcEEEEEeccc-ccHHHHHH--hCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 190 KDIYVVFELME-SDLHQVIK--ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~--~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
..+|+++||.. |+++..+. ...++++..+..+++|++.||.|+|.++|+||||||+|+|++.+|.+||+|||.+...
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 45999999998 79999998 5668999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
.. ....+.|||..|.+||...+ ..++..+|+|++|++.||++.|.+||...+..+....|.++-
T Consensus 175 p~-----~kR~tlcgt~dyl~pEmv~~--~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~--------- 238 (281)
T KOG0580|consen 175 PS-----NKRKTLCGTLDYLPPEMVEG--RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD--------- 238 (281)
T ss_pred CC-----CCceeeecccccCCHhhcCC--CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc---------
Confidence 31 12356899999999999988 789999999999999999999999998877655555443321
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
-..| +.++.++.|||.+||.++|.+|.+..|++.|||+...
T Consensus 239 ---------------~~~p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 239 ---------------LKFP-------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred ---------------ccCC-------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 0001 3578899999999999999999999999999998653
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=383.35 Aligned_cols=330 Identities=41% Similarity=0.762 Sum_probs=269.9
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc-CCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REF 189 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~-~~~ 189 (509)
..++|++.+.||+|+||.||+|.+..++..||||++............+.+|+.+|+.++||||+++++++..... ...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 3568999999999999999999999999999999986543333345568899999999999999999998865432 223
Q ss_pred CcEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 190 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 190 ~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
..+|+||||++++|.+++.. ..+++..+..++.||++||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 93 ~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 93 HDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171 (343)
T ss_pred ceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence 45799999998888887764 57999999999999999999999999999999999999999999999999999754221
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
.....+++.|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.+.......+....+.++.+....+.
T Consensus 172 ------~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 172 ------MTGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred ------ccccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 1345789999999988652 357889999999999999999999999888877777777777777777666666
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCCCCccchhHH
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFE 429 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 429 (509)
......+...++...+..+....+.+++.+.++|.+||..||++|||+.++++||||+.......++ ....+...++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~---~~~~~~~~~~ 321 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDET---EAPPYDDSFD 321 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccccc---CCCCccccHH
Confidence 5555555555544444444445567889999999999999999999999999999999887654443 2234666678
Q ss_pred hhhcCHHHHHHHHHHHHHHhCh
Q 010489 430 RRKLAKDDVREMIYREILEYHP 451 (509)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~p 451 (509)
+.....++++.....+++.+.|
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07880 322 EVDQSLEEWKRLTFTEILSFQP 343 (343)
T ss_pred hhccchHHHHHHHHHHHHhcCC
Confidence 8888899999999999988765
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-47 Score=382.88 Aligned_cols=329 Identities=44% Similarity=0.828 Sum_probs=268.8
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc-CCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~-~~~~ 190 (509)
.++|.+.+.||+|+||.||+|.+..+++.||+|++............+.+|+.++++++||||+++++++..... ....
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 478999999999999999999999999999999997543333445677899999999999999999998854321 2334
Q ss_pred cEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.+|+++++++++|.+++.. ..+++..++.++.||++||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~lv~~~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~- 173 (345)
T cd07877 96 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE- 173 (345)
T ss_pred cEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccccc-
Confidence 5899999998899887754 46999999999999999999999999999999999999999999999999998754221
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
.....|++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.+.......+..
T Consensus 174 -----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 174 -----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred -----ccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 2345789999999987652 4678899999999999999999999999888888888888888888877766665
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCCCCccchhHHh
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFER 430 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 430 (509)
.....++..+.......+...+...++.+.+||.+||..||.+||++.++++||||+++..+...+... ..+..++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~~---~~~~~~~~ 324 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD---PYDQSFES 324 (345)
T ss_pred HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccccCC---CccCcchh
Confidence 555555555544444444444456788999999999999999999999999999999887766555322 34555566
Q ss_pred hhcCHHHHHHHHHHHHHHhCh
Q 010489 431 RKLAKDDVREMIYREILEYHP 451 (509)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~p 451 (509)
+.+..+++....|+++..+.|
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~ 345 (345)
T cd07877 325 RDLLIDEWKSLTYDEVISFVP 345 (345)
T ss_pred cccCHHHHHHHHHHHHHhcCC
Confidence 677778888889988877655
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=374.36 Aligned_cols=254 Identities=28% Similarity=0.514 Sum_probs=220.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecC-cccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIND-VFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~-~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.-+|++.+.||+|.||.|.+|.+...|+.||||.|++ ...+..+.-.+.+||+||..|+||||+.++++|. ...
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFE-----Nkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE-----NKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhc-----CCc
Confidence 3589999999999999999999999999999999864 3455667788999999999999999999999994 445
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+.|||||.. |+|++++...+.|++.++..|++||+.|+.|||.++++|||||.+|||+|.++++||+|||++..+..+
T Consensus 127 KIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred eEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 6999999998 799999999999999999999999999999999999999999999999999999999999999876433
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
. ++.++||+|.|.+||++.+. ..-++.+|.|||||+||.|+.|..||.|.+....+.+|...-
T Consensus 207 k----fLqTFCGSPLYASPEIvNG~-PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga------------ 269 (668)
T KOG0611|consen 207 K----FLQTFCGSPLYASPEIVNGT-PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA------------ 269 (668)
T ss_pred c----HHHHhcCCcccCCccccCCC-CCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc------------
Confidence 2 46789999999999999883 334689999999999999999999999988755554443210
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 407 (509)
. ..|..+..+.-||+.||..||++|.|++++-.|=|+.
T Consensus 270 ------------Y--------rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 270 ------------Y--------REPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred ------------c--------cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 0 0123455688999999999999999999999997764
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-50 Score=385.20 Aligned_cols=255 Identities=29% Similarity=0.460 Sum_probs=221.5
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
..|..++.||+|+||.||+|.+..+++.||||++.-. ....+...+.+|+.+|..++++||.++|+.++.+. .+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le-~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~-----~L 86 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE-EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT-----KL 86 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechh-hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc-----cH
Confidence 3578889999999999999999999999999999743 22345677889999999999999999999997665 48
Q ss_pred EEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
+++||||. |++.+++.....+.+..+..++++++.||.|||..+.+|||||+.|||+..+|.+||+|||.+........
T Consensus 87 wiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999 58899998888889999999999999999999999999999999999999999999999999987654433
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
. ..+++|||.|||||++.+ ..|+.|+||||||++.+||++|.+||.....
T Consensus 167 r---r~tfvGTPfwMAPEVI~~--~~Y~~KADIWSLGITaiEla~GePP~s~~hP------------------------- 216 (467)
T KOG0201|consen 167 R---RKTFVGTPFWMAPEVIKQ--SGYDTKADIWSLGITAIELAKGEPPHSKLHP------------------------- 216 (467)
T ss_pred c---cccccccccccchhhhcc--ccccchhhhhhhhHHHHHHhcCCCCCcccCc-------------------------
Confidence 2 267899999999999986 7999999999999999999999999987553
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
.+++..+++..|..+.. ..++.+++|+..||.+||+.||+|.++|+|+|++.
T Consensus 217 --mrvlflIpk~~PP~L~~---~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 217 --MRVLFLIPKSAPPRLDG---DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred --ceEEEeccCCCCCcccc---ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 12333445555554444 56888999999999999999999999999999986
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=381.70 Aligned_cols=281 Identities=36% Similarity=0.610 Sum_probs=215.1
Q ss_pred eeeeeccCceEEEEEEEc--CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEE
Q 010489 118 QEVIGKGSYGVVGSAVDT--HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 195 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~--~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 195 (509)
.++||+|+||+||+|+++ .+++.||+|.+.... ....+.+|+.+|+.++||||+++++++.... ...+|++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHA---DRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCC---CcEEEEE
Confidence 468999999999999865 467899999986421 2244678999999999999999999885432 3468999
Q ss_pred EecccccHHHHHHhC---------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEE----CCCCCeEEeeecc
Q 010489 196 FELMESDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFGL 262 (509)
Q Consensus 196 ~e~~~~~L~~~l~~~---------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl----~~~~~vkl~DFG~ 262 (509)
|||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 999999998887532 258999999999999999999999999999999999999 4567899999999
Q ss_pred cccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCCh---------HhHHHHH
Q 010489 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV---------VHQLDLM 333 (509)
Q Consensus 263 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---------~~~~~~i 333 (509)
++...............+||+.|+|||++.+. ..++.++|||||||++|||++|++||.+... .+++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 98654332222223456899999999988762 4689999999999999999999999976442 4667788
Q ss_pred HHhcCCCChhHHHHhhhHH-HHHhhhccCCCCC--C----CCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 334 TDLLGTPSTESISRIRNEK-ARRYLGSMRKKQP--V----PFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 334 ~~~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
...+|.|....+..+.... ....+..+..... . .........+..+.+||.+||++||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 8888888877665543211 0011111110000 0 0011112346779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=383.44 Aligned_cols=262 Identities=24% Similarity=0.458 Sum_probs=216.9
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|++++.||+|+||.||+|++..+++.||||+++.... .......+.+|+.++..++||||+++++++.. ...
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-----DEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-----CCE
Confidence 369999999999999999999999999999999864321 22345668899999999999999999998843 456
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 899999998 58999998888899999999999999999999999999999999999999999999999999975432
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+....+.....
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------------ 215 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE------------ 215 (333)
T ss_pred ----ccCCcccCccccChhHhcC--CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc------------
Confidence 1245689999999999987 6899999999999999999999999988765444433321100
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
.. ..+ ........+++++.+||.+||..+|.+||++.++++||||....
T Consensus 216 --------~~--~~~-~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 216 --------TL--QRP-VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred --------cc--cCC-CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 00 000 00111135688999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-47 Score=381.21 Aligned_cols=328 Identities=42% Similarity=0.773 Sum_probs=260.1
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc-CCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~-~~~~ 190 (509)
..+|.+.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++..... ....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468999999999999999999999999999999987543333334567899999999999999999998865422 2334
Q ss_pred cEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.+|+|+||+..+|..++ ...+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~~~lv~e~~~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~- 170 (342)
T cd07879 94 DFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE- 170 (342)
T ss_pred eEEEEecccccCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-
Confidence 57999999998877765 346899999999999999999999999999999999999999999999999998754211
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
.....+++.|+|||++.+. ..++.++|||||||++|||++|+.||.+.+....+..+....|.+..........
T Consensus 171 -----~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 171 -----MTGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred -----CCCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 2345789999999987652 4588899999999999999999999999888888888888888887776665544
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCCCCccchhHHh
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFER 430 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 430 (509)
.....+....+......+...++..++.+.+||.+||+.||++||++++++.||||+.+.+...+....+ +....+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~~---~~~~~~~ 321 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQP---YDDSLEN 321 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCCc---ccchhhh
Confidence 4334444333333333444455678889999999999999999999999999999998876544433222 3344455
Q ss_pred hhcCHHHHHHHHHHHHHHhCh
Q 010489 431 RKLAKDDVREMIYREILEYHP 451 (509)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~p 451 (509)
.....+++...++.++..+.|
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~ 342 (342)
T cd07879 322 EKLSVDEWKKHIYKEVKSFSP 342 (342)
T ss_pred hhCCHHHHHHHhhhhhhccCC
Confidence 566778888888877655543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=388.39 Aligned_cols=264 Identities=25% Similarity=0.375 Sum_probs=211.7
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|++++.||+|+||+||+|.+..+++.||||++++... .......+.+|+.++..++|++|+++++.+.. ...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-----~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-----KLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-----CCe
Confidence 369999999999999999999999999999999964321 22334567889999999999999999999843 456
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|+|||||+ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 899999998 5899999888899999999999999999999999999999999999999999999999999987542211
Q ss_pred CC--------------------------------cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCC
Q 010489 271 PS--------------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK 318 (509)
Q Consensus 271 ~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~ 318 (509)
.. .......+||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--CCCCCchhhhhhHHHHHHHHhCC
Confidence 00 001124589999999999987 68999999999999999999999
Q ss_pred CCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCC---CCC
Q 010489 319 PLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPK---DRP 395 (509)
Q Consensus 319 ~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~---~Rp 395 (509)
.||.+.+..+....+.... .. ..+.. ...+++++++||.+|+. +|. .||
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~------------------------~~--~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~ 285 (363)
T cd05628 234 PPFCSETPQETYKKVMNWK------------------------ET--LIFPP-EVPISEKAKDLILRFCC-EWEHRIGAP 285 (363)
T ss_pred CCCCCCCHHHHHHHHHcCc------------------------Cc--ccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCC
Confidence 9998876544433332110 00 00100 12367899999999876 454 458
Q ss_pred CHHHHhcCCcccCCcC
Q 010489 396 TAEEALADPYFHGLAN 411 (509)
Q Consensus 396 t~~e~l~hp~f~~~~~ 411 (509)
+++|+++||||+++..
T Consensus 286 ~~~ei~~hp~f~~~~~ 301 (363)
T cd05628 286 GVEEIKTNPFFEGVDW 301 (363)
T ss_pred CHHHHhCCCCCCCCCH
Confidence 9999999999987643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-47 Score=379.41 Aligned_cols=327 Identities=50% Similarity=0.837 Sum_probs=260.7
Q ss_pred CeeEeeeeeccCceEEEEEEEcCC--CcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCCC
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHT--GERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~~ 190 (509)
+|++.+.||+|+||.||+|.+..+ +..||||++..........+.+.+|+.+++.+ .||||+++++...... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 588999999999999999999888 89999999875433333456778899999999 5999999998754322 2335
Q ss_pred cEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.+|+++||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 80 ELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred cEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 68999999999999999888889999999999999999999999999999999999999999999999999997643222
Q ss_pred CC-cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 271 PS-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 271 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
.. ........||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...+|.+..+.+..+.
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred ccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 1112346799999999987552 468899999999999999999999999999889999999999999888777766
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCCCCccchhHH
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFE 429 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 429 (509)
......+...+.......+...++..++.+.+|+.+||+.||++|||+.+++.||||+.++++...+......... |+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~--~~ 316 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFS--FE 316 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccCC--cc
Confidence 6555555544444444555556667789999999999999999999999999999999887765555433322222 22
Q ss_pred hhhcCHHHHHHHHHHH
Q 010489 430 RRKLAKDDVREMIYRE 445 (509)
Q Consensus 430 ~~~~~~~~~~~~~~~~ 445 (509)
.. -..++++.+|.++
T Consensus 317 ~~-~~~~~~~~~~~~~ 331 (332)
T cd07857 317 SE-DSMEELRDMIIEE 331 (332)
T ss_pred cc-ccHHHHHHHHhhc
Confidence 22 2345666666543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=388.86 Aligned_cols=264 Identities=23% Similarity=0.335 Sum_probs=210.6
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
.|++++.||+|+||+||+|++..+++.||||++.... ........+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-----~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-----KDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-----CCEE
Confidence 6899999999999999999999999999999996432 223345678899999999999999999999854 3469
Q ss_pred EEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
|+|||||+ |+|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||++.++++||+|||++........
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999998 58999998888899999999999999999999999999999999999999999999999999753211000
Q ss_pred C--------------------------------------------cccccccccccccccccccccccCCCCCceeeehh
Q 010489 272 S--------------------------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI 307 (509)
Q Consensus 272 ~--------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSl 307 (509)
. .......+||+.|+|||++.+ ..++.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSl 234 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--KGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC--CCCCCccceeeh
Confidence 0 000124589999999999877 678999999999
Q ss_pred hhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhc
Q 010489 308 GCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLL 387 (509)
Q Consensus 308 G~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 387 (509)
||++|||++|..||.+.+..+....+... ...... .....+++++.+||.+||
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~------------------------~~~~~~---~~~~~~s~~~~dli~~ll 287 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINW------------------------ENTLHI---PPQVKLSPEAVDLITKLC 287 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHcc------------------------ccccCC---CCCCCCCHHHHHHHHHHc
Confidence 99999999999999876643322222110 000000 011246899999999966
Q ss_pred c--CCCCCCCCHHHHhcCCcccCCcC
Q 010489 388 A--FDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 388 ~--~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
. .+|..|++++++++||||..+..
T Consensus 288 ~~~~~~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 288 CSAEERLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred cCcccccCCCCHHHHhcCcccCCCCh
Confidence 4 45556999999999999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=389.29 Aligned_cols=263 Identities=24% Similarity=0.361 Sum_probs=211.8
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
+|+++++||+|+||.||+|++..+++.||||++.... ........+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-----~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-----KDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-----CCEE
Confidence 6899999999999999999999999999999986422 122345678899999999999999999999854 3469
Q ss_pred EEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
|+|||||+ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999998 58999998888899999999999999999999999999999999999999999999999999753210000
Q ss_pred --------------------------------------------CcccccccccccccccccccccccCCCCCceeeehh
Q 010489 272 --------------------------------------------SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI 307 (509)
Q Consensus 272 --------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSl 307 (509)
........+||+.|+|||++.+ ..|+.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSl 234 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC--CCCCCeeeEEec
Confidence 0000123579999999999987 689999999999
Q ss_pred hhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhc
Q 010489 308 GCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLL 387 (509)
Q Consensus 308 G~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 387 (509)
||++|||++|++||.+.+.......+... ......+ ....+++++.+||.+|+
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~------------------------~~~~~~p---~~~~~s~~~~~li~~l~ 287 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQMKVINW------------------------QTSLHIP---PQAKLSPEASDLIIKLC 287 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHcc------------------------CCCcCCC---CcccCCHHHHHHHHHHc
Confidence 99999999999999887654333222110 0000111 12356889999999987
Q ss_pred cCCCCCCCC---HHHHhcCCcccCCcC
Q 010489 388 AFDPKDRPT---AEEALADPYFHGLAN 411 (509)
Q Consensus 388 ~~dP~~Rpt---~~e~l~hp~f~~~~~ 411 (509)
.||.+|++ ++++++||||+.+..
T Consensus 288 -~~p~~R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 288 -RGPEDRLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred -cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence 49999997 999999999987643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=376.38 Aligned_cols=290 Identities=37% Similarity=0.641 Sum_probs=231.4
Q ss_pred CCCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 110 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 110 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
+..++|++.+.||+|+||.||+|.+..++..||+|.++.... ......+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-----~ 76 (301)
T cd07873 3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----E 76 (301)
T ss_pred ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEec-----C
Confidence 345789999999999999999999999999999999864322 2223456789999999999999999999854 3
Q ss_pred CcEEEEEecccccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 190 KDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 190 ~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
..+|+||||++++|.+++... ..+++..+..++.||++||+|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 77 KSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred CeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 458999999999999888754 4689999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... ......+++.|+|||++.+. ..++.++|||||||++|||++|++||.+.+..+++..+...++.+....+..+
T Consensus 157 ~~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 157 PTK---TYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred CCC---cccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhh
Confidence 221 12334678999999987652 46788999999999999999999999999888888888888888777655433
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
........ ...+...........+.+++.+.+||.+||..||.+|||++|+|+||||+.+.
T Consensus 233 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 233 LSNEEFKS-YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred hccccccc-cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 21110000 00011111111223346788999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=373.98 Aligned_cols=258 Identities=24% Similarity=0.359 Sum_probs=208.5
Q ss_pred eeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 115 y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++|++|+++++++.. ...+|
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~-----~~~~~ 76 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET-----KDALC 76 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc-----CCeEE
Confidence 788999999999999999999999999999986432 122233457789999999999999999998844 34689
Q ss_pred EEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 194 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 194 lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|||||+ ++|..++... ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999998 5787777543 368999999999999999999999999999999999999999999999999997643221
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+...+
T Consensus 157 ----~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~------------- 217 (285)
T cd05631 157 ----TVRGRVGTVGYMAPEVINN--EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV------------- 217 (285)
T ss_pred ----eecCCCCCCCccCHhhhcC--CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh-------------
Confidence 1234579999999999987 689999999999999999999999998765322211111100
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCc
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLA 410 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~f~~~~ 410 (509)
.. .. .......++.+.+||.+||+.||++||+ ++++++||||+++.
T Consensus 218 ----------~~-~~---~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 218 ----------KE-DQ---EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred ----------hc-cc---ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 00 00 0112346889999999999999999997 89999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=384.88 Aligned_cols=256 Identities=24% Similarity=0.359 Sum_probs=212.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCC-cEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTG-ERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~-~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
..+|++.+.||+|+||.||+|.+..++ ..||+|++.... ........+.+|+.+++.++||||+++++++.. .
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~ 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD-----E 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe-----C
Confidence 457999999999999999999876554 689999986422 122345667899999999999999999999844 3
Q ss_pred CcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
..+|+||||+. |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 46899999997 68999998888999999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
. ....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+.......+...
T Consensus 184 ~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~------------ 243 (340)
T PTZ00426 184 R------TYTLCGTPEYIAPEILLN--VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG------------ 243 (340)
T ss_pred C------cceecCChhhcCHHHHhC--CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC------------
Confidence 1 134689999999999877 67899999999999999999999999876643333222110
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCcC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLAN 411 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~~ 411 (509)
. .. ..+.+++.+.+||++||+.||.+|+ +++++++||||+++.+
T Consensus 244 --------------~--~~---~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 244 --------------I--IY---FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred --------------C--CC---CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 0 00 0124578899999999999999995 8999999999987643
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=386.48 Aligned_cols=264 Identities=25% Similarity=0.418 Sum_probs=213.5
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.+|++++.||+|+||.||+|++..+|+.||||++.... ........+.+|+.+|+.++||||+++++++.. ...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-----ENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-----CCe
Confidence 36999999999999999999999999999999996421 122344567889999999999999999999854 456
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|+|||||+ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999998 5899999888889999999999999999999999999999999999999999999999999987542211
Q ss_pred CCc-----------------------------------ccccccccccccccccccccccCCCCCceeeehhhhHHHHHH
Q 010489 271 PSA-----------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEML 315 (509)
Q Consensus 271 ~~~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell 315 (509)
... ......+||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC--CCCCCeeeeecchhHHHHhh
Confidence 000 00113479999999999877 68999999999999999999
Q ss_pred hCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 010489 316 TGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP 395 (509)
Q Consensus 316 ~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 395 (509)
+|.+||.+.+..+....+... ......+ ....+++++.+||.+||. +|.+|+
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~------------------------~~~~~~~---~~~~~s~~~~~li~~ll~-~p~~R~ 285 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINW------------------------KETLQFP---DEVPLSPEAKDLIKRLCC-EAERRL 285 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcC------------------------CCccCCC---CCCCCCHHHHHHHHHHcc-CHhhcC
Confidence 999999887654333222110 0000111 112468899999999997 999999
Q ss_pred C---HHHHhcCCcccCCcC
Q 010489 396 T---AEEALADPYFHGLAN 411 (509)
Q Consensus 396 t---~~e~l~hp~f~~~~~ 411 (509)
+ +.++++||||++...
T Consensus 286 ~~~~~~~ll~h~~~~~~~~ 304 (364)
T cd05599 286 GNNGVNEIKSHPFFKGVDW 304 (364)
T ss_pred CCCCHHHHhcCCCcCCCCH
Confidence 8 999999999987643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=378.40 Aligned_cols=260 Identities=28% Similarity=0.508 Sum_probs=225.2
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
..+-|.+.+.||+|-|++|.+|+|..||+.||||++.+...+......+.+|++.|+.++|||||++|++.-. ..
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT-----QT 90 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT-----QT 90 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc-----cc
Confidence 4567999999999999999999999999999999998765555566788999999999999999999999843 34
Q ss_pred cEEEEEeccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEE-CCCCCeEEeeeccccccc
Q 010489 191 DIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA-NADCKLKICDFGLARVSF 267 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl-~~~~~vkl~DFG~a~~~~ 267 (509)
.+|+|+|+-+ |+|+++|.++. .+.|+.++.++.||+.|+.|+|...+|||||||+|+.+ .+-|-|||+|||++..+.
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 5999999998 59999998764 79999999999999999999999999999999999975 556899999999998765
Q ss_pred CCCCCcccccccccccccccccccccccCCCC-CceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
.... +++.||+..|.|||++.+ ..|+ +++||||||||||-|++|++||...++.+.+.+|.+.--+
T Consensus 171 PG~k----L~TsCGSLAYSAPEILLG--DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt------- 237 (864)
T KOG4717|consen 171 PGKK----LTTSCGSLAYSAPEILLG--DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT------- 237 (864)
T ss_pred Ccch----hhcccchhhccCchhhhc--CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc-------
Confidence 4432 577899999999999998 4555 7899999999999999999999998888777766543211
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCC
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 412 (509)
+| .-++.++++||..||..||++|.+.++|..|+|++.....
T Consensus 238 -------------------vP-----shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 238 -------------------VP-----SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred -------------------Cc-----hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 11 2367889999999999999999999999999999987553
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=381.08 Aligned_cols=328 Identities=45% Similarity=0.781 Sum_probs=263.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.+ +||||+++++++... +..
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~---~~~ 82 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE---NDK 82 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC---CCc
Confidence 4689999999999999999999998999999999865444444556678899999999 999999999987442 224
Q ss_pred cEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.+|+||||++++|..++... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 83 DIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred eEEEEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 58999999999999988765 78999999999999999999999999999999999999999999999999997654332
Q ss_pred CC--cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 271 PS--AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 271 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
.. ......+.||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+....+....+....+.+..+.+..+
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred ccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 11 1123456799999999987652 56788999999999999999999999999888888888888888888777766
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCCCCccchhH
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEF 428 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~ 428 (509)
........+...............+.++.++.+||.+||+.||.+|||+.++++||||+++.....++.........+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~- 319 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLD- 319 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCccCCcc-
Confidence 5555555555444444444455566688999999999999999999999999999999988665554433222222111
Q ss_pred HhhhcCHHHHHHHHHHH
Q 010489 429 ERRKLAKDDVREMIYRE 445 (509)
Q Consensus 429 ~~~~~~~~~~~~~~~~~ 445 (509)
+.+++...+.+.+++++
T Consensus 320 ~~~~~~~~~~~~~~~~~ 336 (337)
T cd07852 320 DNVKLSVAEYRNKLYEE 336 (337)
T ss_pred ccceeeHHHHHhhhhhc
Confidence 45566777777777765
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=387.85 Aligned_cols=264 Identities=25% Similarity=0.396 Sum_probs=211.4
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|++++.||+|+||.||+|.+..+++.||||++.+.. ........+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-----AQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-----CCe
Confidence 36999999999999999999999999999999985421 122345667889999999999999999999854 346
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|+||||++ ++|.+++...+.+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999997 6899999888889999999999999999999999999999999999999999999999999996321110
Q ss_pred CC--------------------------------------------cccccccccccccccccccccccCCCCCceeeeh
Q 010489 271 PS--------------------------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 306 (509)
Q Consensus 271 ~~--------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwS 306 (509)
.. .......+||+.|+|||++.+ ..++.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwS 233 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ--QGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc--CCCCCceeeEe
Confidence 00 000012579999999999877 67999999999
Q ss_pred hhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHh
Q 010489 307 IGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERL 386 (509)
Q Consensus 307 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 386 (509)
|||++|||++|.+||.+.+..+.+..+... ..... +. ....+++++.+||.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------------~~~~~--~p-~~~~~s~~~~dli~~l 286 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIINW------------------------RETLY--FP-DDIHLSVEAEDLIRRL 286 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHcc------------------------CCccC--CC-CCCCCCHHHHHHHHHH
Confidence 999999999999999877654443333211 00000 00 1124678999999999
Q ss_pred ccCCCCCC---CCHHHHhcCCcccCCcC
Q 010489 387 LAFDPKDR---PTAEEALADPYFHGLAN 411 (509)
Q Consensus 387 L~~dP~~R---pt~~e~l~hp~f~~~~~ 411 (509)
|. +|.+| +++.+++.||||++...
T Consensus 287 L~-~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 287 IT-NAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred hc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 98 77765 59999999999987543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=378.00 Aligned_cols=248 Identities=32% Similarity=0.491 Sum_probs=206.4
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEecc
Q 010489 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM 199 (509)
Q Consensus 121 lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 199 (509)
||+|+||.||+|.+..+++.||+|+++... ........+.+|+.+++.++||||+++++++.. ...+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-----PEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-----CCeEEEEEcCC
Confidence 799999999999999999999999986432 223345677899999999999999999998843 35689999999
Q ss_pred c-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCcccccc
Q 010489 200 E-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD 278 (509)
Q Consensus 200 ~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 278 (509)
+ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ....
T Consensus 76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~ 152 (312)
T cd05585 76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNT 152 (312)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC---cccc
Confidence 8 58999998888999999999999999999999999999999999999999999999999999975432221 1245
Q ss_pred cccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhh
Q 010489 279 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLG 358 (509)
Q Consensus 279 ~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 358 (509)
.+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+..
T Consensus 153 ~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~----------------------- 207 (312)
T cd05585 153 FCGTPEYLAPELLLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ----------------------- 207 (312)
T ss_pred ccCCcccCCHHHHcC--CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc-----------------------
Confidence 689999999999987 6899999999999999999999999987664332222110
Q ss_pred ccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC---CHHHHhcCCcccCC
Q 010489 359 SMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP---TAEEALADPYFHGL 409 (509)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~e~l~hp~f~~~ 409 (509)
. +.. ....+++.+.+||.+||..||.+|| ++.++|.||||...
T Consensus 208 ---~--~~~---~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 208 ---E--PLR---FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred ---C--CCC---CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 0 011 1134678899999999999999997 58999999999865
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=387.57 Aligned_cols=263 Identities=24% Similarity=0.354 Sum_probs=211.5
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|++++.||+|+||.||+|++..+++.||||++.+.. ........+.+|+.+|+.++||||+++++.+.. ...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-----KDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc-----CCE
Confidence 47999999999999999999999999999999986421 112234567889999999999999999999843 456
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|+|||||+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999998 6899999888889999999999999999999999999999999999999999999999999975321000
Q ss_pred C----------------------------------------CcccccccccccccccccccccccCCCCCceeeehhhhH
Q 010489 271 P----------------------------------------SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 310 (509)
Q Consensus 271 ~----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~i 310 (509)
. ........+||+.|||||++.+ ..++.++|||||||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvi 233 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC--CCCCcceeeeeccce
Confidence 0 0000123579999999999987 678999999999999
Q ss_pred HHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCC
Q 010489 311 FAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFD 390 (509)
Q Consensus 311 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 390 (509)
+|||++|+.||.+.+..+....+... ...... .....+++++.+||.+|+ .+
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~------------------------~~~~~~---~~~~~~s~~~~~li~~l~-~~ 285 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINW------------------------ETTLHI---PSQAKLSREASDLILRLC-CG 285 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhcc------------------------CccccC---CCCCCCCHHHHHHHHHHh-cC
Confidence 99999999999887654332222110 000001 112357889999999987 49
Q ss_pred CCCCC---CHHHHhcCCcccCCc
Q 010489 391 PKDRP---TAEEALADPYFHGLA 410 (509)
Q Consensus 391 P~~Rp---t~~e~l~hp~f~~~~ 410 (509)
|.+|+ ++.++++||||+++.
T Consensus 286 p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 286 AEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred HhhcCCCCCHHHHhCCCCcCCCC
Confidence 99999 999999999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-47 Score=383.99 Aligned_cols=264 Identities=30% Similarity=0.476 Sum_probs=215.9
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|++.+.||+|+||.||+|++..+++.||||+++.... .......+.+|+.++..++||||+++++++. +...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ-----DEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee-----cCCe
Confidence 379999999999999999999999999999999864321 2234566788999999999999999998884 3456
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|+||||+. ++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999997 5899999888899999999999999999999999999999999999999999999999999997654322
Q ss_pred C--------------------------CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCC
Q 010489 271 P--------------------------SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK 324 (509)
Q Consensus 271 ~--------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 324 (509)
. .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--TPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcC--CCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 0 0011234579999999999987 68999999999999999999999999887
Q ss_pred ChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-HHHHhcC
Q 010489 325 NVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-AEEALAD 403 (509)
Q Consensus 325 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-~~e~l~h 403 (509)
+.......+.... .....+ ....+++.+.+||.+||. ||.+||+ ++++++|
T Consensus 234 ~~~~~~~~i~~~~------------------------~~~~~p---~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETYNKIINWK------------------------ESLRFP---PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHHHHHhccC------------------------CcccCC---CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 6443333222110 000011 112368899999999998 9999999 9999999
Q ss_pred CcccCCcC
Q 010489 404 PYFHGLAN 411 (509)
Q Consensus 404 p~f~~~~~ 411 (509)
|||+++..
T Consensus 286 p~~~~~~~ 293 (350)
T cd05573 286 PFFKGIDW 293 (350)
T ss_pred CCcCCCCH
Confidence 99987643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=377.71 Aligned_cols=251 Identities=31% Similarity=0.444 Sum_probs=204.8
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcE-EEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGER-VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~-vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
...+.+.||+|+||+||+|... |.. ||||++............+.+|+.+|.+++|||||++++++..+.. .+
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~ 115 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SL 115 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ce
Confidence 3455677999999999999765 666 9999997654444446789999999999999999999999976531 48
Q ss_pred EEEEeccc-ccHHHHHHh--CCCCCHHHHHHHHHHHHhHhhhhhhCC-eeecCCCCCcEEECCCC-CeEEeeeccccccc
Q 010489 193 YVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTAN-VFHRDLKPKNILANADC-KLKICDFGLARVSF 267 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~~-ivHrDlKp~NILl~~~~-~vkl~DFG~a~~~~ 267 (509)
+||||||+ |+|.+++.. ...+++..+..|+.||++||.|||+++ ||||||||+|||++.++ ++||+|||+++...
T Consensus 116 ~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 99999999 689999987 578999999999999999999999999 99999999999999998 99999999998754
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
... ...+...||+.|||||++.+....|+.|+||||||++||||+||+.||.+.........+...
T Consensus 196 ~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~----------- 261 (362)
T KOG0192|consen 196 ISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVG----------- 261 (362)
T ss_pred ccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-----------
Confidence 322 123447899999999999841158999999999999999999999999987752222111110
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..+.+.+ ..+++.+..||.+||..||.+||++.+++.
T Consensus 262 -------------~~Rp~~p-----~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 262 -------------GLRPPIP-----KECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred -------------CCCCCCC-----ccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 0111111 127888999999999999999999999876
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=357.49 Aligned_cols=298 Identities=35% Similarity=0.553 Sum_probs=240.7
Q ss_pred CCCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCC---Cc
Q 010489 110 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP---SR 186 (509)
Q Consensus 110 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~---~~ 186 (509)
.+.+.|+-+.+||+|.||.||+|+.+.+|+.||+|++-...+....-...++|+++|..|+|+|++.++++|... ..
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 345778889999999999999999999999999998643222222334568999999999999999999988543 22
Q ss_pred CCCCcEEEEEecccccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 187 REFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 187 ~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
.+...+|+||++|+.+|.-++... .+++..+++.++.+++.||.|+|+..|+|||+||+|+||+.+|.+||+|||+++.
T Consensus 94 r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred cccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 344569999999999999999765 5899999999999999999999999999999999999999999999999999976
Q ss_pred ccCCC-CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 266 SFNDA-PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 266 ~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
..... .....++..+.|.||++||.+.|. ..|+++.|||..|||+.||++|.+.|.+.+...++..|..++|....+.
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 53322 222335667889999999999885 8899999999999999999999999999999999999999999988887
Q ss_pred HHHhhhHHHHHhhhc--cCCCCCCCCCCCCC--CCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 345 ISRIRNEKARRYLGS--MRKKQPVPFSHKFP--NADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
|.....-..-.-+.. +++.+......... .-++++.||+.+||..||.+|+++.++|.|.||..
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 766544333222211 11111111111111 12678999999999999999999999999999964
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-49 Score=357.80 Aligned_cols=289 Identities=43% Similarity=0.746 Sum_probs=248.2
Q ss_pred eEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEE
Q 010489 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 195 (509)
Q Consensus 116 ~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 195 (509)
+--+.||-|+||+||.+.+..+|+.||+|++...+......+++.+|+++|..++|.|++..+++...+...-+..+|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 33478999999999999999999999999998877777788999999999999999999999999887766667789999
Q ss_pred EecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccc
Q 010489 196 FELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (509)
Q Consensus 196 ~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 275 (509)
+|+|..+|+.+|..-+.++.++++-+++||++||+|||+.+|.||||||.|+|+++++.+||||||+++....+... .
T Consensus 136 TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~--h 213 (449)
T KOG0664|consen 136 TELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL--N 213 (449)
T ss_pred HHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh--h
Confidence 99999999999999999999999999999999999999999999999999999999999999999999976544433 3
Q ss_pred ccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHH
Q 010489 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (509)
Q Consensus 276 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (509)
++..+-|.+|+|||++.|. ..|+.++||||+|||+.||+.++..|...+..+++++|.+++|+|+.+.+..........
T Consensus 214 MTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H 292 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH 292 (449)
T ss_pred hHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence 4667889999999999884 789999999999999999999999999999999999999999999998876544333223
Q ss_pred hhhccCCCCCCCCCCCCC-----CCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 356 YLGSMRKKQPVPFSHKFP-----NADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.+..-.+ +..+...+. ....++.+++.+||.+||++|.+.++++.|+|....
T Consensus 293 ~LR~~~k--~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 293 VLRAGLR--APDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hhccCCC--CCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 3322221 122222221 234568899999999999999999999999998643
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-47 Score=378.89 Aligned_cols=251 Identities=25% Similarity=0.442 Sum_probs=207.7
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEe
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 197 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 197 (509)
+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++.. ...+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-----KDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-----CCEEEEEEe
Confidence 469999999999999999999999999964321 22345678899999999999999999998843 346899999
Q ss_pred ccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCcccc
Q 010489 198 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276 (509)
Q Consensus 198 ~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 276 (509)
|++ ++|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~---~~ 152 (328)
T cd05593 76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---TM 152 (328)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc---cc
Confidence 998 58888888888899999999999999999999999999999999999999999999999999875322211 12
Q ss_pred cccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHh
Q 010489 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 356 (509)
Q Consensus 277 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (509)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--------------------- 209 (328)
T cd05593 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------------- 209 (328)
T ss_pred ccccCCcCccChhhhcC--CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc---------------------
Confidence 44689999999999877 6789999999999999999999999987654332222110
Q ss_pred hhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCc
Q 010489 357 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (509)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~ 410 (509)
.... ....+++++.+||.+||..||++|+ ++.++++||||.+..
T Consensus 210 -----~~~~-----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 258 (328)
T cd05593 210 -----EDIK-----FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN 258 (328)
T ss_pred -----CCcc-----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 0000 1134678899999999999999997 899999999998653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=374.00 Aligned_cols=320 Identities=49% Similarity=0.867 Sum_probs=266.0
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
..++|++.+.||.|+||.||+|.+..+++.||||++..........+.+.+|+.+++.++||||+++++++... ..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----~~ 83 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP----LE 83 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----CC
Confidence 35689999999999999999999999999999999865433334456778999999999999999999988542 23
Q ss_pred cEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
..|++|||++++|..++.. ..+++..+..++.||++||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 84 DIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred cEEEEeehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence 5899999999888887754 46889999999999999999999999999999999999999999999999998753211
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
.....+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.........+.+.+|.++.+....+..
T Consensus 162 -----~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd07856 162 -----MTGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235 (328)
T ss_pred -----cCCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 1345788999999987542 4688999999999999999999999999888888888889999999888776655
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCCCCccchhHHh
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFER 430 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 430 (509)
.....+........+.++....+.+++.+.++|.+||+.||++||++++++.||||.....+..++.. ...+++.++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 313 (328)
T cd07856 236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVA--EEKFDWSFND 313 (328)
T ss_pred hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCc--hhhcCCchhc
Confidence 55555555555555555555667788999999999999999999999999999999988776555432 2367788888
Q ss_pred hhcCHHHHHHHHHH
Q 010489 431 RKLAKDDVREMIYR 444 (509)
Q Consensus 431 ~~~~~~~~~~~~~~ 444 (509)
..+..+.++-+.+.
T Consensus 314 ~~~~~~~~~~~~~~ 327 (328)
T cd07856 314 ADLPVDTWKVMMYS 327 (328)
T ss_pred ccCCHHHHHHHhcC
Confidence 88889988877653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-47 Score=377.41 Aligned_cols=251 Identities=26% Similarity=0.447 Sum_probs=208.0
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEe
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 197 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 197 (509)
+.||+|+||.||+|.+..+|..||+|+++.... .......+.+|+.+++.++||||+++++++.. ...+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCEEEEEEe
Confidence 469999999999999999999999999864321 22345567789999999999999999998844 346899999
Q ss_pred ccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCcccc
Q 010489 198 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276 (509)
Q Consensus 198 ~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 276 (509)
|++ ++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~ 152 (323)
T cd05595 76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC---cc
Confidence 998 58988888888899999999999999999999999999999999999999999999999999875322221 12
Q ss_pred cccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHh
Q 010489 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 356 (509)
Q Consensus 277 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (509)
...+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~--------------------- 209 (323)
T cd05595 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------------------- 209 (323)
T ss_pred ccccCCcCcCCcccccC--CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------------
Confidence 34679999999999877 6889999999999999999999999987664333322211
Q ss_pred hhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCc
Q 010489 357 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (509)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~ 410 (509)
... . ....+++++.+||.+||..||++|+ ++.++++||||.+..
T Consensus 210 -----~~~--~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 210 -----EEI--R---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred -----CCC--C---CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 000 0 0124688999999999999999998 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=353.19 Aligned_cols=272 Identities=30% Similarity=0.464 Sum_probs=220.6
Q ss_pred cccCCCCCeeEe-eeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCC
Q 010489 107 TEYGEASRYQIQ-EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPP 184 (509)
Q Consensus 107 ~~~~~~~~y~i~-~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~ 184 (509)
.+....++|.+- ++||-|-.|.|..|.++.||+.+|+|++. +..+..+|+++.... .|||||.++++|...
T Consensus 55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-------Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-------DSPKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-------cCHHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 455556678774 58999999999999999999999999884 345567899986655 599999999998543
Q ss_pred CcCCCCcEEEEEeccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC---CCCeEEe
Q 010489 185 SRREFKDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKIC 258 (509)
Q Consensus 185 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~---~~~vkl~ 258 (509)
+.....+.+|||.|+ |+|+..++.++ .|+|.++..|+.||..|+.|||+.+|.||||||+|+|... +..+||+
T Consensus 128 -~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 128 -YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred -ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence 345667899999999 58999998776 4999999999999999999999999999999999999875 4569999
Q ss_pred eecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcC
Q 010489 259 DFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338 (509)
Q Consensus 259 DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g 338 (509)
|||+|+.... ...+.+.|-||.|.|||++.. .+|+..+|+||+|||+|.||+|.+||......
T Consensus 207 DfGFAK~t~~----~~~L~TPc~TPyYvaPevlg~--eKydkscdmwSlgVimYIlLCGyPPFYS~hg~----------- 269 (400)
T KOG0604|consen 207 DFGFAKETQE----PGDLMTPCFTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----------- 269 (400)
T ss_pred ccccccccCC----CccccCCcccccccCHHHhCc--hhcCCCCCccchhHHHHHhhcCCCcccccCCc-----------
Confidence 9999986432 222456789999999999987 78999999999999999999999999765421
Q ss_pred CCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCC
Q 010489 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDRE 415 (509)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~ 415 (509)
..+...-.+|+ ..+.......|..+|.+++|+|+++|..+|.+|.|+++++.|||+.+...+...
T Consensus 270 aispgMk~rI~------------~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~t 334 (400)
T KOG0604|consen 270 AISPGMKRRIR------------TGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQT 334 (400)
T ss_pred cCChhHHhHhh------------ccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCC
Confidence 11111222221 222333455677889999999999999999999999999999999887655443
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=366.64 Aligned_cols=282 Identities=38% Similarity=0.638 Sum_probs=224.9
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
+|++.+.||+|++|.||+|.+..++..||||+++...........+.+|+.+++.++||||+++++++.. ...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-----ESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-----CCeEE
Confidence 5899999999999999999999999999999986533333334667889999999999999999999854 34689
Q ss_pred EEEecccccHHHHHHhC---CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 194 VVFELMESDLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 194 lv~e~~~~~L~~~l~~~---~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+||||++++|.+++... ..+++..++.++.||++||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred EEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 99999999998887643 468999999999999999999999999999999999999999999999999987543221
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
. ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+....+....+...++.+....+.....
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 R---VYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred c---cccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 1 12334678999999987652 4578899999999999999999999999887777777777677665554433221
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
. ..+..................+++++.+||.+||..||.+|||+.++++||||
T Consensus 232 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 L--PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred h--HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 1 11111111111112222344578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=375.38 Aligned_cols=256 Identities=24% Similarity=0.410 Sum_probs=210.3
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCC-CcceeeeeecCCCcCCCCc
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHP-DIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~-niv~~~~~~~~~~~~~~~~ 191 (509)
+|++++.||+|+||.||+|.+..+++.||||++.... ........+..|+.++..+.|+ +|+.+++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----MDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-----CCE
Confidence 5899999999999999999999999999999986432 1223456678899999999765 57788888743 346
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|+||||++ ++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 899999998 6899999888889999999999999999999999999999999999999999999999999987432211
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
. .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-------------- 216 (324)
T cd05587 156 K---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH-------------- 216 (324)
T ss_pred C---ceeeecCCccccChhhhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------
Confidence 1 1234689999999999987 67899999999999999999999999877654433322110
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH-----HHHhcCCcccCCc
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA-----EEALADPYFHGLA 410 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~f~~~~ 410 (509)
.. . ....+++.+.+||.+||..||.+|+++ +++++||||+.+.
T Consensus 217 ------------~~--~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~ 264 (324)
T cd05587 217 ------------NV--S---YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRID 264 (324)
T ss_pred ------------CC--C---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 00 0 112467889999999999999999976 8999999998753
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=382.46 Aligned_cols=281 Identities=23% Similarity=0.294 Sum_probs=217.1
Q ss_pred CCCeeEeeeeeccCceEEEEEEEc--CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDT--HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~--~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
..+|++++.||+|+||.||+|... .++..||+|.+... ....+|+.+|+.++||||+++++++.. .
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~-----~ 158 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRW-----K 158 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEee-----C
Confidence 357999999999999999999754 35678999987532 234589999999999999999998843 3
Q ss_pred CcEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 190 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 190 ~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
..+|+|||++.++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 159 ~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 159 STVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred CEEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 46899999999999999977788999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCCh---HhHHHHHHHhcCCCChhHHH
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV---VHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~g~~~~~~~~ 346 (509)
... .......||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+... ..++..+.+.++..+.+...
T Consensus 239 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 239 PDT-PQCYGWSGTLETNSPELLAL--DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred ccc-ccccccccccCccCHhHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 221 11234689999999999877 6799999999999999999999999987643 44555666655544332111
Q ss_pred Hhhh---HHHHHhhhccCCCCCCCCCCC--CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 347 RIRN---EKARRYLGSMRKKQPVPFSHK--FPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 347 ~~~~---~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.... .....+... ...+..+... ....+.++.+||.+||..||++|||+.++|.||||...
T Consensus 316 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 316 NGSTNLCKHFKQYAIV--LRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred ccchhHHHHHHhhccc--ccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 1000 011111111 1111111111 12456789999999999999999999999999999753
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=368.94 Aligned_cols=282 Identities=37% Similarity=0.614 Sum_probs=223.5
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
+|++.+.||+|+||.||+|++..+|+.||+|.++...........+.+|+.+++.++||||+++++++.. ...+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-----DKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-----CCceE
Confidence 5899999999999999999999999999999986533222333567789999999999999999998844 34689
Q ss_pred EEEecccccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCC
Q 010489 194 VVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (509)
Q Consensus 194 lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 272 (509)
+|+||++++|.+++.. .+.+++..++.++.||++||.|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 76 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 76 LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 9999999999888865 46799999999999999999999999999999999999999999999999999975432211
Q ss_pred cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCC-CCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL-FPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
......+++.|+|||++.+. ..++.++|||||||++|+|++|..| |.+.+..+.+..+...++.+....+..+...
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred --CcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 12345788999999988652 4578999999999999999998876 5666777778888887777766554332211
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
......... .....+....+.+++++.+||.+||..||.+|||++++++||||
T Consensus 232 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 232 PDYKPYPMY--PATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccccCCC--CCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 000000000 00011223345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-48 Score=357.98 Aligned_cols=260 Identities=26% Similarity=0.421 Sum_probs=223.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
..+|..+++||+|.||+|-+|+.+.+++.||||++++.. ....+...-+.|-++|+..+||.+..+...|.. ..
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt-----~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT-----QD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc-----Cc
Confidence 357889999999999999999999999999999997642 334456677889999999999999988777643 44
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|+||||.. |.|+.++.+...++++.++++..+|+.||.|||+.+||+||||.+|+|+|.+|++||+|||+++.....
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 5999999998 589999988889999999999999999999999999999999999999999999999999999754333
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
.. ...++||||.|.|||++.. ..|+.++|+|.+||++|||++|+.||...+....+.+|... .++
T Consensus 322 g~---t~kTFCGTPEYLAPEVleD--nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e----------d~k 386 (516)
T KOG0690|consen 322 GD---TTKTFCGTPEYLAPEVLED--NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME----------DLK 386 (516)
T ss_pred cc---eeccccCChhhcCchhhcc--ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh----------hcc
Confidence 22 3467899999999999988 79999999999999999999999999998876666555321 000
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCcCC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLANV 412 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~f~~~~~~ 412 (509)
....++++++.|+..+|.+||.+|.. |.|+.+|+||.++.+.
T Consensus 387 ---------------------FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~ 433 (516)
T KOG0690|consen 387 ---------------------FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE 433 (516)
T ss_pred ---------------------CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence 01357899999999999999999974 8999999999988764
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=376.58 Aligned_cols=264 Identities=23% Similarity=0.391 Sum_probs=213.4
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|.+.+.||+|+||.||+|.+..+|+.||||+++.... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-----~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-----KDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCe
Confidence 369999999999999999999999999999999975322 22344567889999999999999999998843 346
Q ss_pred EEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+|+||||++ ++|.+++... +.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 899999997 6899998776 68999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccccccccccccccc----cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
... ......||+.|+|||++... ...++.++|||||||++|||++|+.||.+.+....+..+...
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--------- 224 (330)
T cd05601 156 KMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--------- 224 (330)
T ss_pred Cce--eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC---------
Confidence 221 12335799999999998631 146788999999999999999999999876654433322211
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
.....+ ...+.+++.+.+||.+||. ||.+||+++++++||||+.+..
T Consensus 225 -----------------~~~~~~-~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~ 271 (330)
T cd05601 225 -----------------QRFLKF-PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW 271 (330)
T ss_pred -----------------CCccCC-CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence 000000 1123578899999999998 9999999999999999987543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=374.90 Aligned_cols=252 Identities=24% Similarity=0.409 Sum_probs=207.6
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCCCcEEEEE
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 196 (509)
+.||+|+||.||+|+++.+++.||||++++.. ........+..|+.++..+ .||||+++++++.. ...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-----~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-----PDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-----CCEEEEEE
Confidence 46999999999999999999999999986432 1223455677899988876 69999999999844 34689999
Q ss_pred eccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccc
Q 010489 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (509)
Q Consensus 197 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 275 (509)
||++ ++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~---~ 152 (320)
T cd05590 76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK---T 152 (320)
T ss_pred cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC---c
Confidence 9998 58999998888999999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHH
Q 010489 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (509)
Q Consensus 276 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (509)
....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~-------------------- 210 (320)
T cd05590 153 TSTFCGTPDYIAPEILQE--MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-------------------- 210 (320)
T ss_pred ccccccCccccCHHHHcC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc--------------------
Confidence 244689999999999877 6789999999999999999999999988765443333211
Q ss_pred hhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH------HHHhcCCcccCCcC
Q 010489 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA------EEALADPYFHGLAN 411 (509)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~------~e~l~hp~f~~~~~ 411 (509)
... . ....+++++.+||.+||+.||.+||++ +++++||||+.+..
T Consensus 211 -------~~~-~---~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 211 -------DEV-V---YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred -------CCC-C---CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 000 0 012367889999999999999999998 99999999987643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=376.22 Aligned_cols=252 Identities=27% Similarity=0.470 Sum_probs=207.3
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEe
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 197 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 197 (509)
+.||+|+||.||+|.+..+|+.||+|+++.... .......+.+|+++++.++||||+++++++.. ...+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-----~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-----CCEEEEEEe
Confidence 469999999999999999999999999975322 22345667889999999999999999998844 346899999
Q ss_pred ccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhh-CCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccc
Q 010489 198 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (509)
Q Consensus 198 ~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 275 (509)
|++ ++|..++.....+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (325)
T cd05594 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---T 152 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---c
Confidence 998 5888888888889999999999999999999997 7999999999999999999999999999875322221 1
Q ss_pred ccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHH
Q 010489 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (509)
Q Consensus 276 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (509)
....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~-------------------- 210 (325)
T cd05594 153 MKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-------------------- 210 (325)
T ss_pred cccccCCcccCCHHHHcc--CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc--------------------
Confidence 234679999999999877 6889999999999999999999999987664333222210
Q ss_pred hhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCcC
Q 010489 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLAN 411 (509)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~~ 411 (509)
.. ..+ ....++++.+||.+||+.||++|+ ++.++++||||.+...
T Consensus 211 ------~~--~~~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 260 (325)
T cd05594 211 ------EE--IRF---PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVW 260 (325)
T ss_pred ------CC--CCC---CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence 00 000 124678899999999999999997 9999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=374.73 Aligned_cols=262 Identities=24% Similarity=0.412 Sum_probs=208.1
Q ss_pred CeeEeeeeeccCceEEEEEEEc---CCCcEEEEEEecCcc--cChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcC
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVF--EHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~ 187 (509)
+|++++.||+|+||.||+|++. .+++.||+|++.+.. ........+.+|+.+++.++ ||+|+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT---- 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec----
Confidence 4899999999999999999764 478999999986421 12233456788999999995 9999999988843
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 188 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
...+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 77 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 77 -EAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred -CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 356899999998 589999988888999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
....... ....+||+.|+|||++.+. ..++.++|||||||++|||++|..||...........+..
T Consensus 156 ~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~----------- 221 (332)
T cd05614 156 LSEEKER--TYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR----------- 221 (332)
T ss_pred cccCCCc--cccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH-----------
Confidence 3322211 2346899999999998762 3578899999999999999999999975432111111100
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCc
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~ 410 (509)
... ....+ ....+++.+.+||.+||..||++|| +++++++||||+...
T Consensus 222 --------~~~---~~~~~-----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 222 --------RIL---KCDPP-----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred --------HHh---cCCCC-----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 000 00111 1134688899999999999999999 889999999998653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=373.44 Aligned_cols=254 Identities=27% Similarity=0.434 Sum_probs=206.0
Q ss_pred eeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHH---HHcCCCCcceeeeeecCCCcCCCC
Q 010489 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLL---RLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 115 y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l---~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
|++++.||+|+||.||+|.+..+++.||||+++... ........+.+|++++ +.++||||+++++++.. ..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-----~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-----ED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-----CC
Confidence 788999999999999999999999999999996432 1223345666777665 45679999999999843 35
Q ss_pred cEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|+||||+++ +|...+. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~~lv~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEEEEcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 68999999985 7776664 457999999999999999999999999999999999999999999999999998753222
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
.. .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 155 ~~---~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------------- 216 (324)
T cd05589 155 GD---RTSTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND------------- 216 (324)
T ss_pred CC---cccccccCccccCHhHhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Confidence 21 1245689999999999887 67899999999999999999999999887654433322110
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCc
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~ 410 (509)
... ....+++.+.+||.+||..||.+|| ++.++++||||+++.
T Consensus 217 -------------~~~-----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 217 -------------EVR-----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred -------------CCC-----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 000 1124678899999999999999999 799999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=379.39 Aligned_cols=264 Identities=25% Similarity=0.397 Sum_probs=212.5
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|++++.||+|+||.||+|.+..+++.||||+++... ........+.+|+.++..++||+|+++++.+. +...
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-----~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ-----DKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCE
Confidence 36899999999999999999999999999999986422 12234566788999999999999999999884 3456
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|+|||||+ ++|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999998 5899999888899999999999999999999999999999999999999999999999999987542211
Q ss_pred CC--------------------------------cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCC
Q 010489 271 PS--------------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK 318 (509)
Q Consensus 271 ~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~ 318 (509)
.. .......+||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--CCCCCcceeccccceeeecccCC
Confidence 00 001124589999999999887 68999999999999999999999
Q ss_pred CCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC---
Q 010489 319 PLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP--- 395 (509)
Q Consensus 319 ~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp--- 395 (509)
+||.+.+.......+... ... ..+.. ...+++++++||.+|+. ||.+|+
T Consensus 234 ~Pf~~~~~~~~~~~i~~~------------------------~~~--~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~ 285 (360)
T cd05627 234 PPFCSETPQETYRKVMNW------------------------KET--LVFPP-EVPISEKAKDLILRFCT-DSENRIGSN 285 (360)
T ss_pred CCCCCCCHHHHHHHHHcC------------------------CCc--eecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCC
Confidence 999887654433322210 000 00100 12367899999999875 999998
Q ss_pred CHHHHhcCCcccCCcC
Q 010489 396 TAEEALADPYFHGLAN 411 (509)
Q Consensus 396 t~~e~l~hp~f~~~~~ 411 (509)
+++++++||||+++.+
T Consensus 286 ~~~ei~~hp~f~~~~~ 301 (360)
T cd05627 286 GVEEIKSHPFFEGVDW 301 (360)
T ss_pred CHHHHhcCCCCCCCCH
Confidence 4899999999998644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-46 Score=378.18 Aligned_cols=263 Identities=25% Similarity=0.359 Sum_probs=211.5
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
..+|++.+.||+|+||.||+|.+..+++.||+|++++.. ........+.+|+.+++.++||||+++++++.. ..
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~-----~~ 116 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD-----DK 116 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-----CC
Confidence 468999999999999999999999999999999986421 122334557789999999999999999998843 35
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|+|||||+ |+|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 6999999998 588887754 46899999999999999999999999999999999999999999999999999764322
Q ss_pred CCCcccccccccccccccccccccc--cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
.. ......+||+.|+|||++.+. ...++.++|||||||++|||++|++||.+.+.......+...
T Consensus 196 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~----------- 262 (370)
T cd05596 196 GM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH----------- 262 (370)
T ss_pred Cc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-----------
Confidence 11 112346899999999988652 134789999999999999999999999887654333322110
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCC--CCCHHHHhcCCcccCC
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD--RPTAEEALADPYFHGL 409 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~e~l~hp~f~~~ 409 (509)
.....+. ....++.++.+||.+||..+|.+ |++++++++||||++.
T Consensus 263 ---------------~~~~~~~-~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 263 ---------------KNSLTFP-DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred ---------------CCcCCCC-CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 0001111 12346889999999999999988 9999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=372.91 Aligned_cols=251 Identities=25% Similarity=0.410 Sum_probs=207.3
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCCCcEEEEE
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 196 (509)
+.||+|+||.||+|++..+++.||||+++... ........+..|+.++..+ +||+|+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-----~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-----KDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCeEEEEE
Confidence 46999999999999999999999999986432 1223445677899998876 79999999999854 34689999
Q ss_pred eccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccc
Q 010489 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (509)
Q Consensus 197 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 275 (509)
||++ ++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (321)
T cd05591 76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---T 152 (321)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc---c
Confidence 9998 58988998888999999999999999999999999999999999999999999999999999875432221 1
Q ss_pred ccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHH
Q 010489 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (509)
Q Consensus 276 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (509)
....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~------------------- 211 (321)
T cd05591 153 TTTFCGTPDYIAPEILQE--LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD------------------- 211 (321)
T ss_pred ccccccCccccCHHHHcC--CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 245679999999999877 68899999999999999999999999887754443332210
Q ss_pred hhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-------CHHHHhcCCcccCCc
Q 010489 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-------TAEEALADPYFHGLA 410 (509)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-------t~~e~l~hp~f~~~~ 410 (509)
... ....+++++.+||.+||+.||++|| +++++++||||..+.
T Consensus 212 -------~~~-----~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~ 261 (321)
T cd05591 212 -------DVL-----YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEID 261 (321)
T ss_pred -------CCC-----CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence 000 0123578899999999999999999 999999999997653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-46 Score=377.78 Aligned_cols=263 Identities=25% Similarity=0.368 Sum_probs=209.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
..+|++.+.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.+++.++||||+++++++.. ..
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-----~~ 116 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-----DK 116 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CC
Confidence 468999999999999999999999999999999986421 122334567789999999999999999999844 35
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|+|||||+ |+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 6999999998 589888865 46899999999999999999999999999999999999999999999999999865322
Q ss_pred CCCccccccccccccccccccccccc--CCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
. .......+||+.|+|||++.+.. ..++.++|||||||++|||++|+.||.+.+.......+....
T Consensus 196 ~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~---------- 263 (370)
T cd05621 196 G--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK---------- 263 (370)
T ss_pred C--ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence 1 11124568999999999986521 237889999999999999999999998876544333322110
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCC--CCCHHHHhcCCcccCC
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD--RPTAEEALADPYFHGL 409 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~e~l~hp~f~~~ 409 (509)
....+. ....++..+++||.+||..++.+ |+++.++++||||+..
T Consensus 264 ----------------~~~~~p-~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 264 ----------------NSLNFP-EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred ----------------cccCCC-CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 000110 11246788999999999866544 8999999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=371.62 Aligned_cols=257 Identities=24% Similarity=0.410 Sum_probs=210.9
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCCCc
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 191 (509)
+|++++.||+|+||.||+|++..+++.||||++++... ..........|..++..+ .|++|+.+++++.. ...
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-----MDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-----CCE
Confidence 58899999999999999999999999999999875321 223345567788888877 48899999988843 346
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|+||||++ |+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 899999998 6899999888889999999999999999999999999999999999999999999999999997532221
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
. .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+...
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-------------- 216 (323)
T cd05616 156 V---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-------------- 216 (323)
T ss_pred C---ccccCCCChhhcCHHHhcC--CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 1 1245689999999999987 68999999999999999999999999887654433332210
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCcC
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLAN 411 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~f~~~~~ 411 (509)
. ..+ ....++++.+|+.+||+.||.+|++ ..++++||||+.+.+
T Consensus 217 ------------~--~~~---p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~ 265 (323)
T cd05616 217 ------------N--VAY---PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 265 (323)
T ss_pred ------------C--CCC---CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence 0 000 1246788999999999999999997 489999999987543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=388.99 Aligned_cols=266 Identities=25% Similarity=0.363 Sum_probs=216.3
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc---CC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR---RE 188 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~---~~ 188 (509)
..+|++.+.||+|+||+||+|.+..+|+.||||++............+.+|+.++..+.|+||+++++.+..... ..
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 468999999999999999999999999999999987544444556778899999999999999999887654321 11
Q ss_pred CCcEEEEEeccc-ccHHHHHHhC----CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccc
Q 010489 189 FKDIYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 263 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 263 (509)
...+++||||+. |+|.+++... ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 224789999998 6898888642 46899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChh
Q 010489 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (509)
+........ ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 191 ~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~--~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~------- 260 (496)
T PTZ00283 191 KMYAATVSD-DVGRTFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG------- 260 (496)
T ss_pred eeccccccc-cccccccCCcceeCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC-------
Confidence 865332211 11245689999999999987 67999999999999999999999999876643332221100
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
... ...+.+++++.+||.+||..||.+||++.++++|||++.+.
T Consensus 261 ------------------~~~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~ 304 (496)
T PTZ00283 261 ------------------RYD-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI 304 (496)
T ss_pred ------------------CCC-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence 000 11235788999999999999999999999999999987543
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=371.00 Aligned_cols=251 Identities=29% Similarity=0.481 Sum_probs=205.9
Q ss_pred eeeeeccCceEEEEEEEc---CCCcEEEEEEecCcc--cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 118 QEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++.||+|+||.||+|++. .+++.||||+++... ........+.+|+.+|+.++||||+++++++.. ...+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-----GGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-----CCeE
Confidence 368999999999999864 478899999986421 122334567789999999999999999998844 3468
Q ss_pred EEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
|+||||+. ++|.+++...+.+.+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 76 YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred EEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999998 58999998888899999999999999999999999999999999999999999999999999875322221
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+..
T Consensus 156 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~---------------- 214 (323)
T cd05584 156 ---VTHTFCGTIEYMAPEILMR--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK---------------- 214 (323)
T ss_pred ---cccccCCCccccChhhccC--CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc----------------
Confidence 1234679999999999877 6788999999999999999999999987664333322211
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCC
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGL 409 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~ 409 (509)
.... ..+.+++.+.+||.+||+.||++|| +++++++||||...
T Consensus 215 ----------~~~~-----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 215 ----------GKLN-----LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred ----------CCCC-----CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 0001 1134678899999999999999999 89999999999764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=360.82 Aligned_cols=279 Identities=34% Similarity=0.582 Sum_probs=226.5
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCC--CC----cceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH--PD----IVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~n----iv~~~~~~~~~~ 185 (509)
..+|.+.+.+|+|.||.|..|.+..++..||||+++... ......+-|+++|+++.+ |+ +|.+.++|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF---- 160 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF---- 160 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh----
Confidence 679999999999999999999999999999999997532 233455679999999953 22 55555555
Q ss_pred cCCCCcEEEEEecccccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC------------
Q 010489 186 RREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA------------ 251 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~------------ 251 (509)
+..+++|||+|.++-++++.+..+. +++..+++.+.+||+++++|||+.+++|.||||+|||+.+
T Consensus 161 -dyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 161 -DYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred -hccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 4557799999999999999998875 6899999999999999999999999999999999999642
Q ss_pred --------CCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCC
Q 010489 252 --------DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 323 (509)
Q Consensus 252 --------~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 323 (509)
...|+|+|||.|+...... +..+.|+.|+|||++.+ -+++..+||||+||||+||++|...|++
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEViLg--LGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYRAPEVILG--LGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc------ceeeeccccCCchheec--cCcCCccCceeeeeEEEEeeccceeccc
Confidence 2358999999998643322 45789999999999998 6899999999999999999999999999
Q ss_pred CChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccC---------------CCCCCCCCCCCCCCC---HHHHHHHHH
Q 010489 324 KNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMR---------------KKQPVPFSHKFPNAD---PLALHLLER 385 (509)
Q Consensus 324 ~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~---~~~~~li~~ 385 (509)
.+..++++++..++|..+...+.+.+..+ +....+ ...+.++.......+ .++.|||++
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~K---yf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEK---YFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHh---hhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 99999999999999988888877764222 211110 011222222222222 348899999
Q ss_pred hccCCCCCCCCHHHHhcCCcccCC
Q 010489 386 LLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 386 ~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
||.+||.+|+|+.|+|.||||+.+
T Consensus 389 mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 389 MLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred HHccCccccccHHHHhcCHHhhcC
Confidence 999999999999999999999865
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=369.97 Aligned_cols=279 Identities=24% Similarity=0.380 Sum_probs=215.3
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||.||+|++..++..||+|.+.... .......+.+|+++|+.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 77 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GE 77 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CE
Confidence 368999999999999999999999999999999986432 223456788999999999999999999998543 45
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhC-CeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~-~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+|+||||++ ++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 899999998 58999998888899999999999999999999986 6999999999999999999999999998754322
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH---
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS--- 346 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~--- 346 (509)
. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.... ++.+......
T Consensus 158 ~-----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~ 226 (331)
T cd06649 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI----FGRPVVDGEEGEP 226 (331)
T ss_pred c-----cccCCCCcCcCCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----hcccccccccCCc
Confidence 1 234579999999999987 6799999999999999999999999987654332222 1111100000
Q ss_pred --------------------HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 347 --------------------RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 347 --------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
.............+....+ ........++++++||.+||++||++|||+.++++||||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 227 HSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPP--PKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cccCcccccccccccccccccccchhHHHHHHHHHhCCC--cCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 0000000000000000000 011112467899999999999999999999999999999
Q ss_pred cCC
Q 010489 407 HGL 409 (509)
Q Consensus 407 ~~~ 409 (509)
+..
T Consensus 305 ~~~ 307 (331)
T cd06649 305 KRS 307 (331)
T ss_pred hhc
Confidence 753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=368.55 Aligned_cols=281 Identities=36% Similarity=0.604 Sum_probs=212.0
Q ss_pred eeeeeccCceEEEEEEEcC--CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEE
Q 010489 118 QEVIGKGSYGVVGSAVDTH--TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 195 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 195 (509)
..+||+|+||.||+|.+.. ++..||+|.+... .....+.+|+.+++.++||||+++++++.... ...+|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT----GISMSACREIALLRELKHPNVIALQKVFLSHS---DRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC----CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccC---CCeEEEE
Confidence 3689999999999998654 5689999998642 12345678999999999999999999885432 3468999
Q ss_pred EecccccHHHHHHhC---------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEE----CCCCCeEEeeecc
Q 010489 196 FELMESDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFGL 262 (509)
Q Consensus 196 ~e~~~~~L~~~l~~~---------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl----~~~~~vkl~DFG~ 262 (509)
|||++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 79 FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 999999988887522 248899999999999999999999999999999999999 5668999999999
Q ss_pred cccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCCh---------HhHHHHH
Q 010489 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV---------VHQLDLM 333 (509)
Q Consensus 263 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---------~~~~~~i 333 (509)
++................||+.|+|||++.+. ..++.++|||||||++|||++|++||..... ..++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 98654333222223456889999999988652 4588999999999999999999999975432 3456677
Q ss_pred HHhcCCCChhHHHHhhhHH-HHHhhhccCCC--CCC----CCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 334 TDLLGTPSTESISRIRNEK-ARRYLGSMRKK--QPV----PFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 334 ~~~~g~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
...+|.+..+.+..+.... ........... ... .........+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 7778877766655432110 00000000000 000 0011112346779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=370.12 Aligned_cols=251 Identities=26% Similarity=0.427 Sum_probs=204.5
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCCCcEEEEE
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 196 (509)
+.||+|+||.||+|.++.+|+.||+|+++.... ..........|..++..+ .||+|+++++++.. ...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-----KEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-----CCEEEEEE
Confidence 469999999999999999999999999965321 122345567788888764 89999999999843 45699999
Q ss_pred eccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccc
Q 010489 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (509)
Q Consensus 197 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 275 (509)
||+. ++|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (316)
T cd05620 76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN---R 152 (316)
T ss_pred CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC---c
Confidence 9998 58999998888899999999999999999999999999999999999999999999999999874321111 1
Q ss_pred ccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHH
Q 010489 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (509)
Q Consensus 276 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (509)
....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~-------------------- 210 (316)
T cd05620 153 ASTFCGTPDYIAPEILQG--LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV-------------------- 210 (316)
T ss_pred eeccCCCcCccCHHHHcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------------
Confidence 245689999999999987 6899999999999999999999999987664332222210
Q ss_pred hhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH-HHHhcCCcccCCc
Q 010489 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA-EEALADPYFHGLA 410 (509)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~e~l~hp~f~~~~ 410 (509)
..+ .....+++++.+||.+||..||++||++ +++++||||+...
T Consensus 211 -------~~~----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 211 -------DTP----HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred -------CCC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence 000 0012367889999999999999999997 5899999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=368.91 Aligned_cols=265 Identities=23% Similarity=0.405 Sum_probs=210.6
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|++++.||+|+||.||+|++..+++.||||++.+.. ........+.+|+.++..++|+||+.+++++.. ..+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-----ENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec-----CCe
Confidence 37999999999999999999999999999999986421 122334567889999999999999999999843 356
Q ss_pred EEEEEeccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+|+||||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999997 589999876 457999999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccccccccccccccc---cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
... .....+||+.|+|||++... ...++.++|||||||++|||++|+.||.+.+..+....+...
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~---------- 223 (331)
T cd05597 156 GTV--QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH---------- 223 (331)
T ss_pred CCc--cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC----------
Confidence 211 11234799999999998631 145788999999999999999999999876654433322110
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCC--CCCHHHHhcCCcccCCc
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD--RPTAEEALADPYFHGLA 410 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~e~l~hp~f~~~~ 410 (509)
.....+....+.+++.+++||++||..++++ |++++++++||||.+..
T Consensus 224 ----------------~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 224 ----------------KEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred ----------------CCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence 1111122223457889999999999765544 78999999999998754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=360.65 Aligned_cols=282 Identities=40% Similarity=0.647 Sum_probs=225.9
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
.|++++.||.|++|.||+|++..+++.||||+++...........+.+|++++++++||||+++++++.. ....|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc-----CCcEE
Confidence 3889999999999999999999999999999986433333334568899999999999999999998843 34689
Q ss_pred EEEecccccHHHHHHh--CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 194 VVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 194 lv~e~~~~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
+||||+.++|..++.. ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++........
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 9999999889888865 35689999999999999999999999999999999999999999999999999875432211
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
......+++.|+|||++.+. ..++.++|||||||++|||++|+.||.+.+..+.+..+...++.+....+.....
T Consensus 156 ---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (284)
T cd07860 156 ---TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS- 230 (284)
T ss_pred ---ccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH-
Confidence 12334678999999987652 4468899999999999999999999999888888888888888776654432221
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
...+...+.......+....+.+++.+.++|.+||+.||.+|||++++++||||
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 231 -LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred -HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 111111222222222223345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=369.93 Aligned_cols=251 Identities=28% Similarity=0.478 Sum_probs=204.4
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHH-HHHHcCCCCcceeeeeecCCCcCCCCcEEEEE
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIK-LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 196 (509)
+.||+|+||+||+|++..+|+.||||++.... ........+..|.. +++.++||||+++++.+.. ...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-----~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----ADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-----CCEEEEEE
Confidence 46999999999999999999999999986432 12223445566655 4578999999999998843 34689999
Q ss_pred eccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccc
Q 010489 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (509)
Q Consensus 197 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 275 (509)
||++ ++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (323)
T cd05575 76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK---T 152 (323)
T ss_pred cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC---c
Confidence 9998 58999998888999999999999999999999999999999999999999999999999999875322221 1
Q ss_pred ccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHH
Q 010489 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (509)
Q Consensus 276 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (509)
....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+....+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~-------------------- 210 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN-------------------- 210 (323)
T ss_pred cccccCChhhcChhhhcC--CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc--------------------
Confidence 244679999999999877 6799999999999999999999999987664333322211
Q ss_pred hhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH----HHHhcCCcccCCc
Q 010489 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA----EEALADPYFHGLA 410 (509)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~e~l~hp~f~~~~ 410 (509)
. +. ...+..++.+.+||.+||+.||.+||++ .++++||||..+.
T Consensus 211 -------~-~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 211 -------K-PL---RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred -------C-CC---CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 0 00 1123568889999999999999999987 6999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=368.61 Aligned_cols=251 Identities=28% Similarity=0.469 Sum_probs=203.9
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHH-cCCCCcceeeeeecCCCcCCCCcEEEEE
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRL-LRHPDIVEIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~ 196 (509)
+.||+|+||.||+|.+..+++.||||+++.... ..........|..++.. ..||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-----KEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence 469999999999999999999999999875321 22334455677777765 479999999998843 34689999
Q ss_pred eccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccc
Q 010489 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (509)
Q Consensus 197 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 275 (509)
||++ ++|..++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~---~ 152 (316)
T cd05592 76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG---K 152 (316)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC---c
Confidence 9998 58999998888999999999999999999999999999999999999999999999999999975432221 1
Q ss_pred ccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHH
Q 010489 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (509)
Q Consensus 276 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (509)
....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-------------------- 210 (316)
T cd05592 153 ASTFCGTPDYIAPEILKG--QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-------------------- 210 (316)
T ss_pred cccccCCccccCHHHHcC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--------------------
Confidence 245689999999999887 6789999999999999999999999988765333322211
Q ss_pred hhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH-HHHhcCCcccCCc
Q 010489 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA-EEALADPYFHGLA 410 (509)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~e~l~hp~f~~~~ 410 (509)
..+ .....+++++.+||.+||..||.+||++ .++++||||+.+.
T Consensus 211 -------~~~----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 211 -------DRP----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred -------CCC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence 000 0012367889999999999999999986 5888999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=366.08 Aligned_cols=293 Identities=41% Similarity=0.640 Sum_probs=231.2
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
...+|++.+.||+|+||.||+|.+..+|+.||+|+++...........+.+|+.+++.++|+||+++++++.... ..
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CC
Confidence 346899999999999999999999999999999998643222222334568999999999999999999985432 24
Q ss_pred cEEEEEecccccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|+||||++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 82 SIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred eEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 58999999999998888753 57999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
... .....+++.|+|||++.+. ..++.++|||||||++|||++|++||.+.+..+.+..+...++.+....+....
T Consensus 162 ~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 162 AKP---MTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cCC---CCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 211 2334568899999988652 467899999999999999999999999999988999998888887765544332
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
........ .........+...+...++.+.+||.+||.+||++|||++++++||||++..-
T Consensus 238 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 238 DLPLVGKF-TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred cccccccc-cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence 11100000 00011111122223446889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=370.89 Aligned_cols=250 Identities=29% Similarity=0.457 Sum_probs=206.7
Q ss_pred eeeeccCceEEEEEEE---cCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEE
Q 010489 119 EVIGKGSYGVVGSAVD---THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 195 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~---~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 195 (509)
+.||+|+||.||++.+ ..+|+.||+|+++...........+.+|+.+|++++||||+++++++.. ...+|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-----EGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCEEEEE
Confidence 6799999999999976 3578999999997533333344567789999999999999999999844 3468999
Q ss_pred Eeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCcc
Q 010489 196 FELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 274 (509)
Q Consensus 196 ~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 274 (509)
|||++ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--- 153 (318)
T cd05582 77 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--- 153 (318)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC---
Confidence 99998 68999998888899999999999999999999999999999999999999999999999999976433221
Q ss_pred cccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHH
Q 010489 275 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354 (509)
Q Consensus 275 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (509)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+...
T Consensus 154 ~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~------------------ 213 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA------------------ 213 (318)
T ss_pred ceecccCChhhcCHHHHcC--CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC------------------
Confidence 1234689999999999877 67889999999999999999999999876654333322110
Q ss_pred HhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCC
Q 010489 355 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGL 409 (509)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~f~~~ 409 (509)
... ....+++.+.+||.+||+.||++||+ +++++.||||+.+
T Consensus 214 --------~~~-----~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 214 --------KLG-----MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred --------CCC-----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 000 11246788999999999999999999 7889999999865
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=367.84 Aligned_cols=266 Identities=23% Similarity=0.401 Sum_probs=211.8
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|++.++||+|+||.||++++..+++.||+|++.+.. ........+.+|+.++..++|++|+++++++.. ...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-----ENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----CCE
Confidence 36999999999999999999999999999999986421 112233457789999999999999999998843 346
Q ss_pred EEEEEeccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+|+||||+. |+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 899999997 689999976 467999999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccccccccccccccc---cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
.. ......+||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+.+..+....+..
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~----------- 222 (332)
T cd05623 156 GT--VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN----------- 222 (332)
T ss_pred Cc--ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhC-----------
Confidence 21 112345799999999988531 14688999999999999999999999988765444333321
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCC--CCCHHHHhcCCcccCCcC
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD--RPTAEEALADPYFHGLAN 411 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~e~l~hp~f~~~~~ 411 (509)
......+......+++++.+||.+||..++.+ |++++++++||||.++..
T Consensus 223 ---------------~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~ 274 (332)
T cd05623 223 ---------------HKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW 274 (332)
T ss_pred ---------------CCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence 01111122233467899999999999765554 689999999999987643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=368.90 Aligned_cols=261 Identities=23% Similarity=0.388 Sum_probs=204.9
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCCCcEEEEE
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 196 (509)
+.||+|+||.||+|.+..+++.||||+++.... .......+.+|+.+++.+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-----~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-----ESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-----CCEEEEEE
Confidence 469999999999999999999999999975322 223455678899999888 69999999999844 34689999
Q ss_pred eccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccc
Q 010489 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (509)
Q Consensus 197 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 275 (509)
|||+ ++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (329)
T cd05588 76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC---c
Confidence 9998 58998888888999999999999999999999999999999999999999999999999999874322111 1
Q ss_pred ccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHH
Q 010489 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (509)
Q Consensus 276 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (509)
....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+....... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~----------~~~~~~~~~-----~~~ 215 (329)
T cd05588 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD----------NPDQNTEDY-----LFQ 215 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceechHHHHHHHHHCCCCcccccccc----------cccccchHH-----HHH
Confidence 245689999999999987 688999999999999999999999996422100 000000000 000
Q ss_pred hhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC------HHHHhcCCcccCCcC
Q 010489 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT------AEEALADPYFHGLAN 411 (509)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt------~~e~l~hp~f~~~~~ 411 (509)
.+ ... ... ....+++.+.+||.+||..||.+|++ ++++++||||..+..
T Consensus 216 ~~---~~~-~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 216 VI---LEK-QIR---IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred HH---HcC-CCC---CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 00 001 001 11246788999999999999999987 799999999976543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=359.38 Aligned_cols=285 Identities=41% Similarity=0.715 Sum_probs=231.1
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
+|++.+.||+|+||.||+|.+..+|..||+|++............+.+|+.+++.++||||+++++++.. ...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-----GSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-----CCeeE
Confidence 5899999999999999999999999999999987543333445678899999999999999999999854 34689
Q ss_pred EEEecccccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCC
Q 010489 194 VVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (509)
Q Consensus 194 lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 272 (509)
+||||++++|.+++.. ...+++..+..++.||++||+|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 76 ~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 76 LVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9999997799998864 45799999999999999999999999999999999999999999999999999986543322
Q ss_pred cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHH
Q 010489 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (509)
Q Consensus 273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (509)
.......|+.+|+|||.+.+. ..++.++|||||||++|||++|.+||.+......+..+...++.+....+.......
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred -CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 112345789999999987652 457899999999999999999999999988888888888888877665544322111
Q ss_pred HHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010489 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (509)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 407 (509)
... ...+....+.++...++..+..+.+||.+||..||.+||+++++|+||||.
T Consensus 233 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 233 DYN-KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhh-cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 000 011122222333444567788999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=358.14 Aligned_cols=257 Identities=26% Similarity=0.440 Sum_probs=217.0
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
-|.++++||+|+||.||+|.|+.+|+.+|||++.. ..+.+++.+|+.||++++.|++|++|+.+.-. .++|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~-----sDLW 104 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKH-----SDLW 104 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccC-----CceE
Confidence 47788999999999999999999999999999853 46788999999999999999999999987543 3599
Q ss_pred EEEeccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 194 VVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 194 lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
||||||+ |++.++++. +.+|+++++..+++..++||+|||...-||||||..|||++.+|..||+|||.|..+.+...
T Consensus 105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 9999999 789998864 56899999999999999999999999999999999999999999999999999976644332
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
+ ..+.+|||.|||||++.. -.|+.++||||||++..||..|++||.+-.....+
T Consensus 185 K---RNTVIGTPFWMAPEVI~E--IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI--------------------- 238 (502)
T KOG0574|consen 185 K---RNTVIGTPFWMAPEVIEE--IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI--------------------- 238 (502)
T ss_pred h---hCccccCcccccHHHHHH--hccchhhhHhhhcchhhhhhcCCCCccccccccee---------------------
Confidence 2 356899999999999987 68999999999999999999999999764432111
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCC
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 412 (509)
..++..+|..+. .....+.++.||+++||.+.|++|-||.++++|||+++...+
T Consensus 239 ------FMIPT~PPPTF~-KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~ 292 (502)
T KOG0574|consen 239 ------FMIPTKPPPTFK-KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGC 292 (502)
T ss_pred ------EeccCCCCCCCC-ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcc
Confidence 112223332222 223457889999999999999999999999999999865443
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=371.20 Aligned_cols=259 Identities=27% Similarity=0.357 Sum_probs=202.8
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
..+|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++|+||+++++++. ....
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 146 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFD-----HNGE 146 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEec-----cCCe
Confidence 457889999999999999999999999999999986432 2234567889999999999999999999884 3456
Q ss_pred EEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|+|||||.+ +|.. .....+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 147 ~~lv~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 147 IQVLLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEEEEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 8999999995 5543 2346778888999999999999999999999999999999999999999999998653222
Q ss_pred CCcccccccccccccccccccccc---cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
. .....+||..|+|||++... ...++.++|||||||++|||++|+.||......+....+...
T Consensus 223 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~----------- 288 (353)
T PLN00034 223 D---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI----------- 288 (353)
T ss_pred c---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH-----------
Confidence 1 12345899999999987431 123456899999999999999999999743321111111100
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
....+ ......+++++.+||.+||..||++|||+.|+|+||||.+..
T Consensus 289 -------------~~~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 289 -------------CMSQP---PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred -------------hccCC---CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 00000 011235678899999999999999999999999999998753
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=367.32 Aligned_cols=260 Identities=23% Similarity=0.394 Sum_probs=203.6
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCCCcEEEEE
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 196 (509)
+.||+|+||.||+|.+..+++.||+|++++... .......+.+|+.++..+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----ESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-----CCEEEEEE
Confidence 469999999999999999999999999975422 233455677899988776 79999999999844 34689999
Q ss_pred eccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccc
Q 010489 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (509)
Q Consensus 197 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 275 (509)
||++ ++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~---~ 152 (329)
T cd05618 76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---c
Confidence 9998 58988888888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHH
Q 010489 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (509)
Q Consensus 276 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (509)
....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.......+ ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----------~~~~~~~~~~----~~~ 216 (329)
T cd05618 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD----------NPDQNTEDYL----FQV 216 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceecccHHHHHHhhCCCCCccCCCcC----------CcccccHHHH----HHH
Confidence 234689999999999987 688999999999999999999999995321100 0000000000 000
Q ss_pred hhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC------HHHHhcCCcccCCc
Q 010489 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT------AEEALADPYFHGLA 410 (509)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt------~~e~l~hp~f~~~~ 410 (509)
.. ..... .....+..+.+||.+||..||++||+ +.++++||||+.+.
T Consensus 217 i~---~~~~~-----~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 269 (329)
T cd05618 217 IL---EKQIR-----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 269 (329)
T ss_pred Hh---cCCCC-----CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 00 00111 11346788999999999999999998 58999999998754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=358.40 Aligned_cols=282 Identities=37% Similarity=0.678 Sum_probs=218.2
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++.+.||+|+||.||+|.++.+|+.||+|++..........+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-----KRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-----CCEE
Confidence 37999999999999999999999999999999886432222233557789999999999999999999844 3468
Q ss_pred EEEEecccccH-HHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 193 YVVFELMESDL-HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 193 ~lv~e~~~~~L-~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
|+||||+++++ ..++.....+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99999999754 44545556799999999999999999999999999999999999999999999999999986533221
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
......++..|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.............
T Consensus 156 ---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 156 ---DYTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred ---cccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 12345688999999987652 45788999999999999999999999988877766666655554333211111000
Q ss_pred HHHHhhhccCCCC---CCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 352 KARRYLGSMRKKQ---PVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 352 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
.+........ ..+....++.++..+.+||.+||..||++||++.|++.||||
T Consensus 232 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 232 ---QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ---cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000000000 111122345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=367.24 Aligned_cols=251 Identities=25% Similarity=0.438 Sum_probs=206.5
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCCCcEEEEE
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 196 (509)
+.||+|+||+||+|.+..+++.||||++++.. ........+.+|+.+++.+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-----~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-----KDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence 46999999999999999999999999987432 1223455677899999888 69999999998843 34699999
Q ss_pred eccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccc
Q 010489 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (509)
Q Consensus 197 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 275 (509)
||++ ++|...+...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (318)
T cd05570 76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---T 152 (318)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC---c
Confidence 9998 58988888888999999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHH
Q 010489 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (509)
Q Consensus 276 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (509)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~-------------------- 210 (318)
T cd05570 153 TSTFCGTPDYIAPEILSY--QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE-------------------- 210 (318)
T ss_pred ccceecCccccCHHHhcC--CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc--------------------
Confidence 234579999999999987 6889999999999999999999999987664333222210
Q ss_pred hhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH-----HHHhcCCcccCCc
Q 010489 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA-----EEALADPYFHGLA 410 (509)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~f~~~~ 410 (509)
... . ....+++.+.+||.+||..||++||++ .++++||||+...
T Consensus 211 -------~~~-~---~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 211 -------DEV-R---YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred -------CCC-C---CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 000 0 012467889999999999999999999 9999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=366.10 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=204.8
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHH-cCCCCcceeeeeecCCCcCCCCcEEEEE
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRL-LRHPDIVEIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~ 196 (509)
+.||+|+||.||+|.+..+++.||||+++.... ..........|..++.. +.||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-----KENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-----CCEEEEEE
Confidence 469999999999999999999999999875321 12234556778888876 489999999999854 34689999
Q ss_pred eccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccc
Q 010489 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (509)
Q Consensus 197 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 275 (509)
||++ |+|..++.....+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++........ .
T Consensus 76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (316)
T cd05619 76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA---K 152 (316)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC---c
Confidence 9998 68999998878899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHH
Q 010489 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (509)
Q Consensus 276 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (509)
....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+....+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~-------------------- 210 (316)
T cd05619 153 TCTFCGTPDYIAPEILLG--QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM-------------------- 210 (316)
T ss_pred eeeecCCccccCHHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------------
Confidence 234679999999999877 6789999999999999999999999987664333222210
Q ss_pred hhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHH-HHhcCCcccCCcC
Q 010489 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE-EALADPYFHGLAN 411 (509)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~-e~l~hp~f~~~~~ 411 (509)
..+. + ...++.++.+||.+||..||++||++. ++++||||+.+..
T Consensus 211 -------~~~~-~---~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 211 -------DNPC-Y---PRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred -------CCCC-C---CccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence 0000 0 123678899999999999999999996 9999999987643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=365.62 Aligned_cols=256 Identities=23% Similarity=0.399 Sum_probs=208.8
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCCCc
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 191 (509)
+|++.+.||+|+||.||+|.++.+|+.||||++++... .......+..|+.+++.+. |++|+.+++++.. ...
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-----VDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-----CCE
Confidence 47889999999999999999999999999999864321 2234456778999998886 5677788888743 346
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|+||||++ ++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 899999998 5899999888899999999999999999999999999999999999999999999999999987532221
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
. .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+...
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-------------- 216 (323)
T cd05615 156 V---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH-------------- 216 (323)
T ss_pred c---cccCccCCccccCHHHHcC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 1 1234579999999999877 67899999999999999999999999877653333222110
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCc
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLA 410 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~f~~~~ 410 (509)
... ....+++++.+|+.+||..||.+|++ .+++++||||+.+.
T Consensus 217 ------------~~~-----~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 217 ------------NVS-----YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred ------------CCC-----CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 000 11246788999999999999999997 58999999998754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=371.66 Aligned_cols=263 Identities=25% Similarity=0.362 Sum_probs=209.3
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
..+|++.+.||+|+||.||+|++..+++.||+|++.... ........+.+|+.+++.++||||+++++++.. ..
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-----~~ 116 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-----DR 116 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-----CC
Confidence 468999999999999999999999999999999986421 122334557789999999999999999999843 35
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|+|||||+ ++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 6999999998 578888765 46899999999999999999999999999999999999999999999999999865322
Q ss_pred CCCccccccccccccccccccccccc--CCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
.. ......+||+.|+|||++.+.. ..++.++|||||||++|||++|+.||.+.+.......+...
T Consensus 196 ~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~----------- 262 (371)
T cd05622 196 GM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH----------- 262 (371)
T ss_pred Cc--ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------
Confidence 11 1123568999999999986521 23789999999999999999999999887654433332211
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCC--CCCHHHHhcCCcccCC
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD--RPTAEEALADPYFHGL 409 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~e~l~hp~f~~~ 409 (509)
.....+. ....+++.+.+||.+||..++.+ |++++++++||||++.
T Consensus 263 ---------------~~~~~~~-~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 263 ---------------KNSLTFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred ---------------CCcccCC-CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 0001111 12357889999999999844433 7899999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=369.61 Aligned_cols=259 Identities=30% Similarity=0.441 Sum_probs=222.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.+.|.+++++|+|+||.+++++++..+..|++|++.-.............|+.++++++|||||.+.+.|... ...
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~----~~~ 78 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED----GQL 78 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC----Cce
Confidence 4679999999999999999999999999999999976555555566788999999999999999999998543 234
Q ss_pred EEEEEeccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 192 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
++|||+||+ |++.+.+.+.+ .|+++.+..|+.||+.|+.|||+++|+|||||+.||+++.++.|||+|||+|+....
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 999999999 58988886543 699999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... ...+++|||.||+||++.+ .+|+.|+|||||||++|||++-+++|.+.+.......|......|-
T Consensus 159 ~~~---~a~tvvGTp~YmcPEil~d--~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl------- 226 (426)
T KOG0589|consen 159 EDS---LASTVVGTPYYMCPEILSD--IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL------- 226 (426)
T ss_pred chh---hhheecCCCcccCHHHhCC--CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC-------
Confidence 542 2366899999999999998 7999999999999999999999999999887655555543322211
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
-...+.+++.||..||..+|..||++.++|.+|.+...
T Consensus 227 -----------------------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 227 -----------------------PSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred -----------------------CccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 12457789999999999999999999999999988633
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=356.98 Aligned_cols=258 Identities=34% Similarity=0.586 Sum_probs=211.4
Q ss_pred eeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEE
Q 010489 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 194 (509)
Q Consensus 115 y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 194 (509)
|++++.||+|+||+||+|.+..+++.||+|++..............+|+.++++++||||+++++++.. ...+++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 899999999999999999999999999999997643333333445669999999999999999999954 456899
Q ss_pred EEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCc
Q 010489 195 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273 (509)
Q Consensus 195 v~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 273 (509)
||||+++ +|.+++...+.+++..+..++.||++||++||+.||+||||||+||+++.++.++|+|||.+..... ..
T Consensus 76 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~---~~ 152 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE---NN 152 (260)
T ss_dssp EEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS---TT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc
Confidence 9999997 9999998788899999999999999999999999999999999999999999999999999975411 11
Q ss_pred ccccccccccccccccccc-cccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHH
Q 010489 274 IFWTDYVATRWYRAPELCG-SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (509)
Q Consensus 274 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (509)
.......+|+.|+|||++. + ..++.++||||||+++|+|++|..||......+....+.........
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------- 220 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQG--KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLP---------- 220 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTT--SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHH----------
T ss_pred ccccccccccccccccccccc--ccccccccccccccccccccccccccccccchhhhhhhhhccccccc----------
Confidence 2235568999999999987 4 67899999999999999999999999887544444443332211100
Q ss_pred HHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
..... .....+.+.++|.+||+.||++||++.++++||||
T Consensus 221 -----~~~~~---------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 221 -----SSSQQ---------SREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp -----HHTTS---------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred -----ccccc---------cchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 00000 00112679999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=359.45 Aligned_cols=288 Identities=37% Similarity=0.636 Sum_probs=226.5
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|++.+.||+|+||.||+|.+..+++.||||+++...........+.+|+.+++.+. ||||+++++++..........
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3699999999999999999999999999999998654333333456788999999995 699999999886554333445
Q ss_pred EEEEEecccccHHHHHHhC-----CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC-CCCeEEeeeccccc
Q 010489 192 IYVVFELMESDLHQVIKAN-----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARV 265 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~~-----~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~-~~~vkl~DFG~a~~ 265 (509)
+|+||||++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 8999999999998888643 35799999999999999999999999999999999999998 88999999999875
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
....... .....+++.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+....+..+...++.+....+
T Consensus 161 ~~~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 161 FSIPVKS---YTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cCCCccc---cCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 4322111 2234678999999987652 46789999999999999999999999998887777777777777665543
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 407 (509)
......... ...+...+.......+..++.+.+||.+||..||.+||++.+++.||||+
T Consensus 237 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDW---HEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccch---hhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 322111100 00111122222233456788999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=365.03 Aligned_cols=265 Identities=23% Similarity=0.386 Sum_probs=211.2
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|++.+.||+|+||.||+|++..+++.||+|++.+.. ........+.+|+.++..+.|++|+.+++++.. ...
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-----~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-----ENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CCE
Confidence 37999999999999999999999999999999986421 122334557789999999999999999999843 456
Q ss_pred EEEEEeccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+|+||||+. |+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 899999998 689999976 467999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCccccccccccccccccccccccc---CCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
... .....+||+.|+|||++.+.. ..++.++|||||||++|||++|+.||.+.+..+....+..
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~----------- 222 (331)
T cd05624 156 GTV--QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN----------- 222 (331)
T ss_pred Cce--eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc-----------
Confidence 211 123357999999999876421 3578899999999999999999999987665433322211
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCC--CCCHHHHhcCCcccCCc
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD--RPTAEEALADPYFHGLA 410 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~e~l~hp~f~~~~ 410 (509)
.....++......+++++.+||.+||..++.+ |++++++++||||+.+.
T Consensus 223 ---------------~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 223 ---------------HEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred ---------------CCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence 01111222334567889999999999976655 57899999999998653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=359.53 Aligned_cols=287 Identities=41% Similarity=0.669 Sum_probs=230.3
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccC---hhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH---VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
+|++.+.||+|+||.||+|.+..+++.||||+++..... ......+..|+.+++.++|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence 588999999999999999999999999999998653322 2234556789999999999999999999854 35
Q ss_pred cEEEEEecccccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|+||||+.++|.+++.... .+++..+..++.||++||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 689999999889999998766 7999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
... .....+++.|+|||.+.+. ..++.++|||||||++|||++|.+||.+.+..+.+..+...++.+....+....
T Consensus 156 ~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NRK---MTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred Ccc---ccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 211 2334678899999987542 467889999999999999999999999888877777777777776655443221
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 412 (509)
.. ..+ .......+.+....+...+..+.+||.+||.+||++|||+.++++||||++...+
T Consensus 232 ~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~ 291 (298)
T cd07841 232 SL--PDY-VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP 291 (298)
T ss_pred cc--ccc-ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence 11 011 1111122233334456678899999999999999999999999999999875443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=360.34 Aligned_cols=294 Identities=36% Similarity=0.548 Sum_probs=225.8
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc---C
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR---R 187 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~---~ 187 (509)
..++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++..... .
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3568999999999999999999999999999999986433322333456789999999999999999998865432 1
Q ss_pred CCCcEEEEEecccccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 188 EFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 188 ~~~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
.....|+||||++++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++...
T Consensus 90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 234579999999999988886553 7899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCC-cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 267 FNDAPS-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 267 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
...... ........++..|+|||++.+. ..++.++||||||+++|||++|.+||.+.+....+..+..+.|..+.+..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW 248 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 332211 1112345688999999987652 45788999999999999999999999998888888888888877665543
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCC--CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFS--HKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
...........+. .+........ ......++.+.+||.+||..||.+|||++++|+||||
T Consensus 249 ~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 249 PGVDKLELFKKME-LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccccchhhhhhcc-CCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 3221111100000 0000000000 0011246778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=371.69 Aligned_cols=278 Identities=26% Similarity=0.354 Sum_probs=206.7
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
..|++++.||+|+||.||+|.+..++..||+|+... .....|+.+++.++||||+++++++... ...
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 132 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK--------GTTLIEAMLLQNVNHPSVIRMKDTLVSG-----AIT 132 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc--------cccHHHHHHHHhCCCCCCcChhheEEeC-----Cee
Confidence 479999999999999999999999999999997532 1235699999999999999999998543 458
Q ss_pred EEEEecccccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 193 YVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 193 ~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
|+|||++.++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 133 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 212 (357)
T PHA03209 133 CMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA 212 (357)
T ss_pred EEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcc
Confidence 99999999999988865 45799999999999999999999999999999999999999999999999999975322211
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCC-CCCCCCh---------HhHHHHHHHhcCCCC
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKP-LFPGKNV---------VHQLDLMTDLLGTPS 341 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~-pf~~~~~---------~~~~~~i~~~~g~~~ 341 (509)
.....||+.|+|||++.+ ..++.++|||||||++|||+++.. +|..... ..++..+...++..+
T Consensus 213 ----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 286 (357)
T PHA03209 213 ----FLGLAGTVETNAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHP 286 (357)
T ss_pred ----cccccccccccCCeecCC--CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccCh
Confidence 234679999999999987 679999999999999999998654 4443221 122233333333322
Q ss_pred hhHHHHhhhHHHHHhhhcc-CCCCCCCC--CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 342 TESISRIRNEKARRYLGSM-RKKQPVPF--SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
..............++... ....+... ......++..+.+||.+||+.||.+|||+.|+|+||||+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 287 EEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred hhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 2111000000011111100 00111100 01112456788999999999999999999999999999863
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=357.06 Aligned_cols=258 Identities=26% Similarity=0.379 Sum_probs=207.9
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
.|++.+.||+|+||.||++.+..+++.||||++.... ........+.+|+.+++.++||||+++++.+... ..+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-----DAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC-----CeE
Confidence 4889999999999999999999999999999986422 1222234567899999999999999999988443 458
Q ss_pred EEEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 193 YVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
|+||||++ ++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999998 5788777543 46999999999999999999999999999999999999999999999999999764322
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
.. ....+|++.|+|||++.+ ..++.++||||+||++|||++|+.||.+.........+...+
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~------------ 217 (285)
T cd05605 156 ET----IRGRVGTVGYMAPEVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRV------------ 217 (285)
T ss_pred Cc----cccccCCCCccCcHHhcC--CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHh------------
Confidence 21 234579999999999876 678999999999999999999999998765432222111100
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGL 409 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~ 409 (509)
... +. ......++.+.+||.+||..||++|| +++++++||||...
T Consensus 218 -----------~~~-~~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 218 -----------KED-QE---EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred -----------hhc-cc---ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 000 00 11134678899999999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=357.22 Aligned_cols=286 Identities=37% Similarity=0.657 Sum_probs=222.7
Q ss_pred CCCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 110 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 110 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
+..++|++.+.||+|++|.||+|.++.+++.||||.+...... .....+.+|+.+++.++|+||+++++++.. .
T Consensus 2 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~ 75 (291)
T cd07844 2 GKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHT-----K 75 (291)
T ss_pred CCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEec-----C
Confidence 3457899999999999999999999989999999998643222 122346789999999999999999999843 3
Q ss_pred CcEEEEEecccccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 190 KDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 190 ~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
...|+||||+.++|.+++... ..+++..++.++.|+++||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 76 KTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred CeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 568999999999999988764 4689999999999999999999999999999999999999999999999999875322
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCC-hHhHHHHHHHhcCCCChhHHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN-VVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
... ......++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.. ..+++..+.+.++.+....+..
T Consensus 156 ~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07844 156 PSK---TYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPG 231 (291)
T ss_pred CCc---cccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhh
Confidence 111 11234578899999987652 457889999999999999999999998766 5667777777777776655433
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCC--HHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNAD--PLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
........ ........+.+.....+..+ ..+.++|.+||..||++|||+.++++||||
T Consensus 232 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 232 VSSNPEFK-PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhhccccc-cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 32110000 00000111111222233444 789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=365.47 Aligned_cols=299 Identities=42% Similarity=0.682 Sum_probs=226.6
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc-----
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR----- 186 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~----- 186 (509)
.++|++.+.||.|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 478999999999999999999999999999999986432 2345668899999999999999999987754321
Q ss_pred ----CCCCcEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC-CCCeEEeeec
Q 010489 187 ----REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFG 261 (509)
Q Consensus 187 ----~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~-~~~vkl~DFG 261 (509)
.+...+|+||||++++|.+++.. +.+++..++.++.||++||.|||+.||+||||||+||+++. ++.+||+|||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 82 VGSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred cccccccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 12245899999999998887754 47999999999999999999999999999999999999975 5578999999
Q ss_pred ccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCC
Q 010489 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341 (509)
Q Consensus 262 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~ 341 (509)
++.................|+..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+.......+.+....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 997643221111112334688999999986542 4688899999999999999999999998887666666555544443
Q ss_pred hhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCC
Q 010489 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDRE 415 (509)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~ 415 (509)
.+........... ...........++....+..+.++.+||.+||..||.+|||++++|+||||+.+..+...
T Consensus 240 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~ 312 (342)
T cd07854 240 EEDRNELLNVIPS-FVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDE 312 (342)
T ss_pred hHHhhhhhhhhhh-hhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCccc
Confidence 3322222111111 111011111122223345678899999999999999999999999999999877654433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=378.32 Aligned_cols=280 Identities=25% Similarity=0.315 Sum_probs=208.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
...|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+++|++++|+||+++++++... ..
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~-----~~ 234 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVG-----GL 234 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEEC-----CE
Confidence 457999999999999999999999999999999642 23356899999999999999999988443 45
Q ss_pred EEEEEecccccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.|+|||++.++|..++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 235 ~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 235 TCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 8999999999999888764 469999999999999999999999999999999999999999999999999997653322
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCC-CCCC------hHhHHHHHHHhcCCCChh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF-PGKN------VVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~------~~~~~~~i~~~~g~~~~~ 343 (509)
.. ......+||+.|+|||++.+ ..++.++|||||||+||||++|..|+ .... ...++..+....+....+
T Consensus 315 ~~-~~~~~~~GT~~Y~APE~~~~--~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 315 ST-PFHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred cc-ccccccCCCcCCcCHHHHcC--CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 11 11234679999999999987 67999999999999999999987554 3221 122333333322211111
Q ss_pred H----HHHhhhHHHHHhhhc-cCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 344 S----ISRIRNEKARRYLGS-MRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 344 ~----~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
. ..++........... ........| ..+...++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAW-TRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcch-hhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0 000000000000000 001111111 122356778999999999999999999999999999964
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-47 Score=398.25 Aligned_cols=267 Identities=25% Similarity=0.397 Sum_probs=225.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|.|+++||+|+||.|.+++++.+++.||+|++++... ...+...|..|-.+|.....+-|+.++..| .+..
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~~ 148 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDER 148 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCcc
Confidence 4689999999999999999999999999999999976321 123456678899999999999999998888 5567
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
++|+|||||+ |||..++.+.++++++.+++++..|+.||.-||+.|+|||||||+|||+|..|++||+|||.+-.+..+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 8999999998 699999998889999999999999999999999999999999999999999999999999998766433
Q ss_pred CCCcccccccccccccccccccccc--c-CCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSF--F-SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~--~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
. .......+|||.|.|||++... . +.|++.+|+||+||++|||+.|..||..++..+.+..|..-
T Consensus 229 G--~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h---------- 296 (1317)
T KOG0612|consen 229 G--TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH---------- 296 (1317)
T ss_pred C--cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch----------
Confidence 3 3334567999999999998533 2 56999999999999999999999999988877666655431
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC---HHHHhcCCcccCCcCCC
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT---AEEALADPYFHGLANVD 413 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~f~~~~~~~ 413 (509)
.....++ ....+|+++++||++++. +|+.|.. ++++..||||.++.+..
T Consensus 297 ----------------k~~l~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~ 348 (1317)
T KOG0612|consen 297 ----------------KESLSFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDN 348 (1317)
T ss_pred ----------------hhhcCCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhh
Confidence 1112222 123589999999999998 8999998 99999999999988743
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=366.75 Aligned_cols=251 Identities=29% Similarity=0.485 Sum_probs=203.7
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHH-HHHHcCCCCcceeeeeecCCCcCCCCcEEEEE
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIK-LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 196 (509)
+.||+|+||.||+|.+..+|+.||||++..... .......+.+|.. +++.++||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----TEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-----CCEEEEEE
Confidence 469999999999999999999999999864321 2233445566665 4677999999999998843 34689999
Q ss_pred eccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccc
Q 010489 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (509)
Q Consensus 197 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 275 (509)
||+. ++|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---~ 152 (325)
T cd05604 76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---T 152 (325)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC---C
Confidence 9998 58888888888999999999999999999999999999999999999999999999999999875322221 1
Q ss_pred ccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHH
Q 010489 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (509)
Q Consensus 276 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (509)
....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+....+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~-------------------- 210 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRK--QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH-------------------- 210 (325)
T ss_pred cccccCChhhCCHHHHcC--CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc--------------------
Confidence 245689999999999987 6789999999999999999999999987664333222211
Q ss_pred hhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH----HHHhcCCcccCCc
Q 010489 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA----EEALADPYFHGLA 410 (509)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~e~l~hp~f~~~~ 410 (509)
.. . ...+..+..+.++|.+||+.||.+||++ .++++||||....
T Consensus 211 ------~~--~---~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 211 ------KP--L---VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred ------CC--c---cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 00 0 1123567889999999999999999976 5999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=357.32 Aligned_cols=254 Identities=25% Similarity=0.376 Sum_probs=202.0
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEecc
Q 010489 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM 199 (509)
Q Consensus 121 lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 199 (509)
||+|+||+||+|.+..+++.||+|++..... .......+..|+.+++.++|+||+++.+++.. ...+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-----KTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-----CCeEEEEEeCC
Confidence 7999999999999999999999999864321 22234567789999999999999999998843 34589999999
Q ss_pred c-ccHHHHHH----hCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCcc
Q 010489 200 E-SDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 274 (509)
Q Consensus 200 ~-~~L~~~l~----~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 274 (509)
+ ++|..++. ....+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-- 153 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-- 153 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--
Confidence 8 57877663 2356999999999999999999999999999999999999999999999999999764332211
Q ss_pred cccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHH
Q 010489 275 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354 (509)
Q Consensus 275 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (509)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+..
T Consensus 154 -~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~------------------- 211 (280)
T cd05608 154 -TKGYAGTPGFMAPELLQG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ------------------- 211 (280)
T ss_pred -ccccCCCcCccCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH-------------------
Confidence 234579999999999987 6889999999999999999999999976542111100000
Q ss_pred HhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCcC
Q 010489 355 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLAN 411 (509)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~~ 411 (509)
... ..+. ......++.+.+|+.+||+.||++|| +++++++||||+++.+
T Consensus 212 ----~~~-~~~~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~ 265 (280)
T cd05608 212 ----RIL-NDSV---TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNW 265 (280)
T ss_pred ----hhc-ccCC---CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence 000 0011 11234788899999999999999999 8899999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=344.85 Aligned_cols=277 Identities=26% Similarity=0.396 Sum_probs=220.7
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCCCcEEEEE
Q 010489 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~ 196 (509)
.+.||+|+||.|-.|....+|..||||++.+. ......++.+|++++.+++ |+||+.++++| ++...+|+||
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FYLVf 155 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFYLVF 155 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEEEEE
Confidence 46899999999999999999999999999764 3345678999999999986 99999999999 5556699999
Q ss_pred eccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCC---eEEeeecccccccCCCC-
Q 010489 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLARVSFNDAP- 271 (509)
Q Consensus 197 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~---vkl~DFG~a~~~~~~~~- 271 (509)
|-|. |.|...|+++..|++.++..++.+|+.||.|||.+||.||||||+|||-.+... ||||||.++.......+
T Consensus 156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 9998 589999999999999999999999999999999999999999999999876544 79999998864322211
Q ss_pred ---Ccccccccccccccccccccc---cccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 272 ---SAIFWTDYVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 272 ---~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
....+.+.+|+..|||||+.. +....|+.++|.||||||||.||+|.+||.|....+-- +--|.+...-
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG----WdrGe~Cr~C- 310 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG----WDRGEVCRVC- 310 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC----ccCCCccHHH-
Confidence 222245678999999999753 33356999999999999999999999999886531100 0001111100
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCC
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 413 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 413 (509)
...++..+.......+...|..++.+++|||..+|..|+.+|.++.++++|||++......
T Consensus 311 -------Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ek 371 (463)
T KOG0607|consen 311 -------QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEK 371 (463)
T ss_pred -------HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhc
Confidence 0122333444445555677888999999999999999999999999999999998776543
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=368.03 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=201.7
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHc---CCCCcceeeeeecCCCcCCCCcEEEEE
Q 010489 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLL---RHPDIVEIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 121 lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~ 196 (509)
||+|+||+||+|++..+++.||||++.+.. ...........|..++..+ .||+|+.+++++.. ...+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-----~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT-----DSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-----CCeEEEEE
Confidence 799999999999999999999999986421 1222344556677777665 69999999998844 34689999
Q ss_pred eccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccc
Q 010489 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (509)
Q Consensus 197 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 275 (509)
||+. ++|..++...+.+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~---~ 152 (330)
T cd05586 76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK---T 152 (330)
T ss_pred cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---C
Confidence 9998 58999998888999999999999999999999999999999999999999999999999999875322221 1
Q ss_pred ccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHH
Q 010489 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (509)
Q Consensus 276 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (509)
....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~-------------------- 211 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF-------------------- 211 (330)
T ss_pred ccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc--------------------
Confidence 2456899999999998652 4588999999999999999999999987664332222210
Q ss_pred hhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC----CHHHHhcCCcccCCc
Q 010489 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP----TAEEALADPYFHGLA 410 (509)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----t~~e~l~hp~f~~~~ 410 (509)
.....+ ...+++.+.+||.+||..||.+|| ++.++++||||....
T Consensus 212 ------~~~~~~----~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 212 ------GKVRFP----KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred ------CCCCCC----CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 000000 123678899999999999999998 799999999998654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=358.26 Aligned_cols=286 Identities=40% Similarity=0.659 Sum_probs=228.8
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
.+|++.+.||.|+||.||+|.+..+++.||+|.++...........+.+|+.+++.++||||+++++++.... ...+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcE
Confidence 5799999999999999999999999999999998743333233345678999999999999999999885432 2569
Q ss_pred EEEEecccccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 193 YVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 193 ~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
|+||||++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 82 ~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 82 YMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred EEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 9999999999998887654 599999999999999999999999999999999999999999999999999986543321
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
......+++.|+|||.+.+. ..++.++|||||||++|+|++|.+||.+....+.+..+...++.|....+..+..-
T Consensus 162 ---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 162 ---PYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred ---ccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 12345688999999988652 34688999999999999999999999998888888888888888777665443211
Q ss_pred HHHHhhhccCCCCCCCCCCCCCC--CCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPN--ADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
..... ..........+...++. .++.+.+||.+||+.||++|||+.|+|+||||
T Consensus 238 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 238 PGAKK-KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred chhcc-cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 10000 01111112222334444 38889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=362.68 Aligned_cols=260 Identities=28% Similarity=0.438 Sum_probs=205.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~~ 190 (509)
...|+++++||+||.+.||++... ....||+|++.....+......+..|+..|.+|+ |.+||+++++-+. ++
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-----d~ 433 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-----DG 433 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-----Cc
Confidence 357999999999999999999764 4567888877655566677888999999999996 9999999998865 35
Q ss_pred cEEEEEecccccHHHHHHhCCC-CCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~-l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
++||||||-+.||..+|.+... .+.-.++.+..||+.|+.++|..||||.||||.|+|+- .|.+||+|||+|.....+
T Consensus 434 ~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 434 YLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred eEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 6999999999999999987754 33358899999999999999999999999999999985 789999999999877655
Q ss_pred CCCcccccccccccccccccccccccC---------CCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCC
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFS---------KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~---------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~ 340 (509)
.. .+...+.+||+.|||||.+..... +.+.++||||||||||+|+.|++||..-. .++..+..+. .|
T Consensus 513 TT-sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~-~P 588 (677)
T KOG0596|consen 513 TT-SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAIT-DP 588 (677)
T ss_pred cc-ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhc-CC
Confidence 43 334456799999999998754211 25678999999999999999999995321 1122211110 11
Q ss_pred ChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCC--CHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNA--DPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
. ..+ .|+.. ..+++++++.||++||++||++.++|+|||++.
T Consensus 589 ~----------------------~~I----efp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 589 N----------------------HEI----EFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred C----------------------ccc----cccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 1 111 12222 223999999999999999999999999999975
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=366.38 Aligned_cols=283 Identities=23% Similarity=0.365 Sum_probs=214.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.++||+|+||.||+|.+..++..+|+|.+.... .......+.+|+++++.++||||+++++++.. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 77 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGE 77 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCE
Confidence 368999999999999999999999999999999886432 22345678899999999999999999999854 346
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhC-CeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~-~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+|+||||+. ++|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999998 58999998888899999999999999999999975 7999999999999999999999999998754322
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHH-hcCCCChhHHHH-
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTD-LLGTPSTESISR- 347 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~-~~g~~~~~~~~~- 347 (509)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.. ..+.+.......
T Consensus 158 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred c-----cccCCCCccccCHHHhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 1 134579999999999877 6789999999999999999999999987654322221110 111111000000
Q ss_pred hhh---------------HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 348 IRN---------------EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 348 ~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.+. ..............+... .....+.++.+||.+||++||++|||++|++.||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL--PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccC--CCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 000 000000000000111000 112357889999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=363.96 Aligned_cols=251 Identities=28% Similarity=0.467 Sum_probs=203.5
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHH-HHHHcCCCCcceeeeeecCCCcCCCCcEEEEE
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIK-LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 196 (509)
+.||+|+||+||+|++..+++.||+|++..... .......+..|.. +++.++||||+++++++.. ...+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-----~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-----ADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-----CCeEEEEE
Confidence 469999999999999999999999999864221 1122334455554 4678899999999998843 34689999
Q ss_pred eccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccc
Q 010489 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (509)
Q Consensus 197 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 275 (509)
||++ ++|.+++...+.+++..+..++.||++||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~---~ 152 (325)
T cd05602 76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---T 152 (325)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC---C
Confidence 9998 58999998888899999999999999999999999999999999999999999999999999975432221 1
Q ss_pred ccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHH
Q 010489 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (509)
Q Consensus 276 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (509)
....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+.+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-------------------- 210 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN-------------------- 210 (325)
T ss_pred cccccCCccccCHHHHcC--CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh--------------------
Confidence 245689999999999887 6899999999999999999999999987765443332211
Q ss_pred hhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHH----HHhcCCcccCCc
Q 010489 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE----EALADPYFHGLA 410 (509)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~----e~l~hp~f~~~~ 410 (509)
.+. ...+.+++.+.+||.+||+.||.+|+++. ++++|+||....
T Consensus 211 --------~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~ 258 (325)
T cd05602 211 --------KPL---QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN 258 (325)
T ss_pred --------CCc---CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence 000 11245788899999999999999999875 899999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=360.03 Aligned_cols=293 Identities=38% Similarity=0.629 Sum_probs=228.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc---CC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR---RE 188 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~---~~ 188 (509)
.++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999999999999999986432222223456789999999999999999998765432 23
Q ss_pred CCcEEEEEecccccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 189 FKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 189 ~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
...+|+||||+++++...+.. ...+++..++.++.||++||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 456899999999988887765 3479999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCC--------cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCC
Q 010489 268 NDAPS--------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339 (509)
Q Consensus 268 ~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~ 339 (509)
..... ....+...|++.|+|||++.+. ..++.++|||||||++|||++|++||.+.+.......+....+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 32211 1112345788999999987652 45889999999999999999999999999888888888877776
Q ss_pred CChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
+....+........... .......+......+...++.+.+||.+||..||++|||+.+++.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 246 PTEETWPGWRSLPGCEG-VHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CChhhchhhhhcccccc-cccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 66544332111000000 0011111222223345567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=355.39 Aligned_cols=285 Identities=36% Similarity=0.665 Sum_probs=219.5
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++. .....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR-----RKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc-----cCCeE
Confidence 3699999999999999999999989999999988653333334456788999999999999999999984 34568
Q ss_pred EEEEeccccc-HHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 193 YVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 193 ~lv~e~~~~~-L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
|+||||+++. |..+......+++..++.++.||+.||+|||+.||+||||+|+||+++.++.++|+|||++........
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred EEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 9999999964 555555555799999999999999999999999999999999999999999999999999876533221
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
......++..|+|||++.+. ..++.++|||||||++|||++|++||.+....+....+....+.............
T Consensus 156 ---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 156 ---VYTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred ---ccCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 23446789999999988652 45788999999999999999999999988777766666665554332211111000
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
...............+....++.++..+.+|+.+||..||++||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0000000000001111122345778899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=363.72 Aligned_cols=252 Identities=27% Similarity=0.429 Sum_probs=203.0
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHH-HHHHcCCCCcceeeeeecCCCcCCCCcEEEEE
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIK-LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 196 (509)
+.||+|+||.||+|++..+++.||+|++.+... .......+.+|.. +++.++||||+++++++.. ...+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-----~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-----AEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCEEEEEE
Confidence 469999999999999999999999999864321 2223345556655 5788999999999998843 34689999
Q ss_pred eccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccc
Q 010489 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (509)
Q Consensus 197 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 275 (509)
|||+ ++|...+.....+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (321)
T cd05603 76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---T 152 (321)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC---c
Confidence 9998 58888888888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHH
Q 010489 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (509)
Q Consensus 276 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (509)
....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-------------------- 210 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRK--EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH-------------------- 210 (321)
T ss_pred cccccCCcccCCHHHhcC--CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc--------------------
Confidence 244689999999999877 6789999999999999999999999988764333222210
Q ss_pred hhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH----HHHhcCCcccCCcC
Q 010489 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA----EEALADPYFHGLAN 411 (509)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~e~l~hp~f~~~~~ 411 (509)
.+.. ..+..+..+.++|.+||+.||.+||++ .++++|+||..+..
T Consensus 211 --------~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 211 --------KPLQ---LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred --------CCCC---CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 0111 113457789999999999999999875 59999999986543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=353.25 Aligned_cols=281 Identities=41% Similarity=0.693 Sum_probs=227.3
Q ss_pred eeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEE
Q 010489 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 194 (509)
Q Consensus 115 y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 194 (509)
|++.+.||.|++|.||+|.+..+|..||+|++............+.+|+.+++.++||||+++++++... ...|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-----~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-----NKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-----CeEEE
Confidence 6788999999999999999999999999999865433333345678899999999999999999998543 56899
Q ss_pred EEecccccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCC
Q 010489 195 VFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (509)
Q Consensus 195 v~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 272 (509)
+|||++++|.+++.... .+++..+..++.|+++||+|||+.+++||||+|+||+++.++.++|+|||++........
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 99999989999987765 799999999999999999999999999999999999999999999999999975422211
Q ss_pred cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHH
Q 010489 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (509)
Q Consensus 273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (509)
......+++.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+....+..+....+++....+......
T Consensus 155 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (283)
T cd07835 155 --TYTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL- 230 (283)
T ss_pred --ccCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc-
Confidence 12334678999999987652 45788999999999999999999999998887777777777788777655443211
Q ss_pred HHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
..+...+............+..+..+.++|.+||+.||.+|||++++++||||
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 231 -PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred -hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 11222222222223333455678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=354.68 Aligned_cols=281 Identities=38% Similarity=0.692 Sum_probs=225.9
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
+|++.+.||.|++|.||+|++..+|..||||+++.... ......+.+|+.+++.++|+||+++++++... ...|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTE-----NKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-----CcEE
Confidence 48999999999999999999999999999999865322 22345667899999999999999999998543 4589
Q ss_pred EEEecccccHHHHHHhC---CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 194 VVFELMESDLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 194 lv~e~~~~~L~~~l~~~---~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+||||++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 75 LVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred EEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 99999999999888654 368999999999999999999999999999999999999999999999999997543221
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
. ......+++.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+....+....+.|....+..+..
T Consensus 155 ~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 155 N---TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred c---ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 1 12345678999999987652 4578899999999999999999999999888888888877777777766554431
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
. ..+....+...........+..++.+.++|.+||+.||.+||++.++++||||
T Consensus 231 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 231 L--PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred C--chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 1 11111111111111222334568889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=355.86 Aligned_cols=287 Identities=38% Similarity=0.668 Sum_probs=225.7
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++.+.||+|++|.||+|.+..+|+.||+|.+............+.+|+.+++.++||||+++++++.. ....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-----EKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-----CCeE
Confidence 57999999999999999999999999999999986433222334567889999999999999999999854 3468
Q ss_pred EEEEecccccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC-CCCeEEeeecccccccCC
Q 010489 193 YVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVSFND 269 (509)
Q Consensus 193 ~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~-~~~vkl~DFG~a~~~~~~ 269 (509)
|+||||++++|.+.+.... .+++..+..++.||+.||+|||++||+||||||+||+++. ++.+||+|||++......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9999999999988886654 3578889999999999999999999999999999999985 457999999999754322
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
.. ......+++.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+....
T Consensus 157 ~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 VR---TFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred cc---ccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 11 12345778999999987652 457889999999999999999999999888777777777777777665543221
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
.. ..+........+.......+..++.+.++|.+||..||++||++.++++||||.++.
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 233 SL--PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred cc--hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 11 111111111111122223456788899999999999999999999999999998754
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=352.75 Aligned_cols=280 Identities=39% Similarity=0.726 Sum_probs=221.7
Q ss_pred eeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCCCcEE
Q 010489 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 115 y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
|++.+.||+|+||.||+|.+..+++.||+|+++....... .....+|+.+++++. |+||+++++++... ....++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEE
Confidence 6789999999999999999999999999999875433222 234467999999885 99999999998643 124689
Q ss_pred EEEecccccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCC
Q 010489 194 VVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (509)
Q Consensus 194 lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 272 (509)
+||||++++|.+.+... ..+++..+..++.|++.||+|||+.||+||||||+||+++. +.+||+|||++........
T Consensus 77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 77 LVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 99999999998888764 57899999999999999999999999999999999999999 9999999999976533322
Q ss_pred cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHH
Q 010489 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (509)
Q Consensus 273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (509)
.....+++.|+|||++... ..++.++|||||||++|||++|.+||.+.+..+.+..+...++.+............
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 155 ---YTEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred ---cCCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 2345689999999976542 457889999999999999999999999998888888888888887775533222111
Q ss_pred HHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
...+ .++......+....+..+..+.+||.+||.+||++||+++++++||||
T Consensus 231 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 231 HMNY--NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccc--cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0000 000001111111224568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=361.59 Aligned_cols=259 Identities=22% Similarity=0.390 Sum_probs=204.7
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCCCcEEEEE
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 196 (509)
+.||+|+||.||+|.+..+++.||+|+++.... .......+.+|+.++..+ .||+|+.+++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-----TSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-----CCEEEEEE
Confidence 469999999999999999999999999975322 223456678899999888 59999999998843 34699999
Q ss_pred eccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccc
Q 010489 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (509)
Q Consensus 197 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 275 (509)
||++ ++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (327)
T cd05617 76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---T 152 (327)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC---c
Confidence 9998 58988888888899999999999999999999999999999999999999999999999999875322111 1
Q ss_pred ccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHH
Q 010489 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (509)
Q Consensus 276 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (509)
....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ...+.+. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~---------~~~~~~~--------~ 213 (327)
T cd05617 153 TSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM---------NTEDYLF--------Q 213 (327)
T ss_pred eecccCCcccCCHHHHCC--CCCCchheeehhHHHHHHHHhCCCCCCccCCCccc---------ccHHHHH--------H
Confidence 245689999999999877 68899999999999999999999999643211000 0000000 0
Q ss_pred hhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC------HHHHhcCCcccCCcC
Q 010489 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT------AEEALADPYFHGLAN 411 (509)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt------~~e~l~hp~f~~~~~ 411 (509)
. +. ..+..+ ...+++.+.++|.+||..||++|++ ++++++||||+.+.+
T Consensus 214 ~---~~-~~~~~~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 214 V---IL-EKPIRI---PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred H---HH-hCCCCC---CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence 0 00 011111 1246788999999999999999998 579999999987653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=390.83 Aligned_cols=264 Identities=27% Similarity=0.392 Sum_probs=212.6
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
...+|++++.||+|+||+||+|.+..++..||+|++............+.+|+.+|+.|+||||++++++|.... ..
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~---~~ 87 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA---NQ 87 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC---CC
Confidence 457899999999999999999999999999999998754444455677899999999999999999999886432 24
Q ss_pred cEEEEEeccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHhHhhhhhhC-------CeeecCCCCCcEEECC-------
Q 010489 191 DIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTA-------NVFHRDLKPKNILANA------- 251 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~-------~ivHrDlKp~NILl~~------- 251 (509)
.+||||||++ ++|.++|.. .+.+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 6899999998 589888864 35799999999999999999999985 4999999999999964
Q ss_pred ----------CCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCC
Q 010489 252 ----------DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 321 (509)
Q Consensus 252 ----------~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 321 (509)
.+.+||+|||++........ ....+||+.|+|||++.+....++.++||||||||||||++|..||
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~----~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESM----AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred ccccccccCCCCceEEccCCcccccccccc----ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 34589999999976432221 2345799999999998653356889999999999999999999999
Q ss_pred CCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHh
Q 010489 322 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401 (509)
Q Consensus 322 ~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 401 (509)
...+...++.... ..... ......++++.+||.+||..+|.+||++.++|
T Consensus 244 ~~~~~~~qli~~l--------------------------k~~p~----lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL 293 (1021)
T PTZ00266 244 HKANNFSQLISEL--------------------------KRGPD----LPIKGKSKELNILIKNLLNLSAKERPSALQCL 293 (1021)
T ss_pred CcCCcHHHHHHHH--------------------------hcCCC----CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence 7655432221110 00111 11234578899999999999999999999999
Q ss_pred cCCcccCCcC
Q 010489 402 ADPYFHGLAN 411 (509)
Q Consensus 402 ~hp~f~~~~~ 411 (509)
.|||++.+..
T Consensus 294 ~h~~ik~i~~ 303 (1021)
T PTZ00266 294 GYQIIKNVGP 303 (1021)
T ss_pred ccHHHhhcCC
Confidence 9999986644
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=354.14 Aligned_cols=286 Identities=38% Similarity=0.687 Sum_probs=222.6
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++.+.||+|+||.||+|.+..+++.||||+++...........+.+|+++++.++|+||+++++++.. ....
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEE
Confidence 37999999999999999999999999999999986543333445678899999999999999999999854 3468
Q ss_pred EEEEecccccHHHHH-HhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 193 YVVFELMESDLHQVI-KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 193 ~lv~e~~~~~L~~~l-~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
|+||||+++++...+ .....+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++........
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 76 YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 999999997655544 4456799999999999999999999999999999999999999999999999999986543332
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
.......++.+|+|||++.+. ..++.++||||||+++|+|++|++||.+....+.+..+...++.............
T Consensus 156 --~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 156 --SPLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred --ccccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 122456789999999998772 37889999999999999999999999988877777777666665554332221110
Q ss_pred HHHHhhhccCCCCCCCCCCCCCC-CCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPN-ADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
....-........+..+...++. +++++.+||++||..||++||+++++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00000000000001111112223 47889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=356.35 Aligned_cols=288 Identities=39% Similarity=0.650 Sum_probs=217.7
Q ss_pred CeeEeeeeeccCceEEEEEEEcC--CCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTH--TGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~--~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
+|++.++||+|+||.||+|.+.. ++..||+|.+.... ........+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHA---DK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC---Cc
Confidence 58999999999999999999988 89999999987532 11223456788999999999999999999986541 24
Q ss_pred cEEEEEecccccHHHHHHhC-----CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC----CCCeEEeeec
Q 010489 191 DIYVVFELMESDLHQVIKAN-----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA----DCKLKICDFG 261 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~-----~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~----~~~vkl~DFG 261 (509)
.+|+||||++++|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 68999999998888777432 26899999999999999999999999999999999999999 8999999999
Q ss_pred ccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChH---------hHHHH
Q 010489 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV---------HQLDL 332 (509)
Q Consensus 262 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---------~~~~~ 332 (509)
++.................+|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.... ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 998653332212222345789999999987652 46789999999999999999999999866532 24455
Q ss_pred HHHhcCCCChhHHHHhhhHH-HHHhhhccCCCCCCC------CCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCc
Q 010489 333 MTDLLGTPSTESISRIRNEK-ARRYLGSMRKKQPVP------FSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405 (509)
Q Consensus 333 i~~~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 405 (509)
+...++.+............ ......... ....+ +...+...+..+.++|.+||+.||++|||+.|+++|||
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFK-TKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhcc-CCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 55666655554332221110 000000000 00000 00111256788999999999999999999999999999
Q ss_pred c
Q 010489 406 F 406 (509)
Q Consensus 406 f 406 (509)
|
T Consensus 316 f 316 (316)
T cd07842 316 F 316 (316)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=344.92 Aligned_cols=258 Identities=26% Similarity=0.427 Sum_probs=209.1
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccC---hhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH---VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
..|.+.+.||+|++|.||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD----- 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC-----
Confidence 4588999999999999999999999999999998643221 12345678899999999999999999998543
Q ss_pred CcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
..+|+||||++ ++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++....
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 46999999998 58999998888899999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
............|+..|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------- 221 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISG--EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT------------- 221 (263)
T ss_pred cccccccccCCCcCccccCcceecc--CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc-------------
Confidence 2211111134578899999999987 5689999999999999999999999976543222111100
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
.... ......++..+.+||.+||..||.+|||+.++++||||
T Consensus 222 -------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 222 -------------QPTN---PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred -------------cCCC---CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 0000 01113467889999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=375.48 Aligned_cols=257 Identities=23% Similarity=0.330 Sum_probs=209.5
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCC-CcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHT-GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~-~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
..|.+.+.||+|+||.||+|.+..+ +..||+|++.. ........+.+|+.+|+.++||||+++++++.. ...
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-----~~~ 139 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML--NDERQAAYARSELHCLAACDHFGIVKHFDDFKS-----DDK 139 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-----CCE
Confidence 3599999999999999999998877 78899997643 223444567789999999999999999999843 356
Q ss_pred EEEEEeccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 192 IYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
+||||||++ |+|.+++.. ...+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 999999998 588877643 346899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
...... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 220 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~---------- 286 (478)
T PTZ00267 220 SDSVSL-DVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG---------- 286 (478)
T ss_pred CCcccc-ccccccCCCccccCHhHhCC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----------
Confidence 332211 11245689999999999877 68999999999999999999999999876643332222110
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
...+. ...+++.+.+||.+||..||++||++++++.|+|++.+
T Consensus 287 ---------------~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 287 ---------------KYDPF-----PCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred ---------------CCCCC-----CccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 00011 12467889999999999999999999999999999754
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=350.81 Aligned_cols=258 Identities=26% Similarity=0.395 Sum_probs=206.1
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
.|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++|++|+.+++.+.. ...+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-----KDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-----CCEE
Confidence 37888999999999999999999999999999864322 22233557789999999999999999998843 3468
Q ss_pred EEEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 193 YVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
|+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999998 5888887543 35899999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...........
T Consensus 156 ~~----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~--------------- 214 (285)
T cd05630 156 QT----IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--------------- 214 (285)
T ss_pred cc----ccCCCCCccccChHHHcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---------------
Confidence 11 234579999999999877 678999999999999999999999997643211100000
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGL 409 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~f~~~ 409 (509)
........ ......++.+.+|+.+||+.||++||| ++|+++||||+.+
T Consensus 215 -----~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 215 -----RLVKEVQE-------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred -----hhhhhhhh-------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 00000000 011346788999999999999999999 9999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=348.01 Aligned_cols=284 Identities=36% Similarity=0.620 Sum_probs=217.7
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
...+|++.+.||+|+||.||+|.+..+|..||+|.+..... ......+.+|+.+++.++|+||+++++++.. ..
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~~ 76 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHT-----KE 76 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-----CC
Confidence 34689999999999999999999999999999999864322 1223456789999999999999999999843 34
Q ss_pred cEEEEEecccccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
..|+||||+.+++.+.+... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 77 TLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 68999999998888777553 56888999999999999999999999999999999999999999999999998754221
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCC-hHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN-VVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
.. ......+++.|+|||++.+. ..++.++|||||||++|||++|..||.+.+ ..+++..+...+|.|........
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 157 SQ---TYSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred CC---CCCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhh
Confidence 11 12334678999999988652 457889999999999999999999997654 34566666666776665543332
Q ss_pred hhHHHHHhhhc-cCCCCCCCCCCCCC--CCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 349 RNEKARRYLGS-MRKKQPVPFSHKFP--NADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 349 ~~~~~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
... ..+... .....+......+. ..++.+.+++.+||..||++|||+.+++.||||
T Consensus 233 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 233 SKL--PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhc--ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 110 000000 00011111111111 236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=362.29 Aligned_cols=257 Identities=28% Similarity=0.416 Sum_probs=214.0
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccC-hhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
....|.-++.||.|+||.||-|++..+.+.||||++...... ......+++|+++|+.++|||+|.+.++|+...
T Consensus 24 PEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~---- 99 (948)
T KOG0577|consen 24 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH---- 99 (948)
T ss_pred HHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc----
Confidence 345677889999999999999999999999999999754332 234567999999999999999999999997553
Q ss_pred CcEEEEEecccccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 190 KDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 190 ~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
..|+|||||-|+-.+++.-. .++.+.++..|..+.+.||+|||+.+.||||||..|||+++.|.|||+|||.|.....
T Consensus 100 -TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 100 -TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred -hHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 47999999998777777543 5799999999999999999999999999999999999999999999999999976522
Q ss_pred CCCCcccccccccccccccccccccc-cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
..+++|||+|||||++... .+.|+-++|||||||+..||.-.++|+...+....+.-|..
T Consensus 179 -------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ------------ 239 (948)
T KOG0577|consen 179 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------ 239 (948)
T ss_pred -------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh------------
Confidence 2568999999999987543 36799999999999999999999999877665444433321
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
...|.-. -+.++..++.|+..||++-|.+|||.+++|.|+|+..
T Consensus 240 --------------NesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 240 --------------NESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred --------------cCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 1111111 2356778999999999999999999999999999853
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=349.10 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=199.7
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEecc
Q 010489 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM 199 (509)
Q Consensus 121 lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 199 (509)
||+|+||.||++.++.+|+.||+|++..... .......+..|+.+++.++||||+++++++.. ...+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-----~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-----KTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-----CCeEEEEEecC
Confidence 7999999999999999999999999864221 11223445679999999999999999998843 34689999999
Q ss_pred c-ccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCcccc
Q 010489 200 E-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276 (509)
Q Consensus 200 ~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 276 (509)
+ ++|.+++...+ .+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++........ .
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~----~ 151 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT----I 151 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce----e
Confidence 8 58888775443 588999999999999999999999999999999999999999999999999876533221 2
Q ss_pred cccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHh
Q 010489 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 356 (509)
Q Consensus 277 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (509)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+. . ..
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~-----------~--------~~ 210 (277)
T cd05607 152 TQRAGTNGYMAPEILKE--EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK-----------R--------RT 210 (277)
T ss_pred eccCCCCCccCHHHHcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH-----------H--------Hh
Confidence 34578999999999877 569999999999999999999999997643211100000 0 00
Q ss_pred hhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH----HHHhcCCcccCCcC
Q 010489 357 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA----EEALADPYFHGLAN 411 (509)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~e~l~hp~f~~~~~ 411 (509)
+ ... ........++++.+||.+||+.||++||++ ++++.||||+.+..
T Consensus 211 ~---~~~----~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 211 L---EDE----VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred h---ccc----cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 0 000 001123568889999999999999999999 77889999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=351.29 Aligned_cols=281 Identities=25% Similarity=0.378 Sum_probs=212.8
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
+|++.+.||+|+||.||+|.+..++..||+|.++... .......+.+|+++++.++||||+++++++.. ...+|
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 75 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-----DGEIS 75 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCEEE
Confidence 6999999999999999999999999999999986432 22334568899999999999999999999854 34699
Q ss_pred EEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhh-CCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 194 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 194 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
+||||++ ++|.+++...+.+++..+..++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 76 lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred EEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 9999998 5899999888889999999999999999999997 599999999999999999999999999987543221
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH------
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI------ 345 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~------ 345 (509)
....+|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+............
T Consensus 155 ----~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 155 ----ANSFVGTRSYMSPERLQG--THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred ----cccCCCCcCccChhHhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccC
Confidence 234578999999999876 67889999999999999999999999876533222222111000000000
Q ss_pred ---HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 346 ---SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 346 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
...................+ ........++++.+||.+||..||++|||+.++++||||...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPP--PKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCC--ccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 00000000000000001111 011112367889999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=347.46 Aligned_cols=282 Identities=48% Similarity=0.778 Sum_probs=230.6
Q ss_pred eeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEE
Q 010489 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 194 (509)
Q Consensus 115 y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 194 (509)
|++.+.||.|++|.||+|.+..+++.+|+|.++...........+.+|+.+++.++|++|+++++++... ..+|+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-----GDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-----CCEEE
Confidence 6778999999999999999998999999999875443334456788999999999999999999988543 56899
Q ss_pred EEecccccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCc
Q 010489 195 VFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273 (509)
Q Consensus 195 v~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 273 (509)
||||++++|.+.+... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||.+.......
T Consensus 76 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--- 152 (283)
T cd05118 76 VFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--- 152 (283)
T ss_pred EEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence 9999999998888764 589999999999999999999999999999999999999999999999999997654332
Q ss_pred ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHH
Q 010489 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353 (509)
Q Consensus 274 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (509)
.......++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||++.+..+.+..+...++.+....+...... .
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 230 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL-A 230 (283)
T ss_pred ccccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh-h
Confidence 112345688999999998762 37889999999999999999999999999988888888888888776655443321 1
Q ss_pred HHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
......+............+.++..+.+||.+||..||.+||++.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 11111122222223333445678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=357.25 Aligned_cols=286 Identities=23% Similarity=0.322 Sum_probs=206.0
Q ss_pred Eeeeeecc--CceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEE
Q 010489 117 IQEVIGKG--SYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 194 (509)
Q Consensus 117 i~~~lG~G--~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 194 (509)
++++||+| +|++||++.++.+|+.||||+++...........+.+|+.+++.++||||+++++++... ..+|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEEE
Confidence 56889999 788999999999999999999975433334456677899999999999999999998543 45899
Q ss_pred EEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 195 VFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 195 v~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
||||++ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.+........
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999998 5888888653 4689999999999999999999999999999999999999999999999987543321111
Q ss_pred Cc----ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChh-HHH
Q 010489 272 SA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE-SIS 346 (509)
Q Consensus 272 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~-~~~ 346 (509)
.. .......++..|+|||++.+....++.++|||||||++|||++|+.||........... ...+..+.. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~~ 234 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE--KLNGTVPCLLDTT 234 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHH--HhcCCcccccccc
Confidence 00 00122357788999999875334689999999999999999999999976543322211 111111100 000
Q ss_pred HhhhHHHHHhh------hccCC----------CCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 347 RIRNEKARRYL------GSMRK----------KQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 347 ~~~~~~~~~~~------~~~~~----------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.+..+...... ..... .............++.+.+||.+||+.||++|||++++++||||+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 00000000000 00000 00000011123457889999999999999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=324.72 Aligned_cols=288 Identities=31% Similarity=0.607 Sum_probs=232.7
Q ss_pred cccCCCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCC
Q 010489 107 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPS 185 (509)
Q Consensus 107 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~ 185 (509)
.+++..++|++.+++|+|.|+.||.|.+..+++.++||+++.. ..+.+.+|++||+.|. ||||++++++..++.
T Consensus 32 i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~ 106 (338)
T KOG0668|consen 32 IDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPE 106 (338)
T ss_pred eeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCcc
Confidence 4678889999999999999999999999999999999998742 3567899999999997 999999999997764
Q ss_pred cCCCCcEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC-CCeEEeeeccc
Q 010489 186 RREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLA 263 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~-~~vkl~DFG~a 263 (509)
. ....+|+||++. +...+. +.|+.-.+..+++|++.||.|||++||+|||+||.|++||.. -.++|+|+|+|
T Consensus 107 S---ktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 107 S---KTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred c---cCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchH
Confidence 3 456899999995 554444 358889999999999999999999999999999999999975 46999999999
Q ss_pred ccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCC-CCCCChHhHHHHHHHhcCCCCh
Q 010489 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL-FPGKNVVHQLDLMTDLLGTPST 342 (509)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~g~~~~ 342 (509)
.++..... ..-.+.++.|--||++... +.|+..-|+|||||+|+.|+..+.| |.|.+..+|+..|.+++|+...
T Consensus 181 EFYHp~~e----YnVRVASRyfKGPELLVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el 255 (338)
T KOG0668|consen 181 EFYHPGKE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDEL 255 (338)
T ss_pred hhcCCCce----eeeeeehhhcCCchheeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHH
Confidence 98765543 2334788999999998874 7899999999999999999998866 5789999999999999998543
Q ss_pred h-HHHHhhhHHHHHhhhccCCCCCCCCCCCC-----CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 343 E-SISRIRNEKARRYLGSMRKKQPVPFSHKF-----PNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 343 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
. -+.+..-.-.+++-..+......+|.... .-++|++.|||.++|..|-.+|+||.|++.||||..+.
T Consensus 256 ~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 256 YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 2 22222222222332323333333333222 23579999999999999999999999999999997653
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=358.04 Aligned_cols=254 Identities=26% Similarity=0.462 Sum_probs=198.5
Q ss_pred CCCeeEeeeeeccCceEEEEEEE-----cCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~ 185 (509)
.++|++.++||+|+||.||+|.+ ..+++.||||+++.. ........+.+|+.+|+.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 35899999999999999999975 245678999998643 2223456788999999999 899999999987533
Q ss_pred cCCCCcEEEEEeccc-ccHHHHHHhC------------------------------------------------------
Q 010489 186 RREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 210 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~-~~L~~~l~~~------------------------------------------------------ 210 (509)
...+|+||||++ |+|.+++...
T Consensus 84 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 84 ---NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 235899999998 6898888642
Q ss_pred --------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCcccccccccc
Q 010489 211 --------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 282 (509)
Q Consensus 211 --------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt 282 (509)
..+++..+..++.||++||+|||+.||+||||||+|||++.++.+||+|||+++........ .......++
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~ 239 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGSARLP 239 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch-hcccCCCCC
Confidence 24778889999999999999999999999999999999999999999999999864322211 111233567
Q ss_pred cccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccC
Q 010489 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMR 361 (509)
Q Consensus 283 ~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 361 (509)
+.|+|||++.+ ..++.++|||||||++|||++ |..||.+......+... +.
T Consensus 240 ~~y~aPE~~~~--~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~--------------~~------------ 291 (338)
T cd05102 240 LKWMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR--------------LK------------ 291 (338)
T ss_pred ccccCcHHhhc--CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH--------------Hh------------
Confidence 88999999876 678999999999999999997 99999875432211110 00
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 362 KKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..... .....+++.+.+||.+||..||++|||+.++++
T Consensus 292 ~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 292 DGTRM---RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred cCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 00000 011346788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=352.85 Aligned_cols=263 Identities=28% Similarity=0.424 Sum_probs=215.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
...|+.-++||+|+||.||-|+.+.||+.||+|++.+... ........+.|-.||.++..+.||.+-.+|.+ ..
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT-----kd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET-----KD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC-----CC
Confidence 4568889999999999999999999999999999854322 22234456889999999999999999888844 45
Q ss_pred cEEEEEeccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 191 DIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
.+|+||..|+ |||.-+|...+ .|++..+.+++.+|+.||++||..+||+|||||+|||+|+.|+++|+|+|+|..+.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 6999999999 58988887766 89999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
...+ ..+.+||.+|||||++.. ..|+...|+|||||++|||+.|+.||.......
T Consensus 339 ~g~~----~~~rvGT~GYMAPEvl~n--e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv------------------- 393 (591)
T KOG0986|consen 339 EGKP----IRGRVGTVGYMAPEVLQN--EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV------------------- 393 (591)
T ss_pred CCCc----cccccCcccccCHHHHcC--CcccCCccHHHHHhHHHHHHcccCchhhhhhhh-------------------
Confidence 4443 345699999999999988 679999999999999999999999996543211
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCcCC
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLANV 412 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~f~~~~~~ 412 (509)
+.+...+.. ...+..++ ...++++++|.+.+|++||++|.. ++++.+||||+.+.+.
T Consensus 394 -k~eEvdrr~----~~~~~ey~---~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 394 -KREEVDRRT----LEDPEEYS---DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR 455 (591)
T ss_pred -hHHHHHHHH----hcchhhcc---cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence 111111111 11122222 356899999999999999999974 6799999999987764
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=346.17 Aligned_cols=258 Identities=26% Similarity=0.391 Sum_probs=207.9
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
.|++.+.||+|+||+||+|.+..+++.||+|.+..... .......+.+|+.+|+.++|++|+.+.+++... ..+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK-----DAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC-----CEE
Confidence 37888999999999999999999999999999864321 222344577899999999999999999888443 458
Q ss_pred EEEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 193 YVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
|+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999998 4787777543 36999999999999999999999999999999999999999999999999998754222
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
. ......|++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.........+....
T Consensus 156 ~----~~~~~~g~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~------------ 217 (285)
T cd05632 156 E----SIRGRVGTVGYMAPEVLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRV------------ 217 (285)
T ss_pred C----cccCCCCCcCccChHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh------------
Confidence 1 1234579999999999876 678999999999999999999999998765433222221100
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGL 409 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~f~~~ 409 (509)
.... .......++.+.+|+.+||..||++||+ +.+++.|+||+..
T Consensus 218 -----------~~~~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 218 -----------LETE----EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred -----------hccc----cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 0000 0112346788999999999999999999 8999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=338.65 Aligned_cols=254 Identities=29% Similarity=0.468 Sum_probs=208.3
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
.|++++.||+|++|.||+|.+..+++.||+|++............+.+|+.+++.++|+|++++++.+... ...+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE----DGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC----CCEEE
Confidence 48999999999999999999999999999999865433344556788999999999999999998876422 23589
Q ss_pred EEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 194 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 194 lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
++|||++ ++|.+++... ..+++..++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999998 5888888753 468999999999999999999999999999999999999999999999999997653322
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
. ......|++.|+|||++.+ ..++.++|||||||++++|++|+.||.+.+.......+..
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~--------------- 216 (257)
T cd08223 157 D---MASTLIGTPYYMSPELFSN--KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE--------------- 216 (257)
T ss_pred C---ccccccCCcCccChhHhcC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---------------
Confidence 1 1234578999999999877 6788999999999999999999999987654322211110
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
...+ ......++.+.+||.+||+.||++||++.++++||||
T Consensus 217 -----------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 217 -----------GKLP----PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -----------cCCC----CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0000 0113467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=346.02 Aligned_cols=281 Identities=43% Similarity=0.736 Sum_probs=231.5
Q ss_pred eeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEE
Q 010489 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 194 (509)
Q Consensus 115 y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 194 (509)
|++.+.||+|+||.||+|.+..+++.||+|++............+..|+.+++.++|+||+++++++... ..+|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEE
Confidence 6778999999999999999999999999999875433333456677899999999999999999988543 46899
Q ss_pred EEecccccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCc
Q 010489 195 VFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273 (509)
Q Consensus 195 v~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 273 (509)
||||++++|.+++... ..+++..+..++.|++.||+|||+.||+||||+|+||+++.++.+||+|||++........
T Consensus 76 v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 76 VFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred EecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 9999999999999876 5799999999999999999999999999999999999999999999999999976533221
Q ss_pred ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHH
Q 010489 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353 (509)
Q Consensus 274 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (509)
......++..|+|||.+.+. ..++.++|||||||++|||++|.+||.+.+....+..+...++.+....+..+....
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP- 230 (282)
T ss_pred -ccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc-
Confidence 12334667889999988662 478899999999999999999999999999888888888888888776665443221
Q ss_pred HHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
.+...++..........++..+..+.++|.+||..||++||++++++.||||
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 231 -DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred -cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1111222222233334456678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=349.25 Aligned_cols=289 Identities=37% Similarity=0.636 Sum_probs=226.5
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCC-----c
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-----R 186 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-----~ 186 (509)
.++|++.+.||+|+||.||+|.+..+|+.||||+++...........+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 46799999999999999999999999999999998653332333456678999999999999999999886543 1
Q ss_pred CCCCcEEEEEecccccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 187 REFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 187 ~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
.+...+|+|+||+++++...+... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~ 165 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccccc
Confidence 123478999999999888887654 4699999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
....... ......++..|+|||.+.+. ..++.++|||||||++|||++|++||...+....+..+....+.+....+
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 166 YNSEESR--PYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred ccCCccc--ccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 5433221 12233568889999987652 45788999999999999999999999988888888888887777665443
Q ss_pred HHhhhHHHHHhhhccCC--CCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 346 SRIRNEKARRYLGSMRK--KQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
..+..... ...... .....+...+..+++.+.+||.+||..||.+||++.+++.||||
T Consensus 243 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 243 PDVIKLPY---FNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccc---ccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 22211000 000000 00011222344568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=356.37 Aligned_cols=262 Identities=26% Similarity=0.458 Sum_probs=222.4
Q ss_pred CCCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 110 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 110 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
...+-|.+.+.||+|.|++|.+|++..++..||||.+++..-+....+.+.+|+++|+.|+|||||+++.++...
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~----- 127 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE----- 127 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec-----
Confidence 345679999999999999999999999999999999987666656666789999999999999999999999544
Q ss_pred CcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
..+|+||||+. |++++++.+++...+..+..++.|++.|++|||+++|||||||++|||++.+.++||+|||++..+..
T Consensus 128 ~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred ceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc
Confidence 45999999997 69999999999999999999999999999999999999999999999999999999999999988643
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
.. ...++||++.|.|||++.+. ..-++.+|+||+|++||.|+.|..||.|.+..+.-...
T Consensus 208 ~~----~lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv--------------- 267 (596)
T KOG0586|consen 208 GL----MLQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV--------------- 267 (596)
T ss_pred cc----cccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCcccccccchh---------------
Confidence 22 35678999999999999884 45578999999999999999999999987642211100
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 412 (509)
. ..+..++ --++-++.+||+++|..+|.+|++.+++..|.|.......
T Consensus 268 -------l----~gk~rIp-----~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 268 -------L----RGKYRIP-----FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred -------e----eeeeccc-----ceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 0 0111111 1246678999999999999999999999999999765544
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=364.37 Aligned_cols=261 Identities=25% Similarity=0.408 Sum_probs=212.2
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
..+.|.|+..||.|+||.||+|.++.++-..|.|+|.- ........++-||.||..+.||+||++++.|+.. +
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~e-----n 102 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE-----N 102 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc-----C
Confidence 34567889999999999999999999999999999853 3445677889999999999999999999998654 4
Q ss_pred cEEEEEecccccH-HHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 191 DIYVVFELMESDL-HQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 191 ~~~lv~e~~~~~L-~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
.+||+.|||+|+- ..++.. ...|++.++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+.....
T Consensus 103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh
Confidence 5999999999754 334433 45799999999999999999999999999999999999999999999999999865322
Q ss_pred CCCCcccccccccccccccccccccc---cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
. .....+++|||+|||||+.... ..+|+.++||||||++|.||.-+.+|-..-+....+-.|.+.
T Consensus 183 t---~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS--------- 250 (1187)
T KOG0579|consen 183 T---RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--------- 250 (1187)
T ss_pred H---HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc---------
Confidence 1 1224578999999999986322 367999999999999999999999998776665544433321
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.+|.-+ ....++..+.||+.+||.+||..||+++++|+||||.+.
T Consensus 251 -----------------ePPTLl--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 251 -----------------EPPTLL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred -----------------CCCccc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 111111 012345678999999999999999999999999999864
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=354.71 Aligned_cols=291 Identities=38% Similarity=0.605 Sum_probs=228.0
Q ss_pred CCCeeE-eeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChh------------hHHhHHHHHHHHHHcCCCCcceee
Q 010489 112 ASRYQI-QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS------------DATRILREIKLLRLLRHPDIVEIK 178 (509)
Q Consensus 112 ~~~y~i-~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~------------~~~~~~~Ei~~l~~l~h~niv~~~ 178 (509)
.++|.. .+.||.|+||+||+|.+..+++.||||+++....... ....+.+|+.+++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 457764 5779999999999999999999999999864322110 012467899999999999999999
Q ss_pred eeecCCCcCCCCcEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEe
Q 010489 179 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 258 (509)
Q Consensus 179 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~ 258 (509)
+++... ...|+||||+.++|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 87 DVYVEG-----DFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEEecC-----CcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEEC
Confidence 998543 468999999999999999888889999999999999999999999999999999999999999999999
Q ss_pred eecccccccCCC-----------CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChH
Q 010489 259 DFGLARVSFNDA-----------PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 327 (509)
Q Consensus 259 DFG~a~~~~~~~-----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 327 (509)
|||++....... ..........+++.|+|||.+.+. ..++.++|||||||++|||++|.+||.+.+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999997653111 001112334678899999988652 45788999999999999999999999999988
Q ss_pred hHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010489 328 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (509)
Q Consensus 328 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 407 (509)
+.+..+...++.+....+....... .+ .......+..+....+..+..+.+||.+||..||++||+++++|.||||+
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~ 317 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLP--LY-TEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK 317 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcc--cc-cccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence 8888888888877654332211100 00 00111112222233456688899999999999999999999999999998
Q ss_pred CCcC
Q 010489 408 GLAN 411 (509)
Q Consensus 408 ~~~~ 411 (509)
....
T Consensus 318 ~~~~ 321 (335)
T PTZ00024 318 SDPL 321 (335)
T ss_pred CCCC
Confidence 6543
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=343.34 Aligned_cols=282 Identities=39% Similarity=0.649 Sum_probs=221.2
Q ss_pred eeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc---CCCCcceeeeeecCCCcCCCCc
Q 010489 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL---RHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 115 y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~niv~~~~~~~~~~~~~~~~ 191 (509)
|++.+.||+|+||.||+|.+..+++.||+|.++...........+.+|+.+++.+ .||||+++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6789999999999999999988899999999975433333344566788877766 5999999999997654333445
Q ss_pred EEEEEecccccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+|++|||+.++|.+++.... .+++..+..++.|++.||.|||+.+|+|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 89999999999988887643 5899999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
.. .....++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+....
T Consensus 161 ~~----~~~~~~~~~~~~PE~~~~--~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 161 MA----LTSVVVTLWYRAPEVLLQ--SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred cc----cccccccccccChHHhcc--CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 21 233468899999999877 678899999999999999999999999988877777776655544432221110
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
... ........+..+....+..++.+.+||.+||..||.+||++.++++||||
T Consensus 235 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLP----RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccc----hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 000 00011112222233344567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=343.47 Aligned_cols=258 Identities=26% Similarity=0.415 Sum_probs=206.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. .......+.+|+.+++.++||||+++++.+.. ...
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-----~~~ 80 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-----RDK 80 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----CCE
Confidence 35799999999999999999999999999999998643 22334567789999999999999999998844 346
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|+||||++ ++|.+++...+.+++..+..++.|++.||.|||+.||+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 81 LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 899999998 5899999888899999999999999999999999999999999999999999999999999987543221
Q ss_pred CCcccccccccccccccccccccc-cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
. ......|++.|+|||++... ...++.++|||||||++|+|++|..||........+..+..
T Consensus 161 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~-------------- 223 (267)
T cd06645 161 A---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK-------------- 223 (267)
T ss_pred c---ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc--------------
Confidence 1 12345799999999987421 14688899999999999999999999965443221111100
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCc
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 405 (509)
....+..+ .....++..+.+||.+||..||++||+++++++|||
T Consensus 224 -----------~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 224 -----------SNFQPPKL-KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred -----------cCCCCCcc-cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 00001001 111235678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=362.74 Aligned_cols=253 Identities=33% Similarity=0.538 Sum_probs=210.4
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEec
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 198 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 198 (509)
-+||+|.||+||.|++..|...+|||.+.. ......+.+..||.+.+.|+|.|||+++|.+ .+.+++-|.||-
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpe--kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEq 653 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPE--KDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQ 653 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccc--ccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeec
Confidence 479999999999999999999999999964 3345677889999999999999999999987 455678999999
Q ss_pred cc-ccHHHHHHh-CCCC--CHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC-CCCeEEeeecccccccCCCCCc
Q 010489 199 ME-SDLHQVIKA-NDDL--TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVSFNDAPSA 273 (509)
Q Consensus 199 ~~-~~L~~~l~~-~~~l--~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~-~~~vkl~DFG~a~~~~~~~~~~ 273 (509)
++ |+|..++.. .+++ .|..+.++.+||++||.|||++.|||||||-+|+||+. .|.+||+|||-++....-.+-
T Consensus 654 VPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~- 732 (1226)
T KOG4279|consen 654 VPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC- 732 (1226)
T ss_pred CCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcc-
Confidence 98 588888875 4777 78889999999999999999999999999999999985 689999999999876443332
Q ss_pred ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHH
Q 010489 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353 (509)
Q Consensus 274 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (509)
..++.||..|||||++......|++++|||||||++.||.||++||..-. .|......
T Consensus 733 --TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg-------------spqAAMFk------- 790 (1226)
T KOG4279|consen 733 --TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG-------------SPQAAMFK------- 790 (1226)
T ss_pred --ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC-------------ChhHhhhh-------
Confidence 35678999999999998777889999999999999999999999996532 22221111
Q ss_pred HHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
++.++..++.| ..++.+++.||.+|+.+||.+||+|.++|++||++.-
T Consensus 791 ---VGmyKvHP~iP-----eelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 791 ---VGMYKVHPPIP-----EELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred ---hcceecCCCCc-----HHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 12222333332 3578899999999999999999999999999999765
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=344.71 Aligned_cols=254 Identities=26% Similarity=0.458 Sum_probs=212.2
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+++++.+.||||+++++++.. ...
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-----DSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCe
Confidence 36999999999999999999999999999999986422 122345678899999999999999999999843 356
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||+.||+||||+|+|||++.++.+||+|||++......
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 899999995 799999988889999999999999999999999999999999999999999999999999999765332
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
.....|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+..
T Consensus 155 -----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 212 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILS--KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--------------- 212 (290)
T ss_pred -----CCCCCCCccccChhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------
Confidence 134578999999999876 5788999999999999999999999987663322222110
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCc
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~ 410 (509)
...+. ....++.+.++|.+||..||.+|+ +++++++||||+.+.
T Consensus 213 -----------~~~~~-----~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 213 -----------GKVRF-----PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred -----------CCccC-----CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 00011 123478899999999999999999 999999999997654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=345.75 Aligned_cols=283 Identities=40% Similarity=0.697 Sum_probs=225.1
Q ss_pred eeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEE
Q 010489 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 194 (509)
Q Consensus 115 y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 194 (509)
|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++|+|++++++++.... ....|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 67899999999999999999999999999999754333344566789999999999999999999985431 256899
Q ss_pred EEecccccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCc
Q 010489 195 VFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273 (509)
Q Consensus 195 v~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 273 (509)
||||++++|..++... ..+++..+..++.||++||+|||+.|++|+||||+||+++.++.+||+|||++.........
T Consensus 78 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~- 156 (287)
T cd07840 78 VFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA- 156 (287)
T ss_pred EeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc-
Confidence 9999999999888765 57999999999999999999999999999999999999999999999999999865443211
Q ss_pred ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHH
Q 010489 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353 (509)
Q Consensus 274 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (509)
..+...++..|+|||.+.+. ..++.++|||||||++|||++|+.||...+....+..+....+.+....+.......
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 233 (287)
T cd07840 157 -DYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP- 233 (287)
T ss_pred -cccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch-
Confidence 12334678899999987652 467899999999999999999999999988888888888877776655433221110
Q ss_pred HHhhhccCCCC--CCCCCCCCCC-CCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 354 RRYLGSMRKKQ--PVPFSHKFPN-ADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 354 ~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
+........ +..+...+.. .++.+.++|.+||..||.+||+++++++||||
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 234 --WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred --hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 000000000 0111112233 38889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=335.83 Aligned_cols=253 Identities=27% Similarity=0.435 Sum_probs=209.5
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
+|.+.+.||+|++|.||+|.+..+++.||+|.+............+.+|+.+++.++||||+++++++... ...|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-----GKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-----CEEE
Confidence 48899999999999999999999999999999865433445667788999999999999999999988543 4689
Q ss_pred EEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 194 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 194 lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+||||++ ++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999997 5899988764 578999999999999999999999999999999999999999999999999987654322
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
. ......|++.|+|||++.+ ..++.++|+|||||++++|++|+.||...+.......+..
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 215 (256)
T cd08529 156 N---FANTIVGTPYYLSPELCED--KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR--------------- 215 (256)
T ss_pred c---hhhccccCccccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---------------
Confidence 1 1234578999999999877 6788999999999999999999999987664322221111
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
....+. ....++.+.++|.+||+.+|++||++.++++|||+
T Consensus 216 ------------~~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 216 ------------GVFPPV---SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ------------CCCCCC---ccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 000011 11457789999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=339.03 Aligned_cols=259 Identities=26% Similarity=0.424 Sum_probs=205.5
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc---ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE---HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.|++.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++... ...
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 79 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AEK 79 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CCC
Confidence 58899999999999999999999999999999864322 123445688899999999999999999987532 224
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.++++|||++ ++|.+++...+.+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++......
T Consensus 80 ~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 6899999998 589999988888999999999999999999999999999999999999999999999999998754321
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
...........++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~-------------- 223 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISG--EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT-------------- 223 (266)
T ss_pred cccCCccccCCccccccCHHHhCC--CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc--------------
Confidence 111111233568899999999876 6788999999999999999999999976443221111100
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 407 (509)
.... + ......++.+.+|| +||..||++||+++|+++||||+
T Consensus 224 ----------~~~~-~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 224 ----------QPTN-P----QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ----------CCCC-C----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 0000 0 01123567788898 67778999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=344.73 Aligned_cols=260 Identities=29% Similarity=0.497 Sum_probs=212.0
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
...+|++.+.||.|+||.||+|.+..+++.||+|.+... .......+.+|+.+++.++||||+++++.+.. ..
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 89 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ--KQPKKELIINEILVMKELKNPNIVNFLDSFLV-----GD 89 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc--cCchHHHHHHHHHHHHhcCCCceeeeeeeEec-----Cc
Confidence 346799999999999999999999999999999998642 22335667899999999999999999999854 34
Q ss_pred cEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|+|+||+.+ +|..++.. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred eEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 58999999985 77777654 46899999999999999999999999999999999999999999999999998754332
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
... .....|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 169 ~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~------------- 230 (296)
T cd06655 169 QSK---RSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN------------- 230 (296)
T ss_pred ccc---CCCcCCCccccCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------
Confidence 211 233578999999999876 67889999999999999999999999876654333222110
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
. .+.......+++.+.+||.+||..||.+||++.++++||||+....
T Consensus 231 -------------~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 231 -------------G--TPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred -------------C--CcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 0 0000112346788999999999999999999999999999986544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=342.36 Aligned_cols=262 Identities=24% Similarity=0.396 Sum_probs=208.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.+.|++++.||.|+||.||+|.+..++..||+|.+... .......+.+|+.+++.++||||+++++.+... ..
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 83 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-----GK 83 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-----Ce
Confidence 46799999999999999999999999999999998642 334566788999999999999999999988543 46
Q ss_pred EEEEEecccc-cHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELMES-DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+|+||||+++ +|..++.+ ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred EEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 8999999995 66666644 457899999999999999999999999999999999999999999999999998753222
Q ss_pred CCCcccccccccccccccccccccc---cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
.. ......+++.|+|||++.+. ...++.++|||||||++|||++|.+||...+.......+..
T Consensus 164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~----------- 229 (292)
T cd06644 164 LQ---RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK----------- 229 (292)
T ss_pred cc---ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc-----------
Confidence 11 12345788999999987531 14578899999999999999999999976553222111100
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
...+ .......++.++.+||.+||..||++||+++++++||||..+..
T Consensus 230 ---------------~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 277 (292)
T cd06644 230 ---------------SEPP--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS 277 (292)
T ss_pred ---------------CCCc--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 0000 00112346778999999999999999999999999999987643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=352.99 Aligned_cols=251 Identities=29% Similarity=0.538 Sum_probs=213.9
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEe
Q 010489 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 197 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 197 (509)
.+.||+|-||+||-|+++.+|+.||||+|.+..........+.+|+.||+.+.||.||.+.-.|.++ ..+++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~-----ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETP-----ERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCC-----ceEEEEeh
Confidence 3789999999999999999999999999987655555667889999999999999999998888554 45999999
Q ss_pred cccccHHHHHHh--CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC---CCeEEeeecccccccCCCCC
Q 010489 198 LMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVSFNDAPS 272 (509)
Q Consensus 198 ~~~~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~---~~vkl~DFG~a~~~~~~~~~ 272 (509)
-+.||+.+.|.. .++|++...++++.||+.||.|||.++|+|+||||+|||+.+. -++||||||+|++.....
T Consensus 644 Kl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-- 721 (888)
T KOG4236|consen 644 KLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-- 721 (888)
T ss_pred hhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence 999998888854 4689999999999999999999999999999999999999765 369999999999874433
Q ss_pred cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCCh-HhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV-VHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
+..+.+|||.|.|||+++. +.|+..-|+||+|||+|.-|.|..||....+ .+|+....
T Consensus 722 --FRrsVVGTPAYLaPEVLrn--kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa----------------- 780 (888)
T KOG4236|consen 722 --FRRSVVGTPAYLAPEVLRN--KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA----------------- 780 (888)
T ss_pred --hhhhhcCCccccCHHHHhh--ccccccccceeeeEEEEEEecccccCCCccchhHHhhccc-----------------
Confidence 3467899999999999988 7999999999999999999999999975432 22221110
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
--.+ ...|..++++++|||..+|+..-.+|.+....|.|||+++.
T Consensus 781 ---------FMyP----p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 781 ---------FMYP----PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred ---------cccC----CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 0011 23466789999999999999999999999999999999865
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=346.72 Aligned_cols=263 Identities=27% Similarity=0.433 Sum_probs=212.6
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccC-hhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
+|++.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.+++.++||||+++++.+.. ....
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 76 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-----ETYL 76 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-----CCEE
Confidence 699999999999999999999999999999998653222 2345678899999999999999999998843 4568
Q ss_pred EEEEecccc-cHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 193 YVVFELMES-DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 193 ~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
|+||||+.+ +|.+++... ..+++..+..++.|+++||+|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 77 CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999984 898888754 57999999999999999999999999999999999999999999999999998754221
Q ss_pred CCC--------------------------cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCC
Q 010489 270 APS--------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 323 (509)
Q Consensus 270 ~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 323 (509)
... ........||..|+|||++.+ ..++.++|||||||++|+|++|..||.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--DGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--CCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 110 001123578999999999877 6789999999999999999999999987
Q ss_pred CChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC----HHH
Q 010489 324 KNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT----AEE 399 (509)
Q Consensus 324 ~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e 399 (509)
.+....+..+.. .. ..+. .....++.+.++|.+||..||++||+ +++
T Consensus 235 ~~~~~~~~~~~~--------------------------~~--~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ 285 (316)
T cd05574 235 SNRDETFSNILK--------------------------KE--VTFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAE 285 (316)
T ss_pred CchHHHHHHHhc--------------------------CC--ccCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHHH
Confidence 664333222110 00 0111 11226788999999999999999999 999
Q ss_pred HhcCCcccCCcCC
Q 010489 400 ALADPYFHGLANV 412 (509)
Q Consensus 400 ~l~hp~f~~~~~~ 412 (509)
+|+||||++....
T Consensus 286 ll~~~~~~~~~~~ 298 (316)
T cd05574 286 IKQHPFFRGVNWA 298 (316)
T ss_pred HHcCchhhcCChh
Confidence 9999999886543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=322.47 Aligned_cols=258 Identities=23% Similarity=0.397 Sum_probs=210.0
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCCCcE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 192 (509)
+.+++..||.|+-|.|++++.+.+|...|||.+.+. .+..+.++++..+.++.... +|.||+.+++|.... .+
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~-----dV 166 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT-----DV 166 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc-----hH
Confidence 446678899999999999999999999999999764 44566788999999876654 999999999997664 37
Q ss_pred EEEEecccccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhh-CCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 193 YVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 193 ~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|.||.|..-+..++.. .++++|..+-++...++.||.||.. +||+|||+||+|||+|..|++||||||++..+.+..
T Consensus 167 ~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 167 FICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 99999999766666654 3579999999999999999999976 589999999999999999999999999998765544
Q ss_pred CCcccccccccccccccccccccc-cCCCCCceeeehhhhHHHHHHhCCCCCCCCCh-HhHHHHHHHhcCCCChhHHHHh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV-VHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
.. +...|.+.|||||.+.-. ...|+.++||||||+.++||.||+.||.+.+. .+.+..+..
T Consensus 247 Ah----trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln------------- 309 (391)
T KOG0983|consen 247 AH----TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN------------- 309 (391)
T ss_pred cc----ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-------------
Confidence 32 445899999999988643 36799999999999999999999999998542 222322221
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
..|..+.. -...++.+++|+..||++|+.+||...++|+|||+...
T Consensus 310 --------------~ePP~L~~-~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 310 --------------EEPPLLPG-HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred --------------cCCCCCCc-ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 11111111 12378999999999999999999999999999999754
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=340.38 Aligned_cols=258 Identities=26% Similarity=0.405 Sum_probs=205.8
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
..+|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++.+... ..
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-----~~ 80 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-----EK 80 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-----CE
Confidence 457999999999999999999999999999999986432 23345677899999999999999999988543 45
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|+||||++ ++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 81 LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 899999998 5898888877889999999999999999999999999999999999999999999999999997653222
Q ss_pred CCcccccccccccccccccccccc-cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
.. .....|++.|+|||.+... ...++.++|||||||++|||++|+.||...........+..
T Consensus 161 ~~---~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~-------------- 223 (267)
T cd06646 161 AK---RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK-------------- 223 (267)
T ss_pred cc---cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec--------------
Confidence 11 2345789999999987431 24578899999999999999999999965432111100000
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCc
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 405 (509)
....+..+ .....++..+.+||.+||..||++||+++++|+|+|
T Consensus 224 -----------~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 224 -----------SNFQPPKL-KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred -----------CCCCCCCC-ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 00000001 111246788999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=351.31 Aligned_cols=247 Identities=28% Similarity=0.445 Sum_probs=203.0
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
..+++++.||+|-||.||.|.... ...||+|.++.. ......+++|+++|++|+|++||++++++... .-+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~pi 276 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----EPI 276 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecC-----Cce
Confidence 346778999999999999998653 347999999753 23346678999999999999999999999543 349
Q ss_pred EEEEeccc-ccHHHHHHh--CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 193 YVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
|||||||. |+|.++++. ...+.......++.||++|++||+++++|||||...||||+++..+||+|||+|+...++
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 99999999 899999987 457899999999999999999999999999999999999999999999999999954333
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
.... ..+.--..-|.|||.+.. ..++.|+|||||||+|+||+| |+.||++.+..+.+..+.+...
T Consensus 357 ~Y~~--~~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyR---------- 422 (468)
T KOG0197|consen 357 EYTA--SEGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYR---------- 422 (468)
T ss_pred ceee--cCCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCc----------
Confidence 3211 111122345999999987 789999999999999999998 8899999887776666544321
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
-|.| +.+++++.++|..||..+|++|||++.+..
T Consensus 423 ---------------lp~P-----~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 423 ---------------LPRP-----EGCPDEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred ---------------CCCC-----CCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 1111 368899999999999999999999997654
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=339.95 Aligned_cols=260 Identities=24% Similarity=0.413 Sum_probs=206.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcC-CC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRR-EF 189 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~-~~ 189 (509)
.+.|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +|+||+++++++...... ..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 467999999999999999999999999999999986432 2345678899999998 699999999998654321 13
Q ss_pred CcEEEEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 190 KDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
..+|+||||+. ++|.+++... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 46899999998 5888888763 36899999999999999999999999999999999999999999999999999754
Q ss_pred cCCCCCcccccccccccccccccccccc---cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChh
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (509)
..... ......|++.|+|||++.+. ...++.++|||||||++|||++|..||...........+.
T Consensus 162 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~--------- 229 (272)
T cd06637 162 DRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP--------- 229 (272)
T ss_pred ccccc---cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh---------
Confidence 32221 12346799999999988531 1458889999999999999999999996543221111100
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
.... .......++..+.+||.+||..||.+|||+.++++||||
T Consensus 230 ------------------~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 230 ------------------RNPA--PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ------------------cCCC--CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0000 001112467789999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=335.68 Aligned_cols=262 Identities=26% Similarity=0.431 Sum_probs=210.1
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++.+.||.|+||+||+|....++..+|+|++...... .....+.+|+.+++.++|+||+++++.+.. ....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ-TSVDELRKEVQAMSQCNHPNVVKYYTSFVV-----GDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc-hHHHHHHHHHHHHHhcCCCCEEEEEEEEee-----CCEE
Confidence 3699999999999999999999889999999998643222 256778999999999999999999998844 3468
Q ss_pred EEEEeccc-ccHHHHHHhC---CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 193 YVVFELME-SDLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
|+|||+++ ++|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 99999998 5888888764 4589999999999999999999999999999999999999999999999999976544
Q ss_pred CCCCc-ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 269 DAPSA-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 269 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
..... .......|+..|+|||++... ..++.++|+|||||++|+|++|+.||...+....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~------------ 221 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ------------ 221 (267)
T ss_pred CccccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc------------
Confidence 32221 112335789999999998762 3688999999999999999999999976543221111100
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
. ..........+...++.+.+|+.+||..||++||+++++++||||
T Consensus 222 -----------~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 222 -----------N--DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred -----------C--CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0 000111111234678889999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=340.98 Aligned_cols=262 Identities=25% Similarity=0.401 Sum_probs=220.4
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCc-ccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~ 188 (509)
...+|..+.+||+|+||.|.+|..+.+.+.||||++++. ..+..+..--..|-++|.... -|.++.++.+|.+-
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm---- 422 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM---- 422 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh----
Confidence 456899999999999999999999999999999999753 233445555667888887764 68889998888544
Q ss_pred CCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 189 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
..+|+||||+. |+|...+++-+++.+..+.+++.+|+-||-|||++|||+||||.+|||++.+|++||+|||+++...
T Consensus 423 -DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 423 -DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred -hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 45999999998 6999999999999999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
-+.. ...++||||.|+|||++.- .+|+.++|+||+||+|||||.|++||.|++..+.+..|..-.
T Consensus 502 ~~~~---TTkTFCGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn---------- 566 (683)
T KOG0696|consen 502 FDGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN---------- 566 (683)
T ss_pred cCCc---ceeeecCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc----------
Confidence 2222 2357899999999999876 899999999999999999999999999999876665553210
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH-----HHHhcCCcccCCcCCC
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA-----EEALADPYFHGLANVD 413 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~f~~~~~~~ 413 (509)
+. ....+|.++.++...+|.+.|.+|..+ .++..||||+.+.+..
T Consensus 567 ------------------vs---yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek 616 (683)
T KOG0696|consen 567 ------------------VS---YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEK 616 (683)
T ss_pred ------------------Cc---CcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHH
Confidence 00 112468899999999999999999753 6899999999877643
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=342.92 Aligned_cols=258 Identities=28% Similarity=0.468 Sum_probs=209.7
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
...+|++.+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.+.|+||+++++.+... .
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~-----~ 90 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVG-----D 90 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC--cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC-----C
Confidence 4568999999999999999999999999999999986432 23346678999999999999999999988543 4
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
..|+||||+. ++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred EEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 5899999998 578887754 46899999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
... .....|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||........+..+..
T Consensus 170 ~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-------------- 230 (296)
T cd06654 170 QSK---RSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-------------- 230 (296)
T ss_pred ccc---cCcccCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc--------------
Confidence 211 233578999999999876 6788999999999999999999999977654322211110
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
....+ ......+++.+.+||.+||..||++||++.++++||||...
T Consensus 231 -----------~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 231 -----------NGTPE---LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred -----------CCCCC---CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 00000 01113467789999999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=341.04 Aligned_cols=258 Identities=25% Similarity=0.400 Sum_probs=203.0
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.+.||||+++++.+... ...+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 75 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-----NRIS 75 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEEE
Confidence 6889999999999999999999999999999986432 233446788999999999999999999998543 4589
Q ss_pred EEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCc
Q 010489 194 VVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273 (509)
Q Consensus 194 lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 273 (509)
+||||+++...... ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.+||+|||++.......
T Consensus 76 lv~e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 76 ICTEFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred EEEecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 99999996433322 357899999999999999999999999999999999999999999999999997543221
Q ss_pred ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHH
Q 010489 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353 (509)
Q Consensus 274 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (509)
....+||..|+|||++.+ ..++.++|||||||++|+|++|+.||.......... ........+
T Consensus 150 --~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~--------~~~~~~~~~----- 212 (279)
T cd06619 150 --AKTYVGTNAYMAPERISG--EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL--------MPLQLLQCI----- 212 (279)
T ss_pred --ccCCCCChhhcCceeecC--CCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc--------chHHHHHHH-----
Confidence 234589999999999877 678999999999999999999999996532111000 000000000
Q ss_pred HHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
....+ ........++++.+||.+||..||++||+++++++||||...
T Consensus 213 -------~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 213 -------VDEDP--PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred -------hccCC--CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 00000 011123467889999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=338.74 Aligned_cols=262 Identities=24% Similarity=0.412 Sum_probs=207.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++.........
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 467999999999999999999999999999999986421 2235567899999998 799999999998755433445
Q ss_pred cEEEEEeccc-ccHHHHHH----hCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 191 DIYVVFELME-SDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~----~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
..|+||||++ ++|.+++. ....+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 6899999998 48887775 245789999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCccccccccccccccccccccccc---CCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCCh
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~ 342 (509)
....... .....|+..|+|||++.... ..++.++|||||||++|||++|++||...+....+..+..
T Consensus 178 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~------- 247 (291)
T cd06639 178 LTSTRLR---RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR------- 247 (291)
T ss_pred ccccccc---ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc-------
Confidence 4322211 12357899999999875421 2368899999999999999999999976554322221110
Q ss_pred hHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010489 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (509)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 407 (509)
..+... ......+..+.+||.+||..||++||++.++++||||+
T Consensus 248 --------------------~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 248 --------------------NPPPTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred --------------------CCCCCC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 000000 01123567799999999999999999999999999994
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=336.45 Aligned_cols=256 Identities=29% Similarity=0.501 Sum_probs=206.8
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccCh-------hhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV-------SDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~-------~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 186 (509)
+|.+.+.||.|+||.||+|.+..+++.||+|.+....... ...+.+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence 4778899999999999999999899999999886432211 123567889999999999999999998844
Q ss_pred CCCCcEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 187 REFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 187 ~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
....++||||+++ +|.+++...+.+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++.
T Consensus 78 --~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 78 --ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred --CCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 3468999999984 8999998888899999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCc---ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCCh
Q 010489 266 SFNDAPSA---IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342 (509)
Q Consensus 266 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~ 342 (509)
........ .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+.......+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------- 226 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQ--TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE------- 226 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhcc--CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-------
Confidence 54221110 11123568899999999876 6788999999999999999999999986543222111100
Q ss_pred hHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
...+ ......+..+.++|.+||+.||.+||++.++++||||
T Consensus 227 -------------------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 227 -------------------NASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred -------------------cCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 0000 1113467889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=359.28 Aligned_cols=262 Identities=28% Similarity=0.481 Sum_probs=218.5
Q ss_pred cccCCCCCe-eEeeeeeccCceEEEEEEEcCCCcEEEEEEec--CcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecC
Q 010489 107 TEYGEASRY-QIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN--DVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLP 183 (509)
Q Consensus 107 ~~~~~~~~y-~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~--~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~ 183 (509)
.+....+|| +...+||+|+|-+||+|.|..+|..||.-.++ +........+++..|+.+|+.|+||||+++++.|.+
T Consensus 33 ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d 112 (632)
T KOG0584|consen 33 VEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD 112 (632)
T ss_pred cccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec
Confidence 334445666 55678999999999999999999999976553 444555667899999999999999999999999977
Q ss_pred CCcCCCCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCC--eeecCCCCCcEEECCC-CCeEEee
Q 010489 184 PSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANAD-CKLKICD 259 (509)
Q Consensus 184 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~--ivHrDlKp~NILl~~~-~~vkl~D 259 (509)
... ..+-+|+|++. |+|..++++.+.++...++.|++||++||.|||++. |||||||.+||+|+.+ |.|||+|
T Consensus 113 ~~n---~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGD 189 (632)
T KOG0584|consen 113 TDN---KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGD 189 (632)
T ss_pred CCC---ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecc
Confidence 543 56889999998 899999999999999999999999999999999985 9999999999999865 8999999
Q ss_pred ecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCC
Q 010489 260 FGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339 (509)
Q Consensus 260 FG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~ 339 (509)
+|||+....... ...+|||.|||||++.. .|+..+||||||++|+||+|+..||.......|+.+-+
T Consensus 190 LGLAtl~r~s~a-----ksvIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV----- 256 (632)
T KOG0584|consen 190 LGLATLLRKSHA-----KSVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKV----- 256 (632)
T ss_pred hhHHHHhhcccc-----ceeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHH-----
Confidence 999997644332 44799999999999864 89999999999999999999999998766554443221
Q ss_pred CChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
....+|..+.. --+|++++||.+||.. .++|+|+.|+|+||||..
T Consensus 257 --------------------~SGiKP~sl~k---V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 257 --------------------TSGIKPAALSK---VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred --------------------HcCCCHHHhhc---cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 11222222222 1378899999999999 999999999999999975
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=339.33 Aligned_cols=256 Identities=24% Similarity=0.375 Sum_probs=205.3
Q ss_pred eeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEE
Q 010489 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 194 (509)
Q Consensus 115 y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 194 (509)
|++.+.||.|+||.||+|.+..++..+|+|.+... .......+.+|+.+++.+.||||+++++++... ...|+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~~ 79 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWI 79 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-----CEEEE
Confidence 78889999999999999999999999999998642 234456788999999999999999999988543 45899
Q ss_pred EEecccc-cHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCC
Q 010489 195 VFELMES-DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (509)
Q Consensus 195 v~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 272 (509)
||||+++ +|..++.. ...+++..+..++.|+++||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence 9999985 67666654 45799999999999999999999999999999999999999999999999999875432211
Q ss_pred cccccccccccccccccccccc---cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 273 AIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 273 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
......|++.|+|||++... ...++.++|||||||++|||++|.+||...+.......+...
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~------------- 223 (282)
T cd06643 159 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS------------- 223 (282)
T ss_pred --ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc-------------
Confidence 12345789999999987421 145778999999999999999999999876543322221110
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
..+ .. .....++..+.+||.+||..||.+||++.++++||||..
T Consensus 224 -------------~~~-~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 224 -------------EPP-TL-AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred -------------CCC-CC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 000 00 011235778999999999999999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=370.76 Aligned_cols=287 Identities=25% Similarity=0.295 Sum_probs=202.5
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCC-CcEEEEEEe--------------c-CcccChhhHHhHHHHHHHHHHcCCCCcc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHT-GERVAIKKI--------------N-DVFEHVSDATRILREIKLLRLLRHPDIV 175 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~-~~~vAiK~~--------------~-~~~~~~~~~~~~~~Ei~~l~~l~h~niv 175 (509)
..+|++++.||+|+||+||+|..+.. +..+++|.+ . ...........+.+|+.+|+.++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 46899999999999999999876432 222222211 1 1111122345678999999999999999
Q ss_pred eeeeeecCCCcCCCCcEEEEEecccccHHHHHHhC-----CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEEC
Q 010489 176 EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN-----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 250 (509)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-----~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~ 250 (509)
++++++... ...|+|+|++.++|..++... .......+..|+.||+.||.|||++||+||||||+|||++
T Consensus 227 ~l~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 227 KIEEILRSE-----ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301 (501)
T ss_pred cEeEEEEEC-----CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 999998443 458999999999888877543 2234567888999999999999999999999999999999
Q ss_pred CCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCC-CCCC--ChH
Q 010489 251 ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL-FPGK--NVV 327 (509)
Q Consensus 251 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~~--~~~ 327 (509)
.++.+||+|||+++....... ......+||+.|+|||++.+ ..++.++|||||||++|||++|..+ |.+. ...
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAG--DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred CCCCEEEEeCCCceecCcccc--cccccccCCcCCCCchhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 999999999999986533221 11234689999999999987 6799999999999999999999854 4322 233
Q ss_pred hHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccC-CCCCCCCCCC--CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 010489 328 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMR-KKQPVPFSHK--FPNADPLALHLLERLLAFDPKDRPTAEEALADP 404 (509)
Q Consensus 328 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 404 (509)
.++..+...++.+..+.... ......++.... ...+..+... ....++.+.++|.+||.+||.+|||+.|+|+||
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDP--PCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHHHhcccChhhcCCc--HHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 44444444444332221110 001111111100 0001111111 123567789999999999999999999999999
Q ss_pred cccCC
Q 010489 405 YFHGL 409 (509)
Q Consensus 405 ~f~~~ 409 (509)
||...
T Consensus 456 ~f~~~ 460 (501)
T PHA03210 456 LFSAE 460 (501)
T ss_pred hhhcC
Confidence 99753
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=338.80 Aligned_cols=280 Identities=41% Similarity=0.718 Sum_probs=224.1
Q ss_pred eeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCCCcEE
Q 010489 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 115 y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
|++.+.||+|+||.||+|....+++.||||++...... .......+|+..++.++ |+||+++++++.. ....|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~ 74 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELY 74 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEE
Confidence 67889999999999999999889999999998654332 22334567999999999 9999999998854 35689
Q ss_pred EEEecccccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 194 VVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 194 lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
+||||++++|.+.+.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 75 FVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred EEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 999999989999887764 789999999999999999999999999999999999999999999999999976533221
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
.....|+..|+|||++.+. ..++.++|+||||++++||++|++||++....+....+...++.+....+......
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 155 ----YTDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred ----cCCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 2345789999999987542 56789999999999999999999999999988888888888888776543322110
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
. ...-..+....+.......+..++.+.+||.+||..||++|||++|++.||||
T Consensus 230 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 230 A-SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred h-ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0 00000111111112222334457889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=333.97 Aligned_cols=260 Identities=27% Similarity=0.458 Sum_probs=207.0
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc---ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE---HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
.+|++.+.||+|+||.||+|.+..++..||||++..... .......+.+|+.+++.+.||||+++++++.... .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM---E 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC---C
Confidence 469999999999999999999999999999998853221 1234567888999999999999999999875432 2
Q ss_pred CcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
..+|++|||++ ++|.+++...+.+++..+..++.|++.||+|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 45889999998 58999988877899999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
............|+..|+|||++.+ ..++.++|||||||++|||++|+.||...........+. ..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~-------- 225 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISG--EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQP-------- 225 (265)
T ss_pred ccccccccccCCCCccccChhhhcC--CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCC--------
Confidence 2111111234568999999999876 678899999999999999999999997644322211110 000
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 407 (509)
..+ ...+..+..+.++|.+||. +|++||+++++++|||+.
T Consensus 226 --------------~~~----~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 226 --------------TNP----VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred --------------CCC----CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 000 0112456778999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=340.53 Aligned_cols=261 Identities=25% Similarity=0.445 Sum_probs=208.0
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++++.||+|+||.||+|.+..++..||+|.++... .......+.+|+.+++.++||||+++++.+.. ...+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFI-----EGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-----CCeE
Confidence 36899999999999999999999999999999886432 23345678899999999999999999998854 3568
Q ss_pred EEEEecccc-cHHHHHHhC---CCCCHHHHHHHHHHHHhHhhhhhh-CCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 193 YVVFELMES-DLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 193 ~lv~e~~~~-~L~~~l~~~---~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
|+||||+++ +|..++... ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999999985 787777653 379999999999999999999997 599999999999999999999999999987543
Q ss_pred CCCCCccccccccccccccccccccccc----CCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChh
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFF----SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (509)
... .....|++.|+|||.+.+.. ..++.++|||||||++|+|++|..||...........+....
T Consensus 155 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------ 223 (286)
T cd06622 155 ASL-----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIV------ 223 (286)
T ss_pred CCc-----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHh------
Confidence 221 13346888999999875421 245789999999999999999999997644322221111100
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
...+ ....+.+++++.+||.+||..||++||++.+++.||||.....
T Consensus 224 ------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 224 ------------------DGDP---PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred ------------------hcCC---CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 0111 1122347888999999999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=343.81 Aligned_cols=260 Identities=28% Similarity=0.470 Sum_probs=210.1
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
...+|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++|+||+++++++.. ..
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 89 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLV-----GD 89 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CC
Confidence 3478999999999999999999999999999999986422 2334567889999999999999999999854 34
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
..|+||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 90 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred EEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 6899999998 578887754 46899999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
... .....|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+....+..+..
T Consensus 169 ~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-------------- 229 (297)
T cd06656 169 QSK---RSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-------------- 229 (297)
T ss_pred ccC---cCcccCCccccCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc--------------
Confidence 211 234578999999999877 6788999999999999999999999976553221111000
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
.. .+........++.+.+|+.+||..||++||+++++++||||+....
T Consensus 230 ------------~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 230 ------------NG--TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred ------------CC--CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 00 0000112346778999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=335.32 Aligned_cols=257 Identities=25% Similarity=0.414 Sum_probs=206.2
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc----ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE----HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
+|++.+.||.|+||.||+|.. .+++.+|+|.+..... .......+.+|+.+++.++|+||+++++++.. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-----D 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-----C
Confidence 478899999999999999986 4789999998864221 12234568899999999999999999999843 3
Q ss_pred CcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
..+|+||||++ ++|.+++.+.+.+++..+..++.|++.||+|||+.||+|+||||+||+++.++.+||+|||++.....
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 56899999998 58999998878899999999999999999999999999999999999999999999999999875421
Q ss_pred CC---CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 269 DA---PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 269 ~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
.. ..........|+..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------- 224 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINE--SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHR-------- 224 (265)
T ss_pred ccccccccccccccCCCccccChhhhcC--CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhcc--------
Confidence 11 11111234578999999999877 678899999999999999999999997654322211111000
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
..........+.++.+||.+||..||.+||++.++++||||
T Consensus 225 --------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 225 --------------------GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred --------------------CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00011123467889999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=340.58 Aligned_cols=260 Identities=26% Similarity=0.427 Sum_probs=209.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||.|+||.||+|.+..++..||+|.+.. ........+.+|+.+++.++||||+++++.+... ..
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 76 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI--ESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE-----NK 76 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEee--CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC-----Ce
Confidence 3579999999999999999999988999999999863 2334556788999999999999999999998543 45
Q ss_pred EEEEEecccc-cHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+|+||||+++ +|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 8999999985 788887664 47999999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccccccccccccccc---cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
... .....|++.|+|||++... ...++.++|||||||++|+|++|++||.+.+....+..+..
T Consensus 157 ~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------- 222 (280)
T cd06611 157 LQK---RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK----------- 222 (280)
T ss_pred ccc---cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc-----------
Confidence 211 2345789999999987421 14577899999999999999999999987654322221110
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
..+..+ .....++.++.+||.+||..||.+||++.++++||||...
T Consensus 223 ----------------~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 223 ----------------SEPPTL-DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred ----------------CCCCCc-CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 000000 0112467789999999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=337.17 Aligned_cols=258 Identities=25% Similarity=0.452 Sum_probs=202.1
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHH-HHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKL-LRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~-l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|++.+.||+|+||.||+|.+..+|+.||||.++...... ....+..|+.+ ++.+.||||+++++++.. ...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-----~~~ 74 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFR-----EGD 74 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEec-----CCc
Confidence 36899999999999999999999999999999987543322 23455667765 567789999999999854 345
Q ss_pred EEEEEecccccHHHHHHh----CCCCCHHHHHHHHHHHHhHhhhhhhC-CeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 192 IYVVFELMESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~-~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
+|++|||++++|.+++.. ...+++..+..++.||+.||+|||++ +++||||||+|||++.++.+||+|||++...
T Consensus 75 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 75 VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred EEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 899999999988777754 24689999999999999999999997 9999999999999999999999999999765
Q ss_pred cCCCCCcccccccccccccccccccccc--cCCCCCceeeehhhhHHHHHHhCCCCCCCCC-hHhHHHHHHHhcCCCChh
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN-VVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~g~~~~~ 343 (509)
..... .+...|+..|+|||++.+. ...++.++|+|||||++|+|++|+.||.... ..+.+..+
T Consensus 155 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---------- 220 (283)
T cd06617 155 VDSVA----KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV---------- 220 (283)
T ss_pred ccccc----cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH----------
Confidence 32211 1234688999999987542 1356889999999999999999999996422 11111110
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
... ..+ ......++.++.+||.+||..||.+||++.++++||||...
T Consensus 221 -------------~~~---~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 221 -------------VEE---PSP---QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred -------------Hhc---CCC---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 000 000 00112357889999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=341.46 Aligned_cols=262 Identities=24% Similarity=0.445 Sum_probs=204.3
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 191 (509)
.+|...+.||+|+||.||++.+..+++.||||.+...... .....+.+|+.++.++. |+||+++++++..+ ..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~ 77 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GD 77 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-----Cc
Confidence 4577788999999999999999999999999998643222 34567889999999996 99999999988543 45
Q ss_pred EEEEEecccccHHHHHH-----hCCCCCHHHHHHHHHHHHhHhhhhhhC-CeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 192 IYVVFELMESDLHQVIK-----ANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~-----~~~~l~~~~~~~i~~qil~aL~yLH~~-~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
.+++|||++.++.++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 78 CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 89999999876554432 235799999999999999999999974 999999999999999999999999999976
Q ss_pred ccCCCCCccccccccccccccccccccccc-CCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
....... ....|++.|+|||++.+.. ..++.++|||||||++|+|++|+.||..... ....+....
T Consensus 158 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~------- 224 (288)
T cd06616 158 LVDSIAK----TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVV------- 224 (288)
T ss_pred hccCCcc----ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhc-------
Confidence 4332211 2346899999999987621 2688999999999999999999999975431 111111100
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
....+.........+++++.+||.+||..||++|||++++++||||+..
T Consensus 225 ----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 225 ----------------KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred ----------------CCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 0111111111123578899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=330.97 Aligned_cols=253 Identities=28% Similarity=0.473 Sum_probs=211.2
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
+|++++.||.|+||.||.+++..+++.+|+|.+............+.+|+.++++++|+||+++++++.. ...++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEE
Confidence 5899999999999999999999999999999986544444556678899999999999999999999954 34689
Q ss_pred EEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 194 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 194 lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
++|||++ ++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999998 5899988765 468999999999999999999999999999999999999999999999999997653322
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
. ......|++.|+|||++.+ ..++.++|||||||++|||++|..||...+..+....+..
T Consensus 156 ~---~~~~~~~~~~y~ape~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--------------- 215 (256)
T cd08221 156 S---MAETVVGTPYYMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--------------- 215 (256)
T ss_pred c---cccccCCCccccCHhhcCC--CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc---------------
Confidence 1 1244578999999999877 5688899999999999999999999987654333322211
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
.... ......+.++.++|.+||..||.+||++.++|+|||+
T Consensus 216 ------------~~~~---~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 216 ------------GNYT---PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ------------CCCC---CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 0000 0114567889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=332.75 Aligned_cols=258 Identities=29% Similarity=0.448 Sum_probs=207.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||.|+||.||+|.+..+++.+|+|++.... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~ 74 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDK 74 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCE
Confidence 357999999999999999999999999999999986432 2356778899999999999999999998843 346
Q ss_pred EEEEEecccc-cHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+|++|||+++ +|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.+||+|||++......
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 8999999995 788888766 68999999999999999999999999999999999999999999999999998764322
Q ss_pred CCCcccccccccccccccccccccc-cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
.. ......++..|+|||.+.+. ...++.++|||||||++|+|++|.+||.+.+.......+...
T Consensus 155 ~~---~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~------------ 219 (262)
T cd06613 155 IA---KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS------------ 219 (262)
T ss_pred hh---ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------------
Confidence 11 12345789999999998651 126888999999999999999999999876543322221110
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 405 (509)
.+ .+.. .......+.++.+||.+||..||.+|||+.+++.|+|
T Consensus 220 ----------~~---~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 220 ----------NF---PPPK-LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ----------cC---CCcc-ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 00 0000 0011234677999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=340.73 Aligned_cols=261 Identities=25% Similarity=0.397 Sum_probs=209.3
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
+|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++.+.. ...+
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~ 76 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-----KRHL 76 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-----CCEE
Confidence 68999999999999999999999999999999864321 12334577899999999999999999998843 3468
Q ss_pred EEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
|+||||++ ++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++.......
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 77 CMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 99999998 48999998888899999999999999999999999999999999999999999999999999864211110
Q ss_pred C------------cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCC
Q 010489 272 S------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339 (509)
Q Consensus 272 ~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~ 339 (509)
. ........|+..|+|||.+.+ ..++.++|+|||||++|||++|..||.+....+.+..+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~--- 231 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD--- 231 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---
Confidence 0 001123467889999999876 67899999999999999999999999876543222211110
Q ss_pred CChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC---HHHHhcCCcccCC
Q 010489 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT---AEEALADPYFHGL 409 (509)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~f~~~ 409 (509)
. ..+.......++.+.+||.+||..||++||+ +.++|+||||...
T Consensus 232 -----------------------~--~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 232 -----------------------D--IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred -----------------------c--cCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 0 0000111246788999999999999999998 7999999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=335.25 Aligned_cols=261 Identities=26% Similarity=0.441 Sum_probs=207.9
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccC----hhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH----VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
+|+..+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+++++.++|+||+++++++.. .
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE-----D 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc-----C
Confidence 478889999999999999999999999999998643211 1235678899999999999999999999843 3
Q ss_pred CcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCC-CeEEeeeccccccc
Q 010489 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVSF 267 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~-~vkl~DFG~a~~~~ 267 (509)
..+++||||+. ++|.+++...+.+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||++....
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 46899999998 48999998888899999999999999999999999999999999999998876 59999999987654
Q ss_pred CCCCC-cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 268 NDAPS-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 268 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
..... ........||..|+|||++.+ ..++.++|||||||++|+|++|..||...........+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 224 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA--------- 224 (268)
T ss_pred cccccCCccccccccccceeCHhHhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh---------
Confidence 33211 111123578899999999876 678899999999999999999999997544322222111100
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 407 (509)
..... .......++.+.+++.+||..||.+||++.++++||||+
T Consensus 225 --------------~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 225 --------------SATTA---PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred --------------ccCCC---CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 00000 011124678899999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=375.36 Aligned_cols=264 Identities=33% Similarity=0.480 Sum_probs=202.5
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecC---------
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLP--------- 183 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~--------- 183 (509)
.+|+.++.||+||||.||+|+++-+|+.||||+|.-.. ......++.+|+.+|.+|+|||||+++..+..
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 46788999999999999999999999999999997655 55667889999999999999999999876610
Q ss_pred ---------------------------------------------CC----------------------c----------
Q 010489 184 ---------------------------------------------PS----------------------R---------- 186 (509)
Q Consensus 184 ---------------------------------------------~~----------------------~---------- 186 (509)
.. .
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 00 0
Q ss_pred ---------------------CC-------CCcEEEEEecccccHHHHHHhCCCC--CHHHHHHHHHHHHhHhhhhhhCC
Q 010489 187 ---------------------RE-------FKDIYVVFELMESDLHQVIKANDDL--TPEHYQFFLYQLLRGLKYIHTAN 236 (509)
Q Consensus 187 ---------------------~~-------~~~~~lv~e~~~~~L~~~l~~~~~l--~~~~~~~i~~qil~aL~yLH~~~ 236 (509)
.+ ...+||-||||+.++.+.+.....+ ....++.+++||++||.|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 00 0348999999997666555544444 47889999999999999999999
Q ss_pred eeecCCCCCcEEECCCCCeEEeeeccccccc--------------C-CCCCcccccccccccccccccccccccC-CCCC
Q 010489 237 VFHRDLKPKNILANADCKLKICDFGLARVSF--------------N-DAPSAIFWTDYVATRWYRAPELCGSFFS-KYTP 300 (509)
Q Consensus 237 ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~--------------~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~ 300 (509)
||||||||.||++++++.|||+|||+|+... . ........++.+||..|+|||++.+... .|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999998621 0 0111113467899999999999987422 6999
Q ss_pred ceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccC-CCCCCCCCCCCCCCCHHH
Q 010489 301 AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMR-KKQPVPFSHKFPNADPLA 379 (509)
Q Consensus 301 ~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 379 (509)
|+|+|||||||+||+. ||...- +....+ ..++ ...|.+ ...+.+--+..
T Consensus 798 KiDmYSLGIVlFEM~y---PF~TsM--ERa~iL------------------------~~LR~g~iP~~-~~f~~~~~~~e 847 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGTSM--ERASIL------------------------TNLRKGSIPEP-ADFFDPEHPEE 847 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCchH--HHHHHH------------------------HhcccCCCCCC-cccccccchHH
Confidence 9999999999999995 565422 111111 1111 111222 12223334567
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010489 380 LHLLERLLAFDPKDRPTAEEALADPYFH 407 (509)
Q Consensus 380 ~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 407 (509)
..+|++||+.||.+||||.|+|++.||.
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 8899999999999999999999999985
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=331.08 Aligned_cols=253 Identities=27% Similarity=0.461 Sum_probs=207.9
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
+|++.+.||+|+||.||++.+..+|+.||+|.+............+.+|+.+++.++||||+++++++. .....|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE-----ENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeec-----CCCeEE
Confidence 589999999999999999999999999999998643333345567889999999999999999999884 345689
Q ss_pred EEEeccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 194 VVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 194 lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+||||+. ++|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++.......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999998 58988886543 58899999999999999999999999999999999999999999999999997643322
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
.. .....|++.|+|||++.+ ..++.++|+|||||++++|++|+.||...+..+....+..
T Consensus 156 ~~---~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--------------- 215 (256)
T cd08218 156 EL---ARTCIGTPYYLSPEICEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--------------- 215 (256)
T ss_pred hh---hhhccCCccccCHHHhCC--CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc---------------
Confidence 11 123468899999999877 6788899999999999999999999976554333222210
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
...+ ......+..+.++|.+||..+|.+||++.++++||||
T Consensus 216 -----------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 216 -----------GSYP----PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -----------CCCC----CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 0000 0113467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=336.99 Aligned_cols=256 Identities=29% Similarity=0.458 Sum_probs=209.7
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++.+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++|+||+++++++... ..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-----SKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-----CeE
Confidence 36899999999999999999999999999999986432 233456678999999999999999999988543 468
Q ss_pred EEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
|+|+||++ ++|.+++... .+++..+..++.|++.||.|||+.+|+||||+|+||+++.++.++|+|||+++.......
T Consensus 75 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 99999998 4888888765 899999999999999999999999999999999999999999999999999976543321
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
. .....|++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+.
T Consensus 154 ~---~~~~~~~~~y~~PE~~~~--~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~----------------- 211 (274)
T cd06609 154 K---RNTFVGTPFWMAPEVIKQ--SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP----------------- 211 (274)
T ss_pred c---cccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh-----------------
Confidence 1 234578999999999887 568999999999999999999999997654322111111
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
...+..+ .....++.+.++|.+||..||++|||++++++||||...
T Consensus 212 ----------~~~~~~~--~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 212 ----------KNNPPSL--EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred ----------hcCCCCC--cccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 0001000 011267789999999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=336.87 Aligned_cols=260 Identities=25% Similarity=0.427 Sum_probs=206.1
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCc-CCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSR-REF 189 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~-~~~ 189 (509)
.+.|++.+.||.|+||.||+|.+..+++.||+|++... ......+..|+.+++.+ .|+||+++++++..... ...
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 46899999999999999999999999999999988542 23345678899999988 69999999999864322 234
Q ss_pred CcEEEEEecccc-cHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 190 KDIYVVFELMES-DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 190 ~~~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
..+|++|||+++ +|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 568999999984 888888653 45889999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCcccccccccccccccccccccc---cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChh
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (509)
..... ......|++.|+|||++... ...++.++|||||||++|||++|..||...........+.
T Consensus 172 ~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~--------- 239 (282)
T cd06636 172 DRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP--------- 239 (282)
T ss_pred hcccc---CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh---------
Confidence 22111 12345789999999987521 1467889999999999999999999997644322111100
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
.. .........++..+.+||.+||..||.+||++.|+|+||||
T Consensus 240 ------------------~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 240 ------------------RN--PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ------------------hC--CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 00 01111123467889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=336.38 Aligned_cols=262 Identities=24% Similarity=0.415 Sum_probs=206.0
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~ 189 (509)
...+|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++........
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 3568999999999999999999999999999999875421 2234577899999999 69999999998865443445
Q ss_pred CcEEEEEeccc-ccHHHHHH----hCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 190 KDIYVVFELME-SDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~----~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
..+|+||||++ ++|.+++. ....+++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++.
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~ 172 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCcee
Confidence 67999999998 57877764 23568999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCcccccccccccccccccccccc---cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCC
Q 010489 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341 (509)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~ 341 (509)
....... ......|++.|+|||++... ...++.++|||||||++|||++|+.||........+..+.
T Consensus 173 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~------- 242 (286)
T cd06638 173 QLTSTRL---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP------- 242 (286)
T ss_pred ecccCCC---ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc-------
Confidence 6532211 12334799999999987531 1457889999999999999999999997654322211110
Q ss_pred hhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
...+... ......+..+.+||.+||..||++|||+.++++|+||
T Consensus 243 --------------------~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 243 --------------------RNPPPTL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred --------------------ccCCCcc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 0000000 0011246779999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=337.81 Aligned_cols=246 Identities=20% Similarity=0.251 Sum_probs=198.5
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCcccCh-hhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEe
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV-SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 197 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 197 (509)
..||+|++|.||+|.. +|+.||||+++...... ...+.+.+|+.+|++++||||+++++++.... .....+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 5699999999999976 68999999987543222 22466779999999999999999999885411 12346899999
Q ss_pred ccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhh-CCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccc
Q 010489 198 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (509)
Q Consensus 198 ~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 275 (509)
|++ |+|.+++...+.+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----
Confidence 999 5899999888889999999999999999999998 499999999999999999999999999997643221
Q ss_pred ccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHH
Q 010489 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (509)
Q Consensus 276 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (509)
....||..|+|||++.+....++.++|||||||++|||++|+.||.+.+..+....+...
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~------------------- 237 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINK------------------- 237 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-------------------
Confidence 234789999999998753357899999999999999999999999876643333222110
Q ss_pred hhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
....+. ...+++.+.+||.+||+.||++|||+.++++
T Consensus 238 -------~~~~~~---~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 238 -------NNSLKL---PLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred -------CCCCCC---CCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 000111 1246788999999999999999999999986
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=333.47 Aligned_cols=262 Identities=28% Similarity=0.483 Sum_probs=207.3
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccC--------hhhHHhHHHHHHHHHHcCCCCcceeeeeecCCC
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH--------VSDATRILREIKLLRLLRHPDIVEIKHIMLPPS 185 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~--------~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~ 185 (509)
+|.+.+.||.|+||.||+|.+..+|+.||+|.++..... ....+.+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 588999999999999999999999999999987532111 1123457789999999999999999998844
Q ss_pred cCCCCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 186 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
...+++||||+. ++|.+++...+.+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.
T Consensus 80 ---~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 80 ---EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ---CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 345899999998 5899999888889999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
....... ........|+..|+|||.+......++.++|+||||+++|+|++|..||........+..+.
T Consensus 157 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---------- 225 (272)
T cd06629 157 KSDDIYD-NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLG---------- 225 (272)
T ss_pred ccccccc-ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhh----------
Confidence 5432211 11123456889999999987632347899999999999999999999996544322111100
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
. ....+.......+.++..+.+||.+||..||.+||+++++|+||||
T Consensus 226 --------------~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 226 --------------N-KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred --------------c-cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0 0001111112234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=331.36 Aligned_cols=255 Identities=31% Similarity=0.511 Sum_probs=209.6
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
+|++++.||.|+||.||+|.+..++..||+|.++...........+..|+.+++.++||||+++++.+... ....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence 58999999999999999999999999999999875444445567788999999999999999999877543 234589
Q ss_pred EEEeccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHhHhhhhh-----hCCeeecCCCCCcEEECCCCCeEEeeeccc
Q 010489 194 VVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIH-----TANVFHRDLKPKNILANADCKLKICDFGLA 263 (509)
Q Consensus 194 lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH-----~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 263 (509)
++|||++ ++|.+++.. ...+++..+..++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999998 588888865 357999999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChh
Q 010489 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (509)
........ ......|++.|+|||++.+ ..++.++|+||||+++++|++|..||.+.+.......+..
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------- 224 (265)
T cd08217 158 KILGHDSS---FAKTYVGTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE-------- 224 (265)
T ss_pred ccccCCcc---cccccccCCCccChhhhcC--CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc--------
Confidence 86543221 1234578999999999877 5688999999999999999999999987653222211110
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
... .......+..+.+|+.+||..+|++||++.++++|||+
T Consensus 225 -------------------~~~---~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 225 -------------------GKF---RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred -------------------CCC---CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 000 01112457889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=348.05 Aligned_cols=255 Identities=24% Similarity=0.323 Sum_probs=205.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.+...++..||+|.||+||+|++-. .||||+++.........+.|..|+.++++-+|.||+-+.|++..+.
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~------ 461 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP------ 461 (678)
T ss_pred HHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc------
Confidence 4567889999999999999997653 5999999877777778899999999999999999999999997664
Q ss_pred EEEEEecccc-cHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+.||+.+|+| +|+.++.-. .+|.......|+.||++|+.|||.++|||||||..||++.++++|||+|||++.....-
T Consensus 462 ~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 462 LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 4999999997 788888643 47888999999999999999999999999999999999999999999999999754322
Q ss_pred CCCcccccccccccccccccccccc-cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
. .........|...|||||+++.. ..+|++.+||||||||+|||++|..||...+ .+++- ...|.-
T Consensus 542 ~-g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-~dqIi---fmVGrG-------- 608 (678)
T KOG0193|consen 542 S-GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-RDQII---FMVGRG-------- 608 (678)
T ss_pred c-cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-hhheE---EEeccc--------
Confidence 1 11112345688899999998643 3569999999999999999999999998433 22221 111110
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
...........+++.++++|+..||.+++++||.+.+||.
T Consensus 609 --------------~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 609 --------------YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred --------------ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 0011222334567779999999999999999999999887
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=333.51 Aligned_cols=261 Identities=27% Similarity=0.452 Sum_probs=207.6
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCc-CCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSR-REF 189 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~-~~~ 189 (509)
.++|++.+.||.|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ .|+||+++++++..... ...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 478999999999999999999999899999999986432 2345688999999998 69999999999876543 334
Q ss_pred CcEEEEEecccc-cHHHHHHh----CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 190 KDIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 190 ~~~~lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
..+|+||||+++ +|.+++.. ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 568999999995 78777754 3579999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCcccccccccccccccccccccc---cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCC
Q 010489 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341 (509)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~ 341 (509)
....... ......|++.|+|||++... ...++.++|||||||++|+|++|.+||........+..+..
T Consensus 162 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------ 232 (275)
T cd06608 162 QLDSTLG---RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR------ 232 (275)
T ss_pred ecccchh---hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc------
Confidence 5432221 12345789999999987532 13577899999999999999999999976543222221110
Q ss_pred hhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
..+... ......+..+.+||.+||..||++|||+.++++|||+
T Consensus 233 ---------------------~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 233 ---------------------NPPPTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ---------------------cCCCCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 000000 0011356789999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=339.78 Aligned_cols=259 Identities=21% Similarity=0.333 Sum_probs=197.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcC----------------CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTH----------------TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~----------------~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv 175 (509)
.++|++.++||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+|+.++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 4689999999999999999997532 34579999986432 233456788999999999999999
Q ss_pred eeeeeecCCCcCCCCcEEEEEeccc-ccHHHHHHhCC-------------------CCCHHHHHHHHHHHHhHhhhhhhC
Q 010489 176 EIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND-------------------DLTPEHYQFFLYQLLRGLKYIHTA 235 (509)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-------------------~l~~~~~~~i~~qil~aL~yLH~~ 235 (509)
++++++... ...|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.
T Consensus 83 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 83 RLLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred EEEEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 999998543 45899999998 58988885432 367788999999999999999999
Q ss_pred CeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHH
Q 010489 236 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEML 315 (509)
Q Consensus 236 ~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell 315 (509)
||+||||||+|||++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|||+
T Consensus 158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY-RIQGRAVLPIRWMAWECILM--GKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred CccccCcchhheEEcCCccEEECCCccceecccCcee-EecCcCCCCccccCHHHHhc--CCCCchhhhHHHHHHHHHHH
Confidence 9999999999999999999999999999764332211 11123456788999999876 67999999999999999998
Q ss_pred h--CCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCC
Q 010489 316 T--GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD 393 (509)
Q Consensus 316 ~--g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 393 (509)
+ +..||.+.+..+.+..+...+ .... ........+.++..+.+||.+||..||++
T Consensus 235 ~~~~~~p~~~~~~~~~~~~~~~~~--------------------~~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~ 291 (304)
T cd05096 235 MLCKEQPYGELTDEQVIENAGEFF--------------------RDQG---RQVYLFRPPPCPQGLYELMLQCWSRDCRE 291 (304)
T ss_pred HccCCCCCCcCCHHHHHHHHHHHh--------------------hhcc---ccccccCCCCCCHHHHHHHHHHccCCchh
Confidence 7 557887655433222211110 0000 00001112356788999999999999999
Q ss_pred CCCHHHHhc
Q 010489 394 RPTAEEALA 402 (509)
Q Consensus 394 Rpt~~e~l~ 402 (509)
|||+.++.+
T Consensus 292 RPs~~~i~~ 300 (304)
T cd05096 292 RPSFSDIHA 300 (304)
T ss_pred CcCHHHHHH
Confidence 999999955
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=329.50 Aligned_cols=261 Identities=31% Similarity=0.491 Sum_probs=210.3
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
+|.+.+.||+|+||.||+|.+..+++.||+|.++...........+.+|+.+++.++|+||+++++++... ..++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR-----EKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC-----CEEE
Confidence 68999999999999999999988999999999875444334677889999999999999999999987433 4589
Q ss_pred EEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCC
Q 010489 194 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (509)
Q Consensus 194 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 272 (509)
+|+||++ ++|.+++.....+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.........
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999998 589999988778999999999999999999999999999999999999999999999999999765433322
Q ss_pred ccc-cccccccccccccccccccc-CCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 273 AIF-WTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 273 ~~~-~~~~~gt~~y~aPE~~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
... .....+++.|+|||++.+.. ..++.++|||||||++|+|++|+.||...+..........
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~--------------- 220 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG--------------- 220 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh---------------
Confidence 111 22457889999999987631 2378899999999999999999999976432111111000
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
....... .....+++.+.+||.+||+.||.+||++.+++.|||+
T Consensus 221 ---------~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 221 ---------AGHKPPI---PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ---------cCCCCCC---CcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0000011 1123457889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=332.60 Aligned_cols=254 Identities=27% Similarity=0.448 Sum_probs=208.7
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
.|++.+.||.|+||.||+|.+..+++.||+|++..... .....+.+.+|++++++++||||+++++++. +...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ-----DEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhc-----CCCeE
Confidence 48999999999999999999999999999999865322 2245677889999999999999999998884 34569
Q ss_pred EEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
|+|+||+. ++|.+.+.....+++..+..++.||++||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence 99999998 58999988777899999999999999999999999999999999999999999999999999876533221
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
.....|+..|+|||++.+ ..++.++|+||||+++|+|++|..||...+.........
T Consensus 156 ----~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----------------- 212 (258)
T cd05578 156 ----TTSTSGTPGYMAPEVLCR--QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA----------------- 212 (258)
T ss_pred ----ccccCCChhhcCHHHHcc--cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH-----------------
Confidence 234578899999999877 568999999999999999999999998765311100000
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH--HHHhcCCcc
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA--EEALADPYF 406 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--~e~l~hp~f 406 (509)
.... ... ...+..++.+.++|.+||..||.+||++ .|+++||||
T Consensus 213 -------~~~~-~~~---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 213 -------KQET-ADV---LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -------Hhcc-ccc---cCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 0000 000 1112456889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=331.06 Aligned_cols=252 Identities=31% Similarity=0.529 Sum_probs=206.8
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++.+.||+|+||.||+|.+..++..||+|.+... .....+.+|+.+++.++||||+++++.+... ..+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~ 73 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYFKN-----TDL 73 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CcE
Confidence 5799999999999999999999988999999998642 2256788999999999999999999988543 468
Q ss_pred EEEEeccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 193 YVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
|+++||++ ++|.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.+||+|||++.......
T Consensus 74 ~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 74 WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred EEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 99999999 488888865 4578999999999999999999999999999999999999999999999999997653322
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
.. .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.
T Consensus 154 ~~---~~~~~~~~~y~~PE~~~~--~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~---------------- 212 (256)
T cd06612 154 AK---RNTVIGTPFWMAPEVIQE--IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP---------------- 212 (256)
T ss_pred cc---cccccCCccccCHHHHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc----------------
Confidence 11 233468899999999877 678999999999999999999999997654322111100
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
...+..+ ......+..+.++|.+||+.||++|||+.++|+||||
T Consensus 213 -----------~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 213 -----------NKPPPTL-SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred -----------cCCCCCC-CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 0000000 1112356789999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=335.89 Aligned_cols=257 Identities=28% Similarity=0.484 Sum_probs=208.8
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
+|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.+.||||+++++++... ..+|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~ 75 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDIS 75 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEEE
Confidence 68889999999999999999999999999999865432 24456788999999999999999999988544 5689
Q ss_pred EEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhh-CCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 194 VVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 194 lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+++||++ ++|.+++... ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||.+.......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 9999999 6899998776 789999999999999999999999 999999999999999999999999999987543221
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCCh--HhHHHHHHHhcCCCChhHHHHh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV--VHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
. ....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...+. ......+..
T Consensus 156 ~-----~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 215 (265)
T cd06605 156 A-----KTFVGTSSYMAPERIQG--NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY------------- 215 (265)
T ss_pred h-----hcccCChhccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHH-------------
Confidence 1 12578899999999877 6889999999999999999999999976431 000111100
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.. ...+.... ...+++.+.++|.+||..||++|||+.+++.||||+.+
T Consensus 216 -------~~----~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 216 -------IV----NEPPPRLP--SGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred -------Hh----cCCCCCCC--hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 00 01110000 01167889999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=328.19 Aligned_cols=252 Identities=28% Similarity=0.463 Sum_probs=206.6
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
+|++.+.||+|+||.||+|.+..+++.||||.+............+.+|+.+++.++||||+++++.+.. ....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-----DKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-----CCEEE
Confidence 5899999999999999999999999999999987543344456778899999999999999999998743 34689
Q ss_pred EEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCC-CeEEeeecccccccCC
Q 010489 194 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVSFND 269 (509)
Q Consensus 194 lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~-~vkl~DFG~a~~~~~~ 269 (509)
+||||++ ++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999998 4899988764 3589999999999999999999999999999999999998654 5799999999865432
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
.. .....|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+.......+..
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-------------- 215 (256)
T cd08220 156 SK----AYTVVGTPCYISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-------------- 215 (256)
T ss_pred cc----ccccccCCcccCchhccC--CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh--------------
Confidence 22 123578999999999876 5788999999999999999999999977654322211110
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
. ...+ ....+++.+.+++.+||..||++|||+.++++||||
T Consensus 216 ---------~--~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 216 ---------G--TFAP-----ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ---------c--CCCC-----CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 0 0000 112467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=340.76 Aligned_cols=258 Identities=26% Similarity=0.495 Sum_probs=206.9
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
.|.....||+|+||.||++.+..++..||||++... .......+.+|+.+++.++|+||+++++.+.. ....|
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~ 95 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-----GDELW 95 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-----CCeEE
Confidence 455567899999999999999999999999998642 22345668899999999999999999998854 34689
Q ss_pred EEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCC
Q 010489 194 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (509)
Q Consensus 194 lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 272 (509)
+||||+++ +|.+++. .+.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 96 lv~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~ 174 (292)
T cd06658 96 VVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK 174 (292)
T ss_pred EEEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence 99999985 6777664 457999999999999999999999999999999999999999999999999998754322221
Q ss_pred cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHH
Q 010489 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (509)
Q Consensus 273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (509)
.....|++.|+|||.+.+ ..++.++|||||||++|||++|..||.+.+....+..+...
T Consensus 175 ---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~---------------- 233 (292)
T cd06658 175 ---RKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN---------------- 233 (292)
T ss_pred ---CceeecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------------
Confidence 234578999999999876 67889999999999999999999999876543322221110
Q ss_pred HHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCC
Q 010489 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412 (509)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 412 (509)
+... . ......+..+.++|.+||..||.+|||++++++||||+....+
T Consensus 234 -------~~~~----~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 234 -------LPPR----V-KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred -------CCCc----c-ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 0000 0 0112457789999999999999999999999999999865443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=311.38 Aligned_cols=264 Identities=25% Similarity=0.405 Sum_probs=206.0
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
...||+|.+.||+|||+.||++.+..+++.||+|++.... ..+.+..++|+...++++|||++++++..+........
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 3579999999999999999999999999999999997543 46678889999999999999999999988776555566
Q ss_pred cEEEEEeccc-ccHHHHHHhC----CCCCHHHHHHHHHHHHhHhhhhhhCC--eeecCCCCCcEEECCCCCeEEeeeccc
Q 010489 191 DIYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLA 263 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~~--ivHrDlKp~NILl~~~~~vkl~DFG~a 263 (509)
..||+++|.. |+|.+.+... ..+++.++..|+.+|++||++||+.. .+||||||.|||+.+.+.++|.|||.+
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 7999999987 7898888542 36999999999999999999999998 999999999999999999999999998
Q ss_pred ccccCCCCCc------ccccccccccccccccccccc-cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHh
Q 010489 264 RVSFNDAPSA------IFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL 336 (509)
Q Consensus 264 ~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 336 (509)
+...-..... ..+.....|..|+|||++.-. ....+.++|||||||+||+|+.|..||...- ..
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~---------~~ 247 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY---------QQ 247 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh---------hc
Confidence 7532111110 112334568899999987432 2457889999999999999999999994211 00
Q ss_pred cCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 337 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
-|.... ++ ......++.. +..+..+.+||+.||+.||.+||++.+++.+
T Consensus 248 GgSlaL----------------Av-~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 248 GGSLAL----------------AV-QNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CCeEEE----------------ee-eccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 000000 00 0000111111 2267889999999999999999999999873
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=331.47 Aligned_cols=251 Identities=20% Similarity=0.287 Sum_probs=199.3
Q ss_pred CCCeeEeeeeeccCceEEEEEEEc---CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
..+|++.+.||+|+||.||+|... ..+..||+|.++... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG---- 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC----
Confidence 357999999999999999999765 356789999987532 223345788999999999999999999998543
Q ss_pred CCcEEEEEecccc-cHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 189 FKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 189 ~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
..+|+||||+++ +|.+++... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||.+...
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 79 -NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred -CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 458999999984 788888764 57899999999999999999999999999999999999999999999999987653
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
...... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+...
T Consensus 158 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~--------- 224 (266)
T cd05064 158 KSEAIY--TTMSGKSPVLWAAPEAIQY--HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG--------- 224 (266)
T ss_pred cccchh--cccCCCCceeecCHHHHhh--CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC---------
Confidence 221111 0112345678999999877 688999999999999999775 99999876654333322110
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
...+ ..+.++..+.+++.+||+.+|.+||+++++++
T Consensus 225 ------------------~~~~---~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 225 ------------------FRLP---APRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ------------------CCCC---CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 0001 12346778999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=338.89 Aligned_cols=256 Identities=28% Similarity=0.518 Sum_probs=206.7
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
.|.....||+|+||.||+|.+..++..||||++.... ......+.+|+.+++.+.||||+++++++.. ....|
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~ 94 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEELW 94 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheee-----CCeEE
Confidence 3555668999999999999999999999999986422 2334567899999999999999999998844 34689
Q ss_pred EEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCC
Q 010489 194 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (509)
Q Consensus 194 lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 272 (509)
+||||+++ +|..++. ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 95 iv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~ 173 (297)
T cd06659 95 VLMEFLQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 173 (297)
T ss_pred EEEecCCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc
Confidence 99999985 6777654 457899999999999999999999999999999999999999999999999998754332211
Q ss_pred cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHH
Q 010489 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (509)
Q Consensus 273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (509)
.....|++.|+|||++.+ ..++.++|||||||++|||++|+.||...+....+..+..
T Consensus 174 ---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~----------------- 231 (297)
T cd06659 174 ---RKSLVGTPYWMAPEVISR--TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD----------------- 231 (297)
T ss_pred ---ccceecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-----------------
Confidence 234578999999999877 6789999999999999999999999987654333322210
Q ss_pred HHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
. +..........++.+.++|.+||+.||++||+++++++||||.+..
T Consensus 232 ----------~-~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 232 ----------S-PPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred ----------c-CCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 0 0111112235678899999999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=349.20 Aligned_cols=253 Identities=26% Similarity=0.390 Sum_probs=196.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCC-----CcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHT-----GERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~ 185 (509)
.++|++.+.||+|+||.||+|++..+ +..||||+++... .......+.+|+.+++.+ +|+||+++++++...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~- 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTHG- 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC-
Confidence 45799999999999999999986443 3579999997532 223456788999999999 899999999998543
Q ss_pred cCCCCcEEEEEeccc-ccHHHHHHhC------------------------------------------------------
Q 010489 186 RREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 210 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~-~~L~~~l~~~------------------------------------------------------ 210 (509)
..+|+|||||. |+|.+++...
T Consensus 115 ----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 115 ----GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ----CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 45899999998 6888887532
Q ss_pred ----------------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCcc
Q 010489 211 ----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 274 (509)
Q Consensus 211 ----------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 274 (509)
.++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ .
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~-~ 269 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY-V 269 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce-e
Confidence 24788899999999999999999999999999999999999999999999999765332211 1
Q ss_pred cccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHH
Q 010489 275 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353 (509)
Q Consensus 275 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (509)
......+++.|||||++.+ ..++.++|||||||++|||++ |+.||...........+..
T Consensus 270 ~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~------------------ 329 (374)
T cd05106 270 VKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK------------------ 329 (374)
T ss_pred eccCCCCccceeCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHH------------------
Confidence 1122345678999999876 679999999999999999997 9999976543211111100
Q ss_pred HHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
... .... ....++++.++|.+||+.||.+|||+.++++
T Consensus 330 ----~~~--~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 330 ----RGY--QMSR-----PDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ----ccc--CccC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 0000 0135788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=333.10 Aligned_cols=252 Identities=27% Similarity=0.401 Sum_probs=195.5
Q ss_pred eeeccCceEEEEEEEcCCCcEEEEEEecCcccCh-hhHHhHHHHHHHHH---HcCCCCcceeeeeecCCCcCCCCcEEEE
Q 010489 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV-SDATRILREIKLLR---LLRHPDIVEIKHIMLPPSRREFKDIYVV 195 (509)
Q Consensus 120 ~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~-~~~~~~~~Ei~~l~---~l~h~niv~~~~~~~~~~~~~~~~~~lv 195 (509)
.||+|+||.||+|.+..+++.||+|.+....... .......+|..+++ ...||+|+.+++.+... +..|+|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-----DKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-----CeEEEE
Confidence 4899999999999999999999999986432221 12223344544443 34799999999988543 458999
Q ss_pred Eeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCcc
Q 010489 196 FELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 274 (509)
Q Consensus 196 ~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 274 (509)
|||++ ++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 99998 5898888888889999999999999999999999999999999999999999999999999987543221
Q ss_pred cccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHH
Q 010489 275 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354 (509)
Q Consensus 275 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (509)
.....||+.|+|||.+.+. ..++.++|||||||++|+|++|..||.+....... .+...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-------------~~~~~------ 210 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-------------EIDRM------ 210 (279)
T ss_pred -ccCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-------------HHHHH------
Confidence 1234799999999987631 46889999999999999999999999764321110 00000
Q ss_pred HhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCc
Q 010489 355 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (509)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~ 410 (509)
.. ..+. ...+..++++.++|.+||..||.+|| ++.++++||||+++.
T Consensus 211 --~~----~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 211 --TL----TVNV---ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred --hh----cCCc---CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 00 0000 11234678899999999999999999 699999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=327.02 Aligned_cols=254 Identities=29% Similarity=0.492 Sum_probs=206.9
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc---ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE---HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
+|+..+.||+|+||.||+|.+..++..||+|.+..... .....+.+.+|+.+++.++|+||+++++++.. ..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE-----ED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec-----CC
Confidence 57788999999999999999988999999999854221 12345678899999999999999999998843 34
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|++|||++ ++|.+++...+.+++..+..++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 6899999998 489999988878999999999999999999999999999999999999999999999999998765332
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
. ......|+..|+|||.+... ..++.++|+|||||++|+|++|+.||...........+...
T Consensus 156 ~----~~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~------------- 217 (258)
T cd06632 156 S----FAKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS------------- 217 (258)
T ss_pred c----cccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc-------------
Confidence 2 12345789999999988662 23889999999999999999999999765422221111000
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
. ......+.+++.+.+|+.+||..||.+||++.+++.|||+
T Consensus 218 -------------~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 218 -------------K---ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred -------------c---cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 0 0011123467889999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=335.68 Aligned_cols=256 Identities=27% Similarity=0.424 Sum_probs=207.8
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
..+|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++.+++... .
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-----~ 88 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-----H 88 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-----C
Confidence 4579999999999999999999999999999999864322 233446788999999999999999999998543 4
Q ss_pred cEEEEEecccccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
..|+||||+.+++.+++.. .+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++......
T Consensus 89 ~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 89 TAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred eEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 5899999999998887764 457999999999999999999999999999999999999999999999999998754221
Q ss_pred CCCcccccccccccccccccccccc-cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
....|++.|+|||++.+. ...++.++||||||+++|||++|.+||.+.+.......+..
T Consensus 169 -------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~------------- 228 (307)
T cd06607 169 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------- 228 (307)
T ss_pred -------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-------------
Confidence 235788899999987421 24688899999999999999999999977654332211110
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
...+ ......++..+.+||.+||..||++||++.+++.||||..
T Consensus 229 -------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 229 -------------NDSP---TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred -------------CCCC---CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 0000 0011235678999999999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=328.28 Aligned_cols=250 Identities=24% Similarity=0.419 Sum_probs=204.3
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEecc
Q 010489 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM 199 (509)
Q Consensus 121 lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 199 (509)
||.|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++.+.. ...+|++|||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-----KKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-----CCccEEEEecC
Confidence 6999999999999999999999999864322 22345678899999999999999999998843 34589999999
Q ss_pred c-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCcccccc
Q 010489 200 E-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD 278 (509)
Q Consensus 200 ~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 278 (509)
+ ++|.+++.....+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++........ ...
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~----~~~ 151 (262)
T cd05572 76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK----TWT 151 (262)
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc----ccc
Confidence 8 68999998888899999999999999999999999999999999999999999999999999986543321 133
Q ss_pred cccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCCh--HhHHHHHHHhcCCCChhHHHHhhhHHHHHh
Q 010489 279 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV--VHQLDLMTDLLGTPSTESISRIRNEKARRY 356 (509)
Q Consensus 279 ~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (509)
..|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||..... ......+..
T Consensus 152 ~~~~~~~~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------- 208 (262)
T cd05572 152 FCGTPEYVAPEIILN--KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK--------------------- 208 (262)
T ss_pred ccCCcCccChhHhcC--CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc---------------------
Confidence 578999999999876 6789999999999999999999999976552 111111100
Q ss_pred hhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCc
Q 010489 357 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLA 410 (509)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~f~~~~ 410 (509)
......+ ....++.+.++|.+||..||++||+ ++|+++||||+++.
T Consensus 209 -----~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 209 -----GNGKLEF---PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred -----cCCCCCC---CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence 0001111 1123778999999999999999999 99999999998764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=327.24 Aligned_cols=258 Identities=31% Similarity=0.470 Sum_probs=212.4
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
+|++.+.||+|++|.||+|.+..+++.||||++...... .....+.+|+.++..++|+||+++++++... ..+|
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE-----GEIS 75 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-----CeEE
Confidence 689999999999999999999999999999998653322 4457788999999999999999999998544 4589
Q ss_pred EEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhh-CCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 194 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 194 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
+||||++ ++|.+++.....+++..+..++.|+++||.|||+ .|++||||+|+||+++.++.++|+|||++........
T Consensus 76 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 76 IVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999 6899999888889999999999999999999999 9999999999999999999999999999986543322
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
. .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+....
T Consensus 156 ~---~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-------------- 216 (264)
T cd06623 156 Q---CNTFVGTVTYMSPERIQG--ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-------------- 216 (264)
T ss_pred c---ccceeecccccCHhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh--------------
Confidence 2 124578899999999877 678899999999999999999999997654211111111100
Q ss_pred HHHHhhhccCCCCCCCCCCCCCC-CCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPN-ADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
...... .... .+..+.++|.+||..+|++||++.++++||||+..
T Consensus 217 ----------~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 217 ----------DGPPPS---LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred ----------cCCCCC---CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 000011 1122 67889999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=331.24 Aligned_cols=257 Identities=29% Similarity=0.527 Sum_probs=208.3
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
.|...+.||+|++|.||++.+..+++.||+|++... .......+.+|+.+++.+.||||+++++++... ...|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~-----~~~~ 92 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG-----DELW 92 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcC-----CeEE
Confidence 455568999999999999999999999999988532 223345678999999999999999999988543 4589
Q ss_pred EEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCC
Q 010489 194 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (509)
Q Consensus 194 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 272 (509)
+++||+. ++|.+++.. .++++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++.........
T Consensus 93 ~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~ 171 (285)
T cd06648 93 VVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR 171 (285)
T ss_pred EEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence 9999997 588888876 67999999999999999999999999999999999999999999999999988754332221
Q ss_pred cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHH
Q 010489 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (509)
Q Consensus 273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (509)
.....|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+...
T Consensus 172 ---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~---------------- 230 (285)
T cd06648 172 ---RKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN---------------- 230 (285)
T ss_pred ---cccccCCccccCHHHhcC--CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc----------------
Confidence 133578999999999876 57899999999999999999999999775543332222110
Q ss_pred HHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
.+ +.......+++.+.+||.+||..||++||++.++++||||+...+
T Consensus 231 -----------~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 231 -----------LP-PKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred -----------CC-CCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 00 001111236788999999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=333.04 Aligned_cols=252 Identities=23% Similarity=0.375 Sum_probs=201.9
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCC-----cEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTG-----ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
.+|++.+.||+|+||.||+|.+...+ ..||+|.++... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--- 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE--- 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC---
Confidence 47899999999999999999876554 689999886432 223445688999999999999999999998543
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEEC
Q 010489 188 EFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 250 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~ 250 (509)
...|++|||++ ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++
T Consensus 81 --~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 81 --QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158 (283)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence 45899999998 6899988754 4578899999999999999999999999999999999999
Q ss_pred CCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhH
Q 010489 251 ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQ 329 (509)
Q Consensus 251 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~ 329 (509)
.++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+.
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYY-RVQSKSLLPVRWMPPEAILY--GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred CCCcEEECCCcceeeccccccc-cccCCCcccccccCHHHhcc--CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999999754322211 11234467889999999876 678999999999999999998 9999987654332
Q ss_pred HHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 330 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 330 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
...+.. ..... ....+++++.+|+.+||+.||.+||++.+++++
T Consensus 236 ~~~i~~---------------------------~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 236 IEMIRS---------------------------RQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHc---------------------------CCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 222111 00000 113568899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=358.90 Aligned_cols=256 Identities=24% Similarity=0.422 Sum_probs=202.6
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeee-ecCCCcCC-C
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHI-MLPPSRRE-F 189 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~-~~~~~~~~-~ 189 (509)
-+++|.+.|.+|||+.||+|.+...|..||+|++-.. +......+.+||.+|++|+ |+|||.+++. ........ .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 4689999999999999999999888899999998543 4566788899999999998 9999999993 33322222 3
Q ss_pred CcEEEEEeccc-ccHHHHHHh--CCCCCHHHHHHHHHHHHhHhhhhhhCC--eeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 190 KDIYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~~--ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
..++|.||||. |.|.+++.. ...|++.++..|++|+++|+.+||..+ |||||||-|||||+.+|+.||||||.|.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 56889999999 699999964 346999999999999999999999998 9999999999999999999999999997
Q ss_pred cccCCCCCcccc------cccccccccccccccccc-cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhc
Q 010489 265 VSFNDAPSAIFW------TDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 337 (509)
Q Consensus 265 ~~~~~~~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 337 (509)
............ -...-|+.|+|||++.-+ ....++|+|||+|||+||-|+....||.+.-....
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI-------- 266 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI-------- 266 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE--------
Confidence 543332111100 012468999999976321 15689999999999999999999999976421100
Q ss_pred CCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
+......| .++..+..+.+||+.||+.||++||++.+++.+
T Consensus 267 ----------------------lng~Y~~P---~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 267 ----------------------LNGNYSFP---PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred ----------------------EeccccCC---CCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 01111111 125678889999999999999999999999873
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=324.51 Aligned_cols=259 Identities=26% Similarity=0.438 Sum_probs=207.7
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc---cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF---EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
.+|++.+.||+|+||.||+|.+..++..||+|.+.... ........+.+|+.+++.++|+||+++++++.... .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~---~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE---E 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC---C
Confidence 46999999999999999999999999999999875321 12234567889999999999999999999875432 2
Q ss_pred CcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
..++++|||++ ++|.+++...+.+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||+++....
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 45889999998 58999998877899999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
............|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||...........+ ...+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~-------- 225 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISG--EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI---ATQP-------- 225 (264)
T ss_pred ccccCccccccCCcccccCHhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH---HcCC--------
Confidence 2111111234578999999999877 57889999999999999999999999765432221111 1000
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
.. .......++.+.++|.+||. +|.+||++.+++.|||.
T Consensus 226 ---------------~~---~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 226 ---------------TK---PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ---------------CC---CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 00 11123567889999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=333.27 Aligned_cols=265 Identities=27% Similarity=0.405 Sum_probs=209.0
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
.+|++++.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+++++.++||||+++++.+... ..+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~ 78 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-----NNI 78 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-----CEE
Confidence 57999999999999999999999999999999886432 223456788999999999999999999998544 468
Q ss_pred EEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhh-CCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
|+||||++ ++|.+++...+.+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999998 5888888887889999999999999999999997 699999999999999999999999999986542221
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
....+|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.......... .....+
T Consensus 159 -----~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~--------~~~~~~----- 218 (284)
T cd06620 159 -----ADTFVGTSTYMSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ--------DDPMGI----- 218 (284)
T ss_pred -----cCccccCcccCCHHHHcc--CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh--------hhhhHH-----
Confidence 123578999999999876 578899999999999999999999998654321100 000000
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
...+..+....+..+ .....+..+.+||.+||..||.+|||+.|+++|+||..
T Consensus 219 ---~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 219 ---LDLLQQIVQEPPPRL--PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred ---HHHHHHHhhccCCCC--CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 000111111111111 01135678999999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=326.50 Aligned_cols=252 Identities=27% Similarity=0.413 Sum_probs=199.6
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHH-HHcCCCCcceeeeeecCCCcCCCCcEEEEE
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLL-RLLRHPDIVEIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 196 (509)
+.||.|+||.||+|.+..+++.||||.+..... .......+..|..++ ....|+||+++++++.. ...+|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-----KDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-----CCeEEEEE
Confidence 579999999999999999999999999864321 112233445565554 44589999999999843 34689999
Q ss_pred eccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccc
Q 010489 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (509)
Q Consensus 197 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 275 (509)
||++ ++|.+++...+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++.....
T Consensus 77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 149 (260)
T cd05611 77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------- 149 (260)
T ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence 9998 58999998888899999999999999999999999999999999999999999999999999875422
Q ss_pred ccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHH
Q 010489 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (509)
Q Consensus 276 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (509)
.....|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+...
T Consensus 150 ~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------------- 208 (260)
T cd05611 150 NKKFVGTPDYLAPETILG--VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR------------------- 208 (260)
T ss_pred cccCCCCcCccChhhhcC--CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-------------------
Confidence 123468899999999877 55899999999999999999999999876543222211100
Q ss_pred hhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC---HHHHhcCCcccCCcC
Q 010489 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT---AEEALADPYFHGLAN 411 (509)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~f~~~~~ 411 (509)
.... .......+++.+.++|.+||..||++||+ ++|+|.||||+.+.+
T Consensus 209 -----~~~~---~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 209 -----RINW---PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred -----ccCC---CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 0000 01112356888999999999999999995 589999999987643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=346.22 Aligned_cols=252 Identities=27% Similarity=0.418 Sum_probs=196.3
Q ss_pred CCeeEeeeeeccCceEEEEEEE-----cCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~ 186 (509)
++|++.+.||+|+||.||+|.+ ..++..||||+++... .......+.+|+.+|+.+ +||||+++++++...
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~-- 111 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVG-- 111 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC--
Confidence 4799999999999999999964 3467789999986432 233456788999999999 899999999998544
Q ss_pred CCCCcEEEEEeccc-ccHHHHHHhCC------------------------------------------------------
Q 010489 187 REFKDIYVVFELME-SDLHQVIKAND------------------------------------------------------ 211 (509)
Q Consensus 187 ~~~~~~~lv~e~~~-~~L~~~l~~~~------------------------------------------------------ 211 (509)
...|+|||||+ |+|.+++....
T Consensus 112 ---~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 112 ---GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ---CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 45899999998 68988885421
Q ss_pred ---------------------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 212 ---------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 212 ---------------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 47788899999999999999999999999999999999999999999999997653322
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.......... +.
T Consensus 269 ~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~--------------~~ 331 (375)
T cd05104 269 NYV-VKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM--------------IK 331 (375)
T ss_pred ccc-ccCCCCCCcceeChhHhcC--CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHH--------------HH
Confidence 111 1122345678999999877 689999999999999999998 88999765432111110 00
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
...... .....+.++.+||.+||..||++||++.++++
T Consensus 332 --------~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 332 --------EGYRML-------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred --------hCccCC-------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 000000 01234678999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=333.60 Aligned_cols=259 Identities=29% Similarity=0.490 Sum_probs=209.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|.+.+.||+|+||.||++.+..++..||+|.+... .......+.+|+.+++.++||||+++++.+... ..
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~ 90 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVG-----DE 90 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeC-----Cc
Confidence 46899999999999999999999889999999998532 223346688999999999999999999988543 45
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.|+|+||++ ++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 899999998 588888765 368899999999999999999999999999999999999999999999999887543222
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
. ......|++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+...++..+.
T Consensus 170 ~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~---------------- 228 (293)
T cd06647 170 S---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---------------- 228 (293)
T ss_pred c---ccccccCChhhcCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh----------------
Confidence 1 1234578999999999876 678899999999999999999999998765422211110
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
... .+.......++..+.+||.+||..||++||++.+++.||||+....
T Consensus 229 -----------~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 229 -----------TNG-TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred -----------cCC-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence 000 0000112235678999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=324.26 Aligned_cols=249 Identities=28% Similarity=0.449 Sum_probs=203.1
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
+|++.+.||+|+||.||++.+..++..||+|.++... .....+.+.+|+.+++.++|+||+++++.+. +...+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFE-----ADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----ECCEEE
Confidence 5899999999999999999999999999999986432 2344567788999999999999999999984 345699
Q ss_pred EEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 194 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 194 lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 9999998 5888887643 468999999999999999999999999999999999999999999999999997653322
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
. ......|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+..
T Consensus 155 ~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~--------------- 214 (255)
T cd08219 155 A---YACTYVGTPYYVPPEIWEN--MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ--------------- 214 (255)
T ss_pred c---ccccccCCccccCHHHHcc--CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc---------------
Confidence 1 1234578999999999877 5789999999999999999999999987653222221110
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
....+ ....++..+.+||.+||..||++||++.+++.-
T Consensus 215 ------------~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 215 ------------GSYKP---LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ------------CCCCC---CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00000 112456789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=325.67 Aligned_cols=251 Identities=31% Similarity=0.485 Sum_probs=198.4
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEe
Q 010489 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 197 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 197 (509)
...||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.+++.++|+||+++++++... ..+|+|+|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e 85 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN-----GFFKIFME 85 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-----CEEEEEEe
Confidence 36899999999999999999999999988643 234556788999999999999999999988543 46899999
Q ss_pred ccc-ccHHHHHHhC-CCC--CHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC-CCCeEEeeecccccccCCCCC
Q 010489 198 LME-SDLHQVIKAN-DDL--TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVSFNDAPS 272 (509)
Q Consensus 198 ~~~-~~L~~~l~~~-~~l--~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~-~~~vkl~DFG~a~~~~~~~~~ 272 (509)
|+. ++|.+++... ..+ ++..+..++.||+.||+|||+.||+||||||+||+++. ++.++|+|||++........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~- 164 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP- 164 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-
Confidence 998 5899888754 455 88889999999999999999999999999999999976 67999999999875432221
Q ss_pred cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHH
Q 010489 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (509)
Q Consensus 273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (509)
......|++.|+|||++.+....++.++||||||+++|+|++|+.||........... ..
T Consensus 165 --~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~--------------~~---- 224 (268)
T cd06624 165 --CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF--------------KV---- 224 (268)
T ss_pred --ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh--------------hh----
Confidence 1233468999999999865334588999999999999999999999965331110000 00
Q ss_pred HHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
. .....+ .....+++++.+|+.+||..+|.+|||+.+++.||||
T Consensus 225 -----~-~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 225 -----G-MFKIHP----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -----h-hhccCC----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 0 000000 1113467889999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=335.66 Aligned_cols=252 Identities=22% Similarity=0.377 Sum_probs=200.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcE----EEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGER----VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~----vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
..+|++.+.||+|+||.||+|.+..++.. ||+|+++.. ........+.+|+.+++.+.||||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---
Confidence 35799999999999999999987666654 899988642 2234456788999999999999999999998643
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 188 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
..++++||+. |+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ---~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 82 ---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred ---CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccc
Confidence 2589999998 6899988764 4688999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
....... .......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....+....+..
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~--------- 226 (316)
T cd05108 159 LGADEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK--------- 226 (316)
T ss_pred ccCCCcc-eeccCCccceeecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhC---------
Confidence 5433221 11122345678999999877 688999999999999999997 9999977543221111100
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
....+. .+.++..+.+++.+||..||.+||++.+++.+
T Consensus 227 ----------------~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 227 ----------------GERLPQ-----PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ----------------CCCCCC-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 001111 13456789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=328.93 Aligned_cols=252 Identities=27% Similarity=0.384 Sum_probs=195.6
Q ss_pred eeeccCceEEEEEEEcCCCcEEEEEEecCcccCh-hhHHhHHHHH---HHHHHcCCCCcceeeeeecCCCcCCCCcEEEE
Q 010489 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV-SDATRILREI---KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 195 (509)
Q Consensus 120 ~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~-~~~~~~~~Ei---~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 195 (509)
.||+|+||.||+|.+..+++.||+|++....... ........|. .+++...||+|+.+++++.. ...+|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-----PDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCEEEEE
Confidence 4899999999999999999999999986432211 1112233343 34455679999999988844 3458999
Q ss_pred Eeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCcc
Q 010489 196 FELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 274 (509)
Q Consensus 196 ~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 274 (509)
|||+. ++|.+++...+.+++..++.++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++.......
T Consensus 76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 99998 5888888888889999999999999999999999999999999999999999999999999987543221
Q ss_pred cccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHH
Q 010489 275 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354 (509)
Q Consensus 275 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (509)
....+|+..|+|||++.+. ..++.++||||+||++|||++|+.||.+..........
T Consensus 152 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~--------------------- 208 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--------------------- 208 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---------------------
Confidence 1235799999999998642 46889999999999999999999999765321111000
Q ss_pred HhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCc
Q 010489 355 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (509)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~ 410 (509)
... ...... .....++.+.+++.+||..||.+|| ++.++++||||+...
T Consensus 209 ~~~----~~~~~~---~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 209 RMT----LTMAVE---LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred HHh----hccCCC---CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 000 000011 1123578899999999999999999 999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=330.17 Aligned_cols=253 Identities=27% Similarity=0.379 Sum_probs=202.2
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEecc
Q 010489 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM 199 (509)
Q Consensus 121 lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 199 (509)
||+|+||+||+|.+..+|+.||+|.+..... .......+.+|+.+|+.++||||+++++++.. ...+|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-----KDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-----CCeEEEEEecC
Confidence 6999999999999999999999999864322 12234456789999999999999999998843 34689999999
Q ss_pred c-ccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCcccc
Q 010489 200 E-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276 (509)
Q Consensus 200 ~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 276 (509)
+ ++|.+++...+ .+++..+..++.|++.||.|||+.||+||||+|+||+++.++.+||+|||++........ .
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~----~ 151 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK----I 151 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc----c
Confidence 8 58998887665 799999999999999999999999999999999999999999999999999876432111 2
Q ss_pred cccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHh
Q 010489 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 356 (509)
Q Consensus 277 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (509)
....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..
T Consensus 152 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------------- 208 (277)
T cd05577 152 KGRAGTPGYMAPEVLQG--EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR--------------------- 208 (277)
T ss_pred ccccCCCCcCCHHHhcC--CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh---------------------
Confidence 34568889999999876 5688999999999999999999999976543111111100
Q ss_pred hhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCcC
Q 010489 357 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLAN 411 (509)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~~ 411 (509)
.. ...+. ...+..++.+.++|.+||+.||.+|| ++.+++.||||..+..
T Consensus 209 --~~-~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 209 --RT-LEMAV---EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred --cc-ccccc---cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence 00 00011 11234688999999999999999999 8999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=328.34 Aligned_cols=265 Identities=24% Similarity=0.385 Sum_probs=205.9
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|+..+.||.|++|.||+|.+..+++.||+|.+..... ......+.+|+++++.++||||+++++++... ....+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeE
Confidence 368999999999999999999999999999999864322 23456788999999999999999999988543 23458
Q ss_pred EEEEeccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 193 YVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999998 478776642 3468999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCCh--HhHHHHHHHhcCCCChhHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV--VHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~g~~~~~~~ 345 (509)
.... ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||..... ....+....
T Consensus 157 ~~~~-----~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------- 219 (287)
T cd06621 157 NSLA-----GTFTGTSFYMAPERIQG--KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY---------- 219 (287)
T ss_pred cccc-----ccccCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH----------
Confidence 2221 23467889999999876 6789999999999999999999999976532 001111100
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
+..............-...++.+.+||.+||..||.+|||+.|+++||||+..
T Consensus 220 -----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 220 -----------IVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred -----------HhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 00000000000000001246789999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=340.43 Aligned_cols=285 Identities=21% Similarity=0.265 Sum_probs=203.1
Q ss_pred eeeecc--CceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEE
Q 010489 119 EVIGKG--SYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 119 ~~lG~G--~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 196 (509)
..||+| +||+||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++... ..+|+||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG-----SWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC-----CceEEEE
Confidence 456666 999999999999999999999875433444557788999999999999999999998543 4589999
Q ss_pred eccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCc
Q 010489 197 ELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273 (509)
Q Consensus 197 e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 273 (509)
||+. ++|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+|++|||.+..........
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 9998 5888888764 358999999999999999999999999999999999999999999999998654322111110
Q ss_pred -cc---ccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 274 -IF---WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 274 -~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
.. .....++..|+|||++.+....++.++|||||||++|||++|.+||.+.........+.. +.+.........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 236 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLK--GPPYSPLDITTF 236 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhc--CCCCCCcccccc
Confidence 00 011235667999999876434578999999999999999999999987664433322221 111100000000
Q ss_pred hHHHH-------Hhh----hccCC-----CC-CCCCC-CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 350 NEKAR-------RYL----GSMRK-----KQ-PVPFS-HKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 350 ~~~~~-------~~~----~~~~~-----~~-~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
..... ... ..... .. ..... ......++.+.+||.+||..||++|||+.++|+||||+.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 00000 000 00000 00 00000 01123567899999999999999999999999999997653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=324.49 Aligned_cols=245 Identities=23% Similarity=0.347 Sum_probs=195.9
Q ss_pred eeeccCceEEEEEEE--cCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEe
Q 010489 120 VIGKGSYGVVGSAVD--THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 197 (509)
Q Consensus 120 ~lG~G~~g~V~~~~~--~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 197 (509)
+||+|+||.||+|.. ..++..||+|+++...........+.+|+.+++.+.||||+++++++.. ...++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEe
Confidence 589999999999964 4578899999987544444456778899999999999999999998732 24699999
Q ss_pred ccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCcccc
Q 010489 198 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276 (509)
Q Consensus 198 ~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 276 (509)
|++ ++|.+++.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.............
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 76 LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999 5899999887889999999999999999999999999999999999999999999999999997654332211111
Q ss_pred cccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHH
Q 010489 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (509)
Q Consensus 277 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (509)
....++..|+|||.+.. ..++.++|||||||++|||++ |..||.+.+..+....+..
T Consensus 156 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~-------------------- 213 (257)
T cd05116 156 THGKWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-------------------- 213 (257)
T ss_pred CCCCCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC--------------------
Confidence 22344678999998876 678899999999999999998 9999987654333222211
Q ss_pred hhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
....+ ....+++++.+||.+||+.||++||++.+|.+
T Consensus 214 -------~~~~~---~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 214 -------GERME---CPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred -------CCCCC---CCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 00000 11347889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=377.48 Aligned_cols=263 Identities=30% Similarity=0.404 Sum_probs=215.1
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
++.-...||.|.||.||.|.+..+|...|+|-++-........+.+.+|..+|..|+|||+|+++++-... ..+|
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR-----ekv~ 1310 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR-----EKVY 1310 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH-----HHHH
Confidence 45667789999999999999999999999999864433345566788999999999999999999987544 3489
Q ss_pred EEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC-C
Q 010489 194 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA-P 271 (509)
Q Consensus 194 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~-~ 271 (509)
|.||||+ |+|.+++...+-.++...+.+..|++.|+.|||++|||||||||+|||++.+|.+|++|||.|....... .
T Consensus 1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 9999999 6899998887778888889999999999999999999999999999999999999999999998765443 1
Q ss_pred Cccccccccccccccccccccccc-CCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
-.....++.||+.|||||++.+.. .....++||||||||+.||+||+.||..-+...++-.-
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~----------------- 1453 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH----------------- 1453 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH-----------------
Confidence 222346789999999999997753 34667899999999999999999999765543222111
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
-.+...++.| ..++++..|||.+||..||++|.++.|+|+|-|-+.-.
T Consensus 1454 -------V~~gh~Pq~P-----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1454 -------VAAGHKPQIP-----ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred -------HhccCCCCCc-----hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence 1112222222 23789999999999999999999999999999876543
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=323.81 Aligned_cols=253 Identities=29% Similarity=0.490 Sum_probs=205.4
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
+|.+.+.||+|+||.||+|.+..+|..||+|.+............+.+|+.+++.++|+||+++++.+.. ...+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-----NGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-----CCeEE
Confidence 5889999999999999999999999999999986432222345667899999999999999999998844 34689
Q ss_pred EEEeccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCC-eEEeeecccccccCC
Q 010489 194 VVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-LKICDFGLARVSFND 269 (509)
Q Consensus 194 lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~-vkl~DFG~a~~~~~~ 269 (509)
+|+||+. ++|.+++.... .+++..+..++.|+++||.|||+.+|+|+||||+||+++.++. +||+|||.+......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999997 58988886543 5799999999999999999999999999999999999998865 699999999765332
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
... .....|++.|+|||++.+ ..++.++|+|||||+++||++|..||...+.......+..
T Consensus 156 ~~~---~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------- 216 (257)
T cd08225 156 MEL---AYTCVGTPYYLSPEICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-------------- 216 (257)
T ss_pred ccc---ccccCCCccccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--------------
Confidence 211 123468999999998876 5788999999999999999999999976553222211100
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
. .+....+..+..+.++|.+||..+|++|||+.++++||||
T Consensus 217 -------------~---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 217 -------------G---YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred -------------c---cCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 0 0011123567789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=324.61 Aligned_cols=248 Identities=22% Similarity=0.441 Sum_probs=200.9
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
.+|.+.+.||+|+||.||+|.+..++..||+|.+... ......+.+|+.+++.++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 77 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPF 77 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcC-----CCCc
Confidence 4689999999999999999999999999999998642 2345678899999999999999999998844 3458
Q ss_pred EEEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 193 YVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+++|||++ ++|.+++... ..+++..+..++.|+++||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 99999997 6899888654 35899999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||++.+..+....+..
T Consensus 158 ~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~------------- 220 (263)
T cd05052 158 TYTA--HAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------------- 220 (263)
T ss_pred eeec--cCCCCCccccCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-------------
Confidence 2111 112234667999998876 678899999999999999998 9999987664332222211
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.. .. .....+++.+.++|.+||..||++||++.++++
T Consensus 221 ----------~~----~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 221 ----------GY----RM---ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ----------CC----CC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 00 00 011346788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=364.52 Aligned_cols=148 Identities=23% Similarity=0.412 Sum_probs=132.1
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
..+|.++++||+|+||.||+|.+..+++.||||+++... ........+.+|+.+++.++||||+++++++. ...
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ-----SAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE-----ECC
Confidence 368999999999999999999999999999999986432 22334567889999999999999999998874 335
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
.+||||||+. ++|.+++...+.+++..++.|+.||+.||+|||.+||+||||||+||||+.++.+||+|||+++
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 6899999997 5899999888889999999999999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=327.82 Aligned_cols=257 Identities=31% Similarity=0.498 Sum_probs=206.9
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC---CCCcceeeeeecCCCcCCCC
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR---HPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~~~~~~~~~~~~~~~ 190 (509)
.|++.+.||+|+||.||+|.+..+++.||+|.++... .......+.+|+.+++.+. |||++++++++.. ..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-----~~ 75 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-----GP 75 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-----CC
Confidence 4788899999999999999999999999999986432 2234567889999999987 9999999998843 34
Q ss_pred cEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
..|+||||+++ +|.+++.. +.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 76 RLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 58999999985 78887755 47999999999999999999999999999999999999999999999999999765433
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
... .....|+..|+|||.+.+. ..++.++|+|||||++|+|++|..||.+.........+
T Consensus 155 ~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~---------------- 214 (277)
T cd06917 155 SSK---RSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI---------------- 214 (277)
T ss_pred ccc---cccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc----------------
Confidence 321 2345789999999987652 45788999999999999999999999765432211110
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
....+..+ .....+.++.+++.+||..||++||++.+++.||||+...
T Consensus 215 -----------~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 215 -----------PKSKPPRL--EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred -----------ccCCCCCC--CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 00011111 1112677899999999999999999999999999997643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=325.23 Aligned_cols=255 Identities=21% Similarity=0.365 Sum_probs=200.2
Q ss_pred eeEeeeeeccCceEEEEEEEcC---CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc-CCCC
Q 010489 115 YQIQEVIGKGSYGVVGSAVDTH---TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 190 (509)
Q Consensus 115 y~i~~~lG~G~~g~V~~~~~~~---~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~-~~~~ 190 (509)
|.+.+.||+|+||.||+|.... ++..||||.++...........+.+|+.+++.++||||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999998764 34789999987544444556678999999999999999999998865442 3334
Q ss_pred cEEEEEeccc-ccHHHHHHhC------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccc
Q 010489 191 DIYVVFELME-SDLHQVIKAN------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 263 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 263 (509)
..+++|||+. ++|..++... ..+++..+..++.|++.||.|||+.||+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 5799999998 5888777432 36899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCCh
Q 010489 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPST 342 (509)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~ 342 (509)
+......... ......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+....+....+..
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~------- 230 (273)
T cd05035 161 KKIYSGDYYR-QGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH------- 230 (273)
T ss_pred eecccccccc-ccccccCCccccCHhhccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------
Confidence 8654322111 1112245678999999876 678999999999999999999 8899977554332221111
Q ss_pred hHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.... .....+++.+.+++.+||+.||++||++.++++
T Consensus 231 --------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~ 267 (273)
T cd05035 231 --------------------GNRL---KQPEDCLDELYDLMYSCWRADPKDRPTFTKLRE 267 (273)
T ss_pred --------------------CCCC---CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000 111346788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=341.23 Aligned_cols=235 Identities=29% Similarity=0.449 Sum_probs=194.6
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEe
Q 010489 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 197 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 197 (509)
++-||.|+.|.||+|+. .++.||||+++.. -..+|+-|++|+||||+.|.++|... ..+|||||
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqs-----PcyCIiME 192 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQS-----PCYCIIME 192 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCC-----ceeEEeee
Confidence 45699999999999975 4789999988531 12478889999999999999999543 45899999
Q ss_pred ccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCcccc
Q 010489 198 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276 (509)
Q Consensus 198 ~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 276 (509)
||. |-|..+++....++......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||-++....... .
T Consensus 193 fCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST----k 268 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST----K 268 (904)
T ss_pred ccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhh----h
Confidence 999 88999999999999999999999999999999999999999999999999999999999999986543321 1
Q ss_pred cccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHh
Q 010489 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 356 (509)
Q Consensus 277 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (509)
-.++||..|||||++.. .+.+.|+|||||||||||||||..||..-+. .+.| +..|...
T Consensus 269 MSFaGTVaWMAPEvIrn--ePcsEKVDIwSfGVVLWEmLT~EiPYkdVds---sAII-wGVGsNs--------------- 327 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRN--EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS---SAII-WGVGSNS--------------- 327 (904)
T ss_pred hhhhhhHhhhCHHHhhc--CCcccccceehhHHHHHHHHhcCCCccccch---heeE-EeccCCc---------------
Confidence 35799999999999988 7899999999999999999999999975432 1111 1111111
Q ss_pred hhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 357 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
-..|++ ..++..++=||+.||.-.|..||++.++|.|
T Consensus 328 -----L~LpvP-----stcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 328 -----LHLPVP-----STCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred -----ccccCc-----ccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 011111 3467778999999999999999999999998
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=327.89 Aligned_cols=256 Identities=32% Similarity=0.537 Sum_probs=209.7
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~~ 190 (509)
.+|.+.+.||.|+||.||+|.+..++..||+|++.... ........+.+|+.+++.+. ||||+++++++.. ..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-----EE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-----Cc
Confidence 36999999999999999999999999999999986422 22334467789999999998 9999999998843 34
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|+||||++ ++|.+++...+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 5899999995 799999988889999999999999999999999999999999999999999999999999998765432
Q ss_pred CCC-----------------cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHH
Q 010489 270 APS-----------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL 332 (509)
Q Consensus 270 ~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 332 (509)
... ........|+..|+|||++.. ..++.++|||||||++++|++|+.||...+....+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCC--CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 211 011234568899999998876 5688899999999999999999999987653222211
Q ss_pred HHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH----HHHhcCCcc
Q 010489 333 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA----EEALADPYF 406 (509)
Q Consensus 333 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~e~l~hp~f 406 (509)
+.. .... .....++.+.+||.+||..||.+||++ +++++||||
T Consensus 234 ~~~--------------------------~~~~-----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILK--------------------------LEYS-----FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHh--------------------------cCCC-----CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 110 0000 112457889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=339.15 Aligned_cols=255 Identities=25% Similarity=0.427 Sum_probs=198.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEc-----CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~ 185 (509)
.++|++.+.||+|+||.||+|.+. .+++.||+|+++... .......+.+|+.+++++ .|+||+++++++...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~- 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKP- 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-
Confidence 358999999999999999999743 345789999986432 223456778999999999 799999999988543
Q ss_pred cCCCCcEEEEEeccc-ccHHHHHHhC------------------------------------------------------
Q 010489 186 RREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 210 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~-~~L~~~l~~~------------------------------------------------------ 210 (509)
...++++|||+. ++|.+++...
T Consensus 84 ---~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 84 ---GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ---CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 245899999998 5888887532
Q ss_pred -------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccccccccccc
Q 010489 211 -------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283 (509)
Q Consensus 211 -------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~ 283 (509)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ........++.
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~-~~~~~~~~~~~ 239 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDARLPL 239 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc-hhhccCCCCCc
Confidence 2578999999999999999999999999999999999999999999999999986533221 11123345677
Q ss_pred ccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCC
Q 010489 284 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRK 362 (509)
Q Consensus 284 ~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 362 (509)
.|+|||++.+ ..++.++|||||||++|||++ |..||.+....+.+.... ..
T Consensus 240 ~y~aPE~~~~--~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~--------------------------~~ 291 (337)
T cd05054 240 KWMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL--------------------------KE 291 (337)
T ss_pred cccCcHHhcC--CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH--------------------------hc
Confidence 8999999877 689999999999999999998 999998644322111100 00
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 363 KQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
.... ......++++.+++.+||+.+|++||++.++++|
T Consensus 292 ~~~~---~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 292 GTRM---RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred cCCC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0000 0012457889999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=320.12 Aligned_cols=253 Identities=31% Similarity=0.521 Sum_probs=210.1
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
+|++.+.||+|+||.||+|.+..++..||+|++............+.+|+++++.++|||++++.+.+... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence 58999999999999999999998999999999975444445667788999999999999999999988544 4689
Q ss_pred EEEecccc-cHHHHHHhC----CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 194 VVFELMES-DLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 194 lv~e~~~~-~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
+|+||+++ +|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 99999985 898888763 6799999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... ......|++.|+|||.+.+ ..++.++|+||+|+++++|++|..||...+.......+.
T Consensus 156 ~~~---~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-------------- 216 (258)
T cd08215 156 TVD---LAKTVVGTPYYLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL-------------- 216 (258)
T ss_pred Ccc---eecceeeeecccChhHhcc--CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh--------------
Confidence 321 1234578999999999876 578899999999999999999999997655322221110
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
.....+ .....+..+.+++.+||..+|++|||+.++|+||||
T Consensus 217 -------------~~~~~~---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 217 -------------KGQYPP---IPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred -------------cCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 000111 112467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=319.16 Aligned_cols=253 Identities=33% Similarity=0.549 Sum_probs=210.6
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
+|++.+.||+|++|.||+|.+..+++.||+|.+............+.+|++++++++|+|++++++++.. ....|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-----SDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-----CCEEE
Confidence 5889999999999999999999999999999997654433556788999999999999999999998844 34689
Q ss_pred EEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCC
Q 010489 194 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (509)
Q Consensus 194 lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 272 (509)
++|||+++ +|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.........
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 76 IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred EEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999985 89999988888999999999999999999999999999999999999999999999999999865433221
Q ss_pred cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHH
Q 010489 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (509)
Q Consensus 273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (509)
.....|+..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+.
T Consensus 156 ---~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~------------------ 212 (254)
T cd06627 156 ---DASVVGTPYWMAPEVIEM--SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV------------------ 212 (254)
T ss_pred ---ccccccchhhcCHhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh------------------
Confidence 234578999999999876 458899999999999999999999997654322111110
Q ss_pred HHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
....+ ...+.++..+.+++.+||..+|++||++.+++.||||
T Consensus 213 --------~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 213 --------QDDHP----PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred --------ccCCC----CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 00000 1113467889999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=341.92 Aligned_cols=266 Identities=24% Similarity=0.383 Sum_probs=213.9
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
+-|..++.||-|+||.|++++...|...||+|.+.+.. .....+..+..|-.||.....+-||+|+..| .+...
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdn 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDN 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCc
Confidence 45788999999999999999999999999999986532 2223456778899999999999999999888 45566
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC--
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN-- 268 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~-- 268 (509)
+|+||||++ ||+..+|.+.+-|.|+.+++++.++..|+++.|..|+|||||||+|||||.+|++||+||||++.+..
T Consensus 704 LYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999998 69999999999999999999999999999999999999999999999999999999999999964210
Q ss_pred ------CCCC-------------------------------cccccccccccccccccccccccCCCCCceeeehhhhHH
Q 010489 269 ------DAPS-------------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 311 (509)
Q Consensus 269 ------~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il 311 (509)
.... .+.....+||+.|+|||++.. ..|+..+|+||.||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r--~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR--TGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc--cCccccchhhHhhHHH
Confidence 0000 001124689999999999988 7899999999999999
Q ss_pred HHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCC
Q 010489 312 AEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDP 391 (509)
Q Consensus 312 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 391 (509)
|||+.|++||-.....+....+.. ++.++. + ....++++++.+||.++.. ++
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~n-----------------w~~~l~-------~---~~~~~ls~e~~~li~kLc~-sa 913 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVIN-----------------WRNFLH-------I---PYQGNLSKEALDLIQKLCC-SA 913 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeee-----------------hhhccc-------c---ccccccCHHHHHHHHHHhc-Ch
Confidence 999999999987664332221110 011110 0 1224689999999998665 88
Q ss_pred CCCCC---HHHHhcCCcccCCcCCC
Q 010489 392 KDRPT---AEEALADPYFHGLANVD 413 (509)
Q Consensus 392 ~~Rpt---~~e~l~hp~f~~~~~~~ 413 (509)
+.|.. ++++..||||+++...+
T Consensus 914 d~RLGkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 914 DSRLGKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred hhhhcccchhhhhcCccccccchHh
Confidence 88874 77899999999886543
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=325.91 Aligned_cols=256 Identities=21% Similarity=0.376 Sum_probs=199.4
Q ss_pred eeEeeeeeccCceEEEEEEEcCCCc--EEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc-CCCCc
Q 010489 115 YQIQEVIGKGSYGVVGSAVDTHTGE--RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFKD 191 (509)
Q Consensus 115 y~i~~~lG~G~~g~V~~~~~~~~~~--~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 191 (509)
|.+.+.||+|+||.||+|....++. .||+|.++...........+.+|+.+++.++|+||+++++++..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999877765 69999887544445556788899999999999999999998754321 22345
Q ss_pred EEEEEeccc-ccHHHHHHh------CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 192 IYVVFELME-SDLHQVIKA------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~------~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
.+++|||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 799999998 688877642 2348899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChh
Q 010489 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (509)
......... ......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+.........+..
T Consensus 161 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-------- 229 (272)
T cd05075 161 KIYNGDYYR-QGRIAKMPVKWIAIESLAD--RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ-------- 229 (272)
T ss_pred ccCccccee-cCCcccCCcccCCHHHccC--CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc--------
Confidence 653322110 1122346778999999877 678999999999999999999 8899987554322221110
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
.... ...+.++..+.++|.+||+.||++|||+.+++++
T Consensus 230 -------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 230 -------------------GNRL---KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -------------------CCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0000 0113467789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=328.70 Aligned_cols=255 Identities=27% Similarity=0.414 Sum_probs=207.7
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
..|+.++.||.|+||.||+|.+..++..||||.+... ........+.+|+.+++.+.||||+++++++.. ....
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 77 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----GTKL 77 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCEE
Confidence 4688899999999999999999999999999998643 223445678899999999999999999999844 3468
Q ss_pred EEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 193 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 193 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
|+||||+++ +|.+++.. +.+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 78 ~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 78 WIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999985 78888764 5789999999999999999999999999999999999999999999999999976533221
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
......++..|+|||++.+ ..++.++|+|||||++|||++|..||.+.........+.
T Consensus 157 ---~~~~~~~~~~y~apE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~----------------- 214 (277)
T cd06640 157 ---KRNTFVGTPFWMAPEVIQQ--SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP----------------- 214 (277)
T ss_pred ---ccccccCcccccCHhHhcc--CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-----------------
Confidence 1233468899999999876 578899999999999999999999997655322211110
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
...+ ......++..+.+|+.+||..||++||++.++++||||...
T Consensus 215 ----------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 215 ----------KNNP---PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ----------cCCC---CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 0000 11122456779999999999999999999999999999653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=327.97 Aligned_cols=251 Identities=23% Similarity=0.356 Sum_probs=201.0
Q ss_pred CCeeEeeeeeccCceEEEEEEEcC-----CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
.+|.+.+.||+|+||.||+|.+.. ++..||||.++.... ......+.+|+++|+.++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 80 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEG--- 80 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecC---
Confidence 568999999999999999998743 467899999865322 22456788999999999999999999998544
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhCC--------------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC
Q 010489 188 EFKDIYVVFELME-SDLHQVIKAND--------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 252 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~~--------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~ 252 (509)
...|+||||++ ++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 81 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~ 158 (280)
T cd05049 81 --DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD 158 (280)
T ss_pred --CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC
Confidence 45899999998 58999887542 47889999999999999999999999999999999999999
Q ss_pred CCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHH
Q 010489 253 CKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLD 331 (509)
Q Consensus 253 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~ 331 (509)
+.+||+|||++......... .......+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+...
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235 (280)
T ss_pred CeEEECCcccceecccCcce-ecCCCCcccceecChhhhcc--CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999999754322211 11123356788999999877 679999999999999999998 999998766433332
Q ss_pred HHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 332 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 332 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.+.. .... ......+..+.+|+.+||..||++||++.|+++
T Consensus 236 ~~~~---------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 236 CITQ---------------------------GRLL---QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHc---------------------------CCcC---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2211 0000 011246788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=332.03 Aligned_cols=254 Identities=28% Similarity=0.411 Sum_probs=205.6
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
.|++.+.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.+.||||+++++++... ...|
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 78 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKG-----TKLW 78 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccC-----CceE
Confidence 57788999999999999999999999999999864322 23456788999999999999999999988543 4589
Q ss_pred EEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCC
Q 010489 194 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (509)
Q Consensus 194 lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 272 (509)
+||||+++ +|.+++.. +.+++..+..++.||++||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 79 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 79 IIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred EEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 99999984 78777754 5789999999999999999999999999999999999999999999999999976432221
Q ss_pred cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHH
Q 010489 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (509)
Q Consensus 273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (509)
......|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||...........+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~------------------- 213 (277)
T cd06642 157 --KRNTFVGTPFWMAPEVIKQ--SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI------------------- 213 (277)
T ss_pred --hhhcccCcccccCHHHhCc--CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh-------------------
Confidence 1233468899999999877 67889999999999999999999999754432211110
Q ss_pred HHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
....+. ......+..+.++|.+||..+|++||++.++++||||..+
T Consensus 214 --------~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 214 --------PKNSPP---TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred --------hcCCCC---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 000010 1112456789999999999999999999999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=327.15 Aligned_cols=259 Identities=22% Similarity=0.365 Sum_probs=201.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcC-----CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 186 (509)
.++|++.+.||+|+||.||+|..+. .+..||+|.++... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 81 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG-- 81 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence 4689999999999999999997542 35589999886432 223345678899999999999999999988543
Q ss_pred CCCCcEEEEEeccc-ccHHHHHHhC----------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCe
Q 010489 187 REFKDIYVVFELME-SDLHQVIKAN----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 255 (509)
Q Consensus 187 ~~~~~~~lv~e~~~-~~L~~~l~~~----------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~v 255 (509)
...|+||||+. ++|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 82 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 ---QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred ---CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence 35899999998 6899998653 234667888999999999999999999999999999999999999
Q ss_pred EEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHH
Q 010489 256 KICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMT 334 (509)
Q Consensus 256 kl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~ 334 (509)
||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus 159 ~L~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~--~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 159 KIGDFGMTRDIYETDYYR-KGGKGLLPVRWMAPESLKD--GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred EECcCCcccccccccccc-ccCCCcccccccCHHHhcc--CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999997543222111 1122345678999999876 678999999999999999998 788997755433222211
Q ss_pred HhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc------CCcccC
Q 010489 335 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA------DPYFHG 408 (509)
Q Consensus 335 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~------hp~f~~ 408 (509)
. ...+ ......++.+.+++.+||..||++|||+.++++ ||||++
T Consensus 236 ~--------------------------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 236 D--------------------------GGYL----DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred c--------------------------CCCC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 0 0000 011235678999999999999999999999987 999987
Q ss_pred C
Q 010489 409 L 409 (509)
Q Consensus 409 ~ 409 (509)
+
T Consensus 286 ~ 286 (288)
T cd05061 286 V 286 (288)
T ss_pred C
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=335.45 Aligned_cols=281 Identities=23% Similarity=0.308 Sum_probs=201.0
Q ss_pred EeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEE
Q 010489 117 IQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 117 i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 196 (509)
+.+.+|. +|.||.+++..+++.||||+++...........+.+|+.+++.++|+||+++++++... ...|++|
T Consensus 6 i~~~~~~--~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-----~~~~~~~ 78 (314)
T cd08216 6 IGKCFED--LMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-----SELYVVS 78 (314)
T ss_pred hhHhhcC--CceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-----CeEEEEE
Confidence 3444444 45566666677999999999975433445667899999999999999999999988543 4589999
Q ss_pred eccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCC-
Q 010489 197 ELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS- 272 (509)
Q Consensus 197 e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~- 272 (509)
||++ ++|.+++... ..+++..+..++.|+++||+|||+++|+||||||+|||++.++.+||+|||.+.........
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 79 PLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred eccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 9999 5788888753 46899999999999999999999999999999999999999999999999988654322111
Q ss_pred ---cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 273 ---AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 273 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
........++..|+|||++.+....++.++|||||||++|||++|..||........+ +....+...... ....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~-~~~~ 235 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML--LEKVRGTVPCLL-DKST 235 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhccCcccc-ccCc
Confidence 1111334678899999998663346889999999999999999999999876543322 112222111100 0000
Q ss_pred hHHHHHhhhccCC--------CCCCCC-CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 350 NEKARRYLGSMRK--------KQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 350 ~~~~~~~~~~~~~--------~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
.......+.. ...... .......++++.+|+.+||..||++|||++++|+||||+.+.
T Consensus 236 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 236 ---YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred ---hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 0000000000 000000 001123456789999999999999999999999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=361.36 Aligned_cols=256 Identities=28% Similarity=0.376 Sum_probs=199.8
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|++.++||+|+||.||+|.+..+|+.||||++..... ......++.+|+.+++.++||||+++++++.. ...
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-----~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-----GDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-----CCE
Confidence 689999999999999999999999999999999975332 22345678899999999999999999998843 346
Q ss_pred EEEEEeccc-ccHHHHHHhC-----------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEee
Q 010489 192 IYVVFELME-SDLHQVIKAN-----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 259 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~-----------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~D 259 (509)
.|+||||++ ++|.+++... ..++...+..++.||++||+|||++||+||||||+|||++.++.+||+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence 899999998 5888887531 2355677888999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCC---------------cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCC
Q 010489 260 FGLARVSFNDAPS---------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK 324 (509)
Q Consensus 260 FG~a~~~~~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 324 (509)
||+++........ .......+||+.|||||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--VPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--CCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999765211100 001123579999999999877 67899999999999999999999999764
Q ss_pred ChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 325 NVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 325 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
........ .. . ..+... ..+..+++.+.+++.+||..||++|++..+.+.+
T Consensus 235 ~~~ki~~~--~~-----------------------i--~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 235 KGRKISYR--DV-----------------------I--LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred chhhhhhh--hh-----------------------c--cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 42111100 00 0 000000 1123577889999999999999999887665544
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=331.11 Aligned_cols=255 Identities=27% Similarity=0.422 Sum_probs=206.4
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
..|...+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++|||++++++++... ..
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 99 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-----HT 99 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-----Ce
Confidence 348889999999999999999999999999999864322 223456788999999999999999999998543 45
Q ss_pred EEEEEecccccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.|+||||+.|+|.+++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++.....
T Consensus 100 ~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 100 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred EEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 899999999988887754 45799999999999999999999999999999999999999999999999999865321
Q ss_pred CCcccccccccccccccccccccc-cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
.....|++.|+|||++... ...++.++|||||||++|||++|..||.+.+....+..+...
T Consensus 178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~------------- 239 (317)
T cd06635 178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------------- 239 (317)
T ss_pred -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc-------------
Confidence 1234788999999987421 246888999999999999999999999765433322222110
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
..+. ......++.+.+||.+||+.+|.+||++.++++|+|+..
T Consensus 240 -------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 240 -------------ESPT---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -------------cCCC---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0000 011245678999999999999999999999999999954
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=324.17 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=202.5
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|++.+.||+|+||.||+|++..+++.||||.++... ........+.+|+.+++.++||||+++++++... ..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-----NE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-----Ce
Confidence 57999999999999999999999999999999886422 2334456688999999999999999999988543 45
Q ss_pred EEEEEeccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 192 IYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
.|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 899999999 588877753 345899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
..... ......|++.|+|||.+.+ ..++.++|+||||+++|||++|+.||...... .......
T Consensus 157 ~~~~~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~----------- 219 (267)
T cd08228 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQK----------- 219 (267)
T ss_pred cchhH---HHhcCCCCccccChhhhcc--CCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHHH-----------
Confidence 32221 1234578899999999876 67889999999999999999999999654321 0000000
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
+... ...+. .....+..+.++|.+||..||++||++.++++ ++++
T Consensus 220 ----------~~~~-~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~--~~~~ 264 (267)
T cd08228 220 ----------IEQC-DYPPL----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ--IAKQ 264 (267)
T ss_pred ----------HhcC-CCCCC----ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH--HHHH
Confidence 0000 00010 11235678999999999999999999999998 4543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=325.57 Aligned_cols=253 Identities=21% Similarity=0.370 Sum_probs=198.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEc-----CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 186 (509)
.++|++.+.||+|+||.||+|.+. .++..||||++... ........+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--- 80 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--- 80 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC---
Confidence 457999999999999999999764 24568999998642 223345668899999999999999999998843
Q ss_pred CCCCcEEEEEeccc-ccHHHHHHhCC----------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCe
Q 010489 187 REFKDIYVVFELME-SDLHQVIKAND----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 255 (509)
Q Consensus 187 ~~~~~~~lv~e~~~-~~L~~~l~~~~----------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~v 255 (509)
....++||||++ ++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+|||++.++.+
T Consensus 81 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 81 --GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred --CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCE
Confidence 345899999998 58998886532 35778889999999999999999999999999999999999999
Q ss_pred EEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHH
Q 010489 256 KICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMT 334 (509)
Q Consensus 256 kl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~ 334 (509)
||+|||+++......... ......+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+....+.+..+.
T Consensus 159 ~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (277)
T cd05062 159 KIGDFGMTRDIYETDYYR-KGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235 (277)
T ss_pred EECCCCCccccCCcceee-cCCCCccCHhhcChhHhhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999987543222111 1122356788999999876 678999999999999999999 789998765433332221
Q ss_pred HhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 335 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 335 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
.. .... ....+++.+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~---------------------------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 236 EG---------------------------GLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred cC---------------------------CcCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 10 0000 112456789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=322.44 Aligned_cols=254 Identities=30% Similarity=0.505 Sum_probs=204.5
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEecc
Q 010489 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM 199 (509)
Q Consensus 121 lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 199 (509)
||.|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++.+. .....|++|||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ-----GKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee-----cCcEEEEEEecC
Confidence 6899999999999999999999999864321 2234567889999999999999999988874 345689999999
Q ss_pred c-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCC-----c
Q 010489 200 E-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS-----A 273 (509)
Q Consensus 200 ~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~-----~ 273 (509)
. ++|.+++.+.+.+++..+..++.||++||.|||+.||+||||+|+||+++.++.++|+|||++......... .
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 8 589999988778999999999999999999999999999999999999999999999999998764332110 1
Q ss_pred ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHH
Q 010489 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353 (509)
Q Consensus 274 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (509)
.......++..|+|||.+.. ..++.++||||||+++|+|++|..||...........+..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------------ 215 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN------------------ 215 (265)
T ss_pred ccccCcccCccccCHHHhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------------
Confidence 11234578899999999876 5688899999999999999999999977654332222111
Q ss_pred HHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH---HHHhcCCcccCCc
Q 010489 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA---EEALADPYFHGLA 410 (509)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~---~e~l~hp~f~~~~ 410 (509)
.. ..+... ...++.+.+|+.+||+.+|++|||+ .++|+||||+++.
T Consensus 216 --------~~--~~~~~~-~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 216 --------GK--IEWPED-VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred --------CC--cCCCcc-ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 00 001000 1247889999999999999999999 9999999998653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=320.44 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=197.5
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++.+.||+|+||.||+|..+ .+..+|+|.+.... .....+.+|+.+|+.++||||+++++++.. ...+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 74 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-----QKPL 74 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEcc-----CCCE
Confidence 46899999999999999999875 45689999876321 223567889999999999999999998844 3458
Q ss_pred EEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 193 YVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
|+||||++ ++|.+++... +.+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 99999998 6899888653 468999999999999999999999999999999999999999999999999987643222
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
.. ......++..|+|||++.+ ..++.++||||||+++|||++ |+.||...+..+.+..+...
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~------------- 217 (256)
T cd05114 155 YT--SSSGAKFPVKWSPPEVFNF--SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG------------- 217 (256)
T ss_pred ee--ccCCCCCchhhCChhhccc--CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-------------
Confidence 11 1122345668999999876 678999999999999999999 89999876654433332210
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..... ....+..+.+|+.+||..||++||++.++++
T Consensus 218 --------------~~~~~---~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 218 --------------FRLYR---PKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred --------------CCCCC---CCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00000 0124677999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=324.72 Aligned_cols=247 Identities=22% Similarity=0.359 Sum_probs=195.1
Q ss_pred CCeeEeeee--eccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCC
Q 010489 113 SRYQIQEVI--GKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 113 ~~y~i~~~l--G~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~ 189 (509)
+.|++.+.+ |+|+||.||++.++.++..+|+|.+....... .|+.....+ +||||+++++.+...
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~----- 81 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTL----- 81 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecC-----
Confidence 356666665 99999999999999999999999986421111 133333323 699999999998543
Q ss_pred CcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCC-CeEEeeeccccccc
Q 010489 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVSF 267 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~-~vkl~DFG~a~~~~ 267 (509)
..+|+||||++ ++|.+++.....+++..+..++.||++||.|||+.||+||||||+||+++.++ .++|+|||++....
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 46899999997 69999998888999999999999999999999999999999999999999998 99999999987542
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhH-HHHHHHhcCCCChhHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQ-LDLMTDLLGTPSTESIS 346 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~g~~~~~~~~ 346 (509)
.. ....|+..|+|||++.+ ..++.++|||||||++|+|++|..||........ ...+
T Consensus 162 ~~-------~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~------------- 219 (267)
T PHA03390 162 TP-------SCYDGTLDYFSPEKIKG--HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL------------- 219 (267)
T ss_pred CC-------ccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHH-------------
Confidence 21 23468999999999977 6789999999999999999999999975432110 0000
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-HHHHhcCCcccC
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-AEEALADPYFHG 408 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-~~e~l~hp~f~~ 408 (509)
.... .. + ....+..++.+.+||.+||+.||.+||+ ++++|+||||+.
T Consensus 220 ----------~~~~-~~-~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 220 ----------LKRQ-QK-K---LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred ----------HHhh-cc-c---CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 0000 00 0 0112357889999999999999999996 599999999963
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=326.62 Aligned_cols=256 Identities=23% Similarity=0.349 Sum_probs=202.1
Q ss_pred CCCeeEeeeeeccCceEEEEEEE-----cCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 186 (509)
..+|.+.+.||+|+||.||++.+ ..++..||+|.+... .......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 78 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE--- 78 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---
Confidence 35799999999999999999975 235567999988642 23345678899999999999999999999854
Q ss_pred CCCCcEEEEEeccc-ccHHHHHHhCC-------------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC
Q 010489 187 REFKDIYVVFELME-SDLHQVIKAND-------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 252 (509)
Q Consensus 187 ~~~~~~~lv~e~~~-~~L~~~l~~~~-------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~ 252 (509)
...+|+||||++ ++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 79 --~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 79 --GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 156 (288)
T ss_pred --CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 345899999998 68988886543 48999999999999999999999999999999999999999
Q ss_pred CCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHH
Q 010489 253 CKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLD 331 (509)
Q Consensus 253 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~ 331 (509)
+.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+.
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~ 233 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 233 (288)
T ss_pred CcEEeccCCccccccCCcee-ecCCCCCccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999754322211 11223456788999999876 678999999999999999998 899997765433222
Q ss_pred HHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 332 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 332 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.+.. ..... .....++++.+|+.+||+.||.+|||+.++++ .++.+
T Consensus 234 ~i~~---------------------------~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~--~l~~~ 279 (288)
T cd05093 234 CITQ---------------------------GRVLQ---RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS--LLQNL 279 (288)
T ss_pred HHHc---------------------------CCcCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH--HHHHH
Confidence 2211 00001 11245778999999999999999999999976 45443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=328.70 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=206.4
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
..|...+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++|||++++++++... ..
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 95 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-----HT 95 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CE
Confidence 347778899999999999999999999999999864322 223446788999999999999999999998543 45
Q ss_pred EEEEEecccccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.|+||||+.+++.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 96 ~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 96 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 899999999998888765 45789999999999999999999999999999999999999999999999999864211
Q ss_pred CCcccccccccccccccccccccc-cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
.....|+..|+|||++... ...++.++|||||||++|+|++|.+||...+.......+..
T Consensus 174 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-------------- 234 (313)
T cd06633 174 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------------- 234 (313)
T ss_pred -----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--------------
Confidence 1345789999999987421 14688899999999999999999999977654333222111
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
...+. ......+..+.+|+.+||+.+|.+||++.+++.||||+.
T Consensus 235 ------------~~~~~---~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 235 ------------NDSPT---LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred ------------cCCCC---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 00000 111235677999999999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=321.26 Aligned_cols=248 Identities=23% Similarity=0.376 Sum_probs=199.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|+++++||+|+||.||+|... ++..||+|.+... ....+.+.+|+.+++.++|+||+++++++.. ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 75 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK-----EEP 75 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-----CCC
Confidence 357999999999999999999864 5677999987642 2235678899999999999999999998843 345
Q ss_pred EEEEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 192 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
.|++|||+. ++|.+++... ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 899999997 6899988653 4688999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
.... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+...
T Consensus 156 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~----------- 220 (261)
T cd05072 156 NEYT--AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG----------- 220 (261)
T ss_pred Ccee--ccCCCccceecCCHHHhcc--CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-----------
Confidence 2211 1123346778999999876 678899999999999999998 99999876543322222110
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
... .....++.++.+++.+||..||++||+++++++
T Consensus 221 ----------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 221 ----------------YRM---PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred ----------------CCC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 000 112346788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=325.49 Aligned_cols=252 Identities=21% Similarity=0.381 Sum_probs=199.6
Q ss_pred CCeeEeeeeeccCceEEEEEEE----cCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVD----THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~----~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
.+|++.+.||+|+||.||+|.. ..++..||+|.+... ........+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---- 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE---- 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC----
Confidence 5789999999999999999985 345678999998643 2233446788999999999999999999988543
Q ss_pred CCcEEEEEeccc-ccHHHHHHhC-----------------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEEC
Q 010489 189 FKDIYVVFELME-SDLHQVIKAN-----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 250 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~-----------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~ 250 (509)
...|+||||+. ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++
T Consensus 80 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 80 -QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred -CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 45899999998 5898888532 2478889999999999999999999999999999999999
Q ss_pred CCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhH
Q 010489 251 ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQ 329 (509)
Q Consensus 251 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~ 329 (509)
.++.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....+.
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYR-VQPKSLLPIRWMPPEAIMY--GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235 (283)
T ss_pred CCCcEEeccccccccccCCccee-cccCCCccceecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999997653322111 1233456778999999876 678999999999999999998 9999987654322
Q ss_pred HHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 330 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 330 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
...+.. .... .....+++.+.+++.+||+.||.+||++.+++++
T Consensus 236 ~~~~~~---------------------------~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 236 IEMVRK---------------------------RQLL---PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHc---------------------------CCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 222110 0000 1123467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=324.32 Aligned_cols=254 Identities=27% Similarity=0.417 Sum_probs=205.7
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
-|++.+.||+|+||.||+|.+..++..||||.+.... .......+.+|+.+++.++||||+++++++.. ....|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 78 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLW 78 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe-----CCeEE
Confidence 4778899999999999999998899999999875422 22345678899999999999999999999843 34689
Q ss_pred EEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCC
Q 010489 194 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (509)
Q Consensus 194 lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 272 (509)
+||||+++ +|.+++.. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 79 lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 79 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 99999985 78777754 5789999999999999999999999999999999999999999999999999875432211
Q ss_pred cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHH
Q 010489 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (509)
Q Consensus 273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (509)
......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+.
T Consensus 157 --~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------------------ 214 (277)
T cd06641 157 --KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP------------------ 214 (277)
T ss_pred --hhccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh------------------
Confidence 1233578899999999876 577889999999999999999999997644322221110
Q ss_pred HHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
...+ ......++..+.+++.+||..||.+||++.++++||||...
T Consensus 215 ---------~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 215 ---------KNNP---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ---------cCCC---CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 0000 01113467889999999999999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=328.45 Aligned_cols=255 Identities=28% Similarity=0.512 Sum_probs=205.7
Q ss_pred eeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEE
Q 010489 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 194 (509)
Q Consensus 115 y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 194 (509)
|....+||+|+||.||++....++..||||++... .......+.+|+.+++.++|+||+++++.+.. ....|+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~l 94 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV 94 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEe-----CCEEEE
Confidence 34457899999999999999999999999998532 22345568899999999999999999998854 346899
Q ss_pred EEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCc
Q 010489 195 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273 (509)
Q Consensus 195 v~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 273 (509)
||||+++ +|.+++ ....+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.........
T Consensus 95 v~e~~~~~~L~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~- 172 (292)
T cd06657 95 VMEFLEGGALTDIV-THTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR- 172 (292)
T ss_pred EEecCCCCcHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccc-
Confidence 9999985 677665 4457899999999999999999999999999999999999999999999999998754332211
Q ss_pred ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHH
Q 010489 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353 (509)
Q Consensus 274 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (509)
.....|++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+......+..+...
T Consensus 173 --~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~----------------- 231 (292)
T cd06657 173 --RKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN----------------- 231 (292)
T ss_pred --ccccccCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-----------------
Confidence 233578999999998876 57889999999999999999999999876644333222110
Q ss_pred HHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
.+..+ .....+++.+.+++.+||..||.+||++.++++||||....
T Consensus 232 ----------~~~~~-~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 232 ----------LPPKL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred ----------CCccc-CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 00011 11234678899999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=325.97 Aligned_cols=263 Identities=22% Similarity=0.391 Sum_probs=206.6
Q ss_pred CeeEeeeeeccCceEEEEEEEc---CCCcEEEEEEecCccc--ChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcC
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFE--HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~~--~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~ 187 (509)
.|++.+.||.|+||.||+|.+. .+|..||+|+++.... .......+.+|+.+++.+ .|++|+.+++++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT---- 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec----
Confidence 3889999999999999999874 4789999999864221 222345678899999999 59999999988843
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 188 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
...+|+||||++ ++|.+++.....+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++...
T Consensus 77 -~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 77 -DTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred -CCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 346899999999 589999988888999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
...... ......|+..|+|||.+.+....++.++|||||||++|+|++|..||...........+..
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~----------- 222 (290)
T cd05613 156 HEDEVE--RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR----------- 222 (290)
T ss_pred cccccc--ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH-----------
Confidence 332211 1234578999999999865334578899999999999999999999964332111111100
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCc
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~ 410 (509)
... ....+. ...+++.+.+|+.+||..||++|| ++++++.||||+.+.
T Consensus 223 --------~~~---~~~~~~-----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 223 --------RIL---KSEPPY-----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred --------Hhh---ccCCCC-----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 000 011111 124678899999999999999997 899999999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=328.89 Aligned_cols=250 Identities=25% Similarity=0.383 Sum_probs=196.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcE--EEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGER--VAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~--vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~ 188 (509)
.++|++.+.||+|+||.||+|.+..++.. +|+|.++.. ........+.+|+.++.++ +||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~----- 79 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----- 79 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-----
Confidence 45799999999999999999998877764 577776532 2233456788899999999 89999999999844
Q ss_pred CCcEEEEEeccc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC
Q 010489 189 FKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 251 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~ 251 (509)
...+|+||||++ ++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 159 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC
Confidence 345899999998 68999886542 5789999999999999999999999999999999999999
Q ss_pred CCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHH
Q 010489 252 DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQL 330 (509)
Q Consensus 252 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~ 330 (509)
++.+||+|||++........ .....++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+..
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 233 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 233 (303)
T ss_pred CCcEEeCccccCcccchhhh----cccCCCcccccCHHHHhc--cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH
Confidence 99999999999864211111 111234667999998876 578899999999999999998 99999766543222
Q ss_pred HHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 331 DLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 331 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
..+. ..... ......++.+.+||.+||+.||++||++++++++
T Consensus 234 ~~~~---------------------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 234 EKLP---------------------------QGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHHh---------------------------cCCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1110 00000 0112357789999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=326.47 Aligned_cols=259 Identities=22% Similarity=0.326 Sum_probs=201.3
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCC----------------cEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTG----------------ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~----------------~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv 175 (509)
.++|++++.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+++++.++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 468999999999999999999876543 568999986432 224456788999999999999999
Q ss_pred eeeeeecCCCcCCCCcEEEEEeccc-ccHHHHHHhCC-----------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCC
Q 010489 176 EIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND-----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 243 (509)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlK 243 (509)
++++++... ...+++|||+. ++|.+++.... .+++..+..++.|++.||+|||+.||+|||||
T Consensus 83 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk 157 (296)
T cd05051 83 RLLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157 (296)
T ss_pred EEEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence 999998543 45899999998 58999887655 68999999999999999999999999999999
Q ss_pred CCcEEECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh--CCCCC
Q 010489 244 PKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT--GKPLF 321 (509)
Q Consensus 244 p~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~--g~~pf 321 (509)
|+||+++.++.++|+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~~p~ 234 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYY-RVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEILTLCREQPY 234 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcce-eecCcCCCCceecCHHHhhc--CCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence 99999999999999999999764322211 11223456788999999876 678999999999999999998 67888
Q ss_pred CCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHh
Q 010489 322 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401 (509)
Q Consensus 322 ~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 401 (509)
...+..+.+..+.... ............+.++.++.+|+.+||+.||.+|||+.+++
T Consensus 235 ~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~ 291 (296)
T cd05051 235 EHLTDQQVIENAGHFF-----------------------RDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIH 291 (296)
T ss_pred CCcChHHHHHHHHhcc-----------------------ccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHH
Confidence 6654333222221110 00000000111234578899999999999999999999997
Q ss_pred c
Q 010489 402 A 402 (509)
Q Consensus 402 ~ 402 (509)
+
T Consensus 292 ~ 292 (296)
T cd05051 292 L 292 (296)
T ss_pred H
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=325.37 Aligned_cols=258 Identities=33% Similarity=0.535 Sum_probs=211.8
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
....|++.+.||.|+||.||+|.+..++..||+|++..... ....+.+|+.+++.++|+||+++++.+... .
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 88 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG-----D 88 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----C
Confidence 34568999999999999999999998999999999864322 456788999999999999999999998544 4
Q ss_pred cEEEEEeccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 191 DIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
..|+|+||++ ++|.+++.... .+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 89 ELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 5899999999 69999998876 899999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... ......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 169 ~~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~------------- 230 (286)
T cd06614 169 EKS---KRNSVVGTPYWMAPEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT------------- 230 (286)
T ss_pred chh---hhccccCCcccCCHhHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------------
Confidence 221 1133467889999999876 6789999999999999999999999976554322221110
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
..... ......++..+.+||.+||+.+|.+||++.++++|+||...
T Consensus 231 --------------~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 231 --------------KGIPP-LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred --------------cCCCC-CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 00000 01112367789999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=316.16 Aligned_cols=259 Identities=29% Similarity=0.457 Sum_probs=211.0
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
+|.+.+.||+|++|.||+|.+..++..|++|++............+.+|+.++++++||||+++++.+.... ...++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 488899999999999999999999999999998754333345678889999999999999999999885442 24689
Q ss_pred EEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCC
Q 010489 194 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (509)
Q Consensus 194 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 272 (509)
+++||++ ++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999996 689999988779999999999999999999999999999999999999999999999999999876443321
Q ss_pred cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHH
Q 010489 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (509)
Q Consensus 273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (509)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|..||..... ....+....
T Consensus 158 -~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~--------------- 217 (260)
T cd06606 158 -EGTGSVRGTPYWMAPEVIRG--EEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIG--------------- 217 (260)
T ss_pred -ccccCCCCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhcc---------------
Confidence 01233578899999999877 5688999999999999999999999977551 111111100
Q ss_pred HHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
.... ........++.+.+||.+||..||.+||++.++++||||
T Consensus 218 --------~~~~---~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 218 --------SSGE---PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred --------ccCC---CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 0000 011112347889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=326.99 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=196.2
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCc--EEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGE--RVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~--~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~ 189 (509)
++|++.+.||+|+||.||+|....++. .+|+|.++.. ......+.+.+|+.++.++ +||||+++++++...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~----- 75 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENR----- 75 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC-----
Confidence 579999999999999999999877765 4788887632 2334456788999999999 799999999988443
Q ss_pred CcEEEEEeccc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC
Q 010489 190 KDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 252 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~ 252 (509)
..+|+||||++ ++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.+
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~ 155 (297)
T cd05089 76 GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN 155 (297)
T ss_pred CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC
Confidence 45899999998 68999986532 48889999999999999999999999999999999999999
Q ss_pred CCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHH
Q 010489 253 CKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLD 331 (509)
Q Consensus 253 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~ 331 (509)
+.+||+|||++........ ......+..|+|||++.+ ..++.++|||||||++|||++ |..||.+....+...
T Consensus 156 ~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~ 229 (297)
T cd05089 156 LASKIADFGLSRGEEVYVK----KTMGRLPVRWMAIESLNY--SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229 (297)
T ss_pred CeEEECCcCCCccccceec----cCCCCcCccccCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999864221111 111123457999999876 678999999999999999997 999998765433222
Q ss_pred HHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 332 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 332 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
.+.. .... .....+++.+.+||.+||..||.+||+++++++.
T Consensus 230 ~~~~---------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 230 KLPQ---------------------------GYRM---EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHhc---------------------------CCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1110 0000 0112467889999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=319.81 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=200.0
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCC---CcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
++|++.+.||+|+||.||+|....+ ...||||.++... .......+.+|+.+++.++||||+++++.+.. .
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 77 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-----S 77 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-----C
Confidence 5799999999999999999988654 4589999886432 23345678899999999999999999998843 3
Q ss_pred CcEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 190 KDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
...|+||||++ ++|.+++... +.+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 45899999998 5899988664 478999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
..... .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+...
T Consensus 158 ~~~~~-~~~~~~~~~~~y~~Pe~~~~--~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~---------- 224 (266)
T cd05033 158 DSEAT-YTTKGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG---------- 224 (266)
T ss_pred ccccc-eeccCCCCCccccChhhhcc--CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC----------
Confidence 22211 11112345678999999876 678999999999999999998 99999765433222222110
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
...+. ...+++.+.+|+.+||+.||++||++.+++++
T Consensus 225 ---------------~~~~~-----~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 225 ---------------YRLPP-----PMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ---------------CCCCC-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00011 12467889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=339.56 Aligned_cols=253 Identities=25% Similarity=0.394 Sum_probs=197.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCC-----CcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHT-----GERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~ 185 (509)
.++|++++.||+|+||.||+|.+... +..||||+++.. ......+.+.+|+.+|+.+. ||||+++++++..
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~-- 112 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK-- 112 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence 46899999999999999999986433 357999998643 22334567889999999996 9999999999844
Q ss_pred cCCCCcEEEEEeccc-ccHHHHHHhC------------------------------------------------------
Q 010489 186 RREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 210 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~-~~L~~~l~~~------------------------------------------------------ 210 (509)
...+|||||||+ |+|.+++...
T Consensus 113 ---~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 113 ---SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred ---CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 345899999998 6888877542
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEE
Q 010489 211 ------------------------------------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL 248 (509)
Q Consensus 211 ------------------------------------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NIL 248 (509)
..+++..+..++.||++||+|||+.+|+||||||+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil 269 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence 24778888999999999999999999999999999999
Q ss_pred ECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChH
Q 010489 249 ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVV 327 (509)
Q Consensus 249 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~ 327 (509)
++.++.+||+|||+++........ .......+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+....
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFD--NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 999999999999999765332211 11223457788999999876 678999999999999999997 99999764321
Q ss_pred hHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 328 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 328 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..+... + ......+ ....+++.+.+++.+||..||++||++.++.+
T Consensus 347 ~~~~~~--------------~------------~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 347 STFYNK--------------I------------KSGYRMA---KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHH--------------H------------hcCCCCC---CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 111100 0 0000000 11346788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=323.64 Aligned_cols=252 Identities=21% Similarity=0.370 Sum_probs=198.8
Q ss_pred CCeeEeeeeeccCceEEEEEEEcC-----CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
+.|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 81 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER--- 81 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC---
Confidence 469999999999999999999877 77899999886432 223345688899999999999999999988543
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhCC-------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCC---CeE
Q 010489 188 EFKDIYVVFELME-SDLHQVIKAND-------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLK 256 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~~-------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~---~vk 256 (509)
...|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+++++||||||+|||++.++ .+|
T Consensus 82 --~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 82 --LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred --CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceE
Confidence 34799999997 58999887653 489999999999999999999999999999999999998765 599
Q ss_pred EeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHH
Q 010489 257 ICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTD 335 (509)
Q Consensus 257 l~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~ 335 (509)
|+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+..
T Consensus 160 l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~ 236 (277)
T cd05036 160 IADFGMARDIYRASYY-RKGGRAMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236 (277)
T ss_pred eccCccccccCCccce-ecCCCCCccHhhCCHHHHhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999865222111 00112234568999999876 679999999999999999997 9999987664332222111
Q ss_pred hcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 336 LLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 336 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
. .... ....+++.+.+++.+||+.||++||++.++++|
T Consensus 237 ~---------------------------~~~~---~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 237 G---------------------------GRLD---PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C---------------------------CcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 0000 113457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=334.14 Aligned_cols=264 Identities=27% Similarity=0.432 Sum_probs=194.9
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
+.|.-...||+|+||.||+|.-. +|..||||++....... .+++.+|+.+|.+++|||+|+++|+|..... ..
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~ 147 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HR 147 (361)
T ss_pred hCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eE
Confidence 45666789999999999999764 45899999886533221 4559999999999999999999999965431 48
Q ss_pred EEEEeccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCC---eeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 193 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~---ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
+||+|||. |+|.+++.... .++|.....|+.++++||+|||... ||||||||+|||+|++++.||+|||+|+..
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG 227 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence 99999999 79999997654 8999999999999999999999854 999999999999999999999999999654
Q ss_pred cCCCCCccccccc-ccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 267 FNDAPSAIFWTDY-VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 267 ~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
... ... .... .||.+|+|||++.. +..+.|+|||||||+|+||++|+.+..............+. .
T Consensus 228 ~~~-~~~--~~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~--------~ 294 (361)
T KOG1187|consen 228 PEG-DTS--VSTTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA--------K 294 (361)
T ss_pred Ccc-ccc--eeeecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH--------H
Confidence 321 111 1222 89999999999876 68999999999999999999999888654311111111100 0
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCC--CCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFP--NADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..+.......++.. .... ..++ ..-..+..+..+|++.+|.+||++.|+++
T Consensus 295 ~~~~~~~~~eiiD~---~l~~---~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 295 PLLEEGKLREIVDP---RLKE---GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHHHCcchhheeCC---CccC---CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 00011111111110 0000 1111 11223677889999999999999999755
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=318.43 Aligned_cols=245 Identities=22% Similarity=0.327 Sum_probs=194.7
Q ss_pred eeeeccCceEEEEEEEcCCC---cEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEE
Q 010489 119 EVIGKGSYGVVGSAVDTHTG---ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 195 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~---~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 195 (509)
++||+|+||.||+|....++ ..||+|.+...... .....+.+|+.+++.+.|+||+++++++.. ...++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEE
Confidence 46999999999999865554 78999998754322 345678899999999999999999998742 247999
Q ss_pred Eeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCcc
Q 010489 196 FELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 274 (509)
Q Consensus 196 ~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 274 (509)
|||+. ++|.+++.....+++..+..++.|++.||+|||+.|++||||||+|||++.++.+||+|||+++..........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99998 68999998888899999999999999999999999999999999999999999999999999986533222111
Q ss_pred cccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHH
Q 010489 275 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353 (509)
Q Consensus 275 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 353 (509)
......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~----------------- 214 (257)
T cd05060 154 ATTAGRWPLKWYAPECINY--GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG----------------- 214 (257)
T ss_pred cccCccccccccCHHHhcC--CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-----------------
Confidence 1111223467999999876 678999999999999999998 99999765543322222110
Q ss_pred HHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.+. .....+++.+.++|.+||..||++||++.++++
T Consensus 215 ----------~~~---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 215 ----------ERL---PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ----------CcC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 000 111346788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=314.29 Aligned_cols=251 Identities=31% Similarity=0.529 Sum_probs=206.6
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
+|.+.+.||+|++|.||+|.+..+++.||+|++..... .....+.+|+.+++.++|++|+++++++... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 73 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELW 73 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEE
Confidence 48889999999999999999998999999999865322 3557788999999999999999999988544 4589
Q ss_pred EEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 194 VVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 194 lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
+++||++ ++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+........
T Consensus 74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 9999999 6899888776 5899999999999999999999999999999999999999999999999999976543321
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
.....|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+....+..+..
T Consensus 154 ----~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------- 211 (253)
T cd05122 154 ----RNTMVGTPYWMAPEVING--KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---------------- 211 (253)
T ss_pred ----ccceecCCcccCHHHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----------------
Confidence 234578899999999876 5688999999999999999999999976643222221110
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCc
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 405 (509)
...+. . .....++..+.++|.+||..||++|||+.++++|||
T Consensus 212 ----------~~~~~-~-~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 212 ----------NGPPG-L-RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ----------cCCCC-c-CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 00000 0 001123678999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=322.54 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=199.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCc----EEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGE----RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~----~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
..+|+++++||+|+||+||+|.+..++. .||+|.++... .......+.+|+.+++.+.||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--- 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS--- 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC---
Confidence 3579999999999999999999877776 48999886432 233456788999999999999999999988543
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 188 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
..+++|||++ |+|.+++... +.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ---~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 82 ---TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred ---CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceee
Confidence 3689999998 6899888764 5699999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
....... .......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||...........+.
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~---------- 225 (279)
T cd05109 159 LDIDETE-YHADGGKVPIKWMALESILH--RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE---------- 225 (279)
T ss_pred cccccce-eecCCCccchhhCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH----------
Confidence 5332211 11122345678999999876 678999999999999999998 899997654322111111
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
. ....+ ..+..++.+.+++.+||..||++||++.++++
T Consensus 226 --------------~---~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 226 --------------K---GERLP---QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred --------------C---CCcCC---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 00001 11346788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=324.92 Aligned_cols=253 Identities=27% Similarity=0.451 Sum_probs=199.8
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCC-----CcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHT-----GERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~ 185 (509)
.++|++.+.||+|+||.||++.+... ...||+|.+.... .......+.+|+.+++.+ +|+||+++++++...
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~- 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE- 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC-
Confidence 35799999999999999999987643 3789999986532 233456788999999999 799999999988443
Q ss_pred cCCCCcEEEEEeccc-ccHHHHHHh----------------CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEE
Q 010489 186 RREFKDIYVVFELME-SDLHQVIKA----------------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL 248 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~-~~L~~~l~~----------------~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NIL 248 (509)
..+|++|||+. ++|..++.. ...+++..+..++.||+.||.|||+.||+||||||+|||
T Consensus 89 ----~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 89 ----GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred ----CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 45899999998 689888854 246889999999999999999999999999999999999
Q ss_pred ECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChH
Q 010489 249 ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVV 327 (509)
Q Consensus 249 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~ 327 (509)
++.++.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYR-KTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred EcCCCeEEeCcccccccccccccee-ccCCCCCCccccCHHHhcc--CCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 9999999999999998654322111 1122245677999999876 678999999999999999997 99999876543
Q ss_pred hHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 328 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 328 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
+....+.. .... ......++.+.+|+.+||..||++|||+.+++++
T Consensus 242 ~~~~~~~~---------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 242 ELFKLLKE---------------------------GYRM---EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHc---------------------------CCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 32222110 0000 0112457889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=317.92 Aligned_cols=245 Identities=23% Similarity=0.397 Sum_probs=192.3
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEec
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 198 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 198 (509)
+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++++... ..+|+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----CCeEEEEee
Confidence 46999999999999999999999999876432 223446788999999999999999999998543 458999999
Q ss_pred cc-ccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCcccc
Q 010489 199 ME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276 (509)
Q Consensus 199 ~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 276 (509)
+. ++|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......... ..
T Consensus 75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~ 153 (252)
T cd05084 75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS-TG 153 (252)
T ss_pred ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccc-cC
Confidence 98 58998886644 68999999999999999999999999999999999999999999999999987543211110 01
Q ss_pred cccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHH
Q 010489 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (509)
Q Consensus 277 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (509)
....++..|+|||.+.+ ..++.++|||||||++|||++ |..||...........+..
T Consensus 154 ~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-------------------- 211 (252)
T cd05084 154 GMKQIPVKWTAPEALNY--GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-------------------- 211 (252)
T ss_pred CCCCCceeecCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc--------------------
Confidence 11123457999999876 678999999999999999997 8899965443221111110
Q ss_pred hhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..+.. .....+..+.+|+.+||..||++|||+.++++
T Consensus 212 -------~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 212 -------GVRLP---CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -------CCCCC---CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00011 11245778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=342.10 Aligned_cols=243 Identities=32% Similarity=0.499 Sum_probs=199.8
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~~ 190 (509)
...|.+...+|.|+|+.|..|.+..+++.+|+|++.+. .....+|+.++... .||||+++.+++ .+..
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~------~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~ 389 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR------ADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGK 389 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc------ccccccccchhhhhcCCCcceeeccee-----cCCc
Confidence 46789999999999999999999999999999999753 12234577666554 699999999999 4556
Q ss_pred cEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEE-CCCCCeEEeeecccccccC
Q 010489 191 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA-NADCKLKICDFGLARVSFN 268 (509)
Q Consensus 191 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl-~~~~~vkl~DFG~a~~~~~ 268 (509)
++|+|||++.| .+.+.+.....+. .++..|++||+.|+.|||++|||||||||+|||+ +..|+++|+|||.++....
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred eeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 79999999996 5666666655454 7888899999999999999999999999999999 6999999999999986544
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
+ +.+.+-|..|.|||++.. ..|++++||||||++||+||+|+.||...... ..|...++.+.
T Consensus 469 ~------~~tp~~t~~y~APEvl~~--~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~------- 530 (612)
T KOG0603|consen 469 S------CDTPALTLQYVAPEVLAI--QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPK------- 530 (612)
T ss_pred h------hcccchhhcccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCc-------
Confidence 3 233477899999999986 79999999999999999999999999775532 11111111111
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
++ ..+|..+++||.+||+.||.+|+++.+++.||||
T Consensus 531 -------------------~s---~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 531 -------------------FS---ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -------------------cc---cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 11 3578999999999999999999999999999999
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=338.92 Aligned_cols=261 Identities=22% Similarity=0.392 Sum_probs=224.8
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCc-ccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
..+.+++..||-|+||.|-++.-......+|+|++++. .........+..|-.||..++.|.||++|..| .+..
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~k 493 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSK 493 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccch
Confidence 45677888999999999999976655556999998753 33445667788999999999999999999988 6667
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
++|++||-|- |+|+..+...+.|++..+++++..+++|++|||++|||+|||||+|+|++.+|-+||.|||+|+.....
T Consensus 494 yvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 8999999986 689999999999999999999999999999999999999999999999999999999999999987554
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
... -++||||.|.|||++.. ...+.++|.||||+++||||+|.+||.+.+.......|.+.+.. +.
T Consensus 574 ~KT----wTFcGTpEYVAPEIILn--KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~--------i~ 639 (732)
T KOG0614|consen 574 RKT----WTFCGTPEYVAPEIILN--KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK--------IE 639 (732)
T ss_pred Cce----eeecCCcccccchhhhc--cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh--------hh
Confidence 432 35899999999999987 78899999999999999999999999999988888887664311 10
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCcCC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLANV 412 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~f~~~~~~ 412 (509)
++ ..++..+.+||+++...+|.+|.. +.+|.+|.||.++.+.
T Consensus 640 ----------~P-----------r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe 686 (732)
T KOG0614|consen 640 ----------FP-----------RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE 686 (732)
T ss_pred ----------cc-----------cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence 01 134566999999999999999986 8999999999988764
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=317.58 Aligned_cols=251 Identities=28% Similarity=0.444 Sum_probs=207.6
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
+|++.+.||+|+||.||++.+..+++.||+|.+............+.+|+.+++.++|+||+++++++... ...|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-----NKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEE
Confidence 58999999999999999999999999999999875443444566778999999999999999999888543 4689
Q ss_pred EEEeccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 194 VVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 194 lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
+||||++ ++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 9999997 488888765 35689999999999999999999999999999999999999999999999999987544
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
.. .....|++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+..
T Consensus 156 ~~-----~~~~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------- 215 (256)
T cd08530 156 NM-----AKTQIGTPHYMAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR------------- 215 (256)
T ss_pred CC-----cccccCCccccCHHHHCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------------
Confidence 31 233568899999999876 6788999999999999999999999987654322111100
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
..... .....+.++.++|.+||..+|++||++.++++||++
T Consensus 216 --------------~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 216 --------------GKYPP---IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred --------------CCCCC---CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 00000 112457789999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=320.58 Aligned_cols=253 Identities=26% Similarity=0.399 Sum_probs=200.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCc---EEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGE---RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~---~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
..+|++.+.||+|+||.||+|.+..++. .||+|.++... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 76 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK----- 76 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence 3579999999999999999998865543 79999886432 22345678899999999999999999999843
Q ss_pred CCcEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 189 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
....|+||||++ ++|.+++... +.+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++...
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 345899999998 5899988765 46899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
..............++..|+|||.+.+ ..++.++|+|||||++||+++ |..||.+....+....+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~--------- 225 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG--------- 225 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhcc--CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC---------
Confidence 433221111122234568999999876 678999999999999999886 99999776543332222111
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
...+ ....+++.+.+++.+||+.+|.+||++.++++
T Consensus 226 ------------------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 226 ------------------YRLP---APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ------------------CcCC---CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 0000 11246788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=317.40 Aligned_cols=246 Identities=26% Similarity=0.434 Sum_probs=200.9
Q ss_pred eeeeccCceEEEEEEEcCC---CcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEE
Q 010489 119 EVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 195 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 195 (509)
+.||+|+||.||+|.+... +..||+|.++...... ....+.+|+.+++.++|+||+++++++.. ...+++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEE
Confidence 4699999999999998866 8899999997543322 46778899999999999999999998854 3458999
Q ss_pred Eeccc-ccHHHHHHhC---------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 196 FELME-SDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 196 ~e~~~-~~L~~~l~~~---------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
|||++ ++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.+..
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccc
Confidence 99996 7999999875 7899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
...... ........++..|+|||.+.. ..++.++|||||||++|||++ |..||.+....+....+..
T Consensus 155 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--------- 222 (262)
T cd00192 155 VYDDDY-YRKKTGGKLPIRWMAPESLKD--GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK--------- 222 (262)
T ss_pred cccccc-cccccCCCcCccccCHHHhcc--CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---------
Confidence 543321 111234567889999999876 578999999999999999999 6999987654332222211
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
.... .....+++++.+++.+||..||.+||++.+++++
T Consensus 223 ------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 223 ------------------GYRL---PKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ------------------CCCC---CCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0000 1113457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=317.86 Aligned_cols=247 Identities=26% Similarity=0.414 Sum_probs=197.9
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
.+|++.+.||+|+||.||+|.+. +++.||+|.++... .....+.+|+.+++.++||||+++++++.. ....
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 76 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL-----EEPI 76 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEec-----CCCe
Confidence 57999999999999999999865 45789999986422 234567899999999999999999998743 3458
Q ss_pred EEEEeccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 193 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
|+||||++ ++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999995 68999987654 6899999999999999999999999999999999999999999999999999875422
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
.... .....++..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+....+..+..
T Consensus 157 ~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~------------- 219 (261)
T cd05068 157 IYEA--REGAKFPIKWTAPEAALY--NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ------------- 219 (261)
T ss_pred cccc--cCCCcCceeccCcccccc--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-------------
Confidence 2111 111223457999999876 678999999999999999999 9999987654333322211
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
....+ .....+..+.+++.+||..||.+||++.++++
T Consensus 220 --------------~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 220 --------------GYRMP---CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred --------------CCCCC---CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 00000 11245778999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=324.35 Aligned_cols=260 Identities=24% Similarity=0.389 Sum_probs=203.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++.+.||+|+||.||+|.+..+++.||||.++.... ......+.+|+.++..+. ||||+++++++.. ..
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~ 87 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-----DS 87 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeec-----CC
Confidence 4679999999999999999999998999999999864322 223456677887776665 9999999999854 34
Q ss_pred cEEEEEecccccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhh-CCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 191 DIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
.+|+||||+++.+..++.. ...+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++.....
T Consensus 88 ~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 88 DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 6899999999888777765 4578999999999999999999997 5999999999999999999999999999875432
Q ss_pred CCCCccccccccccccccccccccccc--CCCCCceeeehhhhHHHHHHhCCCCCCCCChH-hHHHHHHHhcCCCChhHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV-HQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~ 345 (509)
... .....++..|+|||.+.+.. ..++.++|||||||++|+|++|+.||...... +.+..+
T Consensus 168 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~------------ 231 (296)
T cd06618 168 SKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI------------ 231 (296)
T ss_pred CCc----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHH------------
Confidence 221 12336788999999986521 34788999999999999999999999653211 111111
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
+. ...+. + ......+.++.+||.+||..||.+||+++++++||||...
T Consensus 232 -----------~~---~~~~~-~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 232 -----------LQ---EEPPS-L-PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred -----------hc---CCCCC-C-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 00 00000 0 0011357789999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=325.01 Aligned_cols=257 Identities=26% Similarity=0.407 Sum_probs=206.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
..+|...+.||+|+||.||+|++..++..||+|.+.... ........+.+|+.+++.++|+|++++++++... .
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 88 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----H 88 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----C
Confidence 345888899999999999999999999999999986421 2223456678999999999999999999998543 4
Q ss_pred cEEEEEecccccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
..|+||||+.+++.+++.. ...+++..+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||++......
T Consensus 89 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 89 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred eeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 5899999999988887754 456899999999999999999999999999999999999999999999999998754221
Q ss_pred CCCcccccccccccccccccccccc-cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
....|++.|+|||.+.+. ...++.++|||||||++|+|++|..||...+.......+..
T Consensus 169 -------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------- 228 (308)
T cd06634 169 -------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------- 228 (308)
T ss_pred -------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh-------------
Confidence 235788999999987431 14578899999999999999999999976543222211110
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
...+. ......+..+.+||.+||..+|++||+++++++|||+...
T Consensus 229 -------------~~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 229 -------------NESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred -------------cCCCC---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 00000 0112456789999999999999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=317.76 Aligned_cols=249 Identities=21% Similarity=0.336 Sum_probs=197.1
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
..+|++++.||+|+||.||+|.... +..||+|.+.... .....+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 73 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-----RP 73 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccC-----CC
Confidence 3579999999999999999997653 4569999886422 2235678999999999999999999998443 34
Q ss_pred EEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++.....
T Consensus 74 ~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 74 IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred cEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 799999998 5899888764 46899999999999999999999999999999999999999999999999998765332
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~------------ 217 (256)
T cd05113 154 EYT--SSVGSKFPVRWSPPEVLLY--SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG------------ 217 (256)
T ss_pred cee--ecCCCccChhhCCHHHHhc--CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC------------
Confidence 211 1112345678999999876 578999999999999999998 99999765543222222110
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
.... .....++.+.+++.+||..||.+||++.+++++
T Consensus 218 ---------------~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 218 ---------------LRLY---RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ---------------CCCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0000 012346789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=316.98 Aligned_cols=287 Identities=30% Similarity=0.495 Sum_probs=220.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-----C---CCcceeeeeecC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-----H---PDIVEIKHIMLP 183 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-----h---~niv~~~~~~~~ 183 (509)
.+||.+.++||-|-|++||+|.+..+.++||+|+++.. ....+..+.||++|++++ | .+||++++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 47999999999999999999999999999999999743 123455688999999885 2 469999999876
Q ss_pred CCcCCCCcEEEEEecccccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhh-CCeeecCCCCCcEEECCC--------
Q 010489 184 PSRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANAD-------- 252 (509)
Q Consensus 184 ~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDlKp~NILl~~~-------- 252 (509)
.. ..+.++|||+|+++..|+.+|... +.++...++.|++|||.||.|||. .||||.||||+|||+..+
T Consensus 154 sG-pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 154 SG-PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred cC-CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhh
Confidence 54 456789999999999999999765 479999999999999999999997 599999999999994211
Q ss_pred --------------------------------------------------------------------------------
Q 010489 253 -------------------------------------------------------------------------------- 252 (509)
Q Consensus 253 -------------------------------------------------------------------------------- 252 (509)
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence
Q ss_pred ------------------------------------------------------------------------------CC
Q 010489 253 ------------------------------------------------------------------------------CK 254 (509)
Q Consensus 253 ------------------------------------------------------------------------------~~ 254 (509)
.+
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 01
Q ss_pred eEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCC------ChHh
Q 010489 255 LKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK------NVVH 328 (509)
Q Consensus 255 vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~------~~~~ 328 (509)
|||+|||-|..... .++.-+-|+.|+|||++.+ ..|++.+||||++|+++||+||..+|..+ .+.+
T Consensus 393 vKIaDlGNACW~~k------hFT~DIQTRQYRapEVllG--sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDED 464 (590)
T KOG1290|consen 393 VKIADLGNACWVHK------HFTEDIQTRQYRAPEVLLG--SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDED 464 (590)
T ss_pred EEEeeccchhhhhh------hhchhhhhhhccCcceeec--CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHH
Confidence 23333333332111 1234467899999999999 89999999999999999999999999543 3578
Q ss_pred HHHHHHHhcCCCChhHHHHhhhHHHHHhhh------ccCCCCCCCCCC------CCCC-CCHHHHHHHHHhccCCCCCCC
Q 010489 329 QLDLMTDLLGTPSTESISRIRNEKARRYLG------SMRKKQPVPFSH------KFPN-ADPLALHLLERLLAFDPKDRP 395 (509)
Q Consensus 329 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~------~~~~-~~~~~~~li~~~L~~dP~~Rp 395 (509)
+++.|..++|..+......-+.. +.|+. .+.+-++-++.. .|+. ...++.+||.-||+++|++||
T Consensus 465 HiA~i~ELLG~iPr~ia~~Gk~S--RdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~ 542 (590)
T KOG1290|consen 465 HIALIMELLGKIPRKIALGGKYS--RDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRP 542 (590)
T ss_pred HHHHHHHHHhhccHHHHhcCcch--HhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccc
Confidence 99999999999888766544332 22222 222222222211 1221 234578899999999999999
Q ss_pred CHHHHhcCCcccCCcCC
Q 010489 396 TAEEALADPYFHGLANV 412 (509)
Q Consensus 396 t~~e~l~hp~f~~~~~~ 412 (509)
||.++|+|||+..+..+
T Consensus 543 tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 543 TAAQCLKHPWLNPVAGP 559 (590)
T ss_pred cHHHHhcCccccCCCCC
Confidence 99999999999877654
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=318.52 Aligned_cols=247 Identities=27% Similarity=0.400 Sum_probs=196.8
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.++||+|+||.||+|.+..+ ..||+|+++.... ....+.+|+.+++.++||||+++++.+.. ..
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~ 74 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 74 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC------CC
Confidence 45799999999999999999988655 4599999864222 23567899999999999999999987632 23
Q ss_pred EEEEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 192 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
.|+||||++ ++|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||.++....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 699999998 5899998753 3589999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
.... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.........+..
T Consensus 155 ~~~~--~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~------------ 218 (262)
T cd05071 155 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER------------ 218 (262)
T ss_pred cccc--cccCCcccceecCHhHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc------------
Confidence 2211 1123356778999998876 678999999999999999999 8889977654332222111
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..+.+ ....++..+.+|+.+||+.||++||++.++++
T Consensus 219 ---------------~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 219 ---------------GYRMP---CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ---------------CCCCC---CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 00000 11346788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=318.88 Aligned_cols=247 Identities=27% Similarity=0.395 Sum_probs=197.6
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||+|+||.||+|.+. .+..||+|.+..... ....+.+|+.+++.++|++|+++++++.. ..
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~ 74 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVSE------EP 74 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEECC------CC
Confidence 357999999999999999999765 566799999864322 23567899999999999999999988732 23
Q ss_pred EEEEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 192 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
.|++|||++ ++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 799999998 5899988753 3589999999999999999999999999999999999999999999999999976433
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
..... .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...
T Consensus 155 ~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~----------- 219 (260)
T cd05070 155 NEYTA--RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG----------- 219 (260)
T ss_pred ccccc--ccCCCCCccccChHHHhc--CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------
Confidence 22111 122345678999998876 678999999999999999999 89999876654433332210
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.+.+ .....+..+.+|+.+||..||++|||+.++++
T Consensus 220 ----------------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 220 ----------------YRMP---CPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred ----------------CCCC---CCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0000 11346778999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=324.57 Aligned_cols=251 Identities=22% Similarity=0.357 Sum_probs=198.4
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCC-----CcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHT-----GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
.+|++.+.||+|+||.||+|.+..+ +..||||+++.... ......+.+|+.++..++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--- 80 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE--- 80 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC---
Confidence 4688899999999999999987543 57899999874322 23345678899999999999999999998544
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEEC
Q 010489 188 EFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 250 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~ 250 (509)
...++++||+. ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++
T Consensus 81 --~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 81 --QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF 158 (283)
T ss_pred --CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence 34899999998 5788887432 2478889999999999999999999999999999999999
Q ss_pred CCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhH
Q 010489 251 ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQ 329 (509)
Q Consensus 251 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~ 329 (509)
.++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+.
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYY-KLMGNSLLPIRWMSPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred CCCceEecccccccccccchhe-eeccCccCCccccCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999998764322211 11233456789999999876 678999999999999999998 8889987654433
Q ss_pred HHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 330 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 330 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
...+... ...+ ....++..+.+|+.+||+.||.+||++.++++
T Consensus 236 ~~~i~~~---------------------------~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 236 IEMIRNR---------------------------QVLP---CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HHHHHcC---------------------------CcCC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 3322210 0000 11356788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=318.36 Aligned_cols=247 Identities=23% Similarity=0.354 Sum_probs=196.4
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
.+|++.+.||+|+||.||+|.+. ++..+|+|.+..... ....+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 74 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ-----RPI 74 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-----Cce
Confidence 46889999999999999999876 467899999864222 234577899999999999999999988433 458
Q ss_pred EEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 193 YVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
|+||||++ ++|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred EEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 99999997 5899988754 468999999999999999999999999999999999999999999999999997653222
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 155 ~~~--~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~------------- 217 (256)
T cd05059 155 YTS--SQGTKFPVKWAPPEVFDY--SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG------------- 217 (256)
T ss_pred ccc--cCCCCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC-------------
Confidence 111 112234457999999876 678999999999999999999 89999775543322221110
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
... ......++.+.+++.+||..+|++|||+.++++
T Consensus 218 --------------~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~ 253 (256)
T cd05059 218 --------------YRL---YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLS 253 (256)
T ss_pred --------------CcC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 000 011246788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=318.36 Aligned_cols=252 Identities=24% Similarity=0.386 Sum_probs=199.7
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCc---EEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGE---RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~---~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
.+|+..+.||+|+||.||+|.+..++. .+|+|+++... .......+..|+.+++.++||||+++.+++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 78 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF----- 78 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC-----
Confidence 468899999999999999999876654 79999886432 233456788999999999999999999998443
Q ss_pred CcEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 190 KDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
...|+||||++ ++|.+++... +.+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++....
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 45899999998 5888888654 578999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
..............++.|+|||++.. ..++.++|||||||++|||++ |..||...+..+....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~--------- 227 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF--------- 227 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhc--CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC---------
Confidence 33221111111233467999999876 678999999999999999997 999997765433333222110
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..+. ...++..+.+|+.+||..||++||++.++++
T Consensus 228 ------------------~~~~---~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 228 ------------------RLPA---PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ------------------CCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0010 1245778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=320.04 Aligned_cols=247 Identities=26% Similarity=0.422 Sum_probs=201.4
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
.+|+++++||.|+||.||+|.+.. +..+|+|++... .......+.+|+.+++.++||||+++++++... ...
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 77 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG-----EPV 77 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEecC-----CCe
Confidence 569999999999999999999887 889999998643 223455688999999999999999999988443 458
Q ss_pred EEEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 193 YVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 99999998 5999998753 46899999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+...
T Consensus 158 ~~~---~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~------------ 220 (261)
T cd05148 158 VYL---SSDKKIPYKWTAPEAASH--GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG------------ 220 (261)
T ss_pred ccc---ccCCCCceEecCHHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC------------
Confidence 211 123356778999999876 678899999999999999998 89999876643333322110
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
...+ ....+++.+.+++.+||..||.+|||+.++++
T Consensus 221 -------------~~~~-----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 221 -------------YRMP-----CPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred -------------CcCC-----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0001 11356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=322.33 Aligned_cols=250 Identities=23% Similarity=0.343 Sum_probs=198.9
Q ss_pred CCeeEeeeeeccCceEEEEEEEc-----CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
.+|.+.+.||+|+||.||+|.+. .++..+|+|.+... .....+.+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG--- 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC---
Confidence 57999999999999999999753 34567999988642 223446788999999999999999999998543
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEEC
Q 010489 188 EFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 250 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~ 250 (509)
...++||||++ ++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 80 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 80 --DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157 (291)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 45899999998 68999886542 388999999999999999999999999999999999999
Q ss_pred CCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhH
Q 010489 251 ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQ 329 (509)
Q Consensus 251 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~ 329 (509)
.++.+||+|||++........ ........++..|+|||.+.+ ..++.++|||||||++|||++ |..||...+..+.
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 234 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234 (291)
T ss_pred cCCcEEECCCCcccccCCCce-eecCCCCCcceeecChHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999975433221 111233467889999999877 678999999999999999998 9999977654332
Q ss_pred HHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 330 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 330 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
...+.. .... ......+..+.+|+.+||..||++||++.++++
T Consensus 235 ~~~~~~---------------------------~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 235 IECITQ---------------------------GRVL---ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHhC---------------------------CCCC---CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 221110 0000 111235778999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=320.04 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=196.9
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcE----EEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGER----VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~----vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
.+|++++.||+|+||+||+|....++.. ||+|.+... ........+..|+.+++.+.||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~----- 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG----- 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-----
Confidence 5789999999999999999998777764 677766432 122334567788889999999999999998742
Q ss_pred CCcEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 189 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
...++++||+. |+|.+++... +.+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++..
T Consensus 81 -~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 81 -ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred -CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 23688999998 7999999754 57899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
..... ........++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.......+.+..
T Consensus 160 ~~~~~-~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~---------- 226 (279)
T cd05111 160 YPDDK-KYFYSEHKTPIKWMALESILF--GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK---------- 226 (279)
T ss_pred cCCCc-ccccCCCCCcccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC----------
Confidence 33221 111234467788999999876 678999999999999999998 9999987654322221110
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
....+. ...++..+.+++.+||..||.+|||+.|+++
T Consensus 227 -----------------~~~~~~---~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 227 -----------------GERLAQ---PQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -----------------CCcCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 000000 1124567899999999999999999999977
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=319.03 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=199.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCC-----CcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHT-----GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 186 (509)
.++|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++.+.||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG-- 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC--
Confidence 35799999999999999999987643 4789999986432 223455678999999999999999999998543
Q ss_pred CCCCcEEEEEeccc-ccHHHHHHhC----------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCe
Q 010489 187 REFKDIYVVFELME-SDLHQVIKAN----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 255 (509)
Q Consensus 187 ~~~~~~~lv~e~~~-~~L~~~l~~~----------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~v 255 (509)
...|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+
T Consensus 82 ---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 82 ---QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred ---CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence 45899999997 6899888643 236788999999999999999999999999999999999999999
Q ss_pred EEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHH
Q 010489 256 KICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMT 334 (509)
Q Consensus 256 kl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~ 334 (509)
||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+.......+.
T Consensus 159 kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 235 (277)
T cd05032 159 KIGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235 (277)
T ss_pred EECCcccchhhccCccc-ccCCCCCccccccCHHHHhc--CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence 99999998765332211 11123456789999999876 678999999999999999998 999998765433222211
Q ss_pred HhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 335 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 335 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
...... .....+..+.+||.+||..+|++|||+.++++
T Consensus 236 ---------------------------~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 236 ---------------------------DGGHLD---LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred ---------------------------cCCCCC---CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000000 11234788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=316.01 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=198.1
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
..+|+++++||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++.++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~ 74 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS---MSPEAFLAEANLMKQLQHPRLVRLYAVVTQ------EP 74 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC---CcHHHHHHHHHHHHhcCCcCeeeEEEEEcc------CC
Confidence 357999999999999999999864 57889999986432 234568899999999999999999987632 24
Q ss_pred EEEEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 192 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
.|++|||+. ++|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 799999997 6899888653 3689999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
.... ......++..|+|||++.+ ..++.++|||||||++|||++ |++||.+.+..+....+....
T Consensus 155 ~~~~--~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------- 220 (260)
T cd05067 155 NEYT--AREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY---------- 220 (260)
T ss_pred CCcc--cccCCcccccccCHHHhcc--CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC----------
Confidence 2211 1123356678999999876 678899999999999999999 999998766433332221100
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..+ .....+.++.++|.+||..||++||++++++.
T Consensus 221 ---------------~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 221 ---------------RMP-----RPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred ---------------CCC-----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 001 11245678999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=311.56 Aligned_cols=261 Identities=24% Similarity=0.406 Sum_probs=207.4
Q ss_pred eeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHH-HHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL-RLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 115 y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
.+-+..||.|+||+|++..++.+|+..|||.|+.... ..+.++++.|.... +.-++||||++++++... +..|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E-----GdcW 139 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE-----GDCW 139 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC-----Ccee
Confidence 3446789999999999999999999999999975433 35567888898864 556799999999998543 4589
Q ss_pred EEEecccccHHHHHH-----hCCCCCHHHHHHHHHHHHhHhhhhhh-CCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 194 VVFELMESDLHQVIK-----ANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 194 lv~e~~~~~L~~~l~-----~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
|.||+|+-+|..+.+ +...++|..+-.|....+.||.||.. ..|||||+||+|||++..|.|||||||++..+.
T Consensus 140 iCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 140 ICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred eeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 999999976544442 34579999999999999999999975 589999999999999999999999999998765
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCCh-HhHHHHHHHhcCCCChhHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV-VHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~g~~~~~~~~ 346 (509)
+.... +.-+|.+.|||||.+......|+.++||||||++|||+.||+.||.+-+. .+|+..+. .|.|+.
T Consensus 220 ~SiAk----T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv--~gdpp~---- 289 (361)
T KOG1006|consen 220 DSIAK----TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV--IGDPPI---- 289 (361)
T ss_pred HHHHh----hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH--cCCCCe----
Confidence 44432 34589999999999877656699999999999999999999999976432 23333222 122221
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
...+...-..+..+..+|..||.+|-.+||...+++++||++...
T Consensus 290 -------------------l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 290 -------------------LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred -------------------ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 111222234678899999999999999999999999999997654
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=316.51 Aligned_cols=252 Identities=25% Similarity=0.406 Sum_probs=199.6
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCc---EEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGE---RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~---~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
.+|++.+.||+|+||.||+|.++.+++ .||||.++... .......+..|+.+++.+.||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----- 77 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS----- 77 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC-----
Confidence 569999999999999999999887665 69999986532 234456789999999999999999999988433
Q ss_pred CcEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 190 KDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
...++||||++ ++|.+++... +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++....
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 45899999998 4788888653 568999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCccccccc--ccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 268 NDAPSAIFWTDY--VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 268 ~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
............ .++..|+|||.+.+ ..++.++|||||||++|||++ |..||...+..+....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-------- 227 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-------- 227 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhcc--CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC--------
Confidence 322211111111 12457999999876 678999999999999999886 99999776543322222110
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.+.+. ...+++.+.+++.+||..+|.+||++.+++.
T Consensus 228 -------------------~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 228 -------------------YRLPP---PMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred -------------------CcCCC---cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00111 1346778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=315.52 Aligned_cols=253 Identities=28% Similarity=0.478 Sum_probs=201.2
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCc-ccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|++.+.||+|+||.||+|.+..+|+.||+|.++.. .........+.+|+.+++.++|++|+++++++... ..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-----~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-----NE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----Ce
Confidence 5799999999999999999999999999999988632 22233456788999999999999999999998543 45
Q ss_pred EEEEEeccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 192 IYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
.++||||++ ++|..++.. ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 899999998 589888754 245899999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
...... .....|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...... .... ..
T Consensus 157 ~~~~~~---~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~------------~~ 218 (267)
T cd08224 157 SSKTTA---AHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSL------------CK 218 (267)
T ss_pred cCCCcc---cceecCCccccCHHHhcc--CCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHH------------Hh
Confidence 322211 233578999999999876 67899999999999999999999999654310 0000 00
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.+. . ....+.+ .+..+..+.++|.+||..+|++|||+.++++
T Consensus 219 ~~~--------~--~~~~~~~----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 219 KIE--------K--CDYPPLP----ADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred hhh--------c--CCCCCCC----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 000 0 0001111 1245678999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=314.93 Aligned_cols=244 Identities=22% Similarity=0.338 Sum_probs=191.0
Q ss_pred eeeccCceEEEEEEEc--CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEe
Q 010489 120 VIGKGSYGVVGSAVDT--HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 197 (509)
Q Consensus 120 ~lG~G~~g~V~~~~~~--~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 197 (509)
.||+|+||.||+|... ..+..||+|++.... .......+.+|+.+++.++||||+++++++.. ...++|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e 74 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVME 74 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEE
Confidence 4899999999999765 445679999886432 23344668899999999999999999998732 24799999
Q ss_pred ccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccc
Q 010489 198 LME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (509)
Q Consensus 198 ~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 275 (509)
|++ ++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++............
T Consensus 75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 998 588888864 457999999999999999999999999999999999999999999999999999754332221111
Q ss_pred ccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHH
Q 010489 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354 (509)
Q Consensus 276 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (509)
.....++..|+|||.+.. ..++.++|||||||++|||++ |..||.+....+....+..
T Consensus 155 ~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------------- 213 (257)
T cd05115 155 RSAGKWPLKWYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ------------------- 213 (257)
T ss_pred cCCCCCCcccCCHHHHcc--CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-------------------
Confidence 122234578999999876 678999999999999999996 9999987654332222211
Q ss_pred HhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 355 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..... ..+.+++++.++|.+||..||++||++.++++
T Consensus 214 --------~~~~~---~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 214 --------GKRLD---CPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred --------CCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00000 11346788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=318.73 Aligned_cols=267 Identities=24% Similarity=0.415 Sum_probs=199.3
Q ss_pred CCeeEeeeeeccCceEEEEEE----EcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~----~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
.+|++.+.||+|+||.||+|. +..++..||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--- 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC---
Confidence 479999999999999999997 4457889999998642 2344567889999999999999999999875432
Q ss_pred CCcEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 189 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
...+|+||||++ ++|.+++... ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 245899999997 6899998764 46899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCCh--hH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST--ES 344 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~--~~ 344 (509)
..............++..|+|||++.+ ..++.++|||||||++|||++|..|+..... ... ...+.... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~----~~~~~~~~~~~~ 231 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFM----RMMGNDKQGQMI 231 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhcc--CCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhh----hhcccccccccc
Confidence 332221111112234556999999876 6789999999999999999999877643321 111 11111100 00
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
... .... +......+ ....++..+.+||.+||..+|++|||+.++++
T Consensus 232 ~~~-----~~~~---~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 232 VYH-----LIEL---LKNNGRLP---APPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hHH-----HHHH---HhcCCcCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 000 0001 11111111 12356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=322.32 Aligned_cols=258 Identities=23% Similarity=0.374 Sum_probs=197.2
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCC--------------cEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceee
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTG--------------ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~--------------~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~ 178 (509)
.+|++.+.||+|+||.||+|.+..++ ..||+|+++... .......+.+|+++++.++|+||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 58999999999999999999875432 359999986432 233445688999999999999999999
Q ss_pred eeecCCCcCCCCcEEEEEeccc-ccHHHHHHhCC------------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCC
Q 010489 179 HIMLPPSRREFKDIYVVFELME-SDLHQVIKAND------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPK 245 (509)
Q Consensus 179 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~ 245 (509)
+++... ...|+||||+. ++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+
T Consensus 84 ~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 158 (295)
T cd05097 84 GVCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATR 158 (295)
T ss_pred EEEcCC-----CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChh
Confidence 998543 45899999998 58888885432 3688899999999999999999999999999999
Q ss_pred cEEECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh--CCCCCCC
Q 010489 246 NILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT--GKPLFPG 323 (509)
Q Consensus 246 NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~--g~~pf~~ 323 (509)
|||++.++.+||+|||++......... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||..
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcce-eccCcCcCceeecChhhhcc--CCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999999764322211 11122355778999999876 678999999999999999988 5678876
Q ss_pred CChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 324 KNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 324 ~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.+....+..+.... ..... .......+..++.+.+|+.+||+.||++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~--------------------~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 236 LSDEQVIENTGEFF--------------------RNQGR---QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cChHHHHHHHHHhh--------------------hhccc---cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 55433322221110 00000 0001112345788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=320.29 Aligned_cols=250 Identities=23% Similarity=0.357 Sum_probs=198.2
Q ss_pred CCeeEeeeeeccCceEEEEEEE-----cCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
.+|++.++||+|+||.||+|.. ..++..+|+|.+... .......+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG--- 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC---
Confidence 5788999999999999999964 235678999988642 234456788999999999999999999988543
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhCC---------------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC
Q 010489 188 EFKDIYVVFELME-SDLHQVIKAND---------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 251 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~~---------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~ 251 (509)
...|++|||++ ++|.+++...+ .+++..+..++.||+.||+|||+.||+||||||+|||++.
T Consensus 80 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~ 157 (280)
T cd05092 80 --RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ 157 (280)
T ss_pred --CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC
Confidence 44899999998 58988887543 4889999999999999999999999999999999999999
Q ss_pred CCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHH
Q 010489 252 DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQL 330 (509)
Q Consensus 252 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~ 330 (509)
++.+||+|||++......... .......+++.|+|||.+.+ ..++.++|||||||++|||++ |.+||......+..
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 234 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILY--RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234 (280)
T ss_pred CCCEEECCCCceeEcCCCcee-ecCCCccccccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH
Confidence 999999999999754322211 11122345788999999877 678999999999999999998 89999765543322
Q ss_pred HHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 331 DLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 331 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..+.. ..+. .....+++.+.+||.+||+.||.+||++.++++
T Consensus 235 ~~~~~---------------------------~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 235 ECITQ---------------------------GREL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHc---------------------------CccC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 22111 0000 011246788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=324.30 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=196.9
Q ss_pred CCeeEeeeeeccCceEEEEEEEcC-------CCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTH-------TGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPP 184 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~-------~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~ 184 (509)
++|.+.+.||+|+||.||+|.+.. +...||+|.++... .......+.+|+.+++.+ +||||+++++++...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 579999999999999999998643 23579999987432 234456788899999999 799999999998443
Q ss_pred CcCCCCcEEEEEeccc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcE
Q 010489 185 SRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI 247 (509)
Q Consensus 185 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NI 247 (509)
..+|+||||++ ++|.+++.... .+++..+..++.|++.||+|||+.|++||||||+||
T Consensus 97 -----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 97 -----GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred -----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 45899999998 58999997542 488899999999999999999999999999999999
Q ss_pred EECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCCh
Q 010489 248 LANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNV 326 (509)
Q Consensus 248 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~ 326 (509)
|++.++.+||+|||+++......... ......+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+...
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYK-KTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhh-ccccCCCccceeChHHhcc--CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 99999999999999987543211110 0112234578999999876 678999999999999999998 8899976553
Q ss_pred HhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 327 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 327 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.+....+.. .... .....++.++.+|+.+||..+|.+||++.++++
T Consensus 249 ~~~~~~~~~---------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 249 EELFKLLKE---------------------------GHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred HHHHHHHHc---------------------------CCCC---CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 222221110 0000 111346788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=318.97 Aligned_cols=268 Identities=24% Similarity=0.336 Sum_probs=197.3
Q ss_pred CCe-eEeeeeeccCceEEEEEE----EcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 113 SRY-QIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 113 ~~y-~i~~~lG~G~~g~V~~~~----~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
++| ++++.||+|+||+||++. ...++..||+|.++... .......+.+|+.+|+.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 78 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ--- 78 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence 355 999999999999998764 34578899999986432 123446678999999999999999999987432
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 188 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
....+|+||||+. ++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 2345899999998 5788888654 6999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
..............++..|+|||.+.+ ..++.++|||||||++|||++|..||...... ....+....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~--- 231 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKE--NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVV--- 231 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcc--cCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchh---
Confidence 432221111122345677999999876 67899999999999999999999998653311 000000000000000
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
......... ...+ ....++..+.+++.+||..||++|||++++++
T Consensus 232 -----~~~~~~~~~-~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 232 -----RLIELLERG-MRLP-----CPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred -----hhhhhhhcC-CCCC-----CCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000000000 0111 11346788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=330.83 Aligned_cols=255 Identities=25% Similarity=0.437 Sum_probs=196.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEE-----cCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~ 185 (509)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++... .......+.+|+.+|..+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-
Confidence 46899999999999999999974 3567899999986432 223456788999999999 689999999987532
Q ss_pred cCCCCcEEEEEeccc-ccHHHHHHhC------------------------------------------------------
Q 010489 186 RREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 210 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~-~~L~~~l~~~------------------------------------------------------ 210 (509)
...+++|||||+ |+|.+++...
T Consensus 84 ---~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 84 ---GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ---CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 245899999998 5888887642
Q ss_pred -------------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccccc
Q 010489 211 -------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT 277 (509)
Q Consensus 211 -------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~ 277 (509)
..+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||++......... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~ 239 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKG 239 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch-hhcC
Confidence 13677888899999999999999999999999999999999999999999999764322211 1112
Q ss_pred ccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHh
Q 010489 278 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 356 (509)
Q Consensus 278 ~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 356 (509)
...+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.......... +.
T Consensus 240 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~--------------~~------- 296 (343)
T cd05103 240 DARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR--------------LK------- 296 (343)
T ss_pred CCCCCcceECcHHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH--------------Hh-------
Confidence 2345678999999876 678999999999999999997 99999764321111100 00
Q ss_pred hhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 357 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
.. ...+.+ ...++.+.+++.+||..||++||++.++++|
T Consensus 297 -~~--~~~~~~-----~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 297 -EG--TRMRAP-----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred -cc--CCCCCC-----CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00 000000 1256789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=317.64 Aligned_cols=253 Identities=26% Similarity=0.426 Sum_probs=200.7
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|++.+.||+|+||.||+|.+..++..||||.+.... ........+.+|+.+++.+.||||+++++++... ..
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----NE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC-----Ce
Confidence 46899999999999999999999999999999886422 2233456788999999999999999999988543 45
Q ss_pred EEEEEecccc-cHHHHHHh----CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 192 IYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 192 ~~lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
.+++|||+++ +|.+++.. ...+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 8999999984 88887753 346899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
..... ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+..... ... ..
T Consensus 157 ~~~~~---~~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~------------~~ 218 (267)
T cd08229 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSL------------CK 218 (267)
T ss_pred ccCCc---ccccccCCcCccCHHHhcC--CCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHH------------hh
Confidence 33221 1234578999999999876 678899999999999999999999997643210 000 00
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
. +... ...+ ......++.+.+||.+||..||++|||+.++++
T Consensus 219 ~---------~~~~-~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 219 K---------IEQC-DYPP----LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred h---------hhcC-CCCC----CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 0 0000 0001 111246788999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=326.25 Aligned_cols=282 Identities=31% Similarity=0.534 Sum_probs=226.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC------CCCcceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR------HPDIVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~------h~niv~~~~~~~~~~ 185 (509)
.++|.+....|+|-|++|.+|.+...|..||||+|... ..-.+.=++|+.||++|+ .-++++++..|
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F---- 503 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF---- 503 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh----
Confidence 57899999999999999999999999999999999642 223345578999999996 24677877776
Q ss_pred cCCCCcEEEEEecccccHHHHHHhCC---CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC-CCeEEeeec
Q 010489 186 RREFKDIYVVFELMESDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFG 261 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~~~L~~~l~~~~---~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~-~~vkl~DFG 261 (509)
...+++|||+|-+.-+|.+++++-+ .|....+..++.|+.-||..|-.+||+|.||||+||||++. ..+||||||
T Consensus 504 -~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 504 -KHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred -hhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence 4456799999999999999998755 58889999999999999999999999999999999999975 458999999
Q ss_pred ccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCC
Q 010489 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341 (509)
Q Consensus 262 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~ 341 (509)
.|....... .+.|..++.|.|||++.| -.|+...|+||+||+||||.||+..|+|.+..+++.+...+-|..+
T Consensus 583 SA~~~~ene-----itPYLVSRFYRaPEIiLG--~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 583 SASFASENE-----ITPYLVSRFYRAPEIILG--LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred ccccccccc-----ccHHHHHHhccCcceeec--CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 997654332 366788999999999999 6999999999999999999999999999999999999999999988
Q ss_pred hhHHHHhhhHHH--H---Hhh-------------hccCCCCC-CCCC------CCCC----CCCHHHHHHHHHhccCCCC
Q 010489 342 TESISRIRNEKA--R---RYL-------------GSMRKKQP-VPFS------HKFP----NADPLALHLLERLLAFDPK 392 (509)
Q Consensus 342 ~~~~~~~~~~~~--~---~~~-------------~~~~~~~~-~~~~------~~~~----~~~~~~~~li~~~L~~dP~ 392 (509)
..++.+-..... . .|+ ..|....| ..+. ..++ ..-..+.+||.+||..||+
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~ 735 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE 735 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence 887765432110 0 000 00111111 0010 0111 1224578999999999999
Q ss_pred CCCCHHHHhcCCcccC
Q 010489 393 DRPTAEEALADPYFHG 408 (509)
Q Consensus 393 ~Rpt~~e~l~hp~f~~ 408 (509)
+|.|+.++|+||||..
T Consensus 736 KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 736 KRITVNQALKHPFITE 751 (752)
T ss_pred hcCCHHHHhcCCcccC
Confidence 9999999999999963
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=314.55 Aligned_cols=246 Identities=27% Similarity=0.390 Sum_probs=196.0
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++.+.||+|+||.||+|.+..+ ..+|+|.+.... .....+.+|+.+++.++|+|++++++++.. ...
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~ 75 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE------EPI 75 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC------CCc
Confidence 5799999999999999999987654 469999875321 223567889999999999999999988732 237
Q ss_pred EEEEeccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 193 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
|+||||+. ++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 99999998 58999987543 4889999999999999999999999999999999999999999999999999765322
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... ......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+....+...
T Consensus 156 ~~~--~~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~------------ 219 (260)
T cd05069 156 EYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG------------ 219 (260)
T ss_pred ccc--ccCCCccchhhCCHHHhcc--CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------------
Confidence 211 1123346778999998876 678999999999999999999 89999876543333222110
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
...+ .....+..+.+|+.+||..||++||+++++++
T Consensus 220 ---------------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 220 ---------------YRMP---CPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ---------------CCCC---CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0001 11245778999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=318.32 Aligned_cols=248 Identities=27% Similarity=0.444 Sum_probs=193.2
Q ss_pred eEeeeeeccCceEEEEEEEc----CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 116 QIQEVIGKGSYGVVGSAVDT----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 116 ~i~~~lG~G~~g~V~~~~~~----~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.+.+.||.|+||.||+|... ..+..|+||.++.. ........+.+|++++++++||||+++++++... ..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-----~~ 75 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-----EP 75 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-----SS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccc-----cc
Confidence 46789999999999999877 45678999999642 3334578899999999999999999999999733 33
Q ss_pred EEEEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 192 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
+++|||||. |+|.+++... ..+++..+..|+.||++||.|||+.+|+|+||+++|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 899999998 6899999886 6899999999999999999999999999999999999999999999999999986522
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
.... .......+...|+|||.+.. ..++.++||||||+++|||++ |+.||...+..+....+.+..
T Consensus 156 ~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~---------- 222 (259)
T PF07714_consen 156 KSKY-KNDSSQQLPLRYLAPEVLKD--GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ---------- 222 (259)
T ss_dssp SSSE-EESTTSESGGGGS-HHHHHH--SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE----------
T ss_pred cccc-cccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccc----------
Confidence 2111 11233456788999999877 568999999999999999999 689997765443333221110
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..+ ....++..+.++|.+||..||++||++.++++
T Consensus 223 ---------------~~~-----~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 223 ---------------RLP-----IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ---------------ETT-----SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ---------------cce-----eccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 000 11246788999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=313.47 Aligned_cols=242 Identities=22% Similarity=0.402 Sum_probs=195.4
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
.+|++.+.||+|+||.||++... |..||+|.++.. ...+.+.+|+.+++.++|++++++++++... ....
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~ 75 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGL 75 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCce
Confidence 57999999999999999999754 788999988532 2345688999999999999999999876432 2458
Q ss_pred EEEEeccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 193 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
|++|||++ ++|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999998 58999987654 4889999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
. ....++..|+|||++.+ ..++.++|||||||++|||++ |+.||...+..+....+..
T Consensus 156 ~------~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~------------- 214 (256)
T cd05082 156 Q------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------- 214 (256)
T ss_pred C------CCCccceeecCHHHHcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-------------
Confidence 1 22345678999999876 678999999999999999997 9999976543222211110
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..+. ...+.+++.+.+++.+||..||++|||+.++++
T Consensus 215 --------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 215 --------------GYKM---DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred --------------CCCC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0000 112356788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=314.45 Aligned_cols=248 Identities=26% Similarity=0.419 Sum_probs=199.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||+|+||.||+|.+. .+..||||.+.... .....+.+|+.+++.++|+||+++++++.. ...
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 75 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-----EEP 75 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeec-----CCc
Confidence 468999999999999999999875 45789999986422 234568899999999999999999998743 345
Q ss_pred EEEEEeccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 192 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
.++||||++ ++|.+++.... .+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++.....
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 899999998 58999987643 689999999999999999999999999999999999999999999999999876532
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
.... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+....
T Consensus 156 ~~~~--~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~---------- 221 (261)
T cd05034 156 DEYT--AREGAKFPIKWTAPEAANY--GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY---------- 221 (261)
T ss_pred hhhh--hhhccCCCccccCHHHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 2111 0112234568999999876 678999999999999999998 999998766544333322110
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..+. ....+..+.+++.+||..||++||+++++++
T Consensus 222 ---------------~~~~-----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 222 ---------------RMPR-----PPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ---------------CCCC-----CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0011 1234678999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=322.12 Aligned_cols=251 Identities=26% Similarity=0.428 Sum_probs=197.3
Q ss_pred CCeeEeeeeeccCceEEEEEEEcC-------CCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTH-------TGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPP 184 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~-------~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~ 184 (509)
.+|.+.+.||+|+||.||+|.+.. ....||+|.++... .......+.+|+.+++.+ .||||+++++++...
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 589999999999999999997632 34579999886432 234456788999999999 599999999988433
Q ss_pred CcCCCCcEEEEEeccc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcE
Q 010489 185 SRREFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI 247 (509)
Q Consensus 185 ~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NI 247 (509)
..+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 91 -----~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 91 -----GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred -----CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 45899999998 6899988653 3488899999999999999999999999999999999
Q ss_pred EECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCCh
Q 010489 248 LANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNV 326 (509)
Q Consensus 248 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~ 326 (509)
|++.++.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+...
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYK-KTSNGRLPVKWMAPEALFD--RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred EEcCCCcEEEcccccccccccccccc-ccccCCCCccccCHHHHcc--CCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999997653221111 0112234567999999876 678999999999999999999 8899977654
Q ss_pred HhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 327 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 327 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.+....+.. .... .....++..+.+|+.+||..||++||++.++++
T Consensus 243 ~~~~~~~~~---------------------------~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 243 EELFKLLRE---------------------------GHRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHc---------------------------CCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 333222210 0000 011346778999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=320.91 Aligned_cols=265 Identities=16% Similarity=0.189 Sum_probs=192.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCC---CcEEEEEEecCcccChhh---------HHhHHHHHHHHHHcCCCCcceeee
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSD---------ATRILREIKLLRLLRHPDIVEIKH 179 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~---~~~vAiK~~~~~~~~~~~---------~~~~~~Ei~~l~~l~h~niv~~~~ 179 (509)
..+|++.+.||+|+||.||+|.+..+ +..+|+|+.......... ......+...+..+.|++|+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 35899999999999999999998777 667777764321111100 011223344456678999999998
Q ss_pred eecCCCcCCCCcEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEee
Q 010489 180 IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 259 (509)
Q Consensus 180 ~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~D 259 (509)
+..... ......++++|++..++.+.+......++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|
T Consensus 91 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 91 CGSFKR-CRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred eeeEec-CCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence 764332 1122457899998888877777666678899999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCc----ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHH
Q 010489 260 FGLARVSFNDAPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTD 335 (509)
Q Consensus 260 FG~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 335 (509)
||+|+......... .......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+......+.....
T Consensus 170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred cCCceeeccCCcccccccccccccCCCccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 99998653222110 11123479999999999887 6799999999999999999999999987632211111000
Q ss_pred hcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 336 LLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 336 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
. .++..+.... ...+.+++.+.+++..||..+|++||++.++++
T Consensus 248 --------------~----~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 248 --------------C----DFIKRLHEGK-----IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred --------------H----HHHHHhhhhh-----hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0 0011111110 012345788999999999999999999999876
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=319.00 Aligned_cols=264 Identities=23% Similarity=0.390 Sum_probs=204.6
Q ss_pred CeeEeeeeeccCceEEEEEEEc---CCCcEEEEEEecCccc--ChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcC
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFE--HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~~--~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~ 187 (509)
+|++.+.||+|+||.||+|.+. .++..||||.+++... .......+.+|+.++..+ .||+|+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~---- 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT---- 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec----
Confidence 4889999999999999999854 4678999999864211 122345678899999999 59999999988743
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 188 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
...+|+||||+. ++|.+++.....+++..++.++.|+++||.|||+.|++||||||+||+++.++.++|+|||+++..
T Consensus 77 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 77 -DTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred -CCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 345899999998 589999887778999999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
...... ......|+..|+|||.+.+.....+.++||||||+++|||++|..||...........+.
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~------------ 221 (288)
T cd05583 156 LAEEEE--RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEIS------------ 221 (288)
T ss_pred cccccc--ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHH------------
Confidence 332211 112356899999999986632347889999999999999999999996433211111000
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC---HHHHhcCCcccCCcC
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT---AEEALADPYFHGLAN 411 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~f~~~~~ 411 (509)
..... ...+. ....++.+.++|.+||+.||++||| +.++|+||||+.+.+
T Consensus 222 -------~~~~~---~~~~~-----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 222 -------RRILK---SKPPF-----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred -------HHHHc---cCCCC-----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 00000 01111 1235778999999999999999998 577899999987654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=314.81 Aligned_cols=252 Identities=29% Similarity=0.491 Sum_probs=200.2
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc---ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE---HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
+|.+.+.||+|+||.||++.+..++..+++|+++.... .......+.+|+.+++.++||||+++++.+... .
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-----D 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-----C
Confidence 68999999999999999999988888788887654221 122344567899999999999999999988543 3
Q ss_pred cEEEEEeccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 191 DIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
..++||||++ ++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++. +.+||+|||++..
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceee
Confidence 5899999998 478777753 357999999999999999999999999999999999999975 6799999999876
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
....... .....|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.........+..
T Consensus 155 ~~~~~~~---~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~---------- 219 (260)
T cd08222 155 LMGSCDL---ATTFTGTPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE---------- 219 (260)
T ss_pred cCCCccc---ccCCCCCcCccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc----------
Confidence 5432221 234568899999998866 6788899999999999999999999976553222211110
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
...+ ......+.++.++|.+||..||++||++.++++||||
T Consensus 220 ----------------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 220 ----------------GPTP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ----------------CCCC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 0000 0112457789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=320.94 Aligned_cols=252 Identities=25% Similarity=0.413 Sum_probs=198.6
Q ss_pred CCCeeEeeeeeccCceEEEEEEEc-------CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDT-------HTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLP 183 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~-------~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~ 183 (509)
..+|.+.+.||+|+||.||+|++. ..+..||+|.+.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 457999999999999999999753 234579999886432 234456788999999999 79999999998844
Q ss_pred CCcCCCCcEEEEEeccc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCc
Q 010489 184 PSRREFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 246 (509)
Q Consensus 184 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~N 246 (509)
. ...|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 93 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 93 D-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred C-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 3 45899999998 5899888653 247788899999999999999999999999999999
Q ss_pred EEECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCC
Q 010489 247 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 325 (509)
Q Consensus 247 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~ 325 (509)
||++.++.+||+|||+++......... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+..
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYK-KTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccc-cccCCCCCceeeCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999999999999999997653322111 1123356778999999876 678999999999999999998 788997765
Q ss_pred hHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 326 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..+....+.. .... .....++..+.+|+.+||..+|.+||++.++++
T Consensus 245 ~~~~~~~~~~---------------------------~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 245 VEELFKLLKE---------------------------GHRM---DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred HHHHHHHHHc---------------------------CCcC---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 4333222210 0000 011346788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=319.96 Aligned_cols=252 Identities=26% Similarity=0.409 Sum_probs=198.2
Q ss_pred CCeeEeeeeeccCceEEEEEEE-----cCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~ 186 (509)
++|.+.+.||+|+||.||+|.+ ..++..||+|.++... .......+.+|+.+++++ +||||+++++++...
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 111 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIG-- 111 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC--
Confidence 5799999999999999999975 3355689999886532 233456788999999999 799999999988543
Q ss_pred CCCCcEEEEEeccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccc
Q 010489 187 REFKDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 263 (509)
Q Consensus 187 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 263 (509)
..+|+||||+. ++|.+++.... .+++..+..++.|++.||.|||+++|+|+||||+|||++.++.+||+|||++
T Consensus 112 ---~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 ---GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ---CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 45899999998 68999887543 3899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCCh
Q 010489 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPST 342 (509)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~ 342 (509)
+........ .......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+...........
T Consensus 189 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~-------- 257 (302)
T cd05055 189 RDIMNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI-------- 257 (302)
T ss_pred ccccCCCce-eecCCCCcccccCCHhhhcc--CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH--------
Confidence 755332211 11123356788999999876 678999999999999999998 999997654322111110
Q ss_pred hHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
. ..... ......++.+.+|+.+||..+|++|||+.++++
T Consensus 258 ---------------~---~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 258 ---------------K---EGYRM---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred ---------------H---cCCcC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0 00000 011235788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=316.99 Aligned_cols=267 Identities=25% Similarity=0.391 Sum_probs=200.6
Q ss_pred CeeEeeeeeccCceEEEEEEE----cCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 114 RYQIQEVIGKGSYGVVGSAVD----THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~----~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
-|++++.||+|+||.||+|.. ..++..||+|.++... .......+.+|+.+++.+.||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG 80 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence 478999999999999999973 4678899999986432 233456788999999999999999999988543 12
Q ss_pred CcEEEEEeccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 190 KDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
...++||||++ ++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 45899999997 58999886653 68999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChh-HHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE-SIS 346 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~-~~~ 346 (509)
.............|+..|+|||++.+ ..++.++|||||||++|||+++..|+..... ...+..+....+ ...
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~ellt~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 233 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQ--SKFYIASDVWSFGVTLYELLTYCDSESSPMT-----LFLKMIGPTHGQMTVT 233 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhcc--CCCCccccchhhhhhhhhhhcCCCCCccccc-----hhhhhcccccccccHH
Confidence 33221111234567778999999876 6789999999999999999998876533211 111111111111 000
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
. ....+ ...... .....++..+.+|+.+||+.||++||++.++++
T Consensus 234 ~-----~~~~~---~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 234 R-----LVRVL---EEGKRL---PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred H-----HHHHH---HcCccC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0 00011 111111 112457889999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=318.60 Aligned_cols=250 Identities=23% Similarity=0.388 Sum_probs=195.4
Q ss_pred CeeEeeeeeccCceEEEEEEEcC-----CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++.++||||+++++.+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 74 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ----- 74 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----
Confidence 47889999999999999998653 23578888876432 22345678899999999999999999998843
Q ss_pred CCcEEEEEeccc-ccHHHHHHhC------------------------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCC
Q 010489 189 FKDIYVVFELME-SDLHQVIKAN------------------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 243 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~------------------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlK 243 (509)
....|++|||+. ++|.+++... ..+++..+..++.|++.||+|||+.||+|||||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik 154 (290)
T cd05045 75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA 154 (290)
T ss_pred CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence 345899999998 6888887542 247888999999999999999999999999999
Q ss_pred CCcEEECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCC
Q 010489 244 PKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFP 322 (509)
Q Consensus 244 p~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~ 322 (509)
|+|||++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHcc--CCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999999764322211 11122345678999998876 678999999999999999998 999998
Q ss_pred CCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 323 GKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 323 ~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
+.........+... . ..+ ....++..+.+|+.+||+.||++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~-----------------------~--~~~-----~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 232 GIAPERLFNLLKTG-----------------------Y--RME-----RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCCHHHHHHHHhCC-----------------------C--CCC-----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 76543222211100 0 000 11246788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=324.14 Aligned_cols=252 Identities=26% Similarity=0.420 Sum_probs=197.7
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCC-------CcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHT-------GERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPP 184 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~ 184 (509)
.+|++++.||+|+||.||+|.+... +..||+|.++.. ........+.+|+.+++++ +||||+++++++..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-
Confidence 4799999999999999999986432 236899987643 2234456788999999999 79999999999854
Q ss_pred CcCCCCcEEEEEeccc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcE
Q 010489 185 SRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI 247 (509)
Q Consensus 185 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NI 247 (509)
...+|++|||++ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 90 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 90 ----DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 345899999998 58999886532 477888999999999999999999999999999999
Q ss_pred EECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCCh
Q 010489 248 LANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNV 326 (509)
Q Consensus 248 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~ 326 (509)
|++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEcCCCcEEECCcccceeccccccc-ccccCCCcCceEcCHHHhcc--CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999764322111 11122344578999999877 678999999999999999998 8899987654
Q ss_pred HhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 327 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 327 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
.+....+.. .... .....++..+.+|+.+||..+|.+||++.+++++
T Consensus 243 ~~~~~~~~~---------------------------~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 243 EELFKLLKE---------------------------GHRM---DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHc---------------------------CCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 333322211 0000 0112457789999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=310.34 Aligned_cols=245 Identities=30% Similarity=0.478 Sum_probs=201.5
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEecc
Q 010489 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM 199 (509)
Q Consensus 121 lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 199 (509)
||.|+||.||+|.+..+++.||+|.+..... .......+..|+.+++.++|+||+++++.+. ....+|+||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ-----TEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee-----cCCeeEEEEecC
Confidence 6999999999999988999999999865322 2234567889999999999999999998874 345689999999
Q ss_pred c-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCcccccc
Q 010489 200 E-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD 278 (509)
Q Consensus 200 ~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 278 (509)
+ ++|.+++.....+++..+..++.|+++||.|||+.+++|+||||+||+++.++.++|+|||++........ ....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~ 152 (250)
T cd05123 76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNT 152 (250)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC---cccC
Confidence 5 79999998888899999999999999999999999999999999999999999999999999976543321 1234
Q ss_pred cccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhh
Q 010489 279 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLG 358 (509)
Q Consensus 279 ~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 358 (509)
..++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+..
T Consensus 153 ~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~----------------------- 207 (250)
T cd05123 153 FCGTPEYLAPEVLLG--KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK----------------------- 207 (250)
T ss_pred CcCCccccChHHhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-----------------------
Confidence 578899999999876 5678899999999999999999999976553221111110
Q ss_pred ccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH---HHHhcCCcc
Q 010489 359 SMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA---EEALADPYF 406 (509)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~---~e~l~hp~f 406 (509)
...+ .....+..+.++|++||..||++||++ +++++||||
T Consensus 208 ---~~~~-----~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 208 ---DPLR-----FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ---CCCC-----CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 0000 112347789999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=311.53 Aligned_cols=246 Identities=23% Similarity=0.366 Sum_probs=196.4
Q ss_pred eeeeccCceEEEEEEEcC-CCc--EEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEE
Q 010489 119 EVIGKGSYGVVGSAVDTH-TGE--RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 195 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~-~~~--~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 195 (509)
+.||+|++|.||+|.+.. .+. .||||.+...... ...+.+.+|+.++++++||||+++++.+.. ..+++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEE
Confidence 468999999999998765 333 6999998754332 456788899999999999999999998854 458999
Q ss_pred Eeccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCC
Q 010489 196 FELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (509)
Q Consensus 196 ~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 272 (509)
|||++ ++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99997 68999987754 6899999999999999999999999999999999999999999999999999875432221
Q ss_pred cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
........++..|+|||.+.+ ..++.++|||||||++|||++ |..||...+..+....+...
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~--------------- 216 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRT--RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE--------------- 216 (257)
T ss_pred eecccCCCCCceecCHHHhcc--cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc---------------
Confidence 111123457788999999876 678999999999999999998 99999766544333222110
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
....+ .....+..+.+++.+||..+|++||++.++++
T Consensus 217 ---------~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 217 ---------GERLE-----RPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ---------CCcCC-----CCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 00000 01235678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=314.96 Aligned_cols=253 Identities=21% Similarity=0.356 Sum_probs=200.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcC----CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTH----TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~----~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+... ........+.+|+.+++.+.||||+++++++...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--- 80 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED--- 80 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC---
Confidence 4689999999999999999999876 3578999988643 2334567788999999999999999999987543
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhC--------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEe
Q 010489 188 EFKDIYVVFELME-SDLHQVIKAN--------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 258 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~--------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~ 258 (509)
....++++||++ ++|.+++... ..+++..+..++.||+.||+|||+.+++||||||+|||++.++.+||+
T Consensus 81 -~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 81 -GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred -CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence 234799999998 6898888653 358999999999999999999999999999999999999999999999
Q ss_pred eecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhc
Q 010489 259 DFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLL 337 (509)
Q Consensus 259 DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~ 337 (509)
|||+++......... ......++..|+|||++.+ ..++.++|||||||++||+++ |+.||...+..+....+..
T Consensus 160 d~g~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-- 234 (280)
T cd05043 160 DNALSRDLFPMDYHC-LGDNENRPVKWMALESLVN--KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD-- 234 (280)
T ss_pred CCCCcccccCCceEE-eCCCCCcchhccCHHHHhc--CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc--
Confidence 999998653322111 1122346778999999876 678999999999999999998 9999977554222111110
Q ss_pred CCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..... ....+++.+.+++.+||..||++|||+.++++
T Consensus 235 -------------------------~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 235 -------------------------GYRLA---QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred -------------------------CCCCC---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00000 11245788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=310.22 Aligned_cols=243 Identities=25% Similarity=0.429 Sum_probs=198.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
..+|++.+.||.|+||.||+|... |+.||+|.++.... ..+++.+|+.+++.++|+||+++++++.. ...
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 74 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNP 74 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCC
Confidence 357899999999999999999764 88999999975322 45778899999999999999999999854 345
Q ss_pred EEEEEeccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 192 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
.|+||||++ ++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||.++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc
Confidence 899999998 59999987665 699999999999999999999999999999999999999999999999999986522
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
.. ....++..|+|||.+.. ..++.++|||||||++|||++ |..||......+....+..
T Consensus 155 ~~------~~~~~~~~~~ape~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~------------ 214 (256)
T cd05039 155 GQ------DSGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK------------ 214 (256)
T ss_pred cc------ccCCCcccccCchhhcC--CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc------------
Confidence 11 12244567999999876 678899999999999999997 9999976543222111100
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.... ......++.+.++|.+||..+|++||++.++++
T Consensus 215 ---------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 215 ---------------GYRM---EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ---------------CCCC---CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0000 011245788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=317.19 Aligned_cols=258 Identities=22% Similarity=0.371 Sum_probs=195.3
Q ss_pred CCeeEeeeeeccCceEEEEEEEcC----------------CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcce
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTH----------------TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVE 176 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~----------------~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~ 176 (509)
++|++.+.||+|+||.||+|.+.. ++..||+|.+... ........+.+|+.+++.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 579999999999999999985432 3457999998643 22334567889999999999999999
Q ss_pred eeeeecCCCcCCCCcEEEEEeccc-ccHHHHHHhCC-----------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCC
Q 010489 177 IKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND-----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKP 244 (509)
Q Consensus 177 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp 244 (509)
+++++... ...|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+.||+||||||
T Consensus 84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp 158 (296)
T cd05095 84 LLAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLAT 158 (296)
T ss_pred EEEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCCh
Confidence 99998543 34899999998 68998886542 367788999999999999999999999999999
Q ss_pred CcEEECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh--CCCCCC
Q 010489 245 KNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT--GKPLFP 322 (509)
Q Consensus 245 ~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~--g~~pf~ 322 (509)
+|||++.++.++|+|||+++......... ......+++.|+|||...+ ..++.++|||||||++|||++ |..||.
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYR-IQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCccee-ccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 99999999999999999997643322111 1122345678999998766 678999999999999999998 678887
Q ss_pred CCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 323 GKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 323 ~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..+..+....... +.......... ...+.+++.+.+|+.+||..||++||++.++++
T Consensus 236 ~~~~~~~~~~~~~--------------------~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 236 QLSDEQVIENTGE--------------------FFRDQGRQVYL---PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ccChHHHHHHHHH--------------------HHhhccccccC---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6544322211100 00000000000 011345688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=320.65 Aligned_cols=268 Identities=27% Similarity=0.438 Sum_probs=210.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccC-----hhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH-----VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 186 (509)
..+|-++..||+|||+.||+|.+....++||+|+-.....+ ....+...+|.+|.+.|.||.||++|++|..+.
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt- 540 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT- 540 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc-
Confidence 46899999999999999999999999999999974321111 123456789999999999999999999996443
Q ss_pred CCCCcEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhC--CeeecCCCCCcEEECC---CCCeEEeee
Q 010489 187 REFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--NVFHRDLKPKNILANA---DCKLKICDF 260 (509)
Q Consensus 187 ~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~--~ivHrDlKp~NILl~~---~~~vkl~DF 260 (509)
..+|-|+|||+| +|.-+++.+..+++.+++.|+.||+.||.||... .|||-||||.|||+.. -|.+||+||
T Consensus 541 ---dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 541 ---DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ---ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 347999999997 7888888888999999999999999999999976 4999999999999854 478999999
Q ss_pred cccccccCCCCCcc----ccccccccccccccccccc--ccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHH
Q 010489 261 GLARVSFNDAPSAI----FWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMT 334 (509)
Q Consensus 261 G~a~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~ 334 (509)
|+++++.++..... ..+...||.||++||.+.- .....+.++||||+|||+|.++.|+.||..... +.+.+.
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdILq 695 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDILQ 695 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHHHh
Confidence 99998766544321 2345689999999996532 235678899999999999999999999965432 111110
Q ss_pred HhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 335 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 335 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
. .. .+ ....+.++ .-|.+++++++||++||++.-++|....++-.||||..
T Consensus 696 e-------NT-----------Il----kAtEVqFP-~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 696 E-------NT-----------IL----KATEVQFP-PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred h-------hc-----------hh----cceeccCC-CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 0 00 00 00111111 12467899999999999999999999999999999953
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=316.59 Aligned_cols=252 Identities=22% Similarity=0.324 Sum_probs=197.5
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcC-----CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 186 (509)
..+|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.+.||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~-- 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG-- 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--
Confidence 3579999999999999999998743 67899999986432 223346688999999999999999999988543
Q ss_pred CCCCcEEEEEeccc-ccHHHHHHhCC----------------------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCC
Q 010489 187 REFKDIYVVFELME-SDLHQVIKAND----------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 243 (509)
Q Consensus 187 ~~~~~~~lv~e~~~-~~L~~~l~~~~----------------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlK 243 (509)
...|+||||++ ++|.+++.... .+++..+..++.||+.||.|||+.|++|||||
T Consensus 81 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~ 157 (288)
T cd05050 81 ---KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA 157 (288)
T ss_pred ---CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 45899999998 58988886432 37788899999999999999999999999999
Q ss_pred CCcEEECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCC
Q 010489 244 PKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFP 322 (509)
Q Consensus 244 p~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~ 322 (509)
|+|||++.++.+||+|||++.......... ......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYK-ASENDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred HhheEecCCCceEECccccceecccCcccc-ccCCCccChhhcCHHHHhc--CCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999987543222111 0122345677999999876 678999999999999999997 888997
Q ss_pred CCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 323 GKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 323 ~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
+.+..+....+.. ....+ .....+..+.+||.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~---------------------------~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 235 GMAHEEVIYYVRD---------------------------GNVLS---CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCCHHHHHHHHhc---------------------------CCCCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 6554332221110 00000 11245788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=311.13 Aligned_cols=249 Identities=25% Similarity=0.413 Sum_probs=198.6
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCC---CcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
.+|.+.+.||+|+||.||+|.+... ...||||...... .....+.+.+|+.+++.+.||||+++++++...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~----- 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN----- 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-----
Confidence 4689999999999999999987544 3578999876432 234456788999999999999999999987532
Q ss_pred CcEEEEEeccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 190 KDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
..|+||||++ ++|.+++.... .+++..+..++.|++.||+|||+.|++||||||+|||++.++.+||+|||+++...
T Consensus 80 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 80 -PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred -CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 3689999998 68999987644 58999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
..... ..+...++..|+|||.+.. ..++.++|||||||++|||++ |..||.+.+..+....+..
T Consensus 159 ~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~----------- 223 (270)
T cd05056 159 DESYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN----------- 223 (270)
T ss_pred cccce--ecCCCCccccccChhhhcc--CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-----------
Confidence 33111 1122344568999998876 678999999999999999996 9999987664433322211
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.... ...+.+++.+.++|.+||..+|.+|||+.+++.
T Consensus 224 ----------------~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 224 ----------------GERL---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred ----------------CCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000 112456788999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=330.05 Aligned_cols=252 Identities=25% Similarity=0.373 Sum_probs=197.0
Q ss_pred CCeeEeeeeeccCceEEEEEEEc-----CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSR 186 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~ 186 (509)
++|.+.+.||+|+||.||+|++. .++..||||+++.... ......+.+|+.+|..+. ||||+++++++...
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~-- 113 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTKG-- 113 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC--
Confidence 46889999999999999999853 3557899999975322 233456889999999997 99999999998543
Q ss_pred CCCCcEEEEEeccc-ccHHHHHHhCC------------------------------------------------------
Q 010489 187 REFKDIYVVFELME-SDLHQVIKAND------------------------------------------------------ 211 (509)
Q Consensus 187 ~~~~~~~lv~e~~~-~~L~~~l~~~~------------------------------------------------------ 211 (509)
..+|+|||||. |+|.+++...+
T Consensus 114 ---~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 114 ---GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ---CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 45899999998 68998886432
Q ss_pred --------------------------------------------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcE
Q 010489 212 --------------------------------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI 247 (509)
Q Consensus 212 --------------------------------------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NI 247 (509)
.+++..+..++.||+.||.|||+.+|+||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 356777888999999999999999999999999999
Q ss_pred EECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCCh
Q 010489 248 LANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNV 326 (509)
Q Consensus 248 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~ 326 (509)
|++.++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.....
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFN--NLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred EEeCCCEEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcC--CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 9999999999999999764322211 11123467889999999876 678999999999999999998 8899976443
Q ss_pred HhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 327 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 327 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.+.+..... ... .+ .....++.++.+|+.+||..||.+||++.++++
T Consensus 348 ~~~~~~~~~----------------------~~~---~~----~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 348 NEQFYNAIK----------------------RGY---RM----AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred hHHHHHHHH----------------------cCC---CC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 222111100 000 00 011246788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=312.32 Aligned_cols=256 Identities=25% Similarity=0.381 Sum_probs=202.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCc----EEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGE----RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~----~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
..+|++.+.||+|+||.||+|.++.+|. .||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS---- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence 3579999999999999999999876665 58999876432 23345678899999999999999999998854
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 188 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
...++||||++ ++|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 81 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 81 --SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred --CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 34799999998 6899988764 4699999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
........ ......++..|+|||.+.. ..++.++|+|||||++|||++ |+.||.+....+....+..
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------- 226 (279)
T cd05057 159 LDVDEKEY-HAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK--------- 226 (279)
T ss_pred ccCcccce-ecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC---------
Confidence 54322211 1112234568999998865 678899999999999999998 9999987654322221110
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
....+. ....+..+.+++.+||..||.+||++.++++ .|..+
T Consensus 227 ------------------~~~~~~---~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~--~l~~~ 268 (279)
T cd05057 227 ------------------GERLPQ---PPICTIDVYMVLVKCWMIDAESRPTFKELIN--EFSKM 268 (279)
T ss_pred ------------------CCCCCC---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH--HHHHH
Confidence 111111 1235678999999999999999999999987 55443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=311.42 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=186.6
Q ss_pred eeeeccCceEEEEEEEcC--CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEE
Q 010489 119 EVIGKGSYGVVGSAVDTH--TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 196 (509)
+.||+|+||.||+|.... ....+|+|.+... ........+.+|+.+++.++||||+++++.+... ..+|+||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~-----~~~~lv~ 74 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES-----IPYLLVL 74 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC-----CceEEEE
Confidence 369999999999996432 4457888877532 2233445678999999999999999999988543 4589999
Q ss_pred eccc-ccHHHHHHhCC-----CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 197 ELME-SDLHQVIKAND-----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 197 e~~~-~~L~~~l~~~~-----~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
||++ ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch
Confidence 9998 58999886643 24677889999999999999999999999999999999999999999999986532221
Q ss_pred CCcccccccccccccccccccccc-----cCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
.. .......+++.|+|||++... ...++.++|||||||++|||++ |..||......+.+..+...
T Consensus 155 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-------- 225 (269)
T cd05042 155 YY-ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE-------- 225 (269)
T ss_pred he-eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc--------
Confidence 11 011233567789999987431 1356889999999999999999 78899765543322221110
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.....+........++.+.+++..|| .||++|||++++++
T Consensus 226 -----------------~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 226 -----------------QDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred -----------------cCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 00011111122356788899999999 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=339.88 Aligned_cols=279 Identities=20% Similarity=0.253 Sum_probs=183.6
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCC----CcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCC-
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHT----GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS- 185 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~----~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~- 185 (509)
..++|++.+.||+|+||.||+|.+..+ +..||||++..... ......| .++...+.++..+...+....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 356899999999999999999999988 99999998853211 1111111 122222333433333322211
Q ss_pred cCCCCcEEEEEeccc-ccHHHHHHhCCC--------------------CCHHHHHHHHHHHHhHhhhhhhCCeeecCCCC
Q 010489 186 RREFKDIYVVFELME-SDLHQVIKANDD--------------------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKP 244 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~--------------------l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp 244 (509)
......+++||||++ ++|.+++..... ..+..+..++.||+.||+|||+.||+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 134456899999998 578888764321 12344678999999999999999999999999
Q ss_pred CcEEECC-CCCeEEeeecccccccCCCCCccccccccccccccccccccccc--------------------CCCCCcee
Q 010489 245 KNILANA-DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFF--------------------SKYTPAID 303 (509)
Q Consensus 245 ~NILl~~-~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------------------~~~~~~~D 303 (509)
+|||++. ++.+||+|||+|+....... .....++||+.|||||.+.... ..++.++|
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 9999986 58999999999975432221 1224578999999999653211 12445679
Q ss_pred eehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCC---CCCCCCCHHHH
Q 010489 304 IWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFS---HKFPNADPLAL 380 (509)
Q Consensus 304 iwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 380 (509)
|||||||||||+++..++ .+...++..+....+......... . ......... ......+..+.
T Consensus 362 VwSlGviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~---------~---~~~~~~~~~~~~~~~d~~~~~~~ 427 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDLVAWRKL---------V---EPRASPDLRRGFEVLDLDGGAGW 427 (566)
T ss_pred cHHHHHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcHHHHHHh---------h---ccccchhhhhhhhhccccchHHH
Confidence 999999999999976554 333333333333222221111100 0 000000000 11112244577
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 381 HLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 381 ~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
+||.+||++||++|||+.++|+||||++...
T Consensus 428 dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 428 ELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred HHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 9999999999999999999999999987544
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=307.93 Aligned_cols=247 Identities=29% Similarity=0.476 Sum_probs=198.9
Q ss_pred eEeeeeeccCceEEEEEEEcCCC----cEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 116 QIQEVIGKGSYGVVGSAVDTHTG----ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 116 ~i~~~lG~G~~g~V~~~~~~~~~----~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++.+.||.|+||.||+|.+...+ ..||+|+++... .......+..|+.+++.+.|+||+++++++... ..
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 75 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----EP 75 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----Ce
Confidence 56789999999999999998766 899999986432 222567788999999999999999999998544 45
Q ss_pred EEEEEeccc-ccHHHHHHhCCC--CCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 192 IYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~--l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
.|++|||+. ++|.+++..... +++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 899999998 589998876544 99999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
..... .....+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+.......+..
T Consensus 156 ~~~~~--~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~------------ 219 (258)
T smart00219 156 DDYYK--KKGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK------------ 219 (258)
T ss_pred ccccc--cccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc------------
Confidence 32111 112236789999998865 678999999999999999998 7899977554333222211
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.... ......+.++.+++.+||..||++|||+.++++
T Consensus 220 ---------------~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 220 ---------------GYRL---PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ---------------CCCC---CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 0000 011236788999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=328.38 Aligned_cols=256 Identities=23% Similarity=0.379 Sum_probs=203.9
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCc---E-EEEEEecC-cccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGE---R-VAIKKIND-VFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~---~-vAiK~~~~-~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
+-.+.++||+|+||.||+|.-+..+. . ||||..+. ..........+++|+++|+.++|||||+++|+......
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P-- 235 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP-- 235 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc--
Confidence 44567899999999999998665322 3 89999874 22445677889999999999999999999999966543
Q ss_pred CCcEEEEEeccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 189 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
+|||||+|. |+|.+++++.+ .++..+...++++.+.||+|||+++++||||-..|+|++.++.+||+|||+++..
T Consensus 236 ---l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 236 ---LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred ---cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 899999999 59999999887 4999999999999999999999999999999999999999999999999999754
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
....... ...--...|+|||.+.. ..|+.++|||||||++||+.+ |..||++....+....|..-
T Consensus 313 ~~~~~~~---~~~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~--------- 378 (474)
T KOG0194|consen 313 SQYVMKK---FLKKLPIRWLAPETLNT--GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN--------- 378 (474)
T ss_pred cceeecc---ccccCcceecChhhhcc--CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc---------
Confidence 2111100 01123467999999987 689999999999999999998 88899998865444433110
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
..+.+.+ ...+.++..++.+||..||++||++.++.+ +++.+.
T Consensus 379 -----------------~~r~~~~---~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~--~l~~~~ 421 (474)
T KOG0194|consen 379 -----------------GYRMPIP---SKTPKELAKVMKQCWKKDPEDRPTMSTIKK--KLEALE 421 (474)
T ss_pred -----------------CccCCCC---CCCHHHHHHHHHHhccCChhhccCHHHHHH--HHHHHH
Confidence 0000000 145677889999999999999999999987 665443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=341.44 Aligned_cols=250 Identities=26% Similarity=0.416 Sum_probs=203.2
Q ss_pred CCeeEeeeeeccCceEEEEEEEc-----CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
.+-+..+.||+|+||+||+|+-. .....||||.++... .....++|.||+.+|..|+|||||+++|+|..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~--- 561 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREG--- 561 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC---
Confidence 45677899999999999999643 234689999997642 233567899999999999999999999999554
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhCC----------C----CCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC
Q 010489 188 EFKDIYVVFELME-SDLHQVIKAND----------D----LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 252 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~~----------~----l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~ 252 (509)
+-+|+|+|||. |||.++|.... . |+..+...|+.||+.|++||-++.+|||||-..|+||.++
T Consensus 562 --~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 562 --DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred --CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence 44899999999 89999996432 2 7888999999999999999999999999999999999999
Q ss_pred CCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHH
Q 010489 253 CKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLD 331 (509)
Q Consensus 253 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~ 331 (509)
..|||+|||+++.......-.. .....-..+|||||.+.. ++++.++||||+||+|||+.+ |+.||.+-+..+-++
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~-~~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe 716 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKV-RGNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE 716 (774)
T ss_pred eEEEecccccchhhhhhhhhcc-cCCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence 9999999999987544332111 111233568999998876 799999999999999999997 899999887655555
Q ss_pred HHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHh
Q 010489 332 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401 (509)
Q Consensus 332 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 401 (509)
.|... . -.+ .-.++++++.+||..||..+|++||++.||-
T Consensus 717 ~i~~g---------------~----------lL~-----~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 717 CIRAG---------------Q----------LLS-----CPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHHcC---------------C----------ccc-----CCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 44321 0 011 1146889999999999999999999999984
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=311.75 Aligned_cols=242 Identities=25% Similarity=0.389 Sum_probs=189.0
Q ss_pred eeeeccCceEEEEEEEcCCCc--EEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCCCcEEEE
Q 010489 119 EVIGKGSYGVVGSAVDTHTGE--RVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVV 195 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~--~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv 195 (509)
+.||+|+||.||+|....++. .+|+|.++.. ........+.+|+.++.++ .||||+++++++... ..+|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv 74 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLA 74 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC-----CCceEE
Confidence 368999999999999888776 4688887632 2233456788999999999 799999999998543 458999
Q ss_pred Eeccc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEe
Q 010489 196 FELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 258 (509)
Q Consensus 196 ~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~ 258 (509)
|||+. ++|.+++.... .+++..+..++.|++.||+|||+.|++||||||+|||++.++.+||+
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~ 154 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 154 (270)
T ss_pred EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence 99998 68999886542 47899999999999999999999999999999999999999999999
Q ss_pred eecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhc
Q 010489 259 DFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLL 337 (509)
Q Consensus 259 DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~ 337 (509)
|||++........ ......+..|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus 155 dfgl~~~~~~~~~----~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~--- 225 (270)
T cd05047 155 DFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP--- 225 (270)
T ss_pred CCCCccccchhhh----ccCCCCccccCChHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh---
Confidence 9999863211110 111234567999999876 678999999999999999997 999997655322221110
Q ss_pred CCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..... .....++.++.+|+.+||..||.+|||+.++++
T Consensus 226 ------------------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 226 ------------------------QGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ------------------------CCCCC---CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 00000 011245778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=306.86 Aligned_cols=247 Identities=25% Similarity=0.400 Sum_probs=197.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||+|+||.||+|... .+..||+|.+... ......+.+|+.+++.++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~ 74 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EP 74 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CC
Confidence 468999999999999999999754 4567999988642 2234678899999999999999999998743 34
Q ss_pred EEEEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 192 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
.|++|||++ ++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 799999998 5899998763 3578889999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
.... ......++..|+|||++.. ..++.++|+|||||++|+|++ |..||.+.+..+....+..
T Consensus 155 ~~~~--~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~------------ 218 (260)
T cd05073 155 NEYT--AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER------------ 218 (260)
T ss_pred CCcc--cccCCcccccccCHhHhcc--CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC------------
Confidence 2111 1122345678999999876 678999999999999999998 9999987654333222211
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.... ......+.++.+++.+||..||++||++.++++
T Consensus 219 ---------------~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 219 ---------------GYRM---PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ---------------CCCC---CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0000 011346778999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=308.28 Aligned_cols=228 Identities=25% Similarity=0.349 Sum_probs=184.7
Q ss_pred cCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEeccc-cc
Q 010489 124 GSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SD 202 (509)
Q Consensus 124 G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~ 202 (509)
|.||.||+|++..+++.||+|++.... ...+|...+....||||+++++++.. ....|+||||++ ++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVS-----EDSVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheec-----CCeEEEEEecCCCCC
Confidence 899999999999999999999986421 12345555556679999999998843 346899999998 58
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCcccccccccc
Q 010489 203 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 282 (509)
Q Consensus 203 L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt 282 (509)
|.+++.....+++..+..++.|+++||.|||+.||+||||||+||+++.++.++|+|||.+...... .....++
T Consensus 72 L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~------~~~~~~~ 145 (237)
T cd05576 72 LWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS------CDGEAVE 145 (237)
T ss_pred HHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc------cccCCcC
Confidence 9999988778999999999999999999999999999999999999999999999999987654322 1234567
Q ss_pred cccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCC
Q 010489 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRK 362 (509)
Q Consensus 283 ~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 362 (509)
..|+|||.+.+ ..++.++||||+||++|||++|+.||...... +. .
T Consensus 146 ~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------------~~---------------~ 191 (237)
T cd05576 146 NMYCAPEVGGI--SEETEACDWWSLGAILFELLTGKTLVECHPSG-----------------IN---------------T 191 (237)
T ss_pred ccccCCcccCC--CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------------cc---------------c
Confidence 88999999876 67889999999999999999999887532110 00 0
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH-----HHHhcCCcc
Q 010489 363 KQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA-----EEALADPYF 406 (509)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~f 406 (509)
..... ..+.+++.+.+||.+||+.||++||++ +++++||||
T Consensus 192 ~~~~~---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 192 HTTLN---IPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ccccC---CcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 00000 112367889999999999999999986 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=307.40 Aligned_cols=248 Identities=25% Similarity=0.398 Sum_probs=196.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
..+|++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|+++++.+.||+|+++++++... ..
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 73 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTER-----SP 73 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccC-----Cc
Confidence 357999999999999999999875 467899998864322 235678899999999999999999988443 45
Q ss_pred EEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.|+||||+. ++|.+++... +.++++.+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 74 ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred eEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 899999998 5788888654 46899999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... ......++..|+|||.+.+ ..++.++|||||||++|||++ |..||...........+..
T Consensus 154 ~~~--~~~~~~~~~~~~aPe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------- 216 (256)
T cd05112 154 QYT--SSTGTKFPVKWSSPEVFSF--SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA------------- 216 (256)
T ss_pred ccc--ccCCCccchhhcCHhHhcc--CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC-------------
Confidence 211 1122345678999999876 678899999999999999998 9999976654332222110
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
...... ....+..+.+|+.+||..+|++||++.++++
T Consensus 217 --------------~~~~~~---~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 217 --------------GFRLYK---PRLASQSVYELMQHCWKERPEDRPSFSLLLH 253 (256)
T ss_pred --------------CCCCCC---CCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 000000 0124678999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=308.40 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=186.9
Q ss_pred eeeeccCceEEEEEEEc--CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEE
Q 010489 119 EVIGKGSYGVVGSAVDT--HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~--~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 196 (509)
+.||+|+||.||+|... .++..+|+|.++.... ......+.+|+.+++.++||||+++++++... ..+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~ 74 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV-----TPYLLVM 74 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----CCcEEEE
Confidence 36899999999999754 3567899998865322 23345688899999999999999999988443 4589999
Q ss_pred eccc-ccHHHHHHhCC-----CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 197 ELME-SDLHQVIKAND-----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 197 e~~~-~~L~~~l~~~~-----~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
||++ ++|.+++.... .+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 9998 68988886432 45677888999999999999999999999999999999999999999999997532221
Q ss_pred CCccccccccccccccccccccccc-----CCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
. ........|++.|+|||++.+.. ..++.++|||||||++|||++ |..||......+.......
T Consensus 155 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------- 224 (269)
T cd05087 155 Y-YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR--------- 224 (269)
T ss_pred e-eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh---------
Confidence 1 11112346788999999875421 135789999999999999996 9999976543222111100
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
. .....+........++.+.+++.+|| .+|++|||+++++.
T Consensus 225 --------------~--~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 225 --------------E--QQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred --------------c--ccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 0 00000111111235677999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=310.42 Aligned_cols=252 Identities=22% Similarity=0.362 Sum_probs=198.6
Q ss_pred CCeeEeeeeeccCceEEEEEEEcC-----CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
++|++++.||+|+||.||+|+.+. ..+.||+|.+... ........+.+|+.++++++|+||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE---- 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEECC----
Confidence 578999999999999999998654 3467999987542 222245678899999999999999999998843
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhCC---------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEE
Q 010489 188 EFKDIYVVFELME-SDLHQVIKAND---------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 257 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~~---------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl 257 (509)
....|+||||++ ++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|
T Consensus 80 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 80 -AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred -CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEE
Confidence 345899999998 68999997665 6899999999999999999999999999999999999999999999
Q ss_pred eeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHh
Q 010489 258 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDL 336 (509)
Q Consensus 258 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~ 336 (509)
+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+......+..+.
T Consensus 159 ~~~~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~-- 232 (275)
T cd05046 159 SLLSLSKDVYNSEY--YKLRNALIPLRWLAPEAVQE--DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ-- 232 (275)
T ss_pred cccccccccCcccc--cccCCceeEEeecChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH--
Confidence 99999875432211 11234467788999998876 567889999999999999998 788996544322111110
Q ss_pred cCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 337 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
.. ...+. ....++..+.+++.+||..||.+||++.+++.+
T Consensus 233 -------------------------~~-~~~~~-~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 233 -------------------------AG-KLELP-VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred -------------------------cC-CcCCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 00 00000 112467889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=310.71 Aligned_cols=255 Identities=21% Similarity=0.368 Sum_probs=197.3
Q ss_pred eeEeeeeeccCceEEEEEEEc---CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC-CC
Q 010489 115 YQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE-FK 190 (509)
Q Consensus 115 y~i~~~lG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~-~~ 190 (509)
|.+.+.||+|+||.||+|... .++..||||++............+.+|+++++.++||||+++++++....... ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 667899999999999999854 35789999998765444555677889999999999999999999886543221 12
Q ss_pred cEEEEEeccc-ccHHHHHHhC------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccc
Q 010489 191 DIYVVFELME-SDLHQVIKAN------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 263 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 263 (509)
..++++||+. ++|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 3578999998 6887776432 24788999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCCh
Q 010489 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPST 342 (509)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~ 342 (509)
+......... ......+++.|++||.+.. ..++.++|||||||++|||++ |.+||.+.+..+....+..
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~------- 230 (273)
T cd05074 161 KKIYSGDYYR-QGCASKLPVKWLALESLAD--NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK------- 230 (273)
T ss_pred ccccCCccee-cCCCccCchhhcCHhHHhc--CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc-------
Confidence 8653222110 1122345678999999876 678899999999999999999 8899976554222211110
Q ss_pred hHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..... ..+..+..+.+++.+||..+|++||++.++++
T Consensus 231 --------------------~~~~~---~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 231 --------------------GNRLK---QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred --------------------CCcCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00000 01345678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=310.13 Aligned_cols=238 Identities=20% Similarity=0.278 Sum_probs=182.7
Q ss_pred eeeeccCceEEEEEEEcC------------CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc
Q 010489 119 EVIGKGSYGVVGSAVDTH------------TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~------------~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 186 (509)
+.||+|+||.||+|.... ....||+|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~-- 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD-- 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 368999999999997432 2335888887542 223345678899999999999999999998543
Q ss_pred CCCCcEEEEEecccc-cHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCC-------eEE
Q 010489 187 REFKDIYVVFELMES-DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-------LKI 257 (509)
Q Consensus 187 ~~~~~~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~-------vkl 257 (509)
...++||||+++ .|..++.. ...+++..+..++.||++||+|||++||+||||||+|||++.++. +|+
T Consensus 77 ---~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 77 ---VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred ---CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 347999999995 66666654 356999999999999999999999999999999999999987664 899
Q ss_pred eeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHH-hCCCCCCCCChHhHHHHHHHh
Q 010489 258 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEML-TGKPLFPGKNVVHQLDLMTDL 336 (509)
Q Consensus 258 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~ 336 (509)
+|||++...... ....|+..|+|||.+... ..++.++|||||||++|||+ +|..||.+....+.....
T Consensus 154 ~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~--- 222 (262)
T cd05077 154 SDPGIPITVLSR-------QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY--- 222 (262)
T ss_pred CCCCCCccccCc-------ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH---
Confidence 999998654221 234678899999987632 57889999999999999998 588888765432111000
Q ss_pred cCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 337 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
.. .. ......++++.+||.+||..||.+||++.+++++
T Consensus 223 ---------------------~~---~~-----~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 223 ---------------------EG---QC-----MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ---------------------hc---Cc-----cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 00 00 0011235678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=305.78 Aligned_cols=244 Identities=26% Similarity=0.423 Sum_probs=192.9
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEec
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 198 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 198 (509)
++||.|+||.||+|.+.. ++.||+|.+...... .....+.+|+.+++.+.|+||+++++++... ...|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQK-----QPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----CCeEEEEEc
Confidence 469999999999999877 999999988653322 3456788999999999999999999988443 458999999
Q ss_pred cc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCcccc
Q 010489 199 ME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276 (509)
Q Consensus 199 ~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 276 (509)
+. ++|.+++... ..+++..+..++.|++.||.|||+++++||||||+|||++.++.+||+|||++......... ...
T Consensus 74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~ 152 (251)
T cd05041 74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT-VSD 152 (251)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcce-ecc
Confidence 97 5798888653 46899999999999999999999999999999999999999999999999999754321111 000
Q ss_pred cccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHH
Q 010489 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (509)
Q Consensus 277 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (509)
....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.........+...
T Consensus 153 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~------------------- 211 (251)
T cd05041 153 GLKQIPIKWTAPEALNY--GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG------------------- 211 (251)
T ss_pred ccCcceeccCChHhhcc--CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-------------------
Confidence 11234567999999876 678999999999999999999 88999776543222211110
Q ss_pred hhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
...+ .....+..+.+++.+||..+|.+|||+.|+++
T Consensus 212 --------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 212 --------YRMP---APQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred --------CCCC---CCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0000 01245778999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=316.14 Aligned_cols=251 Identities=25% Similarity=0.384 Sum_probs=197.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCc----EEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGE----RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~----~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
..+|++.+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+++.+.||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP--- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---
Confidence 3578899999999999999999887776 46888775432 223344678999999999999999999988543
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 188 EFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
..++++||++ |+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ---~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 82 ---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred ---CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccc
Confidence 2578999998 68999887654 689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
....... .......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.........+..
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~--------- 226 (303)
T cd05110 159 LEGDEKE-YNADGGKMPIKWMALECIHY--RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK--------- 226 (303)
T ss_pred ccCcccc-cccCCCccccccCCHHHhcc--CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC---------
Confidence 5332211 11223456778999999876 678999999999999999997 8999977543222111110
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
....+ ..+..+..+.+++.+||..||++||++.++++
T Consensus 227 ------------------~~~~~---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 227 ------------------GERLP---QPPICTIDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred ------------------CCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00000 11335678999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=332.42 Aligned_cols=262 Identities=25% Similarity=0.435 Sum_probs=214.6
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~~ 190 (509)
.+.++|.+.||.|.+|.||+++++.+++..|+|+..... ....++..|..+|+.+ .|||++.+++++.-.......
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 356899999999999999999999999999999886432 2234566788999887 499999999999766556677
Q ss_pred cEEEEEeccc-ccHHHHHHh--CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 191 DIYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
.+|||||||+ |+.-++++. ..++.|+.+..|++.++.||.+||...++|||||-.|||++.+|.|||+|||++....
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 8999999999 577777753 4579999999999999999999999999999999999999999999999999998753
Q ss_pred CCCCCcccccccccccccccccccccc---cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
.... ...+.+|||.|||||++... ...|+..+|+||||++..||.-|.+|+.+......+
T Consensus 175 sT~g---rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL-------------- 237 (953)
T KOG0587|consen 175 STVG---RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL-------------- 237 (953)
T ss_pred cccc---cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh--------------
Confidence 3222 23567999999999998543 235778999999999999999999999765542222
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 407 (509)
..+++.+| +--..+...+..+.+||..||.+|-.+||+..++|+|||+.
T Consensus 238 -------------F~IpRNPP-PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 238 -------------FLIPRNPP-PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred -------------ccCCCCCC-ccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 11222222 22233456788899999999999999999999999999997
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=304.39 Aligned_cols=243 Identities=24% Similarity=0.416 Sum_probs=191.5
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEec
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 198 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 198 (509)
++||+|+||.||+|... ++..||+|.++.... ......+.+|+.+++.++||||+++++++... ...++||||
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQR-----QPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-----CccEEEEEC
Confidence 36899999999999864 688999999865332 23345688999999999999999999988543 458999999
Q ss_pred cc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCcccc
Q 010489 199 ME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276 (509)
Q Consensus 199 ~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 276 (509)
++ ++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......... .
T Consensus 74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~--~ 151 (250)
T cd05085 74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS--S 151 (250)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc--C
Confidence 98 5888888653 468999999999999999999999999999999999999999999999999987532221111 1
Q ss_pred cccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHH
Q 010489 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (509)
Q Consensus 277 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (509)
....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+..
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~-------------------- 209 (250)
T cd05085 152 GLKQIPIKWTAPEALNY--GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-------------------- 209 (250)
T ss_pred CCCCCcccccCHHHhcc--CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc--------------------
Confidence 11244567999999876 678899999999999999998 9999987654322211110
Q ss_pred hhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.... .....++..+.+|+.+||..+|++||++.++++
T Consensus 210 -------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 210 -------GYRM---SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred -------CCCC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0000 112346788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=305.83 Aligned_cols=267 Identities=22% Similarity=0.382 Sum_probs=213.5
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~ 189 (509)
..+|.++++||+|+|++|.+++++.|.+.||+|++++... ...+..-+..|-.+.... +||.+|.++.+|.+.+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes---- 324 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES---- 324 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc----
Confidence 4689999999999999999999999999999999986543 334555667788887665 6999999999996554
Q ss_pred CcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
.+++|.||++ |+|.-.+++..++++++++++..+|+.||.|||+.|||+||||.+|+|+|..|++||+|+|+++....
T Consensus 325 -rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 325 -RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred -eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 4999999998 58988888889999999999999999999999999999999999999999999999999999986443
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCC--CChHhHHHHHHHhcCCCChhHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG--KNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~--~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
.... .+++||||.|.|||++++ ..|+..+|+|+|||+++||+.|+.||.- .+..+ ...-
T Consensus 404 ~gd~---tstfcgtpnyiapeilrg--eeygfsvdwwalgvlmfemmagrspfdivgm~n~d-------------~nte- 464 (593)
T KOG0695|consen 404 PGDT---TSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPD-------------MNTE- 464 (593)
T ss_pred CCcc---cccccCCCcccchhhhcc--cccCceehHHHHHHHHHHHHcCCCCcceecCCCcc-------------cchh-
Confidence 3322 367899999999999999 7999999999999999999999999952 11110 0000
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC------HHHHhcCCcccCCcCCC
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT------AEEALADPYFHGLANVD 413 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt------~~e~l~hp~f~~~~~~~ 413 (509)
.|+..+.-...+.+ ...++-.+..+++..|.+||.+|.. +.++..|+||+.+.+..
T Consensus 465 --------dylfqvilekqiri---prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~ 526 (593)
T KOG0695|consen 465 --------DYLFQVILEKQIRI---PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDL 526 (593)
T ss_pred --------HHHHHHHhhhcccc---cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHH
Confidence 00000000000000 0234556788999999999999964 78999999999876643
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=306.17 Aligned_cols=240 Identities=25% Similarity=0.441 Sum_probs=194.5
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++.+.||+|+||.||++. .+++.||+|.++.. .....+.+|+.+++.++||||+++++++... ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~ 73 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN------GL 73 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC------Cc
Confidence 579999999999999999985 47889999998642 2345678999999999999999999987432 36
Q ss_pred EEEEeccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 193 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
|+||||+. ++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++......
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 99999998 58999987653 5889999999999999999999999999999999999999999999999998754221
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
. .....+..|+|||.+.+ ..++.++|+|||||++|||++ |++||.+.+..+....+..
T Consensus 154 ~------~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------- 212 (254)
T cd05083 154 V------DNSKLPVKWTAPEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK------------- 212 (254)
T ss_pred C------CCCCCCceecCHHHhcc--CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-------------
Confidence 1 12344567999998876 678899999999999999997 9999987654332221110
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
...+. ....+++.+.+|+.+||..+|++||++.++++
T Consensus 213 -------------~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 213 -------------GYRME----PPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred -------------CCCCC----CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00000 11346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=307.01 Aligned_cols=247 Identities=23% Similarity=0.388 Sum_probs=188.5
Q ss_pred eeeeccCceEEEEEEEcC---CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEE
Q 010489 119 EVIGKGSYGVVGSAVDTH---TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 195 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~---~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 195 (509)
+.||+|+||.||+|.+.. .+..||||.+... ........+.+|+.+++.++||||+++++++.... ...|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE----GSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC----CCcEEE
Confidence 468999999999998643 3457999987532 22344567889999999999999999999775322 347899
Q ss_pred Eeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCc
Q 010489 196 FELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273 (509)
Q Consensus 196 ~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 273 (509)
|||+. ++|.+++... ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.........
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99998 6899988764 356788888999999999999999999999999999999999999999999997543221110
Q ss_pred -ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhC-CCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 274 -IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 274 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
.......++..|+|||.+.+ ..++.++|||||||++|||++| .+||...+..+....+..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~---------------- 217 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ---------------- 217 (262)
T ss_pred ecccccCcCCccccChhHhcc--CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc----------------
Confidence 11123356778999999876 6789999999999999999995 677766543222111100
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..+.... ...++.+.+++.+||..+|++||++.++++
T Consensus 218 -----------~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 218 -----------GRRLLQP---EYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred -----------CCCCCCC---CcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0000000 134678999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=311.66 Aligned_cols=237 Identities=20% Similarity=0.277 Sum_probs=182.4
Q ss_pred eeeccCceEEEEEEEcCC------------------------CcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcc
Q 010489 120 VIGKGSYGVVGSAVDTHT------------------------GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175 (509)
Q Consensus 120 ~lG~G~~g~V~~~~~~~~------------------------~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv 175 (509)
.||+|+||.||+|....+ ...||+|.+... .......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 599999999999974321 245889988532 223345678899999999999999
Q ss_pred eeeeeecCCCcCCCCcEEEEEeccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCC
Q 010489 176 EIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC 253 (509)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~ 253 (509)
++++++... ...|+||||++ ++|..++.. .+.+++..+..++.||++||+|||++||+||||||+|||++..+
T Consensus 80 ~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 80 FVHGVCVRG-----SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred eEEEEEEeC-----CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence 999998544 35799999999 467777765 45789999999999999999999999999999999999997654
Q ss_pred -------CeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHH-hCCCCCCCCC
Q 010489 254 -------KLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEML-TGKPLFPGKN 325 (509)
Q Consensus 254 -------~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~ 325 (509)
.+||+|||++...... ....++..|+|||.+.+. ..++.++|||||||++|||+ +|..||.+..
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cccCccceeeecCCccccccccc-------cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 3899999988643221 223578889999988653 56899999999999999995 6899997654
Q ss_pred hHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 326 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
..+..... . .....+ ...++.+.++|.+||+.+|++|||+.++|++
T Consensus 227 ~~~~~~~~------------------------~---~~~~~~-----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 227 PSEKERFY------------------------E---KKHRLP-----EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred hHHHHHHH------------------------H---hccCCC-----CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 32211100 0 000000 1234679999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=311.25 Aligned_cols=238 Identities=17% Similarity=0.273 Sum_probs=184.9
Q ss_pred eeeeccCceEEEEEEEcCCCc-------EEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 119 EVIGKGSYGVVGSAVDTHTGE-------RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~-------~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
+.||+|+||.||+|.+...+. .||+|.+... .......+..|+.+++.+.||||+++++++..+ ..
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~ 73 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DE 73 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CC
Confidence 369999999999998865544 3888877532 223445678899999999999999999998543 34
Q ss_pred EEEEEeccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCC--------eEEeeec
Q 010489 192 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--------LKICDFG 261 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~--------vkl~DFG 261 (509)
.++||||++ |+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++|||
T Consensus 74 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 74 SIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 799999998 58888887654 5899999999999999999999999999999999999987765 6999999
Q ss_pred ccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCC-CCCCCCChHhHHHHHHHhcCCC
Q 010489 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLDLMTDLLGTP 340 (509)
Q Consensus 262 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~~~~~~i~~~~g~~ 340 (509)
++..... .....+++.|+|||++.+. ..++.++|||||||++|||++|. +||...+........
T Consensus 154 ~~~~~~~-------~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~------- 218 (258)
T cd05078 154 ISITVLP-------KEILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY------- 218 (258)
T ss_pred cccccCC-------chhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-------
Confidence 9865422 1234688899999998752 45788999999999999999995 666544322111100
Q ss_pred ChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
. ..... ....+..+.+||.+||+.||++|||++++++.
T Consensus 219 -----------------~---~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 219 -----------------E---DRHQL-----PAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred -----------------H---ccccC-----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 0 00000 11245679999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=308.66 Aligned_cols=269 Identities=25% Similarity=0.411 Sum_probs=200.7
Q ss_pred CCeeEeeeeeccCceEEEEEEEc----CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDT----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~----~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
.+|++.+.||+|+||.||+|... .++..||||+++..... .....+.+|+.+++.+.|+||+++++++....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~--- 79 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPG--- 79 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCC---
Confidence 46888999999999999999854 35889999998754332 34667899999999999999999999875422
Q ss_pred CCcEEEEEeccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 189 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
....++||||++ ++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 345899999997 58999887654 6999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
..............++..|+|||.+.+ ..++.++|||||||++|||++|..||....... ....+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~~~~~~-- 230 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRT--SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMIGIAQGQM-- 230 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHcc--CCCCcccchHHHhhhhheeeccCCCcccccchh-----ccccccccccc--
Confidence 422221111122345567999998876 578899999999999999999999986532210 00111100000
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
........+. .....+ ....++.++.+|+.+||..||.+|||+.++++
T Consensus 231 --~~~~~~~~~~---~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 231 --IVTRLLELLK---EGERLP---RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred --cHHHHHHHHH---cCCcCC---CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000011111 111111 11245678999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=340.86 Aligned_cols=251 Identities=23% Similarity=0.404 Sum_probs=202.9
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCC-----cEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTG-----ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
..-++.+.||+|+||.||.|.-.... ..||||.+++. ....+...+++|..+|+.++|||||+++|++++..
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~-- 768 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG-- 768 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC--
Confidence 45678899999999999999765432 34999998754 34567788999999999999999999999998743
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhC-------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEee
Q 010489 188 EFKDIYVVFELME-SDLHQVIKAN-------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 259 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~-------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~D 259 (509)
..+|++|||+ |||..+|+.. ..++..+...++.||++|+.||+++++|||||...|+|++....|||+|
T Consensus 769 ---~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 ---PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred ---CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence 3799999999 6999999875 2589999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcC
Q 010489 260 FGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLG 338 (509)
Q Consensus 260 FG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g 338 (509)
||+|+........... ....-...|||||.+.. ..++.|+|||||||+|||+++ |..||++.+..+.+......-
T Consensus 846 FGlArDiy~~~yyr~~-~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg- 921 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKH-GEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG- 921 (1025)
T ss_pred cchhHhhhhchheecc-CccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-
Confidence 9999944332211100 01112246999999987 789999999999999999998 789999988755544222110
Q ss_pred CCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
+.+ ..+.++..+.++|..||+.+|++||++..|++
T Consensus 922 ------------------------RL~-----~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 ------------------------RLD-----PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ------------------------ccC-----CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 000 01356777899999999999999999999987
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=306.67 Aligned_cols=245 Identities=28% Similarity=0.411 Sum_probs=191.4
Q ss_pred eeeeccCceEEEEEEEcCCC------cEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 119 EVIGKGSYGVVGSAVDTHTG------ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~------~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
+.||+|+||.||+|...... ..||||.+.... .......+.+|+.+++.++||||+++++++... ...
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 74 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN-----EPQ 74 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC-----CCe
Confidence 36999999999999876443 689999886432 123456788999999999999999999988543 358
Q ss_pred EEEEeccc-ccHHHHHHhC-------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCC-----CeEEee
Q 010489 193 YVVFELME-SDLHQVIKAN-------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-----KLKICD 259 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~-------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~-----~vkl~D 259 (509)
|+||||++ ++|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++ .+||+|
T Consensus 75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence 99999998 5898888642 3478899999999999999999999999999999999999887 899999
Q ss_pred ecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcC
Q 010489 260 FGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLG 338 (509)
Q Consensus 260 FG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g 338 (509)
||++.......... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||...+..+....+..
T Consensus 155 fg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~--- 228 (269)
T cd05044 155 FGLARDIYKSDYYR-KEGEGLLPVRWMAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA--- 228 (269)
T ss_pred cccccccccccccc-cCcccCCCccccCHHHHcc--CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc---
Confidence 99997543222111 1122355788999999876 678999999999999999998 9999987654332222210
Q ss_pred CCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.... ......+..+.+||.+||..+|.+||++.++++
T Consensus 229 ------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 229 ------------------------GGRL---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ------------------------CCcc---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0000 111345678999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=302.07 Aligned_cols=250 Identities=20% Similarity=0.292 Sum_probs=184.2
Q ss_pred eeeccCceEEEEEEEcCC--CcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEe
Q 010489 120 VIGKGSYGVVGSAVDTHT--GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 197 (509)
Q Consensus 120 ~lG~G~~g~V~~~~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 197 (509)
+||+|+||.||+|..... ...+++|.+... ........+.+|+.+++.++||||+++++.+... ...|+|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~lv~e 75 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-----IPYLLVFE 75 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhccCCcchhheEEEecCC-----CccEEEEe
Confidence 599999999999975432 335667766532 2223456788999999999999999999998543 45899999
Q ss_pred ccc-ccHHHHHHhC----CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCC
Q 010489 198 LME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (509)
Q Consensus 198 ~~~-~~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 272 (509)
|++ ++|.+++... ..+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||++........
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~- 154 (268)
T cd05086 76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY- 154 (268)
T ss_pred cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh-
Confidence 999 5899988754 2466778889999999999999999999999999999999999999999999864321111
Q ss_pred cccccccccccccccccccccc-----cCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 273 AIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 273 ~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
.......+|+..|+|||++... ...++.++|||||||++|||++ |..||...+..+.+..+..-
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~---------- 224 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD---------- 224 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhh----------
Confidence 0111345788999999987531 1245789999999999999997 56788765543332221110
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..............++.+.+++..|| .+|++||+++++++
T Consensus 225 ---------------~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 225 ---------------QQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ---------------cccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 00000001112246778999999999 68999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=303.89 Aligned_cols=250 Identities=28% Similarity=0.462 Sum_probs=197.5
Q ss_pred CeeEeeeeeccCceEEEEEEEcC-CCcEEEEEEecCcc--------cChhhHHhHHHHHHHHHH-cCCCCcceeeeeecC
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTH-TGERVAIKKINDVF--------EHVSDATRILREIKLLRL-LRHPDIVEIKHIMLP 183 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~-~~~~vAiK~~~~~~--------~~~~~~~~~~~Ei~~l~~-l~h~niv~~~~~~~~ 183 (509)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+.... ........+.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37889999999999999999887 68899999875321 122344567789988865 789999999999854
Q ss_pred CCcCCCCcEEEEEecccc-cHHHHHH----hCCCCCHHHHHHHHHHHHhHhhhhhh-CCeeecCCCCCcEEECCCCCeEE
Q 010489 184 PSRREFKDIYVVFELMES-DLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKI 257 (509)
Q Consensus 184 ~~~~~~~~~~lv~e~~~~-~L~~~l~----~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkl 257 (509)
....|++|||+++ +|.+++. ....+++..++.++.|++.||.|||+ .||+|+||||+|||++.++.+||
T Consensus 81 -----~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l 155 (269)
T cd08528 81 -----NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI 155 (269)
T ss_pred -----CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEE
Confidence 3468999999984 7877763 23468999999999999999999996 78999999999999999999999
Q ss_pred eeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhc
Q 010489 258 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 337 (509)
Q Consensus 258 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 337 (509)
+|||++....... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|++||...+.......+...
T Consensus 156 ~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~- 228 (269)
T cd08528 156 TDFGLAKQKQPES----KLTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEA- 228 (269)
T ss_pred ecccceeeccccc----ccccccCcccCcChhhhcC--CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhc-
Confidence 9999997653322 2245678999999999876 67899999999999999999999999765533222211110
Q ss_pred CCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
...+. .....++.+.+||.+||+.||++||++.|+..+
T Consensus 229 ------------------------~~~~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 229 ------------------------VYEPL----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ------------------------cCCcC----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 00010 112357889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=327.73 Aligned_cols=205 Identities=31% Similarity=0.474 Sum_probs=172.2
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCC-cCCCCcE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RREFKDI 192 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-~~~~~~~ 192 (509)
-+..-+.||+||||.||+++++.+|+.||||.++... ......+..+|+++|++++|+|||+++++-.+.. ..-...-
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 4556688999999999999999999999999987543 4566778889999999999999999988653322 0012345
Q ss_pred EEEEeccc-ccHHHHHHhC---CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEEC--CCCC--eEEeeecccc
Q 010489 193 YVVFELME-SDLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN--ADCK--LKICDFGLAR 264 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~--~~~~--vkl~DFG~a~ 264 (509)
.+|||||. |+|...+.+- ..|++.++..++.++..||.|||.+|||||||||.||++- .+|+ -||+|||.|+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 89999998 6899998643 4799999999999999999999999999999999999863 4454 6999999999
Q ss_pred cccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCC
Q 010489 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK 324 (509)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 324 (509)
...++. .+.+.+||+.|.+||++.. .+.|+..+|.|||||++|+++||..||-..
T Consensus 173 el~d~s----~~~S~vGT~~YLhPel~E~-q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 173 ELDDNS----LFTSLVGTEEYLHPELYER-QKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred cCCCCC----eeeeecCchhhcChHHHhh-ccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 765444 4678999999999999874 268999999999999999999999999543
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=303.13 Aligned_cols=236 Identities=19% Similarity=0.278 Sum_probs=185.6
Q ss_pred eeeeccCceEEEEEEEcCCC----------cEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 119 EVIGKGSYGVVGSAVDTHTG----------ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~----------~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
+.||+|+||.||+|.+..++ ..|++|.+.... .....+.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR----- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-----
Confidence 46999999999999998776 357888765321 115678899999999999999999998854
Q ss_pred CCcEEEEEeccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCC-------CeEEee
Q 010489 189 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-------KLKICD 259 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~-------~vkl~D 259 (509)
...++||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 73 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 73 -DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 23699999998 58888887765 799999999999999999999999999999999999999888 799999
Q ss_pred ecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcC
Q 010489 260 FGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLG 338 (509)
Q Consensus 260 FG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g 338 (509)
||++...... ....++..|+|||++.+....++.++|||||||++|||++ |..||...+........
T Consensus 152 fg~a~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~----- 219 (259)
T cd05037 152 PGIPITVLSR-------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY----- 219 (259)
T ss_pred CCcccccccc-------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH-----
Confidence 9999764321 2245777899999987632378899999999999999999 57778654321111000
Q ss_pred CCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
. .....+. .....+.++|.+||..||.+|||+.++++
T Consensus 220 -------------------~-~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 220 -------------------Q-DQHRLPM-------PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -------------------h-cCCCCCC-------CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 0000010 11267899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=300.27 Aligned_cols=258 Identities=24% Similarity=0.354 Sum_probs=202.3
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.+...+.++||+|-||.|.+|.- ..+..||+|.++.. ........+.+||++|.+|+||||+.++++|..+..
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP----- 609 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPD-ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP----- 609 (807)
T ss_pred hhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcc-cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-----
Confidence 34678899999999999999974 34689999999753 333345789999999999999999999999976543
Q ss_pred EEEEEeccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 192 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
+++++|||+ |+|.+++.++. .+.......|+.||+.|++||.+.++|||||.+.|||++.++++||+|||+++-+..
T Consensus 610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccccc
Confidence 899999999 89999998873 334556677999999999999999999999999999999999999999999996554
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh--CCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT--GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~--g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
...-.. -...+-...|||||.+.- ++++.++|+|+||+++||+++ ...||.........+....++..+..
T Consensus 690 g~yy~v-qgr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~---- 762 (807)
T KOG1094|consen 690 GDYYRV-QGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR---- 762 (807)
T ss_pred CCceee-ecceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc----
Confidence 433221 123355678999997765 689999999999999999764 67898765544433333322222111
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
...-...+-++..+.+||.+||..|-++||+++++..
T Consensus 763 -------------------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 763 -------------------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred -------------------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 1111222356778999999999999999999999854
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=310.23 Aligned_cols=278 Identities=19% Similarity=0.274 Sum_probs=187.3
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEc----------------CCCcEEEEEEecCcccChh------------hHHhHHHH
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDT----------------HTGERVAIKKINDVFEHVS------------DATRILRE 162 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~----------------~~~~~vAiK~~~~~~~~~~------------~~~~~~~E 162 (509)
..++|++.++||+|+||+||+|... ..++.||||+++....... .......|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3568999999999999999999642 3456899999864211100 11223457
Q ss_pred HHHHHHcCCCCc-----ceeeeeecCCC---cCCCCcEEEEEeccc-ccHHHHHHhC-----------------------
Q 010489 163 IKLLRLLRHPDI-----VEIKHIMLPPS---RREFKDIYVVFELME-SDLHQVIKAN----------------------- 210 (509)
Q Consensus 163 i~~l~~l~h~ni-----v~~~~~~~~~~---~~~~~~~~lv~e~~~-~~L~~~l~~~----------------------- 210 (509)
+.++.+++|.++ +++++++.... .......|+||||++ ++|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 56666664321 112345899999998 5888877532
Q ss_pred -CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccccccccccccccccc
Q 010489 211 -DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289 (509)
Q Consensus 211 -~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE 289 (509)
..+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++.......... .....+|+.|+|||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~g~~tp~Y~aPE 380 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN--PLYGMLDPRYSPPE 380 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC--ccccCCCcceeChh
Confidence 124567788999999999999999999999999999999999999999999997543222111 11224589999999
Q ss_pred ccccccC------------------CCC--CceeeehhhhHHHHHHhCCC-CCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 290 LCGSFFS------------------KYT--PAIDIWSIGCIFAEMLTGKP-LFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 290 ~~~~~~~------------------~~~--~~~DiwSlG~il~ell~g~~-pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
++..... .|+ .+.||||+|||+|+|++|.. ||.+....... .... .....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~---~~~~----~~~~~-- 451 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE---LRQY----DNDLN-- 451 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH---Hhhc----cchHH--
Confidence 8753110 122 34799999999999999985 77543211100 0000 00000
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCC---CCCCCHHHHhcCCcccC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDP---KDRPTAEEALADPYFHG 408 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP---~~Rpt~~e~l~hp~f~~ 408 (509)
.+ ... ......++ .+...++.+.||+.+||..+| .+|+|++|+|+||||..
T Consensus 452 ------~~-r~~-~~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 452 ------RW-RMY-KGQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred ------HH-Hhh-cccCCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 00 000 11111222 355678999999999999876 68999999999999953
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=306.65 Aligned_cols=243 Identities=27% Similarity=0.496 Sum_probs=195.1
Q ss_pred eEeeeeeccCceEEEEEEEcC----CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 116 QIQEVIGKGSYGVVGSAVDTH----TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 116 ~i~~~lG~G~~g~V~~~~~~~----~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.+.++||+|-||.||+|.... ..-.||||..+... ...+.+.++.|..+|+.++|||||+++|++....
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P------ 464 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP------ 464 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc------
Confidence 345689999999999997432 23468999876532 3345778999999999999999999999996543
Q ss_pred EEEEEeccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+|||||++. |.|..+++.+. .|+......+++||+.||.|||+...|||||-..||||.+...|||+|||+++...++
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 799999999 89999998764 7899999999999999999999999999999999999999999999999999987554
Q ss_pred CCCccccccccc--ccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 270 APSAIFWTDYVA--TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 270 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
..- +...| ..-|||||-+.- ..++.++|||.|||.+||++. |..||.|-...+.+-.|.+
T Consensus 545 ~yY----kaS~~kLPIKWmaPESINf--RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn----------- 607 (974)
T KOG4257|consen 545 AYY----KASRGKLPIKWMAPESINF--RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN----------- 607 (974)
T ss_pred chh----hccccccceeecCccccch--hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC-----------
Confidence 321 11222 345999998865 789999999999999999886 8999988544322211111
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHh
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 401 (509)
..+.|.| +.++|.+..|+.+||++||.+||++.++.
T Consensus 608 --------------GeRlP~P-----~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 608 --------------GERLPCP-----PNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred --------------CCCCCCC-----CCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 1222322 57899999999999999999999987653
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=303.26 Aligned_cols=248 Identities=23% Similarity=0.446 Sum_probs=205.1
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
.+..+..+||-|-||.||.+.++.-.-.||||.++ ++.....+|++|+.+|+.++|||+|+++++|.... -+
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK---EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep-----PF 338 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP-----PF 338 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhh---hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCC-----Ce
Confidence 45677889999999999999999888899999987 34567889999999999999999999999996543 38
Q ss_pred EEEEeccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 193 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
|||+|||. |+|+++++... .++.-....++.||..|++||..+++|||||-..|+||.++..||++|||+++++..+
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 99999998 89999998764 4677778889999999999999999999999999999999999999999999998666
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
..... .+.--..-|.|||-+.- ..++.|+|||+|||+|||+.| |..||+|-+....+.++.+..
T Consensus 419 TYTAH--AGAKFPIKWTAPEsLAy--NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy----------- 483 (1157)
T KOG4278|consen 419 TYTAH--AGAKFPIKWTAPESLAY--NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY----------- 483 (1157)
T ss_pred ceecc--cCccCcccccCcccccc--cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc-----------
Confidence 54321 11112346999998754 678899999999999999998 789999987655544443321
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
+-..| ..|++.+..|++.||.+.|.+||++.|+-+
T Consensus 484 ------------RM~~P-------eGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 484 ------------RMDGP-------EGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred ------------cccCC-------CCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 11111 368889999999999999999999998843
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=315.32 Aligned_cols=253 Identities=26% Similarity=0.415 Sum_probs=213.3
Q ss_pred CCCCCeeEeeeeeccCceEEEEEEEcCCCc---EEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc
Q 010489 110 GEASRYQIQEVIGKGSYGVVGSAVDTHTGE---RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 110 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~---~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 186 (509)
.+.....|.++||.|.||.||+|+.+..|+ .||||.++.- ........|+.|+.||-++.||||+++.++....
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks-- 702 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS-- 702 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC--
Confidence 345677899999999999999999877664 7999999753 3345667899999999999999999999998433
Q ss_pred CCCCcEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 187 REFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 187 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
.-+.||.|||+ |.|..+|+.+ +.|+..+...+++.|+.|++||-++|.|||||-..||||+.+-.+|++|||+++
T Consensus 703 ---~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 703 ---KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred ---ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEecccccee
Confidence 44899999999 7899999766 579999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCccccccccc--ccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCC
Q 010489 265 VSFNDAPSAIFWTDYVA--TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPS 341 (509)
Q Consensus 265 ~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~ 341 (509)
...++.... +++.-| ...|.|||.+.- .+++.++||||+||+|||.++ |..||...+..+-+..|.+....|+
T Consensus 780 vledd~~~~--ytt~GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp 855 (996)
T KOG0196|consen 780 VLEDDPEAA--YTTLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP 855 (996)
T ss_pred ecccCCCcc--ccccCCccceeecChhHhhh--cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC
Confidence 876655332 232223 367999999876 789999999999999999875 9999998887776666655443332
Q ss_pred hhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
+ .+++..+-+|+..||++|-.+||.+.+|+.
T Consensus 856 P------------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 856 P------------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred C------------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 2 368889999999999999999999999987
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=266.41 Aligned_cols=211 Identities=26% Similarity=0.458 Sum_probs=173.8
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHH-cCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL-LRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~-l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++...+..||+|+||.|-+.++..+|...|+|.+..... ....+++++|+.+..+ ..+|.+|.+++.+. ....
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~-----regd 119 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALF-----REGD 119 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhh-----cccc
Confidence 445567889999999999999999999999999975433 3455778899998655 46999999999774 4456
Q ss_pred EEEEEecccccHHHH----HHhCCCCCHHHHHHHHHHHHhHhhhhhhC-CeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 192 IYVVFELMESDLHQV----IKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~----l~~~~~l~~~~~~~i~~qil~aL~yLH~~-~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
++|.||.|..+|..+ +...+.++|..+-+|+..++.||.|||++ .|+|||+||+||||+.+|+|||||||.+..+
T Consensus 120 vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 120 VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 999999999776544 45667899999999999999999999986 8999999999999999999999999999877
Q ss_pred cCCCCCcccccccccccccccccccccc--cCCCCCceeeehhhhHHHHHHhCCCCCCC-CChHhHHHHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEMLTGKPLFPG-KNVVHQLDLM 333 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~-~~~~~~~~~i 333 (509)
.+.... +-..|...|||||.+... ...|+.++||||||+++.||.+++.||+. .+..+++..+
T Consensus 200 ~dSiAk----t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 200 VDSIAK----TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred hhhhHH----HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence 555443 224788999999987543 24699999999999999999999999964 3444455444
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=281.95 Aligned_cols=242 Identities=39% Similarity=0.652 Sum_probs=196.3
Q ss_pred CceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEecccc-cH
Q 010489 125 SYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DL 203 (509)
Q Consensus 125 ~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L 203 (509)
+||.||+|.+..+++.||+|++........ ...+.+|++.++.++|++|+++++.+... ...++++||+++ +|
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCH
Confidence 589999999998999999999865322211 57788999999999999999999988543 458999999996 99
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccccccccccc
Q 010489 204 HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283 (509)
Q Consensus 204 ~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~ 283 (509)
..++.....+++..+..++.+++.+|.|||+.+|+|+||+|+||+++.++.++|+|||.+....... ......++.
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~ 150 (244)
T smart00220 75 FDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTP 150 (244)
T ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCc
Confidence 9998877669999999999999999999999999999999999999999999999999998754332 123457889
Q ss_pred ccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCC-ChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCC
Q 010489 284 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK-NVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRK 362 (509)
Q Consensus 284 ~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 362 (509)
.|+|||.+.+ ..++.++||||||+++++|++|..||... +.......+..
T Consensus 151 ~~~~pE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~--------------------------- 201 (244)
T smart00220 151 EYMAPEVLLG--KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK--------------------------- 201 (244)
T ss_pred CCCCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc---------------------------
Confidence 9999999875 67888999999999999999999999763 22111111100
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 363 KQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
...........++..+.+++.+||..||++||++.++++||||
T Consensus 202 -~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 202 -PKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred -cCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 0001111111266789999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=317.07 Aligned_cols=246 Identities=32% Similarity=0.468 Sum_probs=189.4
Q ss_pred eeeeeccCce-EEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCCCcEEEE
Q 010489 118 QEVIGKGSYG-VVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIYVV 195 (509)
Q Consensus 118 ~~~lG~G~~g-~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv 195 (509)
.+++|.|+-| .||+|.- .|+.||||.+-. .....+.+||..|+.-+ |||||++++.- .+...+||+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIa 581 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIA 581 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEE
Confidence 4678999988 5899964 588999998742 23446679999999885 99999998765 344569999
Q ss_pred EecccccHHHHHHhCC-C---CCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC---CC--CeEEeeecccccc
Q 010489 196 FELMESDLHQVIKAND-D---LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DC--KLKICDFGLARVS 266 (509)
Q Consensus 196 ~e~~~~~L~~~l~~~~-~---l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~---~~--~vkl~DFG~a~~~ 266 (509)
.|+|..+|.+++.... . ........++.|+++||++||+.+||||||||.||||+. ++ .++|+|||+++..
T Consensus 582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 9999999999998741 1 111345778999999999999999999999999999986 34 6899999999987
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhC-CCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
..+...-....+..||-+|+|||++.. ..-+.++||||||||+|+.++| ..||...-. ....|.. |..
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~--~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~--~~~----- 730 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLRE--DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILT--GNY----- 730 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhc--cccCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhc--Ccc-----
Confidence 766655444567889999999999987 5567799999999999999997 789954321 1111110 000
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 407 (509)
.+...-+..+.++.|||.+||.+||..||+|.++|.||+|=
T Consensus 731 ---------------------~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 731 ---------------------TLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred ---------------------ceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 00001111122799999999999999999999999999993
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=292.14 Aligned_cols=283 Identities=28% Similarity=0.451 Sum_probs=208.2
Q ss_pred CCeeEeeeeeccCceEEEEEEEcC---CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTH---TGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~---~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~ 188 (509)
..|.++.+||+|.|++||+|.+.. ..++||+|.+... ....++..|+++|..+. +.||+++.+++- .
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~r-----n 106 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCFR-----N 106 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhhc-----c
Confidence 468899999999999999998877 7889999998542 34467889999999986 999999999884 3
Q ss_pred CCcEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC-CCeEEeeecccccc
Q 010489 189 FKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVS 266 (509)
Q Consensus 189 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~-~~vkl~DFG~a~~~ 266 (509)
.....+||||++. +..+++. .++..+++.+++.++.||.++|.+|||||||||+|+|.+.. +.-.|+|||+|...
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred CCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHH
Confidence 4558999999996 4555543 36788999999999999999999999999999999999854 67899999999721
Q ss_pred cCCC--------------C-----------------Cc----------ccccccccccccccccccccccCCCCCceeee
Q 010489 267 FNDA--------------P-----------------SA----------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 305 (509)
Q Consensus 267 ~~~~--------------~-----------------~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw 305 (509)
.... . .. .......||++|+|||++... +.-++++|||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiDiw 262 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAIDIW 262 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCcccee
Confidence 0000 0 00 001124799999999998874 6778999999
Q ss_pred hhhhHHHHHHhCCCCCC-CCChHhHHHHHHHhcCCCChhHHHHhhhH----------HHHHhh--------hccCC-CCC
Q 010489 306 SIGCIFAEMLTGKPLFP-GKNVVHQLDLMTDLLGTPSTESISRIRNE----------KARRYL--------GSMRK-KQP 365 (509)
Q Consensus 306 SlG~il~ell~g~~pf~-~~~~~~~~~~i~~~~g~~~~~~~~~~~~~----------~~~~~~--------~~~~~-~~~ 365 (509)
|.|||+.-+++++.||- ..++.+.+..|..++|...-......-.. .+.... ..+.. .++
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 99999999999998874 45666677777776664322211110000 000000 11111 111
Q ss_pred CCCCCCCCCC-CHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 366 VPFSHKFPNA-DPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 366 ~~~~~~~~~~-~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
......+.++ ++.+.||+.+||..||.+|+||+++|+||||..
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 1122223333 458999999999999999999999999999974
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=304.54 Aligned_cols=252 Identities=25% Similarity=0.408 Sum_probs=204.5
Q ss_pred CCeeEeeeeeccCceEEEEEEEcC-CCc--EEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTH-TGE--RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~-~~~--~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
++..+.++||+|.||+|++|.+.. +|+ .||||+++..... .....|++|+.+|.+|+|+|++++|++.++..
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~-~~mddflrEas~M~~L~H~hliRLyGvVl~qp---- 184 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN-AIMDDFLREASHMLKLQHPHLIRLYGVVLDQP---- 184 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc-hhHHHHHHHHHHHHhccCcceeEEeeeeccch----
Confidence 456678999999999999998765 333 6899999754332 25678999999999999999999999997642
Q ss_pred CcEEEEEeccc-ccHHHHHHh--CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 190 KDIYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
+.||||+++ |+|++.+.+ ...|-......++.||+.||.||.++++|||||-..|+|+-..-.|||+||||.+.+
T Consensus 185 --~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 185 --AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred --hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceecc
Confidence 789999999 799998876 346888889999999999999999999999999999999999999999999999977
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
........+....--...|.|||.+.. ..++.++|||++||++|||++ |+.||.|......++.|.+.
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~--------- 331 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRH--RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG--------- 331 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhcc--ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc---------
Confidence 554433222122223456999999987 789999999999999999998 67999998876666555311
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
...+. -+.++.++.+++..||+.+|.+|||+..|.+.
T Consensus 332 ----------------erLpR-----Pk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 332 ----------------ERLPR-----PKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ----------------ccCCC-----CCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 11111 13578889999999999999999999988654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=307.24 Aligned_cols=313 Identities=22% Similarity=0.254 Sum_probs=241.2
Q ss_pred HHHcCCCCcceeeeeecCCCcCCCCcEEEEEeccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCe-eecCC
Q 010489 166 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANV-FHRDL 242 (509)
Q Consensus 166 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~i-vHrDl 242 (509)
|+.+.|.|+.++++.+..+ ..+++|.+||. |+|.+.+.. ...+++.....++++|+.||.|||...| .|+.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence 4578899999999999766 45899999999 799999977 3478888999999999999999999877 99999
Q ss_pred CCCcEEECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccc--cC---CCCCceeeehhhhHHHHHHhC
Q 010489 243 KPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF--FS---KYTPAIDIWSIGCIFAEMLTG 317 (509)
Q Consensus 243 Kp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~---~~~~~~DiwSlG~il~ell~g 317 (509)
++.|+++|..+.+||+|||+.......... .......-...|.|||++... .. ..+.+.||||+|+|++|+++.
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~-~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEP-EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccc-cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 999999999999999999998765321000 001111234569999998763 11 146789999999999999999
Q ss_pred CCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH
Q 010489 318 KPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA 397 (509)
Q Consensus 318 ~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 397 (509)
..||......... .+.+..++. .......|.-.......+++..++..||..+|.+||++
T Consensus 155 ~~~~~~~~~~~~~-----------~eii~~~~~---------~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~ 214 (484)
T KOG1023|consen 155 SGPFDLRNLVEDP-----------DEIILRVKK---------GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSI 214 (484)
T ss_pred cCccccccccCCh-----------HHHHHHHHh---------cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccH
Confidence 9999764321110 111111110 00111111111111455679999999999999999999
Q ss_pred HHHhcCCcccCCcCC----------CCCCCCCCCCccchhHHhhhcCHHHHHHHHHHHHHHhChhhHHHHhhcCCCcccc
Q 010489 398 EEALADPYFHGLANV----------DREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFM 467 (509)
Q Consensus 398 ~e~l~hp~f~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~v~~~l~~g~~~~~~ 467 (509)
+++-. -++.+... .....+++..+++..+++|+.+..+.+++...++.+++|..|++.++.|..|.++
T Consensus 215 ~~i~~--~~~~~~~~~~~~~nl~D~m~~~le~Y~~nLe~~v~eRt~~l~~e~~k~d~LL~~mLP~~VA~~lk~G~~v~pe 292 (484)
T KOG1023|consen 215 EQIRS--KLLTINKGGSSKGNLMDSLFRMLESYADNLEKLVDERTAELEEEKKKTDTLLGQMLPKSVAESLKLGKTVDPE 292 (484)
T ss_pred HHHHh--hhhhhcccccccchhHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHhcCHHHhhHhhcCCcCCcc
Confidence 98754 22211111 1122356778899999999999999999999999999999999999999999999
Q ss_pred CCCCcchHHHHHHHHHhhcCCCCCCCCcccccCCCCccccCC
Q 010489 468 YPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRYVCFS 509 (509)
Q Consensus 468 ~~~~v~~~~~~fs~i~~~~~~~~~s~p~~~~~~~~~~~~~~~ 509 (509)
.|+.||+| |+||+|||++++.++|+|||++|||+|+.|.
T Consensus 293 ~~~~vti~---fsDiv~fT~l~~~~~P~~vv~~lNdlyt~Fd 331 (484)
T KOG1023|consen 293 SFDSVTIY---FSDIVGFTVLSSNSTPIQVVTLLNDLYTTFD 331 (484)
T ss_pred ccCceeee---eHHHHHHHHHHhcCCCceeeeeccchHHhhh
Confidence 99999999 9999999999999999999999999999983
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=305.66 Aligned_cols=262 Identities=27% Similarity=0.435 Sum_probs=214.6
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
...+|+++..+|.|+||.||+|+++.+++..|+|+++. ....+.+-+..|+-+++.++|||||.+++-+....
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkL--ep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d----- 85 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKL--EPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD----- 85 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeec--cCCccccccccceeeeecCCCcChHHHHhhhhhhc-----
Confidence 34689999999999999999999999999999999974 33445677789999999999999999999886543
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.++|+||||+ |+|.+...-.+++++.++.+..+..++||+|||++|=+|||||-.|||+++.|.+|++|||.+..+...
T Consensus 86 klwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 86 KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred CcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh
Confidence 4899999999 578888777889999999999999999999999999999999999999999999999999998765332
Q ss_pred CCCcccccccccccccccccccc-cccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCG-SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
.. ...++.|||.|||||+.. +..+.|...+|||++|+...|+---++|-........+.++.+-.-.|+.
T Consensus 166 i~---KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~------ 236 (829)
T KOG0576|consen 166 IA---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT------ 236 (829)
T ss_pred hh---hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc------
Confidence 22 246789999999999742 22367999999999999999998888776554444444444332222111
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
+ +.-...++.+-+|++.+|.++|++||+++.+|+|||..+
T Consensus 237 -------------------l-kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 237 -------------------L-KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred -------------------c-cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 1 111245677899999999999999999999999999863
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=331.97 Aligned_cols=251 Identities=23% Similarity=0.323 Sum_probs=183.9
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
.|...+.||+|+||.||+|.+..++..||||+++.... ....|++++++++|||||++++++... ...|
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~ 759 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSE-----KGAY 759 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcC-----CCCE
Confidence 35566789999999999999989999999999864221 113468899999999999999999544 3479
Q ss_pred EEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhh---hCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 194 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 194 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH---~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+|||||+ |+|.+++. .+++..+..++.|+++||+||| +.+|+||||||+||+++.++..++. ||.+......
T Consensus 760 lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~ 835 (968)
T PLN00113 760 LIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD 835 (968)
T ss_pred EEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC
Confidence 9999998 68998885 3899999999999999999999 6699999999999999999888876 7765432111
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChH-hHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV-HQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~ 348 (509)
....||+.|||||++.+ ..++.++|||||||++|||++|+.||...... ..+.......-.
T Consensus 836 -------~~~~~t~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------- 897 (968)
T PLN00113 836 -------TKCFISSAYVAPETRET--KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYS--------- 897 (968)
T ss_pred -------CCccccccccCcccccC--CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcC---------
Confidence 22478999999999877 68999999999999999999999999543210 001000000000
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
......++.. ...... ........++.+++.+||+.||++|||++|+++
T Consensus 898 -~~~~~~~~~~---~~~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 946 (968)
T PLN00113 898 -DCHLDMWIDP---SIRGDV-SVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946 (968)
T ss_pred -ccchhheeCc---cccCCC-CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH
Confidence 0000000000 000000 000112235778999999999999999999988
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=285.35 Aligned_cols=267 Identities=25% Similarity=0.315 Sum_probs=199.2
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHH--cCCCCcceeeeeecCCCcCCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL--LRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~~~~~~~~~~~~~~~ 190 (509)
...++.+.||+|.||.||+|.- .++.||||++.. .+.+.+..|-.|.+. ++|+||++++++-...... ..
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~ 281 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RM 281 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-cc
Confidence 3456789999999999999964 579999999863 456677788887665 5799999998876444322 45
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhC---------CeeecCCCCCcEEECCCCCeEEeee
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA---------NVFHRDLKPKNILANADCKLKICDF 260 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~---------~ivHrDlKp~NILl~~~~~vkl~DF 260 (509)
.++||++|.+ |+|.+++..+ .++|....+++..+++||+|||+- .|+|||||..||||..|++.-|+||
T Consensus 282 eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 6899999998 8999999765 799999999999999999999963 5999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccccccccccccccccCCCC-----CceeeehhhhHHHHHHhCCCCCC-CCChHhHHHHHH
Q 010489 261 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYT-----PAIDIWSIGCIFAEMLTGKPLFP-GKNVVHQLDLMT 334 (509)
Q Consensus 261 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-----~~~DiwSlG~il~ell~g~~pf~-~~~~~~~~~~i~ 334 (509)
|+|..+....+... ....+||.+|||||++.+. -... .+.||||+|.|||||+++-.-+. +.-..-++..-.
T Consensus 361 GLAl~~~p~~~~~d-~~~qVGT~RYMAPEvLEga-inl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 361 GLALRLEPGKPQGD-THGQVGTRRYMAPEVLEGA-INLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ceeEEecCCCCCcc-hhhhhhhhhhcCHHHHhhh-cccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 99988765544333 2347999999999999763 1222 36899999999999999875443 333333444444
Q ss_pred HhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCC--CCCHHHHHHHHHhccCCCCCCCCHHHH
Q 010489 335 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFP--NADPLALHLLERLLAFDPKDRPTAEEA 400 (509)
Q Consensus 335 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rpt~~e~ 400 (509)
.+-..|+.+.+....- +++....+...|. ..-..+.+.++.||..||+.|.|+.=+
T Consensus 439 evG~hPt~e~mq~~VV----------~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVV----------RKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HhcCCCCHHHHHHHHH----------hhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 4445566555443221 1111111222221 233558899999999999999998544
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=290.95 Aligned_cols=204 Identities=25% Similarity=0.425 Sum_probs=175.7
Q ss_pred ccCCCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc----Ch--hhHHhHHHHHHHHHHcC---CCCcceee
Q 010489 108 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE----HV--SDATRILREIKLLRLLR---HPDIVEIK 178 (509)
Q Consensus 108 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~--~~~~~~~~Ei~~l~~l~---h~niv~~~ 178 (509)
++....+|..++.+|+|+||.|++|.++.+...|+||.|.+... +. .....+--||+||..++ |+||++++
T Consensus 556 ~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlL 635 (772)
T KOG1152|consen 556 EYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLL 635 (772)
T ss_pred eecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhh
Confidence 34445679999999999999999999999999999999865311 11 11223557999999998 99999999
Q ss_pred eeecCCCcCCCCcEEEEEeccc-c-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeE
Q 010489 179 HIMLPPSRREFKDIYVVFELME-S-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLK 256 (509)
Q Consensus 179 ~~~~~~~~~~~~~~~lv~e~~~-~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vk 256 (509)
++| ++..++||+||--+ | +|+++|.....++|.+++.|++|++.|+++||+.||||||||-+|+.++.+|-+|
T Consensus 636 dfF-----Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~k 710 (772)
T KOG1152|consen 636 DFF-----EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVK 710 (772)
T ss_pred hee-----ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEE
Confidence 999 55567999999887 4 8999999999999999999999999999999999999999999999999999999
Q ss_pred EeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCC
Q 010489 257 ICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFP 322 (509)
Q Consensus 257 l~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 322 (509)
|+|||.|....... ...++||..|.|||++.|. ...+..-|||+||++||.++...-||.
T Consensus 711 lidfgsaa~~ksgp-----fd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 711 LIDFGSAAYTKSGP-----FDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EeeccchhhhcCCC-----cceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999997653332 4567999999999999983 445678999999999999999998885
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=273.85 Aligned_cols=262 Identities=24% Similarity=0.332 Sum_probs=192.4
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHH--HcCCCCcceeeeeecCCCcCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLR--LLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~--~l~h~niv~~~~~~~~~~~~~ 188 (509)
...+..+.+.||+|.||.||+|.. .|+.||||++.. .+.....+|.+|.+ .|+|+||+.++..-..+. ..
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs 280 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILGFIAADNKDN-GS 280 (513)
T ss_pred hhheeEEEEEecCccccceeeccc--cCCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhhhhhccccCC-Cc
Confidence 356789999999999999999965 599999999863 34456677777765 579999999988765443 44
Q ss_pred CCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhC--------CeeecCCCCCcEEECCCCCeEEee
Q 010489 189 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--------NVFHRDLKPKNILANADCKLKICD 259 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~--------~ivHrDlKp~NILl~~~~~vkl~D 259 (509)
...+|||.+|-+ |+|++++.+ ..++.+....++..++.||++||.. .|+|||||..||||.++|..-|+|
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 567999999999 899999987 5799999999999999999999953 499999999999999999999999
Q ss_pred ecccccccCCC-CCcccccccccccccccccccccccCC----CCCceeeehhhhHHHHHHhC----------CCCCCCC
Q 010489 260 FGLARVSFNDA-PSAIFWTDYVATRWYRAPELCGSFFSK----YTPAIDIWSIGCIFAEMLTG----------KPLFPGK 324 (509)
Q Consensus 260 FG~a~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~----~~~~~DiwSlG~il~ell~g----------~~pf~~~ 324 (509)
+|||-....+. .-.......+||.+|||||++...... --..+||||||.|+||++.+ ++||.+-
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 99997654442 122234567999999999998653111 11358999999999999863 3566542
Q ss_pred ChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCC--HHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 325 NVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNAD--PLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 325 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
-+ ..|+.+.+.++ +.. ++....++..|...+ -.+..+|+.||..+|.-|.||-.+.+
T Consensus 440 Vp-----------~DPs~eeMrkV--------VCv--~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 440 VP-----------SDPSFEEMRKV--------VCV--QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CC-----------CCCCHHHHhcc--------eee--cccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 21 11222222111 111 111122233333322 23567899999999999999877765
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=291.00 Aligned_cols=251 Identities=28% Similarity=0.483 Sum_probs=196.6
Q ss_pred eEeeeeeccCceEEEEEEEc----C---CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcC
Q 010489 116 QIQEVIGKGSYGVVGSAVDT----H---TGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 116 ~i~~~lG~G~~g~V~~~~~~----~---~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~ 187 (509)
.+.+.||+|+||.|++|.-. . ....||||.++..... .+.+.+..|+++|+.+. |+||+.+++++..
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~---- 373 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ---- 373 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc----
Confidence 56779999999999999632 1 1457999998765444 67788999999999985 9999999999955
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEEC
Q 010489 188 EFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 250 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~ 250 (509)
.+.+++|+||+. |+|..++...+ .++..+...+++||+.|++||++.+++||||-..|||+.
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 456899999999 89999997665 388899999999999999999999999999999999999
Q ss_pred CCCCeEEeeecccccccCCCCCcccccccccc--cccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChH
Q 010489 251 ADCKLKICDFGLARVSFNDAPSAIFWTDYVAT--RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVV 327 (509)
Q Consensus 251 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt--~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~ 327 (509)
.+..+||+|||+|+.......-.. ....|+ ..|||||.+.. ..|+.++||||+||+||||.+ |..||++-...
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~--~~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRT--KSSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred CCCEEEEccccceeccCCCCceEe--cCCCCccceeecCHHHhcc--CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 999999999999986433332111 112222 34999999987 789999999999999999998 77999873211
Q ss_pred hHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010489 328 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (509)
Q Consensus 328 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 407 (509)
.+.+..++.. .+-.+| ..+++++.++++.||..+|++||++.++.+ +|.
T Consensus 529 --------------~~l~~~l~~G--------~r~~~P-------~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~--~~~ 577 (609)
T KOG0200|consen 529 --------------EELLEFLKEG--------NRMEQP-------EHCSDEIYDLMKSCWNADPEDRPTFSECVE--FFE 577 (609)
T ss_pred --------------HHHHHHHhcC--------CCCCCC-------CCCCHHHHHHHHHHhCCCcccCCCHHHHHH--HHH
Confidence 1111111110 011111 246888999999999999999999999987 554
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=280.95 Aligned_cols=248 Identities=25% Similarity=0.388 Sum_probs=198.0
Q ss_pred eeEeeeeeccCceEEEEEEEcCCCc----EEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 115 YQIQEVIGKGSYGVVGSAVDTHTGE----RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 115 y~i~~~lG~G~~g~V~~~~~~~~~~----~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.+..++||.|+||+||+|.....|+ +||||++... .......+++.|+-+|.++.|||+++++++++...
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~----- 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST----- 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-----
Confidence 3456899999999999998755554 6888887542 33344678999999999999999999999997654
Q ss_pred cEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 191 DIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
+.||++||+ |.|.++++.+ +.+-......|.+||++||.|||.++++||||-..||||.+-.++||.|||+|+....
T Consensus 772 -~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred -HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 689999999 7999999865 4788899999999999999999999999999999999999999999999999998755
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
+...-. .....-.+-|||=|.+.. ..|+.++|||||||++||+|| |..|+.+....+.-+.+.+.
T Consensus 851 d~~ey~-~~~gK~pikwmale~i~~--~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g----------- 916 (1177)
T KOG1025|consen 851 DEKEYS-APGGKVPIKWMALESIRI--RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG----------- 916 (1177)
T ss_pred cccccc-ccccccCcHHHHHHHhhc--cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc-----------
Confidence 543211 112223456899998876 789999999999999999998 88999886643332222110
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.+.+. .+.++-++.-++.+||..|+..||+++++..
T Consensus 917 --------------eRLsq-----PpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 917 --------------ERLSQ-----PPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred --------------ccCCC-----CCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 11111 1456778899999999999999999998865
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=251.16 Aligned_cols=260 Identities=26% Similarity=0.401 Sum_probs=194.8
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~~ 190 (509)
.+.|.|.+.||+|.||.+.+|.|+.++..+++|.+.+.. ...+.+.+|..---.|. |.||+.-|++.... .+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt----~d 95 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT----SD 95 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhc----Cc
Confidence 357999999999999999999999999999999997542 34567888887655554 99999888776433 34
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC--CCCeEEeeeccccccc
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVSF 267 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~--~~~vkl~DFG~a~~~~ 267 (509)
.+++++||++ |+|..-+... .+-|...+.++.|++.||.|||++++||||||.+||||-. ..+|||||||+.+...
T Consensus 96 ~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred eEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 6789999999 8998877654 5889999999999999999999999999999999999743 3479999999987532
Q ss_pred CCCCCccccccccccccccccccccccc---CCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
.-. ...--+..|.+||++.... -...+.+|+|.||+|+|.+|||.+||......++
T Consensus 175 ~tV------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~--------------- 233 (378)
T KOG1345|consen 175 TTV------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK--------------- 233 (378)
T ss_pred cee------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc---------------
Confidence 211 1122345689999764321 2356789999999999999999999974332111
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCC---CCHHHHhcCCcccC
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR---PTAEEALADPYFHG 408 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---pt~~e~l~hp~f~~ 408 (509)
..-....+++ +.....+..|...++.+..+.++-|..+|++| -++......-|...
T Consensus 234 ----~Y~~~~~w~~----rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 234 ----PYWEWEQWLK----RKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred ----hHHHHHHHhc----ccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 0011111211 11113345567789999999999999999999 56666666667643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=239.78 Aligned_cols=212 Identities=37% Similarity=0.634 Sum_probs=180.8
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEeccc
Q 010489 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME 200 (509)
Q Consensus 121 lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~ 200 (509)
||+|++|.||++....+++.+++|++....... ....+.+|+..++.++|++|+++++++... ...+++||+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCC
Confidence 689999999999998889999999986432211 346788999999999999999999998543 45899999999
Q ss_pred -ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC-CCCeEEeeecccccccCCCCCccccc
Q 010489 201 -SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVSFNDAPSAIFWT 277 (509)
Q Consensus 201 -~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~-~~~vkl~DFG~a~~~~~~~~~~~~~~ 277 (509)
++|.+++... ..+++..+..++.+++++|.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~ 151 (215)
T cd00180 75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLK 151 (215)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhh
Confidence 6899988765 57899999999999999999999999999999999999999 89999999999976533321 123
Q ss_pred ccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhh
Q 010489 278 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYL 357 (509)
Q Consensus 278 ~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 357 (509)
...+...|++||.+... ..++.+.|+|++|+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 35678899999998762 3778899999999999999
Q ss_pred hccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 010489 358 GSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404 (509)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 404 (509)
..+.+++.+||..||++||++.++++|+
T Consensus 188 -------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1267899999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=302.53 Aligned_cols=208 Identities=15% Similarity=0.175 Sum_probs=147.4
Q ss_pred HcCC-CCcceeeeeecCCCc--CCCCcEEEEEecccccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCC
Q 010489 168 LLRH-PDIVEIKHIMLPPSR--REFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 243 (509)
Q Consensus 168 ~l~h-~niv~~~~~~~~~~~--~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlK 243 (509)
.+.| +||..+++.+..... .....++++||+++++|.+++... ..+++.+++.+++||++||+|||++||+|||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 3445 577777777632221 122457889999999999999653 469999999999999999999999999999999
Q ss_pred CCcEEECCCC-------------------CeEEeeecccccccCCC-------------CCccccccccccccccccccc
Q 010489 244 PKNILANADC-------------------KLKICDFGLARVSFNDA-------------PSAIFWTDYVATRWYRAPELC 291 (509)
Q Consensus 244 p~NILl~~~~-------------------~vkl~DFG~a~~~~~~~-------------~~~~~~~~~~gt~~y~aPE~~ 291 (509)
|+||||+..| .+||+|||+++...... +........+||++|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 9999996544 45555566554321000 000001124689999999998
Q ss_pred ccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCC
Q 010489 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHK 371 (509)
Q Consensus 292 ~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (509)
.+ ..|+.++|||||||+||||++|.+||..... .+..+... . .+ + .
T Consensus 188 ~~--~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~-------------------~---~~---~-----~ 233 (793)
T PLN00181 188 NG--SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHR-------------------V---LP---P-----Q 233 (793)
T ss_pred cc--CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHh-------------------h---cC---h-----h
Confidence 87 6799999999999999999999888753211 11000000 0 00 0 0
Q ss_pred CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 372 FPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 372 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.....+.+.+++.+||.+||.+||++.|+|+||||...
T Consensus 234 ~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 234 ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred hhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 01123457789999999999999999999999999764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=240.40 Aligned_cols=200 Identities=38% Similarity=0.652 Sum_probs=171.5
Q ss_pred eeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEE
Q 010489 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 194 (509)
Q Consensus 115 y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 194 (509)
|.+.+.||.|++|.||+|.+..+++.+|+|.+...... .....+.+|+..++.++|+|++++++.+... ...++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEE
Confidence 56789999999999999999988999999998753222 2467788999999999999999999988543 45899
Q ss_pred EEecccc-cHHHHHHhCCC-CCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCC
Q 010489 195 VFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (509)
Q Consensus 195 v~e~~~~-~L~~~l~~~~~-l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 272 (509)
++|++++ +|.+++..... +++..+..++.+++.+|.+||+.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred EEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999996 99999987766 899999999999999999999999999999999999999999999999999876443211
Q ss_pred cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCC
Q 010489 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 323 (509)
Q Consensus 273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 323 (509)
......++..|++||.+. ....++.++|+|+||+++++|++|+.||..
T Consensus 155 --~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 --LLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred --cccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 123457888999999983 226788899999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-31 Score=278.54 Aligned_cols=267 Identities=28% Similarity=0.349 Sum_probs=202.7
Q ss_pred eEeeeeeccCceEEEEEEEcCCCcEEEEEEecC---cccChh-hHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKIND---VFEHVS-DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 116 ~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~-~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.-...+|.|++|.|+.+......+.++.|.... ...... ....+..|+.+-..+.|||++..+..+.... .
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~-----~ 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID-----G 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc-----c
Confidence 356789999999999888877777777776541 111111 1223667888888899999988777664332 2
Q ss_pred EEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 192 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
.+-+||||++||+.++...+.++..++..++.|++.||+|||+.||.||||||+|+++..+|.+||+|||.+........
T Consensus 396 ~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 396 ILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred chhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 34449999999999999888899999999999999999999999999999999999999999999999999976543332
Q ss_pred C-cccccccccccccccccccccccCCCCC-ceeeehhhhHHHHHHhCCCCCCCCChHhHHH-HHHHhcCCCChhHHHHh
Q 010489 272 S-AIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD-LMTDLLGTPSTESISRI 348 (509)
Q Consensus 272 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~DiwSlG~il~ell~g~~pf~~~~~~~~~~-~i~~~~g~~~~~~~~~~ 348 (509)
. .....+.+|+..|+|||++.+ ..|++ .+||||.|+|++.|++|+.||.-....++.. .+.
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~--~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~-------------- 539 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTG--KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN-------------- 539 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccc--cccCcchhhhhhccceEEEEecCCCccccccccccchhhhc--------------
Confidence 2 234567899999999999988 67776 5899999999999999999996543221110 000
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 412 (509)
..........+...+..++...+.+|.+||+.||.+|.|+++|++.+||+.+...
T Consensus 540 ---------~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c 594 (601)
T KOG0590|consen 540 ---------YSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC 594 (601)
T ss_pred ---------cccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence 0000111112223344566778999999999999999999999999999987544
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=239.40 Aligned_cols=253 Identities=19% Similarity=0.328 Sum_probs=198.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCC-----CcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHT-----GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 186 (509)
..|+++...+-+|.||.||.|..+.. .+.|-+|.++.. ....+...++.|...+..+.|||+..+.++...
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie--- 358 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE--- 358 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEee---
Confidence 45788889999999999999966543 234666766532 334456678899999999999999999998864
Q ss_pred CCCCcEEEEEeccc-ccHHHHHHhC--------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEE
Q 010489 187 REFKDIYVVFELME-SDLHQVIKAN--------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 257 (509)
Q Consensus 187 ~~~~~~~lv~e~~~-~~L~~~l~~~--------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl 257 (509)
+....++++.+++ |+|..++... +.++..+...++.|++.|++|||+.||||.||-..|++|++.-+|||
T Consensus 359 -~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 359 -DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred -ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 3345688899998 8999888722 24677788889999999999999999999999999999999999999
Q ss_pred eeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHh
Q 010489 258 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDL 336 (509)
Q Consensus 258 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~ 336 (509)
+|=.+++..........- ...-....|||||.+.. ..|+.++|+|||||+||||+| |+.|+..-+..+....+.+.
T Consensus 438 tDsaLSRDLFP~DYhcLG-DnEnRPvkWMslEal~n--~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG 514 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLG-DNENRPVKWMSLEALQN--SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG 514 (563)
T ss_pred ccchhccccCcccccccC-CCCCCcccccCHHHHhh--hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence 999999977654432211 11123456999999987 789999999999999999998 88999876655444333221
Q ss_pred cCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 337 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.+-.+| -++++++..++..||+.+|++||+++|+..
T Consensus 515 -----------------------yRlaQP-------~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 -----------------------YRLAQP-------FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred -----------------------ceecCC-------CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 111122 268899999999999999999999999865
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=225.96 Aligned_cols=165 Identities=21% Similarity=0.252 Sum_probs=126.5
Q ss_pred ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccccccc
Q 010489 201 SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY 279 (509)
Q Consensus 201 ~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~ 279 (509)
|+|.+++... ..+++..++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||++...... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--------~~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE--------QS 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc--------cC
Confidence 6788888764 46999999999999999999999998 999999999999999 9999765321 12
Q ss_pred ccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHh-HHHHHHHhcCCCChhHHHHhhhHHHHHhhh
Q 010489 280 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH-QLDLMTDLLGTPSTESISRIRNEKARRYLG 358 (509)
Q Consensus 280 ~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 358 (509)
.||+.|||||++.+ ..|+.++|||||||++|||++|+.||....... .+..+...
T Consensus 65 ~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~---------------------- 120 (176)
T smart00750 65 RVDPYFMAPEVIQG--QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG---------------------- 120 (176)
T ss_pred CCcccccChHHhcC--CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHH----------------------
Confidence 68999999999987 689999999999999999999999997654321 11111110
Q ss_pred ccCCCCCCCCCCCCCCCC--HHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010489 359 SMRKKQPVPFSHKFPNAD--PLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (509)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 407 (509)
+....+... ......+ ..+.+||.+||..||.+||++.++++|+|+.
T Consensus 121 -~~~~~~~~~-~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 121 -MPADDPRDR-SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred -hccCCcccc-ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 000000000 0001122 2589999999999999999999999999974
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=235.78 Aligned_cols=167 Identities=20% Similarity=0.225 Sum_probs=128.3
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcC-CCcEEEEEEecCccc---ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTH-TGERVAIKKINDVFE---HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~-~~~~vAiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
.++|.+.+.||+|+||+||+|++.. +++.||||++..... .......+.+|+++|+.++|+||+..+..+
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~------ 90 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT------ 90 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc------
Confidence 4579999999999999999998876 678889998753211 222355688999999999999998533221
Q ss_pred CCCcEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCC-CCCcEEECCCCCeEEeeeccccc
Q 010489 188 EFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDL-KPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 188 ~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDl-Kp~NILl~~~~~vkl~DFG~a~~ 265 (509)
...|+|||||+| +|. .+... . ...++.|+++||.|||+.||+|||| ||+|||++.++.+||+|||+|+.
T Consensus 91 --~~~~LVmE~~~G~~L~-~~~~~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLH-LARPH---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred --CCcEEEEEccCCCCHH-HhCcc---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 236999999986 564 32211 1 1467899999999999999999999 99999999999999999999987
Q ss_pred ccCCCCCcc-----ccccccccccccccccccc
Q 010489 266 SFNDAPSAI-----FWTDYVATRWYRAPELCGS 293 (509)
Q Consensus 266 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~ 293 (509)
......... ..+...+++.|+|||.+..
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 644322111 1245678999999998864
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=216.35 Aligned_cols=233 Identities=21% Similarity=0.304 Sum_probs=182.1
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCCCcE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 192 (509)
.|+|+++||+|+||+.+.|.+..+++.||||.-... .++.++..|.+..+.|. .++|..++.+- .++.+-
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~N 99 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYN 99 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchh
Confidence 699999999999999999999999999999976432 34567778999988886 68888876554 444566
Q ss_pred EEEEecccccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCC-----CeEEeeecccccc
Q 010489 193 YVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-----KLKICDFGLARVS 266 (509)
Q Consensus 193 ~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~-----~vkl~DFG~a~~~ 266 (509)
.||||+++.+|.+++.-. .+|+...+..++.|++.-++|+|++.+|+|||||+|+||..-+ .|.|+|||+|+.+
T Consensus 100 iLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 100 ILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 899999998888888654 4799999999999999999999999999999999999997544 4899999999987
Q ss_pred cCCCCCc-cc---ccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCC---hHhHHHHHHHhcCC
Q 010489 267 FNDAPSA-IF---WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN---VVHQLDLMTDLLGT 339 (509)
Q Consensus 267 ~~~~~~~-~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~g~ 339 (509)
.+...+. +. ..+..||..||+=.-..+ .+-+.+.|+-|||-++++.|-|..||.|-. ..+..++|-+.-..
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlG--rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred cCccccccCccccccccccceeeeEeecccc--chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 6554332 22 245689999999888777 677889999999999999999999998854 33444455433333
Q ss_pred CChhHHHHhhhHHHHHhh
Q 010489 340 PSTESISRIRNEKARRYL 357 (509)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~ 357 (509)
.+.+.++.--.+....|+
T Consensus 258 T~i~~Lc~g~P~efa~Yl 275 (449)
T KOG1165|consen 258 TPIEVLCEGFPEEFATYL 275 (449)
T ss_pred CCHHHHHhcCHHHHHHHH
Confidence 333333333333333443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-25 Score=220.41 Aligned_cols=265 Identities=34% Similarity=0.520 Sum_probs=202.1
Q ss_pred eeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChh-hHHhHHHHHHHHHHcCCC-CcceeeeeecCCCcCCCCcE
Q 010489 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS-DATRILREIKLLRLLRHP-DIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 115 y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~-~~~~~~~Ei~~l~~l~h~-niv~~~~~~~~~~~~~~~~~ 192 (509)
|.+.+.||.|+||.||++.+. ..+|+|.+........ ....+.+|+.+++.+.|+ +|+++.+.+... ...
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE-----GSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC-----CEE
Confidence 788999999999999999887 7899999876544433 467788999999999988 799999998333 237
Q ss_pred EEEEecccc-cHHHHHHhCC---CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCC-CeEEeeeccccccc
Q 010489 193 YVVFELMES-DLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVSF 267 (509)
Q Consensus 193 ~lv~e~~~~-~L~~~l~~~~---~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~-~vkl~DFG~a~~~~ 267 (509)
+++++++.+ .+.+++.... .+++..+..++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||+++...
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 999999995 6776666654 799999999999999999999999999999999999999988 79999999998543
Q ss_pred CCCCCc---cccccccccccccccccccccc-CCCCCceeeehhhhHHHHHHhCCCCCCCCCh---HhHHHHHHHhcCCC
Q 010489 268 NDAPSA---IFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV---VHQLDLMTDLLGTP 340 (509)
Q Consensus 268 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~g~~ 340 (509)
...... ......+||..|+|||.+.+.. ..+....|+||+|++++++++|..||..... .............+
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 332221 1235679999999999987621 3678899999999999999999999877653 11111111111111
Q ss_pred ChhHHHHhhhHHHHHhhhccCCCCCCCCCCCC-CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.......... ......+.+++.+|+..+|..|.+..+...++|....
T Consensus 234 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 234 ----------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred ----------------------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 0000000000 1123568999999999999999999999998776543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=224.21 Aligned_cols=255 Identities=20% Similarity=0.219 Sum_probs=187.9
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCC-cEEEEEEecCcccChhhHHhHHHHHHHHHHcCC----CCcceeeeeecCCCcCC
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTG-ERVAIKKINDVFEHVSDATRILREIKLLRLLRH----PDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~-~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h----~niv~~~~~~~~~~~~~ 188 (509)
+|.+.+.||+|+||.||+|.+..++ ..+|+|......... . ..+..|+.++..+.. +++..+++... ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~-~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK-P-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----ST 92 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC-C-ccchhHHHHHHHHhhhcCCCCCCEEEEecc----CC
Confidence 7999999999999999999987775 678999875422111 1 156789999988873 57888877763 12
Q ss_pred CCcEEEEEecccccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC-----CCeEEeeec
Q 010489 189 FKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-----CKLKICDFG 261 (509)
Q Consensus 189 ~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~-----~~vkl~DFG 261 (509)
..+-||||+.++.+|.++.... +.++...+..|+.|++.+|++||+.|++||||||+|+++... ..+.|.|||
T Consensus 93 ~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 93 EDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred CceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 3457999999999999988654 589999999999999999999999999999999999999865 359999999
Q ss_pred ccc--cccCCCCCc---c-c-ccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHH
Q 010489 262 LAR--VSFNDAPSA---I-F-WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMT 334 (509)
Q Consensus 262 ~a~--~~~~~~~~~---~-~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~ 334 (509)
+|+ ......... . . ...+.||..|+++....+ ...+.+.|+||++.++.|++.|..||.+.........+.
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCC--CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 998 432222110 0 1 134569999999999887 788999999999999999999999997655322211111
Q ss_pred HhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 335 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 335 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.. ...... .. .....+.++.+++..+-..+...+|....+..
T Consensus 251 ~~---------------~~~~~~-----~~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 251 KD---------------PRKLLT-----DR------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred HH---------------hhhhcc-----cc------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 10 000000 00 11223455667777777788888888777655
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=206.84 Aligned_cols=207 Identities=25% Similarity=0.353 Sum_probs=168.8
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCC-CCcceeeeeecCCCcCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH-PDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~~~~~~~~~~~~~~ 189 (509)
..+.|+++++||+|+||.+|+|....+|+.||||+-..... ...+..|.++.+.|++ ..|..+..+. .+.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~ 83 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYG-----TEK 83 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhc-----ccc
Confidence 46789999999999999999999999999999998754322 2457789999999974 6677766665 334
Q ss_pred CcEEEEEecccccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC---CCeEEeeeccccc
Q 010489 190 KDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARV 265 (509)
Q Consensus 190 ~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~---~~vkl~DFG~a~~ 265 (509)
.+-.+|||+++.+|.+++.- ...++...+..++-|++.-++|+|.++++||||||+|+|+.-+ ..+.|+|||+|+.
T Consensus 84 ~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 84 DYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence 45689999999998888864 4579999999999999999999999999999999999997643 4589999999987
Q ss_pred ccCCCCCc-c---cccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHh
Q 010489 266 SFNDAPSA-I---FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH 328 (509)
Q Consensus 266 ~~~~~~~~-~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 328 (509)
+.+..... + ......||..|.+-....+ ..-+.+.|+-|+|.+|..+.-|..||.|-....
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g--~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLG--IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhh--hhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 65433221 1 1234689999999877665 466788999999999999999999999866543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-27 Score=247.19 Aligned_cols=228 Identities=27% Similarity=0.408 Sum_probs=172.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
..+|..++.|..|+||.||.++|+.+.+.+|+ ++++. . -|++ ||..+.+ .
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq----~---------lilR-----nilt~a~-----------n 131 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQ----N---------LILR-----NILTFAG-----------N 131 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-ccccc----c---------hhhh-----ccccccC-----------C
Confidence 46799999999999999999999999999999 45431 0 1111 1222211 1
Q ss_pred EEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 192 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
.++| ||-..+++..+.++.+. +.+++|||+-||+|||+||+|+||+.-|++|++|||+++.......
T Consensus 132 pfvv-----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 132 PFVV-----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ccee-----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 2333 66666666666666544 7799999999999999999999999999999999999875322111
Q ss_pred C------------cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCC
Q 010489 272 S------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339 (509)
Q Consensus 272 ~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~ 339 (509)
. .......||||.|+|||++.. ..|++.+|||++|+|+||.+.|..||.|+...+.+..+....
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr--qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~-- 274 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD-- 274 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhh--hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh--
Confidence 1 111234699999999999887 789999999999999999999999999988766555433211
Q ss_pred CChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC---CHHHHhcCCcccCCcCC
Q 010489 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP---TAEEALADPYFHGLANV 412 (509)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~e~l~hp~f~~~~~~ 412 (509)
+.|.+......++++++|.++|+.+|..|. .+.++.+|+||+.+.+.
T Consensus 275 --------------------------i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 275 --------------------------IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred --------------------------ccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 112222345688999999999999999994 57899999999988765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-27 Score=240.72 Aligned_cols=242 Identities=24% Similarity=0.385 Sum_probs=195.8
Q ss_pred eeeccCceEEEEEEE---cCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCCCcEEEE
Q 010489 120 VIGKGSYGVVGSAVD---THTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIYVV 195 (509)
Q Consensus 120 ~lG~G~~g~V~~~~~---~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv 195 (509)
.+|.|+||.|++++. ...|..||+|+.++.............|-.++..++ ||.++++...+.. ...+|++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-----~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-----DGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-----ccchhHh
Confidence 379999999988753 346788999998764433333335566888888887 9999999888844 3458999
Q ss_pred Eecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCcc
Q 010489 196 FELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 274 (509)
Q Consensus 196 ~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 274 (509)
+++..| +|...+.....+.+...+.+...++-|++++|+.+|+|||+|++||+++.+|++|+.|||+++.......
T Consensus 76 ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred hhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 999985 8999888888999999999999999999999999999999999999999999999999999987543332
Q ss_pred cccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHH
Q 010489 275 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354 (509)
Q Consensus 275 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (509)
.|||..|||||++. .+..++|+||+|++++||++|..||.+ +....|.+.
T Consensus 153 ----~cgt~eymApEI~~----gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~------------------ 202 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN----GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA------------------ 202 (612)
T ss_pred ----cccchhhhhhHhhh----ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh------------------
Confidence 29999999999976 367799999999999999999999987 222222221
Q ss_pred HhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCcCC
Q 010489 355 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLANV 412 (509)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~f~~~~~~ 412 (509)
..+. -...++.+.+++..++..+|..|.. +.|+++|+||+.+.+.
T Consensus 203 --------~~~~-----p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 203 --------ELEM-----PRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred --------ccCC-----chhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 0000 0235677999999999999999975 5799999999987765
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=199.07 Aligned_cols=176 Identities=11% Similarity=0.120 Sum_probs=133.1
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhh-HHh------HHHHHHHHHHcCCCCcceeeeeecCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSD-ATR------ILREIKLLRLLRHPDIVEIKHIMLPP 184 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~-~~~------~~~Ei~~l~~l~h~niv~~~~~~~~~ 184 (509)
.++|+++++||.|+||.||++.. ++..+|||++......... ... +.+|+..+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 57999999999999999999754 4668999999754332222 122 57899999999999999998886543
Q ss_pred CcC---CCCcEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeee
Q 010489 185 SRR---EFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 260 (509)
Q Consensus 185 ~~~---~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DF 260 (509)
... .....+|||||++| +|.++. .+++ ....+++.+|..||..|++|||+||+||+++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 211 12457999999997 676663 2333 2456999999999999999999999999999998 999999
Q ss_pred cccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHH
Q 010489 261 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEML 315 (509)
Q Consensus 261 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell 315 (509)
|.......+... ..++.. ..|+.++|+||||+++..+.
T Consensus 179 g~~~~~~e~~a~---------------d~~vle--r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAK---------------DRIDLE--RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhH---------------HHHHHH--hHhcccccccceeEeehHHH
Confidence 988654221111 012333 46778999999999988765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=196.66 Aligned_cols=140 Identities=23% Similarity=0.250 Sum_probs=108.5
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhh------------------------HHhHHHHHHHHHHcCCCC
Q 010489 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSD------------------------ATRILREIKLLRLLRHPD 173 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~------------------------~~~~~~Ei~~l~~l~h~n 173 (509)
.+.||+|+||.||+|.+. +|+.||||+++........ .....+|+++|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 8999999998643211100 112345999999998887
Q ss_pred cceeeeeecCCCcCCCCcEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhh-hhCCeeecCCCCCcEEECC
Q 010489 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI-HTANVFHRDLKPKNILANA 251 (509)
Q Consensus 174 iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yL-H~~~ivHrDlKp~NILl~~ 251 (509)
+.....+.. ...+|||||++| ++.........+++..+..++.|++.+|.|| |+.||+||||||+|||++
T Consensus 81 v~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~- 152 (190)
T cd05147 81 IPCPEPILL-------KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCCcEEEe-------cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence 744332221 113899999996 4444444556899999999999999999999 799999999999999998
Q ss_pred CCCeEEeeecccccc
Q 010489 252 DCKLKICDFGLARVS 266 (509)
Q Consensus 252 ~~~vkl~DFG~a~~~ 266 (509)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 578999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=231.16 Aligned_cols=250 Identities=27% Similarity=0.410 Sum_probs=183.1
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc--cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
+|...+.||++.|=+|.+|++.+ |. |+||++-+.. .......+.++|++ ...++|||.+.+.-+.. ....
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~-----t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV-----TDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH-----hhHH
Confidence 68889999999999999998753 44 9999974432 23345566667777 67789999999877653 3345
Q ss_pred EEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC--C
Q 010489 192 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN--D 269 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~--~ 269 (509)
.|||-+|...+|++.+..+.-+..-+.+.|+.||+.||.-+|..||+|+|||.+||||++=..+.|+||..-+...- +
T Consensus 96 AylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 79999999999999999888899999999999999999999999999999999999999988899999986654321 1
Q ss_pred CCCc--cccccccccccccccccccccc---------CCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHh-
Q 010489 270 APSA--IFWTDYVATRWYRAPELCGSFF---------SKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDL- 336 (509)
Q Consensus 270 ~~~~--~~~~~~~gt~~y~aPE~~~~~~---------~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~- 336 (509)
.+.. .++.+...-.+|.|||.+.... ...+++.||||+||+++||++ |++||.-. | +...
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----Q---L~aYr 248 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----Q---LLAYR 248 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----H---HHhHh
Confidence 1111 1112222334799999764311 125778999999999999998 68888421 1 1110
Q ss_pred cC-CCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 337 LG-TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 337 ~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
-| .-. ....+..+ -+..++.||..|++.||++|.+|++.|+.
T Consensus 249 ~~~~~~-----------~e~~Le~I--------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 249 SGNADD-----------PEQLLEKI--------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccCccC-----------HHHHHHhC--------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 00 000 00111111 12348899999999999999999999984
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=201.14 Aligned_cols=240 Identities=20% Similarity=0.270 Sum_probs=149.8
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCc-ccChhhHHhHHHHHHHHHHcCC----------CCcceeeeeec
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRH----------PDIVEIKHIML 182 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~Ei~~l~~l~h----------~niv~~~~~~~ 182 (509)
.+...+.||.|+++.||.+.+..||+.+|+|++... .......+.+.+|.-....+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 466788999999999999999999999999987422 2233345666666644433322 12222222221
Q ss_pred CCCc-------C--CC---CcEEEEEecccccHHHHHH---hCCCC----CHHHHHHHHHHHHhHhhhhhhCCeeecCCC
Q 010489 183 PPSR-------R--EF---KDIYVVFELMESDLHQVIK---ANDDL----TPEHYQFFLYQLLRGLKYIHTANVFHRDLK 243 (509)
Q Consensus 183 ~~~~-------~--~~---~~~~lv~e~~~~~L~~~l~---~~~~l----~~~~~~~i~~qil~aL~yLH~~~ivHrDlK 243 (509)
.... . .. -+.+++|+-+.++|.+++. ..... .......+..|+++.+++||+.||+|+|||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 1100 0 00 1357888988888877764 22222 122234456899999999999999999999
Q ss_pred CCcEEECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccc------cCCCCCceeeehhhhHHHHHHhC
Q 010489 244 PKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEMLTG 317 (509)
Q Consensus 244 p~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~~DiwSlG~il~ell~g 317 (509)
|+|++++.+|.++|+||+........ ......+..|.+||+.... ...++.+.|.|+||+++|.|+||
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~------~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTR------YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEE------EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred eeeEEEcCCCCEEEcChHHHeecCce------eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999877643211 1113455779999976431 13578899999999999999999
Q ss_pred CCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 010489 318 KPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR 394 (509)
Q Consensus 318 ~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 394 (509)
+.||........ ....+... .+++..+++||..+|++||.+|
T Consensus 247 ~lPf~~~~~~~~----------------------------------~~~~f~~C-~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEAD----------------------------------PEWDFSRC-RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGST----------------------------------SGGGGTTS-S---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCcccc----------------------------------ccccchhc-CCcCHHHHHHHHHHccCCcccC
Confidence 999976542100 00012222 2678889999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=189.33 Aligned_cols=140 Identities=22% Similarity=0.187 Sum_probs=110.5
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChh------------------------hHHhHHHHHHHHHHcCCCC
Q 010489 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS------------------------DATRILREIKLLRLLRHPD 173 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~------------------------~~~~~~~Ei~~l~~l~h~n 173 (509)
.+.||+|+||.||+|.+. +|+.||||+++....... ......+|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 899999999875321100 0122357899999999998
Q ss_pred cceeeeeecCCCcCCCCcEEEEEeccccc-HHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhh-CCeeecCCCCCcEEECC
Q 010489 174 IVEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANA 251 (509)
Q Consensus 174 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDlKp~NILl~~ 251 (509)
|.....+... ..||||||++|. +.........++...+..++.|++.+|.+||+ .||+||||||+|||++
T Consensus 81 i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~- 152 (190)
T cd05145 81 VPVPEPILLK-------KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCCceEEEec-------CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-
Confidence 8554443321 138999999974 43333344578889999999999999999999 9999999999999998
Q ss_pred CCCeEEeeecccccc
Q 010489 252 DCKLKICDFGLARVS 266 (509)
Q Consensus 252 ~~~vkl~DFG~a~~~ 266 (509)
++.++|+|||+|...
T Consensus 153 ~~~~~liDFG~a~~~ 167 (190)
T cd05145 153 DGKPYIIDVSQAVEL 167 (190)
T ss_pred CCCEEEEEcccceec
Confidence 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-23 Score=199.01 Aligned_cols=203 Identities=25% Similarity=0.370 Sum_probs=143.0
Q ss_pred CCCCcceeeeeecCC----------------------CcCCCCcEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHh
Q 010489 170 RHPDIVEIKHIMLPP----------------------SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLR 227 (509)
Q Consensus 170 ~h~niv~~~~~~~~~----------------------~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~ 227 (509)
+|||||++..+|.+. ...+...+|+||.-...+|.+++-.+ ..+......++.|+++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~-~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTR-HRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcC-CCchHHHHHHHHHHHH
Confidence 599999999888432 11334569999999999999999765 4667778889999999
Q ss_pred HhhhhhhCCeeecCCCCCcEEEC--CCC--CeEEeeecccccccCCCCCccc---ccccccccccccccccccccCC---
Q 010489 228 GLKYIHTANVFHRDLKPKNILAN--ADC--KLKICDFGLARVSFNDAPSAIF---WTDYVATRWYRAPELCGSFFSK--- 297 (509)
Q Consensus 228 aL~yLH~~~ivHrDlKp~NILl~--~~~--~vkl~DFG~a~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~--- 297 (509)
|+.|||.+||.|||||.+|||+. +|+ .+.|+|||++-......-.-.. .-+.-|...-||||+.....++
T Consensus 353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av 432 (598)
T KOG4158|consen 353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV 432 (598)
T ss_pred HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence 99999999999999999999974 343 4799999988532211111111 1123577789999997653222
Q ss_pred -CCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCC
Q 010489 298 -YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNAD 376 (509)
Q Consensus 298 -~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (509)
--.++|.|+.|.+.||+++..-||.+.-... + +. +.| .+. .+...-..++
T Consensus 433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L------------~~---------r~Y----qe~---qLPalp~~vp 483 (598)
T KOG4158|consen 433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEML-L------------DT---------RTY----QES---QLPALPSRVP 483 (598)
T ss_pred eccchhhhhhhhhhHHHHhccCCcccccchhe-e------------ch---------hhh----hhh---hCCCCcccCC
Confidence 1237899999999999999999998733110 0 00 000 001 1111223578
Q ss_pred HHHHHHHHHhccCCCCCCCCH---HHHhc
Q 010489 377 PLALHLLERLLAFDPKDRPTA---EEALA 402 (509)
Q Consensus 377 ~~~~~li~~~L~~dP~~Rpt~---~e~l~ 402 (509)
+.+++|+..+|+.||++|+++ ..+|+
T Consensus 484 p~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 484 PVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred hHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 899999999999999999984 45554
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=181.26 Aligned_cols=190 Identities=16% Similarity=0.071 Sum_probs=136.9
Q ss_pred EeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChh--hHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCCCcEE
Q 010489 117 IQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS--DATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 117 i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~--~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
+...|++|+||+|+.+.. .+..++.+.+........ ....+.+|+++|++|. |++|++++++. ..|
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~~ 74 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GRH 74 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CEE
Confidence 467899999999998854 677888777754322111 1235789999999996 58898887752 269
Q ss_pred EEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCC-CCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 194 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDL-KPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 194 lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDl-Kp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
++|||+.| +|.+.+.. . ...++.|++++|.+||++||+|||| ||+|||++.+|.++|+|||+|........
T Consensus 75 lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred EEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 99999997 45443211 1 2357889999999999999999999 79999999999999999999985432221
Q ss_pred Ccc--ccc--------ccccccccccccccccccCCCC-CceeeehhhhHHHHHHhCCCCCCCCC
Q 010489 272 SAI--FWT--------DYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKN 325 (509)
Q Consensus 272 ~~~--~~~--------~~~gt~~y~aPE~~~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~ 325 (509)
... ... -...++.|++|+.-.-. ...+ .+.++++.|+-+|.++||+.|+.+..
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l-~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVL-KRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh-ccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 000 000 01357888888853221 1222 56789999999999999998886654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=178.20 Aligned_cols=136 Identities=21% Similarity=0.250 Sum_probs=106.1
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-----CCCCcceeeeeecCCCcCCCCcE
Q 010489 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-----RHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-----~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
.+.||+|+||.||. +..++.. +||++.... ......+.+|+.+++.+ .||||+++++++.+.. ..+.+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEE
Confidence 47899999999995 7777666 699886421 22446789999999999 5799999999996642 12343
Q ss_pred E-EEEeccc---ccHHHHHHhCCCCCHHHHHHHHHHHHhHh-hhhhhCCeeecCCCCCcEEECC----CCCeEEeeeccc
Q 010489 193 Y-VVFELME---SDLHQVIKANDDLTPEHYQFFLYQLLRGL-KYIHTANVFHRDLKPKNILANA----DCKLKICDFGLA 263 (509)
Q Consensus 193 ~-lv~e~~~---~~L~~~l~~~~~l~~~~~~~i~~qil~aL-~yLH~~~ivHrDlKp~NILl~~----~~~vkl~DFG~a 263 (509)
+ +||||++ ++|.+++... .+++. ..++.|++.++ +|||+++|+||||||+|||++. ++.++|+||+.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 7899955 5999999664 56666 35688888888 9999999999999999999974 347999995543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.3e-22 Score=197.92 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=165.6
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCC---CcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeee-------eec
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH-------IML 182 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~-------~~~ 182 (509)
..+.+.+..+.+++|.+........ ...++-|..+. .+........+++-.+....|-+..-+.+ .+.
T Consensus 244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~--d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~ 321 (516)
T KOG1033|consen 244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADV--DSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSK 321 (516)
T ss_pred ccccccccccccccCCchhhhhcccchhhhhccchhhhc--cchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcc
Confidence 3455566667777776665543322 22233332211 11123344455666655555444333322 111
Q ss_pred CCCcCCCCcEEEEEeccc-ccHHHHHHhCC---CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEe
Q 010489 183 PPSRREFKDIYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 258 (509)
Q Consensus 183 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~ 258 (509)
........++||.|++|. .+|.+|+.... ..+....+.++.|++.|++| +|.+|||+||.||+...+..+||.
T Consensus 322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIg 398 (516)
T KOG1033|consen 322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIG 398 (516)
T ss_pred ccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhh
Confidence 111122346899999999 68999997543 46778899999999999999 999999999999999999999999
Q ss_pred eecccccccCCC---CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHH
Q 010489 259 DFGLARVSFNDA---PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTD 335 (509)
Q Consensus 259 DFG~a~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 335 (509)
|||+........ +.....+..+||++||+||.+.+ ..|+.++||||||+||+||+.- |.... +...
T Consensus 399 DFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g--~~y~~kvdIyaLGlil~EL~~~---f~T~~--er~~---- 467 (516)
T KOG1033|consen 399 DFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG--QQYSEKVDIYALGLILAELLIQ---FSTQF--ERIA---- 467 (516)
T ss_pred hhhheeecccCCcccchhhhhhhcccccccCCHHHHhh--hhhhhhcchhhHHHHHHHHHHH---hccHH--HHHH----
Confidence 999987654433 11223456799999999999998 7999999999999999999972 21110 0000
Q ss_pred hcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 336 LLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 336 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
....+++ . .++..+..-.|...+|+.+||.+.|.+||++.+.--|+|.
T Consensus 468 --------t~~d~r~------------g---~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 468 --------TLTDIRD------------G---IIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred --------hhhhhhc------------C---CCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 0001111 0 0111111223556789999999999999988777666664
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=179.28 Aligned_cols=142 Identities=18% Similarity=0.135 Sum_probs=110.7
Q ss_pred CeeEeeeeeccCceEEEEEE-EcCCCcEEEEEEecCcccCh--------------------h--hHHhHHHHHHHHHHcC
Q 010489 114 RYQIQEVIGKGSYGVVGSAV-DTHTGERVAIKKINDVFEHV--------------------S--DATRILREIKLLRLLR 170 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~-~~~~~~~vAiK~~~~~~~~~--------------------~--~~~~~~~Ei~~l~~l~ 170 (509)
-|.+.+.||+|+||.||+|. +..+|+.||||+++...... . ....+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999998 67789999999986422100 0 1123568999999997
Q ss_pred CCC--cceeeeeecCCCcCCCCcEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCC-eeecCCCCCc
Q 010489 171 HPD--IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN-VFHRDLKPKN 246 (509)
Q Consensus 171 h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~-ivHrDlKp~N 246 (509)
+.. +.++++. ...|+||||++| +|.........+....+..++.||+.+|.+||+.| |+||||||+|
T Consensus 109 ~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe---------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhh
Confidence 633 3333321 124899999997 45554444456677778899999999999999999 9999999999
Q ss_pred EEECCCCCeEEeeeccccc
Q 010489 247 ILANADCKLKICDFGLARV 265 (509)
Q Consensus 247 ILl~~~~~vkl~DFG~a~~ 265 (509)
|+++ ++.++|+|||.+..
T Consensus 180 Ili~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred EEEE-CCCEEEEEChhhhc
Confidence 9999 88999999999864
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-20 Score=204.53 Aligned_cols=192 Identities=24% Similarity=0.322 Sum_probs=152.8
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC---CCCcceeeeeecCCCcCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR---HPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~~~~~~~~~~~~~~ 189 (509)
..|.|.+.||+|+||.||+|.+.. |+.||+|+-+....+. +.-=.+++.+|+ -+.|..+..+++..+
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~---- 767 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVFQN---- 767 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHccCC----
Confidence 579999999999999999999876 9999999875432222 111223444444 244555544443332
Q ss_pred CcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC-------CCeEEeeec
Q 010489 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-------CKLKICDFG 261 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~-------~~vkl~DFG 261 (509)
.-++|+||.+ |+|.+++...+.+++..+..|+.|++..++.||.++|||+||||+|+||... --++|+|||
T Consensus 768 -~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 768 -ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred -cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 2589999999 8999999988899999999999999999999999999999999999998532 248999999
Q ss_pred ccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCC
Q 010489 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK 318 (509)
Q Consensus 262 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~ 318 (509)
.+..+.--... ..+...++|-.+-.+|+..| ..++..+|.|.|+.+++-||.|+
T Consensus 847 ~siDm~lfp~~-~~F~~~~~td~f~C~EM~~g--rpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 847 RSIDMKLFPDG-TKFKAVWHTDLFDCIEMREG--RPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred cceeeeEcCCC-cEEeeeeccccchhHHHhcC--CCCchhhhhHHHHHHHHHHHHHH
Confidence 99654332222 34577889999999999988 79999999999999999999997
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-21 Score=207.89 Aligned_cols=264 Identities=26% Similarity=0.377 Sum_probs=204.0
Q ss_pred CCeeEeeeeeccCceEEEEEEEcC-CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTH-TGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~~ 190 (509)
..|.+.+.||+|+|+.|-.+.... +...+|+|.+............+..|..+-+.+. |+|++.+++....+ .
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~-----~ 94 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP-----R 94 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC-----c
Confidence 357888889999999998887643 4456778877654333334455566888888887 99999999887544 4
Q ss_pred cEEEEEeccc-ccHHHHH-HhCC-CCCHHHHHHHHHHHHhHhhhhh-hCCeeecCCCCCcEEECCCC-CeEEeeeccccc
Q 010489 191 DIYVVFELME-SDLHQVI-KAND-DLTPEHYQFFLYQLLRGLKYIH-TANVFHRDLKPKNILANADC-KLKICDFGLARV 265 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l-~~~~-~l~~~~~~~i~~qil~aL~yLH-~~~ivHrDlKp~NILl~~~~-~vkl~DFG~a~~ 265 (509)
..+++++|.. ++++..+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+ .+|++|||+|..
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 4799999977 4787777 5444 6788889999999999999999 99999999999999999999 999999999988
Q ss_pred ccCCCCCccccccccc-ccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 266 SFNDAPSAIFWTDYVA-TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
..............+| ++.|+|||...+. ....+..|+||+|+++.-+++|..||......+.
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~--------------- 238 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG--------------- 238 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCccccccccc---------------
Confidence 7663333344566788 9999999998763 3456789999999999999999999965442110
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
.+.. ........-...|...+..+.+++.++|..+|..|.+.+++..+||+..
T Consensus 239 ----------~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 239 ----------RYSS-WKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ----------ccee-ecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0000 0011111122345677888999999999999999999999999999977
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3e-19 Score=167.37 Aligned_cols=135 Identities=21% Similarity=0.275 Sum_probs=108.7
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCcccCh------hhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV------SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
+.||+|++|.||+|.. .|..|++|+........ .....+.+|+.++..+.|++|.....++... ...
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----ENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CCC
Confidence 5799999999999976 67889999865322111 1124577899999999999987666555332 346
Q ss_pred EEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 193 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 193 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
+++|||++| +|.+++..... ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||++..
T Consensus 75 ~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 899999986 78888765432 7788999999999999999999999999999999 78999999999875
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.6e-20 Score=169.49 Aligned_cols=243 Identities=17% Similarity=0.247 Sum_probs=178.9
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
+...++.+|.+.-.|..|+++. .|..+++|+++-......-.+.+..|.-.|+-+.||||..+++.|..+ .++
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnl 262 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNL 262 (448)
T ss_pred hhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCc
Confidence 4456778899999999999965 466788888764333334445677888899999999999999999554 458
Q ss_pred EEEEeccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCC-ee-ecCCCCCcEEECCCCCeEEe--eeccccc
Q 010489 193 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTAN-VF-HRDLKPKNILANADCKLKIC--DFGLARV 265 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~-iv-HrDlKp~NILl~~~~~vkl~--DFG~a~~ 265 (509)
.++..||+ |+|+.++.... ..+..++..++.++++|++|||+.. ++ ---|....++||++.+.+|. |--++.
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf- 341 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF- 341 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee-
Confidence 99999999 89999997654 3677888999999999999999975 33 33578889999998876653 322221
Q ss_pred ccCCCCCcccccccccccccccccccccccCCC-CCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
.. .+..-.|.||+||.+....... -.++|+|||++++|||.|...||..-...+---+|
T Consensus 342 --qe-------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki----------- 401 (448)
T KOG0195|consen 342 --QE-------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI----------- 401 (448)
T ss_pred --ec-------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh-----------
Confidence 11 1234578899999987632222 24789999999999999999999876543321111
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHh
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 401 (509)
-+..++. ...|++++.+..|+.-|+..||.+||.+..++
T Consensus 402 -----------aleglrv-------~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 402 -----------ALEGLRV-------HIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred -----------hhccccc-------cCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 0111111 22357888899999999999999999877653
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=161.72 Aligned_cols=137 Identities=23% Similarity=0.194 Sum_probs=104.4
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccCh--------------------hhHHhHHHHHHHHHHcCCCC
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV--------------------SDATRILREIKLLRLLRHPD 173 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~--------------------~~~~~~~~Ei~~l~~l~h~n 173 (509)
.|.+.+.||+|+||.||+|... +|+.||||+++...... .......+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3778899999999999999875 79999999875321000 01123567899999998774
Q ss_pred --cceeeeeecCCCcCCCCcEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEEC
Q 010489 174 --IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 250 (509)
Q Consensus 174 --iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~ 250 (509)
+...++. ...++||||++| +|..+.. ......++.+++.++.++|..||+||||||+||+++
T Consensus 95 i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~ 159 (198)
T cd05144 95 FPVPKPIDW---------NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD 159 (198)
T ss_pred CCCCceeec---------CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc
Confidence 3333321 235899999996 5544322 134567889999999999999999999999999999
Q ss_pred CCCCeEEeeecccccc
Q 010489 251 ADCKLKICDFGLARVS 266 (509)
Q Consensus 251 ~~~~vkl~DFG~a~~~ 266 (509)
.++.++|+|||++...
T Consensus 160 ~~~~~~liDfg~~~~~ 175 (198)
T cd05144 160 DDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCcEEEEECCccccC
Confidence 9999999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=161.06 Aligned_cols=131 Identities=27% Similarity=0.370 Sum_probs=101.4
Q ss_pred eeeccCceEEEEEEEcCCCcEEEEEEecCcc-cC-----hhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EH-----VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 120 ~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~-----~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
.||+|+||.||+|. .+|..|++|+..... .. .....++.+|+.+++.+.|+++.....++... ...+
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKT 73 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCE
Confidence 48999999999997 467889999864321 11 11235677899999999988755443333222 2358
Q ss_pred EEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 194 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 194 lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
+||||++| +|.+++..... .++.|++.+|.+||+.|++|||++|.||+++ ++.++++|||++..
T Consensus 74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999985 77777654321 7899999999999999999999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.8e-18 Score=179.05 Aligned_cols=139 Identities=24% Similarity=0.331 Sum_probs=107.6
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEe-cCcccC-----hhhHHhHHHHHHHHHHcCCCCcceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI-NDVFEH-----VSDATRILREIKLLRLLRHPDIVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~-~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~ 185 (509)
...|...+.||+|+||+||++... +..+++|+. .+.... .....++.+|+.+++.++|++++....+....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~- 408 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP- 408 (535)
T ss_pred ccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC-
Confidence 345567899999999999999764 344555543 221111 11235678999999999999998876655432
Q ss_pred cCCCCcEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 186 RREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
...++||||++| +|.+++. ....++.|++++|.|||+.||+||||||+|||+ .++.++|+|||+++
T Consensus 409 ----~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 409 ----EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred ----CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 236899999985 7887774 356789999999999999999999999999999 67899999999997
Q ss_pred cc
Q 010489 265 VS 266 (509)
Q Consensus 265 ~~ 266 (509)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 64
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-17 Score=153.76 Aligned_cols=136 Identities=25% Similarity=0.247 Sum_probs=96.7
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHh----------------------HHHHHHHHHHcCCCC--
Q 010489 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR----------------------ILREIKLLRLLRHPD-- 173 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~----------------------~~~Ei~~l~~l~h~n-- 173 (509)
.+.||+|+||.||+|.+. +++.||||+++........... ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999876 8999999998643221111111 135666666665443
Q ss_pred cceeeeeecCCCcCCCCcEEEEEecccc-cHH-HHHHhCCCCCHHHHHHHHHHHHhHhhhhhh-CCeeecCCCCCcEEEC
Q 010489 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLH-QVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILAN 250 (509)
Q Consensus 174 iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~-~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDlKp~NILl~ 250 (509)
+.+.+++. ..++||||+++ .+. ..+.... . ...+..++.+++.++.++|. .||+||||||+||+++
T Consensus 81 ~~~~~~~~---------~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 81 VPKPIDLN---------RHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD 149 (187)
T ss_pred CCceEecC---------CCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence 33333321 25899999997 221 1111111 1 16678899999999999999 9999999999999999
Q ss_pred CCCCeEEeeecccccc
Q 010489 251 ADCKLKICDFGLARVS 266 (509)
Q Consensus 251 ~~~~vkl~DFG~a~~~ 266 (509)
++.++|+|||.+...
T Consensus 150 -~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 -DGKVYIIDVPQAVEI 164 (187)
T ss_pred -CCcEEEEECcccccc
Confidence 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.2e-16 Score=150.24 Aligned_cols=139 Identities=22% Similarity=0.280 Sum_probs=102.3
Q ss_pred eeee-ccCceEEEEEEEcCCCcEEEEEEecCc------cc-----ChhhHHhHHHHHHHHHHcCCCCc--ceeeeeecCC
Q 010489 119 EVIG-KGSYGVVGSAVDTHTGERVAIKKINDV------FE-----HVSDATRILREIKLLRLLRHPDI--VEIKHIMLPP 184 (509)
Q Consensus 119 ~~lG-~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~-----~~~~~~~~~~Ei~~l~~l~h~ni--v~~~~~~~~~ 184 (509)
..|| .||.|+||.+.. .+..++||.+... .. ......++.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4566 777888888865 3778999977421 01 11233567899999999998885 5555553322
Q ss_pred CcCCCCcEEEEEecccc--cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecc
Q 010489 185 SRREFKDIYVVFELMES--DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 262 (509)
Q Consensus 185 ~~~~~~~~~lv~e~~~~--~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 262 (509)
. ......++|||+++| +|.+++.. ..+++.. +.||+.+|.+||+.||+||||||+|||++.++.++|+|||.
T Consensus 115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 115 H-GLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred c-CcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 1 111123699999995 78877754 4566543 57899999999999999999999999999999999999998
Q ss_pred ccc
Q 010489 263 ARV 265 (509)
Q Consensus 263 a~~ 265 (509)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 875
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.6e-17 Score=167.54 Aligned_cols=258 Identities=25% Similarity=0.241 Sum_probs=198.4
Q ss_pred CCeeEeeeeec--cCceEEEEEEE--cCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcC
Q 010489 113 SRYQIQEVIGK--GSYGVVGSAVD--THTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 113 ~~y~i~~~lG~--G~~g~V~~~~~--~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~ 187 (509)
..+.+.+.+|+ |.+|.||.+.. ..++..+|+|+-+..........+-.+|+...+.+. |++.++.+..+ .
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----e 188 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----E 188 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----c
Confidence 45677889999 99999999988 889999999986544443444455567887777775 99999977666 4
Q ss_pred CCCcEEEEEecccccHHHHHHhCCC-CCHHHHHHHHHHHHh----HhhhhhhCCeeecCCCCCcEEECCC-CCeEEeeec
Q 010489 188 EFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLR----GLKYIHTANVFHRDLKPKNILANAD-CKLKICDFG 261 (509)
Q Consensus 188 ~~~~~~lv~e~~~~~L~~~l~~~~~-l~~~~~~~i~~qil~----aL~yLH~~~ivHrDlKp~NILl~~~-~~vkl~DFG 261 (509)
..+.+|+-+|+|+.+|..+...... +++..++.++.+..+ ||.++|+.+|+|-|+||+||++..+ ...+++|||
T Consensus 189 ~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 189 GSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred cCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 4456899999999999888876654 888999999999999 9999999999999999999999999 789999999
Q ss_pred ccccccCCCCCccc--ccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCC--ChHhHHHHHHHhc
Q 010489 262 LARVSFNDAPSAIF--WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK--NVVHQLDLMTDLL 337 (509)
Q Consensus 262 ~a~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~--~~~~~~~~i~~~~ 337 (509)
+........-.... .....|..-|++||+..+ -++.+.||+++|.++.+..+|..++... +.+.++..+.
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~--- 342 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY--- 342 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc---
Confidence 98876544321111 112256778999999875 6888999999999999999988666543 3222222111
Q ss_pred CCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
-..+.+...+.++...+..|++.||..|++++.++.|+++....
T Consensus 343 -----------------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~ 386 (524)
T KOG0601|consen 343 -----------------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL 386 (524)
T ss_pred -----------------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh
Confidence 00112223455566699999999999999999999999997443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.1e-17 Score=172.23 Aligned_cols=267 Identities=22% Similarity=0.251 Sum_probs=196.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.+.+.+.+-+-+|+++.++.+.-..+|...++|+..... ....+.+.+..+-.++-...+|-++...--+ ....
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~rs 877 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCRS 877 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCCC
Confidence 346778888999999999999888888888887654211 1111233333444444444556666543332 2234
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
..+++++|++ ++|...+...+..+++.+..++..+.++++|||+..+.|||++|.|+|+..+|+.+++|||.......-
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred CcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccc
Confidence 5899999998 589999988888898899999999999999999999999999999999999999999999843321100
Q ss_pred --------CC--------------------CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCC
Q 010489 270 --------AP--------------------SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 321 (509)
Q Consensus 270 --------~~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 321 (509)
.. .........||+.|.+||.+.+ ......+|+|++|++++|.++|.+||
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg--~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG--RRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc--ccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 0011234579999999999988 67888999999999999999999999
Q ss_pred CCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHH---
Q 010489 322 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE--- 398 (509)
Q Consensus 322 ~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~--- 398 (509)
...........| .. ...+|..-....++++.+++.++|..+|.+|..+.
T Consensus 1036 na~tpq~~f~ni---------------------------~~-~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~ 1087 (1205)
T KOG0606|consen 1036 NAETPQQIFENI---------------------------LN-RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAA 1087 (1205)
T ss_pred CCcchhhhhhcc---------------------------cc-CCCCCCCCccccChhhhhhhhhhhccCchhccCccccc
Confidence 876543222111 11 11223333345688899999999999999999877
Q ss_pred HHhcCCcccCCcCCC
Q 010489 399 EALADPYFHGLANVD 413 (509)
Q Consensus 399 e~l~hp~f~~~~~~~ 413 (509)
++-.|+||+...+..
T Consensus 1088 e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1088 EVKGHPFFQDVDWEN 1102 (1205)
T ss_pred ccccCCccCCCCccc
Confidence 999999999877654
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.6e-15 Score=133.39 Aligned_cols=131 Identities=23% Similarity=0.213 Sum_probs=105.9
Q ss_pred EeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCC--CCcceeeeeecCCCcCCCCcEEE
Q 010489 117 IQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH--PDIVEIKHIMLPPSRREFKDIYV 194 (509)
Q Consensus 117 i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~l 194 (509)
+.+.||+|.++.||++... +..+++|.+..... ...+.+|+.+++.+.| ..+++++...... +..|+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-----~~~~~ 70 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESD-----GWSYL 70 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----CccEE
Confidence 4578999999999999874 37899998864322 4567889999999986 5888887766332 45799
Q ss_pred EEeccccc-HHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhC---CeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 195 VFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 195 v~e~~~~~-L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~---~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
+|||+++. +..+ +......++.+++++|++||.. +++|+||+|+|||++..+.++++|||.+..
T Consensus 71 v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 71 LMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 99999864 3322 5566777899999999999985 799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.5e-13 Score=125.25 Aligned_cols=139 Identities=21% Similarity=0.244 Sum_probs=99.3
Q ss_pred eeeeeccCceEEEEEEEcC------CCcEEEEEEecCc---ccC-----------------hhhHHh----HHHHHHHHH
Q 010489 118 QEVIGKGSYGVVGSAVDTH------TGERVAIKKINDV---FEH-----------------VSDATR----ILREIKLLR 167 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~------~~~~vAiK~~~~~---~~~-----------------~~~~~~----~~~Ei~~l~ 167 (509)
...||.|--+.||.|.... .+..+|||+.+-. +.. ....+. ..+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999997643 3579999986421 000 011112 238999999
Q ss_pred HcCC--CCcceeeeeecCCCcCCCCcEEEEEeccccc-HHHHHHhCCCCCHHHHHHHHHHHHhHhhhh-hhCCeeecCCC
Q 010489 168 LLRH--PDIVEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYI-HTANVFHRDLK 243 (509)
Q Consensus 168 ~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~-L~~~l~~~~~l~~~~~~~i~~qil~aL~yL-H~~~ivHrDlK 243 (509)
++.. -++..++++. .-+|||||++++ +..-..+...+++..+..+..+++.+|..| |..||||+||+
T Consensus 82 rl~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 9863 4555555432 248999999863 322222233466667788899999999999 89999999999
Q ss_pred CCcEEECCCCCeEEeeecccccc
Q 010489 244 PKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 244 p~NILl~~~~~vkl~DFG~a~~~ 266 (509)
+.|||+. ++.++|+|||.+...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999996 578999999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=5.6e-15 Score=139.32 Aligned_cols=246 Identities=19% Similarity=0.210 Sum_probs=159.8
Q ss_pred EEEEEEEcCCCcEEEEEEecCccc-Chh-hHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEeccc-ccHH
Q 010489 128 VVGSAVDTHTGERVAIKKINDVFE-HVS-DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLH 204 (509)
Q Consensus 128 ~V~~~~~~~~~~~vAiK~~~~~~~-~~~-~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~ 204 (509)
.||++.+...|..|..-.+..... +.. .......-..-|-++-|.|||+++.++.+....+.....++.|||. |.+.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 466776666666665443321000 000 0011111123345567999999999987776666777899999999 7888
Q ss_pred HHHHhC----CCCCHHHHHHHHHHHHhHhhhhhhCC--eeecCCCCCcEEECCCCCeEEeeecccccccCCCCCcc--cc
Q 010489 205 QVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI--FW 276 (509)
Q Consensus 205 ~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~~--ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~--~~ 276 (509)
+.+++. ..+.....++|+.||+.||.|||+.. |+|+++...-|++..+|-+||.--..... ........ ..
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~-h~s~~~~~~~Ek 239 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDST-HPSVNSTREAEK 239 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCcccc-chhhhhhhHhhh
Confidence 888643 35888889999999999999999985 99999999999999999888753221111 00000000 00
Q ss_pred cccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCC-CCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHH
Q 010489 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKP-LFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (509)
Q Consensus 277 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~-pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 355 (509)
.-..|-++|.|||.-.. ...+.++|||++|....||..|.. |-.+.+...--..+...
T Consensus 240 ~~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~------------------- 298 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGTT--TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANV------------------- 298 (458)
T ss_pred hccccCCccccCCcCcc--cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhh-------------------
Confidence 11245688999997443 456778999999999999998873 22222211111011000
Q ss_pred hhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
.+.-..+.-++++.+||+-.|..||++.+++.||.+-.++
T Consensus 299 ---------------i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh 338 (458)
T KOG1266|consen 299 ---------------IIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH 338 (458)
T ss_pred ---------------eeeccCccccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence 0011122346789999999999999999999999875444
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=5.6e-14 Score=143.44 Aligned_cols=250 Identities=22% Similarity=0.213 Sum_probs=178.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEc-CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDT-HTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~-~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~ 189 (509)
..+|..+..||.|.|+.|+.+... .++..|++|.+.+......+...-+.|+.+...+. |.+++..+..+. ..
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~-----~~ 338 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS-----QL 338 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc-----cc
Confidence 357888999999999999998755 67889999988765555445455567888877764 899998777663 33
Q ss_pred CcEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC-CCeEEeeeccccccc
Q 010489 190 KDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVSF 267 (509)
Q Consensus 190 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~-~~vkl~DFG~a~~~~ 267 (509)
...|+-.|||++ ++...+.....+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||+...+.
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 457899999984 444333444568889999999999999999999999999999999999886 778999999886321
Q ss_pred CCCCCcccccccccccccc-cccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 268 NDAPSAIFWTDYVATRWYR-APELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
-.. ....++-+++ ..|++... ..+..+.|++|||.-+.+.++|.+.-.......
T Consensus 419 ~~~------~~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~------------------ 473 (524)
T KOG0601|consen 419 FSS------GVFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGVQSL------------------ 473 (524)
T ss_pred eec------ccccccccccccchhhccc-cccccccccccccccccccccCcccCcccccce------------------
Confidence 111 1112333344 35554442 577889999999999999999984332211100
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 407 (509)
.+ +....+ ..+....++..+.+.++..|+..||.+.++..|.=|.
T Consensus 474 ~i-----------~~~~~p-----~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 474 TI-----------RSGDTP-----NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ee-----------eccccc-----CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 00 000011 1122335678899999999999999999998876553
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.47 E-value=7e-14 Score=146.18 Aligned_cols=141 Identities=22% Similarity=0.321 Sum_probs=93.6
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccCh--------------------------------hhHHh---
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV--------------------------------SDATR--- 158 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~--------------------------------~~~~~--- 158 (509)
.|.. +.||+|++|.||+|+.+.+|+.||||+++...... ...+.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3555 78999999999999998889999999986431100 00112
Q ss_pred ---HHHHHHHHHHcC----CCCcceeeeeecCCCcCCCCcEEEEEecccc-cHHHH--HHhCC----CCCHHHHHHHHHH
Q 010489 159 ---ILREIKLLRLLR----HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQV--IKAND----DLTPEHYQFFLYQ 224 (509)
Q Consensus 159 ---~~~Ei~~l~~l~----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~--l~~~~----~l~~~~~~~i~~q 224 (509)
+.+|+..+.+++ +...+.+-.++.+-+ ..-+|||||++| .+.++ +...+ .+.+..+..++.|
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s----t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYC----SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccC----CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 233444443332 333344434442211 235899999996 56553 33333 2445555566666
Q ss_pred HHhHhhhhhhCCeeecCCCCCcEEECCCC----CeEEeeecccccc
Q 010489 225 LLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDFGLARVS 266 (509)
Q Consensus 225 il~aL~yLH~~~ivHrDlKp~NILl~~~~----~vkl~DFG~a~~~ 266 (509)
++ ..|++|+|+||.||+++.+| +++++|||++...
T Consensus 276 if-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 276 VF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 65 58999999999999999988 9999999998754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.46 E-value=2e-12 Score=133.31 Aligned_cols=169 Identities=22% Similarity=0.357 Sum_probs=124.4
Q ss_pred EEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEecccccHHHHHHhC
Q 010489 131 SAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN 210 (509)
Q Consensus 131 ~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~ 210 (509)
.|..+.++.+|.|.+.+.... .....+.+-++-|+.++||||+++++.+ +....+|||+|-+.. |..++..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~ylvTErV~P-l~~~lk~- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYLVTERVRP-LETVLKE- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEEEeecccc-HHHHHHH-
Confidence 456677889999988865322 3345567788899999999999999988 444579999998863 2223332
Q ss_pred CCCCHHHHHHHHHHHHhHhhhhh-hCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccccccccccccccccc
Q 010489 211 DDLTPEHYQFFLYQLLRGLKYIH-TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289 (509)
Q Consensus 211 ~~l~~~~~~~i~~qil~aL~yLH-~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE 289 (509)
+....+...+.||+.||.||| +++++|++|.-+-|+|+..|++||++|-++.....-... .....---.|..|+
T Consensus 101 --l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~---~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 101 --LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP---AKSLYLIESFDDPE 175 (690)
T ss_pred --hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc---cccchhhhcccChh
Confidence 236778888999999999997 678999999999999999999999999988643222210 01112222366777
Q ss_pred ccccccCCCCCceeeehhhhHHHHHHhC
Q 010489 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTG 317 (509)
Q Consensus 290 ~~~~~~~~~~~~~DiwSlG~il~ell~g 317 (509)
.+.. -+-..|.|-|||+++|++.|
T Consensus 176 ~~~~----s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 176 EIDP----SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcCc----cccchhhhhHHHHHHHHhCc
Confidence 6433 12457999999999999999
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.5e-13 Score=136.86 Aligned_cols=140 Identities=22% Similarity=0.264 Sum_probs=93.2
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCcccChh--h------------------------------------HHhHH
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS--D------------------------------------ATRIL 160 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~--~------------------------------------~~~~~ 160 (509)
+.||.|++|.||+|+.+ +|+.||||+.+......- + .-.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999864 799999999854211000 0 00234
Q ss_pred HHHHHHHHcC----CCCcceeeeeecCCCcCCCCcEEEEEecccc-cHHHHHHhC-CCCCHHHHHHHHHHHHh-Hhhhhh
Q 010489 161 REIKLLRLLR----HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLR-GLKYIH 233 (509)
Q Consensus 161 ~Ei~~l~~l~----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qil~-aL~yLH 233 (509)
+|+..+.++. |.+-+.+-.++...+ ..-+|||||++| +|.++.... .... ...++.+++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH
Confidence 4555555542 333334434442211 225899999986 566554321 1222 2345556655 467899
Q ss_pred hCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 234 TANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 234 ~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
..|++|+|+||.||+++.+|+++|+|||++...
T Consensus 275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred hCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999999999999999999999999999998654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.6e-13 Score=120.11 Aligned_cols=126 Identities=17% Similarity=0.128 Sum_probs=92.1
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcc-eeeeeecCCCcCCCCcEEEEE
Q 010489 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV-EIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~ 196 (509)
++.|+.|.++.||++... +..|++|....... ......+|+.+++.+.+.+++ +++.... ..-++||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~-------~~~~lv~ 70 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP-------ETGVLIT 70 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC-------CCCeEEE
Confidence 467899999999999754 78899998753211 123456899999988765544 4444321 1137999
Q ss_pred ecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCe-----eecCCCCCcEEECCCCCeEEeeecccc
Q 010489 197 ELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV-----FHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 197 e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~i-----vHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
||++| ++... ......++.+++++|+.||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 71 e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 71 EFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 99997 33321 01123457899999999999985 9999999999998 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.3e-11 Score=105.68 Aligned_cols=142 Identities=23% Similarity=0.302 Sum_probs=104.0
Q ss_pred EeeeeeccCceEEEEEEEcCCCcEEEEEEe-cCcccCh-----hhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 117 IQEVIGKGSYGVVGSAVDTHTGERVAIKKI-NDVFEHV-----SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 117 i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~-~~~~~~~-----~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.+..|-+|+-+.|+++. ..|+.+.||.- .+...++ -..++..+|+++|.++.--.|.-..-++.+..
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~----- 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY----- 83 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-----
Confidence 46788899999999995 46888888863 2222222 23466789999999886444443333333322
Q ss_pred cEEEEEecccc--cHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCC---eEEeeeccc
Q 010489 191 DIYVVFELMES--DLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLA 263 (509)
Q Consensus 191 ~~~lv~e~~~~--~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~---vkl~DFG~a 263 (509)
.-.|+|||++| .+.+++.... .........++.+|-+.+.-||..+|||+||..+||++..++. +.|+|||++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 24899999998 7888876542 2333333788899999999999999999999999999987653 589999998
Q ss_pred cc
Q 010489 264 RV 265 (509)
Q Consensus 264 ~~ 265 (509)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 65
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.4e-11 Score=105.52 Aligned_cols=132 Identities=22% Similarity=0.333 Sum_probs=92.7
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEE-ecCcccChh-----hHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKK-INDVFEHVS-----DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~-~~~~~~~~~-----~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
..+++|+-+.++.+.. -|..+++|. +++...+.. ...+..+|++++..++--.|...+=+..++. ..
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~-----~~ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD-----NG 74 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC-----CC
Confidence 4578999999999854 355567775 333323222 2345678999999887544443322333332 25
Q ss_pred EEEEeccccc-HHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 193 YVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 193 ~lv~e~~~~~-L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
.|+|||++|. |.+.+... ...++..+-.-+.-||..||||+||.++||++..++ +.++|||++..
T Consensus 75 ~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 75 LIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 8999999985 55566554 245667777778889999999999999999997654 99999999975
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.4e-10 Score=114.60 Aligned_cols=214 Identities=17% Similarity=0.215 Sum_probs=152.9
Q ss_pred ceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEecccc--cH
Q 010489 126 YGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES--DL 203 (509)
Q Consensus 126 ~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~--~L 203 (509)
-.+.|+|....+|..|++|.++.... ........-+++++++.|+|||++.+++....+ ....+++|++|.++ +|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCchH
Confidence 35789999999999999999942111 111122345788999999999999999985443 34568999999984 77
Q ss_pred HHHHHh---------------CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 204 HQVIKA---------------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 204 ~~~l~~---------------~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
.++.-. +...+|..+|.++.||..||.++|+.|+.-+-|.|.+||++.+.+++|...|.......
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 776632 22477899999999999999999999998899999999999998999988887766543
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHh--HHHHHHHhcCCCChhHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH--QLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~i~~~~g~~~~~~~~ 346 (509)
+.. |.+.+ -.+-|.=.||.+++.|.||..--...+... .+..|
T Consensus 446 d~~-----------------~~le~-----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I------------- 490 (655)
T KOG3741|consen 446 DPT-----------------EPLES-----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI------------- 490 (655)
T ss_pred CCC-----------------cchhH-----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-------------
Confidence 331 11211 235688899999999999963211111100 01111
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
.+..+.+++++|.-+...++++ -++.+++.|
T Consensus 491 -------------------------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 491 -------------------------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred -------------------------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 1234566788888888888876 677777765
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.6e-10 Score=105.59 Aligned_cols=142 Identities=19% Similarity=0.281 Sum_probs=99.1
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCC--cceeeeeecCCCcCCCCcEEEEE
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD--IVEIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~ 196 (509)
+.||.|.++.||++... .|..|++|........ .....+.+|+.+++.+.+.+ +.+++.+..... ..+..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEE
Confidence 67899999999999764 3688999987542211 13456789999999997643 456665543221 123468999
Q ss_pred ecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhh-----------------------------------------
Q 010489 197 ELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT----------------------------------------- 234 (509)
Q Consensus 197 e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~----------------------------------------- 234 (509)
||++| .+...+.. ..+++.....++.+++++|..||+
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99997 34333221 345666666667777777777663
Q ss_pred ---------------CCeeecCCCCCcEEECC--CCCeEEeeeccccc
Q 010489 235 ---------------ANVFHRDLKPKNILANA--DCKLKICDFGLARV 265 (509)
Q Consensus 235 ---------------~~ivHrDlKp~NILl~~--~~~vkl~DFG~a~~ 265 (509)
..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24699999999999998 56789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.09 E-value=2e-09 Score=103.76 Aligned_cols=138 Identities=14% Similarity=0.085 Sum_probs=93.8
Q ss_pred ceEEEEEEEcCCCcEEEEEEecCcccCh---------hhHHhHHHHHHHHHHcCCCCcce--eeeeecCCCcCCCCcEEE
Q 010489 126 YGVVGSAVDTHTGERVAIKKINDVFEHV---------SDATRILREIKLLRLLRHPDIVE--IKHIMLPPSRREFKDIYV 194 (509)
Q Consensus 126 ~g~V~~~~~~~~~~~vAiK~~~~~~~~~---------~~~~~~~~Ei~~l~~l~h~niv~--~~~~~~~~~~~~~~~~~l 194 (509)
...|.++. ..|+.|.||......... .....+.+|...+..|..-+|.. ++.+...........-++
T Consensus 35 ~rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 35 GRRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred CceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence 33455553 357789999663211000 01113678999888885444433 233332111111234689
Q ss_pred EEecccc--cHHHHHHh--CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC-------CCCeEEeeeccc
Q 010489 195 VFELMES--DLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-------DCKLKICDFGLA 263 (509)
Q Consensus 195 v~e~~~~--~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~-------~~~vkl~DFG~a 263 (509)
|||++++ +|.+++.. ....+......++.+++..+.-||..||+|+||++.|||++. ++.+.|+||+.+
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 9999997 68888753 245667778899999999999999999999999999999975 467999999988
Q ss_pred cc
Q 010489 264 RV 265 (509)
Q Consensus 264 ~~ 265 (509)
..
T Consensus 193 ~~ 194 (268)
T PRK15123 193 QI 194 (268)
T ss_pred cc
Confidence 53
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=4.5e-09 Score=103.16 Aligned_cols=258 Identities=16% Similarity=0.154 Sum_probs=159.4
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHH-cCCCCcce----eeeeecCCCcCCCCcE
Q 010489 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL-LRHPDIVE----IKHIMLPPSRREFKDI 192 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~-l~h~niv~----~~~~~~~~~~~~~~~~ 192 (509)
.+.||+|+-+.+|-.-.. + ..+.|+....-. ....+ -+..|.. -.||-+.. -... +.+. .....+
T Consensus 16 gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Ppp--a~~aq---k~a~la~~p~~p~~~~rvaWPqa~-L~G~-~~~~~i 85 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPP--AAQAQ---KVAELAATPDAPLLNYRVAWPQAT-LHGG-RRGKVI 85 (637)
T ss_pred CccccCCccceeeecchh--h-chhheeecCCCc--hHHHH---HHHHhccCCCCcchhhhhcccHHH-hhCC-Ccccee
Confidence 467999999999976322 2 234576654211 11111 1222222 23554432 0111 1111 222336
Q ss_pred EEEEecccc--cHHHHHHh------CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 193 YVVFELMES--DLHQVIKA------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 193 ~lv~e~~~~--~L~~~l~~------~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
-+.|..+.| .+..++.. ...+.|+.+.+.++.|+.+.+-||..|.+-+|+.++|+||.+++.|.|.|=..-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 788888875 45555431 2357889999999999999999999999999999999999999999999854332
Q ss_pred cccCCCCCcccccccccccccccccccc-cc--cCCCCCceeeehhhhHHHHHHhC-CCCCCCCChHhHHHHHHHhcCCC
Q 010489 265 VSFNDAPSAIFWTDYVATRWYRAPELCG-SF--FSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVHQLDLMTDLLGTP 340 (509)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~--~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~g~~ 340 (509)
.. ...+...+.+|.+.|.+||.-. +. ...-+...|.|.||++++++|.| +.||.|-..... -+.|
T Consensus 166 i~----~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~-------ap~p 234 (637)
T COG4248 166 IN----ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISD-------APNP 234 (637)
T ss_pred ec----cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCC-------CCCc
Confidence 22 1222345568999999999743 11 12346679999999999999987 899987431000 0111
Q ss_pred ChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCC--CCCCCCHHH
Q 010489 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFD--PKDRPTAEE 399 (509)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d--P~~Rpt~~e 399 (509)
.+..|......... +.-+...+.+.+..|.-+++.+..|..+|+..- +.-|||++.
T Consensus 235 ~E~~Ia~g~f~ya~---~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 235 LETDIAHGRFAYAS---DQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred chhhhhcceeeech---hccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 11122221111111 112233455555666778999999999999843 568999753
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.3e-10 Score=120.53 Aligned_cols=155 Identities=23% Similarity=0.331 Sum_probs=111.5
Q ss_pred HHHhHhhhhhh-CCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccccc--------ccccccccccccccccc
Q 010489 224 QLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT--------DYVATRWYRAPELCGSF 294 (509)
Q Consensus 224 qil~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~--------~~~gt~~y~aPE~~~~~ 294 (509)
+++.||.|+|. .++||+.|.|++|.++..|.+||+.|+++........ ..+. -..-...|.|||++.+
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~--~p~~~yd~~lp~~~~~~~~f~apE~~~~- 183 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE--YPFSEYDPPLPLLLQPHLNFLAPEYLLG- 183 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc--cccccCCCCCChhhccCcccccchhhcc-
Confidence 34489999996 5899999999999999999999999998865432111 0011 1133567999999887
Q ss_pred cCCCCCceeeehhhhHHHHHH-hCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCC
Q 010489 295 FSKYTPAIDIWSIGCIFAEML-TGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFP 373 (509)
Q Consensus 295 ~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (509)
...+.++|+||+||++|.+. .|+..+.+.........-... ... .. ...-.
T Consensus 184 -~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~---------------------~~~---~~---~~~s~ 235 (700)
T KOG2137|consen 184 -TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL---------------------LNA---GA---FGYSN 235 (700)
T ss_pred -ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc---------------------ccc---cc---ccccc
Confidence 67889999999999999999 566666554321111110000 000 00 01114
Q ss_pred CCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 374 NADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 374 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
++++++++=|.++|..|+..||++.+++.-|||.+-
T Consensus 236 ~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~ 271 (700)
T KOG2137|consen 236 NLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDP 271 (700)
T ss_pred cCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence 678999999999999999999999999999999753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.9e-09 Score=98.13 Aligned_cols=127 Identities=28% Similarity=0.304 Sum_probs=80.9
Q ss_pred EEEEEEEcCCCcEEEEEEecCc--------------cc--------Ch--hhHHhHHHHHHHHHHcCCC--Ccceeeeee
Q 010489 128 VVGSAVDTHTGERVAIKKINDV--------------FE--------HV--SDATRILREIKLLRLLRHP--DIVEIKHIM 181 (509)
Q Consensus 128 ~V~~~~~~~~~~~vAiK~~~~~--------------~~--------~~--~~~~~~~~Ei~~l~~l~h~--niv~~~~~~ 181 (509)
.||.|.. ..|..+|||+.+.. .. .. .......+|.+.|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888876 46789999986421 00 00 0123467899999999865 455665543
Q ss_pred cCCCcCCCCcEEEEEeccc--ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhh-hhhCCeeecCCCCCcEEECCCCCeEEe
Q 010489 182 LPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKY-IHTANVFHRDLKPKNILANADCKLKIC 258 (509)
Q Consensus 182 ~~~~~~~~~~~~lv~e~~~--~~L~~~l~~~~~l~~~~~~~i~~qil~aL~y-LH~~~ivHrDlKp~NILl~~~~~vkl~ 258 (509)
.-+|||||++ |.....+... .++.+....++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+
T Consensus 80 ---------~~~ivME~I~~~G~~~~~l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---------RNVIVMEYIGEDGVPLPRLKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---------TTEEEEE--EETTEEGGCHHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE-
T ss_pred ---------CCEEEEEecCCCccchhhHHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEE
Confidence 1389999999 6322222221 12245567778888886655 589999999999999999877 99999
Q ss_pred eecccccc
Q 010489 259 DFGLARVS 266 (509)
Q Consensus 259 DFG~a~~~ 266 (509)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.3e-09 Score=98.81 Aligned_cols=109 Identities=27% Similarity=0.372 Sum_probs=84.4
Q ss_pred HHhHHHHHHHHHHcCCCCc--ceeeeeecCCCcCCCCcEEEEEecccc--cHHHHHHhCCCCCHHHHHHHHHHHHhHhhh
Q 010489 156 ATRILREIKLLRLLRHPDI--VEIKHIMLPPSRREFKDIYVVFELMES--DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231 (509)
Q Consensus 156 ~~~~~~Ei~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~--~L~~~l~~~~~l~~~~~~~i~~qil~aL~y 231 (509)
..+..+|...+..|..-.| .+.+.+...... .....++|+|++++ +|.+++.....++......++.+++..+.-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~-~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKG-GGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCC-CceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence 3467788888887764333 333444332221 11346899999986 788888875557778888999999999999
Q ss_pred hhhCCeeecCCCCCcEEECCCC---CeEEeeeccccc
Q 010489 232 IHTANVFHRDLKPKNILANADC---KLKICDFGLARV 265 (509)
Q Consensus 232 LH~~~ivHrDlKp~NILl~~~~---~vkl~DFG~a~~ 265 (509)
||..||+|+|+++.|||++.++ .+.|+||+-++.
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999999887 899999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG4171 consensus Adenylate/guanylate kinase [Nucleotide transport and metabolism] | Back alignment and domain information |
|---|
Probab=98.93 E-value=9.9e-11 Score=121.22 Aligned_cols=75 Identities=16% Similarity=0.171 Sum_probs=70.7
Q ss_pred hhcCHHHHHHHHHHHHHHhChhhHHHHhhcCCCccccCCCCcchHHHHHHHHHhhcCCCCCCCCcccccCCCCccccC
Q 010489 431 RKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRYVCF 508 (509)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~p~~v~~~l~~g~~~~~~~~~~v~~~~~~fs~i~~~~~~~~~s~p~~~~~~~~~~~~~~ 508 (509)
...+.+++|++..++++++.|..||++|..|+.+.+..|+.||+. |+||+|||++|+..+|+|||++||+||+-|
T Consensus 402 ~~~~Le~EKkkTd~LLy~mlP~~VA~qLr~g~~v~a~~f~~vTil---FsdIv~Ft~ic~~ctp~~vV~~LN~lyt~f 476 (671)
T KOG4171|consen 402 MTRELEEEKKKTDTLLYSMLPRSVAQQLRQGESVDAKEFDDVTIL---FSDIVGFTAICSQCTPMQVVNMLNELYTRF 476 (671)
T ss_pred HHHHHHHHHhhHHHHHHHhCCHHHHHHHHcCCCcCccccCceEEE---EeccchHHhHhhccCcHHHHHHHHHHHHHH
Confidence 334567889999999999999999999999999999999999999 999999999999999999999999999987
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.3e-08 Score=95.40 Aligned_cols=135 Identities=26% Similarity=0.258 Sum_probs=96.5
Q ss_pred eeEeeeeeccCceEEEEEEEcCCCcEEEEEEec-------Cccc---------Ch----hhHHhHHHHHHHHHHcCCC--
Q 010489 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-------DVFE---------HV----SDATRILREIKLLRLLRHP-- 172 (509)
Q Consensus 115 y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~-------~~~~---------~~----~~~~~~~~Ei~~l~~l~h~-- 172 (509)
+.++.+||-|.-+.||.|.+. .|..+|||.=+ +... +. .......+|.++|.+|.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 467789999999999999875 68999999631 1000 00 1123457899999998644
Q ss_pred CcceeeeeecCCCcCCCCcEEEEEeccccc-HHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC
Q 010489 173 DIVEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 251 (509)
Q Consensus 173 niv~~~~~~~~~~~~~~~~~~lv~e~~~~~-L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~ 251 (509)
.+.+.++. +.-.+||||++|- |... +++.+....++..|++-+.-+-..||||+|+.+-|||+++
T Consensus 172 ~VP~P~~~---------nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 172 KVPKPIAW---------NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCCcccc---------ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence 45544332 2358999999983 3322 1234455566666676666666899999999999999999
Q ss_pred CCCeEEeeecccc
Q 010489 252 DCKLKICDFGLAR 264 (509)
Q Consensus 252 ~~~vkl~DFG~a~ 264 (509)
+|.+.++||--+.
T Consensus 238 dg~~~vIDwPQ~v 250 (304)
T COG0478 238 DGDIVVIDWPQAV 250 (304)
T ss_pred CCCEEEEeCcccc
Confidence 9999999997654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.3e-07 Score=86.58 Aligned_cols=142 Identities=15% Similarity=0.154 Sum_probs=101.2
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEecCc----ccChhhHHhHHHHHHHHHHcCCCCc--ceeeeeecCCCcCCCCcEEE
Q 010489 121 IGKGSYGVVGSAVDTHTGERVAIKKINDV----FEHVSDATRILREIKLLRLLRHPDI--VEIKHIMLPPSRREFKDIYV 194 (509)
Q Consensus 121 lG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~~~~Ei~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~l 194 (509)
-|+||-+-|+.... .|+.|-+|.-... .........+.+|+..|+.|..-+| .++. ++..........-+|
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 35688888888753 3446888875411 1112345678899999998864333 3333 221111111234689
Q ss_pred EEecccc--cHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCC--eEEeeeccccc
Q 010489 195 VFELMES--DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARV 265 (509)
Q Consensus 195 v~e~~~~--~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~--vkl~DFG~a~~ 265 (509)
|+|-++| +|.+++... .+.+......++.+++.++.-||+.|+.|+|+-+.|||++.+|. ++++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9998884 898888653 34577778899999999999999999999999999999987777 99999987654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.4e-07 Score=85.22 Aligned_cols=143 Identities=16% Similarity=0.221 Sum_probs=89.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChh-hH------HhHHHHHHHHHHcCCCCcc---eeeeee
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS-DA------TRILREIKLLRLLRHPDIV---EIKHIM 181 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~-~~------~~~~~Ei~~l~~l~h~niv---~~~~~~ 181 (509)
.++|.+.+++-......|.+.. ..|..+.+|..+....... .. ....+++..+..++...+. .++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4678899999888877776663 4678999998754221111 11 1123444444444333322 222222
Q ss_pred cCCCcCCCCcEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeee
Q 010489 182 LPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 260 (509)
Q Consensus 182 ~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DF 260 (509)
.-....-....+++|||++| .|.+... +++ .+...|.+++.-||..|++|+|..|.|++++.+ .++++||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEEC
Confidence 11111112335689999998 4544321 233 244567788999999999999999999999855 5999999
Q ss_pred ccccc
Q 010489 261 GLARV 265 (509)
Q Consensus 261 G~a~~ 265 (509)
+..+.
T Consensus 179 ~~k~~ 183 (229)
T PF06176_consen 179 QGKRM 183 (229)
T ss_pred ccccc
Confidence 87653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.8e-07 Score=84.81 Aligned_cols=137 Identities=20% Similarity=0.160 Sum_probs=93.8
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhh-----------------H-----HhHHHHHHHHHHcC--CCC
Q 010489 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSD-----------------A-----TRILREIKLLRLLR--HPD 173 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~-----------------~-----~~~~~Ei~~l~~l~--h~n 173 (509)
...|..|.-+.||+|.. ..+..+|+|+.+........ . .-..+|..-|+++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34677888889999964 56889999997532111000 0 11246777787775 444
Q ss_pred cceeeeeecCCCcCCCCcEEEEEecccccH--HHHHHhCCCCCHHHHHHHHHHHHhHhhhhhh-CCeeecCCCCCcEEEC
Q 010489 174 IVEIKHIMLPPSRREFKDIYVVFELMESDL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILAN 250 (509)
Q Consensus 174 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L--~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDlKp~NILl~ 250 (509)
+.+.+.+. .-.|||||++... .-.+. .-.+...++..+..++++.+.-|-. .++||+||..-|||+.
T Consensus 132 vP~Pi~~~---------~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~ 201 (268)
T COG1718 132 VPEPIAFR---------NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH 201 (268)
T ss_pred CCCceeec---------CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence 44444443 2489999998531 11111 1123444788888999999998876 9999999999999998
Q ss_pred CCCCeEEeeecccccc
Q 010489 251 ADCKLKICDFGLARVS 266 (509)
Q Consensus 251 ~~~~vkl~DFG~a~~~ 266 (509)
++.+.|+|||-|...
T Consensus 202 -~~~p~iID~~QaV~~ 216 (268)
T COG1718 202 -DGEPYIIDVSQAVTI 216 (268)
T ss_pred -CCeEEEEECcccccc
Confidence 889999999988643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=4.3e-08 Score=101.12 Aligned_cols=242 Identities=16% Similarity=0.123 Sum_probs=159.6
Q ss_pred eeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCC-cceeeeeecCCCcCCCCcEE
Q 010489 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD-IVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 115 y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~~~~~~~~~~~~~~~~~~ 193 (509)
|....-+++|+++++++.+...+...+ .+++... ....-++++|.+++||| .+..++ +.+.+.+.+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~-----d~~~E~~~~ 310 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLE-----DYDGEDYLW 310 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccc-----cCCcccccc
Confidence 455677899999999999877666655 7766432 23345788999999999 333222 224556789
Q ss_pred EEEeccccc--HHHHH-HhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 194 VVFELMESD--LHQVI-KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 194 lv~e~~~~~--L~~~l-~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
++++++.+. ..... ...-.+..-+...+.+.-+++|++||+.-=+||| |||..+ +..|..||+.+..+....
T Consensus 311 i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 311 IPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred hhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc
Confidence 999999853 21111 1111234444556677778899999998778999 887754 689999999987654332
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
......+|+.++|||+... ..+....|.|++|+-..+|--|.+|-...- ... ...|..+.
T Consensus 386 ----~~~t~~~~~~~~~pev~~~--~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~----~~~g~~p~-------- 445 (829)
T KOG0576|consen 386 ----KPRTAIGTPEPLAPEVIQE--NTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVL----PMIGNGPN-------- 445 (829)
T ss_pred ----ccccCCCCCCCCCchhhcc--cccccCCCccCCCcchhhcCCCCCCCCCCc--ccc----CCCCCCCC--------
Confidence 2355789999999998877 688999999999998888888877654310 000 00000000
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
.....-...|... .-.++...|+..-|..|+....++.|.+|.+
T Consensus 446 ------------s~~L~~~~aw~~~--~~~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 446 ------------SPMLTDKSAWSPV--FHRDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred ------------ccccchhhhcCcc--cccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 0000000011100 1124777899999999999999999988865
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.42 E-value=4.2e-07 Score=99.86 Aligned_cols=207 Identities=18% Similarity=0.228 Sum_probs=143.0
Q ss_pred HHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhh
Q 010489 156 ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234 (509)
Q Consensus 156 ~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~ 234 (509)
......|+..+..+.|+|++.++.+-...-... ..+.+..++|.+ ++...+..-+..+....+.+..++++||+|+|+
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 344556777788899999999988775543211 123455577774 788888888899999999999999999999999
Q ss_pred CCeeecCCCCC---cEEECCCCCeEEe--eecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhh
Q 010489 235 ANVFHRDLKPK---NILANADCKLKIC--DFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGC 309 (509)
Q Consensus 235 ~~ivHrDlKp~---NILl~~~~~vkl~--DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~ 309 (509)
....|.-|-.+ +--++.++.+.++ ||+.+......... ....-+..+.|||.............|+|.+|.
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~----~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS----FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccc----hhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 97666665555 4445666777777 89888754332221 122445567788877652222333479999999
Q ss_pred HHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCC-HHHHHHHHHhcc
Q 010489 310 IFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNAD-PLALHLLERLLA 388 (509)
Q Consensus 310 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~li~~~L~ 388 (509)
.+..+..|..+-.-.. .+ ..++ +..+ ....+++.+|+.
T Consensus 381 l~~~~~~~~~i~~~~~------~~--------------------~~~l---------------~~~~~~~~~d~~~~~~~ 419 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSA------VP--------------------VSLL---------------DVLSTSELLDALPKCLD 419 (1351)
T ss_pred HHhhhhhcCccccccc------ch--------------------hhhh---------------ccccchhhhhhhhhhcc
Confidence 9999998864321100 00 0000 0111 157889999999
Q ss_pred CCCCCCCCHHHHhcCCcccC
Q 010489 389 FDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 389 ~dP~~Rpt~~e~l~hp~f~~ 408 (509)
-|+++|+++.+++.|+|.+-
T Consensus 420 ~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 420 EDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred hhhhhccchhhhhhchhccc
Confidence 99999999999999999863
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.39 E-value=3.7e-06 Score=79.39 Aligned_cols=132 Identities=17% Similarity=0.168 Sum_probs=78.1
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCc--ceeeeeecCCCcCCCCcEEEEE
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI--VEIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~ 196 (509)
..||.|..+.||+. .+..+++|..... .....+.+|.++++.+..-.+ .+.+++... .....+||
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~----~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~-----~~~~glv~ 73 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPG----FDKETIKREFDASRKVFSLGIPTPHPFDLVED-----GGRLGLIY 73 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCC----CCHHHHHHHHHHHHHHHHcCCCCCceEEEEec-----CCeeeeee
Confidence 67899999999984 2556788877532 123456889999988864333 455555522 23367899
Q ss_pred eccccc--HH--------------HHHH-------hC--CCCCHHH-HHHHHHHH----------Hh-Hhhhhh----hC
Q 010489 197 ELMESD--LH--------------QVIK-------AN--DDLTPEH-YQFFLYQL----------LR-GLKYIH----TA 235 (509)
Q Consensus 197 e~~~~~--L~--------------~~l~-------~~--~~l~~~~-~~~i~~qi----------l~-aL~yLH----~~ 235 (509)
|+++|. +. ..+. .- ....... ...+..++ .+ ...+|. ..
T Consensus 74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~ 153 (226)
T TIGR02172 74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS 153 (226)
T ss_pred eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence 999873 11 1110 00 0111110 01111111 11 111222 12
Q ss_pred CeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 236 NVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 236 ~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
.++|+|+.|.||+++.++ +.|+||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 479999999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=2.4e-06 Score=75.30 Aligned_cols=130 Identities=19% Similarity=0.232 Sum_probs=90.7
Q ss_pred eeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEE
Q 010489 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 194 (509)
Q Consensus 115 y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 194 (509)
-++.+.||+|.+|.||++.. .|..+|+|+-+. +.....+..|+++|..++-.++.+=+-.+ +..++
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~----ds~r~~l~kEakiLeil~g~~~~p~vy~y--------g~~~i 89 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRR----DSPRRNLEKEAKILEILAGEGVTPEVYFY--------GEDFI 89 (201)
T ss_pred hhhhhhhhcccccEEEEeec--cCceEEEEEecC----CcchhhHHHHHHHHHHhhhcCCCceEEEe--------chhhh
Confidence 35578899999999999965 477999997643 33456788999999999877765432222 12366
Q ss_pred EEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCC-CCcEEECCCCCeEEeeeccccc
Q 010489 195 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK-PKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 195 v~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlK-p~NILl~~~~~vkl~DFG~a~~ 265 (509)
.|||+.| .|.++.... +. .-+..++++---|-..||-|..|. |.-++|..++.+.|+||..|+.
T Consensus 90 ~me~i~G~~L~~~~~~~---~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 90 RMEYIDGRPLGKLEIGG---DR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcCcchhhhhhcc---cH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 7999998 665554321 22 233455666556778899999996 5444444555999999998874
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=5.7e-06 Score=86.57 Aligned_cols=139 Identities=23% Similarity=0.311 Sum_probs=85.6
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCcccChh--h--------------------------H----------HhHH
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS--D--------------------------A----------TRIL 160 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~--~--------------------------~----------~~~~ 160 (509)
+.|+.++-|.||+|+-+ +|+.||||+.+......- + . -.+.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 67999999999999865 599999999753211000 0 0 1123
Q ss_pred HHHHHHHHcC----CCCcceeeeeecCCCcCCCCcEEEEEecccc-cHHHH--HHhCCCCCHHHHHHHHHHHHhH-hhhh
Q 010489 161 REIKLLRLLR----HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQV--IKANDDLTPEHYQFFLYQLLRG-LKYI 232 (509)
Q Consensus 161 ~Ei~~l~~l~----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~--l~~~~~l~~~~~~~i~~qil~a-L~yL 232 (509)
+|..-+.+++ ...-+.+-.++..-+ ..-.|+|||++| .+.+. +.. ..++...+.. .++++ +..+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t----~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~---~~~~~f~~q~ 281 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYT----TRRVLTMEWIDGIKISDIAALKS-AGIDRKELAE---LLVRAFLRQL 281 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhcc----CCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHH---HHHHHHHHHH
Confidence 4555554442 222233334443211 224899999998 44444 333 3344333222 22221 2223
Q ss_pred hhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 233 H~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
=..|++|.|..|.||+++.+|++.+.|||+....
T Consensus 282 ~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 282 LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred HhcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 3489999999999999999999999999998654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.1e-05 Score=76.19 Aligned_cols=139 Identities=21% Similarity=0.228 Sum_probs=79.2
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCC--cceeeeeecCCCcCCCCcEEEE
Q 010489 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD--IVEIKHIMLPPSRREFKDIYVV 195 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv 195 (509)
++.|+.|..+.||++.... ..+++|..... .....+.+|+.+++.+.... +.+++...... ......+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~--~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD--EFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET--EETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccc--cccccceEE
Confidence 4779999999999998654 48999987532 34567778999998886433 44555433221 222347999
Q ss_pred Eeccccc-HHH----------------HHH---hC----CCCCHHH------HHHH---------------HHHHHh-Hh
Q 010489 196 FELMESD-LHQ----------------VIK---AN----DDLTPEH------YQFF---------------LYQLLR-GL 229 (509)
Q Consensus 196 ~e~~~~~-L~~----------------~l~---~~----~~l~~~~------~~~i---------------~~qil~-aL 229 (509)
|++++|. +.. .+. .. ..+.... ...+ ...+.+ .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 9999863 333 111 11 1111100 0000 111222 23
Q ss_pred hhhh-------hCCeeecCCCCCcEEEC-CCCCeEEeeecccc
Q 010489 230 KYIH-------TANVFHRDLKPKNILAN-ADCKLKICDFGLAR 264 (509)
Q Consensus 230 ~yLH-------~~~ivHrDlKp~NILl~-~~~~vkl~DFG~a~ 264 (509)
..++ ...++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3333 24599999999999999 66667899999775
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.6e-05 Score=72.48 Aligned_cols=132 Identities=26% Similarity=0.314 Sum_probs=91.5
Q ss_pred CCeeEeeeeeccCc-eEEEEEEEcCCCcEEEEEEecC---c--------cc-Ch-------hhHHhHHHHHHHHHHcC--
Q 010489 113 SRYQIQEVIGKGSY-GVVGSAVDTHTGERVAIKKIND---V--------FE-HV-------SDATRILREIKLLRLLR-- 170 (509)
Q Consensus 113 ~~y~i~~~lG~G~~-g~V~~~~~~~~~~~vAiK~~~~---~--------~~-~~-------~~~~~~~~Ei~~l~~l~-- 170 (509)
.+++.++.||.|.- |.||++.. .|+.||+|.++. . .. .. .....+..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67899999999999 99999964 588999999421 0 00 00 11234667888766654
Q ss_pred -CCCc--ceeeeeecCCCc-------------CCCCcEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhh
Q 010489 171 -HPDI--VEIKHIMLPPSR-------------REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234 (509)
Q Consensus 171 -h~ni--v~~~~~~~~~~~-------------~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~ 234 (509)
+.++ |++++++.-... .......||.||....- .++.. -+.+|++-|..+|.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~~----~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQIR----DIPQMLRDLKILHK 182 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccchh----HHHHHHHHHHHHHH
Confidence 5566 899888854310 11122467888877432 22222 34677788889999
Q ss_pred CCeeecCCCCCcEEECCCCCeEEeeeccc
Q 010489 235 ANVFHRDLKPKNILANADCKLKICDFGLA 263 (509)
Q Consensus 235 ~~ivHrDlKp~NILl~~~~~vkl~DFG~a 263 (509)
.||+-+|+|+.|.. .-||+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred CCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999997 3489999965
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.04 E-value=5.6e-05 Score=72.28 Aligned_cols=70 Identities=13% Similarity=0.064 Sum_probs=45.2
Q ss_pred eeeccCc-eEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCCCcEEEEEe
Q 010489 120 VIGKGSY-GVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIYVVFE 197 (509)
Q Consensus 120 ~lG~G~~-g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e 197 (509)
.|-.|.+ +.||++... +..+.||...... ...+.+|+.+++.+. +--+.+++++.... ...++|||
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-----~~~~lv~e 72 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDD-----GRAWLLTS 72 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecC-----CccEEEEE
Confidence 3555655 789999643 4678888765321 335668999988885 33344566555322 23689999
Q ss_pred cccc
Q 010489 198 LMES 201 (509)
Q Consensus 198 ~~~~ 201 (509)
+++|
T Consensus 73 ~i~G 76 (244)
T cd05150 73 AVPG 76 (244)
T ss_pred eeCC
Confidence 9987
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.99 E-value=9e-05 Score=83.37 Aligned_cols=82 Identities=20% Similarity=0.241 Sum_probs=54.7
Q ss_pred eeeeeccCceEEEEEEEcCCC--cEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCc--ceeeeeecCCCcCCCCcE
Q 010489 118 QEVIGKGSYGVVGSAVDTHTG--ERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDI--VEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~~~--~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~ni--v~~~~~~~~~~~~~~~~~ 192 (509)
++.|+.|.+..+|+......+ ..+++|+...... ......+.+|+++|+.+. |.++ .+++.++.+.. ..+..
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~-~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~--v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL-LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDAS--VIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc-CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCC--cCCCc
Confidence 577899999999998754332 4677787543211 122346789999999996 6665 66666654331 22346
Q ss_pred EEEEeccccc
Q 010489 193 YVVFELMESD 202 (509)
Q Consensus 193 ~lv~e~~~~~ 202 (509)
|+||||++|.
T Consensus 120 flVME~v~G~ 129 (822)
T PLN02876 120 FYIMEYLEGR 129 (822)
T ss_pred eEEEEecCCc
Confidence 8999999874
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.97 E-value=5e-05 Score=77.33 Aligned_cols=175 Identities=23% Similarity=0.341 Sum_probs=118.1
Q ss_pred HHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhC
Q 010489 156 ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 235 (509)
Q Consensus 156 ~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~ 235 (509)
..+++-...+++.+.|++....+++..... ....+|||+++.+|.+.+..+. +..... + .+
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~----~r~IVV~e~~~~Sled~~~~~~-l~~~s~-------~-------~~ 86 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKH----ERVIVVMEHYTMSLEDILKTGN-LKDESL-------L-------AH 86 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCcc----ceEEEEehhhccchHHHHHhcc-cchhhh-------c-------cc
Confidence 456677788999999999999888764332 2389999999999999887664 321111 1 12
Q ss_pred CeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHH
Q 010489 236 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEML 315 (509)
Q Consensus 236 ~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell 315 (509)
++.|- +.++++| -++. . | | ...++|+||||+|.|+.|+.
T Consensus 87 ~~~~~------------~~~~~td-~~~t-------------~------~--~-------~~~~pKsdVwsl~~i~~el~ 125 (725)
T KOG1093|consen 87 GVLHL------------NIIYITD-HFLT-------------K------Y--P-------SPIGPKSDVWSLGFIILELY 125 (725)
T ss_pred cccee------------hhhhccc-cccc-------------c------C--C-------CCCCcchhhhhHHHHHHHHH
Confidence 22211 1233344 0100 0 0 1 11225999999999999999
Q ss_pred hCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 010489 316 TGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP 395 (509)
Q Consensus 316 ~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 395 (509)
-|...|......+++..+.++.-.+.....-.... ... -.++....+++.+|+...|..||
T Consensus 126 L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~--~~~-----------------~~~d~~~~~~~~~c~~~~~~ir~ 186 (725)
T KOG1093|consen 126 LGISLEAELTESEYLEILLKYYTDDQELLSTAMEH--LIQ-----------------LLADKKRLPLLKKCLWLEPIIRP 186 (725)
T ss_pred HhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHH--HHH-----------------HhhhHhHHHHhccCCcccccccc
Confidence 99999988888888888887765544432221111 111 12455678899999999999999
Q ss_pred CHHHHhcCCcccCC
Q 010489 396 TAEEALADPYFHGL 409 (509)
Q Consensus 396 t~~e~l~hp~f~~~ 409 (509)
...++.+|+-|...
T Consensus 187 l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 187 LPMELSKRCSFTEV 200 (725)
T ss_pred chhHHhcCccHHHH
Confidence 99999999999654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00012 Score=76.47 Aligned_cols=138 Identities=26% Similarity=0.342 Sum_probs=84.4
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCcccCh--hh---------------------------HHh------HHHHH
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV--SD---------------------------ATR------ILREI 163 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~--~~---------------------------~~~------~~~Ei 163 (509)
+.||.-+.|.||+|+-+. |+.||||+-+...... .+ .+. +.+|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 679999999999998765 9999999865322111 00 011 23344
Q ss_pred HHHHH----cCCCC---cceeeeeecCCCcCCCCcEEEEEecccc----cHHHHHHhCCCCCHHHHHHHHHHHHhHh-hh
Q 010489 164 KLLRL----LRHPD---IVEIKHIMLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLYQLLRGL-KY 231 (509)
Q Consensus 164 ~~l~~----l~h~n---iv~~~~~~~~~~~~~~~~~~lv~e~~~~----~L~~~l~~~~~l~~~~~~~i~~qil~aL-~y 231 (509)
+-..+ +.|-+ -|.+-.++..-+ ..-.|+||||+| |+ +.+.+.+ ++...+.. .+.++. +-
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl-~~i~~~g-i~~~~i~~---~l~~~~~~q 316 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDL-DAIDKRG-ISPHDILN---KLVEAYLEQ 316 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCH-HHHHHcC-CCHHHHHH---HHHHHHHHH
Confidence 43322 33444 122333332221 124899999997 44 4454443 45443333 333322 22
Q ss_pred hhhCCeeecCCCCCcEEECC----CCCeEEeeecccccc
Q 010489 232 IHTANVFHRDLKPKNILANA----DCKLKICDFGLARVS 266 (509)
Q Consensus 232 LH~~~ivHrDlKp~NILl~~----~~~vkl~DFG~a~~~ 266 (509)
|=..|++|.|=.|.||++.. ++.+.+-|||+....
T Consensus 317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 34578999999999999994 678999999998754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00024 Score=65.33 Aligned_cols=128 Identities=20% Similarity=0.241 Sum_probs=88.9
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCcc--------------cChhhHHhHHHHHHHHHHcC------CCCcceee
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVF--------------EHVSDATRILREIKLLRLLR------HPDIVEIK 178 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--------------~~~~~~~~~~~Ei~~l~~l~------h~niv~~~ 178 (509)
..||+|+.=.||.- ......+||++.... ..........+|+.-...+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 56999999888875 234557889886533 11123456677887776666 78899999
Q ss_pred eeecCCCcCCCCcEEEEEeccc---c----cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC
Q 010489 179 HIMLPPSRREFKDIYVVFELME---S----DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 251 (509)
Q Consensus 179 ~~~~~~~~~~~~~~~lv~e~~~---~----~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~ 251 (509)
|+..+.. .+-+|+|.+. | +|.+++.. +.+++ .. ...+-+-..||-+.+|+.+||+|.||++..
T Consensus 84 G~veT~~-----G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 84 GFVETNL-----GLGLVVELIRDADGNISPTLEDYLKE-GGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEEecCC-----ceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEe
Confidence 9985543 3678888763 2 57888744 45665 33 333344556888999999999999999864
Q ss_pred CC----CeEEee
Q 010489 252 DC----KLKICD 259 (509)
Q Consensus 252 ~~----~vkl~D 259 (509)
.. .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 32 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00012 Score=69.64 Aligned_cols=31 Identities=35% Similarity=0.503 Sum_probs=25.6
Q ss_pred CCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 235 ANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 235 ~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
.+++|+|+.|.|||++.++..-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3589999999999998665457999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.75 E-value=7.8e-06 Score=92.00 Aligned_cols=199 Identities=15% Similarity=0.057 Sum_probs=132.9
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCc-cc--ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FE--HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~--~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
..|++.--+|-|.+++--.-+.+..+ +.+|+.+.- +. .....+..+.|..-++...|+++.....-..+ .+.
T Consensus 1229 e~~EV~l~i~~~~~~R~k~Lr~kid~--Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~p---s~s 1303 (2724)
T KOG1826|consen 1229 EHSEVNLGISNHFHFRNKWLRSKIDW--FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPP---SES 1303 (2724)
T ss_pred hhhheeeecccceeeccchHhhhhce--eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCC---CCC
Confidence 35566555666665543222222222 344443321 00 11122334455556667789998876554433 233
Q ss_pred CcEEEEEeccc-ccHHHHHHhC----CCCCHHHHHHHHHHHHhHhhhhhhCC-----eeecCCCCCcEEECCCCCeEEee
Q 010489 190 KDIYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTAN-----VFHRDLKPKNILANADCKLKICD 259 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~~-----ivHrDlKp~NILl~~~~~vkl~D 259 (509)
...|.+++|+. |.++..+.++ ..+....+.....+.+.+..-+|+.. .+|++||+-|.+|..+..+|+++
T Consensus 1304 ~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk 1383 (2724)
T KOG1826|consen 1304 TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGK 1383 (2724)
T ss_pred hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccc
Confidence 45689999998 7898888654 24555555555555577777777642 69999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCC
Q 010489 260 FGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 321 (509)
Q Consensus 260 FG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 321 (509)
+|+.+..... .......++++.|++|++... -.++.++|+|..|+-+|++..|..+|
T Consensus 1384 ~gLdKIknp~---~sf~Gl~l~sp~~v~qli~N~--ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1384 GGLDKIKNPV---LSFFGLELCSPIYVLQLIKNE--IKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred cccccccCch---HhhhhhhhCCHHHHHHHHHHH--HhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 9999843222 222355688899999999876 57788899999999999999998777
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00055 Score=64.94 Aligned_cols=72 Identities=11% Similarity=0.171 Sum_probs=44.6
Q ss_pred eeeeeccCceEEEEEEEcC-CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCc-ceeeeeecCCCcCCCCcEEEE
Q 010489 118 QEVIGKGSYGVVGSAVDTH-TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI-VEIKHIMLPPSRREFKDIYVV 195 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv 195 (509)
++.|..|-...||++.... .++.|++|+...... ......+|+.+++.+...++ .+++... . -.++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~----~~~l 70 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATF-----Q----NGLI 70 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEe-----C----CcEE
Confidence 4667888888999996432 356888997643211 11223478999988864444 3443322 1 1479
Q ss_pred Eecccc
Q 010489 196 FELMES 201 (509)
Q Consensus 196 ~e~~~~ 201 (509)
|||++|
T Consensus 71 ~e~i~G 76 (235)
T cd05157 71 YEFIPG 76 (235)
T ss_pred EEeeCC
Confidence 999886
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00012 Score=66.85 Aligned_cols=96 Identities=23% Similarity=0.203 Sum_probs=76.8
Q ss_pred HHHHHHHHcCC-CCcceeeeeecCCCcCCCCcEEEEEeccc-ccHHHH---HHhCCCCCHHHHHHHHHHHHhHhhhhhh-
Q 010489 161 REIKLLRLLRH-PDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQV---IKANDDLTPEHYQFFLYQLLRGLKYIHT- 234 (509)
Q Consensus 161 ~Ei~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~---l~~~~~l~~~~~~~i~~qil~aL~yLH~- 234 (509)
.|.-+|+.+.+ +++.+++|.|- -++|.||.+ +.+... +..-...+|..+..|+.++++.+++|+.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG---------~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~ 78 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG---------RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHG 78 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC---------CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence 58888999986 69999999981 267899988 344311 1112246899999999999999999987
Q ss_pred --CCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 235 --ANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 235 --~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
..+.-.|++|+|+-++++|++|++|...+..
T Consensus 79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 3478899999999999999999999987754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00024 Score=69.81 Aligned_cols=140 Identities=24% Similarity=0.298 Sum_probs=95.5
Q ss_pred eEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc----------------cC------hhh--HHhHHHHHHHHHHcCC
Q 010489 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF----------------EH------VSD--ATRILREIKLLRLLRH 171 (509)
Q Consensus 116 ~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----------------~~------~~~--~~~~~~Ei~~l~~l~h 171 (509)
.|-.+|..|.-+.||.|.. .+|..+|||+.+-.. .+ ..- .--..+|++-|++|..
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 4556788899999999975 578889999874210 00 000 0113467888888876
Q ss_pred CCcceeeeeecCCCcCCCCcEEEEEeccccc-HHHHHHhCCCCCHHHHHHHHHHHHhHhhhh-hhCCeeecCCCCCcEEE
Q 010489 172 PDIVEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYI-HTANVFHRDLKPKNILA 249 (509)
Q Consensus 172 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~-L~~~l~~~~~l~~~~~~~i~~qil~aL~yL-H~~~ivHrDlKp~NILl 249 (509)
..|...--+.+ ..-.|||+|++++ ...=..+.-.++...+..+-.|++.-+.-| |.+++||.||.--|+|+
T Consensus 226 aGIP~PePIlL-------k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 226 AGIPCPEPILL-------KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY 298 (520)
T ss_pred cCCCCCCceee-------ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE
Confidence 66543222221 1237999999842 211112234577778888888888888877 56899999999999999
Q ss_pred CCCCCeEEeeecccc
Q 010489 250 NADCKLKICDFGLAR 264 (509)
Q Consensus 250 ~~~~~vkl~DFG~a~ 264 (509)
- +|.+.|+|.+-+.
T Consensus 299 h-dG~lyiIDVSQSV 312 (520)
T KOG2270|consen 299 H-DGKLYIIDVSQSV 312 (520)
T ss_pred E-CCEEEEEEccccc
Confidence 4 7899999998764
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.002 Score=65.74 Aligned_cols=77 Identities=21% Similarity=0.188 Sum_probs=51.8
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecCcc----c-ChhhHHhHHHHHHHHHHcC---CCCcceeeeeecCCCcCCC
Q 010489 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF----E-HVSDATRILREIKLLRLLR---HPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~-~~~~~~~~~~Ei~~l~~l~---h~niv~~~~~~~~~~~~~~ 189 (509)
.+.||.|.+..||++.....++.|+||.-.... . ......+...|...|+.+. ...+.+++.+-.
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~------- 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE------- 103 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC-------
Confidence 367999999999999886443689999853111 1 1224556778888888763 245666666531
Q ss_pred CcEEEEEecccc
Q 010489 190 KDIYVVFELMES 201 (509)
Q Consensus 190 ~~~~lv~e~~~~ 201 (509)
..-++|||++++
T Consensus 104 ~~~~lVME~L~~ 115 (401)
T PRK09550 104 ELAVTVMEDLSD 115 (401)
T ss_pred CCCEEEEecCCC
Confidence 225899999874
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00061 Score=65.66 Aligned_cols=131 Identities=17% Similarity=0.250 Sum_probs=73.3
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcc-eeeeeecCCCcCCCCcEEEEEecc
Q 010489 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV-EIKHIMLPPSRREFKDIYVVFELM 199 (509)
Q Consensus 121 lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~~ 199 (509)
+..|-...+|+.. .++..+++|......... .-...+|..+++.+....++ +++... . -++||||+
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~--~-------~~~v~e~i 70 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVN--E-------HWLLVEWL 70 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEe--C-------CEEEEEec
Confidence 4567788899886 456788888754321111 01246789999888644343 333322 1 26899999
Q ss_pred ccc-H--------------HHHHHh---CC----CCCH-HHHHHHHHHH---------HhHhhhhhh--------CCeee
Q 010489 200 ESD-L--------------HQVIKA---ND----DLTP-EHYQFFLYQL---------LRGLKYIHT--------ANVFH 239 (509)
Q Consensus 200 ~~~-L--------------~~~l~~---~~----~l~~-~~~~~i~~qi---------l~aL~yLH~--------~~ivH 239 (509)
+|. + ...+.+ .. +++. ..+..+..++ ...+..+-. ..++|
T Consensus 71 ~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H 150 (256)
T TIGR02721 71 EGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLH 150 (256)
T ss_pred cCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeec
Confidence 862 1 111111 11 1121 1122222122 111111211 24899
Q ss_pred cCCCCCcEEECCCCCeEEeeeccccc
Q 010489 240 RDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 240 rDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
+|+.|.||+++.++ +.|+||..|..
T Consensus 151 ~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 151 MDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CCCCcCcEEEeCCC-CEEEeccccCc
Confidence 99999999999877 88999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0034 Score=61.89 Aligned_cols=76 Identities=14% Similarity=0.117 Sum_probs=51.3
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCC---CCcceeeeeecCCCcCCCCcEEE
Q 010489 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH---PDIVEIKHIMLPPSRREFKDIYV 194 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h---~niv~~~~~~~~~~~~~~~~~~l 194 (509)
.+.||.|..+.||+.... .+ .+.+|..+. ......+.+|...|+.|.. -.+.++++++.... ..+.-++
T Consensus 19 ~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~--~~g~~~L 90 (297)
T PRK10593 19 VECISEQPYAALWALYDS-QG-NPMPLMARS----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ--SPGPDVL 90 (297)
T ss_pred eeecCCccceeEEEEEcC-CC-CEEEEEecc----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC--cCCCeEE
Confidence 567999999999998532 23 466776432 1123467889999998863 35667777664321 1234799
Q ss_pred EEecccc
Q 010489 195 VFELMES 201 (509)
Q Consensus 195 v~e~~~~ 201 (509)
|||+++|
T Consensus 91 VmE~i~G 97 (297)
T PRK10593 91 LLERLRG 97 (297)
T ss_pred EEeccCC
Confidence 9999885
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0012 Score=65.11 Aligned_cols=139 Identities=15% Similarity=0.052 Sum_probs=79.9
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCC--cceeeeeecCCC--cCCCCcEE
Q 010489 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD--IVEIKHIMLPPS--RREFKDIY 193 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~~~~~~~~~~--~~~~~~~~ 193 (509)
++.|..|....+|++.. .+..+++|+... .....+..|+.+++.+.+.+ +.+++... .+. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~-~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADR-DGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCC-CCcEeeeeCCceE
Confidence 56777888889999853 345788998753 22345677888888885433 33433211 100 01123468
Q ss_pred EEEecccccH---------H---HHH---Hh-CCCC----------CHHHH--H--------HHHHHHHhHhhhhhh---
Q 010489 194 VVFELMESDL---------H---QVI---KA-NDDL----------TPEHY--Q--------FFLYQLLRGLKYIHT--- 234 (509)
Q Consensus 194 lv~e~~~~~L---------~---~~l---~~-~~~l----------~~~~~--~--------~i~~qil~aL~yLH~--- 234 (509)
+|+++++|.. . ..+ .. ...+ .+... . .....+..++.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999998621 0 111 00 0000 10000 0 011112333444442
Q ss_pred ----CCeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 235 ----ANVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 235 ----~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
.++||+|+.|.|||++.++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 469999999999999987777899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0022 Score=63.53 Aligned_cols=144 Identities=17% Similarity=0.145 Sum_probs=80.5
Q ss_pred eeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCC--cceeeeeecCC-CcCCCCc
Q 010489 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD--IVEIKHIMLPP-SRREFKD 191 (509)
Q Consensus 115 y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~~~~~~~~~-~~~~~~~ 191 (509)
...++.++.|....||++.. .+| .+++|+.... .....+..|+.++..|.... +.+++...... .....+.
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~----~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKR----VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred ceeccccCCccccceEEEEe-CCC-cEEEEEecCC----CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 34467788888889999853 334 5778876431 11234556788888775333 33333221100 0012345
Q ss_pred EEEEEeccccc-H-----H------HHH---Hh-CCCC--------CHHHH-----H----------HHHHHHHhHhhhh
Q 010489 192 IYVVFELMESD-L-----H------QVI---KA-NDDL--------TPEHY-----Q----------FFLYQLLRGLKYI 232 (509)
Q Consensus 192 ~~lv~e~~~~~-L-----~------~~l---~~-~~~l--------~~~~~-----~----------~i~~qil~aL~yL 232 (509)
.+++++|++|. + . ..+ .. ...+ ..... . .....+.+.++++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 78999998762 1 0 111 10 0011 00100 0 0011223345555
Q ss_pred h-------hCCeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 233 H-------TANVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 233 H-------~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
. ..++||+|+.+.||+++.++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 3 2579999999999999988777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0039 Score=62.11 Aligned_cols=30 Identities=33% Similarity=0.352 Sum_probs=25.7
Q ss_pred CCeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 235 ANVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 235 ~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 379999999999999866555899999875
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0027 Score=61.80 Aligned_cols=30 Identities=33% Similarity=0.604 Sum_probs=25.5
Q ss_pred CeeecCCCCCcEEECCCCCe-EEeeeccccc
Q 010489 236 NVFHRDLKPKNILANADCKL-KICDFGLARV 265 (509)
Q Consensus 236 ~ivHrDlKp~NILl~~~~~v-kl~DFG~a~~ 265 (509)
.++|+|+.|.|||++.++.+ -|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 48999999999999975664 6999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0065 Score=60.74 Aligned_cols=81 Identities=17% Similarity=0.078 Sum_probs=51.2
Q ss_pred eeeccCceEEEEEEEcCCCcEEEEEEec----Cc-ccChhhHHhHHHHHHHHHHcC--CC-CcceeeeeecCCCcCCCCc
Q 010489 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN----DV-FEHVSDATRILREIKLLRLLR--HP-DIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 120 ~lG~G~~g~V~~~~~~~~~~~vAiK~~~----~~-~~~~~~~~~~~~Ei~~l~~l~--h~-niv~~~~~~~~~~~~~~~~ 191 (509)
.||.|....||++.....++.|+||.-. .. ........+...|...|+... -| .+.+++.+- + ..
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D--~-----e~ 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD--T-----EM 74 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc--c-----cc
Confidence 5899999999999875444689999742 11 122344566678888887764 34 344454432 1 22
Q ss_pred EEEEEecccc--cHHHHH
Q 010489 192 IYVVFELMES--DLHQVI 207 (509)
Q Consensus 192 ~~lv~e~~~~--~L~~~l 207 (509)
..+|||+++. .|...+
T Consensus 75 ~~~vMEdL~~~~ilR~~L 92 (370)
T TIGR01767 75 AVTVMEDLSHHKIARKGL 92 (370)
T ss_pred ceehHhhCccchHHHHHH
Confidence 4689999963 344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0064 Score=60.05 Aligned_cols=29 Identities=38% Similarity=0.416 Sum_probs=26.2
Q ss_pred CeeecCCCCCcEEECCC----CCeEEeeecccc
Q 010489 236 NVFHRDLKPKNILANAD----CKLKICDFGLAR 264 (509)
Q Consensus 236 ~ivHrDlKp~NILl~~~----~~vkl~DFG~a~ 264 (509)
.+||+|+.|.|||++.+ +.+.|+||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 58999999999999985 889999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.00078 Score=65.23 Aligned_cols=135 Identities=19% Similarity=0.202 Sum_probs=89.7
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecC---cc---c------------Chhh--HHhHHHHHHHHHHcCC-C
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIND---VF---E------------HVSD--ATRILREIKLLRLLRH-P 172 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~---~~---~------------~~~~--~~~~~~Ei~~l~~l~h-~ 172 (509)
-|.++.+||-|.-+.||.+.+. .|...++|.=+. .+ . .+.. .-...+|...|+.|.. -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 3567899999999999999764 588888885210 00 0 0001 1234678999988863 2
Q ss_pred C-cceeeeeecCCCcCCCCcEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEEC
Q 010489 173 D-IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 250 (509)
Q Consensus 173 n-iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~ 250 (509)
. +.+.+++ ..-++|||++.| .|.+.-.- ..+..+...+..-+--|..+|+||+|..--||+|+
T Consensus 172 fpVPkpiD~---------~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 172 FPVPKPIDH---------NRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCCcccc---------cceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEe
Confidence 2 2233332 235899999986 44333211 11223344455556678889999999999999999
Q ss_pred CCCCeEEeeecccc
Q 010489 251 ADCKLKICDFGLAR 264 (509)
Q Consensus 251 ~~~~vkl~DFG~a~ 264 (509)
.++.++++||--+.
T Consensus 237 dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMV 250 (465)
T ss_pred cCCCEEEeechHhh
Confidence 99999999997553
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.016 Score=58.72 Aligned_cols=84 Identities=20% Similarity=0.146 Sum_probs=54.4
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEec----CcccChhhHHhHHHHHHHHHHcC--CCC-cceeeeeecCCCcCCCC
Q 010489 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLRLLR--HPD-IVEIKHIMLPPSRREFK 190 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~----~~~~~~~~~~~~~~Ei~~l~~l~--h~n-iv~~~~~~~~~~~~~~~ 190 (509)
.+.||.|.-..||++.+...++.|+||.-. ......-...+...|..+|+.+. .|. +.+++.+- ..
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D-------~e 106 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD-------SV 106 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC-------cH
Confidence 577999999999999874445689999742 11122445677788889888764 343 44454432 12
Q ss_pred cEEEEEecccc--cHHHHHH
Q 010489 191 DIYVVFELMES--DLHQVIK 208 (509)
Q Consensus 191 ~~~lv~e~~~~--~L~~~l~ 208 (509)
...+|||+++. .|.+.+.
T Consensus 107 ~~~~vMEdL~~~~ilR~~Li 126 (409)
T PRK12396 107 MNCCVMEDLSDHTILRTALI 126 (409)
T ss_pred HhhHHHHhCcccHHHHHHHH
Confidence 24789999863 3444443
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.037 Score=55.74 Aligned_cols=135 Identities=15% Similarity=0.106 Sum_probs=74.6
Q ss_pred eeeeeccCceEEEEEEEcC----CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcc-eeeeeecCCCcCCCCcE
Q 010489 118 QEVIGKGSYGVVGSAVDTH----TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV-EIKHIMLPPSRREFKDI 192 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~----~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~~~~~~~~~~~~~~~~~ 192 (509)
++.|-.|-.-.+|++.... .++.|++|+...... ..-...+|..+++.+..-++. ++++.+..
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~---~~idR~~E~~~~~~l~~~gl~P~~~~~~~~--------- 108 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE---LFFDRDDEIRTFECMSRHGQGPRLLGRFPN--------- 108 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC---eeechHHHHHHHHHHHHcCCCCceEEEECC---------
Confidence 3455558888999986422 346899997753211 111225788888888644443 44444411
Q ss_pred EEEEecccc-cHH--------------HHHH---hCC------CCCHHHHHHHHHHH-----------------HhHhhh
Q 010489 193 YVVFELMES-DLH--------------QVIK---AND------DLTPEHYQFFLYQL-----------------LRGLKY 231 (509)
Q Consensus 193 ~lv~e~~~~-~L~--------------~~l~---~~~------~l~~~~~~~i~~qi-----------------l~aL~y 231 (509)
..|.+|+++ .+. ..+. ... ...+..+..++.++ ...+..
T Consensus 109 g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~ 188 (344)
T PLN02236 109 GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINL 188 (344)
T ss_pred ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHH
Confidence 246788764 221 1111 100 01122333332221 111111
Q ss_pred ----h----hhCCeeecCCCCCcEEECC-CCCeEEeeecccc
Q 010489 232 ----I----HTANVFHRDLKPKNILANA-DCKLKICDFGLAR 264 (509)
Q Consensus 232 ----L----H~~~ivHrDlKp~NILl~~-~~~vkl~DFG~a~ 264 (509)
+ +...++|+|+++.|||++. ++.+.|+||..|.
T Consensus 189 L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 189 LEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 2235899999999999976 4689999999875
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.073 Score=52.53 Aligned_cols=31 Identities=23% Similarity=0.454 Sum_probs=28.2
Q ss_pred CeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 236 NVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 236 ~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
.++|+|+.+.||+++..+-+=|.||+++...
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 4899999999999999988999999998753
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.043 Score=54.97 Aligned_cols=28 Identities=32% Similarity=0.464 Sum_probs=24.8
Q ss_pred eeecCCCCCcEEECC-CCCeEEeeecccc
Q 010489 237 VFHRDLKPKNILANA-DCKLKICDFGLAR 264 (509)
Q Consensus 237 ivHrDlKp~NILl~~-~~~vkl~DFG~a~ 264 (509)
+||.|+-+.|||++. ++.++++||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 699999999999974 5789999999774
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.049 Score=53.99 Aligned_cols=30 Identities=17% Similarity=0.135 Sum_probs=27.7
Q ss_pred CeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 236 NVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 236 ~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
++||+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999999999999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.012 Score=58.12 Aligned_cols=74 Identities=23% Similarity=0.347 Sum_probs=58.1
Q ss_pred CCCcEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhC-CeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 188 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 188 ~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~-~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
+..+.|++|++-++.+.-. ..-.++++..|+.+.+..++-+..+ ..-|||+...||||+ +|+|.|+||-+++..
T Consensus 297 e~~y~yl~~kdhgt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 297 ETLYLYLHFKDHGTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred CceEEEEEEecCCceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence 4457899999888765422 1235678888888888877776654 589999999999999 999999999999853
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.13 Score=52.60 Aligned_cols=75 Identities=17% Similarity=0.160 Sum_probs=49.6
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-----ChhhHHhHHHHHHHHHHcC---CCCcceeeeeecCCCcCCC
Q 010489 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-----HVSDATRILREIKLLRLLR---HPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-----~~~~~~~~~~Ei~~l~~l~---h~niv~~~~~~~~~~~~~~ 189 (509)
.+.||.|....||+..+. +..|+||.-..... ......+...|...|+.+. ...+.+++.++.+.
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~----- 109 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM----- 109 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC-----
Confidence 578999999999999763 45689997541111 1123445566777777664 24677777766322
Q ss_pred CcEEEEEecccc
Q 010489 190 KDIYVVFELMES 201 (509)
Q Consensus 190 ~~~~lv~e~~~~ 201 (509)
-+++||++++
T Consensus 110 --~vlvME~L~~ 119 (418)
T PLN02756 110 --ALIGMRYLEP 119 (418)
T ss_pred --CEEEEeecCC
Confidence 4788999975
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.23 Score=50.66 Aligned_cols=29 Identities=31% Similarity=0.287 Sum_probs=23.9
Q ss_pred CCeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 235 ANVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 235 ~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
...||.|+-+.|||.+. +.++++||-.|.
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence 35799999999999864 469999998664
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.94 E-value=0.24 Score=48.37 Aligned_cols=73 Identities=15% Similarity=0.112 Sum_probs=43.3
Q ss_pred eEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC---CCCcceeeeeecCCCcCCCCcE
Q 010489 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR---HPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 116 ~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~~~~~~~~~~~~~~~~~ 192 (509)
+-.+.|+-|....+|+.. .+++.+.||+-.. .....+..|..-|+.|. --.+.+++.+..... .-
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~-----~~ 87 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD-----DA 87 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS-----CC
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC-----Cc
Confidence 345778889999999986 6788899997642 22245667888888884 333556666553322 24
Q ss_pred EEEEeccc
Q 010489 193 YVVFELME 200 (509)
Q Consensus 193 ~lv~e~~~ 200 (509)
|+||||++
T Consensus 88 fLlle~l~ 95 (288)
T PF03881_consen 88 FLLLEFLE 95 (288)
T ss_dssp EEEEE---
T ss_pred eEEEEeec
Confidence 99999986
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.87 E-value=0.39 Score=47.96 Aligned_cols=28 Identities=36% Similarity=0.387 Sum_probs=24.0
Q ss_pred CCeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 235 ANVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 235 ~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
.++||+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 4689999999999995 4 57899999775
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.70 E-value=0.15 Score=47.15 Aligned_cols=102 Identities=18% Similarity=0.241 Sum_probs=63.4
Q ss_pred EEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEecccccHHHHHHhCCCCCHHHHH
Q 010489 140 RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ 219 (509)
Q Consensus 140 ~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~ 219 (509)
...+|++....... ...-+..+.+++.++. .|+++.. .....+-++.|+|..- ... ..
T Consensus 87 ~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~N-------Dn~~~yGvIlE~Cy~~-----------~i~-~~ 144 (308)
T PF07387_consen 87 PLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKN-------DNNYKYGVILERCYKI-----------KIN-FS 144 (308)
T ss_pred hhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeec-------CCCceeEEEEeeccCc-----------ccc-hh
Confidence 34566664322111 2233466778887764 5666641 1233467899998631 000 01
Q ss_pred HHHHHHHhHhhhhhh--CCeeecCCCCCcEEECCCCCeEEeeeccc
Q 010489 220 FFLYQLLRGLKYIHT--ANVFHRDLKPKNILANADCKLKICDFGLA 263 (509)
Q Consensus 220 ~i~~qil~aL~yLH~--~~ivHrDlKp~NILl~~~~~vkl~DFG~a 263 (509)
.++.-=+.+|.-.|+ .+.+|+|..|+||+-|+.|.+||.|=+..
T Consensus 145 N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 145 NFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 122222567778895 36899999999999999999999998753
|
The function of this family is unknown. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.47 E-value=0.065 Score=53.05 Aligned_cols=29 Identities=24% Similarity=0.377 Sum_probs=25.7
Q ss_pred CCeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 235 ANVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 235 ~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
.++||+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47999999999999987 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.42 E-value=0.33 Score=45.23 Aligned_cols=67 Identities=16% Similarity=0.238 Sum_probs=40.4
Q ss_pred eEEEEEEEcCCC-cEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEEeccc
Q 010489 127 GVVGSAVDTHTG-ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME 200 (509)
Q Consensus 127 g~V~~~~~~~~~-~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~ 200 (509)
|.|..|....+| ..|-+|+-. ......+..|+.-|+.|.-.|-+.+-.++..+ ....+.|+||||++
T Consensus 27 G~inea~~v~dg~~~~FvK~n~-----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G--~~~~~sylVle~L~ 94 (286)
T COG3001 27 GDINEAWRLRDGTDPFFVKCNQ-----REQLSMFTAEADGLELLARSNTITVPKVIAVG--ASRDHSYLVLEYLP 94 (286)
T ss_pred ccccceeEeecCCcceEEEecc-----hhhHHHHHHHHHHHHHHHhcCCccccceEEec--CCCCeeEEEEeecc
Confidence 445555444444 478888542 23456677888888877655533333333322 33456899999997
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.91 E-value=0.62 Score=48.51 Aligned_cols=73 Identities=10% Similarity=0.020 Sum_probs=43.1
Q ss_pred EeeeeeccCceEEEEEEEcC--------CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcc-eeeeeecCCCcC
Q 010489 117 IQEVIGKGSYGVVGSAVDTH--------TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV-EIKHIMLPPSRR 187 (509)
Q Consensus 117 i~~~lG~G~~g~V~~~~~~~--------~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~~~~~~~~~~~~ 187 (509)
-++.|..|-.-.+|++.... .++.|.+++.-.... ..-.-.+|..+++.+...+|. ++++.+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te---~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----- 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD---ELYNPISEFEVYKTMSKYRIAPQLLNTFS----- 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc---ceeCHHHHHHHHHHHHHCCCCCceEEEeC-----
Confidence 45667677778899886432 156788887643211 111234688888877654544 3444431
Q ss_pred CCCcEEEEEecccc
Q 010489 188 EFKDIYVVFELMES 201 (509)
Q Consensus 188 ~~~~~~lv~e~~~~ 201 (509)
-+.|.||++|
T Consensus 181 ----gg~I~efi~g 190 (442)
T PTZ00296 181 ----GGRIEEWLYG 190 (442)
T ss_pred ----CCEEEEeeCC
Confidence 1456788775
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=93.51 E-value=0.015 Score=59.59 Aligned_cols=73 Identities=29% Similarity=0.462 Sum_probs=60.0
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 184 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~ 184 (509)
+...++.+..+|.|+||+|+.+..+..+..+|||.|... .......+.++|+.-+..+.|++++++.+.|...
T Consensus 47 ~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlk-n~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~ 119 (516)
T KOG1033|consen 47 EANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLK-NREESRSRVLREVSSLAEFEHPGIKRYFHAWYER 119 (516)
T ss_pred hhccccccccccccCccccCCccccccchhhHHHHhccc-chhhhhhhhhccccchhhhcccchhhheeceecC
Confidence 456788899999999999999999888889999988542 2223456788999999999999999998887543
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.46 E-value=0.058 Score=48.90 Aligned_cols=28 Identities=25% Similarity=0.413 Sum_probs=25.0
Q ss_pred eeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 237 VFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 237 ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
.+|+|+.|.||+++.+| ++|+||+.|..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 59999999999998777 99999998853
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 509 | ||||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-81 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-80 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-76 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-76 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-76 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-76 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-76 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-76 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-76 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-76 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-76 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-76 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-76 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-76 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-75 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-75 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-74 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-74 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-74 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-74 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-74 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-74 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-73 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-73 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-73 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-72 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-69 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-69 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-69 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-69 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-69 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-69 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-69 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-69 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-69 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-69 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-69 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-69 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-69 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-69 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-69 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-69 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-69 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-69 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-69 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-69 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-69 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-69 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-69 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-69 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-69 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-68 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-68 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-68 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-68 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-68 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-68 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-68 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-68 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-68 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-68 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-68 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-68 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-68 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-68 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-68 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-68 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-68 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-68 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-68 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-68 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-68 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-68 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-68 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-68 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-67 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-67 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-67 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-67 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-67 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-67 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-67 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-67 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-66 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-66 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-66 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-66 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-65 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-61 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-60 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-60 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-60 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-60 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-59 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-59 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-54 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-50 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-49 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-49 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-49 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-49 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-49 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-49 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-49 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-49 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-49 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-48 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-48 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-48 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-48 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-48 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-48 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-48 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-48 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-48 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-48 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-48 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-48 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-48 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-48 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-48 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-48 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-47 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-47 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-47 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-46 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-46 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-46 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-46 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-46 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-46 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-46 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-44 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-43 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-43 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-38 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-38 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-38 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-38 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-38 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-38 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-38 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-38 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-38 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-38 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-38 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-38 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-38 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-38 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-38 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-38 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-38 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-38 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-38 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-38 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-38 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-38 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-38 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-38 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-38 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-38 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-38 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-38 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-38 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-37 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-37 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-37 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-37 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-37 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-37 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-37 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-37 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-37 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-37 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-37 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-36 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 9e-36 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-35 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-35 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-35 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-34 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-34 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-34 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-34 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-34 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-34 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-34 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-34 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-34 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-34 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-34 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-33 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-33 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-33 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-33 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-33 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-33 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-33 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-33 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-33 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-33 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-33 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-33 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-33 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-33 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-33 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-33 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-33 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-32 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-32 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-32 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-32 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-30 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-30 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-30 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-30 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-25 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-25 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-25 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-24 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-23 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-22 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-21 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-21 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-21 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-20 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-20 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-20 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-20 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-20 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-20 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-20 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-20 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-20 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-20 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-20 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-20 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-20 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-20 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-20 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-20 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 7e-20 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-20 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-20 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-20 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-20 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-20 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-19 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-19 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-19 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-19 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-19 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-19 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-19 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-19 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-19 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-19 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-19 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-19 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-18 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-18 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-18 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-18 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-17 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-17 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-17 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-17 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-17 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-16 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-16 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-16 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-16 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-16 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-16 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-16 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-15 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-15 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-15 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-15 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-15 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-15 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-15 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-14 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-14 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-14 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-14 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-13 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 9e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-11 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-11 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-11 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-11 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-11 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 5e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 9e-10 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-09 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-09 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-09 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-09 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 8e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-07 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-06 |
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 580 bits (1496), Expect = 0.0
Identities = 164/365 (44%), Positives = 226/365 (61%), Gaps = 5/365 (1%)
Query: 88 PTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN 147
M + E + RY IG+G+YG+V SA D RVAIKKI+
Sbjct: 2 HHHHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS 61
Query: 148 DVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVI 207
FEH + R LREIK+L RH +I+ I I+ P+ + KD+Y+V +LME+DL++++
Sbjct: 62 -PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL 120
Query: 208 KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267
K L+ +H +FLYQ+LRGLKYIH+ANV HRDLKP N+L N C LKICDFGLARV+
Sbjct: 121 KTQH-LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179
Query: 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 327
D F T+YVATRWYRAPE+ + YT +IDIWS+GCI AEML+ +P+FPGK+ +
Sbjct: 180 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238
Query: 328 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLL 387
QL+ + +LG+PS E ++ I N KAR YL S+ K VP++ FPNAD AL LL+++L
Sbjct: 239 DQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKML 298
Query: 388 AFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREIL 447
F+P R E+ALA PY + EP + +F+ E L K+ ++E+I+ E
Sbjct: 299 TFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETA 356
Query: 448 EYHPQ 452
+ P
Sbjct: 357 RFQPG 361
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 576 bits (1486), Expect = 0.0
Identities = 145/351 (41%), Positives = 217/351 (61%), Gaps = 13/351 (3%)
Query: 107 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL 166
Y +S +Q++ ++G+G+YGVV SA TGE VAIKKI F+ A R LREIK+L
Sbjct: 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKIL 63
Query: 167 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLL 226
+ +H +I+ I +I P S F ++Y++ ELM++DLH+VI L+ +H Q+F+YQ L
Sbjct: 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM-LSDDHIQYFIYQTL 122
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI-------FWTDY 279
R +K +H +NV HRDLKP N+L N++C LK+CDFGLAR+ A ++
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 280 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339
VATRWYRAPE+ + +KY+ A+D+WS GCI AE+ +P+FPG++ HQL L+ ++GT
Sbjct: 183 VATRWYRAPEVMLT-SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241
Query: 340 PSTES-ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 398
P +++ + I + +AR Y+ S+ P FP +P + LL+R+L FDP R TA+
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301
Query: 399 EALADPYFHGLANVDREPSTQPISKLEFEF--ERRKLAKDDVREMIYREIL 447
EAL PY + + EP +PI FEF + L D++++I+ EI
Sbjct: 302 EALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 571 bits (1473), Expect = 0.0
Identities = 136/424 (32%), Positives = 213/424 (50%), Gaps = 52/424 (12%)
Query: 93 MDPHKKSALETEFFTEYGE---ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV 149
H S E +F Y I+ +IG+GSYG V A D +T + VAIKK+N +
Sbjct: 3 HHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM 62
Query: 150 FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA 209
FE + D RILREI +L L+ I+ + +++P +F ++Y+V E+ +SDL ++ K
Sbjct: 63 FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT 122
Query: 210 NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269
LT EH + LY LL G +IH + + HRDLKP N L N DC +K+CDFGLAR ++
Sbjct: 123 PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182
Query: 270 APSAI-------------------FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 310
+ I T +V TRWYRAPEL YT +IDIWS GCI
Sbjct: 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI-LLQENYTKSIDIWSTGCI 241
Query: 311 FAEMLTG-----------KPLFPG-----------------KNVVHQLDLMTDLLGTPST 342
FAE+L PLFPG K+ QL+++ +++GTP+
Sbjct: 242 FAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTE 301
Query: 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402
+ + I + +Y+ ++P+ K+P+ ++LLE +L F+P R T ++AL
Sbjct: 302 DDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD 361
Query: 403 DPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGE 462
PY + E + L F+ + L++ +R + +E+ +HP+++ +
Sbjct: 362 HPYLKDVRKKKLENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPELVIPSVFTIH 420
Query: 463 QTSF 466
+ +F
Sbjct: 421 ENNF 424
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 555 bits (1431), Expect = 0.0
Identities = 140/378 (37%), Positives = 219/378 (57%), Gaps = 16/378 (4%)
Query: 87 APTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI 146
+P PA +++ +T + + Y+ + +G G+YG V SAVD TG +VAIKK+
Sbjct: 3 SPPPARSGFYRQEVTKTAWEVR----AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL 58
Query: 147 NDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLP-PSRREFKDIYVVFELMESDLHQ 205
F+ A R RE++LL+ +RH +++ + + P + +F D Y+V M +DL +
Sbjct: 59 YRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK 118
Query: 206 VIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265
++K L + QF +YQ+L+GL+YIH A + HRDLKP N+ N DC+LKI DFGLAR
Sbjct: 119 LMKHEK-LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177
Query: 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
+ ++ T YV TRWYRAPE+ ++ +YT +DIWS+GCI AEM+TGK LF G +
Sbjct: 178 ADSE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230
Query: 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLER 385
+ QL + + GTP E + R+++++A+ Y+ + + + F+ NA PLA++LLE+
Sbjct: 231 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK 290
Query: 386 LLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYRE 445
+L D + R TA EALA PYF L + + EP Q + F+ D+ + + Y+E
Sbjct: 291 MLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKY---DDSFDDVDRTLDEWKRVTYKE 347
Query: 446 ILEYHPQMLQEYLRGGEQ 463
+L + P E
Sbjct: 348 VLSFKPPRQLGARVSKET 365
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 551 bits (1422), Expect = 0.0
Identities = 135/340 (39%), Positives = 199/340 (58%), Gaps = 12/340 (3%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
Y +G G+YG V SA+D +GE+VAIKK++ F+ A R RE+ LL+ ++H
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 173 DIVEIKHIMLPPSR-REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+++ + + P S R F D Y+V M++DL +++ + E Q+ +YQ+L+GLKY
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--FSEEKIQYLVYQMLKGLKY 141
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
IH+A V HRDLKP N+ N DC+LKI DFGLAR + + T YV TRWYRAPE+
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MTGYVVTRWYRAPEVI 195
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
S+ Y +DIWS+GCI AEMLTGK LF GK+ + QL + + G P TE + ++ ++
Sbjct: 196 LSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411
A+ Y+ S+ + F+ FP A P A LLE++L D R TA +AL P+F +
Sbjct: 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314
Query: 412 VDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 451
+ E Q + E KL D+ ++ IY+EI+ + P
Sbjct: 315 PEEETEAQQ--PFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 551 bits (1421), Expect = 0.0
Identities = 125/369 (33%), Positives = 186/369 (50%), Gaps = 20/369 (5%)
Query: 93 MDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIND---- 148
M ++A+ + S Y +Q I GSYG V + VD+ G VAIK++ +
Sbjct: 2 MQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSD 60
Query: 149 -----VFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDL 203
+ R+LREI+LL HP+I+ ++ I + +Y+V ELM +DL
Sbjct: 61 GRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDL 120
Query: 204 HQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 262
QVI ++P+H Q+F+Y +L GL +H A V HRDL P NIL + + ICDF L
Sbjct: 121 AQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNL 180
Query: 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFP 322
AR DA T YV RWYRAPEL F +T +D+WS GC+ AEM K LF
Sbjct: 181 AREDTADA----NKTHYVTHRWYRAPELVMQ-FKGFTKLVDMWSAGCVMAEMFNRKALFR 235
Query: 323 GKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYL-GSMRKKQPVPFSHKFPNADPLALH 381
G +QL+ + +++GTP E + + AR YL S+ ++ P ADP+AL
Sbjct: 236 GSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALD 295
Query: 382 LLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREM 441
L+ ++L F+P+ R + E+AL PYF L + F F+ D+ ++
Sbjct: 296 LIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLSE---RFHFDESVTDVYDMHKI 352
Query: 442 IYREILEYH 450
E+ ++
Sbjct: 353 FTAEVERFN 361
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 548 bits (1413), Expect = 0.0
Identities = 150/368 (40%), Positives = 220/368 (59%), Gaps = 18/368 (4%)
Query: 96 HKKSALETEFF------TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV 149
H S F+ T + RYQ +G G+YG V +A DT TG RVA+KK++
Sbjct: 6 HHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 65
Query: 150 FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE-FKDIYVVFELMESDLHQVIK 208
F+ + A R RE++LL+ ++H +++ + + P E F D+Y+V LM +DL+ ++K
Sbjct: 66 FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 125
Query: 209 ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268
LT +H QF +YQ+LRGLKYIH+A++ HRDLKP N+ N DC+LKI DFGLAR + +
Sbjct: 126 CQK-LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184
Query: 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH 328
T YVATRWYRAPE+ ++ Y +DIWS+GCI AE+LTG+ LFPG + +
Sbjct: 185 ------EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 237
Query: 329 QLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLA 388
QL L+ L+GTP E + +I +E AR Y+ S+ + + F++ F A+PLA+ LLE++L
Sbjct: 238 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 297
Query: 389 FDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILE 448
D R TA +ALA YF + D EP P + E R L D+ + + Y E++
Sbjct: 298 LDSDKRITAAQALAHAYFAQYHDPDDEPVADPY---DQSLESRDLLIDEWKSLTYDEVIS 354
Query: 449 YHPQMLQE 456
+ P L +
Sbjct: 355 FVPPPLDQ 362
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 546 bits (1410), Expect = 0.0
Identities = 139/386 (36%), Positives = 221/386 (57%), Gaps = 43/386 (11%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-H 171
+Y++ + +GKG+YG+V ++D TGE VA+KKI D F++ +DA R REI +L L H
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+IV + +++ + +D+Y+VF+ ME+DLH VI+AN L P H Q+ +YQL++ +KY
Sbjct: 69 ENIVNLLNVLRADN---DRDVYLVFDYMETDLHAVIRANI-LEPVHKQYVVYQLIKVIKY 124
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARV------------------SFNDAPSA 273
+H+ + HRD+KP NIL NA+C +K+ DFGL+R + N
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 274 IFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL 332
TDYVATRWYRAPE L GS +KYT ID+WS+GCI E+L GKP+FPG + ++QL+
Sbjct: 185 PILTDYVATRWYRAPEILLGS--TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242
Query: 333 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKF----------------PNAD 376
+ ++ PS E + I++ A+ + S+++K + S+K + +
Sbjct: 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN 302
Query: 377 PLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKD 436
AL LL++LL F+P R +A +AL P+ N + EP+ I + + K + D
Sbjct: 303 EEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPIN-DNVKHSID 361
Query: 437 DVREMIYREILEYHPQMLQEYLRGGE 462
D R ++Y EI +++ + +
Sbjct: 362 DYRNLVYSEISRRKRELISNKHQNVQ 387
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 548 bits (1414), Expect = 0.0
Identities = 145/422 (34%), Positives = 208/422 (49%), Gaps = 57/422 (13%)
Query: 87 APTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI 146
K +A +++ RY+I+ +IG GSYG V A D VAIKKI
Sbjct: 27 GQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI 86
Query: 147 NDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQV 206
VFE + D RILREI +L L H +V++ I++P +F ++YVV E+ +SD ++
Sbjct: 87 LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKL 146
Query: 207 IKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV- 265
+ LT H + LY LL G+KY+H+A + HRDLKP N L N DC +K+CDFGLAR
Sbjct: 147 FRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206
Query: 266 -----------------------SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAI 302
+ T +V TRWYRAPEL YT AI
Sbjct: 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-QENYTEAI 265
Query: 303 DIWSIGCIFAEMLT-----------GKPLFPGKNVV--------------------HQLD 331
D+WSIGCIFAE+L PLFPG + QL+
Sbjct: 266 DVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLN 325
Query: 332 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDP 391
++ ++LGTPS E I + E A+RY+ K++ + +FP + A+HLL+R+L F+P
Sbjct: 326 VIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNP 385
Query: 392 KDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 451
R T E LA P+F + + E + +L F + + + +R +EI YHP
Sbjct: 386 NKRITINECLAHPFFKEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYHP 444
Query: 452 QM 453
++
Sbjct: 445 EI 446
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 536 bits (1382), Expect = 0.0
Identities = 123/409 (30%), Positives = 210/409 (51%), Gaps = 27/409 (6%)
Query: 83 QFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVA 142
+ ++ + + ++ F RYQ + IG G+ G+V +A D VA
Sbjct: 36 HYNMSKSKVDNQFYSVEVGDSTFTVL----KRYQNLKPIGSGAQGIVCAAYDAVLDRNVA 91
Query: 143 IKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLP-PSRREFKDIYVVFELMES 201
IKK++ F++ + A R RE+ L++ + H +I+ + ++ P + EF+D+Y+V ELM++
Sbjct: 92 IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA 151
Query: 202 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 261
+L QVI+ +L E + LYQ+L G+K++H+A + HRDLKP NI+ +DC LKI DFG
Sbjct: 152 NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 209
Query: 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 321
LAR A ++ T YV TR+YRAPE+ Y +DIWS+GCI EM+ K LF
Sbjct: 210 LART----AGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILF 263
Query: 322 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNA------ 375
PG++ + Q + + + LGTP E + ++ R Y+ + K + F FP++
Sbjct: 264 PGRDYIDQWNKVIEQLGTPCPEFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADS 322
Query: 376 ------DPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFE 429
A LL ++L DP R + ++AL PY + + P + + +
Sbjct: 323 EHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE-APPPQIYDKQLD 381
Query: 430 RRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQ 478
R+ ++ +E+IY+E++ + ++G S + +
Sbjct: 382 EREHTIEEWKELIYKEVMNSEEKTKNGVVKGQPSPSGAAVNSSESLPPS 430
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 527 bits (1360), Expect = 0.0
Identities = 122/382 (31%), Positives = 199/382 (52%), Gaps = 27/382 (7%)
Query: 87 APTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI 146
+ + + + ++ F RYQ + IG G+ G+V +A D VAIKK+
Sbjct: 3 SRSKRDNNFYSVEIGDSTFTVL----KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL 58
Query: 147 NDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP-SRREFKDIYVVFELMESDLHQ 205
+ F++ + A R RE+ L++ + H +I+ + ++ P S EF+D+Y+V ELM+++L Q
Sbjct: 59 SRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ 118
Query: 206 VIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265
VI+ +L E + LYQ+L G+K++H+A + HRDLKP NI+ +DC LKI DFGLAR
Sbjct: 119 VIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176
Query: 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
A ++ T YV TR+YRAPE+ Y +DIWS+GCI EM+ G LFPG +
Sbjct: 177 ----AGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTD 230
Query: 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNA---------- 375
+ Q + + + LGTP E + ++ R Y+ + K F FP+
Sbjct: 231 HIDQWNKVIEQLGTPCPEFMKKL-QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNK 289
Query: 376 --DPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKL 433
A LL ++L D R + +EAL PY + + P + + + R+
Sbjct: 290 LKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAE-APPPKIPDKQLDEREH 348
Query: 434 AKDDVREMIYREILEYHPQMLQ 455
++ +E+IY+E+++
Sbjct: 349 TIEEWKELIYKEVMDLEHHHHH 370
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 518 bits (1336), Expect = 0.0
Identities = 127/315 (40%), Positives = 173/315 (54%), Gaps = 15/315 (4%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
SRY + +G G G+V SAVD +RVAIKKI V LREIK++R L H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRLDH 67
Query: 172 PDIVEIKHIMLPPSRR---------EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 222
+IV++ I+ P + E +Y+V E ME+DL V++ L EH + F+
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP-LLEEHARLFM 126
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVSFNDAPSAIFWTDYVA 281
YQLLRGLKYIH+ANV HRDLKP N+ N D LKI DFGLAR+ ++ +
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 282 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341
T+WYR+P L S + YT AID+W+ GCIFAEMLTGK LF G + + Q+ L+ + +
Sbjct: 187 TKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245
Query: 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
E + + Y+ + + P + P A+ LE++L F P DR TAEEAL
Sbjct: 246 EEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEAL 304
Query: 402 ADPYFHGLANVDREP 416
+ PY + EP
Sbjct: 305 SHPYMSIYSFPMDEP 319
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 478 bits (1232), Expect = e-168
Identities = 114/351 (32%), Positives = 180/351 (51%), Gaps = 27/351 (7%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 170
E R+Q++ + G+G++G V + TG VAIKK+ + R L+ ++ L +L
Sbjct: 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQDLAVLH 77
Query: 171 HPDIVEIKHIMLPPSRREFKDIY--VVFELMESDLHQVIK----ANDDLTPEHYQFFLYQ 224
HP+IV+++ R+ +DIY VV E + LH+ + P + FL+Q
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 225 LLRGLKYIH--TANVFHRDLKPKNILAN-ADCKLKICDFGLARVSFNDAPSAIFWTDYVA 281
L+R + +H + NV HRD+KP N+L N AD LK+CDFG A+ P+ Y+
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN----VAYIC 193
Query: 282 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341
+R+YRAPEL YT A+DIWS+GCIFAEM+ G+P+F G N QL + +LG PS
Sbjct: 194 SRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252
Query: 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKF----PNADPLALHLLERLLAFDPKDRPTA 397
E + ++ L + +P+S+ F A LL LL + P++R
Sbjct: 253 REVLRKLNPSHTDVDL---YNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP 309
Query: 398 EEALADPYFHGLAN-VDREPSTQPISKLEFEFERRKL--AKDDVREMIYRE 445
EAL PYF L + + P+ + + + F F ++ + + + R+
Sbjct: 310 YEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 446 bits (1149), Expect = e-155
Identities = 123/404 (30%), Positives = 202/404 (50%), Gaps = 31/404 (7%)
Query: 85 PIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIK 144
+ P L ++ T Y +VIG GS+GVV A + E VAIK
Sbjct: 12 GVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIK 70
Query: 145 KINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RREFKDIYVVFELMESDL 203
K+ + D RE++++R+++HP++V++K +++ + +V E + +
Sbjct: 71 KV------LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETV 124
Query: 204 HQVI----KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKIC 258
++ K + + ++YQLLR L YIH+ + HRD+KP+N+L + LK+
Sbjct: 125 YRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLI 184
Query: 259 DFGLARVSFNDAPSAIFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTG 317
DFG A++ P+ Y+ +R+YRAPEL G+ + YT IDIWS GC+ AE++ G
Sbjct: 185 DFGSAKILIAGEPN----VSYICSRYYRAPELIFGA--TNYTTNIDIWSTGCVMAELMQG 238
Query: 318 KPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKF-PNAD 376
+PLFPG++ + QL + +LGTPS E I + + +P PFS F P
Sbjct: 239 QPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKF---PQIRPHPFSKVFRPRTP 295
Query: 377 PLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD-REPSTQPISKLEFEFERRKLAK 435
P A+ L+ RLL + P R TA EAL P+F L + R P+ + + L F + + +L
Sbjct: 296 PDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPL-FNWTKEEL-- 352
Query: 436 DDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQF 479
VR + ++ H + + RG + +F P ++ K
Sbjct: 353 -SVRPDLISRLVPQHAEA-ELLSRGIDVHNFQ-PIPLESLKVTL 393
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 433 bits (1115), Expect = e-150
Identities = 105/392 (26%), Positives = 182/392 (46%), Gaps = 66/392 (16%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
+ +Y + + +G GS+G+V D +G+R A+KK+ D RE+ ++++L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDH 59
Query: 172 PDIVEIKHIM---------------------------------LPPSRREFKDIYVVFEL 198
+I+++ + + + K + V+ E
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 199 MESDLHQVI----KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DC 253
+ LH+V+ ++ + ++YQL R + +IH+ + HRD+KP+N+L N+ D
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 254 KLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFA 312
LK+CDFG A+ PS Y+ +R+YRAPEL G+ ++YTP+ID+WSIGC+F
Sbjct: 180 TLKLCDFGSAKKLIPSEPS----VAYICSRFYRAPELMLGA--TEYTPSIDLWSIGCVFG 233
Query: 313 EMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKF 372
E++ GKPLF G+ + QL + ++GTP+ E + R+ + +
Sbjct: 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFP---TLKAKDWRKIL 290
Query: 373 PNADP-LALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREP----------STQPI 421
P P LA+ LLE++L ++P R EA+A P+F L N Q I
Sbjct: 291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNI 350
Query: 422 SKL-EFEFERRKLAKDDVREMIYREILEYHPQ 452
+L F + +V I + + +
Sbjct: 351 PQLFNFSPYELSIIPGNVLNRILPKNFSPNYK 382
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 425 bits (1094), Expect = e-146
Identities = 110/355 (30%), Positives = 181/355 (50%), Gaps = 28/355 (7%)
Query: 107 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL 166
+ + Y +VIG GS+GVV A +GE VAIKK+ D RE++++
Sbjct: 48 PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIM 101
Query: 167 RLLRHPDIVEIKHIMLPPS-RREFKDIYVVFELMESDLHQVIK----ANDDLTPEHYQFF 221
R L H +IV +++ +++ + +V + + +++V + A L + + +
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 161
Query: 222 LYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVSFNDAPSAIFWTDYV 280
+YQL R L YIH+ + HRD+KP+N+L + D LK+CDFG A+ P+ Y+
Sbjct: 162 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN----VSYI 217
Query: 281 ATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339
+R+YRAPEL G+ + YT +ID+WS GC+ AE+L G+P+FPG + V QL + +LGT
Sbjct: 218 CSRYYRAPELIFGA--TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 275
Query: 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPKDRPTAE 398
P+ E I + + + P++ F P P A+ L RLL + P R T
Sbjct: 276 PTREQIREMNPNYTEFKF---PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 332
Query: 399 EALADPYFHGLANV-DREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQ 452
EA A +F L + + P+ + L F F ++L + ++ H +
Sbjct: 333 EACAHSFFDELRDPNVKLPNGRDTPAL-FNFTTQEL---SSNPPLATILIPPHAR 383
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 393 bits (1012), Expect = e-135
Identities = 89/316 (28%), Positives = 151/316 (47%), Gaps = 24/316 (7%)
Query: 105 FFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK 164
E+G YQ+ +G+G Y V A++ E+V +K + V +I REIK
Sbjct: 28 HVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIK 82
Query: 165 LLRLLR-HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 223
+L LR P+I+ + I+ P V + +D Q+ + LT +F++Y
Sbjct: 83 ILENLRGGPNIITLADIVKDPV--SRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMY 137
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 282
++L+ L Y H+ + HRD+KP N++ + KL++ D+GLA + VA+
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----EYNVRVAS 193
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLDLMTDLLGTPS 341
R+++ PEL + Y ++D+WS+GC+ A M+ K P F G + QL + +LGT
Sbjct: 194 RYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252
Query: 342 TES-ISRIRNEKARRYLGSMRKKQPVPFSHKFPN-----ADPLALHLLERLLAFDPKDRP 395
I + E R+ + + + + P AL L++LL +D + R
Sbjct: 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 312
Query: 396 TAEEALADPYFHGLAN 411
TA EA+ PYF+ +
Sbjct: 313 TAREAMEHPYFYTVVK 328
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 359 bits (923), Expect = e-122
Identities = 104/309 (33%), Positives = 158/309 (51%), Gaps = 12/309 (3%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Y+ IG+GSYGVV + TG+ VAIKK + + LREI++L+ L+HP+
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYI 232
+V + + R + +++VFE + + + + + +Q L+ + +
Sbjct: 64 LVNLLEVF-----RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LC 291
H N HRD+KP+NIL +K+CDFG AR PS + D VATRWYR+PE L
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFAR-LLTG-PSDYY-DDEVATRWYRSPELLV 175
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
G ++Y P +D+W+IGC+FAE+L+G PL+PGK+ V QL L+ LG
Sbjct: 176 GD--TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411
+ + + P KFPN AL LL+ L DP +R T E+ L PYF +
Sbjct: 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293
Query: 412 VDREPSTQP 420
++
Sbjct: 294 IEDLAKEHD 302
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 341 bits (876), Expect = e-114
Identities = 97/296 (32%), Positives = 155/296 (52%), Gaps = 12/296 (4%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Y+ ++G+GSYG+V + TG VAIKK + + +REIKLL+ LRH +
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYI 232
+V + + ++ K Y+VFE ++ + ++ + L + Q +L+Q++ G+ +
Sbjct: 86 LVNLLEVC-----KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC- 291
H+ N+ HRD+KP+NIL + +K+CDFG AR + P ++ D VATRWYRAPEL
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAA-PGEVY-DDEVATRWYRAPELLV 197
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
G KY A+D+W+IGC+ EM G+PLFPG + + QL + LG
Sbjct: 198 GD--VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407
+ K+ P ++P + + L ++ L DP RP E L +F
Sbjct: 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 319 bits (820), Expect = e-106
Identities = 115/321 (35%), Positives = 166/321 (51%), Gaps = 30/321 (9%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRI--LREIKLLRL 168
A RY+ + +G+G + V A D +T + VAIKKI D LREIKLL+
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLR 227
L HP+I+ + S I +VF+ ME+DL +IK N LTP H + ++ L+
Sbjct: 69 LSHPNIIGLLDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
GL+Y+H + HRDLKP N+L + + LK+ DFGLA+ SF P+ + T V TRWYRA
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK-SFGS-PNRAY-THQVVTRWYRA 180
Query: 288 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES-- 344
PE L G+ Y +D+W++GCI AE+L P PG + + QL + + LGTP+ E
Sbjct: 181 PELLFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238
Query: 345 -ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
+ + + + + +P H F A L L++ L F+P R TA +AL
Sbjct: 239 DMCSLPDYV------TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292
Query: 404 PYFHGLANVDREPSTQPISKL 424
YF P P +L
Sbjct: 293 KYF------SNRPGPTPGCQL 307
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 317 bits (815), Expect = e-106
Identities = 124/324 (38%), Positives = 174/324 (53%), Gaps = 24/324 (7%)
Query: 93 MDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH 152
M H + E G +YQ E +G+G+YGVV A D+ G VA+K+I +
Sbjct: 1 MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR--LDA 57
Query: 153 VSDATRI--LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA- 209
+ +REI LL+ L HP+IV + ++ + +VFE ME DL +V+
Sbjct: 58 EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC-----LTLVFEFMEKDLKKVLDEN 112
Query: 210 NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269
L + +LYQLLRG+ + H + HRDLKP+N+L N+D LK+ DFGLAR +F
Sbjct: 113 KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR-AFGI 171
Query: 270 APSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH 328
P + T V T WYRAP+ L GS KY+ ++DIWSIGCIFAEM+TGKPLFPG
Sbjct: 172 -PVRSY-THEVVTLWYRAPDVLMGS--KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD 227
Query: 329 QLDLMTDLLGTPSTES---ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLER 385
QL + +LGTP+ + + K R + + + P+S P + LL
Sbjct: 228 QLPKIFSILGTPNPREWPQVQELPLWKQRTF----QVFEKKPWSSIIPGFCQEGIDLLSN 283
Query: 386 LLAFDPKDRPTAEEALADPYFHGL 409
+L FDP R +A +A+ PYF L
Sbjct: 284 MLCFDPNKRISARDAMNHPYFKDL 307
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 316 bits (813), Expect = e-105
Identities = 100/308 (32%), Positives = 142/308 (46%), Gaps = 28/308 (9%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI-----LREIKLLR 167
SRY+ IG G+YG V A D H+G VA+K + + +RE+ LLR
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VPNGGGGGGGLPISTVREVALLR 66
Query: 168 LLR---HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFL 222
L HP++V + + + +VFE ++ DL + L E + +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 282
Q LRGL ++H + HRDLKP+NIL + +K+ DFGLAR ++ + T V T
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMA---LTPVVVT 182
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
WYRAPE+ S Y +D+WS+GCIFAEM KPLF G + QL + DL+G P
Sbjct: 183 LWYRAPEVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240
Query: 343 ES---ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
+ + P P P + LL +L F+P R +A
Sbjct: 241 DDWPRDVSLPRGAFPPR-------GPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFR 293
Query: 400 ALADPYFH 407
AL Y H
Sbjct: 294 ALQHSYLH 301
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 317 bits (814), Expect = e-105
Identities = 112/328 (34%), Positives = 169/328 (51%), Gaps = 23/328 (7%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
Y + +G+G+Y V T VA+K+I E + T I RE+ LL+ L+H +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHAN 61
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYI 232
IV + I+ + +VFE ++ DL Q + + + + + FL+QLLRGL Y
Sbjct: 62 IVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LC 291
H V HRDLKP+N+L N +LK+ DFGLAR + + P+ + + V T WYR P+ L
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLAR-AKSI-PTKTY-DNEVVTLWYRPPDILL 173
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES---ISRI 348
GS + Y+ ID+W +GCIF EM TG+PLFPG V QL + +LGTP+ E+ I
Sbjct: 174 GS--TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231
Query: 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408
K Y K + P D LL +LL F+ ++R +AE+A+ P+F
Sbjct: 232 EEFKTYNY----PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL- 286
Query: 409 LANVDREPSTQPISKLEFEFERRKLAKD 436
++ P + F + +L K+
Sbjct: 287 --SLGERIHKLPDTTSIFALKEIQLQKE 312
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 310 bits (798), Expect = e-103
Identities = 113/300 (37%), Positives = 167/300 (55%), Gaps = 25/300 (8%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLRH 171
+Y E IG+G+YGVV A + GE A+KKI E + +REI +L+ L+H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR--LEKEDEGIPSTTIREISILKELKH 59
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLK 230
+IV++ ++ R + +VFE ++ DL +++ L + FL QLL G+
Sbjct: 60 SNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE- 289
Y H V HRDLKP+N+L N + +LKI DFGLAR +F P + T + T WYRAP+
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLAR-AFGI-PVRKY-THEIVTLWYRAPDV 171
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES---IS 346
L GS KY+ IDIWS+GCIFAEM+ G PLFPG + QL + +LGTP++++ ++
Sbjct: 172 LMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
+ Y + +P+P+ D + LL ++L DP R TA++AL YF
Sbjct: 230 ELPK-----YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = e-103
Identities = 112/304 (36%), Positives = 168/304 (55%), Gaps = 25/304 (8%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLRH 171
+Y+ E IG+G+YG V A + T E VA+K++ + + LREI LL+ L+H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKH 60
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLK 230
+IV + ++ + + +VFE + DL + + N DL PE + FL+QLL+GL
Sbjct: 61 KNIVRLHDVLHSDKK-----LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE- 289
+ H+ NV HRDLKP+N+L N + +LK+ +FGLAR +F P + + V T WYR P+
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR-AFGI-PVRCY-SAEVVTLWYRPPDV 172
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES---I 345
L G+ Y+ +ID+WS GCIFAE+ G+PLFPG +V QL + LLGTP+ E +
Sbjct: 173 LFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
+++ + K + P + LL+ LL +P R +AEEAL PY
Sbjct: 231 TKLPDYKPYP-----MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285
Query: 406 FHGL 409
F
Sbjct: 286 FSDF 289
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 312 bits (801), Expect = e-103
Identities = 112/340 (32%), Positives = 162/340 (47%), Gaps = 28/340 (8%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRL 168
E S+Y+ IG+G++G V A TG++VA+KK+ E+ + I LREIK+L+L
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALREIKILQL 72
Query: 169 LRHPDIVEIKHIM---LPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQ 224
L+H ++V + I P R IY+VF+ E DL ++ T + +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY---VA 281
LL GL YIH + HRD+K N+L D LK+ DFGLAR +F+ Y V
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR-AFSL-AKNSQPNRYTNRVV 190
Query: 282 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340
T WYR PE L G Y P ID+W GCI AEM T P+ G HQL L++ L G+
Sbjct: 191 TLWYRPPELLLGE--RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248
Query: 341 STES---ISRIRNEKARRYLGSMRKKQPVPFSHKFPN--ADPLALHLLERLLAFDPKDRP 395
+ E + + K Q + DP AL L+++LL DP R
Sbjct: 249 TPEVWPNVDNYELYEKLEL----VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 304
Query: 396 TAEEALADPYFHGL---ANVDREPSTQPISKLEFEFERRK 432
+++AL +F +++ ST S E+ R+
Sbjct: 305 DSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRR 344
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 309 bits (795), Expect = e-102
Identities = 105/329 (31%), Positives = 159/329 (48%), Gaps = 29/329 (8%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDT-HTGERVAIKKINDVFEHVSDATRI--LREIKLLRLL 169
+Y+ IG+G+YG V A D + G VA+K++ + + + +RE+ +LR L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRHL 68
Query: 170 R---HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQ 224
HP++V + + + +VFE ++ DL + + E + ++Q
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
LLRGL ++H+ V HRDLKP+NIL + ++K+ DFGLAR ++ + T V T W
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMA---LTSVVVTLW 184
Query: 285 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
YRAPE L S Y +D+WS+GCIFAEM KPLF G + V QL + D++G P E
Sbjct: 185 YRAPEVLLQS---SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241
Query: 344 S---ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400
+ + P + D L LL + L F+P R +A A
Sbjct: 242 DWPRDVALPRQAFHSK-------SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 401 LADPYFHGL-ANVDREPSTQPISKLEFEF 428
L+ PYF L + S P S+ E
Sbjct: 295 LSHPYFQDLERCKENLDSHLPPSQNTSEL 323
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 309 bits (794), Expect = e-102
Identities = 111/309 (35%), Positives = 165/309 (53%), Gaps = 29/309 (9%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLR 170
RY+ +G+G+YG V A+DT T E VAIK+I EH + +RE+ LL+ L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR--LEHEEEGVPGTAIREVSLLKELQ 91
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 230
H +I+E+K ++ R ++++FE E+DL + + N D++ + FLYQL+ G+
Sbjct: 92 HRNIIELKSVIHHNHR-----LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 231 YIHTANVFHRDLKPKNILANADCK-----LKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
+ H+ HRDLKP+N+L + LKI DFGLAR +F P F T + T WY
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGI-PIRQF-THEIITLWY 203
Query: 286 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344
R PE L GS Y+ ++DIWSI CI+AEML PLFPG + + QL + ++LG P +
Sbjct: 204 RPPEILLGS--RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261
Query: 345 ---ISRIRNEKARRYLGSMRKKQPVPFSHKFPNA-DPLALHLLERLLAFDPKDRPTAEEA 400
++ + + + S K + D L LL +L DP R +A+ A
Sbjct: 262 WPGVTALPD-----WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNA 316
Query: 401 LADPYFHGL 409
L PYF
Sbjct: 317 LEHPYFSHN 325
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 305 bits (784), Expect = e-101
Identities = 107/314 (34%), Positives = 171/314 (54%), Gaps = 31/314 (9%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 170
+S+++ E +G G+Y V ++ TG VA+K++ E + +T I REI L++ L+
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI-REISLMKELK 61
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN------DDLTPEHYQFFLYQ 224
H +IV + ++ ++ + +VFE M++DL + + + L ++F +Q
Sbjct: 62 HENIVRLYDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
LL+GL + H + HRDLKP+N+L N +LK+ DFGLAR +F P F + V T W
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGI-PVNTF-SSEVVTLW 173
Query: 285 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
YRAP+ L GS Y+ +IDIWS GCI AEM+TGKPLFPG N QL L+ D++GTP+
Sbjct: 174 YRAPDVLMGS--RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231
Query: 344 S---ISRIRNEKARRYLGSMRKKQPVPFSHKFPNA-----DPLALHLLERLLAFDPKDRP 395
++++ Y +++++ P D + L LL +P R
Sbjct: 232 LWPSVTKLPK-----YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL 286
Query: 396 TAEEALADPYFHGL 409
+A++AL P+F
Sbjct: 287 SAKQALHHPWFAEY 300
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 1e-87
Identities = 107/366 (29%), Positives = 168/366 (45%), Gaps = 52/366 (14%)
Query: 112 ASRYQIQ-EVIGKGSYGVVGSAV--DTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 168
++ + +G+G+YG V A D + A+K+I +S + REI LLR
Sbjct: 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG--TGISMSA--CREIALLRE 74
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD---------LTPEHYQ 219
L+HP+++ ++ + L + + ++++F+ E DL +IK + L +
Sbjct: 75 LKHPNVISLQKVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 220 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK----LKICDFGLARVSFNDAPSAIF 275
LYQ+L G+ Y+H V HRDLKP NIL + +KI D G AR FN P
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNS-PLKPL 189
Query: 276 --WTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN------- 325
V T WYRAPE L G+ YT AIDIW+IGCIFAE+LT +P+F +
Sbjct: 190 ADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247
Query: 326 --VVHQLDLMTDLLGTPSTES---ISRIRNEKARRYLGSMRKKQPVPF----SHKFPNAD 376
QLD + +++G P+ + I ++ D
Sbjct: 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 307
Query: 377 PLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQP-ISKLEFEFERRKLAK 435
A HLL++LL DP R T+E+A+ DPYF + T + + + +R+
Sbjct: 308 SKAFHLLQKLLTMDPIKRITSEQAMQDPYFL-----EDPLPTSDVFAGCQIPYPKREFLT 362
Query: 436 DDVREM 441
++ +
Sbjct: 363 EEEPDD 368
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 235 bits (600), Expect = 3e-72
Identities = 90/400 (22%), Positives = 152/400 (38%), Gaps = 67/400 (16%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLR-LLRHP 172
+ ++V+G G+ G + VA+K+I +D RE++LLR HP
Sbjct: 25 SFCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILPECFSFAD-----REVQLLRESDEHP 78
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKY 231
+++ + ++ + Y+ EL + L + ++ D L Q GL +
Sbjct: 79 NVIRYFC-----TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 232 IHTANVFHRDLKPKNIL-----ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 286
+H+ N+ HRDLKP NIL A+ K I DFGL + S + T +
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 287 APE-LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344
APE L T +DI+S GC+F +++ G F
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL------------------- 234
Query: 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
+R + + H + D +A L+E+++A DP+ RP+A+ L P
Sbjct: 235 ---------QRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285
Query: 405 YFHGLAN-----------VDREPSTQPISKLEFEFERRKLAKDDVREMIYREILE----- 448
+F L +++E PI K + E R + K D RE I +
Sbjct: 286 FFWSLEKQLQFFQDVSDRIEKESLDGPIVK-QLERGGRAVVKMDWRENITVPLQTDLRKF 344
Query: 449 --YHPQMLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEEHY 486
Y +++ LR Y + L + +
Sbjct: 345 RTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGTLPDDF 384
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 3e-65
Identities = 112/434 (25%), Positives = 184/434 (42%), Gaps = 64/434 (14%)
Query: 18 HSFTNNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQHLQQLTIVEDFDFSGLKLIR 77
H ++S+ + N + + K + + Q++Q+LT E I
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMGKVKATPMTPEQAMK--QYMQKLTAFE------HHEIF 53
Query: 78 VPKRIQFPIAPTPATMDPHKKSALETEFFTEYGE---------ASRYQIQEVIGKGSYGV 128
I F + + + G A RY++ +VIGKGS+G
Sbjct: 54 SYPEIYF-LGLNAKKRQGMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQ 112
Query: 129 VGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188
V A D + VA+K + + + EI++L LR D +++
Sbjct: 113 VVKAYDHKVHQHVALKMVRNE-KRFHRQAAE--EIRILEHLRKQDKDNTMNVIHMLENFT 169
Query: 189 FKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPK 245
F++ I + FEL+ +L+++IK N + + F + +L+ L +H + H DLKP+
Sbjct: 170 FRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPE 229
Query: 246 NIL--ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAI 302
NIL +K+ DFG + + Y+ +R+YRAPE + G+ +Y I
Sbjct: 230 NILLKQQGRSGIKVIDFGSS--CYEHQRV----YTYIQSRFYRAPEVILGA---RYGMPI 280
Query: 303 DIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN------------ 350
D+WS+GCI AE+LTG PL PG++ QL M +LLG PS + + +
Sbjct: 281 DMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPR 340
Query: 351 -------EKARRYLGSMRKK----QPVPFSHKFPNA-----DPLALHLLERLLAFDPKDR 394
L R + + P S ++ NA DPL L L++ L +DP R
Sbjct: 341 YCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400
Query: 395 PTAEEALADPYFHG 408
T +AL P+
Sbjct: 401 MTPGQALRHPWLRR 414
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 5e-65
Identities = 75/321 (23%), Positives = 111/321 (34%), Gaps = 51/321 (15%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP- 172
Y I + IG G V ++ + AIK +N EI L L+
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 173 -DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
I+ + + + IY+V E DL+ +K + P + + +L +
Sbjct: 88 DKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 142
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL- 290
IH + H DLKP N L D LK+ DFG+A +++ V T Y PE
Sbjct: 143 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ-MQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 291 --------CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
G SK +P D+WS+GCI M GK F
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-----------------I 243
Query: 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402
IS++ + + F + +L+ L DPK R + E LA
Sbjct: 244 NQISKLHAI--------IDPNHEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
Query: 403 DPYFHGLANVDREPSTQPISK 423
PY + P Q
Sbjct: 293 HPYV----QIQTHPVNQMAKG 309
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 212 bits (540), Expect = 4e-64
Identities = 55/361 (15%), Positives = 95/361 (26%), Gaps = 58/361 (16%)
Query: 79 PKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASR-YQIQEVIGKGSYGVVGSAVDTHT 137
+ ++ P A A ET + + R ++ E + G VV D
Sbjct: 27 EEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVER 86
Query: 138 GERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK---HIMLPP--------- 184
E A+K S+ R+ L E + ++LP
Sbjct: 87 LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146
Query: 185 ---------SRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-------QFFLYQLLRG 228
+ ++ DL + D + QL+R
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
+ + + H P N+ D +L + D P+ Y
Sbjct: 207 AANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPA------SSVPVTYAPR 260
Query: 289 ELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348
E + + +T A++ W +G + F + L P T+
Sbjct: 261 EFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTD----- 315
Query: 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408
+ F L+ R L FD + R EA+ P F
Sbjct: 316 ----------------SLAFGS-CTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358
Query: 409 L 409
L
Sbjct: 359 L 359
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 2e-62
Identities = 95/346 (27%), Positives = 151/346 (43%), Gaps = 63/346 (18%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI--NDVFEHVSDATRILREIKLLRLL 169
RY+I +IGKGS+G V A D E VAIK I F + + E++LL L+
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-----QIEVRLLELM 107
Query: 170 RHPDIVEIKHIMLPPSRREFKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLL 226
D +I+ F++ + +VFE++ +L+ +++ + ++ + F Q+
Sbjct: 108 NKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 227 RGLKYIHT--ANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIFWTD---- 278
L ++ T ++ H DLKP+NIL +KI DFG S+
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG----------SSCQLGQRIYQ 217
Query: 279 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338
Y+ +R+YR+PE+ Y AID+WS+GCI EM TG+PLF G N V Q++ + ++LG
Sbjct: 218 YIQSRFYRSPEVL--LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 339 TPS--------------------------TESISRIRNEKARRYLGSMRKKQPVPFSHKF 372
P T+ R R L ++ + +
Sbjct: 276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRR 335
Query: 373 PN------ADPLAL-HLLERLLAFDPKDRPTAEEALADPYFHGLAN 411
AD L L+ R+L +DPK R AL +F A+
Sbjct: 336 AGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 4e-62
Identities = 73/330 (22%), Positives = 115/330 (34%), Gaps = 47/330 (14%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP- 172
Y I + IG G V ++ + AIK +N EI L L+
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 173 -DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
I+ + + IY+V E DL+ +K + P + + +L +
Sbjct: 69 DKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 123
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL- 290
IH + H DLKP N L D LK+ DFG+A +++ V T Y PE
Sbjct: 124 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ-MQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 291 --------CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
G SK +P D+WS+GCI M GK F
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-----------------I 224
Query: 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402
IS++ + + F + +L+ L DPK R + E LA
Sbjct: 225 NQISKLHAI--------IDPNHEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
Query: 403 DPYFHGLANVDREPSTQPISKLEFEFERRK 432
PY + + + ++++ +
Sbjct: 274 HPYVQIQTHPVNQMAKGTTEEMKYVLGQLV 303
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 8e-62
Identities = 87/339 (25%), Positives = 141/339 (41%), Gaps = 57/339 (16%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTG-ERVAIKKINDVFEHVSDATRILREIKLLRLLR 170
++RY+I + +G+G++G V +D G VA+K + +V + +A R EI++L L
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARS--EIQVLEHLN 69
Query: 171 HPDIVEIKHIMLPPSRREFKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLR 227
D + E I +VFEL+ + IK N +H + YQ+ +
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICK 129
Query: 228 GLKYIHTANVFHRDLKPKNIL-------------------ANADCKLKICDFGLARVSFN 268
+ ++H+ + H DLKP+NIL + +K+ DFG
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG------- 182
Query: 269 DAPSAIFWTD----YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 323
SA + + V+TR YRAPE + ++ D+WSIGCI E G +FP
Sbjct: 183 ---SATYDDEHHSTLVSTRHYRAPEVILAL---GWSQPCDVWSIGCILIEYYLGFTVFPT 236
Query: 324 KNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLA---- 379
+ L +M +LG I + R K + + + PL
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFML 296
Query: 380 ---------LHLLERLLAFDPKDRPTAEEALADPYFHGL 409
L++++L +DP R T EAL P+F L
Sbjct: 297 SQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 1e-61
Identities = 68/343 (19%), Positives = 132/343 (38%), Gaps = 65/343 (18%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
+ + + +G G++G V + A+K + ++ + + + +I E +L+ +++
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKI--EADILKKIQN 90
Query: 172 PDIVEIKHIMLPPSRREFKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRG 228
D + +I+ + + D + ++FE + L+++I N+ E + + ++L+
Sbjct: 91 DD-INNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 229 LKYIHTANVFHRDLKPKNIL-------------------------ANADCKLKICDFGLA 263
L Y+ ++ H DLKP+NIL +K+ DFG
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-- 207
Query: 264 RVSFNDAPSAIFWTD----YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGK 318
A F +D + TR YRAPE + + + D+WS GC+ AE+ TG
Sbjct: 208 --------CATFKSDYHGSIINTRQYRAPEVILNL---GWDVSSDMWSFGCVLAELYTGS 256
Query: 319 PLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYL-------------GSMRKKQP 365
LF + L +M ++ + +Y+ S+ +
Sbjct: 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKH 316
Query: 366 VPFSHKFPNA--DPLALHLLERLLAFDPKDRPTAEEALADPYF 406
V L L +L DP RP+ E L +
Sbjct: 317 VKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 3e-61
Identities = 83/364 (22%), Positives = 123/364 (33%), Gaps = 53/364 (14%)
Query: 79 PKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTG 138
Q +P T D K S+ E + G Y I + IG G V ++
Sbjct: 24 KFERQHMDSPDLGTDDDDKASSSANECISVKGR--IYSILKQIGSGGSSKVFQVLNE-KK 80
Query: 139 ERVAIKKINDVFEHVSDATRILREIKLLRLLRHP--DIVEIKHIMLPPSRREFKDIYVVF 196
+ AIK +N EI L L+ I+ + + + IY+V
Sbjct: 81 QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----QYIYMVM 135
Query: 197 ELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLK 256
E DL+ +K + P + + +L + IH + H DLKP N L D LK
Sbjct: 136 ECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLK 194
Query: 257 ICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDIWSI 307
+ DFG+A +++ V Y PE G SK +P D+WS+
Sbjct: 195 LIDFGIAN-QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253
Query: 308 GCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVP 367
GCI M GK F IS++ + +
Sbjct: 254 GCILYYMTYGKTPFQQI-----------------INQISKLHAI--------IDPNHEIE 288
Query: 368 FSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFE 427
F + +L+ L DPK R + E LA PY + P Q E
Sbjct: 289 FP---DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV----QIQTHPVNQMAKGTTEE 341
Query: 428 FERR 431
+
Sbjct: 342 MKYV 345
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 6e-61
Identities = 92/350 (26%), Positives = 140/350 (40%), Gaps = 57/350 (16%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTG-ERVAIKKINDVFEHVSDATRILREIKLLRLLR 170
RY+I +G+G++G V +D G +VA+K I +V +A R+ EI +L+ ++
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARL--EINVLKKIK 74
Query: 171 HPDIVEIKHIMLPPSRREFKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLR 227
D +L F + + FEL+ + + +K N+ H + YQL
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134
Query: 228 GLKYIHTANVFHRDLKPKNIL-------------------ANADCKLKICDFGLARVSFN 268
L+++H + H DLKP+NIL + + +++ DFG
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG------- 187
Query: 269 DAPSAIFWTD----YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 323
SA F + VATR YR PE + + D+WSIGCI E G LF
Sbjct: 188 ---SATFDHEHHTTIVATRHYRPPEVILEL---GWAQPCDVWSIGCILFEYYRGFTLFQT 241
Query: 324 KNVVHQLDLMTDLLGTPSTESISRIRNEK------ARRYLGSMRKKQPVPFSHKFPNA-- 375
L +M +LG + I R R +K S + +
Sbjct: 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYML 301
Query: 376 -----DPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQP 420
L+ R+L FDP R T EAL P+F GL +R T
Sbjct: 302 QDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSR 351
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-59
Identities = 74/334 (22%), Positives = 127/334 (38%), Gaps = 49/334 (14%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
+RY + +G G + V A D VA+K + + ++A EIKLL+ +
Sbjct: 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAED--EIKLLQRVND 74
Query: 172 PDIVEIKHIMLPPSRR-----EFKDIYV-----VFELMESDLHQVIKANDD--LTPEHYQ 219
D + + + K VFE++ +L +IK + + + +
Sbjct: 75 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 134
Query: 220 FFLYQLLRGLKYIHT-ANVFHRDLKPKNILAN------ADCKLKICDFGLARVSFNDAPS 272
QLL GL Y+H + H D+KP+N+L ++KI D G A
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-- 192
Query: 273 AIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV----- 326
T+ + TR YR+PE L G+ + DIWS C+ E++TG LF
Sbjct: 193 ----TNSIQTREYRSPEVLLGA---PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245
Query: 327 -VHQLDLMTDLLGTPSTESISRIR----------NEKARRYLGSMRKKQPVPFSHKFPNA 375
+ + +LLG + + + + L + + +KF
Sbjct: 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 305
Query: 376 DPLAL-HLLERLLAFDPKDRPTAEEALADPYFHG 408
+ + L +L DP+ R A + P+
Sbjct: 306 EAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 3e-59
Identities = 75/317 (23%), Positives = 118/317 (37%), Gaps = 56/317 (17%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
AS ++ V+G+G++G V A + AIKKI + IL E+ LL L H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNH 61
Query: 172 PDIVEIKH--------IMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPE-HYQFF 221
+V + + ++ +++ E E L+ +I + + Y
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 222 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW----- 276
Q+L L YIH+ + HRDLKP NI + +KI DFGLA+
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 277 ------TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQL 330
T + T Y A E+ Y ID++S+G IF EM+ P G V+
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDG-TGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVN-- 236
Query: 331 DLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAF 389
++ L + + F F N + ++ L+
Sbjct: 237 -ILKKL-------------------------RSVSIEFPPDFDDNKMKVEKKIIRLLIDH 270
Query: 390 DPKDRPTAEEALADPYF 406
DP RP A L +
Sbjct: 271 DPNKRPGARTLLNSGWL 287
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-58
Identities = 77/330 (23%), Positives = 114/330 (34%), Gaps = 51/330 (15%)
Query: 79 PKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTG 138
P+R+ F + P + FF + +Q +G GSYG V G
Sbjct: 28 PRRVSFRGEASETLQSPGYDPSRPESFFQQ-----SFQRLSRLGHGSYGEVFKVRSKEDG 82
Query: 139 ERVAIKKINDVFEHVSDATRILREIK-LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 197
A+K+ F D R L E+ ++ +HP V ++ + E +Y+ E
Sbjct: 83 RLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ-----AWEEGGILYLQTE 137
Query: 198 LMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLK 256
L L Q +A PE +L L L ++H+ + H D+KP NI + K
Sbjct: 138 LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCK 197
Query: 257 ICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
+ DFGL + Y APEL Y A D++S+G E+
Sbjct: 198 LGDFGLLVELGTAGAGEVQ----EGDPRYMAPELLQG---SYGTAADVFSLGLTILEVAC 250
Query: 317 GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNAD 376
L G QL + P F+ +
Sbjct: 251 NMELPHGGEGWQQL-----------------------------RQGYLPPEFTAGLSSE- 280
Query: 377 PLALHLLERLLAFDPKDRPTAEEALADPYF 406
+L +L DPK R TAE LA P
Sbjct: 281 --LRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 4e-58
Identities = 80/351 (22%), Positives = 140/351 (39%), Gaps = 48/351 (13%)
Query: 96 HKKSALETEFFTEYGEA-SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS 154
H S ++ Y ++ +Y + IG+GS+G T G + IK+IN +S
Sbjct: 6 HHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEIN--ISRMS 63
Query: 155 DATR--ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIK-AN 210
R RE+ +L ++HP+IV+ + S E +Y+V + E DL + I
Sbjct: 64 SKEREESRREVAVLANMKHPNIVQYRE-----SFEENGSLYIVMDYCEGGDLFKRINAQK 118
Query: 211 DDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269
L E + Q+ LK++H + HRD+K +NI D +++ DFG+ARV +
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178
Query: 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQ 329
A + T +Y +PE+C + Y DIW++GC+ E+ T K F +
Sbjct: 179 VELA---RACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGS---- 229
Query: 330 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAF 389
M +L + +I + + +S+ + L+ +L
Sbjct: 230 ---MKNL--------VLKIISGSFPPV--------SLHYSYDLRS-------LVSQLFKR 263
Query: 390 DPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVRE 440
+P+DRP+ L + P F + +
Sbjct: 264 NPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKR 314
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 1e-57
Identities = 87/305 (28%), Positives = 134/305 (43%), Gaps = 49/305 (16%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN------DVFEHVSDATRILREIKLLR 167
Y + + +G G+ G V A + T ++VAI+ I+ A + EI++L+
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL 226
L HP I++IK+ + +D Y+V ELME +L + N L + + YQ+L
Sbjct: 196 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 227 RGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
++Y+H + HRDLKP+N+L DC +KI DFG +++ + T
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTP 305
Query: 284 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
Y APE L + Y A+D WS+G I L+G P F L
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----------K 354
Query: 343 ESISRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
+ I + +Y F + AL L+++LL DPK R T EEAL
Sbjct: 355 DQI------TSGKY----------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 398
Query: 402 ADPYF 406
P+
Sbjct: 399 RHPWL 403
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 1e-57
Identities = 62/308 (20%), Positives = 120/308 (38%), Gaps = 26/308 (8%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+ + +++G+G+ V TG+ AIK N++ + +RE ++L+ L H +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI-SFLRPVDVQMREFEVLKKLNHKN 68
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAN---DDLTPEHYQFFLYQLLRGL 229
IV++ I + R ++ E L+ V++ L + L ++ G+
Sbjct: 69 IVKLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 230 KYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
++ + HR++KP NI+ + K+ DFG AR +D + T Y
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEY 181
Query: 286 RAPEL------CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF-PGKNVVHQLDLMTDLLG 338
P++ KY +D+WSIG F TG F P + ++M ++
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 398
+ +IS ++ + S S L +L +L D + +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGFD 298
Query: 399 EALADPYF 406
+ A+
Sbjct: 299 QFFAETSD 306
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-57
Identities = 69/327 (21%), Positives = 121/327 (37%), Gaps = 55/327 (16%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+ ++ + +G+G +GVV A + AIK+I + +++RE+K L L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHP 63
Query: 173 DIVEIKH-------IMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQF---F 221
IV + +Y+ +L +L + +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 222 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV---------SFNDAPS 272
Q+ ++++H+ + HRDLKP NI D +K+ DFGL P+
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL 332
T V T+ Y +PE + Y+ +DI+S+G I E+L P V
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY--PFSTQMERV----- 234
Query: 333 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPK 392
+++ +RN K F F P +++ +L+ P
Sbjct: 235 ----------RTLTDVRNLK---------------FPPLFTQKYPCEYVMVQDMLSPSPM 269
Query: 393 DRPTAEEALADPYFHGLANVDREPSTQ 419
+RP A + + F L + Q
Sbjct: 270 ERPEAINIIENAVFEDLDFPGKTVLRQ 296
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-56
Identities = 83/308 (26%), Positives = 129/308 (41%), Gaps = 52/308 (16%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRL 168
A Y++ IG GSYG G+ + K+++ + +++A + ++ E+ LLR
Sbjct: 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD--YGSMTEAEKQMLVSEVNLLRE 61
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKA---NDDLTPEHY-QFFLY 223
L+HP+IV ++ R +Y+V E E DL VI E + +
Sbjct: 62 LKHPNIVRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 224 QLLRGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD 278
QL LK H + V HRDLKP N+ + +K+ DFGLAR+ +D A
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA---KT 175
Query: 279 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338
+V T +Y +PE Y DIWS+GC+ E+ P F + +L
Sbjct: 176 FVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFS-------QKEL-- 224
Query: 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 398
+IR K RR P +S + ++ R+L RP+ E
Sbjct: 225 ------AGKIREGKFRRI--------PYRYSDELNE-------IITRMLNLKDYHRPSVE 263
Query: 399 EALADPYF 406
E L +P
Sbjct: 264 EILENPLI 271
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 3e-56
Identities = 91/341 (26%), Positives = 139/341 (40%), Gaps = 55/341 (16%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN------DVFEHVSDATRILREIKLLR 167
Y + + +G G+ G V A + T ++VAIK I+ A + EI++L+
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL 226
L HP I++IK+ + +D Y+V ELME +L + N L + + YQ+L
Sbjct: 71 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 227 RGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
++Y+H + HRDLKP+N+L DC +KI DFG +++ + T
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETS---LMRTLCGTP 180
Query: 284 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
Y APE L + Y A+D WS+G I L+G P F L
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL------------ 228
Query: 343 ESISRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
+I + K F + AL L+++LL DPK R T EEAL
Sbjct: 229 --KDQITSGK-------------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273
Query: 402 ADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMI 442
P+ E + L E + +
Sbjct: 274 RHPWLQD------EDMKRKFQDLLSEENESTALPQVLAQPS 308
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 5e-56
Identities = 71/310 (22%), Positives = 111/310 (35%), Gaps = 63/310 (20%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
++ E+IG G +G V A G+ IK++ + + RE+K L L H
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNEKAEREVKALAKLDH 63
Query: 172 PDIVEIKH-----------IMLPPSRREFKDIYVVFELMES-DLHQVIK-ANDDLTPEHY 218
+IV SR + K +++ E + L Q I+ + +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 219 -QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT 277
Q+ +G+ YIH+ + +RDLKP NI ++KI DFGL ND
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS-- 181
Query: 278 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDL 336
T Y +PE S Y +D++++G I AE+L F
Sbjct: 182 --KGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETSKF---------- 227
Query: 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT 396
+ +R F K LL++LL+ P+DRP
Sbjct: 228 --------FTDLR-----------DGIISDIFDKKEKT-------LLQKLLSKKPEDRPN 261
Query: 397 AEEALADPYF 406
E L
Sbjct: 262 TSEILRTLTV 271
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 8e-55
Identities = 71/364 (19%), Positives = 138/364 (37%), Gaps = 29/364 (7%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+ + +++G+G+ V TG+ AIK N++ + +RE ++L+ L H +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI-SFLRPVDVQMREFEVLKKLNHKN 68
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAN---DDLTPEHYQFFLYQLLRGL 229
IV++ I + R ++ E L+ V++ L + L ++ G+
Sbjct: 69 IVKLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 230 KYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
++ + HR++KP NI+ + K+ DFG AR +D + T Y
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEY 181
Query: 286 RAPEL------CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF-PGKNVVHQLDLMTDLLG 338
P++ KY +D+WSIG F TG F P + ++M ++
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 398
+ +IS ++ + S S L +L +L D + +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGFD 298
Query: 399 EALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYL 458
+ A+ V S Q ++ + A E++Y++ + QE +
Sbjct: 299 QFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTAT-IFHELVYKQT-KIISSN-QELI 355
Query: 459 RGGE 462
G
Sbjct: 356 YEGR 359
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-54
Identities = 78/328 (23%), Positives = 131/328 (39%), Gaps = 51/328 (15%)
Query: 88 PTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN 147
P + Y + ++I++ IG+G + V A G VA+KK+
Sbjct: 7 GMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQ 66
Query: 148 DVFEHVSDATR--ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLH 204
+F+ + R ++EI LL+ L HP++++ S E ++ +V EL ++ DL
Sbjct: 67 -IFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA-----SFIEDNELNIVLELADAGDLS 120
Query: 205 QVIKA---NDDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 260
++IK L PE + QL L+++H+ V HRD+KP N+ A +K+ D
Sbjct: 121 RMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDL 180
Query: 261 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL 320
GL R + +A V T +Y +PE + Y DIWS+GC+ EM +
Sbjct: 181 GLGRFFSSKTTAA---HSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSP 235
Query: 321 FPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVP---FSHKFPNADP 377
F G ++ L +I P+P +S +
Sbjct: 236 FYGDK-MNLYSLC------------KKIEQCDY----------PPLPSDHYSEELRQ--- 269
Query: 378 LALHLLERLLAFDPKDRPTAEEALADPY 405
L+ + DP+ RP
Sbjct: 270 ----LVNMCINPDPEKRPDVTYVYDVAK 293
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 9e-54
Identities = 89/374 (23%), Positives = 139/374 (37%), Gaps = 61/374 (16%)
Query: 79 PKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTG 138
P + P P + E + RY +GKG + D T
Sbjct: 7 PGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTK 66
Query: 139 ERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 197
E A K + + ++ EI + R L H +V ++VV E
Sbjct: 67 EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF-----VFVVLE 121
Query: 198 LMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLK 256
L L ++ K LT +++L Q++ G +Y+H V HRDLK N+ N D ++K
Sbjct: 122 LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVK 181
Query: 257 ICDFGLARVSFNDAPSAIFWT-----DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 311
I DFGLA + + +Y+ APE+ ++ +D+WSIGCI
Sbjct: 182 IGDFGLA--TKVEYDGERKKVLCGTPNYI------APEVLSK--KGHSFEVDVWSIGCIM 231
Query: 312 AEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHK 371
+L GKP F + E+ RI+ Y P +
Sbjct: 232 YTLLVGKPPFETSCL---------------KETYLRIKK---NEY------SIPKHIN-- 265
Query: 372 FPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLE----FE 427
P+A L++++L DP RPT E L D +F P+ PI+ L F
Sbjct: 266 -----PVAASLIQKMLQTDPTARPTINELLNDEFF----TSGYIPARLPITCLTIPPRFS 316
Query: 428 FERRKLAKDDVREM 441
L + + +
Sbjct: 317 IAPSSLDPSNRKPL 330
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-52
Identities = 83/319 (26%), Positives = 127/319 (39%), Gaps = 57/319 (17%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 172
RY +GKG + D T E A K + + ++ EI + R L H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+V ++VV EL L ++ K LT +++L Q++ G +Y
Sbjct: 76 HVVGFHGFFEDN-----DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 130
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT-----DYVATRWYR 286
+H V HRDLK N+ N D ++KI DFGLA + + +Y+
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA--TKVEYDGERKKVLCGTPNYI------ 182
Query: 287 APELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
APE+ ++ +D+WSIGCI +L GKP F + E+
Sbjct: 183 APEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------------KETYL 225
Query: 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
RI+ Y P + P+A L++++L DP RPT E L D +F
Sbjct: 226 RIKK---NEY------SIPKHIN-------PVAASLIQKMLQTDPTARPTINELLNDEFF 269
Query: 407 HGLANVDREPSTQPISKLE 425
P+ PI+ L
Sbjct: 270 ----TSGYIPARLPITCLT 284
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 1e-51
Identities = 83/365 (22%), Positives = 134/365 (36%), Gaps = 84/365 (23%)
Query: 93 MDPHKKSALETEFFTEYGEA---SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-- 147
H S E +F +Y ++ IG+GSYGVV A++ T AIK +N
Sbjct: 3 HHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN 62
Query: 148 -DVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQ 205
+ D RI E++L++ L HP+I + + + + I +V EL L
Sbjct: 63 KIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-----EDEQYICLVMELCHGGHLLD 117
Query: 206 VIKANDDLTPEHYQF----------------------------------------FLYQL 225
+ D + + Q+
Sbjct: 118 KLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177
Query: 226 LRGLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIF-WTDYVAT 282
L Y+H + HRD+KP+N L N ++K+ DFGL++ + + T T
Sbjct: 178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
++ APE+ + Y P D WS G + +L G FPG N
Sbjct: 238 PYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVN---------------DA 282
Query: 343 ESISRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEEAL 401
++IS++ + + F + + PLA LL LL + +R A AL
Sbjct: 283 DTISQV-------------LNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329
Query: 402 ADPYF 406
P+
Sbjct: 330 QHPWI 334
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 2e-51
Identities = 65/303 (21%), Positives = 110/303 (36%), Gaps = 43/303 (14%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
Y + +G+G + V H G A+K+I D RE + RL HP+
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREADMHRLFNHPN 87
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRG 228
I+ + L + + +++ + L I+ + LT + + L + RG
Sbjct: 88 ILRLVAYCLRERGAKHE-AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA------IFWTDYVAT 282
L+ IH HRDLKP NIL + + + D G + + W T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 283 RWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341
YRAPEL D+WS+GC+ M+ G+ +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF--------------QK 252
Query: 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
+S++ ++ + +P S + +A LL ++ DP RP L
Sbjct: 253 GDSVALA-----------VQNQLSIPQSPRHSSA---LWQLLNSMMTVDPHQRPHIPLLL 298
Query: 402 ADP 404
+
Sbjct: 299 SQL 301
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 2e-51
Identities = 91/320 (28%), Positives = 136/320 (42%), Gaps = 53/320 (16%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
RY I ++GKGS+G V D T + A+K IN D + ILRE++LL+ L HP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 173 DIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 228
+I+++ I +D Y+V EL +L I + + Q+ G
Sbjct: 82 NIMKLFEI--------LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG 133
Query: 229 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
+ Y+H N+ HRDLKP+NIL DC +KI DFGL+ + D + T +Y
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK----MKDRIGTAYY 189
Query: 286 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344
APE L G Y D+WS G I +L+G P F GKN +
Sbjct: 190 IAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKN---------------EYDI 230
Query: 345 ISRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
+ R+ + F ++ A L+ ++L F P R TA + L
Sbjct: 231 LKRV-------------ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277
Query: 404 PYFHGLANVDREPSTQPISK 423
P+ ++ S P +
Sbjct: 278 PWIQKYSSETPTISDLPSLE 297
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-51
Identities = 71/299 (23%), Positives = 121/299 (40%), Gaps = 42/299 (14%)
Query: 113 SRY-QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
R+ + IG+GS+ V +DT T VA ++ D S+ R E ++L+ L+H
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH 84
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLK 230
P+IV + + K I +V ELM S L +K + + + + Q+L+GL+
Sbjct: 85 PNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143
Query: 231 YIHTAN--VFHRDLKPKNILANA-DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
++HT + HRDLK NI +KI D GLA + A+ T + A
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPE----FM-A 198
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
PE+ KY ++D+++ G EM T + + Q+
Sbjct: 199 PEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI----------------- 238
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
Y +P F A P ++E + + +R + ++ L +F
Sbjct: 239 --------YRRVTSGVKPASFDK---VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 5e-51
Identities = 90/336 (26%), Positives = 141/336 (41%), Gaps = 56/336 (16%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
YQ + +G G+YG V D T AIK I S +++L E+ +L+LL HP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 173 DIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 228
+I+++ F+D Y+V E + +L I + Q+L G
Sbjct: 97 NIMKLYDF--------FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG 148
Query: 229 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
+ Y+H N+ HRDLKP+N+L D +KI DFGL+ V N + + T +Y
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK----MKERLGTAYY 204
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
APE+ KY D+WSIG I +L G P F G+ E +
Sbjct: 205 IAPEV---LRKKYDEKCDVWSIGVILFILLAGYPPFGGQT---------------DQEIL 246
Query: 346 SRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
++ K F S ++ N A L++++L FD + R +A++AL P
Sbjct: 247 RKVEKGK-------------YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHP 293
Query: 405 YFHGLANVDREPSTQPISKLEFE-----FERRKLAK 435
+ + + P E +KLA+
Sbjct: 294 WIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQ 329
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 5e-51
Identities = 80/321 (24%), Positives = 134/321 (41%), Gaps = 52/321 (16%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRH 171
RY+ Q V+GKGS+G V D TG+ A+K I+ + +D +LRE++LL+ L H
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 172 PDIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLR 227
P+I+++ F+D Y+V E+ +L I + + + Q+L
Sbjct: 86 PNIMKLYEF--------FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 228 GLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
G+ Y+H + HRDLKP+N+L + D ++I DFGL+ D + T +
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK----MKDKIGTAY 193
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344
Y APE+ Y D+WS G I +L+G P F G N +
Sbjct: 194 YIAPEV---LHGTYDEKCDVWSTGVILYILLSGCPPFNGAN---------------EYDI 235
Query: 345 ISRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
+ ++ +K F ++ A L+ ++L + P R +A +AL
Sbjct: 236 LKKV-------------EKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282
Query: 404 PYFHGLANVDREPSTQPISKL 424
+ +
Sbjct: 283 EWIQTYTKEQISVDVPSLDNA 303
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 3e-50
Identities = 80/399 (20%), Positives = 140/399 (35%), Gaps = 93/399 (23%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLR-LLRH 171
+ ++++G GS G V + G VA+K++ + L EIKLL H
Sbjct: 15 NLVVSEKILGYGSSGTV-VFQGSFQGRPVAVKRML-----IDFCDIALMEIKLLTESDDH 68
Query: 172 PDIVEIKHIMLPPSRREFKD---IYVVFELMESDLHQVIKANDDLTPEHYQF-------F 221
P+++ +Y+ EL +L ++++ +
Sbjct: 69 PNVIRYYCS--------ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 222 LYQLLRGLKYIHTANVFHRDLKPKNIL-------------ANADCKLKICDFGLAR-VSF 267
L Q+ G+ ++H+ + HRDLKP+NIL + ++ I DFGL + +
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 268 NDAPSAIFWTDYVATRWYRAPEL-----CGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLF 321
+ + T +RAPEL + T +IDI+S+GC+F +L+ GK F
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 322 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH 381
K S I + A
Sbjct: 241 GDKY-----------------SRESNIIRGI---------FSLDEMKCLHDRSLIAEATD 274
Query: 382 LLERLLAFDPKDRPTAEEALADPYFHGLA--------------NVDREPSTQPISKLEFE 427
L+ +++ DP RPTA + L P F + +R+P + + K +
Sbjct: 275 LISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSDRLEIENRDPPSALLMKFD-A 333
Query: 428 FERRKLAKDDVREMIYREILE-------YHPQMLQEYLR 459
+ D + ++ YH L + LR
Sbjct: 334 GSDFVIPSGDWTVKFDKTFMDNLERYRKYHSSKLMDLLR 372
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-49
Identities = 73/367 (19%), Positives = 127/367 (34%), Gaps = 104/367 (28%)
Query: 112 ASR----YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLR 167
ASR ++ + +G+G +GVV A + AIK+I + +++RE+K L
Sbjct: 1 ASRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIR-LPNRELAREKVMREVKALA 59
Query: 168 LLRHPDIVEIKH------------------------------------------------ 179
L HP IV +
Sbjct: 60 KLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS 119
Query: 180 ----IMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQ---FFLYQLLRGLKY 231
+ +Y+ +L +L + L + Q+ +++
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND---------APSAIFWTDYVAT 282
+H+ + HRDLKP NI D +K+ DFGL D P+ T V T
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
+ Y +PE + Y+ +DI+S+G I E+L V +
Sbjct: 240 KLYMSPEQIHG--NNYSHKVDIFSLGLILFELLY--SFSTQMERVRII------------ 283
Query: 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402
+ +RN K P+ F+ K+P +++ +L+ P +RP A + +
Sbjct: 284 ---TDVRNLKF-----------PLLFTQKYPQ----EHMMVQDMLSPSPTERPEATDIIE 325
Query: 403 DPYFHGL 409
+ F L
Sbjct: 326 NAIFENL 332
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 2e-49
Identities = 87/332 (26%), Positives = 129/332 (38%), Gaps = 64/332 (19%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-----------DVFEHVSDATRILR 161
Y +G G+YG V + + AIK I D I
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 162 EIKLLRLLRHPDIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEH 217
EI LL+ L HP+I+++ + F+D Y+V E E +L + I
Sbjct: 96 EISLLKSLDHPNIIKLFDV--------FEDKKYFYLVTEFYEGGELFEQIINRHKFDECD 147
Query: 218 YQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAI 274
+ Q+L G+ Y+H N+ HRD+KP+NIL N+ +KI DFGL+ D
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK--- 204
Query: 275 FWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLM 333
D + T +Y APE L KY D+WS G I +L G P F G+N
Sbjct: 205 -LRDRLGTAYYIAPEVLKK----KYNEKCDVWSCGVIMYILLCGYPPFGGQND------- 252
Query: 334 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPK 392
+ I ++ K F + + N A L++ +L +D
Sbjct: 253 --------QDIIKKVEKGK-------------YYFDFNDWKNISDEAKELIKLMLTYDYN 291
Query: 393 DRPTAEEALADPYFHGLANVDREPSTQPISKL 424
R TAEEAL + AN + + +
Sbjct: 292 KRCTAEEALNSRWIKKYANNINKSDQKTLCGA 323
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-49
Identities = 95/358 (26%), Positives = 151/358 (42%), Gaps = 49/358 (13%)
Query: 87 APTPATMDPHKKSALETEFFTEYGE--ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIK 144
P A+M ++ +EF + Y ++E +GKG++ VV V TG A K
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60
Query: 145 KINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDL 203
IN D ++ RE ++ R L+HP+IV + + +E Y+VF+L+ +L
Sbjct: 61 IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGEL 115
Query: 204 HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDF 260
+ I A + + + Q+L + Y H+ + HR+LKP+N+L +K+ DF
Sbjct: 116 FEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADF 175
Query: 261 GLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKP 319
GLA ND+ W + T Y +PE L Y+ +DIW+ G I +L G P
Sbjct: 176 GLAIE-VNDSE---AWHGFAGTPGYLSPEVLKK---DPYSKPVDIWACGVILYILLVGYP 228
Query: 320 LFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPL 378
F ++ Q L I K + S ++ P
Sbjct: 229 PFWDED---QHRLY---------AQI----------------KAGAYDYPSPEWDTVTPE 260
Query: 379 ALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFE-RRKLAK 435
A L++ +L +PK R TA++AL P+ V Q +F RRKL
Sbjct: 261 AKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKG 318
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 7e-49
Identities = 86/319 (26%), Positives = 139/319 (43%), Gaps = 51/319 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
Y ++E +GKG++ VV V TG A K IN D ++ RE ++ R L+HP
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+IV + + +E Y+VF+L+ +L + I A + + + Q+L + Y
Sbjct: 66 NIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 232 IHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
H+ + HR+LKP+N+L +K+ DFGLA ND+ W + T Y +P
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSE---AWHGFAGTPGYLSP 176
Query: 289 E-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
E L Y+ +DIW+ G I +L G P F ++ Q L I
Sbjct: 177 EVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLY---------AQI-- 219
Query: 348 IRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
K + S ++ P A L++ +L +PK R TA++AL P+
Sbjct: 220 --------------KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265
Query: 407 HGLANVDREPSTQPISKLE 425
+RE I + +
Sbjct: 266 -----CNRERVASAIHRQD 279
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-48
Identities = 91/324 (28%), Positives = 141/324 (43%), Gaps = 47/324 (14%)
Query: 96 HKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSD 155
H S+ + + A RY I ++GKGS+G V D T + A+K IN D
Sbjct: 5 HHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64
Query: 156 ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLT 214
+ ILRE++LL+ L HP+I+++ I+ + Y+V EL +L I +
Sbjct: 65 TSTILREVELLKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFS 119
Query: 215 PEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAP 271
+ Q+ G+ Y+H N+ HRDLKP+NIL DC +KI DFGL+ +
Sbjct: 120 EHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT- 178
Query: 272 SAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQL 330
D + T +Y APE L G Y D+WS G I +L+G P F GKN +
Sbjct: 179 ---KMKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKN---EY 228
Query: 331 DLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAF 389
D++ + + + F + A L+ ++L F
Sbjct: 229 DIL---------KRV----------------ETGKYAFDLPQWRTISDDAKDLIRKMLTF 263
Query: 390 DPKDRPTAEEALADPYFHGLANVD 413
P R TA + L P+ ++ +
Sbjct: 264 HPSLRITATQCLEHPWIQKYSSEE 287
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-48
Identities = 79/357 (22%), Positives = 140/357 (39%), Gaps = 64/357 (17%)
Query: 93 MDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----D 148
M+P K+ +E Y I E +G G + +V + TG A K I
Sbjct: 2 MEPFKQQKVE----------DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSR 51
Query: 149 VFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVI 207
I RE+ +LR + H +++ + + D+ ++ EL+ +L +
Sbjct: 52 ASRRGVSREEIEREVSILRQVLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFL 106
Query: 208 KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLA 263
+ L+ E F+ Q+L G+ Y+HT + H DLKP+NI+ +K+ DFGLA
Sbjct: 107 AQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166
Query: 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 323
+ + + T + APE+ + D+WSIG I +L+G F G
Sbjct: 167 HEIEDGVE----FKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLG 220
Query: 324 KNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHL 382
+ + + +I+ + + F + F + LA
Sbjct: 221 DT---KQETL---------ANITSVSYD----------------FDEEFFSHTSELAKDF 252
Query: 383 LERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLE----FEFERRKLAK 435
+ +LL + + R T +EAL P+ + N + + LE + RR+
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQ-YVRRRWKL 308
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-48
Identities = 86/302 (28%), Positives = 123/302 (40%), Gaps = 49/302 (16%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
Y ++ IG+GS+G V AV T R A KKI V D R +EI++++ L HP
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK--YFVEDVDRFKQEIEIMKSLDHP 66
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+I+ + + DIY+V EL +L + + + +L + Y
Sbjct: 67 NIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAY 121
Query: 232 IHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
H NV HRDLKP+N L + D LK+ DFGLA F V T +Y +P
Sbjct: 122 CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR-FKPGK---MMRTKVGTPYYVSP 177
Query: 289 E-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
+ L G Y P D WS G + +L G P F ++M I
Sbjct: 178 QVLEG----LYGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEVM---------LKI-- 219
Query: 348 IRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
++ F + N P A L+ RLL PK R T+ +AL +F
Sbjct: 220 --------------REGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF 265
Query: 407 HG 408
Sbjct: 266 EK 267
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 177 bits (449), Expect = 1e-48
Identities = 71/343 (20%), Positives = 130/343 (37%), Gaps = 22/343 (6%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
++++E +G G +G V + TGE+VAIK+ + R EI++++ L HP+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPN 73
Query: 174 IVEIKHIMLPPSRREFKD-IYVVFELMES-DLHQVIKANDD---LTPEHYQFFLYQLLRG 228
+V + + + D + E E DL + + ++ L + L +
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 229 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
L+Y+H + HRDLKP+NI+ KI D G A+ T++V T Y
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE----LCTEFVGTLQY 189
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
APEL KYT +D WS G + E +TG F Q + +
Sbjct: 190 LAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR-EKSNEHIVV 246
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
+ P P +H L+ +L + + R T +
Sbjct: 247 YDDLTGAVKF-----SSVLPTP-NHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300
Query: 406 FHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILE 448
F L ++ ++ + + +++ + + + +
Sbjct: 301 FQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQ 343
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-48
Identities = 71/302 (23%), Positives = 122/302 (40%), Gaps = 57/302 (18%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRH 171
++I +GKG +G V A + + +A+K + E ++ RE+++ LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLK 230
P+I+ + +R +Y++ E +++ ++ + ++ +L L
Sbjct: 69 PNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT-----DYVATRWY 285
Y H+ V HRD+KP+N+L + +LKI DFG + APS+ DY+
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYL----- 174
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
PE+ + +D+WS+G + E L GKP F E+
Sbjct: 175 -PPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---------------ETY 216
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPN-ADPLALHLLERLLAFDPKDRPTAEEALADP 404
RI + FP+ A L+ RLL +P RP E L P
Sbjct: 217 KRISRVE-----------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259
Query: 405 YF 406
+
Sbjct: 260 WI 261
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-48
Identities = 77/318 (24%), Positives = 129/318 (40%), Gaps = 51/318 (16%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-------DVFEHVSDATRILREIKL 165
Y+ +E++G+G VV + T + A+K I+ E L+E+ +
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 166 LRLL-RHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLY 223
LR + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 77 LRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
LL + +H N+ HRDLKP+NIL + D +K+ DFG + + + T
Sbjct: 132 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ-LDPGE---KLREVCGTP 187
Query: 284 WYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339
Y APE + S Y +D+WS G I +L G P F + Q+ ++
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLML------ 238
Query: 340 PSTESISRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAE 398
I F S ++ + L+ R L P+ R TAE
Sbjct: 239 ---RMI----------------MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAE 279
Query: 399 EALADPYFHGLANVDREP 416
EALA P+F +
Sbjct: 280 EALAHPFFQQYVVEEVRH 297
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 8e-48
Identities = 80/349 (22%), Positives = 142/349 (40%), Gaps = 61/349 (17%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLRL 168
Y E +G G + VV + TG + A K I I RE+ +L+
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 169 LRHPDIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQ 224
++HP+++ + + +++ + ++ EL+ +L + + LT E FL Q
Sbjct: 71 IQHPNVITLHEV--------YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 225 LLRGLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVSFNDAPSAIFWTDYV 280
+L G+ Y+H+ + H DLKP+NI+ ++KI DFGLA + +
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIF 178
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340
T + APE+ + D+WSIG I +L+G F G + + +
Sbjct: 179 GTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETL------- 226
Query: 341 STESISRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEE 399
++S + E F + F N LA + RLL DPK R T ++
Sbjct: 227 --ANVSAVNYE----------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268
Query: 400 ALADPYFHGL---ANVDREPSTQPISKLEFEFERRK---LAKDDVREMI 442
+L P+ + R+ S + K + R+K + + ++
Sbjct: 269 SLQHPWIKPKDTQQALSRKASAVNMEKFKKFAARKKSNNGSGGGLNDIF 317
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-47
Identities = 78/385 (20%), Positives = 146/385 (37%), Gaps = 59/385 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLRL 168
Y I E +G G + +V + TG A K I I RE+ +LR
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLR 227
+ HP+I+ + + D+ ++ EL+ +L + + L+ E F+ Q+L
Sbjct: 72 VLHPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 228 GLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
G+ Y+HT + H DLKP+NI+ +K+ DFGLA + + + T
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE----FKNIFGTP 182
Query: 284 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
+ APE+ + D+WSIG I +L+G F G + + +
Sbjct: 183 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETL---------A 228
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEEALA 402
+I+ + + F + F LA + +LL + + R T +EAL
Sbjct: 229 NITAVSYD----------------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272
Query: 403 DPYFHGL---ANVDREPSTQPISKLEFEFERRKLAK-----DDVREMIYREILEYHPQML 454
P+ + + R S + + ++ RR+ + + + H +
Sbjct: 273 HPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWKLSFSIVSLCNHLTRSLMKKVHLRTS 332
Query: 455 QEYLRG--GEQTSFMYPSGVDRFKR 477
++ + + + +R
Sbjct: 333 EDLRNCESDTEENIARRKALHPRRR 357
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-47
Identities = 72/302 (23%), Positives = 133/302 (44%), Gaps = 56/302 (18%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 172
+++ ++GKGS+ V A HTG VAIK I+ R+ E+K+ L+HP
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLK 230
I+E+ + + +Y+V E+ + ++++ +K + + F++Q++ G+
Sbjct: 72 SILELYNYFEDSNY-----VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT-----DYVATRWY 285
Y+H+ + HRDL N+L + +KI DFGLA + P +T +Y+
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA--TQLKMPHEKHYTLCGTPNYI----- 179
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
+PE+ S + D+WS+GC+F +L G+P F V ++
Sbjct: 180 -SPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTV---------------KNTL 221
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPN-ADPLALHLLERLLAFDPKDRPTAEEALADP 404
+++ Y + P+ A L+ +LL +P DR + L P
Sbjct: 222 NKV---VLADY--------------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264
Query: 405 YF 406
+
Sbjct: 265 FM 266
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-47
Identities = 72/317 (22%), Positives = 120/317 (37%), Gaps = 57/317 (17%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRH 171
+ I +GKG +G V A + +A+K + E ++ REI++ LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLK 230
P+I+ + + R IY++ E +L++ ++ + + F+ +L L
Sbjct: 74 PNILRMYNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT-----DYVATRWY 285
Y H V HRD+KP+N+L +LKI DFG + APS T DY+
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRTMCGTLDYL----- 179
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
PE+ + +D+W G + E L G P F + E+
Sbjct: 180 -PPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT---------------ETH 221
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPN-ADPLALHLLERLLAFDPKDRPTAEEALADP 404
RI N + FP + L+ +LL + P R + + P
Sbjct: 222 RRIVNVDLK-----------------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264
Query: 405 YFHGLANVDREPSTQPI 421
+ + P Q
Sbjct: 265 WVKANSRRVLPPVYQST 281
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-47
Identities = 75/315 (23%), Positives = 129/315 (40%), Gaps = 49/315 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLRL 168
Y++ E +G G + +V TG+ A K I I RE+ +LR
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLR 227
+RHP+I+ + I D+ ++ EL+ +L + + LT + FL Q+L
Sbjct: 65 IRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD 119
Query: 228 GLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
G+ Y+H+ + H DLKP+NI+ + ++K+ DFG+A + + T
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE----FKNIFGTP 175
Query: 284 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
+ APE+ + D+WSIG I +L+G F G+ + + +
Sbjct: 176 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGET---KQETL---------T 221
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEEALA 402
+IS + + F + F N LA + RLL DPK R T ++L
Sbjct: 222 NISAVNYD----------------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265
Query: 403 DPYFHGLANVDREPS 417
+ + +
Sbjct: 266 HSWIKAIRRRNVRGE 280
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 9e-47
Identities = 70/319 (21%), Positives = 134/319 (42%), Gaps = 62/319 (19%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN------------------------DV 149
+Y +++ IGKGSYGVV A + + A+K ++
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 150 FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIK 208
+ ++ +EI +L+ L HP++V++ ++ P+ +Y+VFEL+ + +V
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDH---LYMVFELVNQGPVMEVPT 130
Query: 209 ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268
L+ + +F+ L++G++Y+H + HRD+KP N+L D +KI DFG++
Sbjct: 131 -LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF-- 187
Query: 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVV 327
A+ V T + APE ++ A+D+W++G + G+ F +
Sbjct: 188 KGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER-- 244
Query: 328 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLL 387
+ L S+I+++ P P+ L+ R+L
Sbjct: 245 -----IMCLH--------SKIKSQALE-----------FP---DQPDIAEDLKDLITRML 277
Query: 388 AFDPKDRPTAEEALADPYF 406
+P+ R E P+
Sbjct: 278 DKNPESRIVVPEIKLHPWV 296
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-46
Identities = 88/351 (25%), Positives = 139/351 (39%), Gaps = 46/351 (13%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
YQ+ E +GKG++ VV V G+ A IN D ++ RE ++ RLL+HP
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+IV + + E Y++F+L+ +L + I A + + + Q+L + +
Sbjct: 71 NIVRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 125
Query: 232 IHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
H V HR+LKP+N+L +K+ DFGLA + W + T Y +P
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI--EVEGEQQA-WFGFAGTPGYLSP 182
Query: 289 E-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
E L Y +D+W+ G I +L G P F ++ Q L + I
Sbjct: 183 EVLRK---DPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLY---------QQI-- 225
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
K F P A L+ ++L +P R TA EAL P+
Sbjct: 226 --------------KAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271
Query: 407 HGLANVDREPSTQPISKLEFEFE-RRKLAKDDVREMIYREILEYHPQMLQE 456
+ V Q +F RRKL + M+ Q + +
Sbjct: 272 SHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVMLATRNFSVRKQEIIK 322
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-46
Identities = 59/319 (18%), Positives = 99/319 (31%), Gaps = 71/319 (22%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL-RLLR 170
+ + E IG G +G V V G AIK+ D LRE+ L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLT---PEHY-QFFLYQL 225
H +V + E + + E L I N + E + L Q+
Sbjct: 70 HSHVVRYFS-----AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 226 LRGLKYIHTANVFHRDLKPKNIL-------------------ANADCKLKICDFGLARVS 266
RGL+YIH+ ++ H D+KP NI A+ KI D G
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT-R 183
Query: 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV 326
+ + A E+ ++ + P DI+++ +PL +
Sbjct: 184 ISSPQV------EEGDSRFLANEVLQENYT-HLPKADIFALALTVVCAAGAEPLPRNGDQ 236
Query: 327 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERL 386
H++ R+ + LL+ +
Sbjct: 237 WHEI------------------------------RQGRLPRIPQVLS---QEFTELLKVM 263
Query: 387 LAFDPKDRPTAEEALADPY 405
+ DP+ RP+A +
Sbjct: 264 IHPDPERRPSAMALVKHSV 282
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-46
Identities = 76/321 (23%), Positives = 133/321 (41%), Gaps = 53/321 (16%)
Query: 96 HKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSD 155
H S+ + + + + +G G++G V + +G IK IN
Sbjct: 5 HHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKD-RSQVP 63
Query: 156 ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLT 214
+I EI++L+ L HP+I++I + ++ ++Y+V E E +L + I +
Sbjct: 64 MEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQA-R 117
Query: 215 PEHY-----QFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVS 266
+ + Q++ L Y H+ +V H+DLKP+NIL + +KI DFGLA +
Sbjct: 118 GKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177
Query: 267 FNDAPSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
+D T+ T Y APE T DIWS G + +LTG F G +
Sbjct: 178 KSDE----HSTNAAGTALYMAPEVFKR----DVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229
Query: 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLER 385
++ + + ++ + P A+ LL++
Sbjct: 230 ---LEEVQ---------QKA----------------TYKEPNYAVECRPLTPQAVDLLKQ 261
Query: 386 LLAFDPKDRPTAEEALADPYF 406
+L DP+ RP+A + L +F
Sbjct: 262 MLTKDPERRPSAAQVLHHEWF 282
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-46
Identities = 56/343 (16%), Positives = 115/343 (33%), Gaps = 64/343 (18%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN---------------DVFEHVSDATR 158
Y+I + +G + + + A+KK D S
Sbjct: 32 DYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 159 ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEH 217
E++++ +++ + + I+ ++Y+++E ME+ + + + L +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNY 144
Query: 218 YQ--------FFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFN 268
+ +L YIH N+ HRD+KP NIL + + ++K+ DFG +
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES----E 200
Query: 269 DAPSAIFWT-----DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 323
+++ PE + S +DIWS+G M F
Sbjct: 201 YMVDKKIKGSRGTYEFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254
Query: 324 KNVVHQLDLMTDLLGTPSTESISRIRNEKAR---RYLGSMRKKQPVPFSHKFPNADPLAL 380
K + +L + IR + + + +
Sbjct: 255 KISLVEL--------------FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDI 300
Query: 381 HLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISK 423
L+ L +P +R T+E+AL + D ++ + K
Sbjct: 301 DFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYK 343
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-45
Identities = 89/363 (24%), Positives = 156/363 (42%), Gaps = 68/363 (18%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
Y++ + IGKG++ V A TG VAIK I+ + + ++ RE++++++L HP+
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
IV++ ++ K +Y++ E ++ + A+ + + + Q++ ++Y
Sbjct: 76 IVKLFEVIETE-----KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 130
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW-----YRA 287
H + HRDLK +N+L +AD +KI DFG S F + Y A
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGF---------SNEFTVGGKLDAFCGAPPYAA 181
Query: 288 PELCGSFFS--KYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344
PEL F KY P +D+WS+G I +++G F G+N + +L
Sbjct: 182 PEL----FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-------LKELR------- 223
Query: 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
R+ +R K +PF + + D +LL+R L +P R T E+ + D
Sbjct: 224 -ERV-----------LRGKYRIPF---YMSTD--CENLLKRFLVLNPIKRGTLEQIMKDR 266
Query: 405 YFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQT 464
+ N E +L+ E D R I + Y + +QE L +
Sbjct: 267 WI----NAGHEE-----DELKPFVEPELDISDQKRIDIMVG-MGYSQEEIQESLSKMKYD 316
Query: 465 SFM 467
Sbjct: 317 EIT 319
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-45
Identities = 85/339 (25%), Positives = 128/339 (37%), Gaps = 51/339 (15%)
Query: 87 APTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI 146
+ + LE ++ E + V+GKG+YG+V + D R+AIK+I
Sbjct: 1 SMRSTEEGDCESDLLEYDY-----EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI 55
Query: 147 NDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME----SD 202
+ + EI L + L+H +IV+ S E I + E + S
Sbjct: 56 P--ERDSRYSQPLHEEIALHKHLKHKNIVQYLG-----SFSENGFIKIFMEQVPGGSLSA 108
Query: 203 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFG 261
L + + F+ Q+L GLKY+H + HRD+K N+L N LKI DFG
Sbjct: 109 LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFG 168
Query: 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 321
++ P + T Y APE+ Y A DIWS+GC EM TGKP
Sbjct: 169 TSKRLAGINPCT---ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP-- 223
Query: 322 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH 381
P + M +G + +P + A
Sbjct: 224 PFYELGEPQAAM---------------------FKVGMFKVHPEIP-----ESMSAEAKA 257
Query: 382 LLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQP 420
+ + DP R A + L D + L ++ TQP
Sbjct: 258 FILKCFEPDPDKRACANDLLVDEF---LKVSSKKKKTQP 293
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-45
Identities = 80/338 (23%), Positives = 127/338 (37%), Gaps = 56/338 (16%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN---DVFEHVSDATRILREIKLLRLL 169
Y++ EVIGKG + VV ++ TG++ A+K ++ + RE + +L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVI----KANDDLTPEHYQFFLYQ 224
+HP IVE+ +Y+VFE M+ +DL I A + ++ Q
Sbjct: 84 KHPHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 225 LLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVA 281
+L L+Y H N+ HRD+KP +L +K+ FG+A V
Sbjct: 139 ILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL---VAGGRVG 195
Query: 282 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340
T + APE + Y +D+W G I +L+G F G
Sbjct: 196 TPHFMAPEVVKR---EPYGKPVDVWGCGVILFILLSGCLPFYGTK--------------- 237
Query: 341 STESI-SRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAE 398
E + I K ++ + A L+ R+L DP +R T
Sbjct: 238 --ERLFEGIIKGK-------------YKMNPRQWSHISESAKDLVRRMLMLDPAERITVY 282
Query: 399 EALADPYFHGLANVDREPSTQPISKLEFEFE-RRKLAK 435
EAL P+ + + +F RRKL
Sbjct: 283 EALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKG 320
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-45
Identities = 78/304 (25%), Positives = 116/304 (38%), Gaps = 49/304 (16%)
Query: 108 EYGEASR-YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL 166
EY E Q +G+GS+G V D TG + A+KK+ E E+
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRV-----EELVAC 104
Query: 167 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQ 224
L P IV + + RE + + EL+E S L Q+IK L + ++L Q
Sbjct: 105 AGLSSPRIVPLYG-----AVREGPWVNIFMELLEGGS-LGQLIKQMGCLPEDRALYYLGQ 158
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVSFNDAPSAIFWTDY--VA 281
L GL+Y+HT + H D+K N+L ++D + +CDFG A D T
Sbjct: 159 ALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 282 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341
T + APE+ +DIWS C+ ML G + Q L
Sbjct: 219 TETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPW------TQYFRGPLCL---- 266
Query: 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
+I +E +P P+ PL ++ L +P R +A E
Sbjct: 267 -----KIASEPPPIR--------EIP-----PSCAPLTAQAIQEGLRKEPVHRASAMELR 308
Query: 402 ADPY 405
Sbjct: 309 RKVG 312
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-45
Identities = 76/318 (23%), Positives = 125/318 (39%), Gaps = 48/318 (15%)
Query: 114 RYQIQ-EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-H 171
YQ+Q +V+G+G++ V + ++ T + A+K I + +R+ RE+++L + H
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEK--QPGHIRSRVFREVEMLYQCQGH 70
Query: 172 PDIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLR 227
+++E+ F++ Y+VFE M + I + +
Sbjct: 71 RNVLELIEF--------FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVAS 122
Query: 228 GLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARV----SFNDAPSAIFWTDYV 280
L ++H + HRDLKP+NIL N +KICDF L S
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 281 ATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 337
+ Y APE+ S Y D+WS+G I +L+G P F G+ +
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242
Query: 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNAD-----PLALHLLERLLAFDPK 392
I+ K + FP+ D A L+ +LL D K
Sbjct: 243 PACQNMLFESIQEGK---------------YE--FPDKDWAHISCAAKDLISKLLVRDAK 285
Query: 393 DRPTAEEALADPYFHGLA 410
R +A + L P+ G A
Sbjct: 286 QRLSAAQVLQHPWVQGCA 303
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-45
Identities = 83/402 (20%), Positives = 158/402 (39%), Gaps = 57/402 (14%)
Query: 22 NNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQHLQQLTIVEDFDFSGLKLIRVPKR 81
++ +++++ +N F+ +++ + + ++ I D + +
Sbjct: 2 HHHHHHSSGVDNKFNKERRRARR---EIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEA 58
Query: 82 IQFPIAPTPATMDPHKKSALETEFFTEYGEAS----RYQIQEVIGKGSYGVVGSAVDTHT 137
+ A T + + +S + ++ A +Y ++VIG+G VV V T
Sbjct: 59 KKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT 118
Query: 138 GERVAIKKIN------DVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFK 190
G A+K + + RE +LR + HP I+ +
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY-----ESSS 173
Query: 191 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA 249
+++VF+LM +L + L+ + + + LL + ++H N+ HRDLKP+NIL
Sbjct: 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL 233
Query: 250 NADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFFS---KYTPAIDIW 305
+ + ++++ DFG + + T Y APE L S Y +D+W
Sbjct: 234 DDNMQIRLSDFGFSCH-LEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLW 289
Query: 306 SIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQP 365
+ G I +L G P F + Q+ ++ I +
Sbjct: 290 ACGVILFTLLAGSPPFWHRR---QILML---------RMI----------------MEGQ 321
Query: 366 VPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
F S ++ + L+ RLL DP+ R TAE+AL P+F
Sbjct: 322 YQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 5e-45
Identities = 70/295 (23%), Positives = 121/295 (41%), Gaps = 39/295 (13%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+ + + +G+G+YG V AV+ T E VA+K ++ V I +EI + ++L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHEN 66
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
+V+ + Y+ E +L I+ + + Q F +QL+ G+ Y+
Sbjct: 67 VVKFYGHRREGN-----IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H + HRD+KP+N+L + LKI DFGLA V + + T Y APEL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPELLK 180
Query: 293 SFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
++ +D+WS G + ML G+ + + D + +
Sbjct: 181 R--REFHAEPVDVWSCGIVLTAMLAGELPWDQPS-----DSCQEYS--------DWKEKK 225
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
P+ D L LL ++L +P R T + D ++
Sbjct: 226 TYL-----------NPWKK----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 8e-45
Identities = 74/350 (21%), Positives = 130/350 (37%), Gaps = 53/350 (15%)
Query: 102 ETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILR 161
++ F+ Y + +G+GS+ + V + + A+K I+ +
Sbjct: 3 DSPFYQHY---DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQK 54
Query: 162 EIKLLRLLR-HPDIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPE 216
EI L+L HP+IV++ + F D ++V EL+ +L + IK +
Sbjct: 55 EITALKLCEGHPNIVKLHEV--------FHDQLHTFLVMELLNGGELFERIKKKKHFSET 106
Query: 217 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSA 273
+ + +L+ + ++H V HRDLKP+N+L N + ++KI DFG AR+ D
Sbjct: 107 EASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP- 165
Query: 274 IFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL 332
T Y APE L + Y + D+WS+G I ML+G+ F +
Sbjct: 166 --LKTPCFTLHYAAPELLNQ---NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS 220
Query: 333 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDP 391
+++ +I+ F + N A L++ LL DP
Sbjct: 221 AVEIM--------KKIKKGD-------------FSFEGEAWKNVSQEAKDLIQGLLTVDP 259
Query: 392 KDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREM 441
R + + + + P P K
Sbjct: 260 NKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATFHAF 309
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 9e-45
Identities = 91/361 (25%), Positives = 148/361 (40%), Gaps = 64/361 (17%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 172
Y I+E +G+GS+G V A T ++VA+K I+ + + R+ REI L+LLRHP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
I+++ ++ P DI +V E +L I +T + + F Q++ ++Y
Sbjct: 70 HIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW-----YRA 287
H + HRDLKP+N+L + + +KI DFGL S I Y A
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGL---------SNIMTDGNFLKTSCGSPNYAA 175
Query: 288 PELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
PE+ Y P +D+WS G + ML G+ F + + +
Sbjct: 176 PEVING--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK--------------- 218
Query: 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
++ + P S P A L+ R++ DP R T +E DP+F
Sbjct: 219 KVNSCVYV---------MPDFLS-------PGAQSLIRRMIVADPMQRITIQEIRRDPWF 262
Query: 407 HGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSF 466
NV+ +P+ E + V ++ E + + + E LR E
Sbjct: 263 ----NVNLPDYLRPME----EVQGSYADSRIVSKLG--EAMGFSEDYIVEALRSDENNEV 312
Query: 467 M 467
Sbjct: 313 K 313
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-44
Identities = 64/331 (19%), Positives = 117/331 (35%), Gaps = 58/331 (17%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HP 172
R +++ V+ +G + V A D +G A+K++ I++E+ ++ L HP
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL--SNEEEKNRAIIQEVCFMKKLSGHP 86
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELME---SDLHQVI---KANDDLTPEHYQFFLYQLL 226
+IV+ L E L + + ++ L+ + YQ
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 227 RGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVA--- 281
R ++++H + HRDLK +N+L + +K+CDFG A + +
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 282 ------TRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLM 333
T YR PE+ +S DIW++GCI + + F +
Sbjct: 207 EITRNTTPMYRTPEII-DLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------ 259
Query: 334 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD 393
RI N G F + L+ +L +P++
Sbjct: 260 -------------RIVN-------GKYSIPPHDTQYTVFHS-------LIRAMLQVNPEE 292
Query: 394 RPTAEEALADPYFHGLANVDREPSTQPISKL 424
R + E + +A PI++L
Sbjct: 293 RLSIAEVVHQL--QEIAAARNVNPKSPITEL 321
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-44
Identities = 78/331 (23%), Positives = 128/331 (38%), Gaps = 52/331 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
Y I E +G G++GVV V+ TG K IN + D + EI ++ L HP
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHP 108
Query: 173 DIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHY-QFFLYQLLR 227
++ + F+D + ++ E + +L I A D E ++ Q
Sbjct: 109 KLINLHDA--------FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE 160
Query: 228 GLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
GLK++H ++ H D+KP+NI+ +KI DFGLA N P I AT +
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK-LN--PDEIVKVT-TATAEF 216
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
APE+ D+W+IG + +L+G F G++ E++
Sbjct: 217 AAPEIVD--REPVGFYTDMWAIGVLGYVLLSGLSPFAGED---------------DLETL 259
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
++ F F + P A ++ LL +P+ R T +AL P
Sbjct: 260 QNVKRCD-------------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306
Query: 405 YFHGLANVDREPSTQPISKLEFEFERRKLAK 435
+ G + + + K A
Sbjct: 307 WLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 337
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-44
Identities = 64/303 (21%), Positives = 121/303 (39%), Gaps = 51/303 (16%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN--DVFEHVSDATRILREIKLLRLLRH 171
+Y + +++G+GSYG V +D+ T R A+K + + + + +EI+LLR LRH
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK--ANDDLTPEHYQFFLYQLLRGL 229
+++++ ++ + + +Y+V E + +++ + QL+ GL
Sbjct: 66 KNVIQLVDVLYNEEK---QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT-----DYVATRW 284
+Y+H+ + H+D+KP N+L LKI G+A A T +
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ---- 178
Query: 285 YRAPELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
PE+ + ++ +DIWS G + TG F G N+ L
Sbjct: 179 --PPEIA-NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-------KLF------ 222
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
I +P + P LL+ +L ++P R + +
Sbjct: 223 --ENIGKGSYA-----------IP-----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264
Query: 404 PYF 406
+F
Sbjct: 265 SWF 267
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-44
Identities = 73/332 (21%), Positives = 134/332 (40%), Gaps = 58/332 (17%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+Y I E +G+G +G+V V+T + + K + +D + +EI +L + RH
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHR 61
Query: 173 DIVEIKHIMLPPSRREFKD---IYVVFELME-SDLH-QVIKANDDLTPEHYQFFLYQLLR 227
+I+ + F+ + ++FE + D+ ++ + +L +++Q+
Sbjct: 62 NILHLHES--------FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113
Query: 228 GLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
L+++H+ N+ H D++P+NI+ +KI +FG AR + Y
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN----FRLLFTAPEY 169
Query: 286 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344
APE + A D+WS+G + +L+G F + + +
Sbjct: 170 YAPEVHQHDV---VSTATDMWSLGTLVYVLLSGINPFLAET---------------NQQI 211
Query: 345 ISRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
I I N + F + F A+ ++RLL + K R TA EAL
Sbjct: 212 IENIMNAE-------------YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258
Query: 404 PYFHGLANVDREPSTQPISKLEFEFERRKLAK 435
P+ L ST+ I L+ L K
Sbjct: 259 PW---LKQKIERVSTKVIRTLKHRRYYHTLIK 287
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 159 bits (402), Expect = 3e-44
Identities = 46/339 (13%), Positives = 91/339 (26%), Gaps = 81/339 (23%)
Query: 110 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-------------------- 149
V+G+ A D TGE +
Sbjct: 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 129
Query: 150 ---FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQV 206
++ A LR I L++ P ++ + L + ++ M+S+L
Sbjct: 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 189
Query: 207 IKANDDLTPEHYQF-------FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 259
+ + H Q++R L +H + H L+P +I+ + + +
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 249
Query: 260 FGLARVSFNDAPSAIFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDIWSIGCI 310
F +R + PEL + T + D W++G +
Sbjct: 250 FEHLVRDGAR-------VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302
Query: 311 FAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSH 370
+ + + + R + +P
Sbjct: 303 IYWIWCADLPITKDAALGGSEWI--------------------------FRSCKNIP--- 333
Query: 371 KFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409
LLE L + +DR +A+ P + L
Sbjct: 334 ------QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 4e-44
Identities = 73/317 (23%), Positives = 125/317 (39%), Gaps = 44/317 (13%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+ + + +G+G+YG V AV+ T E VA+K ++ V I +EI + ++L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHEN 66
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
+V+ + Y+ E +L I+ + + Q F +QL+ G+ Y+
Sbjct: 67 VVKFYGHRREGN-----IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H + HRD+KP+N+L + LKI DFGLA V + + T Y APEL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPEL-- 178
Query: 293 SFFS--KYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
++ +D+WS G + ML G+ + + D +
Sbjct: 179 --LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS-----DSCQEYS--------DWKE 223
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF-HG 408
+ P+ D L LL ++L +P R T + D ++
Sbjct: 224 KKTYL-----------NPWKK----IDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268
Query: 409 LANVDREPSTQPISKLE 425
L + P E
Sbjct: 269 LKKGAKRPRVTSGGVSE 285
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-44
Identities = 86/368 (23%), Positives = 142/368 (38%), Gaps = 56/368 (15%)
Query: 79 PKRIQFPIAPTPATMDPHKKSALETEFFTEYGEAS----RYQIQEVIGKGSYGVVGSAVD 134
+ + F + ++L +++ + ++++ +G+G+ +V
Sbjct: 15 TENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQ 74
Query: 135 THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD-IY 193
T + A+K + D + EI +L L HP+I+++K I E I
Sbjct: 75 KGTQKPYALKVLK----KTVDKKIVRTEIGVLLRLSHPNIIKLKEIF------ETPTEIS 124
Query: 194 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---A 249
+V EL+ +L I + + Q+L + Y+H + HRDLKP+N+L
Sbjct: 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATP 184
Query: 250 NADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIG 308
D LKI DFGL+++ + T Y APE L G Y P +D+WS+G
Sbjct: 185 APDAPLKIADFGLSKIVEHQV----LMKTVCGTPGYCAPEILRG---CAYGPEVDMWSVG 237
Query: 309 CIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPF 368
I +L G F + + RI N + F
Sbjct: 238 IITYILLCGFEPFYDERGDQFM--------------FRRILNCE-------------YYF 270
Query: 369 -SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFE 427
S + A L+ +L+ DPK R T +AL P+ G A + KL+
Sbjct: 271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA-ANFVHMDTAQKKLQEF 329
Query: 428 FERRKLAK 435
RRKL
Sbjct: 330 NARRKLKA 337
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-44
Identities = 74/331 (22%), Positives = 130/331 (39%), Gaps = 48/331 (14%)
Query: 114 RYQI-QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL-RLLRH 171
YQ+ ++V+G G G V TG++ A+K + D + + +E+ +
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD-------SPKARQEVDHHWQASGG 81
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVI--KANDDLTPEHYQFFLYQLLRG 228
P IV I + + + + ++ E ME +L I + + T + +
Sbjct: 82 PHIVCILDVYENMHHGK-RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 229 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
++++H+ N+ HRD+KP+N+L D LK+ DFG A+ + +A T +Y
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-----LQTPCYTPYY 195
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
APE+ G KY + D+WS+G I +L G P F M
Sbjct: 196 VAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM-----------K 242
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPKDRPTAEEALADP 404
RIR + F + A L+ LL DP +R T + + P
Sbjct: 243 RRIRLGQ-------------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289
Query: 405 YFHGLANVDREPSTQPISKLEFEFERRKLAK 435
+ + V + P E + ++ +
Sbjct: 290 WINQSMVVPQTPLHTARVLQEDKDHWDEVKE 320
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-44
Identities = 77/340 (22%), Positives = 134/340 (39%), Gaps = 62/340 (18%)
Query: 113 SRYQIQ-EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
+ Y + + +G+G + VV + TG+ A K + IL EI +L L +
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 172 -PDIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHY-----QFF 221
P ++ + + +++ I ++ E ++ + E
Sbjct: 88 CPRVINLHEV--------YENTSEIILILEYAAGGEIFSLCLPELA---EMVSENDVIRL 136
Query: 222 LYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTD 278
+ Q+L G+ Y+H N+ H DLKP+NIL +KI DFG++R A +
Sbjct: 137 IKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK-IGHAC---ELRE 192
Query: 279 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338
+ T Y APE+ + T A D+W+IG I +LT F G++ +
Sbjct: 193 IMGTPEYLAPEILN--YDPITTATDMWNIGIIAYMLLTHTSPFVGED---NQETY----- 242
Query: 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTA 397
+IS++ V +S + F + LA ++ LL +P+ RPTA
Sbjct: 243 ----LNISQVN----------------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTA 282
Query: 398 EEALADPYF--HGLANVDREPSTQPISKLEFEFERRKLAK 435
E L+ + N+ T S+ + R K
Sbjct: 283 EICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSEDK 322
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 5e-44
Identities = 46/335 (13%), Positives = 88/335 (26%), Gaps = 70/335 (20%)
Query: 110 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE------------------ 151
V+G+ A D TGE +
Sbjct: 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 134
Query: 152 -----HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQV 206
+ A LR I L++ P ++ + L + ++ M+S+L
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194
Query: 207 IKANDDLTPEHYQ-------FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 259
+ + H Q++R L +H + H L+P +I+ + + +
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254
Query: 260 FGLARVSFNDAPSAIFWTDYVATRWYRAPELC---GSFFSKYTPAIDIWSIGCIFAEMLT 316
F A + A A + + T A D W++G +
Sbjct: 255 FEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
Query: 317 GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNAD 376
+ + + R + +P
Sbjct: 313 ADLPNTDDAALGGSEWI--------------------------FRSCKNIP--------- 337
Query: 377 PLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411
LLE L + +DR +A+ P + L
Sbjct: 338 QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 372
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 8e-44
Identities = 75/301 (24%), Positives = 118/301 (39%), Gaps = 55/301 (18%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 172
Y + + +G G++G V TG +VA+K +N + +I REI+ L+L RHP
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
I+++ ++ P+ D ++V E + +L I + + + Q+L + Y
Sbjct: 72 HIIKLYQVISTPT-----DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW-----YR 286
H V HRDLKP+N+L +A KI DFGL S + Y
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGL---------SNMMSDGEFLRTSCGSPNYA 177
Query: 287 APELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
APE+ Y P +DIWS G I +L G F ++ + L
Sbjct: 178 APEVISG--RLYAGPEVDIWSCGVILYALLCGTLPFDDEH-------VPTLF-------- 220
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
+IR P + LL +L DP R T ++ +
Sbjct: 221 KKIRGGVFY---------IPEYLN-------RSVATLLMHMLQVDPLKRATIKDIREHEW 264
Query: 406 F 406
F
Sbjct: 265 F 265
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-43
Identities = 88/338 (26%), Positives = 136/338 (40%), Gaps = 49/338 (14%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
RY + IG G++GV D T E VA+K I + + REI R LRHP+
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE---RGAAIDENVQREIINHRSLRHPN 77
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
IV K ++L P+ + ++ E +L++ I + + +FF QLL G+ Y
Sbjct: 78 IVRFKEVILTPT-----HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYC 132
Query: 233 HTANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 290
H+ + HRDLK +N L + +LKICDFG ++ S + V T Y APE+
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEV 188
Query: 291 CGSFFS--KYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
+Y D+WS G ML G F ++I R
Sbjct: 189 ----LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY-----------RKTIQR 233
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407
I + K +P + P HL+ R+ DP R + E +F
Sbjct: 234 ILSVKYS-----------IPDDIRIS---PECCHLISRIFVADPATRISIPEIKTHSWF- 278
Query: 408 GLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYRE 445
L N+ + + + +F+ + + D I E
Sbjct: 279 -LKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISE 315
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-43
Identities = 74/328 (22%), Positives = 118/328 (35%), Gaps = 62/328 (18%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLRL 168
+ Y++ ++GKG +G V + +VAIK I + +SD+ E+ LL
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 169 LR----HPDIVEIKHIMLPPSRREFKDIYVVFELMES--DLHQVIKANDDLTPEHYQFFL 222
+ HP ++ + + +V E DL I L + F
Sbjct: 91 VGAGGGHPGVIRLLDWFETQ-----EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVSFNDAPSAIFWTDYVA 281
Q++ +++ H+ V HRD+K +NIL + K+ DFG + TD+
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG----ALLHDEPY-TDFDG 200
Query: 282 TRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340
TR Y PE +Y +WS+G + +M+ G F
Sbjct: 201 TRVYSPPEWIS--RHQYHALPATVWSLGILLYDMVCGDIPF------------------- 239
Query: 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400
E I + P S P L+ R LA P RP+ EE
Sbjct: 240 --ERDQEILEAELH---------FPAHVS-------PDCCALIRRCLAPKPSSRPSLEEI 281
Query: 401 LADPYFH-GLANVDREPSTQPISKLEFE 427
L DP+ +V PS + L +
Sbjct: 282 LLDPWMQTPAEDVPLNPSKGGPAPLAWS 309
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-43
Identities = 73/335 (21%), Positives = 128/335 (38%), Gaps = 59/335 (17%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
Y I E +G G++GVV + TG A K + H SD + +EI+ + +LRHP
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHP 214
Query: 173 DIVEIKHIMLPPSRREFKD---IYVVFELME-SDL-HQVIKANDDLTPEHYQFFLYQLLR 227
+V + F+D + +++E M +L +V ++ ++ + ++ Q+ +
Sbjct: 215 TLVNLHDA--------FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 266
Query: 228 GLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
GL ++H N H DLKP+NI+ +LK+ DFGL T +
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS----VKVTTGTAEF 322
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
APE+ D+WS+G + +L+G F G+N E++
Sbjct: 323 AAPEVAE--GKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---------------DDETL 365
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
+++ F + +LL DP R T +AL P
Sbjct: 366 RNVKSCD-------------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 412
Query: 405 YFHGLANVDREPSTQPISKLEF----EFERRKLAK 435
+ L + I + + + K
Sbjct: 413 W---LTPGNAPGRDSQIPSSRYTKIRDSIKTKYDA 444
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-43
Identities = 80/321 (24%), Positives = 125/321 (38%), Gaps = 56/321 (17%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK-LLRLLRHP 172
Y+++E IG GSY V + T A+K I+ EI+ LLR +HP
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK------SKRDPTEEIEILLRYGQHP 76
Query: 173 DIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 228
+I+ +K + + D +YVV ELM+ +L I + L+ + +
Sbjct: 77 NIITLKDV--------YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKT 128
Query: 229 LKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
++Y+H V HRDLKP NIL + ++ICDFG A+ + T
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG---LLMTPCYTAN 185
Query: 285 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
+ APE L Y A DIWS+G + MLTG F +++
Sbjct: 186 FVAPEVLER---QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA--------- 233
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPKDRPTAEEALA 402
RI + K S + + A L+ ++L DP R TA L
Sbjct: 234 ---RIGSGK-------------FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277
Query: 403 DPYFHGLANVDREPSTQPISK 423
P+ + + + +
Sbjct: 278 HPWIVHWDQLPQYQLNRQDAP 298
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-42
Identities = 70/305 (22%), Positives = 115/305 (37%), Gaps = 59/305 (19%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLRLL 169
+YQ+ ++G G +G V S + VAIK + + + + TR+ E+ LL+ +
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 170 RH--PDIVEIKHIMLPPSRREFKDIYVVFELMES--DLHQVIKANDDLTPEHYQFFLYQL 225
++ + P ++ E E DL I L E + F +Q+
Sbjct: 104 SSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 158
Query: 226 LRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
L +++ H V HRD+K +NIL + + +LK+ DFG ++ TD+ TR
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG----ALLKDTVY-TDFDGTRV 213
Query: 285 YRAPELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
Y PE + +Y + +WS+G + +M+ G F E
Sbjct: 214 YSPPEWIR--YHRYHGRSAAVWSLGILLYDMVCGDIPF---------------------E 250
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
I + S HL+ LA P DRPT EE
Sbjct: 251 HDEEIIRGQVFF---------RQRVS-------SECQHLIRWCLALRPSDRPTFEEIQNH 294
Query: 404 PYFHG 408
P+
Sbjct: 295 PWMQD 299
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-42
Identities = 77/367 (20%), Positives = 136/367 (37%), Gaps = 65/367 (17%)
Query: 102 ETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILR 161
+ +Y +V+G G G V + T E+ A+K + D + R
Sbjct: 56 KNAIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARR 103
Query: 162 EIKLL-RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQ 219
E++L R + P IV I + K + +V E ++ +L I+ D Q
Sbjct: 104 EVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGD------Q 156
Query: 220 FF--------LYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFN 268
F + + ++Y+H+ N+ HRD+KP+N+L + LK+ DFG A+ + +
Sbjct: 157 AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
Query: 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH 328
T T +Y APE+ G KY + D+WS+G I +L G P F +
Sbjct: 217 HNS----LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNH--- 267
Query: 329 QLDLMTDLLGTPSTESI-SRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERL 386
G + + +RIR + F + L+ L
Sbjct: 268 ---------GLAISPGMKTRIRMGQ-------------YEFPNPEWSEVSEEVKMLIRNL 305
Query: 387 LAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREI 446
L +P R T E + P+ V + P E + + ++ + +
Sbjct: 306 LKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRV 365
Query: 447 LEYHPQM 453
++
Sbjct: 366 DYEQIKI 372
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-41
Identities = 79/359 (22%), Positives = 135/359 (37%), Gaps = 63/359 (17%)
Query: 88 PTPATMDPHKKSALETEFFTEYGEASRYQI--QEVIGKGSYGVVGSAVDTHTGERVAIKK 145
P P H+ + + Y + E++G G +G V +T TG ++A K
Sbjct: 67 PAPPAPFDHRIVTAKQGAVNSF-----YTVSKTEILGGGRFGQVHKCEETATGLKLAAKI 121
Query: 146 INDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF---KDIYVVFELME-S 201
I + D + EI ++ L H +++++ F DI +V E ++
Sbjct: 122 IKT--RGMKDKEEVKNEISVMNQLDHANLIQLYDA--------FESKNDIVLVMEYVDGG 171
Query: 202 DLHQVIKANDDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNIL--ANADCKLKIC 258
+L I E F+ Q+ G++++H + H DLKP+NIL ++KI
Sbjct: 172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKII 231
Query: 259 DFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTG 317
DFGLAR + P T + APE + F + D+WS+G I +L+G
Sbjct: 232 DFGLARR-YK--PREKL-KVNFGTPEFLAPEVVNYDF---VSFPTDMWSVGVIAYMLLSG 284
Query: 318 KPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHK-FPNAD 376
F G N E+++ I + + F +
Sbjct: 285 LSPFLGDN---------------DAETLNNILACR-------------WDLEDEEFQDIS 316
Query: 377 PLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAK 435
A + +LL + R +A EAL P+ + S Q + + + K
Sbjct: 317 EEAKEFISKLLIKEKSWRISASEALKHPWLSD-HKLHSRLSAQKKKNRGSDA-QDFVTK 373
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 75/383 (19%), Positives = 135/383 (35%), Gaps = 78/383 (20%)
Query: 85 PIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIK 144
+ P ++ +A E E+ +Y +G G++G V +AVD + V +K
Sbjct: 2 ALEEPPKAVELEGLAACEGEYS------QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVK 55
Query: 145 KIN------DVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 198
I D + ++ EI +L + H +I+++ I +V E
Sbjct: 56 FIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ-----GFFQLVMEK 110
Query: 199 MES--DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLK 256
S DL I + L + QL+ + Y+ ++ HRD+K +NI+ D +K
Sbjct: 111 HGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIK 170
Query: 257 ICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS--KYT-PAIDIWSIGCIFAE 313
+ DFG A F+T + T Y APE+ Y P +++WS+G
Sbjct: 171 LIDFGSAAYLERGKL---FYT-FCGTIEYCAPEV----LMGNPYRGPELEMWSLGVTLYT 222
Query: 314 MLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFP 373
++ + F + P S
Sbjct: 223 LVFEENPF---------------------CELEET---VEAAI------HPPYLVS---- 248
Query: 374 NADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKL 433
+ L+ LL P+ R T E+ + DP+ TQP++ ++ +E
Sbjct: 249 ---KELMSLVSGLLQPVPERRTTLEKLVTDPWV-----------TQPVNLADYTWEEVFR 294
Query: 434 AKDDVREMIYREILEYHPQMLQE 456
++ LE + L +
Sbjct: 295 VNKPESGVLSAASLEMGNRSLSD 317
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-41
Identities = 75/352 (21%), Positives = 124/352 (35%), Gaps = 75/352 (21%)
Query: 95 PHKKSALE---TEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE 151
PH KS L+ +Y +V+G G G V + T E+ A+K + D
Sbjct: 2 PHVKSGLQIKKNAIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-- 54
Query: 152 HVSDATRILREIKLL-RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVI-- 207
+ RE++L R + P IV I + K + +V E ++ +L I
Sbjct: 55 -----PKARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQD 108
Query: 208 KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLAR 264
+ + T + + ++Y+H+ N+ HRD+KP+N+L + LK+ DFG
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-- 166
Query: 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK 324
A E G KY + D+WS+G I +L G P F
Sbjct: 167 ----------------------AKETTG---EKYDKSCDMWSLGVIMYILLCGYPPFYSN 201
Query: 325 NVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLL 383
+ + M +RIR + F + L+
Sbjct: 202 HGLAISPGM-----------KTRIRMGQ-------------YEFPNPEWSEVSEEVKMLI 237
Query: 384 ERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAK 435
LL +P R T E + P+ V + P E + + +
Sbjct: 238 RNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKE 289
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-41
Identities = 74/384 (19%), Positives = 126/384 (32%), Gaps = 46/384 (11%)
Query: 91 ATMDPHKKSALETEFFTEYG-EASRYQIQEVIGKG--SYGVVGSAVDTHTGERVAIKKIN 147
A H L + + + E Y++ VIGKG V A TGE V +++IN
Sbjct: 2 AHHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN 61
Query: 148 DVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQ 205
T + E+ + +L HP+IV + + + +++VV M S
Sbjct: 62 LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-----ELWVVTSFMAYGS-AKD 115
Query: 206 VIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG-- 261
+I D + + L +L+ L YIH HR +K +IL + D K+ +
Sbjct: 116 LICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN 175
Query: 262 --LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKP 319
+ F V + +PE+ Y DI+S+G E+ G
Sbjct: 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235
Query: 320 ----------LF----------PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGS 359
L + + +L + + +S R
Sbjct: 236 PFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNG 295
Query: 360 MRKKQPVP--FSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPS 417
P FS F H +E+ L +P RP+A L +F + E
Sbjct: 296 DSPSHPYHRTFSPHF-------HHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEAL 348
Query: 418 TQPISKLEFEFERRKLAKDDVREM 441
+ + + D +
Sbjct: 349 PELLRPVTPITNFEGSQSQDHSGI 372
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 6e-40
Identities = 85/358 (23%), Positives = 136/358 (37%), Gaps = 64/358 (17%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 172
Y + + +G G++G V TG +VA+K +N + +I REI+ L+L RHP
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
I+++ ++ P DI++V E + +L I N L + + Q+L G+ Y
Sbjct: 77 HIIKLYQVISTP-----SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW-----YR 286
H V HRDLKP+N+L +A KI DFGL S + Y
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHMNAKIADFGL---------SNMMSDGEFLRTSCGSPNYA 182
Query: 287 APELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
APE+ Y P +DIWS G I +L G F +V
Sbjct: 183 APEVISG--RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK-------------- 226
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
+I + P + P + LL+ +L DP R T ++ +
Sbjct: 227 -KICDGIFY---------TPQYLN-------PSVISLLKHMLQVDPMKRATIKDIREHEW 269
Query: 406 FHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQ 463
F D P + + + + ++E+ E E + + L
Sbjct: 270 F----KQDLPKYLFPE---DPSYSSTMIDDEALKEVC--EKFECSEEEVLSCLYNRNH 318
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-39
Identities = 70/305 (22%), Positives = 121/305 (39%), Gaps = 44/305 (14%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK-LLRLL 169
A + IG+G+YG V V +G+ +A+K+I + ++L ++ ++R
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSS 78
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELM----ESDLHQVIKANDDLTPEHY-QFFLYQ 224
P IV+ + D ++ ELM + V DD+ PE
Sbjct: 79 DCPYIVQFYGALFREG-----DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 225 LLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
++ L ++ + HRD+KP NIL + +K+CDFG +S S I T R
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG---ISGQLVDS-IAKTRDAGCR 189
Query: 284 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341
Y APE + Y D+WS+G E+ TG+ +P + + + D L
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP------KWNSVFDQL---- 239
Query: 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
+++ + + + FS F ++ + L D RP +E L
Sbjct: 240 ----TQVVKGDPPQ----LSNSEEREFSPSF-------INFVNLCLTKDESKRPKYKELL 284
Query: 402 ADPYF 406
P+
Sbjct: 285 KHPFI 289
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 78/368 (21%), Positives = 142/368 (38%), Gaps = 79/368 (21%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
RY + +G G + V + D + VA+K + EH ++ EI+LL+ +R+
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETAL--DEIRLLKSVRN 92
Query: 172 PDIVEIKHIMLPPSRREFKD-------IYVVFELMESDLHQVIKANDD--LTPEHYQFFL 222
D + M+ +FK I +VFE++ L + I ++ L + +
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKII 152
Query: 223 YQLLRGLKYIHT-ANVFHRDLKPKNILANAD----------------------------- 252
Q+L+GL Y+HT + H D+KP+NIL + +
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 253 ----------CKLKICDFGLARVSFNDAPSAIF----WTDYVATRWYRAPELCGSFFSKY 298
L+ + +V D +A + +T+ + TR YR+ E+ S Y
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVL--IGSGY 270
Query: 299 TPAIDIWSIGCIFAEMLTGKPLFPGKN------VVHQLDLMTDLLGTPSTESISRIRNEK 352
DIWS C+ E+ TG LF + + L+ +LLG + I +
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV--AGKY 328
Query: 353 ARRYL---GSMRKKQPVPFS---------HKFPNAD-PLALHLLERLLAFDPKDRPTAEE 399
++ + G ++ + +++ + L +L P+ R TA E
Sbjct: 329 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAE 388
Query: 400 ALADPYFH 407
L P+ +
Sbjct: 389 CLRHPWLN 396
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-38
Identities = 90/393 (22%), Positives = 151/393 (38%), Gaps = 71/393 (18%)
Query: 76 IRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGE---ASRYQIQEVIGKGSYGVVGSA 132
I + + F A P S + + + + + IG GS+G V A
Sbjct: 14 IPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFA 73
Query: 133 VDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191
D E VAIKK++ + I++E++ L+ LRHP+ ++ + L
Sbjct: 74 RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----T 128
Query: 192 IYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 250
++V E +++ + E + L+GL Y+H+ N+ HRD+K NIL +
Sbjct: 129 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS 188
Query: 251 ADCKLKICDFGLA-----RVSFNDAPSAIFWTDYVATRWYRAPEL-CGSFFSKYTPAIDI 304
+K+ DFG A SF P +W APE+ +Y +D+
Sbjct: 189 EPGLVKLGDFGSASIMAPANSFVGTP---YWM---------APEVILAMDEGQYDGKVDV 236
Query: 305 WSIGCIFA-EMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKK 363
WS+G I E+ KP N + L + +P +++
Sbjct: 237 WSLG-ITCIELAERKPPLFNMNAMSALYHIAQ-NESP------ALQSGH----------- 277
Query: 364 QPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISK 423
+S F N ++ L P+DRPT+E L + V RE I
Sbjct: 278 ----WSEYFRN-------FVDSCLQKIPQDRPTSEVLLKHRF------VLRERPPTVIMD 320
Query: 424 LEFEFERRKLAKDDVREMIYREILEYHPQMLQE 456
L +R K A ++ + YR++ + QE
Sbjct: 321 L---IQRTKDAVRELDNLQYRKM---KKILFQE 347
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-38
Identities = 79/306 (25%), Positives = 129/306 (42%), Gaps = 39/306 (12%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
Y++QEVIG G+ VV +A E+VAIK+I ++ + + +L+EI+ + H
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHH 72
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTP-----EHYQFFL 222
P+IV + ++++V +L+ D+ + I A + L
Sbjct: 73 PNIVSYYTSFVVKD-----ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR--VSFNDAPSAIFWTDYV 280
++L GL+Y+H HRD+K NIL D ++I DFG++ + D +V
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340
T + APE+ Y DIWS G E+ TG + H+ M L+ T
Sbjct: 188 GTPCWMAPEVMEQ-VRGYDFKADIWSFGITAIELATGAAPY------HKYPPMKVLMLTL 240
Query: 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400
+N+ G K+ + F ++ L DP+ RPTA E
Sbjct: 241 --------QNDPPSLETGVQDKEMLKKYGKSFRK-------MISLCLQKDPEKRPTAAEL 285
Query: 401 LADPYF 406
L +F
Sbjct: 286 LRHKFF 291
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-38
Identities = 66/298 (22%), Positives = 111/298 (37%), Gaps = 54/298 (18%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRIL-----REIKLLRLLR 170
+ ++ IGKG +G+V VAIK + RE+ ++ L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVI-KANDDLTPEHYQFFLYQLLRG 228
HP+IV++ +M P +V E + DL+ + + + + G
Sbjct: 82 HPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 229 LKYIHTAN--VFHRDLKPKNIL-----ANADCKLKICDFGLARVSFNDAPSAIFWTDYVA 281
++Y+ N + HRDL+ NI NA K+ DFGL++ S + + +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV------SGLLG 188
Query: 282 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341
+ APE G+ YT D +S I +LTG+ F +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK------------- 235
Query: 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
+ I+ IR E R +P + P +++E + DPK RP
Sbjct: 236 IKFINMIREEGLR---------PTIP-----EDCPPRLRNVIELCWSGDPKKRPHFSY 279
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 62/302 (20%), Positives = 111/302 (36%), Gaps = 43/302 (14%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK-LLRLL 169
E + + +G G+ G V TG +A+K++ + + RIL ++ +L+
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRILMDLDVVLKSH 81
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRG 228
P IV+ + + D+++ ELM + ++ K PE +++
Sbjct: 82 DCPYIVQCFGTFITNT-----DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKA 136
Query: 229 LKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
L Y+ V HRD+KP NIL + ++K+CDFG +S Y A
Sbjct: 137 LYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFG---ISGRLVDD-KAKDRSAGCAAYMA 192
Query: 288 PE---LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344
PE Y D+WS+G E+ TG+ + E
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK--------------TDFEV 238
Query: 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
++++ E+ + FS F ++ L D + RP + L
Sbjct: 239 LTKVLQEEPP------LLPGHMGFSGDF-------QSFVKDCLTKDHRKRPKYNKLLEHS 285
Query: 405 YF 406
+
Sbjct: 286 FI 287
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 71/313 (22%), Positives = 124/313 (39%), Gaps = 32/313 (10%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 170
+ ++ +G G+ GVV +G +A K I + + +I+RE+++L
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHECN 89
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGL 229
P IV +I + E M+ L QV+K + + +++GL
Sbjct: 90 SPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 144
Query: 230 KYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFND-APSAIFWTDYVATRWYRA 287
Y+ + HRD+KP NIL N+ ++K+CDFG++ + A S +V TR Y +
Sbjct: 145 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS------FVGTRSYMS 198
Query: 288 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLDLMTDLLGTPSTESI 345
PE L G + Y+ DIWS+G EM G+ P+ P +L + G +
Sbjct: 199 PERLQG---THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255
Query: 346 SRIRNEKARRYLGSMRKKQPVPFS--HKFPNADPLAL----------HLLERLLAFDPKD 393
+ G + F N P L + + L +P +
Sbjct: 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 315
Query: 394 RPTAEEALADPYF 406
R ++ + +
Sbjct: 316 RADLKQLMVHAFI 328
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-37
Identities = 80/305 (26%), Positives = 129/305 (42%), Gaps = 62/305 (20%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+Y E IG+G+ G V +A+D TG+ VAI+++N + I+ EI ++R ++P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNP 77
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+IV S +++VV E + L V+ + + L+ L++
Sbjct: 78 NIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEF 131
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFNDAPSAIFWTDYVAT 282
+H+ V HRD+K NIL D +K+ DFG R + V T
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM------------VGT 179
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFA-EMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341
++ APE+ Y P +DIWS+G I A EM+ G+P + +N + L L+ GTP
Sbjct: 180 PYWMAPEVVTR--KAYGPKVDIWSLG-IMAIEMIEGEPPYLNENPLRALYLIAT-NGTP- 234
Query: 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
+ P S F + L R L D + R +A+E L
Sbjct: 235 -------------------ELQNPEKLSAIFRD-------FLNRCLEMDVEKRGSAKELL 268
Query: 402 ADPYF 406
+
Sbjct: 269 QHQFL 273
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-37
Identities = 64/297 (21%), Positives = 108/297 (36%), Gaps = 58/297 (19%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGE---RVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+ + IG GS+G V + G+ VA+K +N E+ +LR RH
Sbjct: 27 TVGQRIGSGSFGTV------YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLK 230
+I+ P + +V + E S L+ + A++ + Q RG+
Sbjct: 81 NILLFMGYSTAP------QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMD 134
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE- 289
Y+H ++ HRDLK NI + D +KI DFGLA + S F + + APE
Sbjct: 135 YLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF-EQLSGSILWMAPEV 193
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN-------VVHQLDLMTDLLGTPST 342
+ + Y+ D+++ G + E++TG+ + N +V + L DL
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR-- 251
Query: 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
N L+ L +RP+
Sbjct: 252 ------------------------------SNCPKRMKRLMAECLKKKRDERPSFPR 278
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-37
Identities = 44/310 (14%), Positives = 95/310 (30%), Gaps = 53/310 (17%)
Query: 80 KRIQFPIAPTPATMDPHKK-SALETEFFTEYGEASRYQIQEVIGKGSYGVV-----GSAV 133
+ P++ P T + K A++ + + G + ++G+G++ V G
Sbjct: 32 SGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGS-KLVYVHHLLGEGAFAQVYEATQGDLN 90
Query: 134 DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD-I 192
D ++ +K + + + ++ L+ ++ F++
Sbjct: 91 DAKNKQKFVLKVQKP--ANPWEFYIGTQLMERLKPSMQHMFMKFYSAH------LFQNGS 142
Query: 193 YVVFELME-SDLHQVIK-----ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 246
+V EL L I + F ++L ++ +H + H D+KP N
Sbjct: 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDN 202
Query: 247 IL-----------ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSF 294
+ + L + D G + IF T ++ E L
Sbjct: 203 FILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK-CETSGFQCVEMLSN-- 259
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH-----------QLDLMTD----LLGT 339
+ ID + + ML G + LD+ + +L
Sbjct: 260 -KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNI 318
Query: 340 PSTESISRIR 349
P + +
Sbjct: 319 PDCHHLPSLD 328
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-37
Identities = 67/304 (22%), Positives = 122/304 (40%), Gaps = 46/304 (15%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK-LLRLL 169
+A + +G+G+YGVV +G+ +A+K+I + + R+L ++ +R +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTV 63
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELM----ESDLHQVIKANDDLTPEHYQFFLYQL 225
P V + D+++ ELM + QVI + + +
Sbjct: 64 DCPFTVTFYGALFREG-----DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 226 LRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
++ L+++H+ +V HRD+KP N+L NA ++K+CDFG +S + +
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFG---ISGYLVDD-VAKDIDAGCKP 174
Query: 285 YRAPE--LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
Y APE Y+ DIWS+G E+ + FP + + ++ PS
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEPS- 231
Query: 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402
P + KF + + L + K+RPT E +
Sbjct: 232 ----------------------PQLPADKFS---AEFVDFTSQCLKKNSKERPTYPELMQ 266
Query: 403 DPYF 406
P+F
Sbjct: 267 HPFF 270
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-37
Identities = 75/305 (24%), Positives = 126/305 (41%), Gaps = 62/305 (20%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
IG+GS G+V A + H+G +VA+K ++ + E+ ++R +H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHF 102
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
++VE+ S ++++V+ E ++ L ++ L E +L+ L Y
Sbjct: 103 NVVEMYK-----SYLVGEELWVLMEFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAY 156
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFNDAPSAIFWTDYVAT 282
+H V HRD+K +IL D ++K+ DFG R S V T
Sbjct: 157 LHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL------------VGT 204
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFA-EMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341
++ APE+ S Y +DIWS+G I EM+ G+P + + V + + D P
Sbjct: 205 PYWMAPEVISR--SLYATEVDIWSLG-IMVIEMVDGEPPYFSDSPVQAMKRLRD-SPPP- 259
Query: 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
+ K S + LER+L DP++R TA+E L
Sbjct: 260 -------------------KLKNSHKVSPVLRD-------FLERMLVRDPQERATAQELL 293
Query: 402 ADPYF 406
P+
Sbjct: 294 DHPFL 298
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-37
Identities = 82/353 (23%), Positives = 143/353 (40%), Gaps = 70/353 (19%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLR-LLR 170
A +++ E++G G+YG V TG+ AIK ++ + + I +EI +L+
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE---IKQEINMLKKYSH 79
Query: 171 HPDIVEIKHIMLPPSRREFKD-IYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQL 225
H +I + + D +++V E +DL + K N L E + ++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREI 138
Query: 226 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFNDAPSAIFW 276
LRGL ++H V HRD+K +N+L + ++K+ DFG++ R +F
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--------- 189
Query: 277 TDYVATRWYRAPE--LCGSFF-SKYTPAIDIWSIGCIFA-EMLTGKPLFPGKNVVHQLDL 332
+ T ++ APE C + Y D+WS+G I A EM G P +
Sbjct: 190 ---IGTPYWMAPEVIACDENPDATYDFKSDLWSLG-ITAIEMAEGAPPL------CDMHP 239
Query: 333 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPK 392
M L P R++++K +S KF + +E L +
Sbjct: 240 MRALFLIP-RNPAPRLKSKK---------------WSKKFQS-------FIESCLVKNHS 276
Query: 393 DRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYRE 445
RP E+ + P+ D+ Q +L+ +R K + + E Y
Sbjct: 277 QRPATEQLMKHPFIR-----DQPNERQVRIQLKDHIDRTKKKRGEKDETEYEY 324
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 53/222 (23%), Positives = 96/222 (43%), Gaps = 22/222 (9%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
+I E+IGKG +G V GE VAI+ I+ ++ RE+ R RH ++V
Sbjct: 36 EIGELIGKGRFGQVYHG--RWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 176 E-IKHIMLPPSRREFKDIYVVFELME-SDLHQVI-KANDDLTPEHYQFFLYQLLRGLKYI 232
+ M PP + ++ L + L+ V+ A L + ++++G+ Y+
Sbjct: 93 LFMGACMSPP------HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR--APEL 290
H + H+DLK KN+ + + K+ I DFGL +S + W APE+
Sbjct: 147 HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 291 -------CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
++ D++++G I+ E+ + F +
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-36
Identities = 66/287 (22%), Positives = 117/287 (40%), Gaps = 47/287 (16%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
I+E IG GS+G V A G VA+K + + H LRE+ +++ LRHP+IV
Sbjct: 40 NIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 176 EIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD---LTPEHYQFFLYQLLRGLKY 231
+ P + +V E + L++++ + L Y + +G+ Y
Sbjct: 98 LFMGAVTQPPN-----LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 232 IHTAN--VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
+H N + HR+LK N+L + +K+CDFGL+R+ + S+ T + APE
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS---KSAAGTPEWMAPE 209
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
+ D++S G I E+ T + + N + ++ +
Sbjct: 210 VLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLN---------------PAQVVAAVG 252
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT 396
+ R +P N +P ++E +P RP+
Sbjct: 253 FKCKR---------LEIP-----RNLNPQVAAIIEGCWTNEPWKRPS 285
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-36
Identities = 60/296 (20%), Positives = 105/296 (35%), Gaps = 48/296 (16%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
EV+GKG +G TGE + +K++ E L+E+K++R L HP+++
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT--FLKEVKVMRCLEHPNVL 70
Query: 176 E-IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYI 232
+ I + + + E ++ L +IK+ D F + G+ Y+
Sbjct: 71 KFIGVLYKDK------RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H+ N+ HRDL N L + + + DFGLAR+ ++ + + G
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 293 SF---------FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
+ Y +D++S G + E++ P P T
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD--------------YLPRTM 230
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
R P PN P + R DP+ RP+ +
Sbjct: 231 DFGLNVRGFLDR---------YCP-----PNCPPSFFPITVRCCDLDPEKRPSFVK 272
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 75/292 (25%), Positives = 119/292 (40%), Gaps = 57/292 (19%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
+++EV+G+G++GVV A + VAIK+I S+ + E++ L + HP+IV
Sbjct: 11 EVEEVVGRGAFGVVCKA--KWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIV 64
Query: 176 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTPEHYQFFLYQLLRGLKY 231
++ L P + +V E E L+ V+ + T H + Q +G+ Y
Sbjct: 65 KLYGACLNP-------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 232 IHTAN---VFHRDLKPKNILANADCK-LKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
+H+ + HRDLKP N+L A LKICDFG A T+ + + A
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM------TNNKGSAAWMA 171
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
PE+ S Y+ D++S G I E++T + F I
Sbjct: 172 PEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--------------RIMW 215
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
+ R P+ N L+ R + DP RP+ EE
Sbjct: 216 AVHNGTRP---------PLI-----KNLPKPIESLMTRCWSKDPSQRPSMEE 253
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-35
Identities = 77/341 (22%), Positives = 134/341 (39%), Gaps = 73/341 (21%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
++I +G G++G V A + TG A K I + + + EI++L H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIEILATCDH 75
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLR 227
P IV++ ++++ E + +++ + LT Q Q+L
Sbjct: 76 PYIVKLLGAYYHDG-----KLWIMIEFCPGGAVDAI--MLELDRGLTEPQIQVVCRQMLE 128
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFNDAPSAIFWTD 278
L ++H+ + HRDLK N+L + +++ DFG++ R SF P +W
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP---YWM- 184
Query: 279 YVATRWYRAPELCGSFFSK---YTPAIDIWSIGCIFA-EMLTGKPLFPGKNVVHQLDLMT 334
APE+ K Y DIWS+G I EM +P P H+L+ M
Sbjct: 185 --------APEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEP--P----HHELNPMR 229
Query: 335 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR 394
LL +++ L P +S +F L+ L +P+ R
Sbjct: 230 VLLKIA--------KSDPPT--L-----LTPSKWSVEF-------RDFLKIALDKNPETR 267
Query: 395 PTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAK 435
P+A + L P+ V S + + +L E + + +
Sbjct: 268 PSAAQLLEHPF------VSSITSNKALRELVAEAKAEVMEE 302
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 5e-35
Identities = 72/316 (22%), Positives = 118/316 (37%), Gaps = 67/316 (21%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGER-VAIKKINDVFEHVSDAT---RILREIKLLR 167
A +Y+++ I G G + A+D + R V +K H DA + E + L
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLK----GLVHSGDAEAQAMAMAERQFLA 134
Query: 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLL 226
+ HP IV+I + + R Y+V E + L + L +L ++L
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEIL 192
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 286
L Y+H+ + + DLKP+NI+ + +LK+ D G ++ + T ++
Sbjct: 193 PALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI--NSFGYL-----YGTPGFQ 244
Query: 287 APELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
APE+ + T A DI+++G A + P G+ V
Sbjct: 245 APEIVR---TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------ 283
Query: 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH-LLERLLAFDPKDRP-TAEEALADP 404
+ + PV + LL R + DP+ R TAEE A
Sbjct: 284 -------------LPEDDPVL-------KTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQ- 322
Query: 405 YFHGLANVDREPSTQP 420
L V RE Q
Sbjct: 323 ----LTGVLREVVAQD 334
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-35
Identities = 79/312 (25%), Positives = 120/312 (38%), Gaps = 75/312 (24%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
+ E IGKGS+G V +D T + VAIK I D+ E + I +EI +L
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDS 79
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLR 227
P + + L + ++++ E + DL + L L ++L+
Sbjct: 80 PYVTKYYGSYLKDT-----KLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILK 130
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFNDAPSAIFWTD 278
GL Y+H+ HRD+K N+L + ++K+ DFG+A R +F P FW
Sbjct: 131 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTP---FWM- 186
Query: 279 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-EMLTGKPLFPGKNVVHQLDLMTDLL 337
APE+ S Y DIWS+G I A E+ G+P +L M L
Sbjct: 187 --------APEVIKQ--SAYDSKADIWSLG-ITAIELARGEPPH------SELHPMKVLF 229
Query: 338 GTPSTESISRIRNEKARRYLGSMRKKQPV---PFSHKFPNADPLALHLLERLLAFDPKDR 394
P + P +S +E L +P R
Sbjct: 230 LIP--------------------KNNPPTLEGNYSKPLKE-------FVEACLNKEPSFR 262
Query: 395 PTAEEALADPYF 406
PTA+E L +
Sbjct: 263 PTAKELLKHKFI 274
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 75/300 (25%), Positives = 109/300 (36%), Gaps = 34/300 (11%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
Q+ + IGKG YG V GE+VA+K E S EI L+RH +I+
Sbjct: 40 QMVKQIGKGRYGEVWMG--KWRGEKVAVKVFFTT-EEASWFRE--TEIYQTVLMRHENIL 94
Query: 176 E-IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
I + +Y++ + E+ L+ +K+ L + Y + GL ++H
Sbjct: 95 GFIAADIKGTGSW--TQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHLH 151
Query: 234 TANVF--------HRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY--VATR 283
T HRDLK KNIL + I D GLA F + + V T+
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK-FISDTNEVDIPPNTRVGTK 210
Query: 284 WYRAPE-LCGSFFSKYTPA---IDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339
Y PE L S + + D++S G I E+ G +QL +
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG-GIVEEYQLPYHDLVPSD 269
Query: 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
PS E + I K R P L+ A +P R TA
Sbjct: 270 PSYEDMREIVCIKKLR--------PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-34
Identities = 84/348 (24%), Positives = 136/348 (39%), Gaps = 60/348 (17%)
Query: 85 PIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIK 144
+ P + MD +S T+F Y+++ ++G+G G V A DT VA+K
Sbjct: 13 GLVPRGSHMDGTAESREGTQF-------GPYRLRRLVGRGGMGDVYEAEDTVRERIVALK 65
Query: 145 KINDVFEHVSDAT---RILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI-YVVFELME 200
+++ SD R+ RE + L+ P +V I H E YV L+
Sbjct: 66 LMSE--TLSSDPVFRTRMQREARTAGRLQEPHVVPI-H-----DFGEIDGQLYVDMRLIN 117
Query: 201 -SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 259
DL +++ L P + Q+ L H A HRD+KP+NIL +AD + D
Sbjct: 118 GVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVD 177
Query: 260 FGLARVSFNDAP----SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEML 315
FG+A + D V T +Y APE S T DI+++ C+ E L
Sbjct: 178 FGIAS-ATTDEKLTQLGNT-----VGTLYYMAPERFSE--SHATYRADIYALTCVLYECL 229
Query: 316 TGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNA 375
TG P + G + S+ ++ + S P
Sbjct: 230 TGSPPYQGDQL-----------------SV-------MGAHI----NQAIPRPSTVRPGI 261
Query: 376 DPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISK 423
++ R +A +P+DR L+ LA D++ +T + +
Sbjct: 262 PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRATDILRR 309
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-34
Identities = 80/333 (24%), Positives = 140/333 (42%), Gaps = 58/333 (17%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+ + E +G+GSYG V A+ TG+ VAIK++ V + + I++EI +++ P
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDLQE---IIKEISIMQQCDSPH 85
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRGL 229
+V+ + D+++V E SD+ ++ N LT + L L+GL
Sbjct: 86 VVKYYGSYFKNT-----DLWIVMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGL 138
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGL-ARVSFNDAPSAIFWTDYVATRWYRAP 288
+Y+H HRD+K NIL N + K+ DFG+ +++ A + T ++ AP
Sbjct: 139 EYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV----IGTPFWMAP 194
Query: 289 ELCGSFFSKYTPAIDIWSIGCIFA-EMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
E+ Y DIWS+G I A EM GKP + + + + ++ P
Sbjct: 195 EVIQE--IGYNCVADIWSLG-ITAIEMAEGKPPYADIHPMRAIFMIPT-NPPP------- 243
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407
++P +S F +++ L P+ R TA + L P+
Sbjct: 244 -------------TFRKPELWSDNF-------TDFVKQCLVKSPEQRATATQLLQHPF-- 281
Query: 408 GLANVDREPSTQPISKLEFEFERRKLAKDDVRE 440
V + L E KL + + ++
Sbjct: 282 ----VRSAKGVSILRDLINEAMDVKLKRQESQQ 310
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-34
Identities = 73/299 (24%), Positives = 119/299 (39%), Gaps = 60/299 (20%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATR-ILREIKLLRLLRHPD 173
++E+IG G +G V A G+ VA+K D E +S + +E KL +L+HP+
Sbjct: 10 TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 174 IVEIKHI-MLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
I+ ++ + + P ++ +V E L++V+ + P+ + Q+ RG+ Y
Sbjct: 68 IIALRGVCLKEP------NLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNY 120
Query: 232 IHTAN---VFHRDLKPKNIL--------ANADCKLKICDFGLARVSFNDAPSAIFWTDYV 280
+H + HRDLK NIL ++ LKI DFGLAR +
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGA--- 177
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340
W APE+ + S ++ D+WS G + E+LTG+ F G +
Sbjct: 178 -YAW-MAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGID--------------- 218
Query: 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
+ K P+P L+E DP RP+
Sbjct: 219 GLAVAYGVAMNKLA---------LPIP-----STCPEPFAKLMEDCWNPDPHSRPSFTN 263
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-34
Identities = 78/305 (25%), Positives = 127/305 (41%), Gaps = 58/305 (19%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDAT---RILREIKLLRL 168
RY+I + +G G V A DT +VAIK I R RE+
Sbjct: 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFI--PPREKEETLKRFEREVHNSSQ 67
Query: 169 LRHPDIVEIKHIMLPPSRREFKDI-------YVVFELME-SDLHQVIKANDDLTPEHYQF 220
L H +IV + D+ Y+V E +E L + I+++ L+ +
Sbjct: 68 LSHQNIVSMI------------DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAIN 115
Query: 221 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 280
F Q+L G+K+ H + HRD+KP+NIL +++ LKI DFG+A+ + +++ T++V
Sbjct: 116 FTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL---SETSLTQTNHV 172
Query: 281 -ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339
T Y +PE DI+SIG + EML G+P F G+ V
Sbjct: 173 LGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGETAV------------ 218
Query: 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-TAE 398
SI+ + ++ P + + +++ R D +R T +
Sbjct: 219 ----SIA----------IKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQ 264
Query: 399 EALAD 403
E D
Sbjct: 265 EMKDD 269
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 76/306 (24%), Positives = 129/306 (42%), Gaps = 55/306 (17%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDAT---RILREIKLLRL 168
+ RY++ E++G G V A D VA+K + + D + R RE +
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA--DLARDPSFYLRFRREAQNAAA 68
Query: 169 LRHPDIVEI--------KHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQ 219
L HP IV + LP Y+V E ++ L ++ +TP+
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLP---------YIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 220 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY 279
+ + L + H + HRD+KP NI+ +A +K+ DFG+AR + D+ +++ T
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR-AIADSGNSVTQTAA 178
Query: 280 V-ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338
V T Y +PE D++S+GC+ E+LTG+P F G
Sbjct: 179 VIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGD-------------- 222
Query: 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-TA 397
+P + + +R + P+P S + ++ + LA +P++R TA
Sbjct: 223 SPVSVAYQHVRED-------------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTA 269
Query: 398 EEALAD 403
E AD
Sbjct: 270 AEMRAD 275
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-33
Identities = 43/288 (14%), Positives = 90/288 (31%), Gaps = 50/288 (17%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
+ + G + G + +K + + E LR+ HP+++
Sbjct: 13 NFLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 176 EIKHIML-PPSRREFKDIYVVFELMES-DLHQVI--KANDDLTPEHYQFFLYQLLRGLKY 231
+ PP+ ++ M L+ V+ N + F + RG+ +
Sbjct: 71 PVLGACQSPPAPH----PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 232 IHTAN--VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
+HT + L ++++ + D +I + + + + APE
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS--------PGRMYAPAWVAPE 178
Query: 290 -LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348
L + D+WS + E++T + F + + E ++
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS---------------NMEIGMKV 223
Query: 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT 396
E R +P P P L++ + DP RP
Sbjct: 224 ALEGLR---------PTIP-----PGISPHVSKLMKICMNEDPAKRPK 257
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 72/303 (23%), Positives = 111/303 (36%), Gaps = 40/303 (13%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
+QE IGKG +G V GE VA+K + R EI +LRH +I+
Sbjct: 45 VLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS--REERSWFR-EAEIYQTVMLRHENIL 99
Query: 176 -----EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGL 229
+ K +++V + E L + +T E GL
Sbjct: 100 GFIAADNKDNGTWT------QLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGL 152
Query: 230 KYIHTANVF--------HRDLKPKNILANADCKLKICDFGLARV-SFNDAPSAIFWTDYV 280
++H V HRDLK KNIL + I D GLA I V
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 281 ATRWYRAPE-LCGSFFSKYTPA---IDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL 336
T+ Y APE L S K+ + DI+++G +F E+ + G + +QL +
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLV 271
Query: 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT 396
PS E + ++ E+ R +P + A + ++ + R T
Sbjct: 272 PSDPSVEEMRKVVCEQKLR--------PNIPNRWQSCEALRVMAKIMRECWYANGAARLT 323
Query: 397 AEE 399
A
Sbjct: 324 ALR 326
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 4e-33
Identities = 75/314 (23%), Positives = 125/314 (39%), Gaps = 69/314 (21%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIK--------KINDVFEHVSDATRILREIKLL 166
++ +++G+GS+ V A + T AIK K N V +V RE ++
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKV-PYV------TRERDVM 84
Query: 167 RLLRHPDIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFL 222
L HP V++ F+D +Y ++ +L + I+ +F+
Sbjct: 85 SRLDHPFFVKLYF--------TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT 136
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 282
+++ L+Y+H + HRDLKP+NIL N D ++I DFG A+V ++ A + +V T
Sbjct: 137 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGT 195
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
Y +PEL + D+W++GCI +++ G P F N
Sbjct: 196 AQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEY--------------- 238
Query: 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDRPT----- 396
+I + FP P A L+E+LL D R
Sbjct: 239 LIFQKIIKLEYD-----------------FPEKFFPKARDLVEKLLVLDATKRLGCEEME 281
Query: 397 -AEEALADPYFHGL 409
A P+F +
Sbjct: 282 GYGPLKAHPFFESV 295
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 9e-33
Identities = 62/305 (20%), Positives = 107/305 (35%), Gaps = 40/305 (13%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
+ E +GKG YG V + GE VA+K + R E+ +LRH +I+
Sbjct: 11 TLLECVGKGRYGEVWRG--SWQGENVAVKIFSS--RDEKSWFR-ETELYNTVMLRHENIL 65
Query: 176 -----EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGL 229
++ ++++ E L+ ++ L + + GL
Sbjct: 66 GFIASDMTSRHSST------QLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGL 118
Query: 230 KYIHTA--------NVFHRDLKPKNILANADCKLKICDFGLARV-SFNDAPSAIFWTDYV 280
++H + HRDLK KNIL + + I D GLA + S + + V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 281 ATRWYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL 336
T+ Y APE L + +DIW+ G + E+ G ++ +
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN-GIVEDYKPPFYDVV 237
Query: 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT 396
PS E + ++ +R +P L++ +P R T
Sbjct: 238 PNDPSFEDMRKVVCVDQQR--------PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289
Query: 397 AEEAL 401
A
Sbjct: 290 ALRIK 294
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 71/300 (23%), Positives = 116/300 (38%), Gaps = 34/300 (11%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
Q+ EV +G +G V A E VA+K + + E+ L ++H +I+
Sbjct: 27 QLLEVKARGRFGCVWKA--QLLNEYVAVKIF---PIQDKQSWQNEYEVYSLPGMKHENIL 81
Query: 176 E-IKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
+ I S D++++ E L +KAN ++ + RGL Y+H
Sbjct: 82 QFIGAEKRGTSVD--VDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGLAYLH 138
Query: 234 TA----------NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
+ HRD+K KN+L + I DFGLA F SA V TR
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK-FEAGKSAGDTHGQVGTR 197
Query: 284 WYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340
Y APE+ +F ID++++G + E+ + G + L ++ P
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257
Query: 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLAL-HLLERLLAFDPKDRPTAEE 399
S E + + K +R PV + +A L +E D + R +A
Sbjct: 258 SLEDMQEVVVHKKKR---------PVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-29
Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 32/228 (14%)
Query: 102 ETEFFTEYGEASRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDAT 157
T+F E + + +GKG++G V +TGE VA+KK+
Sbjct: 4 PTQF-----EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLR 56
Query: 158 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTP 215
REI++L+ L+H +IV+ K + RR ++ ++ E + L ++ + + +
Sbjct: 57 DFEREIEILKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDH 113
Query: 216 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275
+ Q+ +G++Y+ T HRDL +NIL + ++KI DFGL +V D
Sbjct: 114 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF--- 170
Query: 276 WTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
+ WY APE SK++ A D+WS G + E+ T
Sbjct: 171 ---FKVKEPGESPIFWY-APE--SLTESKFSVASDVWSFGVVLYELFT 212
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 7e-29
Identities = 65/303 (21%), Positives = 118/303 (38%), Gaps = 52/303 (17%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
V+G+G +G V + TG+ A KK+N + + E K+L + IV +
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 179 HIMLPPSRREFKDIYVVFELMES-DL----HQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
+ + + +V +M D+ + V + N F+ Q++ GL+++H
Sbjct: 252 YAFETKTD-----LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLAR--VSFNDAPSAIFWTDYVATRWYRAPELC 291
N+ +RDLKP+N+L + D ++I D GLA + Y T + APEL
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-----YAGTPGFMAPELL 361
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
+Y ++D +++G EM+ + F + + + R+ +
Sbjct: 362 LG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ-----------RVLEQ 408
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYF 406
V + KF P + E LL DP+ R + + P F
Sbjct: 409 -------------AVTYPDKFS---PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452
Query: 407 HGL 409
+
Sbjct: 453 RDI 455
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-29
Identities = 68/302 (22%), Positives = 125/302 (41%), Gaps = 49/302 (16%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDI 174
+I IGKGS+G V T + A+K +N ++ + +E+++++ L HP +
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 175 VEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLK 230
V + + F+D +++V +L+ DL ++ N E + F+ +L+ L
Sbjct: 78 VNLWY--------SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALD 129
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE- 289
Y+ + HRD+KP NIL + + I DF +A + + T+ Y APE
Sbjct: 130 YLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM----AGTKPYMAPEM 185
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
+ Y+ A+D WS+G E+L G+ + ++ T S E +
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS------------STSSKEIVHTFE 233
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNA-DPLALHLLERLLAFDPKDR-PTAEEALADPYFH 407
+P+A + LL++LL +P R + PY +
Sbjct: 234 TTVVT-----------------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN 276
Query: 408 GL 409
+
Sbjct: 277 DI 278
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 32/240 (13%)
Query: 90 PATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKK 145
M + T+F E + + +GKG++G V +TGE VA+KK
Sbjct: 23 QGAMGSAFEDRDPTQF-----EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK 77
Query: 146 INDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLH 204
+ REI++L+ L+H +IV+ K + RR ++ ++ E + L
Sbjct: 78 LQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLR 132
Query: 205 QVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 263
++ + + + + Q+ +G++Y+ T HRDL +NIL + ++KI DFGL
Sbjct: 133 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192
Query: 264 RVSFNDAPSAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
+V D Y WY APE SK++ A D+WS G + E+ T
Sbjct: 193 KVLPQDK------EYYKVKEPGESPIFWY-APE--SLTESKFSVASDVWSFGVVLYELFT 243
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 66/306 (21%), Positives = 113/306 (36%), Gaps = 55/306 (17%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
VIG+G++ V TG+ A+K +N + + E +L I ++
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 179 HIMLPPSRREFKD---IYVVFELMES-DL-HQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
F+D +Y+V E DL + K + + E +F+L +++ + +H
Sbjct: 128 F--------AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLAR--VSFNDAPSAIFWTDYVATRWYRAPEL- 290
HRD+KP NIL + +++ DFG + S + V T Y +PE+
Sbjct: 180 RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA----VGTPDYLSPEIL 235
Query: 291 ----CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
G Y P D W++G EM G+ F + E+
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA---------------ETYG 280
Query: 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR---PTAEEALAD 403
+I + K+ + A ++RLL P+ R A +
Sbjct: 281 KI-----------VHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328
Query: 404 PYFHGL 409
P+F GL
Sbjct: 329 PFFFGL 334
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 69/299 (23%), Positives = 114/299 (38%), Gaps = 47/299 (15%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
V+GKG +G V + TG+ A KK+ + L E ++L + +V +
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 179 HIMLPPSRREFKDIYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 235
+ + +V LM DL H F+ ++ GL+ +H
Sbjct: 251 YAYETKDA-----LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 236 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFF 295
+ +RDLKP+NIL + ++I D GLA V T Y APE+ +
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKN-- 359
Query: 296 SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355
+YT + D W++GC+ EM+ G+ F + + + + ++
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-----------LVKEV---- 404
Query: 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYFHGL 409
P +S +F A L +LL DP +R +A E P F L
Sbjct: 405 ---------PEEYSERFSPQ---ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 69/307 (22%), Positives = 123/307 (40%), Gaps = 49/307 (15%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPD 173
++I +VIG+G++G V + + A+K +N ++ E +L
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 174 IVEIKHIMLPPSRREFKD---IYVVFELMES-DL-HQVIKANDDLTPEHYQFFLYQLLRG 228
I + + F+D +Y+V + DL + K D L E +F+L +++
Sbjct: 136 ITTLHY--------AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA 187
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
+ +H + HRD+KP NIL + + +++ DFG D + V T Y +P
Sbjct: 188 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSV-AVGTPDYISP 245
Query: 289 EL---CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
E+ +Y P D WS+G EML G+ F +++V E+
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---------------ETY 290
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR---PTAEEALA 402
+I M K+ F + + A L+ RL+ + R E+
Sbjct: 291 GKI-----------MNHKERFQFPTQVTDVSENAKDLIRRLIC-SREHRLGQNGIEDFKK 338
Query: 403 DPYFHGL 409
P+F G+
Sbjct: 339 HPFFSGI 345
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 30/216 (13%)
Query: 116 QIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLL 169
+ +G+G +G V +TGE+VA+K + + +EI++LR L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK---PESGGNHIADLKKEIEILRNL 80
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLR 227
H +IV+ K I + I ++ E + S L + + N + + + + Q+ +
Sbjct: 81 YHENIVKYKGIC---TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICK 137
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT----- 282
G+ Y+ + HRDL +N+L ++ ++KI DFGL + D Y
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY------YTVKDDRDS 191
Query: 283 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
WY APE SK+ A D+WS G E+LT
Sbjct: 192 PVFWY-APE--CLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 70/312 (22%), Positives = 123/312 (39%), Gaps = 49/312 (15%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
++ E+IG+G YG V + VA+K + + + + I + L+ H +I
Sbjct: 16 KLLELIGRGRYGAVYKG--SLDERPVAVKVFSF--ANRQNFIN-EKNIYRVPLMEHDNIA 70
Query: 176 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ + +V E + L + + + + + RGL Y+HT
Sbjct: 71 RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH-SVTRGLAYLHT 129
Query: 235 ANVF---------HRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY-----V 280
HRDL +N+L D I DFGL+ + D V
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 281 ATRWYRAPE-LCGSF----FSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVV-HQLDLM 333
T Y APE L G+ +D++++G I+ E+ LFPG++V +Q+
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249
Query: 334 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNA---DPLALHLLERLL--- 387
T++ P+ E + + + + +R P KFP A + LA+ L+ +
Sbjct: 250 TEVGNHPTFEDMQVLVSREKQR---------P-----KFPEAWKENSLAVRSLKETIEDC 295
Query: 388 -AFDPKDRPTAE 398
D + R TA+
Sbjct: 296 WDQDAEARLTAQ 307
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 1e-27
Identities = 71/303 (23%), Positives = 112/303 (36%), Gaps = 55/303 (18%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKI-------NDVFEHVSDATRILREIKLLRLLRHP 172
+IG+G +G V TG+ A+K + + +L + P
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD---CP 252
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
IV + + P + + + +LM DLH + + + +F+ +++ GL++
Sbjct: 253 FIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
+H V +RDLKP NIL + ++I D GLA P A V T Y APE+
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYMAPEVL 362
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
Y + D +S+GC+ ++L G F R
Sbjct: 363 QK-GVAYDSSADWFSLGCMLFKLLRGHSPF-------------------------RQHKT 396
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYF 406
K + + M V F P LLE LL D R A+E P+F
Sbjct: 397 KDKHEIDRMTLTMAVELPDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453
Query: 407 HGL 409
L
Sbjct: 454 RSL 456
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 40/294 (13%), Positives = 71/294 (24%), Gaps = 71/294 (24%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDAT---RILREIKLLRL 168
RY++ G A+DT +VA+ ++ + V L L
Sbjct: 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVD--PQGVLPDDVLQETLSRTLRLSR 87
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLR 227
+ P + + ++ + VV E + L +V + +P + L
Sbjct: 88 IDKPGVARVLDVVHTRAG-----GLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAA 140
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
H A V P + + D + +
Sbjct: 141 AADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-----------------------TMP 177
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQL-DLMTDLLGTPSTESIS 346
P DI IG +L + P V L D G
Sbjct: 178 DA---------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAG-------- 220
Query: 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400
QP+ + + + R + D R +
Sbjct: 221 -----------------QPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 69/287 (24%), Positives = 114/287 (39%), Gaps = 46/287 (16%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPD 173
Y++ +VIG+G++G V T + A+K ++ SD+ E ++ P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 174 IVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGL 229
+V++ + F+D +Y+V E M DL ++ N D+ + +F+ +++ L
Sbjct: 131 VVQLFY--------AFQDDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLAL 181
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
IH+ HRD+KP N+L + LK+ DFG N T V T Y +PE
Sbjct: 182 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM-KMNKEGMVRCDT-AVGTPDYISPE 239
Query: 290 --LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
Y D WS+G EML G F ++V + S+
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---------------GTYSK 284
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR 394
I M K + F + A +L+ L D + R
Sbjct: 285 I-----------MNHKNSLTF-PDDNDISKEAKNLICAFLT-DREVR 318
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 74/312 (23%), Positives = 127/312 (40%), Gaps = 55/312 (17%)
Query: 102 ETEFFTEYGEASRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDAT 157
T F E + +GKG++G V +TG VA+K++
Sbjct: 17 PTIF-----EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH--SGPDQQR 69
Query: 158 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTP 215
REI++L+ L IV+ + + P R + + +V E + S L ++ + L
Sbjct: 70 DFQREIQILKALHSDFIVKYRGVSYGPGR---QSLRLVMEYLPSGCLRDFLQRHRARLDA 126
Query: 216 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275
+ Q+ +G++Y+ + HRDL +NIL ++ +KI DFGLA++ D
Sbjct: 127 SRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD------ 180
Query: 276 WTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT--GKPLFPGKN 325
D YV WY APE + ++ D+WS G + E+ T K P
Sbjct: 181 -KDYYVVREPGQSPIFWY-APE--SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 236
Query: 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH-LLE 384
+ + D + + + E+ +R + P A P +H L++
Sbjct: 237 FLRMMGCERD--VPALSRLLELL--EEGQR----LPA----------PPACPAEVHELMK 278
Query: 385 RLLAFDPKDRPT 396
A P+DRP+
Sbjct: 279 LCWAPSPQDRPS 290
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 53/235 (22%), Positives = 98/235 (41%), Gaps = 38/235 (16%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGER----VAIKKINDVFEHVSDATR--ILREIKLLRLL 169
+ +V+G G++G V + GE+ VAIK++ E S IL E ++ +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASV 74
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLR 227
+P + + I L + + ++ +LM L ++ + D + ++ + Q+ +
Sbjct: 75 DNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT----- 282
G+ Y+ + HRDL +N+L +KI DFGLA++ +
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-------EKEYHAEGGKV 181
Query: 283 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
+W A E YT D+WS G E++T G + G + L+
Sbjct: 182 PIKWM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-27
Identities = 53/235 (22%), Positives = 101/235 (42%), Gaps = 40/235 (17%)
Query: 116 QIQEVIGKGSYGVV--GSAVDTHTGE-RVAIKKINDVFEHVSDATRI--LREIKLLRLLR 170
+ ++G+G +G V G + + VA+K + + + + E +++ L
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMKNLD 71
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRG 228
HP IV++ I+ +++ EL +L ++ N + L + Q+ +
Sbjct: 72 HPHIVKLIGIIEEEP------TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 125
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------ 282
+ Y+ + N HRD+ +NIL + +K+ DFGL+R ++ DY
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE--------DYYKASVTRLP 177
Query: 283 -RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
+W +PE S F ++T A D+W E+L+ GK F V+ L+
Sbjct: 178 IKWM-SPE---SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 228
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 54/231 (23%), Positives = 98/231 (42%), Gaps = 37/231 (16%)
Query: 116 QIQEVIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+ + +G G +GVV G + VA+K I E +E + + L HP
Sbjct: 11 TLLKELGSGQFGVVKLGKWKGQY---DVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPK 64
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLKY 231
+V+ + + IY+V E + + L ++++ L P Y + G+ +
Sbjct: 65 LVKFYGVCS-----KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-------RW 284
+ + HRDL +N L + D +K+ DFG+ R +D YV++ +W
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD--------QYVSSVGTKFPVKW 171
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
APE + KY+ D+W+ G + E+ + GK + VV ++
Sbjct: 172 S-APE--VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 55/235 (23%), Positives = 105/235 (44%), Gaps = 37/235 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+ ++ +G G YG V V VA+K + E + L+E +++ ++HP
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 69
Query: 173 DIVEIKHIML--PPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLR 227
++V++ + PP Y++ E M +L ++ + +++ + Q+
Sbjct: 70 NLVQLLGVCTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWTDYV 280
++Y+ N HRDL +N L + +K+ DFGL+R+ D +A I WT
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT--- 179
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
APE ++K++ D+W+ G + E+ T G +PG + V L+
Sbjct: 180 ------APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 40/235 (17%)
Query: 116 QIQEVIGKGSYGVV--GSAVDTHTGE-RVAIKKINDVFEHVSDATRI--LREIKLLRLLR 170
++ IG+G +G V G + VAIK SD+ R L+E +R
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFD 74
Query: 171 HPDIVEIKHIML-PPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLR 227
HP IV++ ++ P ++++ EL +L ++ L + YQL
Sbjct: 75 HPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 127
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT----- 282
L Y+ + HRD+ +N+L +++ +K+ DFGL+R + Y
Sbjct: 128 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------TYYKASKGKL 179
Query: 283 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
+W APE F ++T A D+W G E+L G F G V+ +++
Sbjct: 180 PIKWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 58/231 (25%), Positives = 105/231 (45%), Gaps = 35/231 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLR 170
++ + IGKG +G V + G +VA+K I + DAT L E ++ LR
Sbjct: 21 KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKN------DATAQAFLAEASVMTQLR 72
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLR 227
H ++V++ +++ E +Y+V E M L +++ L + F +
Sbjct: 73 HSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 128
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF---WTDYVATRW 284
++Y+ N HRDL +N+L + D K+ DFGL + + + + WT
Sbjct: 129 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------- 181
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 331
APE K++ D+WS G + E+ + G+ +P K+VV +++
Sbjct: 182 --APE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 57/234 (24%), Positives = 95/234 (40%), Gaps = 34/234 (14%)
Query: 116 QIQEVIGKGSYGVVGSAV---DTHTGERVAIKKI-NDVFEHVSDATRILREIKLLRLLRH 171
++ E +G GS+GVV + VA+K + DV +RE+ + L H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 229
+++ + ++L P + +V EL L ++ + + Q+ G+
Sbjct: 81 RNLIRLYGVVLTPP------MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------- 282
Y+ + HRDL +N+L +KI DFGL R + YV
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH------YVMQEHRKVPF 188
Query: 283 RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
W APE S ++ A D W G EM T G+ + G N ++H++D
Sbjct: 189 AWC-APE---SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 37/231 (16%)
Query: 116 QIQEVIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+ IG G +G+V G ++ +VAIK I E + E +++ L HP
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKD---KVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPK 64
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKY 231
+V++ + L E I +V E ME L ++ E + G+ Y
Sbjct: 65 LVQLYGVCL-----EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-------RW 284
+ A V HRDL +N L + +K+ DFG+ R +D Y ++ +W
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--------QYTSSTGTKFPVKW 171
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
+PE FS+Y+ D+WS G + E+ + GK + ++ VV +
Sbjct: 172 A-SPE--VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 50/236 (21%), Positives = 93/236 (39%), Gaps = 34/236 (14%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGER--VAIKKINDVFEHVSDATRILREIKLLRL 168
+ + +V+G G +G V G + + V IK I D + + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAIGS 71
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLL 226
L H IV + + S + +V + + L ++ + L P+ + Q+
Sbjct: 72 LDHAHIVRLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT---- 282
+G+ Y+ + HR+L +N+L + ++++ DFG+A + D +
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-------DKQLLYSEAK 178
Query: 283 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
+W A E F KYT D+WS G E++T G + G V L+
Sbjct: 179 TPIKWM-ALE--SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 58/229 (25%), Positives = 87/229 (37%), Gaps = 35/229 (15%)
Query: 102 ETEFFTEYGEASRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDAT 157
T F + +G+G +G V + TGE VA+K +
Sbjct: 25 PTVF-----HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK---ADAGPQH 76
Query: 158 RI--LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLT 214
R +EI +LR L H I++ K + +V E + L + + +
Sbjct: 77 RSGWKQEIDILRTLYHEHIIKYKGCCEDAGA---ASLQLVMEYVPLGSLRDYLPRHS-IG 132
Query: 215 PEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 274
F Q+ G+ Y+H + HRDL +N+L + D +KI DFGLA+
Sbjct: 133 LAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH---- 188
Query: 275 FWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
Y WY APE K+ A D+WS G E+LT
Sbjct: 189 --EYYRVREDGDSPVFWY-APE--CLKEYKFYYASDVWSFGVTLYELLT 232
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 56/228 (24%), Positives = 100/228 (43%), Gaps = 29/228 (12%)
Query: 118 QEVIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
+ +G G++G V G + VA+K + + + +L E +++ L +P IV
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 176 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ I S +V E+ E L++ ++ N + ++ ++Q+ G+KY+
Sbjct: 82 RMIGICEAES------WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-------RWYRA 287
+N HRDL +N+L KI DFGL++ D Y A +WY A
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE------NYYKAQTHGKWPVKWY-A 188
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
PE + K++ D+WS G + E + G+ + G V L+
Sbjct: 189 PE--CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 68/259 (26%), Positives = 115/259 (44%), Gaps = 37/259 (14%)
Query: 93 MDPHKKSALET---EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGER---VAIKKI 146
+DPH EF E +A+ I +V+G G +G V S ++ VAIK +
Sbjct: 23 VDPHTFEDPTQTVHEFAKEL-DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 147 NDVFEHVSDATRI--LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DL 203
++ R L E ++ HP+I+ ++ ++ + K + +V E ME+ L
Sbjct: 82 K---VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT-----KSKPVMIVTEYMENGSL 133
Query: 204 HQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 262
++ +D T L + G+KY+ HRDL +NIL N++ K+ DFGL
Sbjct: 134 DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 263 ARVSFNDAPSAIFWTDYVAT------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
RV +D Y RW +PE + K+T A D+WS G + E+++
Sbjct: 194 GRVLEDDP-----EAAYTTRGGKIPIRWT-SPE--AIAYRKFTSASDVWSYGIVLWEVMS 245
Query: 317 -GKPLFPGKN---VVHQLD 331
G+ + + V+ +D
Sbjct: 246 YGERPYWEMSNQDVIKAVD 264
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 55/227 (24%), Positives = 97/227 (42%), Gaps = 25/227 (11%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLRHPD 173
+ E IG+G++G V S VA+K E + + L+E ++L+ HP+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR---ETLPPDLKAKFLQEARILKQYSHPN 173
Query: 174 IVEIKHIML--PPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGL 229
IV + + P IY+V EL++ D ++ L + + G+
Sbjct: 174 IVRLIGVCTQKQP-------IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGM 226
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
+Y+ + HRDL +N L LKI DFG++R + +A V +W APE
Sbjct: 227 EYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT-APE 285
Query: 290 LCGSF-FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
+ + +Y+ D+WS G + E + G +P + ++
Sbjct: 286 ---ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 50/231 (21%), Positives = 92/231 (39%), Gaps = 37/231 (16%)
Query: 116 QIQEVIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+ +G G +GVV G + VAIK I E + E K++ L H
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQY---DVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEK 80
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKY 231
+V++ + + + I+++ E M + L ++ + + ++Y
Sbjct: 81 LVQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-------RW 284
+ + HRDL +N L N +K+ DFGL+R +D +Y ++ RW
Sbjct: 136 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--------EYTSSVGSKFPVRW 187
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
PE +SK++ DIW+ G + E+ + GK + +
Sbjct: 188 S-PPE--VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 64/313 (20%), Positives = 124/313 (39%), Gaps = 39/313 (12%)
Query: 38 NNKKSNNINTSSSSSSHEGQHLQQLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHK 97
+ I S +G + + +G + + I + ++P
Sbjct: 18 RASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLS--ALNPEL 75
Query: 98 KSALETEFFTEYGEASRYQIQEVIGKGSYGVV--GSAVDTHTGE-RVAIKKINDVFEHVS 154
A++ + EVIG+G +G V G+ +D + A+K +N + +
Sbjct: 76 VQAVQ-HVVIGP-SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-G 132
Query: 155 DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND-D 212
+ ++ L E +++ HP+++ + I L VV M+ DL I+ +
Sbjct: 133 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHN 188
Query: 213 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272
T + F Q+ +G+K++ + HRDL +N + + +K+ DFGLAR
Sbjct: 189 PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD------- 241
Query: 273 AIFWTDYVAT----------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLF 321
++ ++ + +W A E K+T D+WS G + E++T G P +
Sbjct: 242 -MYDKEFDSVHNKTGAKLPVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 297
Query: 322 PGKN---VVHQLD 331
P N + L
Sbjct: 298 PDVNTFDITVYLL 310
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 52/233 (22%), Positives = 101/233 (43%), Gaps = 33/233 (14%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+ ++ +G G YG V V VA+K + E + L+E +++ ++HP
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 276
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLRGL 229
++V++ + Y++ E M +L ++ + +++ + Q+ +
Sbjct: 277 NLVQLLGVCT-----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 331
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND-------APSAIFWTDYVAT 282
+Y+ N HR+L +N L + +K+ DFGL+R+ D A I WT
Sbjct: 332 EYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----- 386
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 331
APE ++K++ D+W+ G + E+ T G +PG V L+
Sbjct: 387 ----APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 61/261 (23%), Positives = 112/261 (42%), Gaps = 37/261 (14%)
Query: 90 PATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVV--GSAVDTHTGE-RVAIKKI 146
+ ++P A++ + EVIG+G +G V G+ +D + A+K +
Sbjct: 4 LSALNPELVQAVQ-HVVIGP-SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 61
Query: 147 NDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQ 205
N + + + ++ L E +++ HP+++ + I L VV M+ DL
Sbjct: 62 NRITDI-GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS----PLVVLPYMKHGDLRN 116
Query: 206 VIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264
I+ + T + F Q+ +G+KY+ + HRDL +N + + +K+ DFGLAR
Sbjct: 117 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
Query: 265 VSFNDAPSAIFWTDYVAT----------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEM 314
++ +Y + +W A E K+T D+WS G + E+
Sbjct: 177 D--------MYDKEYYSVHNKTGAKLPVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWEL 225
Query: 315 LT-GKPLFPGKN---VVHQLD 331
+T G P +P N + L
Sbjct: 226 MTRGAPPYPDVNTFDITVYLL 246
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 33/233 (14%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGER---VAIKKINDVFEHVSDATRI--LREIKLLRLLR 170
I+++IG G G V G+R VAIK + ++ R L E ++
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLSEASIMGQFD 108
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRG 228
HP+I+ ++ ++ + +V E ME+ L ++ +D T L + G
Sbjct: 109 HPNIIRLEGVVT-----RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------ 282
++Y+ HRDL +N+L +++ K+ DFGL+RV +D +A Y T
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA-----YTTTGGKIPI 218
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
RW APE F ++ A D+WS G + E+L G+ + V+ ++
Sbjct: 219 RWT-APE--AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 49/241 (20%), Positives = 94/241 (39%), Gaps = 33/241 (13%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGE-RVAIKKINDVFEHVSDATRILREIKLLRLL 169
+ + +++G+G +G V G+ +VA+K + + L E ++
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAN------DDLTPEHYQFFL 222
HP+++ + + + S + V+ M+ DLH + + + + F+
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD-YVA 281
+ G++Y+ N HRDL +N + D + + DFGL++ I+ D Y
Sbjct: 154 VDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK--------IYSGDYYRQ 205
Query: 282 T-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQL 330
+W A E YT D+W+ G E+ T G +PG + L
Sbjct: 206 GRIAKMPVKWI-AIE--SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262
Query: 331 D 331
Sbjct: 263 L 263
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 61/238 (25%), Positives = 111/238 (46%), Gaps = 36/238 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGER----VAIKKINDVFEHVSDATRI--LREIKLL 166
S Q+VIG G +G V + + + VAIK + ++ R+ L E ++
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAGIM 100
Query: 167 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQ 224
H +I+ ++ ++ ++K + ++ E ME+ L + ++ D + L
Sbjct: 101 GQFSHHNIIRLEGVIS-----KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-- 282
+ G+KY+ N HRDL +NIL N++ K+ DFGL+RV +D Y +
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-----EATYTTSGG 210
Query: 283 ----RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
RW APE + + K+T A D+WS G + E++T G+ + + V+ ++
Sbjct: 211 KIPIRWT-APE---AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 51/233 (21%), Positives = 97/233 (41%), Gaps = 34/233 (14%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGER----VAIKKINDVFEHVSDATRILREIKLLRLLRH 171
+ +V+G G++G V + GE+ VAIK++ + IL E ++ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMASVDN 76
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 229
P + + I L + + ++ +LM L ++ + D + ++ + Q+ +G+
Sbjct: 77 PHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------- 282
Y+ + HRDL +N+L +KI DFGLA++ +
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-------EKEYHAEGGKVPI 183
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
+W A E YT D+WS G E++T G + G + L+
Sbjct: 184 KWM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 35/233 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+++ +G+G +G V T RVAIK + L+E ++++ LRH
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHE 239
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGL 229
+V++ ++ + IY+V E M L +K L Q+ G+
Sbjct: 240 KLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 293
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------- 282
Y+ N HRDL+ NIL + K+ DFGLAR+ ++ +Y A
Sbjct: 294 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--------EYTARQGAKFPI 345
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 331
+W APE + + ++T D+WS G + E+ T G+ +PG + V+ Q++
Sbjct: 346 KWT-APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 57/228 (25%), Positives = 105/228 (46%), Gaps = 29/228 (12%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLR 170
++ + IGKG +G V + G +VA+K I + DAT L E ++ LR
Sbjct: 193 KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKN------DATAQAFLAEASVMTQLR 244
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLR 227
H ++V++ +++ E +Y+V E M L +++ L + F +
Sbjct: 245 HSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 300
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
++Y+ N HRDL +N+L + D K+ DFGL + + + + +W A
Sbjct: 301 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWT-A 354
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 331
PE K++ D+WS G + E+ + G+ +P K+VV +++
Sbjct: 355 PE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 54/242 (22%), Positives = 100/242 (41%), Gaps = 34/242 (14%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGE-RVAIKKINDVFEHVSDATRILREIKLLRLL 169
++ + ++GKG +G V +VA+K + SD LRE ++
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 170 RHPDIVEIKHIMLPP-SRREFKDIYVVFELMES-DLHQVIKAN------DDLTPEHYQFF 221
HP + ++ + L ++ V+ M+ DLH + A+ +L + F
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 222 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY-- 279
+ + G++Y+ + N HRDL +N + D + + DFGL+R I+ DY
Sbjct: 143 MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK--------IYSGDYYR 194
Query: 280 ------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQ 329
+ +W A E + YT D+W+ G E++T G+ + G + +
Sbjct: 195 QGCASKLPVKWL-ALE--SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251
Query: 330 LD 331
L
Sbjct: 252 LI 253
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 62/236 (26%), Positives = 101/236 (42%), Gaps = 41/236 (17%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 170
++ E +G G +G V G +VA+K + + L E L++ L+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHT---KVAVKSLK---QGSMSPDAFLAEANLMKQLQ 66
Query: 171 HPDIVEIKHIML-PPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLL 226
H +V + ++ P IY++ E ME+ L +K LT Q+
Sbjct: 67 HQRLVRLYAVVTQEP-------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT---- 282
G+ +I N HRDL+ NIL + KI DFGLAR+ ++ +Y A
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN--------EYTAREGAK 171
Query: 283 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
+W APE + +T D+WS G + E++T G+ +PG V+ L+
Sbjct: 172 FPIKWT-APE--AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 67/243 (27%), Positives = 104/243 (42%), Gaps = 41/243 (16%)
Query: 111 EASRYQIQEVIGKGSYGVV--GSAVDTHTGE-RVAIKKINDVFEHVSDATRILREIKLLR 167
E VIGKG +GVV G +D + AIK ++ + E LRE L+R
Sbjct: 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM-QQVEAFLREGLLMR 77
Query: 168 LLRHPDIVEIKHIML---PPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFL 222
L HP+++ + IML +V+ M DL Q I++ + T + F
Sbjct: 78 GLNHPNVLALIGIMLPPEGL-------PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFG 130
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 282
Q+ RG++Y+ HRDL +N + + +K+ DFGLAR I +Y +
Sbjct: 131 LQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD--------ILDREYYSV 182
Query: 283 ----------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVH 328
+W A E ++T D+WS G + E+LT G P + + + H
Sbjct: 183 QQHRHARLPVKWT-ALE--SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH 239
Query: 329 QLD 331
L
Sbjct: 240 FLA 242
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 35/233 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+++ +G+G +G V T RVAIK + L+E ++++ LRH
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHE 322
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGL 229
+V++ ++ + IY+V E M L +K L Q+ G+
Sbjct: 323 KLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 376
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------- 282
Y+ N HRDL+ NIL + K+ DFGLAR+ ++ +Y A
Sbjct: 377 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--------EYTARQGAKFPI 428
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 331
+W APE + + ++T D+WS G + E+ T G+ +PG + V+ Q++
Sbjct: 429 KWT-APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 76/308 (24%), Positives = 125/308 (40%), Gaps = 66/308 (21%)
Query: 120 VIGKGSYG---VVGSAVDTHTGERVAIKKIN--DVFEHVSDATRILREIKLLRLLRHPDI 174
V+GKG YG V +TG+ A+K + + + D E +L ++HP I
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 175 VEIKHIMLPPSRREFKDIYVVF------ELMESDLHQVIKANDDLTPEHYQFFLYQLLRG 228
V++ + + +Y++ EL + ++ + F+L ++
Sbjct: 84 VDLIYAFQTGGK-----LYLILEYLSGGELF---MQ--LEREGIFMEDTACFYLAEISMA 133
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
L ++H + +RDLKP+NI+ N +K+ DFGL + S +D + T Y AP
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT---HTFCGTIEYMAP 190
Query: 289 E-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
E L S + A+D WS+G + +MLTG P F G+N ++I +
Sbjct: 191 EILMR---SGHNRAVDWWSLGALMYDMLTGAPPFTGENR---------------KKTIDK 232
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR----PT-AEEAL 401
I K P A LL++LL + R P A E
Sbjct: 233 ILKCKLN-----------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQ 275
Query: 402 ADPYFHGL 409
A P+F +
Sbjct: 276 AHPFFRHI 283
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 66/293 (22%), Positives = 116/293 (39%), Gaps = 68/293 (23%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIK--------KINDVFEHVSDATRILREIKLL 166
+ + +G GS+G V +G A+K K+ + EH + RIL+ +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-EHTLNEKRILQAV--- 98
Query: 167 RLLRHPDIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFL 222
P +V+++ FKD +Y+V E + ++ ++ + H +F+
Sbjct: 99 ---NFPFLVKLEF--------SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYA 147
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 282
Q++ +Y+H+ ++ +RDLKP+N+L + +++ DFG A+ WT T
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WT-LCGT 201
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
APE+ S Y A+D W++G + EM G P F +
Sbjct: 202 PEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--------------- 244
Query: 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR 394
+ +I + K R FP + LL LL D R
Sbjct: 245 QIYEKIVSGKVR-----------------FPSHFSSDLKDLLRNLLQVDLTKR 280
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 37/233 (15%)
Query: 117 IQEVIGKGSYGVVGSAVDTHTGER--VAIK--KINDVFEHVSDATRILREIKLLRLLRHP 172
+G G++G V V ++ VAIK K + ++RE +++ L +P
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE---MMREAQIMHQLDNP 70
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLK 230
IV + + + + +V E+ LH+ + + + + L+Q+ G+K
Sbjct: 71 YIVRLIGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 124
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-------R 283
Y+ N HRDL +N+L KI DFGL++ D Y A +
Sbjct: 125 YLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY------YTARSAGKWPLK 178
Query: 284 WYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
WY APE F K++ D+WS G E L+ G+ + V+ ++
Sbjct: 179 WY-APE---CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 72/299 (24%), Positives = 124/299 (41%), Gaps = 52/299 (17%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
++GKG++G V + TG A+K + +V + + E ++L+ RHP + +K
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 179 HIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 237
+ R + V E +L + T E +F+ +++ L+Y+H+ +V
Sbjct: 72 YAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 238 FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFFS 296
+RD+K +N++ + D +KI DFGL + +D + + T Y APE L +
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED---N 180
Query: 297 KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 356
Y A+D W +G + EM+ G+ F ++ I E+ R
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---------------ERLFELILMEEIR-- 223
Query: 357 LGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR-----PTAEEALADPYFHGL 409
FP P A LL LL DPK R A+E + +F +
Sbjct: 224 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 71/298 (23%), Positives = 122/298 (40%), Gaps = 78/298 (26%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIK--------KINDVFEHVSDATRILREIKLL 166
+QI +G GS+G V H G A+K ++ V EH +D +L +
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQV-EHTNDERLMLSIV--- 63
Query: 167 RLLRHPDIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFL 222
HP I+ + F+D I+++ + +E +L +++ + +F+
Sbjct: 64 ---THPFIIRMWG--------TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYA 112
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT----- 277
++ L+Y+H+ ++ +RDLKP+NIL + + +KI DFG A+ + +T
Sbjct: 113 AEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTP 167
Query: 278 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 337
DY+ APE+ + Y +ID WS G + EML G F N +
Sbjct: 168 DYI------APEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---------- 209
Query: 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR 394
++ +I N + R FP + LL RL+ D R
Sbjct: 210 -----KTYEKILNAELR-----------------FPPFFNEDVKDLLSRLITRDLSQR 245
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
++++ +G G +G V A +VA+K + L E +++ L+H +V
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT-KVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 176 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGLKYI 232
++ ++ + IY++ E M L +K+++ F Q+ G+ +I
Sbjct: 247 KLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-------RWY 285
N HRDL+ NIL +A KI DFGLARV ++ +Y A +W
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN--------EYTAREGAKFPIKWT 352
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 331
APE F +T D+WS G + E++T G+ +PG V+ L+
Sbjct: 353 -APE--AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 40/235 (17%)
Query: 116 QIQEVIGKGSYGVV--GSAVDTHTGE-RVAIKKINDVFEHVSDATRI--LREIKLLRLLR 170
++ IG+G +G V G + VAIK SD+ R L+E +R
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK---NCTSDSVREKFLQEALTMRQFD 449
Query: 171 HPDIVEIKHIML-PPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLR 227
HP IV++ ++ P ++++ EL +L ++ L + YQL
Sbjct: 450 HPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 502
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT----- 282
L Y+ + HRD+ +N+L +++ +K+ DFGL+R + Y
Sbjct: 503 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------TYYKASKGKL 554
Query: 283 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
+W APE F ++T A D+W G E+L G F G V+ +++
Sbjct: 555 PIKWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 62/331 (18%), Positives = 122/331 (36%), Gaps = 35/331 (10%)
Query: 20 FTNNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQHLQQLTIVEDFDFSGLK----L 75
++ +++ + + + + +H ++ + G
Sbjct: 239 LKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPAR 298
Query: 76 IRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDT 135
I P + + T P + + +G G++G V V
Sbjct: 299 ITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYR 358
Query: 136 HTGER--VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193
++ VAIK + E +D ++RE +++ L +P IV + + + +
Sbjct: 359 MRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA------LM 411
Query: 194 VVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 251
+V E+ LH+ + + + + L+Q+ G+KY+ N HR+L +N+L
Sbjct: 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVN 471
Query: 252 DCKLKICDFGLARVSFNDAPSAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDI 304
KI DFGL++ D Y A +WY APE F K++ D+
Sbjct: 472 RHYAKISDFGLSKALGADDSY------YTARSAGKWPLKWY-APE--CINFRKFSSRSDV 522
Query: 305 WSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
WS G E L+ G+ + V+ ++
Sbjct: 523 WSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 73/299 (24%), Positives = 124/299 (41%), Gaps = 51/299 (17%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
++GKG++G V + TG A+K + +V + L E ++L+ RHP + +K
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 179 HIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-N 236
+ R + V E +L + + + +F+ +++ L Y+H+ N
Sbjct: 215 YSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 269
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 296
V +RDLK +N++ + D +KI DFGL + D + + T Y APE+ +
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVLED--N 324
Query: 297 KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 356
Y A+D W +G + EM+ G+ F ++ + I E+ R
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---------------EKLFELILMEEIR-- 367
Query: 357 LGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR-----PTAEEALADPYFHGL 409
FP P A LL LL DPK R A+E + +F G+
Sbjct: 368 ---------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 67/302 (22%), Positives = 118/302 (39%), Gaps = 61/302 (20%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKI-------NDVFEHVSDATRILREIKLLRLLRHP 172
++GKGS+G V A T + AIK + +D E T + + + L HP
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC----TMVEKRV-LSLAWEHP 78
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+ + ++ V E + DL I++ F+ +++ GL++
Sbjct: 79 FLTHMFCTFQTKEN-----LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 133
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLAR--VSFNDAPSAIFWTDYVATRWYRAPE 289
+H+ + +RDLK NIL + D +KI DFG+ + + + + + T Y APE
Sbjct: 134 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-----FCGTPDYIAPE 188
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
+ KY ++D WS G + EML G+ F G++ + + IR
Sbjct: 189 ILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE----EELFH-----------SIR 231
Query: 350 NEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR-PTAEEALADPYFH 407
+ +P + A LL +L +P+ R + P F
Sbjct: 232 MDNPF-----------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 274
Query: 408 GL 409
+
Sbjct: 275 EI 276
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 7e-23
Identities = 68/341 (19%), Positives = 125/341 (36%), Gaps = 66/341 (19%)
Query: 88 PTPATMDPHKKSALETEFFTEYGEASRYQIQE-----VIGKGSYGVVGSAVDTHTGERVA 142
T P +K+A F G R ++ + V+GKGS+G V + T E A
Sbjct: 311 IGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYA 370
Query: 143 IKKI-------NDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 195
+K + +D E T + + + L + P + ++ R +Y V
Sbjct: 371 VKILKKDVVIQDDDVEC----TMVEKRV-LALPGKPPFLTQLHSCFQTMDR-----LYFV 420
Query: 196 FELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 254
E + DL I+ H F+ ++ GL ++ + + +RDLK N++ +++
Sbjct: 421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH 480
Query: 255 LKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEM 314
+KI DFG+ + + D + + T Y APE+ Y ++D W+ G + EM
Sbjct: 481 IKIADFGMCKENIWDGVTT---KTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEM 535
Query: 315 LTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFP- 373
L G+ F G++ E I +P
Sbjct: 536 LAGQAPFEGEDE---------------DELFQSIMEHNVA-----------------YPK 563
Query: 374 NADPLALHLLERLLAFDPKDR-----PTAEEALADPYFHGL 409
+ A+ + + L+ P R + +F +
Sbjct: 564 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 73/306 (23%), Positives = 121/306 (39%), Gaps = 64/306 (20%)
Query: 120 VIGKGSYG---VVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVE 176
V+G+GS+G +V + + A+K + V D R E +L + HP IV+
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 177 IKHIMLPPSRREFKDIYVVF------ELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 230
+ + + +Y++ +L + T E +F+L +L L
Sbjct: 91 LHYAFQTEGK-----LYLILDFLRGGDLF---TR--LSKEVMFTEEDVKFYLAELALALD 140
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE- 289
++H+ + +RDLKP+NIL + + +K+ DFGL++ S + A + T Y APE
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA---YSFCGTVEYMAPEV 197
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
+ +T + D WS G + EMLTG F GK+ E+++ I
Sbjct: 198 VNR---RGHTQSADWWSFGVLMFEMLTGTLPFQGKDR---------------KETMTMIL 239
Query: 350 NEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR-----PTAEEALAD 403
K P P A LL L +P +R EE
Sbjct: 240 KAKLG-----------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282
Query: 404 PYFHGL 409
+F +
Sbjct: 283 SFFSTI 288
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 63/310 (20%), Positives = 114/310 (36%), Gaps = 73/310 (23%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKI-------NDVFEHVSDATRILREIKLLRLLRHP 172
V+GKGS+G V + T E A+K + +D E T + + + L + P
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVEC----TMVEKRV-LALPGKPP 81
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFE------LMESDLHQVIKANDDLTPEHYQFFLYQLL 226
+ ++ R +Y V E LM H I+ H F+ ++
Sbjct: 82 FLTQLHSCFQTMDR-----LYFVMEYVNGGDLM---YH--IQQVGRFKEPHAVFYAAEIA 131
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 286
GL ++ + + +RDLK N++ +++ +KI DFG+ + + D + + T Y
Sbjct: 132 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT---KTFCGTPDYI 188
Query: 287 APE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
APE + Y ++D W+ G + EML G+ F G++ E
Sbjct: 189 APEIIAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---------------DELF 230
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR----PT-AEE 399
I +P + A+ + + L+ P R P +
Sbjct: 231 QSIMEHNVA-----------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERD 273
Query: 400 ALADPYFHGL 409
+F +
Sbjct: 274 IKEHAFFRYI 283
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 78/346 (22%), Positives = 123/346 (35%), Gaps = 65/346 (18%)
Query: 82 IQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQE-----VIGKGSYGVVGSAVDTH 136
I P P +P A + + + VIGKGS+G V A
Sbjct: 2 ISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKA 61
Query: 137 TGERVAIKKIN-DVFEHVSDATRILREIK-LLRLLRHPDIVEIKHIMLPPSRREFKDIYV 194
A+K + + I+ E LL+ ++HP +V + + +Y
Sbjct: 62 EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK-----LYF 116
Query: 195 VF------ELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL 248
V EL H ++ +F+ ++ L Y+H+ N+ +RDLKP+NIL
Sbjct: 117 VLDYINGGELF---YH--LQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENIL 171
Query: 249 ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG 308
++ + + DFGL + + + T + T Y APE+ Y +D W +G
Sbjct: 172 LDSQGHIVLTDFGLCKENIEHNSTT--ST-FCGTPEYLAPEVLHK--QPYDRTVDWWCLG 226
Query: 309 CIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPF 368
+ EML G P F +N M D I N+ +
Sbjct: 227 AVLYEMLYGLPPFYSRNT----AEMYD-----------NILNKPLQ-------------- 257
Query: 369 SHKFP-NADPLALHLLERLLAFDPKDR----PTAEEALADPYFHGL 409
N A HLLE LL D R E + +F +
Sbjct: 258 ---LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 38/239 (15%), Positives = 78/239 (32%), Gaps = 40/239 (16%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGE-------RVAIKKINDVFEHVSDATRILREIKLLRL 168
E +G+G++ + V G+ V +K ++ + S++ ++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES--FFEAASMMSK 68
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLL 226
L H +V + + + +V E ++ L +K N + + QL
Sbjct: 69 LSHKHLVLNYGVCV-----CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKL--------KICDFGLARVSFNDAPSAIFWTD 278
+ ++ + H ++ KNIL + K+ D G++ + D
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--------VLPKD 175
Query: 279 Y--VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
W PE C A D WS G E+ + G + + +
Sbjct: 176 ILQERIPWV-PPE-CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 61/255 (23%), Positives = 106/255 (41%), Gaps = 56/255 (21%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKL 165
++ +G+G++G V + + VA+K + D + A R RE +L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAEL 70
Query: 166 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAN-------------- 210
L L+H IV+ + + + +VFE M+ DL++ ++A+
Sbjct: 71 LTNLQHEHIVKFYGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 211 --DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268
+L Q+ G+ Y+ + + HRDL +N L A+ +KI DFG++R
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD--- 182
Query: 269 DAPSAIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKP 319
++ TDY RW PE + K+T D+WS G I E+ T GK
Sbjct: 183 -----VYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFTYGKQ 234
Query: 320 LFPGKN---VVHQLD 331
+ + V+ +
Sbjct: 235 PWFQLSNTEVIECIT 249
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 61/250 (24%), Positives = 98/250 (39%), Gaps = 60/250 (24%)
Query: 111 EASRYQIQ--EVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LR 161
E +R +I +G+GS+G+V G A E RVAIK +N E S RI L
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLN 77
Query: 162 EIKLLRLLRHPDIVEIKHIML--PPSRREFKDIYVVFELMES-DLHQVIKAN-------- 210
E +++ +V + ++ P V+ ELM DL +++
Sbjct: 78 EASVMKEFNCHHVVRLLGVVSQGQP-------TLVIMELMTRGDLKSYLRSLRPAMANNP 130
Query: 211 --DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268
+ ++ G+ Y++ HRDL +N + D +KI DFG+ R
Sbjct: 131 VLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--- 187
Query: 269 DAPSAIFWTDYVATRWYR------------APELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
I+ TDY YR +PE +T D+WS G + E+ T
Sbjct: 188 -----IYETDY-----YRKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIAT 235
Query: 317 -GKPLFPGKN 325
+ + G +
Sbjct: 236 LAEQPYQGLS 245
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 58/254 (22%), Positives = 102/254 (40%), Gaps = 55/254 (21%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKL 165
++ +G+G++G V + + VA+K + + S++ R RE +L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAEL 96
Query: 166 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD------------ 212
L +L+H IV + E + + +VFE M DL++ ++++
Sbjct: 97 LTMLQHQHIVRFFGVCT-----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 213 ---LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269
L Q+ G+ Y+ + HRDL +N L +KI DFG++R
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD---- 207
Query: 270 APSAIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPL 320
I+ TDY RW PE + K+T D+WS G + E+ T GK
Sbjct: 208 ----IYSTDYYRVGGRTMLPIRWM-PPE--SILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
Query: 321 FPGKN---VVHQLD 331
+ + + +
Sbjct: 261 WYQLSNTEAIDCIT 274
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 63/280 (22%), Positives = 109/280 (38%), Gaps = 39/280 (13%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIK-LLRLLRHPDIVEI 177
VIG+GSY V T A+K + ++ D + E + HP +V +
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 178 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 236
SR ++ V E + DL ++ L EH +F+ ++ L Y+H
Sbjct: 76 HSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 130
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFF 295
+ +RDLK N+L +++ +K+ D+G+ + + + + T Y APE L G
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRG--- 184
Query: 296 SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355
Y ++D W++G + EM+ G+ F D I ++ R
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------QNTEDYLFQVILEKQIR- 237
Query: 356 YLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR 394
P + A +L+ L DPK+R
Sbjct: 238 ----------------IPRSLSVKAASVLKSFLNKDPKER 261
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 64/285 (22%), Positives = 110/285 (38%), Gaps = 58/285 (20%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKI-------NDVFEHVSDATRILREIKLLRLLRHP 172
V+GKGS+G V A TG+ A+K + +D E T + I L HP
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVEC----TMTEKRI-LSLARNHP 84
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+ ++ P R ++ V E + DL I+ + +F+ +++ L +
Sbjct: 85 FLTQLFCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMF 139
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-L 290
+H + +RDLK N+L + + K+ DFG+ + + + + T Y APE L
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT---ATFCGTPDYIAPEIL 196
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350
Y PA+D W++G + EML G F +N + I N
Sbjct: 197 QE---MLYGPAVDWWAMGVLLYEMLCGHAPFEAENE---------------DDLFEAILN 238
Query: 351 EKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR 394
++ +P A +L+ + +P R
Sbjct: 239 DEVV-----------------YPTWLHEDATGILKSFMTKNPTMR 266
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 65/309 (21%), Positives = 127/309 (41%), Gaps = 60/309 (19%)
Query: 120 VIGKGSYG---VVGSAVDTHTGERVAIK---------KINDVFEHVSDATRILREIKLLR 167
V+G G+YG +V TG+ A+K K EH ++L I+
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT-EHTRTERQVLEHIR--- 116
Query: 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL 226
+ P +V + + ++ ++++ + + +L + + T Q ++ +++
Sbjct: 117 --QSPFLVTLHYAFQTETK-----LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 169
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 286
L+++H + +RD+K +NIL +++ + + DFGL++ D + + + T Y
Sbjct: 170 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETERAYD-FCGTIEYM 227
Query: 287 APELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
AP++ S + A+D WS+G + E+LTG F + ++
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR----------- 276
Query: 347 RIRNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR----PT-AEEA 400
RI + +P LA L++RLL DPK R P A+E
Sbjct: 277 RILKSEPP-----------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI 319
Query: 401 LADPYFHGL 409
+F +
Sbjct: 320 KEHLFFQKI 328
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 54/236 (22%), Positives = 93/236 (39%), Gaps = 51/236 (21%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKL 165
S + E +G+ +G V G GE VAIK + + R E L
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEAML 65
Query: 166 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAN-------------- 210
L+HP++V + ++ + + + ++F DLH+ +
Sbjct: 66 RARLQHPNVVCLLGVVT-----KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 211 --DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268
L P + + Q+ G++Y+ + +V H+DL +N+L +KI D GL R
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE--- 177
Query: 269 DAPSAIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
++ DY RW APE + K++ DIWS G + E+ +
Sbjct: 178 -----VYAADYYKLLGNSLLPIRWM-APE--AIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 62/280 (22%), Positives = 109/280 (38%), Gaps = 39/280 (13%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIK-LLRLLRHPDIVEI 177
VIG+GSY V T A++ + ++ D + E + HP +V +
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 178 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 236
SR ++ V E + DL ++ L EH +F+ ++ L Y+H
Sbjct: 119 HSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFF 295
+ +RDLK N+L +++ +K+ D+G+ + + + + T Y APE L G
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRG--- 227
Query: 296 SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355
Y ++D W++G + EM+ G+ F D I ++ R
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------QNTEDYLFQVILEKQIR- 280
Query: 356 YLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR 394
P + A +L+ L DPK+R
Sbjct: 281 ----------------IPRSLSVKAASVLKSFLNKDPKER 304
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 58/270 (21%), Positives = 99/270 (36%), Gaps = 51/270 (18%)
Query: 94 DPHKKSALETEFFTEYGEASRYQIQ--EVIGKGSYGVV--GSAVDTHTGE---RVAIKKI 146
+P+ A +T ++ E R I +G G++G V G +VA+K +
Sbjct: 9 NPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL 68
Query: 147 NDVFEHVSDATRI--LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DL 203
E S+ + L E ++ H +IV + L + +++ ELM DL
Sbjct: 69 P---EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL-----QSLPRFILMELMAGGDL 120
Query: 204 HQVIKANDDLTPEHYQFFLYQLL-------RGLKYIHTANVFHRDLKPKNILANA---DC 253
++ + + LL G +Y+ + HRD+ +N L
Sbjct: 121 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 180
Query: 254 KLKICDFGLARVSFNDAPSAIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIW 305
KI DFG+AR I+ Y +W PE +T D W
Sbjct: 181 VAKIGDFGMARD--------IYRASYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTW 229
Query: 306 SIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
S G + E+ + G +P K+ V+ +
Sbjct: 230 SFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 60/252 (23%), Positives = 107/252 (42%), Gaps = 52/252 (20%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKL 165
R ++ + +G+G++G V A VA+K + E + + + E+K+
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 83
Query: 166 L-RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAN------------- 210
L + H ++V +L + + V+ E + +L +++
Sbjct: 84 LIHIGHHLNVVN----LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 211 ---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267
D LT EH + +Q+ +G++++ + HRDL +NIL + +KICDFGLAR
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD-- 197
Query: 268 NDAPSAIFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GK 318
I+ YV +W APE F YT D+WS G + E+ + G
Sbjct: 198 ------IYKDPDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLLWEIFSLGA 248
Query: 319 PLFPGKNVVHQL 330
+PG + +
Sbjct: 249 SPYPGVKIDEEF 260
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 58/276 (21%), Positives = 99/276 (35%), Gaps = 51/276 (18%)
Query: 88 PTPATMDPHKKSALETEFFTEYGEASRYQIQ--EVIGKGSYGVV--GSAVDTHTGE---R 140
+P+ A +T ++ E R I +G G++G V G +
Sbjct: 44 TIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQ 103
Query: 141 VAIKKINDVFEHVSDATRI--LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 198
VA+K + E S+ + L E ++ H +IV + L + +++ EL
Sbjct: 104 VAVKTLP---EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL-----QSLPRFILLEL 155
Query: 199 MES-DLHQVIKANDDLTPEHYQFFLYQLL-------RGLKYIHTANVFHRDLKPKNILAN 250
M DL ++ + + LL G +Y+ + HRD+ +N L
Sbjct: 156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT 215
Query: 251 A---DCKLKICDFGLARVSFNDAPSAIFWTDYVAT--------RWYRAPELCGSFFSKYT 299
KI DFG+AR I+ Y +W PE +T
Sbjct: 216 CPGPGRVAKIGDFGMARD--------IYRAGYYRKGGCAMLPVKWM-PPE--AFMEGIFT 264
Query: 300 PAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
D WS G + E+ + G +P K+ V+ +
Sbjct: 265 SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 6e-19
Identities = 64/289 (22%), Positives = 108/289 (37%), Gaps = 67/289 (23%)
Query: 80 KRIQFPIAPTPATMDPHKKSALET-EFFTEYGEASRYQIQEVIGKGSYGVV--GSAVDTH 136
K I+ + +DP + E EF + Q + +G G++G V +A
Sbjct: 17 KIIESYEGNSYTFIDPTQLPYNEKWEF-----PRNNLQFGKTLGAGAFGKVVEATAFGLG 71
Query: 137 TGE---RVAIKKINDVFEHVSDATRI--LREIKLL-RLLRHPDIVEIKHIML------PP 184
+ +VA+K + + + E+K++ L +H +IV +L P
Sbjct: 72 KEDAVLKVAVKMLK---STAHADEKEALMSELKIMSHLGQHENIVN----LLGACTHGGP 124
Query: 185 SRREFKDIYVVFELME---------------SDLHQVIKANDDLTPEHYQFFLYQLLRGL 229
+ V+ E AN + F Q+ +G+
Sbjct: 125 -------VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGM 177
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------- 282
++ + N HRD+ +N+L KI DFGLAR ND ++Y+
Sbjct: 178 AFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND-------SNYIVKGNARLPV 230
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQL 330
+W APE F YT D+WS G + E+ + G +PG V +
Sbjct: 231 KWM-APE--SIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 8e-19
Identities = 60/270 (22%), Positives = 105/270 (38%), Gaps = 79/270 (29%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKL 165
+ + +G+G +G V +A VA+K + E+ S + L E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNV 79
Query: 166 LRLLRHPDIVEIKHIML------PPSRREFKDIYVVFELMES-DLHQVIKAN-------- 210
L+ + HP +++ + P + ++ E + L ++ +
Sbjct: 80 LKQVNHPHVIK----LYGACSQDGP-------LLLIVEYAKYGSLRGFLRESRKVGPGYL 128
Query: 211 ----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 254
LT F +Q+ +G++Y+ + HRDL +NIL K
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK 188
Query: 255 LKICDFGLARVSFNDAPSAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIW 305
+KI DFGL+R ++ D YV +W A E S F YT D+W
Sbjct: 189 MKISDFGLSRD--------VYEEDSYVKRSQGRIPVKWM-AIE---SLFDHIYTTQSDVW 236
Query: 306 SIGCIFAEMLT--GKPLFPG---KNVVHQL 330
S G + E++T G P +PG + + + L
Sbjct: 237 SFGVLLWEIVTLGGNP-YPGIPPERLFNLL 265
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 8e-19
Identities = 55/251 (21%), Positives = 95/251 (37%), Gaps = 73/251 (29%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKL 165
+ + IG+G++G V A E VA+K + E S + RE L
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAAL 103
Query: 166 LRLLRHPDIVEIKHIML--PPSRREFKDIYVVFELMES-DLHQVIKANDD---------- 212
+ +P+IV++ + P + ++FE M DL++ +++
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKP-------MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156
Query: 213 --------------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 258
L+ Q+ G+ Y+ HRDL +N L + +KI
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 216
Query: 259 DFGLARVSFNDAPSAIFWTDYVATRWYR------------APELCGS-FFSKYTPAIDIW 305
DFGL+R I+ DY Y+ PE S F+++YT D+W
Sbjct: 217 DFGLSRN--------IYSADY-----YKADGNDAIPIRWMPPE---SIFYNRYTTESDVW 260
Query: 306 SIGCIFAEMLT 316
+ G + E+ +
Sbjct: 261 AYGVVLWEIFS 271
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 61/264 (23%), Positives = 108/264 (40%), Gaps = 72/264 (27%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGE-----RVAIKKINDVFEHVSDATRI--LREI 163
+ + + +G+G++G V AV + VA+K + + ++ + E+
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 91
Query: 164 KLL-RLLRHPDIVEIKHIML------PPSRREFKDIYVVFELMES-DLHQVIKAN----- 210
+++ + +H +I+ +L P +YV+ E +L + ++A
Sbjct: 92 EMMKMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLRARRPPGM 140
Query: 211 -----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 259
+ +T + YQL RG++Y+ + HRDL +N+L + +KI D
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD 200
Query: 260 FGLARVSFNDAPSAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCI 310
FGLAR I D Y T +W APE + F YT D+WS G +
Sbjct: 201 FGLARD--------INNIDYYKKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVL 248
Query: 311 FAEMLT-GK---PLFPGKNVVHQL 330
E+ T G P P + + L
Sbjct: 249 MWEIFTLGGSPYPGIPVEELFKLL 272
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 65/260 (25%), Positives = 95/260 (36%), Gaps = 67/260 (25%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKL 165
+R + +G G++G V +A + VA+K + R + E+K+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKV 79
Query: 166 L-RLLRHPDIVEIKHIML------PPSRREFKDIYVVFELMES-DLHQVIKAN------- 210
L L H +IV +L P V+ E DL ++
Sbjct: 80 LSYLGNHMNIVN----LLGACTIGGP-------TLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 211 -----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 259
L E F YQ+ +G+ ++ + N HRDL +NIL KICD
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 188
Query: 260 FGLARVSFNDAPSAIFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIF 311
FGLAR I YV +W APE F YT D+WS G
Sbjct: 189 FGLARD--------IKNDSNYVVKGNARLPVKWM-APESI--FNCVYTFESDVWSYGIFL 237
Query: 312 AEMLT-GKPLFPGKNVVHQL 330
E+ + G +PG V +
Sbjct: 238 WELFSLGSSPYPGMPVDSKF 257
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 61/261 (23%), Positives = 107/261 (40%), Gaps = 72/261 (27%)
Query: 116 QIQEVIGKGSYGVV--GSAVDTHTGE-----RVAIKKINDVFEHVSDATRI--LREIKLL 166
+ + +G+G +G V AV + VA+K + + ++ + E++++
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMM 140
Query: 167 -RLLRHPDIVEIKHIML------PPSRREFKDIYVVFELMES-DLHQVIKAN-------- 210
+ +H +I+ +L P +YV+ E +L + ++A
Sbjct: 141 KMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLRARRPPGMEYS 189
Query: 211 --------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 262
+ +T + YQL RG++Y+ + HRDL +N+L + +KI DFGL
Sbjct: 190 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 249
Query: 263 ARVSFNDAPSAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCIFAE 313
AR I D Y T +W APE + F YT D+WS G + E
Sbjct: 250 ARD--------INNIDYYKKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLMWE 297
Query: 314 MLT-GKPLFPG---KNVVHQL 330
+ T G +PG + + L
Sbjct: 298 IFTLGGSPYPGIPVEELFKLL 318
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 57/252 (22%), Positives = 89/252 (35%), Gaps = 64/252 (25%)
Query: 94 DPHKKSALETEFFTEYGEASRYQIQ--EVIGKGSYGVV--GSAVDTHTGERVAIKKINDV 149
H T Y I+ +VIG+G++G V AIK++
Sbjct: 4 HHHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-- 61
Query: 150 FEHVSDATRI--LREIKLL-RLLRHPDIVEIKHIML------PPSRREFKDIYVVFELME 200
E+ S E+++L +L HP+I+ +L +Y+ E
Sbjct: 62 -EYASKDDHRDFAGELEVLCKLGHHPNIIN----LLGACEHRGY-------LYLAIEYAP 109
Query: 201 S-DLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 243
+L ++ + L+ + F + RG+ Y+ HRDL
Sbjct: 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA 169
Query: 244 PKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-------RWYRAPELCGSFFS 296
+NIL + KI DFGL+R + YV RW A E +S
Sbjct: 170 ARNILVGENYVAKIADFGLSR--GQEV--------YVKKTMGRLPVRWM-AIE--SLNYS 216
Query: 297 KYTPAIDIWSIG 308
YT D+WS G
Sbjct: 217 VYTTNSDVWSYG 228
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 61/264 (23%), Positives = 108/264 (40%), Gaps = 72/264 (27%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGE-----RVAIKKINDVFEHVSDATRI--LREI 163
R + + +G+G++G V A+ + +VA+K + ++ + E+
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEM 125
Query: 164 KLL-RLLRHPDIVEIKHIML------PPSRREFKDIYVVFELMES-DLHQVIKAN----- 210
+++ + +H +I+ +L P +YV+ E +L + ++A
Sbjct: 126 EMMKMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLQARRPPGL 174
Query: 211 -----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 259
+ L+ + YQ+ RG++Y+ + HRDL +N+L D +KI D
Sbjct: 175 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 234
Query: 260 FGLARVSFNDAPSAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCI 310
FGLAR I D Y T +W APE + F YT D+WS G +
Sbjct: 235 FGLARD--------IHHIDYYKKTTNGRLPVKWM-APE---ALFDRIYTHQSDVWSFGVL 282
Query: 311 FAEMLT-GK---PLFPGKNVVHQL 330
E+ T G P P + + L
Sbjct: 283 LWEIFTLGGSPYPGVPVEELFKLL 306
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 83.4 bits (205), Expect = 9e-18
Identities = 51/349 (14%), Positives = 92/349 (26%), Gaps = 75/349 (21%)
Query: 106 FTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI------NDVFEHVSDATRI 159
F+ + Q E IG+G +G V + HT VAIK I H I
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEI 70
Query: 160 LREIKLLRLL---------RHPDIVEIKHIML-------------------------PPS 185
L EI + + L R + + + P
Sbjct: 71 LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130
Query: 186 RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF-HRDLKP 244
+ +++V E + + + L+QL L + F HRDL
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHW 190
Query: 245 KNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDI 304
N+L K+ + S + + + + YT +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSS------------TIPSCGLQVSII------DYTLSRLE 232
Query: 305 WSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK-------ARRYL 357
+F ++ + LF G +Q D + L+ + +
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDG-DYQFD-IYRLMKKENNNRWGEYHPYSNVLWLHYLTDKM 290
Query: 358 GSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
+ + +L F +A + L
Sbjct: 291 LKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 72/307 (23%), Positives = 118/307 (38%), Gaps = 77/307 (25%)
Query: 74 KLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQ--EVIGKGSYGVV-- 129
K R ++Q + + E E+ ++ E R ++ +V+G G++G V
Sbjct: 5 KQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKW-EFPRENLEFGKVLGSGAFGKVMN 63
Query: 130 GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKLL-RLLRHPDIVEIKHIML- 182
+A +VA+K + E + R + E+K++ +L H +IV +L
Sbjct: 64 ATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKMMTQLGSHENIVN----LLG 116
Query: 183 -----PPSRREFKDIYVVFELME------------------------SDLHQVIKANDDL 213
P IY++FE + + + L
Sbjct: 117 ACTLSGP-------IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 214 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273
T E F YQ+ +G++++ + HRDL +N+L +KICDFGLAR
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD-------- 221
Query: 274 IFWTD-YVAT-------RWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEMLT-GKPLFPG 323
I YV +W APE S F YT D+WS G + E+ + G +PG
Sbjct: 222 IMSDSNYVVRGNARLPVKWM-APE---SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277
Query: 324 KNVVHQL 330
V
Sbjct: 278 IPVDANF 284
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 39/167 (23%), Positives = 68/167 (40%), Gaps = 30/167 (17%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRIL-REIKLLRLLR 170
+++ + IG G++G + + +T E VAIK E + L E + + L
Sbjct: 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLG 62
Query: 171 H-PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL------- 222
I ++ + K +V EL+ L + D F L
Sbjct: 63 SGDGIPQVYY-----FGPCGKYNAMVLELLGPSLEDLFDLCD------RTFSLKTVLMIA 111
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNIL-----ANADCKLKICDFGLAR 264
QL+ ++Y+H+ N+ +RD+KP+N L + I DF LA+
Sbjct: 112 IQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 5e-16
Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 16/159 (10%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV-SDATRILREIKLLRLLR 170
+RY++ IG GS+G + D GE VAIK E V + ++ E K+ ++++
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQ 62
Query: 171 H-PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRG 228
I I+ E +V EL+ L + + + Q++
Sbjct: 63 GGVGIPTIRW-----CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISR 117
Query: 229 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLAR 264
++YIH+ N HRD+KP N L + I DFGLA+
Sbjct: 118 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 55/235 (23%), Positives = 90/235 (38%), Gaps = 76/235 (32%)
Query: 120 VIGKGSYGVV--GSAVDTHTGERVAIKKINDV-------FEHVSDATRILREIKLLRLLR 170
+IG G +G V G D G +VA+K+ F EI+ L R
Sbjct: 46 LIGHGVFGKVYKGVLRD---GAKVALKRRTPESSQGIEEF---------ETEIETLSFCR 93
Query: 171 HPDIV-------EIKHIMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHY 218
HP +V E ++L +++ M + L+ ++ E
Sbjct: 94 HPHLVSLIGFCDERNEMIL------------IYKYMENGNLKRHLYGSDLPTMSMSWE-- 139
Query: 219 QFFLYQLL-------RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271
Q L RGL Y+HT + HRD+K NIL + + KI DFG+++
Sbjct: 140 -----QRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194
Query: 272 SAIFWTDYVATRW-----YRAPELCGSFFS--KYTPAIDIWSIGCIFAEMLTGKP 319
+ +++T Y PE +F + T D++S G + E+L +
Sbjct: 195 T------HLSTVVKGTLGYIDPE----YFIKGRLTEKSDVYSFGVVLFEVLCARS 239
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 33/168 (19%), Positives = 71/168 (42%), Gaps = 21/168 (12%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
++ + + IG G +G++ A T+ E+ A + E+ + + E+K + + D
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK--VEY-QENGPLFSELKFYQRVAKKD 94
Query: 174 IVE-------IKHIMLP-------PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ 219
++ + ++ +P + ++V E + DL ++ N
Sbjct: 95 CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVL 154
Query: 220 FFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLAR 264
++L L+YIH H D+K N+L N D ++ + D+GL+
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-QVYLADYGLSY 201
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 36/167 (21%), Positives = 68/167 (40%), Gaps = 30/167 (17%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRIL-REIKLLRLLR 170
Y++ IG+GS+GV+ + ++VAIK FE L E + +LL
Sbjct: 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-----FEPRRSDAPQLRDEYRTYKLLA 63
Query: 171 H-PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL------- 222
I + + +E +V +L+ L ++ +F +
Sbjct: 64 GCTGIPNVYY-----FGQEGLHNVLVIDLLGPSLEDLLDLCG------RKFSVKTVAMAA 112
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNIL-----ANADCKLKICDFGLAR 264
Q+L ++ IH ++ +RD+KP N L + + + DFG+ +
Sbjct: 113 KQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 39/159 (24%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV-SDATRILREIKLLRLLR 170
+++++ IG GS+G + + T E VAIK E+V + ++L E K+ R+L+
Sbjct: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKIYRILQ 60
Query: 171 -HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRG 228
I ++ E +V +L+ L + L+ + Q++
Sbjct: 61 GGTGIPNVRW-----FGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
Query: 229 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLAR 264
++++H+ + HRD+KP N L ++ I DFGLA+
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 43/140 (30%), Positives = 66/140 (47%), Gaps = 18/140 (12%)
Query: 199 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 258
+E + D LT EH + +Q+ +G++++ + HRDL +NIL + +KIC
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 235
Query: 259 DFGLARVSFNDAPSAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIF 311
DFGLAR + D DYV +W APE F YT D+WS G +
Sbjct: 236 DFGLARDIYKD-------PDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLL 285
Query: 312 AEMLT-GKPLFPGKNVVHQL 330
E+ + G +PG + +
Sbjct: 286 WEIFSLGASPYPGVKIDEEF 305
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 5e-13
Identities = 60/231 (25%), Positives = 94/231 (40%), Gaps = 67/231 (29%)
Query: 120 VIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSD--ATRILREIKLLRLLRHPDIV 175
+G+G +GVV G V+ VA+KK+ + + ++ + +EIK++ +H ++V
Sbjct: 38 KMGEGGFGVVYKGY-VN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 176 -------EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLL-- 226
+ + L V+ M N L L L
Sbjct: 94 ELLGFSSDGDDLCL------------VYVYMP---------NGSL-----LDRLSCLDGT 127
Query: 227 ----------------RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270
G+ ++H + HRD+K NIL + KI DFGLAR S A
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 271 PSAIFWTDYVA-TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKP 319
+ + T + T Y APE L G + TP DI+S G + E++TG P
Sbjct: 188 QTVM--TSRIVGTTAYMAPEALRG----EITPKSDIYSFGVVLLEIITGLP 232
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 36/174 (20%), Positives = 72/174 (41%), Gaps = 30/174 (17%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+++ IG+G +G + A D ++ E V V SD + E+K + P+
Sbjct: 36 AWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 174 IVE-------IKHIMLPP-------SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ 219
++ +K++ +P + +++ + SDL ++ +AN +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA------KR 148
Query: 220 FFL-------YQLLRGLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLAR 264
F ++L L+YIH H D+K N+L ++ + D+GLA
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 23/174 (13%), Positives = 62/174 (35%), Gaps = 30/174 (17%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTG--------ERVAIKKINDVFEHVSDATRILREIKL 165
+++++ + + G++ A T T ++ ++K + R+ E
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-----LDAKD--GRLFNEQNF 95
Query: 166 L-RLLRHPDIVEIKHIMLPPS----------RREFKDIYVVFELMESDLHQVIKANDDLT 214
R + + + K + P + K ++V + L + +
Sbjct: 96 FQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHV 155
Query: 215 -PEHYQFFL-YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI--CDFGLAR 264
E + +LL L+++H H ++ +NI + + + ++ +G A
Sbjct: 156 LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 66.0 bits (160), Expect = 1e-11
Identities = 62/416 (14%), Positives = 124/416 (29%), Gaps = 111/416 (26%)
Query: 133 VDTHTGE-RVAIKKINDVFE----------HVSDATR-ILREIKLLRLLRHPDIVEIKHI 180
+D TGE + K I VFE V D + IL + EI HI
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSK------------EEIDHI 54
Query: 181 MLPPSRREFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQL--------LRGLK 230
++ +F + S ++++ + L Y+F + + +
Sbjct: 55 IMSKDAVS--GTLRLFWTLLSKQEEMVQKFVEEVLRIN-YKFLMSPIKTEQRQPSMMTRM 111
Query: 231 YIHTANVFHRD-----------LKPKNILANADCKLK----ICDFG--------LARVSF 267
YI + + D L+P L A +L+ + G +A
Sbjct: 112 YIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVC 171
Query: 268 NDA------PSAIFWTDYVATRWYRAPE--------LCGSFFSKYTPAIDIWSIGCIFAE 313
IFW + + +PE L +T D S +
Sbjct: 172 LSYKVQCKMDFKIFW---LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH 228
Query: 314 MLTGKP--LFPGKNVVHQLDLMTDLLGTPSTESI------SRI----RNEKARRYLGSMR 361
+ + L K + L ++ ++ + ++ +I R ++ +L +
Sbjct: 229 SIQAELRRLLKSKPYENCLLVLLNVQ---NAKAWNAFNLSCKILLTTRFKQVTDFLSAAT 285
Query: 362 KKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA-DPYFHGL--ANVDREPST 418
H LL + L P+D P E L +P + ++ +T
Sbjct: 286 TTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP--REVLTTNPRRLSIIAESIRDGLAT 343
Query: 419 QPISKLEFEFER-RKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVD 473
++ + + D + +I + P ++ ++P
Sbjct: 344 ---------WDNWKHVNCDKLTTIIESSLNVLEPAEYRKMF----DRLSVFPPSAH 386
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 2e-10
Identities = 81/562 (14%), Positives = 164/562 (29%), Gaps = 170/562 (30%)
Query: 60 QQLTIVEDF-------DFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEA 112
+Q +V+ F ++ L + + + P T ++ + + + F +Y
Sbjct: 74 KQEEMVQKFVEEVLRINYKFL-MSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKY-NV 131
Query: 113 SR-----------YQIQEVIGKGSYGVVGS-----AVDTHTGERVAIKKINDVF-----E 151
SR +++ GV+GS A+D +V K +F
Sbjct: 132 SRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKN 191
Query: 152 HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQ----VI 207
S T + KLL + H R + L++S ++ V+
Sbjct: 192 CNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR-RLLKSKPYENCLLVL 250
Query: 208 KANDDL-TPEHYQFFLYQ--------------LLRGLKYIHTANVFHRD-LKP---KNIL 248
++ + + F L H + H L P K++L
Sbjct: 251 ---LNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL 307
Query: 249 ANADCKLKICDFGLARVSFNDAPSAI--FWT---DYVATRW--YRAPELCGSFFSKYTPA 301
L L R P + D +A W ++ K T
Sbjct: 308 LKY---LDCRPQDLPREVLTTNPRRLSIIAESIRDGLA-TWDNWKHVN-----CDKLTTI 358
Query: 302 IDIWSIGCI--------FAEMLTGKPLFPGKNVVHQLDLMTDLLGT----PSTESISRIR 349
I+ S+ + F + L+ +FP + + T LL + +
Sbjct: 359 IES-SLNVLEPAEYRKMF-DRLS---VFP-PSA----HIPTILLSLIWFDVIKSDVMVVV 408
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL-------- 401
N+ + S+ +KQP + ++ + L ++ ++
Sbjct: 409 NKLHKY---SLVEKQPKESTI--------SIPSIYLELKVKLENEYALHRSIVDHYNIPK 457
Query: 402 -----------ADPYF------HGLANVDREPSTQPISK--LEFEFERRKLAKD------ 436
D YF H L N++ L+F F +K+ D
Sbjct: 458 TFDSDDLIPPYLDQYFYSHIGHH-LKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNA 516
Query: 437 ---------DVREMIYRE-ILEYHPQM------LQEYLRGGEQTSFMYPSGVDRFKR--Q 478
++ Y+ I + P+ + ++L E+ + +
Sbjct: 517 SGSILNTLQQLK--FYKPYICDNDPKYERLVNAILDFLPKIEENLICSK-----YTDLLR 569
Query: 479 FAHLEEH---YGKGERSTPLQR 497
A + E + + + +QR
Sbjct: 570 IALMAEDEAIFEEAHKQ--VQR 589
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 49/219 (22%), Positives = 94/219 (42%), Gaps = 43/219 (19%)
Query: 120 VIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV-- 175
++G+G +G V G D G VA+K++ + + + E++++ + H +++
Sbjct: 37 ILGRGGFGKVYKGRLAD---GTLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRL 92
Query: 176 -----EIKHIMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLT-PEHYQFFLYQ 224
+L V+ M S L + ++ L P+ + L
Sbjct: 93 RGFCMTPTERLL------------VYPYMANGSVASCLRERPESQPPLDWPKRQRIAL-G 139
Query: 225 LLRGLKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVA 281
RGL Y+H + HRD+K NIL + + + + DFGLA++ + + + T
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVT-TAVRG 197
Query: 282 TRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEMLTGK 318
T + APE G K + D++ G + E++TG+
Sbjct: 198 TIGHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQ 232
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 509 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.34 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.16 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.11 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.77 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.62 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.45 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.36 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.31 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.16 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.1 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.94 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.71 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.57 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.36 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.35 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.27 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.12 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.11 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.0 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.0 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.9 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.89 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.68 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.57 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.2 | |
| 1y10_A | 407 | Hypothetical protein RV1264/MT1302; adenylyl cycla | 95.74 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.11 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.75 | |
| 3hls_A | 66 | Guanylate cyclase soluble subunit beta-1; coiled-c | 90.3 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 87.07 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-70 Score=554.49 Aligned_cols=337 Identities=50% Similarity=0.891 Sum_probs=293.3
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCC-CcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP-SRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-~~~~~~ 190 (509)
.++|++++.||+|+||+||+|+++.+|+.||||+++.........+.+++|+++|+.++|||||++++++... .+.+..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 4689999999999999999999999999999999987656666678899999999999999999999998654 234557
Q ss_pred cEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.+|||||||+|+|.+++...+.+++..++.|++||+.||+|||++|||||||||+|||++.+|.+||+|||+|+......
T Consensus 133 ~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~ 212 (398)
T 4b99_A 133 SVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP 212 (398)
T ss_dssp CEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999998654322
Q ss_pred -CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 271 -PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 271 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
.......+.+||++|||||++.+. ..|+.++||||+|||+|||++|++||.+.+..+++..|....|.|+...+..+.
T Consensus 213 ~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~ 291 (398)
T 4b99_A 213 AEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 291 (398)
T ss_dssp ---CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred cccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence 122234568999999999998763 467999999999999999999999999999999999999999999998887777
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCCCCccchhHH
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFE 429 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 429 (509)
......++..++...+.++...++.++++++|||.+||.+||++|||++|+|+||||+.+.+++.++...+ .+++.++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~~~~--~~~~~~~ 369 (398)
T 4b99_A 292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAP--PFDFAFD 369 (398)
T ss_dssp --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCCCSS--CCCCHHH
T ss_pred hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccCCCC--CCCCccc
Confidence 77777788888888888888888999999999999999999999999999999999999887776665433 4567778
Q ss_pred hhhcCHHHHHHHHHHHHHHhCh
Q 010489 430 RRKLAKDDVREMIYREILEYHP 451 (509)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~p 451 (509)
...+..+++++.+++|+..++.
T Consensus 370 ~~~~~~~~~k~~i~~ei~~~~~ 391 (398)
T 4b99_A 370 REALTRERIKEAIVAEIEDFHA 391 (398)
T ss_dssp HSCCCHHHHHHHHHHHHHHHHH
T ss_pred hhhcCHHHHHHHHHHHHHHHHH
Confidence 8888999999999999988875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-65 Score=497.66 Aligned_cols=262 Identities=26% Similarity=0.455 Sum_probs=224.9
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+++|+.++|||||++++++. +...
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence 47999999999999999999999999999999996432 22234567899999999999999999999994 4456
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|||||||+ |+|.+++.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999998 5999999998999999999999999999999999999999999999999999999999999998764332
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
.. ....+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|...
T Consensus 187 ~~-~~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~-------------- 249 (311)
T 4aw0_A 187 KQ-ARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL-------------- 249 (311)
T ss_dssp TC-CCBCCCCSCGGGCCHHHHHH--SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------------
T ss_pred Cc-ccccCcccCcccCCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------
Confidence 22 22456799999999999987 78999999999999999999999999988765555444321
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHH------HhcCCcccCCcCCC
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE------ALADPYFHGLANVD 413 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e------~l~hp~f~~~~~~~ 413 (509)
. ..+ ...+++++++||.+||++||++|||++| +++||||+++.+..
T Consensus 250 ------------~--~~~---p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~ 301 (311)
T 4aw0_A 250 ------------E--YDF---PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 301 (311)
T ss_dssp ------------C--CCC---CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred ------------C--CCC---CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHH
Confidence 0 011 1357899999999999999999999987 58999999886543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-64 Score=499.08 Aligned_cols=258 Identities=29% Similarity=0.507 Sum_probs=220.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
..+|+++++||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|+.+|+.++|||||++++++.. ...
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~ 145 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDE 145 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCE
Confidence 3579999999999999999999999999999999964322 234567899999999999999999999954 456
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|||||||+ |+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+......
T Consensus 146 ~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 146 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp EEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 999999998 589888865 579999999999999999999999999999999999999999999999999998764433
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
. ..++.+||++|||||++.+ ..|+.++||||||||+|||++|++||.+.+..+.+..|....
T Consensus 225 ~---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~------------- 286 (346)
T 4fih_A 225 P---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL------------- 286 (346)
T ss_dssp C---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-------------
T ss_pred C---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-------------
Confidence 2 2356799999999999987 689999999999999999999999999887766555443211
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
+ +....+..+++++++||.+||++||++|||++|+|+||||+...
T Consensus 287 --------------~-~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 287 --------------P-PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp --------------C-CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred --------------C-CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 0 01122346789999999999999999999999999999998643
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-64 Score=484.57 Aligned_cols=255 Identities=31% Similarity=0.524 Sum_probs=205.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++++.||+|+||+||+|+++.+|+.||||++++... .......+.+|+.+|+.++|||||++++++.+ ..
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-----KD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CC
Confidence 4689999999999999999999999999999999975432 22335678999999999999999999999954 45
Q ss_pred cEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.+|||||||+|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 87 ~~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 87 EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 69999999999999999999999999999999999999999999999999999999999999999999999998653322
Q ss_pred CCcccccccccccccccccccccccCCC-CCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
...+.+||+.|||||++.+ ..| +.++|||||||++|||++|++||.+.+....+..+...
T Consensus 167 ----~~~~~~GT~~Y~APE~~~~--~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~------------- 227 (275)
T 3hyh_A 167 ----FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG------------- 227 (275)
T ss_dssp ------------CTTSCHHHHSS--SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-------------
T ss_pred ----ccCCeeECcccCChhhhcC--CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC-------------
Confidence 2345799999999999987 454 68999999999999999999999987754444333221
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
.. . ....+++++++||.+||++||++|||++|+|+||||+.
T Consensus 228 -------------~~--~---~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 228 -------------VY--T---LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp -------------CC--C---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred -------------CC--C---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 00 1 11347899999999999999999999999999999974
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-64 Score=498.38 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=216.1
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||+||+|+++.+|+.||||+++...........+.+|+.+|+.|+|||||++++++.+ ...
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-----~~~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-----NGS 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-----CCE
Confidence 468999999999999999999999999999999997655555667789999999999999999999999943 456
Q ss_pred EEEEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 192 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
+|||||||+ |+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 999999998 6999999754 3579999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
. ....+..+||+.|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..+...
T Consensus 178 ~---~~~~~~~~GT~~YmAPE~l~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~------------ 240 (350)
T 4b9d_A 178 T---VELARACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG------------ 240 (350)
T ss_dssp H---HHHHHHHHSCCTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT------------
T ss_pred C---cccccccCCCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC------------
Confidence 1 112345789999999999988 78999999999999999999999999998866555444321
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
..+ .....+++++.+||.+||++||++|||++|+|+||||+.
T Consensus 241 --------------~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 241 --------------SFP----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp --------------CCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred --------------CCC----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 000 122457899999999999999999999999999999974
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-62 Score=479.63 Aligned_cols=259 Identities=26% Similarity=0.373 Sum_probs=215.3
Q ss_pred CCe-eEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRY-QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y-~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++| ++.++||+|+||+||+|.++.++..||||++............+.+|+.+|+.|+|||||++++++.... .....
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcE
Confidence 455 7888999999999999999999999999999765555556778999999999999999999999985421 22356
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCC--eeecCCCCCcEEECC-CCCeEEeeeccccccc
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANA-DCKLKICDFGLARVSF 267 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~--ivHrDlKp~NILl~~-~~~vkl~DFG~a~~~~ 267 (509)
+|||||||+ |+|.+++.+.+.+++..++.|+.||+.||+|||++| ||||||||+||||+. +|.+||+|||+|+...
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 899999998 699999999899999999999999999999999998 999999999999985 7999999999998642
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
.. ...+.+||+.|||||++.+ .|+.++|||||||++|||+||++||.+.+....+......
T Consensus 184 ~~-----~~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~----------- 244 (290)
T 3fpq_A 184 AS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS----------- 244 (290)
T ss_dssp TT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-----------
T ss_pred CC-----ccCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-----------
Confidence 21 2356799999999999864 6999999999999999999999999876543332211100
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
...+. .....+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 245 --------------~~~~~---~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 245 --------------GVKPA---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp --------------TCCCG---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred --------------CCCCC---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 00111 112346789999999999999999999999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-62 Score=499.81 Aligned_cols=257 Identities=29% Similarity=0.492 Sum_probs=221.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
..+|+++++||+|+||+||+|+++.+|+.||||+++... ....+.+.+|+.+|+.++|||||++++++.. ...
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~ 222 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDE 222 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-----CCE
Confidence 357999999999999999999999999999999996432 2334568899999999999999999999954 356
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|||||||+ |+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+......
T Consensus 223 ~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp EEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred EEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 999999999 589888865 579999999999999999999999999999999999999999999999999998764433
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
. ...+.+||+.|||||++.+ ..|+.++||||||||+|||++|++||.+.+..+.+..|....
T Consensus 302 ~---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~------------- 363 (423)
T 4fie_A 302 P---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL------------- 363 (423)
T ss_dssp C---CBCCCEECTTTCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-------------
T ss_pred c---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-------------
Confidence 2 2356799999999999987 689999999999999999999999999888766555443211
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.+....+..+++++++||.+||+.||++|||++|+|+||||+..
T Consensus 364 ---------------~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 364 ---------------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp ---------------CCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ---------------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 01112345689999999999999999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-63 Score=487.07 Aligned_cols=258 Identities=28% Similarity=0.430 Sum_probs=213.6
Q ss_pred CCeeEeeeeeccCceEEEEEEEc---CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
++|++++.||+|+||+||+|++. .+++.||||++++.........++.+|+.+|+.++|||||++++++.+ .
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-----E 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-----T
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----C
Confidence 57999999999999999999874 468899999997543333334467889999999999999999999954 4
Q ss_pred CcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
..+|||||||+ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 56999999998 69999999999999999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... ...+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|...
T Consensus 179 ~~~---~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~------------ 241 (304)
T 3ubd_A 179 HEK---KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA------------ 241 (304)
T ss_dssp --C---CCCSCCCCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred CCc---cccccccCcccCCHHHhcc--CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC------------
Confidence 222 2356799999999999987 78999999999999999999999999998876655544321
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCcC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLAN 411 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~f~~~~~ 411 (509)
..+ ....+++++.+||.+||++||++||| ++|+++||||+++.+
T Consensus 242 --------------~~~-----~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw 290 (304)
T 3ubd_A 242 --------------KLG-----MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW 290 (304)
T ss_dssp --------------CCC-----CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred --------------CCC-----CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence 001 11357899999999999999999998 589999999987643
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-62 Score=482.38 Aligned_cols=259 Identities=27% Similarity=0.362 Sum_probs=215.3
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
...|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.+|+.++|||||++++++.+ ...
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~-----~~~ 124 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVRE-----GPW 124 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEE-----TTE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEE-----CCE
Confidence 4579999999999999999999999999999999974321 2479999999999999999999943 456
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCC-CeEEeeecccccccCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~-~vkl~DFG~a~~~~~~ 269 (509)
+|||||||+ |+|.+++...+.+++..++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.....
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999998 59999999989999999999999999999999999999999999999999998 6999999999876443
Q ss_pred CCCc--ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 270 APSA--IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 270 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
.... ......+||+.|||||++.+ ..|+.++||||||||+|||++|++||.+.+....+..|..
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~------------ 270 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS------------ 270 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH------------
T ss_pred CcccceecCCccccCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc------------
Confidence 2211 11234689999999999988 7899999999999999999999999988765443333321
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHH-------------hcCCcccCCcCC
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA-------------LADPYFHGLANV 412 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~-------------l~hp~f~~~~~~ 412 (509)
.+.++....+.+++++.+||.+||++||.+|||+.|+ |+|||+.....+
T Consensus 271 ----------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P 332 (336)
T 4g3f_A 271 ----------------EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP 332 (336)
T ss_dssp ----------------SCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred ----------------CCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence 0112223346789999999999999999999999997 679999876543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-60 Score=496.04 Aligned_cols=342 Identities=42% Similarity=0.740 Sum_probs=280.6
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
..++|++++.||+|+||+||+|+++.+++.||||++..........+++.+|+.+|+.++||||+++++++.........
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 34789999999999999999999999999999999987666666778899999999999999999999999877656667
Q ss_pred cEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.+|+||||++++|.+++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+......
T Consensus 131 ~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 131 ELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp CEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred eEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 89999999999999999988899999999999999999999999999999999999999999999999999998754222
Q ss_pred CC------------------------cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh----------
Q 010489 271 PS------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT---------- 316 (509)
Q Consensus 271 ~~------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~---------- 316 (509)
.. ....+.++||++|+|||++... ..|+.++||||||||+|||++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~~~~~~~~~ 289 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence 11 0124567899999999986432 579999999999999999999
Q ss_pred -CCCCCCCCC--------------------hHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCC
Q 010489 317 -GKPLFPGKN--------------------VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNA 375 (509)
Q Consensus 317 -g~~pf~~~~--------------------~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (509)
|+++|++.+ ..+++..|...+|.|+.+.+..+.......++..++......+...++.+
T Consensus 290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (458)
T 3rp9_A 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS 369 (458)
T ss_dssp GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence 788888865 36789999999999999999999888888999888888888888889999
Q ss_pred CHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCCCCccchhHHhhhcCHHHHHHHHHHHHHHhChhhH
Q 010489 376 DPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQML 454 (509)
Q Consensus 376 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~v 454 (509)
++++++||.+||.+||++|||++|+|+||||+++.+...++.......+.+. +...+..+++++.+++|+..++|...
T Consensus 370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~~~~~ 447 (458)
T 3rp9_A 370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYHPEIQ 447 (458)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSC-TTSCCCHHHHHHHHHHHHTTTCTTCC
T ss_pred CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCcc-ccccCCHHHHHHHHHHHHHHhCcccc
Confidence 9999999999999999999999999999999998876655443221122221 23467888999999999999998643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-59 Score=484.60 Aligned_cols=342 Identities=37% Similarity=0.701 Sum_probs=290.2
Q ss_pred cCCCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 109 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 109 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
....++|++++.||+|+||.||+|++..+++.||||+++.........+++.+|+.+|+.++||||+++++++.......
T Consensus 22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence 33467899999999999999999999999999999999876666667788999999999999999999999997765555
Q ss_pred CCcEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 189 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 189 ~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
...+|+||||++++|.+++.....+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 102 ~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 102 FDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred CCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 57799999999999999999888899999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCc-------------------ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-----------CC
Q 010489 269 DAPSA-------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-----------GK 318 (509)
Q Consensus 269 ~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-----------g~ 318 (509)
..... ...+..+||++|+|||++... ..|+.++||||||||+|||++ |.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 32110 123667999999999986442 679999999999999999998 56
Q ss_pred CCCCCCC-----------------hHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHH
Q 010489 319 PLFPGKN-----------------VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH 381 (509)
Q Consensus 319 ~pf~~~~-----------------~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (509)
++|++.+ ..+++..|...+|.|+.+.+..+.......++..++...+.++...++.+++++.+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 340 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence 6676654 46889999999999999999999888888898888888888888888899999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCCCCccchhHHh-hhcCHHHHHHHHHHHHHHhChhh
Q 010489 382 LLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFER-RKLAKDDVREMIYREILEYHPQM 453 (509)
Q Consensus 382 li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~p~~ 453 (509)
||.+||++||++|||++|+|+||||+++.+...++..... +...+++ ..+..+++++++++|+..++|..
T Consensus 341 Ll~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~--~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~ 411 (432)
T 3n9x_A 341 LLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKK--IILPFDDWMVLSETQLRYIFLKEVQSFHPEL 411 (432)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCC--CCCSSCTTCCCCHHHHHHHHHHHHHHHCTTC
T ss_pred HHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCC--CCCChhhcccCCHHHHHHHHHHHHHHhCccc
Confidence 9999999999999999999999999999887766543321 2222233 46788999999999999999863
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-60 Score=476.51 Aligned_cols=285 Identities=26% Similarity=0.433 Sum_probs=220.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEc---CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~ 187 (509)
.++|+++++||+|+||+||+|+++ .+++.||||++... ....++.+|+++|+.+ .||||+++++++.
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~----- 90 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFR----- 90 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEE-----
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEE-----
Confidence 467999999999999999999875 46789999998642 2345678999999998 5999999999984
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC-CCeEEeeeccccc
Q 010489 188 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARV 265 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~-~~vkl~DFG~a~~ 265 (509)
+..++|||||||+ ++|.+++ +.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ECCEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 3456999999998 5899888 359999999999999999999999999999999999999877 8999999999975
Q ss_pred ccCCCCC-------------------------cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCC
Q 010489 266 SFNDAPS-------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL 320 (509)
Q Consensus 266 ~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~p 320 (509)
....... ....+..+||++|||||++.+. ..|+.++||||+|||+|||++|+.|
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCCC
Confidence 4322110 1123456899999999998763 4689999999999999999999999
Q ss_pred C-CCCChHhHHHHHHHhcCCCChhHHHHhhh--------------HHHHHhhhccCCCC---------CCCCCCCCCCCC
Q 010489 321 F-PGKNVVHQLDLMTDLLGTPSTESISRIRN--------------EKARRYLGSMRKKQ---------PVPFSHKFPNAD 376 (509)
Q Consensus 321 f-~~~~~~~~~~~i~~~~g~~~~~~~~~~~~--------------~~~~~~~~~~~~~~---------~~~~~~~~~~~~ 376 (509)
| .+.+..+++..|..++|++.......... ......+....... .......+..++
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 8 56678889999999988654433221100 00000000000000 011123456789
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 377 PLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 377 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
++++|||.+||++||++|||++|+|+||||+++
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-58 Score=467.82 Aligned_cols=330 Identities=41% Similarity=0.777 Sum_probs=279.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc-CCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~-~~~~ 190 (509)
.++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++..... ....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999999999999999997655555667788999999999999999999999976532 2345
Q ss_pred cEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.+|+||||++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 181 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE- 181 (367)
T ss_dssp CCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred eEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc-
Confidence 6799999998899998876 57999999999999999999999999999999999999999999999999999864322
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
.+..+||++|+|||++.+. ..++.++||||||||+|||++|++||.+.+..+++..+...+|.|+.+.+..+..
T Consensus 182 -----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 182 -----MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp -----CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred -----cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 2456899999999988653 5789999999999999999999999999999999999999999999999999888
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCCCCccchhHHh
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFER 430 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 430 (509)
.....++..++......+...++.+++.+.+||.+||..||.+|||++++|+||||+.+.+...++... .+++.+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~---~~~~~~~~ 332 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ---KYDDSFDD 332 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC---CCCCC---
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCC---CCCCChhh
Confidence 888888888887777788888889999999999999999999999999999999999988876665443 35566777
Q ss_pred hhcCHHHHHHHHHHHHHHhChh
Q 010489 431 RKLAKDDVREMIYREILEYHPQ 452 (509)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~p~ 452 (509)
.....+++++.+++++..++|.
T Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~ 354 (367)
T 1cm8_A 333 VDRTLDEWKRVTYKEVLSFKPP 354 (367)
T ss_dssp --CCHHHHHHHHHHHHHTCCC-
T ss_pred hcCCHHHHHHHHHHHHHHhccc
Confidence 7888999999999999999886
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-59 Score=457.56 Aligned_cols=264 Identities=25% Similarity=0.401 Sum_probs=199.6
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc------
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR------ 186 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~------ 186 (509)
++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.+|+.|+|||||++++++.....
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 36999999999999999999999999999999996432 23345678999999999999999999999864331
Q ss_pred -CCCCcEEEEEeccc-ccHHHHHHhCCC---CCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeec
Q 010489 187 -REFKDIYVVFELME-SDLHQVIKANDD---LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 261 (509)
Q Consensus 187 -~~~~~~~lv~e~~~-~~L~~~l~~~~~---l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG 261 (509)
....++|||||||+ |+|.+++..... .++..+..|+.||++||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 12345899999998 689999987654 4556788999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCc---------ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHH
Q 010489 262 LARVSFNDAPSA---------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL 332 (509)
Q Consensus 262 ~a~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 332 (509)
+|+......... ...++.+||+.|||||++.+ ..|+.++||||||||+|||++ ||.+.. +....
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~ 236 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY---PFSTQM--ERVRT 236 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcC--CCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHH
Confidence 998754332211 12345689999999999987 789999999999999999996 775432 22222
Q ss_pred HHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 333 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 333 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
+........+ ..++..++.+.+||.+||+.||++|||+.|+|+||||+++..
T Consensus 237 ~~~~~~~~~p---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 237 LTDVRNLKFP---------------------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HHHHHTTCCC---------------------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred HHHHhcCCCC---------------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 2221111110 011234567889999999999999999999999999987654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-58 Score=470.28 Aligned_cols=335 Identities=40% Similarity=0.741 Sum_probs=263.0
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.+. ||||+++++++.... ...
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~~ 85 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN---DRD 85 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT---SSC
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC---CCE
Confidence 6899999999999999999999999999999999776666677788999999999997 999999999986532 346
Q ss_pred EEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC-
Q 010489 192 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA- 270 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~- 270 (509)
+|+|||||+++|..++.. +.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+......
T Consensus 86 ~~lv~e~~~~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 86 VYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEEEEECCSEEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred EEEEecccCcCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 899999999999999876 479999999999999999999999999999999999999999999999999998653211
Q ss_pred -----------------CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHH
Q 010489 271 -----------------PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLM 333 (509)
Q Consensus 271 -----------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 333 (509)
......+.++||++|+|||++.+. ..|+.++||||||||+|||++|++||.+.+..+++..+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 011123557999999999998753 57899999999999999999999999999999999999
Q ss_pred HHhcCCCChhHHHHhhhHHHHHhhhccCCCC---CCCCCCCC-------------CCCCHHHHHHHHHhccCCCCCCCCH
Q 010489 334 TDLLGTPSTESISRIRNEKARRYLGSMRKKQ---PVPFSHKF-------------PNADPLALHLLERLLAFDPKDRPTA 397 (509)
Q Consensus 334 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-------------~~~~~~~~~li~~~L~~dP~~Rpt~ 397 (509)
...+|.|..+.+..+.......++..+.... ...+...+ ..+++++.+||.+||++||++|||+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 9999999998887665544444433322211 11222222 2678999999999999999999999
Q ss_pred HHHhcCCcccCCcCCCCCCCCCCCCccchhHH-hhhcCHHHHHHHHHHHHHHhChhhH
Q 010489 398 EEALADPYFHGLANVDREPSTQPISKLEFEFE-RRKLAKDDVREMIYREILEYHPQML 454 (509)
Q Consensus 398 ~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~p~~v 454 (509)
+|+|+||||+.+++...++...... ...++ ......+++++.+++++.++.++..
T Consensus 324 ~e~l~Hp~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (388)
T 3oz6_A 324 NDALKHPFVSIFHNPNEEPNCDHII--TIPINDNVKHSIDDYRNLVYSEISRRKRELI 379 (388)
T ss_dssp HHHTTSTTTTTTCCGGGCCCCSSCC--CCC------CCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHhCCHHHHHhcCCccCCCCCCCC--CCCccccccCCHHHHHHHHHHHHHHhhhhhh
Confidence 9999999999988877666544332 22333 3466789999999999988887644
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-58 Score=467.29 Aligned_cols=332 Identities=44% Similarity=0.817 Sum_probs=275.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCC-cCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-~~~~~ 190 (509)
.++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++.... .....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999999999999999999765555566778899999999999999999999986542 23346
Q ss_pred cEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.+|+|||+++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 108 ~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~- 185 (367)
T 2fst_X 108 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE- 185 (367)
T ss_dssp CCEEEEECCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----------
T ss_pred eEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc-
Confidence 6899999999999888865 57999999999999999999999999999999999999999999999999999864321
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
.+..+||++|+|||++.+. ..++.++|||||||++|||++|++||.+.+..+++..+...+|.|..+.+..+..
T Consensus 186 -----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 186 -----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp ----------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred -----CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 2456899999999998753 5789999999999999999999999999999999999999999999999999888
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCCCCccchhHHh
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFER 430 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 430 (509)
.....++..+.......+...++.+++.+.+||.+||..||.+|||++|+|+||||+.+.++..++... .+++.++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~---~~~~~~~~ 336 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD---PYDQSLES 336 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCC---CCCGGGSS
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCC---CCCcchhh
Confidence 888888888877777777777888999999999999999999999999999999999988776655443 35566677
Q ss_pred hhcCHHHHHHHHHHHHHHhChhhH
Q 010489 431 RKLAKDDVREMIYREILEYHPQML 454 (509)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~p~~v 454 (509)
..+..+++++++++|+..++|..+
T Consensus 337 ~~~~~~~~~~~~~~e~~~~~~~~~ 360 (367)
T 2fst_X 337 RDLLIDEWKSLTYDEVISFVPPPL 360 (367)
T ss_dssp CCCCHHHHHHHHHHHHHHCCCCC-
T ss_pred ccCCHHHHHHHHHHHHHHhccCcc
Confidence 788899999999999999988743
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-57 Score=475.32 Aligned_cols=333 Identities=36% Similarity=0.670 Sum_probs=261.3
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc-CCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~-~~~~ 190 (509)
.++|++++.||+|+||+||+|++..+|+.||||++..........+++.+|+.+|+.++||||+++++++..... .+..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999999999999999998665566667889999999999999999999999976532 3456
Q ss_pred cEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.+|+|||||+++|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 141 ~~~lv~E~~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 218 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218 (464)
T ss_dssp EEEEEEECCSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CC
T ss_pred eEEEEEeCCCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc
Confidence 7899999999999888854 49999999999999999999999999999999999999999999999999998653322
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
..+..+||++|+|||++.+ ..|+.++||||||||+|||++|++||.+.+..+++..|...+|.|..+.+..+.
T Consensus 219 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~- 291 (464)
T 3ttj_A 219 ----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ- 291 (464)
T ss_dssp ----CC----CCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC-
T ss_pred ----ccCCCcccccccCHHHHcC--CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc-
Confidence 2356799999999999987 689999999999999999999999999999999999999999999998877664
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCC------------CHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCC
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNA------------DPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPST 418 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~ 418 (509)
.....++...+......+...++.. ++++++||.+||.+||++|||++|+|+||||+.+.++.....
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~~- 370 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEA- 370 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHSC-
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcccccC-
Confidence 3344555444333333333222222 567999999999999999999999999999997765433221
Q ss_pred CCCCccchhHHhhhcCHHHHHHHHHHHHHHhChhhH
Q 010489 419 QPISKLEFEFERRKLAKDDVREMIYREILEYHPQML 454 (509)
Q Consensus 419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~v 454 (509)
.+....+..++++....+++++++++++........
T Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~ 406 (464)
T 3ttj_A 371 PPPQIYDKQLDEREHTIEEWKELIYKEVMNSEEKTK 406 (464)
T ss_dssp CC-----------CCCHHHHHHHHHHHHHC------
T ss_pred CCCccCCcchhhccCCHHHHHHHHHHHHHHhhhccc
Confidence 112234455667778889999999999887665443
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-57 Score=445.68 Aligned_cols=257 Identities=24% Similarity=0.299 Sum_probs=205.8
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
..+++++.++||+|+||+||+|+.. ..||||+++.........+.+.+|+.+|++++|||||++++++.. .
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~ 104 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------D 104 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------S
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------C
Confidence 3468999999999999999999754 359999997655555667889999999999999999999998743 2
Q ss_pred cEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 191 DIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
.+|||||||+ |+|.+++... ..+++..+..|+.||+.||+|||+++||||||||+||||+.++.+||+|||+|+....
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 4799999999 6999999764 5799999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccccccccccccccc-cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
.... ......+||+.|||||++.+. ...|+.++|||||||+||||+||+.||.+.+....+..+...
T Consensus 185 ~~~~-~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~----------- 252 (307)
T 3omv_A 185 WSGS-QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGR----------- 252 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHT-----------
T ss_pred CCcc-eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhc-----------
Confidence 2221 123557899999999998642 246899999999999999999999999886654433322110
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
...+..+....+.+++++.+||.+||+.||++|||+.|+++
T Consensus 253 --------------~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 253 --------------GYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp --------------TCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred --------------CCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 11111223344678899999999999999999999998754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-57 Score=481.86 Aligned_cols=262 Identities=26% Similarity=0.366 Sum_probs=213.4
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHH---HHHHHHHcCCCCcceeeeeecCCCc
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILR---EIKLLRLLRHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~---Ei~~l~~l~h~niv~~~~~~~~~~~ 186 (509)
..++|+++++||+|+||+||+|+++.+|+.||||++++... .......+.+ ++.+++.++|||||+++++|.+
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~--- 263 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--- 263 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC---
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE---
Confidence 35689999999999999999999999999999999964221 1111223333 4566667789999999999954
Q ss_pred CCCCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 187 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 187 ~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
...+|||||||+ |+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus 264 --~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 264 --PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp --SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred --CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeee
Confidence 456999999998 69999999999999999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
..... ..+.+||+.|||||++.+. ..|+.++||||||||+|||++|++||.+.+..+........+
T Consensus 342 ~~~~~-----~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~-------- 407 (689)
T 3v5w_A 342 FSKKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-------- 407 (689)
T ss_dssp CSSCC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH--------
T ss_pred cCCCC-----CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc--------
Confidence 54332 2457999999999998642 579999999999999999999999998754322211111100
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCcC
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLAN 411 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~f~~~~~ 411 (509)
. .. . .....+++++++||.+||+.||.+|++ ++||++||||+++.+
T Consensus 408 ------------~---~~--~---~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 408 ------------T---MA--V---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp ------------H---CC--C---CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred ------------C---CC--C---CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 0 00 0 112357899999999999999999998 799999999998765
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=448.26 Aligned_cols=336 Identities=48% Similarity=0.844 Sum_probs=283.6
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||.||+|.+..+++.||||++... ........+.+|+.+|+.++||||+++++++..........
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 46899999999999999999999999999999999642 23344577889999999999999999999997765555567
Q ss_pred EEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 192 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
+|+||||++++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 105 ~~iv~e~~~~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 183 (364)
T 3qyz_A 105 VYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183 (364)
T ss_dssp EEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEEcccCcCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCC
Confidence 999999999999998875 4699999999999999999999999999999999999999999999999999986543332
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
........+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...+|.+..+.+..+...
T Consensus 184 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 184 HTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp BCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 22223556899999999987552 56899999999999999999999999999999999999999999999988887777
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCCCCccchhHHhh
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERR 431 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (509)
....+....+.....++...++.+++++.+||.+||++||++|||++|+|+||||+.......++.... .+.+..+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~--~~~~~~~~~ 340 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFDMELD 340 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSS--CCCCC----
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCCCC--cCCcccccc
Confidence 777777777777677777777889999999999999999999999999999999998766554443322 233444556
Q ss_pred hcCHHHHHHHHHHHHHHhChh
Q 010489 432 KLAKDDVREMIYREILEYHPQ 452 (509)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~p~ 452 (509)
.+..+++++.++++..++.|.
T Consensus 341 ~~~~~~~~~~~~~e~~~~~~~ 361 (364)
T 3qyz_A 341 DLPKEKLKELIFEETARFQPG 361 (364)
T ss_dssp -CCHHHHHHHHHHHTGGGCC-
T ss_pred cCCHHHHHHHHHHHHHHhhhh
Confidence 678889999999998888775
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=479.25 Aligned_cols=262 Identities=26% Similarity=0.406 Sum_probs=224.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||+||+|+++.+|+.||||++... .......+.+|+.+|+.|+|||||++++++.. ...
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~~ 228 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNE 228 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-----SSE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCE
Confidence 36899999999999999999999999999999999653 33456778899999999999999999999954 456
Q ss_pred EEEEEeccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC--CCeEEeeeccccccc
Q 010489 192 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVSF 267 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~--~~vkl~DFG~a~~~~ 267 (509)
+|||||||+ |+|.+++.. .+.+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 999999998 599998864 4689999999999999999999999999999999999999865 899999999998764
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
... .....+||+.|||||++.+ ..|+.++||||||||+|||++|++||.+.+..+.+..|......
T Consensus 309 ~~~----~~~~~~GT~~y~APEv~~~--~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~-------- 374 (573)
T 3uto_A 309 PKQ----SVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN-------- 374 (573)
T ss_dssp TTS----EEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--------
T ss_pred CCC----ceeeeEECccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCC--------
Confidence 322 2356799999999999988 78999999999999999999999999998876666555432111
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCC
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 413 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 413 (509)
.....++.+++++++||.+||++||.+|||++|+|+||||+....+.
T Consensus 375 -------------------~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 375 -------------------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421 (573)
T ss_dssp -------------------CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred -------------------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence 11223457899999999999999999999999999999998765543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-57 Score=441.76 Aligned_cols=257 Identities=23% Similarity=0.342 Sum_probs=209.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEc-----CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 186 (509)
..+|.+.+.||+|+||+||+|++. .++..||||+++.. .....+.+.+|+++|++++|||||++++++...
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-- 87 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-- 87 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC--
Confidence 357999999999999999999865 36889999999753 344567899999999999999999999999543
Q ss_pred CCCCcEEEEEeccc-ccHHHHHHhC-------------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC
Q 010489 187 REFKDIYVVFELME-SDLHQVIKAN-------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 252 (509)
Q Consensus 187 ~~~~~~~lv~e~~~-~~L~~~l~~~-------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~ 252 (509)
..+|||||||+ |+|.+++... ..+++..+..|+.||+.||+|||+++|+||||||+|||++.+
T Consensus 88 ---~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 ---DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp ---SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred ---CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence 45899999998 6999999764 369999999999999999999999999999999999999999
Q ss_pred CCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHH
Q 010489 253 CKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLD 331 (509)
Q Consensus 253 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~ 331 (509)
+.+||+|||+|+....... .......+||+.|||||++.+ ..|+.++|||||||+||||+| |+.||.+.+..+.+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~--~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 241 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 241 (299)
T ss_dssp GCEEECCCSCHHHHTGGGC-EEETTTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred CcEEECCcccceecCCCCc-eeecCceecChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999986533221 111234579999999999987 789999999999999999998 899999877654443
Q ss_pred HHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 332 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 332 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
.+... ...+ ....+++++.+||.+||+.||++|||++++++ |++.+.
T Consensus 242 ~i~~~-------------------------~~~~-----~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~--~L~~~~ 288 (299)
T 4asz_A 242 CITQG-------------------------RVLQ-----RPRTCPQEVYELMLGCWQREPHMRKNIKGIHT--LLQNLA 288 (299)
T ss_dssp HHHHT-------------------------CCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred HHHcC-------------------------CCCC-----CCccchHHHHHHHHHHcCCChhHCcCHHHHHH--HHHHHH
Confidence 33221 0011 11357889999999999999999999999954 776543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-56 Score=443.27 Aligned_cols=250 Identities=23% Similarity=0.342 Sum_probs=201.2
Q ss_pred CCeeEeeeeeccCceEEEEEEEc-----CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
.+|.+.++||+|+||+||+|+.+ .++..||||+++.. .....+.+.+|+.+|++++|||||++++++...
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~--- 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEG--- 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC---
Confidence 47899999999999999999864 46889999999753 344567899999999999999999999999543
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhC---------------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC
Q 010489 188 EFKDIYVVFELME-SDLHQVIKAN---------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 251 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~---------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~ 251 (509)
..+|||||||+ |+|.+++... +++++.++..|+.||++||+|||+++||||||||+||||+.
T Consensus 116 --~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 116 --RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp --SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred --CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 45899999999 6999998753 35899999999999999999999999999999999999999
Q ss_pred CCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHH
Q 010489 252 DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQL 330 (509)
Q Consensus 252 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~ 330 (509)
++.+||+|||+|+........ ...+..+||+.|||||++.+ ..|+.++|||||||+||||+| |+.||.+.+..+.+
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~--~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~ 270 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270 (329)
T ss_dssp TTEEEECCCC-----------------CCCCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH
T ss_pred CCcEEEcccccceeccCCCcc-eecCcccccccccChhhhcC--CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 999999999999865433221 12245689999999999987 789999999999999999999 89999987765544
Q ss_pred HHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 331 DLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 331 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..+... ...+ ....+++++.+||.+||+.||++|||++|+++
T Consensus 271 ~~i~~g-------------------------~~~~-----~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 271 DCITQG-------------------------RELE-----RPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312 (329)
T ss_dssp HHHHHT-------------------------CCCC-----CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred HHHHcC-------------------------CCCC-----CcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 433221 0111 11357899999999999999999999999987
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-56 Score=438.54 Aligned_cols=252 Identities=21% Similarity=0.350 Sum_probs=207.2
Q ss_pred CCeeEeeeeeccCceEEEEEEEc-----CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
.+++++++||+|+||+||+|... .+++.||||+++... .....+.+.+|+.+|++++|||||++++++...
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~--- 101 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD--- 101 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC---
Confidence 56899999999999999999853 467899999997532 233457789999999999999999999999543
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEEC
Q 010489 188 EFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 250 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~ 250 (509)
..+|||||||+ |+|.+++... ..+++..+..|+.||++||+|||+++||||||||+||||+
T Consensus 102 --~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 102 --QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp --SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred --CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 45899999998 6999999643 3589999999999999999999999999999999999999
Q ss_pred CCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhH
Q 010489 251 ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQ 329 (509)
Q Consensus 251 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~ 329 (509)
.++.+||+|||+|+........ ...+..+||+.|||||++.+ ..|+.++|||||||+||||+| |..||.+.+..+.
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~--~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~ 256 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYY-KLLGNSLLPIRWMAPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 256 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCB-CSSSSSCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred CCCCEEECCcccceeccCCCce-eEecccccCCcccCHHHHhC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999865432221 12345689999999999987 789999999999999999998 8999998776544
Q ss_pred HHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 330 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 330 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
+..+... ...+. ...+++++.+||.+||+.||++|||+.||+++
T Consensus 257 ~~~i~~~-------------------------~~~~~-----p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 257 VEMIRNR-------------------------QVLPC-----PDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHTT-------------------------CCCCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcC-------------------------CCCCC-----cccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4333210 01111 23578899999999999999999999999873
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-54 Score=438.45 Aligned_cols=329 Identities=41% Similarity=0.765 Sum_probs=274.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc-CCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~-~~~~ 190 (509)
.++|++.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++..... ....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999999999999999997655555566788999999999999999999999965432 1223
Q ss_pred cEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.+|+||||++++|.+++. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 121 ~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~- 197 (371)
T 4exu_A 121 DFYLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 197 (371)
T ss_dssp CCEEEEECCCEEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-------
T ss_pred eEEEEEccccccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC-
Confidence 459999999999988874 35999999999999999999999999999999999999999999999999999754322
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....|.+..+.+..+..
T Consensus 198 -----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 198 -----MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred -----cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 2456899999999998753 5789999999999999999999999999999999999999999999988887776
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCCCCccchhHHh
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFER 430 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 430 (509)
.....+...+.......+...++.+++.+.+||.+||+.||++|||++|+|+||||+.+..+..+...+ ..+....+.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~--~~~~~~~~~ 349 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQ--QPFDDSLEH 349 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCS--SCCCCTTSS
T ss_pred hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccc--cCcCcchhh
Confidence 666666666666555555566678899999999999999999999999999999999876654433222 122233455
Q ss_pred hhcCHHHHHHHHHHHHHHhCh
Q 010489 431 RKLAKDDVREMIYREILEYHP 451 (509)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~p 451 (509)
.+...+++++.+++++.++.|
T Consensus 350 ~~~~~~~~~~~~~~~~~~~~~ 370 (371)
T 4exu_A 350 EKLTVDEWKQHIYKEIVNFSP 370 (371)
T ss_dssp CCCCHHHHHHHHHHHHHHCCC
T ss_pred cccchHHHHHHHHHHHHhccc
Confidence 667889999999999988876
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-55 Score=436.15 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=207.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCC-----CcEEEEEEecCcccChhhHHhHHHHHHHHHHcCC-CCcceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHT-----GERVAIKKINDVFEHVSDATRILREIKLLRLLRH-PDIVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~~~~~~~~~~ 185 (509)
.++|++++.||+|+||+||+|.+..+ ++.||||+++... .....+.+.+|+.+|.++.| ||||+++++|..+
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~- 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-
Confidence 46899999999999999999987654 4689999997532 23456778999999999975 8999999998543
Q ss_pred cCCCCcEEEEEeccc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEE
Q 010489 186 RREFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL 248 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NIL 248 (509)
...+|||||||+ |+|.+++... ..+++..+..|+.||++||+|||+++||||||||+|||
T Consensus 141 ---~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp ---TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ---CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 234899999999 6999999753 34899999999999999999999999999999999999
Q ss_pred ECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChH
Q 010489 249 ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVV 327 (509)
Q Consensus 249 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~ 327 (509)
++.++.+||+|||+|+....... ....+..+||+.|||||++.+ ..|+.++|||||||+||||+| |+.||.+.+..
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~--~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred eCCCCCEEECcchhhhhcccCCC-ceeeccccccccccCHHHHhc--CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999987644332 222345689999999999987 789999999999999999998 99999886543
Q ss_pred hHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 328 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 328 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
+.+..+.. .. ...+. ...+++++.+||.+||+.||++|||+.|+++|
T Consensus 295 ~~~~~~i~----------------------~g--~~~~~-----p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 295 EEFCRRLK----------------------EG--TRMRA-----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHH----------------------HT--CCCCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHH----------------------cC--CCCCC-----CccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 32221110 00 01111 13478999999999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=430.12 Aligned_cols=329 Identities=41% Similarity=0.762 Sum_probs=275.3
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc-CCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~-~~~~ 190 (509)
.++|.+.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++..... ....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999999999999999997655555556788999999999999999999999865432 1223
Q ss_pred cEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.+|+||||++++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~- 179 (353)
T 3coi_A 103 DFYLVMPFMQTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 179 (353)
T ss_dssp CCEEEEECCSEEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----
T ss_pred eEEEEeccccCCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC-
Confidence 469999999999888774 35999999999999999999999999999999999999999999999999999764321
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....|.+..+....+..
T Consensus 180 -----~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 180 -----MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ---------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred -----ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 2446899999999988653 5789999999999999999999999999999999999999999999988887777
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCCCCccchhHHh
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFER 430 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 430 (509)
.....++..++......+...++.+++++.+||.+||..||.+|||++++|+||||+.+.....+.... ..+....+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~--~~~~~~~~~ 331 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQ--QPFDDSLEH 331 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCS--SCCCCTTTT
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCC--CCCccchhh
Confidence 666677776666655666667788999999999999999999999999999999999876654433222 223444556
Q ss_pred hhcCHHHHHHHHHHHHHHhCh
Q 010489 431 RKLAKDDVREMIYREILEYHP 451 (509)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~p 451 (509)
..+..+++++.+++++.++.|
T Consensus 332 ~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 3coi_A 332 EKLTVDEWKQHIYKEIVNFSP 352 (353)
T ss_dssp CCCCHHHHHHHHHHHHHTCCC
T ss_pred ccCCHHHHHHHHHHHHHhhcc
Confidence 678889999999999887765
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=427.88 Aligned_cols=333 Identities=43% Similarity=0.802 Sum_probs=268.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+++.++||||+++++++..........
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 46899999999999999999999999999999999642 33345567889999999999999999999987665555677
Q ss_pred EEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 192 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
+|+||||++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 89 ~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (353)
T 2b9h_A 89 VYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167 (353)
T ss_dssp EEEEECCCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEEEEeccCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence 999999999999998876 5799999999999999999999999999999999999999999999999999986543221
Q ss_pred Cc-------ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChh-
Q 010489 272 SA-------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE- 343 (509)
Q Consensus 272 ~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~- 343 (509)
.. ......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+....|.+...
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T 2b9h_A 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246 (353)
T ss_dssp ------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred cccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence 11 012346899999999987542 578999999999999999999999999999989999998888887643
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCCCCc
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISK 423 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~ 423 (509)
....+.......+..........++...++.+++++.+||.+||..||++|||++|+|+||||+.+......+..+++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~ 326 (353)
T 2b9h_A 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPP 326 (353)
T ss_dssp TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCCCCCCG
T ss_pred cccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccccCCCCc
Confidence 22223333344444444444444444556788999999999999999999999999999999998877665554444443
Q ss_pred --cchhHHhhhcCHHHHHHHHHHHHH
Q 010489 424 --LEFEFERRKLAKDDVREMIYREIL 447 (509)
Q Consensus 424 --~~~~~~~~~~~~~~~~~~~~~~~~ 447 (509)
+++...+..+..+++++.+++|+.
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 2b9h_A 327 SFFEFDHYKEALTTKDLKKLIWNEIF 352 (353)
T ss_dssp GGGGGGCCSSCCCHHHHHHHHHHHHT
T ss_pred ceeeecchhhcCCHHHHHHHHHHHhh
Confidence 333334556788899999998874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=423.12 Aligned_cols=290 Identities=40% Similarity=0.678 Sum_probs=234.5
Q ss_pred CCCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 110 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 110 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
+..++|++++.||+|+||+||+|++. +|+.||||++............+.+|+.+++.++||||+++++++.. .
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~ 91 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-----E 91 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC-----S
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc-----C
Confidence 34578999999999999999999985 58999999997544444445678899999999999999999999853 3
Q ss_pred CcEEEEEecccccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 190 KDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 190 ~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
..+|+|||||+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 92 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 92 RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp SCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred CEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 5689999999999999887654 599999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+....+.+..+...++.+....+...
T Consensus 172 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 172 PVR---SYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp CCC------CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred Ccc---cccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence 222 12446899999999998652 56899999999999999999999999999999999999999998877655443
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
....... ..........++....+..++++.+||.+||++||++|||++|+|+||||+++.
T Consensus 248 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 248 QELPLWK-QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp TTSHHHH-SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hccchhh-hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 2211100 001111122233344567889999999999999999999999999999998764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=434.88 Aligned_cols=329 Identities=36% Similarity=0.669 Sum_probs=250.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCC-cCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-~~~~~ 190 (509)
.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... .....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999999999999999999765555556678899999999999999999999986543 23345
Q ss_pred cEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.+|+|||||+++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 104 ~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 181 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181 (371)
T ss_dssp EEEEEEECCSEEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC--------
T ss_pred ceEEEEEcCCCCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccccc
Confidence 789999999999999886 459999999999999999999999999999999999999999999999999998653221
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+++..+...+|.+..+.+..+..
T Consensus 182 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 182 ----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp ------------CTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred ----ccCCceecCCccCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 2345689999999999987 6799999999999999999999999999999999999999999998877665533
Q ss_pred HHHHHhhhccCCCCCCCCCCCC-----CC-------CCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCC
Q 010489 351 EKARRYLGSMRKKQPVPFSHKF-----PN-------ADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPST 418 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~-----~~-------~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~ 418 (509)
. ...+....+......+...+ +. .++++++||.+||..||.+|||++|+|+||||+.+.++......
T Consensus 256 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~ 334 (371)
T 2xrw_A 256 T-VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAP 334 (371)
T ss_dssp H-HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTCC
T ss_pred H-HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCCC
Confidence 2 22222222211111111111 11 15679999999999999999999999999999876553211111
Q ss_pred CCCCccchhHHhhhcCHHHHHHHHHHHHHHhC
Q 010489 419 QPISKLEFEFERRKLAKDDVREMIYREILEYH 450 (509)
Q Consensus 419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (509)
.+ .......+++....+++++.++.++..+.
T Consensus 335 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (371)
T 2xrw_A 335 PP-KIPDKQLDEREHTIEEWKELIYKEVMDLE 365 (371)
T ss_dssp CC-CCCTTTTCCCCCCHHHHHHHHHHHHHHHC
T ss_pred CC-CCCChhhccccCcHHHHHHHHHHHHHHHh
Confidence 11 11122334556678899999999887653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-53 Score=416.36 Aligned_cols=287 Identities=37% Similarity=0.610 Sum_probs=234.5
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-----CCEE
Confidence 58999999999999999999999999999999997654555556778899999999999999999999843 4568
Q ss_pred EEEEecccccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 193 YVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 193 ~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
|+|||||++++.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 99999999988887765 56899999999999999999999999999999999999999999999999999986532222
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCC-CCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL-FPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
.....+||+.|+|||++.+. ..++.++|||||||++|||++|..| |.+.+..+.+..+...++.+..+.+.....
T Consensus 157 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 157 ---CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ---cccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 13456899999999998762 4489999999999999999987765 777888888889999888887765443321
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
.. .+................+.+++.+.+||.+||+.||++|||++|+|+||||+++.
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 233 LP--DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp ST--TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cc--cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 10 00000000011122334457899999999999999999999999999999998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-53 Score=421.30 Aligned_cols=259 Identities=27% Similarity=0.495 Sum_probs=222.3
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++.. ...
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~~ 88 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-----EKT 88 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCE
Confidence 468999999999999999999999999999999997655555667788999999999999999999999844 456
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|+||||++ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 999999997 6999999888899999999999999999999999999999999999999999999999999997653322
Q ss_pred CCcccccccccccccccccccccccCCC-CCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
.....+||++|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 169 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------------- 229 (328)
T 3fe3_A 169 ----KLDAFCGAPPYAAPELFQG--KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG------------- 229 (328)
T ss_dssp ----GGGTTSSSGGGCCHHHHHT--CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------
T ss_pred ----ccccccCCcceeCcccccC--CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Confidence 2356789999999999877 454 57999999999999999999999987765444333221
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 412 (509)
....+ ..+++++.+||.+||..||.+|||++|+++||||+.....
T Consensus 230 -------------~~~~p-----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (328)
T 3fe3_A 230 -------------KYRIP-----FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE 274 (328)
T ss_dssp -------------CCCCC-----TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTT
T ss_pred -------------CCCCC-----CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcc
Confidence 01111 2468899999999999999999999999999999876543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=415.99 Aligned_cols=284 Identities=38% Similarity=0.660 Sum_probs=231.4
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++++.||+|+||.||+|.+ .+|+.||||++............+.+|+.+++.++||||+++++++... ..+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-----CeE
Confidence 5899999999999999999998 6799999999975433333346678999999999999999999998543 468
Q ss_pred EEEEecccccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 193 YVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 193 ~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
|+||||++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 999999999999998764 6799999999999999999999999999999999999999999999999999976532221
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
.....+||+.|+|||++.+. ..++.++|||||||++|||++|++||.+.+..+.+..+...++.+....+.....
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (288)
T 1ob3_A 156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE- 230 (288)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG-
T ss_pred ---ccccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc-
Confidence 12445899999999998652 4689999999999999999999999999998888888888888776554332211
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
...+...+....+.++......+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 231 -LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp -STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred -ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 01111122223344455556678999999999999999999999999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=435.06 Aligned_cols=288 Identities=36% Similarity=0.651 Sum_probs=234.5
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc-CCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~-~~~~ 190 (509)
..+|++.+.||+|+||+||+|++..++. ||+|++..... ...+|+.+|+.++||||+++++++..... .+..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 3579999999999999999999887666 88888753211 12379999999999999999999865432 3344
Q ss_pred cEEEEEecccccHHHHHH----hCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEEC-CCCCeEEeeeccccc
Q 010489 191 DIYVVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDFGLARV 265 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~----~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~-~~~~vkl~DFG~a~~ 265 (509)
.+|+|||||++++...+. ....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+.
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 588999999988766554 356899999999999999999999999999999999999999 799999999999987
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
...... ....+||++|+|||++.+. ..|+.++|||||||++|||++|++||.+.+..+++..+.+.+|+|..+.+
T Consensus 192 ~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 192 LIAGEP----NVSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp CCTTCC----CCSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccCCCC----CcccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 543332 2456899999999998662 46899999999999999999999999999999999999999999999877
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCC-CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCC
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDR 414 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 414 (509)
......... ..++...+.++...+ +.+++++.+||.+||++||.+|||+.|+|+||||+.+.+...
T Consensus 267 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 333 (394)
T 4e7w_A 267 KTMNPNYME---HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEA 333 (394)
T ss_dssp HHHCGGGSS---SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCC
T ss_pred HhhChhhhh---hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccc
Confidence 654322110 112222223333333 348899999999999999999999999999999998876544
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-53 Score=417.75 Aligned_cols=288 Identities=35% Similarity=0.592 Sum_probs=231.8
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc---ChhhHHhHHHHHHHHHHcC---CCCcceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE---HVSDATRILREIKLLRLLR---HPDIVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~---h~niv~~~~~~~~~~ 185 (509)
.++|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+.+++.++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 4689999999999999999999999999999999863221 1111245567777776664 999999999997654
Q ss_pred cCCCCcEEEEEecccccHHHHHHhCCC--CCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccc
Q 010489 186 RREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 263 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~~~L~~~l~~~~~--l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 263 (509)
......+++||||++++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 444446899999999999999987654 999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChh
Q 010489 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (509)
+....... ....+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+..+...++.++..
T Consensus 168 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 168 RIYSYQMA----LTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp TTSTTCCC----SGGGGCCCSSCCHHHHHT--SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cccCCCcc----cCCccccccccCchHHcC--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 86533222 245689999999999877 679999999999999999999999999999999999998888887765
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.+....... ...+....+.+.....+.+++.+.+||.+||++||++|||+.|+|+||||++.
T Consensus 242 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 242 DWPRDVSLP----RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp TSCSSCSSC----GGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hccchhhcc----ccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 433211100 01112222333334456789999999999999999999999999999999763
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-52 Score=412.17 Aligned_cols=289 Identities=36% Similarity=0.651 Sum_probs=229.6
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++.. ...+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-----KRRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-----CCeE
Confidence 58999999999999999999999999999999987654444456778899999999999999999999843 3568
Q ss_pred EEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 193 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 193 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
|+||||+++ +|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp EEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 999999996 5667777777899999999999999999999999999999999999999999999999999986543222
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.............
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 158 ---YYDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp -----------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred ---ccCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence 12456899999999998652 56899999999999999999999999999999999888888887766543332211
Q ss_pred HHHHhhhccCCCC---CCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCC
Q 010489 352 KARRYLGSMRKKQ---PVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 413 (509)
Q Consensus 352 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 413 (509)
. +........ ..+....++.+++.+.+||.+||+.||.+|||++|+|+||||+++.+..
T Consensus 234 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 234 Q---YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295 (311)
T ss_dssp G---GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred c---ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence 1 111111111 1112223467899999999999999999999999999999999876543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-52 Score=418.70 Aligned_cols=261 Identities=28% Similarity=0.456 Sum_probs=221.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccCh----hhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV----SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~----~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
.++|++++.||+|+||.||+|.++.+|+.||||+++...... .....+.+|+.+|+.++||||+++++++..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---- 86 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN---- 86 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe----
Confidence 467999999999999999999999999999999997533221 134678899999999999999999999844
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCC----CeEEeeecc
Q 010489 188 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDFGL 262 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~----~vkl~DFG~ 262 (509)
...+|+|||||+ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 87 -~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 87 -RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp -SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred -CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 456999999997 69999998888999999999999999999999999999999999999998877 799999999
Q ss_pred cccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCCh
Q 010489 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342 (509)
Q Consensus 263 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~ 342 (509)
+........ ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+.......+.
T Consensus 166 a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 239 (361)
T 2yab_A 166 AHEIEDGVE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE 239 (361)
T ss_dssp CEECCTTCC----CCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred ceEcCCCCc----cccCCCCccEECchHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence 987543221 345689999999999987 68999999999999999999999999988766655554432211111
Q ss_pred hHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
..++.+++.+++||.+||..||.+|||+.|+|+||||+...
T Consensus 240 ---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 240 ---------------------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp ---------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred ---------------------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 12345788999999999999999999999999999998653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=417.66 Aligned_cols=289 Identities=34% Similarity=0.615 Sum_probs=219.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||.||+|.+..+|+.||||+++... .......+.+|+.+|+.++||||+++++++.. ...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~ 77 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHT-----ENK 77 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-----TTE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-----CCe
Confidence 368999999999999999999999999999999986432 22234567899999999999999999999854 346
Q ss_pred EEEEEecccccHHHHHHhC------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 192 IYVVFELMESDLHQVIKAN------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~~------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
+|+||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 78 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 78 LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 8999999999999988653 3599999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
...... .....+||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+.+..+.+..+...+|.+....+
T Consensus 158 ~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 158 FGIPVN---TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp TTSCCC---CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred cCCCcc---cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence 533221 12456899999999998752 46899999999999999999999999999999999999998888776554
Q ss_pred HHhhhHHHHHhhhccCCCCCCCC-----CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCC
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPF-----SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 412 (509)
...... ..+...+....+..+ ......+++++.+||.+||+.||++|||++|+|+||||+++...
T Consensus 234 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 234 PSVTKL--PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp GGGGGC--TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred hhhhhh--hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 332210 000000111111110 01123578899999999999999999999999999999887554
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=417.79 Aligned_cols=330 Identities=37% Similarity=0.673 Sum_probs=258.6
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc---------ChhhHHhHHHHHHHHHHcCCCCcceeeeeec
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE---------HVSDATRILREIKLLRLLRHPDIVEIKHIML 182 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---------~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~ 182 (509)
.++|++++.||+|+||.||+|.+.. |..||||++..... .....+.+.+|+.+++.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 5789999999999999999999865 99999999864221 1223477899999999999999999999986
Q ss_pred CCCcCCCCcEEEEEecccccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeec
Q 010489 183 PPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 261 (509)
Q Consensus 183 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG 261 (509)
.........+|+||||++++|.+.+.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 179 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179 (362)
T ss_dssp ECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTT
T ss_pred eccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecC
Confidence 65444556799999999999999887654 79999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCC
Q 010489 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341 (509)
Q Consensus 262 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~ 341 (509)
++........ ....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+.
T Consensus 180 ~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 180 LAREDTADAN----KTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp C-------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccccc----cceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 9975433222 2456899999999988753 5689999999999999999999999999999999999999999999
Q ss_pred hhHHHHhhhHHHHHhhhccCCC-CCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCC
Q 010489 342 TESISRIRNEKARRYLGSMRKK-QPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQP 420 (509)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~ 420 (509)
.+............++...... ....+....+..++.+.+||.+||+.||.+|||+.|+|+||||+.+..+.......
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~- 333 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGL- 333 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTTC-
T ss_pred hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcccccccc-
Confidence 8877666655555554433222 22333444567889999999999999999999999999999999876543221111
Q ss_pred CCccchhHHhhhcCHHHHHHHHHHHHHHhC
Q 010489 421 ISKLEFEFERRKLAKDDVREMIYREILEYH 450 (509)
Q Consensus 421 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (509)
.-.+.+++...+..++++.+..|+.++.
T Consensus 334 --~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 361 (362)
T 3pg1_A 334 --SERFHFDESVTDVYDMHKIFTAEVERFN 361 (362)
T ss_dssp --CCCCCCCTTCCCHHHHHHHHHHHHHHHC
T ss_pred --ccccChhhhhhhHHHHHHHHHHHHHHhc
Confidence 1112334455667788888888887764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=419.33 Aligned_cols=289 Identities=35% Similarity=0.623 Sum_probs=230.3
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+|+.++||||+++++++.. ...+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-----SSCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEee-----CCEE
Confidence 579999999999999999999999999999999864321 1112245579999999999999999999854 3458
Q ss_pred EEEEecccccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 193 YVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 193 ~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
|+||||++++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 76 TLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred EEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 9999999999999987754 599999999999999999999999999999999999999999999999999975432221
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+++..+...+|.|....+......
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 156 ---TYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp ----------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred ---ccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 13456889999999998653 56899999999999999999999999999999999999999999887765544322
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCC
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 412 (509)
...... ..............+.+++++.+||.+||+.||.+|||++|+|+||||.++...
T Consensus 232 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 232 EEFKTY-NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HHHHHT-CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred hhhccc-ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 111111 111111222223345788999999999999999999999999999999887654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-53 Score=417.40 Aligned_cols=274 Identities=23% Similarity=0.233 Sum_probs=192.7
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
.+|.+.++||+|+||+||+|++ +|+.||||+++.. ........+|+..+..++|||||++++++.... .....+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEE
Confidence 4699999999999999999986 5899999999642 112222345666667899999999999986432 122358
Q ss_pred EEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhC--------CeeecCCCCCcEEECCCCCeEEeeeccc
Q 010489 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--------NVFHRDLKPKNILANADCKLKICDFGLA 263 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~--------~ivHrDlKp~NILl~~~~~vkl~DFG~a 263 (509)
|||||||+ |+|.+++... .++++.+..++.|++.||+|||++ +|+||||||+||||+.++++||+|||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 99999998 6999999764 699999999999999999999987 9999999999999999999999999999
Q ss_pred ccccCCCCC-ccccccccccccccccccccccc----CCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcC
Q 010489 264 RVSFNDAPS-AIFWTDYVATRWYRAPELCGSFF----SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338 (509)
Q Consensus 264 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g 338 (509)
+........ .......+||+.|||||++.+.. ..|+.++||||||||||||+||.+||.......... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~-~~~~~~ 234 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDLVPS 234 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-TTTSCS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc-hhcccc
Confidence 875433321 11123468999999999986521 146789999999999999999998875433211000 000000
Q ss_pred CCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.+..+.+ ...+..-..+++.+.......++..+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~--------~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 235 DPSVEEM--------RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SCCHHHH--------HHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cchHHHH--------HHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 0111111 0001000011111111111123456889999999999999999999987
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=413.68 Aligned_cols=259 Identities=25% Similarity=0.441 Sum_probs=219.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++++.||+|+||.||+|+++.+|+.||||++++... .......+.+|+.+|+.++||||+++++++.. ..
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-----~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-----SS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-----CC
Confidence 3589999999999999999999999999999999964321 22345678899999999999999999999954 34
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|+||||++ |+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 6999999998 589999988889999999999999999999999999999999999999999999999999999854322
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
.. .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+.......+...
T Consensus 159 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------- 220 (337)
T 1o6l_A 159 GA---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------- 220 (337)
T ss_dssp TC---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------
T ss_pred CC---cccccccChhhCChhhhcC--CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------
Confidence 22 2355789999999999987 68999999999999999999999999887654443333210
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCcC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLAN 411 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~~ 411 (509)
... + ...+++++.+||.+||+.||.+|| +++|+++||||+++.+
T Consensus 221 -------------~~~--~---p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~ 269 (337)
T 1o6l_A 221 -------------EIR--F---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp -------------CCC--C---CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred -------------CCC--C---CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence 000 0 124688999999999999999999 9999999999987654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=416.32 Aligned_cols=288 Identities=36% Similarity=0.575 Sum_probs=223.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||+||+|++..+++.||||+++...........+.+|+.+|+.++||||+++++++.. ...
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 107 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-----NHR 107 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-----TTE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-----CCE
Confidence 468999999999999999999999999999999997544433445667899999999999999999999843 456
Q ss_pred EEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEEC-----CCCCeEEeeecccccc
Q 010489 192 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-----ADCKLKICDFGLARVS 266 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~-----~~~~vkl~DFG~a~~~ 266 (509)
+|+||||++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 108 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 108 LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 89999999999999999988999999999999999999999999999999999999994 4556999999999865
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
..... .....+||+.|+|||++.+. ..++.++|||||||++|||++|.+||.+.+..+.+..+...++.+....+.
T Consensus 188 ~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 188 GIPIR---QFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp C--------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred CCccc---ccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence 32221 12456889999999998762 458999999999999999999999999999999998888888887765443
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCC-CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
..... ..+...+.......+... ...+++++.+||.+||+.||.+|||++|+|+||||++..
T Consensus 264 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 264 GVTAL--PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp TGGGS--TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhhhh--hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 22110 000000000000000000 012678999999999999999999999999999998764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=420.04 Aligned_cols=259 Identities=23% Similarity=0.407 Sum_probs=215.8
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~ 189 (509)
.++|++++.||+|+||.||+|+++.+|+.||||++++.. ........+.+|+.+|+.+ .||||+++++++.. .
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-----~ 96 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT-----P 96 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe-----C
Confidence 468999999999999999999999999999999996431 1223456678999999988 69999999999954 3
Q ss_pred CcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
..+|+|||||+ |+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 46999999998 59999999888999999999999999999999999999999999999999999999999999975332
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+...
T Consensus 177 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------------ 239 (353)
T 3txo_A 177 NGV---TTATFCGTPDYIAPEILQE--MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND------------ 239 (353)
T ss_dssp ------------CCGGGCCHHHHHH--HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred CCc---cccccCCCcCeEChhhcCC--CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------
Confidence 221 2345789999999999987 67999999999999999999999999988766555444321
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH------HHHhcCCcccCCcC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA------EEALADPYFHGLAN 411 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~------~e~l~hp~f~~~~~ 411 (509)
... + ...+++.+.+||.+||+.||.+||++ +++++||||+++.+
T Consensus 240 --------------~~~--~---p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w 289 (353)
T 3txo_A 240 --------------EVV--Y---PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW 289 (353)
T ss_dssp --------------CCC--C---CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred --------------CCC--C---CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence 000 0 12368899999999999999999998 99999999998754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=426.12 Aligned_cols=260 Identities=28% Similarity=0.467 Sum_probs=220.5
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++++.||+|+||+||+|.++.+|+.||+|++............+.+|+.+|+.++||||+++++++. +...+
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~~~~ 85 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS-----EEGHH 85 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE-----CSSEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE-----ECCEE
Confidence 5799999999999999999999999999999999765444456677899999999999999999999984 44568
Q ss_pred EEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEEC---CCCCeEEeeecccccccC
Q 010489 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN---ADCKLKICDFGLARVSFN 268 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~---~~~~vkl~DFG~a~~~~~ 268 (509)
|+|||||. |+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 86 ~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp EEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 99999998 58999999989999999999999999999999999999999999999998 467899999999976543
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+....+....
T Consensus 166 ~~~---~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~----------- 229 (444)
T 3soa_A 166 EQQ---AWFGFAGTPGYLSPEVLRK--DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA----------- 229 (444)
T ss_dssp TCC---BCCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-----------
T ss_pred CCc---eeecccCCcccCCHHHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC-----------
Confidence 322 2345789999999999987 689999999999999999999999998877655444432211
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.......++.+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 230 ----------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 230 ----------------YDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp ----------------CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred ----------------CCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 111123456789999999999999999999999999999999753
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=424.37 Aligned_cols=288 Identities=35% Similarity=0.625 Sum_probs=232.8
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc-CCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 191 (509)
.+|++++.||+|+||.||+|++..+|+.||||++.... ....+|+.+|+.++||||+++++++..... .+..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 47999999999999999999999999999999986421 123479999999999999999998854321 23345
Q ss_pred EEEEEecccccHHHHHH----hCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC-CCeEEeeecccccc
Q 010489 192 IYVVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVS 266 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~----~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~-~~vkl~DFG~a~~~ 266 (509)
+++||||++++|.+++. ....+++..++.++.||++||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 128 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 78999999998777664 35689999999999999999999999999999999999999965 56899999999865
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
..... ....+||++|+|||++.+. ..|+.++||||||||+|||++|++||.+.+..+++..+.+.+|.|..+.+.
T Consensus 208 ~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 208 VRGEP----NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CTTCC----CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCC----ceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 43322 2456899999999998762 479999999999999999999999999999999999999999999988775
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCC-CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCC
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDR 414 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 414 (509)
...... ..+ .++.....++... .+.+++++++||.+||.+||.+|||+.|+|+||||+.+.+...
T Consensus 283 ~~~~~~-~~~--~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 348 (420)
T 1j1b_A 283 EMNPNY-TEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV 348 (420)
T ss_dssp HHCSCC-CCC--CCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTC
T ss_pred hhChhh-hhh--ccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccc
Confidence 542110 000 0111111112111 2357899999999999999999999999999999998876544
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=420.07 Aligned_cols=286 Identities=33% Similarity=0.672 Sum_probs=231.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc-----
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR----- 186 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~----- 186 (509)
..+|++++.||+|+||+||+|.+..+|+.||||++..... ...+|+.+|+.++||||+++++++.....
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4689999999999999999999999999999999864321 22379999999999999999999854332
Q ss_pred ----------------------------CCCCcEEEEEecccccHHHHHH----hCCCCCHHHHHHHHHHHHhHhhhhhh
Q 010489 187 ----------------------------REFKDIYVVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHT 234 (509)
Q Consensus 187 ----------------------------~~~~~~~lv~e~~~~~L~~~l~----~~~~l~~~~~~~i~~qil~aL~yLH~ 234 (509)
....++++|||||+++|.+.+. ....+++..++.++.||+.||+|||+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp ------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 2345689999999998777664 35689999999999999999999999
Q ss_pred CCeeecCCCCCcEEEC-CCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHH
Q 010489 235 ANVFHRDLKPKNILAN-ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 313 (509)
Q Consensus 235 ~~ivHrDlKp~NILl~-~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~e 313 (509)
+||+||||||+|||++ .++.+||+|||+|+....... ....+||+.|+|||++.+. ..++.++|||||||++||
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC----CCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC----CcCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHHH
Confidence 9999999999999997 688999999999986543332 2456899999999988762 458999999999999999
Q ss_pred HHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCC-CCCCHHHHHHHHHhccCCCC
Q 010489 314 MLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPK 392 (509)
Q Consensus 314 ll~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~ 392 (509)
|++|++||.+.+..+++..+...+|.|..+.+......... ..++......+...+ ...++++.+||.+||+.||.
T Consensus 235 ll~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE---VRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC-----CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccccc---ccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 99999999999999999999999999998876654321110 001111111122112 34788999999999999999
Q ss_pred CCCCHHHHhcCCcccCCcC
Q 010489 393 DRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 393 ~Rpt~~e~l~hp~f~~~~~ 411 (509)
+|||+.|+|+||||+.+.+
T Consensus 312 ~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 312 LRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp GSCCHHHHHTSGGGHHHHH
T ss_pred hCCCHHHHhcCHHHHHHHh
Confidence 9999999999999987654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=414.22 Aligned_cols=259 Identities=29% Similarity=0.482 Sum_probs=220.0
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++.+.||+|+||.||+|.++.+|+.||||++............+.+|+.+++.++||||+++++++.. ....
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~~ 103 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ESFH 103 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCEE
Confidence 47999999999999999999999999999999997654455566788999999999999999999999854 4568
Q ss_pred EEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCC---CeEEeeecccccccC
Q 010489 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARVSFN 268 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~---~vkl~DFG~a~~~~~ 268 (509)
|+|||||. ++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp EEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 99999998 58999998888899999999999999999999999999999999999998654 599999999986543
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
.. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+.......+....
T Consensus 184 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~----------- 246 (362)
T 2bdw_A 184 SE----AWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA----------- 246 (362)
T ss_dssp CC----SCCCSCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-----------
T ss_pred Cc----ccccCCCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 22 1345689999999999987 689999999999999999999999998877544443332211
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.......+..+++++.+||.+||..||.+|||+.++|+||||...
T Consensus 247 ----------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 247 ----------------YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp ----------------CCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred ----------------CCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 001112234678999999999999999999999999999999753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=412.44 Aligned_cols=256 Identities=30% Similarity=0.520 Sum_probs=213.6
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccC-hhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+|+.++||||+++++++... .
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-----T 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----C
Confidence 46899999999999999999999999999999998642211 12235688999999999999999999999543 4
Q ss_pred cEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.+|+||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 83 DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 58999999999999999888899999999999999999999999999999999999999999999999999998653322
Q ss_pred CCcccccccccccccccccccccccCCC-CCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
.....+||+.|+|||++.+ ..+ ++++|||||||++|+|++|+.||.+.......
T Consensus 163 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~------------------- 217 (336)
T 3h4j_B 163 ----FLKTSCGSPNYAAPEVING--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF------------------- 217 (336)
T ss_dssp ----TTCCCTTSTTTSCGGGSCC--SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-------------------
T ss_pred ----ccccccCCcCcCCHHHHcC--CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-------------------
Confidence 2345689999999999877 444 78999999999999999999999765421100
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
..+... .......+++.+.+||.+||..||.+|||++|+++||||+..
T Consensus 218 --------~~i~~~----~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 218 --------KKVNSC----VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp --------CCCCSS----CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred --------HHHHcC----CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 000000 011123478999999999999999999999999999999753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=411.98 Aligned_cols=259 Identities=25% Similarity=0.401 Sum_probs=218.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~ 189 (509)
.++|++++.||+|+||.||+|+++.+|+.||||++++... .......+.+|..++..+ +||||+++++++.. .
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~-----~ 90 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-----K 90 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-----S
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe-----C
Confidence 4689999999999999999999999999999999964311 122345678899999877 89999999999954 3
Q ss_pred CcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
..+|+|||||+ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 56999999997 59999999888999999999999999999999999999999999999999999999999999985432
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+....+...
T Consensus 171 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------ 233 (345)
T 1xjd_A 171 GDA---KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD------------ 233 (345)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred CCC---cccCCCCCcccCChhhhcC--CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC------------
Confidence 221 1355789999999999987 67999999999999999999999999987765444333210
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHH-HHhcCCcccCCcC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE-EALADPYFHGLAN 411 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~-e~l~hp~f~~~~~ 411 (509)
... + ...+++++.+||.+||..||++||++. ++++||||+++.+
T Consensus 234 --------------~~~--~---p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 234 --------------NPF--Y---PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp --------------CCC--C---CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred --------------CCC--C---CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence 000 0 124688999999999999999999998 9999999998754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-51 Score=401.00 Aligned_cols=257 Identities=28% Similarity=0.472 Sum_probs=215.8
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
..+|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~ 91 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVG-----DE 91 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----CE
Confidence 4689999999999999999999999999999999864322 2346688999999999999999999998543 45
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|+|||||+ ++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp EEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 899999997 6899888764 69999999999999999999999999999999999999999999999999998654333
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
.. ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+....
T Consensus 171 ~~---~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~------------- 232 (297)
T 3fxz_A 171 SK---RSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG------------- 232 (297)
T ss_dssp CC---BCCCCSCGGGCCHHHHHC--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-------------
T ss_pred cc---cCCccCCcCccChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence 22 345689999999999887 689999999999999999999999998877654443332110
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.... .....+++.+.+||.+||+.||++|||++|+|+||||+..
T Consensus 233 ------------~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 233 ------------TPEL---QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp ------------SCCC---SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ------------CCCC---CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 0000 1113467889999999999999999999999999999854
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=405.37 Aligned_cols=256 Identities=25% Similarity=0.447 Sum_probs=218.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++++.||+|+||.||+|+++.+|+.||||++++... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-----CC
Confidence 3589999999999999999999999999999999964321 12335667889999999999999999999854 45
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|+||||++ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 6999999998 599999998889999999999999999999999999999999999999999999999999999864321
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+.......+...
T Consensus 160 ------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------------- 218 (318)
T 1fot_A 160 ------TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA------------- 218 (318)
T ss_dssp ------BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-------------
T ss_pred ------cccccCCccccCHhHhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Confidence 234689999999999987 68999999999999999999999999887765444433221
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCcC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLAN 411 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~~ 411 (509)
... + .+..++++.+||.+||..||.+|| +++++++||||+++.+
T Consensus 219 -------------~~~--~---p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~ 267 (318)
T 1fot_A 219 -------------ELR--F---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 267 (318)
T ss_dssp -------------CCC--C---CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred -------------CCC--C---CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence 000 0 134688999999999999999999 9999999999987654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-51 Score=409.56 Aligned_cols=298 Identities=35% Similarity=0.554 Sum_probs=233.5
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc---C
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR---R 187 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~---~ 187 (509)
..++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+++.++||||+++++++..... .
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 4578999999999999999999999999999999986544433444567899999999999999999999865421 1
Q ss_pred CCCcEEEEEecccccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 188 EFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 188 ~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
....+|+||||++++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 14568999999999998888654 57999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCC-CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 267 FNDAP-SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 267 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
..... ........+||+.|+|||++.+. ..++.++|||||||++|||++|.+||.+.+..+.+..+....+.++.+.+
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 253 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 253 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 42221 11223456899999999988652 56899999999999999999999999999999999999988888776554
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKF--PNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
...........+...... ........ ...++.+.+||.+||+.||++|||++|+|+||||....
T Consensus 254 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 254 PNVDNYELYEKLELVKGQ-KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp TTGGGCGGGTSSCCCSSC-CCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred cccccchhhccccccccc-ccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 433221110000000000 00000000 01367899999999999999999999999999997643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=404.07 Aligned_cols=259 Identities=29% Similarity=0.463 Sum_probs=219.2
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccCh----hhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV----SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~----~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
++|++.+.||+|+||.||+|.+..+|+.||||+++...... .....+.+|+.+|+.++||||+++++++..
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 85 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN----- 85 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----
Confidence 57999999999999999999999999999999986532211 235678899999999999999999999854
Q ss_pred CCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCC----CeEEeeeccc
Q 010489 189 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDFGLA 263 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~----~vkl~DFG~a 263 (509)
...+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 356899999997 69999998888999999999999999999999999999999999999999888 7999999999
Q ss_pred ccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChh
Q 010489 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (509)
+....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus 166 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~- 238 (326)
T 2y0a_A 166 HKIDFGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED- 238 (326)
T ss_dssp EECCTTSC----CCCCCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCH-
T ss_pred eECCCCCc----cccccCCcCcCCceeecC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCc-
Confidence 86543221 245689999999999877 68999999999999999999999999987765555544332211111
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
..++.+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 239 --------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 239 --------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp --------------------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred --------------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 1124568889999999999999999999999999999753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=417.67 Aligned_cols=280 Identities=33% Similarity=0.551 Sum_probs=230.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc------CCCCcceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL------RHPDIVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l------~h~niv~~~~~~~~~~ 185 (509)
..+|++++.||+|+||.||+|.+..+++.||||+++.. ......+.+|+.+++.+ .|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-- 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--
Confidence 46899999999999999999999999999999999642 23445677899988887 56799999999844
Q ss_pred cCCCCcEEEEEecccccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCC--eEEeeec
Q 010489 186 RREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--LKICDFG 261 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~--vkl~DFG 261 (509)
...+|+||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||
T Consensus 171 ---~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 171 ---RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp ---TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred ---CCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 35689999999999999998764 5999999999999999999999999999999999999999987 9999999
Q ss_pred ccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCC
Q 010489 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341 (509)
Q Consensus 262 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~ 341 (509)
+|...... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+++..+...+|.|+
T Consensus 248 ~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~ 319 (429)
T 3kvw_A 248 SSCYEHQR------VYTYIQSRFYRAPEVILG--ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319 (429)
T ss_dssp TCEETTCC------CCSSCSCGGGCCHHHHHT--BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred cceecCCc------ccccCCCCCccChHHHhC--CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99754322 234689999999999987 6799999999999999999999999999999999999999999999
Q ss_pred hhHHHHhhhHHHHHhhhccCCCC-----------------------------CCCCCC-CCCCCCHHHHHHHHHhccCCC
Q 010489 342 TESISRIRNEKARRYLGSMRKKQ-----------------------------PVPFSH-KFPNADPLALHLLERLLAFDP 391 (509)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~-~~~~~~~~~~~li~~~L~~dP 391 (509)
.+.+....... .++..-.... ...+.. .....++.+.+||.+||++||
T Consensus 320 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP 397 (429)
T 3kvw_A 320 QKLLDASKRAK--NFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDP 397 (429)
T ss_dssp HHHHHTBTTHH--HHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSST
T ss_pred HHHHHhhhhhh--hccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCCh
Confidence 88776543221 2211100000 000000 011347889999999999999
Q ss_pred CCCCCHHHHhcCCcccCC
Q 010489 392 KDRPTAEEALADPYFHGL 409 (509)
Q Consensus 392 ~~Rpt~~e~l~hp~f~~~ 409 (509)
++|||++|+|+||||+..
T Consensus 398 ~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 398 AVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp TTSCCHHHHHTSTTTC--
T ss_pred hhCCCHHHHhCChhhccC
Confidence 999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=406.06 Aligned_cols=257 Identities=25% Similarity=0.431 Sum_probs=218.6
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+|+.++||||+++++++.. ...
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~ 75 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFES-----MEE 75 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEec-----CCE
Confidence 46899999999999999999999999999999998642 2345668899999999999999999999843 356
Q ss_pred EEEEEeccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC--CCCeEEeeeccccccc
Q 010489 192 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVSF 267 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~--~~~vkl~DFG~a~~~~ 267 (509)
+|+|||||+ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 999999998 58999997654 7999999999999999999999999999999999999997 7899999999998754
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+.........
T Consensus 156 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----- 224 (321)
T 1tki_A 156 PGD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE----- 224 (321)
T ss_dssp TTC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH-----
T ss_pred CCC----ccccccCChhhcCcHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCCh-----
Confidence 322 2345689999999999887 57899999999999999999999999988766555544432211111
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
..++.+++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 225 ----------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 225 ----------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ----------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ----------------------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 1234678899999999999999999999999999999764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=425.31 Aligned_cols=269 Identities=23% Similarity=0.386 Sum_probs=221.6
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|+++++||+|+||+||+|+++.+++.||||++++... .......+.+|+.++..++||||+++++++.. ..
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-----~~ 147 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD-----DN 147 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC-----SS
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CC
Confidence 4689999999999999999999999999999999964211 11122347889999999999999999999954 45
Q ss_pred cEEEEEeccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 191 DIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
.+|+|||||+ |+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 6999999997 699999987 56899999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCcccccccccccccccccccccc---cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
... ......+||+.|+|||++... ...|+.++|||||||++|||++|++||.+.+..+....|....
T Consensus 228 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------- 297 (437)
T 4aw2_A 228 DGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK-------- 297 (437)
T ss_dssp TSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--------
T ss_pred CCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc--------
Confidence 222 123446899999999998621 1568999999999999999999999999888766555543210
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCC--CCCHHHHhcCCcccCCcCCC
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD--RPTAEEALADPYFHGLANVD 413 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~e~l~hp~f~~~~~~~ 413 (509)
....+......+++++++||++||..+|++ |++++|+++||||+++.+..
T Consensus 298 ------------------~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~ 349 (437)
T 4aw2_A 298 ------------------ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN 349 (437)
T ss_dssp ------------------HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred ------------------ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence 001122233568999999999999999988 99999999999999887644
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=414.66 Aligned_cols=268 Identities=22% Similarity=0.384 Sum_probs=213.5
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~ 189 (509)
..+|+++++||+|+||.||+|+++.+++.||||++++... .......+.+|+.+|+.+ +||||+++++++.. .
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-----~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----E 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-----S
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-----C
Confidence 4689999999999999999999999999999999975432 222344578899999887 89999999999954 3
Q ss_pred CcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
..+|+|||||+ |+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 56999999998 58999999888999999999999999999999999999999999999999999999999999985332
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+....+... ......+
T Consensus 206 ~~~---~~~~~~gt~~Y~aPE~l~~--~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~-------~~~~~~~--- 270 (396)
T 4dc2_A 206 PGD---TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-------QNTEDYL--- 270 (396)
T ss_dssp TTC---CBCCCCBCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------------CCHHHH---
T ss_pred CCC---ccccccCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccc-------hhhHHHH---
Confidence 222 2356799999999999987 689999999999999999999999997543211000 0000000
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH------HHHhcCCcccCCcC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA------EEALADPYFHGLAN 411 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~------~e~l~hp~f~~~~~ 411 (509)
...... .... ....+++++.+||.+||+.||.+||++ +|+++||||+++.+
T Consensus 271 ----~~~i~~---~~~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 271 ----FQVILE---KQIR-----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp ----HHHHHH---CCCC-----CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred ----HHHHhc---cccC-----CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 000000 0111 113478999999999999999999985 89999999998754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=410.71 Aligned_cols=289 Identities=37% Similarity=0.605 Sum_probs=228.3
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccCh---hhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV---SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
.++|++++.||+|+||.||+|.+..+|+.||||+++...... .....+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 83 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH----- 83 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-----
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee-----
Confidence 468999999999999999999999999999999986422111 112457799999999999999999999854
Q ss_pred CCcEEEEEecccccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 189 FKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 189 ~~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
...+|+||||++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 84 KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp TTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred CCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 34589999999999998887653 69999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
.... .....+||+.|+|||++.+. ..++.++|||||||++|||++|.+||.+.+..+.+..+....+.+..+.+..
T Consensus 164 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 164 SPNR---AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp SCCC---CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred CCcc---cCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence 3222 13456899999999998652 4589999999999999999999999999999888888888888776654332
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCC
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 412 (509)
.... ..+ ..+......++...+..+++++.+||.+||..||.+|||++|+|+||||++...+
T Consensus 240 ~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~ 301 (346)
T 1ua2_A 240 MCSL--PDY-VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301 (346)
T ss_dssp TTSS--TTC-CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred hccC--ccc-ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence 2110 000 0011111222233446778999999999999999999999999999999875443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=414.72 Aligned_cols=297 Identities=23% Similarity=0.309 Sum_probs=218.3
Q ss_pred CCCCeeEeeeeecc--CceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 111 EASRYQIQEVIGKG--SYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 111 ~~~~y~i~~~lG~G--~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
..++|++++.||+| +||.||+|++..+|+.||||+++...........+.+|+.+++.++||||+++++++..
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 97 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA----- 97 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE-----
Confidence 45789999999999 99999999999999999999997654445566778899999999999999999999954
Q ss_pred CCcEEEEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 189 FKDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
...+|+|||||+ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 346999999998 6899999775 6799999999999999999999999999999999999999999999999999865
Q ss_pred ccCCCCC----cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhc----
Q 010489 266 SFNDAPS----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL---- 337 (509)
Q Consensus 266 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~---- 337 (509)
....... .......+||+.|+|||++.+....|+.++|||||||++|||++|+.||.+.+....+..+....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 4222111 11123348999999999987643578999999999999999999999998876554443222110
Q ss_pred ----CCCChhHHHHhh----hHHHHHhhh---ccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 338 ----GTPSTESISRIR----NEKARRYLG---SMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 338 ----g~~~~~~~~~~~----~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
..+......... .......+. ........+.......+++.+.+||.+||+.||++|||++|+|+||||
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f 337 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence 000000000000 000000000 000000011112335678999999999999999999999999999999
Q ss_pred cCCcCC
Q 010489 407 HGLANV 412 (509)
Q Consensus 407 ~~~~~~ 412 (509)
+.+...
T Consensus 338 ~~~~~~ 343 (389)
T 3gni_B 338 KQIKRR 343 (389)
T ss_dssp GGC---
T ss_pred HHHhhc
Confidence 887543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=405.40 Aligned_cols=268 Identities=22% Similarity=0.392 Sum_probs=215.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~ 189 (509)
.++|++++.||+|+||.||+|+++.+++.||||++++.. ........+.+|+.+++.+ +||||+++++++.. .
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----E 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-----C
Confidence 357999999999999999999999999999999997543 2334566788999999988 89999999999854 3
Q ss_pred CcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
..+|+||||++ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 56999999998 59999998888999999999999999999999999999999999999999999999999999985432
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.......... ......+
T Consensus 163 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-------~~~~~~~--- 227 (345)
T 3a8x_A 163 PGD---TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-------QNTEDYL--- 227 (345)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------------CHHHH---
T ss_pred CCC---cccccCCCccccCccccCC--CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc-------cccHHHH---
Confidence 221 2355789999999999987 688999999999999999999999996532110000 0000000
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH------HHHhcCCcccCCcC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA------EEALADPYFHGLAN 411 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~------~e~l~hp~f~~~~~ 411 (509)
...... .... + ...+++.+.+||.+||..||.+||++ +++++||||+++.+
T Consensus 228 ----~~~i~~---~~~~--~---p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 228 ----FQVILE---KQIR--I---PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp ----HHHHHH---CCCC--C---CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred ----HHHHHc---CCCC--C---CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 000000 0111 1 13578899999999999999999995 89999999988754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=409.31 Aligned_cols=259 Identities=22% Similarity=0.391 Sum_probs=218.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~ 189 (509)
.++|++++.||+|+||.||+|+++.+|+.||||++++... .......+.+|..+|..+ .||+|+++++++.. .
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----~ 93 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----M 93 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-----S
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-----C
Confidence 4689999999999999999999999999999999964321 123456678899999887 79999999999844 3
Q ss_pred CcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
..+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 56999999998 59999999888999999999999999999999999999999999999999999999999999985432
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+....+...
T Consensus 174 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------------ 236 (353)
T 2i0e_A 174 DGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------------ 236 (353)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred CCc---ccccccCCccccChhhhcC--CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC------------
Confidence 221 2345789999999999987 68999999999999999999999999987765444433221
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCcC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLAN 411 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~~ 411 (509)
... + ...+++++.+||.+||..||.+|| +++++++||||+++.+
T Consensus 237 --------------~~~--~---p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w 285 (353)
T 2i0e_A 237 --------------NVA--Y---PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 285 (353)
T ss_dssp --------------CCC--C---CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred --------------CCC--C---CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence 000 0 135788999999999999999999 4799999999997754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-51 Score=407.42 Aligned_cols=288 Identities=33% Similarity=0.592 Sum_probs=227.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+++.++||||+++++++. +...
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KKKR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cCCE
Confidence 46899999999999999999999999999999998655444445667889999999999999999999984 3456
Q ss_pred EEEEEeccccc-HHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~~~-L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|+||||++++ |..++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 89999999965 55555666789999999999999999999999999999999999999999999999999997653322
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
. ......||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+............
T Consensus 179 ~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 179 E---VYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp --------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred c---ccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 1 12446899999999998762 4789999999999999999999999999999888888888888776654332211
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
.....-...-......+....++.+++.+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 1100000000001111222334578999999999999999999999999999999975
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=406.97 Aligned_cols=278 Identities=22% Similarity=0.426 Sum_probs=228.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-----CCCcceeeeeecCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-----HPDIVEIKHIMLPPSR 186 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-----h~niv~~~~~~~~~~~ 186 (509)
.++|+++++||+|+||.||+|++..+++.||||+++.. ........+|+.+++.+. ||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~-- 108 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY-- 108 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET--
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC--
Confidence 57899999999999999999999999999999999632 334556778999999997 99999999998543
Q ss_pred CCCCcEEEEEecccccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC-------------
Q 010489 187 REFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA------------- 251 (509)
Q Consensus 187 ~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~------------- 251 (509)
..+|+||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 109 ---~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 109 ---DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp ---TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred ---CeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence 4689999999889999998764 5999999999999999999999999999999999999975
Q ss_pred ------------CCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCC
Q 010489 252 ------------DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKP 319 (509)
Q Consensus 252 ------------~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~ 319 (509)
++.+||+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~ 257 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILN--LGWDVSSDMWSFGCVLAELYTGSL 257 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccccCCCCEEEEeccCceecCCC------CcCccCcccccCcHHHcC--CCCCCccchHHHHHHHHHHHHCCC
Confidence 789999999999864322 134689999999999987 689999999999999999999999
Q ss_pred CCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCC-----------------CCCCCHHHHHH
Q 010489 320 LFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHK-----------------FPNADPLALHL 382 (509)
Q Consensus 320 pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~l 382 (509)
||.+.+..+.+..+....+.++...+..........+...... ...+... ....++.+.+|
T Consensus 258 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 335 (360)
T 3llt_A 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDEL--KLAWPENASSINSIKHVKKCLPLYKIIKHELFCDF 335 (360)
T ss_dssp SCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTT--EECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHH
T ss_pred CCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccc--eecCcccccchhhhhhhhhcccccccchHHHHHHH
Confidence 9999999999999999988888766554332211111110000 0000000 01134778899
Q ss_pred HHHhccCCCCCCCCHHHHhcCCccc
Q 010489 383 LERLLAFDPKDRPTAEEALADPYFH 407 (509)
Q Consensus 383 i~~~L~~dP~~Rpt~~e~l~hp~f~ 407 (509)
|.+||+.||.+|||++|+|+||||+
T Consensus 336 i~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 336 LYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHhcCChhhCCCHHHHhcCcccC
Confidence 9999999999999999999999995
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=407.68 Aligned_cols=256 Identities=22% Similarity=0.377 Sum_probs=218.6
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++++.||+|+||.||+|+++.+|+.||||++++.. ........+.+|+.+|+.++||||+++++++.. ..
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~ 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----NS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-----CC
Confidence 468999999999999999999999999999999986421 122345678899999999999999999999854 35
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|+||||++ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 6999999997 699999998889999999999999999999999999999999999999999999999999999865322
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+.......+...
T Consensus 195 ------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------- 253 (350)
T 1rdq_E 195 ------TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------------- 253 (350)
T ss_dssp ------BCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------
T ss_pred ------cccccCCccccCHHHhcC--CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC-------------
Confidence 234689999999999987 68999999999999999999999999887755444433221
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCcC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLAN 411 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~f~~~~~ 411 (509)
... + ...+++.+.+||.+||+.||.+||+ ++++++||||+++.+
T Consensus 254 -------------~~~--~---p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 254 -------------KVR--F---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp -------------CCC--C---CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred -------------CCC--C---CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 000 1 1346889999999999999999998 999999999987643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-51 Score=417.16 Aligned_cols=266 Identities=24% Similarity=0.338 Sum_probs=217.6
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
..++|++++.||+|+||.||+|+++.+++.||||++++... .......+.+|+.+++.++||||+++++++.. .
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~ 141 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-----D 141 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----C
Confidence 35689999999999999999999999999999999864211 11123457789999999999999999999954 4
Q ss_pred CcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
..+|+|||||+ |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 56999999997 689998865 4799999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCccccccccccccccccccccccc--CCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
.. .......+||+.|+|||++.+.. ..|+.++|||||||++|||++|++||.+.+.......|.....
T Consensus 221 ~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-------- 290 (410)
T 3v8s_A 221 EG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN-------- 290 (410)
T ss_dssp TS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--------
T ss_pred CC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc--------
Confidence 22 11234578999999999987621 1278999999999999999999999998886665554432100
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCC--CCCHHHHhcCCcccCCcC
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD--RPTAEEALADPYFHGLAN 411 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~e~l~hp~f~~~~~ 411 (509)
. ... .....+++++++||.+||..+|.+ ||+++|+++||||+++.+
T Consensus 291 ------------~----~~~---p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w 338 (410)
T 3v8s_A 291 ------------S----LTF---PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 338 (410)
T ss_dssp ------------H----CCC---CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred ------------c----ccC---CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence 0 000 012357899999999999999988 999999999999998754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=410.42 Aligned_cols=263 Identities=25% Similarity=0.412 Sum_probs=216.8
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|+.++||||+++++++.. ..
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD-----EE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----CC
Confidence 368999999999999999999999999999999986422 122345678899999999999999999999954 34
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|+|||||. |+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 6999999997 589999998889999999999999999999999999999999999999999999999999999865332
Q ss_pred CCCcccccccccccccccccccccc-cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
. .....+||+.|+|||++.+. ...|+.++|||||||++|||++|+.||.+.........+.. +
T Consensus 169 ~----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~------------~ 232 (384)
T 4fr4_A 169 T----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT------------F 232 (384)
T ss_dssp C----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH------------H
T ss_pred C----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH------------H
Confidence 2 23567899999999998642 14589999999999999999999999986543221111110 0
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-HHHHhcCCcccCCcC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-AEEALADPYFHGLAN 411 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-~~e~l~hp~f~~~~~ 411 (509)
.. .. . .....+++.+.+||.+||+.||.+||+ ++++++||||+++.+
T Consensus 233 --------~~---~~--~---~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 233 --------ET---TV--V---TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp --------HH---CC--C---CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred --------hh---cc--c---CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 00 00 0 011356889999999999999999998 999999999987754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=407.42 Aligned_cols=292 Identities=35% Similarity=0.612 Sum_probs=224.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc--CCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR--REF 189 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~--~~~ 189 (509)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+|++.++.++||||+++++++..... ...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 368999999999999999999999999999999985422 222345678888899999999999999865322 223
Q ss_pred CcEEEEEecccccHHHHHH----hCCCCCHHHHHHHHHHHHhHhhhhh--hCCeeecCCCCCcEEECC-CCCeEEeeecc
Q 010489 190 KDIYVVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIH--TANVFHRDLKPKNILANA-DCKLKICDFGL 262 (509)
Q Consensus 190 ~~~~lv~e~~~~~L~~~l~----~~~~l~~~~~~~i~~qil~aL~yLH--~~~ivHrDlKp~NILl~~-~~~vkl~DFG~ 262 (509)
..+|+||||++++|...+. ....+++..+..++.||+.||.||| +.||+||||||+|||++. ++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 3478999999998766554 4567999999999999999999999 999999999999999997 89999999999
Q ss_pred cccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCCh
Q 010489 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342 (509)
Q Consensus 263 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~ 342 (509)
++....... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+...++.++.
T Consensus 179 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3e3p_A 179 AKKLSPSEP----NVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253 (360)
T ss_dssp CBCCCTTSC----CCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ceecCCCCC----cccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence 986543332 2456899999999998652 45899999999999999999999999999999999999999999998
Q ss_pred hHHHHhhhHHHHHhhhccCCCCCCCCC----CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCC
Q 010489 343 ESISRIRNEKARRYLGSMRKKQPVPFS----HKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDR 414 (509)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 414 (509)
+.+..+........ .......++. ......++++.+||.+||+.||.+|||+.|+|+||||+++.....
T Consensus 254 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 326 (360)
T 3e3p_A 254 EVLRKLNPSHTDVD---LYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT 326 (360)
T ss_dssp HHHHHHCTTCCCGG---GGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred HHHHhcccchhhcc---ccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence 87765532111000 0011111111 122236788999999999999999999999999999998876544
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=416.66 Aligned_cols=270 Identities=22% Similarity=0.337 Sum_probs=219.1
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
..++|++++.||+|+||.||+|+++.+|+.||||++++.. ........+.+|+.++..++||||+++++++.. .
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-----~ 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD-----E 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC-----S
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----C
Confidence 3468999999999999999999999999999999996421 112233457889999999999999999999954 4
Q ss_pred CcEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 190 KDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
..+|+|||||+ |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence 56999999997 6999999875 479999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcccccccccccccccccccccc-----cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCCh
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~ 342 (509)
.... ......+||+.|+|||++... ...|+.++|||||||++|||++|++||.+.+..+....|....
T Consensus 214 ~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~----- 286 (412)
T 2vd5_A 214 ADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK----- 286 (412)
T ss_dssp TTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-----
T ss_pred CCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----
Confidence 3221 112346899999999998631 1468999999999999999999999999887665554443210
Q ss_pred hHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCC---CCHHHHhcCCcccCCcCCCC
Q 010489 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR---PTAEEALADPYFHGLANVDR 414 (509)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---pt~~e~l~hp~f~~~~~~~~ 414 (509)
. ...+......+++++++||.+||. +|.+| |+++|+++||||+++.+...
T Consensus 287 ---------------~------~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 287 ---------------E------HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp ---------------H------HCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred ---------------c------CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 0 000111123578999999999999 99998 59999999999998876544
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=408.43 Aligned_cols=259 Identities=27% Similarity=0.443 Sum_probs=210.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHH-HHHcCCCCcceeeeeecCCCcCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKL-LRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~-l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
.++|++++.||+|+||.||+|+++.+++.||||++++... .......+.+|..+ ++.++||||+++++++.. .
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~-----~ 111 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-----A 111 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-----S
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-----C
Confidence 4689999999999999999999999999999999965322 22334566777776 577899999999999954 3
Q ss_pred CcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
..+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 56999999998 58999998888999999999999999999999999999999999999999999999999999986433
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+..+....+...
T Consensus 192 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------------ 254 (373)
T 2r5t_A 192 HNS---TTSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK------------ 254 (373)
T ss_dssp CCC---CCCSBSCCCCCCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS------------
T ss_pred CCC---ccccccCCccccCHHHhCC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc------------
Confidence 222 1345789999999999987 68999999999999999999999999987765544433220
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH----HHHhcCCcccCCcC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA----EEALADPYFHGLAN 411 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~e~l~hp~f~~~~~ 411 (509)
+.. ..+.+++.+.+||.+||+.||.+||++ .++++||||+++.+
T Consensus 255 ----------------~~~---~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w 302 (373)
T 2r5t_A 255 ----------------PLQ---LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINW 302 (373)
T ss_dssp ----------------CCC---CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred ----------------ccC---CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCH
Confidence 000 113578899999999999999999986 79999999998765
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=399.79 Aligned_cols=297 Identities=42% Similarity=0.649 Sum_probs=229.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCC------
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS------ 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~------ 185 (509)
.++|++++.||+|+||.||+|.+..+++.||||++.. ........+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL--TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEEC--CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEec--CChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 4789999999999999999999999999999999864 23445677889999999999999999999885432
Q ss_pred ---cCCCCcEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEEC-CCCCeEEeeec
Q 010489 186 ---RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDFG 261 (509)
Q Consensus 186 ---~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~-~~~~vkl~DFG 261 (509)
..+...+|+||||++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 88 ~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg 166 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFG 166 (320)
T ss_dssp ---CCSCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred cccccccCceeEEeeccCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCc
Confidence 133467899999999999998864 5799999999999999999999999999999999999997 56799999999
Q ss_pred ccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCC
Q 010489 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341 (509)
Q Consensus 262 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~ 341 (509)
+++................||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+.+..+.+..+....+.+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245 (320)
T ss_dssp TCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred cccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 998654332222223455789999999987542 5789999999999999999999999999998888888877776666
Q ss_pred hhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCC
Q 010489 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 413 (509)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 413 (509)
.+....+.... ..++.........++....+.+++++.+||.+||+.||.+|||++++|+||||+.+..+.
T Consensus 246 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 246 EEDRQELLSVI-PVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp HHHHHHHHTTS-CHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred hhhhhhhhhcC-cccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence 55443322110 011111111222233334467899999999999999999999999999999998765443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=387.48 Aligned_cols=263 Identities=29% Similarity=0.489 Sum_probs=222.1
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-----CCE
Confidence 468999999999999999999999999999999997654555566788899999999999999999999843 345
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCC---eEEeeeccccccc
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLARVSF 267 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~---vkl~DFG~a~~~~ 267 (509)
.|+||||++ ++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 899999998 589999988888999999999999999999999999999999999999987665 9999999997653
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 160 ~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---------- 223 (284)
T 3kk8_A 160 DSEA----WHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA---------- 223 (284)
T ss_dssp SSCB----CCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC----------
T ss_pred cCcc----ccCCCCCcCCcCchhhcC--CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcc----------
Confidence 3221 245689999999999887 678999999999999999999999998877554443332211
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCC
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 412 (509)
.......+..+++++.+||.+||+.||++|||++|+|+||||++....
T Consensus 224 -----------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 271 (284)
T 3kk8_A 224 -----------------YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERV 271 (284)
T ss_dssp -----------------CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCG
T ss_pred -----------------ccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhH
Confidence 011112335678999999999999999999999999999999875443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=399.32 Aligned_cols=258 Identities=28% Similarity=0.461 Sum_probs=207.9
Q ss_pred CCeeEeeeeeccCceEEEEEEEc---CCCcEEEEEEecCccc--ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFE--HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
++|++++.||+|+||.||+|++. .+|+.||||++++... .......+.+|+.+|+.++||||+++++++..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---- 92 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT---- 92 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC----
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc----
Confidence 57999999999999999999985 6899999999975321 22344567889999999999999999999854
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 188 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
...+|+|||||+ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 93 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 93 -GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp -SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred -CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 356999999998 689999988888999999999999999999999999999999999999999999999999999754
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
..... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+...
T Consensus 172 ~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---------- 236 (327)
T 3a62_A 172 IHDGT---VTHTFCGTIEYMAPEILMR--SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC---------- 236 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT----------
T ss_pred ccCCc---cccccCCCcCccCHhhCcC--CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC----------
Confidence 32221 1245689999999999877 67899999999999999999999999987765444433221
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCcC
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLAN 411 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~~ 411 (509)
... ..+.+++.+.+||.+||..||.+|| +++++++||||+++.+
T Consensus 237 ----------------~~~-----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 237 ----------------KLN-----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp ----------------CCC-----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred ----------------CCC-----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence 000 1134688999999999999999999 8999999999987643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=404.06 Aligned_cols=260 Identities=31% Similarity=0.465 Sum_probs=201.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||+||+|++..+++.||||++..... ....+.+|+.+++.++||||+++++++... ..
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 90 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTP-----TH 90 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeC-----CE
Confidence 4689999999999999999999999999999999964322 235577999999999999999999999543 45
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCC--eEEeeecccccccC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARVSFN 268 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~--vkl~DFG~a~~~~~ 268 (509)
+|+|||||+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 91 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 91 LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 899999997 599999988889999999999999999999999999999999999999987765 99999999974322
Q ss_pred CCCCcccccccccccccccccccccccCCCCCc-eeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPA-IDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
... ....+||+.|+|||++.+ ..++.+ +|||||||++|+|++|+.||.+.........+.. .
T Consensus 171 ~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~-----------~ 233 (361)
T 3uc3_A 171 HSQ----PKSTVGTPAYIAPEVLLR--QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ-----------R 233 (361)
T ss_dssp --------------CTTSCHHHHHC--SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH-----------H
T ss_pred cCC----CCCCcCCCCcCChhhhcC--CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH-----------H
Confidence 221 244689999999999876 455544 8999999999999999999987553222211110 0
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
... ..... .....+++.+.+||.+||..||.+|||+.|+++||||....
T Consensus 234 --------~~~---~~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 282 (361)
T 3uc3_A 234 --------ILS---VKYSI---PDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282 (361)
T ss_dssp --------HHT---TCCCC---CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred --------Hhc---CCCCC---CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence 000 00000 01124689999999999999999999999999999996543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=398.99 Aligned_cols=264 Identities=27% Similarity=0.387 Sum_probs=212.6
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||.||+|++..+++.||||++..... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~ 79 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNI 79 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEec-----CCe
Confidence 4689999999999999999999999999999999864321 2234668899999999999999999999854 456
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.|+|||||+ ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 899999998 5899999888889999999999999999999999999999999999999999999999999997653222
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
. .......+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+.........
T Consensus 160 ~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~---------------- 221 (323)
T 3tki_A 160 R-ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW---------------- 221 (323)
T ss_dssp E-ECCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHH----------------
T ss_pred c-ccccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH----------------
Confidence 1 1123456899999999998762 334778999999999999999999998755322111000
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
.. .. .....+..+++.+.+||.+||..||.+|||++|+++||||+....
T Consensus 222 ------~~---~~---~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 222 ------KE---KK---TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp ------HT---TC---TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred ------hc---cc---ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence 00 00 001123457889999999999999999999999999999986543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=397.80 Aligned_cols=291 Identities=35% Similarity=0.593 Sum_probs=234.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEc-CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc---CCCCcceeeeeecCCCcC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDT-HTGERVAIKKINDVFEHVSDATRILREIKLLRLL---RHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~-~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~niv~~~~~~~~~~~~ 187 (509)
.++|++++.||+|+||.||+|.+. .+|+.||||+++...........+.+|+.+++.+ .||||+++++++......
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 368999999999999999999995 6789999999864332222233566788877766 899999999998633223
Q ss_pred CCCcEEEEEecccccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 188 EFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 188 ~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
....+|+||||++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 90 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred CCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 456789999999999999998754 499999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+....+
T Consensus 170 ~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (326)
T 1blx_A 170 YSFQM----ALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243 (326)
T ss_dssp CCGGG----GGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred ccCCC----CccccccccceeCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence 43221 2345689999999999887 67999999999999999999999999999988888888888887766543
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCC
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 412 (509)
....... ...+......+.....+.+++.+.+||.+||..||.+|||+.++|+||||+++...
T Consensus 244 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 244 PRDVALP----RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306 (326)
T ss_dssp CTTCSSC----GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccc----hhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence 3211000 00111122233444556789999999999999999999999999999999877543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=405.37 Aligned_cols=259 Identities=27% Similarity=0.428 Sum_probs=217.6
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||.||+|.+..+|+.||+|++... .......+.+|+.+|+.++||||+++++++.. ...
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~ 122 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYE 122 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SSE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-----CCE
Confidence 35799999999999999999999999999999998643 23345678899999999999999999999954 456
Q ss_pred EEEEEeccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC--CCCeEEeeeccccccc
Q 010489 192 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVSF 267 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~--~~~vkl~DFG~a~~~~ 267 (509)
+|+|||||+ ++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 999999998 58999887654 7999999999999999999999999999999999999974 4779999999998754
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
.... ....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+.+..+....
T Consensus 203 ~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~---------- 266 (387)
T 1kob_A 203 PDEI----VKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD---------- 266 (387)
T ss_dssp TTSC----EEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC----------
T ss_pred CCcc----eeeeccCCCccCchhccC--CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence 3221 234589999999999987 678999999999999999999999999877655444332210
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
.......+..+++++.+||.+||..||.+|||+.|+|+||||++..
T Consensus 267 -----------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 267 -----------------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp -----------------CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred -----------------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 0111223456889999999999999999999999999999998643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=403.64 Aligned_cols=259 Identities=27% Similarity=0.435 Sum_probs=210.5
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc---cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF---EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
++|++.+.||+|+||.||+|.++.+|+.||||++.... ........+.+|+.+++.++||||+++++++.. .
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~ 98 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS-----D 98 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----C
Confidence 47999999999999999999999999999999985321 111235678899999999999999999999843 4
Q ss_pred CcEEEEEeccc-ccHHHHHHhC----CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCC---eEEeeec
Q 010489 190 KDIYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFG 261 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~---vkl~DFG 261 (509)
..+|+|||||+ ++|.+.+... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 56999999998 5888777543 35899999999999999999999999999999999999987655 9999999
Q ss_pred ccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCC
Q 010489 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341 (509)
Q Consensus 262 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~ 341 (509)
++........ .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+... .....+....
T Consensus 179 ~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~~~---- 248 (351)
T 3c0i_A 179 VAIQLGESGL---VAGGRVGTPHFMAPEVVKR--EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGK---- 248 (351)
T ss_dssp TCEECCTTSC---BCCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHHTC----
T ss_pred ceeEecCCCe---eecCCcCCcCccCHHHHcC--CCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHcCC----
Confidence 9986543221 2345689999999999987 6789999999999999999999999987532 1222111110
Q ss_pred hhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.......++.+++.+.+||.+||..||++|||+.++|+||||+..
T Consensus 249 -----------------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 249 -----------------------YKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp -----------------------CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred -----------------------CCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 000011224578899999999999999999999999999999764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-50 Score=420.98 Aligned_cols=260 Identities=33% Similarity=0.533 Sum_probs=218.6
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++.. ...+
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~ 96 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SSSF 96 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-----CCEE
Confidence 57999999999999999999999999999999996543333456778999999999999999999999854 4569
Q ss_pred EEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEEC---CCCCeEEeeecccccccC
Q 010489 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN---ADCKLKICDFGLARVSFN 268 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~---~~~~vkl~DFG~a~~~~~ 268 (509)
|+|||||. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999998 58999998888999999999999999999999999999999999999995 456799999999986543
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... ....+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+......
T Consensus 177 ~~~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--------- 240 (486)
T 3mwu_A 177 NTK----MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA--------- 240 (486)
T ss_dssp C--------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---------
T ss_pred CCc----cCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 221 345689999999999875 5899999999999999999999999988766555444321100
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
.....+..+++++.+||.+||..||.+|||+.++|+||||+....
T Consensus 241 ------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 241 ------------------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp ------------------SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred ------------------CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 011223467899999999999999999999999999999987643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=395.11 Aligned_cols=252 Identities=27% Similarity=0.304 Sum_probs=205.8
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|+++++||+|+||+||+|++..+|+.||||++..............+|+..+..+ .||||+++++++. +...
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence 479999999999999999999999999999999876555555556667777776665 8999999999984 3456
Q ss_pred EEEEEecccccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|+||||++++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred EEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 9999999999999888764 469999999999999999999999999999999999999999999999999997653322
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
. .....||+.|+|||++.+ .++.++|||||||++|||++|..||.+......+ .. +..+
T Consensus 212 ~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~---~~--~~~~--------- 270 (311)
T 3p1a_A 212 A----GEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL---RQ--GYLP--------- 270 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHH---TT--TCCC---------
T ss_pred C----CcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH---hc--cCCC---------
Confidence 2 234579999999999865 6899999999999999999998776553221111 00 0000
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
......+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 271 ------------------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 271 ------------------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp ------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred ------------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 0011356889999999999999999999999999999974
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=392.94 Aligned_cols=259 Identities=27% Similarity=0.454 Sum_probs=219.2
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccCh----hhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV----SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~----~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
++|++.+.||+|+||.||+|.+..+|+.||||+++...... .....+.+|+.+++.++||||+++++++..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 86 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN----- 86 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence 57999999999999999999999999999999986532221 135678899999999999999999999844
Q ss_pred CCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCC----CeEEeeeccc
Q 010489 189 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDFGLA 263 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~----~vkl~DFG~a 263 (509)
...+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 356899999997 69999998888899999999999999999999999999999999999999888 7999999999
Q ss_pred ccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChh
Q 010489 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (509)
........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus 167 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~- 239 (321)
T 2a2a_A 167 HEIEDGVE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE- 239 (321)
T ss_dssp EECCTTCC----CCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH-
T ss_pred eecCcccc----ccccCCCCCccCcccccC--CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh-
Confidence 86543322 245679999999999877 68899999999999999999999999987765555444332211111
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
..+...++.+.+||.+||..||++|||++|+|+||||...
T Consensus 240 --------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 240 --------------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp --------------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred --------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 1123567889999999999999999999999999999764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=420.31 Aligned_cols=259 Identities=31% Similarity=0.490 Sum_probs=214.2
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++++.||+|+||+||+|+++.++..||||++............+.+|+.+|+.++||||+++++++.. ...+
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~ 111 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-----KRNY 111 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCEE
Confidence 47999999999999999999999999999999997644333445678899999999999999999999944 4568
Q ss_pred EEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC---CCeEEeeecccccccC
Q 010489 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVSFN 268 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~---~~vkl~DFG~a~~~~~ 268 (509)
|+|||||. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||++.....
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 99999998 5899999888899999999999999999999999999999999999999764 4599999999987543
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
.. .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+.....
T Consensus 192 ~~----~~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~---------- 254 (494)
T 3lij_A 192 QK----KMKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKY---------- 254 (494)
T ss_dssp TB----CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----------
T ss_pred Cc----cccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----------
Confidence 22 1345689999999999864 689999999999999999999999998876555444432111
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
......+..+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 255 -----------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 255 -----------------TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp -----------------CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred -----------------CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 111223456889999999999999999999999999999997643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=418.12 Aligned_cols=259 Identities=26% Similarity=0.440 Sum_probs=209.5
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++++.||+|+||.||+|.+..+|+.||||+++... ........+.+|+.+|+.++||||+++++++.. ..
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-----~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----TT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----CC
Confidence 468999999999999999999999999999999986432 122344667889999999999999999999844 34
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhh-CCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
.+|+|||||+ ++|.+++...+.+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+|+....
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 6899999998 5899999888899999999999999999999998 9999999999999999999999999999975432
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+.......+...
T Consensus 302 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------ 364 (446)
T 4ejn_A 302 DGA---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------------ 364 (446)
T ss_dssp --------CCSSSCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred CCc---ccccccCCccccCHhhcCC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC------------
Confidence 221 2355789999999999977 68999999999999999999999999887765444433211
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCcC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLAN 411 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~~ 411 (509)
... ....+++++.+||.+||+.||.+|| +++|+++||||+++..
T Consensus 365 --------------~~~-----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~ 413 (446)
T 4ejn_A 365 --------------EIR-----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW 413 (446)
T ss_dssp --------------CCC-----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred --------------CCC-----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence 000 1134688999999999999999999 9999999999987643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=416.39 Aligned_cols=291 Identities=34% Similarity=0.586 Sum_probs=212.9
Q ss_pred CCeeE-eeeeeccCceEEEEEEEc--CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 113 SRYQI-QEVIGKGSYGVVGSAVDT--HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 113 ~~y~i-~~~lG~G~~g~V~~~~~~--~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
+.|++ .++||+|+||.||+|+++ .+++.||||++.... ....+.+|+.+|+.++||||+++++++... ..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~ 92 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSH---AD 92 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCCCTTBCCCCEEEEET---TT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcCCCCeeeEeeEEecC---CC
Confidence 35776 458999999999999966 578999999996432 224577999999999999999999998542 23
Q ss_pred CcEEEEEecccccHHHHHHhC---------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEE----CCCCCeE
Q 010489 190 KDIYVVFELMESDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLK 256 (509)
Q Consensus 190 ~~~~lv~e~~~~~L~~~l~~~---------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl----~~~~~vk 256 (509)
..+|+||||++++|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||+ +.++.+|
T Consensus 93 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 93 RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp TEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred CeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 468999999999998888532 249999999999999999999999999999999999999 6789999
Q ss_pred EeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCCh---------H
Q 010489 257 ICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV---------V 327 (509)
Q Consensus 257 l~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---------~ 327 (509)
|+|||+|+...............+||++|+|||++.+. ..++.++||||||||+|||++|++||.+... .
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 99999998764332222233557899999999998762 4589999999999999999999999987654 4
Q ss_pred hHHHHHHHhcCCCChhHHHHhhhHH-HHHhhhccCCCCCCC------CCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHH
Q 010489 328 HQLDLMTDLLGTPSTESISRIRNEK-ARRYLGSMRKKQPVP------FSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400 (509)
Q Consensus 328 ~~~~~i~~~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 400 (509)
+++..+...+|.|....+..+.... .......+....... ........++.+.+||.+||++||.+|||++|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 7888899999998876655442111 111111111110000 011122347789999999999999999999999
Q ss_pred hcCCcccCCcC
Q 010489 401 LADPYFHGLAN 411 (509)
Q Consensus 401 l~hp~f~~~~~ 411 (509)
|+||||.....
T Consensus 332 L~hp~f~~~~~ 342 (405)
T 3rgf_A 332 MQDPYFLEDPL 342 (405)
T ss_dssp HTSGGGTSSSC
T ss_pred hcChhhccCCC
Confidence 99999987543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=392.50 Aligned_cols=260 Identities=25% Similarity=0.459 Sum_probs=205.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccC------------------------hhhHHhHHHHHHHHH
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH------------------------VSDATRILREIKLLR 167 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~------------------------~~~~~~~~~Ei~~l~ 167 (509)
.++|++.+.||+|+||.||+|++..+++.||||++...... ......+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 36899999999999999999999999999999998643211 112346789999999
Q ss_pred HcCCCCcceeeeeecCCCcCCCCcEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCc
Q 010489 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 246 (509)
Q Consensus 168 ~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~N 246 (509)
.++||||+++++++.... ...+|+||||+++ +|.+++ ....+++..+..++.||+.||+|||++||+||||||+|
T Consensus 92 ~l~h~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPN---EDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp TCCCTTBCCEEEEEECSS---SSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred hCCCCCCCeEEEEEEcCC---CCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 999999999999986432 3568999999984 666543 44579999999999999999999999999999999999
Q ss_pred EEECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccC-CCCCceeeehhhhHHHHHHhCCCCCCCCC
Q 010489 247 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS-KYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325 (509)
Q Consensus 247 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~ 325 (509)
||++.++.+||+|||+++....... .....+||+.|+|||++.+... .++.++|||||||++|+|++|+.||.+.+
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDA---LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSC---EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEECCCCCEEEecCCCccccccccc---cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999986543221 2345689999999999876311 14778999999999999999999998766
Q ss_pred hHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCc
Q 010489 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405 (509)
Q Consensus 326 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 405 (509)
.......+... .... ...+.+++.+.+||.+||+.||++|||+.|+|+|||
T Consensus 245 ~~~~~~~~~~~--------------------------~~~~---~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 245 IMCLHSKIKSQ--------------------------ALEF---PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp HHHHHHHHHHC--------------------------CCCC---CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred HHHHHHHHhcc--------------------------cCCC---CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 43322222110 0000 112467899999999999999999999999999999
Q ss_pred cc
Q 010489 406 FH 407 (509)
Q Consensus 406 f~ 407 (509)
|+
T Consensus 296 ~~ 297 (298)
T 2zv2_A 296 VT 297 (298)
T ss_dssp HH
T ss_pred cc
Confidence 95
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=403.40 Aligned_cols=256 Identities=29% Similarity=0.437 Sum_probs=210.1
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|++++.||+|+||.||+|.++.+|+.||||+++.... ...+|+.++.++ +||||+++++++.. ...
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~ 90 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDD-----GKY 90 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEEC-----SSE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEc-----CCE
Confidence 579999999999999999999999999999999965322 234688888887 79999999999843 456
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC----CCeEEeeecccccc
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD----CKLKICDFGLARVS 266 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~----~~vkl~DFG~a~~~ 266 (509)
+|+|||||+ |+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||+..+ +.+||+|||+++..
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999998 5999999988899999999999999999999999999999999999998543 35999999999865
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCCh---HhHHHHHHHhcCCCChh
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV---VHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~g~~~~~ 343 (509)
...... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+... .+.+..+.
T Consensus 171 ~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~--------- 236 (342)
T 2qr7_A 171 RAENGL---LMTPCYTANFVAPEVLER--QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG--------- 236 (342)
T ss_dssp BCTTCC---BCCSSCCSSCCCHHHHHH--HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH---------
T ss_pred cCCCCc---eeccCCCccccCHHHhcC--CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc---------
Confidence 433221 245689999999999877 5688999999999999999999999986432 11111111
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
..........++.+++++.+||.+||..||++|||+.++|+||||.++..
T Consensus 237 ------------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~ 286 (342)
T 2qr7_A 237 ------------------SGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286 (342)
T ss_dssp ------------------HCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred ------------------cCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence 01111122345678999999999999999999999999999999976543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=395.04 Aligned_cols=285 Identities=31% Similarity=0.596 Sum_probs=221.1
Q ss_pred ccCCCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCc
Q 010489 108 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSR 186 (509)
Q Consensus 108 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~ 186 (509)
..+..++|++++.||+|+||.||+|++..+++.||||+++. .....+.+|+.+++.++ ||||+++++++....
T Consensus 31 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~- 104 (330)
T 3nsz_A 31 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPV- 104 (330)
T ss_dssp CCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT-
T ss_pred cccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCC-
Confidence 33446789999999999999999999999999999999864 23466889999999997 999999999986532
Q ss_pred CCCCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCC-CeEEeeecccc
Q 010489 187 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLAR 264 (509)
Q Consensus 187 ~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~-~vkl~DFG~a~ 264 (509)
....++||||++ ++|.+++. .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 105 --~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 105 --SRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp --TCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred --CCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 346899999998 57877774 489999999999999999999999999999999999999777 89999999998
Q ss_pred cccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCC-CCChHhHHHHHHHhcCCCChh
Q 010489 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFP-GKNVVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~-~~~~~~~~~~i~~~~g~~~~~ 343 (509)
....... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||. +.+..+++..+...++.+...
T Consensus 180 ~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~ 254 (330)
T 3nsz_A 180 FYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 254 (330)
T ss_dssp ECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred EcCCCCc----cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhh
Confidence 6543322 2446899999999998653 568999999999999999999999984 556666777666666543221
Q ss_pred HH-HHhhh---HHHHHhhhccCCCCCCCCC-----CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 344 SI-SRIRN---EKARRYLGSMRKKQPVPFS-----HKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 344 ~~-~~~~~---~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
.. ..... ......+. ......+. .....+++++.+||.+||++||.+|||++|+|+||||+++..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 255 DYIDKYNIELDPRFNDILG---RHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp HHHHHTTCCCCTHHHHHHC---CCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred hHHHHhccccccchhhhhh---hccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 11 10000 00011111 11111111 111237899999999999999999999999999999987653
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=413.62 Aligned_cols=257 Identities=30% Similarity=0.507 Sum_probs=216.3
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|.+++.||+|+||.||+|++..+|+.||||+++.... .......+.+|+.+|+.++||||+++++++... .
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-----S 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----C
Confidence 4689999999999999999999999999999999964211 122346788999999999999999999998543 4
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|+|||||+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 6899999997 699999988889999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
. .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 170 ~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------ 232 (476)
T 2y94_A 170 E----FLRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI------------ 232 (476)
T ss_dssp C----CBCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC------------
T ss_pred c----cccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC------------
Confidence 2 23456899999999998872 234789999999999999999999998876544433332110
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.. ....+++++.+||.+||..||.+|||++++++||||+..
T Consensus 233 --------------~~-----~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 233 --------------FY-----TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp --------------CC-----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred --------------cC-----CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 00 012468899999999999999999999999999999764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-50 Score=398.38 Aligned_cols=263 Identities=26% Similarity=0.460 Sum_probs=192.3
Q ss_pred CeeEe---eeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCC
Q 010489 114 RYQIQ---EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 114 ~y~i~---~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~ 189 (509)
+|++. +.||+|+||.||+|.+..+++.||||++.. .....+.+|+.+++.+. ||||+++++++.. .
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-----~ 78 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQKEITALKLCEGHPNIVKLHEVFHD-----Q 78 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEG-----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEECh-----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-----C
Confidence 56665 789999999999999999999999999864 23456778999999997 9999999999943 4
Q ss_pred CcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCC---CeEEeeeccccc
Q 010489 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARV 265 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~---~vkl~DFG~a~~ 265 (509)
...|+|||||+ ++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 56899999998 59999999988999999999999999999999999999999999999998766 799999999986
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
...... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..... ....+.+
T Consensus 159 ~~~~~~---~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--------~~~~~~~ 225 (325)
T 3kn6_A 159 KPPDNQ---PLKTPCFTLHYAAPELLNQ--NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC--------TSAVEIM 225 (325)
T ss_dssp CCC---------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C--------CCHHHHH
T ss_pred cCCCCC---cccccCCCcCccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc--------ccHHHHH
Confidence 533222 2345689999999999987 68999999999999999999999999875431100 0000011
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
. .+...........+..+++++.+||.+||..||.+|||++++++||||++...
T Consensus 226 ~------------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 226 K------------KIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp H------------HHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred H------------HHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 1 11111111111223457899999999999999999999999999999986543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=399.60 Aligned_cols=281 Identities=32% Similarity=0.528 Sum_probs=225.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCC-----cceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPD-----IVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~n-----iv~~~~~~~~~~ 185 (509)
.++|++.+.||+|+||.||+|.+..+++.||||+++.. ......+.+|+.+++.+. |++ |+.+++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 127 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-- 127 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--
Confidence 46899999999999999999999999999999999642 234566778999998885 554 8888888844
Q ss_pred cCCCCcEEEEEecccccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhh--hCCeeecCCCCCcEEEC--CCCCeEEee
Q 010489 186 RREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIH--TANVFHRDLKPKNILAN--ADCKLKICD 259 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH--~~~ivHrDlKp~NILl~--~~~~vkl~D 259 (509)
...+|+||||++++|.+++... ..+++..+..++.||+.||.||| ..||+||||||+|||++ .++.+||+|
T Consensus 128 ---~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 128 ---RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp ---TTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred ---CCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 3468999999999999999865 46999999999999999999999 57999999999999994 478899999
Q ss_pred ecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCC
Q 010489 260 FGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339 (509)
Q Consensus 260 FG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~ 339 (509)
||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+..+...++.
T Consensus 205 FG~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 276 (382)
T 2vx3_A 205 FGSSCQLGQR------IYQYIQSRFYRSPEVLLG--MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276 (382)
T ss_dssp CTTCEETTCC------CCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred ccCceecccc------cccccCCccccChHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999865322 245689999999999987 67999999999999999999999999999999999999999999
Q ss_pred CChhHHHHhhhHHHHHhhhccCCCCC---------CCCCC-------------------CCC-------CCCHHHHHHHH
Q 010489 340 PSTESISRIRNEKARRYLGSMRKKQP---------VPFSH-------------------KFP-------NADPLALHLLE 384 (509)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~-------------------~~~-------~~~~~~~~li~ 384 (509)
++...+.... ....++..++.... ..+.. ... ..++++++||.
T Consensus 277 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 354 (382)
T 2vx3_A 277 PPAHILDQAP--KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLIL 354 (382)
T ss_dssp CCHHHHTTCT--THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHH
T ss_pred CCHHHHHhhH--HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHH
Confidence 8887665432 22233332221100 00000 000 01147899999
Q ss_pred HhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 385 RLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 385 ~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
+||++||++|||++|+|+||||+...
T Consensus 355 ~mL~~dP~~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 355 RMLDYDPKTRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp HHTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred HhcCCChhhCCCHHHHhcCcccccCC
Confidence 99999999999999999999998653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=397.59 Aligned_cols=256 Identities=27% Similarity=0.442 Sum_probs=200.3
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||+|+||.||+|.+..+++.||||+++.. ...+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~ 122 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHPNIIKLKEIFET-----PTE 122 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----hhHHHHHHHHHHHHhCCCCCCcceeeeEec-----CCe
Confidence 35799999999999999999999999999999998643 234567789999999999999999999954 346
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC---CCCeEEeeeccccccc
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVSF 267 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~---~~~vkl~DFG~a~~~~ 267 (509)
+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++...
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 899999998 599999988888999999999999999999999999999999999999975 8899999999998653
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHh-HHHHHHHhcCCCChhHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH-QLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~ 346 (509)
... .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+..... .+..+..
T Consensus 203 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~----------- 265 (349)
T 2w4o_A 203 HQV----LMKTVCGTPGYCAPEILRG--CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN----------- 265 (349)
T ss_dssp --------------CGGGSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT-----------
T ss_pred ccc----ccccccCCCCccCHHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh-----------
Confidence 322 1245689999999999987 679999999999999999999999997655322 1111111
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.........++.+++++.+||.+||+.||++|||+.++|+||||.+.
T Consensus 266 ----------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 266 ----------------CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp ----------------TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred ----------------CCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 11111122345788999999999999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=382.34 Aligned_cols=256 Identities=32% Similarity=0.474 Sum_probs=217.2
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.. ...+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 81 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFED-----NTDI 81 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCeE
Confidence 579999999999999999999999999999999865332 345678899999999999999999999854 3558
Q ss_pred EEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEE---CCCCCeEEeeecccccccC
Q 010489 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVSFN 268 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl---~~~~~vkl~DFG~a~~~~~ 268 (509)
|+||||++ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 99999998 5899999888889999999999999999999999999999999999999 7889999999999976543
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+....+.......+.
T Consensus 162 ~~~----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 228 (277)
T 3f3z_A 162 GKM----MRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPE------ 228 (277)
T ss_dssp TSC----BCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH------
T ss_pred ccc----hhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc------
Confidence 221 245689999999999865 4899999999999999999999999987765554444332211111
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
..+..+++.+.+||.+||+.||.+|||+.++|+||||++.
T Consensus 229 ---------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 229 ---------------------KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp ---------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred ---------------------hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 1123568899999999999999999999999999999754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=414.91 Aligned_cols=261 Identities=31% Similarity=0.444 Sum_probs=217.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccCh-----------hhHHhHHHHHHHHHHcCCCCcceeeee
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV-----------SDATRILREIKLLRLLRHPDIVEIKHI 180 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~-----------~~~~~~~~Ei~~l~~l~h~niv~~~~~ 180 (509)
.++|+++++||+|+||+||+|.++.+++.||||++....... .....+.+|+.+|+.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 468999999999999999999999999999999986532111 234678899999999999999999999
Q ss_pred ecCCCcCCCCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCC---CeE
Q 010489 181 MLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLK 256 (509)
Q Consensus 181 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~---~vk 256 (509)
+.. ...+|+|||||+ ++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 115 ~~~-----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 115 FED-----KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEC-----SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEc-----CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEE
Confidence 943 456999999998 58999998888999999999999999999999999999999999999999876 699
Q ss_pred EeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHh
Q 010489 257 ICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL 336 (509)
Q Consensus 257 l~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 336 (509)
|+|||++........ ....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+...
T Consensus 190 l~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 262 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYK----LRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262 (504)
T ss_dssp ECCCTTCEECCTTSC----BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred EEECCCCEEcCCCCc----cccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 999999986543321 345689999999999864 6899999999999999999999999998876655554432
Q ss_pred cCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 337 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
...... ..+..+++++++||.+||++||.+|||++|+|+||||+....
T Consensus 263 ~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 263 KYYFDF---------------------------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp CCCCCH---------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred CCCCCc---------------------------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 111111 123467899999999999999999999999999999987543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=384.72 Aligned_cols=255 Identities=30% Similarity=0.478 Sum_probs=206.7
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++.+.||+|+||.||+|.+..++..||+|++..... ......+.+|+.+|+.++||||+++++++.. ...+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~ 95 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-----YHNM 95 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheec-----CCeE
Confidence 579999999999999999999999999999999865422 2345678899999999999999999999843 4568
Q ss_pred EEEEeccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEE---CCCCCeEEeeecccc
Q 010489 193 YVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLAR 264 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl---~~~~~vkl~DFG~a~ 264 (509)
|+||||++ ++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 99999998 488888753 3679999999999999999999999999999999999999 456889999999997
Q ss_pred cccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
....... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.+..+....+...
T Consensus 176 ~~~~~~~----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~-------- 240 (285)
T 3is5_A 176 LFKSDEH----STNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK-------- 240 (285)
T ss_dssp C--------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------
T ss_pred ecCCccc----CcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC--------
Confidence 6533222 245689999999999854 6889999999999999999999999887643332221110
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
...+.......++.+.+||.+||+.||++|||+.|+|+||||++
T Consensus 241 --------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 241 --------------------EPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp --------------------CCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred --------------------CcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 00111122346889999999999999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=415.99 Aligned_cols=260 Identities=30% Similarity=0.483 Sum_probs=220.4
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++.. ...
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 100 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-----KGY 100 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----CCE
Confidence 57999999999999999999999999999999986432 223456778999999999999999999999944 456
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEE---CCCCCeEEeeeccccccc
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVSF 267 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl---~~~~~vkl~DFG~a~~~~ 267 (509)
+|+|||||. ++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 999999998 5899999988899999999999999999999999999999999999999 567899999999998654
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus 181 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-------- 245 (484)
T 3nyv_A 181 ASK----KMKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT-------- 245 (484)
T ss_dssp CCC----SHHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------
T ss_pred ccc----ccccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 322 1345689999999999865 6899999999999999999999999988766555544331111
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
.....+..+++.+.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 246 -------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 246 -------------------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp -------------------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred -------------------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 011123467899999999999999999999999999999987644
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=400.45 Aligned_cols=254 Identities=27% Similarity=0.405 Sum_probs=208.5
Q ss_pred eEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEE
Q 010489 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 195 (509)
Q Consensus 116 ~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 195 (509)
...+.||+|+||.||+|.+..+|+.||+|+++.. .......+.+|+.+|+.++||||+++++++.. ...+|+|
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~lv 164 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFES-----KNDIVLV 164 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEEEEE
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEEEE
Confidence 3467899999999999999999999999999752 23455678899999999999999999999954 3468999
Q ss_pred Eeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEE--CCCCCeEEeeecccccccCCCC
Q 010489 196 FELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA--NADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 196 ~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl--~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
||||+ ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~ 244 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence 99998 5888888654 479999999999999999999999999999999999999 6678999999999987543322
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+.+..+......
T Consensus 245 ----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~------------ 306 (373)
T 2x4f_A 245 ----LKVNFGTPEFLAPEVVNY--DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD------------ 306 (373)
T ss_dssp ----CCCCCSSCTTCCHHHHTT--CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC------------
T ss_pred ----cccccCCCcEeChhhccC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC------------
Confidence 234579999999999876 67899999999999999999999999988776655544332111
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.....++.+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 307 ---------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 307 ---------------LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp ---------------SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred ---------------CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 1112335678999999999999999999999999999999753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=390.95 Aligned_cols=282 Identities=30% Similarity=0.527 Sum_probs=227.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEE-cCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCC------cceeeeeecCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVD-THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD------IVEIKHIMLPP 184 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~~~~~~~~~ 184 (509)
.++|++++.||+|+||.||+|.+ ..+++.||||+++.. ......+.+|+.+++.++|++ |+++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~- 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH- 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE-
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc-
Confidence 46899999999999999999998 568899999999642 234567889999999887654 8999998843
Q ss_pred CcCCCCcEEEEEecccccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC-----------
Q 010489 185 SRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA----------- 251 (509)
Q Consensus 185 ~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~----------- 251 (509)
...+|+||||++++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 89 ----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 89 ----HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp ----TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred ----CCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcc
Confidence 35699999999999999998765 6899999999999999999999999999999999999987
Q ss_pred --------CCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCC
Q 010489 252 --------DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 323 (509)
Q Consensus 252 --------~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 323 (509)
++.+||+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILA--LGWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccCCCceEeeCcccccCccc------cccccCCccccChHHhhC--CCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 678999999999864322 234689999999999987 6899999999999999999999999999
Q ss_pred CChHhHHHHHHHhcCCCChhHHHHhhhHHH--------------HHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccC
Q 010489 324 KNVVHQLDLMTDLLGTPSTESISRIRNEKA--------------RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAF 389 (509)
Q Consensus 324 ~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 389 (509)
.+..+.+..+....+..+...+........ ..+...... ....+.......++.+.+||.+||..
T Consensus 237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK-PLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC-CGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCc-chhhhcccchhhHHHHHHHHHHHhCc
Confidence 999888889999888887766554322110 000000000 00000111123356789999999999
Q ss_pred CCCCCCCHHHHhcCCcccCCc
Q 010489 390 DPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 390 dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
||.+|||+.|+|+||||+.+.
T Consensus 316 dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 316 DPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp STTTSCCHHHHTTSGGGGGGG
T ss_pred CcccccCHHHHhcCHHHHHHh
Confidence 999999999999999998753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=428.84 Aligned_cols=260 Identities=22% Similarity=0.390 Sum_probs=220.5
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~ 188 (509)
..++|++++.||+|+||.||+|+++.+++.||||++++.. ........+..|..+|..+ .||+|+.+++++..
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~----- 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----- 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC-----
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe-----
Confidence 3578999999999999999999999999999999996431 1223446678899999887 69999999999843
Q ss_pred CCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 189 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
...+||||||++ |+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred CCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 456999999998 5999999988899999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|...
T Consensus 494 ~~~~---~~~~~~GT~~Y~APE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~----------- 557 (674)
T 3pfq_A 494 WDGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH----------- 557 (674)
T ss_dssp CTTC---CBCCCCSCSSSCCHHHHTC--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS-----------
T ss_pred cCCc---ccccccCCCcccCHhhhcC--CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-----------
Confidence 3222 2356799999999999987 68999999999999999999999999988765555444221
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH-----HHHhcCCcccCCcC
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA-----EEALADPYFHGLAN 411 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~f~~~~~ 411 (509)
... + ...+++++.+||.+||+.||.+||++ +|+++||||+++.+
T Consensus 558 ---------------~~~--~---p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w 606 (674)
T 3pfq_A 558 ---------------NVA--Y---PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 606 (674)
T ss_dssp ---------------CCC--C---CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred ---------------CCC--C---CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence 000 1 13578999999999999999999997 99999999998765
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=403.14 Aligned_cols=283 Identities=27% Similarity=0.420 Sum_probs=224.5
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC--------CCCcceeeeeecC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR--------HPDIVEIKHIMLP 183 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~--------h~niv~~~~~~~~ 183 (509)
.++|++++.||+|+||+||+|++..+++.||||+++.. ......+.+|+.+|+.++ |+||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 46899999999999999999999999999999999642 334567889999999986 7889999998853
Q ss_pred CCcCCCCcEEEEEecccccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhC-CeeecCCCCCcEEECCCC-------
Q 010489 184 PSRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADC------- 253 (509)
Q Consensus 184 ~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~-~ivHrDlKp~NILl~~~~------- 253 (509)
.. .....+|+||||++++|.+.+... +.+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 113 ~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 113 SG-VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EE-TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred cC-CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 21 133568999999999988888665 4699999999999999999999998 999999999999999776
Q ss_pred ------------------------------------------CeEEeeecccccccCCCCCccccccccccccccccccc
Q 010489 254 ------------------------------------------KLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291 (509)
Q Consensus 254 ------------------------------------------~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 291 (509)
.+||+|||++...... ....+||+.|+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCHHHH
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCChhh
Confidence 7999999999865332 2445899999999999
Q ss_pred ccccCCCCCceeeehhhhHHHHHHhCCCCCCCCC------hHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCC
Q 010489 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN------VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQP 365 (509)
Q Consensus 292 ~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~------~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (509)
.+ ..++.++|||||||++|||++|+.||.+.+ ..+++..+...+|.++...+....... .+.........
T Consensus 266 ~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~--~~~~~~~~~~~ 341 (397)
T 1wak_A 266 IG--SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK--EFFTKKGDLKH 341 (397)
T ss_dssp HT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGG--GTBCTTSSBSS
T ss_pred cC--CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccc--cccCCcccccc
Confidence 87 679999999999999999999999998765 456778888888988876654322110 01000000000
Q ss_pred C----CCC---------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 366 V----PFS---------HKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 366 ~----~~~---------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
. ++. ......++.+.+||.+||+.||++|||++|+|+||||++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0 000 001123467889999999999999999999999999963
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=389.66 Aligned_cols=255 Identities=29% Similarity=0.518 Sum_probs=212.2
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
.|...+.||+|+||.||+|++..+|+.||||++.... ......+.+|+.+++.++||||+++++++... ..+|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~ 118 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----EELW 118 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEE
Confidence 4888899999999999999999999999999986432 23356688999999999999999999998543 4589
Q ss_pred EEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCC
Q 010489 194 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (509)
Q Consensus 194 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 272 (509)
+||||++ ++|.+++. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 119 lv~e~~~~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 197 (321)
T 2c30_A 119 VLMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 197 (321)
T ss_dssp EEECCCCSCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred EEEecCCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc
Confidence 9999998 57888765 457999999999999999999999999999999999999999999999999999865433222
Q ss_pred cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHH
Q 010489 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (509)
Q Consensus 273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (509)
....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+....
T Consensus 198 ---~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~--------------- 257 (321)
T 2c30_A 198 ---RKSLVGTPYWMAPEVISR--SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP--------------- 257 (321)
T ss_dssp ---BCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS---------------
T ss_pred ---cccccCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---------------
Confidence 245689999999999877 678999999999999999999999998876544433322110
Q ss_pred HHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
+ +.......+++.+.+||.+||+.||++|||+.++|+||||...
T Consensus 258 ------------~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 258 ------------P-PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp ------------C-CCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred ------------C-CCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 0 0001123467889999999999999999999999999999753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=419.11 Aligned_cols=263 Identities=26% Similarity=0.391 Sum_probs=215.7
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
..++|++++.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++.. .
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~ 256 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-----K 256 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-----C
Confidence 3468999999999999999999999999999999986421 112234567899999999999999999999854 3
Q ss_pred CcEEEEEeccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 190 KDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
..+|+|||||+ |+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 56999999997 68999987654 4999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
..... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.........+..
T Consensus 337 ~~~~~----~~~~~GT~~Y~APEvl~~--~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~----------- 399 (576)
T 2acx_A 337 PEGQT----IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER----------- 399 (576)
T ss_dssp CTTCC----EECCCSCGGGCCHHHHTT--CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH-----------
T ss_pred ccCcc----ccccCCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH-----------
Confidence 33221 245689999999999987 6799999999999999999999999987643111111110
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCcC
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLAN 411 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~~ 411 (509)
.+... +.. ....+++++.+||.+||+.||.+|| +++|+++||||+++.+
T Consensus 400 ---------~i~~~----~~~---~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 400 ---------LVKEV----PEE---YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp ---------HHHHC----CCC---CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred ---------Hhhcc----ccc---CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence 00001 111 1135789999999999999999999 8999999999998653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=391.00 Aligned_cols=263 Identities=25% Similarity=0.422 Sum_probs=217.0
Q ss_pred CCeeEe-eeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCCC
Q 010489 113 SRYQIQ-EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 113 ~~y~i~-~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~~ 190 (509)
++|.+. +.||+|+||.||+|.+..+++.||||+++...........+.+|+.+++.+. ||||+++++++.. ..
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~-----~~ 102 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN-----TS 102 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe-----CC
Confidence 468887 8999999999999999999999999999765444445677899999999995 6999999999843 45
Q ss_pred cEEEEEecccc-cHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC---CCCeEEeeecccc
Q 010489 191 DIYVVFELMES-DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLAR 264 (509)
Q Consensus 191 ~~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~---~~~vkl~DFG~a~ 264 (509)
.+|+||||+.+ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~ 182 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence 68999999985 888888543 67999999999999999999999999999999999999998 7899999999998
Q ss_pred cccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 183 ~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~----- 251 (327)
T 3lm5_A 183 KIGHACE----LREIMGTPEYLAPEILNY--DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD----- 251 (327)
T ss_dssp EC-------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-----
T ss_pred ccCCccc----cccccCCcCccCCeeecC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccc-----
Confidence 6533221 244689999999999977 68999999999999999999999999987765544443322111
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCC
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 413 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 413 (509)
.....+..+++.+.+||.+||+.||.+|||++++|+||||+++....
T Consensus 252 ----------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~ 298 (327)
T 3lm5_A 252 ----------------------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298 (327)
T ss_dssp ----------------------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred ----------------------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence 11223356789999999999999999999999999999999875543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=383.16 Aligned_cols=257 Identities=25% Similarity=0.413 Sum_probs=213.5
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++.+.||+|+||.||+|.+..++..||||++..... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 82 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-----AT 82 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec-----CC
Confidence 4689999999999999999999999999999999854221 12234568899999999999999999999844 34
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
..|+||||++ ++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 6899999998 589999988888999999999999999999999999999999999999999999999999998654322
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 163 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 223 (279)
T 3fdn_A 163 R-----RTDLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE------------ 223 (279)
T ss_dssp ----------CCCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC------------
T ss_pred c-----ccccCCCCCccCHhHhcc--CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC------------
Confidence 2 244689999999999887 678999999999999999999999998877544443332210
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
.. ....+++.+.+||.+||..||.+|||+.|+|+||||+....
T Consensus 224 ------------~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 224 ------------FT-------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp ------------CC-------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred ------------CC-------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 00 11246788999999999999999999999999999986543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=381.36 Aligned_cols=260 Identities=25% Similarity=0.343 Sum_probs=214.8
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
...|++.+.||+|+||.||+|.+..++..||+|++............+.+|+.+++.++||||+++++++.... .....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCce
Confidence 45699999999999999999999999999999999765555566778899999999999999999999875432 23456
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCC--eeecCCCCCcEEEC-CCCCeEEeeeccccccc
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLARVSF 267 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~--ivHrDlKp~NILl~-~~~~vkl~DFG~a~~~~ 267 (509)
+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.| |+||||||+|||++ .++.+||+|||++....
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 899999997 599999988888999999999999999999999999 99999999999998 78999999999997543
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.............
T Consensus 184 ~~~-----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~----------- 244 (290)
T 1t4h_A 184 ASF-----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS----------- 244 (290)
T ss_dssp TTS-----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-----------
T ss_pred ccc-----cccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc-----------
Confidence 221 234679999999998864 5899999999999999999999999875543322111100
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
...+. ......++++.+||.+||+.||.+|||++++|+||||++
T Consensus 245 --------------~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 245 --------------GVKPA---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp --------------TCCCG---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred --------------cCCcc---ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 00011 111245688999999999999999999999999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=388.42 Aligned_cols=262 Identities=25% Similarity=0.406 Sum_probs=205.0
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc------
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR------ 186 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~------ 186 (509)
++|++++.||+|+||.||+|+++.+|+.||||+++... .......+.+|+.+|+.++||||+++++++.....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 47999999999999999999999999999999996432 23455778999999999999999999998854321
Q ss_pred ----------------------------------------------CCCCcEEEEEecccc-cHHHHHHhCC---CCCHH
Q 010489 187 ----------------------------------------------REFKDIYVVFELMES-DLHQVIKAND---DLTPE 216 (509)
Q Consensus 187 ----------------------------------------------~~~~~~~lv~e~~~~-~L~~~l~~~~---~l~~~ 216 (509)
.....+|+|||||++ +|.+++.... ..++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 122348999999984 8999998764 35666
Q ss_pred HHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCc---------cccccccccccccc
Q 010489 217 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA---------IFWTDYVATRWYRA 287 (509)
Q Consensus 217 ~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~---------~~~~~~~gt~~y~a 287 (509)
.+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......... ......+||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 789999999999999999999999999999999999999999999998764432111 11244689999999
Q ss_pred ccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCC
Q 010489 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVP 367 (509)
Q Consensus 288 PE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (509)
||++.+ ..++.++|||||||++|||++|..|+.. ....+........
T Consensus 245 PE~~~~--~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~-------------------------- 291 (332)
T 3qd2_B 245 PEQIHG--NNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKF-------------------------- 291 (332)
T ss_dssp HHHHHC--CCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCC--------------------------
T ss_pred hHHhcC--CCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCC--------------------------
Confidence 999887 6899999999999999999998766521 1111111100000
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 368 FSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 368 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
...+...++.+.+||.+||+.||.+|||++|+|+||||+++
T Consensus 292 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 292 -PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp -CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred -CcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 00112345678999999999999999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=386.63 Aligned_cols=281 Identities=26% Similarity=0.388 Sum_probs=206.6
Q ss_pred CCCeeEe-eeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCC
Q 010489 112 ASRYQIQ-EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 112 ~~~y~i~-~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~ 189 (509)
.++|++. +.||+|+||.||+|.+..+++.||||++.... ......+.+|+.++.++ +||||+++++++.. .
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~ 83 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-----E 83 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----T
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----C
Confidence 4679995 78999999999999999999999999996532 23456788999999885 79999999999854 3
Q ss_pred CcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCC---eEEeeeccccc
Q 010489 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLARV 265 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~---vkl~DFG~a~~ 265 (509)
..+|+||||++ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 56999999998 699999988888999999999999999999999999999999999999998876 99999999976
Q ss_pred ccCCCC----Ccccccccccccccccccccccc---cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcC
Q 010489 266 SFNDAP----SAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338 (509)
Q Consensus 266 ~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g 338 (509)
...... ........+||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+....+..... +
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~----~ 239 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR----G 239 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-------
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc----c
Confidence 432211 11112345799999999998641 135788999999999999999999999876432100000 0
Q ss_pred CCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
........ .....+...........+..+++.+.+||.+||..||.+|||++|+|+||||++...
T Consensus 240 ~~~~~~~~--------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 240 EACPACQN--------MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304 (316)
T ss_dssp -CCHHHHH--------HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred ccchhHHH--------HHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence 00000000 000000011111111122457889999999999999999999999999999987643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=394.08 Aligned_cols=267 Identities=28% Similarity=0.445 Sum_probs=212.2
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc---cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF---EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++.. .
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~ 100 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED-----E 100 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc-----C
Confidence 57999999999999999999999999999999986421 123455778999999999999999999999944 4
Q ss_pred CcEEEEEeccc-ccHHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHhH
Q 010489 190 KDIYVVFELME-SDLHQVIKA----------------------------------------NDDLTPEHYQFFLYQLLRG 228 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~----------------------------------------~~~l~~~~~~~i~~qil~a 228 (509)
..+|+|||||+ ++|.+++.. ...+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 56899999997 689888842 1124678889999999999
Q ss_pred hhhhhhCCeeecCCCCCcEEECCCC--CeEEeeecccccccCCCC-CcccccccccccccccccccccccCCCCCceeee
Q 010489 229 LKYIHTANVFHRDLKPKNILANADC--KLKICDFGLARVSFNDAP-SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 305 (509)
Q Consensus 229 L~yLH~~~ivHrDlKp~NILl~~~~--~vkl~DFG~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw 305 (509)
|+|||++||+||||||+|||++.++ .+||+|||++........ .........||+.|+|||++.+....++.++|||
T Consensus 181 l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw 260 (345)
T 3hko_A 181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260 (345)
T ss_dssp HHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred HHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence 9999999999999999999998776 899999999986533221 1112345689999999999865445789999999
Q ss_pred hhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHH
Q 010489 306 SIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLER 385 (509)
Q Consensus 306 SlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 385 (509)
||||++|||++|+.||.+.+..+....+...... .....+..+++.+.+||.+
T Consensus 261 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~li~~ 313 (345)
T 3hko_A 261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC---------------------------FENPNYNVLSPLARDLLSN 313 (345)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------------------------TTSGGGGGSCHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccc---------------------------cCCcccccCCHHHHHHHHH
Confidence 9999999999999999987765554443321100 0111223468899999999
Q ss_pred hccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 386 LLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 386 ~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
||+.||.+||++.++|+||||+++.+
T Consensus 314 ~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 314 LLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp HSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred HcCCChhHCCCHHHHhcChhhccChH
Confidence 99999999999999999999987654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=391.44 Aligned_cols=262 Identities=27% Similarity=0.359 Sum_probs=206.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCC--CCcceeeeeecCCCcCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH--PDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~~~~~~~~~~~~~~ 189 (509)
..+|++++.||+|+||.||+|.+. +++.||||++............+.+|+.+|+.++| |||+++++++.. .
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-----~ 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----D 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-----C
Confidence 457999999999999999999884 68999999997654455556788999999999986 999999999854 3
Q ss_pred CcEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 190 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 190 ~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
..+|+|||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 82 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 82 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp SEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred CEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 4699999988899999999999999999999999999999999999999999999999997 688999999999865433
Q ss_pred CCCcccccccccccccccccccccc---------cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCC
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~ 340 (509)
... ......+||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+.... ...+...
T Consensus 161 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~---- 233 (343)
T 3dbq_A 161 TTS-VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAI---- 233 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHH----
T ss_pred ccc-ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--HHHHHHH----
Confidence 221 122456899999999997531 146888999999999999999999999764321 1111100
Q ss_pred ChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
+ ...... ......++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 234 ----------------~---~~~~~~---~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 234 ----------------I---DPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp ----------------H---CTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ----------------h---cCCccc---CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 0 000011 1112346789999999999999999999999999999753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=400.35 Aligned_cols=262 Identities=27% Similarity=0.434 Sum_probs=203.2
Q ss_pred CCCeeEe-eeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHH-HHcCCCCcceeeeeecCCCcCCC
Q 010489 112 ASRYQIQ-EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL-RLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 112 ~~~y~i~-~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l-~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
.++|.+. +.||+|+||+||+|.++.+|+.||||+++. ...+.+|+.++ +..+||||+++++++.... .+.
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY-AGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCC
Confidence 4678887 789999999999999999999999999853 13466889887 4558999999999884311 224
Q ss_pred CcEEEEEeccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC---CCCeEEeeeccc
Q 010489 190 KDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLA 263 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~---~~~vkl~DFG~a 263 (509)
..+|||||||+ |+|.+++...+ .+++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 56899999998 59999998653 5999999999999999999999999999999999999998 789999999999
Q ss_pred ccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChh
Q 010489 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (509)
+...... .....+||+.|+|||++.+ ..|+.++||||||||+|||++|+.||.+.+.... ...
T Consensus 212 ~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----------~~~ 274 (400)
T 1nxk_A 212 KETTSHN----SLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPG 274 (400)
T ss_dssp EECC---------------CTTCCGGGSCC--CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS-----------CCS
T ss_pred cccCCCC----ccccCCCCCCccCHhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc-----------cHH
Confidence 8653222 1345689999999999977 6899999999999999999999999987653210 000
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
....+.. .........+..+++++.+||.+||..||++|||+.++|+||||.+..
T Consensus 275 ~~~~i~~------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 275 MKTRIRM------------GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp HHHHHHH------------TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred HHHHHHc------------CcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 0011100 000111123456899999999999999999999999999999997643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=390.42 Aligned_cols=256 Identities=26% Similarity=0.403 Sum_probs=213.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
..+|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|+.++||||+++++++... .
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~ 127 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----H 127 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----T
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----C
Confidence 3569999999999999999999999999999999864322 223456788999999999999999999998543 4
Q ss_pred cEEEEEecccccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
..|+||||+.|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 128 ~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 128 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp EEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred eEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 6899999999999888854 56799999999999999999999999999999999999999999999999999976432
Q ss_pred CCCcccccccccccccccccccccc-cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
....+||+.|+|||++.+. ...++.++|||||||++|||++|++||.+.+....+..+...
T Consensus 207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~------------ 268 (348)
T 1u5q_A 207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------------ 268 (348)
T ss_dssp ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------------
T ss_pred ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc------------
Confidence 1345899999999987421 257899999999999999999999999887654433322110
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
..+. .....+++.+.+||.+||+.||++|||++++|+||||..
T Consensus 269 --------------~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 269 --------------ESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp --------------CCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred --------------CCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 0110 112356788999999999999999999999999999965
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=387.91 Aligned_cols=263 Identities=29% Similarity=0.426 Sum_probs=220.5
Q ss_pred ccCCCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc
Q 010489 108 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 108 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 186 (509)
.....++|.+.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++..
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 112 (335)
T 2owb_A 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--- 112 (335)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred CcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---
Confidence 3445678999999999999999999999999999999986532 233456678899999999999999999999854
Q ss_pred CCCCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 187 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 187 ~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
...+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 113 --~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 113 --NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 190 (335)
T ss_dssp --SSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred --CCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCcee
Confidence 356899999998 58999998888999999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+...
T Consensus 191 ~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------- 256 (335)
T 2owb_A 191 VEYDGER---KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--------- 256 (335)
T ss_dssp CCSTTCC---BCCCCSCCSSCCHHHHHT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT---------
T ss_pred cccCccc---ccccCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC---------
Confidence 5432221 244689999999999877 67899999999999999999999999876654333222110
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
... ....+++.+.+||.+||..||++|||++++|+||||.....
T Consensus 257 -----------------~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 257 -----------------EYS-----IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp -----------------CCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred -----------------CCC-----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 000 11246788999999999999999999999999999986543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=397.86 Aligned_cols=260 Identities=28% Similarity=0.377 Sum_probs=206.9
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC--CCCcceeeeeecCCCcCCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR--HPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~niv~~~~~~~~~~~~~~~ 190 (509)
.+|++++.||+|+||.||+|.+.. ++.||||++............+.+|+.+|+.+. ||||+++++++... .
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~-----~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----Q 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----S
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-----C
Confidence 469999999999999999999865 899999999754444556678899999999997 59999999998543 4
Q ss_pred cEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.+|+|||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus 130 ~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 130 YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 599999987789999999888999999999999999999999999999999999999995 6899999999998654332
Q ss_pred CCcccccccccccccccccccccc---------cCCCCCceeeehhhhHHHHHHhCCCCCCCCCh-HhHHHHHHHhcCCC
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV-VHQLDLMTDLLGTP 340 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~g~~ 340 (509)
.. ......+||+.|+|||++.+. ...|+.++||||||||+|||++|+.||.+... ...+..+.
T Consensus 209 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~------ 281 (390)
T 2zmd_A 209 TS-VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII------ 281 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH------
T ss_pred cc-ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh------
Confidence 21 123456899999999998541 13688999999999999999999999976432 11111110
Q ss_pred ChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
. ......+ ....++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 282 -----------------~---~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 282 -----------------D---PNHEIEF---PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp -----------------C---TTSCCCC---CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred -----------------C---ccccCCC---CccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 0 0001111 12346789999999999999999999999999999754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=392.42 Aligned_cols=269 Identities=25% Similarity=0.363 Sum_probs=213.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++.+.||+|+||.||+|++..+++.||||+++.... .......+.+|+.+++.++||||+++++++.... ....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence 4689999999999999999999999999999999975432 3344567889999999999999999999885432 1123
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
..|+||||++ ++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 4699999997 699999988889999999999999999999999999999999999999999999999999999865443
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
..........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+....
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~------------ 235 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED------------ 235 (311)
T ss_dssp ------------CCTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC------------
T ss_pred ccccccccccCcCcccCCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC------------
Confidence 322222345679999999999887 689999999999999999999999998877544433222211
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
+.+.......+++++.+||.+||+.||.+||++.+++.|+|++...
T Consensus 236 ---------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 236 ---------------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp ---------------CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred ---------------CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 1111122345788999999999999999999999999999997543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=405.42 Aligned_cols=260 Identities=32% Similarity=0.536 Sum_probs=202.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc------ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE------HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~------~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~ 185 (509)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 4689999999999999999999999999999999864321 11122357899999999999999999998732
Q ss_pred cCCCCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCC---CeEEeeec
Q 010489 186 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFG 261 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~---~vkl~DFG 261 (509)
..+|+|||||+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 212 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 ----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp ----SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred ----CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecc
Confidence 24799999998 58999988888999999999999999999999999999999999999997654 59999999
Q ss_pred ccccccCCCCCcccccccccccccccccccccc-cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHH-HHHHhcCC
Q 010489 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD-LMTDLLGT 339 (509)
Q Consensus 262 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~-~i~~~~g~ 339 (509)
+++...... .....+||+.|+|||++.+. ...|+.++|||||||++|+|++|.+||.+......+. .+..
T Consensus 288 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~---- 359 (419)
T 3i6u_A 288 HSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS---- 359 (419)
T ss_dssp TTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT----
T ss_pred cceecCCCc----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc----
Confidence 998653322 23456899999999998531 2568889999999999999999999998754322111 1111
Q ss_pred CChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
.........+..+++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus 360 -----------------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 360 -----------------------GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp -----------------------TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred -----------------------CCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 0011111223457889999999999999999999999999999974
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=408.01 Aligned_cols=254 Identities=17% Similarity=0.195 Sum_probs=200.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCc-ccChhhHHhHHHHHH---HHHHcCCCCcceeee-------e
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIK---LLRLLRHPDIVEIKH-------I 180 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~Ei~---~l~~l~h~niv~~~~-------~ 180 (509)
.++|++.+.||+|+||.||+|++..+|+.||||++... .......+.+.+|+. +|+.++||||+++++ +
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46899999999999999999999999999999998643 223345677889995 455567999999984 4
Q ss_pred ecCCCc-------CCC-----CcEEEEEecccccHHHHHHhCCCCCH-------HHHHHHHHHHHhHhhhhhhCCeeecC
Q 010489 181 MLPPSR-------REF-----KDIYVVFELMESDLHQVIKANDDLTP-------EHYQFFLYQLLRGLKYIHTANVFHRD 241 (509)
Q Consensus 181 ~~~~~~-------~~~-----~~~~lv~e~~~~~L~~~l~~~~~l~~-------~~~~~i~~qil~aL~yLH~~~ivHrD 241 (509)
+..... .+. ...|+||||++|+|.+++...+.+++ ..+..|+.||+.||+|||++||+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 322210 001 13799999999999999987655555 78888999999999999999999999
Q ss_pred CCCCcEEECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccC-----------CCCCceeeehhhhH
Q 010489 242 LKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS-----------KYTPAIDIWSIGCI 310 (509)
Q Consensus 242 lKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-----------~~~~~~DiwSlG~i 310 (509)
|||+|||++.++.+||+|||+|+.... .....+| +.|+|||++.+ . .|+.++|||||||+
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~--~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEAR--RATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHH--HTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC------cccCCCC-cCccChhhhcc--cccccccccccccCChhhhHHHHHHH
Confidence 999999999999999999999985321 2345678 99999999876 4 78999999999999
Q ss_pred HHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCC
Q 010489 311 FAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFD 390 (509)
Q Consensus 311 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 390 (509)
+|||++|+.||.+.+...... .....++.+++++.+||.+||+.|
T Consensus 303 l~elltg~~Pf~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~li~~~L~~d 347 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSE-----------------------------------WIFRSCKNIPQPVRALLEGFLRYP 347 (377)
T ss_dssp HHHHHHSSCCC------CCSG-----------------------------------GGGSSCCCCCHHHHHHHHHHTCSS
T ss_pred HHHHHHCCCCCcccccccchh-----------------------------------hhhhhccCCCHHHHHHHHHHcCCC
Confidence 999999999997654211100 001112467899999999999999
Q ss_pred CCCCCCHHHHhcCCcccCC
Q 010489 391 PKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 391 P~~Rpt~~e~l~hp~f~~~ 409 (509)
|.+|||+.++|+||||+.+
T Consensus 348 p~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 348 KEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp GGGCCCHHHHHTSHHHHHH
T ss_pred chhCCCHHHHhhChHHHHH
Confidence 9999999999999999764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=381.48 Aligned_cols=256 Identities=29% Similarity=0.450 Sum_probs=213.7
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++.+.||+|+||.||+|++..+|+.||||+++... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 81 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYES-----TTHY 81 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhccc-----CCEE
Confidence 57999999999999999999999999999999997432 2234567899999999999999999999844 3568
Q ss_pred EEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEE---CCCCCeEEeeecccccccC
Q 010489 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVSFN 268 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl---~~~~~vkl~DFG~a~~~~~ 268 (509)
|+||||++ ++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999998 5999999888889999999999999999999999999999999999999 7889999999999975422
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 162 ~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~----------- 223 (304)
T 2jam_A 162 G-----IMSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY----------- 223 (304)
T ss_dssp B-----TTHHHHSCCCBCCTTTBSS--CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC-----------
T ss_pred C-----ccccccCCCCccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 1 1234579999999999987 689999999999999999999999998876544433332210
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.......+..+++.+.+||.+||..||++|||++++|+||||++.
T Consensus 224 ----------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 224 ----------------YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp ----------------CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred ----------------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 001112235678999999999999999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=393.58 Aligned_cols=250 Identities=23% Similarity=0.364 Sum_probs=209.8
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccCh------hhHHhHHHHHHHHHHcCCCCcceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV------SDATRILREIKLLRLLRHPDIVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~ 185 (509)
.++|++++.||+|+||.||+|++..+++.||||+++...... .....+.+|+.+|+.++||||+++++++..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-- 100 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-- 100 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee--
Confidence 358999999999999999999999999999999997532111 133456789999999999999999999943
Q ss_pred cCCCCcEEEEEeccc-c-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccc
Q 010489 186 RREFKDIYVVFELME-S-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 263 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~-~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 263 (509)
...+|+||||+. | +|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 101 ---~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 101 ---QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp ---SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred ---CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 456899999986 5 89999998889999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccccccccccCCC-CCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCCh
Q 010489 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342 (509)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~ 342 (509)
........ ....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||......
T Consensus 178 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------- 236 (335)
T 3dls_A 178 AYLERGKL----FYTFCGTIEYCAPEVLMG--NPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------- 236 (335)
T ss_dssp EECCTTCC----BCEECSCGGGCCHHHHTT--CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------
T ss_pred eECCCCCc----eeccCCCccccChhhhcC--CCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------
Confidence 86543322 245689999999999877 444 88999999999999999999999652210
Q ss_pred hHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
...... ....+++++.+||.+||+.||++|||++++++||||++.
T Consensus 237 -----------------~~~~~~-----~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 237 -----------------VEAAIH-----PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp -----------------TTTCCC-----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred -----------------HhhccC-----CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 000000 112368899999999999999999999999999999753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=378.99 Aligned_cols=261 Identities=28% Similarity=0.476 Sum_probs=215.8
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccC----hhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH----VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
++|++++.||+|+||.||+|.+..+++.||+|+++..... ......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN----- 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-----
Confidence 4699999999999999999999999999999998643221 1235678899999999999999999999854
Q ss_pred CCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCC----CeEEeeeccc
Q 010489 189 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDFGLA 263 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~----~vkl~DFG~a 263 (509)
....|+||||++ ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 345899999997 69999998888899999999999999999999999999999999999999887 8999999999
Q ss_pred ccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChh
Q 010489 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (509)
........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 160 ~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 231 (283)
T 3bhy_A 160 HKIEAGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD-- 231 (283)
T ss_dssp EECC------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC--
T ss_pred eeccCCCc----ccccCCCcCccCcceecC--CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc--
Confidence 86533221 244579999999999877 6789999999999999999999999998776554444332211111
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
...++..++.+.+||.+||..||.+|||+.++|+||||+.+..
T Consensus 232 -------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 232 -------------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp -------------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred -------------------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 1112356788999999999999999999999999999987543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=389.18 Aligned_cols=282 Identities=31% Similarity=0.522 Sum_probs=226.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCC-cEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCC------cceeeeeecCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTG-ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD------IVEIKHIMLPP 184 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~-~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~~~~~~~~~ 184 (509)
.++|++.+.||+|+||.||+|.+..++ ..||||+++.. ......+.+|+.+++.++|++ ++.+++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~-- 92 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN-- 92 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE--
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee--
Confidence 468999999999999999999998777 68999999642 234566788999999998766 888888774
Q ss_pred CcCCCCcEEEEEecccccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEE-------------
Q 010489 185 SRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA------------- 249 (509)
Q Consensus 185 ~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl------------- 249 (509)
....+|+||||++++|.+.+.... .+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 93 ---~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 93 ---FHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp ---ETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred ---eCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence 334689999999999988887654 79999999999999999999999999999999999999
Q ss_pred ------CCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCC
Q 010489 250 ------NADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 323 (509)
Q Consensus 250 ------~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 323 (509)
+.++.+||+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH------HTTIVATRHYRPPEVILE--LGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC------CCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccCCCcEEEeecCcccccccc------ccCCcCCCcccCCeeeec--CCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 56789999999999864322 134689999999999987 6899999999999999999999999999
Q ss_pred CChHhHHHHHHHhcCCCChhHHHHhhhHHH--------------HHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccC
Q 010489 324 KNVVHQLDLMTDLLGTPSTESISRIRNEKA--------------RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAF 389 (509)
Q Consensus 324 ~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 389 (509)
.+..+.+..+...++..+...+........ ..+...... ............++++.+||.+||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK-PLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC-CGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCC-cccccccccchhHHHHHHHHHHHhcC
Confidence 999889999999999888776654322110 000000000 00000011122356789999999999
Q ss_pred CCCCCCCHHHHhcCCcccCCc
Q 010489 390 DPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 390 dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
||.+|||++|+|+||||+++.
T Consensus 321 dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 321 DPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp STTTSCCHHHHTTSGGGGGCC
T ss_pred ChhhCcCHHHHhcChhhcCCC
Confidence 999999999999999998764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=389.62 Aligned_cols=259 Identities=28% Similarity=0.488 Sum_probs=214.8
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccC------hhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH------VSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~------~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~ 185 (509)
++|++.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+++.+ .||||+++++++..
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 171 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-- 171 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--
Confidence 5799999999999999999999999999999998643211 11245678999999999 79999999999843
Q ss_pred cCCCCcEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 186 RREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
....|+||||++| +|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.
T Consensus 172 ---~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 172 ---SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp ---SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred ---CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 4568999999985 899999888889999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccccccccccccccc----cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCC
Q 010489 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340 (509)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~ 340 (509)
....... ....+||+.|+|||++.+. ...++.++|||||||++|+|++|..||.+.+....+..+.......
T Consensus 249 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 324 (365)
T 2y7j_A 249 HLEPGEK----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF 324 (365)
T ss_dssp ECCTTCC----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred ccCCCcc----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 6543221 2456899999999987542 1358889999999999999999999998876555444433211111
Q ss_pred ChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010489 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (509)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 407 (509)
. ...+...++.+.+||.+||..||++|||++++|+||||+
T Consensus 325 ~---------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 325 S---------------------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp C---------------------------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred C---------------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 1 011235678899999999999999999999999999996
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=410.12 Aligned_cols=263 Identities=24% Similarity=0.344 Sum_probs=214.6
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++.. ..
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-----KT 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-----CC
Confidence 4689999999999999999999999999999999964321 12234678899999999999999999999854 35
Q ss_pred cEEEEEeccc-ccHHHHHHhC----CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 191 DIYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
.+|+|||||+ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 6999999998 5899988763 3699999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
....... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.........+.
T Consensus 339 ~~~~~~~---~~~~~GT~~Y~APE~l~~--~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~----------- 402 (543)
T 3c4z_A 339 LKAGQTK---TKGYAGTPGFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK----------- 402 (543)
T ss_dssp CCTTCCC---BCCCCSCTTTSCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHH-----------
T ss_pred ccCCCcc---cccccCCccccChhhhcC--CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHH-----------
Confidence 5433221 244689999999999987 689999999999999999999999998754211111000
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCcC
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLAN 411 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~f~~~~~ 411 (509)
.. .+. .. .. ....+++.+.+||.+||+.||.+||+ ++++++||||+++.+
T Consensus 403 ~~--------i~~---~~--~~---~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 403 QR--------VLE---QA--VT---YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp HH--------HHH---CC--CC---CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred HH--------Hhh---cc--cC---CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence 00 000 00 00 11357899999999999999999996 589999999998654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=380.58 Aligned_cols=259 Identities=23% Similarity=0.387 Sum_probs=196.3
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||.||+|.+..+|+.||||+++...........+.++...++.+.||||+++++++... ..
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-----~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE-----GD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc-----CC
Confidence 4689999999999999999999999999999999975433333334444555557888999999999999543 45
Q ss_pred EEEEEecccccHHHHHHh----CCCCCHHHHHHHHHHHHhHhhhhhhC-CeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 192 IYVVFELMESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~-~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
.|+||||++++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 81 VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 899999999988777643 56899999999999999999999998 9999999999999999999999999999765
Q ss_pred cCCCCCccccccccccccccccccccc--ccCCCCCceeeehhhhHHHHHHhCCCCCCCCCh-HhHHHHHHHhcCCCChh
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV-VHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~g~~~~~ 343 (509)
..... .....||+.|+|||++.. ....++.++|||||||++|+|++|+.||..... ...+.....
T Consensus 161 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------- 228 (290)
T 3fme_A 161 VDDVA----KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE-------- 228 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH--------
T ss_pred ccccc----ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc--------
Confidence 43322 233479999999999631 115788999999999999999999999976332 111111110
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
...+ ......+++++.+||.+||+.||++|||+.|+++||||+.
T Consensus 229 ------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 229 ------------------EPSP---QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp ------------------SCCC---CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ------------------cCCC---CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 0001 0112356889999999999999999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=378.34 Aligned_cols=257 Identities=23% Similarity=0.389 Sum_probs=215.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-----RK 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-----CC
Confidence 4689999999999999999999999999999999864211 11224568899999999999999999999854 35
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 6899999998 599999988888999999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 168 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------------- 227 (284)
T 2vgo_A 168 R-----RRTMCGTLDYLPPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------------- 227 (284)
T ss_dssp C-----BCCCCSCGGGCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------------
T ss_pred c-----cccccCCCCcCCHHHhcc--CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc-------------
Confidence 1 234689999999999887 67899999999999999999999999876654433222110
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
... ..+.+++.+.+||.+||..||.+||+++++++||||+....
T Consensus 228 -------------~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 228 -------------DLK-----FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp -------------CCC-----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred -------------ccC-----CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 000 11346889999999999999999999999999999986543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=377.08 Aligned_cols=261 Identities=29% Similarity=0.435 Sum_probs=219.1
Q ss_pred CCCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 110 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 110 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 86 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED----- 86 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-----
Confidence 44578999999999999999999999999999999986532 233455678899999999999999999999854
Q ss_pred CCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 189 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
...+|+||||++ ++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 87 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 87 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 356899999998 6899999888899999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+..
T Consensus 167 ~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------------ 229 (294)
T 2rku_A 167 YDGER---KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK------------ 229 (294)
T ss_dssp STTCC---BCCCCSCCSSCCHHHHTT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT------------
T ss_pred cCccc---cccccCCCCcCCcchhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh------------
Confidence 32221 244679999999999877 6789999999999999999999999987665433222211
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
.... ....+++.+.+||.+||..||++|||++++++||||.....
T Consensus 230 --------------~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 230 --------------NEYS-----IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp --------------TCCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred --------------ccCC-----CccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence 0000 11246788999999999999999999999999999986543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=379.89 Aligned_cols=267 Identities=23% Similarity=0.404 Sum_probs=215.8
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc--ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE--HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
.++|++++.||+|+||.||+|.+..+++.||||+++.... .......+.+|+.+++.++||||+++++++... +.
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---EK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---CC
Confidence 3689999999999999999999999999999999964321 123456788999999999999999999998543 23
Q ss_pred CcEEEEEecccccHHHHHHh--CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 190 KDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 190 ~~~~lv~e~~~~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
..+|+||||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 81 QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp -CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 46899999999888888865 3579999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
..... .......||+.|+|||++.+....++.++|||||||++|||++|+.||.+.+.......+...
T Consensus 161 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~----------- 228 (305)
T 2wtk_C 161 PFAAD-DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG----------- 228 (305)
T ss_dssp TTCSS-CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-----------
T ss_pred ccccc-cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC-----------
Confidence 32221 123456799999999998763233477999999999999999999999887654433322110
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCC
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 413 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 413 (509)
.. .....+++.+.+||.+||..||.+|||++++++||||+......
T Consensus 229 ---------------~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 229 ---------------SY-----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp ---------------CC-----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred ---------------CC-----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence 00 01135688999999999999999999999999999998765543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=397.72 Aligned_cols=269 Identities=17% Similarity=0.135 Sum_probs=194.5
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHc--CCCCcceeeeeec-------
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL--RHPDIVEIKHIML------- 182 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l--~h~niv~~~~~~~------- 182 (509)
..|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.| +||||++++..+.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 359999999999999999999999999999999976433 234456677886655555 5999887553332
Q ss_pred CCCc------------CCCCcEEEEEecccccHHHHHHhC-CCCCHHHH------HHHHHHHHhHhhhhhhCCeeecCCC
Q 010489 183 PPSR------------REFKDIYVVFELMESDLHQVIKAN-DDLTPEHY------QFFLYQLLRGLKYIHTANVFHRDLK 243 (509)
Q Consensus 183 ~~~~------------~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~------~~i~~qil~aL~yLH~~~ivHrDlK 243 (509)
.... .....+|+|||||+++|.+++... ..+.+... ..++.||+.||+|||++||+|||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 1111 011458999999999999999764 34455555 5777999999999999999999999
Q ss_pred CCcEEECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCC
Q 010489 244 PKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 323 (509)
Q Consensus 244 p~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 323 (509)
|+|||++.+|.+||+|||+|+..... .....||+.|+|||++.+....++.++|||||||++|||++|+.||.+
T Consensus 222 p~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 222 PDNLFIMPDGRLMLGDVSALWKVGTR------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp GGGEEECTTSCEEECCGGGEEETTCE------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred HHHEEECCCCCEEEEecceeeecCCC------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999864211 124567799999999865334789999999999999999999999987
Q ss_pred CChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 324 KNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 324 ~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
...... ..+.. . ..............++.+++.+.+||.+||+.||++|||+.++|+|
T Consensus 296 ~~~~~~-------------~~~~~--------~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 296 VTPGIK-------------GSWKR--------P-SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp CCTTCT-------------TCCCB--------C-CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred cCcccc-------------cchhh--------h-hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 642100 00000 0 0000000111112235789999999999999999999999999999
Q ss_pred CcccCC
Q 010489 404 PYFHGL 409 (509)
Q Consensus 404 p~f~~~ 409 (509)
|||+++
T Consensus 354 p~f~~~ 359 (371)
T 3q60_A 354 PEFLQL 359 (371)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=375.26 Aligned_cols=263 Identities=28% Similarity=0.438 Sum_probs=217.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-------ChhhHHhHHHHHHHHHHcC-CCCcceeeeeecC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-------HVSDATRILREIKLLRLLR-HPDIVEIKHIMLP 183 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~ 183 (509)
.++|++.+.||+|+||.||+|.+..+|+.||||+++.... .......+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 4689999999999999999999999999999999864321 0122456789999999996 9999999999843
Q ss_pred CCcCCCCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecc
Q 010489 184 PSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 262 (509)
Q Consensus 184 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 262 (509)
....|+||||++ ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 96 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 96 -----NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp -----SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred -----CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccc
Confidence 456899999998 59999998888899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccccccccccc----cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcC
Q 010489 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338 (509)
Q Consensus 263 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g 338 (509)
+........ .....||+.|+|||++.+. ...++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 171 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~- 245 (298)
T 1phk_A 171 SCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN- 245 (298)
T ss_dssp CEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-
T ss_pred hhhcCCCcc----cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCC-
Confidence 986543221 2456899999999987521 2468889999999999999999999998876544433332210
Q ss_pred CCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
.......++.+++.+.+||.+||..||.+|||+.++|+||||++..
T Consensus 246 --------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 246 --------------------------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp --------------------------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred --------------------------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 0001112345788999999999999999999999999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=378.56 Aligned_cols=263 Identities=28% Similarity=0.353 Sum_probs=209.3
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++. ...
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE-----EDD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE-----CSS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee-----eCC
Confidence 368999999999999999999999999999999985432 23344577899999999999999999999984 345
Q ss_pred cEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|+||||+++ +|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 68999999985 99999998889999999999999999999999999999999999999999999999999999865332
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..........
T Consensus 165 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~-------------- 226 (294)
T 4eqm_A 165 SLT--QTNHVLGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ-------------- 226 (294)
T ss_dssp ------------CCSSCCHHHHHT--CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS--------------
T ss_pred ccc--ccCccccCccccCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh--------------
Confidence 211 1234679999999999887 6789999999999999999999999988765333211110
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
...+.......+.+++.+.++|.+||+.||.+||+..+.+.+.|..-+
T Consensus 227 ------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 227 ------------DSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp ------------SCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred ------------ccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 111111112234678899999999999999999966666666665443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=374.30 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=205.8
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|++++.||+|+||.||+|.+..+++.||||+++...........+.+|+..+..+ +||||+++++++.. ...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----~~~ 85 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----DDH 85 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----TTE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence 579999999999999999999999999999999976555555667889999999999 89999999999854 346
Q ss_pred EEEEEecccc-cHHHHHHhC----CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC--------------
Q 010489 192 IYVVFELMES-DLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-------------- 252 (509)
Q Consensus 192 ~~lv~e~~~~-~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~-------------- 252 (509)
+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 8999999975 999999764 679999999999999999999999999999999999999844
Q ss_pred -----CCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChH
Q 010489 253 -----CKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 327 (509)
Q Consensus 253 -----~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 327 (509)
+.+||+|||++...... ....||+.|+|||++.+. ..++.++|||||||++|+|++|.+|+......
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 237 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH
T ss_pred ccCCceEEEEcccccccccCCc-------cccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhHH
Confidence 47999999999865332 224699999999998762 35678999999999999999999877543321
Q ss_pred hHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010489 328 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (509)
Q Consensus 328 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 407 (509)
.. +. . ... ......+++.+.+||.+||..||++|||+.++++||||.
T Consensus 238 ~~---~~-----------------------~---~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 284 (289)
T 1x8b_A 238 HE---IR-----------------------Q---GRL----PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284 (289)
T ss_dssp HH---HH-----------------------T---TCC----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred HH---HH-----------------------c---CCC----CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence 11 10 0 000 111235789999999999999999999999999999997
Q ss_pred CC
Q 010489 408 GL 409 (509)
Q Consensus 408 ~~ 409 (509)
+.
T Consensus 285 ~~ 286 (289)
T 1x8b_A 285 SA 286 (289)
T ss_dssp --
T ss_pred hh
Confidence 53
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=374.23 Aligned_cols=257 Identities=27% Similarity=0.467 Sum_probs=190.6
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-----SN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-----SS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-----CC
Confidence 4679999999999999999999999999999999864211 11224678899999999999999999999854 35
Q ss_pred cEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 191 DIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
.+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 6899999997 5899988765 5799999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........+..+
T Consensus 165 ~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------------- 224 (278)
T 3cok_A 165 PHEK---HYTLCGTPNYISPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV--------------- 224 (278)
T ss_dssp --------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C---------------
T ss_pred CCCc---ceeccCCCCcCCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH---------------
Confidence 2211 234579999999999877 67899999999999999999999999875532211100
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.... . .....+++++.+||.+||..||++|||++++++||||...
T Consensus 225 ------------~~~~-~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 225 ------------VLAD-Y---EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp ------------CSSC-C---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred ------------hhcc-c---CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 0000 0 1113468899999999999999999999999999999753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=372.60 Aligned_cols=260 Identities=27% Similarity=0.404 Sum_probs=212.5
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++.. ....
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 80 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ 80 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-----CCEE
Confidence 579999999999999999999999999999999864322 2345678899999999999999999999843 3568
Q ss_pred EEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 193 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 193 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
|+||||+++ +|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 999999984 8999988777899999999999999999999999999999999999999999999999999976432221
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHH-HHHHHhcCCCChhHHHHhhh
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQL-DLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~-~~i~~~~g~~~~~~~~~~~~ 350 (509)
........||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+....... ..+.
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------- 222 (276)
T 2yex_A 161 -ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK---------------- 222 (276)
T ss_dssp -ECCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH----------------
T ss_pred -hhcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh----------------
Confidence 1113456899999999998762 23477899999999999999999999875532111 1000
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
. .. .....+..+++.+.+||.+||..||.+|||++++++||||+..
T Consensus 223 -------~---~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 223 -------E---KK---TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp -------T---TC---TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred -------h---cc---cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 0 00 0011123578899999999999999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=390.76 Aligned_cols=284 Identities=22% Similarity=0.335 Sum_probs=216.5
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||.||+|.+..++..||+|++.... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 105 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGE 105 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TTE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CCE
Confidence 468999999999999999999999999999999987532 33445778999999999999999999999854 345
Q ss_pred EEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhC-CeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~-~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+|+||||+++ +|.+++...+.+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 8999999984 9999999888999999999999999999999996 9999999999999999999999999999754322
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHh-cCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL-LGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-~g~~~~~~~~~~ 348 (509)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+... .+..........
T Consensus 186 ~-----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3eqc_A 186 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258 (360)
T ss_dssp C---------CCCCTTCCHHHHTT--CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred c-----ccCCCCCCCeECHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence 1 234689999999999987 68999999999999999999999999887654432222111 111100000000
Q ss_pred hh--------------HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 349 RN--------------EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 349 ~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
.. ......+.......+. ......+++++.+||.+||+.||.+|||++|+|+||||+...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP--KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp ---------------CCCHHHHHHHHHHSCCC--CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cCCCcccccccCCCCcccchhhhhHHhccCCC--CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 00 0000000000011111 111234688999999999999999999999999999998643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=388.24 Aligned_cols=287 Identities=24% Similarity=0.361 Sum_probs=223.1
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-----------CCCcceeeee
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-----------HPDIVEIKHI 180 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~~~~~ 180 (509)
.++|++++.||+|+||.||+|.+..+++.||||++.. .......+.+|+.+++.+. ||||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 4689999999999999999999999999999999964 2234566788999998886 8999999999
Q ss_pred ecCCCcCCCCcEEEEEecccccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhC-CeeecCCCCCcEEEC------C
Q 010489 181 MLPPSRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILAN------A 251 (509)
Q Consensus 181 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~-~ivHrDlKp~NILl~------~ 251 (509)
+.... .....+++||||++++|.+++... ..+++..+..++.||+.||+|||++ ||+||||||+|||++ .
T Consensus 95 ~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 95 FNHKG-PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEEEE-TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred hhccC-CCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence 85432 123368999999988999999764 4699999999999999999999998 999999999999994 4
Q ss_pred CCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCC------
Q 010489 252 DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN------ 325 (509)
Q Consensus 252 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~------ 325 (509)
.+.+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+
T Consensus 174 ~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp EEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred cceEEEcccccccccCCC------CCCCCCCccccCcHHHhC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 458999999999865332 234589999999999987 679999999999999999999999998764
Q ss_pred hHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCC-------------CCCCCCCHHHHHHHHHhccCCCC
Q 010489 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFS-------------HKFPNADPLALHLLERLLAFDPK 392 (509)
Q Consensus 326 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~li~~~L~~dP~ 392 (509)
..+.+..+...+|.++...+....... .++............ ......++++.+||.+||+.||.
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 323 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTR--TFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 323 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHH--HHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhh--hhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence 456777788888888876654432211 111100000000000 00123456789999999999999
Q ss_pred CCCCHHHHhcCCcccCCcCC
Q 010489 393 DRPTAEEALADPYFHGLANV 412 (509)
Q Consensus 393 ~Rpt~~e~l~hp~f~~~~~~ 412 (509)
+|||++|+|+||||++....
T Consensus 324 ~Rpt~~ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 324 KRADAGGLVNHPWLKDTLGM 343 (373)
T ss_dssp TCBCHHHHHTCGGGTTCTTC
T ss_pred ccCCHHHHhhChhhhcccCc
Confidence 99999999999999876543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=381.03 Aligned_cols=258 Identities=24% Similarity=0.359 Sum_probs=209.2
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCc---EEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGE---RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~---~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
..++|++.+.||+|+||.||+|.+..++. .||||+++... .......+.+|+.+|+.++||||+++++++.
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 120 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVT----- 120 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence 45789999999999999999999986655 49999997532 3345577899999999999999999999984
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 188 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
+...+|+||||++ ++|.+++... +.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 3456899999997 5999999654 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
...............+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+....+....+....
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~------- 271 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAF--RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY------- 271 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC-------
T ss_pred cccCccceeeccCCCCcccccCHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-------
Confidence 6544333333344567889999999876 678999999999999999999 999998876544433332110
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
..+ ....+++.+.+||.+||..||.+|||+.++++ .++.
T Consensus 272 ------------------~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~--~L~~ 310 (325)
T 3kul_A 272 ------------------RLP-----APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS--VLDA 310 (325)
T ss_dssp ------------------CCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred ------------------CCC-----CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH--HHHH
Confidence 001 11357889999999999999999999999988 4443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=375.31 Aligned_cols=260 Identities=33% Similarity=0.539 Sum_probs=216.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.. ...
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 95 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SSS 95 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-----CCe
Confidence 358999999999999999999999999999999997554444556788999999999999999999999854 346
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC---CCeEEeeeccccccc
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVSF 267 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~---~~vkl~DFG~a~~~~ 267 (509)
+|+||||+. ++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 899999997 5899998888889999999999999999999999999999999999999764 469999999998653
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
.... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 176 ~~~~----~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------- 238 (287)
T 2wei_A 176 QNTK----MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK---------- 238 (287)
T ss_dssp CCSS----CSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred CCCc----cccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----------
Confidence 3221 234578999999999875 58899999999999999999999998877544433332210
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
... ....+..+++++.+||.+||..||.+|||+.++|+||||++..
T Consensus 239 ----------------~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 239 ----------------YAF-DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp ----------------CCC-CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred ----------------CCC-CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 000 0112346788999999999999999999999999999998653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=392.04 Aligned_cols=265 Identities=23% Similarity=0.373 Sum_probs=210.8
Q ss_pred CCCeeEeeeeeccCceEEEEEEEc---CCCcEEEEEEecCccc--ChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFE--HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~~--~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~ 185 (509)
.++|++++.||+|+||.||+|++. .+++.||||+++.... .......+.+|+.+|+.+ .||||+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 130 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 130 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence 368999999999999999999984 5899999999864321 122334567899999999 69999999999843
Q ss_pred cCCCCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 186 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
...+|+|||||+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 131 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 131 ---ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp ---TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred ---CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 346899999998 5999999888899999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
....... ......+||+.|+|||++.+....++.++|||||||++|||++|+.||...........+..
T Consensus 208 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~--------- 276 (355)
T 1vzo_A 208 EFVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--------- 276 (355)
T ss_dssp ECCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH---------
T ss_pred ecccCCC--CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH---------
Confidence 6432221 12245689999999999875334578999999999999999999999976543211111110
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCc
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~ 410 (509)
.... ... .....+++.+.+||.+||..||.+|| +++++++||||+.+.
T Consensus 277 ----------~~~~---~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 277 ----------RILK---SEP-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp ----------HHHH---CCC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred ----------HHhc---cCC-----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 0000 011 11235788899999999999999999 999999999998764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=382.89 Aligned_cols=259 Identities=33% Similarity=0.528 Sum_probs=206.8
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc------ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE------HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~------~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 186 (509)
++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++...
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 87 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-- 87 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS--
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC--
Confidence 479999999999999999999999999999999864321 112234678999999999999999999998432
Q ss_pred CCCCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCC---eEEeeecc
Q 010489 187 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGL 262 (509)
Q Consensus 187 ~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~---vkl~DFG~ 262 (509)
.+|+||||++ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 88 ----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 88 ----DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp ----SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred ----ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 3799999998 589999988889999999999999999999999999999999999999987665 99999999
Q ss_pred cccccCCCCCccccccccccccccccccccc-ccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHH-HHHHHhcCCC
Q 010489 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQL-DLMTDLLGTP 340 (509)
Q Consensus 263 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~-~~i~~~~g~~ 340 (509)
+...... .......||+.|+|||++.+ ....++.++|||||||++|+|++|..||.+......+ ..+....
T Consensus 164 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--- 236 (322)
T 2ycf_A 164 SKILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK--- 236 (322)
T ss_dssp CEECCCC----HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC---
T ss_pred ceecccc----cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc---
Confidence 9865321 11244679999999998742 1257889999999999999999999999765432111 1111100
Q ss_pred ChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
.......+..+++.+.+||.+||..||++||+++++|+||||+.
T Consensus 237 ------------------------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 237 ------------------------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp ------------------------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred ------------------------cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 00011122457889999999999999999999999999999974
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=371.41 Aligned_cols=256 Identities=27% Similarity=0.442 Sum_probs=205.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-----PT 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----CC
Confidence 4689999999999999999999999999999999864211 12234578899999999999999999999854 34
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 6899999997 599999988888999999999999999999999999999999999999999999999999999865332
Q ss_pred CCCcccccccccccccccccccccccCCC-CCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
.. .....||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.........+...
T Consensus 165 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------ 226 (276)
T 2h6d_A 165 EF----LRTSCGSPNYAAPEVISG--RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG------------ 226 (276)
T ss_dssp ----------------CCTGGGTT--SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred cc----eecccCCccccCHHHHcC--CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC------------
Confidence 21 234579999999999876 343 68999999999999999999999876643333222110
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
... ....+++.+.+||.+||+.||.+|||++++++||||++.
T Consensus 227 --------------~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 227 --------------VFY-----IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp --------------CCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred --------------ccc-----CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 000 012467889999999999999999999999999999753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=375.46 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=200.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||+|+||+||+|.+ +|..||||++............+.+|+.+|+.++||||+++++++... ..
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~ 108 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP-----PN 108 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-----TC
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----Cc
Confidence 46899999999999999999976 588999999976555555667889999999999999999999999543 45
Q ss_pred EEEEEeccc-ccHHHHHHhCCC---CCHHHHHHHHHHHHhHhhhhhhCC--eeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 192 IYVVFELME-SDLHQVIKANDD---LTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~---l~~~~~~~i~~qil~aL~yLH~~~--ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
+|+||||++ ++|.+++...+. +++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 899999998 589999987653 999999999999999999999999 99999999999999999999999999975
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+....
T Consensus 189 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~-------- 255 (309)
T 3p86_A 189 KASTFL---SSKSAAGTPEWMAPEVLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC-------- 255 (309)
T ss_dssp ----------------CCTTSCHHHHTT--CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC--------
T ss_pred cccccc---ccccCCCCccccChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--------
Confidence 432221 1245689999999999987 678999999999999999999999998776543332221100
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
... .....+++.+.+||.+||+.||.+|||++++++
T Consensus 256 ----------------~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 256 ----------------KRL-----EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp ----------------CCC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCC-----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 000 112357889999999999999999999999998
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=375.03 Aligned_cols=262 Identities=23% Similarity=0.388 Sum_probs=208.3
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
..++|++++.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++++... .
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 89 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-----G 89 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----C
Confidence 346899999999999999999999999999999998643 223456788999999999999999999998543 4
Q ss_pred cEEEEEecccc-cHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 191 DIYVVFELMES-DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 191 ~~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
.+|+||||+++ +|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 90 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred eEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 58999999985 78887765 46799999999999999999999999999999999999999999999999998754211
Q ss_pred CCCCccccccccccccccccccccc---ccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
... ......||+.|+|||++.. ....++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 170 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------- 237 (302)
T 2j7t_A 170 TLQ---KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--------- 237 (302)
T ss_dssp HHH---C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---------
T ss_pred ccc---ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc---------
Confidence 110 1134579999999998731 1157889999999999999999999999877654333222111
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
..+. ......+++.+.+||.+||..||.+|||+.++++||||+.+.
T Consensus 238 -----------------~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 238 -----------------DPPT--LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp -----------------CCCC--CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred -----------------CCcc--cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 0000 011134678899999999999999999999999999998753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=374.72 Aligned_cols=264 Identities=24% Similarity=0.408 Sum_probs=208.0
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCc-CC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSR-RE 188 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~-~~ 188 (509)
..++|++++.||+|+||.||+|.+..+|+.||||++.... .....+.+|+.+++.+ +||||+++++++..... ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 4578999999999999999999999999999999986432 2345678999999999 79999999999865321 11
Q ss_pred CCcEEEEEecccc-cHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 189 FKDIYVVFELMES-DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 189 ~~~~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
...+|+||||+++ +|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 178 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-
T ss_pred cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCcee
Confidence 3568999999985 999999764 4799999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccccccccccccccc---cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCCh
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~ 342 (509)
...... ......||+.|+|||++... ...++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 179 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------ 249 (326)
T 2x7f_A 179 LDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN------ 249 (326)
T ss_dssp ---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------
T ss_pred cCcCcc---ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC------
Confidence 532221 12345799999999998621 156889999999999999999999999876654333222110
Q ss_pred hHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
..+ ......+++.+.+||.+||..||.+||+++++++||||+..
T Consensus 250 --------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 250 --------------------PAP---RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp --------------------CCC---CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred --------------------ccc---cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 000 01123568899999999999999999999999999999753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=374.11 Aligned_cols=256 Identities=28% Similarity=0.470 Sum_probs=208.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||.||+|.+..+|+.||||++... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 98 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTD 98 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT----SCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch----HHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCE
Confidence 46899999999999999999999999999999998642 234567899999999999999999999854 345
Q ss_pred EEEEEecccc-cHHHHHH-hCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELMES-DLHQVIK-ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~~-~L~~~l~-~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+|+||||+++ +|.+++. ....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred EEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 8999999985 8999886 4568999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 179 ~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------- 240 (314)
T 3com_A 179 MA---KRNTVIGTPFWMAPEVIQE--IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN------------- 240 (314)
T ss_dssp BS---CBCCCCSCGGGCCHHHHSS--SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-------------
T ss_pred cc---ccCccCCCCCccChhhcCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC-------------
Confidence 22 1244689999999999877 67899999999999999999999999876643332221110
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.+..+ .....+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 241 --------------~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 241 --------------PPPTF-RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp --------------CCCCC-SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred --------------CCccc-CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 00000 1112357889999999999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=379.26 Aligned_cols=276 Identities=22% Similarity=0.366 Sum_probs=209.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||+|+||.||+|.+..+++.||||+++.... ......+.+|+.+|+.++||||+++++++.... ...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~ 83 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRH 83 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCC
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---Cce
Confidence 4689999999999999999999999999999999974322 233566789999999999999999999886432 246
Q ss_pred EEEEEeccc-ccHHHHHHhCC---CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEE----CCCCCeEEeeeccc
Q 010489 192 IYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFGLA 263 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl----~~~~~vkl~DFG~a 263 (509)
+|+||||++ ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 899999998 68999997643 39999999999999999999999999999999999999 88888999999999
Q ss_pred ccccCCCCCcccccccccccccccccccccc------cCCCCCceeeehhhhHHHHHHhCCCCCCCCChH-hHHHHHHHh
Q 010489 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV-HQLDLMTDL 336 (509)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~ 336 (509)
+....... ....+||+.|+|||++... ...++.++|||||||++|||++|+.||...... .....+..+
T Consensus 164 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 239 (319)
T 4euu_A 164 RELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (319)
T ss_dssp EECCTTCC----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred eecCCCCc----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence 87543322 2456899999999987521 157889999999999999999999999754322 222222222
Q ss_pred cCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCC-------CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCc
Q 010489 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSH-------KFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405 (509)
Q Consensus 337 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 405 (509)
+...+...+..+.. ....+..+.. ....+++.+.+||.+||+.||++|||++|+|+||-
T Consensus 240 ~~~~p~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 240 ITGKPSGAISGVQK----------AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHCCTTCCEEEEC----------STTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred hcCCCcccchhhhc----------ccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 21111111100000 0000111111 11234567899999999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=369.60 Aligned_cols=259 Identities=29% Similarity=0.449 Sum_probs=212.8
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++... ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCce
Confidence 4689999999999999999999999999999999975444455667889999999999999999999987532 2346
Q ss_pred EEEEEeccc-ccHHHHHHhC----CCCCHHHHHHHHHHHHhHhhhhhhCC-----eeecCCCCCcEEECCCCCeEEeeec
Q 010489 192 IYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDFG 261 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~~-----ivHrDlKp~NILl~~~~~vkl~DFG 261 (509)
+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 899999998 5899988653 34999999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCC
Q 010489 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341 (509)
Q Consensus 262 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~ 341 (509)
++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 162 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~----- 231 (279)
T 2w5a_A 162 LARILNHDT---SFAKTFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----- 231 (279)
T ss_dssp HHHHC---C---HHHHHHHSCCTTCCHHHHHC--C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----
T ss_pred hheeecccc---ccccccCCCccccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc-----
Confidence 997653221 11234579999999999877 67899999999999999999999999877643332222110
Q ss_pred hhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
. . ......+++++.+||.+||..||.+||++.++|+|+|+..
T Consensus 232 ---------------------~-~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 232 ---------------------K-F---RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp ---------------------C-C---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred ---------------------c-c---ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 0 0 0111356889999999999999999999999999999965
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=380.82 Aligned_cols=252 Identities=25% Similarity=0.406 Sum_probs=206.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEc-------CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDT-------HTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLP 183 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~-------~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~ 183 (509)
.++|++++.||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+|+.+ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 368999999999999999999864 34568999999754 2334567889999999999 89999999999854
Q ss_pred CCcCCCCcEEEEEeccc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCc
Q 010489 184 PSRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 246 (509)
Q Consensus 184 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~N 246 (509)
...+|+||||++ |+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|
T Consensus 159 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 159 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred -----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 345899999998 59999997653 48999999999999999999999999999999999
Q ss_pred EEECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCC
Q 010489 247 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 325 (509)
Q Consensus 247 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~ 325 (509)
||++.++.+||+|||+++........ .......||+.|+|||++.+ ..|+.++|||||||++|||++ |..||.+..
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTT-CTTTTTTSCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEECCCCCEEEccccCCcccCcccce-ecccCCCcccceECHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999999865432221 11234567899999999877 689999999999999999999 999998866
Q ss_pred hHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 326 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..+....+... ... .....+++++.+||.+||..||.+||++.|+++
T Consensus 311 ~~~~~~~~~~~---------------------------~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 311 VEELFKLLKEG---------------------------HRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp GGGHHHHHHTT---------------------------CCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcC---------------------------CCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 44333222110 000 112357889999999999999999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=378.31 Aligned_cols=263 Identities=25% Similarity=0.423 Sum_probs=191.1
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHH-HHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK-LLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~-~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++++.||+|+||.||+|.+..+|+.||||+++.... ......+.+|+. +++.++||||+++++++... .
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-----~ 94 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-----G 94 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-----S
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-----C
Confidence 4689999999999999999999999999999999975422 234455666766 66778999999999998543 4
Q ss_pred cEEEEEecccccHHHHHHh-----CCCCCHHHHHHHHHHHHhHhhhhhhC-CeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 191 DIYVVFELMESDLHQVIKA-----NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~-----~~~l~~~~~~~i~~qil~aL~yLH~~-~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
..|+||||++++|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 6899999999998888763 56899999999999999999999999 99999999999999999999999999997
Q ss_pred cccCCCCCcccccccccccccccccccccc--cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCCh
Q 010489 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342 (509)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~ 342 (509)
....... .....||+.|+|||++... ...++.++|||||||++|+|++|+.||.+..... ..+
T Consensus 175 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~--------- 239 (327)
T 3aln_A 175 QLVDSIA----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQL--------- 239 (327)
T ss_dssp C----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------
T ss_pred ecccccc----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HHH---------
Confidence 6533221 2334799999999998321 1568999999999999999999999997643210 000
Q ss_pred hHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
........+.........+++.+.+||.+||..||.+|||+.++++||||...
T Consensus 240 --------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 240 --------------TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp --------------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred --------------HHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 00011111111122334678999999999999999999999999999999754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=376.02 Aligned_cols=271 Identities=28% Similarity=0.419 Sum_probs=192.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++... ..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 87 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK-----DE 87 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESS-----SC
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeec-----CC
Confidence 4689999999999999999999998999999998864321 23356678999999999999999999998543 45
Q ss_pred EEEEEeccc-ccHHHHHHh--------CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecc
Q 010489 192 IYVVFELME-SDLHQVIKA--------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 262 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~--------~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 262 (509)
.|+||||++ ++|.+++.. .+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 899999997 589888863 45699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC--CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCC
Q 010489 263 ARVSFNDAP--SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340 (509)
Q Consensus 263 a~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~ 340 (509)
+........ .........||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+............. .+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~ 244 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN--DP 244 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS--SC
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc--CC
Confidence 976533211 11112345799999999998652 46889999999999999999999999876654333221110 00
Q ss_pred ChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
.. ..............++.+.+||.+||..||.+|||+.++++||||++..
T Consensus 245 ~~-------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 245 PS-------------------LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp CC-------------------TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred Cc-------------------cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 00 0000111223356788999999999999999999999999999998653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=368.68 Aligned_cols=254 Identities=27% Similarity=0.409 Sum_probs=212.8
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
.+|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.+.||||+++++++.. ...+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 95 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKL 95 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeE
Confidence 579999999999999999999999999999999864322 2345778899999999999999999999854 3458
Q ss_pred EEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 193 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 193 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
|+||||+++ +|.+++.. +.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 96 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp EEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 999999985 88888754 5799999999999999999999999999999999999999999999999999976543221
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+..
T Consensus 175 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------- 233 (303)
T 3a7i_A 175 ---KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK---------------- 233 (303)
T ss_dssp ---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH----------------
T ss_pred ---ccCccCCCcCccCHHHHhc--CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc----------------
Confidence 1245689999999999877 6789999999999999999999999987654332222211
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
..+. .....+++.+.+||.+||..||.+|||+.++++||||..
T Consensus 234 -----------~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 234 -----------NNPP---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp -----------SCCC---CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred -----------CCCC---CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 0010 112356888999999999999999999999999999965
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=375.41 Aligned_cols=265 Identities=22% Similarity=0.373 Sum_probs=193.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCc---EEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC-
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGE---RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR- 187 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~---~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~- 187 (509)
.++|++++.||+|+||.||+|.+..++. .||||+++...........+.+|+.+++.++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 4689999999999999999999887765 899999976544455677899999999999999999999998654321
Q ss_pred CCCcEEEEEecccc-cHHHHHHhCC------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeee
Q 010489 188 EFKDIYVVFELMES-DLHQVIKAND------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 260 (509)
Q Consensus 188 ~~~~~~lv~e~~~~-~L~~~l~~~~------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DF 260 (509)
.....|+||||+.+ +|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeec
Confidence 11235999999984 8998886432 5999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCC
Q 010489 261 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGT 339 (509)
Q Consensus 261 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~ 339 (509)
|+++......... ......+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 182 g~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~--- 255 (323)
T 3qup_A 182 GLSRKIYSGDYYR-QGCASKLPVKWLALESLAD--NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG--- 255 (323)
T ss_dssp CC------------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT---
T ss_pred ccccccccccccc-ccccccCcccccCchhhcC--CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC---
Confidence 9998653332211 1234467889999999877 679999999999999999999 99999887654443332211
Q ss_pred CChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-------HHHHhcCCcccCC
Q 010489 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-------AEEALADPYFHGL 409 (509)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-------~~e~l~hp~f~~~ 409 (509)
. . ....+.+++.+.+||.+||+.||.+||| ++++++|||+...
T Consensus 256 -----------------------~-~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 256 -----------------------N-R---LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp -----------------------C-C---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred -----------------------C-C---CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 0 0 0112457889999999999999999999 7888899999764
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=376.22 Aligned_cols=261 Identities=26% Similarity=0.414 Sum_probs=183.4
Q ss_pred CCCeeEee-eeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHH-HHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 112 ASRYQIQE-VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREI-KLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 112 ~~~y~i~~-~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei-~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
.++|.+.+ .||+|+||.||+|.+..+|+.||||++... ....+|+ ..++.+.||||+++++++.... ...
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~ 98 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-------PKARQEVDHHWQASGGPHIVCILDVYENMH-HGK 98 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-------HHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCC
Confidence 46899965 699999999999999999999999998542 1122333 3456779999999999985421 223
Q ss_pred CcEEEEEecccc-cHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC---CCCeEEeeeccc
Q 010489 190 KDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLA 263 (509)
Q Consensus 190 ~~~~lv~e~~~~-~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~---~~~vkl~DFG~a 263 (509)
..+|+|||||++ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 458999999985 9999998764 6999999999999999999999999999999999999986 455999999999
Q ss_pred ccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChh
Q 010489 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (509)
....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.
T Consensus 179 ~~~~~~~-----~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--------- 242 (336)
T 3fhr_A 179 KETTQNA-----LQTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK--------- 242 (336)
T ss_dssp EEC-----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred eeccccc-----cccCCCCcCccChhhhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---------
Confidence 8653222 234588999999999876 678899999999999999999999997654321110000
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
..+...........+..+++.+.+||.+||+.||.+|||++|+|+||||++..
T Consensus 243 --------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 243 --------------RRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp ----------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred --------------HhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 00000011111223456889999999999999999999999999999998644
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=383.17 Aligned_cols=256 Identities=21% Similarity=0.318 Sum_probs=207.2
Q ss_pred CCCeeEeeeeeccCceEEEEEE-----EcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAV-----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~-----~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 186 (509)
.++|++++.||+|+||.||+|. +..+++.||||+++.. ........+.+|+.+++.++||||+++++++...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-- 146 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-- 146 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence 4689999999999999999999 5567889999998643 2334556788999999999999999999998543
Q ss_pred CCCCcEEEEEeccc-ccHHHHHHhCC-------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCC---Ce
Q 010489 187 REFKDIYVVFELME-SDLHQVIKAND-------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KL 255 (509)
Q Consensus 187 ~~~~~~~lv~e~~~-~~L~~~l~~~~-------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~---~v 255 (509)
...|+|||||+ ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.+| .+
T Consensus 147 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 ---LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp ---SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ---CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 45799999997 59999997643 589999999999999999999999999999999999999655 49
Q ss_pred EEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHH
Q 010489 256 KICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMT 334 (509)
Q Consensus 256 kl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~ 334 (509)
||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+.
T Consensus 224 kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYY-RKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp EECCCHHHHHHHHHSSC-TTCCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred EECCCcccccccccccc-ccCCCcCCcccEECHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999754222111 11234578999999999877 689999999999999999998 999998877544443332
Q ss_pred HhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 335 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 335 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
... .. .....+++.+.+||.+||+.||.+|||+.++++|.++
T Consensus 301 ~~~---------------------------~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 301 SGG---------------------------RM---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp TTC---------------------------CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCC---------------------------CC---CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 210 00 0113567889999999999999999999999998776
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=370.68 Aligned_cols=259 Identities=24% Similarity=0.407 Sum_probs=208.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||+|+||.||+|.+..+++.||+|++.. ........+.+|+.+++.++||||+++++++.. ...
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~ 81 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKR 81 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CCe
Confidence 4689999999999999999999999999999999854 234556788999999999999999999999854 345
Q ss_pred EEEEEeccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+|+||||++ ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 82 LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp EEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred eEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 899999998 599999987 467999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCc-----------ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcC
Q 010489 270 APSA-----------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338 (509)
Q Consensus 270 ~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g 338 (509)
.... ......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~-------- 231 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING--RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD-------- 231 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT--------
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH--------
Confidence 2211 01124689999999999987 78999999999999999999999999764321000
Q ss_pred CCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
..... ...... ...+.+++.+.+||.+||+.||++|||+.++++ |++.+
T Consensus 232 --~~~~~--------~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l 280 (310)
T 3s95_A 232 --FGLNV--------RGFLDR----------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL 280 (310)
T ss_dssp --SSBCH--------HHHHHH----------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred --Hhhhh--------hccccc----------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence 00000 000000 011356778999999999999999999999998 66544
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=377.23 Aligned_cols=255 Identities=25% Similarity=0.430 Sum_probs=206.8
Q ss_pred CCCeeEeeeeeccCceEEEEEE-----EcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAV-----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~-----~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~ 185 (509)
.++|++++.||+|+||.||+|. +..+++.||||+++.. ........+.+|+.+++.+ .||||+++++++....
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 4689999999999999999998 5667899999999753 2334456789999999999 7899999999986432
Q ss_pred cCCCCcEEEEEeccc-ccHHHHHHhCCC----------------------------------------------------
Q 010489 186 RREFKDIYVVFELME-SDLHQVIKANDD---------------------------------------------------- 212 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~---------------------------------------------------- 212 (509)
..+|+|||||+ |+|.+++.....
T Consensus 100 ----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 100 ----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp ----SCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ----CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 34899999998 599999976543
Q ss_pred --------------CCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCcccccc
Q 010489 213 --------------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD 278 (509)
Q Consensus 213 --------------l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 278 (509)
+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ......
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~ 254 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGD 254 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-CEEC--
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-chhccc
Confidence 89999999999999999999999999999999999999999999999999986543322 122345
Q ss_pred cccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhh
Q 010489 279 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYL 357 (509)
Q Consensus 279 ~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 357 (509)
..||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+......+......
T Consensus 255 ~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~--------------------- 311 (359)
T 3vhe_A 255 ARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE--------------------- 311 (359)
T ss_dssp CEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH---------------------
T ss_pred cCCCceeEChhhhcC--CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc---------------------
Confidence 678999999999877 689999999999999999998 99999876543222211110
Q ss_pred hccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 358 GSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
.... .....+++++.+||.+||+.||.+|||+.++++|
T Consensus 312 -----~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 312 -----GTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp -----TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----CCCC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 0000 1113468899999999999999999999999984
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=378.01 Aligned_cols=273 Identities=19% Similarity=0.309 Sum_probs=210.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChh---------------hHHhHHHHHHHHHHcCCCCcce
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS---------------DATRILREIKLLRLLRHPDIVE 176 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~---------------~~~~~~~Ei~~l~~l~h~niv~ 176 (509)
.++|++++.||+|+||.||+|.+ +|+.||||++........ ....+.+|+.+++.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46899999999999999999998 899999999864221111 1267889999999999999999
Q ss_pred eeeeecCCCcCCCCcEEEEEecccc-cHHHH------HHh--CCCCCHHHHHHHHHHHHhHhhhhhh-CCeeecCCCCCc
Q 010489 177 IKHIMLPPSRREFKDIYVVFELMES-DLHQV------IKA--NDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKN 246 (509)
Q Consensus 177 ~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~------l~~--~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDlKp~N 246 (509)
+++++... ..+|+||||+++ +|.++ +.. ...+++..++.++.||+.||.|||+ .||+||||||+|
T Consensus 108 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp CSEEEESS-----SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred EEEEEeeC-----CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 99998543 468999999985 88887 655 5689999999999999999999999 999999999999
Q ss_pred EEECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCC-ceeeehhhhHHHHHHhCCCCCCCCC
Q 010489 247 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEMLTGKPLFPGKN 325 (509)
Q Consensus 247 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~DiwSlG~il~ell~g~~pf~~~~ 325 (509)
||++.++.+||+|||++...... ......||+.|+|||++.+. ..++. ++|||||||++|||++|..||.+..
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEcCCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999865332 23456899999999998762 25655 9999999999999999999998766
Q ss_pred h-HhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 010489 326 V-VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404 (509)
Q Consensus 326 ~-~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 404 (509)
. .+....+.......+... . .+. ..............+++.+.+||.+||+.||.+|||++|+++||
T Consensus 257 ~~~~~~~~i~~~~~~~~~~~-~--------~~~---~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 257 SLVELFNNIRTKNIEYPLDR-N--------HFL---YPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp CSHHHHHHHTSCCCCCCCSS-S--------SST---TTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred cHHHHHHHHhccCcCCccch-h--------hhh---ccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 5 333332221100000000 0 000 00000001112256789999999999999999999999999999
Q ss_pred cccCC
Q 010489 405 YFHGL 409 (509)
Q Consensus 405 ~f~~~ 409 (509)
||++.
T Consensus 325 ~f~~~ 329 (348)
T 2pml_X 325 WLADT 329 (348)
T ss_dssp GGTTC
T ss_pred cccCC
Confidence 99764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=368.65 Aligned_cols=261 Identities=20% Similarity=0.318 Sum_probs=191.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||.||+|.+..+|+.||||++............+..+..+++.++||||+++++++... ..
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-----~~ 98 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-----TD 98 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----Cc
Confidence 4689999999999999999999999999999999975433222333344455567888999999999998543 46
Q ss_pred EEEEEecccccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhC-CeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~-~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+|+||||+++.+..+... .+.+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 99 ~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 99 VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp EEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 899999997666666544 56899999999999999999999995 9999999999999999999999999999765332
Q ss_pred CCCccccccccccccccccccccc---ccCCCCCceeeehhhhHHHHHHhCCCCCCCCC-hHhHHHHHHHhcCCCChhHH
Q 010489 270 APSAIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN-VVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~g~~~~~~~ 345 (509)
.. .....||+.|+|||++.. ....++.++|||||||++|+|++|+.||.... ..+.+..+..
T Consensus 179 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---------- 244 (318)
T 2dyl_A 179 KA----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ---------- 244 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH----------
T ss_pred cc----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc----------
Confidence 21 234579999999999852 11568899999999999999999999997643 2222211111
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
. ..+ .......+++.+.+||.+||..||.+||+++++++||||+.+
T Consensus 245 -------------~---~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 245 -------------E---EPP--LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp -------------S---CCC--CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred -------------c---CCC--CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 0 000 011123578999999999999999999999999999999764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=364.11 Aligned_cols=258 Identities=28% Similarity=0.406 Sum_probs=203.5
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
+|.....||+|+||.||+|.+..++..||||++... .......+.+|+.+++.++||||+++++++.. ...++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 95 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIK 95 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEE
Confidence 344556899999999999999999999999998653 23345678899999999999999999999843 34689
Q ss_pred EEEeccc-ccHHHHHHhCC---CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC-CCCeEEeeecccccccC
Q 010489 194 VVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVSFN 268 (509)
Q Consensus 194 lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~-~~~vkl~DFG~a~~~~~ 268 (509)
+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999997 68999887652 5678999999999999999999999999999999999987 89999999999986533
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... ......||+.|+|||++.+....++.++|||||||++|+|++|+.||.+...........
T Consensus 176 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-------------- 238 (295)
T 2clq_A 176 INP---CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV-------------- 238 (295)
T ss_dssp --------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH--------------
T ss_pred CCC---cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh--------------
Confidence 221 123467999999999986632348899999999999999999999997543211100000
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
... ... + .....+++++.+||.+||..||++||+++++|+||||+..
T Consensus 239 -------~~~--~~~-~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 239 -------GMF--KVH-P----EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp -------HHH--CCC-C----CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred -------ccc--ccc-c----cccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 000 000 0 1123578899999999999999999999999999999754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=364.65 Aligned_cols=262 Identities=29% Similarity=0.427 Sum_probs=201.0
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCC-------
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS------- 185 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~------- 185 (509)
++|++++.||+|+||.||+|++..+++.||||++.. .......+.+|+.+++.++||||+++++++....
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 579999999999999999999999999999999853 2344567889999999999999999999875431
Q ss_pred -cCCCCcEEEEEeccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecc
Q 010489 186 -RREFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 262 (509)
Q Consensus 186 -~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 262 (509)
......+|+||||++ ++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 123456899999998 59999998654 688999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC-----------CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCCh-HhHH
Q 010489 263 ARVSFNDAP-----------SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV-VHQL 330 (509)
Q Consensus 263 a~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~ 330 (509)
+........ .........||+.|+|||++.+. ..++.++|||||||++|+|++ ||..... ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 976532210 01122456799999999998752 468999999999999999998 5542211 1111
Q ss_pred HHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 331 DLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 331 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
..+ .......+ .......++.+.+||.+||+.||.+|||+.++++||||+.
T Consensus 239 ~~~------------------------~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 239 KKL------------------------RSVSIEFP---PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHH------------------------HSTTCCCC---TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred Hhc------------------------cccccccC---ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 111 00001111 1122456788999999999999999999999999999964
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=371.58 Aligned_cols=256 Identities=20% Similarity=0.243 Sum_probs=203.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+.+|+.+++.+ .||||+++++++.. ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~ 78 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GK 78 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TT
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CC
Confidence 368999999999999999999999999999999986432 123578899999999 89999999999844 34
Q ss_pred cEEEEEecccccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCC-----eEEeeecccc
Q 010489 191 DIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-----LKICDFGLAR 264 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~-----vkl~DFG~a~ 264 (509)
..|+||||++++|.+++... +.+++..+..++.||+.||+|||+.||+||||||+|||++.++. +||+|||+++
T Consensus 79 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 79 YNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred ccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 68999999988999999864 68999999999999999999999999999999999999999887 9999999998
Q ss_pred cccCCCCCcc----cccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCC
Q 010489 265 VSFNDAPSAI----FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340 (509)
Q Consensus 265 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~ 340 (509)
.......... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i---- 232 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLG--KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI---- 232 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH----
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcC--CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH----
Confidence 6543332111 1245689999999999987 68999999999999999999999999875432222211111
Q ss_pred ChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
...... .+........ +++.+||.+||..||.+||+++++++
T Consensus 233 --------~~~~~~-----------~~~~~~~~~~-p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 233 --------GDTKRA-----------TPIEVLCENF-PEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp --------HHHHHH-----------SCHHHHTTTC-HHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred --------Hhhhcc-----------CCHHHHhccC-hHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 000000 0000001122 38999999999999999999998876
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=373.43 Aligned_cols=250 Identities=27% Similarity=0.448 Sum_probs=208.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccCh----hhHHhHHHHHHHHHHcC--CCCcceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV----SDATRILREIKLLRLLR--HPDIVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~----~~~~~~~~Ei~~l~~l~--h~niv~~~~~~~~~~ 185 (509)
.++|++.+.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+++.+. ||||+++++++...
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~- 120 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP- 120 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC-
Confidence 468999999999999999999999999999999986432211 12245678999999996 59999999999543
Q ss_pred cCCCCcEEEEEeccc--ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEEC-CCCCeEEeeecc
Q 010489 186 RREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDFGL 262 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~--~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~-~~~~vkl~DFG~ 262 (509)
..+++|||++. ++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus 121 ----~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 121 ----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp ----SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred ----CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 45899999997 68999998888999999999999999999999999999999999999999 789999999999
Q ss_pred cccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCCh
Q 010489 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342 (509)
Q Consensus 263 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~ 342 (509)
++...... .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||..... +.
T Consensus 197 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~-------- 256 (320)
T 3a99_A 197 GALLKDTV-----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------II-------- 256 (320)
T ss_dssp CEECCSSC-----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH--------
T ss_pred cccccccc-----ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhh------hh--------
Confidence 98654322 2446799999999998762 3347889999999999999999999965321 00
Q ss_pred hHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
. ... .....+++++.+||.+||..||.+|||++++++||||++.
T Consensus 257 ---------------~---~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 257 ---------------R---GQV-----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp ---------------H---CCC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ---------------c---ccc-----cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 0 000 0113578899999999999999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=367.05 Aligned_cols=261 Identities=28% Similarity=0.364 Sum_probs=204.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC--CCCcceeeeeecCCCcCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR--HPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~niv~~~~~~~~~~~~~~ 189 (509)
..+|++++.||+|+||.||+|.+. +++.||||++............+.+|+.+++.++ ||||+++++++...
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~----- 100 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD----- 100 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS-----
T ss_pred cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC-----
Confidence 457999999999999999999885 5899999999754444556678899999999997 59999999998543
Q ss_pred CcEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 190 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 190 ~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
..+|+|||+.+++|.+++...+.+++..+..++.||++||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 101 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 101 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179 (313)
T ss_dssp SEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC----
T ss_pred CEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCc
Confidence 4589999988889999999888999999999999999999999999999999999999996 589999999999865433
Q ss_pred CCCcccccccccccccccccccccc---------cCCCCCceeeehhhhHHHHHHhCCCCCCCCChH-hHHHHHHHhcCC
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV-HQLDLMTDLLGT 339 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~g~ 339 (509)
... .......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||...... ..+..+
T Consensus 180 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~------ 252 (313)
T 3cek_A 180 TTS-VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI------ 252 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH------
T ss_pred ccc-ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH------
Confidence 221 112345799999999998641 136788999999999999999999999764321 111100
Q ss_pred CChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.. ...... .....++.+.+||.+||..||.+||++.++|+||||+..
T Consensus 253 -----------------~~---~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 253 -----------------ID---PNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp -----------------HC---TTSCCC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred -----------------Hh---cccccC---CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 00 000001 112347889999999999999999999999999999754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=373.69 Aligned_cols=273 Identities=22% Similarity=0.238 Sum_probs=207.1
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
..+|++++.||+|+||.||+|++. ++.||||+++.. ........+|+.+|+.++||||+++++++.... .....
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~ 96 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVD 96 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCce
Confidence 468999999999999999999875 799999998642 233445667999999999999999999986543 12345
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhC----------CeeecCCCCCcEEECCCCCeEEeee
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA----------NVFHRDLKPKNILANADCKLKICDF 260 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~----------~ivHrDlKp~NILl~~~~~vkl~DF 260 (509)
+|+|||||+ ++|.+++... .+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+||
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 899999998 5999998764 599999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCccccccccccccccccccccccc---CCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhc
Q 010489 261 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 337 (509)
Q Consensus 261 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 337 (509)
|+++........ ......+||+.|+|||++.+.. ..++.++|||||||++|||++|+.||.+..............
T Consensus 176 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 176 GLALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp TTCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CcccccccccCc-cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 999765433322 1124468999999999987521 245668899999999999999999998765433333333333
Q ss_pred CCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCC--CCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFP--NADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
+.+....+.... . .......+...+. ..++++.+||.+||+.||++|||+.++++
T Consensus 255 ~~~~~~~~~~~~--------~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 255 QHPSLEDMQEVV--------V--HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp SSCCHHHHHHHH--------T--TSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCchhhhhhhh--------h--cccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 333333322111 0 0111111111111 23456999999999999999999999987
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=361.48 Aligned_cols=261 Identities=18% Similarity=0.244 Sum_probs=208.5
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+|+.+++.+ .|++|+++++++. ...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~ 79 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGL 79 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC----TTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETT
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC----CccHHHHHHHHHHHHHhcCCCCCeEEeecC-----CCc
Confidence 46899999999999999999999999999999998642 2234577899999999 7999999999884 345
Q ss_pred cEEEEEecccccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCC-----eEEeeecccc
Q 010489 191 DIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-----LKICDFGLAR 264 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~-----vkl~DFG~a~ 264 (509)
..|+||||++++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++
T Consensus 80 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 80 HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred eeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 689999999889999998754 6999999999999999999999999999999999999988776 9999999998
Q ss_pred cccCCCCCc----ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCC
Q 010489 265 VSFNDAPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340 (509)
Q Consensus 265 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~ 340 (509)
......... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~---- 233 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI---- 233 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH----
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH----
Confidence 764432211 11245689999999999887 67899999999999999999999999875432221111110
Q ss_pred ChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
..... +.+.....+.+++++.+||.+||+.||.+||+++++++ .|+.
T Consensus 234 --------~~~~~-----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~--~l~~ 280 (298)
T 1csn_A 234 --------GEKKQ-----------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG--LFSK 280 (298)
T ss_dssp --------HHHHH-----------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH--HHHH
T ss_pred --------Hhhcc-----------CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH--HHHH
Confidence 00000 00111122357889999999999999999999999987 4543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=363.27 Aligned_cols=270 Identities=21% Similarity=0.359 Sum_probs=204.0
Q ss_pred CCCeeEeeeeeccCceEEEEEE----EcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~----~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
.++|++++.||+|+||.||+|+ +..+++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 83 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--- 83 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH---
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence 4689999999999999999998 6678999999999742 334557788999999999999999999988532
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 188 EFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
....+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 2245799999997 59999997754 599999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
...............||+.|+|||++.+ ..++.++|||||||++|||++|..||..... ......+.......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~ 236 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPPA-----EFMRMIGNDKQGQM 236 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH-----HHHHHHCTTCCTHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcC--CCCChHHHHHHHHHHHHHHHhcccccCCChH-----HHHhhhcCccccch
Confidence 5443322222234567888999999887 6899999999999999999999999865321 11111222211111
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.. ...... +......+ ....+++++.+||.+||+.||++|||+.++++
T Consensus 237 ~~---~~~~~~---~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 237 IV---FHLIEL---LKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HH---HHHHHH---HHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hH---HHHHHH---HhccCcCC---CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00 000011 11111111 12457899999999999999999999999987
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=359.22 Aligned_cols=249 Identities=24% Similarity=0.398 Sum_probs=204.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ....+.+|+.++++++||||+++++++.. ...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~ 79 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAP 79 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSS
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc---CHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCc
Confidence 368999999999999999999986 577899999975322 33568899999999999999999999854 345
Q ss_pred EEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+|+||||++ ++|.+++... +.+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 899999998 5899998654 46999999999999999999999999999999999999999999999999999864322
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 160 ~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~----------- 224 (269)
T 4hcu_A 160 QY--TSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF----------- 224 (269)
T ss_dssp HH--HSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-----------
T ss_pred cc--ccccCcccccccCCHHHhcC--CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc-----------
Confidence 11 11234567889999999876 689999999999999999999 999998876544433322110
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
.. ......++.+.+||.+||+.||.+|||+.++++|
T Consensus 225 ------------~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 225 ------------RL-------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ------------CC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------cC-------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 00 0112457889999999999999999999999984
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=356.72 Aligned_cols=249 Identities=21% Similarity=0.333 Sum_probs=204.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||.||+|.+. ++..||+|+++... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~ 77 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS---MSEDEFFQEAQTMMKLSHPKLVKFYGVCSK-----EYP 77 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT---BCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSS
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC---CcHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCc
Confidence 468999999999999999999775 57789999997432 234568899999999999999999999843 345
Q ss_pred EEEEEeccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+|+||||++ ++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 899999997 57999987654 5999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
.. .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+...
T Consensus 158 ~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~------------ 221 (268)
T 3sxs_A 158 QY--VSSVGTKFPVKWSAPEVFHY--FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG------------ 221 (268)
T ss_dssp CE--EECCSCCCCGGGCCHHHHHH--SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT------------
T ss_pred hh--hcccCCCcCcccCCHHHHhc--cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcC------------
Confidence 21 12234567788999999877 678999999999999999999 99999876654433222110
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
. .. ......++.+.+||.+||+.||.+|||+.++++|
T Consensus 222 --------------~-~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 222 --------------H-RL---YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp --------------C-CC---CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------C-CC---CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 00 0112357889999999999999999999999984
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=373.13 Aligned_cols=253 Identities=25% Similarity=0.416 Sum_probs=207.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcC-------CCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTH-------TGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLP 183 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~-------~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~ 183 (509)
.++|++.+.||+|+||.||+|.+.. .+..||||+++.. ........+.+|+.+++.+ +||||+++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4689999999999999999998753 3357999999754 3344567889999999999 89999999999954
Q ss_pred CCcCCCCcEEEEEeccc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCc
Q 010489 184 PSRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 246 (509)
Q Consensus 184 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~N 246 (509)
. ..+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|
T Consensus 147 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 147 D-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp S-----SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred C-----CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 3 45899999998 59999998653 49999999999999999999999999999999999
Q ss_pred EEECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCC
Q 010489 247 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 325 (509)
Q Consensus 247 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~ 325 (509)
||++.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTT-CCCTTCCCGGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEcCCCcEEEcccCccccccccccc-ccccCCCCCcceeCHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999865432211 11234578899999999877 689999999999999999999 999998876
Q ss_pred hHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 326 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
..+....+... ... .....+++++.+||.+||+.||++|||+.+++++
T Consensus 299 ~~~~~~~~~~~---------------------------~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 299 VEELFKLLKEG---------------------------HRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHHTT---------------------------CCC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcC---------------------------CCC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 54433322211 000 1113578899999999999999999999999984
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=387.01 Aligned_cols=259 Identities=28% Similarity=0.407 Sum_probs=193.4
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.+|.+.+.||+|+||+|+. ....+|+.||||++..... ..+.+|+.+|+.+ +||||+++++++. +...
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~-----~~~~ 92 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEK-----DRQF 92 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEE-----ETTE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCE
Confidence 4699999999999999764 3456899999999864221 2346899999999 7999999999884 3456
Q ss_pred EEEEEecccccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC-----CCCeEEeeeccccc
Q 010489 192 IYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-----DCKLKICDFGLARV 265 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~-----~~~vkl~DFG~a~~ 265 (509)
+|+|||||+++|.+++.... .+.+..+..++.||+.||.|||++||+||||||+|||++. ...+||+|||+|+.
T Consensus 93 ~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 93 QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 89999999999999997654 4666677899999999999999999999999999999953 23588999999987
Q ss_pred ccCCCCCcccccccccccccccccccccc-cCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChh
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (509)
..............+||+.|+|||++.+. ...++.++|||||||++|||++ |..||....... ...+ .+.
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-~~~~---~~~---- 244 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-ANIL---LGA---- 244 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-HHHH---TTC----
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-HHHH---hcc----
Confidence 64333222223557899999999998742 1467889999999999999999 899996543211 1111 000
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
............++.+.+||.+||+.||.+|||++++++||||..+.
T Consensus 245 --------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~ 291 (432)
T 3p23_A 245 --------------------CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291 (432)
T ss_dssp --------------------CCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred --------------------CCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence 00000011122355689999999999999999999999999997643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=365.38 Aligned_cols=253 Identities=23% Similarity=0.378 Sum_probs=207.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEc-----CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 186 (509)
..+|++.+.||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 97 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ--- 97 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec---
Confidence 368999999999999999999873 45689999998743 234456778999999999999999999999844
Q ss_pred CCCCcEEEEEeccc-ccHHHHHHhCCC------------------------CCHHHHHHHHHHHHhHhhhhhhCCeeecC
Q 010489 187 REFKDIYVVFELME-SDLHQVIKANDD------------------------LTPEHYQFFLYQLLRGLKYIHTANVFHRD 241 (509)
Q Consensus 187 ~~~~~~~lv~e~~~-~~L~~~l~~~~~------------------------l~~~~~~~i~~qil~aL~yLH~~~ivHrD 241 (509)
...+|+||||++ ++|.+++..... +++..+..++.||+.||.|||++||+|||
T Consensus 98 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 98 --DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred --CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 345899999998 699999976543 89999999999999999999999999999
Q ss_pred CCCCcEEECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCC
Q 010489 242 LKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPL 320 (509)
Q Consensus 242 lKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~p 320 (509)
|||+|||++.++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|||++ |..|
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDS-YVKRSQGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSC-EECSSCCCSCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cchheEEEcCCCCEEEcccccccccccccc-ceeccCCCCcccccChhhhcC--CCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999986543222 111234567899999999877 678999999999999999999 9999
Q ss_pred CCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHH
Q 010489 321 FPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400 (509)
Q Consensus 321 f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 400 (509)
|.+.........+... .. ......+++.+.+||.+||+.||.+||++.++
T Consensus 253 ~~~~~~~~~~~~~~~~---------------------------~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 302 (314)
T 2ivs_A 253 YPGIPPERLFNLLKTG---------------------------HR---MERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302 (314)
T ss_dssp STTCCGGGHHHHHHTT---------------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHhhcC---------------------------Cc---CCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 9876653333222110 00 01124578899999999999999999999999
Q ss_pred hcC
Q 010489 401 LAD 403 (509)
Q Consensus 401 l~h 403 (509)
+++
T Consensus 303 ~~~ 305 (314)
T 2ivs_A 303 SKD 305 (314)
T ss_dssp HHH
T ss_pred HHH
Confidence 873
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=364.79 Aligned_cols=259 Identities=20% Similarity=0.310 Sum_probs=198.9
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcC---CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTH---TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~---~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
..++|.+.+.||+|+||.||+|.+.. ++..||||+++...........+.+|+.+++.++||||+++++++......
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 34689999999999999999998765 566899999875544555667889999999999999999999999765543
Q ss_pred CCCcEEEEEeccc-ccHHHHHHh------CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeee
Q 010489 188 EFKDIYVVFELME-SDLHQVIKA------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 260 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~------~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DF 260 (509)
.....|+||||++ ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeec
Confidence 3446799999998 589998842 356999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCC
Q 010489 261 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGT 339 (509)
Q Consensus 261 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~ 339 (509)
|++......... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+...
T Consensus 192 g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--- 265 (313)
T 3brb_A 192 GLSKKIYSGDYY-RQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG--- 265 (313)
T ss_dssp SCC-----------------CCGGGSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT---
T ss_pred Ccceeccccccc-CcccccCCCccccCchhhcC--CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC---
Confidence 999765332211 11233467889999999877 689999999999999999999 89999876654433322110
Q ss_pred CChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..+ .....+++.+.+||.+||..||.+|||+.++++
T Consensus 266 -----------------------~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 301 (313)
T 3brb_A 266 -----------------------HRL----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRL 301 (313)
T ss_dssp -----------------------CCC----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCC----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 112357789999999999999999999999987
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=359.34 Aligned_cols=250 Identities=25% Similarity=0.417 Sum_probs=195.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCC---CcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
.++|++.+.||+|+||.||+|.+..+ +..||+|+++.. ........+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 87 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-----
Confidence 46899999999999999999998654 457999998643 233455678899999999999999999999732
Q ss_pred CCcEEEEEeccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 189 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
...|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 88 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 88 -NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred -CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 34799999998 58999997654 7999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
...... ......+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+....+....+...
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~--------- 233 (281)
T 1mp8_A 167 EDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--------- 233 (281)
T ss_dssp --------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT---------
T ss_pred Cccccc--ccccCCCcccccChhhccc--CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC---------
Confidence 332211 1233467889999999876 688999999999999999996 99999887654443332210
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
... ...+.+++.+.+||.+||..||++|||+.++++
T Consensus 234 ------------------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 234 ------------------ERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp ------------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 000 112467899999999999999999999999987
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=369.10 Aligned_cols=252 Identities=22% Similarity=0.368 Sum_probs=197.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEE----EEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERV----AIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~v----AiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
..+|++++.||+|+||.||+|++..+++.+ |+|.++.. ........+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 89 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS---
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---
Confidence 468999999999999999999998887765 67766432 1223456788999999999999999999998643
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 188 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
..++|+||+. |+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 90 ---~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 90 ---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp ---SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred ---CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 2688999988 6899988764 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.........+....
T Consensus 167 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~------- 236 (327)
T 3poz_A 167 LGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE------- 236 (327)
T ss_dssp HTTTCC--------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-------
T ss_pred ccCCccc-ccccCCCccccccChHHhcc--CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC-------
Confidence 5433322 12234567889999999887 789999999999999999999 999998766543332221110
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
..+ ..+.+++.+.+|+.+||+.||.+||++.+++++
T Consensus 237 ------------------~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 237 ------------------RLP-----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ------------------CCC-----CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ------------------CCC-----CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 000 123467889999999999999999999999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=359.59 Aligned_cols=249 Identities=21% Similarity=0.315 Sum_probs=202.3
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
..+|++++.||+|+||.||+|.+. ++..||||+++.... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~ 93 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRP 93 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSS
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC---CHHHHHHHHHHHhcCCCCCEeeEEEEEec-----CCC
Confidence 468999999999999999999876 677899999975322 34568899999999999999999999843 345
Q ss_pred EEEEEeccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 899999997 689999876 467999999999999999999999999999999999999999999999999999765322
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
.. .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+....
T Consensus 174 ~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~----------- 238 (283)
T 3gen_A 174 EY--TSSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL----------- 238 (283)
T ss_dssp HH--HSTTSTTSCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-----------
T ss_pred cc--ccccCCccCcccCCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhccc-----------
Confidence 11 11233467889999999887 678999999999999999998 999998876544433332211
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
.. ......++.+.+||.+||+.||.+|||+.++++|
T Consensus 239 ------------~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 239 ------------RL-------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ------------CC-------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------CC-------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 00 0112457889999999999999999999999984
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=376.94 Aligned_cols=252 Identities=23% Similarity=0.383 Sum_probs=205.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||+|+||.||+|.+..+++.||||+++.. ........+.+|+.+|+.++||||+++++++... ..
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 186 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QP 186 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS-----SS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC-----CC
Confidence 46899999999999999999999999999999998743 2233445788999999999999999999999543 45
Q ss_pred EEEEEeccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+|+|||||+ ++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 899999998 69999987654 6999999999999999999999999999999999999999999999999999754322
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... .......+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+.......+...
T Consensus 267 ~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~------------ 331 (377)
T 3cbl_A 267 VYA-ASGGLRQVPVKWTAPEALNY--GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG------------ 331 (377)
T ss_dssp EEE-CCSSCCEEEGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT------------
T ss_pred cee-ecCCCCCCCcCcCCHhHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------------
Confidence 110 00112245778999999876 678999999999999999998 99999886653333222110
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
...+ ....+++.+.+||.+||+.||++|||++++++
T Consensus 332 -------------~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 332 -------------GRLP-----CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp -------------CCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCCC-----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0011 11346788999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=375.50 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=194.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEc---CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
..+|++.+.||+|+||.||+|++. .++..||||+++... .......+.+|+.+|+.++||||+++++++..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 117 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK----- 117 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----
Confidence 468999999999999999999876 467789999986532 33455678999999999999999999999854
Q ss_pred CCcEEEEEeccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 189 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
...+|+|||||+ ++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 345899999997 69999997654 7999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
..............+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+....+....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~-------- 267 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY-------- 267 (373)
T ss_dssp ----------------CTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE--------
T ss_pred ccCCccceeccCCCcCCCccChhhhcc--CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------
Confidence 443322211223356788999999877 689999999999999999998 999998776543333221110
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..+ ....+++.+.+||.+||+.||.+||++.++++
T Consensus 268 -----------------~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 268 -----------------RLP-----PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp -----------------ECC-----CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCC-----CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 001 11256788999999999999999999999987
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=361.52 Aligned_cols=254 Identities=28% Similarity=0.377 Sum_probs=199.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----DG 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TT
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----CC
Confidence 4789999999999999999999999999999999875432 22335678899999999999999999999844 34
Q ss_pred cEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|+||||+++ +|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 68999999985 99999988888999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 188 ~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-------------- 249 (309)
T 2h34_A 188 KLT--QLGNTVGTLYYMAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ-------------- 249 (309)
T ss_dssp -----------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS--------------
T ss_pred ccc--cccccCCCcCccCHHHHcC--CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc--------------
Confidence 211 1245679999999999877 6889999999999999999999999987653211111100
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-CHHHHhc
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-TAEEALA 402 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-t~~e~l~ 402 (509)
.........+.+++.+.+||.+||..||++|| +++++++
T Consensus 250 --------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 250 --------------AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp --------------CCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred --------------CCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 00111223356788999999999999999999 8888876
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=366.33 Aligned_cols=251 Identities=27% Similarity=0.418 Sum_probs=201.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccCh----hhHHhHHHHHHHHHHc----CCCCcceeeeeecC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV----SDATRILREIKLLRLL----RHPDIVEIKHIMLP 183 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~----~~~~~~~~Ei~~l~~l----~h~niv~~~~~~~~ 183 (509)
.++|++.+.||+|+||.||+|.+..+++.||||+++...... .....+.+|+.+++.+ +||||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 468999999999999999999999999999999986432211 1234456799999998 89999999999854
Q ss_pred CCcCCCCcEEEEEec-cc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEEC-CCCCeEEeee
Q 010489 184 PSRREFKDIYVVFEL-ME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDF 260 (509)
Q Consensus 184 ~~~~~~~~~~lv~e~-~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~-~~~~vkl~DF 260 (509)
. ...++|||+ +. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 110 ~-----~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 110 Q-----EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp --------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred C-----CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 3 457999998 55 69999998888899999999999999999999999999999999999999 8899999999
Q ss_pred cccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCC
Q 010489 261 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340 (509)
Q Consensus 261 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~ 340 (509)
|++....... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+... +.
T Consensus 185 g~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~------ 246 (312)
T 2iwi_A 185 GSGALLHDEP-----YTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQE------IL------ 246 (312)
T ss_dssp SSCEECCSSC-----BCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH------
T ss_pred chhhhcccCc-----ccccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hh------
Confidence 9998654322 2456799999999998762 2335589999999999999999999965221 00
Q ss_pred ChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
. ... .....+++.+.+||.+||+.||++|||++|+++||||+...
T Consensus 247 -----------------~---~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 247 -----------------E---AEL-----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp -----------------H---TCC-----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred -----------------h---hcc-----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 0 000 01135688999999999999999999999999999998643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=358.83 Aligned_cols=253 Identities=21% Similarity=0.316 Sum_probs=204.7
Q ss_pred CCCeeEee-eeeccCceEEEEEE--EcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 112 ASRYQIQE-VIGKGSYGVVGSAV--DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 112 ~~~y~i~~-~lG~G~~g~V~~~~--~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
..+|++.+ .||+|+||.||+|. +..+++.||||+++...........+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 89 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA----- 89 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-----
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC-----
Confidence 35799998 99999999999994 46678899999997654444456788999999999999999999999832
Q ss_pred CCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 189 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
...|+||||++ ++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 90 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 90 -ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp -SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred -CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 34799999998 6899999988889999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
.............||+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+...
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---------- 236 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG---------- 236 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT----------
T ss_pred cCCCcccccccCCCCceeeChHHhcc--CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC----------
Confidence 33322112233457789999999876 678899999999999999999 99999887654332222110
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
... .....+++.+.+||.+||+.||.+||++.++++
T Consensus 237 -----------------~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 237 -----------------ERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp -----------------CCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------------CCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 112357889999999999999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=372.98 Aligned_cols=273 Identities=16% Similarity=0.140 Sum_probs=202.9
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCC-----CcEEEEEEecCcccChhh---------HHhHHHHHHHHHHcCCCCcce
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHT-----GERVAIKKINDVFEHVSD---------ATRILREIKLLRLLRHPDIVE 176 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~~~~~~---------~~~~~~Ei~~l~~l~h~niv~ 176 (509)
..++|++++.||+|+||.||+|.+..+ ++.||||++......... ......|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 346899999999999999999998764 588999998643211000 012345566677788999999
Q ss_pred eeeeecCCCcCCCCcEEEEEecccccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEEC--CCC
Q 010489 177 IKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN--ADC 253 (509)
Q Consensus 177 ~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~--~~~ 253 (509)
+++++.... .....+|||||||+++|.+++... +.+++..+..|+.||+.||+|||++||+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEE-TTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeecc-CCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 999986532 223458999999988999999876 6899999999999999999999999999999999999999 889
Q ss_pred CeEEeeecccccccCCCCCc----ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhH
Q 010489 254 KLKICDFGLARVSFNDAPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQ 329 (509)
Q Consensus 254 ~vkl~DFG~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 329 (509)
.+||+|||+++......... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 99999999997654322111 11234569999999999987 6799999999999999999999999986432221
Q ss_pred HHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 330 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 330 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
........ ........+.... ....+++++.+||.+||..||.+||++.++++ .|..
T Consensus 270 ~~~~~~~~-----------~~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~--~l~~ 326 (364)
T 3op5_A 270 YVRDSKIR-----------YRENIASLMDKCF---------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD--ILLQ 326 (364)
T ss_dssp HHHHHHHH-----------HHHCHHHHHHHHS---------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH--HHHH
T ss_pred HHHHHHHH-----------hhhhHHHHHHHhc---------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH--HHHH
Confidence 11111100 0000111111100 01356789999999999999999999999987 5543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=357.30 Aligned_cols=257 Identities=24% Similarity=0.309 Sum_probs=197.0
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
..++|++.+.||+|+||.||+|.+. ..||||+++...........+.+|+.+++.++||||++++++... .
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~ 92 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------P 92 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------S
T ss_pred CccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC------C
Confidence 3578999999999999999999754 359999997655555667789999999999999999999997632 3
Q ss_pred cEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 191 DIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
.+++||||++ ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence 4799999998 5898888543 5799999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccccccccccccccc-cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
.... .......||+.|+|||++... ...++.++|||||||++|+|++|+.||.+....+.+..+...
T Consensus 173 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----------- 240 (289)
T 3og7_A 173 WSGS-HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR----------- 240 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH-----------
T ss_pred cccc-ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc-----------
Confidence 2211 123456899999999988621 156888999999999999999999999876544333222110
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
......+......+++.+.+||.+||+.||.+|||+.++++
T Consensus 241 --------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 241 --------------GSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp --------------TSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------cccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11112223334567899999999999999999999999987
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=354.69 Aligned_cols=249 Identities=23% Similarity=0.342 Sum_probs=201.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhh-----HHhHHHHHHHHHHcCCCCcceeeeeecCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSD-----ATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~-----~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 186 (509)
.++|++.+.||+|+||.||+|.+..+++.||||++......... .+.+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 95 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP-- 95 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--
Confidence 36899999999999999999999999999999998643222211 16788999999999999999999998543
Q ss_pred CCCCcEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCC--eeecCCCCCcEEECCCCC-----eEE
Q 010489 187 REFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCK-----LKI 257 (509)
Q Consensus 187 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~--ivHrDlKp~NILl~~~~~-----vkl 257 (509)
.++||||++ ++|.+.+... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++. +||
T Consensus 96 -----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 96 -----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp -----TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred -----CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 279999998 6898887654 47999999999999999999999999 999999999999988876 999
Q ss_pred eeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhH--HHHHHH
Q 010489 258 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQ--LDLMTD 335 (509)
Q Consensus 258 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~i~~ 335 (509)
+|||+++..... .....||+.|+|||++.+....++.++|||||||++|||++|+.||.+...... ...+..
T Consensus 171 ~Dfg~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 244 (287)
T 4f0f_A 171 ADFGLSQQSVHS------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244 (287)
T ss_dssp CCCTTCBCCSSC------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH
T ss_pred CCCCcccccccc------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc
Confidence 999999753221 245689999999999854335678999999999999999999999976543221 111100
Q ss_pred hcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 336 LLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 336 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.... ......+++.+.+||.+||+.||.+|||++++++
T Consensus 245 --------------------------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 245 --------------------------EGLR---PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp --------------------------SCCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------cCCC---CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0000 0112457889999999999999999999999987
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=368.09 Aligned_cols=258 Identities=21% Similarity=0.298 Sum_probs=208.9
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEc-----CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS 185 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~ 185 (509)
..++|++++.||+|+||.||+|.+. .+++.||||+++... .......+.+|+.+++.++||||+++++++..
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 121 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV-- 121 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc--
Confidence 3568999999999999999999987 455899999997532 23445678999999999999999999999854
Q ss_pred cCCCCcEEEEEeccc-ccHHHHHHhC------------------------CCCCHHHHHHHHHHHHhHhhhhhhCCeeec
Q 010489 186 RREFKDIYVVFELME-SDLHQVIKAN------------------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHR 240 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~-~~L~~~l~~~------------------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHr 240 (509)
...+|+||||++ ++|.+++... ..+++..+..++.||++||.|||++||+||
T Consensus 122 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 122 ---GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred ---CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 345899999998 5999999764 569999999999999999999999999999
Q ss_pred CCCCCcEEECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCC
Q 010489 241 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKP 319 (509)
Q Consensus 241 DlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~ 319 (509)
||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |..
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccc-cccCCCcccceecChhhhcc--CCcCcccccHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999764322111 11234578999999999877 679999999999999999999 999
Q ss_pred CCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHH
Q 010489 320 LFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399 (509)
Q Consensus 320 pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 399 (509)
||.+.+..+....+.. .... .....+++.+.+||.+||+.||.+||++.+
T Consensus 276 p~~~~~~~~~~~~~~~---------------------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 325 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRD---------------------------GNIL---ACPENCPLELYNLMRLCWSKLPADRPSFCS 325 (343)
T ss_dssp TTTTSCHHHHHHHHHT---------------------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cCCCCChHHHHHHHhC---------------------------CCcC---CCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 9987665433322211 0000 112357889999999999999999999999
Q ss_pred HhcCCcccCC
Q 010489 400 ALADPYFHGL 409 (509)
Q Consensus 400 ~l~hp~f~~~ 409 (509)
+++ .++.+
T Consensus 326 ~~~--~L~~~ 333 (343)
T 1luf_A 326 IHR--ILQRM 333 (343)
T ss_dssp HHH--HHHHT
T ss_pred HHH--HHHHH
Confidence 988 55544
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=357.26 Aligned_cols=250 Identities=22% Similarity=0.418 Sum_probs=209.3
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
...+|++.+.||+|+||.||+|.+..++..||||++... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~ 82 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EP 82 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SS
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CC
Confidence 346899999999999999999999999999999999642 3345778899999999999999999999844 34
Q ss_pred cEEEEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 191 DIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
.+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 5899999998 6999999864 359999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+....
T Consensus 163 ~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~--------- 229 (288)
T 3kfa_A 163 GDTY--TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--------- 229 (288)
T ss_dssp SSSS--EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC---------
T ss_pred CCcc--ccccCCccccCcCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC---------
Confidence 3322 22344567889999999877 678999999999999999999 999998876543333221110
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.. .....+++.+.+||.+||..||.+|||+.++++
T Consensus 230 ------------------~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 230 ------------------RM---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ------------------CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CC---CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 00 112357889999999999999999999999987
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=368.23 Aligned_cols=252 Identities=21% Similarity=0.339 Sum_probs=200.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcE----EEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGER----VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~----vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
..+|++++.||+|+||.||+|.+..+++. ||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 86 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG---- 86 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB----
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----
Confidence 46899999999999999999999888876 6677664321 12223456789999999999999999998842
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 188 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
...++||||+. ++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 87 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 87 --SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp --SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred --CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 34899999998 6899988764 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+...
T Consensus 165 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-------- 233 (325)
T 3kex_A 165 LPPDDKQ-LLYSEAKTPIKWMALESIHF--GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-------- 233 (325)
T ss_dssp SCCCTTC-CC-----CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT--------
T ss_pred cCccccc-ccccCCCCcccccChHHhcc--CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC--------
Confidence 6443322 22345678889999999977 679999999999999999999 99999876643333222110
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
...+ ....+++.+.+||.+||..||.+||++.++++|
T Consensus 234 -----------------~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 234 -----------------ERLA-----QPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp -----------------CBCC-----CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred -----------------CCCC-----CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0000 012356678999999999999999999999985
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=362.14 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=199.1
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCC----cEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTG----ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~----~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 186 (509)
...+|++.+.||+|+||.||+|.+..++ ..||||+++... .......+.+|+.+++.++||||+++++++..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 117 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK--- 117 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec---
Confidence 4578999999999999999999876553 459999997532 33445678899999999999999999999843
Q ss_pred CCCCcEEEEEecccc-cHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 187 REFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 187 ~~~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
...+|+||||+++ +|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 118 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 118 --YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp --SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred --CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 3568999999985 899998765 579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChh
Q 010489 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (509)
................+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+....+...
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~------- 266 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG------- 266 (333)
T ss_dssp ---------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-------
T ss_pred hhccccccccccCCCCccccccCchhccc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC-------
Confidence 75443322222233457889999999876 689999999999999999999 99999876654333222110
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
...+ ....+++.+.+||.+||+.||.+||++.++++
T Consensus 267 ------------------~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 267 ------------------FRLP-----TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 302 (333)
T ss_dssp ------------------CCCC-----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------CcCC-----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0001 11356788999999999999999999999987
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=360.03 Aligned_cols=253 Identities=27% Similarity=0.410 Sum_probs=206.5
Q ss_pred CCCeeEeeeeeccCceEEEEEEE-----cCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~ 185 (509)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++.. ........+.+|+.+++.+ +||||+++++++...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~- 99 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG- 99 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC-
Confidence 46899999999999999999984 457889999999753 2234557789999999999 899999999998543
Q ss_pred cCCCCcEEEEEeccc-ccHHHHHHhCC------------------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCc
Q 010489 186 RREFKDIYVVFELME-SDLHQVIKAND------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 246 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~-~~L~~~l~~~~------------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~N 246 (509)
...|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|
T Consensus 100 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 100 ----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ----CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 45899999998 59999997654 48999999999999999999999999999999999
Q ss_pred EEECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCC
Q 010489 247 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 325 (509)
Q Consensus 247 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~ 325 (509)
||++.++.+||+|||++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+..
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EEEcCCCCEEEccccccccccccccc-eeccCCCCcceeeChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 99999999999999999865443321 12234568899999999877 689999999999999999999 999998765
Q ss_pred hHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 326 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.......+... ... + .....+++.+.+||.+||..||.+|||+.++++
T Consensus 253 ~~~~~~~~~~~----------------------~~~---~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 253 VDSKFYKMIKE----------------------GFR---M----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp SSHHHHHHHHH----------------------TCC---C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhHHHHHhcc----------------------CCC---C----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 43222211110 000 0 011356889999999999999999999999988
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=366.20 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=203.6
Q ss_pred CCCeeEeeeeeccCceEEEEEEE-----cCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~ 185 (509)
.++|++.+.||+|+||.||+|.+ ..++..||||+++... .......+.+|+.+|+.+ .||||+++++++...
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 121 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS- 121 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC-
Confidence 46899999999999999999997 3466789999997432 223446788999999999 899999999998543
Q ss_pred cCCCCcEEEEEeccc-ccHHHHHHhCC-----------------------CCCHHHHHHHHHHHHhHhhhhhhCCeeecC
Q 010489 186 RREFKDIYVVFELME-SDLHQVIKAND-----------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRD 241 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-----------------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrD 241 (509)
..+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+|||
T Consensus 122 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 122 ----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ----CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 45899999998 59999997653 379999999999999999999999999999
Q ss_pred CCCCcEEECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCC
Q 010489 242 LKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPL 320 (509)
Q Consensus 242 lKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~p 320 (509)
|||+|||++.++.+||+|||++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..|
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccc-eeccCccCccCccCHHHhcc--CCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999865433321 22344578899999999877 679999999999999999998 9999
Q ss_pred CCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHH
Q 010489 321 FPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400 (509)
Q Consensus 321 f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 400 (509)
|.+......+..+.. ..... .....+++.+.+||.+||..||.+|||+.++
T Consensus 275 ~~~~~~~~~~~~~~~--------------------------~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 325 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQ--------------------------NGFKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 325 (344)
T ss_dssp STTCCCSHHHHHHHH--------------------------TTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cccCCcHHHHHHHHh--------------------------cCCCC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 987653322211110 00000 0113468899999999999999999999999
Q ss_pred hcC
Q 010489 401 LAD 403 (509)
Q Consensus 401 l~h 403 (509)
++|
T Consensus 326 ~~~ 328 (344)
T 1rjb_A 326 TSF 328 (344)
T ss_dssp HHH
T ss_pred HHH
Confidence 984
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=351.89 Aligned_cols=248 Identities=28% Similarity=0.460 Sum_probs=192.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccC--hhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH--VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
.++|++.+.||+|+||.||+|.+. +..||||+++..... ....+.+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE----- 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-----
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-----
Confidence 468999999999999999999874 889999998643221 22346788999999999999999999998543
Q ss_pred CcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCC---eeecCCCCCcEEECC--------CCCeEE
Q 010489 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN---VFHRDLKPKNILANA--------DCKLKI 257 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~---ivHrDlKp~NILl~~--------~~~vkl 257 (509)
..+|+||||++ ++|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++. ++.+||
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred CceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 45899999998 57777764 568999999999999999999999999 999999999999986 778999
Q ss_pred eeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhc
Q 010489 258 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 337 (509)
Q Consensus 258 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 337 (509)
+|||++........ ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 158 ~Dfg~~~~~~~~~~-----~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-- 228 (271)
T 3dtc_A 158 TDFGLAREWHRTTK-----MSAAGAYAWMAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM-- 228 (271)
T ss_dssp CCCCC------------------CCGGGSCHHHHHH--CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT--
T ss_pred ccCCcccccccccc-----cCCCCccceeCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc--
Confidence 99999976533221 24579999999999877 6789999999999999999999999987664332221110
Q ss_pred CCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
.....+ ....+++.+.+||.+||+.||.+|||+.|+++|
T Consensus 229 ------------------------~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 229 ------------------------NKLALP---IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ------------------------SCCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCCCC---CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 010111 123568899999999999999999999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=359.92 Aligned_cols=262 Identities=21% Similarity=0.251 Sum_probs=203.5
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.++|++++..+..+.. ....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~ 79 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDY 79 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeecC----CCCc
Confidence 468999999999999999999999999999999875422 22357789999999999888877766632 3346
Q ss_pred EEEEEecccccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEE---CCCCCeEEeeeccccccc
Q 010489 192 IYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVSF 267 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl---~~~~~vkl~DFG~a~~~~ 267 (509)
.++||||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 80 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 80 NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred eEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 899999998899999975 4579999999999999999999999999999999999999 788999999999998754
Q ss_pred CCCCCc----ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChh
Q 010489 268 NDAPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 268 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (509)
...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+......
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------------ 225 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ------------ 225 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS------------
T ss_pred CcccCccCCCCcccccCCCccccchHHhcC--CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh------------
Confidence 433211 11235689999999999987 679999999999999999999999998754321111
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
.+..+...... .+.......+++.+.+||.+||+.||++|||++++++ .|+.
T Consensus 226 ~~~~~~~~~~~-----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~ 277 (296)
T 4hgt_A 226 KYERISEKKMS-----------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ--LFRN 277 (296)
T ss_dssp HHHHHHHHHHH-----------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH--HHHH
T ss_pred hhhhhhccccc-----------chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH--HHHH
Confidence 11111100000 0011112356788999999999999999999999988 5543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=364.55 Aligned_cols=257 Identities=22% Similarity=0.357 Sum_probs=188.8
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCC---cCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPS---RRE 188 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~---~~~ 188 (509)
.+|++.+.||+|+||.||+|++..+++.||||++.. ........+.+|+.+++.+. ||||+++++++.... ...
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS--NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecC--CchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 489999999999999999999999999999999853 23345567889999999996 999999999985322 133
Q ss_pred CCcEEEEEecccccHHHHHHh---CCCCCHHHHHHHHHHHHhHhhhhhhCC--eeecCCCCCcEEECCCCCeEEeeeccc
Q 010489 189 FKDIYVVFELMESDLHQVIKA---NDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLA 263 (509)
Q Consensus 189 ~~~~~lv~e~~~~~L~~~l~~---~~~l~~~~~~~i~~qil~aL~yLH~~~--ivHrDlKp~NILl~~~~~vkl~DFG~a 263 (509)
...+|+||||++|+|.+++.. .+.+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++
T Consensus 106 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 106 QAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp SEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred CceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 456899999999999988864 467999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc---------cccccccccccccccccccc-ccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHH
Q 010489 264 RVSFNDAPSA---------IFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLM 333 (509)
Q Consensus 264 ~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 333 (509)
.......... .......||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+........
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-- 263 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN-- 263 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc--
Confidence 8654332211 00124579999999999831 11568899999999999999999999997543211100
Q ss_pred HHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 010489 334 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404 (509)
Q Consensus 334 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 404 (509)
..... ......++.+.+||.+||+.||.+|||+.|+++|-
T Consensus 264 ----------------------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 264 ----------------------------GKYSI---PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp ------------------------------CCC---CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred ----------------------------CcccC---CcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 00000 01134567799999999999999999999999963
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=367.17 Aligned_cols=271 Identities=15% Similarity=0.150 Sum_probs=202.6
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcC---CCcEEEEEEecCcccChh---------hHHhHHHHHHHHHHcCCCCcceeee
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTH---TGERVAIKKINDVFEHVS---------DATRILREIKLLRLLRHPDIVEIKH 179 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~---~~~~vAiK~~~~~~~~~~---------~~~~~~~Ei~~l~~l~h~niv~~~~ 179 (509)
.++|++.+.||+|+||.||+|.+.. ++..||||++........ ....+.+|+.+++.+.||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4689999999999999999999987 788999999864321110 1123567888999999999999999
Q ss_pred eecCCCcCCCCcEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCC--CeEE
Q 010489 180 IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC--KLKI 257 (509)
Q Consensus 180 ~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~--~vkl 257 (509)
++.... .....+|+||||++++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus 116 ~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEF-KGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEES-SSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred cccccc-CCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 986522 2245689999999889999998877899999999999999999999999999999999999999887 9999
Q ss_pred eeecccccccCCCCC----cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCC--hHhHHH
Q 010489 258 CDFGLARVSFNDAPS----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN--VVHQLD 331 (509)
Q Consensus 258 ~DFG~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~~~ 331 (509)
+|||+++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.. ......
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 999999765332111 111245689999999999887 679999999999999999999999996532 111111
Q ss_pred HHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 332 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 332 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.........+.... .. .....+++++.+||.+||..||++||+++++++ .++..
T Consensus 273 ~~~~~~~~~~~~~~---------~~-------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~--~L~~~ 326 (345)
T 2v62_A 273 AKTNLLDELPQSVL---------KW-------------APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK--ILNPH 326 (345)
T ss_dssp HHHHHHHTTTHHHH---------HH-------------SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH--HHCTT
T ss_pred HHHhhcccccHHHH---------hh-------------ccccccHHHHHHHHHHHhhcCcccCCCHHHHHH--HHhcc
Confidence 11111111110000 00 001257889999999999999999999999988 55543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=355.29 Aligned_cols=270 Identities=23% Similarity=0.394 Sum_probs=207.1
Q ss_pred CCCeeEeeeeeccCceEEEEEE----EcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~----~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
..+|++++.||+|+||.||+|+ +..+++.||||+++... .......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG-- 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC--
Confidence 3569999999999999999998 67789999999997432 2234567889999999999999999999986532
Q ss_pred CCCcEEEEEeccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 188 EFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
...+|+||||++ ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 97 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 97 -GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred -CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 245899999998 599999954 45799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
...............||+.|+|||++.+ ..++.++|||||||++|+|++|..||... ...+....+.......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~ 248 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQ--SKFYIASDVWSFGVTLHELLTYCDSDSSP-----MALFLKMIGPTHGQMT 248 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSH-----HHHHHHHHCSCCGGGH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecC--CCCCcchhHHHHHHHHHHHHHccCCCcch-----hhHHhhccCCcccccC
Confidence 6544332222345678999999999877 67889999999999999999999887432 1222222222222111
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
. ......+......+ ..+.+++.+.+||.+||+.||.+|||+.++++
T Consensus 249 ~-------~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 249 V-------TRLVNTLKEGKRLP---CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp H-------HHHHHHHHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred H-------HHHHHHHhccCCCC---CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 0 01111111111111 12467899999999999999999999999987
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=353.58 Aligned_cols=260 Identities=20% Similarity=0.260 Sum_probs=205.8
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+|+.+++.++|++++..+..+.. ....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~ 79 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDY 79 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccC----CCCc
Confidence 4689999999999999999999999999999999864322 2357789999999999888777666532 3346
Q ss_pred EEEEEecccccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEE---CCCCCeEEeeeccccccc
Q 010489 192 IYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVSF 267 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl---~~~~~vkl~DFG~a~~~~ 267 (509)
.|+||||++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 80 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 80 NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred eEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 899999998899999974 4579999999999999999999999999999999999999 478999999999998754
Q ss_pred CCCCCc----ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChH---hHHHHHHHhcCCC
Q 010489 268 NDAPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV---HQLDLMTDLLGTP 340 (509)
Q Consensus 268 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~g~~ 340 (509)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.... ..+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----- 232 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE----- 232 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH-----
T ss_pred ccccccccccccccccccccccCChhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc-----
Confidence 433211 11245689999999999987 67999999999999999999999999874321 11111111
Q ss_pred ChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.... .+.......+++.+.+||.+||+.||.+|||++++++ .|+.+
T Consensus 233 ----------~~~~-----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~--~l~~~ 278 (296)
T 3uzp_A 233 ----------KKMS-----------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ--LFRNL 278 (296)
T ss_dssp ----------HHHH-----------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH--HHHHH
T ss_pred ----------cccC-----------CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH--HHHHH
Confidence 0000 0001112356788999999999999999999999988 55433
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=360.93 Aligned_cols=262 Identities=24% Similarity=0.316 Sum_probs=196.3
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHH--cCCCCcceeeeeecCCCcCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL--LRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~~~~~~~~~~~~~~ 189 (509)
.++|++++.||+|+||.||+|.+ +++.||||++.. .....+.+|.+++.. ++||||+++++++.... ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~ 78 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSS-----RDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSS 78 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecc-----ccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCC
Confidence 46899999999999999999987 689999999864 234556677887777 78999999999875432 234
Q ss_pred CcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhh--------hCCeeecCCCCCcEEECCCCCeEEeee
Q 010489 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH--------TANVFHRDLKPKNILANADCKLKICDF 260 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH--------~~~ivHrDlKp~NILl~~~~~vkl~DF 260 (509)
..+|+||||++ ++|.+++. ...+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+||
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred ceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 56899999998 58999885 457999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCCCCc-ccccccccccccccccccccccC----CCCCceeeehhhhHHHHHHhC----------CCCCCCCC
Q 010489 261 GLARVSFNDAPSA-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEMLTG----------KPLFPGKN 325 (509)
Q Consensus 261 G~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~DiwSlG~il~ell~g----------~~pf~~~~ 325 (509)
|+++......... ......+||+.|+|||++.+... .++.++|||||||++|||++| ..||.+..
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9997654332211 11234589999999999876211 345789999999999999999 88886532
Q ss_pred hHh-HHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 326 VVH-QLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 326 ~~~-~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
... ....+. ............+........++.+.+||.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 238 PNDPSFEDMR--------------------KVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CSSCCHHHHH--------------------HHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCcchhhhh--------------------HHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 110 000000 000000011111111111224567999999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=379.08 Aligned_cols=259 Identities=27% Similarity=0.379 Sum_probs=190.9
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 191 (509)
+.|.+.+.||+|+||+||.+ ...+|+.||||++... ....+.+|+.+|+.+ +||||+++++++.. ...
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~~~ 83 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETT-----DRF 83 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC-----SSE
T ss_pred heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEec-----CCe
Confidence 46788899999999999875 4567999999998542 234567899999876 89999999998843 456
Q ss_pred EEEEEecccccHHHHHHhCCCC-------CHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC------------
Q 010489 192 IYVVFELMESDLHQVIKANDDL-------TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD------------ 252 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~~~~l-------~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~------------ 252 (509)
+|+|||||+++|.+++...... ++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 84 ~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~ 163 (434)
T 2rio_A 84 LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163 (434)
T ss_dssp EEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred EEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCC
Confidence 8999999999999999866433 233456799999999999999999999999999999754
Q ss_pred -CCeEEeeecccccccCCCCC-cccccccccccccccccccccc-----cCCCCCceeeehhhhHHHHHHh-CCCCCCCC
Q 010489 253 -CKLKICDFGLARVSFNDAPS-AIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGK 324 (509)
Q Consensus 253 -~~vkl~DFG~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DiwSlG~il~ell~-g~~pf~~~ 324 (509)
+.+||+|||+++........ .......+||+.|+|||++.+. ...++.++|||||||++|||++ |..||.+.
T Consensus 164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 48999999999876433221 1112356899999999998651 1468999999999999999999 99999765
Q ss_pred ChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 010489 325 NVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404 (509)
Q Consensus 325 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 404 (509)
.... ...+... ... +.........+++++.+||.+||+.||.+|||+.++++||
T Consensus 244 ~~~~-~~i~~~~------------------------~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp 297 (434)
T 2rio_A 244 YSRE-SNIIRGI------------------------FSL-DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297 (434)
T ss_dssp TTHH-HHHHHTC------------------------CCC-CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred hhhH-HHHhcCC------------------------CCc-ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence 4321 1111000 000 0000001113457899999999999999999999999999
Q ss_pred cccC
Q 010489 405 YFHG 408 (509)
Q Consensus 405 ~f~~ 408 (509)
||..
T Consensus 298 ~f~~ 301 (434)
T 2rio_A 298 LFWP 301 (434)
T ss_dssp GGSC
T ss_pred ccCC
Confidence 9964
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=361.33 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=204.5
Q ss_pred CCCeeEeeeeeccCceEEEEEEEc-------CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDT-------HTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLP 183 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~-------~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~ 183 (509)
.++|++.+.||+|+||.||+|.+. .++..||||+++... .......+.+|+.+++.+ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 368999999999999999999875 467789999987532 334567789999999999 89999999999854
Q ss_pred CCcCCCCcEEEEEeccc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCc
Q 010489 184 PSRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 246 (509)
Q Consensus 184 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~N 246 (509)
...+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|
T Consensus 113 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 113 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187 (334)
T ss_dssp -----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred -----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence 345899999998 59999997654 38999999999999999999999999999999999
Q ss_pred EEECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCC
Q 010489 247 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 325 (509)
Q Consensus 247 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~ 325 (509)
||++.++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+..
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSS-EECCSCCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEcCCCCEEEcccccccccccccc-ccccCCCCcccceeChHHhcC--CCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 9999999999999999986543221 111234467899999999876 678999999999999999999 999998876
Q ss_pred hHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 326 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..+....+... . .. .....+++.+.+||.+||..||.+|||+.++++
T Consensus 265 ~~~~~~~~~~~-----------------------~--~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 311 (334)
T 2pvf_A 265 VEELFKLLKEG-----------------------H--RM-----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311 (334)
T ss_dssp HHHHHHHHHHT-----------------------C--CC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcC-----------------------C--CC-----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 54333222110 0 00 112357889999999999999999999999988
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=362.88 Aligned_cols=251 Identities=22% Similarity=0.369 Sum_probs=198.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEE----EEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERV----AIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~v----AiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
..+|++++.||+|+||.||+|.+..+++.| |+|.+... ........+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--- 89 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 89 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS---
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC---
Confidence 468999999999999999999998888766 55655432 2233567788999999999999999999998643
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 188 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
..++|+||+. ++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 90 ---~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 90 ---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp ---SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred ---CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 2688999988 6899988764 5799999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.........+....
T Consensus 167 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~------- 236 (327)
T 3lzb_A 167 LGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE------- 236 (327)
T ss_dssp --------------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-------
T ss_pred ccCcccc-ccccCCCccccccCHHHHcC--CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-------
Confidence 5433221 11234567889999999887 689999999999999999999 999998876544333221110
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..+ ..+.+++.+.+||.+||..||.+||++.|+++
T Consensus 237 ------------------~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 237 ------------------RLP-----QPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp ------------------CCC-----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCC-----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 001 12346788999999999999999999999998
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=365.34 Aligned_cols=269 Identities=23% Similarity=0.378 Sum_probs=209.3
Q ss_pred CCCCeeEeeeeeccCceEEEEEE----EcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~----~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 186 (509)
+..+|++++.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 96 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP-- 96 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC--
Confidence 34689999999999999999998 5678999999999753 334556789999999999999999999988643
Q ss_pred CCCCcEEEEEeccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 187 REFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 187 ~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
+...+|+||||++ ++|.+++.. ...+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 97 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 97 -GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp -SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred -CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence 3356899999996 689999976 3569999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCC-Chh
Q 010489 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP-STE 343 (509)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~-~~~ 343 (509)
................||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ...... ...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----~~~~~~~~~~ 248 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSD--NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL-----RMMGCERDVP 248 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-----HHCC----CC
T ss_pred ecccCCccceeeccCCccccccCHHHhcc--CCCChHHhHHHHHHHHHHHHhCCCCCccccchhh-----hhcccccccc
Confidence 76443332222344578999999999877 6789999999999999999999999975332110 000000 000
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
... ............ ...+.+++.+.+||.+||+.||.+|||+.++++
T Consensus 249 ~~~--------~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 296 (327)
T 3lxl_A 249 ALS--------RLLELLEEGQRL---PAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296 (327)
T ss_dssp HHH--------HHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHH--------HHHHHhhcccCC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 001111111111 112467899999999999999999999999976
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=354.31 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=205.5
Q ss_pred CCeeEee-eeeccCceEEEEEEEc--CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 113 SRYQIQE-VIGKGSYGVVGSAVDT--HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 113 ~~y~i~~-~lG~G~~g~V~~~~~~--~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
++|.+.+ .||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------ 81 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------ 81 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC------
Confidence 5687877 9999999999999854 46788999999753 233456778999999999999999999999832
Q ss_pred CcEEEEEecccc-cHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 190 KDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 190 ~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
..+|+||||+++ +|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 248999999985 899988654 469999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
.............||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+....+...
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~---------- 229 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---------- 229 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT----------
T ss_pred cCcceeeccccccccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC----------
Confidence 33322122233467899999999876 678999999999999999998 99999876654333222110
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 404 (509)
... ...+.+++.+.+||.+||..||.+||++.++++|.
T Consensus 230 -----------------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 230 -----------------KRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp -----------------CCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred -----------------CcC---CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 000 11246789999999999999999999999999853
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=359.17 Aligned_cols=255 Identities=25% Similarity=0.423 Sum_probs=206.6
Q ss_pred CCCeeEeeeeeccCceEEEEEEE-----cCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~ 185 (509)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++... .......+.+|+.+++.+ +||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-
Confidence 46899999999999999999984 4577899999997532 234456788999999999 699999999998543
Q ss_pred cCCCCcEEEEEeccc-ccHHHHHHhCCC----------------CCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEE
Q 010489 186 RREFKDIYVVFELME-SDLHQVIKANDD----------------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL 248 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~----------------l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NIL 248 (509)
...+|+||||++ ++|.+++..... +++..+..++.||+.||.|||+.||+||||||+|||
T Consensus 104 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 104 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp ---TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ---CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 235899999998 599999987653 899999999999999999999999999999999999
Q ss_pred ECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChH
Q 010489 249 ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVV 327 (509)
Q Consensus 249 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~ 327 (509)
++.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred ECCCCCEEECCCccccccccCcc-ceeccCCCcceeecCchhhcc--ccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 99999999999999986543322 122345678999999999877 689999999999999999998 99999876532
Q ss_pred hHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 328 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 328 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
..+..... .. ... .....+++.+.++|.+||+.||.+|||+.++++|
T Consensus 258 ~~~~~~~~----------------------~~----~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 258 EEFCRRLK----------------------EG----TRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHH----------------------HT----CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhc----------------------cC----ccC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22111100 00 000 0113468899999999999999999999999984
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=361.05 Aligned_cols=253 Identities=21% Similarity=0.367 Sum_probs=206.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEc-----CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 186 (509)
.++|++.+.||+|+||.||+|.+. .+++.||||++... ........+.+|+.+++.++||||+++++++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 99 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--- 99 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS---
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc---
Confidence 368999999999999999999876 46789999998743 233445678899999999999999999999844
Q ss_pred CCCCcEEEEEeccc-ccHHHHHHhC----------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCe
Q 010489 187 REFKDIYVVFELME-SDLHQVIKAN----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 255 (509)
Q Consensus 187 ~~~~~~~lv~e~~~-~~L~~~l~~~----------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~v 255 (509)
....|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 100 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 100 --GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred --CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 345899999998 5999988652 357999999999999999999999999999999999999999999
Q ss_pred EEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHH
Q 010489 256 KICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMT 334 (509)
Q Consensus 256 kl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~ 334 (509)
||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 178 kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp EECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred EECcCccccccccccc-cccccCCCCCCCccChhhhcc--CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 9999999976433221 111234567899999999877 678999999999999999999 899998766543332221
Q ss_pred HhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 335 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 335 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
.. . .......+++.+.+||.+||..||.+|||+.++++|
T Consensus 255 ~~--------------------------~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 255 EG--------------------------G----LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TT--------------------------C----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cC--------------------------C----cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 10 0 001123578899999999999999999999999985
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=349.63 Aligned_cols=249 Identities=14% Similarity=0.184 Sum_probs=204.5
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||+|+||.||+|.+. +..||||+++.........+.+.+|+.+++.++||||+++++++.... ...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---APH 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---SSS
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---CCC
Confidence 468999999999999999999874 889999999765445556678999999999999999999999986542 246
Q ss_pred EEEEEeccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCC--eeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 192 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~--ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
+++||||++ ++|.+++.... .+++..+..++.||+.||.|||+.| |+||||||+|||++.++.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 899999998 59999998765 4899999999999999999999999 999999999999999999999999987542
Q ss_pred cCCCCCcccccccccccccccccccccc-cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
. .....||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+.+.......+...
T Consensus 164 ~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--------- 226 (271)
T 3kmu_A 164 Q--------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE--------- 226 (271)
T ss_dssp S--------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHS---------
T ss_pred c--------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhc---------
Confidence 1 1335789999999998752 122334899999999999999999999877654433222110
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.... .....+++.+.+||.+||+.||++|||++++++
T Consensus 227 -----------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 227 -----------------GLRP---TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp -----------------CCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000 112457889999999999999999999999987
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=362.59 Aligned_cols=257 Identities=21% Similarity=0.317 Sum_probs=203.2
Q ss_pred CCCeeEeeeeeccCceEEEEEE-----EcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAV-----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~-----~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 186 (509)
.++|++++.||+|+||.||+|. +..++..||||++... ........+.+|+.+++.++||||+++++++...
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 105 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-- 105 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC--
Confidence 3689999999999999999998 5567889999998643 2334556788999999999999999999998543
Q ss_pred CCCCcEEEEEeccc-ccHHHHHHhCC-------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC---CCe
Q 010489 187 REFKDIYVVFELME-SDLHQVIKAND-------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKL 255 (509)
Q Consensus 187 ~~~~~~~lv~e~~~-~~L~~~l~~~~-------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~---~~v 255 (509)
...|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+
T Consensus 106 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 ---LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp ---SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ---CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence 45799999996 69999998653 48999999999999999999999999999999999999954 469
Q ss_pred EEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHH
Q 010489 256 KICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMT 334 (509)
Q Consensus 256 kl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~ 334 (509)
||+|||++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 183 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 259 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYY-RKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259 (327)
T ss_dssp EECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred EECcccccccccccccc-ccCCCcCCCcceeCHhHhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence 99999999754332211 11234578999999999877 678999999999999999998 999998776543333221
Q ss_pred HhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010489 335 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (509)
Q Consensus 335 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 407 (509)
.. ..+ .....+++.+.+||.+||..||.+||++.++++|.|+-
T Consensus 260 ~~--------------------------~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 260 SG--------------------------GRM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp TT--------------------------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cC--------------------------CCC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11 000 11235788999999999999999999999999998863
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=365.85 Aligned_cols=267 Identities=23% Similarity=0.325 Sum_probs=204.7
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
..++|++.+.||+|+||.||+|.+. +++.||||++... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~ 108 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-----RN 108 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC-----TT
T ss_pred HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CC
Confidence 3468999999999999999999864 6899999988653 23446678899999999999999999999844 34
Q ss_pred cEEEEEeccc-ccHHHHHHhCC----CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 191 DIYVVFELME-SDLHQVIKAND----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~----~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
.+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 5899999998 58988886543 589999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+...
T Consensus 189 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~--------- 256 (321)
T 2qkw_B 189 GTELDQT-HLSTVVKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA--------- 256 (321)
T ss_dssp CSSSSCC-CCBCCCEEETTTCCHHHHHH--CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT---------
T ss_pred ccccccc-ccccccCCCccccCHHHhcC--CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh---------
Confidence 4322221 11244579999999999877 68999999999999999999999999875432211111000
Q ss_pred HHhhhHHHHHhhhccCCC-CCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 346 SRIRNEKARRYLGSMRKK-QPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
.. ......+... .+.......+..+..+.+|+.+||+.||++|||+.++++|
T Consensus 257 ----~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 257 ----VE--SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp ----HH--HHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----hh--ccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00 0000000000 0001111122345678999999999999999999999985
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=352.07 Aligned_cols=250 Identities=23% Similarity=0.385 Sum_probs=201.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcC---CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTH---TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~---~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
.++|++.+.||+|+||.||+|.+.. ++..||+|+++... .......+.+|+.+++.++||||+++++++...
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---- 85 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE---- 85 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS----
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC----
Confidence 3689999999999999999998653 34569999987532 334567789999999999999999999998432
Q ss_pred CCcEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 189 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
..|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 86 --~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 86 --PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp --SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred --CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 3589999998 5899999765 46999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||......+....+...
T Consensus 164 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~--------- 230 (281)
T 3cc6_A 164 EDEDYY--KASVTRLPIKWMSPESINF--RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG--------- 230 (281)
T ss_dssp -----------CCCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT---------
T ss_pred cccccc--ccccCCCCcceeCchhhcc--CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC---------
Confidence 432211 1234467889999999876 688999999999999999998 99999876544333222111
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
...+ ....+++.+.+||.+||..||.+|||+.++++
T Consensus 231 ----------------~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 266 (281)
T 3cc6_A 231 ----------------DRLP-----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVC 266 (281)
T ss_dssp ----------------CCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCC-----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 0001 11346788999999999999999999999988
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=382.30 Aligned_cols=254 Identities=21% Similarity=0.417 Sum_probs=210.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
..+|++.+.||+|+||.||+|.+..++..||||+++... .....+.+|+.+|+.++||||+++++++... ..
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~ 290 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PP 290 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SS
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecC-----Cc
Confidence 467999999999999999999999899999999997432 2356789999999999999999999999543 45
Q ss_pred EEEEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 192 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
+|||||||+ |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 899999998 6999999864 4589999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
... .......+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+.......+...
T Consensus 371 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~----------- 435 (495)
T 1opk_A 371 DTY--TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD----------- 435 (495)
T ss_dssp CCE--ECCTTCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-----------
T ss_pred Cce--eecCCCcCCcceeCHhHHhc--CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----------
Confidence 221 11233456789999999876 678999999999999999999 99999887654333222110
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.. . .....+++.+.+||.+||+.||.+|||+.++++ .|+.+
T Consensus 436 ------------~~--~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~--~L~~~ 476 (495)
T 1opk_A 436 ------------YR--M-----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM 476 (495)
T ss_dssp ------------CC--C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHTS
T ss_pred ------------CC--C-----CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH--HHHHH
Confidence 00 0 112357889999999999999999999999987 55543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=355.45 Aligned_cols=250 Identities=17% Similarity=0.272 Sum_probs=201.1
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCC-------cEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTG-------ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 184 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~-------~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~ 184 (509)
.++|++.+.||+|+||.||+|.+..++ ..||+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 468999999999999999999998877 47999998643 234457789999999999999999999999543
Q ss_pred CcCCCCcEEEEEeccc-ccHHHHHHhCCC-CCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCC--------
Q 010489 185 SRREFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-------- 254 (509)
Q Consensus 185 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~-------- 254 (509)
...|+||||++ ++|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 85 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 85 -----DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp -----TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred -----CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccce
Confidence 34799999998 699999987654 999999999999999999999999999999999999998887
Q ss_pred eEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCC-CCCCCCChHhHHHHH
Q 010489 255 LKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLDLM 333 (509)
Q Consensus 255 vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~~~~~~i 333 (509)
+||+|||++..... .....||+.|+|||++.+. ..++.++|||||||++|||++|. +||...+........
T Consensus 160 ~kl~Dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~ 231 (289)
T 4fvq_A 160 IKLSDPGISITVLP-------KDILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231 (289)
T ss_dssp EEECCCCSCTTTSC-------HHHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred eeeccCcccccccC-------ccccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh
Confidence 99999999865321 1235689999999998752 46899999999999999999955 555544432221111
Q ss_pred HHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 334 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 334 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
.. ... .....++++.+||.+||+.||.+|||+.++++ .++.+.
T Consensus 232 ~~-------------------------~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--~l~~l~ 274 (289)
T 4fvq_A 232 ED-------------------------RHQ-------LPAPKAAELANLINNCMDYEPDHRPSFRAIIR--DLNSLF 274 (289)
T ss_dssp HT-------------------------TCC-------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHH--HHHTCC
T ss_pred hc-------------------------cCC-------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH--HHHHhc
Confidence 00 000 01234567899999999999999999999998 455443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=359.55 Aligned_cols=253 Identities=24% Similarity=0.384 Sum_probs=205.3
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCc-----EEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGE-----RVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~-----~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~ 185 (509)
.++|++.+.||+|+||.||+|.+..++. .||+|+++... .......+.+|+.+++.+ +||||+++++++...
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 122 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHG- 122 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC-
Confidence 4689999999999999999999877664 79999997532 334557788999999999 899999999998543
Q ss_pred cCCCCcEEEEEeccc-ccHHHHHHhC--------------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEEC
Q 010489 186 RREFKDIYVVFELME-SDLHQVIKAN--------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 250 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~-~~L~~~l~~~--------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~ 250 (509)
..+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 123 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 123 ----GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ----SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred ----CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 45899999998 5999988642 4689999999999999999999999999999999999999
Q ss_pred CCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhH
Q 010489 251 ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQ 329 (509)
Q Consensus 251 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~ 329 (509)
.++.+||+|||++......... .......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+......
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNY-IVKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTS-EECSSCEECGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred CCCeEEECccccccccccccce-eecCCCCCCccccCHHHhcc--CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 9999999999999865433221 12234567889999999877 679999999999999999998 9999987654332
Q ss_pred HHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 330 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 330 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
+..+... .... ......++.+.+||.+||+.||.+|||+.++++
T Consensus 276 ~~~~~~~----------------------~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 276 FYKLVKD----------------------GYQM-------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHH----------------------TCCC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhc----------------------CCCC-------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 2211110 0000 011245788999999999999999999999988
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=348.60 Aligned_cols=248 Identities=24% Similarity=0.390 Sum_probs=204.1
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||+|+||.||+|.+. ++..||+|++..... ....+.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 77 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----AP 77 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SS
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CC
Confidence 368999999999999999999986 678899999975322 235688999999999999999999998543 45
Q ss_pred EEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+|+||||++ ++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 899999998 5899999765 56899999999999999999999999999999999999999999999999999765321
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
. ........||+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+...
T Consensus 158 ~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~------------ 221 (267)
T 3t9t_A 158 Q--YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG------------ 221 (267)
T ss_dssp H--HHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT------------
T ss_pred c--ccccccccccccccChhhhcC--CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC------------
Confidence 1 111234567889999999876 678999999999999999999 89999877654433322111
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
... ......++.+.+||.+||..||.+||++.++++
T Consensus 222 -----------~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 257 (267)
T 3t9t_A 222 -----------FRL-------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLR 257 (267)
T ss_dssp -----------CCC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------CcC-------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 000 011245788999999999999999999999987
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=362.34 Aligned_cols=250 Identities=25% Similarity=0.384 Sum_probs=200.8
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEE--EEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERV--AIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~v--AiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~ 188 (509)
.++|++.+.||+|+||.||+|++..++..+ |||.++.. ........+.+|+.+++.+ +||||+++++++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----- 97 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----- 97 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeee-----
Confidence 368999999999999999999999888865 99988642 2223456688999999999 89999999999843
Q ss_pred CCcEEEEEeccc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC
Q 010489 189 FKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 251 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~ 251 (509)
...+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 177 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence 356899999997 59999997654 6999999999999999999999999999999999999999
Q ss_pred CCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHH
Q 010489 252 DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQL 330 (509)
Q Consensus 252 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~ 330 (509)
++.+||+|||+++....... .....+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+..
T Consensus 178 ~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~ 251 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251 (327)
T ss_dssp GGCEEECCTTCEESSCEECC----C----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred CCeEEEcccCcCcccccccc----ccCCCCCccccChhhhcc--ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH
Confidence 99999999999974322111 123467889999999876 678999999999999999998 99999877643322
Q ss_pred HHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 331 DLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 331 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
..+.. .... .....+++.+.+||.+||..||.+|||+++++++
T Consensus 252 ~~~~~---------------------------~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 252 EKLPQ---------------------------GYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHGGG---------------------------TCCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhc---------------------------CCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 21110 0000 1123568899999999999999999999999984
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=388.63 Aligned_cols=250 Identities=21% Similarity=0.315 Sum_probs=201.6
Q ss_pred eeE-eeeeeccCceEEEEEEE--cCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 115 YQI-QEVIGKGSYGVVGSAVD--THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 115 y~i-~~~lG~G~~g~V~~~~~--~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
+.+ .+.||+|+||.||+|.+ ..+++.||||+++...........+.+|+.+|+.++||||+++++++.. ..
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~ 443 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ES 443 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SS
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CC
Confidence 444 34899999999999954 5677899999997654445556789999999999999999999999842 23
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+++|||||+ ++|.+++...+.+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 444 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred EEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 799999998 5899999988899999999999999999999999999999999999999999999999999998764433
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
..........||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+....+....
T Consensus 524 ~~~~~~~~~~~t~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~------------ 589 (635)
T 4fl3_A 524 NYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE------------ 589 (635)
T ss_dssp -----------CGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------
T ss_pred cccccccCCCCceeeeChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------------
Confidence 22222334567889999999977 689999999999999999998 999999877644433332210
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.. .....+++++.+||.+||..||++||+++++++
T Consensus 590 -------------~~-----~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 590 -------------RM-----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp -------------CC-----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------CC-----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 00 011357889999999999999999999999976
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=372.74 Aligned_cols=244 Identities=23% Similarity=0.398 Sum_probs=201.1
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
..++|++++.||+|+||.||+|... |+.||||+++.. ...+.+.+|+.+|+.++||||+++++++.... .
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~ 260 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----G 260 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSC----TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----S
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCc----hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----C
Confidence 3568999999999999999999874 789999999753 24467889999999999999999999985432 3
Q ss_pred cEEEEEeccc-ccHHHHHHhCCC--CCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 191 DIYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~--l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
.+|+|||||+ |+|.+++...+. +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 5899999998 599999987653 7999999999999999999999999999999999999999999999999998542
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
... ....+++.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+....+...
T Consensus 341 ~~~------~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~---------- 402 (450)
T 1k9a_A 341 STQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---------- 402 (450)
T ss_dssp ------------CCCTTTSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT----------
T ss_pred ccc------cCCCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC----------
Confidence 211 22367889999999877 689999999999999999998 99999876543333222110
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
. ..+ ....+++.+.+||.+||..||.+|||+.++++
T Consensus 403 -------------~--~~~-----~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 403 -------------Y--KMD-----APDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp -------------C--CCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------C--CCC-----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0 000 11357899999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=365.11 Aligned_cols=261 Identities=12% Similarity=0.163 Sum_probs=200.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCC--------CcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHT--------GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLP 183 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~--------~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~ 183 (509)
.++|++.+.||+|+||.||+|++..+ ++.||||++... ..+.+|+.+++.++||||+++++.+..
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 46899999999999999999999874 889999998642 357799999999999999984332211
Q ss_pred CC-----------cCCCCcEEEEEecccccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEEC
Q 010489 184 PS-----------RREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 250 (509)
Q Consensus 184 ~~-----------~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~ 250 (509)
.. ......+|+||||++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred CCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence 00 0123568999999988999999876 7899999999999999999999999999999999999999
Q ss_pred CCC--CeEEeeecccccccCCCCC----cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCC
Q 010489 251 ADC--KLKICDFGLARVSFNDAPS----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK 324 (509)
Q Consensus 251 ~~~--~vkl~DFG~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 324 (509)
.++ .+||+|||+++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--CGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 998 8999999999765432211 111234589999999999987 68999999999999999999999999865
Q ss_pred C-hHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 325 N-VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 325 ~-~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
. ....+..... .+.... .........+..+++++.+||.+||..||.+||+++++++
T Consensus 272 ~~~~~~~~~~~~-------------------~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 272 LPNTEDIMKQKQ-------------------KFVDKP--GPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TTCHHHHHHHHH-------------------HHHHSC--CCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CcCHHHHHHHHH-------------------hccCCh--hhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 3 1111111100 000000 0000011122356899999999999999999999999988
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=376.44 Aligned_cols=255 Identities=18% Similarity=0.186 Sum_probs=194.8
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCC-CCcceee---------ee-
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRH-PDIVEIK---------HI- 180 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h-~niv~~~---------~~- 180 (509)
..|.+.+.||+|+||+||+|.+..+|+.||||+++... ......+.+.+|+.+++.+.| +++..+. ++
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45899999999999999999999999999999987322 222335678899999999987 3222111 11
Q ss_pred -----------ecCCCcCCCCcEEEEEecccccHHHHHHh-------CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCC
Q 010489 181 -----------MLPPSRREFKDIYVVFELMESDLHQVIKA-------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDL 242 (509)
Q Consensus 181 -----------~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-------~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDl 242 (509)
+..........++++|+++.++|.+++.. ...+++..+..++.||++||+|||++||+||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 11111111345789999999999888841 235778889999999999999999999999999
Q ss_pred CCCcEEECCCCCeEEeeecccccccCCCCCccccccccccccccccccccc--------ccCCCCCceeeehhhhHHHHH
Q 010489 243 KPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS--------FFSKYTPAIDIWSIGCIFAEM 314 (509)
Q Consensus 243 Kp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~~DiwSlG~il~el 314 (509)
||+|||++.++.+||+|||+++..... ....+| +.|+|||++.+ ....++.++|||||||++|||
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 999999999999999999998764322 345678 99999999831 114688899999999999999
Q ss_pred HhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 010489 315 LTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR 394 (509)
Q Consensus 315 l~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 394 (509)
++|+.||.+.+...... ........+++.+.+||.+||+.||++|
T Consensus 311 ltg~~Pf~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~li~~~l~~dP~~R 355 (413)
T 3dzo_A 311 WCADLPNTDDAALGGSE-----------------------------------WIFRSCKNIPQPVRALLEGFLRYPKEDR 355 (413)
T ss_dssp HHSSCCCCTTGGGSCSG-----------------------------------GGGSSCCCCCHHHHHHHHHHTCSSGGGS
T ss_pred HHCCCCCCCcchhhhHH-----------------------------------HHHhhcccCCHHHHHHHHHHccCChhhC
Confidence 99999998754311100 0001123567899999999999999999
Q ss_pred CCHHHHhcCCcccCC
Q 010489 395 PTAEEALADPYFHGL 409 (509)
Q Consensus 395 pt~~e~l~hp~f~~~ 409 (509)
|++.++++||||+.+
T Consensus 356 pt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 356 LLPLQAMETPEYEQL 370 (413)
T ss_dssp CCHHHHTTSHHHHHH
T ss_pred cCHHHHHhCHHHHHH
Confidence 999999999999754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=351.85 Aligned_cols=259 Identities=25% Similarity=0.417 Sum_probs=195.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCc-ccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++.+.||+|+||.||+|.+..+|+.||||++... .........+.+|+.+++.++||||+++++++.. ..
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~ 105 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DN 105 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CC
Confidence 46899999999999999999999999999999999742 2234456778899999999999999999999854 34
Q ss_pred cEEEEEecccc-cHHHHHHh----CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 191 DIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 191 ~~~lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
.+|+||||+++ +|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence 68999999985 89888864 45799999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... ....
T Consensus 186 ~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~------------ 247 (310)
T 2wqm_A 186 FSSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLC------------ 247 (310)
T ss_dssp ----------------CCSSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHH------------
T ss_pred ecCCCc---cccccCCCeeEeChHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHH------------
Confidence 533221 1234579999999999877 678999999999999999999999997643210 0000
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.. +... ...+ .....+++++.+||.+||..||.+|||+.++++ .++.+
T Consensus 248 ~~---------~~~~-~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~--~l~~l 295 (310)
T 2wqm_A 248 KK---------IEQC-DYPP----LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD--VAKRM 295 (310)
T ss_dssp HH---------HHTT-CSCC----CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred HH---------hhcc-cCCC----CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH--HHHHH
Confidence 00 0000 0000 112357889999999999999999999999998 45443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=350.38 Aligned_cols=254 Identities=23% Similarity=0.360 Sum_probs=200.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCC---CcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
..+|++.+.||+|+||.||+|.+..+ +..||+|.+... ........+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 98 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---- 98 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC----
Confidence 35799999999999999999986543 346899998753 3344567789999999999999999999987533
Q ss_pred CCcEEEEEecccc-cHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 189 FKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 189 ~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
....|+||||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 2457999999985 999999764 46899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCC-cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 267 FNDAPS-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 267 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
...... ........||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~-------- 248 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-------- 248 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT--------
T ss_pred cccchhccccccCCCCCccccChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC--------
Confidence 332211 111234578899999999877 689999999999999999999 66778766543332222110
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
... .....+++.+.+||.+||+.||.+|||+.++++
T Consensus 249 ------------------~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 249 ------------------RRL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp ------------------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 011346788999999999999999999999987
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=375.22 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=205.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
..+|++.+.||+|+||.||+|.+. .+..||||+++... ...+.+.+|+.+|+.++||||+++++++.. ..
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------~~ 256 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EP 256 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC------Cc
Confidence 468999999999999999999875 47789999997532 345678999999999999999999999842 34
Q ss_pred EEEEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 192 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
+|+|||||. |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 799999998 6999999754 3689999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
... .......+|+.|+|||++.. ..++.++|||||||++|||++ |+.||.+.+..+....+....
T Consensus 337 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~---------- 402 (454)
T 1qcf_A 337 NEY--TAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY---------- 402 (454)
T ss_dssp HHH--HTTCSSSSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC----------
T ss_pred Cce--eccCCCcccccccCHHHhcc--CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 111 11123456789999999876 679999999999999999999 999999877544433332110
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
..+ ....+++++.+||.+||..||++|||++++++ .++.+
T Consensus 403 ---------------~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~--~L~~~ 442 (454)
T 1qcf_A 403 ---------------RMP-----RPENCPEELYNIMMRCWKNRPEERPTFEYIQS--VLDDF 442 (454)
T ss_dssp ---------------CCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHTS
T ss_pred ---------------CCC-----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH--HHHHH
Confidence 001 11357889999999999999999999999987 44443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=358.11 Aligned_cols=265 Identities=24% Similarity=0.399 Sum_probs=203.6
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||.||+|.+..+++.||||++.. ........+.+|+.+++.++||||+++++++.... .....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec--CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCce
Confidence 4689999999999999999999999999999999854 23345677889999999999999999999985321 23346
Q ss_pred EEEEEecccc-cHHHHHHh----CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 192 IYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 192 ~~lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
+|+||||+.+ +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 8999999985 89988875 467999999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCc------ccccccccccccccccccccc-cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCC
Q 010489 267 FNDAPSA------IFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339 (509)
Q Consensus 267 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~ 339 (509)
....... .......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----------- 253 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG----------- 253 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-----------
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-----------
Confidence 2211110 011234679999999998652 1236889999999999999999999995311000
Q ss_pred CChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.... ..... .... ...+.+++.+.+||.+||+.||.+|||+.+++++ +..+
T Consensus 254 --~~~~---------~~~~~---~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~ 304 (317)
T 2buj_A 254 --DSVA---------LAVQN---QLSI---PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ--LEAL 304 (317)
T ss_dssp --SCHH---------HHHHC---C--C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHT
T ss_pred --chhh---------HHhhc---cCCC---CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH--hhhc
Confidence 0000 00000 0000 1124578899999999999999999999999994 4444
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=347.76 Aligned_cols=253 Identities=26% Similarity=0.385 Sum_probs=201.1
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCc---EEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGE---RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~---~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
-.|.+.+.||+|+||.||+|.+..++. .||+|++... ........+.+|+.+++.++||||+++++++....
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 95 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE---- 95 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----
Confidence 367888999999999999998765544 7999998753 33345677889999999999999999999986432
Q ss_pred CcEEEEEeccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 190 KDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
...++||||+. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 23489999997 699999976 4578999999999999999999999999999999999999999999999999997543
Q ss_pred CCCC-CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCC-CCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 268 NDAP-SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 268 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
.... .........||+.|+|||.+.+ ..++.++|||||||++|+|++|. +||.+.+..+....+...
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~--------- 244 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQT--YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG--------- 244 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTT--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT---------
T ss_pred CCcccccccCcCCCCCccccChhhhcc--CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC---------
Confidence 2211 1111234578999999999987 68899999999999999999955 556554443322222111
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
... .....+++.+.+||.+||+.||.+|||+.++++
T Consensus 245 ------------------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 245 ------------------RRL---PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp ------------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCC---CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 000 011346788999999999999999999999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=347.26 Aligned_cols=247 Identities=25% Similarity=0.379 Sum_probs=202.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||.||+|.+. ++..||||+++... .....+.+|+.+++.++||||+++++++.. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~ 81 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EP 81 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEcC------CC
Confidence 368999999999999999999875 57789999996432 234678899999999999999999998843 23
Q ss_pred EEEEEeccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 192 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
.|+||||++ ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 799999997 69999986543 699999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
... .......+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+....+...
T Consensus 162 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~----------- 226 (279)
T 1qpc_A 162 NEY--TAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG----------- 226 (279)
T ss_dssp SCE--ECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----------
T ss_pred ccc--ccccCCCCccCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc-----------
Confidence 221 11234467889999999876 678999999999999999999 99999887654433222110
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
... .....+++.+.+||.+||..||++|||+.++++
T Consensus 227 ----------------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 227 ----------------YRM---VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ----------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------cCC---CCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000 111356889999999999999999999999987
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=372.58 Aligned_cols=273 Identities=22% Similarity=0.367 Sum_probs=205.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||+|+||.||+|++..+|+.||||+++.... ......+.+|+.+|+.++||||+++++++.... ...
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~ 83 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRH 83 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCC
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---CCe
Confidence 4689999999999999999999999999999999974322 233566789999999999999999999986432 245
Q ss_pred EEEEEeccc-ccHHHHHHhCC---CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEE----CCCCCeEEeeeccc
Q 010489 192 IYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFGLA 263 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl----~~~~~vkl~DFG~a 263 (509)
+|+|||||+ ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 899999997 58999987543 39999999999999999999999999999999999999 77888999999999
Q ss_pred ccccCCCCCcccccccccccccccccccccc------cCCCCCceeeehhhhHHHHHHhCCCCCCCCCh-HhHHHHHHHh
Q 010489 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV-VHQLDLMTDL 336 (509)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~ 336 (509)
+...... .....+||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+... ......+...
T Consensus 164 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 239 (396)
T 4eut_A 164 RELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (396)
T ss_dssp EECCCGG----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred eEccCCC----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence 8653322 23456899999999987531 13577899999999999999999999975332 1122222222
Q ss_pred cCCCChhHHHHhhhHHHHHhhhccCCCCCCCCC-------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFS-------HKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 337 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
++..+...+..... ....+..|. .....+++.+.+||.+||+.||++||++.++++
T Consensus 240 ~~~~p~~~~~~~~~----------~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 240 ITGKPSGAISGVQK----------AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HHSCCTTCCEEEEC----------STTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred hcCCCcccchhhee----------ccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 22221111110000 000011111 111234567889999999999999999999865
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=350.42 Aligned_cols=247 Identities=28% Similarity=0.378 Sum_probs=202.9
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCC-------
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS------- 185 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~------- 185 (509)
.+|++++.||+|+||.||+|.+..+++.||||+++... ..+.+|+.+++.++||||+++++++....
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 47999999999999999999999999999999986421 34668999999999999999999874311
Q ss_pred ----cCCCCcEEEEEecccc-cHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEe
Q 010489 186 ----RREFKDIYVVFELMES-DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 258 (509)
Q Consensus 186 ----~~~~~~~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~ 258 (509)
......+|+||||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 1123458999999995 999999754 579999999999999999999999999999999999999999999999
Q ss_pred eecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcC
Q 010489 259 DFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338 (509)
Q Consensus 259 DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g 338 (509)
|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 165 Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~~------------ 226 (284)
T 2a19_B 165 DFGLVTSLKNDGK----RTRSKGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETSK------------ 226 (284)
T ss_dssp CCTTCEESSCCSC----CCCCCSCCTTSCHHHHHC--SCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH------------
T ss_pred cchhheecccccc----ccccCCcccccChhhhcc--CCCcchhhhHHHHHHHHHHHhcCCcchhHHH------------
Confidence 9999986543322 234579999999999877 6789999999999999999999988742110
Q ss_pred CCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
....+ .... ....+++.+.+||.+||..||.+|||+.++++|.+.
T Consensus 227 -----~~~~~------------~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~ 271 (284)
T 2a19_B 227 -----FFTDL------------RDGI------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271 (284)
T ss_dssp -----HHHHH------------HTTC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----HHHHh------------hccc------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 00000 0000 113467889999999999999999999999998775
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=361.33 Aligned_cols=267 Identities=20% Similarity=0.322 Sum_probs=201.5
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
..++|++.+.||+|+||.||+|.+ .+|+.||||++...... .....+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 100 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----T 100 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS-----S
T ss_pred HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecC-----C
Confidence 356899999999999999999975 46899999998653221 1223578999999999999999999999543 4
Q ss_pred cEEEEEeccc-ccHHHHHHhCC----CCCHHHHHHHHHHHHhHhhhhhhC---CeeecCCCCCcEEECCCCCeEEeeecc
Q 010489 191 DIYVVFELME-SDLHQVIKAND----DLTPEHYQFFLYQLLRGLKYIHTA---NVFHRDLKPKNILANADCKLKICDFGL 262 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~----~l~~~~~~~i~~qil~aL~yLH~~---~ivHrDlKp~NILl~~~~~vkl~DFG~ 262 (509)
..++||||++ ++|.+++.... .+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 180 (326)
T 3uim_A 101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180 (326)
T ss_dssp CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSS
T ss_pred ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcc
Confidence 5799999998 58999997643 499999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCC-----hHhHHHHHHHhc
Q 010489 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN-----VVHQLDLMTDLL 337 (509)
Q Consensus 263 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~ 337 (509)
+......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... .......+....
T Consensus 181 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 181 AKLMDYKDTH--VTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CEECCSSSSC--EECCCCSCGGGCCHHHHHH--SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred ccccCccccc--ccccccCCcCccCHHHhcc--CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 9865433221 2345679999999999876 678999999999999999999999995211 000111110000
Q ss_pred CCCChhHHHHhhhHHHHHhhhccCCCCCCCC-CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
.... ......... .......++.+.+|+.+||+.||.+|||+.++++|-.-
T Consensus 257 ~~~~------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 257 KEKK------------------LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SSCC------------------STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hchh------------------hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 0000 000000000 01112234679999999999999999999999996543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=348.80 Aligned_cols=242 Identities=26% Similarity=0.419 Sum_probs=189.3
Q ss_pred CCCeeEe-eeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHH-HHcCCCCcceeeeeecCCCcCCC
Q 010489 112 ASRYQIQ-EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL-RLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 112 ~~~y~i~-~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l-~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
.++|.+. +.||+|+||.||+|.+..+++.||||+++. ...+.+|+.++ +.++||||+++++++.... ...
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~ 87 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY-AGR 87 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCC
Confidence 3578887 789999999999999999999999999853 23466899888 6668999999999885311 124
Q ss_pred CcEEEEEeccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC---CCCeEEeeeccc
Q 010489 190 KDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLA 263 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~---~~~vkl~DFG~a 263 (509)
..+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 56899999998 49999998764 6999999999999999999999999999999999999998 788999999998
Q ss_pred ccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChh
Q 010489 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (509)
.... + ..++.++|||||||++|||++|+.||.+.........+
T Consensus 168 ~~~~-------------------------~--~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~---------- 210 (299)
T 3m2w_A 168 KETT-------------------------G--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---------- 210 (299)
T ss_dssp EECT-------------------------T--CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS----------
T ss_pred cccc-------------------------c--ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH----------
Confidence 6421 1 35677999999999999999999999765432110000
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
...............+..+++++.+||.+||+.||.+|||+.|+|+||||++...
T Consensus 211 -------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 211 -------------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp -------------CCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred -------------HHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 0000001111111112457899999999999999999999999999999987543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=349.74 Aligned_cols=242 Identities=30% Similarity=0.454 Sum_probs=191.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||+|+||.||+|.+. ++.||||++.. ....+.+.+|+.+++.++||||+++++++.. .
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~ 73 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACLN-------P 73 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------T
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------C
Confidence 358999999999999999999874 78999999853 2345678899999999999999999998752 2
Q ss_pred EEEEEeccc-ccHHHHHHhCC---CCCHHHHHHHHHHHHhHhhhhhh---CCeeecCCCCCcEEECCCCC-eEEeeeccc
Q 010489 192 IYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHT---ANVFHRDLKPKNILANADCK-LKICDFGLA 263 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qil~aL~yLH~---~~ivHrDlKp~NILl~~~~~-vkl~DFG~a 263 (509)
.|+||||++ ++|.+++.... .+++..+..++.||++||+|||+ +||+||||||+|||++.++. +||+|||++
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~ 153 (307)
T 2eva_A 74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153 (307)
T ss_dssp TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccc
Confidence 699999998 59999998665 47899999999999999999999 89999999999999998887 799999999
Q ss_pred ccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChh
Q 010489 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (509)
...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ...
T Consensus 154 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~--------- 215 (307)
T 2eva_A 154 CDIQTH------MTNNKGSAAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IMW--------- 215 (307)
T ss_dssp -----------------CCTTSSCHHHHTC--CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HHH---------
T ss_pred cccccc------cccCCCCCceEChhhhCC--CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HHH---------
Confidence 754321 133579999999999987 68999999999999999999999999754321100 000
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.. . ....+ .....+++.+.+||.+||+.||.+|||++++++
T Consensus 216 ---~~---------~--~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 216 ---AV---------H--NGTRP----PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp ---HH---------H--TTCCC----CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HH---------h--cCCCC----CcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 0 00001 112457889999999999999999999999987
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=370.66 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=198.5
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||+|+||.||+|.+.. +..||||+++... .....+.+|+.+|+.++||||+++++++.. ..
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~ 252 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 252 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cc
Confidence 4679999999999999999999864 4679999997532 234678899999999999999999999843 34
Q ss_pred EEEEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 192 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
+|+|||||+ |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 799999998 5999999643 5699999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
.... ......+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+....+.+..+....
T Consensus 333 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~---------- 398 (452)
T 1fmk_A 333 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---------- 398 (452)
T ss_dssp ------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----------
T ss_pred Ccee--cccCCcccccccCHhHHhc--CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 2211 1233467889999999876 689999999999999999999 999998876544333322110
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..+ ..+.+++.+.+||.+||+.||++|||++++++
T Consensus 399 ---------------~~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 399 ---------------RMP-----CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp ---------------CCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCC-----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 011 11357888999999999999999999999987
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=363.32 Aligned_cols=254 Identities=22% Similarity=0.359 Sum_probs=193.8
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCC---CcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
...|++.+.||+|+||.||+|.+..+ +..||||.++.. ........+.+|+.+++.++||||+++++++...
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~---- 162 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---- 162 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----
Confidence 34689999999999999999987543 246899988643 3335567889999999999999999999987543
Q ss_pred CCcEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 189 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
....|+||||++ ++|.+++... ..+++..+..++.||++||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccc
Confidence 235799999998 5999999765 46899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCC-cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 267 FNDAPS-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 267 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
...... ........+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~-------- 312 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-------- 312 (373)
T ss_dssp ---------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT--------
T ss_pred cccccccccccCCCCCcccccChHHhcC--CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC--------
Confidence 332211 111234567889999999877 689999999999999999999 67888776543322221110
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
... .....+++.+.+||.+||..||++|||+.++++
T Consensus 313 ------------------~~~----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 313 ------------------RRL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp ------------------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 011346788999999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=371.29 Aligned_cols=258 Identities=19% Similarity=0.242 Sum_probs=201.6
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|+++++||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+.|++++..+..+. .....
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~~ 77 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFG----VEGDY 77 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEE----EETTE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEE----eeCCE
Confidence 4689999999999999999999999999999998864322 234778999999998755544444432 23356
Q ss_pred EEEEEecccccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEE---CCCCCeEEeeeccccccc
Q 010489 192 IYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVSF 267 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl---~~~~~vkl~DFG~a~~~~ 267 (509)
.||||||++++|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||| +.++.+||+|||+++...
T Consensus 78 ~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 78 NVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 899999998899999975 4679999999999999999999999999999999999999 588999999999998764
Q ss_pred CCCCCc----ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChh
Q 010489 268 NDAPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 268 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (509)
...... ......+||+.|+|||++.+ ..++.++||||||||||||++|+.||.+.........+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i------- 228 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI------- 228 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH-------
T ss_pred CCccccccccccccccCCCccccCHHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH-------
Confidence 433211 11235689999999999987 68999999999999999999999999875543222222111
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
........+. .....+++++.+||.+||..||++||++.+|++
T Consensus 229 -----~~~~~~~~~~-----------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 229 -----SEKKVATSIE-----------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp -----HHHHHHSCHH-----------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred -----hhccccccHH-----------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1111100000 111346788999999999999999999998765
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=354.92 Aligned_cols=266 Identities=23% Similarity=0.342 Sum_probs=202.6
Q ss_pred eeEeeeeeccCceEEEEEE----EcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 115 YQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 115 y~i~~~lG~G~~g~V~~~~----~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
|++++.||+|+||.||+|. +..+++.||||+++.. ........+.+|+.+|+.++||||+++++++.... ..
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~ 108 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG---AA 108 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---TT
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC---Cc
Confidence 4999999999999998774 4458899999999753 23345677899999999999999999999986432 34
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|+||||++ ++|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred eEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 6899999998 5899988765 5999999999999999999999999999999999999999999999999999876443
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
...........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+...... .
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-----~~~~~~~~~~~~-~--- 256 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKE--YKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-----FLELIGIAQGQM-T--- 256 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-----HHHHHCSCCHHH-H---
T ss_pred ccccccccCCCCCceeeChHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCcccccchh-----hhhhhcccccch-h---
Confidence 322222344578899999999877 67889999999999999999999999653211 111111111110 0
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.......+. ..... .....+++.+.+||.+||+.||.+|||+.++++
T Consensus 257 ~~~~~~~~~---~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 257 VLRLTELLE---RGERL---PRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHHHH---TTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHh---cccCC---CCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 001111111 11111 112457899999999999999999999999987
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=347.03 Aligned_cols=243 Identities=22% Similarity=0.391 Sum_probs=194.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||+|+||.||+|.+ +|+.||||+++.. ...+.+.+|+.+++.++||||+++++++... ...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~ 89 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGG 89 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------C
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCc
Confidence 46899999999999999999986 4889999998642 2456788999999999999999999987543 235
Q ss_pred EEEEEecccc-cHHHHHHhCCC--CCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 192 IYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 192 ~~lv~e~~~~-~L~~~l~~~~~--l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
+|+||||+++ +|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 8999999985 99999976543 89999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
.. ....+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+....+....+..
T Consensus 170 ~~------~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~------------ 229 (278)
T 1byg_A 170 TQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------ 229 (278)
T ss_dssp ------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT------------
T ss_pred cc------cCCCccccccCHHHhCC--CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc------------
Confidence 21 23467899999999876 688999999999999999998 9999987654332222110
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.... .....+++.+.+||.+||..||.+|||+.++++
T Consensus 230 ---------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 230 ---------------GYKM---DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ---------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCC---CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 0000 112457889999999999999999999999987
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=350.62 Aligned_cols=259 Identities=22% Similarity=0.355 Sum_probs=198.6
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcC-CCc--EEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTH-TGE--RVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~-~~~--~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
..+|++++.||+|+||.||+|.+.. ++. .||||+++... ........+.+|+.+++.++||||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence 3589999999999999999998643 333 68999986432 2234567889999999999999999999998643
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 188 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
..++||||+. ++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 94 ---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 94 ---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp ---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred ---CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 2799999998 6899988764 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
...............+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-------- 240 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE-------- 240 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS--------
T ss_pred ccccccchhhhccCCCCceeeCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc--------
Confidence 6443322222234578889999999876 678899999999999999999 99999887654333322110
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.... .....+++.+.+||.+||..||.+|||+.++++ +++.+
T Consensus 241 ------------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~l~~~ 282 (291)
T 1u46_A 241 ------------------GERL---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEA 282 (291)
T ss_dssp ------------------CCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred ------------------CCCC---CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH--HHHHh
Confidence 0000 112357889999999999999999999999998 55443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=362.68 Aligned_cols=243 Identities=15% Similarity=0.178 Sum_probs=192.9
Q ss_pred CCCeeEeeeeeccCceEEEEE-----EEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC---CCCcceeeeeecC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSA-----VDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR---HPDIVEIKHIMLP 183 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~-----~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~~~~~~~~ 183 (509)
..+|.+.+.||+|+||+||+| .+..+++.||||+++.. ....+.+|+.+++.+. |+||+.+++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 468999999999999999999 46778999999999642 3446778888888887 9999999999854
Q ss_pred CCcCCCCcEEEEEeccc-ccHHHHHHh-----CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC------
Q 010489 184 PSRREFKDIYVVFELME-SDLHQVIKA-----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA------ 251 (509)
Q Consensus 184 ~~~~~~~~~~lv~e~~~-~~L~~~l~~-----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~------ 251 (509)
. ...|+|||||+ |+|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||++.
T Consensus 139 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 139 Q-----NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp S-----SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred C-----CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence 4 45899999998 699999973 457999999999999999999999999999999999999998
Q ss_pred -----CCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCCh
Q 010489 252 -----DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV 326 (509)
Q Consensus 252 -----~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 326 (509)
++.+||+|||+|+....... .......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.....
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPK-GTIFTAKCETSGFQCVEMLSN--KPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCT-TEEECCSSCTTSCCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred ccccccCCEEEeeCchhhhhhccCC-CceeeeecCCCCCCChHHhcC--CCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 89999999999975432222 223456789999999999987 6799999999999999999999999964331
Q ss_pred HhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 327 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 327 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
... .... .+.. ...++.+.+++.+||..+|.+|++..+.+.
T Consensus 291 ~~~-----------------------------~~~~----~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 291 GEC-----------------------------KPEG----LFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp TEE-----------------------------EECS----CCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred Cce-----------------------------eech----hccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 000 0000 0000 023567889999999999999966544444
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=350.38 Aligned_cols=264 Identities=23% Similarity=0.318 Sum_probs=201.5
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc--cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
...|...+.||+|+||.||+|.+ +++.||||++.... ........+.+|+.+++.++||||+++++++...
T Consensus 30 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----- 102 (307)
T 2nru_A 30 RPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG----- 102 (307)
T ss_dssp SBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----
T ss_pred ccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC-----
Confidence 34566679999999999999975 68899999986432 2233457788999999999999999999998543
Q ss_pred CcEEEEEeccc-ccHHHHHHh---CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 190 KDIYVVFELME-SDLHQVIKA---NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~---~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
...|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 182 (307)
T 2nru_A 103 DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA 182 (307)
T ss_dssp SSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccc
Confidence 45899999997 689988863 34699999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
....... .......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+......+..+.........
T Consensus 183 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 255 (307)
T 2nru_A 183 SEKFAQT-VMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEK--- 255 (307)
T ss_dssp CCSCSSC-EECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSC---
T ss_pred ccccccc-ccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhh---
Confidence 5432221 12244689999999998865 5789999999999999999999999876543222222111000000
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
....++. . .........+..+.+||.+||..||.+|||+.++++
T Consensus 256 ------~~~~~~~---~----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 256 ------TIEDYID---K----KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp ------CHHHHSC---S----SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------hhhhhcc---c----cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0001110 0 001111223567899999999999999999999987
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=379.34 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=198.9
Q ss_pred CCCeeEee-eeeccCceEEEEEEEc--CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 112 ASRYQIQE-VIGKGSYGVVGSAVDT--HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 112 ~~~y~i~~-~lG~G~~g~V~~~~~~--~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
..+|.+.+ .||+|+||.||+|.++ .++..||||+++... .......+.+|+.+|+.++||||+++++++..
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----- 407 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----- 407 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-----
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-----
Confidence 34566666 8999999999999775 356689999997542 23456788999999999999999999999853
Q ss_pred CCcEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 189 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
..+|+|||||+ |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 24899999998 5899988654 46999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
..............+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+....+...
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~--------- 555 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--------- 555 (613)
T ss_dssp C--------------CCTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT---------
T ss_pred cCCCceeeeccCCCCccceeCHhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---------
Confidence 433221111223356789999999876 689999999999999999998 99999887654433333211
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
...+ ..+.+++++.+||.+||..||++||++.++++
T Consensus 556 ----------------~~~~-----~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 556 ----------------KRME-----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp ----------------CCCC-----CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred ----------------CCCC-----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0000 11357899999999999999999999999865
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=358.51 Aligned_cols=273 Identities=22% Similarity=0.275 Sum_probs=193.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHH--HHHcCCCCcceeeeeecCCCcCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKL--LRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~--l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
.++|++++.||+|+||.||+|.+ +++.||||++... ....+..|..+ +..++||||+++++.+........
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 46899999999999999999975 6899999998632 22333444444 456899999999976543333444
Q ss_pred CcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhC---------CeeecCCCCCcEEECCCCCeEEee
Q 010489 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA---------NVFHRDLKPKNILANADCKLKICD 259 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~---------~ivHrDlKp~NILl~~~~~vkl~D 259 (509)
..+|+|||||+ ++|.+++... .+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred ceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 56899999997 5999998665 458999999999999999999999 999999999999999999999999
Q ss_pred ecccccccCCCC-----Cccccccccccccccccccccccc-----CCCCCceeeehhhhHHHHHHhCCCCC-CCCChHh
Q 010489 260 FGLARVSFNDAP-----SAIFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAEMLTGKPLF-PGKNVVH 328 (509)
Q Consensus 260 FG~a~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~ 328 (509)
||+++....... ........+||+.|+|||++.+.. ..++.++|||||||++|||++|..|| .+.....
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 999986543221 111123568999999999986521 24567899999999999999997554 4433221
Q ss_pred HHHHHH-HhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCC---CCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 329 QLDLMT-DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFP---NADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 329 ~~~~i~-~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
....+. .....+....+.. .... ......+...++ .+++.+.+||.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~--------~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQV--------LVSR--EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHH--------HHTT--SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhhcccCCCchHHHHHh--------hhcc--cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 111111 1112222222111 1111 111111222222 24567999999999999999999999965
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=390.44 Aligned_cols=284 Identities=25% Similarity=0.344 Sum_probs=210.4
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCC-cCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-~~~~~~ 191 (509)
++|++.+.||+|+||.||+|.+..+|+.||||+++.. ........+.+|+.+++.++||||+++++++.... ......
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 6899999999999999999999999999999998653 23445677899999999999999999999875422 223566
Q ss_pred EEEEEeccc-ccHHHHHHhCC---CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCC---eEEeeecccc
Q 010489 192 IYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLAR 264 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~---vkl~DFG~a~ 264 (509)
.|+|||||+ ++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++. +||+|||++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 899999997 69999997654 6999999999999999999999999999999999999997765 9999999998
Q ss_pred cccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+........ +......
T Consensus 173 ~~~~~~~----~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~------~~i~~~~ 240 (676)
T 3qa8_A 173 ELDQGEL----CTEFVGTLQYLAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWH------GKVREKS 240 (676)
T ss_dssp BTTSCCC----CCCCCSCCTTCSSCSSCC--SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSS------TTCC---
T ss_pred ccccccc----cccccCCcccCChHHhcc--CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhh------hhhhccc
Confidence 6543322 245689999999999987 689999999999999999999999997754321110 0000000
Q ss_pred HHHhhhHHHHHhhhccCCCCC-CCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 345 ISRIRNEKARRYLGSMRKKQP-VPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
....... ............ .......+.+++.+.+||.+||.+||++|||++++++||||+.+.+
T Consensus 241 ~~~~~~~--~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~ 306 (676)
T 3qa8_A 241 NEHIVVY--DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306 (676)
T ss_dssp ---CCSC--CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred chhhhhh--hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence 0000000 000000000000 0111222346788999999999999999999999999999976544
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=349.91 Aligned_cols=270 Identities=22% Similarity=0.361 Sum_probs=206.8
Q ss_pred CCCeeEeeeeeccCceEEEEEE----EcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~----~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
..+|++++.||+|+||.||+|+ +..+++.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 115 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG-- 115 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC--
Confidence 4579999999999999999998 5678999999999752 3345677899999999999999999999886532
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 188 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
...+++||||++ ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 116 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 116 -RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred -CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 235899999998 5999999876 4699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
...............++..|+|||++.+ ..++.++|||||||++|||++|..||.... .......+.......
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~~~~~~~-----~~~~~~~~~~~~~~~ 267 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPP-----AEFMRMIGNDKQGQM 267 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHHTTCGGGSHH-----HHHHHHHCTTCCTHH
T ss_pred ccccccccccccCCCCceeEECchhhcC--CCCCchhhHHHHHHHHHHHHhcCCCCCCCH-----HHHHHhhccccchhh
Confidence 6443321111233467888999999877 678899999999999999999999885421 111122222221111
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.. ......+. .....+ ....+++++.+||.+||..||.+|||+.++++
T Consensus 268 ~~---~~~~~~~~---~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 268 IV---FHLIELLK---NNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HH---HHHHHHHH---TTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hH---HHHHHHhh---cCCCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 00111111 111111 12457899999999999999999999999987
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=351.93 Aligned_cols=262 Identities=25% Similarity=0.333 Sum_probs=191.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHH--cCCCCcceeeeeecCCCcCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL--LRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~~~~~~~~~~~~~~ 189 (509)
.++|++++.||+|+||.||+|.+. ++.||||++.. .......+|..++.. ++||||+++++++.... ...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-----~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~ 107 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFT-----TEEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSW 107 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEG-----GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGG
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEec-----cccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCC
Confidence 358999999999999999999875 89999999853 223344556666655 48999999999986542 222
Q ss_pred CcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhC--------CeeecCCCCCcEEECCCCCeEEeee
Q 010489 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--------NVFHRDLKPKNILANADCKLKICDF 260 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~--------~ivHrDlKp~NILl~~~~~vkl~DF 260 (509)
..+|+||||++ ++|.+++... .+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 56899999998 4999999654 699999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCC-cccccccccccccccccccccccCCCCCc------eeeehhhhHHHHHHhC----------CCCCCC
Q 010489 261 GLARVSFNDAPS-AIFWTDYVATRWYRAPELCGSFFSKYTPA------IDIWSIGCIFAEMLTG----------KPLFPG 323 (509)
Q Consensus 261 G~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~------~DiwSlG~il~ell~g----------~~pf~~ 323 (509)
|++......... .......+||+.|+|||++.+ ..+..+ +|||||||++|||++| ..||..
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE--SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTT--CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhccc--ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999765433221 111234689999999999876 344444 9999999999999999 666654
Q ss_pred CChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 324 KNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 324 ~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
..... +....+. ............+.......+++++.+||.+||+.||.+|||+.++++|
T Consensus 265 ~~~~~-----------~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 265 LVPSD-----------PSYEDMR--------EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TSCSS-----------CCHHHHH--------HHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hcCCC-----------CchhhhH--------HHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 32100 0000000 0000000011111111112356779999999999999999999999983
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=373.87 Aligned_cols=247 Identities=26% Similarity=0.394 Sum_probs=202.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||+|+||.||+|.+.. +..||||+++... .....+.+|+.+|+.++||||+++++++.. ..
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~ 335 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 335 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee------cc
Confidence 4579999999999999999999864 4679999997532 234678899999999999999999999843 34
Q ss_pred EEEEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 192 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
+|||||||+ ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 799999998 5999999643 5699999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
.. ........++..|+|||++.. ..++.++|||||||+||||++ |+.||.+....+.+..+....
T Consensus 416 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~---------- 481 (535)
T 2h8h_A 416 NE--YTARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---------- 481 (535)
T ss_dssp HH--HHTTCSTTSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC----------
T ss_pred Cc--eecccCCcCcccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 11 011123457889999999876 689999999999999999999 999998876544433322110
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
..+ ....+++.+.+||.+||+.||++|||++++++
T Consensus 482 ---------------~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 482 ---------------RMP-----CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp ---------------CCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCC-----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 001 11357888999999999999999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=348.73 Aligned_cols=260 Identities=22% Similarity=0.281 Sum_probs=200.9
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
..++|++.+.||+|+||.||+|.+.. .||+|+++.........+.+.+|+.+++.++||||+++++++... .
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 102 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP-----P 102 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS-----S
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----C
Confidence 35789999999999999999998753 499999875433333445677899999999999999999998543 4
Q ss_pred cEEEEEeccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 191 DIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
.+|+||||++ ++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 5899999998 68999987654 699999999999999999999999999999999999998 78999999999875422
Q ss_pred CCC--Ccccccccccccccccccccccc-------cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCC
Q 010489 269 DAP--SAIFWTDYVATRWYRAPELCGSF-------FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339 (509)
Q Consensus 269 ~~~--~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~ 339 (509)
... .........||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+.........+...
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--- 258 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG--- 258 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT---
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC---
Confidence 111 11112345799999999998642 135788999999999999999999999876653333222110
Q ss_pred CChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
..+. .....+++++.+||.+||..||.+|||+.++++ .++.+.
T Consensus 259 -----------------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~ 301 (319)
T 2y4i_B 259 -----------------------MKPN---LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLP 301 (319)
T ss_dssp -----------------------CCCC---CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC-
T ss_pred -----------------------CCCC---CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHH
Confidence 0010 111246778999999999999999999999998 666554
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=347.07 Aligned_cols=261 Identities=23% Similarity=0.297 Sum_probs=197.0
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHH--cCCCCcceeeeeecCCCcCCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL--LRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~~~~~~~~~~~~~~~ 190 (509)
++|++.+.||+|+||.||+|.+ +|+.||||++.. .....+.+|+++++. ++||||+++++++.... ....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~ 113 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWT 113 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc-----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-Cccc
Confidence 5799999999999999999987 589999999863 234567789999988 78999999999986543 2223
Q ss_pred cEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhh--------hCCeeecCCCCCcEEECCCCCeEEeeec
Q 010489 191 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH--------TANVFHRDLKPKNILANADCKLKICDFG 261 (509)
Q Consensus 191 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH--------~~~ivHrDlKp~NILl~~~~~vkl~DFG 261 (509)
.+|+||||+++ +|.+++.. ..+++..+..++.||+.||.||| +.||+||||||+|||++.++.+||+|||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 68999999985 99999976 46999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccCCCCCc-ccccccccccccccccccccccC----CCCCceeeehhhhHHHHHHhC----------CCCCCCCCh
Q 010489 262 LARVSFNDAPSA-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEMLTG----------KPLFPGKNV 326 (509)
Q Consensus 262 ~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~DiwSlG~il~ell~g----------~~pf~~~~~ 326 (509)
++.......... .......||+.|+|||++.+... .++.++|||||||++|||++| ..||.....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 997654332210 01244589999999999876211 233689999999999999999 778865432
Q ss_pred HhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 327 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKF--PNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 327 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
.. +..+.+. ..+. .......+...+ ..+++.+.+||.+||+.||++|||+.++++|
T Consensus 273 ~~-----------~~~~~~~--------~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 273 SD-----------PSVEEMR--------KVVC--EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SS-----------CCHHHHH--------HHHT--TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred Cc-----------ccHHHHH--------HHHH--HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 10 0000000 0000 000001111111 1234578999999999999999999999984
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=360.35 Aligned_cols=253 Identities=19% Similarity=0.175 Sum_probs=189.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc------ChhhHHhHHHHHHHHHHcC---------CCCcce
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE------HVSDATRILREIKLLRLLR---------HPDIVE 176 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~------~~~~~~~~~~Ei~~l~~l~---------h~niv~ 176 (509)
.++|++++.||+|+||+||+|++ +|+.||||+++.... .......+.+|+.+|+.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 35799999999999999999987 689999999975321 2233467889999999886 666666
Q ss_pred eeeeec-----------------CC--------CcCCCCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhh
Q 010489 177 IKHIML-----------------PP--------SRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLK 230 (509)
Q Consensus 177 ~~~~~~-----------------~~--------~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~ 230 (509)
+.+++. .. ...+...+|||||||+ |++.+.+.. +.+++..++.++.||+.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 665542 10 0112467999999997 456555543 57899999999999999999
Q ss_pred hhh-hCCeeecCCCCCcEEECCCC--------------------CeEEeeecccccccCCCCCccccccccccccccccc
Q 010489 231 YIH-TANVFHRDLKPKNILANADC--------------------KLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289 (509)
Q Consensus 231 yLH-~~~ivHrDlKp~NILl~~~~--------------------~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE 289 (509)
||| ++||+||||||+|||++.++ .+||+|||+|+.... ...+||+.|+|||
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--------~~~~gt~~y~aPE 247 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--------GIVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------TEEECCCCTTCSG
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------CcEEEeecccChh
Confidence 999 99999999999999999887 899999999986532 2348999999999
Q ss_pred ccccccCCCCCceeeehhhhH-HHHHHhCCCCCCCCChHh-HHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCC
Q 010489 290 LCGSFFSKYTPAIDIWSIGCI-FAEMLTGKPLFPGKNVVH-QLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVP 367 (509)
Q Consensus 290 ~~~~~~~~~~~~~DiwSlG~i-l~ell~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (509)
++.+ .. +.++||||||++ .++++.|..||.+..... ....+ +.... .....
T Consensus 248 ~~~g--~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~-----------------------~~~~~-~~~~~ 300 (336)
T 2vuw_A 248 LFTG--DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKM-----------------------LKQMT-FKTKC 300 (336)
T ss_dssp GGCC--CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHH-----------------------HHTCC-CSSCC
T ss_pred hhcC--CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhh-----------------------hhhhc-cCccc
Confidence 9987 33 889999998777 788899999984321100 00011 00000 00111
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHh-cCCccc
Q 010489 368 FSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL-ADPYFH 407 (509)
Q Consensus 368 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l-~hp~f~ 407 (509)
....++.+++++.+||.+||++| |++|+| +||||+
T Consensus 301 ~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 301 NTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp CSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred chhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 11122346788999999999987 999999 999995
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=373.37 Aligned_cols=250 Identities=25% Similarity=0.430 Sum_probs=202.3
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCC---CcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
.++|++.+.||+|+||.||+|.+..+ +..||||+++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----- 462 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 462 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----
Confidence 46899999999999999999998653 467999988643 233445678999999999999999999999832
Q ss_pred CCcEEEEEeccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 189 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
..+|+||||++ |+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 463 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 463 -NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred -CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 24799999998 69999997654 6999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+...
T Consensus 542 ~~~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~--------- 608 (656)
T 2j0j_A 542 EDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--------- 608 (656)
T ss_dssp CC------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT---------
T ss_pred CCCcce--eccCCCCCcceeCHHHhcC--CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---------
Confidence 332211 1233467889999999876 689999999999999999997 99999887755444333211
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
...+ ..+.+++.+.+||.+||..||.+|||+.++++
T Consensus 609 ----------------~~~~-----~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 609 ----------------ERLP-----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp ----------------CCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCC-----CCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0001 12357889999999999999999999999987
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=326.63 Aligned_cols=231 Identities=17% Similarity=0.104 Sum_probs=184.8
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccC-hhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~ 104 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----RA 104 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----CC
Confidence 36899999999999999999999999999999999754332 3445778999999999999999999999844 35
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
..|+||||++ ++|.+++... ..+.++..++.||+.||+|||++||+||||||+|||++.+|.+||+++|
T Consensus 105 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 105 GGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred cEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 6899999998 5899988543 4666788999999999999999999999999999999999999998543
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
|++ .++.++|||||||++|||++|+.||.+.+....+...
T Consensus 175 ---------------~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---------------- 214 (286)
T 3uqc_A 175 ---------------TMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---------------- 214 (286)
T ss_dssp ---------------CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC----------------
T ss_pred ---------------ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH----------------
Confidence 332 3678999999999999999999999876532111000
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
.......+.......+.+++++.+||.+||+.||.+| |+.|+++ .++.
T Consensus 215 --------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~--~L~~ 262 (286)
T 3uqc_A 215 --------ERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN--LMQQ 262 (286)
T ss_dssp --------CBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH--HHHH
T ss_pred --------HHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH--HHHH
Confidence 0000111111222335688999999999999999999 9999998 4543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=374.54 Aligned_cols=245 Identities=25% Similarity=0.364 Sum_probs=197.1
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcC-CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTH-TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++.+.||+|+||.||+|.+.. +|+.||||++... ........+.+|+.+|+.++||||+++++++.........
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3789999999999999999999976 7899999998642 2234456788999999999999999999998654332223
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
..||||||++ ++|.+++.. .+++..+..|+.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.....
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 3799999998 478776654 79999999999999999999999999999999999999875 9999999999865322
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
...+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.... +.+...
T Consensus 235 -------~~~~gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~~~------ 288 (681)
T 2pzi_A 235 -------GYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPEDD------ 288 (681)
T ss_dssp -------SCCCCCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCTTC------
T ss_pred -------CccCCCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCcccccc----------cccccc------
Confidence 34579999999999875 3588999999999999999999998753210 000000
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 407 (509)
.....++.+.+||.+||..||.+||+..+++.|+|+.
T Consensus 289 ---------------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 289 ---------------------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ---------------------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---------------------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0001346789999999999999999999999998875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.53 Aligned_cols=188 Identities=18% Similarity=0.124 Sum_probs=134.9
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCccc--------ChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCC
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE--------HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--------~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~ 189 (509)
...+.|++|.+..++....|+.||+|++.+... .....+.+.+|+++|+++ .|+||+++++++ ++.
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~ 314 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENA 314 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECS
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EEC
Confidence 456788888888888888999999999864321 123346689999999999 699999999999 455
Q ss_pred CcEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 190 KDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 190 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
..+|||||||+| +|.++|...+++++. .|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+....
T Consensus 315 ~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 315 QSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp SEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred CEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 679999999995 899999998888875 4789999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCC
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL 320 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~p 320 (509)
... ...+.+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus 392 ~~~---~~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCS---WPTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --C---CSHHHHHHHHHHHHHHC--------------------CCCCTTHHH
T ss_pred CCc---cccCceechhhccHHHhCC---CCCCcccccccccchhhhccccch
Confidence 322 2356799999999999876 567789999999999988776543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-29 Score=267.59 Aligned_cols=190 Identities=21% Similarity=0.256 Sum_probs=142.4
Q ss_pred eEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccCh------hhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV------SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 116 ~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
...+.||+|+||.||+| ...+..+|+|+........ ...+++.+|+.+|++++||||+++..++...
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~----- 411 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL----- 411 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET-----
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC-----
Confidence 44679999999999999 3467899999864322111 1235578999999999999999444333322
Q ss_pred CcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
...|||||||+ ++|.+++.. +..++.||++||.|||++||+||||||+|||++. .+||+|||+|+....
T Consensus 412 ~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 412 DNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp TTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred CccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 23599999998 699998865 5689999999999999999999999999999998 999999999987533
Q ss_pred CCCCc----ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCC
Q 010489 269 DAPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFP 322 (509)
Q Consensus 269 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 322 (509)
..... ......+||+.|||||++......|+..+|+||..+-..+.+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 21111 0123578999999999987654568888999999999999888877663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.7e-26 Score=220.70 Aligned_cols=147 Identities=16% Similarity=0.158 Sum_probs=116.0
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccCh----------------hhHHhHHHHHHHHHHcCCCCcce
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV----------------SDATRILREIKLLRLLRHPDIVE 176 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~----------------~~~~~~~~Ei~~l~~l~h~niv~ 176 (509)
..|.+++.||+|+||.||+|.+ .+|+.||||+++...... .....+.+|+.+|+.++ | ++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 4567779999999999999999 889999999986321110 13456889999999999 4 55
Q ss_pred eeeeecCCCcCCCCcEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCe
Q 010489 177 IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 255 (509)
Q Consensus 177 ~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~v 255 (509)
+.+++.. ...|+|||||+| +|.+ +. ......++.||+.||.|||++||+||||||+|||++ +|.+
T Consensus 166 v~~~~~~------~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~v 231 (282)
T 1zar_A 166 VPKVYAW------EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGI 231 (282)
T ss_dssp SCCEEEE------ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEE
T ss_pred cCeEEec------cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcE
Confidence 5555421 346999999985 8877 32 133557999999999999999999999999999999 9999
Q ss_pred EEeeecccccccCCCCCccccccccccccccccccccc
Q 010489 256 KICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293 (509)
Q Consensus 256 kl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 293 (509)
||+|||+|+. +..|+|||++.+
T Consensus 232 kl~DFG~a~~----------------~~~~~a~e~l~r 253 (282)
T 1zar_A 232 WIIDFPQSVE----------------VGEEGWREILER 253 (282)
T ss_dssp EECCCTTCEE----------------TTSTTHHHHHHH
T ss_pred EEEECCCCeE----------------CCCCCHHHHHHH
Confidence 9999999863 345789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.1e-22 Score=193.46 Aligned_cols=139 Identities=17% Similarity=0.149 Sum_probs=108.9
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcE--EEEEEecCcccCh----------------------hhHHhHHHHHHHHHHc
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGER--VAIKKINDVFEHV----------------------SDATRILREIKLLRLL 169 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~--vAiK~~~~~~~~~----------------------~~~~~~~~Ei~~l~~l 169 (509)
-|.+.+.||+|+||.||+|.+..+|+. ||||+++...... .....+.+|+.+|+.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 488999999999999999998778999 9999875321110 1123578999999999
Q ss_pred CCCCc--ceeeeeecCCCcCCCCcEEEEEecccc------cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhh-hCCeeec
Q 010489 170 RHPDI--VEIKHIMLPPSRREFKDIYVVFELMES------DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH-TANVFHR 240 (509)
Q Consensus 170 ~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~------~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH-~~~ivHr 240 (509)
.|+++ ..+++. ...+|||||+++ .|.++... .++..+..++.||+.||.||| +.||+||
T Consensus 128 ~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHr 195 (258)
T 1zth_A 128 KEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHA 195 (258)
T ss_dssp HHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECS
T ss_pred HhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 88864 333332 135899999963 56666432 235577889999999999999 9999999
Q ss_pred CCCCCcEEECCCCCeEEeeecccccc
Q 010489 241 DLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 241 DlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
||||+|||++. .++|+|||+|...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999988 9999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=7.8e-19 Score=175.79 Aligned_cols=135 Identities=16% Similarity=0.151 Sum_probs=96.3
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccC------------hhhHH--------hHHHHHHHHHHcCCCC
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH------------VSDAT--------RILREIKLLRLLRHPD 173 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~------------~~~~~--------~~~~Ei~~l~~l~h~n 173 (509)
-|++++.||.|+||.||+|.+. +|+.||||+++..... ..... ...+|...|.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4899999999999999999875 6999999987531100 00011 1234666666665444
Q ss_pred cce--eeeeecCCCcCCCCcEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEEC
Q 010489 174 IVE--IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 250 (509)
Q Consensus 174 iv~--~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~ 250 (509)
+.. .+++ ...+|||||++| .|.++. ....+..++.||+.+|.|||++|||||||||.|||++
T Consensus 175 v~vp~p~~~---------~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIAQ---------SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEEE---------ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE
T ss_pred CCCCeeeec---------cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe
Confidence 321 1211 123799999996 454332 1234567889999999999999999999999999999
Q ss_pred CCCC----------eEEeeecccc
Q 010489 251 ADCK----------LKICDFGLAR 264 (509)
Q Consensus 251 ~~~~----------vkl~DFG~a~ 264 (509)
.+|. +.|+||+-+.
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCE
T ss_pred CCCCcccccccccceEEEEeCCcc
Confidence 8773 8999999765
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=4.3e-12 Score=121.44 Aligned_cols=138 Identities=13% Similarity=0.110 Sum_probs=104.8
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 191 (509)
..|++...++.|+.+.||++.. .+..+++|....... .....+.+|+.+|+.+. +..+.+++++... .+.
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~ 84 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERH-----DGW 84 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-----CCc
Confidence 3588999999999999999964 368899999864211 12235789999999985 6667788877632 345
Q ss_pred EEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhh------------------------------------
Q 010489 192 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT------------------------------------ 234 (509)
Q Consensus 192 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~------------------------------------ 234 (509)
.|+||||++| +|.+.+. +......++.+++++|..||+
T Consensus 85 ~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred eEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 7999999997 5655421 122334678899999999998
Q ss_pred -----------------------CCeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 235 -----------------------ANVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 235 -----------------------~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999865556799999774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=5.5e-11 Score=113.21 Aligned_cols=132 Identities=14% Similarity=0.066 Sum_probs=92.9
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCC--cceeeeeecCCCcCCCCc
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD--IVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~~~~~~~~~~~~~~~~ 191 (509)
.|.+....+.|..+.||++.. .+|..+++|..... ....+.+|+.+++.+.+.+ +.+++.+... .+.
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~~ 89 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGR 89 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSC
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CCC
Confidence 455555445666799999954 46778999987542 2245678999999986545 4457776633 244
Q ss_pred EEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCC----------------------------------
Q 010489 192 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN---------------------------------- 236 (509)
Q Consensus 192 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~---------------------------------- 236 (509)
.|+||||++| .+ . . .... ...++.++++.|..||+..
T Consensus 90 ~~~v~e~i~G~~l-~-~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 90 DWLLLGEVPGQDL-L-S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp EEEEEECCSSEET-T-T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred CEEEEEecCCccc-C-c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 7999999997 45 3 1 1122 2245677777777777643
Q ss_pred ------------------------eeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 237 ------------------------VFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 237 ------------------------ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999876666799999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.16 E-value=3.2e-11 Score=118.18 Aligned_cols=184 Identities=18% Similarity=0.268 Sum_probs=116.7
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCc--ceeeeeecCCCcCCCCcEEE
Q 010489 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDI--VEIKHIMLPPSRREFKDIYV 194 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~ni--v~~~~~~~~~~~~~~~~~~l 194 (509)
++.++.|....||++. ..+++|+... ......+.+|+.+|+.+. +..+ .+++..... .......|+
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~--~~~~~~~~~ 93 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP--SETYQMSFA 93 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC--CSSCSCSCE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCC--CCCCCcceE
Confidence 3568999999999873 4688998643 234567889999999884 3332 333333211 111223589
Q ss_pred EEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhh---------------------------------------
Q 010489 195 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT--------------------------------------- 234 (509)
Q Consensus 195 v~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~--------------------------------------- 234 (509)
||++++| .+..... ..++.++...++.|+++.|..||+
T Consensus 94 vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp EEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred EEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9999997 4433222 246777777788888888888775
Q ss_pred -------------------CCeeecCCCCCcEEECC--CCCeEEeeecccccccCCCCCccccccccccccc---ccccc
Q 010489 235 -------------------ANVFHRDLKPKNILANA--DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY---RAPEL 290 (509)
Q Consensus 235 -------------------~~ivHrDlKp~NILl~~--~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y---~aPE~ 290 (509)
..++|+|++|.|||++. .+.+.|+||+.+....... +......+ ..|+.
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-------Dl~~~~~~~~~~~~~~ 244 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-------DFISLMEDDEEYGMEF 244 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-------HHHTTCCTTTSCCHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-------HHHHHHhhccccCHHH
Confidence 23799999999999998 4567899999986531110 00111111 22222
Q ss_pred cccccCCC------------CCceeeehhhhHHHHHHhCCCCC
Q 010489 291 CGSFFSKY------------TPAIDIWSIGCIFAEMLTGKPLF 321 (509)
Q Consensus 291 ~~~~~~~~------------~~~~DiwSlG~il~ell~g~~pf 321 (509)
.......| ....+.|++|.++|.+.+|..+|
T Consensus 245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11100111 11258999999999999998766
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.11 E-value=3.3e-10 Score=113.60 Aligned_cols=143 Identities=15% Similarity=0.229 Sum_probs=102.9
Q ss_pred eEeeeeeccCceEEEEEEEcCCCcEEEEEEec--CcccChhhHHhHHHHHHHHHHcC--CCCcceeeeeecCCCcCCCCc
Q 010489 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN--DVFEHVSDATRILREIKLLRLLR--HPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 116 ~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~--~~~~~~~~~~~~~~Ei~~l~~l~--h~niv~~~~~~~~~~~~~~~~ 191 (509)
.-++.|+.|.++.||++... +..+++|+.. ... .......+.+|+.+++.|. +..+.+++.++.... ..+.
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~ 115 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGR 115 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSS
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCC
Confidence 34678999999999999753 4678888764 211 1122456789999999997 445777877764432 2245
Q ss_pred EEEEEeccccc-HHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhh------------------------------------
Q 010489 192 IYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT------------------------------------ 234 (509)
Q Consensus 192 ~~lv~e~~~~~-L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~------------------------------------ 234 (509)
.|+||||++|. +.+. ....+++.....++.+++++|..||+
T Consensus 116 ~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp CEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred eEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 79999999973 3221 12347788888999999999999997
Q ss_pred ----------------------CCeeecCCCCCcEEECCCCC--eEEeeeccccc
Q 010489 235 ----------------------ANVFHRDLKPKNILANADCK--LKICDFGLARV 265 (509)
Q Consensus 235 ----------------------~~ivHrDlKp~NILl~~~~~--vkl~DFG~a~~ 265 (509)
..+||+|++|.|||++.++. +.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999997763 68999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=4.3e-07 Score=88.72 Aligned_cols=133 Identities=22% Similarity=0.213 Sum_probs=87.1
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCC---CcceeeeeecCCCcCCCCcEEE
Q 010489 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP---DIVEIKHIMLPPSRREFKDIYV 194 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~~~~~~~~~~~~~~~~~~l 194 (509)
++.++.|....||+. |..+++|+... ......+.+|+.+|+.+.+. .+.+++.+... ..+..|+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~----~~g~~~~ 90 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR----SDGNPFV 90 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC----TTSCEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc----CCCceEE
Confidence 456889999999988 56788997532 23456788999999999753 23444444421 1244689
Q ss_pred EEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhh---------------------------------------
Q 010489 195 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT--------------------------------------- 234 (509)
Q Consensus 195 v~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~--------------------------------------- 234 (509)
|||+++| .+..... ..++......++.++.+.|..||+
T Consensus 91 v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 91 GYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp EEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred EEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 9999997 3433211 123444444444444444444442
Q ss_pred ---------------------CCeeecCCCCCcEEECC---CCCe-EEeeeccccc
Q 010489 235 ---------------------ANVFHRDLKPKNILANA---DCKL-KICDFGLARV 265 (509)
Q Consensus 235 ---------------------~~ivHrDlKp~NILl~~---~~~v-kl~DFG~a~~ 265 (509)
..++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 24699999999999987 4665 8999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=2.4e-06 Score=81.44 Aligned_cols=131 Identities=18% Similarity=0.208 Sum_probs=84.3
Q ss_pred eeeccCce-EEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCCCcEEEEEe
Q 010489 120 VIGKGSYG-VVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIYVVFE 197 (509)
Q Consensus 120 ~lG~G~~g-~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e 197 (509)
.+..|..| .||+......+..+++|.-.. .....+.+|..+|+.+. +--+.+++.++.. .+..|+|||
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~~lvme 100 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDAWLLTT 100 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeEEEEEE
Confidence 45556555 699988777778899997642 34556788999999885 3235566666533 245799999
Q ss_pred cccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhh------------------------------------------
Q 010489 198 LMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT------------------------------------------ 234 (509)
Q Consensus 198 ~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~------------------------------------------ 234 (509)
+++| .+.+..... ......+..++...|.-||.
T Consensus 101 ~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred eeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 9987 444333211 11112223333333333331
Q ss_pred ----------------CCeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 235 ----------------ANVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 235 ----------------~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
..++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 127999999999999877667799999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=2.6e-06 Score=86.27 Aligned_cols=78 Identities=17% Similarity=0.072 Sum_probs=48.4
Q ss_pred EeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc--C---hhhHHhHHHHHHHHHHcCC--CCc-ceeeeeecCCCcCC
Q 010489 117 IQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE--H---VSDATRILREIKLLRLLRH--PDI-VEIKHIMLPPSRRE 188 (509)
Q Consensus 117 i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~---~~~~~~~~~Ei~~l~~l~h--~ni-v~~~~~~~~~~~~~ 188 (509)
-.+.||.|.++.||++....+++.|+||....... . .....++..|+.+|+.+.. +.. .+++.+. .
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~---- 107 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T---- 107 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T----
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C----
Confidence 35689999999999997666678899998653211 0 0123456789999988742 333 3454432 1
Q ss_pred CCcEEEEEecccc
Q 010489 189 FKDIYVVFELMES 201 (509)
Q Consensus 189 ~~~~~lv~e~~~~ 201 (509)
...++|||++++
T Consensus 108 -~~~~lvmE~l~g 119 (397)
T 2olc_A 108 -EMAVTVMEDLSH 119 (397)
T ss_dssp -TTTEEEECCCTT
T ss_pred -CccEEEEEeCCC
Confidence 124899999975
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.16 E-value=1.6e-05 Score=78.25 Aligned_cols=30 Identities=20% Similarity=0.324 Sum_probs=27.3
Q ss_pred CCeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 235 ANVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 235 ~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
.++||+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=1.1e-05 Score=80.28 Aligned_cols=84 Identities=8% Similarity=0.149 Sum_probs=51.8
Q ss_pred eEeeee-eccCceEEEEEEEc--C----CCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcC-C--CCcceeeeeecCC
Q 010489 116 QIQEVI-GKGSYGVVGSAVDT--H----TGERVAIKKINDVFE-HVSDATRILREIKLLRLLR-H--PDIVEIKHIMLPP 184 (509)
Q Consensus 116 ~i~~~l-G~G~~g~V~~~~~~--~----~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h--~niv~~~~~~~~~ 184 (509)
...+.| +.|....+|++... . ++..+++|....... .......+.+|+.+|+.|. + -.+.+++.+....
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345778 88989999988643 0 156788997643210 0001235678999888875 2 3456676665332
Q ss_pred CcCCCCcEEEEEecccc
Q 010489 185 SRREFKDIYVVFELMES 201 (509)
Q Consensus 185 ~~~~~~~~~lv~e~~~~ 201 (509)
. ..+..|+|||+++|
T Consensus 103 ~--~~g~~~~v~e~l~G 117 (357)
T 3ats_A 103 D--VLGTPFFLMDYVEG 117 (357)
T ss_dssp T--TTSSCEEEEECCCC
T ss_pred C--ccCCceEEEEecCC
Confidence 1 11346899999986
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00034 Score=71.12 Aligned_cols=32 Identities=16% Similarity=0.313 Sum_probs=28.2
Q ss_pred hhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 233 HTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 233 H~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
+...++|+|++|.|||++.++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 456799999999999998776 99999998864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00063 Score=65.76 Aligned_cols=68 Identities=13% Similarity=-0.006 Sum_probs=42.0
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCc-ceeeeeecCCCcCCCCcEEEEE
Q 010489 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI-VEIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~ 196 (509)
++.|+.|....+|++ ..+++|+....... .....+|+.+++.+....+ .+++..... .-++++
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~~~-------~~~~v~ 86 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVDPA-------TGVMVT 86 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEECTT-------TCCEEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEECC-------CCEEEE
Confidence 578999999999999 45888877532111 1123468888877753333 345443311 137899
Q ss_pred ecc-cc
Q 010489 197 ELM-ES 201 (509)
Q Consensus 197 e~~-~~ 201 (509)
||+ +|
T Consensus 87 e~i~~g 92 (301)
T 3dxq_A 87 RYIAGA 92 (301)
T ss_dssp ECCTTC
T ss_pred eecCCC
Confidence 999 65
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0025 Score=60.99 Aligned_cols=76 Identities=12% Similarity=0.003 Sum_probs=51.2
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCC---CcceeeeeecCCCcCCCC
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP---DIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~~~~~~~~~~~~~~~ 190 (509)
+..-.+.+|.|..+.||++.. .+|+.|.+|+...... .....+.+|+..|+.|.-. -+.+++.+.
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--------- 83 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--------- 83 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEecc---------
Confidence 455678899999999999974 5789999998643211 1123466899999988532 233444332
Q ss_pred cEEEEEecccc
Q 010489 191 DIYVVFELMES 201 (509)
Q Consensus 191 ~~~lv~e~~~~ 201 (509)
.-++||||+++
T Consensus 84 ~~~lv~e~l~~ 94 (288)
T 3f7w_A 84 DRTLAMEWVDE 94 (288)
T ss_dssp TTEEEEECCCC
T ss_pred CceEEEEeecc
Confidence 13789999863
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0011 Score=60.09 Aligned_cols=97 Identities=19% Similarity=0.115 Sum_probs=64.9
Q ss_pred cHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhh-hhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccccccc
Q 010489 202 DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYI-HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY 279 (509)
Q Consensus 202 ~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yL-H~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~ 279 (509)
+|.+++.. +.++++++++.+++|.+.+|.-+ +.+.-..+=+-|..|++..+|.|.+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------------
Confidence 68888875 46899999999999999998876 212212334457899999999998764 2111
Q ss_pred ccccccccccccccccCCCCCceeeehhhhHHHHHHhC
Q 010489 280 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG 317 (509)
Q Consensus 280 ~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g 317 (509)
.....+.|||... ...+.+.=|||||+++|..+--
T Consensus 98 ~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp ---------CCSS---SSSCHHHHHHHHHHHHHHHHTT
T ss_pred ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhhc
Confidence 1122366888753 3456778899999999999853
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0011 Score=64.37 Aligned_cols=73 Identities=16% Similarity=0.101 Sum_probs=53.2
Q ss_pred EeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC---CCCcceeeeeecCCCcCCCCcEE
Q 010489 117 IQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR---HPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 117 i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
-.+.|+.|....+|+... .+..+++|.... .....+.+|...|+.|. ...+.+++.+... .+..|
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~ 107 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINER-----SYRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSF 107 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEG-----GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCc-----ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceE
Confidence 357799999999999964 467888997643 23456788999988874 2456677666532 24579
Q ss_pred EEEecccc
Q 010489 194 VVFELMES 201 (509)
Q Consensus 194 lv~e~~~~ 201 (509)
+|||+++|
T Consensus 108 lvme~l~G 115 (312)
T 3jr1_A 108 LLLEALNK 115 (312)
T ss_dssp EEEECCCC
T ss_pred EEEEeccC
Confidence 99999985
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0031 Score=61.42 Aligned_cols=137 Identities=17% Similarity=0.123 Sum_probs=76.5
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCC--cceeeeeecCCCc--CCCCcEEE
Q 010489 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD--IVEIKHIMLPPSR--REFKDIYV 194 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~~~~~~~~~~~--~~~~~~~l 194 (509)
..|+ |....||++.. .+|+.+++|...... .....+..|+.+++.|.... +++++.. .+.. ...+..++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~---~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFA 104 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCC---CCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEE
Confidence 4566 88889998853 346679999885321 12345667888888875322 3334332 1110 11245688
Q ss_pred EEeccccc-H-----H------HHH---H---hC------CCCCHHHH----------------------HHHHHHHHhH
Q 010489 195 VFELMESD-L-----H------QVI---K---AN------DDLTPEHY----------------------QFFLYQLLRG 228 (509)
Q Consensus 195 v~e~~~~~-L-----~------~~l---~---~~------~~l~~~~~----------------------~~i~~qil~a 228 (509)
+|++++|. + . ..+ . .. ..++.... ...+.+++..
T Consensus 105 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 184 (328)
T 1zyl_A 105 VFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAA 184 (328)
T ss_dssp EEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHH
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHH
Confidence 99999862 1 1 111 1 00 01221111 0111122222
Q ss_pred hhhh----hhCCeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 229 LKYI----HTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 229 L~yL----H~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
+.-+ ....+||+|+++.|||++ + .+.|+||+.+.
T Consensus 185 l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 185 VTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 2211 234689999999999998 4 89999999775
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.11 E-value=0.004 Score=60.49 Aligned_cols=142 Identities=13% Similarity=0.101 Sum_probs=75.1
Q ss_pred eEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCc--ceeeeeecCCCc--CCCCc
Q 010489 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI--VEIKHIMLPPSR--REFKD 191 (509)
Q Consensus 116 ~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni--v~~~~~~~~~~~--~~~~~ 191 (509)
.-++.|+.|....||++... .| .+++|..... .....+..|+.+++.|....+ .+++... .+.. ...+.
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~-~g~~~~~~~g~ 97 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRK-DGELLGELSGR 97 (322)
T ss_dssp EEEEEECC---EEEEEEEES-SC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBT-TCCSCEEETTE
T ss_pred eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCCcccCCC-CCCEEEEECCE
Confidence 34567888988999999643 33 6889987642 112345568888877753232 2332211 1100 01234
Q ss_pred EEEEEeccccc-H-----------HHH---HHh-CCC--------CCHHHHHHHH---------------HHHHhHhhhh
Q 010489 192 IYVVFELMESD-L-----------HQV---IKA-NDD--------LTPEHYQFFL---------------YQLLRGLKYI 232 (509)
Q Consensus 192 ~~lv~e~~~~~-L-----------~~~---l~~-~~~--------l~~~~~~~i~---------------~qil~aL~yL 232 (509)
.+++|++++|. + -.. +.. ... .........+ ..+.+.++++
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 68999999862 1 001 111 001 1111111100 1123334444
Q ss_pred h-------hCCeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 233 H-------TANVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 233 H-------~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
+ ..++||+|+.+.|||++.++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3 2369999999999999877556899999775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0048 Score=62.79 Aligned_cols=71 Identities=13% Similarity=0.104 Sum_probs=47.5
Q ss_pred eeeeeccCceEEEEEEEcC-------CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCc-ceeeeeecCCCcCCC
Q 010489 118 QEVIGKGSYGVVGSAVDTH-------TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI-VEIKHIMLPPSRREF 189 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~-------~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~~~~~~~~~~~~~~ 189 (509)
++.|+.|....||++.... .+..|++|+.... . ....+.+|+.+++.|...++ .++++.+. +
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~-----~- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E--TESHLVAESVIFTLLSERHLGPKLYGIFS-----G- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C--CHHHHHHHHHHHHHHHHTTSSSCEEEEET-----T-
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--C--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC-----C-
Confidence 5678889899999997542 2578999987431 1 11345579999988863334 55665541 1
Q ss_pred CcEEEEEecccc
Q 010489 190 KDIYVVFELMES 201 (509)
Q Consensus 190 ~~~~lv~e~~~~ 201 (509)
.+|+||++|
T Consensus 148 ---g~v~e~l~G 156 (429)
T 1nw1_A 148 ---GRLEEYIPS 156 (429)
T ss_dssp ---EEEECCCCE
T ss_pred ---CEEEEEeCC
Confidence 388999975
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0024 Score=62.53 Aligned_cols=32 Identities=25% Similarity=0.455 Sum_probs=27.5
Q ss_pred hCCeeecCCCCCcEEECCC----CCeEEeeeccccc
Q 010489 234 TANVFHRDLKPKNILANAD----CKLKICDFGLARV 265 (509)
Q Consensus 234 ~~~ivHrDlKp~NILl~~~----~~vkl~DFG~a~~ 265 (509)
...++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3479999999999999875 6799999998864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0026 Score=63.28 Aligned_cols=72 Identities=8% Similarity=0.002 Sum_probs=41.9
Q ss_pred eeeeeccCceEEEEEEEcC--------CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCC-cceeeeeecCCCcCC
Q 010489 118 QEVIGKGSYGVVGSAVDTH--------TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD-IVEIKHIMLPPSRRE 188 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~--------~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~~~~~~~~~~~~~ 188 (509)
.+.|+.|....||++.... .+..|++|+..... ........|..+++.+...+ +.++++.. .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~---- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N---- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T----
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C----
Confidence 4567888888999997542 13678888764321 11112357888888875333 34555543 1
Q ss_pred CCcEEEEEecccc
Q 010489 189 FKDIYVVFELMES 201 (509)
Q Consensus 189 ~~~~~lv~e~~~~ 201 (509)
-++||||++|
T Consensus 109 ---~~~v~e~i~G 118 (369)
T 3c5i_A 109 ---GGRIEEWLYG 118 (369)
T ss_dssp ---TEEEEECCCS
T ss_pred ---CcEEEEEecC
Confidence 1689999986
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0045 Score=61.77 Aligned_cols=135 Identities=13% Similarity=0.151 Sum_probs=78.6
Q ss_pred eeeeeccCceEEEEEEEcC-------CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCC
Q 010489 118 QEVIGKGSYGVVGSAVDTH-------TGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~-------~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~ 189 (509)
++.|..|-...+|++.... .+..|.+|+.... ......+.+|..+++.|. +.-..++++++. +
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~-----~- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFP-----E- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEET-----T-
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC-----C-
Confidence 3567778888999997532 3578999975321 122345568999998885 322345665542 1
Q ss_pred CcEEEEEeccccc-H--------------HHHHH---hCC-----CCC--HHHHHHHHHHHHh-----------------
Q 010489 190 KDIYVVFELMESD-L--------------HQVIK---AND-----DLT--PEHYQFFLYQLLR----------------- 227 (509)
Q Consensus 190 ~~~~lv~e~~~~~-L--------------~~~l~---~~~-----~l~--~~~~~~i~~qil~----------------- 227 (509)
.+||||++|. | .+.+. ... ... +..+..+..++..
T Consensus 126 ---g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 202 (379)
T 3feg_A 126 ---GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL 202 (379)
T ss_dssp ---EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred ---ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence 2899999861 1 11111 111 111 3555656555432
Q ss_pred --Hhhhhh----h----CCeeecCCCCCcEEECCC----CCeEEeeecccc
Q 010489 228 --GLKYIH----T----ANVFHRDLKPKNILANAD----CKLKICDFGLAR 264 (509)
Q Consensus 228 --aL~yLH----~----~~ivHrDlKp~NILl~~~----~~vkl~DFG~a~ 264 (509)
.+..|. . ..++|+|+.+.|||++.+ +.+.|+||..|.
T Consensus 203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 122332 2 258999999999999876 789999999875
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0068 Score=59.56 Aligned_cols=31 Identities=19% Similarity=0.326 Sum_probs=27.4
Q ss_pred CCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 235 ANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 235 ~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3689999999999999888899999987753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.57 E-value=0.048 Score=55.77 Aligned_cols=72 Identities=17% Similarity=0.182 Sum_probs=45.8
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCc-ceeeeeecCCCcCCCCcEEEEE
Q 010489 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI-VEIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~ 196 (509)
++.|+.|-...+|++.....+..|++|+........ -...+|..+++.|...++ .++++++. . .+||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~---idR~~E~~vl~~L~~~gl~P~ll~~~~--~-------G~v~ 180 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI---INREREKKISCILYNKNIAKKIYVFFT--N-------GRIE 180 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC---SCHHHHHHHHHHHTTSSSBCCEEEEET--T-------EEEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh---cCHHHHHHHHHHHHhcCCCCCEEEEeC--C-------eEEE
Confidence 467888989999999765445788999864321111 112479999999975555 45666551 1 2599
Q ss_pred ecccc
Q 010489 197 ELMES 201 (509)
Q Consensus 197 e~~~~ 201 (509)
||++|
T Consensus 181 e~I~G 185 (458)
T 2qg7_A 181 EFMDG 185 (458)
T ss_dssp ECCCS
T ss_pred EeeCC
Confidence 99975
|
| >1y10_A Hypothetical protein RV1264/MT1302; adenylyl cyclase fold, lyase; HET: 1PE; 2.30A {Mycobacterium tuberculosis} PDB: 1y11_A* | Back alignment and structure |
|---|
Probab=95.74 E-value=0.00021 Score=71.74 Aligned_cols=72 Identities=19% Similarity=0.032 Sum_probs=56.5
Q ss_pred CHHHHHHHHHHHHHHhCh-------hhHHHHhhcCCCc------------cccCCCCcchHHHHHHHHHhhcCCCCCCCC
Q 010489 434 AKDDVREMIYREILEYHP-------QMLQEYLRGGEQT------------SFMYPSGVDRFKRQFAHLEEHYGKGERSTP 494 (509)
Q Consensus 434 ~~~~~~~~~~~~~~~~~p-------~~v~~~l~~g~~~------------~~~~~~~v~~~~~~fs~i~~~~~~~~~s~p 494 (509)
...+++++....+.+++| ..++..|+.+..+ ....+..+|++ |+||+|||.+++..+|
T Consensus 159 ~~~ee~~kse~LL~~iLP~L~~~l~~~va~~L~~~~~~~~v~~~~r~~~~~~~~~~~vTVl---FaDIvgFT~ls~~~~p 235 (407)
T 1y10_A 159 TELDIAKGSQALVSQIVPLLGPMIQDMLFMQLRHMMETEAVNAGERAAGKPLPGARQVTVA---FADLVGFTQLGEVVSA 235 (407)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCCTTCEEEEEE---EEEECSBCTTSCBCCH
T ss_pred CcHhHHHHHHHHHHHhcccccccchHHHHHHHHhcccchhhhhhhhcccccccceeeEEEE---EEEccCchHHHhhCCH
Confidence 344566777777888888 7888887766432 11246778999 9999999999999999
Q ss_pred cccccCCCCccccC
Q 010489 495 LQRQHASLPRYVCF 508 (509)
Q Consensus 495 ~~~~~~~~~~~~~~ 508 (509)
.+++.+||..|++|
T Consensus 236 ~evv~lLn~~~~~~ 249 (407)
T 1y10_A 236 EELGHLAGRLAGLA 249 (407)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHH
Confidence 99999999987765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.11 E-value=0.17 Score=50.99 Aligned_cols=72 Identities=11% Similarity=0.008 Sum_probs=44.9
Q ss_pred eeeeeccCceEEEEEEEcCC-------CcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCC-cceeeeeecCCCcCCC
Q 010489 118 QEVIGKGSYGVVGSAVDTHT-------GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD-IVEIKHIMLPPSRREF 189 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~~~~~~~~~~~~~~ 189 (509)
++.|..|-...+|++..... +..|++|+....... .-...+|..+++.+...+ ..++++.+.
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~---~idR~~E~~~l~~L~~~gi~P~l~~~~~------- 144 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK---FYDSKVELDVFRYLSNINIAPNIIADFP------- 144 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C---CCCHHHHHHHHHHHHHTTSSCCEEEEET-------
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch---hcCHHHHHHHHHHHHhcCCCCCEEEEcC-------
Confidence 45677788889999976421 578999986432111 112357888888875323 345554331
Q ss_pred CcEEEEEecccc
Q 010489 190 KDIYVVFELMES 201 (509)
Q Consensus 190 ~~~~lv~e~~~~ 201 (509)
-++||||++|
T Consensus 145 --~~~I~efI~G 154 (424)
T 3mes_A 145 --EGRIEEFIDG 154 (424)
T ss_dssp --TEEEEECCCS
T ss_pred --CCEEEEEeCC
Confidence 2789999986
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.75 E-value=0.35 Score=48.37 Aligned_cols=29 Identities=31% Similarity=0.421 Sum_probs=24.9
Q ss_pred eeecCCCCCcEEE------CCCCCeEEeeeccccc
Q 010489 237 VFHRDLKPKNILA------NADCKLKICDFGLARV 265 (509)
Q Consensus 237 ivHrDlKp~NILl------~~~~~vkl~DFG~a~~ 265 (509)
+||+|+.+.|||+ +.+..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567799999998753
|
| >3hls_A Guanylate cyclase soluble subunit beta-1; coiled-coil domain, signaling helix, S-helix, CGMP biosynthesis, cytoplasm, GTP-binding, heme, iron; 2.15A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=90.30 E-value=0.22 Score=35.68 Aligned_cols=34 Identities=15% Similarity=0.109 Sum_probs=29.1
Q ss_pred HHhhhcCHHHHHHHHHHHHHHhChhhHHHHhhcC
Q 010489 428 FERRKLAKDDVREMIYREILEYHPQMLQEYLRGG 461 (509)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~~p~~v~~~l~~g 461 (509)
.++++...++++++.++.+++++|..|+++|+.|
T Consensus 33 Lee~t~~L~~EK~ktd~LL~~mLP~~VA~~Lk~G 66 (66)
T 3hls_A 33 LQLTLRALEDEKKKTDTLLYSVLPPSVANELRHK 66 (66)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTSCHHHHHHHHC-
T ss_pred HHHHHHHHHHHHHHHHHHHHHcCCHHHHHHHhCc
Confidence 4566777889999999999999999999999876
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=87.07 E-value=0.045 Score=56.06 Aligned_cols=63 Identities=16% Similarity=0.116 Sum_probs=17.4
Q ss_pred eEeeeeeccCceEEEEEEEcCCCcEEEE------EEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeee
Q 010489 116 QIQEVIGKGSYGVVGSAVDTHTGERVAI------KKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIM 181 (509)
Q Consensus 116 ~i~~~lG~G~~g~V~~~~~~~~~~~vAi------K~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~ 181 (509)
.+.+.|| ||.||++........||+ |..+...........+.+|..+++.++|||+++.+.+.
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 3456676 999999987655568888 66543222233345678899999999999999987765
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 509 | ||||
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-96 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-89 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-88 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-78 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-77 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-74 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-73 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-71 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-71 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-71 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-69 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-69 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-67 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-67 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-67 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-66 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-66 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-65 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-65 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-65 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-65 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-65 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-64 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-64 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-63 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-62 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-61 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-59 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-59 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-58 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-56 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-55 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-53 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-51 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-49 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-48 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-48 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-48 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-48 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-47 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-46 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-46 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-44 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-43 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-43 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-42 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-39 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-23 |
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 294 bits (752), Expect = 1e-96
Identities = 161/341 (47%), Positives = 220/341 (64%), Gaps = 5/341 (1%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
RY IG+G+YG+V SA D RVAIKKI+ FEH + R LREIK+L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP-FEHQTYCQRTLREIKILLRFRH 65
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+I+ I I+ P+ + KD+Y+V LM +DL++++K L+ +H +FLYQ+LRGLKY
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKY 124
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
IH+ANV HRDLKP N+L N C LKICDFGLARV+ D F T+YVATRWYRAPE+
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
+ YT +IDIWS+GCI AEML+ +P+FPGK+ + QL+ + +LG+PS E ++ I N
Sbjct: 185 LNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411
KAR YL S+ K VP++ FPNAD AL LL+++L F+P R E+ALA PY +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
Query: 412 VDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQ 452
EP + +F+ E L K+ ++E+I+ E + P
Sbjct: 304 PSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETARFQPG 342
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 276 bits (705), Expect = 2e-89
Identities = 148/346 (42%), Positives = 217/346 (62%), Gaps = 12/346 (3%)
Query: 107 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL 166
T + RYQ +G G+YG V +A DT TG RVA+KK++ F+ + A R RE++LL
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 167 RLLRHPDIVEIKHIMLPP-SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQL 225
+ ++H +++ + + P S EF D+Y+V LM +DL+ ++K LT +H QF +YQ+
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQI 130
Query: 226 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
LRGLKYIH+A++ HRDLKP N+ N DC+LKI DFGLAR + ++ T YVATRWY
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------MTGYVATRWY 184
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
RAPE+ + + Y +DIWS+GCI AE+LTG+ LFPG + + QL L+ L+GTP E +
Sbjct: 185 RAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
+I +E AR Y+ S+ + + F++ F A+PLA+ LLE++L D R TA +ALA Y
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303
Query: 406 FHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 451
F + D EP P + FE R L D+ + + Y E++ + P
Sbjct: 304 FAQYHDPDDEPVADPY---DQSFESRDLLIDEWKSLTYDEVISFVP 346
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 272 bits (696), Expect = 3e-88
Identities = 137/346 (39%), Positives = 212/346 (61%), Gaps = 12/346 (3%)
Query: 107 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL 166
T + + Y+ + +G G+YG V SAVD TG +VAIKK+ F+ A R RE++LL
Sbjct: 12 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 71
Query: 167 RLLRHPDIVEIKHIMLPPSRRE-FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQL 225
+ +RH +++ + + P + F D Y+V M +DL +++K ++ L + QF +YQ+
Sbjct: 72 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQM 130
Query: 226 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
L+GL+YIH A + HRDLKP N+ N DC+LKI DFGLAR + ++ T YV TRWY
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM------TGYVVTRWY 184
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
RAPE+ + + +YT +DIWS+GCI AEM+TGK LF G + + QL + + GTP E +
Sbjct: 185 RAPEVILN-WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
R+++++A+ Y+ + + + F+ NA PLA++LLE++L D + R TA EALA PY
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303
Query: 406 FHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 451
F L + + EP Q K + F+ D+ + + Y+E+L + P
Sbjct: 304 FESLHDTEDEPQVQ---KYDDSFDDVDRTLDEWKRVTYKEVLSFKP 346
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (625), Expect = 7e-78
Identities = 108/303 (35%), Positives = 153/303 (50%), Gaps = 7/303 (2%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 170
E S+Y+ IG+G++G V A TG++VA+KK+ E LREIK+L+LL+
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 67
Query: 171 HPDIVEIKHIML---PPSRREFKDIYVVFELMESDLHQV-IKANDDLTPEHYQFFLYQLL 226
H ++V + I P R IY+VF+ E DL + T + + LL
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 127
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VSFNDAPSAIFWTDYVATRWY 285
GL YIH + HRD+K N+L D LK+ DFGLAR S +T+ V T WY
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
R PEL Y P ID+W GCI AEM T P+ G HQL L++ L G+ + E
Sbjct: 188 RPPELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 346 SRIRNEKARRYLGSMR-KKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
+ N + L ++ +K+ V K DP AL L+++LL DP R +++AL
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 405 YFH 407
+F
Sbjct: 307 FFW 309
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (626), Expect = 1e-77
Identities = 120/354 (33%), Positives = 194/354 (54%), Gaps = 23/354 (6%)
Query: 107 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL 166
+ + RYQ + IG G+ G+V +A D VAIKK++ F++ + A R RE+ L+
Sbjct: 11 STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70
Query: 167 RLLRHPDIVEIKHIMLPPSR-REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQL 225
+ + H +I+ + ++ P EF+D+Y+V ELM+++L QVI+ D E + LYQ+
Sbjct: 71 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYLLYQM 128
Query: 226 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
L G+K++H+A + HRDLKP NI+ +DC LKI DFGLAR + T YV TR+Y
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM----MTPYVVTRYY 184
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
RAPE+ Y +DIWS+GCI EM+ K LFPG++ + Q + + + LGTP E +
Sbjct: 185 RAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNA------------DPLALHLLERLLAFDPKD 393
++ R Y+ + K + F FP++ A LL ++L DP
Sbjct: 243 KKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 394 RPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREIL 447
R + ++AL PY + + E P + + + R+ ++ +E+IY+E++
Sbjct: 302 RISVDDALQHPYINVWYDPA-EVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM 354
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (606), Expect = 1e-74
Identities = 105/331 (31%), Positives = 170/331 (51%), Gaps = 21/331 (6%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
Y +VIG GS+GVV A +GE VAIKK+ D RE++++R L H +
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRKLDHCN 74
Query: 174 IVEIKHIMLPPSRREFKD-IYVVFELMESDLHQVI----KANDDLTPEHYQFFLYQLLRG 228
IV +++ ++ + + +V + + +++V +A L + + ++YQL R
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 229 LKYIHTANVFHRDLKPKNILANADCKL-KICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
L YIH+ + HRD+KP+N+L + D + K+CDFG A+ P Y+ +R+YRA
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP----NVSYICSRYYRA 190
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
PEL YT +ID+WS GC+ AE+L G+P+FPG + V QL + +LGTP+ E I
Sbjct: 191 PELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
+ ++ P++ F P P A+ L RLL + P R T EA A +F
Sbjct: 250 MNPNYTEFKFPQIKAH---PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
Query: 407 HGLANVDREPSTQPISKLEFEFERRKLAKDD 437
L + + + + F F ++L+ +
Sbjct: 307 DELRDPNVKLPNGRDTPALFNFTTQELSSNP 337
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (591), Expect = 3e-73
Identities = 103/310 (33%), Positives = 154/310 (49%), Gaps = 22/310 (7%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDAT---RILREIKLLRLLRHPDIV 175
+ +G+G + V A D +T + VAIKKI + LREIKLL+ L HP+I+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 176 EIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ S +I +VF+ ME+D + + LTP H + ++ L+GL+Y+H
Sbjct: 64 GLLDAFGHKS-----NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
+ HRDLKP N+L + + LK+ DFGLA+ + + +T V TRWYRAPEL
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA---YTHQVVTRWYRAPELL-FG 174
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354
Y +D+W++GCI AE+L P PG + + QL + + LGTP+ E + +
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 355 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDR 414
+ +P H F A L L++ L F+P R TA +AL YF
Sbjct: 235 VT---FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF------SN 285
Query: 415 EPSTQPISKL 424
P P +L
Sbjct: 286 RPGPTPGCQL 295
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (578), Expect = 3e-71
Identities = 115/313 (36%), Positives = 167/313 (53%), Gaps = 21/313 (6%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Q E IG+G+YGVV A + TGE VA+KKI E + +REI LL+ L HP+
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKY 231
IV++ ++ ++ +Y+VFE + DL + + A+ + + +L+QLL+GL +
Sbjct: 63 IVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
H+ V HRDLKP+N+L N + +K+ DFGLAR +T V T WYRAPE+
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR---TYTHEVVTLWYRAPEIL 174
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
Y+ A+DIWS+GCIFAEM+T + LFPG + + QL + LGTP
Sbjct: 175 LG-CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP--GVT 231
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411
Y S K FS P D LL ++L +DP R +A+ ALA P+F +
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV-- 289
Query: 412 VDREPSTQPISKL 424
T+P+ L
Sbjct: 290 ------TKPVPHL 296
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 4e-71
Identities = 64/308 (20%), Positives = 119/308 (38%), Gaps = 28/308 (9%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
++ +G G+ GVV +G +A K I+ + + +I+RE+++L P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRNQIIRELQVLHECNSPY 65
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
IV +I + E M+ L QV+K + + +++GL Y+
Sbjct: 66 IVGFYGAF-----YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 233 HTAN-VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
+ + HRD+KP NIL N+ ++K+CDFG++ + +V TR Y +PE
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-----NSFVGTRSYMSPERL 175
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
+ Y+ DIWS+G EM G+ P + + + + E+ R R
Sbjct: 176 --QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 352 KARRYLGSMRKKQPVPFSHKFPNA-------------DPLALHLLERLLAFDPKDRPTAE 398
M + P+ + + L +P +R +
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 399 EALADPYF 406
+ + +
Sbjct: 294 QLMVHAFI 301
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (577), Expect = 6e-71
Identities = 103/305 (33%), Positives = 151/305 (49%), Gaps = 16/305 (5%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGER-VAIKKINDVFEHVSDATRILREIKLLRLL--- 169
+Y+ IG+G+YG V A D G R VA+K++ +RE+ +LR L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLR 227
HP++V + + + +VFE ++ DL + + + E + ++QLLR
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
GL ++H+ V HRDLKP+NIL + ++K+ DFGLAR+ T V T WYRA
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA----LTSVVVTLWYRA 183
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
PE+ S Y +D+WS+GCIFAEM KPLF G + V QL + D++G P E R
Sbjct: 184 PEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407
+ + K P + D L LL + L F+P R +A AL+ PYF
Sbjct: 242 DVALPRQAF----HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
Query: 408 GLANV 412
L
Sbjct: 298 DLERC 302
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 222 bits (567), Expect = 1e-69
Identities = 104/293 (35%), Positives = 157/293 (53%), Gaps = 11/293 (3%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Y E IG+G+YGVV A + + GE A+KKI E + +REI +L+ L+H +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
IV++ ++ + + + V L + + L + FL QLL G+ Y H
Sbjct: 62 IVKLYDVI----HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
V HRDLKP+N+L N + +LKI DFGLAR +T + T WYRAP++
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK---YTHEIVTLWYRAPDVLMG 174
Query: 294 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353
KY+ IDIWS+GCIFAEM+ G PLFPG + QL + +LGTP++++ + +
Sbjct: 175 -SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT--EL 231
Query: 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
+Y + +P+P+ D + LL ++L DP R TA++AL YF
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 5e-69
Identities = 105/294 (35%), Positives = 151/294 (51%), Gaps = 11/294 (3%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Y+ E IG+G+YG V A + T E VA+K++ + + LREI LL+ L+H +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
IV + ++ + K V + N DL PE + FL+QLL+GL + H
Sbjct: 63 IVRLHDVL----HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
+ NV HRDLKP+N+L N + +LK+ +FGLAR ++ V T WYR P++
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC---YSAEVVTLWYRPPDVLFG 175
Query: 294 FFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
Y+ +ID+WS GCIFAE+ PLFPG +V QL + LLGTP+ E + K
Sbjct: 176 -AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT--K 232
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
Y + P + LL+ LL +P R +AEEAL PYF
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 1e-67
Identities = 69/293 (23%), Positives = 119/293 (40%), Gaps = 40/293 (13%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Y E IG+G+ G V +A+D TG+ VAI+++N + I+ EI ++R ++P+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
IV +++VV E + + + + L+ L+++H
Sbjct: 79 IVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
+ V HRD+K NIL D +K+ DFG + + V T ++ APE+
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTR 190
Query: 294 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353
Y P +DIWS+G + EM+ G+P + +N + L L+
Sbjct: 191 --KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-------------------- 228
Query: 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
P + L R L D + R +A+E L +
Sbjct: 229 --------ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 2e-67
Identities = 71/295 (24%), Positives = 120/295 (40%), Gaps = 37/295 (12%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+ + + +G+G+YG V AV+ T E VA+K + D+ V I +EI + ++L H +
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHEN 64
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLH-QVIKANDDLTPEHYQFFLYQLLRGLKYI 232
+V+ + Y+ E I+ + + Q F +QL+ G+ Y+
Sbjct: 65 VVKFYGHRREGNI-----QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H + HRD+KP+N+L + LKI DFGLA V F T Y APEL
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
+ +D+WS G + ML G+ + + Q
Sbjct: 179 R-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--------------------- 216
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407
K+ + + + D L LL ++L +P R T + D +++
Sbjct: 217 -------SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 217 bits (553), Expect = 2e-67
Identities = 80/326 (24%), Positives = 135/326 (41%), Gaps = 43/326 (13%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
Y ++V+G G++ V A D T + VAIK I + EI +L ++HP+
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPN 68
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
IV + I +Y++ +L+ +L I T ++Q+L +KY+
Sbjct: 69 IVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 123
Query: 233 HTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
H + HRDLKP+N+L + D K+ I DFGL+++ + + T Y APE
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL----STACGTPGYVAPE 179
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
+ Y+ A+D WSIG I +L G P F +N +
Sbjct: 180 VLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE------------------ 219
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409
+ K + S + + A + L+ DP+ R T E+AL P+ G
Sbjct: 220 ---------QILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270
Query: 410 ANVDREPSTQPISKLEFEFERRKLAK 435
+D+ +++ F + K +
Sbjct: 271 TALDKNIHQSVSEQIKKNFAKSKWKQ 296
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 215 bits (549), Expect = 1e-66
Identities = 76/350 (21%), Positives = 135/350 (38%), Gaps = 53/350 (15%)
Query: 103 TEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILR 161
E F + + IG GS+G V A D E VAIKK++ + I++
Sbjct: 5 AELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 162 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQF 220
E++ L+ LRHP+ ++ + L ++V E S + L
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKKPLQEVEIAA 119
Query: 221 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 280
+ L+GL Y+H+ N+ HRD+K NIL + +K+ DFG A + +V
Sbjct: 120 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFV 172
Query: 281 ATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339
T ++ APE + +Y +D+WS+G E+ KP N + L +
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------ 226
Query: 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
+ + P S + + ++ L P+DRPT+E
Sbjct: 227 --------------------AQNESPALQSGHWS---EYFRNFVDSCLQKIPQDRPTSEV 263
Query: 400 ALADPYFHGLANVDREPSTQPISKLEFEF----ERRKLAKDDVREMIYRE 445
L + + P T + ++ E L +++++++E
Sbjct: 264 LLKHRFV-----LRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKILFQE 308
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 213 bits (544), Expect = 9e-66
Identities = 91/312 (29%), Positives = 153/312 (49%), Gaps = 26/312 (8%)
Query: 108 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLR 167
E+G YQ+ +G+G Y V A++ E+V +K + V + +I REIK+L
Sbjct: 30 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILE 84
Query: 168 LLR-HPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQL 225
LR P+I+ + I+ P R +VFE + +D Q+ + LT +F++Y++
Sbjct: 85 NLRGGPNIITLADIVKDPVSRT---PALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEI 138
Query: 226 LRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
L+ L Y H+ + HRD+KP N++ + + KL++ D+GLA + VA+R+
Sbjct: 139 LKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE----YNVRVASRY 194
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLDLMTDLLGTPSTE 343
++ PEL + Y ++D+WS+GC+ A M+ K P F G + QL + +LGT
Sbjct: 195 FKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253
Query: 344 SISRIRNEKARRYLGSMRKKQP------VPFSHKFPNADPLALHLLERLLAFDPKDRPTA 397
N + + + S P AL L++LL +D + R TA
Sbjct: 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313
Query: 398 EEALADPYFHGL 409
EA+ PYF+ +
Sbjct: 314 REAMEHPYFYTV 325
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 1e-65
Identities = 71/333 (21%), Positives = 140/333 (42%), Gaps = 48/333 (14%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Y I E +G+G +G+V V+T + + K + +D + +EI +L + RH +
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRN 62
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLKY 231
I+ + +++ ++FE + D+ + I + +L +++Q+ L++
Sbjct: 63 ILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117
Query: 232 IHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
+H+ N+ H D++P+NI+ +KI +FG AR + +T Y APE
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT----APEYYAPE 173
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
+ + A D+WS+G + +L+G F + ++
Sbjct: 174 VHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE------------------ 213
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409
++ + F A+ ++RLL + K R TA EAL P+
Sbjct: 214 ---------NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ- 263
Query: 410 ANVDREPSTQPISKLEFEFERRKLAKDDVREMI 442
++R ST+ I L+ L K D+ ++
Sbjct: 264 -KIER-VSTKVIRTLKHRRYYHTLIKKDLNMVV 294
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (537), Expect = 3e-65
Identities = 67/316 (21%), Positives = 113/316 (35%), Gaps = 50/316 (15%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
++I +G G++G V A + T A K I+ + + + EI +L HP+
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYMVEIDILASCDHPN 70
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVI--KANDDLTPEHYQFFLYQLLRGLKY 231
IV++ +++++ E + + LT Q Q L L Y
Sbjct: 71 IVKLLDAF-----YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNY 125
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
+H + HRDLK NIL D +K+ DFG++ + ++ T ++ APE+
Sbjct: 126 LHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---RDSFIGTPYWMAPEVV 182
Query: 292 GSFFSK---YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348
SK Y D+WS+G EM +P N + L +
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-------------- 228
Query: 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408
K P + L++ L + R T + L P+
Sbjct: 229 --------------KSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV-- 272
Query: 409 LANVDREPSTQPISKL 424
S +PI +L
Sbjct: 273 -----TVDSNKPIREL 283
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 210 bits (535), Expect = 4e-65
Identities = 74/306 (24%), Positives = 124/306 (40%), Gaps = 49/306 (16%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDA-------TRILREIKLL 166
Y+ +E++G+G VV + T + A+K I+ A L+E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 167 RLLR-HPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQ 224
R + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 64 RKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 118
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
LL + +H N+ HRDLKP+NIL + D +K+ DFG + + T
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL----REVCGTPS 174
Query: 285 YRAPELC----GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340
Y APE+ Y +D+WS G I +L G P F + + L +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM-------- 226
Query: 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400
+ S ++ + L+ R L P+ R TAEEA
Sbjct: 227 -------------------IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
Query: 401 LADPYF 406
LA P+F
Sbjct: 268 LAHPFF 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 212 bits (541), Expect = 5e-65
Identities = 74/333 (22%), Positives = 127/333 (38%), Gaps = 45/333 (13%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
Y I E +G G++GVV + TG A K + H SD + +EI+ + +LRHP
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHPT 84
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVI-KANDDLTPEHYQFFLYQLLRGLKY 231
+V + + ++ +++E M +L + + ++ ++ + ++ Q+ +GL +
Sbjct: 85 LVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 139
Query: 232 IHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
+H N H DLKP+NI+ +LK+ DFGL T + APE
Sbjct: 140 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH----LDPKQSVKVTTGTAEFAAPE 195
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
+ D+WS+G + +L+G F G+N L
Sbjct: 196 VA--EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN----------------- 236
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409
++ F + +LL DP R T +AL P+
Sbjct: 237 ----------VKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP- 285
Query: 410 ANVDREPSTQPISKLEFEFERRKLAKDDVREMI 442
N S P S+ + K D E +
Sbjct: 286 GNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPL 318
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 6e-65
Identities = 69/296 (23%), Positives = 118/296 (39%), Gaps = 45/296 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRH 171
++I +GKG +G V A + + +A+K + E ++ RE+++ LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLK 230
P+I+ + +R +Y++ E +++ ++ + ++ +L L
Sbjct: 66 PNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 120
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 290
Y H+ V HRD+KP+N+L + +LKI DFG + APS+ T T Y PE+
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTT-LCGTLDYLPPEM 175
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350
+ +D+WS+G + E L GKP F +
Sbjct: 176 IEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------- 216
Query: 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
R + P A L+ RLL +P RP E L P+
Sbjct: 217 ---------SRVEFTFP-----DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 211 bits (539), Expect = 1e-64
Identities = 75/326 (23%), Positives = 129/326 (39%), Gaps = 48/326 (14%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
Y I E +G G++GVV V+ TG K IN + D + EI ++ L HP
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHPK 87
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLKY 231
++ + + ++ ++ E + +L I A D ++ ++ Q GLK+
Sbjct: 88 LINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 142
Query: 232 IHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
+H ++ H D+KP+NI+ +KI DFGLA D AT + APE
Sbjct: 143 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV----KVTTATAEFAAPE 198
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
+ D+W+IG + +L+G F G++ + L +
Sbjct: 199 IVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV---------------- 240
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409
++ F + P A ++ LL +P+ R T +AL P+ G
Sbjct: 241 -----------KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG- 288
Query: 410 ANVDREPSTQPISKLEFEFERRKLAK 435
D T I + R+K+ +
Sbjct: 289 ---DHSNLTSRIPSSRYNKIRQKIKE 311
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 5e-64
Identities = 79/304 (25%), Positives = 118/304 (38%), Gaps = 48/304 (15%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
A Y++ IG GSYG G+ + K+++ ++ ++ E+ LLR L+H
Sbjct: 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 62
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD----LTPEHYQFFLYQLL 226
P+IV ++ + +Y+V E E DL VI L E + QL
Sbjct: 63 PNIVRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119
Query: 227 RGLKYIH-----TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVA 281
LK H V HRDLKP N+ + +K+ DFGLAR+ +D A +V
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA---KAFVG 176
Query: 282 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341
T +Y +PE Y DIWS+GC+ E+ P F +
Sbjct: 177 TPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG---------- 224
Query: 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
+IR K RR ++ R+L RP+ EE L
Sbjct: 225 -----KIREGKFRRI---------------PYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
Query: 402 ADPY 405
+P
Sbjct: 265 ENPL 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 8e-63
Identities = 69/296 (23%), Positives = 119/296 (40%), Gaps = 41/296 (13%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
+ IG+GS+ V +DT T VA ++ D S+ R E ++L+ L+HP+I
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
V + + K I +V ELM S L +K + + + + Q+L+GL+++H
Sbjct: 71 VRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 234 TAN--VFHRDLKPKNIL-ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 290
T + HRDLK NI +KI D GLA + F + T + APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-----FAKAVIGTPEFMAPEM 184
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350
+ KY ++D+++ G EM T + + Q+
Sbjct: 185 ---YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-------------------- 221
Query: 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
R V + A P ++E + + +R + ++ L +F
Sbjct: 222 --------YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-62
Identities = 78/351 (22%), Positives = 140/351 (39%), Gaps = 46/351 (13%)
Query: 114 RYQI-QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK-LLRLLRH 171
Y++ +V+G G G V + T E+ A+K + D + RE++ R +
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQC 64
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRG 228
P IV I + K + +V E ++ +L I+ D T + +
Sbjct: 65 PHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 229 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
++Y+H+ N+ HRD+KP+N+L + LK+ DFG A+ + S T T +Y
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSHNSLTTPCYTPYY 179
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
APE+ G KY + D+WS+G I +L G P F + + M +
Sbjct: 180 VAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI-------- 229
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
R Q + ++ L+ LL +P R T E + P+
Sbjct: 230 ---------------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 274
Query: 406 FHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQE 456
V + P L+ + ER + K+++ + ++Y +++
Sbjct: 275 IMQSTKVPQTPLHTSRV-LKEDKERWEDVKEEMTSALATMRVDYEQIKIKK 324
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-61
Identities = 72/304 (23%), Positives = 121/304 (39%), Gaps = 47/304 (15%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 172
++ +++G+GS+ V A + T AIK + + + RE ++ L HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
V++ + +Y + +L + I+ +F+ +++ L+Y
Sbjct: 69 FFVKLYFTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
+H + HRDLKP+NIL N D ++I DFG A+V ++ A +V T Y +PEL
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA-RANSFVGTAQYVSPELL 182
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
+ D+W++GCI +++ G P F N +
Sbjct: 183 TE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI------------------ 222
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA------LADPY 405
K F KF P A L+E+LL D R EE A P+
Sbjct: 223 ----------IKLEYDFPEKFF---PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
Query: 406 FHGL 409
F +
Sbjct: 270 FESV 273
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 4e-59
Identities = 63/293 (21%), Positives = 104/293 (35%), Gaps = 38/293 (12%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+ + + IG GS+G V VA+K +N E+ +LR RH
Sbjct: 8 GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLK 230
+I+ + +V + E S L+ + + Q +G+
Sbjct: 65 NILLFMGYS------TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE- 289
Y+H ++ HRDLK NI + D +KI DFGLA V + S F + + APE
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMAPEV 177
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
+ + Y+ D+++ G + E++TG+ + N Q+ M
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--------------- 222
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402
R S N L+ L +RP + LA
Sbjct: 223 ----------GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 194 bits (493), Expect = 7e-59
Identities = 72/293 (24%), Positives = 119/293 (40%), Gaps = 33/293 (11%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 172
RY++ E++G G V A D VA+K + D+ S R RE + L HP
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
IV + + Y+V E ++ L ++ +TP+ + + L +
Sbjct: 68 AIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
H + HRD+KP NI+ +A +K+ DFG+AR + S + T Y +PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
D++S+GC+ E+LTG+P F G + V
Sbjct: 187 RG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV----------------- 227
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-TAEEALAD 403
++ P+P S + ++ + LA +P++R TA E AD
Sbjct: 228 ----------REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 8e-58
Identities = 74/304 (24%), Positives = 115/304 (37%), Gaps = 47/304 (15%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLRLL 169
Y E +G G + VV + TG + A K I I RE+ +L+ +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRG 228
+HP+++ + + D+ ++ EL+ L + + LT E FL Q+L G
Sbjct: 71 QHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 229 LKYIHTANVFHRDLKPKNILANAD----CKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
+ Y+H+ + H DLKP+NI+ ++KI DFGLA + T
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPE 181
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344
+ APE+ D+WSIG I +L+G F G L +
Sbjct: 182 FVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV----------- 228
Query: 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
F N LA + RLL DPK R T +++L P
Sbjct: 229 ----------------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 272
Query: 405 YFHG 408
+
Sbjct: 273 WIKP 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 2e-56
Identities = 69/307 (22%), Positives = 118/307 (38%), Gaps = 57/307 (18%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLR 167
S+YQ+ ++G G +G V S + VAIK + + + + TR+ E+ LL+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 168 LLR--HPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLY 223
+ ++ + P ++ E E DL I L E + F +
Sbjct: 63 KVSSGFSGVIRLLDWFERPDS-----FVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVSFNDAPSAIFWTDYVAT 282
Q+L +++ H V HRD+K +NIL + + +LK+ DFG + + +TD+ T
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGT 172
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
R Y PE + + + +WS+G + +M+ G F +
Sbjct: 173 RVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------------- 216
Query: 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402
+ V F + HL+ LA P DRPT EE
Sbjct: 217 -------------------IRGQVFFRQRVS---SECQHLIRWCLALRPSDRPTFEEIQN 254
Query: 403 DPYFHGL 409
P+ +
Sbjct: 255 HPWMQDV 261
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 3e-55
Identities = 65/300 (21%), Positives = 116/300 (38%), Gaps = 45/300 (15%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLL-RLLRH 171
+ + +++GKGS+G V A T + AIK + DV D + E ++L H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLK 230
P + + + ++++ V E + DL I++ F+ +++ GL+
Sbjct: 63 PFLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 117
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 290
++H+ + +RDLK NIL + D +KI DFG+ + + + T Y APE+
Sbjct: 118 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPEI 174
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350
KY ++D WS G + EML G+ F G++
Sbjct: 175 LLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH------------------- 213
Query: 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE-EALADPYFHGL 409
+ + A LL +L +P+ R + P F +
Sbjct: 214 ---------SIRMDNPFYPRWLE---KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-53
Identities = 68/302 (22%), Positives = 125/302 (41%), Gaps = 48/302 (15%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPD 173
+ +++GKG++G V + TG A+K + +V + + E ++L+ RHP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
+ +K+ R + V E L + T E +F+ +++ L+Y+
Sbjct: 67 LTALKYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H+ +V +RD+K +N++ + D +KI DFGL + +D + + T Y APE+
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF---CGTPEYLAPEVLE 178
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
+ Y A+D W +G + EM+ G+ F ++ +L+
Sbjct: 179 D--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------------------- 217
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFH 407
+ + F P A LL LL DPK R A+E + +F
Sbjct: 218 ---------LMEEIRFPRTLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
Query: 408 GL 409
+
Sbjct: 266 SI 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 177 bits (450), Expect = 1e-51
Identities = 66/306 (21%), Positives = 115/306 (37%), Gaps = 49/306 (16%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLRLL 169
+ + +IG+G +G V TG+ A+K ++ + + + A + L+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRG 228
P IV + + P + + + +LM DLH + + + +F+ +++ G
Sbjct: 65 DCPFIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 119
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
L+++H V +RDLKP NIL + ++I D GLA P A T Y AP
Sbjct: 120 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG-----THGYMAP 174
Query: 289 ELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348
E+ Y + D +S+GC+ ++L G F + ++
Sbjct: 175 EVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--------------- 218
Query: 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALAD 403
+ + P LLE LL D R A+E
Sbjct: 219 -------------RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265
Query: 404 PYFHGL 409
P+F L
Sbjct: 266 PFFRSL 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 175 bits (445), Expect = 2e-51
Identities = 65/302 (21%), Positives = 117/302 (38%), Gaps = 51/302 (16%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPD 173
+QI +G GS+G V H G A+K + ++ + E +L ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKYI 232
I+ + ++ + I+++ + +E + P +F+ ++ L+Y+
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H+ ++ +RDLKP+NIL + + +KI DFG A+ + T Y APE+
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPDYIAPEVVS 174
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
+ Y +ID WS G + EML G F N + + +
Sbjct: 175 T--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------------------- 213
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYFH 407
+ + P P + LL RL+ D R E+ P+F
Sbjct: 214 -------LNAELRFP-----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261
Query: 408 GL 409
+
Sbjct: 262 EV 263
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 3e-50
Identities = 58/293 (19%), Positives = 111/293 (37%), Gaps = 52/293 (17%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
++ + IGKG +G V + G +VA+K I + + A L E ++ LRH
Sbjct: 7 KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND----ATAQAFLAEASVMTQLRHS 60
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGL 229
++V++ +++ E +Y+V E M L +++ L + F + +
Sbjct: 61 NLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
+Y+ N HRDL +N+L + D K+ DFGL + + + + APE
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST------QDTGKLPVKWTAPE 170
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348
K++ D+WS G + E+ + G+ +P + + + R+
Sbjct: 171 AL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---------------KDVVPRV 213
Query: 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
K P P +++ D RP+ +
Sbjct: 214 EKG----------YKMDAP-----DGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 4e-50
Identities = 67/304 (22%), Positives = 112/304 (36%), Gaps = 30/304 (9%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
A +QE IGKG +G V GE VA+K + + EI +LRH
Sbjct: 2 ARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRH 56
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLK 230
+I+ + + +++V + E L + +T E GL
Sbjct: 57 ENILGFIAADNKDNGT-WTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLA 114
Query: 231 YIHTA--------NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-IFWTDYVA 281
++H + HRDLK KNIL + I D GLA + + I V
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 282 TRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 337
T+ Y APE+ + + DI+++G +F E+ + G + +QL +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233
Query: 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA 397
PS E + ++ E+ R +P + A + ++ + R TA
Sbjct: 234 SDPSVEEMRKVVCEQKLRP--------NIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285
Query: 398 EEAL 401
Sbjct: 286 LRIK 289
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 4e-49
Identities = 59/294 (20%), Positives = 111/294 (37%), Gaps = 45/294 (15%)
Query: 120 VIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 177
+G G++G V G + VA+K + + + +L E +++ L +P IV +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 178 KHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 236
I E + +V E+ E L++ ++ N + ++ ++Q+ G+KY+ +N
Sbjct: 74 IGIC------EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 296
HRDL +N+L KI DFGL++ D T + APE
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--Y 185
Query: 297 KYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355
K++ D+WS G + E + G+ + G +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM----------------------- 222
Query: 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE---ALADPYF 406
+ K + + P L+ +D ++RP L + Y+
Sbjct: 223 ----LEKGERMGCPAGCP---REMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 6e-49
Identities = 62/326 (19%), Positives = 128/326 (39%), Gaps = 47/326 (14%)
Query: 98 KSALETEFFTEYGE---ASRYQIQEVIGKGSYGVVGSAVDTH---TGERVAIKKIN--DV 149
K L T T + E +++ +V+G G+YG V TG+ A+K + +
Sbjct: 6 KHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATI 65
Query: 150 FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIK 208
+ E ++L +R + + L + + ++++ + + +L +
Sbjct: 66 VQKAKTTEHTRTERQVLEHIRQSPFL----VTLHYAFQTETKLHLILDYINGGELFTHLS 121
Query: 209 ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268
+ T Q ++ +++ L+++H + +RD+K +NIL +++ + + DFGL++ F
Sbjct: 122 QRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFV 180
Query: 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH 328
+ + + + G S + A+D WS+G + E+LTG F +
Sbjct: 181 ADETERAYDFCGTIEYMAPDIVRGG-DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239
Query: 329 QLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLA 388
+ ++ + P P LA L++RLL
Sbjct: 240 SQAEI----------------------SRRILKSEPPYP-----QEMSALAKDLIQRLLM 272
Query: 389 FDPKDRP-----TAEEALADPYFHGL 409
DPK R A+E +F +
Sbjct: 273 KDPKKRLGCGPRDADEIKEHLFFQKI 298
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 9e-49
Identities = 70/314 (22%), Positives = 115/314 (36%), Gaps = 55/314 (17%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+++ +G+G +G V T RVAIK + L+E ++++ LRH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHE 72
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELME---SDLHQVIKANDDLTPEHYQFFLYQLLRGL 229
+V++ ++ + IY+V E M + L Q+ G+
Sbjct: 73 KLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
Y+ N HRDL+ NIL + K+ DFGLAR+ ++ +A + APE
Sbjct: 127 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR--QGAKFPIKWTAPE 184
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348
++T D+WS G + E+ T G+ +PG LD + P
Sbjct: 185 AALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP-- 240
Query: 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA--DPYF 406
L+ + +P++RPT E A + YF
Sbjct: 241 ----------------------------ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
Query: 407 HGLANVDREPSTQP 420
EP QP
Sbjct: 273 -----TSTEPQYQP 281
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 168 bits (425), Expect = 1e-48
Identities = 63/318 (19%), Positives = 114/318 (35%), Gaps = 48/318 (15%)
Query: 94 DPHKKSALE--TEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGER---VAIKKIND 148
DP F + + S +I++VIG G +G V S G+R VAIK +
Sbjct: 5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS 64
Query: 149 VFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK 208
+ L E ++ HP+++ ++ ++ + + ++ E ME+
Sbjct: 65 GYTE-KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP-----VMIITEFMENGSLDSFL 118
Query: 209 ANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266
+D T L + G+KY+ N HRDL +NIL N++ K+ DFGL+R
Sbjct: 119 RQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178
Query: 267 FNDAPSAIFWT--DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG 323
+D + + + AP + K+T A D+WS G + E+++ G+ +
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAP--EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236
Query: 324 KNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLL 383
++ + P L+
Sbjct: 237 MTNQDVINAIEQDYRLPPPMDCP------------------------------SALHQLM 266
Query: 384 ERLLAFDPKDRPTAEEAL 401
D RP + +
Sbjct: 267 LDCWQKDRNHRPKFGQIV 284
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 167 bits (423), Expect = 1e-48
Identities = 49/298 (16%), Positives = 95/298 (31%), Gaps = 43/298 (14%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
Y++ IG+GS+GV+ + ++VAIK SDA ++ E + +LL
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLAG 59
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLK 230
+ + +E +V +L+ L ++ + + Q+L ++
Sbjct: 60 CTGIPNVYYFG----QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115
Query: 231 YIHTANVFHRDLKPKNILANADC-----KLKICDFGLARVSFNDAPSAIFW----TDYVA 281
IH ++ +RD+KP N L + + DFG+ + + +
Sbjct: 116 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 282 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341
T Y + + + D+ ++G +F L G + G
Sbjct: 176 TARYMSINTH--LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK----------- 222
Query: 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
+ RI KKQ P + P +
Sbjct: 223 -QKYERI-----------GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDY 268
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (428), Expect = 1e-48
Identities = 55/301 (18%), Positives = 107/301 (35%), Gaps = 49/301 (16%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 172
++ + +G GS+G V +G A+K ++ + L E ++L+ + P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
+V+++ + V+ + ++ ++ + H +F+ Q++ +Y+
Sbjct: 102 FLVKLEFSF----KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H+ ++ +RDLKP+N+L + +++ DFG A+ T APE+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPEALAPEIIL 211
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
S Y A+D W++G + EM G P F + +
Sbjct: 212 S--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE--------------------- 248
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYFH 407
V F F LL LL D R + +F
Sbjct: 249 -------KIVSGKVRFPSHFS---SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
Query: 408 G 408
Sbjct: 299 T 299
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (423), Expect = 2e-48
Identities = 54/304 (17%), Positives = 96/304 (31%), Gaps = 44/304 (14%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
RY++ IG GS+G + D GE VAIK +H ++ E K+ ++++
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGV 63
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
+ E +V EL+ S + + + Q++ ++YI
Sbjct: 64 GIPTIRW----CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 233 HTANVFHRDLKPKNILAN---ADCKLKICDFGLARVSFNDAPSAIFW----TDYVATRWY 285
H+ N HRD+KP N L + I DFGLA+ + + T Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
+ + + D+ S+G + G + G +
Sbjct: 180 ASINTH--LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-------------- 223
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE---EALA 402
+Y KK P L + D+P +
Sbjct: 224 ---------KYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
Query: 403 DPYF 406
+ +
Sbjct: 275 NLFH 278
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-48
Identities = 60/295 (20%), Positives = 106/295 (35%), Gaps = 44/295 (14%)
Query: 114 RYQIQEVIGKGSYGVVGSAV---DTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLL 169
++ E +G GS+GVV + VA+K + DV +RE+ + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLR 227
H +++ + ++ + +V EL S L ++ K + Q+
Sbjct: 69 DHRNLIRLYGVV------LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
G+ Y+ + HRDL +N+L +KI DFGL R + + + A
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
PE + ++ A D W G EM T G+ + G N L +
Sbjct: 183 PESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI------------- 227
Query: 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
++ + +P P +++ + A P+DRPT
Sbjct: 228 -------------DKEGERLPRPEDCP---QDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 168 bits (425), Expect = 4e-48
Identities = 66/340 (19%), Positives = 116/340 (34%), Gaps = 47/340 (13%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+RY + +G G + V A D VA+K + EIKLL+ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDA 69
Query: 173 DIVE------------IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQF 220
D + + H + + + + +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 221 FLYQLLRGLKYIHTA-NVFHRDLKPKNILANAD------CKLKICDFGLARVSFNDAPSA 273
QLL GL Y+H + H D+KP+N+L ++KI D G A
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---- 185
Query: 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV------V 327
+T+ + TR YR+PE+ + + DIWS C+ E++TG LF
Sbjct: 186 --YTNSIQTREYRSPEVL--LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241
Query: 328 HQLDLMTDLLGTPSTESISRIRNEK----ARRYLGSMRKKQPVPFSHKF-------PNAD 376
+ + +LLG + + + + +R L ++ K + P +
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301
Query: 377 PLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREP 416
L +L DP+ R A + P+ ++
Sbjct: 302 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR 341
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 164 bits (415), Expect = 2e-47
Identities = 59/310 (19%), Positives = 117/310 (37%), Gaps = 45/310 (14%)
Query: 93 MDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH 152
MDP + + E E + ++ +G G YG V V VA+K + E
Sbjct: 2 MDPSSPNYDKWEM-----ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---ED 53
Query: 153 VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD 212
+ L+E +++ ++HP++V++ + ++ + + L + +
Sbjct: 54 TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQE 111
Query: 213 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272
++ + Q+ ++Y+ N HRDL +N L + +K+ DFGL+R+ D +
Sbjct: 112 VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171
Query: 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLD 331
A + APE +K++ D+W+ G + E+ T G +PG ++ +
Sbjct: 172 A--HAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 227
Query: 332 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDP 391
L + K + P L+ ++P
Sbjct: 228 L---------------------------LEKDYRMERPEGCP---EKVYELMRACWQWNP 257
Query: 392 KDRPTAEEAL 401
DRP+ E
Sbjct: 258 SDRPSFAEIH 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-46
Identities = 60/300 (20%), Positives = 106/300 (35%), Gaps = 50/300 (16%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
++ E +G G +G V + +VA+K + + L E L++ L+H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQ 68
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDL---HQVIKANDDLTPEHYQFFLYQLLRGL 229
+V + ++ + IY++ E ME+ + LT Q+ G+
Sbjct: 69 RLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
+I N HRDL+ NIL + KI DFGLAR + + APE
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPE 180
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348
+ +T D+WS G + E++T G+ +PG + + ++
Sbjct: 181 AI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP-- 236
Query: 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA--DPYF 406
L+ P+DRPT + + + +F
Sbjct: 237 ----------------------------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-46
Identities = 66/321 (20%), Positives = 122/321 (38%), Gaps = 69/321 (21%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGER-----VAIKKINDVFEHVSDATRILREIKLL- 166
+ +V+G G++G V +A + VA+K + + + S+ ++ E+K++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKMMT 95
Query: 167 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD------------- 212
+L H +IV + IY++FE DL +++ +
Sbjct: 96 QLGSHENIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150
Query: 213 ----------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 262
LT E F YQ+ +G++++ + HRDL +N+L +KICDFGL
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLF 321
AR +D+ + + + APE F YT D+WS G + E+ + G +
Sbjct: 211 ARDIMSDSNY-VVRGNARLPVKWMAPESL--FEGIYTIKSDVWSYGILLWEIFSLGVNPY 267
Query: 322 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH 381
PG V + ++ + A
Sbjct: 268 PGIPVDANFYKL--------------------------IQNGFKMDQP---FYATEEIYI 298
Query: 382 LLERLLAFDPKDRPTAEEALA 402
+++ AFD + RP+ +
Sbjct: 299 IMQSCWAFDSRKRPSFPNLTS 319
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 4e-46
Identities = 51/292 (17%), Positives = 101/292 (34%), Gaps = 46/292 (15%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
+ +G G +GVV VAIK I E + E K++ L H +
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKL 61
Query: 175 VEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
V++ + + + I+++ E M L+ + + + + ++Y+
Sbjct: 62 VQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
+ HRDL +N L N +K+ DFGL+R +D ++ + PE+
Sbjct: 117 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS--SVGSKFPVRWSPPEVLM 174
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
SK++ DIW+ G + E+ + GK + +
Sbjct: 175 Y--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH------------------- 213
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
+ + + H ++ +RPT + L++
Sbjct: 214 --------IAQGLRLYRPHLAS---EKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 4e-46
Identities = 60/309 (19%), Positives = 116/309 (37%), Gaps = 48/309 (15%)
Query: 114 RYQIQEV-IGKGSYGVVGSAVDTHTGER--VAIKKINDVFEHVSDATRILREIKLLRLLR 170
I ++ +G G++G V V ++ VAIK + E +D ++RE +++ L
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLD 67
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRG 228
+P IV + + + + + +V E+ LH+ + +++ + L+Q+ G
Sbjct: 68 NPYIVRLIGVC------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
+KY+ N HRDL +N+L KI DFGL++ D + + AP
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181
Query: 289 ELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
E K++ D+WS G E L+ G+ + +
Sbjct: 182 ECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF--------------- 224
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE---ALADP 404
+ + + + P P L+ + +DRP +
Sbjct: 225 ------------IEQGKRMECP---PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
Query: 405 YFHGLANVD 413
Y+ + V+
Sbjct: 270 YYSLASKVE 278
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 3e-45
Identities = 63/292 (21%), Positives = 109/292 (37%), Gaps = 46/292 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
S + IG G +G+V ++VAIK I E + E +++ L HP
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHP 60
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHY-QFFLYQLLRGLK 230
+V++ + L + I +VFE ME L ++ L + G+
Sbjct: 61 KLVQLYGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 290
Y+ A V HRDL +N L + +K+ DFG+ R +D T + +PE+
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEV 173
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
FS+Y+ D+WS G + E+ + GK + ++ ++ ++
Sbjct: 174 F--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-------------- 217
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
R +P A ++ P+DRP L
Sbjct: 218 ---------GFRLYKP-------RLASTHVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 4e-44
Identities = 59/298 (19%), Positives = 115/298 (38%), Gaps = 43/298 (14%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGER----VAIKKINDVFEHVSDATRILREIKLL 166
S Q+VIG G +G V + + + VAIK + + L E ++
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIM 63
Query: 167 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQ 224
H +I+ ++ ++ ++K + ++ E ME + + + + + + L
Sbjct: 64 GQFSHHNIIRLEGVI-----SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 118
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
+ G+KY+ N HRDL +NIL N++ K+ DFGL+RV +D + +
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344
+ APE K+T A D+WS G + E++T + H++
Sbjct: 179 WTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-------------- 222
Query: 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402
+ ++ +P P L+ + + RP + ++
Sbjct: 223 ------------MKAINDGFRLPTPMDCP---SAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-43
Identities = 55/297 (18%), Positives = 108/297 (36%), Gaps = 43/297 (14%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGER----VAIKKINDVFEHVSDATRILREIKLLR 167
+ ++ +V+G G++G V + GE+ VAIK++ + ++ IL E ++
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMA 66
Query: 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLR 227
+ +P + + I L + + + L V + D++ ++ + Q+ +
Sbjct: 67 SVDNPHVCRLLGICLTSTVQ----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 122
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
G+ Y+ + HRDL +N+L +KI DFGLA++ + A
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL-LGAEEKEYHAEGGKVPIKWMA 181
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
E YT D+WS G E++T G + G ++
Sbjct: 182 LESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK----------- 228
Query: 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
++ P P P ++ + D RP E + +
Sbjct: 229 --------------GERLPQP-----PICTIDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 3e-43
Identities = 62/297 (20%), Positives = 108/297 (36%), Gaps = 47/297 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGER---VAIKKINDVFEHVSDATRILREIKLLRLL 169
R ++ IG+G +G V + VAIK + S + L+E +R
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFLQEALTMRQF 65
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLR 227
HP IV++ ++ ++++ EL + L + YQL
Sbjct: 66 DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
L Y+ + HRD+ +N+L +++ +K+ DFGL+R + + + + + A
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKWMA 177
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
PE ++T A D+W G E+L G F G +
Sbjct: 178 PESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-------------- 221
Query: 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
+ + +P PN P L+ + A+DP RP E A
Sbjct: 222 -------------IENGERLPMP---PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 4e-43
Identities = 57/296 (19%), Positives = 109/296 (36%), Gaps = 44/296 (14%)
Query: 114 RYQIQEVIGKGSYGVVGSAVD---THTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 170
EVIG+G +G V A+K +N + + + ++ L E +++
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFS 86
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ--FFLYQLLRG 228
HP+++ + I L VV M+ + N+ P F Q+ +G
Sbjct: 87 HPNVLSLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 142
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VSFNDAPSAIFWTDYVATRWYRA 287
+K++ + HRDL +N + + +K+ DFGLAR + + S T + A
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
E + K+T D+WS G + E++T G P +P N
Sbjct: 203 LESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-------------- 246
Query: 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402
+ + + + P+ ++ + + RP+ E ++
Sbjct: 247 -------------LLQGRRLLQPEYCPDP---LYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (383), Expect = 1e-42
Identities = 54/320 (16%), Positives = 104/320 (32%), Gaps = 70/320 (21%)
Query: 113 SRYQIQEVIGKGSYGVV-----GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLR 167
+ + IG+G++G V + VA+K + + RE L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMA 71
Query: 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD-------------- 212
+P+IV++ + + ++FE M DL++ +++
Sbjct: 72 EFDNPNIVKLLGVCAVGKP-----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 213 ----------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 262
L+ Q+ G+ Y+ HRDL +N L + +KI DFGL
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLF 321
+R ++ D + RW + ++YT D+W+ G + E+ + G +
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFY---NRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 322 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH 381
G + +R + P +
Sbjct: 244 YGMAHEEVIYY---------------------------VRDGNILACPENCP---LELYN 273
Query: 382 LLERLLAFDPKDRPTAEEAL 401
L+ + P DRP+
Sbjct: 274 LMRLCWSKLPADRPSFCSIH 293
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 4e-42
Identities = 64/311 (20%), Positives = 110/311 (35%), Gaps = 63/311 (20%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGER--VAIKKINDVFEHVSDATRILREIKLL-RLL 169
+ + Q+VIG+G++G V A G R AIK++ + D E+++L +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLG 68
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD---------------- 212
HP+I+ + +Y+ E +L ++ +
Sbjct: 69 HHPNIINLLGACEHRGY-----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 213 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272
L+ + F + RG+ Y+ HRDL +NIL + KI DFGL+R
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183
Query: 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLD 331
T + A E S YT D+WS G + E+++ G + G +
Sbjct: 184 ----TMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237
Query: 332 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDP 391
+ R ++P N D L+ + P
Sbjct: 238 KLPQ-----------------------GYRLEKP-------LNCDDEVYDLMRQCWREKP 267
Query: 392 KDRPTAEEALA 402
+RP+ + L
Sbjct: 268 YERPSFAQILV 278
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-42
Identities = 66/315 (20%), Positives = 114/315 (36%), Gaps = 64/315 (20%)
Query: 113 SRYQIQEVIGKGSYGVVGSA-----VDTHTGERVAIKKINDVFEHVSDATRILREIKLL- 166
+R + +G G++G V A + + VA+K + H+++ ++ E+K+L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMSELKVLS 81
Query: 167 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD------------- 212
L H +IV + V+ E DL ++ D
Sbjct: 82 YLGNHMNIVNLLGACTIGGP-----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 213 -----LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267
L E F YQ+ +G+ ++ + N HRDL +NIL KICDFGLAR
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNV 326
ND+ + + +W + YT D+WS G E+ + G +PG V
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFN---CVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 327 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERL 386
+ M +++ + P +++
Sbjct: 254 DSKFYKM--------------------------IKEGFRMLSPEHAP---AEMYDIMKTC 284
Query: 387 LAFDPKDRPTAEEAL 401
DP RPT ++ +
Sbjct: 285 WDADPLKRPTFKQIV 299
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-40
Identities = 59/317 (18%), Positives = 115/317 (36%), Gaps = 65/317 (20%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGE-------RVAIKKINDVFEHVSDATRILREIKL 165
R + + +G+G++G V A + +VA+K + D + ++ E+++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEM 71
Query: 166 L-RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIK--------------- 208
+ + +H +I+ + + +YV+ E +L + ++
Sbjct: 72 MKMIGKHKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126
Query: 209 -ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267
+ L+ + YQ+ RG++Y+ + HRDL +N+L D +KI DFGLAR
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNV 326
+ + +W L YT D+WS G + E+ T G +PG V
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 327 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERL 386
L +++ + N ++
Sbjct: 244 EELFKL---------------------------LKEGHRMDKPSNCTNE---LYMMMRDC 273
Query: 387 LAFDPKDRPTAEEALAD 403
P RPT ++ + D
Sbjct: 274 WHAVPSQRPTFKQLVED 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 8e-40
Identities = 54/307 (17%), Positives = 104/307 (33%), Gaps = 56/307 (18%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREIKLLR 167
+ + +G+GS+G+V V RVAIK +N+ + L E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMK 78
Query: 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD----------LTPE 216
+V + ++ V+ ELM DL +++ +
Sbjct: 79 EFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 217 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276
++ G+ Y++ HRDL +N + D +KI DFG+ R +
Sbjct: 134 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYRKG 192
Query: 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVHQLDLMTD 335
+ + +PE +T D+WS G + E+ T + + G + L + +
Sbjct: 193 GKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250
Query: 336 LLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP 395
P N + L+ ++PK RP
Sbjct: 251 -------------------------GGLLDKP-----DNCPDMLFELMRMCWQYNPKMRP 280
Query: 396 TAEEALA 402
+ E ++
Sbjct: 281 SFLEIIS 287
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-39
Identities = 60/312 (19%), Positives = 111/312 (35%), Gaps = 59/312 (18%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLR 167
R ++ + +G+G++G V A T T VA+K + + H + L+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAN---------------- 210
+ H ++V + P + V+ E + +L +++
Sbjct: 73 IGHHLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 211 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270
D LT EH + +Q+ +G++++ + HRDL +NIL + +KICDFGLAR + D
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188
Query: 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVHQ 329
+ +W + YT D+WS G + E+ + +PG + +
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 330 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAF 389
R+ + P +
Sbjct: 246 F-----------------------------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 276
Query: 390 DPKDRPTAEEAL 401
+P RPT E +
Sbjct: 277 EPSQRPTFSELV 288
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 96.4 bits (239), Expect = 1e-23
Identities = 25/203 (12%), Positives = 59/203 (29%), Gaps = 27/203 (13%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI--------NDVFEHVSDATRILREIKLL 166
I +++G+G V + +K +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 167 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLL 226
+ +++ + +P ++ V+ EL+++ ++ E+ L +L
Sbjct: 61 ARNEFRALQKLQGLAVPK-VYAWEGNAVLMELIDAKELYRVR------VENPDEVLDMIL 113
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VSFNDAPSAIFWTDYVATRWY 285
+ + + H DL N+L ++ + I DF + V + ++
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVL-VSEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172
Query: 286 RAPELCGSFFSKYTPAIDIWSIG 308
Y DI S
Sbjct: 173 S---------RTYRTEKDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 509 | |||
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.3 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.05 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.61 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.22 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.75 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.2 |
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-62 Score=489.30 Aligned_cols=329 Identities=41% Similarity=0.781 Sum_probs=273.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc-CCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~-~~~~ 190 (509)
.++|+++++||+|+||+||+|.++.+|+.||||+++.........+.+.+|+++|+.++|||||++++++..... ....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999999999999999998655555667789999999999999999999999976532 2345
Q ss_pred cEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
++|+|||||+.+|..++. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 97 ~~~lv~e~~~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~- 174 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE- 174 (346)
T ss_dssp CCEEEEECCSEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred eEEEEEecccccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc-
Confidence 689999999878877765 457999999999999999999999999999999999999999999999999999865332
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
.+..+||+.|+|||++.+. ..++.++|||||||++|||++|++||.+.+..+.+..+....+.++.+.+.....
T Consensus 175 -----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 175 -----MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp -----CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred -----cccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 2456899999999998763 5678999999999999999999999999999999999999999999998888777
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCCCCccchhHHh
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFER 430 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 430 (509)
.....+...........+....+.+++++++||.+||.+||++|||++|+|+||||+.+.+...++..+ +++..++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~---~~~~~~~~ 325 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ---KYDDSFDD 325 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC---CCCCC---
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCC---CCCCchhh
Confidence 766677777766667777777888999999999999999999999999999999999987766554433 34455566
Q ss_pred hhcCHHHHHHHHHHHHHHhCh
Q 010489 431 RKLAKDDVREMIYREILEYHP 451 (509)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~p 451 (509)
.....+++++.+++|+.++.|
T Consensus 326 ~~~~~~e~k~~~~~e~~~~~~ 346 (346)
T d1cm8a_ 326 VDRTLDEWKRVTYKEVLSFKP 346 (346)
T ss_dssp --CCHHHHHHHHHHHHHTCCC
T ss_pred hhcCHHHHHHHHHHHhhcCCC
Confidence 667789999999999998876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-60 Score=476.05 Aligned_cols=336 Identities=48% Similarity=0.836 Sum_probs=275.4
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
..+|++++.||+|+||+||+|+++.+|+.||||+++.. ......+.+.+|+.+|+.++||||+++++++..........
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh-cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 46899999999999999999999999999999999753 23445677899999999999999999999998766555567
Q ss_pred EEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 192 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
+|++|++++++|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.......
T Consensus 86 ~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 8888888889999998754 799999999999999999999999999999999999999999999999999986544433
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
........+||+.|+|||++... ..|+.++||||+||++|||++|+.||.+.+..++...+...++.+...........
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred cceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 33334567899999999998553 57889999999999999999999999999999999999999999888776665555
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCCCCccchhHHhh
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERR 431 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (509)
...............++...++.+++++++||.+||+.||.+|||++|+|+||||+.......++.... ...+..+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~~~--~~~~~~~~~ 321 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFDMELD 321 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSS--CC-------
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccccC--ccCCChhhh
Confidence 555556666666666777778889999999999999999999999999999999997766554443322 233445566
Q ss_pred hcCHHHHHHHHHHHHHHhChh
Q 010489 432 KLAKDDVREMIYREILEYHPQ 452 (509)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~p~ 452 (509)
.+..+++++++.+|...+.|+
T Consensus 322 ~~~~~~l~~l~~~e~~~~~~~ 342 (345)
T d1pmea_ 322 DLPKEKLKELIFEETARFQPG 342 (345)
T ss_dssp -CCHHHHHHHHHHHSGGGSTT
T ss_pred hCCHHHHHHHHHHHHHhcCCC
Confidence 778888999999998888875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-62 Score=469.73 Aligned_cols=260 Identities=27% Similarity=0.405 Sum_probs=213.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||+||+|+++.+|+.||||+++.... ....+.+.+|+.+|+.++|||||++++++.. ...
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-----~~~ 77 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNI 77 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----Cce
Confidence 4579999999999999999999999999999999965322 2234678899999999999999999999954 456
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|||||||+ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred eEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999998 5999999888899999999999999999999999999999999999999999999999999998754332
Q ss_pred CCcccccccccccccccccccccccCC-CCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
.. ...+..+||+.|||||++.+ .. ++.++|||||||++|||++|++||.+............
T Consensus 158 ~~-~~~~~~~GT~~Y~APE~~~~--~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~-------------- 220 (271)
T d1nvra_ 158 RE-RLLNKMCGTLPYVAPELLKR--REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-------------- 220 (271)
T ss_dssp EE-CCBCCCCSCGGGSCTHHHHC--SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH--------------
T ss_pred cc-ccccceeeCcCccCHhHhcC--CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh--------------
Confidence 21 12356789999999999876 44 46789999999999999999999987654222211110
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
.. ......++.+++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 221 ------------~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 221 ------------EK--KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ------------TT--CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ------------cC--CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 00 0111223467899999999999999999999999999999974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-61 Score=464.18 Aligned_cols=254 Identities=25% Similarity=0.439 Sum_probs=218.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++++.||+|+||+||+|+++.+++.||||++.+.. ........+.+|+.+|+.++|||||++++++.+ ..
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~ 79 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-----AT 79 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-----CC
Confidence 357999999999999999999999999999999986432 122335678899999999999999999999954 45
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|+|||||+ |+|.+++...+.+++..++.++.||++||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 6999999998 699999998889999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
. ....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 160 ~-----~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------------- 219 (263)
T d2j4za1 160 R-----RTTLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------- 219 (263)
T ss_dssp C-----CEETTEEGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------------
T ss_pred c-----ccccCCCCcccCHHHHcC--CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------
Confidence 2 245689999999999987 68999999999999999999999999987765544433221
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
. + .+ ...+++++.+||.+||+.||++|||++|+|+||||..
T Consensus 220 -------------~-~-~~---p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 220 -------------E-F-TF---PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -------------C-C-CC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -------------C-C-CC---CccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 0 0 01 1347889999999999999999999999999999963
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-60 Score=464.78 Aligned_cols=256 Identities=28% Similarity=0.465 Sum_probs=217.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
..+|++++.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|+.+|+.++|||||++++++.. ...
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~ 91 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLV-----GDE 91 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCE
Confidence 3589999999999999999999999999999999864322 335678999999999999999999999954 356
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|||||||+ |+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 92 ~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp EEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999998 588887765 579999999999999999999999999999999999999999999999999998754332
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
. .....+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+....
T Consensus 171 ~---~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~------------- 232 (293)
T d1yhwa1 171 S---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG------------- 232 (293)
T ss_dssp C---CBCCCCSCGGGCCHHHHSS--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-------------
T ss_pred c---cccccccCCCccChhhhcC--CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence 2 2345689999999999987 689999999999999999999999999877655544332210
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
.... ...+.+++++++||.+||+.||++|||++|+|+||||+.
T Consensus 233 ------------~~~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 233 ------------TPEL---QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp ------------SCCC---SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred ------------CCCC---CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 0000 112357899999999999999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-60 Score=474.04 Aligned_cols=330 Identities=44% Similarity=0.827 Sum_probs=278.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc-CCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~-~~~~ 190 (509)
.++|++++.||+|+||+||+|+++.+|+.||||++++........+++.+|+.+|+.++|||||++++++..... ++..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999999999999999998766666667789999999999999999999999876543 2334
Q ss_pred cEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
.+|+++++++|+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|.....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-- 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-- 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG--
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc--
Confidence 4666666666899998854 5799999999999999999999999999999999999999999999999999975422
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
......||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......+....+.+..+.......
T Consensus 174 ----~~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 174 ----EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp ----GGSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred ----ccccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence 23456899999999987662 4578999999999999999999999999999999999999999998887777666
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCCCCCccchhHHh
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFER 430 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 430 (509)
.....+...........+...+..+++++++||.+||..||.+|||++|+|+||||+++.+++.++...+ +.+.+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~---~~~~~~~ 325 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP---YDQSFES 325 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCC---CCCGGGG
T ss_pred hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCC---CCCcccc
Confidence 6666666666655555666667789999999999999999999999999999999999887776665443 4556778
Q ss_pred hhcCHHHHHHHHHHHHHHhChh
Q 010489 431 RKLAKDDVREMIYREILEYHPQ 452 (509)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~p~ 452 (509)
.....+++++++++|+.++.|.
T Consensus 326 ~~~~~~~~k~~~~~e~~~~~p~ 347 (348)
T d2gfsa1 326 RDLLIDEWKSLTYDEVISFVPP 347 (348)
T ss_dssp CCCCHHHHHHHHHHHHHTCCCC
T ss_pred hhcCHHHHHHHHHHHhhccCCC
Confidence 8889999999999999998874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-61 Score=465.68 Aligned_cols=261 Identities=26% Similarity=0.452 Sum_probs=218.3
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|++++||||+++++++.+ ...
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-----DEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-----SSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-----CCE
Confidence 47999999999999999999999999999999986422 122345678899999999999999999999944 456
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|+|||||+ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999998 5899999988999999999999999999999999999999999999999999999999999998764332
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
.. ......+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 163 ~~-~~~~~~~GT~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-------------- 225 (288)
T d1uu3a_ 163 KQ-ARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-------------- 225 (288)
T ss_dssp --------CCCCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT--------------
T ss_pred cc-cccccccCCccccCceeecc--CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC--------------
Confidence 22 12345689999999999987 68999999999999999999999999987765544433211
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHH------HhcCCcccCCcCC
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE------ALADPYFHGLANV 412 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e------~l~hp~f~~~~~~ 412 (509)
. + .+ ...+++++++||.+||+.||++|||++| +++||||+++.+.
T Consensus 226 ------------~-~-~~---p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 226 ------------E-Y-DF---PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 276 (288)
T ss_dssp ------------C-C-CC---CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred ------------C-C-CC---CccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence 0 0 01 1357899999999999999999999987 5889999987543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-60 Score=456.27 Aligned_cols=257 Identities=27% Similarity=0.388 Sum_probs=214.2
Q ss_pred CCe-eEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRY-QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y-~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++| ++.++||+|+||+||+|+++.+++.||+|++..........+.+.+|+++|++++|||||++++++.... .....
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~ 86 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKC 86 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCE
Confidence 455 7888999999999999999999999999999765445556678899999999999999999999985432 23456
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCC--eeecCCCCCcEEEC-CCCCeEEeeeccccccc
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLARVSF 267 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~--ivHrDlKp~NILl~-~~~~vkl~DFG~a~~~~ 267 (509)
+|+|||||+ |+|.+++.+.+.+++..+..++.||++||+|||+++ |+||||||+|||++ .++.+||+|||+|+...
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 899999998 599999998889999999999999999999999998 99999999999997 47899999999998643
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHH-HHHHhcCCCChhHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD-LMTDLLGTPSTESIS 346 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~-~i~~~~g~~~~~~~~ 346 (509)
.. .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+......+. .+..
T Consensus 167 ~~-----~~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~----------- 227 (270)
T d1t4ha_ 167 AS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS----------- 227 (270)
T ss_dssp TT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-----------
T ss_pred CC-----ccCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-----------
Confidence 22 1245789999999999865 69999999999999999999999998765433221 1110
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 407 (509)
...+.. .....++++.+||.+||++||++|||++|+|+||||+
T Consensus 228 ---------------~~~~~~---~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 228 ---------------GVKPAS---FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ---------------TCCCGG---GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ---------------CCCCcc---cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 011111 1234678999999999999999999999999999996
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-60 Score=457.67 Aligned_cols=257 Identities=29% Similarity=0.458 Sum_probs=207.1
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||+||+|+++.+|+.||||+++.........+.+.+|+++|++++|||||++++++.+.. ...
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC---CCE
Confidence 35799999999999999999999999999999999765555556678899999999999999999999986432 245
Q ss_pred EEEEEeccc-ccHHHHHHh----CCCCCHHHHHHHHHHHHhHhhhhhhCC-----eeecCCCCCcEEECCCCCeEEeeec
Q 010489 192 IYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDFG 261 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~~-----ivHrDlKp~NILl~~~~~vkl~DFG 261 (509)
+|||||||+ |+|.+++.. .+.+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG 159 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 159 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence 899999998 589998853 457999999999999999999999976 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCC
Q 010489 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341 (509)
Q Consensus 262 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~ 341 (509)
+|+....... .....+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+....+...
T Consensus 160 ~a~~~~~~~~---~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~----- 229 (269)
T d2java1 160 LARILNHDTS---FAKAFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----- 229 (269)
T ss_dssp HHHHC--------------CCCSCCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-----
T ss_pred ceeecccCCC---ccccCCCCcccCCHHHHcC--CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----
Confidence 9987643322 2345789999999999987 68999999999999999999999999987764443333210
Q ss_pred hhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
.. ......+++++.+||.+||+.||++|||++|+|+|||+
T Consensus 230 ----------------------~~---~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 230 ----------------------KF---RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ----------------------CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ----------------------CC---CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 00 01123578999999999999999999999999999995
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.8e-60 Score=463.54 Aligned_cols=258 Identities=29% Similarity=0.464 Sum_probs=204.3
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++++.||+|+||+||+|+++.+|+.||||++...... .....+.+|+.+|+.++|||||++++++.+ ...+
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~ 82 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYES-----GGHL 82 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEEC-----SSEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEE
Confidence 5699999999999999999999999999999999753322 223567899999999999999999999944 4569
Q ss_pred EEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEEC---CCCCeEEeeecccccccC
Q 010489 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN---ADCKLKICDFGLARVSFN 268 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~---~~~~vkl~DFG~a~~~~~ 268 (509)
|||||||+ |+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+. .++.+||+|||+|+....
T Consensus 83 ~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred EEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 99999998 69999999988999999999999999999999999999999999999995 578999999999986533
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
.. .....+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+....+...
T Consensus 163 ~~----~~~~~~GT~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~------------ 224 (307)
T d1a06a_ 163 GS----VLSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA------------ 224 (307)
T ss_dssp --------------CTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTT------------
T ss_pred CC----eeeeeeeCccccCcHHHcC--CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhcc------------
Confidence 22 1345689999999999987 68999999999999999999999999987765544433221
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
........++.+++++.+||.+||++||++|||++|+|+||||++.
T Consensus 225 ---------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 225 ---------------EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp ---------------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred ---------------CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 1111122345789999999999999999999999999999999763
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-60 Score=465.00 Aligned_cols=283 Identities=36% Similarity=0.585 Sum_probs=228.2
Q ss_pred EeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChh---hHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEE
Q 010489 117 IQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS---DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (509)
Q Consensus 117 i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~---~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 193 (509)
.+++||+|+||+||+|+++.+|+.||||+++....... ....+.+|+.+|+.++|||||++++++... .++|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~-----~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-----SNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-----TCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC-----Ccee
Confidence 47899999999999999999999999999864322111 134688999999999999999999999544 4589
Q ss_pred EEEecccccHHHHH-HhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCC
Q 010489 194 VVFELMESDLHQVI-KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (509)
Q Consensus 194 lv~e~~~~~L~~~l-~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 272 (509)
||||||.+++...+ .....+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus 77 ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred ehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 99999997655544 44567999999999999999999999999999999999999999999999999999865433222
Q ss_pred cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHH
Q 010489 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (509)
Q Consensus 273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 352 (509)
....+||+.|+|||++.+. ..|+.++|||||||++|||++|.+||.+.+..+++..|.+.+|+|..+.+.......
T Consensus 157 ---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 157 ---YTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp ---CCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred ---ccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 2456899999999998652 568999999999999999999999999999999999999999998876543321110
Q ss_pred HHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
...........++...++..++++++||.+||++||++||||+|+|+||||++...
T Consensus 233 ---~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 233 ---DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp ---TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred ---hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence 00111122223334455678999999999999999999999999999999986543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-60 Score=472.37 Aligned_cols=282 Identities=22% Similarity=0.363 Sum_probs=216.1
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++++.||+|+||+||+|+++.+|+.||||+++... .......+.+|+.+|+.++|||||++++++... ..+
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~ 79 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI 79 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS-----SEE
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEE
Confidence 57999999999999999999999999999999997542 234456789999999999999999999999544 469
Q ss_pred EEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhh-CCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
|||||||+ |+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|+......
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence 99999999 5899999988899999999999999999999997 599999999999999999999999999998653322
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHh-HHHHHHHhcCCCChhHHHHhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH-QLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~~ 349 (509)
.++.+||++|||||++.+ ..|+.++||||||||+|||++|+.||.+.+... +...+....|.+.........
T Consensus 160 -----~~~~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 160 -----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp -----C---CCSSCCCCHHHHHC--SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred -----cccccCCccccCchHHcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 245799999999999988 789999999999999999999999998866433 222223333322211100000
Q ss_pred hH--------------HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 350 NE--------------KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 350 ~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.. .............+... .....++++++||.+||.+||.+|||++|+|+||||++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKL--PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCC--CBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccccccchhHHHHHhhhhccCCccC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 00 00000111111111111 112358899999999999999999999999999999754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-59 Score=465.53 Aligned_cols=257 Identities=25% Similarity=0.443 Sum_probs=221.3
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++||||+++++++.+ ...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~~ 79 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-----SSE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc-----ccc
Confidence 57999999999999999999999999999999996432 122345778899999999999999999999954 456
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|+|||||+ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred cccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999999 5899999999999999999999999999999999999999999999999999999999999998654332
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
. .....+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+....+...
T Consensus 160 ~---~~~~~~GT~~Y~aPE~~~~--~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~-------------- 220 (337)
T d1o6la_ 160 A---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-------------- 220 (337)
T ss_dssp C---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------------
T ss_pred c---ccccceeCHHHhhhhhccC--CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC--------------
Confidence 2 2356799999999999988 78999999999999999999999999998865444333211
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCc
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~ 410 (509)
. .. ....+++++++||.+||++||.+|+ +++|+++||||+++.
T Consensus 221 ------------~--~~---~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 221 ------------E--IR---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp ------------C--CC---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred ------------C--CC---CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence 0 01 1135789999999999999999999 499999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-60 Score=458.85 Aligned_cols=258 Identities=24% Similarity=0.348 Sum_probs=215.2
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
+.|++++.||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|+++|+.++|||||++++++.. ...+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~ 84 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNL 84 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCeE
Confidence 4699999999999999999999999999999999653 23445678899999999999999999999954 3569
Q ss_pred EEEEeccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 193 YVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
|+|||||+ |+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 85 ~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 85 WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 99999998 588888765 4579999999999999999999999999999999999999999999999999997542211
Q ss_pred CCcccccccccccccccccccccc---cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
......+||+.|||||++... ...|+.++|||||||++|||++|++||.+.+..+.+..+...
T Consensus 165 ---~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~----------- 230 (288)
T d2jfla1 165 ---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS----------- 230 (288)
T ss_dssp ---HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS-----------
T ss_pred ---ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------
Confidence 123457899999999998431 256899999999999999999999999987765554443221
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
..+ .....+.+++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 231 ---------------~~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 231 ---------------EPP--TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp ---------------CCC--CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred ---------------CCC--CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 000 01112357899999999999999999999999999999963
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-59 Score=456.54 Aligned_cols=260 Identities=28% Similarity=0.458 Sum_probs=220.7
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc----ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE----HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|++++|||||++++++.+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----- 84 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN----- 84 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----
Confidence 579999999999999999999999999999999864322 12235778999999999999999999999954
Q ss_pred CCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCC----CeEEeeeccc
Q 010489 189 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDFGLA 263 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~----~vkl~DFG~a 263 (509)
...+|||||||+ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence 456999999998 59999999888999999999999999999999999999999999999999877 4999999999
Q ss_pred ccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChh
Q 010489 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (509)
........ .....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..+.......+.
T Consensus 165 ~~~~~~~~----~~~~~~t~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~- 237 (293)
T d1jksa_ 165 HKIDFGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED- 237 (293)
T ss_dssp EECTTSCB----CSCCCCCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCH-
T ss_pred hhcCCCcc----ccccCCCCcccCHHHHcC--CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc-
Confidence 87533221 345689999999999987 68999999999999999999999999998876665555432211111
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
..++.+++.+++||.+||+.||++|||++|+|+||||+...
T Consensus 238 --------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 238 --------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp --------------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred --------------------------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 11245788999999999999999999999999999998653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-59 Score=460.80 Aligned_cols=289 Identities=39% Similarity=0.633 Sum_probs=234.8
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++++.||+|+||+||+|+++.+|+.||||+++...........+.+|+++|++++|||||++++++.+ ...+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-----~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-----ccce
Confidence 58999999999999999999999999999999996543333345678899999999999999999999954 4569
Q ss_pred EEEEecccccHHHHHHh--CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 193 YVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 193 ~lv~e~~~~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
|+|||||++++.+++.. ...+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+......
T Consensus 77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99999999887777654 3579999999999999999999999999999999999999999999999999998654332
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
. .....+||+.|+|||++... ..++.++|||||||++|+|++|+.||.+.+..+++..+....+.+....+.....
T Consensus 157 ~---~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 157 R---TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp B---CTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred c---cceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 2 23456899999999987663 4568899999999999999999999999999999999988888877655443221
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCC
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 412 (509)
. ..+...........+....+.+++++.+||.+||.+||++|||++|+|+||||+++..+
T Consensus 233 ~--~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 233 M--PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp S--TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred c--cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 1 11111111222222333456788999999999999999999999999999999887543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.3e-59 Score=466.95 Aligned_cols=261 Identities=26% Similarity=0.414 Sum_probs=222.0
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++++.||+|+||+||+|+++.+|+.||||++... .....+.+.+|+.+|+.++|||||++++++.. .+.+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~ 98 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEM 98 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-----TTEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEE
Confidence 5899999999999999999999999999999999653 33456778899999999999999999999943 4569
Q ss_pred EEEEeccc-ccHHHHHH-hCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC--CCCeEEeeecccccccC
Q 010489 193 YVVFELME-SDLHQVIK-ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVSFN 268 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~-~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~--~~~vkl~DFG~a~~~~~ 268 (509)
|||||||+ |+|.+++. ..+.+++..+..|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+....
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 99999998 59999885 4467999999999999999999999999999999999999964 58899999999987543
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... ....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..+.......
T Consensus 179 ~~~----~~~~~gT~~Y~aPEv~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-------- 244 (350)
T d1koaa2 179 KQS----VKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM-------- 244 (350)
T ss_dssp TSC----EEEECSCTTTCCHHHHHT--CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS--------
T ss_pred ccc----cceecCcccccCHHHHcC--CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------
Confidence 222 345789999999999987 689999999999999999999999999888766665554322111
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 413 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 413 (509)
....++.+++++++||.+||..||++|||++|+|+||||+....+.
T Consensus 245 -------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~ 290 (350)
T d1koaa2 245 -------------------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 290 (350)
T ss_dssp -------------------CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCS
T ss_pred -------------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCC
Confidence 1122345788999999999999999999999999999998765443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-59 Score=460.93 Aligned_cols=290 Identities=35% Similarity=0.604 Sum_probs=236.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCC-CcEEEEEEecCcccChhhHHhHHHHHHHHHHc---CCCCcceeeeeecCCCcC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHT-GERVAIKKINDVFEHVSDATRILREIKLLRLL---RHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~-~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~niv~~~~~~~~~~~~ 187 (509)
.++|+++++||+|+||+||+|++..+ ++.||||+++...........+.+|+.+|+.| +||||+++++++......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 36899999999999999999999765 67899999865433333344566788887766 799999999998655444
Q ss_pred CCCcEEEEEecccccHHHHHH--hCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 188 EFKDIYVVFELMESDLHQVIK--ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 188 ~~~~~~lv~e~~~~~L~~~l~--~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
....+|++||||++++..+.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 556799999999987655443 335799999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
.... ......+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+++..+...+|.+....+
T Consensus 166 ~~~~----~~~~~~~gT~~Y~APE~~~~--~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 166 YSFQ----MALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCGG----GGGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hccc----ccCCCcccChhhcCcchhcC--CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 4322 22356789999999999987 78999999999999999999999999999999999999999998877654
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
....... ...+......+.......+++.+++||.+||++||++|||++|+|+||||+++..
T Consensus 240 ~~~~~~~----~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 240 PRDVALP----RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp CTTCSSC----GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccch----hhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 3321110 0111223333444556678999999999999999999999999999999998754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.7e-59 Score=465.03 Aligned_cols=258 Identities=27% Similarity=0.431 Sum_probs=221.1
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++++.||+|+||+||+|+++.+|+.||||+++.. ...+...+.+|+.+|+.++|||||++++++.. ...+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~ 101 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYEM 101 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SSEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEE
Confidence 4799999999999999999999999999999999753 23445678899999999999999999999954 4569
Q ss_pred EEEEeccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEEC--CCCCeEEeeecccccccC
Q 010489 193 YVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN--ADCKLKICDFGLARVSFN 268 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~--~~~~vkl~DFG~a~~~~~ 268 (509)
|||||||+ |+|.+.+...+ ++++.+++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+....
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence 99999998 58988876554 799999999999999999999999999999999999998 578999999999987643
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... ....+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+....
T Consensus 182 ~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~----------- 244 (352)
T d1koba_ 182 DEI----VKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD----------- 244 (352)
T ss_dssp TSC----EEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC-----------
T ss_pred CCc----eeeccCcccccCHHHHcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 322 345689999999999987 689999999999999999999999999988766655543321
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 410 (509)
.......++.+++++.+||.+||++||.+|||++|+|+||||++..
T Consensus 245 ----------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 245 ----------------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp ----------------CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred ----------------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 1112234467899999999999999999999999999999998643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-58 Score=455.04 Aligned_cols=255 Identities=26% Similarity=0.392 Sum_probs=214.2
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.+|++++.||+|+||+||+|+++.+|+.||||+++.... .....+.+.+|+.+|+.++|||||++++++... ..
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-----CE
Confidence 369999999999999999999999999999999975433 233456789999999999999999999999543 46
Q ss_pred EEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|+|||||.+ +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 90 ~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp EEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 9999999996 5555666778899999999999999999999999999999999999999999999999999986432
Q ss_pred CCcccccccccccccccccccccc-cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
....+||+.|||||++.+. ...|+.++|||||||++|||++|+.||.+.+..+.+..+..
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~-------------- 228 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------------- 228 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--------------
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--------------
Confidence 2346899999999998642 24689999999999999999999999988775544433321
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
...+.. ....+++++.+||.+||+.||.+|||++|+|+||||..
T Consensus 229 ------------~~~~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 229 ------------NESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp ------------SCCCCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ------------CCCCCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 111111 12356899999999999999999999999999999964
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-58 Score=456.41 Aligned_cols=255 Identities=25% Similarity=0.437 Sum_probs=219.7
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ......+.+.+|+.+|+.++|||||++++++.. ...
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-----CCe
Confidence 57999999999999999999999999999999996432 222345678899999999999999999999954 456
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|+|||||+ |+|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 999999998 588899998899999999999999999999999999999999999999999999999999999875332
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-------------- 216 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-------------- 216 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--------------
T ss_pred -----cccccCcccccCHHHHcC--CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--------------
Confidence 245689999999999987 68999999999999999999999999988765544443221
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCcC
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLAN 411 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~~ 411 (509)
... ..+.+++++.++|.+||.+||.+|+ |++++|+||||+++.+
T Consensus 217 ------------~~~-----~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 217 ------------ELR-----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp ------------CCC-----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred ------------CCC-----CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence 000 1135789999999999999999996 9999999999998643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-58 Score=462.71 Aligned_cols=325 Identities=36% Similarity=0.661 Sum_probs=250.5
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc-CCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 191 (509)
.+|+++++||+|+||+||+|+++.+|+.||||+++..........++.+|+.+|++++||||+++++++..... +...+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999999999999999998765566667789999999999999999999999965432 34578
Q ss_pred EEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 192 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
+|+|||||.+++.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++......
T Consensus 97 ~~iv~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~- 173 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF- 173 (355)
T ss_dssp EEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred eEEEEeccchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccc-
Confidence 99999999998887764 569999999999999999999999999999999999999999999999999987653322
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
..+..+||+.|+|||++.+ ..+++++||||+||++|||++|++||.+.+...+...+...++.+..+.+......
T Consensus 174 ---~~~~~~~t~~y~aPE~l~~--~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (355)
T d2b1pa1 174 ---MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_dssp ----------CCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred ---ccccccccccccChhhhcC--CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence 2355689999999999987 68999999999999999999999999999999999999999998888777655432
Q ss_pred HHHHhhhccCCCCCCCCCCC------------CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCCCCCCCC
Q 010489 352 KARRYLGSMRKKQPVPFSHK------------FPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQ 419 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~ 419 (509)
...+............... ....++++++||.+||.+||++||||+|+|+||||+...++......
T Consensus 249 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~~~- 326 (355)
T d2b1pa1 249 -VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAP- 326 (355)
T ss_dssp -HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHTCC-
T ss_pred -HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccccCC-
Confidence 2222222221111111100 01236779999999999999999999999999999876543222221
Q ss_pred CCCccchhHHhhhcCHHHHHHHHHHHHH
Q 010489 420 PISKLEFEFERRKLAKDDVREMIYREIL 447 (509)
Q Consensus 420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (509)
+....+...+++....+++++.|+.|++
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (355)
T d2b1pa1 327 PPQIYDKQLDEREHTIEEWKELIYKEVM 354 (355)
T ss_dssp CC-------CCCCCCHHHHHHHHHHHHH
T ss_pred CCCCCCcchhhhhcCHHHHHHHHHHHhc
Confidence 1123444566778888999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-58 Score=461.34 Aligned_cols=254 Identities=21% Similarity=0.367 Sum_probs=219.3
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
++|++++.||+|+||.||+|+++.+|+.||||++++.. ........+.+|+++|+.++|||||++++++.. ...
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----NSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc-----ccc
Confidence 58999999999999999999999999999999986422 222345678899999999999999999999944 456
Q ss_pred EEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCC
Q 010489 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 270 (509)
+|+||||+. |+|..++...+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 899999998 589999988889999999999999999999999999999999999999999999999999999875332
Q ss_pred CCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
....+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+....+..+....
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------------- 254 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK------------- 254 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------------
T ss_pred -----cccccCccccCCHHHHcC--CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC-------------
Confidence 235689999999999987 689999999999999999999999999887655544442210
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCc
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~ 410 (509)
+ .....+++++.+||.+||.+||.+|+ |++++++||||+++.
T Consensus 255 --------------~----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 255 --------------V----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp --------------C----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred --------------C----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence 0 01135789999999999999999995 999999999998764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.8e-58 Score=442.27 Aligned_cols=261 Identities=28% Similarity=0.442 Sum_probs=219.8
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccCh-------hhHHhHHHHHHHHHHcC-CCCcceeeeeecCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV-------SDATRILREIKLLRLLR-HPDIVEIKHIMLPP 184 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~-------~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~ 184 (509)
++|++++.||+|+||+||+|+++.+|+.||||++++..... .....+.+|+.+|++++ ||||+++++++.+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 81 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET- 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-
Confidence 68999999999999999999999999999999986532211 12346789999999997 9999999999954
Q ss_pred CcCCCCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccc
Q 010489 185 SRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 263 (509)
Q Consensus 185 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 263 (509)
...+|||||||+ |+|.+++...+.+++..++.++.||++||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 82 ----~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 82 ----NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp ----SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred ----CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchhe
Confidence 456999999998 599999998899999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccccccccc----cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCC
Q 010489 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339 (509)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~ 339 (509)
+...... ..+..+||+.|+|||++.+. ...++.++||||+||++|||++|+.||.+.+..+....+...-
T Consensus 158 ~~~~~~~----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~-- 231 (277)
T d1phka_ 158 CQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN-- 231 (277)
T ss_dssp EECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--
T ss_pred eEccCCC----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC--
Confidence 8754322 13557899999999987532 2457889999999999999999999999887655544443210
Q ss_pred CChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.......++.+++++++||.+||+.||++|||++|+|+||||+..
T Consensus 232 -------------------------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 232 -------------------------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp -------------------------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred -------------------------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 111112334688999999999999999999999999999999853
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.4e-58 Score=448.68 Aligned_cols=284 Identities=38% Similarity=0.660 Sum_probs=234.1
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|+++++||+|+||+||+|+++ +|+.||||+++...........+.+|+.+|++++||||+++++++... ..+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC-----Cce
Confidence 58999999999999999999986 789999999976444444457789999999999999999999999544 458
Q ss_pred EEEEecccccHHHHH-HhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 193 YVVFELMESDLHQVI-KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 193 ~lv~e~~~~~L~~~l-~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
|++|||+.+++...+ ...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|........
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 999999997665555 4467899999999999999999999999999999999999999999999999999986543222
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhH
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 351 (509)
......|++.|+|||++.+. ..++.++|||||||++|||++|++||.+.+..+++..+...+|.+....+.....
T Consensus 156 ---~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~- 230 (286)
T d1ob3a_ 156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE- 230 (286)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG-
T ss_pred ---ccceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh-
Confidence 12445799999999998763 5679999999999999999999999999999999999999999887665543321
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
...+........+.++....+.+++.+.|||.+||++||++|||++|+|+||||++
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 231 -LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp -STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred -hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 11222223333444555666788999999999999999999999999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-57 Score=455.25 Aligned_cols=286 Identities=35% Similarity=0.618 Sum_probs=234.3
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCC-cCCCCcE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RREFKDI 192 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-~~~~~~~ 192 (509)
+|+.+++||+|+||+||+|+++.+|+.||||+++.... ...+|+.+|++++||||+++++++.... ..+..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 69999999999999999999999999999999965321 2247999999999999999999986543 2345678
Q ss_pred EEEEecccccHHHHH----HhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCC-CeEEeeeccccccc
Q 010489 193 YVVFELMESDLHQVI----KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVSF 267 (509)
Q Consensus 193 ~lv~e~~~~~L~~~l----~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~-~vkl~DFG~a~~~~ 267 (509)
|||||||++++...+ .....+++..++.|+.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 999999998765554 3456799999999999999999999999999999999999999875 89999999998654
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
.... ....+||+.|+|||++.+. ..|+.++|||||||++|||++|++||.+.+..+++..+.+.+|.+..+.+..
T Consensus 175 ~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 175 RGEP----NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp TTSC----CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred CCcc----cccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 3322 2456899999999987652 5799999999999999999999999999999999999999999999887765
Q ss_pred hhhHHHHHhhhccCCCCCCCC-CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcCCC
Q 010489 348 IRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 413 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 413 (509)
......... +......++ ....+..++++.+||.+||.+||++|||+.|+|+||||+.+.+..
T Consensus 250 ~~~~~~~~~---~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 313 (350)
T d1q5ka_ 250 MNPNYTEFK---FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313 (350)
T ss_dssp HCC---CCC---CCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred hccchhhcc---ccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCC
Confidence 433221111 111111121 223456899999999999999999999999999999999887654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-57 Score=457.34 Aligned_cols=261 Identities=25% Similarity=0.363 Sum_probs=212.5
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHH---HHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILR---EIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~---Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
.++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+ |+.+++.++|||||++++++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~---- 78 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT---- 78 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE----
Confidence 3589999999999999999999999999999999864221 1111223334 4666777789999999999954
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 188 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
...+|+|||||+ |+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 79 -~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 79 -PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred -CCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 356999999998 699999999899999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
.... ....+||+.|||||++... ..|+.++|||||||++|||++|+.||.+.+..+........
T Consensus 158 ~~~~-----~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~---------- 221 (364)
T d1omwa3 158 SKKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---------- 221 (364)
T ss_dssp SSSC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS----------
T ss_pred CCCc-----ccccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------
Confidence 4332 2446899999999998642 56899999999999999999999999876543322211111
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCcC
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLAN 411 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~f~~~~~ 411 (509)
...+. .....+++++.+||.+||+.||++||| |+|+++||||+++.+
T Consensus 222 ---------------~~~~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 222 ---------------LTMAV---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp ---------------SSCCC---CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred ---------------ccCCC---CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 01111 112357899999999999999999999 899999999998753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-57 Score=450.01 Aligned_cols=256 Identities=25% Similarity=0.434 Sum_probs=218.6
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||+||+|+++.+|+.||||+++.. ..+...+.+|+++|+.++|||||++++++. +...
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~ 75 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFE-----SMEE 75 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCE
Confidence 36899999999999999999999999999999999753 233456789999999999999999999994 3456
Q ss_pred EEEEEeccc-ccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC--CCeEEeeeccccccc
Q 010489 192 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVSF 267 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~--~~vkl~DFG~a~~~~ 267 (509)
+|||||||+ ++|.+++...+ .+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 76 ~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 999999999 58999997665 79999999999999999999999999999999999999854 479999999998653
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..+.+..|.......+.
T Consensus 156 ~~~----~~~~~~~t~~y~ape~~~~--~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----- 224 (321)
T d1tkia_ 156 PGD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE----- 224 (321)
T ss_dssp TTC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH-----
T ss_pred cCC----cccccccccccccchhccC--CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCh-----
Confidence 322 2345689999999999887 68999999999999999999999999998876666555442221111
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
..++.+++++++||.+||..||++|||++|+|+||||++
T Consensus 225 ----------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 225 ----------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ----------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ----------------------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 123457889999999999999999999999999999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-57 Score=447.25 Aligned_cols=257 Identities=25% Similarity=0.409 Sum_probs=217.6
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcc-cChhhHHhHHHHHHHHH-HcCCCCcceeeeeecCCCcCCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLR-LLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~~l~-~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.++. .++|||||++++++.. ..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-----~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-----KE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-----SS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-----CC
Confidence 57999999999999999999999999999999996422 12234456677887765 6899999999999954 45
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|||||||+ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 6999999998 599999999899999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
.. ..+..+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+....+..+..
T Consensus 157 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-------------- 217 (320)
T d1xjda_ 157 DA---KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-------------- 217 (320)
T ss_dssp TC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------------
T ss_pred cc---cccccCCCCCcCCHHHHcC--CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc--------------
Confidence 22 2355789999999999987 7899999999999999999999999998876554443321
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHH-HHhcCCcccCCc
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE-EALADPYFHGLA 410 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~-e~l~hp~f~~~~ 410 (509)
..+ . ....+++++.+||.+||+.||.+|||+. ++++||||+++.
T Consensus 218 -------------~~~-~---~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 218 -------------DNP-F---YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp -------------CCC-C---CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred -------------CCC-C---CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence 011 0 1135789999999999999999999995 899999998764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-57 Score=446.86 Aligned_cols=296 Identities=35% Similarity=0.565 Sum_probs=228.3
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc---C
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR---R 187 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~---~ 187 (509)
..++|+++++||+|+||+||+|++..+|+.||||++...........++.+|+.+|+.++||||+++++++..... .
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 3579999999999999999999999999999999986544444455678899999999999999999999865421 2
Q ss_pred CCCcEEEEEecccccHHHHH-HhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 188 EFKDIYVVFELMESDLHQVI-KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 188 ~~~~~~lv~e~~~~~L~~~l-~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
....+|+|||||++++.... .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 23568999999997666555 44568999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCC-cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 267 FNDAPS-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 267 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
...... .......+||++|+|||++.+. ..|+.++|||||||++|||++|++||.+.+..+.+..+...++.+..+..
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 432211 1122446899999999998763 57899999999999999999999999999999999999999988877654
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKF--PNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 408 (509)
...........+...... .......+ ...++.++|||.+||++||++|||++|+|+||||+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQ-KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TTCCCC-------CCSSC-CBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred cccchhhhhhhhcccccc-cccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 443322221111111110 00000000 124778999999999999999999999999999975
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-57 Score=448.23 Aligned_cols=261 Identities=26% Similarity=0.416 Sum_probs=208.4
Q ss_pred CCCeeEee-eeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHH-cCCCCcceeeeeecCCCcCCC
Q 010489 112 ASRYQIQE-VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL-LRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 112 ~~~y~i~~-~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~-l~h~niv~~~~~~~~~~~~~~ 189 (509)
.++|++++ .||+|+||+||+|+++.+++.||||+++. ...+.+|+.++.+ ++|||||++++++.+.. ...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY-AGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCC
Confidence 35799875 59999999999999999999999999864 2456789998755 58999999999985321 223
Q ss_pred CcEEEEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC---CCCeEEeeeccc
Q 010489 190 KDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLA 263 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~---~~~vkl~DFG~a 263 (509)
..+|||||||+ |+|.+++... ..+++.+++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 56899999998 6999999864 36999999999999999999999999999999999999986 567999999999
Q ss_pred ccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChh
Q 010489 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (509)
+....... ....+||+.|||||++.+ ..|+.++||||||||+|+|+||++||.+.+.......+...
T Consensus 162 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~------- 228 (335)
T d2ozaa1 162 KETTSHNS----LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR------- 228 (335)
T ss_dssp EECCCCCC----CCCCSCCCSSCCCCCCCG--GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------C-------
T ss_pred eeccCCCc----cccccCCcccCCcHHHcC--CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHH-------
Confidence 87544332 245689999999999987 68999999999999999999999999876643332222111
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
............++.+++++.+||.+||+.||++|||+.|+|+||||.+.
T Consensus 229 ----------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 229 ----------------IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp ----------------CCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred ----------------HhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 01111111111223578999999999999999999999999999999653
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-57 Score=435.00 Aligned_cols=250 Identities=26% Similarity=0.439 Sum_probs=207.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccC----hhhHHhHHHHHHHHHHcC--CCCcceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH----VSDATRILREIKLLRLLR--HPDIVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~----~~~~~~~~~Ei~~l~~l~--h~niv~~~~~~~~~~ 185 (509)
.++|++.+.||+|+||+||+|+++.+|+.||||++++.... .....++.+|+.+|++++ |||||++++++..
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-- 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--
Confidence 36899999999999999999999999999999998643211 112344678999999997 8999999999954
Q ss_pred cCCCCcEEEEEeccc--ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC-CCCeEEeeecc
Q 010489 186 RREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGL 262 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~--~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~-~~~vkl~DFG~ 262 (509)
...+|+||||+. +++.+++.....+++..++.++.||++||+|||++||+||||||+|||++. ++.+||+|||+
T Consensus 81 ---~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 81 ---PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp ---SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ---CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccc
Confidence 356899999997 378888888889999999999999999999999999999999999999985 47999999999
Q ss_pred cccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCCh
Q 010489 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342 (509)
Q Consensus 263 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~ 342 (509)
|+...... .+..+||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+.+. +..
T Consensus 158 a~~~~~~~-----~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~------- 218 (273)
T d1xwsa_ 158 GALLKDTV-----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR------- 218 (273)
T ss_dssp CEECCSSC-----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH-------
T ss_pred ceeccccc-----ccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCchH------Hhh-------
Confidence 98643222 3567899999999998762 3456789999999999999999999975321 000
Q ss_pred hHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
... ...+.+++++.+||.+||+.||++|||++|+|+||||+++
T Consensus 219 -------------------~~~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 219 -------------------GQV-----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp -------------------CCC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred -------------------ccc-----CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 000 0113578999999999999999999999999999999865
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=431.15 Aligned_cols=288 Identities=36% Similarity=0.585 Sum_probs=234.2
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|+++++||+|+||+||+|+++.+|+.||||+++..........++.+|+.+|+.++||||+++++++... ..+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc-----cce
Confidence 589999999999999999999999999999999976555556678899999999999999999999999544 458
Q ss_pred EEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCC
Q 010489 193 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (509)
Q Consensus 193 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 271 (509)
++|+|++.+ .+..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+.......
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999996 6677777778999999999999999999999999999999999999999999999999999987543332
Q ss_pred CcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCC-CCCCChHhHHHHHHHhcCCCChhHHHHhhh
Q 010489 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL-FPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (509)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 350 (509)
. .....+++.|+|||++.+. ..++.++|||||||++|||++|+.| |.+.+..+++..+....+.+....+.....
T Consensus 157 ~---~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 157 C---YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp C---CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred c---ceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 2 2345788999999988763 4578999999999999999999977 566777778888888888776654332211
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
. ..+................+..++.+.+||.+||++||++||||+|+|+||||+++.+
T Consensus 233 ~--~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~ 291 (292)
T d1unla_ 233 L--PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp S--TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred c--ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence 0 0000000001112233445678999999999999999999999999999999987654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7e-56 Score=430.05 Aligned_cols=265 Identities=25% Similarity=0.384 Sum_probs=210.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++++.||+|+||+||+|++..+|+.||||+++.... .......+.+|+.+|+.++||||+++++++.... ....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence 3689999999999999999999999999999999975433 3344567899999999999999999999986533 2234
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
.+|||||||+ ++|.+++...+.+++.++..|+.||+.||+|||++||+||||||+|||++.++.++|+|||.+......
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 5899999999 589999988889999999999999999999999999999999999999999999999999998765444
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHhh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 349 (509)
..........+||+.|||||++.+ ..|+.++|||||||++|||+||++||.+.+..+.+..+..
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~-------------- 228 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-------------- 228 (277)
T ss_dssp --------------TTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--------------
T ss_pred cccccccccccCcccccCHHHHcC--CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh--------------
Confidence 433334456789999999999987 6899999999999999999999999998776544333221
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010489 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (509)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 406 (509)
..+.+.....+.+++++.+||.+||++||.+||+..+.|.|+|.
T Consensus 229 -------------~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 229 -------------EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp -------------CCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred -------------cCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 12222334456789999999999999999999944444445665
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.8e-55 Score=435.45 Aligned_cols=288 Identities=31% Similarity=0.564 Sum_probs=223.9
Q ss_pred ccCCCCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCc
Q 010489 108 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSR 186 (509)
Q Consensus 108 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~ 186 (509)
+++..++|+++++||+|+||+||+|+++.+|+.||||+++.. ..+++.+|+.+|+.+. ||||+++++++...
T Consensus 30 ~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~-- 102 (328)
T d3bqca1 30 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDP-- 102 (328)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT--
T ss_pred CCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEec--
Confidence 445567899999999999999999999999999999999642 3456889999999996 99999999998643
Q ss_pred CCCCcEEEEEecccc-cHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCC-CeEEeeecccc
Q 010489 187 REFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLAR 264 (509)
Q Consensus 187 ~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~-~vkl~DFG~a~ 264 (509)
....+|+|||||++ +|..+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 103 -~~~~~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 103 -VSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp -TTCSEEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred -CCCceeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccce
Confidence 23568999999995 66544 35699999999999999999999999999999999999998765 59999999998
Q ss_pred cccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCC-ChHhHHHHHHHhcCCCChh
Q 010489 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK-NVVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~g~~~~~ 343 (509)
....... ....+||+.|+|||++.+. ..|+.++||||+||++|||++|+.||... +..++...+...+|.+...
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~ 253 (328)
T d3bqca1 179 FYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253 (328)
T ss_dssp ECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred eccCCCc----ccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhh
Confidence 7543332 2456899999999998763 56899999999999999999999999654 4556777777777755433
Q ss_pred HHHHhhhH-HHHHhhhccCCCCCC-----CCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCcC
Q 010489 344 SISRIRNE-KARRYLGSMRKKQPV-----PFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 344 ~~~~~~~~-~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 411 (509)
........ ....+.......... ........++++++|||++||.+||++|||++|+|+||||+.+.+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 22211100 001111111111111 111223457899999999999999999999999999999987643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=426.31 Aligned_cols=257 Identities=24% Similarity=0.302 Sum_probs=205.9
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||+||+|+.. ..||||+++.........+.+.+|+.+|++++|||||++++++.. ..
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence 468999999999999999999753 369999997655555667889999999999999999999998743 24
Q ss_pred EEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+|||||||+ |+|.+++... ..+++..+..|+.||++||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 799999999 6999999754 57999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCcccccccccccccccccccccc-cCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... .......||+.|||||++.+. ...|+.++|||||||++|||+||+.||.+.+...++..+...
T Consensus 158 ~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~------------ 224 (276)
T d1uwha_ 158 SGS-HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR------------ 224 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH------------
T ss_pred CCc-ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhc------------
Confidence 221 223567899999999998642 135899999999999999999999999886654433322111
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
...+..+......+++++.+||.+||+.||++|||++|+++|
T Consensus 225 -------------~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 225 -------------GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp -------------TSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 011112223345678999999999999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=426.11 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=202.9
Q ss_pred eeeeccCceEEEEEEEc--CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcEEEEE
Q 010489 119 EVIGKGSYGVVGSAVDT--HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 119 ~~lG~G~~g~V~~~~~~--~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 196 (509)
++||+|+||+||+|... .+++.||||+++.........+.+.+|+.+|++++|||||++++++..+ ..||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~------~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------SWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS------SEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC------CEEEEE
Confidence 47999999999999754 4567899999975544445567899999999999999999999998432 379999
Q ss_pred eccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCCCCCccc
Q 010489 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (509)
Q Consensus 197 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 275 (509)
|||+ |+|.+++.....+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...........
T Consensus 87 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred EcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 9998 689999999899999999999999999999999999999999999999999999999999999876444333222
Q ss_pred ccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHH
Q 010489 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354 (509)
Q Consensus 276 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 354 (509)
.....||+.|||||++.+ ..|+.++|||||||++|||++ |++||.+.+..+....+...
T Consensus 167 ~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~------------------ 226 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG------------------ 226 (277)
T ss_dssp ----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT------------------
T ss_pred ccccCCCceecCchhhcC--CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC------------------
Confidence 344679999999999877 689999999999999999998 89999987654433332210
Q ss_pred HhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHH---hcCCccc
Q 010489 355 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA---LADPYFH 407 (509)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~---l~hp~f~ 407 (509)
...+ ....+++++.+||.+||+.||++|||++++ |+|+|++
T Consensus 227 -------~~~~-----~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 227 -------ERMG-----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp -------CCCC-----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -------CCCC-----CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 0111 113578999999999999999999999998 4566553
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.7e-55 Score=423.73 Aligned_cols=254 Identities=21% Similarity=0.392 Sum_probs=208.2
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++.+.||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.+|++++|||||++++++... ..
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~ 87 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PP 87 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCCCCCEecCCccEeeC-----Ce
Confidence 358999999999999999999999999999999987432 3456789999999999999999999999543 45
Q ss_pred EEEEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 192 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
+|||||||+ |+|.+++... ..+++..+..|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 899999999 6899988754 5789999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCC-CCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF-PGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
... .......||+.|+|||++.+ ..|+.++|||||||++|||++|..|| .+.+.......+..
T Consensus 168 ~~~--~~~~~~~g~~~y~aPE~~~~--~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~------------ 231 (287)
T d1opja_ 168 DTY--TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------------ 231 (287)
T ss_dssp SSS--EEETTEEECGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT------------
T ss_pred CCc--eeeccccccccccChHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc------------
Confidence 322 22344578999999999887 68999999999999999999976554 44443222222111
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 409 (509)
.... .....+++++.+||.+||+.||++|||++|+++ +|+.+
T Consensus 232 ---------------~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~ 273 (287)
T d1opja_ 232 ---------------DYRM---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM 273 (287)
T ss_dssp ---------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred ---------------CCCC---CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence 0000 112357899999999999999999999999977 66544
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-54 Score=421.85 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=196.5
Q ss_pred CCCCeeEeeeeeccCceEEEEEEEcCCCc---EEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGE---RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 111 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~---~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
..++|++.++||+|+||+||+|+++.+++ .||||++... ......+.+.+|+.+|++++|||||++++++...
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--- 99 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS--- 99 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC---
Confidence 45689999999999999999999887665 5889988643 2334567789999999999999999999999543
Q ss_pred CCCcEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 188 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
..+|+|||||+ |+|.+++... +.+++..+..|+.||++||+|||++||+||||||+||||+.++.+||+|||+|+.
T Consensus 100 --~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 100 --TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp --SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred --CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceE
Confidence 45899999998 5888888764 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcc--cccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCCh
Q 010489 266 SFNDAPSAI--FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPST 342 (509)
Q Consensus 266 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~ 342 (509)
......... ......||+.|||||++.+ ..|+.++|||||||++|||+| |++||.+.+..+.+..+...
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~------ 249 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD------ 249 (299)
T ss_dssp ------------------CGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT------
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhc--CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------
Confidence 644332211 1223568999999999877 689999999999999999998 89999887754443333211
Q ss_pred hHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
...+ ....+++.+.+||.+||+.||++|||+.|+++
T Consensus 250 -------------------~~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~ 285 (299)
T d1jpaa_ 250 -------------------YRLP-----PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285 (299)
T ss_dssp -------------------CCCC-----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------------CCCC-----CCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 0111 11357889999999999999999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-54 Score=419.98 Aligned_cols=256 Identities=23% Similarity=0.363 Sum_probs=209.3
Q ss_pred CCeeEeee-eeccCceEEEEEEEcC--CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 113 SRYQIQEV-IGKGSYGVVGSAVDTH--TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 113 ~~y~i~~~-lG~G~~g~V~~~~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
++|.+.+. ||+|+||+||+|.++. ++..||||+++.. ......+.+.+|+++|++++|||||++++++..+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~----- 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE----- 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-----
Confidence 46888884 9999999999998754 4558999999753 3345567899999999999999999999998432
Q ss_pred CcEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 190 KDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
.+|||||||+ |+|.+++... +.+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 82 -~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 82 -ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp -SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred -eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 3799999999 5899987654 579999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
.............||+.|||||++.+ ..++.++|||||||++|||+| |+.||.+.+..+....+...
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~---------- 228 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---------- 228 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT----------
T ss_pred ccccccccccccccCccccChHHHhC--CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC----------
Confidence 44332222345679999999999877 689999999999999999998 89999887654443333210
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHH---hcCCccc
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA---LADPYFH 407 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~---l~hp~f~ 407 (509)
...+ ..+.+++++.+||.+||+.||++|||+.++ |+|+|+.
T Consensus 229 ---------------~~~~-----~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 229 ---------------KRME-----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ---------------CCCC-----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------------CCCC-----CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0111 124578999999999999999999999888 6677774
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-54 Score=413.65 Aligned_cols=249 Identities=24% Similarity=0.407 Sum_probs=195.6
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||.||+|++. ++..||||+++... ...+.+.+|++++++++|||||++++++... ..
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~ 74 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----AP 74 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SS
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc---CcHHHHHHHHHHHHhcCCCCcccccceeccC-----Cc
Confidence 468999999999999999999876 57789999997532 2346789999999999999999999999544 45
Q ss_pred EEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+|+|||||+ |+|.+++... ..+++..+..|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 75 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 75 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred eEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCC
Confidence 899999998 6899988655 56899999999999999999999999999999999999999999999999999875433
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
.... .....||+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+.+..+....
T Consensus 155 ~~~~--~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~----------- 219 (263)
T d1sm2a_ 155 QYTS--STGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF----------- 219 (263)
T ss_dssp ------------CTTSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC-----------
T ss_pred Ccee--ecceecCcccCChHHhcC--CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC-----------
Confidence 2221 234679999999999987 689999999999999999999 567776665544333332210
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
..+ ....+++++.+||.+||+.||++|||++|+++|
T Consensus 220 --------------~~~-----~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 220 --------------RLY-----KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp --------------CCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------CCC-----CccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 000 012467899999999999999999999999985
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-54 Score=425.22 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=205.1
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCc-----EEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGE-----RVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~-----~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~ 185 (509)
.++|+++++||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.+|+++ +|||||++++++...
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~- 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS- 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC-
Confidence 3589999999999999999999876544 69999986432 223446788999999998 899999999999543
Q ss_pred cCCCCcEEEEEeccc-ccHHHHHHhCC-----------------------CCCHHHHHHHHHHHHhHhhhhhhCCeeecC
Q 010489 186 RREFKDIYVVFELME-SDLHQVIKAND-----------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRD 241 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-----------------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrD 241 (509)
..+|+|||||+ |+|.+++.... .+++..+..|+.||++||+|||++||+|||
T Consensus 114 ----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 114 ----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp ----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ----CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 45899999998 69999997542 489999999999999999999999999999
Q ss_pred CCCCcEEECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCC
Q 010489 242 LKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPL 320 (509)
Q Consensus 242 lKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~p 320 (509)
|||+|||++.++.+||+|||+|+....... ........||+.|||||++.+ ..|+.++|||||||++|||++ |++|
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CchhccccccCCeEEEeeccccccccCCCc-eeeeccccCCCccCChHHHcC--CCCCcceeccchhHHHHHHHhCCCCC
Confidence 999999999999999999999987544332 222345678999999999887 789999999999999999997 8999
Q ss_pred CCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHH
Q 010489 321 FPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400 (509)
Q Consensus 321 f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 400 (509)
|.+.+....+..+... ....+ ....+++++.+||.+||+.||++|||++||
T Consensus 267 f~~~~~~~~~~~~~~~--------------------------~~~~~---~p~~~~~~l~~li~~cl~~dP~~RPt~~ei 317 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQN--------------------------GFKMD---QPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317 (325)
T ss_dssp STTCCCSHHHHHHHHT--------------------------TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHHHhc--------------------------CCCCC---CCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 9886644333322110 00000 113578899999999999999999999999
Q ss_pred hcC
Q 010489 401 LAD 403 (509)
Q Consensus 401 l~h 403 (509)
++|
T Consensus 318 ~~~ 320 (325)
T d1rjba_ 318 TSF 320 (325)
T ss_dssp HHH
T ss_pred HHH
Confidence 985
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-54 Score=416.93 Aligned_cols=251 Identities=25% Similarity=0.375 Sum_probs=204.6
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++++.||+|+||.||+|+++ ++..||||+++... ...+.+.+|+.+|++++|||||++++++... .+
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~------~~ 82 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE------PI 82 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SC
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeeccC------Ce
Confidence 58999999999999999999975 67889999997532 2346789999999999999999999987432 36
Q ss_pred EEEEeccc-ccHHHHHHhC--CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 193 YVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
|+|||||+ |+|.+++... ..+++..+..|+.||++||.|||++||+||||||+||||+.++.+||+|||+|+.....
T Consensus 83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC
Confidence 99999998 6888877543 36999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhC-CCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
. ........||+.|||||++.+ ..|+.++|||||||++|||+|| .+||...+..+.+..+...
T Consensus 163 ~--~~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~------------ 226 (272)
T d1qpca_ 163 E--YTAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG------------ 226 (272)
T ss_dssp C--EECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT------------
T ss_pred c--cccccccCCcccccChHHHhC--CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc------------
Confidence 2 122345689999999999877 6799999999999999999995 5566655543333322110
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc--CCccc
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA--DPYFH 407 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~f~ 407 (509)
...+ ....+++++.+||.+||+.||++|||++++++ |+||.
T Consensus 227 -------------~~~~-----~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 227 -------------YRMV-----RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -------------CCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------------CCCC-----CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 0001 11357889999999999999999999999998 77774
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-53 Score=406.85 Aligned_cols=249 Identities=20% Similarity=0.312 Sum_probs=207.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|+++++||+|+||+||+|+++ +++.||||+++.... ....+++|+.++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-----~~ 73 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RP 73 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCS-----SS
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----Cc
Confidence 357999999999999999999985 788999999975322 345789999999999999999999999543 45
Q ss_pred EEEEEeccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+|+||||++ |+|..++.. ...+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 74 ~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 74 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp EEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred eEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 999999998 678888654 457999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... ......||+.|+|||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+....+....
T Consensus 154 ~~~--~~~~~~~t~~y~aPE~~~~--~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~----------- 218 (258)
T d1k2pa_ 154 EYT--SSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL----------- 218 (258)
T ss_dssp SCC--CCCCSCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC-----------
T ss_pred Cce--eecccCCCCCcCCcHHhcC--CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 222 2244679999999999987 689999999999999999998 899998877654443332210
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
..+. ...+++++.+||.+||+.||++|||++++++|
T Consensus 219 --------------~~~~-----p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 219 --------------RLYR-----PHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp --------------CCCC-----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------CCCC-----cccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 0111 13467899999999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=407.27 Aligned_cols=253 Identities=23% Similarity=0.353 Sum_probs=194.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCC----cEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTG----ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~----~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
.++|++.++||+|+||.||+|..+.++ ..||||+++... .......+++|+.+|++++|||||++++++...
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~--- 81 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--- 81 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC---
Confidence 457999999999999999999877654 479999996532 234456789999999999999999999999543
Q ss_pred CCCcEEEEEecccc-cHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 188 EFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 188 ~~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
..+++|||||.+ .+.+++... ..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.
T Consensus 82 --~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 82 --KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp --SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred --CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 458999999985 677766554 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCC-CCCCChHhHHHHHHHhcCCCChhH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL-FPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
...............||+.|||||++.+ ..|+.++|||||||++|||++|..| |.+.+..+.+..+...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-------- 229 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-------- 229 (283)
T ss_dssp --------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT--------
T ss_pred ccCCCccceEeccCCCCccccCHHHHcc--CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc--------
Confidence 6544333323345678999999999877 7899999999999999999996554 5444432222222110
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
...+ ....+++.+.+||.+||..||++|||+.|+++
T Consensus 230 -----------------~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 230 -----------------FRLP-----TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp -----------------CCCC-----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------------CCCC-----CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 0111 11347789999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-54 Score=423.18 Aligned_cols=264 Identities=23% Similarity=0.402 Sum_probs=214.2
Q ss_pred CCeeEeeeeeccCceEEEEEEE---cCCCcEEEEEEecCcc--cChhhHHhHHHHHHHHHHcCC-CCcceeeeeecCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVD---THTGERVAIKKINDVF--EHVSDATRILREIKLLRLLRH-PDIVEIKHIMLPPSR 186 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~---~~~~~~vAiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h-~niv~~~~~~~~~~~ 186 (509)
++|++++.||+|+||+||+|++ +.+|+.||||++++.. ......+.+.+|+++|++++| |||+++++++.+
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~--- 100 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--- 100 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE---
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc---
Confidence 6799999999999999999987 4478999999986432 122334667899999999976 899999999844
Q ss_pred CCCCcEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 187 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 187 ~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
...+|++||||. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 101 --~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 101 --ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp --TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred --CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 456999999998 69999999999999999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
....... ......||+.|+|||.+.+....++.++|||||||+||||++|+.||.+.+..+....+....
T Consensus 179 ~~~~~~~--~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~-------- 248 (322)
T d1vzoa_ 179 FVADETE--RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI-------- 248 (322)
T ss_dssp CCGGGGG--GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--------
T ss_pred hcccccc--cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--------
Confidence 5332221 234568999999999987643467889999999999999999999998876543333322110
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCc
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~ 410 (509)
. ....+ ....+++++.+||.+||.+||.+|| |++|+|+||||+++.
T Consensus 249 -----------~---~~~~~-----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 249 -----------L---KSEPP-----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp -----------H---HCCCC-----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred -----------c---cCCCC-----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 0 00111 1235789999999999999999999 589999999998765
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=405.56 Aligned_cols=253 Identities=26% Similarity=0.394 Sum_probs=200.8
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCcE
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 192 (509)
++|++++.||+|+||.||+|+++.+ ..||||+++... ...+.+.+|+.+|++++|||||++++++... .+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~------~~ 86 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE------PI 86 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEecC------Ce
Confidence 5899999999999999999998754 579999997432 2346789999999999999999999998432 37
Q ss_pred EEEEeccc-ccHHHHHHh--CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 193 YVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 193 ~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
|+|||||+ |+|..++.. .+.+++.++..++.||+.||+|||++||+||||||+||||+.++++||+|||+|+.....
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 99999999 577777753 357999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCC-CCCCCCChHhHHHHHHHhcCCCChhHHHHh
Q 010489 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (509)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 348 (509)
... ......||+.|+|||++.. ..++.++|||||||++|||++|. +||.+....+.+..+....
T Consensus 167 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~----------- 231 (285)
T d1fmka3 167 EYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY----------- 231 (285)
T ss_dssp -----------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----------
T ss_pred Cce--eeccccccccccChHHHhC--CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-----------
Confidence 221 1244679999999999987 78999999999999999999965 5555555444433332110
Q ss_pred hhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc--CCcccCC
Q 010489 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA--DPYFHGL 409 (509)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~f~~~ 409 (509)
..+ ..+.+++++.+||.+||+.||++||+++++++ |+||...
T Consensus 232 --------------~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 232 --------------RMP-----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp --------------CCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred --------------CCC-----CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 111 12457889999999999999999999999988 8888764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=405.18 Aligned_cols=250 Identities=25% Similarity=0.416 Sum_probs=196.0
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCC---CcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~ 189 (509)
++|++++.||+|+||.||+|++..+ +..||||+++.. ........+.+|+.+|++++|||||++++++..
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 79 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 79 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 5899999999999999999998654 356899988643 233445678999999999999999999999843
Q ss_pred CcEEEEEeccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccccc
Q 010489 190 KDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 267 (509)
..+|+|||||+ |+|.+++.. ...+++..+..++.||++||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 34799999998 578877655 4579999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHH
Q 010489 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (509)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 346 (509)
..... ..+...||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+....+...
T Consensus 160 ~~~~~--~~~~~~gt~~y~apE~l~~--~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~---------- 225 (273)
T d1mp8a_ 160 DSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---------- 225 (273)
T ss_dssp -------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT----------
T ss_pred CCcce--eccceecCcccchhhHhcc--CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC----------
Confidence 32221 2244678999999999987 789999999999999999998 89999887764444333210
Q ss_pred HhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
... ...+.+++.+.+||.+||+.||++|||++|+++|
T Consensus 226 -----------------~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 226 -----------------ERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp -----------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCC---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 011 1234678999999999999999999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-52 Score=412.27 Aligned_cols=251 Identities=22% Similarity=0.370 Sum_probs=199.3
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCc----EEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGE----RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~----~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 188 (509)
.+|+++++||+|+||+||+|.+..+|+ .||+|+++.. ......+.+.+|+.+|++++|||||++++++...
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~---- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence 579999999999999999999988876 5788887643 2233457789999999999999999999999643
Q ss_pred CCcEEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccc
Q 010489 189 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (509)
Q Consensus 189 ~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 266 (509)
..+++|||+. ++|.+.+... ..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 84 --~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 84 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp --SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred --CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 3577888877 6888877654 57999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHH
Q 010489 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (509)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 345 (509)
...... .......||+.|||||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+....+...
T Consensus 162 ~~~~~~-~~~~~~~gt~~y~APE~l~~--~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~--------- 229 (317)
T d1xkka_ 162 GAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG--------- 229 (317)
T ss_dssp TTTCC---------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT---------
T ss_pred cccccc-ccccccccCccccChHHHhc--CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---------
Confidence 443322 22344578999999999887 689999999999999999998 78999876654433322211
Q ss_pred HHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
...+ ..+.+++.+.+||.+||..||.+|||+.|+++|
T Consensus 230 ----------------~~~~-----~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 230 ----------------ERLP-----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ----------------CCCC-----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCC-----CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 0111 113578899999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-52 Score=400.67 Aligned_cols=254 Identities=22% Similarity=0.350 Sum_probs=197.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcC-CC--cEEEEEEecCccc-ChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTH-TG--ERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~-~~--~~vAiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 187 (509)
..+|++++.||+|+||.||+|+... ++ ..||||+++.... .....+.+.+|+.+|+.++||||+++++++..+
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~--- 83 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 83 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec---
Confidence 4679999999999999999998643 33 3689999865332 334457789999999999999999999999543
Q ss_pred CCCcEEEEEeccc-ccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeeccccc
Q 010489 188 EFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (509)
Q Consensus 188 ~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 265 (509)
.+++|||||+ +++.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 84 ---~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 84 ---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp ---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred ---chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhh
Confidence 3699999998 678776654 45799999999999999999999999999999999999999999999999999997
Q ss_pred ccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhH
Q 010489 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (509)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 344 (509)
...............||..|+|||++.+ ..++.++|||||||++|||+| |+.||.+.+..+.+..+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~-------- 230 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE-------- 230 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS--------
T ss_pred cccCCCcceecCccccCcccCCHHHHhC--CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC--------
Confidence 6554443333345678899999999987 689999999999999999998 89999988765554443221
Q ss_pred HHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.... ...+.+++.+.+||.+||..||++|||+.++++
T Consensus 231 ------------------~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 231 ------------------GERL---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp ------------------CCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCC---CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0000 112457889999999999999999999999975
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=403.57 Aligned_cols=254 Identities=25% Similarity=0.396 Sum_probs=196.0
Q ss_pred CCeeEeeeeeccCceEEEEEEEcC-----CCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCc
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~ 186 (509)
++|+++++||+|+||.||+|.+.. +++.||||+++... .....+.+.+|+.++.++ +|+||+.+++++...
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-- 89 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 89 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC--
Confidence 579999999999999999998654 45789999986432 234456778888888776 589999999988543
Q ss_pred CCCCcEEEEEeccc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEE
Q 010489 187 REFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA 249 (509)
Q Consensus 187 ~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl 249 (509)
...+|+|||||+ |+|.+++... ..+++..+..++.||++||+|||++||+||||||+||||
T Consensus 90 --~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 90 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp --TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred --CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 245899999998 6899998653 248999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhC-CCCCCCCChHh
Q 010489 250 NADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVH 328 (509)
Q Consensus 250 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~ 328 (509)
+.++.+||+|||+|+........ ......+||+.|||||++.+ ..|+.++|||||||++|||++| .+||.+.+...
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp CGGGCEEECC------CCSCTTS-CCTTSCCCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred CCCCcEEEccCcchhhccccccc-cccCceeeCccccchhHhhc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999865433322 22345689999999999987 7899999999999999999987 56887765433
Q ss_pred HHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 329 QLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 329 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
.+..+... ...+ .....+++++.+||.+||+.||++|||++|+++|
T Consensus 245 ~~~~~~~~-------------------------~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 245 EFCRRLKE-------------------------GTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHH-------------------------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhc-------------------------CCCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22211110 0000 1113578899999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.2e-51 Score=400.28 Aligned_cols=256 Identities=21% Similarity=0.286 Sum_probs=207.1
Q ss_pred CCCeeEeeeeeccCceEEEEEEEc-----CCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 186 (509)
.++|++++.||+|+||+||+|+.+ .+++.||||+++.. ......+.+.+|+.+|++++||||+++++++...
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-- 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAVG-- 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeeccC--
Confidence 357999999999999999999865 35678999998753 2334456789999999999999999999999543
Q ss_pred CCCCcEEEEEeccc-ccHHHHHHhCC------------------------CCCHHHHHHHHHHHHhHhhhhhhCCeeecC
Q 010489 187 REFKDIYVVFELME-SDLHQVIKAND------------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRD 241 (509)
Q Consensus 187 ~~~~~~~lv~e~~~-~~L~~~l~~~~------------------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrD 241 (509)
..+++||||++ |+|.+++.... .+++..+..|+.||+.||+|||+++|||||
T Consensus 89 ---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 89 ---KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ---CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 45899999998 68999886532 388999999999999999999999999999
Q ss_pred CCCCcEEECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCC-CC
Q 010489 242 LKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PL 320 (509)
Q Consensus 242 lKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~-~p 320 (509)
|||+|||++.++.+||+|||+|+....... ....+...||+.|+|||++.+ ..|+.++|||||||++|||++|. +|
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred EcccceEECCCCcEEEccchhheeccCCcc-ccccCCCCcCcCcCCHHHHcc--CCCChhhhhccchhhHHHHHccCCCC
Confidence 999999999999999999999986533222 222345689999999999987 78999999999999999999995 78
Q ss_pred CCCCChHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHH
Q 010489 321 FPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400 (509)
Q Consensus 321 f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 400 (509)
|.+.+..+.+..+... ..+ .....+++++.+||.+||+.||++|||+.|+
T Consensus 243 ~~~~~~~e~~~~v~~~--------------------------~~~----~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev 292 (301)
T d1lufa_ 243 YYGMAHEEVIYYVRDG--------------------------NIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSI 292 (301)
T ss_dssp TTTSCHHHHHHHHHTT--------------------------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHHHcC--------------------------CCC----CCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 8877665444333211 000 1123578899999999999999999999999
Q ss_pred hcCCcccC
Q 010489 401 LADPYFHG 408 (509)
Q Consensus 401 l~hp~f~~ 408 (509)
++ +++.
T Consensus 293 ~~--~L~~ 298 (301)
T d1lufa_ 293 HR--ILQR 298 (301)
T ss_dssp HH--HHHH
T ss_pred HH--HHHH
Confidence 76 5443
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-51 Score=390.53 Aligned_cols=243 Identities=23% Similarity=0.392 Sum_probs=195.0
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||.||+|+. .|..||||+++.. ...+.+.+|+++|++++||||+++++++.... ..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~ 75 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GG 75 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------C
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC----Cc
Confidence 35799999999999999999987 4789999999642 34567889999999999999999999986432 34
Q ss_pred EEEEEeccc-ccHHHHHHhCC--CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccC
Q 010489 192 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 268 (509)
+|+||||++ |+|.+++.... .+++..+..|+.||+.||.|||+.+|+||||||+|||++.+|.+||+|||+++....
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC
Confidence 799999998 68999986543 589999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCChHhHHHHHHHhcCCCChhHHHH
Q 010489 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 347 (509)
.. ....+|+.|+|||++.+ ..++.++|||||||++|||+| |++||.+.+..+....+..
T Consensus 156 ~~------~~~~~~~~y~aPE~l~~--~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~------------ 215 (262)
T d1byga_ 156 TQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------ 215 (262)
T ss_dssp ------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT------------
T ss_pred CC------ccccccccCCChHHHhC--CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc------------
Confidence 21 33578999999999987 689999999999999999998 7888887665443332211
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
....+ ..+.+++++.+||.+||..||.+|||+.++++
T Consensus 216 -------------~~~~~-----~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 216 -------------GYKMD-----APDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp -------------TCCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCCCC-----CCccCCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 00111 12357889999999999999999999999988
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=394.06 Aligned_cols=252 Identities=25% Similarity=0.420 Sum_probs=201.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCC-------cEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTG-------ERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLP 183 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~-------~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~ 183 (509)
.++|++++.||+|+||.||+|++..++ ..||||+++... .......+.+|+..+.++ +|||||++++++..
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 368999999999999999999876554 479999997543 334557788999999888 79999999999954
Q ss_pred CCcCCCCcEEEEEeccc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCc
Q 010489 184 PSRREFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 246 (509)
Q Consensus 184 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~N 246 (509)
. ..+|+|||||+ |+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|
T Consensus 91 ~-----~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 91 D-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp S-----SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred C-----CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 3 45899999998 6899999654 358999999999999999999999999999999999
Q ss_pred EEECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCC
Q 010489 247 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 325 (509)
Q Consensus 247 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~ 325 (509)
||++.++.+||+|||+++......... .....+||+.|+|||++.+ ..|+.++||||||||+|||++ |.+||.+.+
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~--~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYK-KTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTC-CCTTSCCGGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eeecCCCCeEeccchhhcccccccccc-ccccCCCChhhhhhhHhcC--CCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 999999999999999998765443322 2345689999999999987 789999999999999999998 789998766
Q ss_pred hHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 326 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
.......+.. ....+ ....+++++.+||.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~i~~---------------------------~~~~~---~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 243 VEELFKLLKE---------------------------GHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHT---------------------------TCCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHc---------------------------CCCCC---CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 5433222211 00111 11357889999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=398.69 Aligned_cols=249 Identities=25% Similarity=0.377 Sum_probs=200.4
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcE--EEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCCcCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGER--VAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~--vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~~ 189 (509)
++|++.++||+|+||+||+|+++.+|.. ||||+++... .....+.+.+|+++|+++ +|||||++++++...
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~----- 83 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR----- 83 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-----
Confidence 6899999999999999999999888874 6778775432 223456789999999998 699999999999543
Q ss_pred CcEEEEEeccc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCC
Q 010489 190 KDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 252 (509)
Q Consensus 190 ~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~ 252 (509)
..+|+|||||+ |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence 45999999999 6999998654 579999999999999999999999999999999999999999
Q ss_pred CCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCC-CCCCCCChHhHHH
Q 010489 253 CKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLD 331 (509)
Q Consensus 253 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~~~~~ 331 (509)
+.+||+|||+|+........ ....||+.|+|||.+.+ ..|+.++|||||||++|||++|. +||.+.+..+...
T Consensus 164 ~~~kl~DfG~a~~~~~~~~~----~~~~gt~~y~aPE~l~~--~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~ 237 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVKK----TMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237 (309)
T ss_dssp GCEEECCTTCEESSCEECCC--------CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred CceEEccccccccccccccc----cceecCCcccchHHhcc--CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999999764332221 34578999999999977 78999999999999999999975 6787766443332
Q ss_pred HHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 332 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 332 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
.+.. ...+ .....+++++.+||.+||+.||++|||++|+++|
T Consensus 238 ~i~~--------------------------~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 238 KLPQ--------------------------GYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HGGG--------------------------TCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHh--------------------------cCCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 2211 0011 1123578999999999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=391.38 Aligned_cols=253 Identities=26% Similarity=0.410 Sum_probs=206.5
Q ss_pred CCCeeEeeeeeccCceEEEEEEE-----cCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHc-CCCCcceeeeeecCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~ 185 (509)
.++|++++.||+|+||.||+|+. ..+++.||||+++.. ........+.+|+.+++.+ +|||||++++++...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~- 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG- 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc-cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC-
Confidence 36899999999999999999975 346789999999753 2344566789999999999 699999999999543
Q ss_pred cCCCCcEEEEEeccc-ccHHHHHHhCC------------------CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCc
Q 010489 186 RREFKDIYVVFELME-SDLHQVIKAND------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 246 (509)
Q Consensus 186 ~~~~~~~~lv~e~~~-~~L~~~l~~~~------------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~N 246 (509)
..+|+|||||+ |+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|
T Consensus 100 ----~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 100 ----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp ----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ----CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 45899999998 68988886543 58999999999999999999999999999999999
Q ss_pred EEECCCCCeEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHh-CCCCCCCCC
Q 010489 247 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 325 (509)
Q Consensus 247 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~ 325 (509)
||++.++.+||+|||+++....... ....+..+||+.|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccccCcccccccchheeccCCCc-ceEeeecccChHHcCHHHhcC--CCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999987644332 233456789999999999987 789999999999999999998 667776665
Q ss_pred hHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 326 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
....+..+... .. .+. ....+++.+.+||.+||+.||++|||++++++
T Consensus 253 ~~~~~~~~i~~----------------------~~---~~~----~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 253 VDSKFYKMIKE----------------------GF---RML----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SSHHHHHHHHH----------------------TC---CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhc----------------------CC---CCC----CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 43333322110 00 010 11346789999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-50 Score=392.73 Aligned_cols=252 Identities=21% Similarity=0.357 Sum_probs=206.6
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcC-----CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 186 (509)
.++|++++.||+|+||.||+|.+.. ++..||||+++.. ........+.+|+.++++++||||+++++++...
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-- 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-- 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS--
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC--
Confidence 3689999999999999999998753 4578999999753 2334556789999999999999999999999543
Q ss_pred CCCCcEEEEEeccc-ccHHHHHHhC----------CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCe
Q 010489 187 REFKDIYVVFELME-SDLHQVIKAN----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 255 (509)
Q Consensus 187 ~~~~~~~lv~e~~~-~~L~~~l~~~----------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~v 255 (509)
..+++|||||+ |+|.+++... ..+++..+..++.|+++||.|||+++|+||||||+|||++.++++
T Consensus 96 ---~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 ---QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ---CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence 45899999998 6888887532 247899999999999999999999999999999999999999999
Q ss_pred EEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhC-CCCCCCCChHhHHHHHH
Q 010489 256 KICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVHQLDLMT 334 (509)
Q Consensus 256 kl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~ 334 (509)
||+|||+|+....... ........||+.|+|||.+.+ ..++.++|||||||++|||+|| .+||.+.+..+.+..+.
T Consensus 173 Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~--~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~ 249 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249 (308)
T ss_dssp EECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred EEeecccceeccCCcc-eeeccceecccccCCHHHHcc--CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999986543322 222344579999999999987 7899999999999999999998 48888776655444332
Q ss_pred HhcCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 335 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 335 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
+. ...+ ..+.+++.+.+||.+||+.||++|||++++++
T Consensus 250 ~~-------------------------~~~~-----~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 250 EG-------------------------GLLD-----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp TT-------------------------CCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hC-------------------------CCCC-----CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 21 0011 11357789999999999999999999999998
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-49 Score=387.87 Aligned_cols=263 Identities=19% Similarity=0.238 Sum_probs=202.1
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
.++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+++++.++|++++..+..+. .+...
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~~ 77 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDY 77 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEE----EETTE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEE----ecCCE
Confidence 3589999999999999999999999999999999864322 235778999999999877666555443 23346
Q ss_pred EEEEEecccccHHHHHHh-CCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC---CCCeEEeeeccccccc
Q 010489 192 IYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVSF 267 (509)
Q Consensus 192 ~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~---~~~vkl~DFG~a~~~~ 267 (509)
.++|||||++++...+.. .+.+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|+...
T Consensus 78 ~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 78 NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 899999999988777654 458999999999999999999999999999999999999864 4579999999998764
Q ss_pred CCCCCc----ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCCChh
Q 010489 268 NDAPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (509)
Q Consensus 268 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 343 (509)
...... ......+||+.|||||++.+ ..++.++|||||||++|||++|+.||.+.........+....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~------ 229 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS------ 229 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH------
T ss_pred ccccccceeccccCCcCCCccccCHHHHhC--CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh------
Confidence 433211 12345689999999999987 679999999999999999999999998765433222221110
Q ss_pred HHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHH---HhcCCccc
Q 010489 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE---ALADPYFH 407 (509)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e---~l~hp~f~ 407 (509)
.... ..+.....+.+++++.+||.+||+.||++||++++ +|+|+|.+
T Consensus 230 ------~~~~-----------~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 230 ------EKKM-----------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp ------HHHH-----------HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ------cccC-----------CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 0000 00111223467889999999999999999999875 46777654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-48 Score=382.08 Aligned_cols=257 Identities=18% Similarity=0.234 Sum_probs=204.7
Q ss_pred CCCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCC-CCcceeeeeecCCCcCCCC
Q 010489 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH-PDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 112 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~~~~~~~~~~~~~~~ 190 (509)
.++|++++.||+|+||+||+|++..+|+.||||+++... ....+.+|+++++.+.| +||+.+++++. ...
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~ 74 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGL 74 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETT
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEee-----cCC
Confidence 368999999999999999999999999999999886432 22456789999999975 89999998884 345
Q ss_pred cEEEEEecccccHHHHHHhCC-CCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECC-----CCCeEEeeecccc
Q 010489 191 DIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-----DCKLKICDFGLAR 264 (509)
Q Consensus 191 ~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~-----~~~vkl~DFG~a~ 264 (509)
..|+|||||+++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 75 ~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 75 HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 689999999999999887654 7999999999999999999999999999999999999974 5789999999998
Q ss_pred cccCCCCCc----ccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHhcCCC
Q 010489 265 VSFNDAPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340 (509)
Q Consensus 265 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~ 340 (509)
......... ......+||+.|||||++.+ ..++.++|||||||++|||++|+.||.+............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~----- 227 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER----- 227 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH-----
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcC--CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH-----
Confidence 764432211 12345689999999999987 6899999999999999999999999987654322221111
Q ss_pred ChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
+..... ..+.....+.+++++.+++..|+..+|++||+.+.+.+
T Consensus 228 -------i~~~~~-----------~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 228 -------IGEKKQ-----------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp -------HHHHHH-----------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred -------HHhccC-----------CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 100000 00111123457789999999999999999999887765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=383.68 Aligned_cols=252 Identities=21% Similarity=0.318 Sum_probs=198.3
Q ss_pred eeEeeeeeccCceEEEEEEEcCCC---cEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCCCcCCCCc
Q 010489 115 YQIQEVIGKGSYGVVGSAVDTHTG---ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (509)
Q Consensus 115 y~i~~~lG~G~~g~V~~~~~~~~~---~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~~~~ 191 (509)
+.+.++||+|+||+||+|++..++ ..||||+++.. ......+++.+|+++|++++||||+++++++... ...
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~ 103 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGS 103 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCc
Confidence 344688999999999999986543 36999999742 3455668899999999999999999999987533 245
Q ss_pred EEEEEeccc-ccHHHHHHhC-CCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEeeecccccccCC
Q 010489 192 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (509)
Q Consensus 192 ~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 269 (509)
+++|||||+ ++|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 104 ~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 104 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred eEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 899999999 5788877654 46788899999999999999999999999999999999999999999999999875433
Q ss_pred CCC-cccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCChH-hHHHHHHHhcCCCChhHHHH
Q 010489 270 APS-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV-HQLDLMTDLLGTPSTESISR 347 (509)
Q Consensus 270 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~ 347 (509)
... ........||+.|+|||++.. ..++.++|||||||++|||++|..||...... +....+.
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~------------- 248 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------------- 248 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH-------------
T ss_pred ccccceecccccccccccChHHHhc--CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------------
Confidence 222 122344679999999999887 68999999999999999999988777653321 1111110
Q ss_pred hhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010489 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (509)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 403 (509)
. ...+. ..+.+++.+.+||.+||..||++||++.|+++|
T Consensus 249 ----------~---g~~~~----~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 249 ----------Q---GRRLL----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ----------T---TCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------c---CCCCC----CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0 01111 113567899999999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.3e-48 Score=389.60 Aligned_cols=283 Identities=24% Similarity=0.343 Sum_probs=211.4
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-----------CCCcceeeeee
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-----------HPDIVEIKHIM 181 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~~~~~~ 181 (509)
+||+++++||+|+||+||+|+++.+|+.||||+++.. ......+.+|+++++.+. |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 5799999999999999999999999999999999742 223456778999888875 47788888887
Q ss_pred cCCCcCCCCcEEEEEeccc--ccHHHHH--HhCCCCCHHHHHHHHHHHHhHhhhhhh-CCeeecCCCCCcEEECCCCC--
Q 010489 182 LPPSRREFKDIYVVFELME--SDLHQVI--KANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCK-- 254 (509)
Q Consensus 182 ~~~~~~~~~~~~lv~e~~~--~~L~~~l--~~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDlKp~NILl~~~~~-- 254 (509)
... .....+++|+++. ++..... .....+++..++.++.||+.||+|||+ .||+||||||+|||++.++.
T Consensus 90 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 90 NHK---GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEE---ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred eec---cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 432 2234566666654 3333333 334579999999999999999999998 89999999999999987654
Q ss_pred ----eEEeeecccccccCCCCCcccccccccccccccccccccccCCCCCceeeehhhhHHHHHHhCCCCCCCCC-----
Q 010489 255 ----LKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN----- 325 (509)
Q Consensus 255 ----vkl~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~----- 325 (509)
+||+|||.|....... ...+||+.|+|||++.. ..|+.++||||+||++++|++|+.||...+
T Consensus 167 ~~~~~kl~dfg~s~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~ 238 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEHY------TNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238 (362)
T ss_dssp TEEEEEECCCTTCEETTBCC------CSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeeEeeccccccccccc------ccccccccccChhhccc--cCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence 9999999997543222 34689999999999887 689999999999999999999999997543
Q ss_pred -hHhHHHHHHHhcCCCChhHHHHhhhHHHHHhhhc------cCCCCCCC-------CCCCCCCCCHHHHHHHHHhccCCC
Q 010489 326 -VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGS------MRKKQPVP-------FSHKFPNADPLALHLLERLLAFDP 391 (509)
Q Consensus 326 -~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~-------~~~~~~~~~~~~~~li~~~L~~dP 391 (509)
..+.+..+...+|.++.+.+....... .+... +......+ ........++++.|||.+||.+||
T Consensus 239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 239 KDDDHIAQIIELLGELPSYLLRNGKYTR--TFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHH--HHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred chhHHHHHHHHHhCCCCHHHhhcccccc--cccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 345666777888988877654432211 11110 00000000 001112346789999999999999
Q ss_pred CCCCCHHHHhcCCcccCCcC
Q 010489 392 KDRPTAEEALADPYFHGLAN 411 (509)
Q Consensus 392 ~~Rpt~~e~l~hp~f~~~~~ 411 (509)
.+||||+|+|+||||+....
T Consensus 317 ~~Rpta~e~L~Hp~f~~~~~ 336 (362)
T d1q8ya_ 317 RKRADAGGLVNHPWLKDTLG 336 (362)
T ss_dssp TTCBCHHHHHTCGGGTTCTT
T ss_pred hHCcCHHHHhcCcccCCCCC
Confidence 99999999999999986543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-49 Score=386.39 Aligned_cols=272 Identities=23% Similarity=0.258 Sum_probs=192.5
Q ss_pred CCeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHH--HHHHHHHcCCCCcceeeeeecCCCcCCCC
Q 010489 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILR--EIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (509)
Q Consensus 113 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~--Ei~~l~~l~h~niv~~~~~~~~~~~~~~~ 190 (509)
.+|.+.+.||+|+||.||+|+. +|+.||||+++.. ......+ |+..+..++||||+++++++.... ....
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~-----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc-----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-Ccce
Confidence 4799999999999999999975 6899999998642 2233334 555556789999999999997543 2334
Q ss_pred cEEEEEeccc-ccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhh--------CCeeecCCCCCcEEECCCCCeEEeeec
Q 010489 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT--------ANVFHRDLKPKNILANADCKLKICDFG 261 (509)
Q Consensus 191 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~--------~~ivHrDlKp~NILl~~~~~vkl~DFG 261 (509)
.+|+|||||+ |+|.+++.+. .+++..+..++.|++.||+|||+ +||+||||||+||||+.+|.+||+|||
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 6899999998 6999999765 69999999999999999999996 599999999999999999999999999
Q ss_pred ccccccCCCCC-ccccccccccccccccccccccc----CCCCCceeeehhhhHHHHHHhCCCCCCCCChHhHHHHHHHh
Q 010489 262 LARVSFNDAPS-AIFWTDYVATRWYRAPELCGSFF----SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL 336 (509)
Q Consensus 262 ~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 336 (509)
+++........ .......+||+.|||||++.+.. ..++.++|||||||+||||+||.+||......... .....
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~-~~~~~ 232 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-YYDLV 232 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-TTTTS
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc-hhhcc
Confidence 99876443321 11234578999999999986531 12677899999999999999999887543321100 00000
Q ss_pred cCCCChhHHHHhhhHHHHHhhhccCCCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010489 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (509)
Q Consensus 337 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 402 (509)
...+....+. .....-..+++.+...........+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~--------~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 233 PSDPSVEEMR--------KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CSSCCHHHHH--------HHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cccchHHHHH--------HHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 0011111111 111000001111100001122345889999999999999999999987
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=9.3e-27 Score=211.36 Aligned_cols=166 Identities=17% Similarity=0.095 Sum_probs=121.2
Q ss_pred eeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccC----------------hhhHHhHHHHHHHHHHcCCCCcceee
Q 010489 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH----------------VSDATRILREIKLLRLLRHPDIVEIK 178 (509)
Q Consensus 115 y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~----------------~~~~~~~~~Ei~~l~~l~h~niv~~~ 178 (509)
|.+.++||+|+||+||+|.+. +|+.||||+++..... ........+|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568899999999999999885 7899999987521110 01123345788999999999999887
Q ss_pred eeecCCCcCCCCcEEEEEecccccHHHHHHhCCCCCHHHHHHHHHHHHhHhhhhhhCCeeecCCCCCcEEECCCCCeEEe
Q 010489 179 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 258 (509)
Q Consensus 179 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDlKp~NILl~~~~~vkl~ 258 (509)
++.. .+++|||+++... ..+++..+..++.|+++||.|||++||+||||||+|||++.+ .++|+
T Consensus 81 ~~~~---------~~lvme~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 81 AWEG---------NAVLMELIDAKEL------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp EEET---------TEEEEECCCCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEEC
T ss_pred EecC---------CEEEEEeeccccc------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEE
Confidence 6541 2799999996422 124556677899999999999999999999999999999865 59999
Q ss_pred eecccccccCCCCCccccccccccccccc------ccccccccCCCCCceeeehhhhHH
Q 010489 259 DFGLARVSFNDAPSAIFWTDYVATRWYRA------PELCGSFFSKYTPAIDIWSIGCIF 311 (509)
Q Consensus 259 DFG~a~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~~~DiwSlG~il 311 (509)
|||+|........ ..|.. .+.+. ..|+.++|+||+.--+
T Consensus 145 DFG~a~~~~~~~~-----------~~~l~rd~~~~~~~f~---r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGW-----------REILERDVRNIITYFS---RTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTH-----------HHHHHHHHHHHHHHHH---HHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCc-----------HHHHHHHHHHHHHHHc---CCCCCcccHHHHHHHH
Confidence 9999975422111 11111 12222 4688899999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.30 E-value=1.7e-06 Score=79.80 Aligned_cols=79 Identities=13% Similarity=0.099 Sum_probs=51.1
Q ss_pred CeeEeeeeeccCceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCCCcE
Q 010489 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDI 192 (509)
Q Consensus 114 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 192 (509)
.|++.+..+-|+.+.||+.. ..+..+.+|....... .....+.+|...++.+. +--+.+++.+.. ..+..
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~-----~~~~~ 85 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGWS 85 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEE
T ss_pred ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEe-----cCCce
Confidence 56666765555567899885 4566788888753221 22335678999988875 333455555542 23457
Q ss_pred EEEEecccc
Q 010489 193 YVVFELMES 201 (509)
Q Consensus 193 ~lv~e~~~~ 201 (509)
|+||++++|
T Consensus 86 ~lv~~~l~G 94 (263)
T d1j7la_ 86 NLLMSEADG 94 (263)
T ss_dssp EEEEECCSS
T ss_pred EEEEEeccc
Confidence 999999987
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.05 E-value=1.1e-05 Score=79.01 Aligned_cols=77 Identities=18% Similarity=0.052 Sum_probs=47.2
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecCcc----c-ChhhHHhHHHHHHHHHHcC-C--CCcceeeeeecCCCcCCC
Q 010489 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF----E-HVSDATRILREIKLLRLLR-H--PDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~-~~~~~~~~~~Ei~~l~~l~-h--~niv~~~~~~~~~~~~~~ 189 (509)
.+.||.|....||++....+++.|+||.-.... . ......+...|...|+.+. + ..+.+++.+..
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~------- 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT------- 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET-------
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC-------
Confidence 457899999999999887778899999753211 1 1122344567888887763 2 33445554431
Q ss_pred CcEEEEEecccc
Q 010489 190 KDIYVVFELMES 201 (509)
Q Consensus 190 ~~~~lv~e~~~~ 201 (509)
...++|||++++
T Consensus 104 ~~~~lvmE~L~~ 115 (392)
T d2pula1 104 EMAVTVMEDLSH 115 (392)
T ss_dssp TTTEEEECCCTT
T ss_pred CCCEEEEeccCC
Confidence 124789999975
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.61 E-value=0.0001 Score=66.99 Aligned_cols=71 Identities=8% Similarity=-0.009 Sum_probs=45.4
Q ss_pred eeeccCc-eEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCC--cceeeeeecCCCcCCCCcEEEEE
Q 010489 120 VIGKGSY-GVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD--IVEIKHIMLPPSRREFKDIYVVF 196 (509)
Q Consensus 120 ~lG~G~~-g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~ 196 (509)
.+..|.. +.||+... ..+..+.+|..... ....+..|+..|+.+.... +.+++.+... .+..++||
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~-----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-----~~~~~~v~ 85 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLL 85 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEE
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCcc-----CHhHHHHHHHHHHHHHhcCCCCCceeeeccc-----ccceEEEE
Confidence 3445543 67898864 45667888976532 2234667888888775333 4455655532 24579999
Q ss_pred ecccc
Q 010489 197 ELMES 201 (509)
Q Consensus 197 e~~~~ 201 (509)
++++|
T Consensus 86 ~~i~G 90 (255)
T d1nd4a_ 86 GEVPG 90 (255)
T ss_dssp ECCSS
T ss_pred Eeeec
Confidence 99975
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.22 E-value=0.0007 Score=63.94 Aligned_cols=72 Identities=15% Similarity=0.066 Sum_probs=42.9
Q ss_pred ceEEEEEEEcCCCcEEEEEEecCcccChhhHHhHHHHHHHHHHcCCCCcceeeeeecCC--CcCCCCcEEEEEecccc
Q 010489 126 YGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP--SRREFKDIYVVFELMES 201 (509)
Q Consensus 126 ~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~--~~~~~~~~~lv~e~~~~ 201 (509)
--.||++.. .+|..|++|+.+.. .....++..|+..|..|....|.-..-....+ ........+.++++++|
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~---~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPE---RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTT---TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCC---CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 357999965 57888999987532 12345677899998888643332111111111 11223457889998875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.75 E-value=0.0053 Score=59.28 Aligned_cols=71 Identities=13% Similarity=0.021 Sum_probs=46.7
Q ss_pred eeeeeccCceEEEEEEEcC-------CCcEEEEEEecCcccChhhHHhHHHHHHHHHHcC-CCCcceeeeeecCCCcCCC
Q 010489 118 QEVIGKGSYGVVGSAVDTH-------TGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREF 189 (509)
Q Consensus 118 ~~~lG~G~~g~V~~~~~~~-------~~~~vAiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~~ 189 (509)
++.|+.|-.=.+|++.... ..+.|.+++.-. . .......+|..+++.+. +.-..++++++.
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~---~~~idr~~E~~i~~~ls~~gl~Pkll~~~~------- 115 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P---ETESHLVAESVIFTLLSERHLGPKLYGIFS------- 115 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C---CCHHHHHHHHHHHHHHHHTTSSSCEEEEET-------
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c---chhhHHHHHHHHHHHHHhCCCCCeEEEEcC-------
Confidence 3678888888999997543 345677776642 1 12234568999998886 433446777662
Q ss_pred CcEEEEEecccc
Q 010489 190 KDIYVVFELMES 201 (509)
Q Consensus 190 ~~~~lv~e~~~~ 201 (509)
-.+|+||++|
T Consensus 116 --~g~I~efi~g 125 (395)
T d1nw1a_ 116 --GGRLEEYIPS 125 (395)
T ss_dssp --TEEEECCCCE
T ss_pred --CceEEEEecc
Confidence 1678999975
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.20 E-value=0.0073 Score=56.16 Aligned_cols=30 Identities=33% Similarity=0.339 Sum_probs=26.8
Q ss_pred CCeeecCCCCCcEEECCCCCeEEeeecccc
Q 010489 235 ANVFHRDLKPKNILANADCKLKICDFGLAR 264 (509)
Q Consensus 235 ~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 264 (509)
.|+||+|+.++||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988777899999875
|